(dp0
S'path:map04730'
p1
(dp2
S'NAME'
p3
(lp4
S'Long-term depression'
p5
asS'REFERENCE'
p6
(lp7
S'PMID:12415297'
p8
ag8
aS'AUTHORS'
p9
aS'Ito M.'
p10
aS'TITLE'
p11
aS'The molecular organization of cerebellar long-term depression.'
p12
aS'JOURNAL'
p13
aS'Nat Rev Neurosci 3:896-902 (2002)'
p14
aS'PMID:11427694'
p15
ag15
aS'AUTHORS'
p16
aS'Ito M.'
p17
aS'TITLE'
p18
aS'Cerebellar long-term depression: characterization, signal transduction, and functional roles.'
p19
aS'JOURNAL'
p20
aS'Physiol Rev 81:1143-95 (2001)'
p21
aS''
p22
ag22
aS'AUTHORS'
p23
aS'Purves D, Augustine GJ (ed).'
p24
aS'TITLE'
p25
aS'Neuroscience'
p26
aS'JOURNAL'
p27
aS'Sunderland, Mass.:Sinauer Associates (2004)'
p28
aS'PMID:9735948'
p29
ag29
aS'AUTHORS'
p30
aS'Daniel H, Levenes C, Crepel F.'
p31
aS'TITLE'
p32
aS'Cellular mechanisms of cerebellar LTD.'
p33
aS'JOURNAL'
p34
aS'Trends Neurosci 21:401-7 (1998)'
p35
aS'PMID:9602501'
p36
ag36
aS'AUTHORS'
p37
aS'Levenes C, Daniel H, Crepel F.'
p38
aS'TITLE'
p39
aS'Long-term depression of synaptic transmission in the cerebellum: cellular and molecular mechanisms revisited.'
p40
aS'JOURNAL'
p41
aS'Prog Neurobiol 55:79-91 (1998)'
p42
aS'PMID:14509570'
p43
ag43
aS'AUTHORS'
p44
aS'Metzger F, Kapfhammer JP.'
p45
aS'TITLE'
p46
aS'Protein kinase C: its role in activity-dependent Purkinje cell dendritic development and plasticity.'
p47
aS'JOURNAL'
p48
aS'Cerebellum 2:206-14 (2003)'
p49
asS'KO_PATHWAY'
p50
(lp51
S'ko04730'
p52
asS'PATHWAY_MAP'
p53
(lp54
S'map04730'
p55
asS'DISEASE'
p56
(lp57
S'H00063'
p58
aS'Spinocerebellar ataxia (SCA)'
p59
ag58
ag59
aS'H00577'
p60
aS'Syndromic X-linked mental retardation with epilepsy or seizures'
p61
aS'H00699'
p62
aS'Central core disease'
p63
aS'H00749'
p64
aS'Episodic ataxias'
p65
aS'H00775'
p66
aS'Familial or sporadic hemiplegic migraine'
p67
aS'H00833'
p68
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p69
aS'H01274'
p70
aS'Growth delay due to insulin-like growth factor I resistance'
p71
aS'H01310'
p72
aS'Multi-minicore disease (MmD)'
p73
asS'DBLINKS'
p74
(lp75
S'GO: 0048169'
p76
asS'ENTRY'
p77
(lp78
S'map04730'
p79
aS'Pathway'
p80
asS'CLASS'
p81
(lp82
S'Organismal Systems Nervous system'
p83
asS'DESCRIPTION'
p84
(lp85
S'Cerebellar long-term depression (LTD), thought to be a molecular and cellular basis for cerebellar learning, is a process involving a decrease in the synaptic strength between parallel fiber (PF) and Purkinje cells (PCs) induced by the conjunctive activation of PFs and climbing fiber (CF). Multiple signal transduction pathways have been shown to be involved in this process. Activation of PFs terminating on spines in dendritic branchlets leads to glutamate release and activation of both AMPA and mGluRs. Activation of CFs, which make multiple synaptic contacts on proximal dendrites, also via AMPA receptors, opens voltage-gated calcium channels (VGCCs) and causes a generalized influx of calcium. These cellular signals, generated from two different synaptic origins, trigger a cascade of events culminating in a phosphorylation-dependent, long-term reduction in AMPA receptor sensitivity at the PF-PC synapse. This may take place either through receptor internalization and/or through receptor desensitization.'
p86
assS'path:map00310'
p87
(dp88
S'NAME'
p89
(lp90
S'Lysine degradation'
p91
asS'REFERENCE'
p92
(lp93
S'PMID:11802770'
p94
ag94
aS'AUTHORS'
p95
aS'Vaz FM, Wanders RJ.'
p96
aS'TITLE'
p97
aS'Carnitine biosynthesis in mammals.'
p98
aS'JOURNAL'
p99
aS'Biochem J 361:417-29 (2002)'
p100
aS'PMID:1682209'
p101
ag101
aS'AUTHORS'
p102
aS'Large PJ, Robertson A.'
p103
aS'TITLE'
p104
aS'The route of lysine breakdown in Candida tropicalis.'
p105
aS'JOURNAL'
p106
aS'FEMS Microbiol Lett 66:209-13 (1991)'
p107
asS'KO_PATHWAY'
p108
(lp109
S'ko00310'
p110
asS'PATHWAY_MAP'
p111
(lp112
S'map00310'
p113
asS'DISEASE'
p114
(lp115
S'H00178'
p116
aS'Glutaric acidemia'
p117
ag116
ag117
aS'H00188'
p118
aS'Hyperlysinemia'
p119
aS'H00570'
p120
aS'Kabuki syndrome'
p121
aS'H00718'
p122
aS'Sotos syndrome and Weaver syndrome'
p123
aS'H00802'
p124
aS'Ehlers-Danlos syndrome (EDS)'
p125
aS'H00907'
p126
aS'Kleefstra syndrome'
p127
aS'H00980'
p128
aS'Nevo syndrome'
p129
aS'H01192'
p130
aS'Lysyl hydroxylase 3 (LH3) deficiency'
p131
aS'H01242'
p132
aS'Saccharopinuria'
p133
aS'H01247'
p134
aS'Pyridoxine-dependent epilepsy (PDE)'
p135
aS'H01364'
p136
aS'3-Hydroxyacyl-CoA dehydrogenase deficiency'
p137
asS'MODULE'
p138
(lp139
S'M00032'
p140
aS'Lysine degradation, lysine => saccharopine => acetoacetyl-CoA [PATH:map00310]'
p141
asS'ENTRY'
p142
(lp143
S'map00310'
p144
aS'Pathway'
p145
asS'CLASS'
p146
(lp147
S'Metabolism Amino acid metabolism'
p148
assS'path:map00311'
p149
(dp150
S'NAME'
p151
(lp152
S'Penicillin and cephalosporin biosynthesis'
p153
asS'KO_PATHWAY'
p154
(lp155
S'ko00311'
p156
asS'ENTRY'
p157
(lp158
S'map00311'
p159
aS'Pathway'
p160
asS'PATHWAY_MAP'
p161
(lp162
S'map00311'
p163
asS'CLASS'
p164
(lp165
S'Metabolism Biosynthesis of other secondary metabolites'
p166
asS'MODULE'
p167
(lp168
S'M00672'
p169
aS'Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin [PATH:map00311]'
p170
ag169
ag170
aS'M00673'
p171
aS'Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C [PATH:map00311]'
p172
assS'path:map00253'
p173
(dp174
S'DBLINKS'
p175
(lp176
S'GO: 0043644'
p177
asS'NAME'
p178
(lp179
S'Tetracycline biosynthesis'
p180
asS'REFERENCE'
p181
(lp182
S'PMID:16959966'
p183
ag183
aS'AUTHORS'
p184
aS'Petkovic H, Cullum J, Hranueli D, Hunter IS, Peric-Concha N, Pigac J, Thamchaipenet A, Vujaklija D, Long PF'
p185
aS'TITLE'
p186
aS'Genetics of Streptomyces rimosus, the oxytetracycline producer.'
p187
aS'JOURNAL'
p188
aS'Microbiol Mol Biol Rev 70:704-28 (2006)'
p189
aS'PMID:20522541'
p190
ag190
aS'AUTHORS'
p191
aS'Pickens LB, Tang Y'
p192
aS'TITLE'
p193
aS'Oxytetracycline biosynthesis.'
p194
aS'JOURNAL'
p195
aS'J Biol Chem 285:27509-15 (2010)'
p196
aS'PMID:16597959'
p197
ag197
aS'AUTHORS'
p198
aS'Zhang W, Ames BD, Tsai SC, Tang Y'
p199
aS'TITLE'
p200
aS'Engineered biosynthesis of a novel amidated polyketide, using the malonamyl-specific initiation module from the oxytetracycline polyketide synthase.'
p201
aS'JOURNAL'
p202
aS'Appl Environ Microbiol 72:2573-80 (2006)'
p203
ag22
ag22
aS'AUTHORS'
p204
aS'Paul M Dewick.'
p205
aS'TITLE'
p206
aS'Medicinal Natural Products -A Biosynthetic Approach- (2nd ed)'
p207
aS'JOURNAL'
p208
aS'John Wiley and Sons, LTD:376-379 (2001)'
p209
aS'PMID:1134373'
p210
ag210
aS'AUTHORS'
p211
aS'Miller PA, Hash JH'
p212
aS'TITLE'
p213
aS'S-adenosylmethionine:dedimethylamino-4-aminoanhydrotetracycline N-methyltransferase.'
p214
aS'JOURNAL'
p215
aS'Methods Enzymol 43:603-6 (1975)'
p216
aS'PMID:1134374'
p217
ag217
aS'AUTHORS'
p218
aS'Miller PA, Hash JH'
p219
aS'TITLE'
p220
aS'ADP tetracyclin 5a(11a)dehydrogenase.'
p221
aS'JOURNAL'
p222
aS'Methods Enzymol 43:606-7 (1975)'
p223
aS'PMID:19472250'
p224
ag224
aS'AUTHORS'
p225
aS'Wang P, Zhang W, Zhan J, Tang Y'
p226
aS'TITLE'
p227
aS'Identification of OxyE as an ancillary oxygenase during tetracycline biosynthesis.'
p228
aS'JOURNAL'
p229
aS'Chembiochem 10:1544-50 (2009)'
p230
aS'PMID:18422316'
p231
ag231
aS'AUTHORS'
p232
aS'Zhang W, Watanabe K, Cai X, Jung ME, Tang Y, Zhan J'
p233
aS'TITLE'
p234
aS'Identifying the minimal enzymes required for anhydrotetracycline biosynthesis.'
p235
aS'JOURNAL'
p236
aS'J Am Chem Soc 130:6068-9 (2008)'
p237
aS'PMID:10551844'
p238
ag238
aS'AUTHORS'
p239
aS'Petkovic H, Thamchaipenet A, Zhou LH, Hranueli D, Raspor P, Waterman PG, Hunter IS'
p240
aS'TITLE'
p241
aS'Disruption of an aromatase/cyclase from the oxytetracycline gene cluster of Streptomyces rimosus results in production of novel polyketides with shorter chain lengths.'
p242
aS'JOURNAL'
p243
aS'J Biol Chem 274:32829-34 (1999)'
p244
aS'PMID:16148009'
p245
ag245
aS'AUTHORS'
p246
aS'Peric-Concha N, Borovicka B, Long PF, Hranueli D, Waterman PG, Hunter IS'
p247
aS'TITLE'
p248
aS'Ablation of the otcC gene encoding a post-polyketide hydroxylase from the oxytetracyline biosynthetic pathway in Streptomyces rimosus results in novel polyketides with altered chain length.'
p249
aS'JOURNAL'
p250
aS'J Biol Chem 280:37455-60 (2005)'
p251
aS'PMID:17631493'
p252
ag252
aS'AUTHORS'
p253
aS'Zhang W, Watanabe K, Wang CC, Tang Y'
p254
aS'TITLE'
p255
aS'Investigation of early tailoring reactions in the oxytetracycline biosynthetic pathway.'
p256
aS'JOURNAL'
p257
aS'J Biol Chem 282:25717-25 (2007)'
p258
aS'PMID:8163168'
p259
ag259
aS'AUTHORS'
p260
aS'Kim ES, Bibb MJ, Butler MJ, Hopwood DA, Sherman DH.'
p261
aS'TITLE'
p262
aS'Sequences of the oxytetracycline polyketide synthase-encoding otc genes from Streptomyces rimosus.'
p263
aS'JOURNAL'
p264
aS'Gene 141:141-2 (1994)'
p265
aS'PMID:7612997'
p266
ag266
aS'AUTHORS'
p267
aS'Dairi T, Nakano T, Aisaka K, Katsumata R, Hasegawa M.'
p268
aS'TITLE'
p269
aS'Cloning and nucleotide sequence of the gene responsible for chlorination of tetracycline.'
p270
aS'JOURNAL'
p271
aS'Biosci Biotechnol Biochem 59:1099-106 (1995)'
p272
asS'KO_PATHWAY'
p273
(lp274
S'ko00253'
p275
asS'ENTRY'
p276
(lp277
S'map00253'
p278
aS'Pathway'
p279
asS'PATHWAY_MAP'
p280
(lp281
S'map00253'
p282
asS'CLASS'
p283
(lp284
S'Metabolism Metabolism of terpenoids and polyketides'
p285
assS'path:map04630'
p286
(dp287
S'NAME'
p288
(lp289
S'Jak-STAT signaling pathway'
p290
asS'REFERENCE'
p291
(lp292
S'PMID:12039028'
p293
ag293
aS'AUTHORS'
p294
aS'Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW.'
p295
aS'TITLE'
p296
aS'Signaling through the JAK/STAT pathway, recent advances and future challenges.'
p297
aS'JOURNAL'
p298
aS'Gene 285:1-24 (2002)'
p299
aS'PMID:11994400'
p300
ag300
aS'AUTHORS'
p301
aS'Schindler CW.'
p302
aS'TITLE'
p303
aS'Series introduction. JAK-STAT signaling in human disease.'
p304
aS'JOURNAL'
p305
aS'J Clin Invest 109:1133-7 (2002)'
p306
aS'PMID:9716487'
p307
ag307
aS'AUTHORS'
p308
aS'Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L.'
p309
aS'TITLE'
p310
aS'Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.'
p311
aS'JOURNAL'
p312
aS'Biochem J 334 ( Pt 2):297-314 (1998)'
p313
aS'PMID:15003245'
p314
ag314
aS'AUTHORS'
p315
aS'Luo C, Laaja P.'
p316
aS'TITLE'
p317
aS'Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs.'
p318
aS'JOURNAL'
p319
aS'Drug Discov Today 9:268-75 (2004)'
p320
aS'PMID:12479803'
p321
ag321
aS'AUTHORS'
p322
aS'Hou SX, Zheng Z, Chen X, Perrimon N.'
p323
aS'TITLE'
p324
aS'The Jak/STAT pathway in model organisms: emerging roles in cell movement.'
p325
aS'JOURNAL'
p326
aS'Dev Cell 3:765-78 (2002)'
p327
aS'PMID:15032587'
p328
ag328
aS'AUTHORS'
p329
aS'Alexander WS, Hilton DJ.'
p330
aS'TITLE'
p331
aS'The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response.'
p332
aS'JOURNAL'
p333
aS'Annu Rev Immunol 22:503-29 (2004)'
p334
aS'PMID:10409724'
p335
ag335
aS'AUTHORS'
p336
aS'Kim H, Baumann H.'
p337
aS'TITLE'
p338
aS'Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.'
p339
aS'JOURNAL'
p340
aS'Mol Cell Biol 19:5326-38 (1999)'
p341
asS'KO_PATHWAY'
p342
(lp343
S'ko04630'
p344
asS'PATHWAY_MAP'
p345
(lp346
S'map04630'
p347
asS'DISEASE'
p348
(lp349
S'H00408'
p350
aS'Type I diabetes mellitus'
p351
ag350
ag351
aS'H00539'
p352
aS'PTEN hamartoma tumor syndrome (PHTS)'
p353
aS'H00931'
p354
aS'Growth hormone insensitivity with immunodeficiency'
p355
aS'H00935'
p356
aS'Cold-induced sweating syndrome (CISS) and Crisponi syndrome (CRISPS)'
p357
aS'H01018'
p358
aS'Metachondromatosis'
p359
aS'H01109'
p360
aS'Chronic mucocutaneous candidiasis (CMC)'
p361
aS'H01122'
p362
aS'Pulmonary alveolar proteinosis (PAP)'
p363
aS'H01217'
p364
aS'Primary localized cutaneous amyloidosis (PLCA)'
p365
aS'H01227'
p366
aS'Inflammatory bowel disease'
p367
aS'H01388'
p368
aS'Hyperprolactinemia'
p369
asS'MODULE'
p370
(lp371
S'M00684'
p372
aS'JAK-STAT signaling [PATH:map04630]'
p373
asS'DBLINKS'
p374
(lp375
S'GO: 0007259'
p376
asS'ENTRY'
p377
(lp378
S'map04630'
p379
aS'Pathway'
p380
asS'CLASS'
p381
(lp382
S'Environmental Information Processing Signal transduction'
p383
asS'DESCRIPTION'
p384
(lp385
S'The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in animals, from humans to flies. In mammals, the JAK/STAT pathway is the principal signaling mechanism for a wide array of cytokines and growth factors. Following the binding of cytokines to their cognate receptor, STATs are activated by members of the JAK family of tyrosine kinases. Once activated, they dimerize and translocate to the nucleus and modulate the expression of target genes. In addition to the activation of STATs, JAKs mediate the recruitment of other molecules such as the MAP kinases, PI3 kinase etc. These molecules process downstream signals via the Ras-Raf-MAP kinase and PI3 kinase pathways which results in the activation of additional transcription factors.'
p386
assS'path:map00250'
p387
(dp388
S'NAME'
p389
(lp390
S'Alanine, aspartate and glutamate metabolism'
p391
asS'REFERENCE'
p392
(lp393
g22
ag22
aS'AUTHORS'
p394
aS'Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).'
p395
aS'TITLE'
p396
aS'[Cellular Functions and Metabolic Maps] (In Japanese)'
p397
aS'JOURNAL'
p398
aS'Tokyo Kagaku Dojin (1997)'
p399
aS'PMID:9687539'
p400
ag400
aS'AUTHORS'
p401
aS'Wu G'
p402
aS'TITLE'
p403
aS'Intestinal mucosal amino acid catabolism.'
p404
aS'JOURNAL'
p405
aS'J Nutr 128:1249-52 (1998)'
p406
asS'KO_PATHWAY'
p407
(lp408
S'ko00250'
p409
asS'PATHWAY_MAP'
p410
(lp411
S'map00250'
p412
asS'DISEASE'
p413
(lp414
S'H00074'
p415
aS'Canavan disease (CD)'
p416
ag415
ag416
aS'H00185'
p417
aS'Citrullinemia (CTLN)'
p418
aS'H00197'
p419
aS'Adenylosuccinate lyase deficiency'
p420
aS'H00835'
p421
aS'Succinic semialdehyde dehydrogenase (SSADH) deficiency'
p422
aS'H00923'
p423
aS'Congenital systemic glutamine deficiency (CSGD)'
p424
aS'H01028'
p425
aS'Argininosuccinic aciduria (ARGINSA)'
p426
aS'H01097'
p427
aS'Cerebral palsy'
p428
aS'H01257'
p429
aS'GABA-transaminase deficiency'
p430
aS'H01386'
p431
aS'Asparagine synthetase deficiency'
p432
asS'MODULE'
p433
(lp434
S'M00027'
p435
aS'GABA (gamma-Aminobutyrate) shunt [PATH:map00250]'
p436
asS'DBLINKS'
p437
(lp438
S'GO: 0006522 0006531 0006536'
p439
asS'ENTRY'
p440
(lp441
S'map00250'
p442
aS'Pathway'
p443
asS'CLASS'
p444
(lp445
S'Metabolism Amino acid metabolism'
p446
assS'path:map00254'
p447
(dp448
S'DBLINKS'
p449
(lp450
S'GO: 0045122'
p451
asS'NAME'
p452
(lp453
S'Aflatoxin biosynthesis'
p454
asS'REFERENCE'
p455
(lp456
S'PMID:23202305'
p457
ag457
aS'AUTHORS'
p458
aS'Yu J'
p459
aS'TITLE'
p460
aS'Current understanding on aflatoxin biosynthesis and future perspective in reducing aflatoxin contamination.'
p461
aS'JOURNAL'
p462
aS'Toxins (Basel) 4:1024-57 (2012)'
p463
aS'PMID:15022028'
p464
ag464
aS'AUTHORS'
p465
aS'Yabe K, Nakajima H'
p466
aS'TITLE'
p467
aS'Enzyme reactions and genes in aflatoxin biosynthesis.'
p468
aS'JOURNAL'
p469
aS'Appl Microbiol Biotechnol 64:745-55 (2004)'
p470
aS'PMID:22069531'
p471
ag471
aS'AUTHORS'
p472
aS'Ehrlich KC'
p473
aS'TITLE'
p474
aS'Predicted roles of the uncharacterized clustered genes in aflatoxin biosynthesis.'
p475
aS'JOURNAL'
p476
aS'Toxins (Basel) 1:37-58 (2009)'
p477
aS'PMID:20332208'
p478
ag478
aS'AUTHORS'
p479
aS'Korman TP, Crawford JM, Labonte JW, Newman AG, Wong J, Townsend CA, Tsai SC'
p480
aS'TITLE'
p481
aS'Structure and function of an iterative polyketide synthase thioesterase domain catalyzing Claisen cyclization in aflatoxin biosynthesis.'
p482
aS'JOURNAL'
p483
aS'Proc Natl Acad Sci U S A 107:6246-51 (2010)'
p484
aS'PMID:15932995'
p485
ag485
aS'AUTHORS'
p486
aS'Sakuno E, Wen Y, Hatabayashi H, Arai H, Aoki C, Yabe K, Nakajima H'
p487
aS'TITLE'
p488
aS'Aspergillus parasiticus cyclase catalyzes two dehydration steps in aflatoxin biosynthesis.'
p489
aS'JOURNAL'
p490
aS'Appl Environ Microbiol 71:2999-3006 (2005)'
p491
aS'PMID:19211038'
p492
ag492
aS'AUTHORS'
p493
aS'Shima Y, Shiina M, Shinozawa T, Ito Y, Nakajima H, Adachi Y, Yabe K'
p494
aS'TITLE'
p495
aS'Participation in aflatoxin biosynthesis by a reductase enzyme encoded by vrdA gene outside the aflatoxin gene cluster.'
p496
aS'JOURNAL'
p497
aS'Fungal Genet Biol 46:221-31 (2009)'
p498
asS'KO_PATHWAY'
p499
(lp500
S'ko00254'
p501
asS'ENTRY'
p502
(lp503
S'map00254'
p504
aS'Pathway'
p505
asS'PATHWAY_MAP'
p506
(lp507
S'map00254'
p508
asS'CLASS'
p509
(lp510
S'Metabolism Biosynthesis of other secondary metabolites'
p511
assS'path:map00984'
p512
(dp513
S'DBLINKS'
p514
(lp515
S'GO: 0006707'
p516
asS'NAME'
p517
(lp518
S'Steroid degradation'
p519
asS'REFERENCE'
p520
(lp521
S'PMID:21924910'
p522
ag522
aS'AUTHORS'
p523
aS'Ouellet H, Johnston JB, de Montellano PR'
p524
aS'TITLE'
p525
aS'Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis.'
p526
aS'JOURNAL'
p527
aS'Trends Microbiol 19:530-9 (2011)'
p528
aS'PMID:17264217'
p529
ag529
aS'AUTHORS'
p530
aS'Van der Geize R, Yam K, Heuser T, Wilbrink MH, Hara H, Anderton MC, Sim E, Dijkhuizen L, Davies JE, Mohn WW, Eltis LD'
p531
aS'TITLE'
p532
aS'A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages.'
p533
aS'JOURNAL'
p534
aS'Proc Natl Acad Sci U S A 104:1947-52 (2007)'
p535
aS'PMID:22045806'
p536
ag536
aS'AUTHORS'
p537
aS'Thomas ST, VanderVen BC, Sherman DR, Russell DG, Sampson NS'
p538
aS'TITLE'
p539
aS'Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism.'
p540
aS'JOURNAL'
p541
aS'J Biol Chem 286:43668-78 (2011)'
p542
aS'PMID:20889498'
p543
ag543
aS'AUTHORS'
p544
aS'Driscoll MD, McLean KJ, Levy C, Mast N, Pikuleva IA, Lafite P, Rigby SE, Leys D, Munro AW'
p545
aS'TITLE'
p546
aS'Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.'
p547
aS'JOURNAL'
p548
aS'J Biol Chem 285:38270-82 (2010)'
p549
aS'PMID:20843794'
p550
ag550
aS'AUTHORS'
p551
aS'Johnston JB, Ouellet H, Ortiz de Montellano PR'
p552
aS'TITLE'
p553
aS'Functional redundancy of steroid C26-monooxygenase activity in Mycobacterium tuberculosis revealed by biochemical and genetic analyses.'
p554
aS'JOURNAL'
p555
aS'J Biol Chem 285:36352-60 (2010)'
p556
aS'PMID:17630785'
p557
ag557
aS'AUTHORS'
p558
aS'Yang X, Dubnau E, Smith I, Sampson NS'
p559
aS'TITLE'
p560
aS'Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase.'
p561
aS'JOURNAL'
p562
aS'Biochemistry 46:9058-67 (2007)'
p563
aS'PMID:19875455'
p564
ag564
aS'AUTHORS'
p565
aS'Lack NA, Yam KC, Lowe ED, Horsman GP, Owen RL, Sim E, Eltis LD'
p566
aS'TITLE'
p567
aS'Characterization of a carbon-carbon hydrolase from Mycobacterium tuberculosis involved in cholesterol metabolism.'
p568
aS'JOURNAL'
p569
aS'J Biol Chem 285:434-43 (2010)'
p570
aS'PMID:19843168'
p571
ag571
aS'AUTHORS'
p572
aS'Kreit J, Sampson NS'
p573
aS'TITLE'
p574
aS'Cholesterol oxidase: physiological functions.'
p575
aS'JOURNAL'
p576
aS'FEBS J 276:6844-56 (2009)'
p577
aS'PMID:21056662'
p578
ag578
aS'AUTHORS'
p579
aS'Horinouchi M, Hayashi T, Kudo T'
p580
aS'TITLE'
p581
aS'Steroid degradation in Comamonas testosteroni.'
p582
aS'JOURNAL'
p583
aS'J Steroid Biochem Mol Biol 129:4-14 (2012)'
p584
aS'PMID:20554032'
p585
ag585
aS'AUTHORS'
p586
aS'Horinouchi M, Kurita T, Hayashi T, Kudo T'
p587
aS'TITLE'
p588
aS'Steroid degradation genes in Comamonas testosteroni TA441: Isolation of genes encoding a Delta4(5)-isomerase and 3alpha- and 3beta-dehydrogenases and evidence'
p589
aS'for a 100 kb steroid degradation gene hot spot.'
p590
aS'JOURNAL'
p591
aS'J Steroid Biochem Mol Biol 122:253-63 (2010)'
p592
asS'KO_PATHWAY'
p593
(lp594
S'ko00984'
p595
asS'ENTRY'
p596
(lp597
S'map00984'
p598
aS'Pathway'
p599
asS'PATHWAY_MAP'
p600
(lp601
S'map00984'
p602
asS'CLASS'
p603
(lp604
S'Metabolism Xenobiotics biodegradation and metabolism'
p605
assS'path:map00380'
p606
(dp607
S'NAME'
p608
(lp609
S'Tryptophan metabolism'
p610
asS'REFERENCE'
p611
(lp612
S'PMID:15749753'
p613
ag613
aS'AUTHORS'
p614
aS'Woodward AW, Bartel B'
p615
aS'TITLE'
p616
aS'Auxin: regulation, action, and interaction.'
p617
aS'JOURNAL'
p618
aS'Ann Bot 95:707-35 (2005)'
p619
asS'KO_PATHWAY'
p620
(lp621
S'ko00380'
p622
asS'PATHWAY_MAP'
p623
(lp624
S'map00380'
p625
asS'DISEASE'
p626
(lp627
S'H00178'
p628
aS'Glutaric acidemia'
p629
ag628
ag629
aS'H00203'
p630
aS'Acatalasia'
p631
aS'H00548'
p632
aS'Brunner syndrome'
p633
aS'H00689'
p634
aS'Delayed sleep phase syndrome'
p635
aS'H01075'
p636
aS'Peters anomaly'
p637
aS'H01161'
p638
aS'Aromatic L-amino acid decarboxylase (AADC) deficiency'
p639
aS'H01203'
p640
aS'Primary congenital glaucoma (PCG)'
p641
aS'H01364'
p642
aS'3-Hydroxyacyl-CoA dehydrogenase deficiency'
p643
asS'MODULE'
p644
(lp645
S'M00037'
p646
aS'Melatonin biosynthesis, tryptophan => serotonin => melatonin [PATH:map00380]'
p647
ag646
ag647
aS'M00038'
p648
aS'Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate [PATH:map00380]'
p649
asS'DBLINKS'
p650
(lp651
S'GO: 0006568 0009851'
p652
asS'ENTRY'
p653
(lp654
S'map00380'
p655
aS'Pathway'
p656
asS'CLASS'
p657
(lp658
S'Metabolism Amino acid metabolism'
p659
assS'path:map00965'
p660
(dp661
S'NAME'
p662
(lp663
S'Betalain biosynthesis'
p664
asS'REFERENCE'
p665
(lp666
S'PMID:15805475'
p667
ag667
aS'AUTHORS'
p668
aS'Gandia-Herrero F, Escribano J, Garcia-Carmona F'
p669
aS'TITLE'
p670
aS'Betaxanthins as substrates for tyrosinase. An approach to the role of tyrosinase in the biosynthetic pathway of betalains.'
p671
aS'JOURNAL'
p672
aS'Plant Physiol 138:421-32 (2005)'
p673
aS'PMID:16247652'
p674
ag674
aS'AUTHORS'
p675
aS'Sasaki N, Abe Y, Wada K, Koda T, Goda Y, Adachi T, Ozeki Y'
p676
aS'TITLE'
p677
aS'Amaranthin in feather cockscombs is synthesized via glucuronylation at the cyclo-DOPA glucoside step in the betacyanin biosynthetic pathway.'
p678
aS'JOURNAL'
p679
aS'J Plant Res 118:439-42 (2005)'
p680
aS'PMID:12620337'
p681
ag681
aS'AUTHORS'
p682
aS'Strack D, Vogt T, Schliemann W'
p683
aS'TITLE'
p684
aS'Recent advances in betalain research.'
p685
aS'JOURNAL'
p686
aS'Phytochemistry 62:247-69 (2003)'
p687
aS'PMID:11855654'
p688
ag688
aS'AUTHORS'
p689
aS'Vogt T'
p690
aS'TITLE'
p691
aS'Substrate specificity and sequence analysis define a polyphyletic origin of betanidin 5- and 6-O-glucosyltransferase from Dorotheanthus bellidiformis.'
p692
aS'JOURNAL'
p693
aS'Planta 214:492-5 (2002)'
p694
asS'KO_PATHWAY'
p695
(lp696
S'ko00965'
p697
asS'ENTRY'
p698
(lp699
S'map00965'
p700
aS'Pathway'
p701
asS'PATHWAY_MAP'
p702
(lp703
S'map00965'
p704
asS'CLASS'
p705
(lp706
S'Metabolism Biosynthesis of other secondary metabolites'
p707
asS'DESCRIPTION'
p708
(lp709
S'Betalains are water-soluble nitrogen-containing pigments that are present in plants belonging to the order Caryophyllales (such as cactus and amaranth families) and in higher fungi. They contain betalamic acid as the chromophore and are classified into two types: betacyanins and betaxanthins. Betacyanins contain a cyclo-DOPA residue and exhibit red/violet coloration, while betaxanthins contain different amino acids or amino side chains and exhibit a yellow/orange coloration. The condensation of betalamic acid with amino acids (including cyclo-DOPA or amines) in plants is a spontaneous reaction, not an enzyme-catalyzed reaction.'
p710
assS'path:map05120'
p711
(dp712
S'NAME'
p713
(lp714
S'Epithelial cell signaling in Helicobacter pylori infection'
p715
asS'REFERENCE'
p716
(lp717
S'PMID:14700549'
p718
ag718
aS'AUTHORS'
p719
aS'Naumann M, Crabtree JE.'
p720
aS'TITLE'
p721
aS'Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis.'
p722
aS'JOURNAL'
p723
aS'Trends Microbiol 12:29-36 (2004)'
p724
aS'PMID:15694859'
p725
ag725
aS'AUTHORS'
p726
aS'Rieder G, Fischer W, Haas R.'
p727
aS'TITLE'
p728
aS'Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules.'
p729
aS'JOURNAL'
p730
aS'Curr Opin Microbiol 8:67-73 (2005)'
p731
aS'PMID:11389469'
p732
ag732
aS'AUTHORS'
p733
aS'Montecucco C, Rappuoli R.'
p734
aS'TITLE'
p735
aS'Living dangerously: how Helicobacter pylori survives in the human stomach.'
p736
aS'JOURNAL'
p737
aS'Nat Rev Mol Cell Biol 2:457-66 (2001)'
p738
aS'PMID:12197905'
p739
ag739
aS'AUTHORS'
p740
aS'Gerhard M, Rad R, Prinz C, Naumann M.'
p741
aS'TITLE'
p742
aS'Pathogenesis of Helicobacter pylori infection.'
p743
aS'JOURNAL'
p744
aS'Helicobacter 7 Suppl 1:17-23 (2002)'
p745
asS'KO_PATHWAY'
p746
(lp747
S'ko05120'
p748
asS'PATHWAY_MAP'
p749
(lp750
S'map05120'
p751
asS'DISEASE'
p752
(lp753
S'H00320'
p754
aS'Helicobacter pylori infection'
p755
asS'MODULE'
p756
(lp757
S'M00564'
p758
aS'Helicobacter pylori pathogenicity signature, cagA pathogenicity island [PATH:map05120]'
p759
asS'DESCRIPTION Two major virulence factors of H. pylori are the vacuolating cytotoxin (VacA) and the cag type-IV secretion system (T4SS) and its translocated effector protein, cytotoxin-associated antigen A (CagA).'
p760
(lp761
S'VacA binds to lipid rafts and glycosylphosphatidylinositol-anchored proteins (GPI-APs) of the target cell membrane. After insertion into the plasma membrane, VacA channels are endocytosed and eventually reach late endosomal compartments, increasing their permeability to anions with enhancement of the electrogenic vacuolar ATPase (v-ATPase) proton pump. In the presence of weak bases, osmotically active acidotropic ions will accumulate in the endosomes. This leads to water influx and vesicle swelling, an essential step in vacuole formation. In addition, it is reported that the VacA cleavage product binds to the tyrosine phosphatase receptor zeta (Ptprz) on epithelial cells and the induced signaling leads to the phosphorylation of the G protein-coupled receptor kinase-interactor 1 (Git1) and induces ulcerogenesis in mice.'
p762
aS'The other virulence factor cag T4SS mediates the translocation of the effector protein CagA, which is subsequently phosphorylated by a Src kinase. Phosphorylated CagA interacts with the protein tyrosine phosphatase SHP-2, thus stimulating its phosphatase activity. Activated SHP-2 is able to induce MAPK signalling through Ras/Raf-dependent and -independent mechanisms. Deregulation of this pathway by CagA may lead to abnormal proliferation and movement of gastric epithelial cells.'
p763
asS'ENTRY'
p764
(lp765
S'map05120'
p766
aS'Pathway'
p767
asS'CLASS'
p768
(lp769
S'Human Diseases Infectious diseases'
p770
asS'DESCRIPTION'
p771
(lp772
S'Two major virulence factors of H. pylori are the vacuolating cytotoxin (VacA) and the cag type-IV secretion system (T4SS) and its translocated effector protein, cytotoxin-associated antigen A (CagA).'
p773
assS'path:map00770'
p774
(dp775
S'NAME'
p776
(lp777
S'Pantothenate and CoA biosynthesis'
p778
asS'KO_PATHWAY'
p779
(lp780
S'ko00770'
p781
asS'PATHWAY_MAP'
p782
(lp783
S'map00770'
p784
asS'DISEASE'
p785
(lp786
S'H00832'
p787
aS'Core neuroacanthocytosis syndromes'
p788
ag787
ag788
aS'H00833'
p789
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p790
aS'H01002'
p791
aS'Generalized arterial calcification of infancy'
p792
aS'H01394'
p793
aS'Cole disease'
p794
asS'MODULE'
p795
(lp796
S'M00119'
p797
aS'Pantothenate biosynthesis, valine/L-aspartate => pantothenate [PATH:map00770]'
p798
ag797
ag798
aS'M00120'
p799
aS'Coenzyme A biosynthesis, pantothenate => CoA [PATH:map00770]'
p800
asS'DBLINKS'
p801
(lp802
S'GO: 0015940 0015937'
p803
asS'ENTRY'
p804
(lp805
S'map00770'
p806
aS'Pathway'
p807
asS'CLASS'
p808
(lp809
S'Metabolism Metabolism of cofactors and vitamins'
p810
assS'path:map04932'
p811
(dp812
S'NAME'
p813
(lp814
S'Non-alcoholic fatty liver disease (NAFLD)'
p815
asS'REFERENCE'
p816
(lp817
S'PMID:23545492'
p818
ag818
aS'AUTHORS'
p819
aS'Naik A, Kosir R, Rozman D'
p820
aS'TITLE'
p821
aS'Genomic aspects of NAFLD pathogenesis.'
p822
aS'JOURNAL'
p823
aS'Genomics 102:84-95 (2013)'
p824
aS'PMID:19352614'
p825
ag825
aS'AUTHORS'
p826
aS'Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L'
p827
aS'TITLE'
p828
aS'Molecular mechanisms involved in NAFLD progression.'
p829
aS'JOURNAL'
p830
aS'J Mol Med (Berl) 87:679-95 (2009)'
p831
aS'PMID:22705006'
p832
ag832
aS'AUTHORS'
p833
aS'Seki E, Brenner DA, Karin M'
p834
aS'TITLE'
p835
aS'A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.'
p836
aS'JOURNAL'
p837
aS'Gastroenterology 143:307-20 (2012)'
p838
aS'PMID:21038418'
p839
ag839
aS'AUTHORS'
p840
aS'Tilg H, Moschen AR'
p841
aS'TITLE'
p842
aS'Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.'
p843
aS'JOURNAL'
p844
aS'Hepatology 52:1836-46 (2010)'
p845
aS'PMID:16364488'
p846
ag846
aS'AUTHORS'
p847
aS'Larter CZ, Farrell GC'
p848
aS'TITLE'
p849
aS'Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?'
p850
aS'JOURNAL'
p851
aS'J Hepatol 44:253-61 (2006)'
p852
aS'PMID:22570745'
p853
ag853
aS'AUTHORS'
p854
aS'Farrell GC, van Rooyen D, Gan L, Chitturi S'
p855
aS'TITLE'
p856
aS'NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.'
p857
aS'JOURNAL'
p858
aS'Gut Liver 6:149-71 (2012)'
p859
aS'PMID:20619513'
p860
ag860
aS'AUTHORS'
p861
aS'Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P'
p862
aS'TITLE'
p863
aS'The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease.'
p864
aS'JOURNAL'
p865
aS'Clin Nutr 30:6-19 (2011)'
p866
aS'PMID:20303879'
p867
ag867
aS'AUTHORS'
p868
aS'Hotamisligil GS'
p869
aS'TITLE'
p870
aS'Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.'
p871
aS'JOURNAL'
p872
aS'Cell 140:900-17 (2010)'
p873
aS'PMID:17498512'
p874
ag874
aS'AUTHORS'
p875
aS'Parekh S, Anania FA'
p876
aS'TITLE'
p877
aS'Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.'
p878
aS'JOURNAL'
p879
aS'Gastroenterology 132:2191-207 (2007)'
p880
aS'PMID:16374858'
p881
ag881
aS'AUTHORS'
p882
aS'Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ'
p883
aS'TITLE'
p884
aS'JNK1 but not JNK2 promotes the development of steatohepatitis in mice.'
p885
aS'JOURNAL'
p886
aS'Hepatology 43:163-72 (2006)'
p887
aS'PMID:22940046'
p888
ag888
aS'AUTHORS'
p889
aS'Leung TM, Nieto N'
p890
aS'TITLE'
p891
aS'CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.'
p892
aS'JOURNAL'
p893
aS'J Hepatol 58:395-8 (2013)'
p894
aS'PMID:14685853'
p895
ag895
aS'AUTHORS'
p896
aS'Zafrani ES'
p897
aS'TITLE'
p898
aS'Non-alcoholic fatty liver disease: an emerging pathological spectrum.'
p899
aS'JOURNAL'
p900
aS'Virchows Arch 444:3-12 (2004)'
p901
aS'PMID:12891546'
p902
ag902
aS'AUTHORS'
p903
aS'Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ'
p904
aS'TITLE'
p905
aS'Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.'
p906
aS'JOURNAL'
p907
aS'Gastroenterology 125:437-43 (2003)'
p908
aS'PMID:16406828'
p909
ag909
aS'AUTHORS'
p910
aS'Begriche K, Igoudjil A, Pessayre D, Fromenty B'
p911
aS'TITLE'
p912
aS'Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.'
p913
aS'JOURNAL'
p914
aS'Mitochondrion 6:1-28 (2006)'
p915
aS'PMID:9285483'
p916
ag916
aS'AUTHORS'
p917
aS'Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G'
p918
aS'TITLE'
p919
aS'The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.'
p920
aS'JOURNAL'
p921
aS'FASEB J 11:851-7 (1997)'
p922
aS'PMID:21145844'
p923
ag923
aS'AUTHORS'
p924
aS'Malhi H, Kaufman RJ'
p925
aS'TITLE'
p926
aS'Endoplasmic reticulum stress in liver disease.'
p927
aS'JOURNAL'
p928
aS'J Hepatol 54:795-809 (2011)'
p929
aS'PMID:18242193'
p930
ag930
aS'AUTHORS'
p931
aS'Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM'
p932
aS'TITLE'
p933
aS'Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.'
p934
aS'JOURNAL'
p935
aS'Free Radic Biol Med 44:1259-72 (2008)'
p936
aS'PMID:18061659'
p937
ag937
aS'AUTHORS'
p938
aS'Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E'
p939
aS'TITLE'
p940
aS'Mitochondrial involvement in non-alcoholic steatohepatitis.'
p941
aS'JOURNAL'
p942
aS'Mol Aspects Med 29:22-35 (2008)'
p943
aS'PMID:23299992'
p944
ag944
aS'AUTHORS'
p945
aS'Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B'
p946
aS'TITLE'
p947
aS'Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.'
p948
aS'JOURNAL'
p949
aS'Hepatology 58:1497-507 (2013)'
p950
asS'KO_PATHWAY'
p951
(lp952
S'ko04932'
p953
asS'PATHWAY_MAP'
p954
(lp955
S'map04932'
p956
asS'DISEASE'
p957
(lp958
S'H01333'
p959
aS'Nonalcoholic fatty liver disease (NAFLD)'
p960
asS'ENTRY'
p961
(lp962
S'map04932'
p963
aS'Pathway'
p964
asS'CLASS'
p965
(lp966
S'Human Diseases Endocrine and metabolic diseases'
p967
asS'DESCRIPTION'
p968
(lp969
S'Non-alcoholic fatty liver disease (NAFLD) represents a spectrum ranging from simple steatosis to more severe steatohepatitis with hepatic inflammation and fibrosis, known as nonalcoholic steatohepatitis (NASH). NASH may further lead to cirrhosis and hepatocellular carcinoma (HCC). This map shows a stage-dependent progression of NAFLD. In the first stage of NAFLD, excess lipid accumulation has been demonstrated. The main cause is the induction of insulin resistance, which leads to a defect in insulin suppression of free fatty acids (FAAs) disposal. In addition, two transcription factors, SREBP-1c and PPAR-alpha, activate key enzymes of lipogenesis and increase the synthesis of FAAs in liver. In the second stage, as a consequence of the progression to NASH, the production of reactive oxygen species (ROS) is enhanced due to oxidation stress through mitochondrial beta-oxidation of fatty acids and endoplamic reticulum (ER) stress, leading to lipid peroxidation. The lipid peroxidation can further cause the production of cytokines (Fas ligand, TNF-alpha, IL-8 and TGF), promoting cell death, inflammation and fibrosis. The activation of JNK, which is induced by ER stress, TNF-alpha and FAAs, is also associated with NAFLD progression. Increased JNK promotes cytokine production and initiation of HCC.'
p970
assS'path:map00670'
p971
(dp972
S'NAME'
p973
(lp974
S'One carbon pool by folate'
p975
asS'KO_PATHWAY'
p976
(lp977
S'ko00670'
p978
asS'ENTRY'
p979
(lp980
S'map00670'
p981
aS'Pathway'
p982
asS'PATHWAY_MAP'
p983
(lp984
S'map00670'
p985
asS'DISEASE'
p986
(lp987
S'H00183'
p988
aS'Homocystinuria'
p989
ag988
ag989
aS'H00262'
p990
aS'Spina bifida'
p991
aS'H00966'
p992
aS'AICA-ribosiduria'
p993
aS'H01197'
p994
aS'Dihydrofolate reductase (DHFR) deficiency'
p995
aS'H01262'
p996
aS'Formiminotransferase deficiency'
p997
aS'H01285'
p998
aS'Methylcobalamin deficiency type G (cblG)'
p999
asS'MODULE'
p1000
(lp1001
S'M00126'
p1002
aS'Tetrahydrofolate biosynthesis, GTP => THF [PATH:map00670]'
p1003
ag1002
ag1003
aS'M00140'
p1004
aS'C1-unit interconversion, prokaryotes [PATH:map00670]'
p1005
aS'M00141'
p1006
aS'C1-unit interconversion, eukaryotes [PATH:map00670]'
p1007
asS'CLASS'
p1008
(lp1009
S'Metabolism Metabolism of cofactors and vitamins'
p1010
assS'path:map04930'
p1011
(dp1012
S'NAME'
p1013
(lp1014
S'Type II diabetes mellitus'
p1015
asS'REFERENCE'
p1016
(lp1017
S'PMID:15823385'
p1018
ag1018
aS'AUTHORS'
p1019
aS'Stumvoll M, Goldstein BJ, van Haeften TW.'
p1020
aS'TITLE'
p1021
aS'Type 2 diabetes: principles of pathogenesis and therapy.'
p1022
aS'JOURNAL'
p1023
aS'Lancet 365:1333-46 (2005)'
p1024
aS'PMID:15733744'
p1025
ag1025
aS'AUTHORS'
p1026
aS'Gual P, Le Marchand-Brustel Y, Tanti JF.'
p1027
aS'TITLE'
p1028
aS'Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.'
p1029
aS'JOURNAL'
p1030
aS'Biochimie 87:99-109 (2005)'
p1031
aS'PMID:11078440'
p1032
ag1032
aS'AUTHORS'
p1033
aS'Henquin JC.'
p1034
aS'TITLE'
p1035
aS'Triggering and amplifying pathways of regulation of insulin secretion by glucose.'
p1036
aS'JOURNAL'
p1037
aS'Diabetes 49:1751-60 (2000)'
p1038
aS'PMID:11272200'
p1039
ag1039
aS'AUTHORS'
p1040
aS'Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S.'
p1041
aS'TITLE'
p1042
aS'Role of apoptosis in pancreatic beta-cell death in diabetes.'
p1043
aS'JOURNAL'
p1044
aS'Diabetes 50 Suppl 1:S44-7 (2001)'
p1045
aS'PMID:15759102'
p1046
ag1046
aS'AUTHORS'
p1047
aS'Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Miyatsuka T, Matsuhisa M, Yamasaki Y.'
p1048
aS'TITLE'
p1049
aS'Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.'
p1050
aS'JOURNAL'
p1051
aS'J Mol Med 83:429-39 (2005)'
p1052
aS'PMID:12480546'
p1053
ag1053
aS'AUTHORS'
p1054
aS'Sakai K, Matsumoto K, Nishikawa T, Suefuji M, Nakamaru K, Hirashima Y, Kawashima J, Shirotani T, Ichinose K, Brownlee M, Araki E.'
p1055
aS'TITLE'
p1056
aS'Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells.'
p1057
aS'JOURNAL'
p1058
aS'Biochem Biophys Res Commun 300:216-22 (2003)'
p1059
aS'PMID:11390407'
p1060
ag1060
aS'AUTHORS'
p1061
aS'Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A, Weir GC.'
p1062
aS'TITLE'
p1063
aS'Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress.'
p1064
aS'JOURNAL'
p1065
aS'J Biol Chem 276:31099-104 (2001)'
p1066
aS'PMID:9011569'
p1067
ag1067
aS'AUTHORS'
p1068
aS'Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y.'
p1069
aS'TITLE'
p1070
aS'Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.'
p1071
aS'JOURNAL'
p1072
aS'J Clin Invest 99:144-50 (1997)'
p1073
aS'PMID:7491105'
p1074
ag1074
aS'AUTHORS'
p1075
aS'Sharma A, Olson LK, Robertson RP, Stein R.'
p1076
aS'TITLE'
p1077
aS'The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression.'
p1078
aS'JOURNAL'
p1079
aS'Mol Endocrinol 9:1127-34 (1995)'
p1080
aS'PMID:15258147'
p1081
ag1081
aS'AUTHORS'
p1082
aS'Robertson RP.'
p1083
aS'TITLE'
p1084
aS'Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes.'
p1085
aS'JOURNAL'
p1086
aS'J Biol Chem 279:42351-4 (2004)'
p1087
aS'PMID:9974390'
p1088
ag1088
aS'AUTHORS'
p1089
aS'Eto K, Tsubamoto Y, Terauchi Y, Sugiyama T, Kishimoto T, Takahashi N, Yamauchi N, Kubota N, Murayama S, Aizawa T, Akanuma Y, Aizawa S, Kasai H, Yazaki Y, Kadowaki T.'
p1090
aS'TITLE'
p1091
aS'Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion.'
p1092
aS'JOURNAL'
p1093
aS'Science 283:981-5 (1999)'
p1094
aS'PMID:11325516'
p1095
ag1095
aS'AUTHORS'
p1096
aS'Novelli M, Fabregat ME, Fernandez-Alvarez J, Gomis R, Masiello P.'
p1097
aS'TITLE'
p1098
aS'Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes.'
p1099
aS'JOURNAL'
p1100
aS'Mol Cell Endocrinol 175:57-66 (2001)'
p1101
aS'PMID:15585596'
p1102
ag1102
aS'AUTHORS'
p1103
aS'Yang SN, Berggren PO.'
p1104
aS'TITLE'
p1105
aS'Beta-cell CaV channel regulation in physiology and pathophysiology.'
p1106
aS'JOURNAL'
p1107
aS'Am J Physiol Endocrinol Metab 288:E16-28 (2005)'
p1108
asS'KO_PATHWAY'
p1109
(lp1110
S'ko04930'
p1111
asS'PATHWAY_MAP'
p1112
(lp1113
S'map04930'
p1114
asS'DISEASE'
p1115
(lp1116
S'H00409'
p1117
aS'Type II diabetes mellitus'
p1118
ag1117
ag1118
aS'H00410'
p1119
aS'Maturity onset diabetes of the young (MODY)'
p1120
aS'H00512'
p1121
aS'Permanent neonatal diabetes mellitus (PNDM)'
p1122
aS'H00513'
p1123
aS'Transient neonatal diabetes mellitus (TNDM)'
p1124
aS'H00719'
p1125
aS'Leprechaunism'
p1126
aS'H00861'
p1127
aS'Pancreatic agenesis'
p1128
aS'H00942'
p1129
aS'Rabson-Mendenhall syndrome'
p1130
aS'H00967'
p1131
aS'Adiponectin deficiency'
p1132
aS'H01228'
p1133
aS'Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN)'
p1134
aS'H01267'
p1135
aS'Familial hyperinsulinemic hypoglycemia (HHF)'
p1136
asS'DESCRIPTION Insulin resistance is strongly associated with type II diabetes. "Diabetogenic" factors including FFA, TNFalpha and cellular stress induce insulin resistance through inhibition of IRS1 functions. Serine/threonine phosphorylation, interaction with SOCS, regulation of the expression, modification of the cellular localization, and degradation represent the molecular mechanisms stimulated by them. Various kinases (ERK, JNK, IKKbeta, PKCzeta, PKCtheta and mTOR) are involved in this process.'
p1137
(lp1138
S'The development of type II diabetes requires impaired beta-cell function. Chronic hyperglycemia has been shown to induce multiple defects in beta-cells. Hyperglycemia has been proposed to lead to large amounts of reactive oxygen species (ROS) in beta-cells, with subsequent damage to cellular components including PDX-1. Loss of PDX-1, a critical regulator of insulin promoter activity, has also been proposed as an important mechanism leading to beta-cell dysfunction.'
p1139
aS'Although there is little doubt as to the importance of genetic factors in type II diabetes, genetic analysis is difficult due to complex interaction among multiple susceptibility genes and between genetic and environmental factors. Genetic studies have therefore given very diverse results. Kir6.2 and IRS are two of the candidate genes. It is known that Kir6.2 and IRS play central roles in insulin secretion and insulin signal transmission, respectively.'
p1140
asS'ENTRY'
p1141
(lp1142
S'map04930'
p1143
aS'Pathway'
p1144
asS'CLASS'
p1145
(lp1146
S'Human Diseases Endocrine and metabolic diseases'
p1147
asS'DESCRIPTION'
p1148
(lp1149
S'Insulin resistance is strongly associated with type II diabetes. "Diabetogenic" factors including FFA, TNFalpha and cellular stress induce insulin resistance through inhibition of IRS1 functions. Serine/threonine phosphorylation, interaction with SOCS, regulation of the expression, modification of the cellular localization, and degradation represent the molecular mechanisms stimulated by them. Various kinases (ERK, JNK, IKKbeta, PKCzeta, PKCtheta and mTOR) are involved in this process.'
p1150
assS'path:map00480'
p1151
(dp1152
S'NAME'
p1153
(lp1154
S'Glutathione metabolism'
p1155
asS'REFERENCE'
p1156
(lp1157
S'PMID:12675513'
p1158
ag1158
aS'AUTHORS'
p1159
aS'Josch C, Klotz LO, Sies H.'
p1160
aS'TITLE'
p1161
aS'Identification of cytosolic leucyl aminopeptidase (EC 3.4.11.1) as the major cysteinylglycine-hydrolysing activity in rat liver.'
p1162
aS'JOURNAL'
p1163
aS'Biol Chem 384:213-8 (2003)'
p1164
aS'PMID:18482986'
p1165
ag1165
aS'AUTHORS'
p1166
aS'Chu L, Lai Y, Xu X, Eddy S, Yang S, Song L, Kolodrubetz D.'
p1167
aS'TITLE'
p1168
aS'A 52-kDa leucyl aminopeptidase from treponema denticola is a cysteinylglycinase that mediates the second step of glutathione metabolism.'
p1169
aS'JOURNAL'
p1170
aS'J Biol Chem 283:19351-8 (2008)'
p1171
aS'PMID:14583094'
p1172
ag1172
aS'AUTHORS'
p1173
aS"Cappiello M, Lazzarotti A, Buono F, Scaloni A, D'Ambrosio C, Amodeo P, Mendez BL, Pelosi P, Del Corso A, Mura U."
p1174
aS'TITLE'
p1175
aS'New role for leucyl aminopeptidase in glutathione turnover.'
p1176
aS'JOURNAL'
p1177
aS'Biochem J 378:35-44 (2004)'
p1178
aS'PMID:11157967'
p1179
ag1179
aS'AUTHORS'
p1180
aS'Suzuki H, Kamatani S, Kim ES, Kumagai H.'
p1181
aS'TITLE'
p1182
aS'Aminopeptidases A, B, and N and dipeptidase D are the four cysteinylglycinases of Escherichia coli K-12.'
p1183
aS'JOURNAL'
p1184
aS'J Bacteriol 183:1489-90 (2001)'
p1185
aS'PMID:15610825'
p1186
ag1186
aS'AUTHORS'
p1187
aS'Oza SL, Shaw MP, Wyllie S, Fairlamb AH.'
p1188
aS'TITLE'
p1189
aS'Trypanothione biosynthesis in Leishmania major.'
p1190
aS'JOURNAL'
p1191
aS'Mol Biochem Parasitol 139:107-16 (2005)'
p1192
aS'PMID:12049631'
p1193
ag1193
aS'AUTHORS'
p1194
aS'Oza SL, Ariyanayagam MR, Fairlamb AH.'
p1195
aS'TITLE'
p1196
aS'Characterization of recombinant glutathionylspermidine synthetase/amidase from Crithidia fasciculata.'
p1197
aS'JOURNAL'
p1198
aS'Biochem J 364:679-86 (2002)'
p1199
aS'PMID:9677355'
p1200
ag1200
aS'AUTHORS'
p1201
aS'Tetaud E, Manai F, Barrett MP, Nadeau K, Walsh CT, Fairlamb AH.'
p1202
aS'TITLE'
p1203
aS'Cloning and characterization of the two enzymes responsible for trypanothione biosynthesis in Crithidia fasciculata.'
p1204
aS'JOURNAL'
p1205
aS'J Biol Chem 273:19383-90 (1998)'
p1206
aS'PMID:12750367'
p1207
ag1207
aS'AUTHORS'
p1208
aS'Ariyanayagam MR, Oza SL, Mehlert A, Fairlamb AH.'
p1209
aS'TITLE'
p1210
aS'Bis(glutathionyl)spermine and other novel trypanothione analogues in Trypanosoma cruzi.'
p1211
aS'JOURNAL'
p1212
aS'J Biol Chem 278:27612-9 (2003)'
p1213
aS'PMID:12967709'
p1214
ag1214
aS'AUTHORS'
p1215
aS'Oza SL, Ariyanayagam MR, Aitcheson N, Fairlamb AH.'
p1216
aS'TITLE'
p1217
aS'Properties of trypanothione synthetase from Trypanosoma brucei.'
p1218
aS'JOURNAL'
p1219
aS'Mol Biochem Parasitol 131:25-33 (2003)'
p1220
aS'PMID:12121990'
p1221
ag1221
aS'AUTHORS'
p1222
aS'Oza SL, Tetaud E, Ariyanayagam MR, Warnon SS, Fairlamb AH.'
p1223
aS'TITLE'
p1224
aS'A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi.'
p1225
aS'JOURNAL'
p1226
aS'J Biol Chem 277:35853-61 (2002)'
p1227
aS'PMID:15537651'
p1228
ag1228
aS'AUTHORS'
p1229
aS'Comini M, Menge U, Wissing J, Flohe L.'
p1230
aS'TITLE'
p1231
aS'Trypanothione synthesis in crithidia revisited.'
p1232
aS'JOURNAL'
p1233
aS'J Biol Chem 280:6850-60 (2005)'
p1234
aS'PMID:7813456'
p1235
ag1235
aS'AUTHORS'
p1236
aS'Hunter KJ, Le Quesne SA, Fairlamb AH.'
p1237
aS'TITLE'
p1238
aS'Identification and biosynthesis of N1,N9-bis(glutathionyl)aminopropylcadaverine (homotrypanothione) in Trypanosoma cruzi.'
p1239
aS'JOURNAL'
p1240
aS'Eur J Biochem 226:1019-27 (1994)'
p1241
aS'PMID:12751784'
p1242
ag1242
aS'AUTHORS'
p1243
aS'Krauth-Siegel RL, Meiering SK, Schmidt H.'
p1244
aS'TITLE'
p1245
aS'The parasite-specific trypanothione metabolism of trypanosoma and leishmania.'
p1246
aS'JOURNAL'
p1247
aS'Biol Chem 384:539-49 (2003)'
p1248
aS'PMID:18395526'
p1249
ag1249
aS'AUTHORS'
p1250
aS'Krauth-Siegel RL, Comini MA.'
p1251
aS'TITLE'
p1252
aS'Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism.'
p1253
aS'JOURNAL'
p1254
aS'Biochim Biophys Acta 1780:1236-48 (2008)'
p1255
aS'PMID:8892297'
p1256
ag1256
aS'AUTHORS'
p1257
aS'Krauth-Siegel RL, Ludemann H.'
p1258
aS'TITLE'
p1259
aS'Reduction of dehydroascorbate by trypanothione.'
p1260
aS'JOURNAL'
p1261
aS'Mol Biochem Parasitol 80:203-8 (1996)'
p1262
aS'PMID:11150302'
p1263
ag1263
aS'AUTHORS'
p1264
aS'Dormeyer M, Reckenfelderbaumer N, Ludemann H, Krauth-Siegel RL.'
p1265
aS'TITLE'
p1266
aS'Trypanothione-dependent synthesis of deoxyribonucleotides by Trypanosoma brucei ribonucleotide reductase.'
p1267
aS'JOURNAL'
p1268
aS'J Biol Chem 276:10602-6 (2001)'
p1269
aS'PMID:12949079'
p1270
ag1270
aS'AUTHORS'
p1271
aS'Schmidt H, Krauth-Siegel RL.'
p1272
aS'TITLE'
p1273
aS'Functional and physicochemical characterization of the thioredoxin system in Trypanosoma brucei.'
p1274
aS'JOURNAL'
p1275
aS'J Biol Chem 278:46329-36 (2003)'
p1276
aS'PMID:9851611'
p1277
ag1277
aS'AUTHORS'
p1278
aS'Tetaud E, Fairlamb AH.'
p1279
aS'TITLE'
p1280
aS'Cloning, expression and reconstitution of the trypanothione-dependent peroxidase system of Crithidia fasciculata.'
p1281
aS'JOURNAL'
p1282
aS'Mol Biochem Parasitol 96:111-23 (1998)'
p1283
aS'PMID:12446213'
p1284
ag1284
aS'AUTHORS'
p1285
aS'Castro H, Sousa C, Santos M, Cordeiro-da-Silva A, Flohe L, Tomas AM.'
p1286
aS'TITLE'
p1287
aS'Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum.'
p1288
aS'JOURNAL'
p1289
aS'Free Radic Biol Med 33:1552-62 (2002)'
p1290
aS'PMID:10713147'
p1291
ag1291
aS'AUTHORS'
p1292
aS'Wilkinson SR, Temperton NJ, Mondragon A, Kelly JM.'
p1293
aS'TITLE'
p1294
aS'Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi.'
p1295
aS'JOURNAL'
p1296
aS'J Biol Chem 275:8220-5 (2000)'
p1297
aS'PMID:17922848'
p1298
ag1298
aS'AUTHORS'
p1299
aS'Konig J, Fairlamb AH.'
p1300
aS'TITLE'
p1301
aS'A comparative study of type I and type II tryparedoxin peroxidases in Leishmania major.'
p1302
aS'JOURNAL'
p1303
aS'FEBS J 274:5643-58 (2007)'
p1304
aS'PMID:12466271'
p1305
ag1305
aS'AUTHORS'
p1306
aS'Hillebrand H, Schmidt A, Krauth-Siegel RL.'
p1307
aS'TITLE'
p1308
aS'A second class of peroxidases linked to the trypanothione metabolism.'
p1309
aS'JOURNAL'
p1310
aS'J Biol Chem 278:6809-15 (2003)'
p1311
aS'PMID:14982633'
p1312
ag1312
aS'AUTHORS'
p1313
aS'Soksawatmaekhin W, Kuraishi A, Sakata K, Kashiwagi K, Igarashi K.'
p1314
aS'TITLE'
p1315
aS'Excretion and uptake of cadaverine by CadB and its physiological functions in Escherichia coli.'
p1316
aS'JOURNAL'
p1317
aS'Mol Microbiol 51:1401-12 (2004)'
p1318
aS'PMID:6798961'
p1319
ag1319
aS'AUTHORS'
p1320
aS'Pegg AE, Shuttleworth K, Hibasami H.'
p1321
aS'TITLE'
p1322
aS'Specificity of mammalian spermidine synthase and spermine synthase.'
p1323
aS'JOURNAL'
p1324
aS'Biochem J 197:315-20 (1981)'
p1325
asS'KO_PATHWAY'
p1326
(lp1327
S'ko00480'
p1328
asS'PATHWAY_MAP'
p1329
(lp1330
S'map00480'
p1331
asS'DISEASE'
p1332
(lp1333
S'H00597'
p1334
aS'Snyder-Robinson syndrome'
p1335
ag1334
ag1335
aS'H00668'
p1336
aS'Anemia due to disorders of glutathione metabolism'
p1337
aS'H01118'
p1338
aS'Progressive external ophthalmoplegia (PEO)'
p1339
aS'H01225'
p1340
aS'D-2-hydroxyglutaric aciduria (D-2-HGA)'
p1341
aS'H01375'
p1342
aS'Glucose 6-phosphate dehydrogenase deficiency'
p1343
asS'MODULE'
p1344
(lp1345
S'M00118'
p1346
aS'Glutathione biosynthesis, glutamate => glutathione [PATH:map00480]'
p1347
asS'DBLINKS'
p1348
(lp1349
S'GO: 0006749'
p1350
asS'ENTRY'
p1351
(lp1352
S'map00480'
p1353
aS'Pathway'
p1354
asS'CLASS'
p1355
(lp1356
S'Metabolism Metabolism of other amino acids'
p1357
assS'path:map00950'
p1358
(dp1359
S'NAME'
p1360
(lp1361
S'Isoquinoline alkaloid biosynthesis'
p1362
asS'REFERENCE'
p1363
(lp1364
S'PMID:10811648'
p1365
ag1365
aS'AUTHORS'
p1366
aS'Morishige T, Tsujita T, Yamada Y, Sato F'
p1367
aS'TITLE'
p1368
aS"Molecular characterization of the S-adenosyl-L-methionine:3'-hydroxy-N-methylcoclaurine 4'-O-methyltransferase involved in isoquinoline alkaloid biosynthesis in Coptis japonica."
p1369
aS'JOURNAL'
p1370
aS'J Biol Chem 275:23398-405 (2000)'
p1371
aS'PMID:12423366'
p1372
ag1372
aS'AUTHORS'
p1373
aS'Morishige T, Dubouzet E, Choi KB, Yazaki K, Sato F'
p1374
aS'TITLE'
p1375
aS'Molecular cloning of columbamine O-methyltransferase from cultured Coptis japonica cells.'
p1376
aS'JOURNAL'
p1377
aS'Eur J Biochem 269:5659-67 (2002)'
p1378
aS'PMID:14675446'
p1379
ag1379
aS'AUTHORS'
p1380
aS'Ounaroon A, Decker G, Schmidt J, Lottspeich F, Kutchan TM'
p1381
aS'TITLE'
p1382
aS'(R,S)-Reticuline 7-O-methyltransferase and (R,S)-norcoclaurine 6-O-methyltransferase of Papaver somniferum - cDNA cloning and characterization of methyl transfer enzymes of alkaloid biosynthesis in opium poppy.'
p1383
aS'JOURNAL'
p1384
aS'Plant J 36:808-19 (2003)'
p1385
aS'PMID:18230623'
p1386
ag1386
aS'AUTHORS'
p1387
aS'Ikezawa N, Iwasa K, Sato F'
p1388
aS'TITLE'
p1389
aS'Molecular cloning and characterization of CYP80G2, a cytochrome P450 that catalyzes an intramolecular C-C phenol coupling of (S)-reticuline in magnoflorine biosynthesis, from cultured Coptis japonica cells.'
p1390
aS'JOURNAL'
p1391
aS'J Biol Chem 283:8810-21 (2008)'
p1392
aS'PMID:18476877'
p1393
ag1393
aS'AUTHORS'
p1394
aS'Facchini PJ, De Luca V'
p1395
aS'TITLE'
p1396
aS'Opium poppy and Madagascar periwinkle: model non-model systems to investigate alkaloid biosynthesis in plants.'
p1397
aS'JOURNAL'
p1398
aS'Plant J 54:763-84 (2008)'
p1399
aS'PMID:18492807'
p1400
ag1400
aS'AUTHORS'
p1401
aS'Minami H, Kim JS, Ikezawa N, Takemura T, Katayama T, Kumagai H, Sato F'
p1402
aS'TITLE'
p1403
aS'Microbial production of plant benzylisoquinoline alkaloids.'
p1404
aS'JOURNAL'
p1405
aS'Proc Natl Acad Sci U S A 105:7393-8 (2008)'
p1406
ag22
ag22
aS'AUTHORS'
p1407
aS'Rueffer M, Bauer W, Zenk MH.'
p1408
aS'TITLE'
p1409
aS'The formation of corydaline and related alkaloids in Corydalis cava in vivo and in vitro.'
p1410
aS'JOURNAL'
p1411
aS'Can J Chem 72:170-175 (1994)'
p1412
ag22
ag22
aS'AUTHORS'
p1413
aS'Sekine Y, Crevelling C, Bell M, Brossi A.'
p1414
aS'TITLE'
p1415
aS'Mammalian alkaloids: O-methylation of (+-)-norcoclaurine-1-carboxylic acid and related isoquinolines including (S)- and (R)-norcoclaurine with 14C-labeled S-adenosyl-L-methionine in presence of mammalian catechol O-methyltransferase.'
p1416
aS'JOURNAL'
p1417
aS'Helvetica Chimica Acta 73(2):426-432 (1990)'
p1418
ag22
ag22
aS'AUTHORS'
p1419
aS'De-Eknamkul W, Tanahashi T, Zenk MH.'
p1420
aS'TITLE'
p1421
aS'Enzymic 10-hydroxylation and 10-O-methylation of dihydrosanguinarine in dihydrochelirubine formation by Eschscholtzia.'
p1422
aS'JOURNAL'
p1423
aS'Phytochemistry 31(8):2713-2717 (1992)'
p1424
ag22
ag22
aS'AUTHORS'
p1425
aS'Kammerer L, De-Eknamkul W, Zenk MH.'
p1426
aS'TITLE'
p1427
aS'Enzymic 12-hydroxylation and 12-O-methylation of dihydrochelirubine in dihydromacarpine formation by Thalictrum bulgaricum.'
p1428
aS'JOURNAL'
p1429
aS'Phytochemistry 36(6):1409-1416 (1994)'
p1430
ag22
ag22
aS'AUTHORS'
p1431
aS'Schumacher HM, Zenk MH.'
p1432
aS'TITLE'
p1433
aS'Partial purification and characterization of dihydrobenzophenanthridine oxidase from Eschscholtzia californica cell suspension cultures.'
p1434
aS'JOURNAL'
p1435
aS'Plant Cell Reports 7:43-46 (1988)'
p1436
ag22
ag22
aS'AUTHORS'
p1437
aS'Rueffer M, Zenk MH.'
p1438
aS'TITLE'
p1439
aS'Enzymatic formation of protopines by a microsomal cytochrome P-450 system of Corydalis vaginans.'
p1440
aS'JOURNAL'
p1441
aS'Tetrahedron Letters 28(44):5307-5310 (1987)'
p1442
asS'KO_PATHWAY'
p1443
(lp1444
S'ko00950'
p1445
asS'PATHWAY_MAP'
p1446
(lp1447
S'map00950'
p1448
asS'DBLINKS'
p1449
(lp1450
S'GO: 0033075'
p1451
asS'ENTRY'
p1452
(lp1453
S'map00950'
p1454
aS'Pathway'
p1455
asS'CLASS'
p1456
(lp1457
S'Metabolism Biosynthesis of other secondary metabolites'
p1458
asS'DESCRIPTION'
p1459
(lp1460
S'Isoquinoline alkaloids are tyrosine-derived plant alkaloids with an isoquinoline skeleton. Among them benzylisoquinoline alkaloids form an important group with potent pharmacological activity, including analgesic compounds of morphine and codeine, and anti-infective agents of berberine, palmatine, and magnoflorine. Biosynthesis of isoquinoline alkaloids proceeds via decarboxylation of tyrosine or DOPA to yield dopamine, which together with 4-hydroxyphenylacetaldehyde, an aldehyde derived from tyrosine, is converted to reticuline, an important precursor of various benzylisoquinoline alkaloids.'
p1461
assS'path:map04020'
p1462
(dp1463
S'NAME'
p1464
(lp1465
S'Calcium signaling pathway'
p1466
asS'REFERENCE'
p1467
(lp1468
S'PMID:12838335'
p1469
ag1469
aS'AUTHORS'
p1470
aS'Berridge MJ, Bootman MD, Roderick HL.'
p1471
aS'TITLE'
p1472
aS'Calcium signalling: dynamics, homeostasis and remodelling.'
p1473
aS'JOURNAL'
p1474
aS'Nat Rev Mol Cell Biol 4:517-29 (2003)'
p1475
aS'PMID:11413485'
p1476
ag1476
aS'AUTHORS'
p1477
aS'Berridge MJ, Lipp P, Bootman MD.'
p1478
aS'TITLE'
p1479
aS'The versatility and universality of calcium signalling.'
p1480
aS'JOURNAL'
p1481
aS'Nat Rev Mol Cell Biol 1:11-21 (2000)'
p1482
aS'PMID:15111104'
p1483
ag1483
aS'AUTHORS'
p1484
aS'Wang MC, Dolphin A, Kitmitto A.'
p1485
aS'TITLE'
p1486
aS'L-type voltage-gated calcium channels: understanding function through structure.'
p1487
aS'JOURNAL'
p1488
aS'FEBS Lett 564:245-50 (2004)'
p1489
aS'PMID:11299192'
p1490
ag1490
aS'AUTHORS'
p1491
aS'Ferrier GR, Howlett SE.'
p1492
aS'TITLE'
p1493
aS'Cardiac excitation-contraction coupling: role of membrane potential in regulation of contraction.'
p1494
aS'JOURNAL'
p1495
aS'Am J Physiol Heart Circ Physiol 280:H1928-44 (2001)'
p1496
aS'PMID:11698232'
p1497
ag1497
aS'AUTHORS'
p1498
aS'Keef KD, Hume JR, Zhong J.'
p1499
aS'TITLE'
p1500
aS'Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases.'
p1501
aS'JOURNAL'
p1502
aS'Am J Physiol Cell Physiol 281:C1743-56 (2001)'
p1503
aS'PMID:8125957'
p1504
ag1504
aS'AUTHORS'
p1505
aS'Hell JW, Appleyard SM, Yokoyama CT, Warner C, Catterall WA.'
p1506
aS'TITLE'
p1507
aS'Differential phosphorylation of two size forms of the N-type calcium channel alpha 1 subunit which have different COOH termini.'
p1508
aS'JOURNAL'
p1509
aS'J Biol Chem 269:7390-6 (1994)'
p1510
aS'PMID:15000521'
p1511
ag1511
aS'AUTHORS'
p1512
aS'Yunker AM.'
p1513
aS'TITLE'
p1514
aS'Modulation and pharmacology of low voltage-activated (&quotT-Type&quot) calcium channels.'
p1515
aS'JOURNAL'
p1516
aS'J Bioenerg Biomembr 35:577-98 (2003)'
p1517
aS'PMID:9149541'
p1518
ag1518
aS'AUTHORS'
p1519
aS'Yakel JL.'
p1520
aS'TITLE'
p1521
aS'Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription.'
p1522
aS'JOURNAL'
p1523
aS'Trends Pharmacol Sci 18:124-34 (1997)'
p1524
aS'PMID:10997573'
p1525
ag1525
aS'AUTHORS'
p1526
aS'Fukunaga K, Miyamoto E.'
p1527
aS'TITLE'
p1528
aS'A working model of CaM kinase II activity in hippocampal long-term potentiation and memory.'
p1529
aS'JOURNAL'
p1530
aS'Neurosci Res 38:3-17 (2000)'
p1531
aS'PMID:9235901'
p1532
ag1532
aS'AUTHORS'
p1533
aS'Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ.'
p1534
aS'TITLE'
p1535
aS'Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase.'
p1536
aS'JOURNAL'
p1537
aS'J Biol Chem 272:19125-32 (1997)'
p1538
aS'PMID:7861177'
p1539
ag1539
aS'AUTHORS'
p1540
aS'Furuichi T, Mikoshiba K.'
p1541
aS'TITLE'
p1542
aS'Inositol 1, 4, 5-trisphosphate receptor-mediated Ca2+ signaling in the brain.'
p1543
aS'JOURNAL'
p1544
aS'J Neurochem 64:953-60 (1995)'
p1545
aS'PMID:14572802'
p1546
ag1546
aS'AUTHORS'
p1547
aS'Bruce JI, Straub SV, Yule DI.'
p1548
aS'TITLE'
p1549
aS'Crosstalk between cAMP and Ca2+ signaling in non-excitable cells.'
p1550
aS'JOURNAL'
p1551
aS'Cell Calcium 34:431-44 (2003)'
p1552
aS'PMID:10331643'
p1553
ag1553
aS'AUTHORS'
p1554
aS'Lee HC, Munshi C, Graeff R.'
p1555
aS'TITLE'
p1556
aS'Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.'
p1557
aS'JOURNAL'
p1558
aS'Mol Cell Biochem 193:89-98 (1999)'
p1559
aS'PMID:11080247'
p1560
ag1560
aS'AUTHORS'
p1561
aS'Crompton M.'
p1562
aS'TITLE'
p1563
aS'Mitochondrial intermembrane junctional complexes and their role in cell death.'
p1564
aS'JOURNAL'
p1565
aS'J Physiol 529 Pt 1:11-21 (2000)'
p1566
aS'PMID:10508738'
p1567
ag1567
aS'AUTHORS'
p1568
aS'Grewal SS, York RD, Stork PJ.'
p1569
aS'TITLE'
p1570
aS'Extracellular-signal-regulated kinase signalling in neurons.'
p1571
aS'JOURNAL'
p1572
aS'Curr Opin Neurobiol 9:544-53 (1999)'
p1573
aS'PMID:12972622'
p1574
ag1574
aS'AUTHORS'
p1575
aS'Trushin SA, Pennington KN, Carmona EM, Asin S, Savoy DN, Billadeau DD, Paya CV.'
p1576
aS'TITLE'
p1577
aS'Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.'
p1578
aS'JOURNAL'
p1579
aS'Mol Cell Biol 23:7068-81 (2003)'
p1580
aS'PMID:14517314'
p1581
ag1581
aS'AUTHORS'
p1582
aS'Hutchins JR, Dikovskaya D, Clarke PR.'
p1583
aS'TITLE'
p1584
aS'Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.'
p1585
aS'JOURNAL'
p1586
aS'Mol Biol Cell 14:4003-14 (2003)'
p1587
aS'PMID:21338471'
p1588
ag1588
aS'AUTHORS'
p1589
aS'Tornquist K'
p1590
aS'TITLE'
p1591
aS'Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells.'
p1592
aS'JOURNAL'
p1593
aS'Acta Physiol (Oxf) 204:151-7 (2012)'
p1594
aS'PMID:22129055'
p1595
ag1595
aS'AUTHORS'
p1596
aS'Feske S'
p1597
aS'TITLE'
p1598
aS'Immunodeficiency due to defects in store-operated calcium entry.'
p1599
aS'JOURNAL'
p1600
aS'Ann N Y Acad Sci 1238:74-90 (2011)'
p1601
aS'PMID:22002090'
p1602
ag1602
aS'AUTHORS'
p1603
aS'Giachini FR, Lima VV, Hannan JL, Carneiro FS, Webb RC, Tostes RC'
p1604
aS'TITLE'
p1605
aS'STIM1/Orai1-mediated store-operated Ca2+ entry: the tip of the iceberg.'
p1606
aS'JOURNAL'
p1607
aS'Braz J Med Biol Res 44:1080-7 (2011)'
p1608
aS'PMID:19172794'
p1609
ag1609
aS'AUTHORS'
p1610
aS'Baba Y, Kurosaki T'
p1611
aS'TITLE'
p1612
aS'[Regulation of store-operated calcium entry by STIM1].'
p1613
aS'JOURNAL'
p1614
aS'Seikagaku 80:1123-8 (2008)'
p1615
asS'KO_PATHWAY'
p1616
(lp1617
S'ko04020'
p1618
asS'PATHWAY_MAP'
p1619
(lp1620
S'map04020'
p1621
asS'DISEASE'
p1622
(lp1623
S'H00441'
p1624
aS'Progressive osseous heteroplasia (POH)'
p1625
ag1624
ag1625
aS'H00608'
p1626
aS'46,XY disorders of sex development (Disorders in androgen synthesis or action)'
p1627
aS'H00627'
p1628
aS'Premature ovarian failure'
p1629
aS'H00699'
p1630
aS'Central core disease'
p1631
aS'H00715'
p1632
aS'Darier disease'
p1633
aS'H00728'
p1634
aS'Brugada syndrome (BRS)'
p1635
aS'H00746'
p1636
aS'Hypokalemic periodic paralysis (HypoPP)'
p1637
aS'H00749'
p1638
aS'Episodic ataxias'
p1639
aS'H00755'
p1640
aS'Acrokeratosis verruciformis'
p1641
aS'H00759'
p1642
aS'Waardenburg syndrome (WS)'
p1643
aS'H00775'
p1644
aS'Familial or sporadic hemiplegic migraine'
p1645
aS'H00787'
p1646
aS'Congenital stationary night blindness (CSNB)'
p1647
aS'H00801'
p1648
aS'Familial thoracic aortic aneurysm and dissection (TAAD)'
p1649
aS'H00823'
p1650
aS'ABCD syndrome'
p1651
aS'H00865'
p1652
aS'Lethal congenital contractural syndrome (LCCS)'
p1653
aS'H00910'
p1654
aS'Hirschsprung disease (HD)'
p1655
aS'H00937'
p1656
aS'Precocious puberty'
p1657
aS'H01019'
p1658
aS'Catecholaminergic polymorphic ventricular tachycardia'
p1659
aS'H01118'
p1660
aS'Progressive external ophthalmoplegia (PEO)'
p1661
aS'H01129'
p1662
aS'Brody myopathy'
p1663
aS'H01307'
p1664
aS'Nonsyndromic congenital nail disorder (NDNC)'
p1665
aS'H01310'
p1666
aS'Multi-minicore disease (MmD)'
p1667
asS'DESCRIPTION Ca2+ that enters the cell from the outside is a principal source of signal Ca2+. Entry of Ca2+ is driven by the presence of a large electrochemical gradient across the plasma membrane. Cells use this external source of signal Ca2+ by activating various entry channels with widely different properties. The voltage-operated channels (VOCs) are found in excitable cells and generate the rapid Ca2+ fluxes that control fast cellular processes. There are many other Ca2+-entry channels, such as the receptor-operated channels (ROCs), for example the NMDA (N-methyl-D-aspartate) receptors (NMDARs) that respond to glutamate. There also are second-messenger-operated channels (SMOCs) and store-operated channels (SOCs).'
p1668
(lp1669
S'The other principal source of Ca2+ for signalling is the internal stores that are located primarily in the endoplasmic/sarcoplasmic reticulum (ER/SR), in which inositol-1,4,5-trisphosphate receptors (IP3Rs) or ryanodine receptors (RYRs) regulate the release of Ca2+. The principal activator of these channels is Ca2+ itself and this process of Ca2+-induced Ca2+ release is central to the mechanism of Ca2+ signalling. Various second messengers or modulators also control the release of Ca2+. IP3, which is generated by pathways using different isoforms of phospholipase C (PLCbeta, delta, epsilon, gamma and zeta), regulates the IP3Rs. Cyclic ADP-ribose (cADPR) releases Ca2+ via RYRs. Nicotinic acid adenine dinucleotide phosphate (NAADP) may activate a distinct Ca2+ release mechanism on separate acidic Ca2+ stores. Ca2+ release via the NAADP-sensitive mechanism may also feedback onto either RYRs or IP3Rs. cADPR and NAADP are generated by CD38. This enzyme might be sensitive to the cellular metabolism, as ATP and NADH inhibit it.'
p1670
aS'The influx of Ca2+ from the environment or release from internal stores causes a very rapid and dramatic increase in cytoplasmic calcium concentration, which has been widely exploited for signal transduction. Some proteins, such as troponin C (TnC) involved in muscle contraction, directly bind to and sense Ca2+. However, in other cases Ca2+ is sensed through intermediate calcium sensors such as calmodulin (CALM).'
p1671
asS'DBLINKS'
p1672
(lp1673
S'GO: 0019722'
p1674
asS'ENTRY'
p1675
(lp1676
S'map04020'
p1677
aS'Pathway'
p1678
asS'CLASS'
p1679
(lp1680
S'Environmental Information Processing Signal transduction'
p1681
asS'DESCRIPTION'
p1682
(lp1683
S'Ca2+ that enters the cell from the outside is a principal source of signal Ca2+. Entry of Ca2+ is driven by the presence of a large electrochemical gradient across the plasma membrane. Cells use this external source of signal Ca2+ by activating various entry channels with widely different properties. The voltage-operated channels (VOCs) are found in excitable cells and generate the rapid Ca2+ fluxes that control fast cellular processes. There are many other Ca2+-entry channels, such as the receptor-operated channels (ROCs), for example the NMDA (N-methyl-D-aspartate) receptors (NMDARs) that respond to glutamate. There also are second-messenger-operated channels (SMOCs) and store-operated channels (SOCs).'
p1684
assS'path:map00403'
p1685
(dp1686
S'NAME'
p1687
(lp1688
S'Indole diterpene alkaloid biosynthesis'
p1689
asS'REFERENCE'
p1690
(lp1691
S'PMID:18262778'
p1692
ag1692
aS'AUTHORS'
p1693
aS'Saikia S, Nicholson MJ, Young C, Parker EJ, Scott B'
p1694
aS'TITLE'
p1695
aS'The genetic basis for indole-diterpene chemical diversity in filamentous fungi.'
p1696
aS'JOURNAL'
p1697
aS'Mycol Res 112:184-99 (2008)'
p1698
aS'PMID:16494875'
p1699
ag1699
aS'AUTHORS'
p1700
aS'Saikia S, Parker EJ, Koulman A, Scott B'
p1701
aS'TITLE'
p1702
aS'Four gene products are required for the fungal synthesis of the indole-diterpene, paspaline.'
p1703
aS'JOURNAL'
p1704
aS'FEBS Lett 580:1625-30 (2006)'
p1705
aS'PMID:17428785'
p1706
ag1706
aS'AUTHORS'
p1707
aS'Saikia S, Parker EJ, Koulman A, Scott B'
p1708
aS'TITLE'
p1709
aS'Defining paxilline biosynthesis in Penicillium paxilli: functional characterization of two cytochrome P450 monooxygenases.'
p1710
aS'JOURNAL'
p1711
aS'J Biol Chem 282:16829-37 (2007)'
p1712
aS'PMID:19801473'
p1713
ag1713
aS'AUTHORS'
p1714
aS'Nicholson MJ, Koulman A, Monahan BJ, Pritchard BL, Payne GA, Scott B'
p1715
aS'TITLE'
p1716
aS'Identification of two aflatrem biosynthesis gene loci in Aspergillus flavus and metabolic engineering of Penicillium paxilli to elucidate their function.'
p1717
aS'JOURNAL'
p1718
aS'Appl Environ Microbiol 75:7469-81 (2009)'
p1719
aS'PMID:22750140'
p1720
ag1720
aS'AUTHORS'
p1721
aS'Saikia S, Takemoto D, Tapper BA, Lane GA, Fraser K, Scott B'
p1722
aS'TITLE'
p1723
aS'Functional analysis of an indole-diterpene gene cluster for lolitrem B biosynthesis in the grass endosymbiont Epichloe festucae.'
p1724
aS'JOURNAL'
p1725
aS'FEBS Lett 586:2563-9 (2012)'
p1726
aS'PMID:23261604'
p1727
ag1727
aS'AUTHORS'
p1728
aS'Motoyama T, Hayashi T, Hirota H, Ueki M, Osada H'
p1729
aS'TITLE'
p1730
aS'Terpendole E, a kinesin Eg5 inhibitor, is a key biosynthetic intermediate of indole-diterpenes in the producing fungus Chaunopycnis alba.'
p1731
aS'JOURNAL'
p1732
aS'Chem Biol 19:1611-9 (2012)'
p1733
asS'KO_PATHWAY'
p1734
(lp1735
S'ko00403'
p1736
asS'PATHWAY_MAP'
p1737
(lp1738
S'map00403'
p1739
asS'MODULE'
p1740
(lp1741
S'M00661'
p1742
aS'Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline [PATH:map00403]'
p1743
asS'ENTRY'
p1744
(lp1745
S'map00403'
p1746
aS'Pathway'
p1747
asS'CLASS'
p1748
(lp1749
S'Metabolism Biosynthesis of other secondary metabolites'
p1750
asS'DESCRIPTION'
p1751
(lp1752
S'Indole diterpene alkaloids are a group of meroterpenoids consisting of a partial diterpene structure with four isoprene units and an indole moiety. The common cyclic diterpene skeleton is derived from geranylgeranyl diphosphate (GGPP) and an indole moiety is derived from tryptophan or a tryptophan precursor. They are combined in the initial step of biosynthetic reactions that generate paspaline, the first stable and less modified form required for other forms. Most indole diterpene alkaloids have potent mammalian tremorgenic activities, such as ryegrass staggers in livestock, and some have anti-insect properties. This map shows examples of indole diterpene alkaloids isolated from filamentous fungi.'
p1753
assS'path:map00400'
p1754
(dp1755
S'NAME'
p1756
(lp1757
S'Phenylalanine, tyrosine and tryptophan biosynthesis'
p1758
asS'KO_PATHWAY'
p1759
(lp1760
S'ko00400'
p1761
asS'PATHWAY_MAP'
p1762
(lp1763
S'map00400'
p1764
asS'DISEASE'
p1765
(lp1766
S'H00167'
p1767
aS'Phenylketonuria (PKU)'
p1768
asS'MODULE'
p1769
(lp1770
S'M00022'
p1771
aS'Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map00400]'
p1772
ag1771
ag1772
aS'M00023'
p1773
aS'Tryptophan biosynthesis, chorismate => tryptophan [PATH:map00400]'
p1774
aS'M00024'
p1775
aS'Phenylalanine biosynthesis, chorismate => phenylalanine [PATH:map00400]'
p1776
aS'M00025'
p1777
aS'Tyrosine biosynthesis, chorismate => tyrosine [PATH:map00400]'
p1778
aS'M00040'
p1779
aS'Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine [PATH:map00400]'
p1780
asS'DBLINKS'
p1781
(lp1782
S'GO: 0009094 0006571 0000162'
p1783
asS'ENTRY'
p1784
(lp1785
S'map00400'
p1786
aS'Pathway'
p1787
asS'CLASS'
p1788
(lp1789
S'Metabolism Amino acid metabolism'
p1790
assS'path:map00401'
p1791
(dp1792
S'NAME'
p1793
(lp1794
S'Novobiocin biosynthesis'
p1795
asS'REFERENCE'
p1796
(lp1797
S'PMID:12480894'
p1798
ag1798
aS'AUTHORS'
p1799
aS'Pojer F, Li SM, Heide L.'
p1800
aS'TITLE'
p1801
aS'Molecular cloning and sequence analysis of the clorobiocin biosynthetic gene cluster: new insights into the biosynthesis of aminocoumarin antibiotics.'
p1802
aS'JOURNAL'
p1803
aS'Microbiology 148:3901-11 (2002)'
p1804
aS'PMID:11325587'
p1805
ag1805
aS'AUTHORS'
p1806
aS'Chen H, Walsh CT.'
p1807
aS'TITLE'
p1808
aS'Coumarin formation in novobiocin biosynthesis: beta-hydroxylation of the aminoacyl enzyme tyrosyl-S-NovH by a cytochrome P450 NovI.'
p1809
aS'JOURNAL'
p1810
aS'Chem Biol 8:301-12 (2001)'
p1811
aS'PMID:14622269'
p1812
ag1812
aS'AUTHORS'
p1813
aS'Schmutz E, Steffensky M, Schmidt J, Porzel A, Li SM, Heide L.'
p1814
aS'TITLE'
p1815
aS'An unusual amide synthetase (CouL) from the coumermycin A1 biosynthetic gene cluster from Streptomyces rishiriensis DSM 40489.'
p1816
aS'JOURNAL'
p1817
aS'Eur J Biochem 270:4413-9 (2003)'
p1818
aS'PMID:12904558'
p1819
ag1819
aS'AUTHORS'
p1820
aS'Xu H, Kahlich R, Kammerer B, Heide L, Li SM.'
p1821
aS'TITLE'
p1822
aS'CloN2, a novel acyltransferase involved in the attachment of the pyrrole-2-carboxyl moiety to the deoxysugar of clorobiocin.'
p1823
aS'JOURNAL'
p1824
aS'Microbiology 149:2183-91 (2003)'
p1825
aS'PMID:12436260'
p1826
ag1826
aS'AUTHORS'
p1827
aS'Xu H, Wang ZX, Schmidt J, Heide L, Li SM.'
p1828
aS'TITLE'
p1829
aS'Genetic analysis of the biosynthesis of the pyrrole and carbamoyl moieties of coumermycin A1 and novobiocin.'
p1830
aS'JOURNAL'
p1831
aS'Mol Genet Genomics 268:387-96 (2002)'
p1832
aS'PMID:14694473'
p1833
ag1833
aS'AUTHORS'
p1834
aS'Freel Meyers CL, Oberthur M, Xu H, Heide L, Kahne D, Walsh CT'
p1835
aS'TITLE'
p1836
aS'Characterization of NovP and NovN: completion of novobiocin biosynthesis by sequential tailoring of the noviosyl ring.'
p1837
aS'JOURNAL'
p1838
aS'Angew Chem Int Ed Engl 43:67-70 (2004)'
p1839
aS'PMID:12777382'
p1840
ag1840
aS'AUTHORS'
p1841
aS'Pojer F, Kahlich R, Kammerer B, Li SM, Heide L.'
p1842
aS'TITLE'
p1843
aS'CloR, a bifunctional non-heme iron oxygenase involved in clorobiocin biosynthesis.'
p1844
aS'JOURNAL'
p1845
aS'J Biol Chem 278:30661-8 (2003)'
p1846
aS'PMID:12368465'
p1847
ag1847
aS'AUTHORS'
p1848
aS'Li SM, Westrich L, Schmidt J, Kuhnt C, Heide L.'
p1849
aS'TITLE'
p1850
aS'Methyltransferase genes in Streptomyces rishiriensis: new coumermycin derivatives from gene-inactivation experiments.'
p1851
aS'JOURNAL'
p1852
aS'Microbiology 148:3317-26 (2002)'
p1853
aS'PMID:12618544'
p1854
ag1854
aS'AUTHORS'
p1855
aS'Pojer F, Wemakor E, Kammerer B, Chen H, Walsh CT, Li SM, Heide L.'
p1856
aS'TITLE'
p1857
aS'CloQ, a prenyltransferase involved in clorobiocin biosynthesis.'
p1858
aS'JOURNAL'
p1859
aS'Proc Natl Acad Sci U S A 100:2316-21 (2003)'
p1860
asS'KO_PATHWAY'
p1861
(lp1862
S'ko00401'
p1863
asS'ENTRY'
p1864
(lp1865
S'map00401'
p1866
aS'Pathway'
p1867
asS'PATHWAY_MAP'
p1868
(lp1869
S'map00401'
p1870
asS'CLASS'
p1871
(lp1872
S'Metabolism Biosynthesis of other secondary metabolites'
p1873
assS'path:map04745'
p1874
(dp1875
S'NAME'
p1876
(lp1877
S'Phototransduction - fly'
p1878
asS'REFERENCE'
p1879
(lp1880
S'PMID:19623243'
p1881
ag1881
aS'AUTHORS'
p1882
aS'Katz B, Minke B'
p1883
aS'TITLE'
p1884
aS'Drosophila photoreceptors and signaling mechanisms.'
p1885
aS'JOURNAL'
p1886
aS'Front Cell Neurosci 3:2 (2009)'
p1887
aS'PMID:19138592'
p1888
ag1888
aS'AUTHORS'
p1889
aS'Borst A'
p1890
aS'TITLE'
p1891
aS"Drosophila's view on insect vision."
p1892
aS'JOURNAL'
p1893
aS'Curr Biol 19:R36-47 (2009)'
p1894
aS'PMID:19837030'
p1895
ag1895
aS'AUTHORS'
p1896
aS'Yau KW, Hardie RC'
p1897
aS'TITLE'
p1898
aS'Phototransduction motifs and variations.'
p1899
aS'JOURNAL'
p1900
aS'Cell 139:246-64 (2009)'
p1901
aS'PMID:19011871'
p1902
ag1902
aS'AUTHORS'
p1903
aS'Frings S'
p1904
aS'TITLE'
p1905
aS'Primary processes in sensory cells: current advances.'
p1906
aS'JOURNAL'
p1907
aS'J Comp Physiol A Neuroethol Sens Neural Behav Physiol 195:1-19 (2009)'
p1908
aS'PMID:17487503'
p1909
ag1909
aS'AUTHORS'
p1910
aS'Wang T, Montell C'
p1911
aS'TITLE'
p1912
aS'Phototransduction and retinal degeneration in Drosophila.'
p1913
aS'JOURNAL'
p1914
aS'Pflugers Arch 454:821-47 (2007)'
p1915
aS'PMID:12765684'
p1916
ag1916
aS'AUTHORS'
p1917
aS'Hardie RC'
p1918
aS'TITLE'
p1919
aS'TRP channels in Drosophila photoreceptors: the lipid connection.'
p1920
aS'JOURNAL'
p1921
aS'Cell Calcium 33:385-93 (2003)'
p1922
aS'PMID:16460287'
p1923
ag1923
aS'AUTHORS'
p1924
aS'Minke B, Parnas M'
p1925
aS'TITLE'
p1926
aS'Insights on TRP channels from in vivo studies in Drosophila.'
p1927
aS'JOURNAL'
p1928
aS'Annu Rev Physiol 68:649-84 (2006)'
p1929
aS'PMID:10611962'
p1930
ag1930
aS'AUTHORS'
p1931
aS'Montell C'
p1932
aS'TITLE'
p1933
aS'Visual transduction in Drosophila.'
p1934
aS'JOURNAL'
p1935
aS'Annu Rev Cell Dev Biol 15:231-68 (1999)'
p1936
aS'PMID:20144772'
p1937
ag1937
aS'AUTHORS'
p1938
aS'Fain GL, Hardie R, Laughlin SB'
p1939
aS'TITLE'
p1940
aS'Phototransduction and the evolution of photoreceptors.'
p1941
aS'JOURNAL'
p1942
aS'Curr Biol 20:R114-24 (2010)'
p1943
aS'PMID:14761309'
p1944
ag1944
aS'AUTHORS'
p1945
aS'Kim C'
p1946
aS'TITLE'
p1947
aS'Transient receptor potential ion channels and animal sensation: lessons from Drosophila functional research.'
p1948
aS'JOURNAL'
p1949
aS'J Biochem Mol Biol 37:114-21 (2004)'
p1950
aS'PMID:18579072'
p1951
ag1951
aS'AUTHORS'
p1952
aS'Montell C'
p1953
aS'TITLE'
p1954
aS'In search of the holy grail for Drosophila TRP.'
p1955
aS'JOURNAL'
p1956
aS'Neuron 58:825-7 (2008)'
p1957
aS'PMID:15620638'
p1958
ag1958
aS'AUTHORS'
p1959
aS'Osorio D, Nilsson DE'
p1960
aS'TITLE'
p1961
aS'Visual pigments: trading noise for fast recovery.'
p1962
aS'JOURNAL'
p1963
aS'Curr Biol 14:R1051-3 (2004)'
p1964
aS'PMID:20045325'
p1965
ag1965
aS'AUTHORS'
p1966
aS'Wang X, Wang T, Jiao Y, von Lintig J, Montell C'
p1967
aS'TITLE'
p1968
aS'Requirement for an enzymatic visual cycle in Drosophila.'
p1969
aS'JOURNAL'
p1970
aS'Curr Biol 20:93-102 (2010)'
p1971
aS'PMID:18786361'
p1972
ag1972
aS'AUTHORS'
p1973
aS'Liu CH, Satoh AK, Postma M, Huang J, Ready DF, Hardie RC'
p1974
aS'TITLE'
p1975
aS'Ca2+-dependent metarhodopsin inactivation mediated by calmodulin and NINAC myosin III.'
p1976
aS'JOURNAL'
p1977
aS'Neuron 59:778-89 (2008)'
p1978
aS'PMID:18579079'
p1979
ag1979
aS'AUTHORS'
p1980
aS'Leung HT, Tseng-Crank J, Kim E, Mahapatra C, Shino S, Zhou Y, An L, Doerge RW, Pak WL'
p1981
aS'TITLE'
p1982
aS'DAG lipase activity is necessary for TRP channel regulation in Drosophila photoreceptors.'
p1983
aS'JOURNAL'
p1984
aS'Neuron 58:884-96 (2008)'
p1985
aS'PMID:16914683'
p1986
ag1986
aS'AUTHORS'
p1987
aS'Popescu DC, Ham AJ, Shieh BH'
p1988
aS'TITLE'
p1989
aS'Scaffolding protein INAD regulates deactivation of vision by promoting phosphorylation of transient receptor potential by eye protein kinase C in Drosophila.'
p1990
aS'JOURNAL'
p1991
aS'J Neurosci 26:8570-7 (2006)'
p1992
asS'KO_PATHWAY'
p1993
(lp1994
S'ko04745'
p1995
asS'ENTRY'
p1996
(lp1997
S'map04745'
p1998
aS'Pathway'
p1999
asS'PATHWAY_MAP'
p2000
(lp2001
S'map04745'
p2002
asS'CLASS'
p2003
(lp2004
S'Organismal Systems Sensory system'
p2005
asS'DESCRIPTION'
p2006
(lp2007
S'Phototransduction is the process that converts the signal of light (photons) into a change of membrane potential in photoreceptor cells. Drosophila visual signaling is initiated with the activation of rhodopsin by light. Rhodopsin is composed of a protein, opsin, covalently linked to a chromophore, 3-hydroxy-11-cis-retinal. Upon absorption of a light photon the chromophore is isomerized from the 11-cis to the all-trans configuration which induces a structural change that activates the opsin. This photoconversion activates heterotrimeric Gq protein via GTP-GDP exchange, releasing the G(alpha)q subunit. G(alpha)q activates PLC, generating InsP3 and DAG from PIP2. DAG may further release polyunsaturated fatty acids (PUFAs) via action of DAG lipase. This reaction leads to the opening of cation-selective channels (trp and trpl genes) and causes the depolarization of the photoreceptor cells. The transduction proteins rhodopsin, G(alpha)q, PLC, PKC, TRP, and TRPL are coordinated by a polymer of INAD scaffold proteins.'
p2008
assS'path:map04744'
p2009
(dp2010
S'NAME'
p2011
(lp2012
S'Phototransduction'
p2013
asS'REFERENCE'
p2014
(lp2015
S'PMID:19837030'
p2016
ag2016
aS'AUTHORS'
p2017
aS'Yau KW, Hardie RC'
p2018
aS'TITLE'
p2019
aS'Phototransduction motifs and variations.'
p2020
aS'JOURNAL'
p2021
aS'Cell 139:246-64 (2009)'
p2022
aS'PMID:11952100'
p2023
ag2023
aS'AUTHORS'
p2024
aS'Koch KW, Duda T, Sharma RK'
p2025
aS'TITLE'
p2026
aS'Photoreceptor specific guanylate cyclases in vertebrate phototransduction.'
p2027
aS'JOURNAL'
p2028
aS'Mol Cell Biochem 230:97-106 (2002)'
p2029
aS'PMID:9803480'
p2030
ag2030
aS'AUTHORS'
p2031
aS'Jindrova H'
p2032
aS'TITLE'
p2033
aS'Vertebrate phototransduction: activation, recovery, and adaptation.'
p2034
aS'JOURNAL'
p2035
aS'Physiol Res 47:155-68 (1998)'
p2036
aS'PMID:11070368'
p2037
ag2037
aS'AUTHORS'
p2038
aS'Ebrey T, Koutalos Y'
p2039
aS'TITLE'
p2040
aS'Vertebrate photoreceptors.'
p2041
aS'JOURNAL'
p2042
aS'Prog Retin Eye Res 20:49-94 (2001)'
p2043
aS'PMID:11587916'
p2044
ag2044
aS'AUTHORS'
p2045
aS'Pepe IM'
p2046
aS'TITLE'
p2047
aS'Recent advances in our understanding of rhodopsin and phototransduction.'
p2048
aS'JOURNAL'
p2049
aS'Prog Retin Eye Res 20:733-59 (2001)'
p2050
aS'PMID:11551982'
p2051
ag2051
aS'AUTHORS'
p2052
aS'Kramer RH, Molokanova E'
p2053
aS'TITLE'
p2054
aS'Modulation of cyclic-nucleotide-gated channels and regulation of vertebrate phototransduction.'
p2055
aS'JOURNAL'
p2056
aS'J Exp Biol 204:2921-31 (2001)'
p2057
aS'PMID:19720650'
p2058
ag2058
aS'AUTHORS'
p2059
aS'Larhammar D, Nordstrom K, Larsson TA'
p2060
aS'TITLE'
p2061
aS'Evolution of vertebrate rod and cone phototransduction genes.'
p2062
aS'JOURNAL'
p2063
aS'Philos Trans R Soc Lond B Biol Sci 364:2867-80 (2009)'
p2064
aS'PMID:19953307'
p2065
ag2065
aS'AUTHORS'
p2066
aS'Dizhoor AM, Olshevskaya EV, Peshenko IV'
p2067
aS'TITLE'
p2068
aS'Mg2+/Ca2+ cation binding cycle of guanylyl cyclase activating proteins (GCAPs): role in regulation of photoreceptor guanylyl cyclase.'
p2069
aS'JOURNAL'
p2070
aS'Mol Cell Biochem 334:117-24 (2010)'
p2071
aS'PMID:12161344'
p2072
ag2072
aS'AUTHORS'
p2073
aS'Krizaj D, Copenhagen DR'
p2074
aS'TITLE'
p2075
aS'Calcium regulation in photoreceptors.'
p2076
aS'JOURNAL'
p2077
aS'Front Biosci 7:d2023-44 (2002)'
p2078
aS'PMID:9893707'
p2079
ag2079
aS'AUTHORS'
p2080
aS'Shichida Y, Imai H'
p2081
aS'TITLE'
p2082
aS'Visual pigment: G-protein-coupled receptor for light signals.'
p2083
aS'JOURNAL'
p2084
aS'Cell Mol Life Sci 54:1299-315 (1998)'
p2085
aS'PMID:9419388'
p2086
ag2086
aS'AUTHORS'
p2087
aS'Pugh EN Jr, Duda T, Sitaramayya A, Sharma RK'
p2088
aS'TITLE'
p2089
aS'Photoreceptor guanylate cyclases: a review.'
p2090
aS'JOURNAL'
p2091
aS'Biosci Rep 17:429-73 (1997)'
p2092
aS'PMID:18632568'
p2093
ag2093
aS'AUTHORS'
p2094
aS'Luo DG, Xue T, Yau KW'
p2095
aS'TITLE'
p2096
aS'How vision begins: an odyssey.'
p2097
aS'JOURNAL'
p2098
aS'Proc Natl Acad Sci U S A 105:9855-62 (2008)'
p2099
aS'PMID:17545152'
p2100
ag2100
aS'AUTHORS'
p2101
aS'Peshenko IV, Dizhoor AM'
p2102
aS'TITLE'
p2103
aS'Activation and inhibition of photoreceptor guanylyl cyclase by guanylyl cyclase activating protein 1 (GCAP-1): the functional role of Mg2+/Ca2+ exchange in EF-hand domains.'
p2104
aS'JOURNAL'
p2105
aS'J Biol Chem 282:21645-52 (2007)'
p2106
aS'PMID:13678959'
p2107
ag2107
aS'AUTHORS'
p2108
aS'Ridge KD, Abdulaev NG, Sousa M, Palczewski K'
p2109
aS'TITLE'
p2110
aS'Phototransduction: crystal clear.'
p2111
aS'JOURNAL'
p2112
aS'Trends Biochem Sci 28:479-87 (2003)'
p2113
asS'KO_PATHWAY'
p2114
(lp2115
S'ko04744'
p2116
asS'PATHWAY_MAP'
p2117
(lp2118
S'map04744'
p2119
asS'DISEASE'
p2120
(lp2121
S'H00481'
p2122
aS'Cone-rod dystrophy and cone dystrophy'
p2123
ag2122
ag2123
aS'H00527'
p2124
aS'Retinitis pigmentosa (RP)'
p2125
aS'H00787'
p2126
aS'Congenital stationary night blindness (CSNB)'
p2127
aS'H00825'
p2128
aS'Familial flecked retina syndrome'
p2129
aS'H00837'
p2130
aS'Leber congenital amaurosis (LCR)'
p2131
aS'H00973'
p2132
aS'Bradyopsia'
p2133
asS'DBLINKS'
p2134
(lp2135
S'GO: 0009586'
p2136
asS'ENTRY'
p2137
(lp2138
S'map04744'
p2139
aS'Pathway'
p2140
asS'CLASS'
p2141
(lp2142
S'Organismal Systems Sensory system'
p2143
asS'DESCRIPTION'
p2144
(lp2145
S'Phototransduction is a biochemical process by which the photoreceptor cells generate electrical signals in response to captured photons. The vertebrate cascade starts with the absorption of photons by the photoreceptive pigments, the rhodopsins, which consist of a membrane embedded chromophore, 11-cis-retinal, and a G-protein-coupled receptor, opsin. The photon isomerizes 11-cis-retinal to all-trans-retinal which induces a structural change that activates the opsin. This triggers hydrolysis of cGMP by activating a transducinphosphodiesterase 6 (PDE6) cascade, which results in closure of the cGMP-gated cation channels (CNG) in the plasma membrane and membrane hyperpolarization. The hyperpolarization of the membrane potential of the photoreceptor cell modulates the release of neurotransmitters to downstream cells. Recovery from light involves the deactivation of the light- activated intermediates: photolyzed rhodopsin is phosphorylated by rhodopsin kinase (RK) and subsequently capped off by arrestin GTP-binding transducin alpha subunit deactivates through a process that is stimulated by RGS9.'
p2146
assS'path:map03050'
p2147
(dp2148
S'NAME'
p2149
(lp2150
S'Proteasome'
p2151
asS'REFERENCE'
p2152
(lp2153
S'PMID:16338359'
p2154
ag2154
aS'AUTHORS'
p2155
aS'Hirano Y, Murata S, Tanaka K'
p2156
aS'TITLE'
p2157
aS'Large- and small-scale purification of mammalian 26S proteasomes.'
p2158
aS'JOURNAL'
p2159
aS'Methods Enzymol 399:227-40 (2005)'
p2160
aS'PMID:18497808'
p2161
ag2161
aS'AUTHORS'
p2162
aS'Saeki Y, Tanaka K'
p2163
aS'TITLE'
p2164
aS'Cell biology: two hands for degradation.'
p2165
aS'JOURNAL'
p2166
aS'Nature 453:460-1 (2008)'
p2167
aS'PMID:16919475'
p2168
ag2168
aS'AUTHORS'
p2169
aS'Smith DM, Benaroudj N, Goldberg A'
p2170
aS'TITLE'
p2171
aS'Proteasomes and their associated ATPases: a destructive combination.'
p2172
aS'JOURNAL'
p2173
aS'J Struct Biol 156:72-83 (2006)'
p2174
aS'PMID:16181324'
p2175
ag2175
aS'AUTHORS'
p2176
aS'Strehl B, Seifert U, Kruger E, Heink S, Kuckelkorn U, Kloetzel PM'
p2177
aS'TITLE'
p2178
aS'Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.'
p2179
aS'JOURNAL'
p2180
aS'Immunol Rev 207:19-30 (2005)'
p2181
aS'PMID:16922378'
p2182
ag2182
aS'AUTHORS'
p2183
aS'Isono E, Toh-e A'
p2184
aS'TITLE'
p2185
aS'[Biogenesis of the 26S proteasome in the yeast Saccharomyces cerevisiae]'
p2186
aS'JOURNAL'
p2187
aS'Tanpakushitsu Kakusan Koso 51:1224-9 (2006)'
p2188
aS'PMID:16922379'
p2189
ag2189
aS'AUTHORS'
p2190
aS'Hirano Y, Murata S'
p2191
aS'TITLE'
p2192
aS'[Mechanism of the assembly of mammalian 20S proteasome]'
p2193
aS'JOURNAL'
p2194
aS'Tanpakushitsu Kakusan Koso 51:1230-5 (2006)'
p2195
aS'PMID:16922380'
p2196
ag2196
aS'AUTHORS'
p2197
aS'Saeki Y, Yashiroda H'
p2198
aS'TITLE'
p2199
aS'[Diversity of proteasome activators]'
p2200
aS'JOURNAL'
p2201
aS'Tanpakushitsu Kakusan Koso 51:1236-40 (2006)'
p2202
aS'PMID:19483713'
p2203
ag2203
aS'AUTHORS'
p2204
aS'Darwin KH'
p2205
aS'TITLE'
p2206
aS'Prokaryotic ubiquitin-like protein (Pup), proteasomes and pathogenesis.'
p2207
aS'JOURNAL'
p2208
aS'Nat Rev Microbiol 7:485-91 (2009)'
p2209
asS'KO_PATHWAY'
p2210
(lp2211
S'ko03050'
p2212
asS'PATHWAY_MAP'
p2213
(lp2214
S'map03050'
p2215
asS'DISEASE'
p2216
(lp2217
S'H00790'
p2218
aS'Keratosis linearis with ichthyosis congenita and sclerosing keratoderma'
p2219
asS'MODULE'
p2220
(lp2221
S'M00337'
p2222
aS'Immunoproteasome [PATH:map03050]'
p2223
ag2222
ag2223
aS'M00340'
p2224
aS'Proteasome, 20S core particle [PATH:map03050]'
p2225
aS'M00341'
p2226
aS'Proteasome, 19S regulatory particle (PA700) [PATH:map03050]'
p2227
aS'M00342'
p2228
aS'Bacterial proteasome [PATH:map03050]'
p2229
aS'M00343'
p2230
aS'Archaeal proteasome [PATH:map03050]'
p2231
asS'DBLINKS'
p2232
(lp2233
S'GO: 0000502'
p2234
asS'ENTRY'
p2235
(lp2236
S'map03050'
p2237
aS'Pathway'
p2238
asS'CLASS'
p2239
(lp2240
S'Genetic Information Processing Folding, sorting and degradation'
p2241
asS'DESCRIPTION'
p2242
(lp2243
S'The proteasome is a protein-destroying apparatus involved in many essential cellular functions, such as regulation of cell cycle, cell differentiation, signal transduction pathways, antigen processing for appropriate immune responses, stress signaling, inflammatory responses, and apoptosis. It is capable of degrading a variety of cellular proteins in a rapid and timely fashion and most substrate proteins are modified by ubiquitin before their degradation by the proteasome. The proteasome is a large protein complex consisting of a proteolytic core called the 20S particle and ancillary factors that regulate its activity in various ways. The most common form is the 26S proteasome containing one 20S core particle and two 19S regulatory particles that enable the proteasome to degrade ubiquitinated proteins by an ATP-dependent mechanism. Another form is the immunoproteasome containing two 11S regulatory particles, PA28 alpha and PA28 beta, which are induced by interferon gamma under the conditions of intensified immune response. Other regulatory particles include PA28 gamma and PA200. Although PA28 gamma also belongs to a family of activators of the 20S proteasome, it is localized within the nucleus and forms a homoheptamer. PA28 gamma has been implicated in the regulation of cell cycle progression and apoptosis. PA200 has been identified as a large nuclear protein that stimulates proteasomal hydrolysis of peptides.'
p2244
assS'path:map04740'
p2245
(dp2246
S'NAME'
p2247
(lp2248
S'Olfactory transduction'
p2249
asS'REFERENCE'
p2250
(lp2251
S'PMID:11557990'
p2252
ag2252
aS'AUTHORS'
p2253
aS'Firestein S.'
p2254
aS'TITLE'
p2255
aS'How the olfactory system makes sense of scents.'
p2256
aS'JOURNAL'
p2257
aS'Nature 413:211-8 (2001)'
p2258
aS'PMID:16269360'
p2259
ag2259
aS'AUTHORS'
p2260
aS'Ache BW, Young JM.'
p2261
aS'TITLE'
p2262
aS'Olfaction: diverse species, conserved principles.'
p2263
aS'JOURNAL'
p2264
aS'Neuron 48:417-30 (2005)'
p2265
aS'PMID:10908849'
p2266
ag2266
aS'AUTHORS'
p2267
aS'Nakamura T.'
p2268
aS'TITLE'
p2269
aS'Cellular and molecular constituents of olfactory sensation in vertebrates.'
p2270
aS'JOURNAL'
p2271
aS'Comp Biochem Physiol A Mol Integr Physiol 126:17-32 (2000)'
p2272
aS'PMID:10944513'
p2273
ag2273
aS'AUTHORS'
p2274
aS'Zufall F, Leinders-Zufall T.'
p2275
aS'TITLE'
p2276
aS'The cellular and molecular basis of odor adaptation.'
p2277
aS'JOURNAL'
p2278
aS'Chem Senses 25:473-81 (2000)'
p2279
aS'PMID:9547228'
p2280
ag2280
aS'AUTHORS'
p2281
aS'Moon C, Jaberi P, Otto-Bruc A, Baehr W, Palczewski K, Ronnett GV.'
p2282
aS'TITLE'
p2283
aS'Calcium-sensitive particulate guanylyl cyclase as a modulator of cAMP in olfactory receptor neurons.'
p2284
aS'JOURNAL'
p2285
aS'J Neurosci 18:3195-205 (1998)'
p2286
aS'PMID:11826268'
p2287
ag2287
aS'AUTHORS'
p2288
aS'Ronnett GV, Moon C.'
p2289
aS'TITLE'
p2290
aS'G proteins and olfactory signal transduction.'
p2291
aS'JOURNAL'
p2292
aS'Annu Rev Physiol 64:189-222 (2002)'
p2293
aS'PMID:12939389'
p2294
ag2294
aS'AUTHORS'
p2295
aS'Barry PH.'
p2296
aS'TITLE'
p2297
aS'The relative contributions of cAMP and InsP3 pathways to olfactory responses in vertebrate olfactory receptor neurons and the specificity of odorants for both pathways.'
p2298
aS'JOURNAL'
p2299
aS'J Gen Physiol 122:247-50 (2003)'
p2300
aS'PMID:12488531'
p2301
ag2301
aS'AUTHORS'
p2302
aS'Kohout TA, Lefkowitz RJ.'
p2303
aS'TITLE'
p2304
aS'Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization.'
p2305
aS'JOURNAL'
p2306
aS'Mol Pharmacol 63:9-18 (2003)'
p2307
aS'PMID:9020189'
p2308
ag2308
aS'AUTHORS'
p2309
aS'Boekhoff I, Touhara K, Danner S, Inglese J, Lohse MJ, Breer H, Lefkowitz RJ.'
p2310
aS'TITLE'
p2311
aS'Phosducin, potential role in modulation of olfactory signaling.'
p2312
aS'JOURNAL'
p2313
aS'J Biol Chem 272:4606-12 (1997)'
p2314
asS'KO_PATHWAY'
p2315
(lp2316
S'ko04740'
p2317
asS'PATHWAY_MAP'
p2318
(lp2319
S'map04740'
p2320
asS'DBLINKS'
p2321
(lp2322
S'GO: 0007608'
p2323
asS'ENTRY'
p2324
(lp2325
S'map04740'
p2326
aS'Pathway'
p2327
asS'CLASS'
p2328
(lp2329
S'Organismal Systems Sensory system'
p2330
asS'DESCRIPTION'
p2331
(lp2332
S'Within the compact cilia of the olfactory receptor neurons (ORNs) a cascade of enzymatic activity transduces the binding of an odorant molecule to a receptor into an electrical signal that can be transmitted to the brain. Odorant molecules bind to a receptor protein (R) coupled to an olfactory specific Gs-protein (G) and activate a type III adenylyl cyclase (AC), increasing intracellular cAMP levels. cAMP targets an olfactory-specific cyclic-nucleotide gated ion channel (CNG), allowing cations, particularly Na and Ca, to flow down their electrochemical gradients into the cell, depolarizing the ORN. Furthermore, the Ca entering the cell is able to activate a Ca-activated Cl channel, which would allow Cl to flow out of the cell, thus further increasing the depolarization. Elevated intracellular Ca causes adaptation by at least two different molecular steps: inhibition of the activity of adenylyl cyclase via CAMKII-dependent phosphorylation and down-regulation of the affinity of the CNG channel to cAMP.Longer exposure to odorants can stimulate particulate guanylyl cyclase in cilia to produce cGMP and activate PKG, leading to a further increase in amount and duration of intracellular cAMP levels, which may serve to convert inactive forms of protein kinase A (PKA2) to active forms (PKA*). As part of a feedback loop, PKA can inhibit the activation of particulate guanylyl cyclase.'
p2333
assS'path:map04742'
p2334
(dp2335
S'NAME'
p2336
(lp2337
S'Taste transduction'
p2338
asS'REFERENCE'
p2339
(lp2340
S'PMID:12581520'
p2341
ag2341
aS'AUTHORS'
p2342
aS'Zhang Y, Hoon MA, Chandrashekar J, Mueller KL, Cook B, Wu D, Zuker CS, Ryba NJ.'
p2343
aS'TITLE'
p2344
aS'Coding of sweet, bitter, and umami tastes: different receptor cells sharing similar signaling pathways.'
p2345
aS'JOURNAL'
p2346
aS'Cell 112:293-301 (2003)'
p2347
aS'PMID:12887980'
p2348
ag2348
aS'AUTHORS'
p2349
aS'Bigiani A, Ghiaroni V, Fieni F.'
p2350
aS'TITLE'
p2351
aS'Channels as taste receptors in vertebrates.'
p2352
aS'JOURNAL'
p2353
aS'Prog Biophys Mol Biol 83:193-225 (2003)'
p2354
aS'PMID:15738174'
p2355
ag2355
aS'AUTHORS'
p2356
aS'Kinnamon SC, Lin W, Ogura T, Ruiz C, Delay E.'
p2357
aS'TITLE'
p2358
aS'Downstream signaling effectors for umami taste.'
p2359
aS'JOURNAL'
p2360
aS'Chem Senses 30 Suppl 1:i31-i32 (2005)'
p2361
aS'PMID:16032395'
p2362
ag2362
aS'AUTHORS'
p2363
aS'Meyerhof W.'
p2364
aS'TITLE'
p2365
aS'Elucidation of mammalian bitter taste.'
p2366
aS'JOURNAL'
p2367
aS'Rev Physiol Biochem Pharmacol 154:37-72 (2005)'
p2368
aS'PMID:11696554'
p2369
ag2369
aS'AUTHORS'
p2370
aS'Margolskee RF.'
p2371
aS'TITLE'
p2372
aS'Molecular mechanisms of bitter and sweet taste transduction.'
p2373
aS'JOURNAL'
p2374
aS'J Biol Chem 277:1-4 (2002)'
p2375
aS'PMID:10981623'
p2376
ag2376
aS'AUTHORS'
p2377
aS'Gilbertson TA, Damak S, Margolskee RF.'
p2378
aS'TITLE'
p2379
aS'The molecular physiology of taste transduction.'
p2380
aS'JOURNAL'
p2381
aS'Curr Opin Neurobiol 10:519-27 (2000)'
p2382
aS'PMID:11738657'
p2383
ag2383
aS'AUTHORS'
p2384
aS'DeSimone JA, Lyall V, Heck GL, Feldman GM.'
p2385
aS'TITLE'
p2386
aS'Acid detection by taste receptor cells.'
p2387
aS'JOURNAL'
p2388
aS'Respir Physiol 129:231-45 (2001)'
p2389
aS'PMID:12091539'
p2390
ag2390
aS'AUTHORS'
p2391
aS'Lin W, Ogura T, Kinnamon SC.'
p2392
aS'TITLE'
p2393
aS'Acid-activated cation currents in rat vallate taste receptor cells.'
p2394
aS'JOURNAL'
p2395
aS'J Neurophysiol 88:133-41 (2002)'
p2396
aS'PMID:12736236'
p2397
ag2397
aS'AUTHORS'
p2398
aS'Feldman GM, Mogyorosi A, Heck GL, DeSimone JA, Santos CR, Clary RA, Lyall V.'
p2399
aS'TITLE'
p2400
aS'Salt-evoked lingual surface potential in humans.'
p2401
aS'JOURNAL'
p2402
aS'J Neurophysiol 90:2060-4 (2003)'
p2403
aS'PMID:8794107'
p2404
ag2404
aS'AUTHORS'
p2405
aS'Kinnamon SC, Margolskee RF.'
p2406
aS'TITLE'
p2407
aS'Mechanisms of taste transduction.'
p2408
aS'JOURNAL'
p2409
aS'Curr Opin Neurobiol 6:506-13 (1996)'
p2410
aS'PMID:12368808'
p2411
ag2411
aS'AUTHORS'
p2412
aS'Perez CA, Huang L, Rong M, Kozak JA, Preuss AK, Zhang H, Max M, Margolskee RF.'
p2413
aS'TITLE'
p2414
aS'A transient receptor potential channel expressed in taste receptor cells.'
p2415
aS'JOURNAL'
p2416
aS'Nat Neurosci 5:1169-76 (2002)'
p2417
aS'PMID:14637165'
p2418
ag2418
aS'AUTHORS'
p2419
aS'Kim MR, Kusakabe Y, Miura H, Shindo Y, Ninomiya Y, Hino A.'
p2420
aS'TITLE'
p2421
aS'Regional expression patterns of taste receptors and gustducin in the mouse tongue.'
p2422
aS'JOURNAL'
p2423
aS'Biochem Biophys Res Commun 312:500-6 (2003)'
p2424
aS'PMID:9146906'
p2425
ag2425
aS'AUTHORS'
p2426
aS'Uchida Y, Sato T.'
p2427
aS'TITLE'
p2428
aS'Changes in outward K+ currents in response to two types of sweeteners in sweet taste transduction of gerbil taste cells.'
p2429
aS'JOURNAL'
p2430
aS'Chem Senses 22:163-9 (1997)'
p2431
aS'PMID:16183910'
p2432
ag2432
aS'AUTHORS'
p2433
aS'Wettschureck N, Offermanns S.'
p2434
aS'TITLE'
p2435
aS'Mammalian G proteins and their cell type specific functions.'
p2436
aS'JOURNAL'
p2437
aS'Physiol Rev 85:1159-204 (2005)'
p2438
aS'PMID:16269362'
p2439
ag2439
aS'AUTHORS'
p2440
aS'Scott K.'
p2441
aS'TITLE'
p2442
aS'Taste recognition: food for thought.'
p2443
aS'JOURNAL'
p2444
aS'Neuron 48:455-64 (2005)'
p2445
aS'PMID:16436689'
p2446
ag2446
aS'AUTHORS'
p2447
aS'Damak S, Rong M, Yasumatsu K, Kokrashvili Z, Perez CA, Shigemura N, Yoshida R, Mosinger B Jr, Glendinning JI, Ninomiya Y, Margolskee RF.'
p2448
aS'TITLE'
p2449
aS'Trpm5 null mice respond to bitter, sweet, and umami compounds.'
p2450
aS'JOURNAL'
p2451
aS'Chem Senses 31:253-64 (2006)'
p2452
asS'KO_PATHWAY'
p2453
(lp2454
S'ko04742'
p2455
asS'PATHWAY_MAP'
p2456
(lp2457
S'map04742'
p2458
asS'DBLINKS'
p2459
(lp2460
S'GO: 0050909'
p2461
asS'ENTRY'
p2462
(lp2463
S'map04742'
p2464
aS'Pathway'
p2465
asS'CLASS'
p2466
(lp2467
S'Organismal Systems Sensory system'
p2468
asS'DESCRIPTION'
p2469
(lp2470
S'All taste pathways are proposed to converge on common elements that mediate a rise in intracellular Ca2+ followed by neurotransmitter release. Na+ salt depolarizes taste cells by passive influx of Na+ through the amiloride-sensitive Na+ channel (ENaC). Acids depolarize taste cells by a variety of mechanisms, including influx of protons (H+) through ENaC and a proton-gated cation channel (MDEG). Two putative umami receptors have been identified: a truncated variant of the metabotropic glutamate receptor mGluR4 and the heterodimer, T1R1 + T1R3. Umami receptors are coupled to a signaling pathway involving activation of PLCbeta2, production of IP3 and diacylglycerol, release of Ca2+ from intracellular stores and activation of a transient receptor potential channel, TRPM5. Bitter compounds, such as denatonium and PROP, activate particular T2R/TRB isoforms, which activate gustducin heterotrimers. Activated alpha-gustducin stimulates PDE to hydrolyze cAMP, whereas betagamma subunits activate PLCbeta2 to generate IP3, which leads to release of Ca2+ from internal stores. Artificial sweeteners activate GPCRs (T1R heterodimers) apparently linked via PLC to IP3 production and release of Ca2+ from intracellular stores. Sugars apparently activate GPCRs linked via AC to cAMP production which, in turn, may inhibit basolateral K+ channels through phosphorylation by cAMP-activated protein kinase A (PKA).'
p2471
assS'path:map00790'
p2472
(dp2473
S'NAME'
p2474
(lp2475
S'Folate biosynthesis'
p2476
asS'REFERENCE'
p2477
(lp2478
g22
ag22
aS'AUTHORS'
p2479
aS'Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).'
p2480
aS'TITLE'
p2481
aS'[Cellular Functions and Metabolic Maps] (In Japanese)'
p2482
aS'JOURNAL'
p2483
aS'Tokyo Kagaku Dojin (1997)'
p2484
aS'PMID:19675644'
p2485
ag2485
aS'AUTHORS'
p2486
aS'Schwarz G, Mendel RR, Ribbe MW'
p2487
aS'TITLE'
p2488
aS'Molybdenum cofactors, enzymes and pathways.'
p2489
aS'JOURNAL'
p2490
aS'Nature 460:839-47 (2009)'
p2491
aS'PMID:16632608'
p2492
ag2492
aS'AUTHORS'
p2493
aS'Hanzelmann P, Schindelin H'
p2494
aS'TITLE'
p2495
aS"Binding of 5'-GTP to the C-terminal FeS cluster of the radical S-adenosylmethionine enzyme MoaA provides insights into its mechanism."
p2496
aS'JOURNAL'
p2497
aS'Proc Natl Acad Sci U S A 103:6829-34 (2006)'
p2498
aS'PMID:18092812'
p2499
ag2499
aS'AUTHORS'
p2500
aS'Daniels JN, Wuebbens MM, Rajagopalan KV, Schindelin H'
p2501
aS'TITLE'
p2502
aS'Crystal structure of a molybdopterin synthase-precursor Z complex: insight into its sulfur transfer mechanism and its role in molybdenum cofactor deficiency.'
p2503
aS'JOURNAL'
p2504
aS'Biochemistry 47:615-26 (2008)'
p2505
aS'PMID:12571226'
p2506
ag2506
aS'AUTHORS'
p2507
aS'Wuebbens MM, Rajagopalan KV'
p2508
aS'TITLE'
p2509
aS'Mechanistic and mutational studies of Escherichia coli molybdopterin synthase clarify the final step of molybdopterin biosynthesis.'
p2510
aS'JOURNAL'
p2511
aS'J Biol Chem 278:14523-32 (2003)'
p2512
asS'KO_PATHWAY'
p2513
(lp2514
S'ko00790'
p2515
asS'PATHWAY_MAP'
p2516
(lp2517
S'map00790'
p2518
asS'DISEASE'
p2519
(lp2520
S'H00167'
p2521
aS'Phenylketonuria (PKU)'
p2522
ag2521
ag2522
aS'H00213'
p2523
aS'Hypophosphatasia'
p2524
aS'H00831'
p2525
aS'Primary dystonia'
p2526
aS'H01197'
p2527
aS'Dihydrofolate reductase (DHFR) deficiency'
p2528
asS'MODULE'
p2529
(lp2530
S'M00126'
p2531
aS'Tetrahydrofolate biosynthesis, GTP => THF [PATH:map00790]'
p2532
asS'DBLINKS'
p2533
(lp2534
S'GO: 0046656'
p2535
asS'ENTRY'
p2536
(lp2537
S'map00790'
p2538
aS'Pathway'
p2539
asS'CLASS'
p2540
(lp2541
S'Metabolism Metabolism of cofactors and vitamins'
p2542
assS'path:map00791'
p2543
(dp2544
S'DBLINKS'
p2545
(lp2546
S'UMBBD: atr cya cnm cpm'
p2547
ag2547
aS'GO: 0019381'
p2548
asS'NAME'
p2549
(lp2550
S'Atrazine degradation'
p2551
asS'REFERENCE'
p2552
(lp2553
S'PMID:16597948'
p2554
ag2554
aS'AUTHORS'
p2555
aS'Shapir N, Cheng G, Sadowsky MJ, Wackett LP'
p2556
aS'TITLE'
p2557
aS'Purification and characterization of TrzF: biuret hydrolysis by allophanate hydrolase supports growth.'
p2558
aS'JOURNAL'
p2559
aS'Appl Environ Microbiol 72:2491-5 (2006)'
p2560
aS'PMID:16085834'
p2561
ag2561
aS'AUTHORS'
p2562
aS'Cheng G, Shapir N, Sadowsky MJ, Wackett LP.'
p2563
aS'TITLE'
p2564
aS'Allophanate hydrolase, not urease, functions in bacterial cyanuric acid metabolism.'
p2565
aS'JOURNAL'
p2566
aS'Appl Environ Microbiol 71:4437-45 (2005)'
p2567
asS'KO_PATHWAY'
p2568
(lp2569
S'ko00791'
p2570
asS'ENTRY'
p2571
(lp2572
S'map00791'
p2573
aS'Pathway'
p2574
asS'PATHWAY_MAP'
p2575
(lp2576
S'map00791'
p2577
asS'CLASS'
p2578
(lp2579
S'Metabolism Xenobiotics biodegradation and metabolism'
p2580
assS'path:map01220'
p2581
(dp2582
S'NAME'
p2583
(lp2584
S'Degradation of aromatic compounds'
p2585
asS'KO_PATHWAY'
p2586
(lp2587
S'ko01220'
p2588
asS'ENTRY'
p2589
(lp2590
S'map01220'
p2591
aS'Global'
p2592
aS'Pathway'
p2593
asS'PATHWAY_MAP'
p2594
(lp2595
S'map01220'
p2596
asS'CLASS'
p2597
(lp2598
S'Metabolism Overview'
p2599
asS'MODULE'
p2600
(lp2601
S'M00174'
p2602
aS'Methane oxidation, methanotroph, methane => formaldehyde [PATH:map01220]'
p2603
ag2602
ag2603
aS'M00418'
p2604
aS'Toluene degradation, anaerobic, toluene => benzoyl-CoA [PATH:map01220]'
p2605
aS'M00419'
p2606
aS'Cymene degradation, p-cymene => p-cumate [PATH:map01220]'
p2607
aS'M00533'
p2608
aS'Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate [PATH:map01220]'
p2609
aS'M00534'
p2610
aS'Naphthalene degradation, naphthalene => salicylate [PATH:map01220]'
p2611
aS'M00537'
p2612
aS'Xylene degradation, xylene => methylbenzoate [PATH:map01220]'
p2613
aS'M00538'
p2614
aS'Toluene degradation, toluene => benzoate [PATH:map01220]'
p2615
aS'M00539'
p2616
aS'Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate [PATH:map01220]'
p2617
aS'M00540'
p2618
aS'Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA [PATH:map01220]'
p2619
aS'M00541'
p2620
aS'Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA [PATH:map01220]'
p2621
aS'M00543'
p2622
aS'Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate [PATH:map01220]'
p2623
aS'M00544'
p2624
aS'Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate [PATH:map01220]'
p2625
aS'M00545'
p2626
aS'Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA [PATH:map01220]'
p2627
aS'M00547'
p2628
aS'Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map01220]'
p2629
aS'M00548'
p2630
aS'Benzene degradation, benzene => catechol [PATH:map01220]'
p2631
aS'M00551'
p2632
aS'Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map01220]'
p2633
aS'M00568'
p2634
aS'Catechol ortho-cleavage, catechol => 3-oxoadipate [PATH:map01220]'
p2635
aS'M00569'
p2636
aS'Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map01220]'
p2637
aS'M00623'
p2638
aS'Phthalate degradation, phthalate => protocatechuate [PATH:map01220]'
p2639
aS'M00624'
p2640
aS'Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate [PATH:map01220]'
p2641
aS'M00636'
p2642
aS'Phthalate degradation, phthalate => protocatechuate [PATH:map01220]'
p2643
asS'DESCRIPTION'
p2644
(lp2645
S'Microorganisms are known to be capable of degrading diverse chemical substances including man-made chemicals in the environment that are mostly aromatic compounds. This diagram illustrates combination patterns of reaction modules for biodegradation of aromatic compounds, consisting of three main types of ring dihydroxylation modules, followed by meta- or ortho-cleavage modules, together with an optional preprocessing module for converting methyl group to carboxyl group on the aromatic ring.'
p2646
assS'path:map03450'
p2647
(dp2648
S'NAME'
p2649
(lp2650
S'Non-homologous end-joining'
p2651
asS'REFERENCE'
p2652
(lp2653
S'PMID:16971555'
p2654
ag2654
aS'AUTHORS'
p2655
aS'Gennery AR.'
p2656
aS'TITLE'
p2657
aS'Primary immunodeficiency syndromes associated with defective DNA double-strand break repair.'
p2658
aS'JOURNAL'
p2659
aS'Br Med Bull 77-78:71-85 (2006)'
p2660
aS'PMID:17589524'
p2661
ag2661
aS'AUTHORS'
p2662
aS'Zhang Y, Hefferin ML, Chen L, Shim EY, Tseng HM, Kwon Y, Sung P, Lee SE, Tomkinson AE.'
p2663
aS'TITLE'
p2664
aS'Role of Dnl4-Lif1 in nonhomologous end-joining repair complex assembly and suppression of homologous recombination.'
p2665
aS'JOURNAL'
p2666
aS'Nat Struct Mol Biol 14:639-46 (2007)'
p2667
aS'PMID:16895466'
p2668
ag2668
aS'AUTHORS'
p2669
aS'Wyman C, Kanaar R.'
p2670
aS'TITLE'
p2671
aS"DNA double-strand break repair: all's well that ends well."
p2672
aS'JOURNAL'
p2673
aS'Annu Rev Genet 40:363-83 (2006)'
p2674
aS'PMID:15578053'
p2675
ag2675
aS'AUTHORS'
p2676
aS'Weller GR, Brandt VL, Roth DB.'
p2677
aS'TITLE'
p2678
aS'Doing more with less in bacterial DNA repair.'
p2679
aS'JOURNAL'
p2680
aS'Nat Struct Mol Biol 11:1158-9 (2004)'
p2681
aS'PMID:12215643'
p2682
ag2682
aS'AUTHORS'
p2683
aS"Weller GR, Kysela B, Roy R, Tonkin LM, Scanlan E, Della M, Devine SK, Day JP, Wilkinson A, d'Adda di Fagagna F, Devine KM, Bowater RP, Jeggo PA, Jackson SP, Doherty AJ."
p2684
aS'TITLE'
p2685
aS'Identification of a DNA nonhomologous end-joining complex in bacteria.'
p2686
aS'JOURNAL'
p2687
aS'Science 297:1686-9 (2002)'
p2688
aS'PMID:17506672'
p2689
ag2689
aS'AUTHORS'
p2690
aS'Pitcher RS, Brissett NC, Doherty AJ.'
p2691
aS'TITLE'
p2692
aS'Nonhomologous end-joining in bacteria: a microbial perspective.'
p2693
aS'JOURNAL'
p2694
aS'Annu Rev Microbiol 61:259-82 (2007)'
p2695
asS'KO_PATHWAY'
p2696
(lp2697
S'ko03450'
p2698
asS'PATHWAY_MAP'
p2699
(lp2700
S'map03450'
p2701
asS'DISEASE'
p2702
(lp2703
S'H00848'
p2704
aS'Ataxia with ocular apraxia (AOA)'
p2705
ag2704
ag2705
aS'H00924'
p2706
aS'Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation'
p2707
aS'H01344'
p2708
aS'Nijmegen Breakage Syndrome'
p2709
asS'MODULE'
p2710
(lp2711
S'M00292'
p2712
aS'MRX complex [PATH:map03450]'
p2713
ag2712
ag2713
aS'M00297'
p2714
aS'DNA-PK complex [PATH:map03450]'
p2715
asS'DBLINKS'
p2716
(lp2717
S'GO: 0006303'
p2718
asS'ENTRY'
p2719
(lp2720
S'map03450'
p2721
aS'Pathway'
p2722
asS'CLASS'
p2723
(lp2724
S'Genetic Information Processing Replication and repair'
p2725
asS'DESCRIPTION'
p2726
(lp2727
S'Nonhomologous end joining (NHEJ) eliminates DNA double-strand breaks (DSBs) by direct ligation. NHEJ involves binding of the KU heterodimer to double-stranded DNA ends, recruitment of DNA-PKcs (MRX complex in yeast), processing of ends, and recruitment of the DNA ligase IV (LIG4)-XRCC4 complex, which brings about ligation. A recent study shows that bacteria accomplish NHEJ using just two proteins (Ku and DNA ligase), whereas eukaryotes require many factors. NHEJ repairs DSBs at all stages of the cell cycle, bringing about the ligation of two DNA DSBs without the need for sequence homology, and so is error-prone.'
p2728
assS'path:map05340'
p2729
(dp2730
S'NAME'
p2731
(lp2732
S'Primary immunodeficiency'
p2733
asS'REFERENCE'
p2734
(lp2735
S'PMID:16261175'
p2736
ag2736
aS'AUTHORS'
p2737
aS'Cunningham-Rundles C, Ponda PP.'
p2738
aS'TITLE'
p2739
aS'Molecular defects in T- and B-cell primary immunodeficiency diseases.'
p2740
aS'JOURNAL'
p2741
aS'Nat Rev Immunol 5:880-92 (2005)'
p2742
aS'PMID:11941303'
p2743
ag2743
aS'AUTHORS'
p2744
aS'Ballow M.'
p2745
aS'TITLE'
p2746
aS'Primary immunodeficiency disorders: antibody deficiency.'
p2747
aS'JOURNAL'
p2748
aS'J Allergy Clin Immunol 109:581-91 (2002)'
p2749
aS'PMID:17960151'
p2750
ag2750
aS'AUTHORS'
p2751
aS'Marodi L, Notarangelo LD.'
p2752
aS'TITLE'
p2753
aS'Immunological and genetic bases of new primary immunodeficiencies.'
p2754
aS'JOURNAL'
p2755
aS'Nat Rev Immunol 7:851-61 (2007)'
p2756
aS'PMID:17952897'
p2757
ag2757
aS'AUTHORS'
p2758
aS'Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.'
p2759
aS'TITLE'
p2760
aS'Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.'
p2761
aS'JOURNAL'
p2762
aS'J Allergy Clin Immunol 120:776-94 (2007)'
p2763
aS'PMID:18093537'
p2764
ag2764
aS'AUTHORS'
p2765
aS'Fischer A.'
p2766
aS'TITLE'
p2767
aS'Human primary immunodeficiency diseases.'
p2768
aS'JOURNAL'
p2769
aS'Immunity 27:835-45 (2007)'
p2770
aS'PMID:14699405'
p2771
ag2771
aS'AUTHORS'
p2772
aS'Fischer A.'
p2773
aS'TITLE'
p2774
aS'Human primary immunodeficiency diseases: a perspective.'
p2775
aS'JOURNAL'
p2776
aS'Nat Immunol 5:23-30 (2004)'
p2777
aS'PMID:11058677'
p2778
ag2778
aS'AUTHORS'
p2779
aS'Buckley RH.'
p2780
aS'TITLE'
p2781
aS'Primary immunodeficiency diseases due to defects in lymphocytes.'
p2782
aS'JOURNAL'
p2783
aS'N Engl J Med 343:1313-24 (2000)'
p2784
aS'PMID:15661024'
p2785
ag2785
aS'AUTHORS'
p2786
aS'Fischer A, Le Deist F, Hacein-Bey-Abina S, Andre-Schmutz I, Basile Gde S, de Villartay JP, Cavazzana-Calvo M.'
p2787
aS'TITLE'
p2788
aS'Severe combined immunodeficiency. A model disease for molecular immunology and therapy.'
p2789
aS'JOURNAL'
p2790
aS'Immunol Rev 203:98-109 (2005)'
p2791
aS'PMID:14647478'
p2792
ag2792
aS'AUTHORS'
p2793
aS'de Villartay JP, Fischer A, Durandy A.'
p2794
aS'TITLE'
p2795
aS'The mechanisms of immune diversification and their disorders.'
p2796
aS'JOURNAL'
p2797
aS'Nat Rev Immunol 3:962-72 (2003)'
p2798
asS'KO_PATHWAY'
p2799
(lp2800
S'ko05340'
p2801
asS'PATHWAY_MAP'
p2802
(lp2803
S'map05340'
p2804
asS'DISEASE'
p2805
(lp2806
S'H00085'
p2807
aS'Agammaglobulinemias'
p2808
ag2807
ag2808
aS'H00086'
p2809
aS'Hyper IgM syndromes, autosomal recessive type'
p2810
aS'H00088'
p2811
aS'Common variable immunodeficiency (CVID)'
p2812
aS'H00091'
p2813
aS'T-B+Severe combined immunodeficiencies (SCIDs)'
p2814
aS'H00092'
p2815
aS'T-B-Severe combined immunodeficiencies (SCIDs)'
p2816
aS'H00093'
p2817
aS'Combined immunodeficiencies (CIDs)'
p2818
aS'H00095'
p2819
aS'Ectodermal dysplasia associated immunodeficiency (EDA-ID)'
p2820
aS'H00107'
p2821
aS'Other well-defined immunodeficiency syndromes'
p2822
aS'H00984'
p2823
aS'Bare lymphocyte syndrome (BLS) type1'
p2824
aS'H00985'
p2825
aS'Bare lymphocyte syndrome (BLS) type2'
p2826
asS'ENTRY'
p2827
(lp2828
S'map05340'
p2829
aS'Pathway'
p2830
asS'CLASS'
p2831
(lp2832
S'Human Diseases Immune diseases'
p2833
asS'DESCRIPTION'
p2834
(lp2835
S'Primary immunodeficiencies (PIs) are a heterogeneous group of disorders, which affect cellular and humoral immunity or non-specific host defense mechanisms mediated by complement proteins, and cells such as phagocytes and natural killer (NK) cells. These disorders of the immune system cause increased susceptibility to infection, autoimmune disease, and malignancy. Most of PIs are due to genetic defects that affect cell maturation or function at different levels during hematopoiesis. Disruption of the cellular immunity is observed in patients with defects in T cells or both T and B cells. These cellular immunodeficiencies comprise 20% of all PIs. Disorders of humoral immunity affect B-cell differentiation and antibody production. They account for 70% of all PIs.'
p2836
assS'path:map01040'
p2837
(dp2838
S'NAME'
p2839
(lp2840
S'Biosynthesis of unsaturated fatty acids'
p2841
asS'REFERENCE'
p2842
(lp2843
S'PMID:16564093'
p2844
ag2844
aS'AUTHORS'
p2845
aS'Jakobsson A, Westerberg R, Jacobsson A.'
p2846
aS'TITLE'
p2847
aS'Fatty acid elongases in mammals: their regulation and roles in metabolism.'
p2848
aS'JOURNAL'
p2849
aS'Prog Lipid Res 45:237-49 (2006)'
p2850
aS'PMID:12482854'
p2851
ag2851
aS'AUTHORS'
p2852
aS'Moon YA, Horton JD.'
p2853
aS'TITLE'
p2854
aS'Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade.'
p2855
aS'JOURNAL'
p2856
aS'J Biol Chem 278:7335-43 (2003)'
p2857
aS'PMID:12087109'
p2858
ag2858
aS'AUTHORS'
p2859
aS'Han G, Gable K, Kohlwein SD, Beaudoin F, Napier JA, Dunn TM.'
p2860
aS'TITLE'
p2861
aS'The Saccharomyces cerevisiae YBR159w gene encodes the 3-ketoreductase of the microsomal fatty acid elongase.'
p2862
aS'JOURNAL'
p2863
aS'J Biol Chem 277:35440-9 (2002)'
p2864
aS'PMID:11500517'
p2865
ag2865
aS'AUTHORS'
p2866
aS'Su HM, Moser AB, Moser HW, Watkins PA.'
p2867
aS'TITLE'
p2868
aS'Peroxisomal straight-chain Acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis.'
p2869
aS'JOURNAL'
p2870
aS'J Biol Chem 276:38115-20 (2001)'
p2871
aS'PMID:16766224'
p2872
ag2872
aS'AUTHORS'
p2873
aS'Huyghe S, Mannaerts GP, Baes M, Van Veldhoven PP.'
p2874
aS'TITLE'
p2875
aS'Peroxisomal multifunctional protein-2: the enzyme, the patients and the knockout mouse model.'
p2876
aS'JOURNAL'
p2877
aS'Biochim Biophys Acta 1761:973-94 (2006)'
p2878
aS'PMID:17719544'
p2879
ag2879
aS'AUTHORS'
p2880
aS'Denic V, Weissman JS'
p2881
aS'TITLE'
p2882
aS'A molecular caliper mechanism for determining very long-chain fatty acid length.'
p2883
aS'JOURNAL'
p2884
aS'Cell 130:663-77 (2007)'
p2885
asS'KO_PATHWAY'
p2886
(lp2887
S'ko01040'
p2888
asS'ENTRY'
p2889
(lp2890
S'map01040'
p2891
aS'Pathway'
p2892
asS'PATHWAY_MAP'
p2893
(lp2894
S'map01040'
p2895
asS'DISEASE'
p2896
(lp2897
S'H00407'
p2898
aS'Peroxisomal beta-oxidation enzyme deficiency'
p2899
asS'CLASS'
p2900
(lp2901
S'Metabolism Lipid metabolism'
p2902
assS'path:map04110'
p2903
(dp2904
S"DESCRIPTION Mitotic cell cycle progression is accomplished through a reproducible sequence of events, DNA replication (S phase) and mitosis (M phase) separated temporally by gaps known as G1 and G2 phases. Cyclin-dependent kinases (CDKs) are key regulatory enzymes, each consisting of a catalytic CDK subunit and an activating cyclin subunit. CDKs regulate the cell's progression through the phases of the cell cycle by modulating the activity of key substrates. Downstream targets of CDKs include transcription factor E2F and its regulator Rb. Precise activation and inactivation of CDKs at specific points in the cell cycle are required for orderly cell division. Cyclin-CDK inhibitors (CKIs), such as p16Ink4a, p15Ink4b, p27Kip1, and p21Cip1, are involved in the negative regulation of CDK activities, thus providing a pathway through which the cell cycle is negatively regulated."
p2905
(lp2906
S'Eukaryotic cells respond to DNA damage by activating signaling pathways that promote cell cycle arrest and DNA repair. In response to DNA damage, the checkpoint kinase ATM phosphorylates and activates Chk2, which in turn directly phosphorylates and activates p53 tumor suppressor protein. p53 and its transcriptional targets play an important role in both G1 and G2 checkpoints. ATR-Chk1-mediated protein degradation of Cdc25A protein phosphatase is also a mechanism conferring intra-S-phase checkpoint activation.'
p2907
asS'REFERENCE'
p2908
(lp2909
S'PMID:7908906'
p2910
ag2910
aS'AUTHORS'
p2911
aS'Matsuoka S, Yamaguchi M, Matsukage A'
p2912
aS'TITLE'
p2913
aS'D-type cyclin-binding regions of proliferating cell nuclear antigen.'
p2914
aS'JOURNAL'
p2915
aS'J Biol Chem 269:11030-6 (1994)'
p2916
aS'PMID:8242749'
p2917
ag2917
aS'AUTHORS'
p2918
aS'Welch PJ, Wang JY'
p2919
aS'TITLE'
p2920
aS'A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.'
p2921
aS'JOURNAL'
p2922
aS'Cell 75:779-90 (1993)'
p2923
aS'PMID:16936746'
p2924
ag2924
aS'AUTHORS'
p2925
aS'Macaluso M, Montanari M, Giordano A'
p2926
aS'TITLE'
p2927
aS'Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes.'
p2928
aS'JOURNAL'
p2929
aS'Oncogene 25:5263-7 (2006)'
p2930
aS'PMID:15838516'
p2931
ag2931
aS'AUTHORS'
p2932
aS'Cobrinik D'
p2933
aS'TITLE'
p2934
aS'Pocket proteins and cell cycle control.'
p2935
aS'JOURNAL'
p2936
aS'Oncogene 24:2796-809 (2005)'
p2937
aS'PMID:17568790'
p2938
ag2938
aS'AUTHORS'
p2939
aS'Boutros R, Lobjois V, Ducommun B'
p2940
aS'TITLE'
p2941
aS'CDC25 phosphatases in cancer cells: key players? Good targets?'
p2942
aS'JOURNAL'
p2943
aS'Nat Rev Cancer 7:495-507 (2007)'
p2944
aS'PMID:9832503'
p2945
ag2945
aS'AUTHORS'
p2946
aS'Diehl JA, Cheng M, Roussel MF, Sherr CJ'
p2947
aS'TITLE'
p2948
aS'Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.'
p2949
aS'JOURNAL'
p2950
aS'Genes Dev 12:3499-511 (1998)'
p2951
aS'PMID:19020303'
p2952
ag2952
aS'AUTHORS'
p2953
aS'Klein EA, Assoian RK'
p2954
aS'TITLE'
p2955
aS'Transcriptional regulation of the cyclin D1 gene at a glance.'
p2956
aS'JOURNAL'
p2957
aS'J Cell Sci 121:3853-7 (2008)'
p2958
aS'PMID:10385618'
p2959
ag2959
aS'AUTHORS'
p2960
aS'Sherr CJ, Roberts JM'
p2961
aS'TITLE'
p2962
aS'CDK inhibitors: positive and negative regulators of G1-phase progression.'
p2963
aS'JOURNAL'
p2964
aS'Genes Dev 13:1501-12 (1999)'
p2965
aS'PMID:12809600'
p2966
ag2966
aS'AUTHORS'
p2967
aS'Shi Y, Massague J.'
p2968
aS'TITLE'
p2969
aS'Mechanisms of TGF-beta signaling from cell membrane to the nucleus.'
p2970
aS'JOURNAL'
p2971
aS'Cell 113:685-700 (2003)'
p2972
aS'PMID:12925736'
p2973
ag2973
aS'AUTHORS'
p2974
aS'Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H, Hatakeyama S, Nakayama K, Nakayama KI'
p2975
aS'TITLE'
p2976
aS'Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation.'
p2977
aS'JOURNAL'
p2978
aS'Proc Natl Acad Sci U S A 100:10231-6 (2003)'
p2979
aS'PMID:16212951'
p2980
ag2980
aS'AUTHORS'
p2981
aS'Bond M, Sala-Newby GB, Wu YJ, Newby AC'
p2982
aS'TITLE'
p2983
aS'Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation.'
p2984
aS'JOURNAL'
p2985
aS'Cardiovasc Res 69:198-206 (2006)'
p2986
aS'PMID:15838523'
p2987
ag2987
aS'AUTHORS'
p2988
aS'Harris SL, Levine AJ.'
p2989
aS'TITLE'
p2990
aS'The p53 pathway: positive and negative feedback loops.'
p2991
aS'JOURNAL'
p2992
aS'Oncogene 24:2899-908 (2005)'
p2993
aS'PMID:11099028'
p2994
ag2994
aS'AUTHORS'
p2995
aS'Vogelstein B, Lane D, Levine AJ'
p2996
aS'TITLE'
p2997
aS'Surfing the p53 network.'
p2998
aS'JOURNAL'
p2999
aS'Nature 408:307-10 (2000)'
p3000
aS'PMID:7973727'
p3001
ag3001
aS'AUTHORS'
p3002
aS"Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ Jr"
p3003
aS'TITLE'
p3004
aS'Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.'
p3005
aS'JOURNAL'
p3006
aS'Science 266:1376-80 (1994)'
p3007
aS'PMID:9889196'
p3008
ag3008
aS'AUTHORS'
p3009
aS'Petersen BO, Lukas J, Sorensen CS, Bartek J, Helin K'
p3010
aS'TITLE'
p3011
aS'Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.'
p3012
aS'JOURNAL'
p3013
aS'EMBO J 18:396-410 (1999)'
p3014
aS'PMID:17018296'
p3015
ag3015
aS'AUTHORS'
p3016
aS'Sheu YJ, Stillman B'
p3017
aS'TITLE'
p3018
aS'Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression.'
p3019
aS'JOURNAL'
p3020
aS'Mol Cell 24:101-13 (2006)'
p3021
aS'PMID:9029154'
p3022
ag3022
aS'AUTHORS'
p3023
aS'Martinez AM, Afshar M, Martin F, Cavadore JC, Labbe JC, Doree M'
p3024
aS'TITLE'
p3025
aS'Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity.'
p3026
aS'JOURNAL'
p3027
aS'EMBO J 16:343-54 (1997)'
p3028
aS'PMID:15876871'
p3029
ag3029
aS'AUTHORS'
p3030
aS'Lolli G, Johnson LN'
p3031
aS'TITLE'
p3032
aS'CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?'
p3033
aS'JOURNAL'
p3034
aS'Cell Cycle 4:572-7 (2005)'
p3035
aS'PMID:17426725'
p3036
ag3036
aS'AUTHORS'
p3037
aS'Musacchio A, Salmon ED'
p3038
aS'TITLE'
p3039
aS'The spindle-assembly checkpoint in space and time.'
p3040
aS'JOURNAL'
p3041
aS'Nat Rev Mol Cell Biol 8:379-93 (2007)'
p3042
aS'PMID:12573239'
p3043
ag3043
aS'AUTHORS'
p3044
aS'Uhlmann F'
p3045
aS'TITLE'
p3046
aS'Chromosome cohesion and separation: from men and molecules.'
p3047
aS'JOURNAL'
p3048
aS'Curr Biol 13:R104-14 (2003)'
p3049
aS'PMID:15568976'
p3050
ag3050
aS'AUTHORS'
p3051
aS'Stegmeier F, Amon A'
p3052
aS'TITLE'
p3053
aS'Closing mitosis: the functions of the Cdc14 phosphatase and its regulation.'
p3054
aS'JOURNAL'
p3055
aS'Annu Rev Genet 38:203-32 (2004)'
p3056
aS'PMID:9618481'
p3057
ag3057
aS'AUTHORS'
p3058
aS'Moustakas A, Kardassis D'
p3059
aS'TITLE'
p3060
aS'Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members.'
p3061
aS'JOURNAL'
p3062
aS'Proc Natl Acad Sci U S A 95:6733-8 (1998)'
p3063
asS'KO_PATHWAY'
p3064
(lp3065
S'ko04110'
p3066
asS'PATHWAY_MAP'
p3067
(lp3068
S'map04110'
p3069
asS'DISEASE'
p3070
(lp3071
S'H00409'
p3072
aS'Type II diabetes mellitus'
p3073
ag3072
ag3073
aS'H00631'
p3074
aS'Cornelia de Lange syndrome (CdLS)'
p3075
aS'H00713'
p3076
aS'Beckwith-Wiedemann syndrome'
p3077
aS'H00848'
p3078
aS'Ataxia with ocular apraxia (AOA)'
p3079
aS'H00881'
p3080
aS'Li-Fraumeni syndrome'
p3081
aS'H00992'
p3082
aS'Seckel syndrome'
p3083
aS'H01007'
p3084
aS'Choroid plexus papilloma'
p3085
aS'H01023'
p3086
aS'Juvenile polyposis syndrome'
p3087
aS'H01102'
p3088
aS'Pituitary adenomas'
p3089
aS'H01288'
p3090
aS'Mosaic variegated aneuploidy (MVA) syndrome'
p3091
aS'H01385'
p3092
aS'Rienhoff syndrome'
p3093
asS'MODULE'
p3094
(lp3095
S'M00284'
p3096
aS'Origin recognition complex [PATH:map04110]'
p3097
ag3096
ag3097
aS'M00285'
p3098
aS'MCM complex [PATH:map04110]'
p3099
aS'M00297'
p3100
aS'DNA-PK complex [PATH:map04110]'
p3101
aS'M00381'
p3102
aS'SCF-SKP2 complex [PATH:map04110]'
p3103
aS'M00389'
p3104
aS'APC/C complex [PATH:map04110]'
p3105
aS'M00691'
p3106
aS'DNA damage-induced cell cycle checkpoints [PATH:map04110]'
p3107
aS'M00692'
p3108
aS'Cell cycle - G1/S transition [PATH:map04110]'
p3109
aS'M00693'
p3110
aS'Cell cycle - G2/M transition [PATH:map04110]'
p3111
asS'NAME'
p3112
(lp3113
S'Cell cycle'
p3114
asS'DBLINKS'
p3115
(lp3116
S'GO: 0000278'
p3117
asS'ENTRY'
p3118
(lp3119
S'map04110'
p3120
aS'Pathway'
p3121
asS'CLASS'
p3122
(lp3123
S'Cellular Processes Cell growth and death'
p3124
asS'DESCRIPTION'
p3125
(lp3126
S"Mitotic cell cycle progression is accomplished through a reproducible sequence of events, DNA replication (S phase) and mitosis (M phase) separated temporally by gaps known as G1 and G2 phases. Cyclin-dependent kinases (CDKs) are key regulatory enzymes, each consisting of a catalytic CDK subunit and an activating cyclin subunit. CDKs regulate the cell's progression through the phases of the cell cycle by modulating the activity of key substrates. Downstream targets of CDKs include transcription factor E2F and its regulator Rb. Precise activation and inactivation of CDKs at specific points in the cell cycle are required for orderly cell division. Cyclin-CDK inhibitors (CKIs), such as p16Ink4a, p15Ink4b, p27Kip1, and p21Cip1, are involved in the negative regulation of CDK activities, thus providing a pathway through which the cell cycle is negatively regulated."
p3127
assS'path:map04111'
p3128
(dp3129
S'NAME'
p3130
(lp3131
S'Cell cycle - yeast'
p3132
asS'REFERENCE'
p3133
(lp3134
S'PMID:11967159'
p3135
ag3135
aS'AUTHORS'
p3136
aS'Devault A, Vallen EA, Yuan T, Green S, Bensimon A, Schwob E'
p3137
aS'TITLE'
p3138
aS'Identification of Tah11/Sid2 as the ortholog of the replication licensing factor Cdt1 in Saccharomyces cerevisiae.'
p3139
aS'JOURNAL'
p3140
aS'Curr Biol 12:689-94 (2002)'
p3141
aS'PMID:15210110'
p3142
ag3142
aS'AUTHORS'
p3143
aS'de Bruin RA, McDonald WH, Kalashnikova TI, Yates J 3rd, Wittenberg C'
p3144
aS'TITLE'
p3145
aS'Cln3 activates G1-specific transcription via phosphorylation of the SBF bound repressor Whi5.'
p3146
aS'JOURNAL'
p3147
aS'Cell 117:887-98 (2004)'
p3148
aS'PMID:15210111'
p3149
ag3149
aS'AUTHORS'
p3150
aS'Costanzo M, Nishikawa JL, Tang X, Millman JS, Schub O, Breitkreuz K, Dewar D, Rupes I, Andrews B, Tyers M'
p3151
aS'TITLE'
p3152
aS'CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast.'
p3153
aS'JOURNAL'
p3154
aS'Cell 117:899-913 (2004)'
p3155
aS'PMID:12464633'
p3156
ag3156
aS'AUTHORS'
p3157
aS'Pramila T, Miles S, GuhaThakurta D, Jemiolo D, Breeden LL'
p3158
aS'TITLE'
p3159
aS'Conserved homeodomain proteins interact with MADS box protein Mcm1 to restrict ECB-dependent transcription to the M/G1 phase of the cell cycle.'
p3160
aS'JOURNAL'
p3161
aS'Genes Dev 16:3034-45 (2002)'
p3162
aS'PMID:15060174'
p3163
ag3163
aS'AUTHORS'
p3164
aS'Schwickart M, Havlis J, Habermann B, Bogdanova A, Camasses A, Oelschlaegel T, Shevchenko A, Zachariae W'
p3165
aS'TITLE'
p3166
aS'Swm1/Apc13 is an evolutionarily conserved subunit of the anaphase-promoting complex stabilizing the association of Cdc16 and Cdc27.'
p3167
aS'JOURNAL'
p3168
aS'Mol Cell Biol 24:3562-76 (2004)'
p3169
aS'PMID:15797380'
p3170
ag3170
aS'AUTHORS'
p3171
aS'Penkner AM, Prinz S, Ferscha S, Klein F'
p3172
aS'TITLE'
p3173
aS'Mnd2, an essential antagonist of the anaphase-promoting complex during meiotic prophase.'
p3174
aS'JOURNAL'
p3175
aS'Cell 120:789-801 (2005)'
p3176
aS'PMID:18598214'
p3177
ag3177
aS'AUTHORS'
p3178
aS'Pesin JA, Orr-Weaver TL'
p3179
aS'TITLE'
p3180
aS'Regulation of APC/C activators in mitosis and meiosis.'
p3181
aS'JOURNAL'
p3182
aS'Annu Rev Cell Dev Biol 24:475-99 (2008)'
p3183
aS'PMID:7588610'
p3184
ag3184
aS'AUTHORS'
p3185
aS'Dirick L, Bohm T, Nasmyth K'
p3186
aS'TITLE'
p3187
aS'Roles and regulation of Cln-Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae.'
p3188
aS'JOURNAL'
p3189
aS'EMBO J 14:4803-13 (1995)'
p3190
aS'PMID:16285853'
p3191
ag3191
aS'AUTHORS'
p3192
aS'Bahler J'
p3193
aS'TITLE'
p3194
aS'Cell-cycle control of gene expression in budding and fission yeast.'
p3195
aS'JOURNAL'
p3196
aS'Annu Rev Genet 39:69-94 (2005)'
p3197
aS'PMID:8066461'
p3198
ag3198
aS'AUTHORS'
p3199
aS'Peter M, Herskowitz I'
p3200
aS'TITLE'
p3201
aS'Direct inhibition of the yeast cyclin-dependent kinase Cdc28-Cln by Far1.'
p3202
aS'JOURNAL'
p3203
aS'Science 265:1228-31 (1994)'
p3204
aS'PMID:9367986'
p3205
ag3205
aS'AUTHORS'
p3206
aS'Henchoz S, Chi Y, Catarin B, Herskowitz I, Deshaies RJ, Peter M'
p3207
aS'TITLE'
p3208
aS'Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast.'
p3209
aS'JOURNAL'
p3210
aS'Genes Dev 11:3046-60 (1997)'
p3211
aS'PMID:9346239'
p3212
ag3212
aS'AUTHORS'
p3213
aS'Feldman RM, Correll CC, Kaplan KB, Deshaies RJ'
p3214
aS'TITLE'
p3215
aS'A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p.'
p3216
aS'JOURNAL'
p3217
aS'Cell 91:221-30 (1997)'
p3218
aS'PMID:7954792'
p3219
ag3219
aS'AUTHORS'
p3220
aS'Schwob E, Bohm T, Mendenhall MD, Nasmyth K'
p3221
aS'TITLE'
p3222
aS'The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae.'
p3223
aS'JOURNAL'
p3224
aS'Cell 79:233-44 (1994)'
p3225
aS'PMID:9841670'
p3226
ag3226
aS'AUTHORS'
p3227
aS'Mendenhall MD, Hodge AE'
p3228
aS'TITLE'
p3229
aS'Regulation of Cdc28 cyclin-dependent protein kinase activity during the cell cycle of the yeast Saccharomyces cerevisiae.'
p3230
aS'JOURNAL'
p3231
aS'Microbiol Mol Biol Rev 62:1191-243 (1998)'
p3232
aS'PMID:10465783'
p3233
ag3233
aS'AUTHORS'
p3234
aS'Zachariae W, Nasmyth K'
p3235
aS'TITLE'
p3236
aS'Whose end is destruction: cell division and the anaphase-promoting complex.'
p3237
aS'JOURNAL'
p3238
aS'Genes Dev 13:2039-58 (1999)'
p3239
aS'PMID:11269496'
p3240
ag3240
aS'AUTHORS'
p3241
aS'Jares P, Donaldson A, Blow JJ'
p3242
aS'TITLE'
p3243
aS'The Cdc7/Dbf4 protein kinase: target of the S phase checkpoint?'
p3244
aS'JOURNAL'
p3245
aS'EMBO Rep 1:319-22 (2000)'
p3246
aS'PMID:10512865'
p3247
ag3247
aS'AUTHORS'
p3248
aS'Elsasser S, Chi Y, Yang P, Campbell JL'
p3249
aS'TITLE'
p3250
aS'Phosphorylation controls timing of Cdc6p destruction: A biochemical analysis.'
p3251
aS'JOURNAL'
p3252
aS'Mol Biol Cell 10:3263-77 (1999)'
p3253
aS'PMID:10213692'
p3254
ag3254
aS'AUTHORS'
p3255
aS'Skowyra D, Koepp DM, Kamura T, Conrad MN, Conaway RC, Conaway JW, Elledge SJ, Harper JW'
p3256
aS'TITLE'
p3257
aS'Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1.'
p3258
aS'JOURNAL'
p3259
aS'Science 284:662-5 (1999)'
p3260
aS'PMID:16487340'
p3261
ag3261
aS'AUTHORS'
p3262
aS'Mouillon JM, Persson BL'
p3263
aS'TITLE'
p3264
aS'New aspects on phosphate sensing and signalling in Saccharomyces cerevisiae.'
p3265
aS'JOURNAL'
p3266
aS'FEMS Yeast Res 6:171-6 (2006)'
p3267
aS'PMID:15965243'
p3268
ag3268
aS'AUTHORS'
p3269
aS'Bean JM, Siggia ED, Cross FR'
p3270
aS'TITLE'
p3271
aS'High functional overlap between MluI cell-cycle box binding factor and Swi4/6 cell-cycle box binding factor in the G1/S transcriptional program in Saccharomyces cerevisiae.'
p3272
aS'JOURNAL'
p3273
aS'Genetics 171:49-61 (2005)'
p3274
aS'PMID:9024629'
p3275
ag3275
aS'AUTHORS'
p3276
aS'Deshaies RJ'
p3277
aS'TITLE'
p3278
aS'Phosphorylation and proteolysis: partners in the regulation of cell division in budding yeast.'
p3279
aS'JOURNAL'
p3280
aS'Curr Opin Genet Dev 7:7-16 (1997)'
p3281
aS'PMID:15920482'
p3282
ag3282
aS'AUTHORS'
p3283
aS'Asano S, Park JE, Sakchaisri K, Yu LR, Song S, Supavilai P, Veenstra TD, Lee KS'
p3284
aS'TITLE'
p3285
aS'Concerted mechanism of Swe1/Wee1 regulation by multiple kinases in budding yeast.'
p3286
aS'JOURNAL'
p3287
aS'EMBO J 24:2194-204 (2005)'
p3288
aS'PMID:9716410'
p3289
ag3289
aS'AUTHORS'
p3290
aS'Kaiser P, Sia RA, Bardes EG, Lew DJ, Reed SI'
p3291
aS'TITLE'
p3292
aS'Cdc34 and the F-box protein Met30 are required for degradation of the Cdk-inhibitory kinase Swe1.'
p3293
aS'JOURNAL'
p3294
aS'Genes Dev 12:2587-97 (1998)'
p3295
aS'PMID:9925642'
p3296
ag3296
aS'AUTHORS'
p3297
aS'Barral Y, Parra M, Bidlingmaier S, Snyder M'
p3298
aS'TITLE'
p3299
aS'Nim1-related kinases coordinate cell cycle progression with the organization of the peripheral cytoskeleton in yeast.'
p3300
aS'JOURNAL'
p3301
aS'Genes Dev 13:176-87 (1999)'
p3302
aS'PMID:10469560'
p3303
ag3303
aS'AUTHORS'
p3304
aS'Taylor SS'
p3305
aS'TITLE'
p3306
aS'Chromosome segregation: dual control ensures fidelity.'
p3307
aS'JOURNAL'
p3308
aS'Curr Biol 9:R562-4 (1999)'
p3309
aS'PMID:14616062'
p3310
ag3310
aS'AUTHORS'
p3311
aS'Lew DJ, Burke DJ'
p3312
aS'TITLE'
p3313
aS'The spindle assembly and spindle position checkpoints.'
p3314
aS'JOURNAL'
p3315
aS'Annu Rev Genet 37:251-82 (2003)'
p3316
aS'PMID:14514882'
p3317
ag3317
aS'AUTHORS'
p3318
aS'Simanis V'
p3319
aS'TITLE'
p3320
aS'Events at the end of mitosis in the budding and fission yeasts.'
p3321
aS'JOURNAL'
p3322
aS'J Cell Sci 116:4263-75 (2003)'
p3323
aS'PMID:8131744'
p3324
ag3324
aS'AUTHORS'
p3325
aS'Toyn JH, Johnston LH'
p3326
aS'TITLE'
p3327
aS'The Dbf2 and Dbf20 protein kinases of budding yeast are activated after the metaphase to anaphase cell cycle transition.'
p3328
aS'JOURNAL'
p3329
aS'EMBO J 13:1103-13 (1994)'
p3330
aS'PMID:11146641'
p3331
ag3331
aS'AUTHORS'
p3332
aS'Amon A'
p3333
aS'TITLE'
p3334
aS'Together until separin do us part.'
p3335
aS'JOURNAL'
p3336
aS'Nat Cell Biol 3:E12-4 (2001)'
p3337
aS'PMID:10882066'
p3338
ag3338
aS'AUTHORS'
p3339
aS'Ciosk R, Shirayama M, Shevchenko A, Tanaka T, Toth A, Shevchenko A, Nasmyth K'
p3340
aS'TITLE'
p3341
aS"Cohesin's binding to chromosomes depends on a separate complex consisting of Scc2 and Scc4 proteins."
p3342
aS'JOURNAL'
p3343
aS'Mol Cell 5:243-54 (2000)'
p3344
aS'PMID:10811823'
p3345
ag3345
aS'AUTHORS'
p3346
aS'Freeman L, Aragon-Alcaide L, Strunnikov A'
p3347
aS'TITLE'
p3348
aS'The condensin complex governs chromosome condensation and mitotic transmission of rDNA.'
p3349
aS'JOURNAL'
p3350
aS'J Cell Biol 149:811-24 (2000)'
p3351
aS'PMID:18616603'
p3352
ag3352
aS'AUTHORS'
p3353
aS'Fu Y, Pastushok L, Xiao W'
p3354
aS'TITLE'
p3355
aS'DNA damage-induced gene expression in Saccharomyces cerevisiae.'
p3356
aS'JOURNAL'
p3357
aS'FEMS Microbiol Rev 32:908-26 (2008)'
p3358
aS'PMID:19230642'
p3359
ag3359
aS'AUTHORS'
p3360
aS'Friedel AM, Pike BL, Gasser SM'
p3361
aS'TITLE'
p3362
aS'ATR/Mec1: coordinating fork stability and repair.'
p3363
aS'JOURNAL'
p3364
aS'Curr Opin Cell Biol 21:237-44 (2009)'
p3365
aS'PMID:19457865'
p3366
ag3366
aS'AUTHORS'
p3367
aS'Chen SH, Zhou H'
p3368
aS'TITLE'
p3369
aS'Reconstitution of Rad53 activation by Mec1 through adaptor protein Mrc1.'
p3370
aS'JOURNAL'
p3371
aS'J Biol Chem 284:18593-604 (2009)'
p3372
aS'PMID:19021755'
p3373
ag3373
aS'AUTHORS'
p3374
aS'Amon A'
p3375
aS'TITLE'
p3376
aS'A decade of Cdc14--a personal perspective. Delivered on 9 July 2007 at the 32nd FEBS Congress in Vienna, Austria.'
p3377
aS'JOURNAL'
p3378
aS'FEBS J 275:5774-84 (2008)'
p3379
asS'KO_PATHWAY'
p3380
(lp3381
S'ko04111'
p3382
asS'PATHWAY_MAP'
p3383
(lp3384
S'map04111'
p3385
asS'MODULE'
p3386
(lp3387
S'M00284'
p3388
aS'Origin recognition complex [PATH:map04111]'
p3389
ag3388
ag3389
aS'M00285'
p3390
aS'MCM complex [PATH:map04111]'
p3391
aS'M00379'
p3392
aS'SCF-MET30 complex [PATH:map04111]'
p3393
aS'M00389'
p3394
aS'APC/C complex [PATH:map04111]'
p3395
aS'M00407'
p3396
aS'SCF-CDC4 complex [PATH:map04111]'
p3397
aS'M00411'
p3398
aS'SCF-GRR1 complex [PATH:map04111]'
p3399
aS'M00692'
p3400
aS'Cell cycle - G1/S transition [PATH:map04111]'
p3401
aS'M00693'
p3402
aS'Cell cycle - G2/M transition [PATH:map04111]'
p3403
asS'DBLINKS'
p3404
(lp3405
S'GO: 0000278'
p3406
asS'ENTRY'
p3407
(lp3408
S'map04111'
p3409
aS'Pathway'
p3410
asS'CLASS'
p3411
(lp3412
S'Cellular Processes Cell growth and death'
p3413
asS'DESCRIPTION'
p3414
(lp3415
S"Mitotic cell cycle progression is accomplished through a reproducible sequence of events, DNA replication (S phase) and mitosis (M phase) separated temporally by gaps (G1 and G2 phases). G1, S, and G2 phases are collectively known as interphase. In yeast Cdc28 is the catalytic subunit of the cyclin-dependent kinase (CDK). At G1 phase Cdc28 associates with G1-cyclins Cln1 to Cln3, while B-type cyclins Clb1 to Clb6 regulate Cdc28 during S, G2, and M phases. Cln3/Cdc28 activity is required for cells to pass through 'start', the commitment point in G1. When Cln3/Cdc28 accumulates more than a certain threshold, SBF (Swi4/Swi6) and MBF (Mbp1/Swi6) are activated, promoting transcription of Cln1, Cln2, and other genes required for S-phase progression. Cln1 and Cln2 interacting with Cdc28 promote activation of B-type cyclin associated CDK, which drives DNA replication and entry into mitosis. Specifically, Cdc28 association with Clb2 and Clb1 promotes entry into mitosis. Cells suffering from DNA damage, spindle misorientation, or spindle assembly defect do not undergo the metaphase-anaphase transition for chromosome segregation and fail to exit from mitosis. The spindle assembly checkpoint activates Mad2, which in turn prevents chromosome segregation by inhibiting degradation of the securin Pds1. Moreover, Pds1 is phosphorylated and stabilized in response to DNA damage in a Chk1-dependent manner. The spindle checkpoint is also involved in the Cdc14 release from the nucleolus. Cdc14 dephosphorylates Swi5, Sic1, and Cdh1, leading to inhibition of Cdc28 and degradation of cyclin required for mitotic exit."
p3416
assS'path:map04112'
p3417
(dp3418
S'NAME'
p3419
(lp3420
S'Cell cycle - Caulobacter'
p3421
asS'REFERENCE'
p3422
(lp3423
S'PMID:18685108'
p3424
ag3424
aS'AUTHORS'
p3425
aS'Shen X, Collier J, Dill D, Shapiro L, Horowitz M, McAdams HH'
p3426
aS'TITLE'
p3427
aS'Architecture and inherent robustness of a bacterial cell-cycle control system.'
p3428
aS'JOURNAL'
p3429
aS'Proc Natl Acad Sci U S A 105:11340-5 (2008)'
p3430
aS'PMID:20197497'
p3431
ag3431
aS'AUTHORS'
p3432
aS'Curtis PD, Brun YV'
p3433
aS'TITLE'
p3434
aS'Getting in the loop: regulation of development in Caulobacter crescentus.'
p3435
aS'JOURNAL'
p3436
aS'Microbiol Mol Biol Rev 74:13-41 (2010)'
p3437
aS'PMID:15031731'
p3438
ag3438
aS'AUTHORS'
p3439
aS'Skerker JM, Laub MT'
p3440
aS'TITLE'
p3441
aS'Cell-cycle progression and the generation of asymmetry in Caulobacter crescentus.'
p3442
aS'JOURNAL'
p3443
aS'Nat Rev Microbiol 2:325-37 (2004)'
p3444
aS'PMID:19246239'
p3445
ag3445
aS'AUTHORS'
p3446
aS'Jenal U, Galperin MY'
p3447
aS'TITLE'
p3448
aS'Single domain response regulators: molecular switches with emerging roles in cell organization and dynamics.'
p3449
aS'JOURNAL'
p3450
aS'Curr Opin Microbiol 12:152-60 (2009)'
p3451
aS'PMID:19854671'
p3452
ag3452
aS'AUTHORS'
p3453
aS'Thanbichler M'
p3454
aS'TITLE'
p3455
aS'Spatial regulation in Caulobacter crescentus.'
p3456
aS'JOURNAL'
p3457
aS'Curr Opin Microbiol 12:715-21 (2009)'
p3458
aS'PMID:19781638'
p3459
ag3459
aS'AUTHORS'
p3460
aS'Jenal U'
p3461
aS'TITLE'
p3462
aS'The role of proteolysis in the Caulobacter crescentus cell cycle and development.'
p3463
aS'JOURNAL'
p3464
aS'Res Microbiol 160:687-95 (2009)'
p3465
aS'PMID:19287449'
p3466
ag3466
aS'AUTHORS'
p3467
aS'Hengge R'
p3468
aS'TITLE'
p3469
aS'Principles of c-di-GMP signalling in bacteria.'
p3470
aS'JOURNAL'
p3471
aS'Nat Rev Microbiol 7:263-73 (2009)'
p3472
aS'PMID:19687139'
p3473
ag3473
aS'AUTHORS'
p3474
aS'Goley ED, Toro E, McAdams HH, Shapiro L'
p3475
aS'TITLE'
p3476
aS'Dynamic chromosome organization and protein localization coordinate the regulatory circuitry that drives the bacterial cell cycle.'
p3477
aS'JOURNAL'
p3478
aS'Cold Spring Harb Symp Quant Biol 74:55-64 (2009)'
p3479
aS'PMID:19680425'
p3480
ag3480
aS'AUTHORS'
p3481
aS'Li S, Brazhnik P, Sobral B, Tyson JJ'
p3482
aS'TITLE'
p3483
aS'Temporal controls of the asymmetric cell division cycle in Caulobacter crescentus.'
p3484
aS'JOURNAL'
p3485
aS'PLoS Comput Biol 5:e1000463 (2009)'
p3486
asS'KO_PATHWAY'
p3487
(lp3488
S'ko04112'
p3489
asS'PATHWAY_MAP'
p3490
(lp3491
S'map04112'
p3492
asS'MODULE'
p3493
(lp3494
S'M00511'
p3495
aS'PleC-PleD (cell fate control) two-component regulatory system [PATH:map04112]'
p3496
ag3495
ag3496
aS'M00512'
p3497
aS'CckA-CtrA/CpdR (cell cycle control) two-component regulatory system [PATH:map04112]'
p3498
asS'DBLINKS'
p3499
(lp3500
S'GO: 0000278'
p3501
asS'ENTRY'
p3502
(lp3503
S'map04112'
p3504
aS'Pathway'
p3505
asS'CLASS'
p3506
(lp3507
S'Cellular Processes Cell growth and death'
p3508
asS'DESCRIPTION'
p3509
(lp3510
S'Cell cycle progression of Caulobacter crescentus is implemented by an elaborate transcriptional regulatory network. During the life cycle, Caulobacter divides asymmetrically producing two distinct cell types with specialized development programs. The sessile stalked cell immediately initiates a new round of division cycle, whereas the motile swarmer cell remains in the G1 phase for a defined interval before differentiating into the stalked cell and entering into the S phase. The division process is centered around three master regulator proteins, DnaA, GcrA, and CtrA. DnaA and GcrA together drive the synthesis of proteins needed to complete DNA replication. CtrA controls the transcription of a diverse group of genes, which are required for essential morphological, metabolic, and cell cycle events.'
p3511
assS'path:map04113'
p3512
(dp3513
S'NAME'
p3514
(lp3515
S'Meiosis - yeast'
p3516
asS'REFERENCE'
p3517
(lp3518
S'PMID:12730290'
p3519
ag3519
aS'AUTHORS'
p3520
aS'Honigberg SM, Purnapatre K'
p3521
aS'TITLE'
p3522
aS'Signal pathway integration in the switch from the mitotic cell cycle to meiosis in yeast.'
p3523
aS'JOURNAL'
p3524
aS'J Cell Sci 116:2137-47 (2003)'
p3525
aS'PMID:12722950'
p3526
ag3526
aS'AUTHORS'
p3527
aS'Kassir Y, Adir N, Boger-Nadjar E, Raviv NG, Rubin-Bejerano I, Sagee S, Shenhar G'
p3528
aS'TITLE'
p3529
aS'Transcriptional regulation of meiosis in budding yeast.'
p3530
aS'JOURNAL'
p3531
aS'Int Rev Cytol 224:111-71 (2003)'
p3532
aS'PMID:15258924'
p3533
ag3533
aS'AUTHORS'
p3534
aS'Honigberg SM'
p3535
aS'TITLE'
p3536
aS'Ime2p and Cdc28p: co-pilots driving meiotic development.'
p3537
aS'JOURNAL'
p3538
aS'J Cell Biochem 92:1025-33 (2004)'
p3539
aS'PMID:16546077'
p3540
ag3540
aS'AUTHORS'
p3541
aS'Hochwagen A, Amon A'
p3542
aS'TITLE'
p3543
aS'Checking your breaks: surveillance mechanisms of meiotic recombination.'
p3544
aS'JOURNAL'
p3545
aS'Curr Biol 16:R217-28 (2006)'
p3546
aS'PMID:18832063'
p3547
ag3547
aS'AUTHORS'
p3548
aS'Hollingsworth NM'
p3549
aS'TITLE'
p3550
aS'Deconstructing meiosis one kinase at a time: polo pushes past pachytene.'
p3551
aS'JOURNAL'
p3552
aS'Genes Dev 22:2596-600 (2008)'
p3553
aS'PMID:18832066'
p3554
ag3554
aS'AUTHORS'
p3555
aS'Sourirajan A, Lichten M'
p3556
aS'TITLE'
p3557
aS'Polo-like kinase Cdc5 drives exit from pachytene during budding yeast meiosis.'
p3558
aS'JOURNAL'
p3559
aS'Genes Dev 22:2627-32 (2008)'
p3560
aS'PMID:10973068'
p3561
ag3561
aS'AUTHORS'
p3562
aS'Roeder GS, Bailis JM'
p3563
aS'TITLE'
p3564
aS'The pachytene checkpoint.'
p3565
aS'JOURNAL'
p3566
aS'Trends Genet 16:395-403 (2000)'
p3567
aS'PMID:15173822'
p3568
ag3568
aS'AUTHORS'
p3569
aS'Barr FA, Sillje HH, Nigg EA'
p3570
aS'TITLE'
p3571
aS'Polo-like kinases and the orchestration of cell division.'
p3572
aS'JOURNAL'
p3573
aS'Nat Rev Mol Cell Biol 5:429-40 (2004)'
p3574
aS'PMID:12963824'
p3575
ag3575
aS'AUTHORS'
p3576
aS'Lee BH, Amon A'
p3577
aS'TITLE'
p3578
aS'Polo kinase--meiotic cell cycle coordinator.'
p3579
aS'JOURNAL'
p3580
aS'Cell Cycle 2:400-2 (2003)'
p3581
aS'PMID:12737807'
p3582
ag3582
aS'AUTHORS'
p3583
aS'Buonomo SB, Rabitsch KP, Fuchs J, Gruber S, Sullivan M, Uhlmann F, Petronczki M, Toth A, Nasmyth K'
p3584
aS'TITLE'
p3585
aS'Division of the nucleolus and its release of CDC14 during anaphase of meiosis I depends on separase, SPO12, and SLK19.'
p3586
aS'JOURNAL'
p3587
aS'Dev Cell 4:727-39 (2003)'
p3588
aS'PMID:15797379'
p3589
ag3589
aS'AUTHORS'
p3590
aS'Oelschlaegel T, Schwickart M, Matos J, Bogdanova A, Camasses A, Havlis J, Shevchenko A, Zachariae W'
p3591
aS'TITLE'
p3592
aS'The yeast APC/C subunit Mnd2 prevents premature sister chromatid separation triggered by the meiosis-specific APC/C-Ama1.'
p3593
aS'JOURNAL'
p3594
aS'Cell 120:773-88 (2005)'
p3595
aS'PMID:16759372'
p3596
ag3596
aS'AUTHORS'
p3597
aS'Dai W, Wang X'
p3598
aS'TITLE'
p3599
aS'The Yin and Yang of centromeric cohesion of sister chromatids: mitotic kinases meet protein phosphatase 2A.'
p3600
aS'JOURNAL'
p3601
aS'Cell Div 1:9 (2006)'
p3602
aS'PMID:19299562'
p3603
ag3603
aS'AUTHORS'
p3604
aS'Clift D, Bizzari F, Marston AL'
p3605
aS'TITLE'
p3606
aS'Shugoshin prevents cohesin cleavage by PP2A(Cdc55)-dependent inhibition of separase.'
p3607
aS'JOURNAL'
p3608
aS'Genes Dev 23:766-80 (2009)'
p3609
aS'PMID:18598214'
p3610
ag3610
aS'AUTHORS'
p3611
aS'Pesin JA, Orr-Weaver TL'
p3612
aS'TITLE'
p3613
aS'Regulation of APC/C activators in mitosis and meiosis.'
p3614
aS'JOURNAL'
p3615
aS'Annu Rev Cell Dev Biol 24:475-99 (2008)'
p3616
aS'PMID:18946082'
p3617
ag3617
aS'AUTHORS'
p3618
aS'Diamond AE, Park JS, Inoue I, Tachikawa H, Neiman AM'
p3619
aS'TITLE'
p3620
aS'The anaphase promoting complex targeting subunit Ama1 links meiotic exit to cytokinesis during sporulation in Saccharomyces cerevisiae.'
p3621
aS'JOURNAL'
p3622
aS'Mol Biol Cell 20:134-45 (2009)'
p3623
asS'KO_PATHWAY'
p3624
(lp3625
S'ko04113'
p3626
asS'PATHWAY_MAP'
p3627
(lp3628
S'map04113'
p3629
asS'MODULE'
p3630
(lp3631
S'M00284'
p3632
aS'Origin recognition complex [PATH:map04113]'
p3633
ag3632
ag3633
aS'M00285'
p3634
aS'MCM complex [PATH:map04113]'
p3635
aS'M00389'
p3636
aS'APC/C complex [PATH:map04113]'
p3637
asS'DBLINKS'
p3638
(lp3639
S'GO: 0051321'
p3640
asS'ENTRY'
p3641
(lp3642
S'map04113'
p3643
aS'Pathway'
p3644
asS'CLASS'
p3645
(lp3646
S'Cellular Processes Cell growth and death'
p3647
asS'DESCRIPTION'
p3648
(lp3649
S'During meiosis, a single round of DNA replication is followed by two rounds of chromosome segregation, called meiosis I and meiosis II. At meiosis I, one pair of sister chromatids recombines with, then segregates from, its homologous pair, while the sister chromatids segregate from each other at meoisis II. In yeast, the switch to enter growth phase or meiosis phase is controlled by nutritional signals. At the onset of meiosis, nutritional signaling pathways converge on transcriptional regulation of Ime1. Ime1 is a transcriptional activator to promote expression of early meiosis-specific genes required for pre-meiotic DNA replication and meiotic recombination. Two of the early meiosis-specific genes, a transcriptional activator, Ndt80, and a CDK2 homolog, Ime2, are required for the transcription of middle meiosis-specific genes, which includes B-type cyclin genes and genes involved in spore wall formation. Polo-like kinase Cdc5, whose expression is activated by Ndt80, is required for the critical step in meiotic progression. Cdc5 regulates sister-kinetochore co-orientation by promoting the localization of Mam1 and Lrs4, components of the co-orientation complex, to kinetochores. Cdc5 also phosphorylates the meiotic cohesin subunit Rec8, which is essential for its cleavage and removal by separase. Moreover, Cdc5 promotes the release of protein phosphatase Cdc14 from the nuclezus, which is required for anaphase I spindle disassembly and exit from meiosis I. The centromeric protein Sgo1 is a key regulator of meiotic chromosome segregation. Sgo1 with PP2A may protect pericentromeric but not arm cohesion of sister chromatids during meiosis I. Sgo1 then disappears at meiosis II to allow sister chromatids to separate.'
p3650
assS'path:map04114'
p3651
(dp3652
S'NAME'
p3653
(lp3654
S'Oocyte meiosis'
p3655
asS'REFERENCE'
p3656
(lp3657
S'PMID:16760654'
p3658
ag3658
aS'AUTHORS'
p3659
aS'Haccard O, Jessus C'
p3660
aS'TITLE'
p3661
aS'Oocyte maturation, Mos and cyclins--a matter of synthesis: two functionally redundant ways to induce meiotic maturation.'
p3662
aS'JOURNAL'
p3663
aS'Cell Cycle 5:1152-9 (2006)'
p3664
aS'PMID:15182704'
p3665
ag3665
aS'AUTHORS'
p3666
aS'Crane R, Gadea B, Littlepage L, Wu H, Ruderman JV'
p3667
aS'TITLE'
p3668
aS'Aurora A, meiosis and mitosis.'
p3669
aS'JOURNAL'
p3670
aS'Biol Cell 96:215-29 (2004)'
p3671
aS'PMID:15136768'
p3672
ag3672
aS'AUTHORS'
p3673
aS'Perdiguero E, Nebreda AR'
p3674
aS'TITLE'
p3675
aS'Regulation of Cdc25C activity during the meiotic G2/M transition.'
p3676
aS'JOURNAL'
p3677
aS'Cell Cycle 3:733-7 (2004)'
p3678
aS'PMID:17480229'
p3679
ag3679
aS'AUTHORS'
p3680
aS'Perry JA, Kornbluth S'
p3681
aS'TITLE'
p3682
aS'Cdc25 and Wee1: analogous opposites?'
p3683
aS'JOURNAL'
p3684
aS'Cell Div 2:12 (2007)'
p3685
aS'PMID:15182701'
p3686
ag3686
aS'AUTHORS'
p3687
aS'Jessus C, Ozon R'
p3688
aS'TITLE'
p3689
aS'How does Xenopus oocyte acquire its competence to undergo meiotic maturation?'
p3690
aS'JOURNAL'
p3691
aS'Biol Cell 96:187-92 (2004)'
p3692
aS'PMID:16518630'
p3693
ag3693
aS'AUTHORS'
p3694
aS'Revenkova E, Jessberger R'
p3695
aS'TITLE'
p3696
aS'Shaping meiotic prophase chromosomes: cohesins and synaptonemal complex proteins.'
p3697
aS'JOURNAL'
p3698
aS'Chromosoma 115:235-40 (2006)'
p3699
aS'PMID:18631137'
p3700
ag3700
aS'AUTHORS'
p3701
aS'Belloc E, Pique M, Mendez R'
p3702
aS'TITLE'
p3703
aS'Sequential waves of polyadenylation and deadenylation define a translation circuit that drives meiotic progression.'
p3704
aS'JOURNAL'
p3705
aS'Biochem Soc Trans 36:665-70 (2008)'
p3706
aS'PMID:18598214'
p3707
ag3707
aS'AUTHORS'
p3708
aS'Pesin JA, Orr-Weaver TL'
p3709
aS'TITLE'
p3710
aS'Regulation of APC/C activators in mitosis and meiosis.'
p3711
aS'JOURNAL'
p3712
aS'Annu Rev Cell Dev Biol 24:475-99 (2008)'
p3713
aS'PMID:18550795'
p3714
ag3714
aS'AUTHORS'
p3715
aS'Tang W, Wu JQ, Guo Y, Hansen DV, Perry JA, Freel CD, Nutt L, Jackson PK, Kornbluth S'
p3716
aS'TITLE'
p3717
aS'Cdc2 and Mos regulate Emi2 stability to promote the meiosis I-meiosis II transition.'
p3718
aS'JOURNAL'
p3719
aS'Mol Biol Cell 19:3536-43 (2008)'
p3720
aS'PMID:18946022'
p3721
ag3721
aS'AUTHORS'
p3722
aS'Wu JQ, Kornbluth S'
p3723
aS'TITLE'
p3724
aS'Across the meiotic divide - CSF activity in the post-Emi2/XErp1 era.'
p3725
aS'JOURNAL'
p3726
aS'J Cell Sci 121:3509-14 (2008)'
p3727
aS'PMID:16554437'
p3728
ag3728
aS'AUTHORS'
p3729
aS'Schmidt A, Rauh NR, Nigg EA, Mayer TU'
p3730
aS'TITLE'
p3731
aS'Cytostatic factor: an activity that puts the cell cycle on hold.'
p3732
aS'JOURNAL'
p3733
aS'J Cell Sci 119:1213-8 (2006)'
p3734
aS'PMID:18096427'
p3735
ag3735
aS'AUTHORS'
p3736
aS'Vogt E, Kirsch-Volders M, Parry J, Eichenlaub-Ritter U'
p3737
aS'TITLE'
p3738
aS'Spindle formation, chromosome segregation and the spindle checkpoint in mammalian oocytes and susceptibility to meiotic error.'
p3739
aS'JOURNAL'
p3740
aS'Mutat Res 651:14-29 (2008)'
p3741
aS'PMID:18311174'
p3742
ag3742
aS'AUTHORS'
p3743
aS'Perry AC, Verlhac MH'
p3744
aS'TITLE'
p3745
aS'Second meiotic arrest and exit in frogs and mice.'
p3746
aS'JOURNAL'
p3747
aS'EMBO Rep 9:246-51 (2008)'
p3748
aS'PMID:14691134'
p3749
ag3749
aS'AUTHORS'
p3750
aS'Tunquist BJ, Eyers PA, Chen LG, Lewellyn AL, Maller JL'
p3751
aS'TITLE'
p3752
aS'Spindle checkpoint proteins Mad1 and Mad2 are required for cytostatic factor-mediated metaphase arrest.'
p3753
aS'JOURNAL'
p3754
aS'J Cell Biol 163:1231-42 (2003)'
p3755
aS'PMID:14517314'
p3756
ag3756
aS'AUTHORS'
p3757
aS'Hutchins JR, Dikovskaya D, Clarke PR.'
p3758
aS'TITLE'
p3759
aS'Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.'
p3760
aS'JOURNAL'
p3761
aS'Mol Biol Cell 14:4003-14 (2003)'
p3762
asS'KO_PATHWAY'
p3763
(lp3764
S'ko04114'
p3765
asS'PATHWAY_MAP'
p3766
(lp3767
S'map04114'
p3768
asS'DISEASE'
p3769
(lp3770
S'H00574'
p3771
aS'Coffin-Lowry syndrome (CLS)'
p3772
ag3771
ag3772
aS'H00608'
p3773
aS'46,XY disorders of sex development (Disorders in androgen synthesis or action)'
p3774
aS'H00631'
p3775
aS'Cornelia de Lange syndrome (CdLS)'
p3776
aS'H01274'
p3777
aS'Growth delay due to insulin-like growth factor I resistance'
p3778
asS'MODULE'
p3779
(lp3780
S'M00380'
p3781
aS'SCF-BTRC complex [PATH:map04114]'
p3782
ag3781
ag3782
aS'M00389'
p3783
aS'APC/C complex [PATH:map04114]'
p3784
asS'DBLINKS'
p3785
(lp3786
S'GO: 0051321'
p3787
asS'ENTRY'
p3788
(lp3789
S'map04114'
p3790
aS'Pathway'
p3791
asS'CLASS'
p3792
(lp3793
S'Cellular Processes Cell growth and death'
p3794
asS'DESCRIPTION'
p3795
(lp3796
S'During meiosis, a single round of DNA replication is followed by two rounds of chromosome segregation, called meiosis I and meiosis II. At meiosis I, homologous chromosomes recombine and then segregate to opposite poles, while the sister chromatids segregate from each other at meoisis II. In vertebrates, immature oocytes are arrested at the PI (prophase of meiosis I). The resumption of meiosis is stimulated by progesterone, which carries the oocyte through two consecutive M-phases (MI and MII) to a second arrest at MII. The key activity driving meiotic progression is the MPF (maturation-promoting factor), a heterodimer of CDC2 (cell division cycle 2 kinase) and cyclin B. In PI-arrested oocytes, MPF is initially inactive and is activated by the dual-specificity CDC25C phosphatase as the result of new synthesis of Mos induced by progesterone. MPF activation mediates the transition from the PI arrest to MI. The subsequent decrease in MPF levels, required to exit from MI into interkinesis, is induced by a negative feedback loop, where CDC2 brings about the activation of the APC (anaphase-promoting complex), which mediates destruction of cyclin B. Re-activation of MPF for MII requires re-accumulation of high levels of cyclin B as well as the inactivation of the APC by newly synthesized Emi2 and other components of the CSF (cytostatic factor), such as cyclin E or high levels of Mos. CSF antagonizes the ubiquitin ligase activity of the APC, preventing cyclin B destruction and meiotic exit until fertilization occurs. Fertilization triggers a transient increase in cytosolic free Ca2+, which leads to CSF inactivation and cyclin B destruction through the APC. Then eggs are released from MII into the first embryonic cell cycle.'
p3797
assS'path:map00920'
p3798
(dp3799
S'NAME'
p3800
(lp3801
S'Sulfur metabolism'
p3802
asS'REFERENCE'
p3803
(lp3804
S'PMID:22982583'
p3805
ag3805
aS'AUTHORS'
p3806
aS'Grein F, Ramos AR, Venceslau SS, Pereira IA'
p3807
aS'TITLE'
p3808
aS'Unifying concepts in anaerobic respiration: Insights from dissimilatory sulfur metabolism.'
p3809
aS'JOURNAL'
p3810
aS'Biochim Biophys Acta 1827:145-60 (2013)'
p3811
aS'PMID:22633058'
p3812
ag3812
aS'AUTHORS'
p3813
aS'Fauque GD, Barton LL'
p3814
aS'TITLE'
p3815
aS'Hemoproteins in dissimilatory sulfate- and sulfur-reducing prokaryotes.'
p3816
aS'JOURNAL'
p3817
aS'Adv Microb Physiol 60:1-90 (2012)'
p3818
aS'PMID:20143161'
p3819
ag3819
aS'AUTHORS'
p3820
aS'Sakurai H, Ogawa T, Shiga M, Inoue K'
p3821
aS'TITLE'
p3822
aS'Inorganic sulfur oxidizing system in green sulfur bacteria.'
p3823
aS'JOURNAL'
p3824
aS'Photosynth Res 104:163-76 (2010)'
p3825
aS'PMID:22092713'
p3826
ag3826
aS'AUTHORS'
p3827
aS'Falkenby LG, Szymanska M, Holkenbrink C, Habicht KS, Andersen JS, Miller M, Frigaard NU'
p3828
aS'TITLE'
p3829
aS'Quantitative proteomics of Chlorobaculum tepidum: insights into the sulfur metabolism of a phototrophic green sulfur bacterium.'
p3830
aS'JOURNAL'
p3831
aS'FEMS Microbiol Lett 323:142-50 (2011)'
p3832
aS'PMID:21833341'
p3833
ag3833
aS'AUTHORS'
p3834
aS'Gregersen LH, Bryant DA, Frigaard NU'
p3835
aS'TITLE'
p3836
aS'Mechanisms and evolution of oxidative sulfur metabolism in green sulfur bacteria.'
p3837
aS'JOURNAL'
p3838
aS'Front Microbiol 2:116 (2011)'
p3839
aS'PMID:16452431'
p3840
ag3840
aS'AUTHORS'
p3841
aS'Beller HR, Chain PS, Letain TE, Chakicherla A, Larimer FW, Richardson PM, Coleman MA, Wood AP, Kelly DP.'
p3842
aS'TITLE'
p3843
aS'The genome sequence of the obligately chemolithoautotrophic, facultatively anaerobic bacterium Thiobacillus denitrificans.'
p3844
aS'JOURNAL'
p3845
aS'J Bacteriol 188:1473-88 (2006)'
p3846
aS'PMID:9695921'
p3847
ag3847
aS'AUTHORS'
p3848
aS'Pott AS, Dahl C'
p3849
aS'TITLE'
p3850
aS'Sirohaem sulfite reductase and other proteins encoded by genes at the dsr locus of Chromatium vinosum are involved in the oxidation of intracellular sulfur.'
p3851
aS'JOURNAL'
p3852
aS'Microbiology 144 ( Pt 7):1881-94 (1998)'
p3853
aS'PMID:18929068'
p3854
ag3854
aS'AUTHORS'
p3855
aS'Frigaard NU, Dahl C'
p3856
aS'TITLE'
p3857
aS'Sulfur metabolism in phototrophic sulfur bacteria.'
p3858
aS'JOURNAL'
p3859
aS'Adv Microb Physiol 54:103-200 (2009)'
p3860
asS'KO_PATHWAY'
p3861
(lp3862
S'ko00920'
p3863
asS'PATHWAY_MAP'
p3864
(lp3865
S'map00920'
p3866
asS'DISEASE'
p3867
(lp3868
S'H00761'
p3869
aS'SEMD, Pakistani type'
p3870
ag3869
ag3870
aS'H01237'
p3871
aS'Sulfite oxidase deficiency'
p3872
asS'MODULE'
p3873
(lp3874
S'M00176'
p3875
aS'Assimilatory sulfate reduction, sulfate => H2S [PATH:map00920]'
p3876
ag3875
ag3876
aS'M00595'
p3877
aS'Thiosulfate oxidation by SOX complex, thiosulfate => sulfate [PATH:map00920]'
p3878
aS'M00596'
p3879
aS'Dissimilatory sulfate reduction, sulfate => H2S [PATH:map00920]'
p3880
asS'DBLINKS'
p3881
(lp3882
S'GO: 0006790'
p3883
asS'ENTRY'
p3884
(lp3885
S'map00920'
p3886
aS'Pathway'
p3887
asS'CLASS'
p3888
(lp3889
S'Metabolism Energy metabolism'
p3890
asS'DESCRIPTION'
p3891
(lp3892
S"Sulfur is an essential element for life and the metabolism of organic sulfur compounds plays an important role in the global sulfur cycle. Sulfur occurs in various oxidation states ranging from +6 in sulfate to -2 in sulfide (H2S). Sulfate reduction can occur in both an energy consuming assimilatory pathway and an energy producing dissimilatory pathway. The assimilatory pathway, which is found in a wide range of organisms, produces reduced sulfur compounds for the biosynthesis of S-containing amino acids and does not lead to direct excretion of sulfide. In the dissimilatory pathway, which is restricted to obligatory anaerobic bacterial and archaeal lineages, sulfate (or sulfur) is the terminal electron acceptor of the respiratory chain producing large quantities of inorganic sulfide. Both pathways start from the activation of sulfate by reaction with ATP to form adenylyl sulfate (APS). In the assimilatory pathway [MD:M00176] APS is converted to 3'-phosphoadenylyl sulfate (PAPS) and then reduced to sulfite, and sulfite is further reduced to sulfide by the assimilatory sulfite reductase. In the dissimilatory pathway [MD:M00596] APS is directly reduced to sulfite, and sulfite is further reduced to sulfide by the dissimilatory sulfite reductase. The capacity for oxidation of sulfur is quite widespread among bacteria and archaea, comprising phototrophs and chemolithoautotrophs. The SOX (sulfur-oxidation) system [MD:M00595] is a well-known sulfur oxidation pathway and is found in both photosynthetic and non-photosynthetic sulfur-oxidizing bacteria. Green sulfur bacteria and purple sulfur bacteria carry out anoxygenic photosynthesis with reduced sulfur compounds such as sulfide and elemental sulfur, as well as thiosulfate (in some species with the SOX system), as the electron donor for photoautotrophic growth. In some chemolithoautotrophic sulfur oxidizers (such as Thiobacillus denitrificans), it has been suggested that dissimilatory sulfur reduction enzymes operate in the reverse direction, forming a sulfur oxidation pathway from sulfite to APS and then to sulfate."
p3893
assS'path:map00630'
p3894
(dp3895
S'NAME'
p3896
(lp3897
S'Glyoxylate and dicarboxylate metabolism'
p3898
asS'REFERENCE'
p3899
(lp3900
S'PMID:10978349 (EC5.3.1.22)'
p3901
ag3901
aS'AUTHORS'
p3902
aS'Njau RK, Herndon CA, Hawes JW.'
p3903
aS'TITLE'
p3904
aS'Novel beta -hydroxyacid dehydrogenases in Escherichia coli and Haemophilusinfluenzae.'
p3905
aS'JOURNAL'
p3906
aS'J Biol Chem 275:38780-6 (2000)'
p3907
aS'PMID:18065535'
p3908
ag3908
aS'AUTHORS'
p3909
aS'Zarzycki J, Schlichting A, Strychalsky N, Muller M, Alber BE, Fuchs G'
p3910
aS'TITLE'
p3911
aS'Mesaconyl-coenzyme A hydratase, a new enzyme of two central carbon metabolic pathways in bacteria.'
p3912
aS'JOURNAL'
p3913
aS'J Bacteriol 190:1366-74 (2008)'
p3914
aS'PMID:18819910'
p3915
ag3915
aS'AUTHORS'
p3916
aS'Erb TJ, Retey J, Fuchs G, Alber BE'
p3917
aS'TITLE'
p3918
aS'Ethylmalonyl-CoA mutase from Rhodobacter sphaeroides defines a new subclade of coenzyme B12-dependent acyl-CoA mutases.'
p3919
aS'JOURNAL'
p3920
aS'J Biol Chem 283:32283-93 (2008)'
p3921
asS'KO_PATHWAY'
p3922
(lp3923
S'ko00630'
p3924
asS'PATHWAY_MAP'
p3925
(lp3926
S'map00630'
p3927
asS'DISEASE'
p3928
(lp3929
S'H00117'
p3930
aS'Primary hyperoxaluria (HP)'
p3931
ag3930
ag3931
aS'H00174'
p3932
aS'Methylmalonic aciduria (MMA)'
p3933
asS'MODULE'
p3934
(lp3935
S'M00012'
p3936
aS'Glyoxylate cycle [PATH:map00630]'
p3937
ag3936
ag3937
aS'M00373'
p3938
aS'Ethylmalonyl pathway [PATH:map00630]'
p3939
aS'M00532'
p3940
aS'Photorespiration [PATH:map00630]'
p3941
asS'ENTRY'
p3942
(lp3943
S'map00630'
p3944
aS'Pathway'
p3945
asS'CLASS'
p3946
(lp3947
S'Metabolism Carbohydrate metabolism'
p3948
assS'path:map00633'
p3949
(dp3950
S'DBLINKS'
p3951
(lp3952
S'UMBBD: tnt tnt2 dnt'
p3953
ag3953
aS'GO: 0046260'
p3954
asS'NAME'
p3955
(lp3956
S'Nitrotoluene degradation'
p3957
asS'REFERENCE'
p3958
(lp3959
g22
ag22
aS'AUTHORS'
p3960
aS'Esteve-Nunez A, Ramos JL.'
p3961
aS'TITLE'
p3962
aS'Metabolism of 2,4,6-Trinitrotoluene by Pseudomonas sp. JLR11.'
p3963
aS'JOURNAL'
p3964
aS'Environmental science & technology 32:3802-3808 (1998)'
p3965
aS'PMID:8534088'
p3966
ag3966
aS'AUTHORS'
p3967
aS'Gilcrease PC, Murphy VG.'
p3968
aS'TITLE'
p3969
aS'Bioconversion of 2,4-diamino-6-nitrotoluene to a novel metabolite under anoxic and aerobic conditions.'
p3970
aS'JOURNAL'
p3971
aS'Appl Environ Microbiol 61:4209-14 (1995)'
p3972
aS'PMID:11527999'
p3973
ag3973
aS'AUTHORS'
p3974
aS'Esteve-Nunez A, Caballero A, Ramos JL.'
p3975
aS'TITLE'
p3976
aS'Biological degradation of 2,4,6-trinitrotoluene.'
p3977
aS'JOURNAL'
p3978
aS'Microbiol Mol Biol Rev 65:335-52, table of contents (2001)'
p3979
aS'PMID:14751225'
p3980
ag3980
aS'AUTHORS'
p3981
aS'Fleischmann TJ, Walker KC, Spain JC, Hughes JB, Morrie Craig A.'
p3982
aS'TITLE'
p3983
aS'Anaerobic transformation of 2,4,6-TNT by bovine ruminal microbes.'
p3984
aS'JOURNAL'
p3985
aS'Biochem Biophys Res Commun 314:957-63 (2004)'
p3986
aS'PMID:14753774'
p3987
ag3987
aS'AUTHORS'
p3988
aS'Borch T, Gerlach R.'
p3989
aS'TITLE'
p3990
aS'Use of reversed-phase high-performance liquid chromatography-diode array detection for complete separation of 2,4,6-trinitrotoluene metabolites and EPA Method 8330 explosives: influence of temperature and an ion-pair reagent.'
p3991
aS'JOURNAL'
p3992
aS'J Chromatogr A 1022:83-94 (2004)'
p3993
aS'PMID:15490158'
p3994
ag3994
aS'AUTHORS'
p3995
aS'Yin H, Wood TK, Smets BF.'
p3996
aS'TITLE'
p3997
aS'Reductive transformation of TNT by Escherichia coli: pathway description.'
p3998
aS'JOURNAL'
p3999
aS'Appl Microbiol Biotechnol 67:397-404 (2005)'
p4000
aS'PMID:16187099'
p4001
ag4001
aS'AUTHORS'
p4002
aS'Kutty R, Bennett GN.'
p4003
aS'TITLE'
p4004
aS'Biochemical characterization of trinitrotoluene transforming oxygen-insensitive nitroreductases from Clostridium acetobutylicum ATCC 824.'
p4005
aS'JOURNAL'
p4006
aS'Arch Microbiol 184:158-67 (2005)'
p4007
aS'PMID:16535610'
p4008
ag4008
aS'AUTHORS'
p4009
aS'Fiorella PD, Spain JC.'
p4010
aS'TITLE'
p4011
aS'Transformation of 2,4,6-Trinitrotoluene by Pseudomonas pseudoalcaligenes JS52.'
p4012
aS'JOURNAL'
p4013
aS'Appl Environ Microbiol 63:2007-2015 (1997)'
p4014
aS'PMID:17504490'
p4015
ag4015
aS'AUTHORS'
p4016
aS'Gonzalez-Perez MM, van Dillewijn P, Wittich RM, Ramos JL.'
p4017
aS'TITLE'
p4018
aS'Escherichia coli has multiple enzymes that attack TNT and release nitrogen for growth.'
p4019
aS'JOURNAL'
p4020
aS'Environ Microbiol 9:1535-40 (2007)'
p4021
aS'PMID:16535348'
p4022
ag4022
aS'AUTHORS'
p4023
aS'Noguera DR, Freedman DL'
p4024
aS'TITLE'
p4025
aS'Reduction and Acetylation of 2,4-Dinitrotoluene by a Pseudomonas aeruginosa Strain.'
p4026
aS'JOURNAL'
p4027
aS'Appl Environ Microbiol 62:2257-63 (1996)'
p4028
aS'PMID:9922262'
p4029
ag4029
aS'AUTHORS'
p4030
aS'Haigler BE, Johnson GR, Suen WC, Spain JC'
p4031
aS'TITLE'
p4032
aS'Biochemical and genetic evidence for meta-ring cleavage of 2,4, 5-trihydroxytoluene in Burkholderia sp. strain DNT.'
p4033
aS'JOURNAL'
p4034
aS'J Bacteriol 181:965-72 (1999)'
p4035
aS'PMID:12107140'
p4036
ag4036
aS'AUTHORS'
p4037
aS'Johnson GR, Jain RK, Spain JC'
p4038
aS'TITLE'
p4039
aS'Origins of the 2,4-dinitrotoluene pathway.'
p4040
aS'JOURNAL'
p4041
aS'J Bacteriol 184:4219-32 (2002)'
p4042
asS'KO_PATHWAY'
p4043
(lp4044
S'ko00633'
p4045
asS'ENTRY'
p4046
(lp4047
S'map00633'
p4048
aS'Pathway'
p4049
asS'PATHWAY_MAP'
p4050
(lp4051
S'map00633'
p4052
asS'CLASS'
p4053
(lp4054
S'Metabolism Xenobiotics biodegradation and metabolism'
p4055
assS'path:map04614'
p4056
(dp4057
S'NAME'
p4058
(lp4059
S'Renin-angiotensin system'
p4060
asS'REFERENCE'
p4061
(lp4062
S'PMID:17229979'
p4063
ag4063
aS'AUTHORS'
p4064
aS'Kramkowski K, Mogielnicki A, Buczko W.'
p4065
aS'TITLE'
p4066
aS'The physiological significance of the alternative pathways of angiotensin II production.'
p4067
aS'JOURNAL'
p4068
aS'J Physiol Pharmacol 57:529-39 (2006)'
p4069
aS'PMID:15549172'
p4070
ag4070
aS'AUTHORS'
p4071
aS'Danilczyk U, Eriksson U, Oudit GY, Penninger JM.'
p4072
aS'TITLE'
p4073
aS'Physiological roles of angiotensin-converting enzyme 2.'
p4074
aS'JOURNAL'
p4075
aS'Cell Mol Life Sci 61:2714-9 (2004)'
p4076
aS'PMID:15549171'
p4077
ag4077
aS'AUTHORS'
p4078
aS'Warner FJ, Smith AI, Hooper NM, Turner AJ.'
p4079
aS'TITLE'
p4080
aS'Angiotensin-converting enzyme-2: a molecular and cellular perspective.'
p4081
aS'JOURNAL'
p4082
aS'Cell Mol Life Sci 61:2704-13 (2004)'
p4083
aS'PMID:15833268'
p4084
ag4084
aS'AUTHORS'
p4085
aS'Kurdi M, De Mello WC, Booz GW.'
p4086
aS'TITLE'
p4087
aS'Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.'
p4088
aS'JOURNAL'
p4089
aS'Int J Biochem Cell Biol 37:1357-67 (2005)'
p4090
aS'PMID:15109615'
p4091
ag4091
aS'AUTHORS'
p4092
aS'Burrell LM, Johnston CI, Tikellis C, Cooper ME.'
p4093
aS'TITLE'
p4094
aS'ACE2, a new regulator of the renin-angiotensin system.'
p4095
aS'JOURNAL'
p4096
aS'Trends Endocrinol Metab 15:166-9 (2004)'
p4097
aS'PMID:16555051'
p4098
ag4098
aS'AUTHORS'
p4099
aS'von Bohlen und Halbach O, Albrecht D.'
p4100
aS'TITLE'
p4101
aS'The CNS renin-angiotensin system.'
p4102
aS'JOURNAL'
p4103
aS'Cell Tissue Res 326:599-616 (2006)'
p4104
aS'PMID:12793984'
p4105
ag4105
aS'AUTHORS'
p4106
aS'Schmaier AH'
p4107
aS'TITLE'
p4108
aS'The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.'
p4109
aS'JOURNAL'
p4110
aS'Am J Physiol Regul Integr Comp Physiol 285:R1-13 (2003)'
p4111
aS'PMID:12419208'
p4112
ag4112
aS'AUTHORS'
p4113
aS'Eriksson U, Danilczyk U, Penninger JM.'
p4114
aS'TITLE'
p4115
aS'Just the beginning: novel functions for angiotensin-converting enzymes.'
p4116
aS'JOURNAL'
p4117
aS'Curr Biol 12:R745-52 (2002)'
p4118
aS'PMID:16286563'
p4119
ag4119
aS'AUTHORS'
p4120
aS'Dielis AW, Smid M, Spronk HM, Hamulyak K, Kroon AA, ten Cate H, de Leeuw PW.'
p4121
aS'TITLE'
p4122
aS'The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems.'
p4123
aS'JOURNAL'
p4124
aS'Hypertension 46:1236-42 (2005)'
p4125
aS'PMID:16581295'
p4126
ag4126
aS'AUTHORS'
p4127
aS'Kuba K, Imai Y, Penninger JM.'
p4128
aS'TITLE'
p4129
aS'Angiotensin-converting enzyme 2 in lung diseases.'
p4130
aS'JOURNAL'
p4131
aS'Curr Opin Pharmacol 6:271-6 (2006)'
p4132
aS'PMID:12505055'
p4133
ag4133
aS'AUTHORS'
p4134
aS'Erdos EG, Jackman HL, Brovkovych V, Tan F, Deddish PA.'
p4135
aS'TITLE'
p4136
aS'Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin.'
p4137
aS'JOURNAL'
p4138
aS'J Mol Cell Cardiol 34:1569-76 (2002)'
p4139
aS'PMID:12372844'
p4140
ag4140
aS'AUTHORS'
p4141
aS'Shrimpton CN, Smith AI, Lew RA.'
p4142
aS'TITLE'
p4143
aS'Soluble metalloendopeptidases and neuroendocrine signaling.'
p4144
aS'JOURNAL'
p4145
aS'Endocr Rev 23:647-64 (2002)'
p4146
aS'PMID:12019279'
p4147
ag4147
aS'AUTHORS'
p4148
aS'Jackman HL, Massad MG, Sekosan M, Tan F, Brovkovych V, Marcic BM, Erdos EG.'
p4149
aS'TITLE'
p4150
aS'Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A.'
p4151
aS'JOURNAL'
p4152
aS'Hypertension 39:976-81 (2002)'
p4153
aS'PMID:15173164'
p4154
ag4154
aS'AUTHORS'
p4155
aS'Lundequist A, Tchougounova E, Abrink M, Pejler G.'
p4156
aS'TITLE'
p4157
aS'Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II.'
p4158
aS'JOURNAL'
p4159
aS'J Biol Chem 279:32339-44 (2004)'
p4160
aS'PMID:17362841'
p4161
ag4161
aS'AUTHORS'
p4162
aS'Kehoe PG, Wilcock GK.'
p4163
aS'TITLE'
p4164
aS"Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?"
p4165
aS'JOURNAL'
p4166
aS'Lancet Neurol 6:373-8 (2007)'
p4167
asS'KO_PATHWAY'
p4168
(lp4169
S'ko04614'
p4170
asS'ENTRY'
p4171
(lp4172
S'map04614'
p4173
aS'Pathway'
p4174
asS'PATHWAY_MAP'
p4175
(lp4176
S'map04614'
p4177
asS'DISEASE'
p4178
(lp4179
S'H00541'
p4180
aS'Uromodulin-associated kidney diseases'
p4181
ag4180
ag4181
aS'H00575'
p4182
aS'Renal tubular dysgenesis'
p4183
asS'CLASS'
p4184
(lp4185
S'Organismal Systems Endocrine system'
p4186
assS'path:map04360'
p4187
(dp4188
S'NAME'
p4189
(lp4190
S'Axon guidance'
p4191
asS'REFERENCE'
p4192
(lp4193
S'PMID:14682358'
p4194
ag4194
aS'AUTHORS'
p4195
aS'Guan KL, Rao Y.'
p4196
aS'TITLE'
p4197
aS'Signalling mechanisms mediating neuronal responses to guidance cues.'
p4198
aS'JOURNAL'
p4199
aS'Nat Rev Neurosci 4:941-56 (2003)'
p4200
aS'PMID:15630019'
p4201
ag4201
aS'AUTHORS'
p4202
aS'Govek EE, Newey SE, Van Aelst L.'
p4203
aS'TITLE'
p4204
aS'The role of the Rho GTPases in neuronal development.'
p4205
aS'JOURNAL'
p4206
aS'Genes Dev 19:1-49 (2005)'
p4207
aS'PMID:12677003'
p4208
ag4208
aS'AUTHORS'
p4209
aS'Huber AB, Kolodkin AL, Ginty DD, Cloutier JF.'
p4210
aS'TITLE'
p4211
aS'Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance.'
p4212
aS'JOURNAL'
p4213
aS'Annu Rev Neurosci 26:509-63 (2003)'
p4214
aS'PMID:15818466'
p4215
ag4215
aS'AUTHORS'
p4216
aS'Negishi M, Oinuma I, Katoh H.'
p4217
aS'TITLE'
p4218
aS'Plexins: axon guidance and signal transduction.'
p4219
aS'JOURNAL'
p4220
aS'Cell Mol Life Sci 62:1363-71 (2005)'
p4221
aS'PMID:15363605'
p4222
ag4222
aS'AUTHORS'
p4223
aS'Huot J.'
p4224
aS'TITLE'
p4225
aS'Ephrin signaling in axon guidance.'
p4226
aS'JOURNAL'
p4227
aS'Prog Neuropsychopharmacol Biol Psychiatry 28:813-8 (2004)'
p4228
aS'PMID:11891122'
p4229
ag4229
aS'AUTHORS'
p4230
aS'Patel BN, Van Vactor DL.'
p4231
aS'TITLE'
p4232
aS'Axon guidance: the cytoplasmic tail.'
p4233
aS'JOURNAL'
p4234
aS'Curr Opin Cell Biol 14:221-9 (2002)'
p4235
aS'PMID:11687826'
p4236
ag4236
aS'AUTHORS'
p4237
aS'Yu TW, Bargmann CI.'
p4238
aS'TITLE'
p4239
aS'Dynamic regulation of axon guidance.'
p4240
aS'JOURNAL'
p4241
aS'Nat Neurosci 4 Suppl:1169-76 (2001)'
p4242
aS'PMID:12471249'
p4243
ag4243
aS'AUTHORS'
p4244
aS'Dickson BJ.'
p4245
aS'TITLE'
p4246
aS'Molecular mechanisms of axon guidance.'
p4247
aS'JOURNAL'
p4248
aS'Science 298:1959-64 (2002)'
p4249
aS'PMID:15960985'
p4250
ag4250
aS'AUTHORS'
p4251
aS'Barallobre MJ, Pascual M, Del Rio JA, Soriano E.'
p4252
aS'TITLE'
p4253
aS'The Netrin family of guidance factors: emphasis on Netrin-1 signalling.'
p4254
aS'JOURNAL'
p4255
aS'Brain Res Brain Res Rev 49:22-47 (2005)'
p4256
aS'PMID:15084255'
p4257
ag4257
aS'AUTHORS'
p4258
aS'Sabatier C, Plump AS, Le Ma, Brose K, Tamada A, Murakami F, Lee EY, Tessier-Lavigne M.'
p4259
aS'TITLE'
p4260
aS'The divergent Robo family protein rig-1/Robo3 is a negative regulator of slit responsiveness required for midline crossing by commissural axons.'
p4261
aS'JOURNAL'
p4262
aS'Cell 117:157-69 (2004)'
p4263
asS'KO_PATHWAY'
p4264
(lp4265
S'ko04360'
p4266
asS'PATHWAY_MAP'
p4267
(lp4268
S'map04360'
p4269
asS'DISEASE'
p4270
(lp4271
S'H00577'
p4272
aS'Syndromic X-linked mental retardation with epilepsy or seizures'
p4273
ag4272
ag4273
aS'H00698'
p4274
aS'Nemaline myopathy'
p4275
aS'H00764'
p4276
aS'Cri du chat syndrome'
p4277
aS'H01034'
p4278
aS'L1 syndrome'
p4279
aS'H01202'
p4280
aS'Cataract'
p4281
aS'H01287'
p4282
aS'Congenital mirror movements (CMM)'
p4283
asS'DBLINKS'
p4284
(lp4285
S'GO: 0007411'
p4286
asS'ENTRY'
p4287
(lp4288
S'map04360'
p4289
aS'Pathway'
p4290
asS'CLASS'
p4291
(lp4292
S'Organismal Systems Development'
p4293
asS'DESCRIPTION'
p4294
(lp4295
S'Axon guidance represents a key stage in the formation of neuronal network. Axons are guided by a variety of guidance factors, such as netrins, ephrins, Slits, and semaphorins. These guidance cues are read by growth cone receptors, and signal transduction pathways downstream of these receptors converge onto the Rho GTPases to elicit changes in cytoskeletal organization that determine which way the growth cone will turn.'
p4296
assS'path:map00030'
p4297
(dp4298
S'NAME'
p4299
(lp4300
S'Pentose phosphate pathway'
p4301
asS'REFERENCE'
p4302
(lp4303
S'(map 3)'
p4304
ag4304
aS'AUTHORS'
p4305
aS'Nishizuka Y (ed).'
p4306
aS'TITLE'
p4307
aS'[Metabolic Maps] (In Japanese)'
p4308
aS'JOURNAL'
p4309
aS'Tokyo Kagaku Dojin (1980)'
p4310
aS'(map 4)'
p4311
ag4311
aS'AUTHORS'
p4312
aS'Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).'
p4313
aS'TITLE'
p4314
aS'[Cellular Functions and Metabolic Maps] (In Japanese)'
p4315
aS'JOURNAL'
p4316
aS'Tokyo Kagaku Dojin (1997)'
p4317
ag22
ag22
aS'AUTHORS'
p4318
aS'Michal G.'
p4319
aS'TITLE'
p4320
aS'Biochemical Pathways'
p4321
aS'JOURNAL'
p4322
aS'Wiley (1999)'
p4323
aS'PMID:12700258'
p4324
ag4324
aS'AUTHORS'
p4325
aS'Hove-Jensen B, Rosenkrantz TJ, Haldimann A, Wanner BL.'
p4326
aS'TITLE'
p4327
aS'Escherichia coli phnN, encoding ribose 1,5-bisphosphokinase activity (phosphoribosyl diphosphate forming): dual role in phosphonate degradation and NAD biosynthesis pathways.'
p4328
aS'JOURNAL'
p4329
aS'J Bacteriol 185:2793-801 (2003)'
p4330
aS'PMID:16788179'
p4331
ag4331
aS'AUTHORS'
p4332
aS'Orita I, Sato T, Yurimoto H, Kato N, Atomi H, Imanaka T, Sakai Y'
p4333
aS'TITLE'
p4334
aS'The ribulose monophosphate pathway substitutes for the missing pentose phosphate'
p4335
aS'pathway in the archaeon Thermococcus kodakaraensis.'
p4336
aS'JOURNAL'
p4337
aS'J Bacteriol 188:4698-704 (2006)'
p4338
aS'PMID:16428816'
p4339
ag4339
aS'AUTHORS'
p4340
aS'Kato N, Yurimoto H, Thauer RK'
p4341
aS'TITLE'
p4342
aS'The physiological role of the ribulose monophosphate pathway in bacteria and archaea.'
p4343
aS'JOURNAL'
p4344
aS'Biosci Biotechnol Biochem 70:10-21 (2006)'
p4345
aS'PMID:23279921'
p4346
ag4346
aS'AUTHORS'
p4347
aS'Kouril T, Wieloch P, Reimann J, Wagner M, Zaparty M, Albers SV, Schomburg D, Ruoff P, Siebers B'
p4348
aS'TITLE'
p4349
aS'Unraveling the function of the two Entner-Doudoroff branches in the thermoacidophilic Crenarchaeon Sulfolobus solfataricus P2.'
p4350
aS'JOURNAL'
p4351
aS'FEBS J 280:1126-38 (2013)'
p4352
aS'PMID:16458304'
p4353
ag4353
aS'AUTHORS'
p4354
aS'Reher M, Schonheit P'
p4355
aS'TITLE'
p4356
aS'Glyceraldehyde dehydrogenases from the thermoacidophilic euryarchaeota Picrophilus torridus and Thermoplasma acidophilum, key enzymes of the non-phosphorylative Entner-Doudoroff pathway, constitute a novel enzyme family within the aldehyde dehydrogenase superfamily.'
p4357
aS'JOURNAL'
p4358
aS'FEBS Lett 580:1198-204 (2006)'
p4359
aS'PMID:20023024'
p4360
ag4360
aS'AUTHORS'
p4361
aS'Reher M, Fuhrer T, Bott M, Schonheit P'
p4362
aS'TITLE'
p4363
aS'The nonphosphorylative Entner-Doudoroff pathway in the thermoacidophilic euryarchaeon Picrophilus torridus involves a novel 2-keto-3-deoxygluconate- specific aldolase.'
p4364
aS'JOURNAL'
p4365
aS'J Bacteriol 192:964-74 (2010)'
p4366
asS'KO_PATHWAY'
p4367
(lp4368
S'ko00030'
p4369
asS'PATHWAY_MAP'
p4370
(lp4371
S'map00030'
p4372
asS'DISEASE'
p4373
(lp4374
S'H00196'
p4375
aS'Phosphoribosylpyrophosphate synthetase I superactivity'
p4376
ag4375
ag4376
aS'H00668'
p4377
aS'Anemia due to disorders of glutathione metabolism'
p4378
aS'H00946'
p4379
aS'Arts syndrome'
p4380
aS'H01111'
p4381
aS'Cortisone reductase deficiency (CRD)'
p4382
aS'H01135'
p4383
aS'Ribose 5-phosphate isomerase (RPI) deficiency'
p4384
aS'H01189'
p4385
aS'Transaldolase (TALDO) deficiency'
p4386
aS'H01375'
p4387
aS'Glucose 6-phosphate dehydrogenase deficiency'
p4388
asS'MODULE'
p4389
(lp4390
S'M00004'
p4391
aS'Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map00030]'
p4392
ag4391
ag4392
aS'M00005'
p4393
aS'PRPP biosynthesis, ribose 5P => PRPP [PATH:map00030]'
p4394
aS'M00006'
p4395
aS'Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map00030]'
p4396
aS'M00007'
p4397
aS'Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map00030]'
p4398
aS'M00008'
p4399
aS'Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map00030]'
p4400
aS'M00061'
p4401
aS'D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P [PATH:map00030]'
p4402
aS'M00308'
p4403
aS'Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map00030]'
p4404
aS'M00309'
p4405
aS'Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map00030]'
p4406
aS'M00580'
p4407
aS'Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map00030]'
p4408
aS'M00631'
p4409
aS'D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P [PATH:map00030]'
p4410
aS'M00633'
p4411
aS'Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map00030]'
p4412
asS'DBLINKS'
p4413
(lp4414
S'GO: 0006098'
p4415
asS'ENTRY'
p4416
(lp4417
S'map00030'
p4418
aS'Pathway'
p4419
asS'CLASS'
p4420
(lp4421
S'Metabolism Carbohydrate metabolism'
p4422
asS'DESCRIPTION'
p4423
(lp4424
S'The pentose phosphate pathway is a process of glucose turnover that produces NADPH as reducing equivalents and pentoses as essential parts of nucleotides. There are two different phases in the pathway. One is irreversible oxidative phase in which glucose-6P is converted to ribulose-5P by oxidative decarboxylation, and NADPH is generated [MD:M00006]. The other is reversible non-oxidative phase in which phosphorylated sugars are interconverted to generate xylulose-5P, ribulose-5P, and ribose-5P [MD:M00007]. Phosphoribosyl pyrophosphate (PRPP) formed from ribose-5P [MD:M00005] is an activated compound used in the biosynthesis of histidine and purine/pyrimidine nucleotides. This pathway map also shows the Entner-Doudoroff pathway where 6-P-gluconate is dehydrated and then cleaved into pyruvate and glyceraldehyde-3P [MD:M00008].'
p4425
assS'path:map00626'
p4426
(dp4427
S'NAME'
p4428
(lp4429
S'Naphthalene degradation'
p4430
asS'REFERENCE'
p4431
(lp4432
S'PMID:16461648'
p4433
ag4433
aS'AUTHORS'
p4434
aS'Kim SJ, Kweon O, Freeman JP, Jones RC, Adjei MD, Jhoo JW, Edmondson RD, Cerniglia CE.'
p4435
aS'TITLE'
p4436
aS'Molecular cloning and expression of genes encoding a novel dioxygenase involved in low- and high-molecular-weight polycyclic aromatic hydrocarbon degradation in Mycobacterium vanbaalenii PYR-1.'
p4437
aS'JOURNAL'
p4438
aS'Appl Environ Microbiol 72:1045-54 (2006)'
p4439
aS'PMID:8226631'
p4440
ag4440
aS'AUTHORS'
p4441
aS'Denome SA, Stanley DC, Olson ES, Young KD'
p4442
aS'TITLE'
p4443
aS'Metabolism of dibenzothiophene and naphthalene in Pseudomonas strains: complete DNA sequence of an upper naphthalene catabolic pathway.'
p4444
aS'JOURNAL'
p4445
aS'J Bacteriol 175:6890-901 (1993)'
p4446
aS'PMID:1447127'
p4447
ag4447
aS'AUTHORS'
p4448
aS'Eaton RW, Chapman PJ'
p4449
aS'TITLE'
p4450
aS'Bacterial metabolism of naphthalene: construction and use of recombinant bacteria to study ring cleavage of 1,2-dihydroxynaphthalene and subsequent reactions.'
p4451
aS'JOURNAL'
p4452
aS'J Bacteriol 174:7542-54 (1992)'
p4453
aS'PMID:8981987'
p4454
ag4454
aS'AUTHORS'
p4455
aS'Morawski B, Eaton RW, Rossiter JT, Guoping S, Griengl H, Ribbons DW'
p4456
aS'TITLE'
p4457
aS'2-Naphthoate catabolic pathway in Burkholderia strain JT 1500.'
p4458
aS'JOURNAL'
p4459
aS'J Bacteriol 179:115-21 (1997)'
p4460
aS'PMID:15500985'
p4461
ag4461
aS'AUTHORS'
p4462
aS'Safinowski M, Meckenstock RU'
p4463
aS'TITLE'
p4464
aS'Enzymatic reactions in anaerobic 2-methylnaphthalene degradation by the sulphate-reducing enrichment culture N 47.'
p4465
aS'JOURNAL'
p4466
aS'FEMS Microbiol Lett 240:99-104 (2004)'
p4467
aS'PMID:11097910'
p4468
ag4468
aS'AUTHORS'
p4469
aS'Annweiler E, Materna A, Safinowski M, Kappler A, Richnow HH, Michaelis W, Meckenstock RU'
p4470
aS'TITLE'
p4471
aS'Anaerobic degradation of 2-methylnaphthalene by a sulfate-reducing enrichment culture.'
p4472
aS'JOURNAL'
p4473
aS'Appl Environ Microbiol 66:5329-33 (2000)'
p4474
aS'PMID:11823228'
p4475
ag4475
aS'AUTHORS'
p4476
aS'Annweiler E, Michaelis W, Meckenstock RU'
p4477
aS'TITLE'
p4478
aS'Identical ring cleavage products during anaerobic degradation of naphthalene, 2-methylnaphthalene, and tetralin indicate a new metabolic pathway.'
p4479
aS'JOURNAL'
p4480
aS'Appl Environ Microbiol 68:852-8 (2002)'
p4481
aS'PMID:15372028'
p4482
ag4482
aS'AUTHORS'
p4483
aS'Aitken CM, Jones DM, Larter SR'
p4484
aS'TITLE'
p4485
aS'Anaerobic hydrocarbon biodegradation in deep subsurface oil reservoirs.'
p4486
aS'JOURNAL'
p4487
aS'Nature 431:291-4 (2004)'
p4488
aS'PMID:19854898'
p4489
ag4489
aS'AUTHORS'
p4490
aS'Selesi D, Jehmlich N, von Bergen M, Schmidt F, Rattei T, Tischler P, Lueders T, Meckenstock RU'
p4491
aS'TITLE'
p4492
aS'Combined genomic and proteomic approaches identify gene clusters involved in anaerobic 2-methylnaphthalene degradation in the sulfate-reducing enrichment culture N47.'
p4493
aS'JOURNAL'
p4494
aS'J Bacteriol 192:295-306 (2010)'
p4495
asS'KO_PATHWAY'
p4496
(lp4497
S'ko00626'
p4498
asS'PATHWAY_MAP'
p4499
(lp4500
S'map00626'
p4501
asS'MODULE'
p4502
(lp4503
S'M00534'
p4504
aS'Naphthalene degradation, naphthalene => salicylate [PATH:map00626]'
p4505
ag4504
ag4505
aS'M00638'
p4506
aS'Salicylate degradation, salicylate => gentisate [PATH:map00626]'
p4507
asS'DBLINKS'
p4508
(lp4509
S'UMBBD: naph nphs 1mna npa 2mna 2mna2'
p4510
asS'ENTRY'
p4511
(lp4512
S'map00626'
p4513
aS'Pathway'
p4514
asS'CLASS'
p4515
(lp4516
S'Metabolism Xenobiotics biodegradation and metabolism'
p4517
assS'path:map00195'
p4518
(dp4519
S'NAME'
p4520
(lp4521
S'Photosynthesis'
p4522
asS'REFERENCE'
p4523
(lp4524
S'PMID:14764885'
p4525
ag4525
aS'AUTHORS'
p4526
aS'Ferreira KN, Iverson TM, Maghlaoui K, Barber J, Iwata S.'
p4527
aS'TITLE'
p4528
aS'Architecture of the photosynthetic oxygen-evolving center.'
p4529
aS'JOURNAL'
p4530
aS'Science 303:1831-8 (2004)'
p4531
aS'PMID:12518057'
p4532
ag4532
aS'AUTHORS'
p4533
aS'Kamiya N, Shen JR.'
p4534
aS'TITLE'
p4535
aS'Crystal structure of oxygen-evolving photosystem II from Thermosynechococcus vulcanus at 3.7-A resolution.'
p4536
aS'JOURNAL'
p4537
aS'Proc Natl Acad Sci U S A 100:98-103 (2003)'
p4538
aS'PMID:11217865'
p4539
ag4539
aS'AUTHORS'
p4540
aS'Zouni A, Witt HT, Kern J, Fromme P, Krauss N, Saenger W, Orth P.'
p4541
aS'TITLE'
p4542
aS'Crystal structure of photosystem II from Synechococcus elongatus at 3.8 A resolution.'
p4543
aS'JOURNAL'
p4544
aS'Nature 409:739-743 (2001)'
p4545
aS'PMID:11418848'
p4546
ag4546
aS'AUTHORS'
p4547
aS'Jordan P, Fromme P, Witt HT, Klukas O, Saenger W, Krauss N.'
p4548
aS'TITLE'
p4549
aS'Three-dimensional structure of cyanobacterial photosystem I at 2.5 A resolution.'
p4550
aS'JOURNAL'
p4551
aS'Nature 411:909-917 (2001)'
p4552
aS'PMID:11369223'
p4553
ag4553
aS'AUTHORS'
p4554
aS'Jones MR, Fyfe PK.'
p4555
aS'TITLE'
p4556
aS'Photosynthesis: new light on biological oxygen production.'
p4557
aS'JOURNAL'
p4558
aS'Curr Biol 17:R318-R321 (2001)'
p4559
aS'PMID:11914373'
p4560
ag4560
aS'AUTHORS'
p4561
aS'Shen G, Zhao J, Reimer SK, Antonkine ML, Cai Q, Weiland SM, Golbeck JH, Bryant DA.'
p4562
aS'TITLE'
p4563
aS'Assembly of photosystem I. I. Inactivation of the rubA gene encoding a membrane-associated rubredoxin in the cyanobacterium Synechococcus sp. PCC 7002 causes a loss of photosystem I activity.'
p4564
aS'JOURNAL'
p4565
aS'J Biol Chem 277:20343-54 (2002)'
p4566
asS'KO_PATHWAY'
p4567
(lp4568
S'ko00195'
p4569
asS'PATHWAY_MAP'
p4570
(lp4571
S'map00195'
p4572
asS'DISEASE'
p4573
(lp4574
S'H00138'
p4575
aS'Farber lipogranulomatosis'
p4576
ag4575
ag4576
aS'H00424'
p4577
aS'Defects in the degradation of sphingomyelin'
p4578
asS'MODULE'
p4579
(lp4580
S'M00157'
p4581
aS'F-type ATPase, prokaryotes and chloroplasts [PATH:map00195]'
p4582
ag4581
ag4582
aS'M00161'
p4583
aS'Photosystem II [PATH:map00195]'
p4584
aS'M00162'
p4585
aS'Cytochrome b6f complex [PATH:map00195]'
p4586
aS'M00163'
p4587
aS'Photosystem I [PATH:map00195]'
p4588
asS'ENTRY'
p4589
(lp4590
S'map00195'
p4591
aS'Pathway'
p4592
asS'CLASS'
p4593
(lp4594
S'Metabolism Energy metabolism'
p4595
asS'DESCRIPTION'
p4596
(lp4597
S'Photosynthesis in green plants and specialized bacteria is the process of utilizing light energy to synthesize organic compounds from carbon dioxide and water. It consists of the light dependent part (light reaction) and the light independent part (dark reaction, carbon fixation). The light reaction takes place in thylakoid, a membrane-bound compartment inside chloroplasts and cyanobacteria. The light energy is used by photosystems I and II to generate proton motive force and reducing power (NADPH or NADH). The proton motive force is used by ATP synthase to generate ATP, essentially in the same way as the mitochondrial respiratory chain. The supplies of ATP and NAD(P)H are then used to fix carbon dioxide.'
p4598
assS'path:map00196'
p4599
(dp4600
S'NAME'
p4601
(lp4602
S'Photosynthesis - antenna proteins'
p4603
asS'REFERENCE'
p4604
(lp4605
S'PMID:10625426'
p4606
ag4606
aS'AUTHORS'
p4607
aS'Nield J, Orlova EV, Morris EP, Gowen B, van Heel M, Barber J.'
p4608
aS'TITLE'
p4609
aS'3D map of the plant photosystem II supercomplex obtained by cryoelectron microscopy and single particle analysis.'
p4610
aS'JOURNAL'
p4611
aS'Nat Struct Biol 7:44-7 (2000)'
p4612
aS'PMID:15994896'
p4613
ag4613
aS'AUTHORS'
p4614
aS'Sener MK, Jolley C, Ben-Shem A, Fromme P, Nelson N, Croce R, Schulten K.'
p4615
aS'TITLE'
p4616
aS'Comparison of the light-harvesting networks of plant and cyanobacterial photosystem I.'
p4617
aS'JOURNAL'
p4618
aS'Biophys J 89:1630-42 (2005)'
p4619
aS'PMID:14668855'
p4620
ag4620
aS'AUTHORS'
p4621
aS'Ben-Shem A, Frolow F, Nelson N.'
p4622
aS'TITLE'
p4623
aS'Crystal structure of plant photosystem I.'
p4624
aS'JOURNAL'
p4625
aS'Nature 426:630-5 (2003)'
p4626
aS'PMID:15955818'
p4627
ag4627
aS'AUTHORS'
p4628
aS'Jolley C, Ben-Shem A, Nelson N, Fromme P.'
p4629
aS'TITLE'
p4630
aS'Structure of plant photosystem I revealed by theoretical modeling.'
p4631
aS'JOURNAL'
p4632
aS'J Biol Chem 280:33627-36 (2005)'
p4633
aS'PMID:16098971'
p4634
ag4634
aS'AUTHORS'
p4635
aS'Ihalainen JA, Klimmek F, Ganeteg U, van Stokkum IH, van Grondelle R, Jansson S, Dekker JP.'
p4636
aS'TITLE'
p4637
aS'Excitation energy trapping in photosystem I complexes depleted in Lhca1 and Lhca4.'
p4638
aS'JOURNAL'
p4639
aS'FEBS Lett 579:4787-91 (2005)'
p4640
aS'PMID:16401064'
p4641
ag4641
aS'AUTHORS'
p4642
aS'Melkozernov AN, Barber J, Blankenship RE.'
p4643
aS'TITLE'
p4644
aS'Light harvesting in photosystem I supercomplexes.'
p4645
aS'JOURNAL'
p4646
aS'Biochemistry 45:331-45 (2006)'
p4647
asS'KO_PATHWAY'
p4648
(lp4649
S'ko00196'
p4650
asS'ENTRY'
p4651
(lp4652
S'map00196'
p4653
aS'Pathway'
p4654
asS'PATHWAY_MAP'
p4655
(lp4656
S'map00196'
p4657
asS'CLASS'
p4658
(lp4659
S'Metabolism Energy metabolism'
p4660
asS'DESCRIPTION'
p4661
(lp4662
S'The chlorophyll-binding subunits of photosystems I and II are internal antenna light-harvesting proteins of oxygenic photosynthesis. The antenna proteins that exist in phycobilisomes in cyanobacteria and light-harvesting chlorophyll protein complexes in green plants act as peripheral antenna systems, enabling more efficient absorption of light energy.'
p4663
assS'path:map04940'
p4664
(dp4665
S'NAME'
p4666
(lp4667
S'Type I diabetes mellitus'
p4668
asS'REFERENCE'
p4669
(lp4670
S'PMID:9719467'
p4671
ag4671
aS'AUTHORS'
p4672
aS'Rabinovitch A, Suarez-Pinzon WL.'
p4673
aS'TITLE'
p4674
aS'Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.'
p4675
aS'JOURNAL'
p4676
aS'Biochem Pharmacol 55:1139-49 (1998)'
p4677
aS'PMID:11507694'
p4678
ag4678
aS'AUTHORS'
p4679
aS'Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, Concannon P'
p4680
aS'TITLE'
p4681
aS'Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.'
p4682
aS'JOURNAL'
p4683
aS'Am J Hum Genet 69:820-30 (2001)'
p4684
aS'PMID:8072542'
p4685
ag4685
aS'AUTHORS'
p4686
aS'Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, et al.'
p4687
aS'TITLE'
p4688
aS'A genome-wide search for human type 1 diabetes susceptibility genes.'
p4689
aS'JOURNAL'
p4690
aS'Nature 371:130-6 (1994)'
p4691
aS'PMID:8786033'
p4692
ag4692
aS'AUTHORS'
p4693
aS'Fujisawa T, Ikegami H, Kawaguchi Y, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Shima K, Ogihara T.'
p4694
aS'TITLE'
p4695
aS'Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.'
p4696
aS'JOURNAL'
p4697
aS'Diabetologia 38:1493-5 (1995)'
p4698
aS'PMID:12796471'
p4699
ag4699
aS'AUTHORS'
p4700
aS'Jaeckel E, Klein L, Martin-Orozco N, von Boehmer H.'
p4701
aS'TITLE'
p4702
aS'Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.'
p4703
aS'JOURNAL'
p4704
aS'J Exp Med 197:1635-44 (2003)'
p4705
aS'PMID:15889095'
p4706
ag4706
aS'AUTHORS'
p4707
aS'Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS.'
p4708
aS'TITLE'
p4709
aS'Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.'
p4710
aS'JOURNAL'
p4711
aS'Nature 435:220-3 (2005)'
p4712
aS'PMID:15889096'
p4713
ag4713
aS'AUTHORS'
p4714
aS'Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA.'
p4715
aS'TITLE'
p4716
aS'Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.'
p4717
aS'JOURNAL'
p4718
aS'Nature 435:224-8 (2005)'
p4719
aS'PMID:14617043'
p4720
ag4720
aS'AUTHORS'
p4721
aS'Lieberman SM, DiLorenzo TP.'
p4722
aS'TITLE'
p4723
aS'A comprehensive guide to antibody and T-cell responses in type 1 diabetes.'
p4724
aS'JOURNAL'
p4725
aS'Tissue Antigens 62:359-77 (2003)'
p4726
aS'PMID:12752668'
p4727
ag4727
aS'AUTHORS'
p4728
aS'Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.'
p4729
aS'TITLE'
p4730
aS'Granzyme B: a natural born killer.'
p4731
aS'JOURNAL'
p4732
aS'Immunol Rev 193:31-8 (2003)'
p4733
asS'KO_PATHWAY'
p4734
(lp4735
S'ko04940'
p4736
asS'PATHWAY_MAP'
p4737
(lp4738
S'map04940'
p4739
asS'DISEASE'
p4740
(lp4741
S'H00408'
p4742
aS'Type I diabetes mellitus'
p4743
asS'DESCRIPTION Type I diabetes mellitus is a disease that results from autoimmune destruction of the insulin-producing beta-cells. Certain beta-cell proteins act as autoantigens after being processed by antigen-presenting cell (APC), such as macrophages and dendritic cells, and presented in a complex with MHC-II molecules on the surface of the APC. Then immunogenic signals from APC activate CD4+ T cells, predominantly of the Th1 subset. Antigen-activated Th1 cells produce IL-2 and IFNgamma. They activate macrophages and cytotoxic CD8+ T cells, and these effector cells may kill islet beta-cells by one or both of two types of mechanisms: (1) direct interactions of antigen-specific cytotoxic T cells with a beta-cell autoantigen-MHC-I complex on the beta-cell, and (2) non-specific inflammatory mediators, such as free radicals/oxidants and cytokines (IL-1, TNFalpha, TNFbeta, IFNgamma).'
p4744
(lp4745
S'Type I diabetes is a polygenic disease. One of the principle determining genetic factors in diabetes incidence is the inheritance of mutant MHC-II alleles. Another plausible candidate gene is the insulin gene.'
p4746
asS'ENTRY'
p4747
(lp4748
S'map04940'
p4749
aS'Pathway'
p4750
asS'CLASS'
p4751
(lp4752
S'Human Diseases Endocrine and metabolic diseases'
p4753
asS'DESCRIPTION'
p4754
(lp4755
S'Type I diabetes mellitus is a disease that results from autoimmune destruction of the insulin-producing beta-cells. Certain beta-cell proteins act as autoantigens after being processed by antigen-presenting cell (APC), such as macrophages and dendritic cells, and presented in a complex with MHC-II molecules on the surface of the APC. Then immunogenic signals from APC activate CD4+ T cells, predominantly of the Th1 subset. Antigen-activated Th1 cells produce IL-2 and IFNgamma. They activate macrophages and cytotoxic CD8+ T cells, and these effector cells may kill islet beta-cells by one or both of two types of mechanisms: (1) direct interactions of antigen-specific cytotoxic T cells with a beta-cell autoantigen-MHC-I complex on the beta-cell, and (2) non-specific inflammatory mediators, such as free radicals/oxidants and cytokines (IL-1, TNFalpha, TNFbeta, IFNgamma).'
p4756
assS'path:map00622'
p4757
(dp4758
S'NAME'
p4759
(lp4760
S'Xylene degradation'
p4761
asS'REFERENCE'
p4762
(lp4763
S'PMID:11375157'
p4764
ag4764
aS'AUTHORS'
p4765
aS'Haddad S, Eby DM, Neidle EL.'
p4766
aS'TITLE'
p4767
aS'Cloning and expression of the benzoate dioxygenase genes from Rhodococcus sp. strain 19070.'
p4768
aS'JOURNAL'
p4769
aS'Appl Environ Microbiol 67:2507-14 (2001)'
p4770
aS'PMID:7768806'
p4771
ag4771
aS'AUTHORS'
p4772
aS'Kim E, Zylstra GJ'
p4773
aS'TITLE'
p4774
aS'Molecular and biochemical characterization of two meta-cleavage dioxygenases involved in biphenyl and m-xylene degradation by Beijerinckia sp. strain B1.'
p4775
aS'JOURNAL'
p4776
aS'J Bacteriol 177:3095-103 (1995)'
p4777
aS'PMID:15127183'
p4778
ag4778
aS'AUTHORS'
p4779
aS'Morasch B, Schink B, Tebbe CC, Meckenstock RU'
p4780
aS'TITLE'
p4781
aS'Degradation of o-xylene and m-xylene by a novel sulfate-reducer belonging to the'
p4782
aS'genus Desulfotomaculum.'
p4783
aS'JOURNAL'
p4784
aS'Arch Microbiol 181:407-17 (2004)'
p4785
aS'PMID:9150211'
p4786
ag4786
aS'AUTHORS'
p4787
aS'Eaton RW.'
p4788
aS'TITLE'
p4789
aS'p-Cymene catabolic pathway in Pseudomonas putida F1: cloning and characterization of DNA encoding conversion of p-cymene to p-cumate.'
p4790
aS'JOURNAL'
p4791
aS'J Bacteriol 179:3171-80 (1997)'
p4792
aS'PMID:8631713'
p4793
ag4793
aS'AUTHORS'
p4794
aS'Eaton RW.'
p4795
aS'TITLE'
p4796
aS'p-Cumate catabolic pathway in Pseudomonas putida Fl: cloning and characterization of DNA carrying the cmt operon.'
p4797
aS'JOURNAL'
p4798
aS'J Bacteriol 178:1351-62 (1996)'
p4799
asS'KO_PATHWAY'
p4800
(lp4801
S'ko00622'
p4802
asS'PATHWAY_MAP'
p4803
(lp4804
S'map00622'
p4805
asS'MODULE'
p4806
(lp4807
S'M00419'
p4808
aS'Cymene degradation, p-cymene => p-cumate [PATH:map00622]'
p4809
ag4808
ag4809
aS'M00537'
p4810
aS'Xylene degradation, xylene => methylbenzoate [PATH:map00622]'
p4811
aS'M00539'
p4812
aS'Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate [PATH:map00622]'
p4813
aS'M00551'
p4814
aS'Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map00622]'
p4815
aS'M00569'
p4816
aS'Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map00622]'
p4817
asS'DBLINKS'
p4818
(lp4819
S'GO: 0042184'
p4820
ag4820
aS'UMBBD: mxy oxy pxy pcy tol'
p4821
asS'ENTRY'
p4822
(lp4823
S'map00622'
p4824
aS'Pathway'
p4825
asS'CLASS'
p4826
(lp4827
S'Metabolism Xenobiotics biodegradation and metabolism'
p4828
assS'path:map00623'
p4829
(dp4830
S'NAME'
p4831
(lp4832
S'Toluene degradation'
p4833
asS'REFERENCE'
p4834
(lp4835
S'PMID:15184119'
p4836
ag4836
aS'AUTHORS'
p4837
aS'Vardar G, Wood TK'
p4838
aS'TITLE'
p4839
aS'Protein engineering of toluene-o-xylene monooxygenase from Pseudomonas stutzeri OX1 for synthesizing 4-methylresorcinol, methylhydroquinone, and pyrogallol.'
p4840
aS'JOURNAL'
p4841
aS'Appl Environ Microbiol 70:3253-62 (2004)'
p4842
aS'PMID:10629170'
p4843
ag4843
aS'AUTHORS'
p4844
aS'Leuthner B, Heider J'
p4845
aS'TITLE'
p4846
aS'Anaerobic toluene catabolism of Thauera aromatica: the bbs operon codes for enzymes of beta oxidation of the intermediate benzylsuccinate.'
p4847
aS'JOURNAL'
p4848
aS'J Bacteriol 182:272-7 (2000)'
p4849
aS'PMID:11418570'
p4850
ag4850
aS'AUTHORS'
p4851
aS'Leutwein C, Heider J'
p4852
aS'TITLE'
p4853
aS'Succinyl-CoA:(R)-benzylsuccinate CoA-transferase: an enzyme of the anaerobic toluene catabolic pathway in denitrifying bacteria.'
p4854
aS'JOURNAL'
p4855
aS'J Bacteriol 183:4288-95 (2001)'
p4856
aS'PMID:15687214'
p4857
ag4857
aS'AUTHORS'
p4858
aS'Kuhner S, Wohlbrand L, Fritz I, Wruck W, Hultschig C, Hufnagel P, Kube M, Reinhardt R, Rabus R'
p4859
aS'TITLE'
p4860
aS'Substrate-dependent regulation of anaerobic degradation pathways for toluene and'
p4861
aS'ethylbenzene in a denitrifying bacterium, strain EbN1.'
p4862
aS'JOURNAL'
p4863
aS'J Bacteriol 187:1493-503 (2005)'
p4864
aS'PMID:2050632'
p4865
ag4865
aS'AUTHORS'
p4866
aS'Locher HH, Leisinger T, Cook AM'
p4867
aS'TITLE'
p4868
aS'4-Toluene sulfonate methyl-monooxygenase from Comamonas testosteroni T-2: purification and some properties of the oxygenase component.'
p4869
aS'JOURNAL'
p4870
aS'J Bacteriol 173:3741-8 (1991)'
p4871
aS'PMID:8828208'
p4872
ag4872
aS'AUTHORS'
p4873
aS'Junker F, Saller E, Schlafli Oppenberg HR, Kroneck PM, Leisinger T, Cook AM'
p4874
aS'TITLE'
p4875
aS'Degradative pathways for p-toluenecarboxylate and p-toluenesulfonate and their multicomponent oxygenases in Comamonas testosteroni strains PSB-4 and T-2.'
p4876
aS'JOURNAL'
p4877
aS'Microbiology 142 ( Pt 9):2419-27 (1996)'
p4878
aS'PMID:10589735'
p4879
ag4879
aS'AUTHORS'
p4880
aS'Mampel J, Ruff J, Junker F, Cook AM.'
p4881
aS'TITLE'
p4882
aS'The oxygenase component of the 2-aminobenzenesulfonate dioxygenase system from Alcaligenes sp. strain O-1.'
p4883
aS'JOURNAL'
p4884
aS'Microbiology 145 ( Pt 11):3255-64 (1999)'
p4885
aS'PMID:9006050'
p4886
ag4886
aS'AUTHORS'
p4887
aS'Junker F, Kiewitz R, Cook AM'
p4888
aS'TITLE'
p4889
aS'Characterization of the p-toluenesulfonate operon tsaMBCD and tsaR in Comamonas testosteroni T-2.'
p4890
aS'JOURNAL'
p4891
aS'J Bacteriol 179:919-27 (1997)'
p4892
asS'KO_PATHWAY'
p4893
(lp4894
S'ko00623'
p4895
asS'PATHWAY_MAP'
p4896
(lp4897
S'map00623'
p4898
asS'MODULE'
p4899
(lp4900
S'M00418'
p4901
aS'Toluene degradation, anaerobic, toluene => benzoyl-CoA [PATH:map00623]'
p4902
ag4901
ag4902
aS'M00538'
p4903
aS'Toluene degradation, toluene => benzoate [PATH:map00623]'
p4904
aS'M00547'
p4905
aS'Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map00623]'
p4906
asS'DBLINKS'
p4907
(lp4908
S'GO: 0042203'
p4909
ag4909
aS'UMBBD: tol tol2 tsa dct'
p4910
asS'ENTRY'
p4911
(lp4912
S'map00623'
p4913
aS'Pathway'
p4914
asS'CLASS'
p4915
(lp4916
S'Metabolism Xenobiotics biodegradation and metabolism'
p4917
assS'path:map00620'
p4918
(dp4919
S'NAME'
p4920
(lp4921
S'Pyruvate metabolism'
p4922
asS'REFERENCE'
p4923
(lp4924
g22
ag22
aS'AUTHORS'
p4925
aS'Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).'
p4926
aS'TITLE'
p4927
aS'[Cellular Functions and Metabolic Maps] (In Japanese)'
p4928
aS'JOURNAL'
p4929
aS'Tokyo Kagaku Dojin (1997)'
p4930
asS'KO_PATHWAY'
p4931
(lp4932
S'ko00620'
p4933
asS'PATHWAY_MAP'
p4934
(lp4935
S'map00620'
p4936
asS'DISEASE'
p4937
(lp4938
S'H00072'
p4939
aS'Pyruvate dehydrogenase complex deficiency'
p4940
ag4939
ag4940
aS'H00073'
p4941
aS'Pyruvate carboxylase deficiency'
p4942
aS'H01096'
p4943
aS'Pyruvate kinase (PK) deficiency'
p4944
aS'H01354'
p4945
aS'Leigh syndrome'
p4946
asS'MODULE'
p4947
(lp4948
S'M00307'
p4949
aS'Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map00620]'
p4950
asS'DBLINKS'
p4951
(lp4952
S'GO: 0006090'
p4953
asS'ENTRY'
p4954
(lp4955
S'map00620'
p4956
aS'Pathway'
p4957
asS'CLASS'
p4958
(lp4959
S'Metabolism Carbohydrate metabolism'
p4960
assS'path:map00621'
p4961
(dp4962
S'NAME'
p4963
(lp4964
S'Dioxin degradation'
p4965
asS'REFERENCE'
p4966
(lp4967
S'PMID:12450109'
p4968
ag4968
aS'AUTHORS'
p4969
aS'Nojiri H, Omori T.'
p4970
aS'TITLE'
p4971
aS'Molecular bases of aerobic bacterial degradation of dioxins: involvement of angular dioxygenation.'
p4972
aS'JOURNAL'
p4973
aS'Biosci Biotechnol Biochem 66:2001-16 (2002)'
p4974
aS'PMID:16775784'
p4975
ag4975
aS'AUTHORS'
p4976
aS'Jin S, Zhu T, Xu X, Xu Y.'
p4977
aS'TITLE'
p4978
aS'Biodegradation of dibenzofuran by Janibacter terrae strain XJ-1.'
p4979
aS'JOURNAL'
p4980
aS'Curr Microbiol 53:30-6 (2006)'
p4981
aS'PMID:12483604'
p4982
ag4982
aS'AUTHORS'
p4983
aS'Nojiri H, Habe H, Omori T.'
p4984
aS'TITLE'
p4985
aS'Bacterial degradation of aromatic compounds via angular dioxygenation.'
p4986
aS'JOURNAL'
p4987
aS'J Gen Appl Microbiol 47:279-305 (2001)'
p4988
aS'PMID:11322788'
p4989
ag4989
aS'AUTHORS'
p4990
aS'Kasuga K, Habe H, Chung JS, Yoshida T, Nojiri H, Yamane H, Omori T.'
p4991
aS'TITLE'
p4992
aS'Isolation and characterization of the genes encoding a novel oxygenase component of angular dioxygenase from the gram-positive dibenzofuran-degrader Terrabacter sp. strain DBF63.'
p4993
aS'JOURNAL'
p4994
aS'Biochem Biophys Res Commun 283:195-204 (2001)'
p4995
aS'PMID:17142386'
p4996
ag4996
aS'AUTHORS'
p4997
aS'Vezina J, Barriault D, Sylvestre M'
p4998
aS'TITLE'
p4999
aS'Family shuffling of soil DNA to change the regiospecificity of Burkholderia xenovorans LB400 biphenyl dioxygenase.'
p5000
aS'JOURNAL'
p5001
aS'J Bacteriol 189:779-88 (2007)'
p5002
aS'PMID:12501294'
p5003
ag5003
aS'AUTHORS'
p5004
aS'Ouchiyama N, Miyachi S, Omori T'
p5005
aS'TITLE'
p5006
aS'Cloning and nucleotide sequence of carbazole catabolic genes from Pseudomonas stutzeri strain OM1, isolated from activated sludge.'
p5007
aS'JOURNAL'
p5008
aS'J Gen Appl Microbiol 44:57-63 (1998)'
p5009
aS'PMID:9244273'
p5010
ag5010
aS'AUTHORS'
p5011
aS'Sato SI, Ouchiyama N, Kimura T, Nojiri H, Yamane H, Omori T'
p5012
aS'TITLE'
p5013
aS'Cloning of genes involved in carbazole degradation of Pseudomonas sp. strain CA10: nucleotide sequences of genes and characterization of meta-cleavage enzymes and hydrolase.'
p5014
aS'JOURNAL'
p5015
aS'J Bacteriol 179:4841-9 (1997)'
p5016
asS'KO_PATHWAY'
p5017
(lp5018
S'ko00621'
p5019
asS'PATHWAY_MAP'
p5020
(lp5021
S'map00621'
p5022
asS'MODULE'
p5023
(lp5024
S'M00543'
p5025
aS'Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate [PATH:map00621]'
p5026
ag5025
ag5026
aS'M00544'
p5027
aS'Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate [PATH:map00621]'
p5028
asS'DBLINKS'
p5029
(lp5030
S'UMBBD: dpd dbf bph cbp car'
p5031
asS'ENTRY'
p5032
(lp5033
S'map00621'
p5034
aS'Pathway'
p5035
asS'CLASS'
p5036
(lp5037
S'Metabolism Xenobiotics biodegradation and metabolism'
p5038
assS'path:map05162'
p5039
(dp5040
S'NAME'
p5041
(lp5042
S'Measles'
p5043
asS'REFERENCE'
p5044
(lp5045
S'PMID:19203113'
p5046
ag5046
aS'AUTHORS'
p5047
aS'Schneider-Schaulies S, Schneider-Schaulies J'
p5048
aS'TITLE'
p5049
aS'Measles virus-induced immunosuppression.'
p5050
aS'JOURNAL'
p5051
aS'Curr Top Microbiol Immunol 330:243-69 (2009)'
p5052
aS'PMID:19198562'
p5053
ag5053
aS'AUTHORS'
p5054
aS'Navaratnarajah CK, Leonard VH, Cattaneo R'
p5055
aS'TITLE'
p5056
aS'Measles virus glycoprotein complex assembly, receptor attachment, and cell entry.'
p5057
aS'JOURNAL'
p5058
aS'Curr Top Microbiol Immunol 329:59-76 (2009)'
p5059
aS'PMID:19203114'
p5060
ag5060
aS'AUTHORS'
p5061
aS'Hahm B'
p5062
aS'TITLE'
p5063
aS'Hostile communication of measles virus with host innate immunity and dendritic cells.'
p5064
aS'JOURNAL'
p5065
aS'Curr Top Microbiol Immunol 330:271-87 (2009)'
p5066
aS'PMID:19203109'
p5067
ag5067
aS'AUTHORS'
p5068
aS'Naniche D'
p5069
aS'TITLE'
p5070
aS'Human immunology of measles virus infection.'
p5071
aS'JOURNAL'
p5072
aS'Curr Top Microbiol Immunol 330:151-71 (2009)'
p5073
aS'PMID:19198566'
p5074
ag5074
aS'AUTHORS'
p5075
aS'Gerlier D, Valentin H'
p5076
aS'TITLE'
p5077
aS'Measles virus interaction with host cells and impact on innate immunity.'
p5078
aS'JOURNAL'
p5079
aS'Curr Top Microbiol Immunol 329:163-91 (2009)'
p5080
aS'PMID:12620806'
p5081
ag5081
aS'AUTHORS'
p5082
aS'Yokota S, Saito H, Kubota T, Yokosawa N, Amano K, Fujii N'
p5083
aS'TITLE'
p5084
aS'Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1'
p5085
aS'phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex.'
p5086
aS'JOURNAL'
p5087
aS'Virology 306:135-46 (2003)'
p5088
aS'PMID:16963735'
p5089
ag5089
aS'AUTHORS'
p5090
aS'Yanagi Y, Takeda M, Ohno S'
p5091
aS'TITLE'
p5092
aS'Measles virus: cellular receptors, tropism and pathogenesis.'
p5093
aS'JOURNAL'
p5094
aS'J Gen Virol 87:2767-79 (2006)'
p5095
aS'PMID:16237742'
p5096
ag5096
aS'AUTHORS'
p5097
aS'Kerdiles YM, Sellin CI, Druelle J, Horvat B'
p5098
aS'TITLE'
p5099
aS'Immunosuppression caused by measles virus: role of viral proteins.'
p5100
aS'JOURNAL'
p5101
aS'Rev Med Virol 16:49-63 (2006)'
p5102
aS'PMID:16690907'
p5103
ag5103
aS'AUTHORS'
p5104
aS'Schneider-Schaulies S, Dittmer U'
p5105
aS'TITLE'
p5106
aS'Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression.'
p5107
aS'JOURNAL'
p5108
aS'J Gen Virol 87:1423-38 (2006)'
p5109
aS'PMID:20376484'
p5110
ag5110
aS'AUTHORS'
p5111
aS'Avota E, Gassert E, Schneider-Schaulies S'
p5112
aS'TITLE'
p5113
aS'Measles virus-induced immunosuppression: from effectors to mechanisms.'
p5114
aS'JOURNAL'
p5115
aS'Med Microbiol Immunol 199:227-37 (2010)'
p5116
aS'PMID:11582511'
p5117
ag5117
aS'AUTHORS'
p5118
aS'Schneider-Schaulies J, ter Meulen V, Schneider-Schaulies S'
p5119
aS'TITLE'
p5120
aS'Measles virus interactions with cellular receptors: consequences for viral pathogenesis.'
p5121
aS'JOURNAL'
p5122
aS'J Neurovirol 7:391-9 (2001)'
p5123
aS'PMID:20636817'
p5124
ag5124
aS'AUTHORS'
p5125
aS'Griffin DE'
p5126
aS'TITLE'
p5127
aS'Measles virus-induced suppression of immune responses.'
p5128
aS'JOURNAL'
p5129
aS'Immunol Rev 236:176-89 (2010)'
p5130
aS'PMID:11385511'
p5131
ag5131
aS'AUTHORS'
p5132
aS'Avota E, Avots A, Niewiesk S, Kane LP, Bommhardt U, ter Meulen V, Schneider-Schaulies S'
p5133
aS'TITLE'
p5134
aS'Disruption of Akt kinase activation is important for immunosuppression induced by measles virus.'
p5135
aS'JOURNAL'
p5136
aS'Nat Med 7:725-31 (2001)'
p5137
aS'PMID:18922877'
p5138
ag5138
aS'AUTHORS'
p5139
aS'Pfaller CK, Conzelmann KK'
p5140
aS'TITLE'
p5141
aS'Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction.'
p5142
aS'JOURNAL'
p5143
aS'J Virol 82:12365-73 (2008)'
p5144
aS'PMID:17720800'
p5145
ag5145
aS'AUTHORS'
p5146
aS'Yokota S, Okabayashi T, Yokosawa N, Fujii N'
p5147
aS'TITLE'
p5148
aS'Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20.'
p5149
aS'JOURNAL'
p5150
aS'FASEB J 22:74-83 (2008)'
p5151
aS'PMID:12804771'
p5152
ag5152
aS'AUTHORS'
p5153
aS'Takeuchi K, Kadota SI, Takeda M, Miyajima N, Nagata K'
p5154
aS'TITLE'
p5155
aS'Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation.'
p5156
aS'JOURNAL'
p5157
aS'FEBS Lett 545:177-82 (2003)'
p5158
aS'PMID:12410527'
p5159
ag5159
aS'AUTHORS'
p5160
aS'Gotoh B, Komatsu T, Takeuchi K, Yokoo J'
p5161
aS'TITLE'
p5162
aS'Paramyxovirus strategies for evading the interferon response.'
p5163
aS'JOURNAL'
p5164
aS'Rev Med Virol 12:337-57 (2002)'
p5165
aS'PMID:12805463'
p5166
ag5166
aS'AUTHORS'
p5167
aS'Palosaari H, Parisien JP, Rodriguez JJ, Ulane CM, Horvath CM'
p5168
aS'TITLE'
p5169
aS'STAT protein interference and suppression of cytokine signal transduction by measles virus V protein.'
p5170
aS'JOURNAL'
p5171
aS'J Virol 77:7635-44 (2003)'
p5172
aS'PMID:14585342'
p5173
ag5173
aS'AUTHORS'
p5174
aS'Shaffer JA, Bellini WJ, Rota PA'
p5175
aS'TITLE'
p5176
aS'The C protein of measles virus inhibits the type I interferon response.'
p5177
aS'JOURNAL'
p5178
aS'Virology 315:389-97 (2003)'
p5179
asS'KO_PATHWAY'
p5180
(lp5181
S'ko05162'
p5182
asS'PATHWAY_MAP'
p5183
(lp5184
S'map05162'
p5185
asS'DISEASE'
p5186
(lp5187
S'H00394'
p5188
aS'Measles'
p5189
asS'ENTRY'
p5190
(lp5191
S'map05162'
p5192
aS'Pathway'
p5193
asS'CLASS'
p5194
(lp5195
S'Human Diseases Infectious diseases'
p5196
asS'DESCRIPTION'
p5197
(lp5198
S'Measles virus (MV) is highly contagious virus that leads infant death worldwide. Humans are the unique natural reservoir for this virus. It causes severe immunosuppression favouring secondary bacterial infections. Several MV proteins have been suggested to disturb host immunity. After infection of host lymphoid cells via SLAM, MV inhibits cytokine response by direct interference with host signaling systems. Three proteins (P, V, and C) associate with Jak/STAT proteins in interferon-triggered pathway and other important proteins related to apoptosis. Interaction between MV and host brings about the shift towards a Th2 response by decreasing IL-12 production and induces lymphopenia by suppressing cell proliferation.'
p5199
assS'path:map05160'
p5200
(dp5201
S'NAME'
p5202
(lp5203
S'Hepatitis C'
p5204
asS'REFERENCE'
p5205
(lp5206
S'PMID:12691459'
p5207
ag5207
aS'AUTHORS'
p5208
aS'Polyak SJ'
p5209
aS'TITLE'
p5210
aS'Hepatitis C virus--cell interactions and their role in pathogenesis.'
p5211
aS'JOURNAL'
p5212
aS'Clin Liver Dis 7:67-88 (2003)'
p5213
aS'PMID:16107833'
p5214
ag5214
aS'AUTHORS'
p5215
aS'Gale M Jr, Foy EM'
p5216
aS'TITLE'
p5217
aS'Evasion of intracellular host defence by hepatitis C virus.'
p5218
aS'JOURNAL'
p5219
aS'Nature 436:939-45 (2005)'
p5220
aS'PMID:12655344'
p5221
ag5221
aS'AUTHORS'
p5222
aS'Giannini C, Brechot C'
p5223
aS'TITLE'
p5224
aS'Hepatitis C virus biology.'
p5225
aS'JOURNAL'
p5226
aS'Cell Death Differ 10 Suppl 1:S27-38 (2003)'
p5227
aS'PMID:19515018'
p5228
ag5228
aS'AUTHORS'
p5229
aS'Tang H, Grise H'
p5230
aS'TITLE'
p5231
aS'Cellular and molecular biology of HCV infection and hepatitis.'
p5232
aS'JOURNAL'
p5233
aS'Clin Sci (Lond) 117:49-65 (2009)'
p5234
aS'PMID:19708811'
p5235
ag5235
aS'AUTHORS'
p5236
aS'Horner SM, Gale M Jr'
p5237
aS'TITLE'
p5238
aS'Intracellular innate immune cascades and interferon defenses that control hepatitis C virus.'
p5239
aS'JOURNAL'
p5240
aS'J Interferon Cytokine Res 29:489-98 (2009)'
p5241
aS'PMID:17467654'
p5242
ag5242
aS'AUTHORS'
p5243
aS'Bode JG, Brenndorfer ED, Haussinger D'
p5244
aS'TITLE'
p5245
aS'Subversion of innate host antiviral strategies by the hepatitis C virus.'
p5246
aS'JOURNAL'
p5247
aS'Arch Biochem Biophys 462:254-65 (2007)'
p5248
aS'PMID:20537953'
p5249
ag5249
aS'AUTHORS'
p5250
aS'Georgel P, Schuster C, Zeisel MB, Stoll-Keller F, Berg T, Bahram S, Baumert TF'
p5251
aS'TITLE'
p5252
aS'Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.'
p5253
aS'JOURNAL'
p5254
aS'Trends Mol Med 16:277-86 (2010)'
p5255
aS'PMID:16314558'
p5256
ag5256
aS'AUTHORS'
p5257
aS'Freundt EC, Lenardo MJ'
p5258
aS'TITLE'
p5259
aS'Interfering with interferons: Hepatitis C virus counters innate immunity.'
p5260
aS'JOURNAL'
p5261
aS'Proc Natl Acad Sci U S A 102:17539-40 (2005)'
p5262
aS'PMID:18514579'
p5263
ag5263
aS'AUTHORS'
p5264
aS'Ishii S, Koziel MJ'
p5265
aS'TITLE'
p5266
aS'Immune responses during acute and chronic infection with hepatitis C virus.'
p5267
aS'JOURNAL'
p5268
aS'Clin Immunol 128:133-47 (2008)'
p5269
aS'PMID:19074178'
p5270
ag5270
aS'AUTHORS'
p5271
aS'Asselah T, Bieche I, Sabbagh A, Bedossa P, Moreau R, Valla D, Vidaud M, Marcellin P'
p5272
aS'TITLE'
p5273
aS'Gene expression and hepatitis C virus infection.'
p5274
aS'JOURNAL'
p5275
aS'Gut 58:846-58 (2009)'
p5276
aS'PMID:15302943'
p5277
ag5277
aS'AUTHORS'
p5278
aS'Macdonald A, Harris M'
p5279
aS'TITLE'
p5280
aS'Hepatitis C virus NS5A: tales of a promiscuous protein.'
p5281
aS'JOURNAL'
p5282
aS'J Gen Virol 85:2485-502 (2004)'
p5283
aS'PMID:11991644'
p5284
ag5284
aS'AUTHORS'
p5285
aS'Han JQ, Barton DJ'
p5286
aS'TITLE'
p5287
aS"Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA."
p5288
aS'JOURNAL'
p5289
aS'RNA 8:512-25 (2002)'
p5290
aS'PMID:19187070'
p5291
ag5291
aS'AUTHORS'
p5292
aS'Negro F, Sanyal AJ'
p5293
aS'TITLE'
p5294
aS'Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data.'
p5295
aS'JOURNAL'
p5296
aS'Liver Int 29 Suppl 2:26-37 (2009)'
p5297
aS'PMID:19148799'
p5298
ag5298
aS'AUTHORS'
p5299
aS'Koike K'
p5300
aS'TITLE'
p5301
aS'Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.'
p5302
aS'JOURNAL'
p5303
aS'J Gastroenterol 44 Suppl 19:82-8 (2009)'
p5304
ag22
ag22
aS'AUTHORS'
p5305
aS'Tan SL (ed).'
p5306
aS'TITLE'
p5307
aS'Hepatitis C Viruses Genomes and Molecular Biology'
p5308
aS'JOURNAL'
p5309
aS'Horizon Bioscience (2006)'
p5310
asS'KO_PATHWAY'
p5311
(lp5312
S'ko05160'
p5313
asS'PATHWAY_MAP'
p5314
(lp5315
S'map05160'
p5316
asS'DISEASE'
p5317
(lp5318
S'H00413'
p5319
aS'Hepatitis C'
p5320
asS'ENTRY'
p5321
(lp5322
S'map05160'
p5323
aS'Pathway'
p5324
asS'CLASS'
p5325
(lp5326
S'Human Diseases Infectious diseases'
p5327
asS'DESCRIPTION'
p5328
(lp5329
S'Hepatitis C virus (HCV) is a major cause of chronic liver disease. The HCV employ several strategies to perturb host cell immunity. After invasion, HCV RNA genome functions directly as an mRNA in the cytoplasm of the host cell and forms membrane-associated replication complexes along with non-structural proteins. Viral RNA can trigger the RIG-I pathway and interferon production during this process. Translated HCV protein products regulate immune response to inhibit the action of interferon. HCV core and NS5A proteins appear to be the most important molecules with regulatory functions that modulate transcription, cellular proliferation, and apoptosis.'
p5330
assS'path:map05161'
p5331
(dp5332
S'NAME'
p5333
(lp5334
S'Hepatitis B'
p5335
asS'REFERENCE'
p5336
(lp5337
S'PMID:21994545'
p5338
ag5338
aS'AUTHORS'
p5339
aS'Schadler S, Hildt E'
p5340
aS'TITLE'
p5341
aS'HBV life cycle: entry and morphogenesis.'
p5342
aS'JOURNAL'
p5343
aS'Viruses 1:185-209 (2009)'
p5344
aS'PMID:18046710'
p5345
ag5345
aS'AUTHORS'
p5346
aS'Schulze A, Gripon P, Urban S'
p5347
aS'TITLE'
p5348
aS'Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.'
p5349
aS'JOURNAL'
p5350
aS'Hepatology 46:1759-68 (2007)'
p5351
aS'PMID:21647825'
p5352
ag5352
aS'AUTHORS'
p5353
aS'Ng SA, Lee C.'
p5354
aS'TITLE'
p5355
aS'Hepatitis B virus X gene and hepatocarcinogenesis.'
p5356
aS'JOURNAL'
p5357
aS'J Gastroenterol 46:974-990 (2011)'
p5358
aS'PMID:19263472'
p5359
ag5359
aS'AUTHORS'
p5360
aS'Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K'
p5361
aS'TITLE'
p5362
aS'Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.'
p5363
aS'JOURNAL'
p5364
aS'Hepatology 49:1203-17 (2009)'
p5365
aS'PMID:8764004'
p5366
ag5366
aS'AUTHORS'
p5367
aS'Benn J, Su F, Doria M, Schneider RJ'
p5368
aS'TITLE'
p5369
aS'Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of'
p5370
aS'extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases.'
p5371
aS'JOURNAL'
p5372
aS'J Virol 70:4978-85 (1996)'
p5373
aS'PMID:15542625'
p5374
ag5374
aS'AUTHORS'
p5375
aS'Bouchard MJ, Schneider RJ'
p5376
aS'TITLE'
p5377
aS'The enigmatic X gene of hepatitis B virus.'
p5378
aS'JOURNAL'
p5379
aS'J Virol 78:12725-34 (2004)'
p5380
aS'PMID:16891440'
p5381
ag5381
aS'AUTHORS'
p5382
aS'Park NH, Song IH, Chung YH'
p5383
aS'TITLE'
p5384
aS'Chronic hepatitis B in hepatocarcinogenesis.'
p5385
aS'JOURNAL'
p5386
aS'Postgrad Med J 82:507-15 (2006)'
p5387
aS'PMID:15107488'
p5388
ag5388
aS'AUTHORS'
p5389
aS'Kwun HJ, Jang KL'
p5390
aS'TITLE'
p5391
aS'Natural variants of hepatitis B virus X protein have differential effects on the'
p5392
aS'expression of cyclin-dependent kinase inhibitor p21 gene.'
p5393
aS'JOURNAL'
p5394
aS'Nucleic Acids Res 32:2202-13 (2004)'
p5395
aS'PMID:15173177'
p5396
ag5396
aS'AUTHORS'
p5397
aS'Yoo YG, Lee MO'
p5398
aS'TITLE'
p5399
aS'Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.'
p5400
aS'JOURNAL'
p5401
aS'J Biol Chem 279:36242-9 (2004)'
p5402
aS'PMID:17158882'
p5403
ag5403
aS'AUTHORS'
p5404
aS'Cougot D, Wu Y, Cairo S, Caramel J, Renard CA, Levy L, Buendia MA, Neuveut C'
p5405
aS'TITLE'
p5406
aS'The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription.'
p5407
aS'JOURNAL'
p5408
aS'J Biol Chem 282:4277-87 (2007)'
p5409
aS'PMID:16203685'
p5410
ag5410
aS'AUTHORS'
p5411
aS'Kim SY, Kim JK, Kim HJ, Ahn JK'
p5412
aS'TITLE'
p5413
aS'Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression.'
p5414
aS'JOURNAL'
p5415
aS'IUBMB Life 57:651-8 (2005)'
p5416
aS'PMID:9325306'
p5417
ag5417
aS'AUTHORS'
p5418
aS'Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixit VM'
p5419
aS'TITLE'
p5420
aS'Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1).'
p5421
aS'JOURNAL'
p5422
aS'J Biol Chem 272:25783-6 (1997)'
p5423
aS'PMID:16459163'
p5424
ag5424
aS'AUTHORS'
p5425
aS'Zhang X, Zhang H, Ye L'
p5426
aS'TITLE'
p5427
aS'Effects of hepatitis B virus X protein on the development of liver cancer.'
p5428
aS'JOURNAL'
p5429
aS'J Lab Clin Med 147:58-66 (2006)'
p5430
aS'PMID:11099494'
p5431
ag5431
aS'AUTHORS'
p5432
aS'Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD'
p5433
aS'TITLE'
p5434
aS'X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated'
p5435
aS'with up-regulation of the SAPK/JNK pathway.'
p5436
aS'JOURNAL'
p5437
aS'J Biol Chem 276:8328-40 (2001)'
p5438
aS'PMID:18931690'
p5439
ag5439
aS'AUTHORS'
p5440
aS'Sun B, Karin M'
p5441
aS'TITLE'
p5442
aS'NF-kappaB signaling, liver disease and hepatoprotective agents.'
p5443
aS'JOURNAL'
p5444
aS'Oncogene 27:6228-44 (2008)'
p5445
aS'PMID:10454581'
p5446
ag5446
aS'AUTHORS'
p5447
aS'Weil R, Sirma H, Giannini C, Kremsdorf D, Bessia C, Dargemont C, Brechot C, Israel A'
p5448
aS'TITLE'
p5449
aS'Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha.'
p5450
aS'JOURNAL'
p5451
aS'Mol Cell Biol 19:6345-54 (1999)'
p5452
aS'PMID:17188775'
p5453
ag5453
aS'AUTHORS'
p5454
aS'Um HR, Lim WC, Chae SY, Park S, Park JH, Cho H'
p5455
aS'TITLE'
p5456
aS'Raf-1 and protein kinase B regulate cell survival through the activation of NF-kappaB in hepatitis B virus X-expressing cells.'
p5457
aS'JOURNAL'
p5458
aS'Virus Res 125:1-8 (2007)'
p5459
aS'PMID:15132991'
p5460
ag5460
aS'AUTHORS'
p5461
aS'Chung TW, Lee YC, Kim CH'
p5462
aS'TITLE'
p5463
aS'Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through'
p5464
aS'activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.'
p5465
aS'JOURNAL'
p5466
aS'FASEB J 18:1123-5 (2004)'
p5467
aS'PMID:18481805'
p5468
ag5468
aS'AUTHORS'
p5469
aS'Kim HJ, Kim SY, Kim J, Lee H, Choi M, Kim JK, Ahn JK'
p5470
aS'TITLE'
p5471
aS'Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria.'
p5472
aS'JOURNAL'
p5473
aS'IUBMB Life 60:473-80 (2008)'
p5474
aS'PMID:11821950'
p5475
ag5475
aS'AUTHORS'
p5476
aS'Terradillos O, de La Coste A, Pollicino T, Neuveut C, Sitterlin D, Lecoeur H, Gougeon ML, Kahn A, Buendia MA'
p5477
aS'TITLE'
p5478
aS'The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.'
p5479
aS'JOURNAL'
p5480
aS'Oncogene 21:377-86 (2002)'
p5481
aS'PMID:11278872'
p5482
ag5482
aS'AUTHORS'
p5483
aS'Lee YI, Kang-Park S, Do SI, Lee YI'
p5484
aS'TITLE'
p5485
aS'The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade.'
p5486
aS'JOURNAL'
p5487
aS'J Biol Chem 276:16969-77 (2001)'
p5488
aS'PMID:21618535'
p5489
ag5489
aS'AUTHORS'
p5490
aS'Huang WC, Chen WS, Chen YJ, Wang LY, Hsu SC, Chen CC, Hung MC'
p5491
aS'TITLE'
p5492
aS'Hepatitis B virus X protein induces IKKalpha nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells.'
p5493
aS'JOURNAL'
p5494
aS'J Cell Physiol 227:1446-54 (2012)'
p5495
aS'PMID:12839924'
p5496
ag5496
aS'AUTHORS'
p5497
aS'Chung TW, Lee YC, Ko JH, Kim CH'
p5498
aS'TITLE'
p5499
aS'Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.'
p5500
aS'JOURNAL'
p5501
aS'Cancer Res 63:3453-8 (2003)'
p5502
aS'PMID:19784739'
p5503
ag5503
aS'AUTHORS'
p5504
aS'Matsuda Y, Ichida T'
p5505
aS'TITLE'
p5506
aS'Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis.'
p5507
aS'JOURNAL'
p5508
aS'Med Mol Morphol 42:138-42 (2009)'
p5509
aS'PMID:19854353'
p5510
ag5510
aS'AUTHORS'
p5511
aS'Benhenda S, Cougot D, Buendia MA, Neuveut C'
p5512
aS'TITLE'
p5513
aS'Hepatitis B virus X protein molecular functions and its role in virus life cycle'
p5514
aS'and pathogenesis.'
p5515
aS'JOURNAL'
p5516
aS'Adv Cancer Res 103:75-109 (2009)'
p5517
aS'PMID:9843511'
p5518
ag5518
aS'AUTHORS'
p5519
aS'Lara-Pezzi E, Armesilla AL, Majano PL, Redondo JM, Lopez-Cabrera M'
p5520
aS'TITLE'
p5521
aS'The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway.'
p5522
aS'JOURNAL'
p5523
aS'EMBO J 17:7066-77 (1998)'
p5524
aS'PMID:18605975'
p5525
ag5525
aS'AUTHORS'
p5526
aS'Gurtsevitch VE'
p5527
aS'TITLE'
p5528
aS'Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.'
p5529
aS'JOURNAL'
p5530
aS'Biochemistry (Mosc) 73:504-13 (2008)'
p5531
aS'PMID:9738022'
p5532
ag5532
aS'AUTHORS'
p5533
aS'Lee YH, Yun Y'
p5534
aS'TITLE'
p5535
aS'HBx protein of hepatitis B virus activates Jak1-STAT signaling.'
p5536
aS'JOURNAL'
p5537
aS'J Biol Chem 273:25510-5 (1998)'
p5538
aS'PMID:11604508'
p5539
ag5539
aS'AUTHORS'
p5540
aS'Waris G, Huh KW, Siddiqui A'
p5541
aS'TITLE'
p5542
aS'Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress.'
p5543
aS'JOURNAL'
p5544
aS'Mol Cell Biol 21:7721-30 (2001)'
p5545
aS'PMID:11325602'
p5546
ag5546
aS'AUTHORS'
p5547
aS'Diao J, Garces R, Richardson CD'
p5548
aS'TITLE'
p5549
aS'X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis.'
p5550
aS'JOURNAL'
p5551
aS'Cytokine Growth Factor Rev 12:189-205 (2001)'
p5552
aS'PMID:11483993'
p5553
ag5553
aS'AUTHORS'
p5554
aS'Mayr B, Montminy M'
p5555
aS'TITLE'
p5556
aS'Transcriptional regulation by the phosphorylation-dependent factor CREB.'
p5557
aS'JOURNAL'
p5558
aS'Nat Rev Mol Cell Biol 2:599-609 (2001)'
p5559
aS'PMID:22504921'
p5560
ag5560
aS'AUTHORS'
p5561
aS'Dandri M, Locarnini S'
p5562
aS'TITLE'
p5563
aS'New insight in the pathobiology of hepatitis B virus infection.'
p5564
aS'JOURNAL'
p5565
aS'Gut 61 Suppl 1:i6-17 (2012)'
p5566
aS'PMID:21334391'
p5567
ag5567
aS'AUTHORS'
p5568
aS'Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A'
p5569
aS'TITLE'
p5570
aS'The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.'
p5571
aS'JOURNAL'
p5572
aS'J Hepatol 55:762-9 (2011)'
p5573
aS'PMID:20657822'
p5574
ag5574
aS'AUTHORS'
p5575
aS'Wang H, Ryu WS'
p5576
aS'TITLE'
p5577
aS'Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion.'
p5578
aS'JOURNAL'
p5579
aS'PLoS Pathog 6:e1000986 (2010)'
p5580
aS'PMID:18024894'
p5581
ag5581
aS'AUTHORS'
p5582
aS'Wu M, Xu Y, Lin S, Zhang X, Xiang L, Yuan Z'
p5583
aS'TITLE'
p5584
aS'Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by'
p5585
aS'blocking nuclear translocation of Stat1.'
p5586
aS'JOURNAL'
p5587
aS'J Gen Virol 88:3260-9 (2007)'
p5588
aS'PMID:12771941'
p5589
ag5589
aS'AUTHORS'
p5590
aS'Klein A, Guhl E, Tzeng YJ, Fuhrhop J, Levrero M, Graessmann M, Graessmann A'
p5591
aS'TITLE'
p5592
aS'HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.'
p5593
aS'JOURNAL'
p5594
aS'Oncogene 22:2910-9 (2003)'
p5595
aS'PMID:11287574'
p5596
ag5596
aS'AUTHORS'
p5597
aS'Bouchard M, Giannakopoulos S, Wang EH, Tanese N, Schneider RJ'
p5598
aS'TITLE'
p5599
aS'Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway.'
p5600
aS'JOURNAL'
p5601
aS'J Virol 75:4247-57 (2001)'
p5602
asS'KO_PATHWAY'
p5603
(lp5604
S'ko05161'
p5605
asS'ENTRY'
p5606
(lp5607
S'map05161'
p5608
aS'Pathway'
p5609
asS'PATHWAY_MAP'
p5610
(lp5611
S'map05161'
p5612
asS'CLASS'
p5613
(lp5614
S'Human Diseases Infectious diseases'
p5615
asS'DESCRIPTION'
p5616
(lp5617
S'Hepatitis B virus (HBV) is an enveloped virus and contains a partially double-stranded relaxed circular DNA (RC-DNA) genome. After entry into hepatocytes, HBV RC-DNA is transported to the nucleus and converted into a covalently closed circular molecule cccDNA. The cccDNA is the template for transcription of all viral RNAs including the pregenomic RNA (pgRNA), encoding for 7 viral proteins: large, middle, and small envelope proteins (LHBs, MHBs, and SHBs) that form the surface antigen (HBsAg), the core antigen (HBcAg), the e antigen (HBeAg), the HBV polymerase, and the regulatory protein X (HBx). The pgRNA interacts with the viral polymerase protein to initiate the encapsidation into the core particles. Through endoplasmic reticulum, the core particles finish assembling with the envelope proteins and are released. HBV infection leads to a wide spectrum of liver diseases raging from chronic hepatitis, cirrhosis to hepatocellular carcinoma. The mechanism of liver injury is still not clear. However, HBV proteins target host proteins, involved in a variety of functions, thus regulating transcription, cellular signaling cascades, proliferation, differentiation, and apoptosis.'
p5618
assS'path:map05166'
p5619
(dp5620
S'NAME'
p5621
(lp5622
S'HTLV-I infection'
p5623
asS'REFERENCE'
p5624
(lp5625
S'PMID:11244044'
p5626
ag5626
aS'AUTHORS'
p5627
aS'Yoshida M'
p5628
aS'TITLE'
p5629
aS'Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.'
p5630
aS'JOURNAL'
p5631
aS'Annu Rev Immunol 19:475-96 (2001)'
p5632
aS'PMID:12910251'
p5633
ag5633
aS'AUTHORS'
p5634
aS'Gatza ML, Watt JC, Marriott SJ'
p5635
aS'TITLE'
p5636
aS'Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades.'
p5637
aS'JOURNAL'
p5638
aS'Oncogene 22:5141-9 (2003)'
p5639
aS'PMID:21114861'
p5640
ag5640
aS'AUTHORS'
p5641
aS'Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O'
p5642
aS'TITLE'
p5643
aS'Current concepts regarding the HTLV-1 receptor complex.'
p5644
aS'JOURNAL'
p5645
aS'Retrovirology 7:99 (2010)'
p5646
aS'PMID:19861996'
p5647
ag5647
aS'AUTHORS'
p5648
aS'Boxus M, Willems L'
p5649
aS'TITLE'
p5650
aS'Mechanisms of HTLV-1 persistence and transformation.'
p5651
aS'JOURNAL'
p5652
aS'Br J Cancer 101:1497-501 (2009)'
p5653
aS'PMID:17384582'
p5654
ag5654
aS'AUTHORS'
p5655
aS'Matsuoka M, Jeang KT'
p5656
aS'TITLE'
p5657
aS'Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.'
p5658
aS'JOURNAL'
p5659
aS'Nat Rev Cancer 7:270-80 (2007)'
p5660
aS'PMID:17446673'
p5661
ag5661
aS'AUTHORS'
p5662
aS'Yasunaga J, Matsuoka M'
p5663
aS'TITLE'
p5664
aS'[HTLV-I and leukemogenesis].'
p5665
aS'JOURNAL'
p5666
aS'Uirusu 56:241-9 (2006)'
p5667
aS'PMID:18702816'
p5668
ag5668
aS'AUTHORS'
p5669
aS'Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L'
p5670
aS'TITLE'
p5671
aS'The HTLV-1 Tax interactome.'
p5672
aS'JOURNAL'
p5673
aS'Retrovirology 5:76 (2008)'
p5674
aS'PMID:16036567'
p5675
ag5675
aS'AUTHORS'
p5676
aS'Harhaj EW, Harhaj NS'
p5677
aS'TITLE'
p5678
aS'Mechanisms of persistent NF-kappaB activation by HTLV-I tax.'
p5679
aS'JOURNAL'
p5680
aS'IUBMB Life 57:83-91 (2005)'
p5681
aS'PMID:16436385'
p5682
ag5682
aS'AUTHORS'
p5683
aS'Peloponese JM Jr, Jeang KT'
p5684
aS'TITLE'
p5685
aS'Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein.'
p5686
aS'JOURNAL'
p5687
aS'J Biol Chem 281:8927-38 (2006)'
p5688
aS'PMID:16155605'
p5689
ag5689
aS'AUTHORS'
p5690
aS'Marriott SJ, Semmes OJ'
p5691
aS'TITLE'
p5692
aS'Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response.'
p5693
aS'JOURNAL'
p5694
aS'Oncogene 24:5986-95 (2005)'
p5695
aS'PMID:11325603'
p5696
ag5696
aS'AUTHORS'
p5697
aS'Jeang KT'
p5698
aS'TITLE'
p5699
aS'Functional activities of the human T-cell leukemia virus type I Tax oncoprotein:'
p5700
aS'cellular signaling through NF-kappa B.'
p5701
aS'JOURNAL'
p5702
aS'Cytokine Growth Factor Rev 12:207-17 (2001)'
p5703
aS'PMID:19014483'
p5704
ag5704
aS'AUTHORS'
p5705
aS'Bouzar AB, Willems L'
p5706
aS'TITLE'
p5707
aS'How HTLV-1 may subvert miRNAs for persistence and transformation.'
p5708
aS'JOURNAL'
p5709
aS'Retrovirology 5:101 (2008)'
p5710
aS'PMID:16155602'
p5711
ag5711
aS'AUTHORS'
p5712
aS'Sun SC, Yamaoka S'
p5713
aS'TITLE'
p5714
aS'Activation of NF-kappaB by HTLV-I and implications for cell transformation.'
p5715
aS'JOURNAL'
p5716
aS'Oncogene 24:5952-64 (2005)'
p5717
aS'PMID:16155608'
p5718
ag5718
aS'AUTHORS'
p5719
aS'Manel N, Battini JL, Taylor N, Sitbon M'
p5720
aS'TITLE'
p5721
aS'HTLV-1 tropism and envelope receptor.'
p5722
aS'JOURNAL'
p5723
aS'Oncogene 24:6016-25 (2005)'
p5724
aS'PMID:10602469'
p5725
ag5725
aS'AUTHORS'
p5726
aS'Sun SC, Ballard DW'
p5727
aS'TITLE'
p5728
aS'Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases.'
p5729
aS'JOURNAL'
p5730
aS'Oncogene 18:6948-58 (1999)'
p5731
aS'PMID:16155611'
p5732
ag5732
aS'AUTHORS'
p5733
aS'Taylor GP, Matsuoka M'
p5734
aS'TITLE'
p5735
aS'Natural history of adult T-cell leukemia/lymphoma and approaches to therapy.'
p5736
aS'JOURNAL'
p5737
aS'Oncogene 24:6047-57 (2005)'
p5738
aS'PMID:14686485'
p5739
ag5739
aS'AUTHORS'
p5740
aS'Franchini G, Fukumoto R, Fullen JR'
p5741
aS'TITLE'
p5742
aS'T-cell control by human T-cell leukemia/lymphoma virus type 1.'
p5743
aS'JOURNAL'
p5744
aS'Int J Hematol 78:280-96 (2003)'
p5745
aS'PMID:19092975'
p5746
ag5746
aS'AUTHORS'
p5747
aS'Baydoun HH, Bellon M, Nicot C'
p5748
aS'TITLE'
p5749
aS'HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking.'
p5750
aS'JOURNAL'
p5751
aS'AIDS Rev 10:195-204 (2008)'
p5752
aS'PMID:9325311'
p5753
ag5753
aS'AUTHORS'
p5754
aS'Jin DY, Teramoto H, Giam CZ, Chun RF, Gutkind JS, Jeang KT'
p5755
aS'TITLE'
p5756
aS'A human suppressor of c-Jun N-terminal kinase 1 activation by tumor necrosis factor alpha.'
p5757
aS'JOURNAL'
p5758
aS'J Biol Chem 272:25816-23 (1997)'
p5759
aS'PMID:15569630'
p5760
ag5760
aS'AUTHORS'
p5761
aS'Pise-Masison CA, Brady JN'
p5762
aS'TITLE'
p5763
aS'Setting the stage for transformation: HTLV-1 Tax inhibition of p53 function.'
p5764
aS'JOURNAL'
p5765
aS'Front Biosci 10:919-30 (2005)'
p5766
asS'KO_PATHWAY'
p5767
(lp5768
S'ko05166'
p5769
asS'PATHWAY_MAP'
p5770
(lp5771
S'map05166'
p5772
asS'DISEASE'
p5773
(lp5774
S'H00009'
p5775
aS'Adult T-cell leukemia'
p5776
asS'ENTRY'
p5777
(lp5778
S'map05166'
p5779
aS'Pathway'
p5780
asS'CLASS'
p5781
(lp5782
S'Human Diseases Infectious diseases'
p5783
asS'DESCRIPTION'
p5784
(lp5785
S'Human T-lymphotropic virus type 1 (HTLV-1) is a pathogenic retrovirus that is associated with adult T-cell leukemia/lymphoma (ATL). It is also strongly implicated in non-neoplastic chronic inflammatory diseases such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Expression of Tax, a viral regulatory protein is critical to the pathogenesis. Tax is a transcriptional co-factor that interfere several signaling pathways related to anti-apoptosis or cell proliferation. The modulation of the signaling by Tax involve its binding to transcription factors like CREB/ATF, NF-kappa B, SRF, and NFAT.'
p5786
assS'path:map05164'
p5787
(dp5788
S'NAME'
p5789
(lp5790
S'Influenza A'
p5791
asS'REFERENCE'
p5792
(lp5793
S'PMID:19782761'
p5794
ag5794
aS'AUTHORS'
p5795
aS'Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T, Ludwig S'
p5796
aS'TITLE'
p5797
aS'Interplay between influenza A virus and the innate immune signaling.'
p5798
aS'JOURNAL'
p5799
aS'Microbes Infect 12:81-7 (2010)'
p5800
aS'PMID:20020828'
p5801
ag5801
aS'AUTHORS'
p5802
aS'Hale BG, Albrecht RA, Garcia-Sastre A'
p5803
aS'TITLE'
p5804
aS'Innate immune evasion strategies of influenza viruses.'
p5805
aS'JOURNAL'
p5806
aS'Future Microbiol 5:23-41 (2010)'
p5807
aS'PMID:19420020'
p5808
ag5808
aS'AUTHORS'
p5809
aS'Ludwig S'
p5810
aS'TITLE'
p5811
aS'Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy.'
p5812
aS'JOURNAL'
p5813
aS'J Antimicrob Chemother 64:1-4 (2009)'
p5814
aS'PMID:18049471'
p5815
ag5815
aS'AUTHORS'
p5816
aS'von Itzstein M'
p5817
aS'TITLE'
p5818
aS'The war against influenza: discovery and development of sialidase inhibitors.'
p5819
aS'JOURNAL'
p5820
aS'Nat Rev Drug Discov 6:967-74 (2007)'
p5821
aS'PMID:16494716'
p5822
ag5822
aS'AUTHORS'
p5823
aS'Garcia-Sastre A'
p5824
aS'TITLE'
p5825
aS'Antiviral response in pandemic influenza viruses.'
p5826
aS'JOURNAL'
p5827
aS'Emerg Infect Dis 12:44-7 (2006)'
p5828
aS'PMID:18980544'
p5829
ag5829
aS'AUTHORS'
p5830
aS'Ichinohe T, Iwasaki A, Hasegawa H'
p5831
aS'TITLE'
p5832
aS'Innate sensors of influenza virus: clues to developing better intranasal vaccines.'
p5833
aS'JOURNAL'
p5834
aS'Expert Rev Vaccines 7:1435-45 (2008)'
p5835
aS'PMID:19864182'
p5836
ag5836
aS'AUTHORS'
p5837
aS'Peiris JS, Cheung CY, Leung CY, Nicholls JM'
p5838
aS'TITLE'
p5839
aS'Innate immune responses to influenza A H5N1: friend or foe?'
p5840
aS'JOURNAL'
p5841
aS'Trends Immunol 30:574-84 (2009)'
p5842
aS'PMID:18588994'
p5843
ag5843
aS'AUTHORS'
p5844
aS'Thanh TT, van Doorn HR, de Jong MD'
p5845
aS'TITLE'
p5846
aS'Human H5N1 influenza: current insight into pathogenesis.'
p5847
aS'JOURNAL'
p5848
aS'Int J Biochem Cell Biol 40:2671-4 (2008)'
p5849
aS'PMID:17944269'
p5850
ag5850
aS'AUTHORS'
p5851
aS'Neumann G, Shinya K, Kawaoka Y'
p5852
aS'TITLE'
p5853
aS'Molecular pathogenesis of H5N1 influenza virus infections.'
p5854
aS'JOURNAL'
p5855
aS'Antivir Ther 12:617-26 (2007)'
p5856
aS'PMID:17213831'
p5857
ag5857
aS'AUTHORS'
p5858
aS'La Gruta NL, Kedzierska K, Stambas J, Doherty PC'
p5859
aS'TITLE'
p5860
aS'A question of self-preservation: immunopathology in influenza virus infection.'
p5861
aS'JOURNAL'
p5862
aS'Immunol Cell Biol 85:85-92 (2007)'
p5863
aS'PMID:19481124'
p5864
ag5864
aS'AUTHORS'
p5865
aS'Nayak DP, Balogun RA, Yamada H, Zhou ZH, Barman S'
p5866
aS'TITLE'
p5867
aS'Influenza virus morphogenesis and budding.'
p5868
aS'JOURNAL'
p5869
aS'Virus Res 143:147-61 (2009)'
p5870
aS'PMID:17072332'
p5871
ag5871
aS'AUTHORS'
p5872
aS'Hiscott J, Nguyen TL, Arguello M, Nakhaei P, Paz S'
p5873
aS'TITLE'
p5874
aS'Manipulation of the nuclear factor-kappaB pathway and the innate immune response'
p5875
aS'by viruses.'
p5876
aS'JOURNAL'
p5877
aS'Oncogene 25:6844-67 (2006)'
p5878
aS'PMID:19290913'
p5879
ag5879
aS'AUTHORS'
p5880
aS'Ehrhardt C, Ludwig S'
p5881
aS'TITLE'
p5882
aS'A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway.'
p5883
aS'JOURNAL'
p5884
aS'Cell Microbiol 11:863-71 (2009)'
p5885
aS'PMID:21147034'
p5886
ag5886
aS'AUTHORS'
p5887
aS'Pang IK, Iwasaki A'
p5888
aS'TITLE'
p5889
aS'Inflammasomes as mediators of immunity against influenza virus.'
p5890
aS'JOURNAL'
p5891
aS'Trends Immunol 32:34-41 (2011)'
p5892
aS'PMID:17267598'
p5893
ag5893
aS'AUTHORS'
p5894
aS'Satterly N, Tsai PL, van Deursen J, Nussenzveig DR, Wang Y, Faria PA, Levay A, Levy DE, Fontoura BM'
p5895
aS'TITLE'
p5896
aS'Influenza virus targets the mRNA export machinery and the nuclear pore complex.'
p5897
aS'JOURNAL'
p5898
aS'Proc Natl Acad Sci U S A 104:1853-8 (2007)'
p5899
aS'PMID:16882036'
p5900
ag5900
aS'AUTHORS'
p5901
aS'Ehrhardt C, Marjuki H, Wolff T, Nurnberg B, Planz O, Pleschka S, Ludwig S'
p5902
aS'TITLE'
p5903
aS'Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus'
p5904
aS'infection and host cell defence.'
p5905
aS'JOURNAL'
p5906
aS'Cell Microbiol 8:1336-48 (2006)'
p5907
aS'PMID:15502848'
p5908
ag5908
aS'AUTHORS'
p5909
aS'Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC'
p5910
aS'TITLE'
p5911
aS'Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling.'
p5912
aS'JOURNAL'
p5913
aS'Nat Struct Mol Biol 11:1060-7 (2004)'
p5914
aS'PMID:11907320'
p5915
ag5915
aS'AUTHORS'
p5916
aS'Portela A, Digard P'
p5917
aS'TITLE'
p5918
aS'The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal'
p5919
aS'to virus replication.'
p5920
aS'JOURNAL'
p5921
aS'J Gen Virol 83:723-34 (2002)'
p5922
aS'PMID:9060654'
p5923
ag5923
aS'AUTHORS'
p5924
aS'Avalos RT, Yu Z, Nayak DP'
p5925
aS'TITLE'
p5926
aS'Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells.'
p5927
aS'JOURNAL'
p5928
aS'J Virol 71:2947-58 (1997)'
p5929
aS'PMID:20629046'
p5930
ag5930
aS'AUTHORS'
p5931
aS'Bertram S, Glowacka I, Steffen I, Kuhl A, Pohlmann S'
p5932
aS'TITLE'
p5933
aS'Novel insights into proteolytic cleavage of influenza virus hemagglutinin.'
p5934
aS'JOURNAL'
p5935
aS'Rev Med Virol 20:298-310 (2010)'
p5936
asS'KO_PATHWAY'
p5937
(lp5938
S'ko05164'
p5939
asS'PATHWAY_MAP'
p5940
(lp5941
S'map05164'
p5942
asS'DISEASE'
p5943
(lp5944
S'H00398'
p5945
aS'Influenza'
p5946
ag5945
ag5946
aS'H00399'
p5947
aS'Avian influenza'
p5948
asS'ENTRY'
p5949
(lp5950
S'map05164'
p5951
aS'Pathway'
p5952
asS'CLASS'
p5953
(lp5954
S'Human Diseases Infectious diseases'
p5955
asS'DESCRIPTION'
p5956
(lp5957
S'Influenza is a contagious respiratory disease caused by influenza virus infection. Influenza A virus is responsible for both annual seasonal epidemics and periodic worldwide pandemics. Novel strains that cause pandemics arise from avian influenza virus by genetic reassortment among influenza viruses and two surface glycoproteins HA and NA form the basis of serologically distinct virus types. The innate immune system recognizes invaded virus through multiple mechanisms. Viral non-structural NS1 protein is a multifunctional virulence factor that interfere IFN-mediated antiviral response. It inhibits IFN production by blocking activation of transcription factors such as NF-kappa B, IRF3 and AP1. NS1 further inhibits the activation of IFN-induced antiviral genes. PB1-F2 protein is another virulence factor that induce apoptosis of infected cells, which results in life-threatening bronchiolitis.'
p5958
assS'path:map05168'
p5959
(dp5960
S'NAME'
p5961
(lp5962
S'Herpes simplex infection'
p5963
asS'REFERENCE'
p5964
(lp5965
S'PMID:12797447'
p5966
ag5966
aS'AUTHORS'
p5967
aS'Kobelt D, Lechmann M, Steinkasserer A'
p5968
aS'TITLE'
p5969
aS'The interaction between dendritic cells and herpes simplex virus-1.'
p5970
aS'JOURNAL'
p5971
aS'Curr Top Microbiol Immunol 276:145-61 (2003)'
p5972
aS'PMID:12224508'
p5973
ag5973
aS'AUTHORS'
p5974
aS'Leib DA'
p5975
aS'TITLE'
p5976
aS'Counteraction of interferon-induced antiviral responses by herpes simplex viruses.'
p5977
aS'JOURNAL'
p5978
aS'Curr Top Microbiol Immunol 269:171-85 (2002)'
p5979
aS'PMID:20036979'
p5980
ag5980
aS'AUTHORS'
p5981
aS'Martinez-Martin N, Viejo-Borbolla A'
p5982
aS'TITLE'
p5983
aS'Toll-like receptor-mediated recognition of herpes simplex virus.'
p5984
aS'JOURNAL'
p5985
aS'Front Biosci (Schol Ed) 2:718-29 (2010)'
p5986
aS'PMID:10696424'
p5987
ag5987
aS'AUTHORS'
p5988
aS'Roizman B'
p5989
aS'TITLE'
p5990
aS'HSV gene functions: what have we learned that could be generally applicable to its near and distant cousins?'
p5991
aS'JOURNAL'
p5992
aS'Acta Virol 43:75-80 (1999)'
p5993
aS'PMID:12224518'
p5994
ag5994
aS'AUTHORS'
p5995
aS'Bauer D, Tampe R'
p5996
aS'TITLE'
p5997
aS'Herpes viral proteins blocking the transporter associated with antigen processing TAP--from genes to function and structure.'
p5998
aS'JOURNAL'
p5999
aS'Curr Top Microbiol Immunol 269:87-99 (2002)'
p6000
aS'PMID:18508584'
p6001
ag6001
aS'AUTHORS'
p6002
aS'Sandri-Goldin RM'
p6003
aS'TITLE'
p6004
aS'The many roles of the regulatory protein ICP27 during herpes simplex virus infection.'
p6005
aS'JOURNAL'
p6006
aS'Front Biosci 13:5241-56 (2008)'
p6007
aS'PMID:12224517'
p6008
ag6008
aS'AUTHORS'
p6009
aS'Reits E, Griekspoor A, Neefjes J'
p6010
aS'TITLE'
p6011
aS'Herpes viral proteins manipulating the peptide transporter TAP.'
p6012
aS'JOURNAL'
p6013
aS'Curr Top Microbiol Immunol 269:75-83 (2002)'
p6014
aS'PMID:15056211'
p6015
ag6015
aS'AUTHORS'
p6016
aS'Spear PG'
p6017
aS'TITLE'
p6018
aS'Herpes simplex virus: receptors and ligands for cell entry.'
p6019
aS'JOURNAL'
p6020
aS'Cell Microbiol 6:401-10 (2004)'
p6021
aS'PMID:18596690'
p6022
ag6022
aS'AUTHORS'
p6023
aS'Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR'
p6024
aS'TITLE'
p6025
aS'MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs.'
p6026
aS'JOURNAL'
p6027
aS'Nature 454:780-3 (2008)'
p6028
aS'PMID:16076403'
p6029
ag6029
aS'AUTHORS'
p6030
aS'Ellermann-Eriksen S'
p6031
aS'TITLE'
p6032
aS'Macrophages and cytokines in the early defence against herpes simplex virus.'
p6033
aS'JOURNAL'
p6034
aS'Virol J 2:59 (2005)'
p6035
aS'PMID:16297150'
p6036
ag6036
aS'AUTHORS'
p6037
aS'Novak N, Peng WM'
p6038
aS'TITLE'
p6039
aS'Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells.'
p6040
aS'JOURNAL'
p6041
aS'Clin Exp Immunol 142:405-10 (2005)'
p6042
aS'PMID:12525427'
p6043
ag6043
aS'AUTHORS'
p6044
aS'Koelle DM, Corey L'
p6045
aS'TITLE'
p6046
aS'Recent progress in herpes simplex virus immunobiology and vaccine research.'
p6047
aS'JOURNAL'
p6048
aS'Clin Microbiol Rev 16:96-113 (2003)'
p6049
aS'PMID:14747533'
p6050
ag6050
aS'AUTHORS'
p6051
aS'Lin R, Noyce RS, Collins SE, Everett RD, Mossman KL'
p6052
aS'TITLE'
p6053
aS'The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes.'
p6054
aS'JOURNAL'
p6055
aS'J Virol 78:1675-84 (2004)'
p6056
aS'PMID:14963113'
p6057
ag6057
aS'AUTHORS'
p6058
aS'Hagglund R, Roizman B'
p6059
aS'TITLE'
p6060
aS'Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.'
p6061
aS'JOURNAL'
p6062
aS'J Virol 78:2169-78 (2004)'
p6063
aS'PMID:10918307'
p6064
ag6064
aS'AUTHORS'
p6065
aS'Everett RD'
p6066
aS'TITLE'
p6067
aS'ICP0, a regulator of herpes simplex virus during lytic and latent infection.'
p6068
aS'JOURNAL'
p6069
aS'Bioessays 22:761-70 (2000)'
p6070
aS'PMID:12826401'
p6071
ag6071
aS'AUTHORS'
p6072
aS'Wysocka J, Herr W'
p6073
aS'TITLE'
p6074
aS'The herpes simplex virus VP16-induced complex: the makings of a regulatory switch.'
p6075
aS'JOURNAL'
p6076
aS'Trends Biochem Sci 28:294-304 (2003)'
p6077
aS'PMID:19694546'
p6078
ag6078
aS'AUTHORS'
p6079
aS'Paladino P, Mossman KL'
p6080
aS'TITLE'
p6081
aS'Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response.'
p6082
aS'JOURNAL'
p6083
aS'J Interferon Cytokine Res 29:599-607 (2009)'
p6084
aS'PMID:11070032'
p6085
ag6085
aS'AUTHORS'
p6086
aS'Bryant HE, Matthews DA, Wadd S, Scott JE, Kean J, Graham S, Russell WC, Clements JB'
p6087
aS'TITLE'
p6088
aS'Interaction between herpes simplex virus type 1 IE63 protein and cellular protein p32.'
p6089
aS'JOURNAL'
p6090
aS'J Virol 74:11322-8 (2000)'
p6091
aS'PMID:10998601'
p6092
ag6092
aS'AUTHORS'
p6093
aS'Jackson PK, Eldridge AG, Freed E, Furstenthal L, Hsu JY, Kaiser BK, Reimann JD'
p6094
aS'TITLE'
p6095
aS'The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases.'
p6096
aS'JOURNAL'
p6097
aS'Trends Cell Biol 10:429-39 (2000)'
p6098
aS'PMID:10364308'
p6099
ag6099
aS'AUTHORS'
p6100
aS'Long MC, Leong V, Schaffer PA, Spencer CA, Rice SA'
p6101
aS'TITLE'
p6102
aS'ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II.'
p6103
aS'JOURNAL'
p6104
aS'J Virol 73:5593-604 (1999)'
p6105
aS'PMID:15163721'
p6106
ag6106
aS'AUTHORS'
p6107
aS'Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Miura S, Jimbow K, Fujii N'
p6108
aS'TITLE'
p6109
aS'Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway.'
p6110
aS'JOURNAL'
p6111
aS'J Virol 78:6282-6 (2004)'
p6112
aS'PMID:9499021'
p6113
ag6113
aS'AUTHORS'
p6114
aS'Kawaguchi Y, Van Sant C, Roizman B'
p6115
aS'TITLE'
p6116
aS'Eukaryotic elongation factor 1delta is hyperphosphorylated by the protein kinase'
p6117
aS'encoded by the U(L)13 gene of herpes simplex virus 1.'
p6118
aS'JOURNAL'
p6119
aS'J Virol 72:1731-6 (1998)'
p6120
aS'PMID:10196275'
p6121
ag6121
aS'AUTHORS'
p6122
aS'Bruni R, Fineschi B, Ogle WO, Roizman B'
p6123
aS'TITLE'
p6124
aS'A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type-specific manner and Is recruited to the nucleus after infection.'
p6125
aS'JOURNAL'
p6126
aS'J Virol 73:3810-7 (1999)'
p6127
aS'PMID:19879619'
p6128
ag6128
aS'AUTHORS'
p6129
aS'Johnson KE, Knipe DM'
p6130
aS'TITLE'
p6131
aS'Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation.'
p6132
aS'JOURNAL'
p6133
aS'Virology 396:21-9 (2010)'
p6134
aS'PMID:15047834'
p6135
ag6135
aS'AUTHORS'
p6136
aS'Chee AV, Roizman B'
p6137
aS'TITLE'
p6138
aS'Herpes simplex virus 1 gene products occlude the interferon signaling pathway at'
p6139
aS'multiple sites.'
p6140
aS'JOURNAL'
p6141
aS'J Virol 78:4185-96 (2004)'
p6142
aS'PMID:17913820'
p6143
ag6143
aS'AUTHORS'
p6144
aS'Rasmussen SB, Sorensen LN, Malmgaard L, Ank N, Baines JD, Chen ZJ, Paludan SR'
p6145
aS'TITLE'
p6146
aS'Type I interferon production during herpes simplex virus infection is controlled'
p6147
aS'by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems.'
p6148
aS'JOURNAL'
p6149
aS'J Virol 81:13315-24 (2007)'
p6150
aS'PMID:21107701'
p6151
ag6151
aS'AUTHORS'
p6152
aS'Dufour F, Sasseville AM, Chabaud S, Massie B, Siegel RM, Langelier Y'
p6153
aS'TITLE'
p6154
aS'The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFalpha- and FasL-induced apoptosis by interacting with caspase-8.'
p6155
aS'JOURNAL'
p6156
aS'Apoptosis 16:256-71 (2011)'
p6157
aS'PMID:9621021'
p6158
ag6158
aS'AUTHORS'
p6159
aS'Schang LM, Phillips J, Schaffer PA'
p6160
aS'TITLE'
p6161
aS'Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.'
p6162
aS'JOURNAL'
p6163
aS'J Virol 72:5626-37 (1998)'
p6164
aS'PMID:12844494'
p6165
ag6165
aS'AUTHORS'
p6166
aS'Medici MA, Sciortino MT, Perri D, Amici C, Avitabile E, Ciotti M, Balestrieri E, De Smaele E, Franzoso G, Mastino A'
p6167
aS'TITLE'
p6168
aS'Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB.'
p6169
aS'JOURNAL'
p6170
aS'J Biol Chem 278:36059-67 (2003)'
p6171
aS'PMID:17222692'
p6172
ag6172
aS'AUTHORS'
p6173
aS'Nguyen ML, Blaho JA'
p6174
aS'TITLE'
p6175
aS'Apoptosis during herpes simplex virus infection.'
p6176
aS'JOURNAL'
p6177
aS'Adv Virus Res 69:67-97 (2007)'
p6178
asS'KO_PATHWAY'
p6179
(lp6180
S'ko05168'
p6181
asS'PATHWAY_MAP'
p6182
(lp6183
S'map05168'
p6184
asS'MODULE'
p6185
(lp6186
S'M00381'
p6187
aS'SCF-SKP2 complex [PATH:map05168]'
p6188
asS'ENTRY'
p6189
(lp6190
S'map05168'
p6191
aS'Pathway'
p6192
asS'CLASS'
p6193
(lp6194
S'Human Diseases Infectious diseases'
p6195
asS'DESCRIPTION'
p6196
(lp6197
S'Herpes simplex virus (HSV) infections are very common worldwide, with the prevalence of HSV-1 reaching up to 80%-90%. Primary infection with HSV takes place in the mucosa, followed by the establishment of latent infection in neuronal ganglia. HSV is the main cause of herpes infections that lead to the formation of characteristic blistering lesion. HSV express multiple viral accessory proteins that interfere with host immune responses and are indispensable for viral replication. Among these proteins, the immediate early (IE) gene ICP0, ICP4, and ICP27 are essential for regulation of HSV gene expression in productive infection. On the other hand, ORF P and ORF O gene are transcribed during latency and blocks the expression of the IE genes, thus maintaining latent infection.'
p6198
assS'path:map05169'
p6199
(dp6200
S'NAME'
p6201
(lp6202
S'Epstein-Barr virus infection'
p6203
asS'REFERENCE'
p6204
(lp6205
g22
ag22
aS'AUTHORS'
p6206
aS'Kieff E, Rickinson AB.'
p6207
aS'TITLE'
p6208
aS'Epstein-Barr virus and its replication.'
p6209
aS'JOURNAL'
p6210
aS'Fields Virology. New York, Lippincott-Raven'
p6211
aS'PMID:15510157'
p6212
ag6212
aS'AUTHORS'
p6213
aS'Young LS, Rickinson AB.'
p6214
aS'TITLE'
p6215
aS'Epstein-Barr virus: 40 years on.'
p6216
aS'JOURNAL'
p6217
aS'Nat Rev Cancer 4:757-68 (2004)'
p6218
aS'PMID:12910248'
p6219
ag6219
aS'AUTHORS'
p6220
aS'Young LS, Murray PG'
p6221
aS'TITLE'
p6222
aS'Epstein-Barr virus and oncogenesis: from latent genes to tumours.'
p6223
aS'JOURNAL'
p6224
aS'Oncogene 22:5108-21 (2003)'
p6225
aS'PMID:10666279'
p6226
ag6226
aS'AUTHORS'
p6227
aS'Haan KM, Kwok WW, Longnecker R, Speck P'
p6228
aS'TITLE'
p6229
aS'Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.'
p6230
aS'JOURNAL'
p6231
aS'J Virol 74:2451-4 (2000)'
p6232
aS'PMID:16352731'
p6233
ag6233
aS'AUTHORS'
p6234
aS'Knight JS, Sharma N, Robertson ES'
p6235
aS'TITLE'
p6236
aS'Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.'
p6237
aS'JOURNAL'
p6238
aS'Proc Natl Acad Sci U S A 102:18562-6 (2005)'
p6239
aS'PMID:15542638'
p6240
ag6240
aS'AUTHORS'
p6241
aS'Knight JS, Sharma N, Kalman DE, Robertson ES'
p6242
aS'TITLE'
p6243
aS'A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds'
p6244
aS'cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.'
p6245
aS'JOURNAL'
p6246
aS'J Virol 78:12857-67 (2004)'
p6247
aS'PMID:10891508'
p6248
ag6248
aS'AUTHORS'
p6249
aS'Cotter MA 2nd, Robertson ES'
p6250
aS'TITLE'
p6251
aS'Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.'
p6252
aS'JOURNAL'
p6253
aS'Mol Cell Biol 20:5722-35 (2000)'
p6254
aS'PMID:14576817'
p6255
ag6255
aS'AUTHORS'
p6256
aS'Eliopoulos AG, Caamano JH, Flavell J, Reynolds GM, Murray PG, Poyet JL, Young LS'
p6257
aS'TITLE'
p6258
aS'Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling'
p6259
aS'pathway.'
p6260
aS'JOURNAL'
p6261
aS'Oncogene 22:7557-69 (2003)'
p6262
aS'PMID:10683340'
p6263
ag6263
aS'AUTHORS'
p6264
aS'Ikeda M, Ikeda A, Longan LC, Longnecker R'
p6265
aS'TITLE'
p6266
aS'The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.'
p6267
aS'JOURNAL'
p6268
aS'Virology 268:178-91 (2000)'
p6269
aS'PMID:15021898'
p6270
ag6270
aS'AUTHORS'
p6271
aS'Masucci MG'
p6272
aS'TITLE'
p6273
aS'Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.'
p6274
aS'JOURNAL'
p6275
aS'Oncogene 23:2107-15 (2004)'
p6276
aS'PMID:14673102'
p6277
ag6277
aS'AUTHORS'
p6278
aS'Luftig M, Prinarakis E, Yasui T, Tsichritzis T, Cahir-McFarland E, Inoue J, Nakano H, Mak TW, Yeh WC, Li X, Akira S, Suzuki N, Suzuki S, Mosialos G, Kieff E'
p6279
aS'TITLE'
p6280
aS'Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.'
p6281
aS'JOURNAL'
p6282
aS'Proc Natl Acad Sci U S A 100:15595-600 (2003)'
p6283
aS'PMID:16007144'
p6284
ag6284
aS'AUTHORS'
p6285
aS'Mainou BA, Everly DN Jr, Raab-Traub N'
p6286
aS'TITLE'
p6287
aS'Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.'
p6288
aS'JOURNAL'
p6289
aS'Oncogene 24:6917-24 (2005)'
p6290
aS'PMID:18786993'
p6291
ag6291
aS'AUTHORS'
p6292
aS'Young KA, Herbert AP, Barlow PN, Holers VM, Hannan JP'
p6293
aS'TITLE'
p6294
aS'Molecular basis of the interaction between complement receptor type 2 (CR2/CD21)'
p6295
aS'and Epstein-Barr virus glycoprotein gp350.'
p6296
aS'JOURNAL'
p6297
aS'J Virol 82:11217-27 (2008)'
p6298
aS'PMID:17159145'
p6299
ag6299
aS'AUTHORS'
p6300
aS'Portal D, Rosendorff A, Kieff E'
p6301
aS'TITLE'
p6302
aS'Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.'
p6303
aS'JOURNAL'
p6304
aS'Proc Natl Acad Sci U S A 103:19278-83 (2006)'
p6305
aS'PMID:21518914'
p6306
ag6306
aS'AUTHORS'
p6307
aS'Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E'
p6308
aS'TITLE'
p6309
aS'EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from'
p6310
aS'enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.'
p6311
aS'JOURNAL'
p6312
aS'Proc Natl Acad Sci U S A 108:7808-13 (2011)'
p6313
aS'PMID:10644367'
p6314
ag6314
aS'AUTHORS'
p6315
aS'Zhou S, Fujimuro M, Hsieh JJ, Chen L, Hayward SD'
p6316
aS'TITLE'
p6317
aS'A role for SKIP in EBNA2 activation of CBF1-repressed promoters.'
p6318
aS'JOURNAL'
p6319
aS'J Virol 74:1939-47 (2000)'
p6320
aS'PMID:16603506'
p6321
ag6321
aS'AUTHORS'
p6322
aS'Brinkmann MM, Schulz TF'
p6323
aS'TITLE'
p6324
aS'Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.'
p6325
aS'JOURNAL'
p6326
aS'J Gen Virol 87:1047-74 (2006)'
p6327
aS'PMID:18559925'
p6328
ag6328
aS'AUTHORS'
p6329
aS'Anderson LJ, Longnecker R'
p6330
aS'TITLE'
p6331
aS'EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.'
p6332
aS'JOURNAL'
p6333
aS'J Gen Virol 89:1563-8 (2008)'
p6334
aS'PMID:1658397'
p6335
ag6335
aS'AUTHORS'
p6336
aS'Flemington EK, Goldfeld AE, Speck SH'
p6337
aS'TITLE'
p6338
aS'Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis.'
p6339
aS'JOURNAL'
p6340
aS'J Virol 65:7073-7 (1991)'
p6341
aS'PMID:12438576'
p6342
ag6342
aS'AUTHORS'
p6343
aS'Mauser A, Saito S, Appella E, Anderson CW, Seaman WT, Kenney S'
p6344
aS'TITLE'
p6345
aS'The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms.'
p6346
aS'JOURNAL'
p6347
aS'J Virol 76:12503-12 (2002)'
p6348
aS'PMID:19375142'
p6349
ag6349
aS'AUTHORS'
p6350
aS'Sato Y, Shirata N, Kudoh A, Iwahori S, Nakayama S, Murata T, Isomura H, Nishiyama Y, Tsurumi T'
p6351
aS'TITLE'
p6352
aS'Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription.'
p6353
aS'JOURNAL'
p6354
aS'Virology 388:204-11 (2009)'
p6355
aS'PMID:7895172'
p6356
ag6356
aS'AUTHORS'
p6357
aS'Miller CL, Burkhardt AL, Lee JH, Stealey B, Longnecker R, Bolen JB, Kieff E'
p6358
aS'TITLE'
p6359
aS'Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.'
p6360
aS'JOURNAL'
p6361
aS'Immunity 2:155-66 (1995)'
p6362
aS'PMID:10400785'
p6363
ag6363
aS'AUTHORS'
p6364
aS'Boyle SM, Ruvolo V, Gupta AK, Swaminathan S'
p6365
aS'TITLE'
p6366
aS'Association with the cellular export receptor CRM 1 mediates function and intracellular localization of Epstein-Barr virus SM protein, a regulator of gene'
p6367
aS'expression.'
p6368
aS'JOURNAL'
p6369
aS'J Virol 73:6872-81 (1999)'
p6370
aS'PMID:9565632'
p6371
ag6371
aS'AUTHORS'
p6372
aS"Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O'Callaghan CA, Steven N, McMichael AJ, Rickinson AB"
p6373
aS'TITLE'
p6374
aS'Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.'
p6375
aS'JOURNAL'
p6376
aS'J Exp Med 187:1395-402 (1998)'
p6377
ag22
ag22
aS'AUTHORS'
p6378
aS'Isobe Y.'
p6379
aS'TITLE'
p6380
aS'EB virus and oncogenesis. [Japanese]'
p6381
aS'JOURNAL'
p6382
aS'Genomu Igaku. Tokyo, Medical Review Co. Ltd.'
p6383
asS'KO_PATHWAY'
p6384
(lp6385
S'ko05169'
p6386
asS'PATHWAY_MAP'
p6387
(lp6388
S'map05169'
p6389
asS'DISEASE'
p6390
(lp6391
S'H00367'
p6392
aS'Infectious mononucleosis'
p6393
asS'ENTRY'
p6394
(lp6395
S'map05169'
p6396
aS'Pathway'
p6397
asS'CLASS'
p6398
(lp6399
S'Human Diseases Infectious diseases'
p6400
asS'DESCRIPTION'
p6401
(lp6402
S'Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that is associated with oncogenesis. EBV infection to primary human B lymphocytes leads to induction of EBV-specific HLA-restricted cytotoxic T cells, causing infectious mononucleosis during adolescence. Primary infection with EBV is followed by latent infection in which the reservoir B cells are immortalized. EBV tumorigenic potential in Burkitt lymphoma, nasopharyngeal carcinoma, Hodgkin lymphoma, and post-transplant B cell lymphomas has been well-documented. Distinct forms of EBV latency and patterns of latent gene expression can contribute to the different tumours.'
p6403
assS'path:map00100'
p6404
(dp6405
S'NAME'
p6406
(lp6407
S'Steroid biosynthesis'
p6408
asS'REFERENCE'
p6409
(lp6410
g22
ag22
aS'AUTHORS'
p6411
aS'Koshiba K, Kamiya Y.'
p6412
aS'TITLE'
p6413
aS'[Atarasii Syokubutuhorumon no Kagaku] (In Japanese)'
p6414
aS'JOURNAL'
p6415
aS'Koudansya saientific:199-138 (2002)'
p6416
aS'PMID:16531502'
p6417
ag6417
aS'AUTHORS'
p6418
aS'Morikawa T, Mizutani M, Aoki N, Watanabe B, Saga H, Saito S, Oikawa A, Suzuki H, Sakurai N, Shibata D, Wadano A, Sakata K, Ohta D.'
p6419
aS'TITLE'
p6420
aS'Cytochrome P450 CYP710A encodes the sterol C-22 desaturase in Arabidopsis and tomato.'
p6421
aS'JOURNAL'
p6422
aS'Plant Cell 18:1008-22 (2006)'
p6423
aS'PMID:12777052'
p6424
ag6424
aS'AUTHORS'
p6425
aS'Lange BM, Ghassemian M.'
p6426
aS'TITLE'
p6427
aS'Genome organization in Arabidopsis thaliana: a survey for genes involved in isoprenoid and chlorophyll metabolism.'
p6428
aS'JOURNAL'
p6429
aS'Plant Mol Biol 51:925-48 (2003)'
p6430
asS'KO_PATHWAY'
p6431
(lp6432
S'ko00100'
p6433
asS'PATHWAY_MAP'
p6434
(lp6435
S'map00100'
p6436
asS'DISEASE'
p6437
(lp6438
S'H00148'
p6439
aS'Lysosomal acid lipase deficiency'
p6440
ag6439
ag6440
aS'H00161'
p6441
aS'Smith-Lemli-Opitz syndrome'
p6442
aS'H00496'
p6443
aS'Congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD)'
p6444
aS'H00617'
p6445
aS'Desmosterolosis'
p6446
aS'H01143'
p6447
aS'Vitamin D-dependent rickets'
p6448
aS'H01194'
p6449
aS'X-linked chondrodysplasia punctata'
p6450
aS'H01281'
p6451
aS'Lathosterolosis'
p6452
aS'H01371'
p6453
aS'Hypercalcemia infantile'
p6454
asS'MODULE'
p6455
(lp6456
S'M00101'
p6457
aS'Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol [PATH:map00100]'
p6458
ag6457
ag6458
aS'M00102'
p6459
aS'Ergocalciferol biosynthesis [PATH:map00100]'
p6460
aS'M00103'
p6461
aS'Cholecalciferol biosynthesis [PATH:map00100]'
p6462
asS'DBLINKS'
p6463
(lp6464
S'GO: 0016126'
p6465
asS'ENTRY'
p6466
(lp6467
S'map00100'
p6468
aS'Pathway'
p6469
asS'CLASS'
p6470
(lp6471
S'Metabolism Lipid metabolism'
p6472
assS'path:map00532'
p6473
(dp6474
S'NAME'
p6475
(lp6476
S'Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate'
p6477
asS'REFERENCE'
p6478
(lp6479
S'PMID:11042448'
p6480
ag6480
aS'AUTHORS'
p6481
aS'Sugahara K, Kitagawa H.'
p6482
aS'TITLE'
p6483
aS'Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans.'
p6484
aS'JOURNAL'
p6485
aS'Curr Opin Struct Biol 10:518-27 (2000)'
p6486
aS'PMID:11274177'
p6487
ag6487
aS'AUTHORS'
p6488
aS'Li JP, Gong F, El Darwish K, Jalkanen M, Lindahl U.'
p6489
aS'TITLE'
p6490
aS'Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate.'
p6491
aS'JOURNAL'
p6492
aS'J Biol Chem 276:20069-77 (2001)'
p6493
aS'PMID:11099377'
p6494
ag6494
aS'AUTHORS'
p6495
aS'Gotting C, Kuhn J, Zahn R, Brinkmann T, Kleesiek K'
p6496
aS'TITLE'
p6497
aS'Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein'
p6498
aS'beta-d-xylosyltransferase and its first isoform XT-II.'
p6499
aS'JOURNAL'
p6500
aS'J Mol Biol 304:517-28 (2000)'
p6501
aS'PMID:10473568'
p6502
ag6502
aS'AUTHORS'
p6503
aS'Almeida R, Levery SB, Mandel U, Kresse H, Schwientek T, Bennett EP, Clausen H'
p6504
aS'TITLE'
p6505
aS'Cloning and expression of a proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I. A seventh member of the human beta4-galactosyltransferase gene family.'
p6506
aS'JOURNAL'
p6507
aS'J Biol Chem 274:26165-71 (1999)'
p6508
aS'PMID:11551958'
p6509
ag6509
aS'AUTHORS'
p6510
aS'Bai X, Zhou D, Brown JR, Crawford BE, Hennet T, Esko JD'
p6511
aS'TITLE'
p6512
aS'Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase'
p6513
aS'family (beta 3GalT6).'
p6514
aS'JOURNAL'
p6515
aS'J Biol Chem 276:48189-95 (2001)'
p6516
aS'PMID:9506957'
p6517
ag6517
aS'AUTHORS'
p6518
aS'Kitagawa H, Tone Y, Tamura J, Neumann KW, Ogawa T, Oka S, Kawasaki T, Sugahara K'
p6519
aS'TITLE'
p6520
aS'Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans.'
p6521
aS'JOURNAL'
p6522
aS'J Biol Chem 273:6615-8 (1998)'
p6523
aS'PMID:12512856'
p6524
ag6524
aS'AUTHORS'
p6525
aS'Silbert JE, Sugumaran G'
p6526
aS'TITLE'
p6527
aS'Biosynthesis of chondroitin/dermatan sulfate.'
p6528
aS'JOURNAL'
p6529
aS'IUBMB Life 54:177-86 (2002)'
p6530
aS'PMID:17253960'
p6531
ag6531
aS'AUTHORS'
p6532
aS'Izumikawa T, Uyama T, Okuura Y, Sugahara K, Kitagawa H'
p6533
aS'TITLE'
p6534
aS'Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor.'
p6535
aS'JOURNAL'
p6536
aS'Biochem J 403:545-52 (2007)'
p6537
aS'PMID:12716890'
p6538
ag6538
aS'AUTHORS'
p6539
aS'Kitagawa H, Izumikawa T, Uyama T, Sugahara K'
p6540
aS'TITLE'
p6541
aS'Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization.'
p6542
aS'JOURNAL'
p6543
aS'J Biol Chem 278:23666-71 (2003)'
p6544
aS'PMID:21138417'
p6545
ag6545
aS'AUTHORS'
p6546
aS'Izumikawa T, Okuura Y, Koike T, Sakoda N, Kitagawa H'
p6547
aS'TITLE'
p6548
aS'Chondroitin 4-O-sulfotransferase-1 regulates the chain length of chondroitin sulfate in co-operation with chondroitin N-acetylgalactosaminyltransferase-2.'
p6549
aS'JOURNAL'
p6550
aS'Biochem J 434:321-31 (2011)'
p6551
aS'PMID:22899863'
p6552
ag6552
aS'AUTHORS'
p6553
aS'Malmstrom A, Bartolini B, Thelin MA, Pacheco B, Maccarana M'
p6554
aS'TITLE'
p6555
aS'Iduronic Acid in chondroitin/dermatan sulfate: biosynthesis and biological function.'
p6556
aS'JOURNAL'
p6557
aS'J Histochem Cytochem 60:916-25 (2012)'
p6558
aS'PMID:17928217'
p6559
ag6559
aS'AUTHORS'
p6560
aS'Sugahara K, Mikami T'
p6561
aS'TITLE'
p6562
aS'Chondroitin/dermatan sulfate in the central nervous system.'
p6563
aS'JOURNAL'
p6564
aS'Curr Opin Struct Biol 17:536-45 (2007)'
p6565
aS'PMID:14568616'
p6566
ag6566
aS'AUTHORS'
p6567
aS'Kusche-Gullberg M, Kjellen L'
p6568
aS'TITLE'
p6569
aS'Sulfotransferases in glycosaminoglycan biosynthesis.'
p6570
aS'JOURNAL'
p6571
aS'Curr Opin Struct Biol 13:605-11 (2003)'
p6572
aS'PMID:19661164'
p6573
ag6573
aS'AUTHORS'
p6574
aS'Pacheco B, Maccarana M, Malmstrom A'
p6575
aS'TITLE'
p6576
aS'Dermatan 4-O-sulfotransferase 1 is pivotal in the formation of iduronic acid blocks in dermatan sulfate.'
p6577
aS'JOURNAL'
p6578
aS'Glycobiology 19:1197-203 (2009)'
p6579
aS'PMID:17239763'
p6580
ag6580
aS'AUTHORS'
p6581
aS'Prabhakar V, Sasisekharan R'
p6582
aS'TITLE'
p6583
aS'The biosynthesis and catabolism of galactosaminoglycans.'
p6584
aS'JOURNAL'
p6585
aS'Adv Pharmacol 53:69-115 (2006)'
p6586
aS'PMID:12847091'
p6587
ag6587
aS'AUTHORS'
p6588
aS'Mikami T, Mizumoto S, Kago N, Kitagawa H, Sugahara K'
p6589
aS'TITLE'
p6590
aS'Specificities of three distinct human chondroitin/dermatan N-acetylgalactosamine'
p6591
aS'4-O-sulfotransferases demonstrated using partially desulfated dermatan sulfate as an acceptor: implication of differential roles in dermatan sulfate biosynthesis.'
p6592
aS'JOURNAL'
p6593
aS'J Biol Chem 278:36115-27 (2003)'
p6594
asS'KO_PATHWAY'
p6595
(lp6596
S'ko00532'
p6597
asS'PATHWAY_MAP'
p6598
(lp6599
S'map00532'
p6600
asS'DISEASE'
p6601
(lp6602
S'H00762'
p6603
aS'SEMD, Omani type'
p6604
ag6603
ag6604
aS'H00802'
p6605
aS'Ehlers-Danlos syndrome (EDS)'
p6606
asS'MODULE'
p6607
(lp6608
S'M00057'
p6609
aS'Glycosaminoglycan biosynthesis, linkage tetrasaccharide [PATH:map00532]'
p6610
ag6609
ag6610
aS'M00058'
p6611
aS'Glycosaminoglycan biosynthesis, chondroitin sulfate backbone [PATH:map00532]'
p6612
asS'ENTRY'
p6613
(lp6614
S'map00532'
p6615
aS'Pathway'
p6616
asS'CLASS'
p6617
(lp6618
S'Metabolism Glycan biosynthesis and metabolism'
p6619
asS'DESCRIPTION'
p6620
(lp6621
S'Glycosaminoglycans (GAGs) are linear polysaccharide chains consisting of repeating disaccharide units and form proteglycans by covalently attaching to their core proteins. Chondroitin sulfate (CS) is a glycosaminoglycan with the disaccharide unit of beta-D-galactosamine (GalNAc) and beta-D-glucuronic acid (GlcA), and often modified with ester-linked sulfate at certain positions. Dermatan sulfate (DS) is a modified form of CS, in which a portion of D-glucuronate residues is epimerized to L-iduronates (IdoA). CS and DS are linked to serine residues in core proteins via a linkage tetrasaccharide formed by the transfer of xylose and three more residues [MD:M00057]. The assembly process of CS is initiated by transferring GalNAc residue to the linkage tetrasaccharide. The polymerization is catalyzed by bifunctional enzymes (chondroitin synthases) possessing both beta 1,3 glucuronosyltransferase and beta 1,4 N-acetylgalactosaminyltransferase activities [MD:M00058]. Chondroitin polymerization also requires the action of the chondroitin polymerizing factor. There are various O-sulfation patterns in CS and DS, where 4-O sulfation and 6-O sulfation of GalNAc and 2-O-sulfation of the uronic acids (GlcA / IdoA) are mainly found.'
p6622
assS'path:map00533'
p6623
(dp6624
S'NAME'
p6625
(lp6626
S'Glycosaminoglycan biosynthesis - keratan sulfate'
p6627
asS'REFERENCE'
p6628
(lp6629
S'PMID:11030741'
p6630
ag6630
aS'AUTHORS'
p6631
aS'Funderburgh JL.'
p6632
aS'TITLE'
p6633
aS'Keratan sulfate: structure, biosynthesis, and function.'
p6634
aS'JOURNAL'
p6635
aS'Glycobiology 10:951-958 (2000)'
p6636
aS'PMID:14706853'
p6637
ag6637
aS'AUTHORS'
p6638
aS'Seko A, Yamashita K.'
p6639
aS'TITLE'
p6640
aS'beta1,3-N-Acetylglucosaminyltransferase-7 (beta3Gn-T7) acts efficiently on keratan sulfate-related glycans.'
p6641
aS'JOURNAL'
p6642
aS'FEBS Lett 556:216-20 (2004)'
p6643
aS'PMID:12511560'
p6644
ag6644
aS'AUTHORS'
p6645
aS'Seko A, Dohmae N, Takio K, Yamashita K.'
p6646
aS'TITLE'
p6647
aS'Beta 1,4-galactosyltransferase (beta 4GalT)-IV is specific for GlcNAc 6-O-sulfate. Beta 4GalT-IV acts on keratan sulfate-related glycans and a precursor glycan of 6-sulfosialyl-Lewis X.'
p6648
aS'JOURNAL'
p6649
aS'J Biol Chem 278:9150-8 (2003)'
p6650
asS'KO_PATHWAY'
p6651
(lp6652
S'ko00533'
p6653
asS'PATHWAY_MAP'
p6654
(lp6655
S'map00533'
p6656
asS'DISEASE'
p6657
(lp6658
S'H00768'
p6659
aS'Nonsyndromic autosomal recessive mental retardation (NS-ARMR)'
p6660
ag6659
ag6660
aS'H00954'
p6661
aS'Macular corneal dystrophy (MCD)'
p6662
asS'ENTRY'
p6663
(lp6664
S'map00533'
p6665
aS'Pathway'
p6666
asS'CLASS'
p6667
(lp6668
S'Metabolism Glycan biosynthesis and metabolism'
p6669
asS'DESCRIPTION'
p6670
(lp6671
S'Keratan sulfate (KS) is a glycosaminoglycan with the basic disaccharide unit of N-acetyllactosamine, Gal(b1-4)GlcNAc(b1-3), with sulfate esters at C-6 of GlcNAc and Gal residues. There are two types of KS distinguished by the protein linkage: type I for N-linked via the N-glycan core structure and type II for O-linked via the O-glycan core 2 structure.'
p6672
assS'path:map00531'
p6673
(dp6674
S'NAME'
p6675
(lp6676
S'Glycosaminoglycan degradation'
p6677
asS'KO_PATHWAY'
p6678
(lp6679
S'ko00531'
p6680
asS'ENTRY'
p6681
(lp6682
S'map00531'
p6683
aS'Pathway'
p6684
asS'PATHWAY_MAP'
p6685
(lp6686
S'map00531'
p6687
asS'DISEASE'
p6688
(lp6689
S'H00123'
p6690
aS'Mucopolysaccharidosis type IV (MPS4)'
p6691
ag6690
ag6691
aS'H00124'
p6692
aS'GM2 gangliosidoses'
p6693
aS'H00128'
p6694
aS'Mucopolysaccharidosis type I (MPS1)'
p6695
aS'H00129'
p6696
aS'Mucopolysaccharidosis type II (MPS2)'
p6697
aS'H00130'
p6698
aS'Mucopolysaccharidosis type III (MPS3)'
p6699
aS'H00131'
p6700
aS'Mucopolysaccharidosis type VI (MPS6)'
p6701
aS'H00132'
p6702
aS'Mucopolysaccharidosis type VII (MPS7)'
p6703
aS'H00133'
p6704
aS'Mucopolysaccharidosis type IX (MPS9)'
p6705
aS'H00281'
p6706
aS'GM1 gangliosidosis'
p6707
aS'H00421'
p6708
aS'Mucopolysaccharidosis (MPS)'
p6709
aS'H00426'
p6710
aS'Defects in the degradation of ganglioside'
p6711
aS'H00753'
p6712
aS'Urofacial syndrome'
p6713
asS'MODULE'
p6714
(lp6715
S'M00076'
p6716
aS'Dermatan sulfate degradation [PATH:map00531]'
p6717
ag6716
ag6717
aS'M00077'
p6718
aS'Chondroitin sulfate degradation [PATH:map00531]'
p6719
aS'M00078'
p6720
aS'Heparan sulfate degradation [PATH:map00531]'
p6721
aS'M00079'
p6722
aS'Keratan sulfate degradation [PATH:map00531]'
p6723
asS'CLASS'
p6724
(lp6725
S'Metabolism Glycan biosynthesis and metabolism'
p6726
assS'path:map00534'
p6727
(dp6728
S'NAME'
p6729
(lp6730
S'Glycosaminoglycan biosynthesis - heparan sulfate / heparin'
p6731
asS'REFERENCE'
p6732
(lp6733
S'PMID:11390981'
p6734
ag6734
aS'AUTHORS'
p6735
aS'Kim BT, Kitagawa H, Tamura J, Saito T, Kusche-Gullberg M, Lindahl U, Sugahara K'
p6736
aS'TITLE'
p6737
aS'Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4-'
p6738
aS'N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.'
p6739
aS'JOURNAL'
p6740
aS'Proc Natl Acad Sci U S A 98:7176-81 (2001)'
p6741
aS'PMID:10318803'
p6742
ag6742
aS'AUTHORS'
p6743
aS'Kitagawa H, Shimakawa H, Sugahara K'
p6744
aS'TITLE'
p6745
aS'The tumor suppressor EXT-like gene EXTL2 encodes an alpha1, 4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region. The key enzyme for the chain initiation of heparan sulfate.'
p6746
aS'JOURNAL'
p6747
aS'J Biol Chem 274:13933-7 (1999)'
p6748
aS'PMID:9756849'
p6749
ag6749
aS'AUTHORS'
p6750
aS'Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K'
p6751
aS'TITLE'
p6752
aS'The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate.'
p6753
aS'JOURNAL'
p6754
aS'J Biol Chem 273:26265-8 (1998)'
p6755
aS'PMID:11274177'
p6756
ag6756
aS'AUTHORS'
p6757
aS'Li JP, Gong F, El Darwish K, Jalkanen M, Lindahl U.'
p6758
aS'TITLE'
p6759
aS'Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate.'
p6760
aS'JOURNAL'
p6761
aS'J Biol Chem 276:20069-77 (2001)'
p6762
aS'PMID:10742590'
p6763
ag6763
aS'AUTHORS'
p6764
aS'Habuchi O'
p6765
aS'TITLE'
p6766
aS'Diversity and functions of glycosaminoglycan sulfotransferases.'
p6767
aS'JOURNAL'
p6768
aS'Biochim Biophys Acta 1474:115-27 (2000)'
p6769
aS'PMID:9151776'
p6770
ag6770
aS'AUTHORS'
p6771
aS'Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L'
p6772
aS'TITLE'
p6773
aS'Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?'
p6774
aS'JOURNAL'
p6775
aS'J Clin Invest 99:2062-70 (1997)'
p6776
aS'PMID:9988768'
p6777
ag6777
aS'AUTHORS'
p6778
aS'Liu J, Shworak NW, Sinay P, Schwartz JJ, Zhang L, Fritze LM, Rosenberg RD'
p6779
aS'TITLE'
p6780
aS'Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities.'
p6781
aS'JOURNAL'
p6782
aS'J Biol Chem 274:5185-92 (1999)'
p6783
aS'PMID:10520990'
p6784
ag6784
aS'AUTHORS'
p6785
aS'Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG'
p6786
aS'TITLE'
p6787
aS'A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.'
p6788
aS'JOURNAL'
p6789
aS'Cell 99:13-22 (1999)'
p6790
aS'PMID:15304505'
p6791
ag6791
aS'AUTHORS'
p6792
aS'Moon AF, Edavettal SC, Krahn JM, Munoz EM, Negishi M, Linhardt RJ, Liu J, Pedersen LC'
p6793
aS'TITLE'
p6794
aS'Structural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1.'
p6795
aS'JOURNAL'
p6796
aS'J Biol Chem 279:45185-93 (2004)'
p6797
aS'PMID:16099108'
p6798
ag6798
aS'AUTHORS'
p6799
aS'Chen J, Liu J'
p6800
aS'TITLE'
p6801
aS'Characterization of the structure of antithrombin-binding heparan sulfate generated by heparan sulfate 3-O-sulfotransferase 5.'
p6802
aS'JOURNAL'
p6803
aS'Biochim Biophys Acta 1725:190-200 (2005)'
p6804
asS'KO_PATHWAY'
p6805
(lp6806
S'ko00534'
p6807
asS'PATHWAY_MAP'
p6808
(lp6809
S'map00534'
p6810
asS'DISEASE'
p6811
(lp6812
S'H00122'
p6813
aS'Multiple exostoses'
p6814
ag6813
ag6814
aS'H00802'
p6815
aS'Ehlers-Danlos syndrome (EDS)'
p6816
asS'MODULE'
p6817
(lp6818
S'M00059'
p6819
aS'Glycosaminoglycan biosynthesis, heparan sulfate backbone [PATH:map00534]'
p6820
asS'ENTRY'
p6821
(lp6822
S'map00534'
p6823
aS'Pathway'
p6824
asS'CLASS'
p6825
(lp6826
S'Metabolism Glycan biosynthesis and metabolism'
p6827
asS'DESCRIPTION'
p6828
(lp6829
S'Heparan sulfate (HS) and heparin (Hep) are glycosaminoglycans with repeating disaccharide units that consist of alternating residues of alpha-D-glucosamine (GlcN) and uronic acid, the latter being either beta-D-glucuronic acid (GlcA) or alpha-L-iduronic acid (IdoA). In these sugar residues, sulfation modification may be performed at various positions. Structural studies show that Hep possesses a higher degree of sulfation than HS. The biosynthesis of HS/Hep occurs with the addition of the first GlcNAc residue by EXTL3 glycosyltransferase after completion of tetrasaccharide linkage region attached to serine residue of a core protein. The chain polymeraization is then catalyzed by EXT1 and EXT2 transferases. As the chain polymerizes, HS/Hep undergoes a series of modification reactions including N-deacetylation, N-sulfation, epimerization, and subsequently O-sulfation. As final products of biosynthesis, HS is present in the form of hepran sulfate proteoglycan (HSPG) whereas Hep exists as a sugar chain without a core protein. The proteoglycan families with HS, as well as CS (chondroitin sulfate), DS (dermatan sulfate), and KS (keratan sulfate), are composed of two main types depending on the subcellular locations: cell membrane and extracellular matrix [BR:ko00535]. HS/Hep has been shown to bind to a variety of molecules, such as growth factors, chemokines, morphogens, and extracellular matrix components [BR:ko00536].'
p6830
assS'path:map03018'
p6831
(dp6832
S'NAME'
p6833
(lp6834
S'RNA degradation'
p6835
asS'REFERENCE'
p6836
(lp6837
S'PMID:19239894'
p6838
ag6838
aS'AUTHORS'
p6839
aS'Houseley J, Tollervey D'
p6840
aS'TITLE'
p6841
aS'The many pathways of RNA degradation.'
p6842
aS'JOURNAL'
p6843
aS'Cell 136:763-76 (2009)'
p6844
aS'PMID:16968219'
p6845
ag6845
aS'AUTHORS'
p6846
aS'Buttner K, Wenig K, Hopfner KP'
p6847
aS'TITLE'
p6848
aS'The exosome: a macromolecular cage for controlled RNA degradation.'
p6849
aS'JOURNAL'
p6850
aS'Mol Microbiol 61:1372-9 (2006)'
p6851
aS'PMID:16939780'
p6852
ag6852
aS'AUTHORS'
p6853
aS'Schilders G, van Dijk E, Raijmakers R, Pruijn GJ'
p6854
aS'TITLE'
p6855
aS'Cell and molecular biology of the exosome: how to make or break an RNA.'
p6856
aS'JOURNAL'
p6857
aS'Int Rev Cytol 251:159-208 (2006)'
p6858
aS'PMID:17471261'
p6859
ag6859
aS'AUTHORS'
p6860
aS'Hartung S, Hopfner KP'
p6861
aS'TITLE'
p6862
aS'The exosome, plugged.'
p6863
aS'JOURNAL'
p6864
aS'EMBO Rep 8:456-7 (2007)'
p6865
aS'PMID:17447862'
p6866
ag6866
aS'AUTHORS'
p6867
aS'Carpousis AJ'
p6868
aS'TITLE'
p6869
aS'The RNA degradosome of Escherichia coli: an mRNA-degrading machine assembled on RNase E.'
p6870
aS'JOURNAL'
p6871
aS'Annu Rev Microbiol 61:71-87 (2007)'
p6872
aS'PMID:16766188'
p6873
ag6873
aS'AUTHORS'
p6874
aS'Marcaida MJ, DePristo MA, Chandran V, Carpousis AJ, Luisi BF'
p6875
aS'TITLE'
p6876
aS'The RNA degradosome: life in the fast lane of adaptive molecular evolution.'
p6877
aS'JOURNAL'
p6878
aS'Trends Biochem Sci 31:359-65 (2006)'
p6879
aS'PMID:17560162'
p6880
ag6880
aS'AUTHORS'
p6881
aS'Condon C'
p6882
aS'TITLE'
p6883
aS'Maturation and degradation of RNA in bacteria.'
p6884
aS'JOURNAL'
p6885
aS'Curr Opin Microbiol 10:271-8 (2007)'
p6886
asS'KO_PATHWAY'
p6887
(lp6888
S'ko03018'
p6889
asS'PATHWAY_MAP'
p6890
(lp6891
S'map03018'
p6892
asS'MODULE'
p6893
(lp6894
S'M00390'
p6895
aS'Exosome, archaea [PATH:map03018]'
p6896
ag6895
ag6896
aS'M00391'
p6897
aS'Exosome, eukaryotes [PATH:map03018]'
p6898
aS'M00392'
p6899
aS'Ski complex [PATH:map03018]'
p6900
aS'M00393'
p6901
aS'TRAMP complex [PATH:map03018]'
p6902
aS'M00394'
p6903
aS'RNA degradosome [PATH:map03018]'
p6904
aS'M00395'
p6905
aS'Decapping complex [PATH:map03018]'
p6906
aS'M00396'
p6907
aS'Lsm 2-8 complex [PATH:map03018]'
p6908
aS'M00397'
p6909
aS'Lsm 1-7 complex [PATH:map03018]'
p6910
asS'DBLINKS'
p6911
(lp6912
S'GO: 0006401'
p6913
asS'ENTRY'
p6914
(lp6915
S'map03018'
p6916
aS'Pathway'
p6917
asS'CLASS'
p6918
(lp6919
S'Genetic Information Processing Folding, sorting and degradation'
p6920
asS'DESCRIPTION'
p6921
(lp6922
S"The correct processing, quality control and turnover of cellular RNA molecules are critical to many aspects in the expression of genetic information. In eukaryotes, two major pathways of mRNA decay exist and both pathways are initiated by poly(A) shortening of the mRNA. In the 5' to 3' pathway, this is followed by decapping which then permits the 5' to 3' exonucleolytic degradation of transcripts. In the 3' to 5' pathway, the exosome, a large multisubunit complex, plays a key role. The exosome exists in archaeal cells, too. In bacteria, endoribonuclease E, a key enzyme involved in RNA decay and processing, organizes a protein complex called degradosome. RNase E or R interacts with the phosphate-dependent exoribonuclease polynucleotide phosphorylase, DEAD-box helicases, and additional factors in the RNA-degrading complex."
p6923
assS'path:map03460'
p6924
(dp6925
S'NAME'
p6926
(lp6927
S'Fanconi anemia pathway'
p6928
asS'REFERENCE'
p6929
(lp6930
S'PMID:18047734'
p6931
ag6931
aS'AUTHORS'
p6932
aS'Jacquemont C, Taniguchi T'
p6933
aS'TITLE'
p6934
aS'The Fanconi anemia pathway and ubiquitin.'
p6935
aS'JOURNAL'
p6936
aS'BMC Biochem 8 Suppl 1:S10 (2007)'
p6937
aS'PMID:19805513'
p6938
ag6938
aS'AUTHORS'
p6939
aS"Bhagwat N, Olsen AL, Wang AT, Hanada K, Stuckert P, Kanaar R, D'Andrea A, Niedernhofer LJ, McHugh PJ"
p6940
aS'TITLE'
p6941
aS'XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.'
p6942
aS'JOURNAL'
p6943
aS'Mol Cell Biol 29:6427-37 (2009)'
p6944
aS'PMID:21701511'
p6945
ag6945
aS'AUTHORS'
p6946
aS'Deans AJ, West SC'
p6947
aS'TITLE'
p6948
aS'DNA interstrand crosslink repair and cancer.'
p6949
aS'JOURNAL'
p6950
aS'Nat Rev Cancer 11:467-80 (2011)'
p6951
aS'PMID:20064461'
p6952
ag6952
aS'AUTHORS'
p6953
aS'Deans AJ, West SC'
p6954
aS'TITLE'
p6955
aS"FANCM connects the genome instability disorders Bloom's Syndrome and Fanconi Anemia."
p6956
aS'JOURNAL'
p6957
aS'Mol Cell 36:943-53 (2009)'
p6958
aS'PMID:20039786'
p6959
ag6959
aS'AUTHORS'
p6960
aS'Muniandy PA, Liu J, Majumdar A, Liu ST, Seidman MM'
p6961
aS'TITLE'
p6962
aS'DNA interstrand crosslink repair in mammalian cells: step by step.'
p6963
aS'JOURNAL'
p6964
aS'Crit Rev Biochem Mol Biol 45:23-49 (2010)'
p6965
aS'PMID:18518821'
p6966
ag6966
aS'AUTHORS'
p6967
aS'Ciccia A, McDonald N, West SC'
p6968
aS'TITLE'
p6969
aS'Structural and functional relationships of the XPF/MUS81 family of proteins.'
p6970
aS'JOURNAL'
p6971
aS'Annu Rev Biochem 77:259-87 (2008)'
p6972
asS'KO_PATHWAY'
p6973
(lp6974
S'ko03460'
p6975
asS'PATHWAY_MAP'
p6976
(lp6977
S'map03460'
p6978
asS'DISEASE'
p6979
(lp6980
S'H00238'
p6981
aS'Fanconi anemia'
p6982
ag6981
ag6982
aS'H00992'
p6983
aS'Seckel syndrome'
p6984
aS'H01346'
p6985
aS'Bloom syndrome'
p6986
asS'MODULE'
p6987
(lp6988
S'M00293'
p6989
aS'DNA polymerase zeta'
p6990
aS'complex [PATH:map03460]'
p6991
ag6989
ag6990
ag6991
aS'M00295'
p6992
aS'BRCA1-associated genome surveillance complex (BASC) [PATH:map03460]'
p6993
aS'M00413'
p6994
aS'FA core complex [PATH:map03460]'
p6995
aS'M00414'
p6996
aS"Bloom's syndrome complex [PATH:map03460]"
p6997
asS'DBLINKS'
p6998
(lp6999
S'GO: 0043240'
p7000
asS'ENTRY'
p7001
(lp7002
S'map03460'
p7003
aS'Pathway'
p7004
asS'CLASS'
p7005
(lp7006
S'Genetic Information Processing Replication and repair'
p7007
asS'DESCRIPTION'
p7008
(lp7009
S'The Fanconi anemia pathway is required for the efficient repair of damaged DNA, especially interstrand cross-links (ICLs). DNA ICL is directly recognized by FANCM and associated proteins, that recruit the FA core complex. The FA core complex monoubiquitinates FANCD2 and FANCI. The monoubiquitinated FANCD2/FANCI becomes an active form and interacts with a series of DNA repair proteins and facilitates downstream repair pathways. Fanconi anemia is caused by mutations in one of at least 13 FA genes and is characterized by congenital growth abnormalities, bone marrow failure and cancer predisposition.'
p7010
assS'path:map00440'
p7011
(dp7012
S'NAME'
p7013
(lp7014
S'Phosphonate and phosphinate metabolism'
p7015
asS'REFERENCE'
p7016
(lp7017
S'PMID:19489722'
p7018
ag7018
aS'AUTHORS'
p7019
aS'Metcalf WW, van der Donk WA'
p7020
aS'TITLE'
p7021
aS'Biosynthesis of phosphonic and phosphinic acid natural products.'
p7022
aS'JOURNAL'
p7023
aS'Annu Rev Biochem 78:65-94 (2009)'
p7024
aS'PMID:19053721'
p7025
ag7025
aS'AUTHORS'
p7026
aS'Xiao Y, Lee K, Liu P'
p7027
aS'TITLE'
p7028
aS'Syntheses of the P-methylase substrates of the bialaphos biosynthetic pathway.'
p7029
aS'JOURNAL'
p7030
aS'Org Lett 10:5521-4 (2008)'
p7031
aS'PMID:17168571'
p7032
ag7032
aS'AUTHORS'
p7033
aS'van der Donk WA'
p7034
aS'TITLE'
p7035
aS'Rings, radicals, and regeneration: the early years of a bioorganic laboratory.'
p7036
aS'JOURNAL'
p7037
aS'J Org Chem 71:9561-71 (2006)'
p7038
aS'PMID:15616300'
p7039
ag7039
aS'AUTHORS'
p7040
aS'Blodgett JA, Zhang JK, Metcalf WW'
p7041
aS'TITLE'
p7042
aS'Molecular cloning, sequence analysis, and heterologous expression of the phosphinothricin tripeptide biosynthetic gene cluster from Streptomyces viridochromogenes DSM 40736.'
p7043
aS'JOURNAL'
p7044
aS'Antimicrob Agents Chemother 49:230-40 (2005)'
p7045
aS'PMID:15574905'
p7046
ag7046
aS'AUTHORS'
p7047
aS'Schwartz D, Berger S, Heinzelmann E, Muschko K, Welzel K, Wohlleben W'
p7048
aS'TITLE'
p7049
aS'Biosynthetic gene cluster of the herbicide phosphinothricin tripeptide from Streptomyces viridochromogenes Tu494.'
p7050
aS'JOURNAL'
p7051
aS'Appl Environ Microbiol 70:7093-102 (2004)'
p7052
asS'KO_PATHWAY'
p7053
(lp7054
S'ko00440'
p7055
asS'PATHWAY_MAP'
p7056
(lp7057
S'map00440'
p7058
asS'DBLINKS'
p7059
(lp7060
S'GO: 0019634'
p7061
asS'ENTRY'
p7062
(lp7063
S'map00440'
p7064
aS'Pathway'
p7065
asS'CLASS'
p7066
(lp7067
S'Metabolism Metabolism of other amino acids'
p7068
asS'DESCRIPTION'
p7069
(lp7070
S'Natural products containing carbon-phosphorous bonds, so-called C-P compounds, are derivatives of phosphonate and phosphinate with substitution of alkyl group for hydrogen of phosphorus-hydrogen bonds. C-P compounds have been found in many organisms, but only protists and bacteria, mostly Actinobacteria, have biosynthetic capacity. A common reaction in the biosynthetic pathway is C-P bond forming reaction from phosphoenolpyruvate (PEP) to phosphonopyruvate (PnPy) catalyzed by PEP phosphomutase. 2-Aminoethylphosphonate (AEP) is the most abundant C-P compound in the natural world. AEP derivatives include phosphonoprotein, phosphonoglycan, and phosphonolipid. Other known C-P compounds are bioactive substances used in medicine (antibiotics) and agriculture (herbicide) such as fosfomycin, FR-33289, rhizocticin, and bialaphos.'
p7071
assS'path:map04064'
p7072
(dp7073
S'NAME'
p7074
(lp7075
S'NF-kappa B signaling pathway'
p7076
asS'REFERENCE'
p7077
(lp7078
S'PMID:21772278'
p7079
ag7079
aS'AUTHORS'
p7080
aS'Oeckinghaus A, Hayden MS, Ghosh S'
p7081
aS'TITLE'
p7082
aS'Crosstalk in NF-kappaB signaling pathways.'
p7083
aS'JOURNAL'
p7084
aS'Nat Immunol 12:695-708 (2011)'
p7085
aS'PMID:19203223'
p7086
ag7086
aS'AUTHORS'
p7087
aS'Gloire G, Piette J'
p7088
aS'TITLE'
p7089
aS'Redox regulation of nuclear post-translational modifications during NF-kappaB activation.'
p7090
aS'JOURNAL'
p7091
aS'Antioxid Redox Signal 11:2209-22 (2009)'
p7092
aS'PMID:17183360'
p7093
ag7093
aS'AUTHORS'
p7094
aS'Perkins ND'
p7095
aS'TITLE'
p7096
aS'Integrating cell-signalling pathways with NF-kappaB and IKK function.'
p7097
aS'JOURNAL'
p7098
aS'Nat Rev Mol Cell Biol 8:49-62 (2007)'
p7099
aS'PMID:16264088'
p7100
ag7100
aS'AUTHORS'
p7101
aS'Lindstrom TM, Bennett PR'
p7102
aS'TITLE'
p7103
aS'The role of nuclear factor kappa B in human labour.'
p7104
aS'JOURNAL'
p7105
aS'Reproduction 130:569-81 (2005)'
p7106
aS'PMID:22017430'
p7107
ag7107
aS'AUTHORS'
p7108
aS'Razani B, Reichardt AD, Cheng G'
p7109
aS'TITLE'
p7110
aS'Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives.'
p7111
aS'JOURNAL'
p7112
aS'Immunol Rev 244:44-54 (2011)'
p7113
aS'PMID:21173796'
p7114
ag7114
aS'AUTHORS'
p7115
aS'Sun SC'
p7116
aS'TITLE'
p7117
aS'Non-canonical NF-kappaB signaling pathway.'
p7118
aS'JOURNAL'
p7119
aS'Cell Res 21:71-85 (2011)'
p7120
aS'PMID:17431096'
p7121
ag7121
aS'AUTHORS'
p7122
aS'Neumann M, Naumann M'
p7123
aS'TITLE'
p7124
aS'Beyond IkappaBs: alternative regulation of NF-kappaB activity.'
p7125
aS'JOURNAL'
p7126
aS'FASEB J 21:2642-54 (2007)'
p7127
aS'PMID:22119011'
p7128
ag7128
aS'AUTHORS'
p7129
aS'Verhelst K, Carpentier I, Beyaert R'
p7130
aS'TITLE'
p7131
aS'Regulation of TNF-induced NF-kappaB activation by different cytoplasmic ubiquitination events.'
p7132
aS'JOURNAL'
p7133
aS'Cytokine Growth Factor Rev 22:277-86 (2011)'
p7134
aS'PMID:22017435'
p7135
ag7135
aS'AUTHORS'
p7136
aS'Rickert RC, Jellusova J, Miletic AV'
p7137
aS'TITLE'
p7138
aS'Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.'
p7139
aS'JOURNAL'
p7140
aS'Immunol Rev 244:115-33 (2011)'
p7141
aS'PMID:21232019'
p7142
ag7142
aS'AUTHORS'
p7143
aS'Naude PJ, den Boer JA, Luiten PG, Eisel UL'
p7144
aS'TITLE'
p7145
aS'Tumor necrosis factor receptor cross-talk.'
p7146
aS'JOURNAL'
p7147
aS'FEBS J 278:888-98 (2011)'
p7148
aS'PMID:16984817'
p7149
ag7149
aS'AUTHORS'
p7150
aS'Grivennikov SI, Kuprash DV, Liu ZG, Nedospasov SA'
p7151
aS'TITLE'
p7152
aS'Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms.'
p7153
aS'JOURNAL'
p7154
aS'Int Rev Cytol 252:129-61 (2006)'
p7155
aS'PMID:16356770'
p7156
ag7156
aS'AUTHORS'
p7157
aS'Wada T, Nakashima T, Hiroshi N, Penninger JM'
p7158
aS'TITLE'
p7159
aS'RANKL-RANK signaling in osteoclastogenesis and bone disease.'
p7160
aS'JOURNAL'
p7161
aS'Trends Mol Med 12:17-25 (2006)'
p7162
aS'PMID:17098202'
p7163
ag7163
aS'AUTHORS'
p7164
aS'Schulze-Luehrmann J, Ghosh S'
p7165
aS'TITLE'
p7166
aS'Antigen-receptor signaling to nuclear factor kappa B.'
p7167
aS'JOURNAL'
p7168
aS'Immunity 25:701-15 (2006)'
p7169
aS'PMID:15134788'
p7170
ag7170
aS'AUTHORS'
p7171
aS'Weil R, Israel A'
p7172
aS'TITLE'
p7173
aS'T-cell-receptor- and B-cell-receptor-mediated activation of NF-kappaB in lymphocytes.'
p7174
aS'JOURNAL'
p7175
aS'Curr Opin Immunol 16:374-81 (2004)'
p7176
aS'PMID:15905862'
p7177
ag7177
aS'AUTHORS'
p7178
aS'Siebenlist U, Brown K, Claudio E'
p7179
aS'TITLE'
p7180
aS'Control of lymphocyte development by nuclear factor-kappaB.'
p7181
aS'JOURNAL'
p7182
aS'Nat Rev Immunol 5:435-45 (2005)'
p7183
aS'PMID:14657271'
p7184
ag7184
aS'AUTHORS'
p7185
aS'Lucas PC, McAllister-Lucas LM, Nunez G'
p7186
aS'TITLE'
p7187
aS'NF-kappaB signaling in lymphocytes: a new cast of characters.'
p7188
aS'JOURNAL'
p7189
aS'J Cell Sci 117:31-9 (2004)'
p7190
aS'PMID:19726767'
p7191
ag7191
aS'AUTHORS'
p7192
aS'Khan WN'
p7193
aS'TITLE'
p7194
aS'B cell receptor and BAFF receptor signaling regulation of B cell homeostasis.'
p7195
aS'JOURNAL'
p7196
aS'J Immunol 183:3561-7 (2009)'
p7197
aS'PMID:19302050'
p7198
ag7198
aS'AUTHORS'
p7199
aS'Vallabhapurapu S, Karin M'
p7200
aS'TITLE'
p7201
aS'Regulation and function of NF-kappaB transcription factors in the immune system.'
p7202
aS'JOURNAL'
p7203
aS'Annu Rev Immunol 27:693-733 (2009)'
p7204
aS'PMID:17047224'
p7205
ag7205
aS'AUTHORS'
p7206
aS'Hacker H, Karin M'
p7207
aS'TITLE'
p7208
aS'Regulation and function of IKK and IKK-related kinases.'
p7209
aS'JOURNAL'
p7210
aS'Sci STKE 2006:re13 (2006)'
p7211
aS'PMID:21872579'
p7212
ag7212
aS'AUTHORS'
p7213
aS'Sabatel H, Pirlot C, Piette J, Habraken Y'
p7214
aS'TITLE'
p7215
aS'Importance of PIKKs in NF-kappaB activation by genotoxic stress.'
p7216
aS'JOURNAL'
p7217
aS'Biochem Pharmacol 82:1371-83 (2011)'
p7218
aS'PMID:21187855'
p7219
ag7219
aS'AUTHORS'
p7220
aS'Miyamoto S'
p7221
aS'TITLE'
p7222
aS'Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage.'
p7223
aS'JOURNAL'
p7224
aS'Cell Res 21:116-30 (2011)'
p7225
aS'PMID:18832076'
p7226
ag7226
aS'AUTHORS'
p7227
aS'Brzoska K, Szumiel I'
p7228
aS'TITLE'
p7229
aS'Signalling loops and linear pathways: NF-kappaB activation in response to genotoxic stress.'
p7230
aS'JOURNAL'
p7231
aS'Mutagenesis 24:1-8 (2009)'
p7232
aS'PMID:17607554'
p7233
ag7233
aS'AUTHORS'
p7234
aS'Wu ZH, Miyamoto S'
p7235
aS'TITLE'
p7236
aS'Many faces of NF-kappaB signaling induced by genotoxic stress.'
p7237
aS'JOURNAL'
p7238
aS'J Mol Med (Berl) 85:1187-202 (2007)'
p7239
aS'PMID:22390971'
p7240
ag7240
aS'AUTHORS'
p7241
aS'Maelfait J, Beyaert R'
p7242
aS'TITLE'
p7243
aS'Emerging role of ubiquitination in antiviral RIG-I signaling.'
p7244
aS'JOURNAL'
p7245
aS'Microbiol Mol Biol Rev 76:33-45 (2012)'
p7246
aS'PMID:18613837'
p7247
ag7247
aS'AUTHORS'
p7248
aS'Ware CF'
p7249
aS'TITLE'
p7250
aS'Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.'
p7251
aS'JOURNAL'
p7252
aS'Immunol Rev 223:186-201 (2008)'
p7253
aS'PMID:15546385'
p7254
ag7254
aS'AUTHORS'
p7255
aS'Schneider K, Potter KG, Ware CF'
p7256
aS'TITLE'
p7257
aS'Lymphotoxin and LIGHT signaling pathways and target genes.'
p7258
aS'JOURNAL'
p7259
aS'Immunol Rev 202:49-66 (2004)'
p7260
aS'PMID:22152226'
p7261
ag7261
aS'AUTHORS'
p7262
aS'Remouchamps C, Boutaffala L, Ganeff C, Dejardin E'
p7263
aS'TITLE'
p7264
aS'Biology and signal transduction pathways of the Lymphotoxin-alphabeta/LTbetaR system.'
p7265
aS'JOURNAL'
p7266
aS'Cytokine Growth Factor Rev 22:301-10 (2011)'
p7267
aS'PMID:21135871'
p7268
ag7268
aS'AUTHORS'
p7269
aS'Liu S, Chen ZJ'
p7270
aS'TITLE'
p7271
aS'Expanding role of ubiquitination in NF-kappaB signaling.'
p7272
aS'JOURNAL'
p7273
aS'Cell Res 21:6-21 (2011)'
p7274
aS'PMID:19489733'
p7275
ag7275
aS'AUTHORS'
p7276
aS'Skaug B, Jiang X, Chen ZJ'
p7277
aS'TITLE'
p7278
aS'The role of ubiquitin in NF-kappaB regulatory pathways.'
p7279
aS'JOURNAL'
p7280
aS'Annu Rev Biochem 78:769-96 (2009)'
p7281
aS'PMID:20300215'
p7282
ag7282
aS'AUTHORS'
p7283
aS'Wertz IE, Dixit VM'
p7284
aS'TITLE'
p7285
aS'Signaling to NF-kappaB: regulation by ubiquitination.'
p7286
aS'JOURNAL'
p7287
aS'Cold Spring Harb Perspect Biol 2:a003350 (2010)'
p7288
aS'PMID:11875461'
p7289
ag7289
aS'AUTHORS'
p7290
aS'Karin M, Lin A'
p7291
aS'TITLE'
p7292
aS'NF-kappaB at the crossroads of life and death.'
p7293
aS'JOURNAL'
p7294
aS'Nat Immunol 3:221-7 (2002)'
p7295
aS'PMID:12654254'
p7296
ag7296
aS'AUTHORS'
p7297
aS'Lin A, Karin M'
p7298
aS'TITLE'
p7299
aS'NF-kappaB in cancer: a marked target.'
p7300
aS'JOURNAL'
p7301
aS'Semin Cancer Biol 13:107-14 (2003)'
p7302
asS'KO_PATHWAY'
p7303
(lp7304
S'ko04064'
p7305
asS'PATHWAY_MAP'
p7306
(lp7307
S'map04064'
p7308
asS'MODULE'
p7309
(lp7310
S'M00686'
p7311
aS'Toll-like receptor signaling [PATH:map04064]'
p7312
asS'ENTRY'
p7313
(lp7314
S'map04064'
p7315
aS'Pathway'
p7316
asS'CLASS'
p7317
(lp7318
S'Environmental Information Processing Signal transduction'
p7319
asS'DESCRIPTION'
p7320
(lp7321
S'Nuclear factor-kappa B (NF-kappa B) is the generic name of a family of transcription factors that function as dimers and regulate genes involved in immunity, inflammation and cell survival. There are several pathways leading to NF-kappa B-activation. The canonical pathway is induced by tumour necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1) or byproducts of bacterial and viral infections. This pathway relies on IKK- mediated IkappaB-alpha phosphorylation on Ser32 and 36, leading to its'
p7322
assS'path:map04066'
p7323
(dp7324
S'NAME'
p7325
(lp7326
S'HIF-1 signaling pathway'
p7327
asS'REFERENCE'
p7328
(lp7329
S'PMID:20836033'
p7330
ag7330
aS'AUTHORS'
p7331
aS'Semenza GL'
p7332
aS'TITLE'
p7333
aS'Oxygen homeostasis.'
p7334
aS'JOURNAL'
p7335
aS'Wiley Interdiscip Rev Syst Biol Med 2:336-61 (2010)'
p7336
aS'PMID:17955264'
p7337
ag7337
aS'AUTHORS'
p7338
aS'Mole DR, Ratcliffe PJ'
p7339
aS'TITLE'
p7340
aS'Cellular oxygen sensing in health and disease.'
p7341
aS'JOURNAL'
p7342
aS'Pediatr Nephrol 23:681-94 (2008)'
p7343
aS'PMID:22205687'
p7344
ag7344
aS'AUTHORS'
p7345
aS'Palazon A, Aragones J, Morales-Kastresana A, de Landazuri MO, Melero I'
p7346
aS'TITLE'
p7347
aS'Molecular pathways: hypoxia response in immune cells fighting or promoting cancer.'
p7348
aS'JOURNAL'
p7349
aS'Clin Cancer Res 18:1207-13 (2012)'
p7350
aS'PMID:20965423'
p7351
ag7351
aS'AUTHORS'
p7352
aS'Majmundar AJ, Wong WJ, Simon MC'
p7353
aS'TITLE'
p7354
aS'Hypoxia-inducible factors and the response to hypoxic stress.'
p7355
aS'JOURNAL'
p7356
aS'Mol Cell 40:294-309 (2010)'
p7357
aS'PMID:22562152'
p7358
ag7358
aS'AUTHORS'
p7359
aS'Greer SN, Metcalf JL, Wang Y, Ohh M'
p7360
aS'TITLE'
p7361
aS'The updated biology of hypoxia-inducible factor.'
p7362
aS'JOURNAL'
p7363
aS'EMBO J 31:2448-60 (2012)'
p7364
aS'PMID:15448722'
p7365
ag7365
aS'AUTHORS'
p7366
aS'Zagorska A, Dulak J'
p7367
aS'TITLE'
p7368
aS'HIF-1: the knowns and unknowns of hypoxia sensing.'
p7369
aS'JOURNAL'
p7370
aS'Acta Biochim Pol 51:563-85 (2004)'
p7371
aS'PMID:19364912'
p7372
ag7372
aS'AUTHORS'
p7373
aS'Semenza GL'
p7374
aS'TITLE'
p7375
aS'Regulation of oxygen homeostasis by hypoxia-inducible factor 1.'
p7376
aS'JOURNAL'
p7377
aS'Physiology (Bethesda) 24:97-106 (2009)'
p7378
aS'PMID:16234508'
p7379
ag7379
aS'AUTHORS'
p7380
aS'Wenger RH, Stiehl DP, Camenisch G'
p7381
aS'TITLE'
p7382
aS'Integration of oxygen signaling at the consensus HRE.'
p7383
aS'JOURNAL'
p7384
aS'Sci STKE 2005:re12 (2005)'
p7385
aS'PMID:15031665'
p7386
ag7386
aS'AUTHORS'
p7387
aS'Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW'
p7388
aS'TITLE'
p7389
aS'Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.'
p7390
aS'JOURNAL'
p7391
aS'Exp Mol Med 36:1-12 (2004)'
p7392
aS'PMID:18259201'
p7393
ag7393
aS'AUTHORS'
p7394
aS'Weidemann A, Johnson RS'
p7395
aS'TITLE'
p7396
aS'Biology of HIF-1alpha.'
p7397
aS'JOURNAL'
p7398
aS'Cell Death Differ 15:621-7 (2008)'
p7399
aS'PMID:11902584'
p7400
ag7400
aS'AUTHORS'
p7401
aS'Harris AL'
p7402
aS'TITLE'
p7403
aS'Hypoxia--a key regulatory factor in tumour growth.'
p7404
aS'JOURNAL'
p7405
aS'Nat Rev Cancer 2:38-47 (2002)'
p7406
aS'PMID:19147540'
p7407
ag7407
aS'AUTHORS'
p7408
aS'Knaup KX, Jozefowski K, Schmidt R, Bernhardt WM, Weidemann A, Juergensen JS, Warnecke C, Eckardt KU, Wiesener MS'
p7409
aS'TITLE'
p7410
aS'Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability.'
p7411
aS'JOURNAL'
p7412
aS'Mol Cancer Res 7:88-98 (2009)'
p7413
aS'PMID:18505681'
p7414
ag7414
aS'AUTHORS'
p7415
aS'Kaluz S, Kaluzova M, Stanbridge EJ'
p7416
aS'TITLE'
p7417
aS'Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element.'
p7418
aS'JOURNAL'
p7419
aS'Clin Chim Acta 395:6-13 (2008)'
p7420
aS'PMID:20679415'
p7421
ag7421
aS'AUTHORS'
p7422
aS'Cadenas S, Aragones J, Landazuri MO'
p7423
aS'TITLE'
p7424
aS'Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease.'
p7425
aS'JOURNAL'
p7426
aS'Cardiovasc Res 88:219-28 (2010)'
p7427
aS'PMID:19861159'
p7428
ag7428
aS'AUTHORS'
p7429
aS'Berchner-Pfannschmidt U, Tug S, Kirsch M, Fandrey J'
p7430
aS'TITLE'
p7431
aS'Oxygen-sensing under the influence of nitric oxide.'
p7432
aS'JOURNAL'
p7433
aS'Cell Signal 22:349-56 (2010)'
p7434
asS'KO_PATHWAY'
p7435
(lp7436
S'ko04066'
p7437
asS'ENTRY'
p7438
(lp7439
S'map04066'
p7440
aS'Pathway'
p7441
asS'PATHWAY_MAP'
p7442
(lp7443
S'map04066'
p7444
asS'CLASS'
p7445
(lp7446
S'Environmental Information Processing Signal transduction'
p7447
asS'DESCRIPTION'
p7448
(lp7449
S'Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that functions as a master regulator of oxygen homeostasis. It consists of two subunits: an inducibly-expressed HIF-1alpha subunit and a constitutively-expressed HIF-1beta subunit. Under normoxia, HIF-1 alpha undergoes hydroxylation at specific prolyl residues which leads to an immediate ubiquitination and subsequent proteasomal degradation of the subunit. In contrast, under hypoxia, HIF-1 alpha subunit becomes stable and interacts with coactivators such as p300/CBP to modulate its transcriptional activity. Eventually, HIF-1 acts as a master regulator of numerous hypoxia-inducible genes under hypoxic conditions. The target genes of HIF-1 encode proteins that increase O2 delivery and mediate adaptive responses to O2 deprivation. Despite its name, HIF-1 is induced not only in response to reduced oxygen availability but also by other stimulants, such as nitric oxide, or various growth factors.'
p7450
assS'path:map07048'
p7451
(dp7452
S'ENTRY'
p7453
(lp7454
S'map07048'
p7455
aS'Drug'
p7456
aS'Pathway'
p7457
asS'PATHWAY_MAP'
p7458
(lp7459
S'map07048'
p7460
asS'NAME'
p7461
(lp7462
S'Antimigraines'
p7463
asS'REFERENCE'
p7464
(lp7465
g22
ag22
aS'AUTHORS'
p7466
aS'Societas Neurologica Japonica (ed).'
p7467
aS'TITLE'
p7468
aS'[Treatment of chronic headache guideline 2002, II Migraine.] (In Japanese)'
p7469
aS'JOURNAL'
p7470
ag22
asS'COMPOUND'
p7471
(lp7472
S'D00109'
p7473
aS'Aspirin (JP16/USP)'
p7474
ag7473
ag7474
aS'D00118'
p7475
aS'Naproxen (JP16/USP/INN)'
p7476
aS'D00126'
p7477
aS'Ibuprofen (JP16/USP/INN)'
p7478
aS'D00217'
p7479
aS'Acetaminophen (JP16/USP)'
p7480
aS'D00235'
p7481
aS'Atenolol (JP16/USP/INN)'
p7482
aS'D00270'
p7483
aS'Chlorpromazine (USP/INN)'
p7484
aS'D00304'
p7485
aS'Divalproex sodium (USP)'
p7486
aS'D00399'
p7487
aS'Valproic acid (USP)'
p7488
aS'D00415'
p7489
aS'Zolmitriptan (JAN/USAN/INN)'
p7490
aS'D00432'
p7491
aS'Nadolol (JP16/USP/INN)'
p7492
aS'D00451'
p7493
aS'Sumatriptan (JAN/USP/INN)'
p7494
aS'D00479'
p7495
aS'Prochlorperazine maleate (JP16/USP)'
p7496
aS'D00483'
p7497
aS'Propranolol hydrochloride (JP16/USP)'
p7498
aS'D00493'
p7499
aS'Prochlorperazine (JAN/USP/INN)'
p7500
aS'D00601'
p7501
aS'Metoprolol tartrate (JP16/USP)'
p7502
aS'D00619'
p7503
aS'Verapamil hydrochloride (JP16/USP)'
p7504
aS'D00635'
p7505
aS'Metoprolol succinate (USP)'
p7506
aS'D00674'
p7507
aS'Naratriptan hydrochloride (JAN/USAN)'
p7508
aS'D00675'
p7509
aS'Rizatriptan benzoate (JAN/USAN)'
p7510
aS'D00676'
p7511
aS'Sumatriptan succinate (JAN/USAN)'
p7512
aS'D00679'
p7513
aS'Ergotamine tartrate (JP16/USP)'
p7514
aS'D00681'
p7515
aS'Methysergide maleate (USP)'
p7516
aS'D00710'
p7517
aS'Sodium valproate (JP16)'
p7518
aS'D00726'
p7519
aS'Metoclopramide (JP16/INN)'
p7520
aS'D00789'
p7521
aS'Chlorpromazine hydrochloride (JP16/USP)'
p7522
aS'D00809'
p7523
aS'Amitriptyline hydrochloride (JP16/USP)'
p7524
aS'D00816'
p7525
aS'Nortriptyline hydrochloride (JP16/USP/INN)'
p7526
aS'D00970'
p7527
aS'Naproxen sodium (USP)'
p7528
aS'D01122'
p7529
aS'Ibuprofen piconol (JP16/USAN)'
p7530
aS'D01303'
p7531
aS'Flunarizine hydrochloride (JAN/USAN)'
p7532
aS'D01462'
p7533
aS'Lisuride maleate (JAN)'
p7534
aS'D01902'
p7535
aS'Dimetotiazine mesilate (JAN)'
p7536
aS'D01973'
p7537
aS'Eletriptan hydrobromide (JAN/USAN)'
p7538
aS'D02022'
p7539
aS'Prochlorperazine mesilate (JAN)'
p7540
aS'D02211'
p7541
aS'Dihydroergotamine mesilate (JP16)'
p7542
aS'D02213'
p7543
aS'Metoclopramide hydrochloride (JAN)'
p7544
aS'D02356'
p7545
aS'Verapamil (USAN/INN)'
p7546
aS'D02357'
p7547
aS'Methysergide (USAN/INN)'
p7548
aS'D02358'
p7549
aS'Metoprolol (USAN/INN)'
p7550
aS'D02609'
p7551
aS'Prochlorperazine edisylate (USP)'
p7552
aS'D02633'
p7553
aS'Lomerizine hydrochloride (JAN)'
p7554
aS'D02824'
p7555
aS'Almotriptan (USAN)'
p7556
aS'D02825'
p7557
aS'Almotriptan malate (USAN)'
p7558
aS'D03014'
p7559
aS'Avitriptan fumarate (USAN)'
p7560
aS'D04264'
p7561
aS'Frovatriptan succinate (USAN)'
p7562
aS'D04490'
p7563
aS'Ibuprofen aluminum (USAN)'
p7564
aS'D05008'
p7565
aS'Metoclopramide hydrochloride (USAN)'
p7566
aS'D05011'
p7567
aS'Metoprolol fumarate (USP)'
p7568
aS'D05181'
p7569
aS'Aspirin aluminum (JP16)'
p7570
aS'D05740'
p7571
aS'Rizatriptan sulfate (USAN)'
p7572
aS'D06606'
p7573
aS'Ibuprofen lysine (USAN)'
p7574
aS'D07296'
p7575
aS'Flumedroxone (INN)'
p7576
aS'D07448'
p7577
aS'Amitriptyline (INN)'
p7578
aS'D07579'
p7579
aS'Aspirin calcium salt'
p7580
aS'D07581'
p7581
aS'Aspirin magnesium salt'
p7582
aS'D07582'
p7583
aS'Aspirin sodium'
p7584
aS'D07837'
p7585
aS'Dihydroergotamine (INN)'
p7586
aS'D07838'
p7587
aS'Dihydroergotamine tartrate'
p7588
aS'D07854'
p7589
aS'Dimetotiazine (INN)'
p7590
aS'D07887'
p7591
aS'Eletriptan (INN)'
p7592
aS'D07906'
p7593
aS'Ergotamine (INN)'
p7594
aS'D07971'
p7595
aS'Flunarizine (INN)'
p7596
aS'D07997'
p7597
aS'Frovatriptan (INN)'
p7598
aS'D08058'
p7599
aS'Ibuprofen arginine salt'
p7600
aS'D08059'
p7601
aS'Ibuprofen sodium'
p7602
aS'D08132'
p7603
aS'Lisuride (INN)'
p7604
aS'D08255'
p7605
aS'Naratriptan (INN)'
p7606
aS'D08288'
p7607
aS'Nortriptyline (INN)'
p7608
aS'D08443'
p7609
aS'Propranolol (INN)'
p7610
aS'D08485'
p7611
aS'Rizatriptan (INN)'
p7612
assS'path:map03010'
p7613
(dp7614
S'NAME'
p7615
(lp7616
S'Ribosome'
p7617
asS'REFERENCE'
p7618
(lp7619
S'PMID:10476961'
p7620
ag7620
aS'AUTHORS'
p7621
aS'Ban N, Nissen P, Hansen J, Capel M, Moore PB, Steitz TA.'
p7622
aS'TITLE'
p7623
aS'Placement of protein and RNA structures into a 5 A-resolution map of the 50S ribosomal subunit.'
p7624
aS'JOURNAL'
p7625
aS'Nature 400:841-847 (1999)'
p7626
aS'PMID:10476960'
p7627
ag7627
aS'AUTHORS'
p7628
aS'Clemons WM Jr, May JL, Wimberly BT, McCutcheon JP, Capel MS, Ramakrishnan V.'
p7629
aS'TITLE'
p7630
aS'Structure of a bacterial 30S ribosomal subunit at 5.5 A resolution.'
p7631
aS'JOURNAL'
p7632
aS'Nature 400:833-840 (1999)'
p7633
aS'PMID:10497122'
p7634
ag7634
aS'AUTHORS'
p7635
aS'Cate JH, Yusupov MM, Yusupova GZ, Earnest TN, Noller HF.'
p7636
aS'TITLE'
p7637
aS'X-ray crystal structures of 70S ribosome functional complexes.'
p7638
aS'JOURNAL'
p7639
aS'Science 285:2095-2104 (1999)'
p7640
aS'PMID:10937989'
p7641
ag7641
aS'AUTHORS'
p7642
aS'Ban N, Nissen P, Hansen J, Moore PB, Steitz TA.'
p7643
aS'TITLE'
p7644
aS'The complete atomic structure of the large ribosomal subunit at 2.4 A resolution.'
p7645
aS'JOURNAL'
p7646
aS'Science 289:905-920 (2000)'
p7647
aS'PMID:10937990'
p7648
ag7648
aS'AUTHORS'
p7649
aS'Nissen P, Hansen J, Ban N, Moore PB, Steitz TA.'
p7650
aS'TITLE'
p7651
aS'The structural basis of ribosome activity in peptide bond synthesis.'
p7652
aS'JOURNAL'
p7653
aS'Science 289:920-930 (2000)'
p7654
aS'PMID:11014182'
p7655
ag7655
aS'AUTHORS'
p7656
aS'Wimberly BT, Brodersen DE, Clemons WM Jr, Morgan-Warren RJ, Carter AP, Vonrhein C, Hartsch T, Ramakrishnan V.'
p7657
aS'TITLE'
p7658
aS'Structure of the 30S ribosomal subunit.'
p7659
aS'JOURNAL'
p7660
aS'Nature 407:327-339 (2000)'
p7661
aS'PMID:11014183'
p7662
ag7662
aS'AUTHORS'
p7663
aS'Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V.'
p7664
aS'TITLE'
p7665
aS'Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics.'
p7666
aS'JOURNAL'
p7667
aS'Nature 407:340-348 (2000)'
p7668
asS'KO_PATHWAY'
p7669
(lp7670
S'ko03010'
p7671
asS'PATHWAY_MAP'
p7672
(lp7673
S'map03010'
p7674
asS'DISEASE'
p7675
(lp7676
S'H00237'
p7677
aS'Diamond-Blackfan anemia (DBA)'
p7678
asS'MODULE'
p7679
(lp7680
S'M00177'
p7681
aS'Ribosome, eukaryotes [PATH:map03010]'
p7682
ag7681
ag7682
aS'M00178'
p7683
aS'Ribosome, bacteria [PATH:map03010]'
p7684
aS'M00179'
p7685
aS'Ribosome, archaea [PATH:map03010]'
p7686
asS'ENTRY'
p7687
(lp7688
S'map03010'
p7689
aS'Pathway'
p7690
asS'CLASS'
p7691
(lp7692
S'Genetic Information Processing Translation'
p7693
assS'path:map00362'
p7694
(dp7695
S'NAME'
p7696
(lp7697
S'Benzoate degradation'
p7698
asS'REFERENCE'
p7699
(lp7700
S'PMID:19258534'
p7701
ag7701
aS'AUTHORS'
p7702
aS'Carmona M, Zamarro MT, Blazquez B, Durante-Rodriguez G, Juarez JF, Valderrama JA, Barragan MJ, Garcia JL, Diaz E'
p7703
aS'TITLE'
p7704
aS'Anaerobic catabolism of aromatic compounds: a genetic and genomic view.'
p7705
aS'JOURNAL'
p7706
aS'Microbiol Mol Biol Rev 73:71-133 (2009)'
p7707
aS'PMID:12486039'
p7708
ag7708
aS'AUTHORS'
p7709
aS'Hara H, Masai E, Miyauchi K, Katayama Y, Fukuda M.'
p7710
aS'TITLE'
p7711
aS'Characterization of the 4-carboxy-4-hydroxy-2-oxoadipate aldolase gene and operon structure of the protocatechuate 4,5-cleavage pathway genes in Sphingomonas paucimobilis SYK-6.'
p7712
aS'JOURNAL'
p7713
aS'J Bacteriol 185:41-50 (2003)'
p7714
aS'PMID:15277747'
p7715
ag7715
aS'AUTHORS'
p7716
aS'Maruyama K, Shibayama T, Ichikawa A, Sakou Y, Yamada S, Sugisaki H.'
p7717
aS'TITLE'
p7718
aS'Cloning and characterization of the genes encoding enzymes for the protocatechuate meta-degradation pathway of Pseudomonas ochraceae NGJ1.'
p7719
aS'JOURNAL'
p7720
aS'Biosci Biotechnol Biochem 68:1434-41 (2004)'
p7721
aS'PMID:10589735'
p7722
ag7722
aS'AUTHORS'
p7723
aS'Mampel J, Ruff J, Junker F, Cook AM.'
p7724
aS'TITLE'
p7725
aS'The oxygenase component of the 2-aminobenzenesulfonate dioxygenase system from Alcaligenes sp. strain O-1.'
p7726
aS'JOURNAL'
p7727
aS'Microbiology 145 ( Pt 11):3255-64 (1999)'
p7728
aS'PMID:8002948'
p7729
ag7729
aS'AUTHORS'
p7730
aS'Junker F, Field JA, Bangerter F, Ramsteiner K, Kohler HP, Joannou CL, Mason JR, Leisinger T, Cook AM.'
p7731
aS'TITLE'
p7732
aS'Oxygenation and spontaneous deamination of 2-aminobenzenesulphonic acid in Alcaligenes sp. strain O-1 with subsequent meta ring cleavage and spontaneous desulphonation to 2-hydroxymuconic acid.'
p7733
aS'JOURNAL'
p7734
aS'Biochem J 300 ( Pt 2):429-36 (1994)'
p7735
aS'PMID:8990279'
p7736
ag7736
aS'AUTHORS'
p7737
aS'Harwood CS, Gibson J.'
p7738
aS'TITLE'
p7739
aS'Shedding light on anaerobic benzene ring degradation: a process unique to prokaryotes?'
p7740
aS'JOURNAL'
p7741
aS'J Bacteriol 179:301-9 (1997)'
p7742
aS'PMID:17122342'
p7743
ag7743
aS'AUTHORS'
p7744
aS'Peters F, Shinoda Y, McInerney MJ, Boll M.'
p7745
aS'TITLE'
p7746
aS'Cyclohexa-1,5-diene-1-carbonyl-coenzyme A (CoA) hydratases of Geobacter metallireducens and Syntrophus aciditrophicus: Evidence for a common benzoyl-CoA degradation pathway in facultative and strict anaerobes.'
p7747
aS'JOURNAL'
p7748
aS'J Bacteriol 189:1055-60 (2007)'
p7749
aS'PMID:11053377'
p7750
ag7750
aS'AUTHORS'
p7751
aS'Cowles CE, Nichols NN, Harwood CS.'
p7752
aS'TITLE'
p7753
aS'BenR, a XylS homologue, regulates three different pathways of aromatic acid degradation in Pseudomonas putida.'
p7754
aS'JOURNAL'
p7755
aS'J Bacteriol 182:6339-46 (2000)'
p7756
aS'PMID:12514037'
p7757
ag7757
aS'AUTHORS'
p7758
aS'Smith MA, Weaver VB, Young DM, Ornston LN.'
p7759
aS'TITLE'
p7760
aS'Genes for chlorogenate and hydroxycinnamate catabolism (hca) are linked to functionally related genes in the dca-pca-qui-pob-hca chromosomal cluster of Acinetobacter sp. strain ADP1.'
p7761
aS'JOURNAL'
p7762
aS'Appl Environ Microbiol 69:524-32 (2003)'
p7763
aS'PMID:18312395'
p7764
ag7764
aS'AUTHORS'
p7765
aS'Kuntze K, Shinoda Y, Moutakki H, McInerney MJ, Vogt C, Richnow HH, Boll M'
p7766
aS'TITLE'
p7767
aS'6-Oxocyclohex-1-ene-1-carbonyl-coenzyme A hydrolases from obligately anaerobic bacteria: characterization and identification of its gene as a functional marker'
p7768
aS'for aromatic compounds degrading anaerobes.'
p7769
aS'JOURNAL'
p7770
aS'Environ Microbiol 10:1547-56 (2008)'
p7771
aS'PMID:10781543'
p7772
ag7772
aS'AUTHORS'
p7773
aS'Pelletier DA, Harwood CS'
p7774
aS'TITLE'
p7775
aS'2-Hydroxycyclohexanecarboxyl coenzyme A dehydrogenase, an enzyme characteristic of the anaerobic benzoate degradation pathway used by Rhodopseudomonas palustris.'
p7776
aS'JOURNAL'
p7777
aS'J Bacteriol 182:2753-60 (2000)'
p7778
aS'PMID:11282627'
p7779
ag7779
aS'AUTHORS'
p7780
aS'Elshahed MS, Bhupathiraju VK, Wofford NQ, Nanny MA, McInerney MJ'
p7781
aS'TITLE'
p7782
aS'Metabolism of benzoate, cyclohex-1-ene carboxylate, and cyclohexane carboxylate by "Syntrophus aciditrophicus" strain SB in syntrophic association with H(2)-using microorganisms.'
p7783
aS'JOURNAL'
p7784
aS'Appl Environ Microbiol 67:1728-38 (2001)'
p7785
aS'PMID:21219457'
p7786
ag7786
aS'AUTHORS'
p7787
aS'Nogales J, Canales A, Jimenez-Barbero J, Serra B, Pingarron JM, Garcia JL, Diaz E'
p7788
aS'TITLE'
p7789
aS'Unravelling the gallic acid degradation pathway in bacteria: the gal cluster from Pseudomonas putida.'
p7790
aS'JOURNAL'
p7791
aS'Mol Microbiol 79:359-74 (2011)'
p7792
asS'KO_PATHWAY'
p7793
(lp7794
S'ko00362'
p7795
asS'PATHWAY_MAP'
p7796
(lp7797
S'map00362'
p7798
asS'MODULE'
p7799
(lp7800
S'M00540'
p7801
aS'Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA [PATH:map00362]'
p7802
ag7801
ag7802
aS'M00541'
p7803
aS'Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA [PATH:map00362]'
p7804
aS'M00547'
p7805
aS'Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map00362]'
p7806
aS'M00548'
p7807
aS'Benzene degradation, benzene => catechol [PATH:map00362]'
p7808
aS'M00551'
p7809
aS'Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map00362]'
p7810
aS'M00568'
p7811
aS'Catechol ortho-cleavage, catechol => 3-oxoadipate [PATH:map00362]'
p7812
aS'M00569'
p7813
aS'Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map00362]'
p7814
asS'DBLINKS'
p7815
(lp7816
S'UMBBD: benz2 benz abs'
p7817
ag7817
aS'GO: 0043639'
p7818
asS'ENTRY'
p7819
(lp7820
S'map00362'
p7821
aS'Pathway'
p7822
asS'CLASS'
p7823
(lp7824
S'Metabolism Xenobiotics biodegradation and metabolism'
p7825
assS'path:map07045'
p7826
(dp7827
S'ENTRY'
p7828
(lp7829
S'map07045'
p7830
aS'Drug'
p7831
aS'Pathway'
p7832
asS'PATHWAY_MAP'
p7833
(lp7834
S'map07045'
p7835
asS'NAME'
p7836
(lp7837
S'Antineoplastics - protein kinases inhibitors'
p7838
asS'REFERENCE'
p7839
(lp7840
S'PMID:15710326'
p7841
ag7841
aS'AUTHORS'
p7842
aS'Weisberg E, Manley PW, Breitenstein W, Bruggen J, Cowan-Jacob SW, Ray A, Huntly B, Fabbro D, Fendrich G, Hall-Meyers E, Kung AL, Mestan J, Daley GQ, Callahan L, Catley L, Cavazza C, Azam M, Neuberg D, Wright RD, Gilliland DG, Griffin JD.'
p7843
aS'TITLE'
p7844
aS'Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.'
p7845
aS'JOURNAL'
p7846
aS'Cancer Cell 7:129-41 (2005)'
p7847
aS'PMID:17327610'
p7848
ag7848
aS'AUTHORS'
p7849
aS'Chow LQ, Eckhardt SG.'
p7850
aS'TITLE'
p7851
aS'Sunitinib: from rational design to clinical efficacy.'
p7852
aS'JOURNAL'
p7853
aS'J Clin Oncol 25:884-96 (2007)'
p7854
aS'PMID:17956080'
p7855
ag7855
aS'AUTHORS'
p7856
aS'Veach DR, Namavari M, Pillarsetty N, Santos EB, Beresten-Kochetkov T, Lambek C, Punzalan BJ, Antczak C, Smith-Jones PM, Djaballah H, Clarkson B, Larson SM.'
p7857
aS'TITLE'
p7858
aS'Synthesis and Biological Evaluation of a Fluorine-18 Derivative of Dasatinib.'
p7859
aS'JOURNAL'
p7860
aS'J Med Chem : (2007)'
p7861
aS'PMID:15685537'
p7862
ag7862
aS'AUTHORS'
p7863
aS'Debiec-Rychter M, Cools J, Dumez H, Sciot R, Stul M, Mentens N, Vranckx H, Wasag B, Prenen H, Roesel J, Hagemeijer A, Van Oosterom A, Marynen P.'
p7864
aS'TITLE'
p7865
aS'Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.'
p7866
aS'JOURNAL'
p7867
aS'Gastroenterology 128:270-9 (2005)'
p7868
aS'PMID:17419150'
p7869
ag7869
aS'AUTHORS'
p7870
aS'von Mehren M.'
p7871
aS'TITLE'
p7872
aS'Beyond imatinib: second generation c-KIT inhibitors for the management of gastrointestinal stromal tumors.'
p7873
aS'JOURNAL'
p7874
aS'Clin Colorectal Cancer 6 Suppl 1:S30-4 (2006)'
p7875
aS'PMID:17699867'
p7876
ag7876
aS'AUTHORS'
p7877
aS"Guo T, Agaram NP, Wong GC, Hom G, D'Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR"
p7878
aS'TITLE'
p7879
aS'Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.'
p7880
aS'JOURNAL'
p7881
aS'Clin Cancer Res 13:4874-81 (2007)'
p7882
asS'COMPOUND'
p7883
(lp7884
S'D01441'
p7885
aS'Imatinib mesilate (JAN)'
p7886
ag7885
ag7886
aS'D01977'
p7887
aS'Gefitinib (JAN/USAN/INN)'
p7888
aS'D02714'
p7889
aS'Everolimus (JAN/USAN/INN)'
p7890
aS'D03218'
p7891
aS'Axitinib (JAN/USAN)'
p7892
aS'D03252'
p7893
aS'Bosutinib (USAN)'
p7894
aS'D03257'
p7895
aS'Trastuzumab (genetical recombination) (JAN)'
p7896
aS'D03350'
p7897
aS'Canertinib dihydrochloride (USAN)'
p7898
aS'D03455'
p7899
aS'Cetuximab (genetical recombination) (JAN)'
p7900
aS'D03658'
p7901
aS'Dasatinib (INN)'
p7902
aS'D04014'
p7903
aS'Enzastaurin hydrochloride (JAN/USAN)'
p7904
aS'D04023'
p7905
aS'Erlotinib hydrochloride (JAN/USAN)'
p7906
aS'D04024'
p7907
aS'Lapatinib tosilate hydrate (JAN)'
p7908
aS'D04696'
p7909
aS'Lestaurtinib (USAN/INN)'
p7910
aS'D05029'
p7911
aS'Midostaurin (USAN/INN)'
p7912
aS'D05350'
p7913
aS'Panitumumab (genetical recombination) (JAN)'
p7914
aS'D05380'
p7915
aS'Pazopanib hydrochloride (JAN/USAN)'
p7916
aS'D05446'
p7917
aS'Pertuzumab (genetical recombination) (JAN)'
p7918
aS'D05819'
p7919
aS'Semaxanib (USAN/INN)'
p7920
aS'D06005'
p7921
aS'Tandutinib (USAN/INN)'
p7922
aS'D06068'
p7923
aS'Temsirolimus (JAN/USAN/INN)'
p7924
aS'D06272'
p7925
aS'Sorafenib tosilate (JAN)'
p7926
aS'D06285'
p7927
aS'Vatalanib (USAN/INN)'
p7928
aS'D06402'
p7929
aS'Sunitinib malate (JAN/USAN)'
p7930
aS'D06407'
p7931
aS'Vandetanib (JAN/USAN/INN)'
p7932
aS'D06413'
p7933
aS'Nilotinib hydrochloride hydrate (JAN)'
p7934
aS'D06414'
p7935
aS'Dasatinib hydrate (JAN)'
p7936
aS'D06678'
p7937
aS'Motesanib'
p7938
aS'D07907'
p7939
aS'Erlotinib (INN)'
p7940
aS'D08066'
p7941
aS'Imatinib (INN)'
p7942
aS'D08108'
p7943
aS'Lapatinib (INN)'
p7944
aS'D08524'
p7945
aS'Sorafenib (USAN/INN)'
p7946
aS'D08552'
p7947
aS'Sunitinib (INN)'
p7948
aS'D08947'
p7949
aS'Motesanib phosphate (JAN)'
p7950
aS'D08953'
p7951
aS'Nilotinib (USAN/INN)'
p7952
aS'D09724'
p7953
aS'Afatinib (USAN/INN)'
p7954
aS'D09728'
p7955
aS'Bosutinib hydrate (JAN)'
p7956
aS'D09731'
p7957
aS'Crizotinib (JAN/USAN/INN)'
p7958
aS'D09733'
p7959
aS'Afatinib maleate (JAN)'
p7960
aS'D09955'
p7961
aS'Quizartinib (USAN/INN)'
p7962
aS'D09956'
p7963
aS'Quizartinib dihydrochloride (USAN)'
p7964
aS'D09959'
p7965
aS'Ruxolitinib (USAN/INN)'
p7966
aS'D09960'
p7967
aS'Ruxolitinib phosphate (JAN/USAN)'
p7968
aS'D09980'
p7969
aS'Trastuzumab emtansine (genetical recombination) (JAN)'
p7970
aS'D10202'
p7971
aS'Bafetinib (USAN)'
p7972
assS'path:map03013'
p7973
(dp7974
S'NAME'
p7975
(lp7976
S'RNA transport'
p7977
asS'REFERENCE'
p7978
(lp7979
S'PMID:15519698'
p7980
ag7980
aS'AUTHORS'
p7981
aS'Rodriguez MS, Dargemont C, Stutz F'
p7982
aS'TITLE'
p7983
aS'Nuclear export of RNA.'
p7984
aS'JOURNAL'
p7985
aS'Biol Cell 96:639-55 (2004)'
p7986
aS'PMID:20733056'
p7987
ag7987
aS'AUTHORS'
p7988
aS'Suzuki T, Izumi H, Ohno M'
p7989
aS'TITLE'
p7990
aS'Cajal body surveillance of U snRNA export complex assembly.'
p7991
aS'JOURNAL'
p7992
aS'J Cell Biol 190:603-12 (2010)'
p7993
aS'PMID:18313922'
p7994
ag7994
aS'AUTHORS'
p7995
aS'Palancade B, Doye V'
p7996
aS'TITLE'
p7997
aS'Sumoylating and desumoylating enzymes at nuclear pores: underpinning their unexpected duties?'
p7998
aS'JOURNAL'
p7999
aS'Trends Cell Biol 18:174-83 (2008)'
p8000
aS'PMID:17401408'
p8001
ag8001
aS'AUTHORS'
p8002
aS'Pellizzoni L'
p8003
aS'TITLE'
p8004
aS'Chaperoning ribonucleoprotein biogenesis in health and disease.'
p8005
aS'JOURNAL'
p8006
aS'EMBO Rep 8:340-5 (2007)'
p8007
aS'PMID:10872469'
p8008
ag8008
aS'AUTHORS'
p8009
aS'Gingras AC, Raught B, Sonenberg N'
p8010
aS'TITLE'
p8011
aS'eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.'
p8012
aS'JOURNAL'
p8013
aS'Annu Rev Biochem 68:913-63 (1999)'
p8014
aS'PMID:11018020'
p8015
ag8015
aS'AUTHORS'
p8016
aS'Asano K, Clayton J, Shalev A, Hinnebusch AG'
p8017
aS'TITLE'
p8018
aS'A multifactor complex of eukaryotic initiation factors, eIF1, eIF2, eIF3, eIF5, and initiator tRNA(Met) is an important translation initiation intermediate in vivo.'
p8019
aS'JOURNAL'
p8020
aS'Genes Dev 14:2534-46 (2000)'
p8021
aS'PMID:9548260'
p8022
ag8022
aS'AUTHORS'
p8023
aS'Craig AW, Haghighat A, Yu AT, Sonenberg N'
p8024
aS'TITLE'
p8025
aS'Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation.'
p8026
aS'JOURNAL'
p8027
aS'Nature 392:520-3 (1998)'
p8028
aS'PMID:15901496'
p8029
ag8029
aS'AUTHORS'
p8030
aS'Reed R, Cheng H'
p8031
aS'TITLE'
p8032
aS'TREX, SR proteins and export of mRNA.'
p8033
aS'JOURNAL'
p8034
aS'Curr Opin Cell Biol 17:269-73 (2005)'
p8035
aS'PMID:16314458'
p8036
ag8036
aS'AUTHORS'
p8037
aS'Tange TO, Shibuya T, Jurica MS, Moore MJ'
p8038
aS'TITLE'
p8039
aS'Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core.'
p8040
aS'JOURNAL'
p8041
aS'RNA 11:1869-83 (2005)'
p8042
asS'KO_PATHWAY'
p8043
(lp8044
S'ko03013'
p8045
asS'PATHWAY_MAP'
p8046
(lp8047
S'map03013'
p8048
asS'DISEASE'
p8049
(lp8050
S'H00455'
p8051
aS'Spinal muscular atrophy (SMA)'
p8052
ag8051
ag8052
aS'H00465'
p8053
aS'Fragile X Syndrome'
p8054
aS'H00869'
p8055
aS'Leukoencephalopathy with vanishing white matter'
p8056
aS'H01177'
p8057
aS'Infantile bilateral striatal necrosis (IBSN)'
p8058
asS'MODULE'
p8059
(lp8060
S'M00399'
p8061
aS'Cap binding complex [PATH:map03013]'
p8062
ag8061
ag8062
aS'M00405'
p8063
aS'THC complex [PATH:map03013]'
p8064
aS'M00406'
p8065
aS'TREX complex [PATH:map03013]'
p8066
aS'M00426'
p8067
aS'Survival motor neuron (SMN) complex [PATH:map03013]'
p8068
aS'M00427'
p8069
aS'Nuclear pore complex [PATH:map03013]'
p8070
aS'M00428'
p8071
aS'eIF4F complex [PATH:map03013]'
p8072
aS'M00430'
p8073
aS'Exon junction complex (EJC) [PATH:map03013]'
p8074
asS'DBLINKS'
p8075
(lp8076
S'GO: 0050658'
p8077
asS'ENTRY'
p8078
(lp8079
S'map03013'
p8080
aS'Pathway'
p8081
asS'CLASS'
p8082
(lp8083
S'Genetic Information Processing Translation'
p8084
asS'DESCRIPTION'
p8085
(lp8086
S'RNA transport from the nucleus to the cytoplasm is'
p8087
assS'path:map07043'
p8088
(dp8089
S'ENTRY'
p8090
(lp8091
S'map07043'
p8092
aS'Drug'
p8093
aS'Pathway'
p8094
asS'PATHWAY_MAP'
p8095
(lp8096
S'map07043'
p8097
asS'NAME'
p8098
(lp8099
S'Antineoplastics - hormones'
p8100
asS'REFERENCE'
p8101
(lp8102
g22
ag22
aS'AUTHORS'
p8103
aS'Katori S.'
p8104
aS'TITLE'
p8105
aS'[Standard Pharmacology (6th ed)] (In Japanese)'
p8106
aS'JOURNAL'
p8107
aS'Igaku shoin'
p8108
ag22
ag22
aS'AUTHORS'
p8109
aS'Fukai S.'
p8110
aS'TITLE'
p8111
aS'[New Drugs Today (6th ed)] (In Japanese)'
p8112
aS'JOURNAL'
p8113
aS'Jiho (1995)'
p8114
ag22
ag22
aS'AUTHORS'
p8115
aS'David AW, Thomas LL, William OF.'
p8116
aS'TITLE'
p8117
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p8118
aS'JOURNAL'
p8119
aS'Lippincott Williams & Wilkins (2002)'
p8120
ag22
ag22
aS'AUTHORS'
p8121
aS'Walter S.'
p8122
aS'TITLE'
p8123
aS'Drug Discovery: A History'
p8124
aS'JOURNAL'
p8125
aS'Wiley (2005)'
p8126
ag22
ag22
aS'AUTHORS'
p8127
aS'Noguchi S, Hibino S (eds).'
p8128
aS'TITLE'
p8129
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p8130
aS'JOURNAL'
p8131
aS'Hirokawa (2002)'
p8132
ag22
ag22
aS'AUTHORS'
p8133
aS'Tanaka C, Kato R (eds).'
p8134
aS'TITLE'
p8135
aS'[New Pharmacology (4th ed)] (In Japanese)'
p8136
aS'JOURNAL'
p8137
aS'Nankodo (2002)'
p8138
ag22
ag22
aS'AUTHORS'
p8139
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p8140
aS'TITLE'
p8141
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p8142
aS'JOURNAL'
p8143
aS'McGraw-Hill (2001)'
p8144
aS'PMID:17504144'
p8145
ag8145
aS'AUTHORS'
p8146
aS'Musa MA, Khan MO, Cooperwood JS.'
p8147
aS'TITLE'
p8148
aS'Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).'
p8149
aS'JOURNAL'
p8150
aS'Curr Med Chem 14:1249-61 (2007)'
p8151
aS'PMID:12404296'
p8152
ag8152
aS'AUTHORS'
p8153
aS'Buzdar AU, Robertson JF, Eiermann W, Nabholtz JM.'
p8154
aS'TITLE'
p8155
aS'An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.'
p8156
aS'JOURNAL'
p8157
aS'Cancer 95:2006-16 (2002)'
p8158
asS'COMPOUND'
p8159
(lp8160
S'D00292'
p8161
aS'Dexamethasone (JP16/USP/INN)'
p8162
ag8161
ag8162
aS'D00327'
p8163
aS'Fluoxymesterone (JP16/USP/INN)'
p8164
aS'D00472'
p8165
aS'Prednisolone (JP16/USP/INN)'
p8166
aS'D00473'
p8167
aS'Prednisone (USP)'
p8168
aS'D00573'
p8169
aS'Goserelin acetate (JAN/USP)'
p8170
aS'D00574'
p8171
aS'Aminoglutethimide (USP/INN)'
p8172
aS'D00586'
p8173
aS'Flutamide (JP16/USP/INN)'
p8174
aS'D00946'
p8175
aS'Fosfestrol (JAN/INN)'
p8176
aS'D00951'
p8177
aS'Medroxyprogesterone acetate (JAN/USP)'
p8178
aS'D00952'
p8179
aS'Megestrol acetate (USAN)'
p8180
aS'D00960'
p8181
aS'Anastrozole (JAN/USAN/INN)'
p8182
aS'D00961'
p8183
aS'Bicalutamide (JAN/USP/INN)'
p8184
aS'D00963'
p8185
aS'Exemestane (JAN/USP/INN)'
p8186
aS'D00964'
p8187
aS'Letrozole (JAN/USP/INN)'
p8188
aS'D00965'
p8189
aS'Nilutamide (USAN/INN)'
p8190
aS'D00966'
p8191
aS'Tamoxifen citrate (JP16/USP)'
p8192
aS'D00967'
p8193
aS'Toremifene citrate (JAN/USAN)'
p8194
aS'D00989'
p8195
aS'Leuprorelin acetate (JP16)'
p8196
aS'D01010'
p8197
aS'Levothyroxine sodium hydrate (JP16)'
p8198
aS'D01011'
p8199
aS'Liothyronine sodium (JP16/USAN)'
p8200
aS'D01161'
p8201
aS'Fulvestrant (JAN/USAN/INN)'
p8202
aS'D01265'
p8203
aS'Epitiostanol (JAN/INN)'
p8204
aS'D01299'
p8205
aS'Chlormadinone acetate (JP16/USAN)'
p8206
aS'D01602'
p8207
aS'Mepitiostane (JP16/INN)'
p8208
aS'D02217'
p8209
aS'Raloxifene hydrochloride (JAN/USP)'
p8210
aS'D02398'
p8211
aS'Estramustine phosphate sodium (USAN)'
p8212
aS'D02451'
p8213
aS'Fadrozole hydrochloride (USAN)'
p8214
aS'D03778'
p8215
aS'Fadrozole hydrochloride hydrate (JAN)'
p8216
aS'D04066'
p8217
aS'Estramustine (USAN/INN)'
p8218
aS'D04405'
p8219
aS'Goserelin (USAN/INN)'
p8220
aS'D06397'
p8221
aS'Estramustine phosphate sodium hydrate (JAN)'
p8222
aS'D07940'
p8223
aS'Fadrozole (INN)'
p8224
aS'D08113'
p8225
aS'Leuprorelin (INN)'
p8226
aS'D08125'
p8227
aS'Levothyroxine (BAN)'
p8228
aS'D08128'
p8229
aS'Liothyronine (INN)'
p8230
aS'D08129'
p8231
aS'Liothyronine hydrochloride'
p8232
aS'D08465'
p8233
aS'Raloxifene (INN)'
p8234
aS'D08559'
p8235
aS'Tamoxifen (INN)'
p8236
aS'D08620'
p8237
aS'Toremifene (INN)'
p8238
assS'path:map03015'
p8239
(dp8240
S'NAME'
p8241
(lp8242
S'mRNA surveillance pathway'
p8243
asS'REFERENCE'
p8244
(lp8245
S'PMID:15040442'
p8246
ag8246
aS'AUTHORS'
p8247
aS'Maquat LE'
p8248
aS'TITLE'
p8249
aS'Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics.'
p8250
aS'JOURNAL'
p8251
aS'Nat Rev Mol Cell Biol 5:89-99 (2004)'
p8252
aS'PMID:16723977'
p8253
ag8253
aS'AUTHORS'
p8254
aS'Amrani N, Sachs MS, Jacobson A'
p8255
aS'TITLE'
p8256
aS'Early nonsense: mRNA decay solves a translational problem.'
p8257
aS'JOURNAL'
p8258
aS'Nat Rev Mol Cell Biol 7:415-25 (2006)'
p8259
aS'PMID:17183357'
p8260
ag8260
aS'AUTHORS'
p8261
aS'Eulalio A, Behm-Ansmant I, Izaurralde E'
p8262
aS'TITLE'
p8263
aS'P bodies: at the crossroads of post-transcriptional pathways.'
p8264
aS'JOURNAL'
p8265
aS'Nat Rev Mol Cell Biol 8:9-22 (2007)'
p8266
aS'PMID:18158581'
p8267
ag8267
aS'AUTHORS'
p8268
aS'Mandel CR, Bai Y, Tong L'
p8269
aS'TITLE'
p8270
aS"Protein factors in pre-mRNA 3'-end processing."
p8271
aS'JOURNAL'
p8272
aS'Cell Mol Life Sci 65:1099-122 (2008)'
p8273
aS'PMID:16715045'
p8274
ag8274
aS'AUTHORS'
p8275
aS'Clement SL, Lykke-Andersen J'
p8276
aS'TITLE'
p8277
aS'No mercy for messages that mess with the ribosome.'
p8278
aS'JOURNAL'
p8279
aS'Nat Struct Mol Biol 13:299-301 (2006)'
p8280
asS'KO_PATHWAY'
p8281
(lp8282
S'ko03015'
p8283
asS'PATHWAY_MAP'
p8284
(lp8285
S'map03015'
p8286
asS'DISEASE'
p8287
(lp8288
S'H00658'
p8289
aS'Syndromic X-linked mental retardation'
p8290
ag8289
ag8290
aS'H00704'
p8291
aS'Oculopharyngeal muscular dystrophy (OPMD)'
p8292
asS'MODULE'
p8293
(lp8294
S'M00399'
p8295
aS'Cap binding complex [PATH:map03015]'
p8296
ag8295
ag8296
aS'M00430'
p8297
aS'Exon junction complex (EJC) [PATH:map03015]'
p8298
asS'DBLINKS'
p8299
(lp8300
S'GO: 0071028'
p8301
asS'ENTRY'
p8302
(lp8303
S'map03015'
p8304
aS'Pathway'
p8305
asS'CLASS'
p8306
(lp8307
S'Genetic Information Processing Translation'
p8308
asS'DESCRIPTION'
p8309
(lp8310
S'The mRNA surveillance pathway is a quality control mechanism that detects and degrades abnormal mRNAs. These'
p8311
assS'path:map00365'
p8312
(dp8313
S'NAME'
p8314
(lp8315
S'Furfural degradation'
p8316
asS'REFERENCE'
p8317
(lp8318
S'PMID:22031465'
p8319
ag8319
aS'AUTHORS'
p8320
aS'Wierckx N, Koopman F, Ruijssenaars HJ, de Winde JH'
p8321
aS'TITLE'
p8322
aS'Microbial degradation of furanic compounds: biochemistry, genetics, and impact.'
p8323
aS'JOURNAL'
p8324
aS'Appl Microbiol Biotechnol 92:1095-105 (2011)'
p8325
aS'PMID:20194784'
p8326
ag8326
aS'AUTHORS'
p8327
aS'Koopman F, Wierckx N, de Winde JH, Ruijssenaars HJ'
p8328
aS'TITLE'
p8329
aS'Identification and characterization of the furfural and 5-(hydroxymethyl)furfural degradation pathways of Cupriavidus basilensis HMF14.'
p8330
aS'JOURNAL'
p8331
aS'Proc Natl Acad Sci U S A 107:4919-24 (2010)'
p8332
asS'KO_PATHWAY'
p8333
(lp8334
S'ko00365'
p8335
asS'ENTRY'
p8336
(lp8337
S'map00365'
p8338
aS'Pathway'
p8339
asS'PATHWAY_MAP'
p8340
(lp8341
S'map00365'
p8342
asS'CLASS'
p8343
(lp8344
S'Metabolism Xenobiotics biodegradation and metabolism'
p8345
assS'path:map00364'
p8346
(dp8347
S'DBLINKS'
p8348
(lp8349
S'UMBBD: 3fb 4fb box dcb'
p8350
asS'NAME'
p8351
(lp8352
S'Fluorobenzoate degradation'
p8353
asS'REFERENCE'
p8354
(lp8355
S'PMID:16345496'
p8356
ag8356
aS'AUTHORS'
p8357
aS'Schreiber A, Hellwig M, Dorn E, Reineke W, Knackmuss HJ.'
p8358
aS'TITLE'
p8359
aS'Critical Reactions in Fluorobenzoic Acid Degradation by Pseudomonas sp. B13.'
p8360
aS'JOURNAL'
p8361
aS'Appl Environ Microbiol 39:58-67 (1980)'
p8362
aS'PMID:12957954'
p8363
ag8363
aS'AUTHORS'
p8364
aS'Solyanikova IP, Moiseeva OV, Boeren S, Boersma MG, Kolomytseva MP, Vervoort J, Rietjens IM, Golovleva LA, van Berkel WJ.'
p8365
aS'TITLE'
p8366
aS'Conversion of 2-fluoromuconate to cis-dienelactone by purified enzymes of Rhodococcus opacus 1cp.'
p8367
aS'JOURNAL'
p8368
aS'Appl Environ Microbiol 69:5636-42 (2003)'
p8369
aS'PMID:16980423'
p8370
ag8370
aS'AUTHORS'
p8371
aS'Carvalho MF, Ferreira MI, Moreira IS, Castro PM, Janssen DB.'
p8372
aS'TITLE'
p8373
aS'Degradation of fluorobenzene by Rhizobiales strain F11 via ortho cleavage of 4-fluorocatechol and catechol.'
p8374
aS'JOURNAL'
p8375
aS'Appl Environ Microbiol 72:7413-7 (2006)'
p8376
aS'PMID:18355280'
p8377
ag8377
aS'AUTHORS'
p8378
aS'Chae JC, Song B, Zylstra GJ'
p8379
aS'TITLE'
p8380
aS'Identification of genes coding for hydrolytic dehalogenation in the metagenome derived from a denitrifying 4-chlorobenzoate degrading consortium.'
p8381
aS'JOURNAL'
p8382
aS'FEMS Microbiol Lett 281:203-9 (2008)'
p8383
ag22
ag22
aS'AUTHORS'
p8384
aS'Rosenbrock P, Munch JC, Scheunert I, Dorfler U.'
p8385
aS'TITLE'
p8386
aS'Biodegradation of the herbicide bromoxynil and its plant cell wall bound residues in an agricultural soil.'
p8387
aS'JOURNAL'
p8388
aS'Pesticide Biochemistry and Physiology 78:49-57 (2004)'
p8389
aS'PMID:1610174'
p8390
ag8390
aS'AUTHORS'
p8391
aS'Topp E, Xun LY, Orser CS.'
p8392
aS'TITLE'
p8393
aS'Biodegradation of the herbicide bromoxynil (3,5-dibromo-4-hydroxybenzonitrile) by purified pentachlorophenol hydroxylase and whole cells of Flavobacterium sp. strain ATCC 39723 is accompanied by cyanogenesis.'
p8394
aS'JOURNAL'
p8395
aS'Appl Environ Microbiol 58:502-6 (1992)'
p8396
asS'KO_PATHWAY'
p8397
(lp8398
S'ko00364'
p8399
asS'ENTRY'
p8400
(lp8401
S'map00364'
p8402
aS'Pathway'
p8403
asS'PATHWAY_MAP'
p8404
(lp8405
S'map00364'
p8406
asS'CLASS'
p8407
(lp8408
S'Metabolism Xenobiotics biodegradation and metabolism'
p8409
assS'path:map04666'
p8410
(dp8411
S'NAME'
p8412
(lp8413
S'Fc gamma R-mediated phagocytosis'
p8414
asS'REFERENCE'
p8415
(lp8416
S'PMID:12488490'
p8417
ag8417
aS'AUTHORS'
p8418
aS'Garcia-Garcia E, Rosales C'
p8419
aS'TITLE'
p8420
aS'Signal transduction during Fc receptor-mediated phagocytosis.'
p8421
aS'JOURNAL'
p8422
aS'J Leukoc Biol 72:1092-108 (2002)'
p8423
aS'PMID:11708889'
p8424
ag8424
aS'AUTHORS'
p8425
aS'Cox D, Greenberg S'
p8426
aS'TITLE'
p8427
aS'Phagocytic signaling strategies: Fc(gamma)receptor-mediated phagocytosis as a model system.'
p8428
aS'JOURNAL'
p8429
aS'Semin Immunol 13:339-45 (2001)'
p8430
aS'PMID:15466916'
p8431
ag8431
aS'AUTHORS'
p8432
aS'Swanson JA, Hoppe AD'
p8433
aS'TITLE'
p8434
aS'The coordination of signaling during Fc receptor-mediated phagocytosis.'
p8435
aS'JOURNAL'
p8436
aS'J Leukoc Biol 76:1093-103 (2004)'
p8437
aS'PMID:11244038'
p8438
ag8438
aS'AUTHORS'
p8439
aS'Ravetch JV, Bolland S'
p8440
aS'TITLE'
p8441
aS'IgG Fc receptors.'
p8442
aS'JOURNAL'
p8443
aS'Annu Rev Immunol 19:275-90 (2001)'
p8444
aS'PMID:18322649'
p8445
ag8445
aS'AUTHORS'
p8446
aS'Groves E, Dart AE, Covarelli V, Caron E'
p8447
aS'TITLE'
p8448
aS'Molecular mechanisms of phagocytic uptake in mammalian cells.'
p8449
aS'JOURNAL'
p8450
aS'Cell Mol Life Sci 65:1957-76 (2008)'
p8451
aS'PMID:10376013'
p8452
ag8452
aS'AUTHORS'
p8453
aS'Kwiatkowska K, Sobota A'
p8454
aS'TITLE'
p8455
aS'Signaling pathways in phagocytosis.'
p8456
aS'JOURNAL'
p8457
aS'Bioessays 21:422-31 (1999)'
p8458
aS'PMID:10577498'
p8459
ag8459
aS'AUTHORS'
p8460
aS'Greenberg S'
p8461
aS'TITLE'
p8462
aS'Modular components of phagocytosis.'
p8463
aS'JOURNAL'
p8464
aS'J Leukoc Biol 66:712-7 (1999)'
p8465
aS'PMID:10224668'
p8466
ag8466
aS'AUTHORS'
p8467
aS'Lennartz MR'
p8468
aS'TITLE'
p8469
aS'Phospholipases and phagocytosis: the role of phospholipid-derived second messengers in phagocytosis.'
p8470
aS'JOURNAL'
p8471
aS'Int J Biochem Cell Biol 31:415-30 (1999)'
p8472
aS'PMID:11228151'
p8473
ag8473
aS'AUTHORS'
p8474
aS'May RC, Machesky LM'
p8475
aS'TITLE'
p8476
aS'Phagocytosis and the actin cytoskeleton.'
p8477
aS'JOURNAL'
p8478
aS'J Cell Sci 114:1061-77 (2001)'
p8479
aS'PMID:17050193'
p8480
ag8480
aS'AUTHORS'
p8481
aS'Joshi T, Butchar JP, Tridandapani S'
p8482
aS'TITLE'
p8483
aS'Fcgamma receptor signaling in phagocytes.'
p8484
aS'JOURNAL'
p8485
aS'Int J Hematol 84:210-6 (2006)'
p8486
aS'PMID:17308335'
p8487
ag8487
aS'AUTHORS'
p8488
aS'Lee WL, Cosio G, Ireton K, Grinstein S'
p8489
aS'TITLE'
p8490
aS'Role of CrkII in Fcgamma receptor-mediated phagocytosis.'
p8491
aS'JOURNAL'
p8492
aS'J Biol Chem 282:11135-43 (2007)'
p8493
aS'PMID:11304556'
p8494
ag8494
aS'AUTHORS'
p8495
aS'Uchida H, Kondo A, Yoshimura Y, Mazaki Y, Sabe H'
p8496
aS'TITLE'
p8497
aS'PAG3/Papalpha/KIAA0400, a GTPase-activating protein for ADP-ribosylation factor (ARF), regulates ARF6 in Fcgamma receptor-mediated phagocytosis of macrophages.'
p8498
aS'JOURNAL'
p8499
aS'J Exp Med 193:955-66 (2001)'
p8500
aS'PMID:15485887'
p8501
ag8501
aS'AUTHORS'
p8502
aS'Ganesan LP, Wei G, Pengal RA, Moldovan L, Moldovan N, Ostrowski MC, Tridandapani S'
p8503
aS'TITLE'
p8504
aS'The serine/threonine kinase Akt Promotes Fc gamma receptor-mediated phagocytosis in murine macrophages through the activation of p70S6 kinase.'
p8505
aS'JOURNAL'
p8506
aS'J Biol Chem 279:54416-25 (2004)'
p8507
aS'PMID:9545263'
p8508
ag8508
aS'AUTHORS'
p8509
aS'Melendez A, Floto RA, Gillooly DJ, Harnett MM, Allen JM'
p8510
aS'TITLE'
p8511
aS'FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking.'
p8512
aS'JOURNAL'
p8513
aS'J Biol Chem 273:9393-402 (1998)'
p8514
aS'PMID:12821647'
p8515
ag8515
aS'AUTHORS'
p8516
aS'Gu H, Botelho RJ, Yu M, Grinstein S, Neel BG'
p8517
aS'TITLE'
p8518
aS'Critical role for scaffolding adapter Gab2 in Fc gamma R-mediated phagocytosis.'
p8519
aS'JOURNAL'
p8520
aS'J Cell Biol 161:1151-61 (2003)'
p8521
aS'PMID:9417101'
p8522
ag8522
aS'AUTHORS'
p8523
aS'Dana R, Leto TL, Malech HL, Levy R'
p8524
aS'TITLE'
p8525
aS'Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase.'
p8526
aS'JOURNAL'
p8527
aS'J Biol Chem 273:441-5 (1998)'
p8528
aS'PMID:10601359'
p8529
ag8529
aS'AUTHORS'
p8530
aS'Gold ES, Underhill DM, Morrissette NS, Guo J, McNiven MA, Aderem A'
p8531
aS'TITLE'
p8532
aS'Dynamin 2 is required for phagocytosis in macrophages.'
p8533
aS'JOURNAL'
p8534
aS'J Exp Med 190:1849-56 (1999)'
p8535
aS'PMID:10755615'
p8536
ag8536
aS'AUTHORS'
p8537
aS'Gold ES, Morrissette NS, Underhill DM, Guo J, Bassetti M, Aderem A'
p8538
aS'TITLE'
p8539
aS'Amphiphysin IIm, a novel amphiphysin II isoform, is required for macrophage phagocytosis.'
p8540
aS'JOURNAL'
p8541
aS'Immunity 12:285-92 (2000)'
p8542
aS'PMID:10586078'
p8543
ag8543
aS'AUTHORS'
p8544
aS'Raeder EM, Mansfield PJ, Hinkovska-Galcheva V, Shayman JA, Boxer LA'
p8545
aS'TITLE'
p8546
aS'Syk activation initiates downstream signaling events during human polymorphonuclear leukocyte phagocytosis.'
p8547
aS'JOURNAL'
p8548
aS'J Immunol 163:6785-93 (1999)'
p8549
aS'PMID:9581795'
p8550
ag8550
aS'AUTHORS'
p8551
aS'Sanchez-Mejorada G, Rosales C'
p8552
aS'TITLE'
p8553
aS'Signal transduction by immunoglobulin Fc receptors.'
p8554
aS'JOURNAL'
p8555
aS'J Leukoc Biol 63:521-33 (1998)'
p8556
ag22
ag22
aS'AUTHORS'
p8557
aS'Rosales C (ed).'
p8558
aS'TITLE'
p8559
aS'Molecular Mechanisms of Phagocytosis'
p8560
aS'JOURNAL'
p8561
aS'Springer (2005)'
p8562
asS'KO_PATHWAY'
p8563
(lp8564
S'ko04666'
p8565
asS'PATHWAY_MAP'
p8566
(lp8567
S'map04666'
p8568
asS'DISEASE'
p8569
(lp8570
S'H00098'
p8571
aS'Chronic granulomatous disease'
p8572
ag8571
ag8572
aS'H00698'
p8573
aS'Nemaline myopathy'
p8574
aS'H00833'
p8575
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p8576
aS'H01240'
p8577
aS'Immune thrombocytopenia (ITP)'
p8578
aS'H01387'
p8579
aS'Activated PI3K-delta syndrome (APDS)'
p8580
asS'DBLINKS'
p8581
(lp8582
S'GO: 0006909'
p8583
asS'ENTRY'
p8584
(lp8585
S'map04666'
p8586
aS'Pathway'
p8587
asS'CLASS'
p8588
(lp8589
S'Organismal Systems Immune system'
p8590
asS'DESCRIPTION'
p8591
(lp8592
S'Phagocytosis plays an essential role in host-defense mechanisms through the uptake and destruction of infectious pathogens. Specialized cell types including macrophages, neutrophils, and monocytes take part in this process in higher organisms. After opsonization with antibodies (IgG), foreign extracellular materials are recognized by Fc gamma receptors. Cross-linking of Fc gamma receptors initiates a variety of signals mediated by tyrosine phosphorylation of multiple proteins, which lead through the actin cytoskeleton rearrangements and membrane remodeling to the formation of phagosomes. Nascent phagosomes undergo a process of maturation that involves fusion with lysosomes. The acquisition of lysosomal proteases and release of reactive oxygen species are crucial for digestion of engulfed materials in phagosomes.'
p8593
assS'path:map04664'
p8594
(dp8595
S'NAME'
p8596
(lp8597
S'Fc epsilon RI signaling pathway'
p8598
asS'REFERENCE'
p8599
(lp8600
S'PMID:12360215'
p8601
ag8601
aS'AUTHORS'
p8602
aS'Kawakami T, Galli SJ.'
p8603
aS'TITLE'
p8604
aS'Regulation of mast-cell and basophil function and survival by IgE.'
p8605
aS'JOURNAL'
p8606
aS'Nat Rev Immunol 2:773-86 (2002)'
p8607
aS'PMID:14630197'
p8608
ag8608
aS'AUTHORS'
p8609
aS'Siraganian RP.'
p8610
aS'TITLE'
p8611
aS'Mast cell signal transduction from the high-affinity IgE receptor.'
p8612
aS'JOURNAL'
p8613
aS'Curr Opin Immunol 15:639-46 (2003)'
p8614
ag22
ag22
aS'AUTHORS'
p8615
aS'Janeway CA, Travers P, Walport M, Shlomchik MJ.'
p8616
aS'TITLE'
p8617
aS'Immunobiology 6th edition'
p8618
aS'JOURNAL'
p8619
aS'Garland Science Publishing (2005)'
p8620
aS'PMID:10586892'
p8621
ag8621
aS'AUTHORS'
p8622
aS'Turner H, Kinet JP.'
p8623
aS'TITLE'
p8624
aS'Signalling through the high-affinity IgE receptor Fc epsilonRI.'
p8625
aS'JOURNAL'
p8626
aS'Nature 402:B24-30 (1999)'
p8627
aS'PMID:16470226'
p8628
ag8628
aS'AUTHORS'
p8629
aS'Gilfillan AM, Tkaczyk C.'
p8630
aS'TITLE'
p8631
aS'Integrated signalling pathways for mast-cell activation.'
p8632
aS'JOURNAL'
p8633
aS'Nat Rev Immunol 6:218-30 (2006)'
p8634
aS'PMID:11079101'
p8635
ag8635
aS'AUTHORS'
p8636
aS'Nadler MJ, Matthews SA, Turner H, Kinet JP.'
p8637
aS'TITLE'
p8638
aS'Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function.'
p8639
aS'JOURNAL'
p8640
aS'Adv Immunol 76:325-55 (2000)'
p8641
aS'PMID:11449275'
p8642
ag8642
aS'AUTHORS'
p8643
aS'Gu H, Saito K, Klaman LD, Shen J, Fleming T, Wang Y, Pratt JC, Lin G, Lim B, Kinet JP, Neel BG.'
p8644
aS'TITLE'
p8645
aS'Essential role for Gab2 in the allergic response.'
p8646
aS'JOURNAL'
p8647
aS'Nature 412:186-90 (2001)'
p8648
aS'PMID:12145654'
p8649
ag8649
aS'AUTHORS'
p8650
aS'Nadler MJ, Kinet JP.'
p8651
aS'TITLE'
p8652
aS'Uncovering new complexities in mast cell signaling.'
p8653
aS'JOURNAL'
p8654
aS'Nat Immunol 3:707-8 (2002)'
p8655
asS'KO_PATHWAY'
p8656
(lp8657
S'ko04664'
p8658
asS'PATHWAY_MAP'
p8659
(lp8660
S'map04664'
p8661
asS'DISEASE'
p8662
(lp8663
S'H00833'
p8664
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p8665
ag8664
ag8665
aS'H01387'
p8666
aS'Activated PI3K-delta syndrome (APDS)'
p8667
asS'DBLINKS'
p8668
(lp8669
S'GO: 0045576'
p8670
asS'ENTRY'
p8671
(lp8672
S'map04664'
p8673
aS'Pathway'
p8674
asS'CLASS'
p8675
(lp8676
S'Organismal Systems Immune system'
p8677
asS'DESCRIPTION'
p8678
(lp8679
S'Fc epsilon RI-mediated signaling pathways in mast cells are initiated by the interaction of antigen (Ag) with IgE bound to the extracellular domain of the alpha chain of Fc epsilon RI. The activation pathways are regulated both positively and negatively by the interactions of numerous signaling molecules. Mast cells that are thus activated release preformed granules which contain biogenic amines (especially histamines) and proteoglycans (especially heparin). The activation of phospholipase A2 causes the release of membrane lipids followed by development of lipid mediators such as leukotrienes (LTC4, LTD4 and LTE4) and prostaglandins (especially PDG2). There is also secretion of cytokines, the most important of which are TNF-alpha, IL-4 and IL-5. These mediators and cytokines contribute to inflammatory responses.'
p8680
assS'path:map04662'
p8681
(dp8682
S'NAME'
p8683
(lp8684
S'B cell receptor signaling pathway'
p8685
asS'REFERENCE'
p8686
(lp8687
S'PMID:12461567'
p8688
ag8688
aS'AUTHORS'
p8689
aS'Niiro H, Clark EA.'
p8690
aS'TITLE'
p8691
aS'Regulation of B-cell fate by antigen-receptor signals.'
p8692
aS'JOURNAL'
p8693
aS'Nat Rev Immunol 2:945-56 (2002)'
p8694
aS'PMID:10358768'
p8695
ag8695
aS'AUTHORS'
p8696
aS'Kurosaki T.'
p8697
aS'TITLE'
p8698
aS'Genetic analysis of B cell antigen receptor signaling.'
p8699
aS'JOURNAL'
p8700
aS'Annu Rev Immunol 17:555-92 (1999)'
p8701
aS'PMID:15886119'
p8702
ag8702
aS'AUTHORS'
p8703
aS'Nitschke L.'
p8704
aS'TITLE'
p8705
aS'The role of CD22 and other inhibitory co-receptors in B-cell activation.'
p8706
aS'JOURNAL'
p8707
aS'Curr Opin Immunol 17:290-7 (2005)'
p8708
aS'PMID:15752555'
p8709
ag8709
aS'AUTHORS'
p8710
aS'Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM.'
p8711
aS'TITLE'
p8712
aS'Complement: central to innate immunity and bridging to adaptive responses.'
p8713
aS'JOURNAL'
p8714
aS'Immunol Lett 97:171-9 (2005)'
p8715
aS'PMID:12033741'
p8716
ag8716
aS'AUTHORS'
p8717
aS'Kurosaki T.'
p8718
aS'TITLE'
p8719
aS'Regulation of B-cell signal transduction by adaptor proteins.'
p8720
aS'JOURNAL'
p8721
aS'Nat Rev Immunol 2:354-63 (2002)'
p8722
aS'PMID:15364057'
p8723
ag8723
aS'AUTHORS'
p8724
aS'Nitschke L, Tsubata T.'
p8725
aS'TITLE'
p8726
aS'Molecular interactions regulate BCR signal inhibition by CD22 and CD72.'
p8727
aS'JOURNAL'
p8728
aS'Trends Immunol 25:543-50 (2004)'
p8729
aS'PMID:15771577'
p8730
ag8730
aS'AUTHORS'
p8731
aS'Jumaa H, Hendriks RW, Reth M.'
p8732
aS'TITLE'
p8733
aS'B cell signaling and tumorigenesis.'
p8734
aS'JOURNAL'
p8735
aS'Annu Rev Immunol 23:415-45 (2005)'
p8736
aS'PMID:15886112'
p8737
ag8737
aS'AUTHORS'
p8738
aS'Rickert RC.'
p8739
aS'TITLE'
p8740
aS'Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.'
p8741
aS'JOURNAL'
p8742
aS'Curr Opin Immunol 17:237-43 (2005)'
p8743
aS'PMID:15457440'
p8744
ag8744
aS'AUTHORS'
p8745
aS'Zouali M, Sarmay G'
p8746
aS'TITLE'
p8747
aS'B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.'
p8748
aS'JOURNAL'
p8749
aS'Arthritis Rheum 50:2730-41 (2004)'
p8750
aS'PMID:15322145'
p8751
ag8751
aS'AUTHORS'
p8752
aS'Chiles TC.'
p8753
aS'TITLE'
p8754
aS'Regulation and function of cyclin D2 in B lymphocyte subsets.'
p8755
aS'JOURNAL'
p8756
aS'J Immunol 173:2901-7 (2004)'
p8757
aS'PMID:15626471'
p8758
ag8758
aS'AUTHORS'
p8759
aS'Allam A, Marshall AJ'
p8760
aS'TITLE'
p8761
aS'Role of the adaptor proteins Bam32, TAPP1 and TAPP2 in lymphocyte activation.'
p8762
aS'JOURNAL'
p8763
aS'Immunol Lett 97:7-17 (2005)'
p8764
aS'PMID:12119152'
p8765
ag8765
aS'AUTHORS'
p8766
aS'Gold MR'
p8767
aS'TITLE'
p8768
aS'To make antibodies or not: signaling by the B-cell antigen receptor.'
p8769
aS'JOURNAL'
p8770
aS'Trends Pharmacol Sci 23:316-24 (2002)'
p8771
aS'PMID:9697839'
p8772
ag8772
aS'AUTHORS'
p8773
aS'Fu C, Turck CW, Kurosaki T, Chan AC'
p8774
aS'TITLE'
p8775
aS'BLNK: a central linker protein in B cell activation.'
p8776
aS'JOURNAL'
p8777
aS'Immunity 9:93-103 (1998)'
p8778
aS'PMID:11163197'
p8779
ag8779
aS'AUTHORS'
p8780
aS'Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T'
p8781
aS'TITLE'
p8782
aS'BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation.'
p8783
aS'JOURNAL'
p8784
aS'Immunity 13:817-27 (2000)'
p8785
aS'PMID:18086859'
p8786
ag8786
aS'AUTHORS'
p8787
aS'Shinohara H, Maeda S, Watarai H, Kurosaki T'
p8788
aS'TITLE'
p8789
aS'IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells.'
p8790
aS'JOURNAL'
p8791
aS'J Exp Med 204:3285-93 (2007)'
p8792
asS'KO_PATHWAY'
p8793
(lp8794
S'ko04662'
p8795
asS'PATHWAY_MAP'
p8796
(lp8797
S'map04662'
p8798
asS'DISEASE'
p8799
(lp8800
S'H00540'
p8801
aS'Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID)'
p8802
ag8801
ag8802
aS'H00645'
p8803
aS'Incontinentia pigmenti'
p8804
aS'H00882'
p8805
aS'Cocoon syndrome'
p8806
aS'H01387'
p8807
aS'Activated PI3K-delta syndrome (APDS)'
p8808
asS'DBLINKS'
p8809
(lp8810
S'GO: 0050853'
p8811
asS'ENTRY'
p8812
(lp8813
S'map04662'
p8814
aS'Pathway'
p8815
asS'CLASS'
p8816
(lp8817
S'Organismal Systems Immune system'
p8818
asS'DESCRIPTION'
p8819
(lp8820
S'B cells are an important component of adaptive immunity. They produce and secrete millions of different antibody molecules, each of which recognizes a different (foreign) antigen. The B cell receptor (BCR) is an integral membrane protein complex that is composed of two immunoglobulin (Ig) heavy chains, two Ig light chains and two heterodimers of Ig-alpha and Ig-beta. After BCR ligation by antigen, three main protein tyrosine kinases (PTKs) -the SRC-family kinase LYN, SYK and the TEC-family kinase BTK- are activated. Phosphatidylinositol 3-kinase (PI3K) and phospholipase C-gamma 2 (PLC-gamma 2) are important downstream effectors of BCR signalling. This signalling ultimately results in the expression of immediate early genes that further activate the expression of other genes involved in B cell proliferation, differentiation and Ig production as well as other processes.'
p8821
assS'path:map04660'
p8822
(dp8823
S'NAME'
p8824
(lp8825
S'T cell receptor signaling pathway'
p8826
asS'REFERENCE'
p8827
(lp8828
S'PMID:15122199'
p8829
ag8829
aS'AUTHORS'
p8830
aS'Chen L.'
p8831
aS'TITLE'
p8832
aS'Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.'
p8833
aS'JOURNAL'
p8834
aS'Nat Rev Immunol 4:336-47 (2004)'
p8835
aS'PMID:15928679'
p8836
ag8836
aS'AUTHORS'
p8837
aS'Macian F.'
p8838
aS'TITLE'
p8839
aS'NFAT proteins: key regulators of T-cell development and function.'
p8840
aS'JOURNAL'
p8841
aS'Nat Rev Immunol 5:472-84 (2005)'
p8842
aS'PMID:15771581'
p8843
ag8843
aS'AUTHORS'
p8844
aS'Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL.'
p8845
aS'TITLE'
p8846
aS'Tec family kinases in T lymphocyte development and function.'
p8847
aS'JOURNAL'
p8848
aS'Annu Rev Immunol 23:549-600 (2005)'
p8849
aS'PMID:15084594'
p8850
ag8850
aS'AUTHORS'
p8851
aS'Huang Y, Wange RL.'
p8852
aS'TITLE'
p8853
aS'T cell receptor signaling: beyond complex complexes.'
p8854
aS'JOURNAL'
p8855
aS'J Biol Chem 279:28827-30 (2004)'
p8856
aS'PMID:14656980'
p8857
ag8857
aS'AUTHORS'
p8858
aS'Schmitz ML, Bacher S, Dienz O.'
p8859
aS'TITLE'
p8860
aS'NF-kappaB activation pathways induced by T cell costimulation.'
p8861
aS'JOURNAL'
p8862
aS'FASEB J 17:2187-93 (2003)'
p8863
aS'PMID:11905831'
p8864
ag8864
aS'AUTHORS'
p8865
aS'Alegre ML, Frauwirth KA, Thompson CB.'
p8866
aS'TITLE'
p8867
aS'T-cell regulation by CD28 and CTLA-4.'
p8868
aS'JOURNAL'
p8869
aS'Nat Rev Immunol 1:220-8 (2001)'
p8870
aS'PMID:15286727'
p8871
ag8871
aS'AUTHORS'
p8872
aS'Horejsi V, Zhang W, Schraven B.'
p8873
aS'TITLE'
p8874
aS'Transmembrane adaptor proteins: organizers of immunoreceptor signalling.'
p8875
aS'JOURNAL'
p8876
aS'Nat Rev Immunol 4:603-16 (2004)'
p8877
aS'PMID:15343367'
p8878
ag8878
aS'AUTHORS'
p8879
aS'Baniyash M.'
p8880
aS'TITLE'
p8881
aS'TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response.'
p8882
aS'JOURNAL'
p8883
aS'Nat Rev Immunol 4:675-87 (2004)'
p8884
aS'PMID:15099566'
p8885
ag8885
aS'AUTHORS'
p8886
aS'Sechi AS, Wehland J.'
p8887
aS'TITLE'
p8888
aS'Interplay between TCR signalling and actin cytoskeleton dynamics.'
p8889
aS'JOURNAL'
p8890
aS'Trends Immunol 25:257-65 (2004)'
p8891
aS'PMID:12669022'
p8892
ag8892
aS'AUTHORS'
p8893
aS'Okkenhaug K, Vanhaesebroeck B.'
p8894
aS'TITLE'
p8895
aS'PI3K in lymphocyte development, differentiation and activation.'
p8896
aS'JOURNAL'
p8897
aS'Nat Rev Immunol 3:317-30 (2003)'
p8898
aS'PMID:15489916'
p8899
ag8899
aS'AUTHORS'
p8900
aS'Palacios EH, Weiss A.'
p8901
aS'TITLE'
p8902
aS'Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation.'
p8903
aS'JOURNAL'
p8904
aS'Oncogene 23:7990-8000 (2004)'
p8905
aS'PMID:12133805'
p8906
ag8906
aS'AUTHORS'
p8907
aS'Kane LP, Lin J, Weiss A.'
p8908
aS'TITLE'
p8909
aS"It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation."
p8910
aS'JOURNAL'
p8911
aS'Trends Immunol 23:413-20 (2002)'
p8912
aS'PMID:14647476'
p8913
ag8913
aS'AUTHORS'
p8914
aS'Acuto O, Michel F.'
p8915
aS'TITLE'
p8916
aS'CD28-mediated co-stimulation: a quantitative support for TCR signalling.'
p8917
aS'JOURNAL'
p8918
aS'Nat Rev Immunol 3:939-51 (2003)'
p8919
aS'PMID:15308211'
p8920
ag8920
aS'AUTHORS'
p8921
aS'Finkelstein LD, Schwartzberg PL.'
p8922
aS'TITLE'
p8923
aS'Tec kinases: shaping T-cell activation through actin.'
p8924
aS'JOURNAL'
p8925
aS'Trends Cell Biol 14:443-51 (2004)'
p8926
aS'PMID:15345216'
p8927
ag8927
aS'AUTHORS'
p8928
aS'Duan L, Reddi AL, Ghosh A, Dimri M, Band H.'
p8929
aS'TITLE'
p8930
aS'The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling.'
p8931
aS'JOURNAL'
p8932
aS'Immunity 21:7-17 (2004)'
p8933
aS'PMID:14617194'
p8934
ag8934
aS'AUTHORS'
p8935
aS'Schrum AG, Turka LA, Palmer E.'
p8936
aS'TITLE'
p8937
aS'Surface T-cell antigen receptor expression and availability for long-term antigenic signaling.'
p8938
aS'JOURNAL'
p8939
aS'Immunol Rev 196:7-24 (2003)'
p8940
aS'PMID:19132916'
p8941
ag8941
aS'AUTHORS'
p8942
aS'Smith-Garvin JE, Koretzky GA, Jordan MS'
p8943
aS'TITLE'
p8944
aS'T Cell Activation.'
p8945
aS'JOURNAL'
p8946
aS'Annu Rev Immunol (2009)'
p8947
aS'PMID:12195013'
p8948
ag8948
aS'AUTHORS'
p8949
aS'Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO'
p8950
aS'TITLE'
p8951
aS'Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation.'
p8952
aS'JOURNAL'
p8953
aS'Proc Natl Acad Sci U S A 99:11796-801 (2002)'
p8954
aS'PMID:19290929'
p8955
ag8955
aS'AUTHORS'
p8956
aS'Blonska M, Lin X'
p8957
aS'TITLE'
p8958
aS'CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.'
p8959
aS'JOURNAL'
p8960
aS'Immunol Rev 228:199-211 (2009)'
p8961
aS'PMID:17395537'
p8962
ag8962
aS'AUTHORS'
p8963
aS'Rebeaud F, Hailfinger S, Thome M'
p8964
aS'TITLE'
p8965
aS'Dlgh1 and Carma1 MAGUK proteins contribute to signal specificity downstream of TCR activation.'
p8966
aS'JOURNAL'
p8967
aS'Trends Immunol 28:196-200 (2007)'
p8968
aS'PMID:16799472'
p8969
ag8969
aS'AUTHORS'
p8970
aS'Ashwell JD'
p8971
aS'TITLE'
p8972
aS'The many paths to p38 mitogen-activated protein kinase activation in the immune system.'
p8973
aS'JOURNAL'
p8974
aS'Nat Rev Immunol 6:532-40 (2006)'
p8975
aS'PMID:17187070'
p8976
ag8976
aS'AUTHORS'
p8977
aS'Round JL, Humphries LA, Tomassian T, Mittelstadt P, Zhang M, Miceli MC'
p8978
aS'TITLE'
p8979
aS'Scaffold protein Dlgh1 coordinates alternative p38 kinase activation, directing T cell receptor signals toward NFAT but not NF-kappaB transcription factors.'
p8980
aS'JOURNAL'
p8981
aS'Nat Immunol 8:154-61 (2007)'
p8982
asS'KO_PATHWAY'
p8983
(lp8984
S'ko04660'
p8985
asS'PATHWAY_MAP'
p8986
(lp8987
S'map04660'
p8988
asS'DISEASE'
p8989
(lp8990
S'H00408'
p8991
aS'Type I diabetes mellitus'
p8992
ag8991
ag8992
aS'H00540'
p8993
aS'Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID)'
p8994
aS'H00645'
p8995
aS'Incontinentia pigmenti'
p8996
aS'H00882'
p8997
aS'Cocoon syndrome'
p8998
aS'H01387'
p8999
aS'Activated PI3K-delta syndrome (APDS)'
p9000
asS'DBLINKS'
p9001
(lp9002
S'GO: 0050852'
p9003
asS'ENTRY'
p9004
(lp9005
S'map04660'
p9006
aS'Pathway'
p9007
asS'CLASS'
p9008
(lp9009
S'Organismal Systems Immune system'
p9010
asS'DESCRIPTION'
p9011
(lp9012
S'Activation of T lymphocytes is a key event for an efficient response of the immune system. It requires the involvement of the T-cell receptor (TCR) as well as costimulatory molecules such as CD28. Engagement of these receptors through the interaction with a foreign antigen associated with major histocompatibility complex molecules and CD28 counter-receptors B7.1/B7.2, respectively, results in a series of signaling cascades. These cascades comprise an array of protein-tyrosine kinases, phosphatases, GTP-binding proteins and adaptor proteins that regulate generic and specialised functions, leading to T-cell proliferation, cytokine production and differentiation into effector cells.'
p9013
assS'path:map04668'
p9014
(dp9015
S'NAME'
p9016
(lp9017
S'TNF signaling pathway'
p9018
asS'REFERENCE'
p9019
(lp9020
S'PMID:23085193'
p9021
ag9021
aS'AUTHORS'
p9022
aS'Chu WM'
p9023
aS'TITLE'
p9024
aS'Tumor necrosis factor.'
p9025
aS'JOURNAL'
p9026
aS'Cancer Lett 328:222-5 (2013)'
p9027
aS'PMID:23531747'
p9028
ag9028
aS'AUTHORS'
p9029
aS'Shuh M, Bohorquez H, Loss GE Jr, Cohen AJ'
p9030
aS'TITLE'
p9031
aS'Tumor Necrosis Factor-alpha: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury.'
p9032
aS'JOURNAL'
p9033
aS'Ochsner J 13:119-30 (2013)'
p9034
aS'PMID:11897488'
p9035
ag9035
aS'AUTHORS'
p9036
aS'MacEwan DJ'
p9037
aS'TITLE'
p9038
aS'TNF receptor subtype signalling: differences and cellular consequences.'
p9039
aS'JOURNAL'
p9040
aS'Cell Signal 14:477-92 (2002)'
p9041
aS'PMID:22296764'
p9042
ag9042
aS'AUTHORS'
p9043
aS'Newton K, Dixit VM'
p9044
aS'TITLE'
p9045
aS'Signaling in innate immunity and inflammation.'
p9046
aS'JOURNAL'
p9047
aS'Cold Spring Harb Perspect Biol 4 (2012)'
p9048
aS'PMID:10581243'
p9049
ag9049
aS'AUTHORS'
p9050
aS'Pomerantz JL, Baltimore D'
p9051
aS'TITLE'
p9052
aS'NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.'
p9053
aS'JOURNAL'
p9054
aS'EMBO J 18:6694-704 (1999)'
p9055
aS'PMID:21232019'
p9056
ag9056
aS'AUTHORS'
p9057
aS'Naude PJ, den Boer JA, Luiten PG, Eisel UL'
p9058
aS'TITLE'
p9059
aS'Tumor necrosis factor receptor cross-talk.'
p9060
aS'JOURNAL'
p9061
aS'FEBS J 278:888-98 (2011)'
p9062
aS'PMID:20489699'
p9063
ag9063
aS'AUTHORS'
p9064
aS'Faustman D, Davis M'
p9065
aS'TITLE'
p9066
aS'TNF receptor 2 pathway: drug target for autoimmune diseases.'
p9067
aS'JOURNAL'
p9068
aS'Nat Rev Drug Discov 9:482-93 (2010)'
p9069
aS'PMID:14532286'
p9070
ag9070
aS'AUTHORS'
p9071
aS'Chan FK, Shisler J, Bixby JG, Felices M, Zheng L, Appel M, Orenstein J, Moss B, Lenardo MJ'
p9072
aS'TITLE'
p9073
aS'A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses.'
p9074
aS'JOURNAL'
p9075
aS'J Biol Chem 278:51613-21 (2003)'
p9076
asS'KO_PATHWAY'
p9077
(lp9078
S'ko04668'
p9079
asS'PATHWAY_MAP'
p9080
(lp9081
S'map04668'
p9082
asS'DBLINKS'
p9083
(lp9084
S'GO: 0033209'
p9085
asS'ENTRY'
p9086
(lp9087
S'map04668'
p9088
aS'Pathway'
p9089
asS'CLASS'
p9090
(lp9091
S'Environmental Information Processing Signal transduction'
p9092
asS'DESCRIPTION'
p9093
(lp9094
S'Tumor necrosis factor (TNF), as a critical cytokine, can induce a wide range of intracellular signal pathways including apoptosis and cell survival as well as inflammation and immunity. Activated TNF is assembled to a homotrimer and binds to its receptors (TNFR1, TNFR2) resulting in the trimerization of TNFR1 or TNFR2. TNFR1 is expressed by nearly all cells and is the major receptor for TNF (also called TNF-alpha). In contrast, TNFR2 is expressed in limited cells such as CD4 and CD8 T lymphocytes, endothelial cells, microglia, oligodendrocytes, neuron subtypes, cardiac myocytes, thymocytes and human mesenchymal stem cells. It is the receptor for both TNF and LTA (also called TNF-beta). Upon binding of the ligand, TNFR mediates the association of some adaptor proteins such as TRADD or TRAF2, which in turn initiate recruitment of signal transducers. TNFR1 signaling induces activation of many genes, primarily controlled by two distinct pathways, NF-kappa B pathway and the MAPK cascade, or apoptosis and necroptosis. TNFR2 signaling activates NF-kappa B pathway including PI3K-dependent NF-kappa B pathway and JNK pathway leading to survival.'
p9095
assS'path:map00960'
p9096
(dp9097
S'NAME'
p9098
(lp9099
S'Tropane, piperidine and pyridine alkaloid biosynthesis'
p9100
asS'DBLINKS'
p9101
(lp9102
S'UMBBD: caf'
p9103
aS'caf2'
p9104
asS'KO_PATHWAY'
p9105
(lp9106
S'ko00960'
p9107
asS'ENTRY'
p9108
(lp9109
S'map00960'
p9110
aS'Pathway'
p9111
asS'PATHWAY_MAP'
p9112
(lp9113
S'map00960'
p9114
asS'CLASS'
p9115
(lp9116
S'Metabolism Biosynthesis of other secondary metabolites'
p9117
assS'path:map05016'
p9118
(dp9119
S'NAME'
p9120
(lp9121
S"Huntington's disease"
p9122
asS'REFERENCE'
p9123
(lp9124
S'PMID:15459747'
p9125
ag9125
aS'AUTHORS'
p9126
aS'Landles C, Bates GP'
p9127
aS'TITLE'
p9128
aS"Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series."
p9129
aS'JOURNAL'
p9130
aS'EMBO Rep 5:958-63 (2004)'
p9131
aS'PMID:17041811'
p9132
ag9132
aS'AUTHORS'
p9133
aS'Borrell-Pages M, Zala D, Humbert S, Saudou F'
p9134
aS'TITLE'
p9135
aS"Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies."
p9136
aS'JOURNAL'
p9137
aS'Cell Mol Life Sci 63:2642-60 (2006)'
p9138
aS'PMID:18951640'
p9139
ag9139
aS'AUTHORS'
p9140
aS'Bossy-Wetzel E, Petrilli A, Knott AB'
p9141
aS'TITLE'
p9142
aS'Mutant huntingtin and mitochondrial dysfunction.'
p9143
aS'JOURNAL'
p9144
aS'Trends Neurosci 31:609-16 (2008)'
p9145
aS'PMID:16288298'
p9146
ag9146
aS'AUTHORS'
p9147
aS'Cattaneo E, Zuccato C, Tartari M'
p9148
aS'TITLE'
p9149
aS"Normal huntingtin function: an alternative approach to Huntington's disease."
p9150
aS'JOURNAL'
p9151
aS'Nat Rev Neurosci 6:919-30 (2005)'
p9152
aS'PMID:15336977'
p9153
ag9153
aS'AUTHORS'
p9154
aS'Bezprozvanny I, Hayden MR'
p9155
aS'TITLE'
p9156
aS'Deranged neuronal calcium signaling and Huntington disease.'
p9157
aS'JOURNAL'
p9158
aS'Biochem Biophys Res Commun 322:1310-7 (2004)'
p9159
aS'PMID:14526190'
p9160
ag9160
aS'AUTHORS'
p9161
aS'Sawa A, Tomoda T, Bae BI'
p9162
aS'TITLE'
p9163
aS"Mechanisms of neuronal cell death in Huntington's disease."
p9164
aS'JOURNAL'
p9165
aS'Cytogenet Genome Res 100:287-95 (2003)'
p9166
aS'PMID:12372277'
p9167
ag9167
aS'AUTHORS'
p9168
aS'Ross CA.'
p9169
aS'TITLE'
p9170
aS"Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders."
p9171
aS'JOURNAL'
p9172
aS'Neuron 35:819-22 (2002)'
p9173
aS'PMID:15242639'
p9174
ag9174
aS'AUTHORS'
p9175
aS'Ross CA'
p9176
aS'TITLE'
p9177
aS"Huntington's disease: new paths to pathogenesis."
p9178
aS'JOURNAL'
p9179
aS'Cell 118:4-7 (2004)'
p9180
aS'PMID:15695335'
p9181
ag9181
aS'AUTHORS'
p9182
aS'Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinas R, Kristal BS, Hayden MR, Bezprozvanny I'
p9183
aS'TITLE'
p9184
aS"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease."
p9185
aS'JOURNAL'
p9186
aS'Proc Natl Acad Sci U S A 102:2602-7 (2005)'
p9187
aS'PMID:11807533'
p9188
ag9188
aS'AUTHORS'
p9189
aS'Mattson MP.'
p9190
aS'TITLE'
p9191
aS'Accomplices to neuronal death.'
p9192
aS'JOURNAL'
p9193
aS'Nature 415:377-9 (2002)'
p9194
aS'PMID:17081970'
p9195
ag9195
aS'AUTHORS'
p9196
aS'McGill JK, Beal MF'
p9197
aS'TITLE'
p9198
aS"PGC-1alpha, a new therapeutic target in Huntington's disease?"
p9199
aS'JOURNAL'
p9200
aS'Cell 127:465-8 (2006)'
p9201
aS'PMID:15996541'
p9202
ag9202
aS'AUTHORS'
p9203
aS'La Spada AR, Morrison RS'
p9204
aS'TITLE'
p9205
aS"The power of the dark side: Huntington's disease protein and p53 form a deadly alliance."
p9206
aS'JOURNAL'
p9207
aS'Neuron 47:1-3 (2005)'
p9208
aS'PMID:11738471'
p9209
ag9209
aS'AUTHORS'
p9210
aS'Lesort M, Chun W, Tucholski J, Johnson GV'
p9211
aS'TITLE'
p9212
aS"Does tissue transglutaminase play a role in Huntington's disease?"
p9213
aS'JOURNAL'
p9214
aS'Neurochem Int 40:37-52 (2002)'
p9215
aS'PMID:15996546'
p9216
ag9216
aS'AUTHORS'
p9217
aS'Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, Snyder SH, Sawa A'
p9218
aS'TITLE'
p9219
aS"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease."
p9220
aS'JOURNAL'
p9221
aS'Neuron 47:29-41 (2005)'
p9222
aS'PMID:11839795'
p9223
ag9223
aS'AUTHORS'
p9224
aS'Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ'
p9225
aS'TITLE'
p9226
aS'Interaction of Huntington disease protein with transcriptional activator Sp1.'
p9227
aS'JOURNAL'
p9228
aS'Mol Cell Biol 22:1277-87 (2002)'
p9229
asS'KO_PATHWAY'
p9230
(lp9231
S'ko05016'
p9232
asS'PATHWAY_MAP'
p9233
(lp9234
S'map05016'
p9235
asS'DISEASE'
p9236
(lp9237
S'H00059'
p9238
aS"Huntington's disease (HD)"
p9239
asS'MODULE'
p9240
(lp9241
S'M00180'
p9242
aS'RNA polymerase II, eukaryotes [PATH:map05016]'
p9243
asS'ENTRY'
p9244
(lp9245
S'map05016'
p9246
aS'Pathway'
p9247
asS'CLASS'
p9248
(lp9249
S'Human Diseases Neurodegenerative diseases'
p9250
asS'DESCRIPTION'
p9251
(lp9252
S'Huntington disease (HD) is an autosomal-dominant neurodegenerative disorder that primarily affects medium spiny striatal neurons (MSN). The symptoms are choreiform, involuntary movements, personality changes and dementia. HD is caused by a CAG repeat expansion in the IT15gene, which results in a long stretch of polyglutamine close to the amino-terminus of the HD protein huntingtin (Htt). Mutant Htt (mHtt) has effects both in the cytoplasm and in the nucleus. In the cytoplasm, full-length mHtt can interfere with BDNF vesicular transport on microtubules. This mutant protein also may lead to abnormal endocytosis and secretion in neurons, because normal Htt form a complex with the proteins Hip1, clathrin and AP2 that are involved in endocytosis. In addition, mHtt affects Ca2+ signaling by sensitizing InsP3R1 to activation by InsP3, stimulating NMDAR activity, and destabilizing mitochondrial Ca2+ handling. The mHtt translocates to the nucleus, where it forms intranuclear inclusions. Nuclear toxicity is believed to be caused by interference with gene transcription, leading to loss of transcription of neuroprotective molecules such as BDNF. While mHtt binds to p53 and upregulates levels of nuclear p53 as well as p53 transcriptional activity. Augmented p53 mediates mitochondrial dysfunction.'
p9253
assS'path:map05014'
p9254
(dp9255
S'NAME'
p9256
(lp9257
S'Amyotrophic lateral sclerosis (ALS)'
p9258
asS'REFERENCE'
p9259
(lp9260
S'PMID:16924260'
p9261
ag9261
aS'AUTHORS'
p9262
aS'Pasinelli P, Brown RH'
p9263
aS'TITLE'
p9264
aS'Molecular biology of amyotrophic lateral sclerosis: insights from genetics.'
p9265
aS'JOURNAL'
p9266
aS'Nat Rev Neurosci 7:710-23 (2006)'
p9267
aS'PMID:16723044'
p9268
ag9268
aS'AUTHORS'
p9269
aS'Goodall EF, Morrison KE'
p9270
aS'TITLE'
p9271
aS'Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment.'
p9272
aS'JOURNAL'
p9273
aS'Expert Rev Mol Med 8:1-22 (2006)'
p9274
aS'PMID:17015226'
p9275
ag9275
aS'AUTHORS'
p9276
aS'Boillee S, Vande Velde C, Cleveland DW'
p9277
aS'TITLE'
p9278
aS'ALS: a disease of motor neurons and their nonneuronal neighbors.'
p9279
aS'JOURNAL'
p9280
aS'Neuron 52:39-59 (2006)'
p9281
aS'PMID:11239414'
p9282
ag9282
aS'AUTHORS'
p9283
aS'Julien JP.'
p9284
aS'TITLE'
p9285
aS'Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded.'
p9286
aS'JOURNAL'
p9287
aS'Cell 104:581-91 (2001)'
p9288
aS'PMID:16050975'
p9289
ag9289
aS'AUTHORS'
p9290
aS'Manfredi G, Xu Z'
p9291
aS'TITLE'
p9292
aS'Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.'
p9293
aS'JOURNAL'
p9294
aS'Mitochondrion 5:77-87 (2005)'
p9295
aS'PMID:11870681'
p9296
ag9296
aS'AUTHORS'
p9297
aS'Hand CK, Rouleau GA'
p9298
aS'TITLE'
p9299
aS'Familial amyotrophic lateral sclerosis.'
p9300
aS'JOURNAL'
p9301
aS'Muscle Nerve 25:135-59 (2002)'
p9302
aS'PMID:16713195'
p9303
ag9303
aS'AUTHORS'
p9304
aS'Barber SC, Mead RJ, Shaw PJ'
p9305
aS'TITLE'
p9306
aS'Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.'
p9307
aS'JOURNAL'
p9308
aS'Biochim Biophys Acta 1762:1051-67 (2006)'
p9309
aS'PMID:16026864'
p9310
ag9310
aS'AUTHORS'
p9311
aS'von Lewinski F, Keller BU'
p9312
aS'TITLE'
p9313
aS'Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS.'
p9314
aS'JOURNAL'
p9315
aS'Trends Neurosci 28:494-500 (2005)'
p9316
aS'PMID:10970056'
p9317
ag9317
aS'AUTHORS'
p9318
aS'Al-Chalabi A, Leigh PN'
p9319
aS'TITLE'
p9320
aS'Recent advances in amyotrophic lateral sclerosis.'
p9321
aS'JOURNAL'
p9322
aS'Curr Opin Neurol 13:397-405 (2000)'
p9323
aS'PMID:12531867'
p9324
ag9324
aS'AUTHORS'
p9325
aS'Guegan C, Przedborski S'
p9326
aS'TITLE'
p9327
aS'Programmed cell death in amyotrophic lateral sclerosis.'
p9328
aS'JOURNAL'
p9329
aS'J Clin Invest 111:153-61 (2003)'
p9330
aS'PMID:16909017'
p9331
ag9331
aS'AUTHORS'
p9332
aS'Bendotti C, Bao Cutrona M, Cheroni C, Grignaschi G, Lo Coco D, Peviani M, Tortarolo M, Veglianese P, Zennaro E'
p9333
aS'TITLE'
p9334
aS'Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase.'
p9335
aS'JOURNAL'
p9336
aS'Neurodegener Dis 2:128-34 (2005)'
p9337
aS'PMID:14739060'
p9338
ag9338
aS'AUTHORS'
p9339
aS'Emerit J, Edeas M, Bricaire F'
p9340
aS'TITLE'
p9341
aS'Neurodegenerative diseases and oxidative stress.'
p9342
aS'JOURNAL'
p9343
aS'Biomed Pharmacother 58:39-46 (2004)'
p9344
aS'PMID:11715057'
p9345
ag9345
aS'AUTHORS'
p9346
aS'Cleveland DW, Rothstein JD'
p9347
aS'TITLE'
p9348
aS'From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS.'
p9349
aS'JOURNAL'
p9350
aS'Nat Rev Neurosci 2:806-19 (2001)'
p9351
aS'PMID:15310460'
p9352
ag9352
aS'AUTHORS'
p9353
aS'Bendotti C, Carri MT'
p9354
aS'TITLE'
p9355
aS'Lessons from models of SOD1-linked familial ALS.'
p9356
aS'JOURNAL'
p9357
aS'Trends Mol Med 10:393-400 (2004)'
p9358
aS'PMID:12595144'
p9359
ag9359
aS'AUTHORS'
p9360
aS'Robertson J, Kriz J, Nguyen MD, Julien JP'
p9361
aS'TITLE'
p9362
aS'Pathways to motor neuron degeneration in transgenic mouse models.'
p9363
aS'JOURNAL'
p9364
aS'Biochimie 84:1151-60 (2002)'
p9365
aS'PMID:16603792'
p9366
ag9366
aS'AUTHORS'
p9367
aS'Bacman SR, Bradley WG, Moraes CT'
p9368
aS'TITLE'
p9369
aS'Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?'
p9370
aS'JOURNAL'
p9371
aS'Mol Neurobiol 33:113-31 (2006)'
p9372
aS'PMID:18519638'
p9373
ag9373
aS'AUTHORS'
p9374
aS'Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H, Noguchi T, Matsuzawa A, Takeda K, Ichijo H'
p9375
aS'TITLE'
p9376
aS'ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.'
p9377
aS'JOURNAL'
p9378
aS'Genes Dev 22:1451-64 (2008)'
p9379
aS'PMID:14569202'
p9380
ag9380
aS'AUTHORS'
p9381
aS'Simpson EP, Yen AA, Appel SH'
p9382
aS'TITLE'
p9383
aS'Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.'
p9384
aS'JOURNAL'
p9385
aS'Curr Opin Rheumatol 15:730-6 (2003)'
p9386
aS'PMID:12728264'
p9387
ag9387
aS'AUTHORS'
p9388
aS'Vila M, Przedborski S'
p9389
aS'TITLE'
p9390
aS'Targeting programmed cell death in neurodegenerative diseases.'
p9391
aS'JOURNAL'
p9392
aS'Nat Rev Neurosci 4:365-75 (2003)'
p9393
aS'PMID:11513882'
p9394
ag9394
aS'AUTHORS'
p9395
aS'Volkel H, Scholz M, Link J, Selzle M, Werner P, Tunnemann R, Jung G, Ludolph AC, Reuter A'
p9396
aS'TITLE'
p9397
aS'Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin.'
p9398
aS'JOURNAL'
p9399
aS'FEBS Lett 503:201-5 (2001)'
p9400
aS'PMID:17434459'
p9401
ag9401
aS'AUTHORS'
p9402
aS'Eve DJ, Dennis JS, Citron BA'
p9403
aS'TITLE'
p9404
aS'Transcription factor p53 in degenerating spinal cords.'
p9405
aS'JOURNAL'
p9406
aS'Brain Res 1150:174-81 (2007)'
p9407
aS'PMID:16909020'
p9408
ag9408
aS'AUTHORS'
p9409
aS'Van Damme P, Dewil M, Robberecht W, Van Den Bosch L'
p9410
aS'TITLE'
p9411
aS'Excitotoxicity and amyotrophic lateral sclerosis.'
p9412
aS'JOURNAL'
p9413
aS'Neurodegener Dis 2:147-59 (2005)'
p9414
aS'PMID:17566607'
p9415
ag9415
aS'AUTHORS'
p9416
aS'Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE'
p9417
aS'TITLE'
p9418
aS'Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.'
p9419
aS'JOURNAL'
p9420
aS'Neurochem Int 51:74-84 (2007)'
p9421
aS'PMID:17409386'
p9422
ag9422
aS'AUTHORS'
p9423
aS'Kunita R, Otomo A, Mizumura H, Suzuki-Utsunomiya K, Hadano S, Ikeda JE'
p9424
aS'TITLE'
p9425
aS'The Rab5 activator ALS2/alsin acts as a novel Rac1 effector through Rac1-activated endocytosis.'
p9426
aS'JOURNAL'
p9427
aS'J Biol Chem 282:16599-611 (2007)'
p9428
asS'KO_PATHWAY'
p9429
(lp9430
S'ko05014'
p9431
asS'PATHWAY_MAP'
p9432
(lp9433
S'map05014'
p9434
asS'DISEASE'
p9435
(lp9436
S'H00058'
p9437
aS'Amyotrophic lateral sclerosis (ALS)'
p9438
asS'ENTRY'
p9439
(lp9440
S'map05014'
p9441
aS'Pathway'
p9442
asS'CLASS'
p9443
(lp9444
S'Human Diseases Neurodegenerative diseases'
p9445
asS'DESCRIPTION'
p9446
(lp9447
S'Amyotrophic lateral sclerosis (ALS) is a progressive, lethal, degenerative disorder of motor neurons. The hallmark of this disease is the selective death of motor neurons in the brain and spinal cord, leading to paralysis of voluntary muscles. Mutant superoxide dismutase 1 (SOD1), as seen in some familial ALS (FALS) cases, is unstable, forming aggregates in the motor neuron cytoplasm, axoplasm and mitochondria. Within mitochondria, mutant SOD1 may interfere with the anti-apoptotic function of Bcl-2, affect mitochondrial import by interfering with the translocation machinery (TOM/TIM), and generate toxic free radicals (ROS). Reactive oxygen species (ROS), produced within mitochondria, inhibit the function of EAAT2, the main glial glutamate transporter protein, responsible for most of the reuptake of synaptically released glutamate. Glutamate excess increases intracellular calcium, which enhances oxidative stress and mitochondrial damage. Mutant SOD1 can also trigger oxidative reactions , which can then cause damage through the formation of hydroxyl radicals or via nitration of tyrosine residues on proteins. Nitration may target neurofilament proteins, affecting axonal transport. Collectively, these mechanisms are predicted to disturb cellular homeostasis, ultimately triggering motor neuron death.'
p9448
assS'path:map05012'
p9449
(dp9450
S'NAME'
p9451
(lp9452
S"Parkinson's disease"
p9453
asS'REFERENCE'
p9454
(lp9455
S'PMID:17911161'
p9456
ag9456
aS'AUTHORS'
p9457
aS'Thomas B, Beal MF'
p9458
aS'TITLE'
p9459
aS"Parkinson's disease."
p9460
aS'JOURNAL'
p9461
aS'Hum Mol Genet 16 Spec No. 2:R183-94 (2007)'
p9462
aS'PMID:12938733'
p9463
ag9463
aS'AUTHORS'
p9464
aS'Lim KL, Lim TM'
p9465
aS'TITLE'
p9466
aS"Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes."
p9467
aS'JOURNAL'
p9468
aS'IUBMB Life 55:315-22 (2003)'
p9469
aS'PMID:16022590'
p9470
ag9470
aS'AUTHORS'
p9471
aS'Moore DJ, West AB, Dawson VL, Dawson TM'
p9472
aS'TITLE'
p9473
aS"Molecular pathophysiology of Parkinson's disease."
p9474
aS'JOURNAL'
p9475
aS'Annu Rev Neurosci 28:57-87 (2005)'
p9476
aS'PMID:16495942'
p9477
ag9477
aS'AUTHORS'
p9478
aS'Abou-Sleiman PM, Muqit MM, Wood NW'
p9479
aS'TITLE'
p9480
aS"Expanding insights of mitochondrial dysfunction in Parkinson's disease."
p9481
aS'JOURNAL'
p9482
aS'Nat Rev Neurosci 7:207-19 (2006)'
p9483
aS'PMID:18426756'
p9484
ag9484
aS'AUTHORS'
p9485
aS'Mizuno Y, Hattori N, Kubo S, Sato S, Nishioka K, Hatano T, Tomiyama H, Funayama M, Machida Y, Mochizuki H'
p9486
aS'TITLE'
p9487
aS"Progress in the pathogenesis and genetics of Parkinson's disease."
p9488
aS'JOURNAL'
p9489
aS'Philos Trans R Soc Lond B Biol Sci 363:2215-27 (2008)'
p9490
aS'PMID:16278972'
p9491
ag9491
aS'AUTHORS'
p9492
aS'Gandhi S, Wood NW'
p9493
aS'TITLE'
p9494
aS"Molecular pathogenesis of Parkinson's disease."
p9495
aS'JOURNAL'
p9496
aS'Hum Mol Genet 14 Spec No. 2:2749-2755 (2005)'
p9497
aS'PMID:12461550'
p9498
ag9498
aS'AUTHORS'
p9499
aS'Lotharius J, Brundin P'
p9500
aS'TITLE'
p9501
aS"Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein."
p9502
aS'JOURNAL'
p9503
aS'Nat Rev Neurosci 3:932-42 (2002)'
p9504
aS'PMID:15767499'
p9505
ag9505
aS'AUTHORS'
p9506
aS'Eriksen JL, Wszolek Z, Petrucelli L'
p9507
aS'TITLE'
p9508
aS'Molecular pathogenesis of Parkinson disease.'
p9509
aS'JOURNAL'
p9510
aS'Arch Neurol 62:353-7 (2005)'
p9511
aS'PMID:15054086'
p9512
ag9512
aS'AUTHORS'
p9513
aS'Sidhu A, Wersinger C, Vernier P'
p9514
aS'TITLE'
p9515
aS'Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?'
p9516
aS'JOURNAL'
p9517
aS'FASEB J 18:637-47 (2004)'
p9518
aS'PMID:15681812'
p9519
ag9519
aS'AUTHORS'
p9520
aS'Sidhu A, Wersinger C, Moussa CE, Vernier P'
p9521
aS'TITLE'
p9522
aS'The role of alpha-synuclein in both neuroprotection and neurodegeneration.'
p9523
aS'JOURNAL'
p9524
aS'Ann N Y Acad Sci 1035:250-70 (2004)'
p9525
aS'PMID:12971891'
p9526
ag9526
aS'AUTHORS'
p9527
aS'Dauer W, Przedborski S'
p9528
aS'TITLE'
p9529
aS"Parkinson's disease: mechanisms and models."
p9530
aS'JOURNAL'
p9531
aS'Neuron 39:889-909 (2003)'
p9532
aS'PMID:15525720'
p9533
ag9533
aS'AUTHORS'
p9534
aS'Feany MB'
p9535
aS'TITLE'
p9536
aS"New genetic insights into Parkinson's disease."
p9537
aS'JOURNAL'
p9538
aS'N Engl J Med 351:1937-40 (2004)'
p9539
aS'PMID:11331916'
p9540
ag9540
aS'AUTHORS'
p9541
aS'Beal MF'
p9542
aS'TITLE'
p9543
aS"Experimental models of Parkinson's disease."
p9544
aS'JOURNAL'
p9545
aS'Nat Rev Neurosci 2:325-34 (2001)'
p9546
aS'PMID:15770999'
p9547
ag9547
aS'AUTHORS'
p9548
aS'Corti O, Hampe C, Darios F, Ibanez P, Ruberg M, Brice A'
p9549
aS'TITLE'
p9550
aS"Parkinson's disease: from causes to mechanisms."
p9551
aS'JOURNAL'
p9552
aS'C R Biol 328:131-42 (2005)'
p9553
aS'PMID:18680555'
p9554
ag9554
aS'AUTHORS'
p9555
aS'Vila M, Ramonet D, Perier C'
p9556
aS'TITLE'
p9557
aS"Mitochondrial alterations in Parkinson's disease: new clues."
p9558
aS'JOURNAL'
p9559
aS'J Neurochem 107:317-28 (2008)'
p9560
aS'PMID:12728264'
p9561
ag9561
aS'AUTHORS'
p9562
aS'Vila M, Przedborski S'
p9563
aS'TITLE'
p9564
aS'Targeting programmed cell death in neurodegenerative diseases.'
p9565
aS'JOURNAL'
p9566
aS'Nat Rev Neurosci 4:365-75 (2003)'
p9567
aS'PMID:22927178'
p9568
ag9568
aS'AUTHORS'
p9569
aS'Calabresi P, Di Filippo M, Gallina A, Wang Y, Stankowski JN, Picconi B, Dawson VL, Dawson TM'
p9570
aS'TITLE'
p9571
aS"New synaptic and molecular targets for neuroprotection in Parkinson's disease."
p9572
aS'JOURNAL'
p9573
aS'Mov Disord 28:51-60 (2013)'
p9574
aS'PMID:21811441'
p9575
ag9575
aS'AUTHORS'
p9576
aS'Nishi A, Kuroiwa M, Shuto T'
p9577
aS'TITLE'
p9578
aS'Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons.'
p9579
aS'JOURNAL'
p9580
aS'Front Neuroanat 5:43 (2011)'
p9581
aS'PMID:20236221'
p9582
ag9582
aS'AUTHORS'
p9583
aS'Hara M, Fukui R, Hieda E, Kuroiwa M, Bateup HS, Kano T, Greengard P, Nishi A'
p9584
aS'TITLE'
p9585
aS'Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.'
p9586
aS'JOURNAL'
p9587
aS'J Neurochem 113:1046-59 (2010)'
p9588
asS'KO_PATHWAY'
p9589
(lp9590
S'ko05012'
p9591
asS'PATHWAY_MAP'
p9592
(lp9593
S'map05012'
p9594
asS'DISEASE'
p9595
(lp9596
S'H00057'
p9597
aS"Parkinson's disease (PD)"
p9598
asS'ENTRY'
p9599
(lp9600
S'map05012'
p9601
aS'Pathway'
p9602
asS'CLASS'
p9603
(lp9604
S'Human Diseases Neurodegenerative diseases'
p9605
asS'DESCRIPTION'
p9606
(lp9607
S"Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc). Mutations in alpha-synuclein, UCHL1 (a ubiquitin carboxy-terminal hydrolase L1), parkin, DJ1 (a parkin-associated protein involved with oxidative stress), and PINK1 (a putative serine threonine kinase) are known to cause early-onset PD. Mutations or altered expression of these proteins contributes to the damage and subsequent loss of DA neurons through common mechanisms that result in proteasome dysfunction, mitochondrial impairment, and oxidative stress. The demise of DA neurons located in the SNc leads to a drop in the dopaminergic input to the striatum. This results in a reduced activation of the direct pathway and in a disinhibition of the indirect pathway, which is associated with the elevation of adenosine A2A receptor transmission. Such unbalanced activity of the striatal output pathway is at the basis of the motor impairment observed in PD."
p9608
assS'path:map05010'
p9609
(dp9610
S'NAME'
p9611
(lp9612
S"Alzheimer's disease"
p9613
asS'REFERENCE'
p9614
(lp9615
S'PMID:15232608'
p9616
ag9616
aS'AUTHORS'
p9617
aS'Dickson DW'
p9618
aS'TITLE'
p9619
aS'Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?'
p9620
aS'JOURNAL'
p9621
aS'J Clin Invest 114:23-7 (2004)'
p9622
aS'PMID:15750290'
p9623
ag9623
aS'AUTHORS'
p9624
aS'Takuma K, Yan SS, Stern DM, Yamada K'
p9625
aS'TITLE'
p9626
aS"Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease."
p9627
aS'JOURNAL'
p9628
aS'J Pharmacol Sci 97:312-6 (2005)'
p9629
aS'PMID:18675468'
p9630
ag9630
aS'AUTHORS'
p9631
aS'Bezprozvanny I, Mattson MP'
p9632
aS'TITLE'
p9633
aS"Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease."
p9634
aS'JOURNAL'
p9635
aS'Trends Neurosci 31:454-63 (2008)'
p9636
aS'PMID:9848086'
p9637
ag9637
aS'AUTHORS'
p9638
aS'Holscher C'
p9639
aS'TITLE'
p9640
aS"Possible causes of Alzheimer's disease: amyloid fragments, free radicals, and calcium homeostasis."
p9641
aS'JOURNAL'
p9642
aS'Neurobiol Dis 5:129-41 (1998)'
p9643
aS'PMID:18035450'
p9644
ag9644
aS'AUTHORS'
p9645
aS'Bojarski L, Herms J, Kuznicki J'
p9646
aS'TITLE'
p9647
aS"Calcium dysregulation in Alzheimer's disease."
p9648
aS'JOURNAL'
p9649
aS'Neurochem Int 52:621-33 (2008)'
p9650
aS'PMID:15363492'
p9651
ag9651
aS'AUTHORS'
p9652
aS'Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M'
p9653
aS'TITLE'
p9654
aS"Induction of neuronal death by ER stress in Alzheimer's disease."
p9655
aS'JOURNAL'
p9656
aS'J Chem Neuroanat 28:67-78 (2004)'
p9657
aS'PMID:11484003'
p9658
ag9658
aS'AUTHORS'
p9659
aS'Small DH, Mok SS, Bornstein JC'
p9660
aS'TITLE'
p9661
aS"Alzheimer's disease and Abeta toxicity: from top to bottom."
p9662
aS'JOURNAL'
p9663
aS'Nat Rev Neurosci 2:595-8 (2001)'
p9664
aS'PMID:15295589'
p9665
ag9665
aS'AUTHORS'
p9666
aS'Mattson MP'
p9667
aS'TITLE'
p9668
aS"Pathways towards and away from Alzheimer's disease."
p9669
aS'JOURNAL'
p9670
aS'Nature 430:631-9 (2004)'
p9671
aS'PMID:15177383'
p9672
ag9672
aS'AUTHORS'
p9673
aS'Parihar MS, Hemnani T'
p9674
aS'TITLE'
p9675
aS"Alzheimer's disease pathogenesis and therapeutic interventions."
p9676
aS'JOURNAL'
p9677
aS'J Clin Neurosci 11:456-67 (2004)'
p9678
aS'PMID:17568632'
p9679
ag9679
aS'AUTHORS'
p9680
aS'Cowburn RF, Popescu BO, Ankarcrona M, Dehvari N, Cedazo-Minguez A'
p9681
aS'TITLE'
p9682
aS'Presenilin-mediated signal transduction.'
p9683
aS'JOURNAL'
p9684
aS'Physiol Behav 92:93-7 (2007)'
p9685
aS'PMID:17055782'
p9686
ag9686
aS'AUTHORS'
p9687
aS'Shen Y, He P, Zhong Z, McAllister C, Lindholm K'
p9688
aS'TITLE'
p9689
aS"Distinct destructive signal pathways of neuronal death in Alzheimer's disease."
p9690
aS'JOURNAL'
p9691
aS'Trends Mol Med 12:574-9 (2006)'
p9692
aS'PMID:18782350'
p9693
ag9693
aS'AUTHORS'
p9694
aS'Reese LC, Zhang W, Dineley KT, Kayed R, Taglialatela G'
p9695
aS'TITLE'
p9696
aS'Selective induction of calcineurin activity and signaling by oligomeric amyloid beta.'
p9697
aS'JOURNAL'
p9698
aS'Aging Cell 7:824-35 (2008)'
p9699
aS'PMID:10830966'
p9700
ag9700
aS'AUTHORS'
p9701
aS'Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH'
p9702
aS'TITLE'
p9703
aS'Neurotoxicity induces cleavage of p35 to p25 by calpain.'
p9704
aS'JOURNAL'
p9705
aS'Nature 405:360-4 (2000)'
p9706
aS'PMID:16677790'
p9707
ag9707
aS'AUTHORS'
p9708
aS'Hauptmann S, Keil U, Scherping I, Bonert A, Eckert A, Muller WE'
p9709
aS'TITLE'
p9710
aS"Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease."
p9711
aS'JOURNAL'
p9712
aS'Exp Gerontol 41:668-73 (2006)'
p9713
aS'PMID:16529745'
p9714
ag9714
aS'AUTHORS'
p9715
aS'Avila J'
p9716
aS'TITLE'
p9717
aS"Tau phosphorylation and aggregation in Alzheimer's disease pathology."
p9718
aS'JOURNAL'
p9719
aS'FEBS Lett 580:2922-7 (2006)'
p9720
aS'PMID:10527810'
p9721
ag9721
aS'AUTHORS'
p9722
aS'Ivins KJ, Thornton PL, Rohn TT, Cotman CW'
p9723
aS'TITLE'
p9724
aS'Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8.'
p9725
aS'JOURNAL'
p9726
aS'Neurobiol Dis 6:440-9 (1999)'
p9727
aS'PMID:15864339'
p9728
ag9728
aS'AUTHORS'
p9729
aS'Gandy S'
p9730
aS'TITLE'
p9731
aS'The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease.'
p9732
aS'JOURNAL'
p9733
aS'J Clin Invest 115:1121-9 (2005)'
p9734
asS'KO_PATHWAY'
p9735
(lp9736
S'ko05010'
p9737
asS'PATHWAY_MAP'
p9738
(lp9739
S'map05010'
p9740
asS'DISEASE'
p9741
(lp9742
S'H00056'
p9743
aS"Alzheimer's disease (AD)"
p9744
asS'ENTRY'
p9745
(lp9746
S'map05010'
p9747
aS'Pathway'
p9748
asS'CLASS'
p9749
(lp9750
S'Human Diseases Neurodegenerative diseases'
p9751
asS'DESCRIPTION'
p9752
(lp9753
S"Alzheimer's disease (AD) is a chronic disorder that slowly destroys neurons and causes serious cognitive disability. AD is associated with senile plaques and neurofibrillary tangles (NFTs). Amyloid-beta (Abeta), a major component of senile plaques, has various pathological effects on cell and organelle function. The extracellular Abeta oligomers may activate caspases through activation of cell surface death receptors. Alternatively, intracellular Abeta may contribute to pathology by facilitating tau hyper-phosphorylation, disrupting mitochondria function, and triggering calcium dysfunction. To date genetic studies have revealed four genes that may be linked to autosomal dominant or familial early onset AD (FAD). These four genes include: amyloid precursor protein (APP), presenilin 1 (PS1), presenilin 2 (PS2) and apolipoprotein E (ApoE). All mutations associated with APP and PS proteins can lead to an increase in the production of Abeta peptides, specfically the more amyloidogenic form, Abeta42. FAD-linked PS1 mutation downregulates the unfolded protein response and leads to vulnerability to ER stress."
p9754
assS'path:map00740'
p9755
(dp9756
S'NAME'
p9757
(lp9758
S'Riboflavin metabolism'
p9759
asS'REFERENCE'
p9760
(lp9761
S'PMID:12136096'
p9762
ag9762
aS'AUTHORS'
p9763
aS'Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS.'
p9764
aS'TITLE'
p9765
aS'Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation.'
p9766
aS'JOURNAL'
p9767
aS'Nucleic Acids Res 30:3141-51 (2002)'
p9768
aS'PMID:11856310'
p9769
ag9769
aS'AUTHORS'
p9770
aS'Fischer M, Haase I, Feicht R, Richter G, Gerhardt S, Changeux JP, Huber R, Bacher A.'
p9771
aS'TITLE'
p9772
aS'Biosynthesis of riboflavin: 6,7-dimethyl-8-ribityllumazine synthase of Schizosaccharomyces pombe.'
p9773
aS'JOURNAL'
p9774
aS'Eur J Biochem 269:519-26 (2002)'
p9775
aS'PMID:12867427'
p9776
ag9776
aS'AUTHORS'
p9777
aS'Haase I, Fischer M, Bacher A, Schramek N.'
p9778
aS'TITLE'
p9779
aS'Temperature-dependent presteady state kinetics of lumazine synthase from the hyperthermophilic eubacterium Aquifex aeolicus.'
p9780
aS'JOURNAL'
p9781
aS'J Biol Chem 278:37909-15 (2003)'
p9782
aS'PMID:16042598'
p9783
ag9783
aS'AUTHORS'
p9784
aS'Fischer M, Romisch W, Illarionov B, Eisenreich W, Bacher A.'
p9785
aS'TITLE'
p9786
aS'Structures and reaction mechanisms of riboflavin synthases of eubacterial and archaeal origin.'
p9787
aS'JOURNAL'
p9788
aS'Biochem Soc Trans 33:780-4 (2005)'
p9789
asS'KO_PATHWAY'
p9790
(lp9791
S'ko00740'
p9792
asS'PATHWAY_MAP'
p9793
(lp9794
S'map00740'
p9795
asS'DISEASE'
p9796
(lp9797
S'H01002'
p9798
aS'Generalized arterial calcification of infancy'
p9799
ag9798
ag9799
aS'H01113'
p9800
aS'Acid phosphatase deficiency'
p9801
aS'H01394'
p9802
aS'Cole disease'
p9803
asS'MODULE'
p9804
(lp9805
S'M00125'
p9806
aS'Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD [PATH:map00740]'
p9807
asS'DBLINKS'
p9808
(lp9809
S'GO: 0006771'
p9810
asS'ENTRY'
p9811
(lp9812
S'map00740'
p9813
aS'Pathway'
p9814
asS'CLASS'
p9815
(lp9816
S'Metabolism Metabolism of cofactors and vitamins'
p9817
assS'path:map04012'
p9818
(dp9819
S'NAME'
p9820
(lp9821
S'ErbB signaling pathway'
p9822
asS'REFERENCE'
p9823
(lp9824
S'PMID:14967450'
p9825
ag9825
aS'AUTHORS'
p9826
aS'Marmor MD, Skaria KB, Yarden Y.'
p9827
aS'TITLE'
p9828
aS'Signal transduction and oncogenesis by ErbB/HER receptors.'
p9829
aS'JOURNAL'
p9830
aS'Int J Radiat Oncol Biol Phys 58:903-13 (2004)'
p9831
aS'PMID:11252954'
p9832
ag9832
aS'AUTHORS'
p9833
aS'Yarden Y, Sliwkowski MX.'
p9834
aS'TITLE'
p9835
aS'Untangling the ErbB signalling network.'
p9836
aS'JOURNAL'
p9837
aS'Nat Rev Mol Cell Biol 2:127-37 (2001)'
p9838
aS'PMID:16829981'
p9839
ag9839
aS'AUTHORS'
p9840
aS'Citri A, Yarden Y.'
p9841
aS'TITLE'
p9842
aS'EGF-ERBB signalling: towards the systems level.'
p9843
aS'JOURNAL'
p9844
aS'Nat Rev Mol Cell Biol 7:505-16 (2006)'
p9845
aS'PMID:17000658'
p9846
ag9846
aS'AUTHORS'
p9847
aS'Scaltriti M, Baselga J.'
p9848
aS'TITLE'
p9849
aS'The epidermal growth factor receptor pathway: a model for targeted therapy.'
p9850
aS'JOURNAL'
p9851
aS'Clin Cancer Res 12:5268-72 (2006)'
p9852
aS'PMID:16377102'
p9853
ag9853
aS'AUTHORS'
p9854
aS'Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS.'
p9855
aS'TITLE'
p9856
aS'Epidermal growth factor receptor (EGFR) signaling in cancer.'
p9857
aS'JOURNAL'
p9858
aS'Gene 366:2-16 (2006)'
p9859
aS'PMID:14744244'
p9860
ag9860
aS'AUTHORS'
p9861
aS'Holbro T, Hynes NE.'
p9862
aS'TITLE'
p9863
aS'ErbB receptors: directing key signaling networks throughout life.'
p9864
aS'JOURNAL'
p9865
aS'Annu Rev Pharmacol Toxicol 44:195-217 (2004)'
p9866
aS'PMID:12851486'
p9867
ag9867
aS'AUTHORS'
p9868
aS'Liang J, Slingerland JM.'
p9869
aS'TITLE'
p9870
aS'Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.'
p9871
aS'JOURNAL'
p9872
aS'Cell Cycle 2:339-45 (2003)'
p9873
aS'PMID:15864276'
p9874
ag9874
aS'AUTHORS'
p9875
aS'Hynes NE, Lane HA.'
p9876
aS'TITLE'
p9877
aS'ERBB receptors and cancer: the complexity of targeted inhibitors.'
p9878
aS'JOURNAL'
p9879
aS'Nat Rev Cancer 5:341-54 (2005)'
p9880
aS'PMID:16729045'
p9881
ag9881
aS'AUTHORS'
p9882
aS'Oda K, Matsuoka Y, Funahashi A, Kitano H.'
p9883
aS'TITLE'
p9884
aS'A comprehensive pathway map of epidermal growth factor receptor signaling.'
p9885
aS'JOURNAL'
p9886
aS'Mol Syst Biol 1:2005.0010 (2005)'
p9887
aS'PMID:16729043'
p9888
ag9888
aS'AUTHORS'
p9889
aS'Schulze WX, Deng L, Mann M.'
p9890
aS'TITLE'
p9891
aS'Phosphotyrosine interactome of the ErbB-receptor kinase family.'
p9892
aS'JOURNAL'
p9893
aS'Mol Syst Biol 1:2005.0008 (2005)'
p9894
aS'PMID:10880430'
p9895
ag9895
aS'AUTHORS'
p9896
aS'Olayioye MA, Neve RM, Lane HA, Hynes NE.'
p9897
aS'TITLE'
p9898
aS'The ErbB signaling network: receptor heterodimerization in development and cancer.'
p9899
aS'JOURNAL'
p9900
aS'EMBO J 19:3159-67 (2000)'
p9901
aS'PMID:9872057'
p9902
ag9902
aS'AUTHORS'
p9903
aS'McCarty JH.'
p9904
aS'TITLE'
p9905
aS'The Nck SH2/SH3 adaptor protein: a regulator of multiple intracellular signal transduction events.'
p9906
aS'JOURNAL'
p9907
aS'Bioessays 20:913-21 (1998)'
p9908
aS'PMID:15863494'
p9909
ag9909
aS'AUTHORS'
p9910
aS'Clark DE, Williams CC, Duplessis TT, Moring KL, Notwick AR, Long W, Lane WS, Beuvink I, Hynes NE, Jones FE.'
p9911
aS'TITLE'
p9912
aS'ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events.'
p9913
aS'JOURNAL'
p9914
aS'J Biol Chem 280:24175-80 (2005)'
p9915
aS'PMID:10490623'
p9916
ag9916
aS'AUTHORS'
p9917
aS'Muthuswamy SK, Gilman M, Brugge JS.'
p9918
aS'TITLE'
p9919
aS'Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.'
p9920
aS'JOURNAL'
p9921
aS'Mol Cell Biol 19:6845-57 (1999)'
p9922
aS'PMID:9642287'
p9923
ag9923
aS'AUTHORS'
p9924
aS'Hashimoto Y, Katayama H, Kiyokawa E, Ota S, Kurata T, Gotoh N, Otsuka N, Shibata M, Matsuda M.'
p9925
aS'TITLE'
p9926
aS'Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor.'
p9927
aS'JOURNAL'
p9928
aS'J Biol Chem 273:17186-91 (1998)'
p9929
asS'KO_PATHWAY'
p9930
(lp9931
S'ko04012'
p9932
asS'PATHWAY_MAP'
p9933
(lp9934
S'map04012'
p9935
asS'DISEASE'
p9936
(lp9937
S'H00539'
p9938
aS'PTEN hamartoma tumor syndrome (PHTS)'
p9939
ag9938
ag9939
aS'H00865'
p9940
aS'Lethal congenital contractural syndrome (LCCS)'
p9941
aS'H00931'
p9942
aS'Growth hormone insensitivity with immunodeficiency'
p9943
aS'H01102'
p9944
aS'Pituitary adenomas'
p9945
asS'ENTRY'
p9946
(lp9947
S'map04012'
p9948
aS'Pathway'
p9949
asS'CLASS'
p9950
(lp9951
S'Environmental Information Processing Signal transduction'
p9952
asS'DESCRIPTION'
p9953
(lp9954
S'The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, differentiation, cell motility, and survival. Ligand binding to the four closely related members of this RTK family -epidermal growth factor receptor (EGFR, also known as ErbB-1 or HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4)-induces the formation of receptor homo- and heterodimers and the activation of the intrinsic kinase domain, resulting in phosphorylation on specific tyrosine residues (pY) within the cytoplasmic tail. Signaling effectors containing binding pockets for pY-containing peptides are recruited to activated receptors and induce the various signaling pathways. The Shc- and/or Grb2-activated mitogen-activated protein kinase (MAPK) pathway is a common target downstream of all ErbB receptors. Similarly, the phosphatidylinositol-3-kinase (PI-3K) pathway is directly or indirectly activated by most ErbBs. Several cytoplasmic docking proteins appear to be recruited by specific ErbB receptors and less exploited by others. These include the adaptors Crk, Nck, the phospholipase C gamma (PLCgamma), the intracellular tyrosine kinase Src, or the Cbl E3 ubiquitin protein ligase.'
p9955
assS'path:map04015'
p9956
(dp9957
S'NAME'
p9958
(lp9959
S'Rap1 signaling pathway'
p9960
asS'REFERENCE'
p9961
(lp9962
S'PMID:17182900'
p9963
ag9963
aS'AUTHORS'
p9964
aS'Kooistra MR, Dube N, Bos JL'
p9965
aS'TITLE'
p9966
aS'Rap1: a key regulator in cell-cell junction formation.'
p9967
aS'JOURNAL'
p9968
aS'J Cell Sci 120:17-22 (2007)'
p9969
aS'PMID:11331911'
p9970
ag9970
aS'AUTHORS'
p9971
aS'Bos JL, de Rooij J, Reedquist KA'
p9972
aS'TITLE'
p9973
aS'Rap1 signalling: adhering to new models.'
p9974
aS'JOURNAL'
p9975
aS'Nat Rev Mol Cell Biol 2:369-77 (2001)'
p9976
aS'PMID:17383543'
p9977
ag9977
aS'AUTHORS'
p9978
aS'Minato N, Kometani K, Hattori M'
p9979
aS'TITLE'
p9980
aS'Regulation of immune responses and hematopoiesis by the Rap1 signal.'
p9981
aS'JOURNAL'
p9982
aS'Adv Immunol 93:229-64 (2007)'
p9983
aS'PMID:15780587'
p9984
ag9984
aS'AUTHORS'
p9985
aS'Bos JL'
p9986
aS'TITLE'
p9987
aS'Linking Rap to cell adhesion.'
p9988
aS'JOURNAL'
p9989
aS'Curr Opin Cell Biol 17:123-8 (2005)'
p9990
aS'PMID:12508104'
p9991
ag9991
aS'AUTHORS'
p9992
aS'Caron E'
p9993
aS'TITLE'
p9994
aS'Cellular functions of the Rap1 GTP-binding protein: a pattern emerges.'
p9995
aS'JOURNAL'
p9996
aS'J Cell Sci 116:435-40 (2003)'
p9997
aS'PMID:10579920'
p9998
ag9998
aS'AUTHORS'
p9999
aS'Zwartkruis FJ, Bos JL'
p10000
aS'TITLE'
p10001
aS'Ras and Rap1: two highly related small GTPases with distinct function.'
p10002
aS'JOURNAL'
p10003
aS'Exp Cell Res 253:157-65 (1999)'
p10004
aS'PMID:14607972'
p10005
ag10005
aS'AUTHORS'
p10006
aS'Hattori M, Minato N'
p10007
aS'TITLE'
p10008
aS'Rap1 GTPase: functions, regulation, and malignancy.'
p10009
aS'JOURNAL'
p10010
aS'J Biochem 134:479-84 (2003)'
p10011
aS'PMID:19159611'
p10012
ag10012
aS'AUTHORS'
p10013
aS'Pannekoek WJ, Kooistra MR, Zwartkruis FJ, Bos JL'
p10014
aS'TITLE'
p10015
aS'Cell-cell junction formation: the role of Rap1 and Rap1 guanine nucleotide exchange factors.'
p10016
aS'JOURNAL'
p10017
aS'Biochim Biophys Acta 1788:790-6 (2009)'
p10018
aS'PMID:19615876'
p10019
ag10019
aS'AUTHORS'
p10020
aS'Boettner B, Van Aelst L'
p10021
aS'TITLE'
p10022
aS'Control of cell adhesion dynamics by Rap1 signaling.'
p10023
aS'JOURNAL'
p10024
aS'Curr Opin Cell Biol 21:684-93 (2009)'
p10025
aS'PMID:15803158'
p10026
ag10026
aS'AUTHORS'
p10027
aS'Xia Z, Storm DR.'
p10028
aS'TITLE'
p10029
aS'The role of calmodulin as a signal integrator for synaptic plasticity.'
p10030
aS'JOURNAL'
p10031
aS'Nat Rev Neurosci 6:267-76 (2005)'
p10032
aS'PMID:17624948'
p10033
ag10033
aS'AUTHORS'
p10034
aS'Mor A, Dustin ML, Philips MR'
p10035
aS'TITLE'
p10036
aS'Small GTPases and LFA-1 reciprocally modulate adhesion and signaling.'
p10037
aS'JOURNAL'
p10038
aS'Immunol Rev 218:114-25 (2007)'
p10039
aS'PMID:17624944'
p10040
ag10040
aS'AUTHORS'
p10041
aS'Burbach BJ, Medeiros RB, Mueller KL, Shimizu Y'
p10042
aS'TITLE'
p10043
aS'T-cell receptor signaling to integrins.'
p10044
aS'JOURNAL'
p10045
aS'Immunol Rev 218:65-81 (2007)'
p10046
aS'PMID:12765839'
p10047
ag10047
aS'AUTHORS'
p10048
aS'Stork PJ'
p10049
aS'TITLE'
p10050
aS'Does Rap1 deserve a bad Rap?'
p10051
aS'JOURNAL'
p10052
aS'Trends Biochem Sci 28:267-75 (2003)'
p10053
aS'PMID:12351703'
p10054
ag10054
aS'AUTHORS'
p10055
aS'Banihashemi B, Albert PR'
p10056
aS'TITLE'
p10057
aS'Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.'
p10058
aS'JOURNAL'
p10059
aS'Mol Endocrinol 16:2393-404 (2002)'
p10060
aS'PMID:18363565'
p10061
ag10061
aS'AUTHORS'
p10062
aS'Banno A, Ginsberg MH'
p10063
aS'TITLE'
p10064
aS'Integrin activation.'
p10065
aS'JOURNAL'
p10066
aS'Biochem Soc Trans 36:229-34 (2008)'
p10067
aS'PMID:19710505'
p10068
ag10068
aS'AUTHORS'
p10069
aS'Doebele RC, Schulze-Hoepfner FT, Hong J, Chlenski A, Zeitlin BD, Goel K, Gomes S, Liu Y, Abe MK, Nor JE, Lingen MW, Rosner MR'
p10070
aS'TITLE'
p10071
aS'A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis.'
p10072
aS'JOURNAL'
p10073
aS'Blood 114:4592-600 (2009)'
p10074
aS'PMID:21402149'
p10075
ag10075
aS'AUTHORS'
p10076
aS"Breckler M, Berthouze M, Laurent AC, Crozatier B, Morel E, Lezoualc'h F"
p10077
aS'TITLE'
p10078
aS'Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications.'
p10079
aS'JOURNAL'
p10080
aS'Cell Signal 23:1257-66 (2011)'
p10081
asS'KO_PATHWAY'
p10082
(lp10083
S'ko04015'
p10084
asS'PATHWAY_MAP'
p10085
(lp10086
S'map04015'
p10087
asS'DBLINKS'
p10088
(lp10089
S'GO: 0007264'
p10090
asS'ENTRY'
p10091
(lp10092
S'map04015'
p10093
aS'Pathway'
p10094
asS'CLASS'
p10095
(lp10096
S'Environmental Information Processing Signal transduction'
p10097
asS'DESCRIPTION'
p10098
(lp10099
S'Rap1 is a small GTPase that controls diverse processes, such as cell adhesion, cell-cell junction formation and cell polarity. Like all G proteins, Rap1 cycles between an inactive GDP-bound and an active GTP-bound conformation. A variety of extracellular signals control this cycle through the regulation of several unique guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs). Rap1 plays a dominant role in the control of cell-cell and cell-matrix interactions by regulating the function of integrins and other adhesion molecules in various cell types. Rap1 also regulates MAP kinase (MAPK) activity in a manner highly dependent on the context of cell types.'
p10100
assS'path:map04014'
p10101
(dp10102
S'NAME'
p10103
(lp10104
S'Ras signaling pathway'
p10105
asS'REFERENCE'
p10106
(lp10107
S'PMID:18568040'
p10108
ag10108
aS'AUTHORS'
p10109
aS'Karnoub AE, Weinberg RA'
p10110
aS'TITLE'
p10111
aS'Ras oncogenes: split personalities.'
p10112
aS'JOURNAL'
p10113
aS'Nat Rev Mol Cell Biol 9:517-31 (2008)'
p10114
aS'PMID:12778136'
p10115
ag10115
aS'AUTHORS'
p10116
aS'Malumbres M, Barbacid M'
p10117
aS'TITLE'
p10118
aS'RAS oncogenes: the first 30 years.'
p10119
aS'JOURNAL'
p10120
aS'Nat Rev Cancer 3:459-65 (2003)'
p10121
aS'PMID:21686117'
p10122
ag10122
aS'AUTHORS'
p10123
aS'Cox AD, Der CJ'
p10124
aS'TITLE'
p10125
aS'Ras history: The saga continues.'
p10126
aS'JOURNAL'
p10127
aS'Small GTPases 1:2-27 (2010)'
p10128
aS'PMID:12642680'
p10129
ag10129
aS'AUTHORS'
p10130
aS'Cox AD, Der CJ'
p10131
aS'TITLE'
p10132
aS'Ras family signaling: therapeutic targeting.'
p10133
aS'JOURNAL'
p10134
aS'Cancer Biol Ther 1:599-606 (2002)'
p10135
aS'PMID:17428555'
p10136
ag10136
aS'AUTHORS'
p10137
aS'Rajalingam K, Schreck R, Rapp UR, Albert S'
p10138
aS'TITLE'
p10139
aS'Ras oncogenes and their downstream targets.'
p10140
aS'JOURNAL'
p10141
aS'Biochim Biophys Acta 1773:1177-95 (2007)'
p10142
aS'PMID:17384584'
p10143
ag10143
aS'AUTHORS'
p10144
aS'Schubbert S, Shannon K, Bollag G'
p10145
aS'TITLE'
p10146
aS'Hyperactive Ras in developmental disorders and cancer.'
p10147
aS'JOURNAL'
p10148
aS'Nat Rev Cancer 7:295-308 (2007)'
p10149
aS'PMID:22233291'
p10150
ag10150
aS'AUTHORS'
p10151
aS'Poulogiannis G, Luo F, Arends MJ'
p10152
aS'TITLE'
p10153
aS'RAS signalling in the colorectum in health and disease.'
p10154
aS'JOURNAL'
p10155
aS'Cell Commun Adhes 19:1-9 (2012)'
p10156
aS'PMID:22020205'
p10157
ag10157
aS'AUTHORS'
p10158
aS'Berndt N, Hamilton AD, Sebti SM'
p10159
aS'TITLE'
p10160
aS'Targeting protein prenylation for cancer therapy.'
p10161
aS'JOURNAL'
p10162
aS'Nat Rev Cancer 11:775-91 (2011)'
p10163
aS'PMID:21196257'
p10164
ag10164
aS'AUTHORS'
p10165
aS'Overmeyer JH, Maltese WA'
p10166
aS'TITLE'
p10167
aS'Death pathways triggered by activated Ras in cancer cells.'
p10168
aS'JOURNAL'
p10169
aS'Front Biosci (Landmark Ed) 16:1693-713 (2011)'
p10170
aS'PMID:16869784'
p10171
ag10171
aS'AUTHORS'
p10172
aS'Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, McCormick F'
p10173
aS'TITLE'
p10174
aS'Cancer targets in the Ras pathway.'
p10175
aS'JOURNAL'
p10176
aS'Cold Spring Harb Symp Quant Biol 70:461-7 (2005)'
p10177
aS'PMID:14663478'
p10178
ag10178
aS'AUTHORS'
p10179
aS'Cox AD, Der CJ'
p10180
aS'TITLE'
p10181
aS'The dark side of Ras: regulation of apoptosis.'
p10182
aS'JOURNAL'
p10183
aS'Oncogene 22:8999-9006 (2003)'
p10184
aS'PMID:18413813'
p10185
ag10185
aS'AUTHORS'
p10186
aS'Braun BS, Shannon K'
p10187
aS'TITLE'
p10188
aS'Targeting Ras in myeloid leukemias.'
p10189
aS'JOURNAL'
p10190
aS'Clin Cancer Res 14:2249-52 (2008)'
p10191
aS'PMID:20420946'
p10192
ag10192
aS'AUTHORS'
p10193
aS'Pino MS, Chung DC'
p10194
aS'TITLE'
p10195
aS'The chromosomal instability pathway in colon cancer.'
p10196
aS'JOURNAL'
p10197
aS'Gastroenterology 138:2059-72 (2010)'
p10198
aS'PMID:12217381'
p10199
ag10199
aS'AUTHORS'
p10200
aS'Schrader JW, Schallhorn A, Grill B, Guo X'
p10201
aS'TITLE'
p10202
aS'Activation of small GTPases of the Ras and Rho family by growth factors active on mast cells.'
p10203
aS'JOURNAL'
p10204
aS'Mol Immunol 38:1181-6 (2002)'
p10205
aS'PMID:22189424'
p10206
ag10206
aS'AUTHORS'
p10207
aS'Ahearn IM, Haigis K, Bar-Sagi D, Philips MR'
p10208
aS'TITLE'
p10209
aS'Regulating the regulator: post-translational modification of RAS.'
p10210
aS'JOURNAL'
p10211
aS'Nat Rev Mol Cell Biol 13:39-51 (2012)'
p10212
aS'PMID:11313946'
p10213
ag10213
aS'AUTHORS'
p10214
aS'Ehrhardt GR, Korherr C, Wieler JS, Knaus M, Schrader JW'
p10215
aS'TITLE'
p10216
aS'A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.'
p10217
aS'JOURNAL'
p10218
aS'Oncogene 20:188-97 (2001)'
p10219
aS'PMID:16966426'
p10220
ag10220
aS'AUTHORS'
p10221
aS'Goldfinger LE, Ptak C, Jeffery ED, Shabanowitz J, Hunt DF, Ginsberg MH'
p10222
aS'TITLE'
p10223
aS'RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration.'
p10224
aS'JOURNAL'
p10225
aS'J Cell Biol 174:877-88 (2006)'
p10226
aS'PMID:23506953'
p10227
ag10227
aS'AUTHORS'
p10228
aS'Kortum RL, Rouquette-Jazdanian AK, Samelson LE'
p10229
aS'TITLE'
p10230
aS'Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells.'
p10231
aS'JOURNAL'
p10232
aS'Trends Immunol 34:259-68 (2013)'
p10233
aS'PMID:15572660'
p10234
ag10234
aS'AUTHORS'
p10235
aS'Roberts DM, Anderson AL, Hidaka M, Swetenburg RL, Patterson C, Stanford WL, Bautch VL'
p10236
aS'TITLE'
p10237
aS'A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.'
p10238
aS'JOURNAL'
p10239
aS'Mol Cell Biol 24:10515-28 (2004)'
p10240
aS'PMID:10712923'
p10241
ag10241
aS'AUTHORS'
p10242
aS'Reuther GW, Der CJ'
p10243
aS'TITLE'
p10244
aS"The Ras branch of small GTPases: Ras family members don't fall far from the tree."
p10245
aS'JOURNAL'
p10246
aS'Curr Opin Cell Biol 12:157-65 (2000)'
p10247
aS'PMID:21111786'
p10248
ag10248
aS'AUTHORS'
p10249
aS'Fernandez-Medarde A, Santos E'
p10250
aS'TITLE'
p10251
aS'The RasGrf family of mammalian guanine nucleotide exchange factors.'
p10252
aS'JOURNAL'
p10253
aS'Biochim Biophys Acta 1815:170-88 (2011)'
p10254
aS'PMID:18437264'
p10255
ag10255
aS'AUTHORS'
p10256
aS'Iwashita S, Song SY'
p10257
aS'TITLE'
p10258
aS'RasGAPs: a crucial regulator of extracellular stimuli for homeostasis of cellular functions.'
p10259
aS'JOURNAL'
p10260
aS'Mol Biosyst 4:213-22 (2008)'
p10261
aS'PMID:15062121'
p10262
ag10262
aS'AUTHORS'
p10263
aS'Ory S, Morrison DK'
p10264
aS'TITLE'
p10265
aS'Signal transduction: implications for Ras-dependent ERK signaling.'
p10266
aS'JOURNAL'
p10267
aS'Curr Biol 14:R277-8 (2004)'
p10268
aS'PMID:19091743'
p10269
ag10269
aS'AUTHORS'
p10270
aS'Matheny SA, White MA'
p10271
aS'TITLE'
p10272
aS'Signaling threshold regulation by the Ras effector IMP.'
p10273
aS'JOURNAL'
p10274
aS'J Biol Chem 284:11007-11 (2009)'
p10275
asS'KO_PATHWAY'
p10276
(lp10277
S'ko04014'
p10278
asS'PATHWAY_MAP'
p10279
(lp10280
S'map04014'
p10281
asS'DBLINKS'
p10282
(lp10283
S'GO: 0032318'
p10284
asS'ENTRY'
p10285
(lp10286
S'map04014'
p10287
aS'Pathway'
p10288
asS'CLASS'
p10289
(lp10290
S'Environmental Information Processing Signal transduction'
p10291
asS'DESCRIPTION'
p10292
(lp10293
S'The Ras proteins are GTPases that function as molecular switches for signaling pathways regulating cell proliferation, survival, growth, migration, differentiation or cytoskeletal dynamism. Ras proteins transduce signals from extracellular growth factors by cycling between inactive GDP-bound and active GTP-bound states. The exchange of GTP for GDP on RAS is regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Activated RAS (RAS-GTP) regulates multiple cellular functions through effectors including Raf, phosphatidylinositol 3-kinase (PI3K) and Ral guanine nucleotide-dissociation stimulator (RALGDS).'
p10294
assS'path:map04011'
p10295
(dp10296
S'NAME'
p10297
(lp10298
S'MAPK signaling pathway - yeast'
p10299
asS'KO_PATHWAY'
p10300
(lp10301
S'ko04011'
p10302
asS'ENTRY'
p10303
(lp10304
S'map04011'
p10305
aS'Pathway'
p10306
asS'PATHWAY_MAP'
p10307
(lp10308
S'map04011'
p10309
asS'CLASS'
p10310
(lp10311
S'Environmental Information Processing Signal transduction'
p10312
asS'MODULE'
p10313
(lp10314
S'M00516'
p10315
aS'SLN1-YPD1-SSK1/SKN7 (osmosensing) two-component regulatory system [PATH:map04011]'
p10316
asS'DESCRIPTION'
p10317
(lp10318
S'The S. cerevisiae genome encodes multiple MAP kinase orthologs. One (Fus3) mediates cellular response to peptide pheromones. Another (Kss1) permits adjustment to nutrient limiting conditions. A third (Hog1) is necessary for survival under hyperosmotic conditions. A fourth (Slt2/Mpk1) is required for repair of injuries to the cell wall. As in mammalian cells, these pathways consist of a conserved module in which three kinases phosphorylate each other in sequence. The MAPK is phosphorylated by the MAPK/ERK kinase (MEK), which is itself phosphorylated by a MEK kinase (MEKK).'
p10319
assS'path:map04010'
p10320
(dp10321
S'NAME'
p10322
(lp10323
S'MAPK signaling pathway'
p10324
asS'REFERENCE'
p10325
(lp10326
S'PMID:11749383'
p10327
ag10327
aS'AUTHORS'
p10328
aS'Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH.'
p10329
aS'TITLE'
p10330
aS'MAP kinases.'
p10331
aS'JOURNAL'
p10332
aS'Chem Rev 101:2449-76 (2001)'
p10333
aS'PMID:12191611'
p10334
ag10334
aS'AUTHORS'
p10335
aS'Tanoue T, Nishida E.'
p10336
aS'TITLE'
p10337
aS'Docking interactions in the mitogen-activated protein kinase cascades.'
p10338
aS'JOURNAL'
p10339
aS'Pharmacol Ther 93:193-202 (2002)'
p10340
aS'PMID:12947395'
p10341
ag10341
aS'AUTHORS'
p10342
aS'Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S.'
p10343
aS'TITLE'
p10344
aS'MAPK pathways in radiation responses.'
p10345
aS'JOURNAL'
p10346
aS'Oncogene 22:5885-96 (2003)'
p10347
aS'PMID:12676795'
p10348
ag10348
aS'AUTHORS'
p10349
aS'Huang EJ, Reichardt LF.'
p10350
aS'TITLE'
p10351
aS'Trk receptors: roles in neuronal signal transduction.'
p10352
aS'JOURNAL'
p10353
aS'Annu Rev Biochem 72:609-42 (2003)'
p10354
aS'PMID:11369511'
p10355
ag10355
aS'AUTHORS'
p10356
aS'Harper SJ, LoGrasso P.'
p10357
aS'TITLE'
p10358
aS'Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38.'
p10359
aS'JOURNAL'
p10360
aS'Cell Signal 13:299-310 (2001)'
p10361
aS'PMID:12390245'
p10362
ag10362
aS'AUTHORS'
p10363
aS'Takeda K, Ichijo H'
p10364
aS'TITLE'
p10365
aS'Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system.'
p10366
aS'JOURNAL'
p10367
aS'Genes Cells 7:1099-111 (2002)'
p10368
aS'PMID:14597384'
p10369
ag10369
aS'AUTHORS'
p10370
aS'Yang SH, Sharrocks AD, Whitmarsh AJ.'
p10371
aS'TITLE'
p10372
aS'Transcriptional regulation by the MAP kinase signaling cascades.'
p10373
aS'JOURNAL'
p10374
aS'Gene 320:3-21 (2003)'
p10375
aS'PMID:12566928'
p10376
ag10376
aS'AUTHORS'
p10377
aS'Zhu X, Lee HG, Raina AK, Perry G, Smith MA.'
p10378
aS'TITLE'
p10379
aS"The role of mitogen-activated protein kinase pathways in Alzheimer's disease."
p10380
aS'JOURNAL'
p10381
aS'Neurosignals 11:270-81 (2002)'
p10382
aS'PMID:12849693'
p10383
ag10383
aS'AUTHORS'
p10384
aS'Cho H, Lee J, Kwak NJ, Lee KH, Rha S, Kim YH, Cho YY, Yang KH, Kim K, Lim Y.'
p10385
aS'TITLE'
p10386
aS'Silica induces nuclear factor-kappaB activation through TAK1 and NIK in Rat2 cell line.'
p10387
aS'JOURNAL'
p10388
aS'Toxicol Lett 143:323-30 (2003)'
p10389
asS'KO_PATHWAY'
p10390
(lp10391
S'ko04010'
p10392
asS'PATHWAY_MAP'
p10393
(lp10394
S'map04010'
p10395
asS'DISEASE'
p10396
(lp10397
S'H00078'
p10398
aS'Frontotemporal lobar degeneration (FTLD)'
p10399
ag10398
ag10399
aS'H00265'
p10400
aS'Hereditary sensory and autonomic neuropathy (HSAN)'
p10401
aS'H00484'
p10402
aS'Other brachydactylies'
p10403
aS'H00523'
p10404
aS'Noonan syndrome and related disorders'
p10405
aS'H00532'
p10406
aS'RASA1-related disorders'
p10407
aS'H00539'
p10408
aS'PTEN hamartoma tumor syndrome (PHTS)'
p10409
aS'H00540'
p10410
aS'Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID)'
p10411
aS'H00574'
p10412
aS'Coffin-Lowry syndrome (CLS)'
p10413
aS'H00577'
p10414
aS'Syndromic X-linked mental retardation with epilepsy or seizures'
p10415
aS'H00595'
p10416
aS'Myofibrillar myopathies (MFM)'
p10417
aS'H00642'
p10418
aS'Lacrimo-auriculo-dento-digital syndrome (LADD)'
p10419
aS'H00645'
p10420
aS'Incontinentia pigmenti'
p10421
aS'H00677'
p10422
aS'Aplasia of lacrimal and salivary glands'
p10423
aS'H00728'
p10424
aS'Brugada syndrome (BRS)'
p10425
aS'H00746'
p10426
aS'Hypokalemic periodic paralysis (HypoPP)'
p10427
aS'H00749'
p10428
aS'Episodic ataxias'
p10429
aS'H00775'
p10430
aS'Familial or sporadic hemiplegic migraine'
p10431
aS'H00787'
p10432
aS'Congenital stationary night blindness (CSNB)'
p10433
aS'H00800'
p10434
aS'Loeys-Dietz syndrome (LDS)'
p10435
aS'H00801'
p10436
aS'Familial thoracic aortic aneurysm and dissection (TAAD)'
p10437
aS'H00808'
p10438
aS'Idiopathic generalized epilepsies (IGEs)'
p10439
aS'H00856'
p10440
aS'Distal hereditary motor neuropathies (dHMN)'
p10441
aS'H00881'
p10442
aS'Li-Fraumeni syndrome'
p10443
aS'H00882'
p10444
aS'Cocoon syndrome'
p10445
aS'H00894'
p10446
aS'FG syndrome (FGS)'
p10447
aS'H00912'
p10448
aS'Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)'
p10449
aS'H00916'
p10450
aS'Congenital central hypoventilation syndrome (CCHS)'
p10451
aS'H00997'
p10452
aS'CATSHL syndrome'
p10453
aS'H01007'
p10454
aS'Choroid plexus papilloma'
p10455
aS'H01193'
p10456
aS'Familial tumoral calcinosis (FTC)'
p10457
aS'H01207'
p10458
aS'Trigonocephaly'
p10459
aS'H01250'
p10460
aS'Hereditary gingival fibromatosis (HGF)'
p10461
aS'H01276'
p10462
aS'X-linked chronic idiopathic intestinal pseudo-obstruction'
p10463
aS'H01385'
p10464
aS'Rienhoff syndrome'
p10465
asS'MODULE'
p10466
(lp10467
S'M00687'
p10468
aS'MAPK (ERK1/2) signaling [PATH:map04010]'
p10469
ag10468
ag10469
aS'M00688'
p10470
aS'MAPK (JNK) signaling [PATH:map04010]'
p10471
aS'M00689'
p10472
aS'MAPK (p38) signaling [PATH:map04010]'
p10473
aS'M00690'
p10474
aS'MAPK (ERK5) signaling [PATH:map04010]'
p10475
asS'ENTRY'
p10476
(lp10477
S'map04010'
p10478
aS'Pathway'
p10479
asS'CLASS'
p10480
(lp10481
S'Environmental Information Processing Signal transduction'
p10482
asS'DESCRIPTION'
p10483
(lp10484
S'The mitogen-activated protein kinase (MAPK) cascade is a highly conserved module that is involved in various cellular functions, including cell proliferation, differentiation and migration. Mammals express at least four distinctly regulated groups of MAPKs, extracellular signal-related kinases (ERK)-1/2, Jun amino-terminal kinases (JNK1/2/3), p38 proteins (p38alpha/beta/gamma/delta) and ERK5, that are activated by specific MAPKKs: MEK1/2 for ERK1/2, MKK3/6 for the p38, MKK4/7 (JNKK1/2) for the JNKs, and MEK5 for ERK5. Each MAPKK, however, can be activated by more than one MAPKKK, increasing the complexity and diversity of MAPK signalling. Presumably each MAPKKK confers responsiveness to distinct stimuli. For example, activation of ERK1/2 by growth factors depends on the MAPKKK c-Raf, but other MAPKKKs may activate ERK1/2 in response to pro-inflammatory stimuli.'
p10485
assS'path:map04013'
p10486
(dp10487
S'NAME'
p10488
(lp10489
S'MAPK signaling pathway - fly'
p10490
asS'KO_PATHWAY'
p10491
(lp10492
S'ko04013'
p10493
asS'ENTRY'
p10494
(lp10495
S'map04013'
p10496
aS'Pathway'
p10497
asS'PATHWAY_MAP'
p10498
(lp10499
S'map04013'
p10500
asS'CLASS'
p10501
(lp10502
S'Environmental Information Processing Signal transduction'
p10503
asS'MODULE'
p10504
(lp10505
S'M00687'
p10506
aS'MAPK (ERK1/2) signaling [PATH:map04013]'
p10507
ag10506
ag10507
aS'M00688'
p10508
aS'MAPK (JNK) signaling [PATH:map04013]'
p10509
aS'M00689'
p10510
aS'MAPK (p38) signaling [PATH:map04013]'
p10511
assS'path:map00966'
p10512
(dp10513
S'NAME'
p10514
(lp10515
S'Glucosinolate biosynthesis'
p10516
asS'REFERENCE'
p10517
(lp10518
S'PMID:12049923'
p10519
ag10519
aS'AUTHORS'
p10520
aS'Wittstock U, Halkier BA'
p10521
aS'TITLE'
p10522
aS'Glucosinolate research in the Arabidopsis era.'
p10523
aS'JOURNAL'
p10524
aS'Trends Plant Sci 7:263-70 (2002)'
p10525
aS'PMID:15913672'
p10526
ag10526
aS'AUTHORS'
p10527
aS'Windsor AJ, Reichelt M, Figuth A, Svatos A, Kroymann J, Kliebenstein DJ, Gershenzon J, Mitchell-Olds T'
p10528
aS'TITLE'
p10529
aS'Geographic and evolutionary diversification of glucosinolates among near relatives of Arabidopsis thaliana (Brassicaceae).'
p10530
aS'JOURNAL'
p10531
aS'Phytochemistry 66:1321-33 (2005)'
p10532
aS'PMID:14740211'
p10533
ag10533
aS'AUTHORS'
p10534
aS'Textor S, Bartram S, Kroymann J, Falk KL, Hick A, Pickett JA, Gershenzon J'
p10535
aS'TITLE'
p10536
aS'Biosynthesis of methionine-derived glucosinolates in Arabidopsis thaliana: recombinant expression and characterization of methylthioalkylmalate synthase, the condensing enzyme of the chain-elongation cycle.'
p10537
aS'JOURNAL'
p10538
aS'Planta 218:1026-35 (2004)'
p10539
aS'PMID:15358770'
p10540
ag10540
aS'AUTHORS'
p10541
aS'Piotrowski M, Schemenewitz A, Lopukhina A, Muller A, Janowitz T, Weiler EW, Oecking C'
p10542
aS'TITLE'
p10543
aS'Desulfoglucosinolate sulfotransferases from Arabidopsis thaliana catalyze the final step in the biosynthesis of the glucosinolate core structure.'
p10544
aS'JOURNAL'
p10545
aS'J Biol Chem 279:50717-25 (2004)'
p10546
aS'PMID:12586901'
p10547
ag10547
aS'AUTHORS'
p10548
aS'Mikkelsen MD, Halkier BA'
p10549
aS'TITLE'
p10550
aS'Metabolic engineering of valine- and isoleucine-derived glucosinolates in Arabidopsis expressing CYP79D2 from Cassava.'
p10551
aS'JOURNAL'
p10552
aS'Plant Physiol 131:773-9 (2003)'
p10553
ag22
ag22
aS'AUTHORS'
p10554
aS'Sixue C, Erik A.'
p10555
aS'TITLE'
p10556
aS'Update on glucosinolate metabolism and transport.'
p10557
aS'JOURNAL'
p10558
aS'Plant Physiol Biochem 39:743-758 (2001)'
p10559
asS'KO_PATHWAY'
p10560
(lp10561
S'ko00966'
p10562
asS'PATHWAY_MAP'
p10563
(lp10564
S'map00966'
p10565
asS'MODULE'
p10566
(lp10567
S'M00370'
p10568
aS'Glucosinolate biosynthesis, tryptophan => glucobrassicin [PATH:map00966]'
p10569
asS'DBLINKS'
p10570
(lp10571
S'GO: 0019761'
p10572
asS'ENTRY'
p10573
(lp10574
S'map00966'
p10575
aS'Pathway'
p10576
asS'CLASS'
p10577
(lp10578
S'Metabolism Biosynthesis of other secondary metabolites'
p10579
asS'DESCRIPTION'
p10580
(lp10581
S'Glucosinolates are biologically active secondary metabolites found in Brassicaceae (mustard family) and related families.These compounds are genetically variable within plant species and used as natural pesticides, such as against insect herbivores. All glucosinolates share a common structure consisting of a beta-thioglucose moiety, a sulfonated oxime moiety, and a variable aglycone side chain derived from an alpha-amino acid. Genes encoding glucosinolate biosynthetic enzymes have been identified in Arabidopsis thaliana by genetic polymorphisms and loss-of-function mutations. This map shows examples of side chain elongation in methionine-derived glucosinolates and the core pathway for biosynthesis of glucosinolates from amino acids.'
p10582
assS'path:map03060'
p10583
(dp10584
S'NAME'
p10585
(lp10586
S'Protein export'
p10587
asS'REFERENCE'
p10588
(lp10589
S'PMID:10087917'
p10590
ag10590
aS'AUTHORS'
p10591
aS'Dalbey RE, Robinson C.'
p10592
aS'TITLE'
p10593
aS'Protein translocation into and across the bacterial plasma membrane and the plant thylakoid membrane.'
p10594
aS'JOURNAL'
p10595
aS'Trends Biochem Sci 24:17-22 (1999)'
p10596
aS'PMID:10652088'
p10597
ag10597
aS'AUTHORS'
p10598
aS'Berks BC, Sargent F, Palmer T.'
p10599
aS'TITLE'
p10600
aS'The Tat protein export pathway.'
p10601
aS'JOURNAL'
p10602
aS'Mol Microbiol 35:260-74 (2000)'
p10603
aS'PMID:10747959'
p10604
ag10604
aS'AUTHORS'
p10605
aS'Wexler M, Sargent F, Jack RL, Stanley NR, Bogsch EG, Robinson C, Berks BC, Palmer T.'
p10606
aS'TITLE'
p10607
aS'TatD is a cytoplasmic protein with DNase activity. No requirement for TatD family proteins in sec-independent protein export.'
p10608
aS'JOURNAL'
p10609
aS'J Biol Chem 275:16717-22 (2000)'
p10610
aS'PMID:11007775'
p10611
ag10611
aS'AUTHORS'
p10612
aS'Jongbloed JD, Martin U, Antelmann H, Hecker M, Tjalsma H, Venema G, Bron S, van Dijl JM, Muller J.'
p10613
aS'TITLE'
p10614
aS'TatC is a specificity determinant for protein secretion via the twin-arginine translocation pathway.'
p10615
aS'JOURNAL'
p10616
aS'J Biol Chem 275:41350-7 (2000)'
p10617
aS'PMID:18046402'
p10618
ag10618
aS'AUTHORS'
p10619
aS'Rapoport TA'
p10620
aS'TITLE'
p10621
aS'Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes.'
p10622
aS'JOURNAL'
p10623
aS'Nature 450:663-9 (2007)'
p10624
aS'PMID:17368028'
p10625
ag10625
aS'AUTHORS'
p10626
aS'Flower AM'
p10627
aS'TITLE'
p10628
aS'The SecY translocation complex: convergence of genetics and structure.'
p10629
aS'JOURNAL'
p10630
aS'Trends Microbiol 15:203-10 (2007)'
p10631
aS'PMID:16212506'
p10632
ag10632
aS'AUTHORS'
p10633
aS'Osborne AR, Rapoport TA, van den Berg B'
p10634
aS'TITLE'
p10635
aS'Protein translocation by the Sec61/SecY channel.'
p10636
aS'JOURNAL'
p10637
aS'Annu Rev Cell Dev Biol 21:529-50 (2005)'
p10638
aS'PMID:12475201'
p10639
ag10639
aS'AUTHORS'
p10640
aS'Paetzel M, Karla A, Strynadka NC, Dalbey RE'
p10641
aS'TITLE'
p10642
aS'Signal peptidases.'
p10643
aS'JOURNAL'
p10644
aS'Chem Rev 102:4549-80 (2002)'
p10645
aS'PMID:10924740'
p10646
ag10646
aS'AUTHORS'
p10647
aS'Paetzel M, Dalbey RE, Strynadka NC'
p10648
aS'TITLE'
p10649
aS'The structure and mechanism of bacterial type I signal peptidases. A novel antibiotic target.'
p10650
aS'JOURNAL'
p10651
aS'Pharmacol Ther 87:27-49 (2000)'
p10652
aS'PMID:17259602'
p10653
ag10653
aS'AUTHORS'
p10654
aS'Ng SY, Chaban B, VanDyke DJ, Jarrell KF'
p10655
aS'TITLE'
p10656
aS'Archaeal signal peptidases.'
p10657
aS'JOURNAL'
p10658
aS'Microbiology 153:305-14 (2007)'
p10659
aS'PMID:19299134'
p10660
ag10660
aS'AUTHORS'
p10661
aS'Desvaux M, Hebraud M, Talon R, Henderson IR'
p10662
aS'TITLE'
p10663
aS'Secretion and subcellular localizations of bacterial proteins: a semantic awareness issue.'
p10664
aS'JOURNAL'
p10665
aS'Trends Microbiol 17:139-45 (2009)'
p10666
aS'PMID:15063851'
p10667
ag10667
aS'AUTHORS'
p10668
aS'Nakatogawa H, Murakami A, Ito K'
p10669
aS'TITLE'
p10670
aS'Control of SecA and SecM translation by protein secretion.'
p10671
aS'JOURNAL'
p10672
aS'Curr Opin Microbiol 7:145-50 (2004)'
p10673
asS'KO_PATHWAY'
p10674
(lp10675
S'ko03060'
p10676
asS'PATHWAY_MAP'
p10677
(lp10678
S'map03060'
p10679
asS'MODULE'
p10680
(lp10681
S'M00401'
p10682
aS'Sec61 complex [PATH:map03060]'
p10683
asS'DBLINKS'
p10684
(lp10685
S'GO: 0043952 0043953'
p10686
asS'ENTRY'
p10687
(lp10688
S'map03060'
p10689
aS'Pathway'
p10690
asS'CLASS'
p10691
(lp10692
S'Genetic Information Processing Folding, sorting and degradation'
p10693
asS'DESCRIPTION'
p10694
(lp10695
S'The protein export is the active transport of proteins from the cytoplasm to the exterior of the cell, or to the periplasmic compartment in Gram-negative bacteria. The sec dependent pathway is the general protein export system that transports newly synthesized proteins into or across the cell membrane. The translocation channel is formed from a conserved trimeric membrane protein complex, called the Sec61/SecY complex. The twin-arginine translocation (Tat) pathway is another protein transport system that transports folded proteins in bacteria, archaea, and chloroplasts. Many Tat systems comprise three functionally different membrane proteins, TatA, TatB, and TatC, but TatA and TatE seem to have overlapping functions, with TatA having by far the more important role.'
p10696
assS'path:map04024'
p10697
(dp10698
S'NAME'
p10699
(lp10700
S'cAMP signaling pathway'
p10701
asS'REFERENCE'
p10702
(lp10703
S'PMID:11493633'
p10704
ag10704
aS'AUTHORS'
p10705
aS'Fimia GM, Sassone-Corsi P'
p10706
aS'TITLE'
p10707
aS'Cyclic AMP signalling.'
p10708
aS'JOURNAL'
p10709
aS'J Cell Sci 114:1971-2 (2001)'
p10710
aS'PMID:18323530'
p10711
ag10711
aS'AUTHORS'
p10712
aS'Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M'
p10713
aS'TITLE'
p10714
aS'Cyclic AMP: master regulator of innate immune cell function.'
p10715
aS'JOURNAL'
p10716
aS'Am J Respir Cell Mol Biol 39:127-32 (2008)'
p10717
aS'PMID:24281338'
p10718
ag10718
aS'AUTHORS'
p10719
aS'Oldenburger A, Maarsingh H, Schmidt M'
p10720
aS'TITLE'
p10721
aS'Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung.'
p10722
aS'JOURNAL'
p10723
aS'Pharmaceuticals (Basel) 5:1291-331 (2012)'
p10724
aS'PMID:24613710'
p10725
ag10725
aS'AUTHORS'
p10726
aS'Ahuja M, Jha A, Maleth J, Park S, Muallem S'
p10727
aS'TITLE'
p10728
aS'cAMP and Ca signaling in secretory epithelia: Crosstalk and synergism.'
p10729
aS'JOURNAL'
p10730
aS'Cell Calcium 55:385-393 (2014)'
p10731
aS'PMID:22082266'
p10732
ag10732
aS'AUTHORS'
p10733
aS'Shirshev SV'
p10734
aS'TITLE'
p10735
aS'Role of Epac proteins in mechanisms of cAMP-dependent immunoregulation.'
p10736
aS'JOURNAL'
p10737
aS'Biochemistry (Mosc) 76:981-98 (2011)'
p10738
aS'PMID:18176800'
p10739
ag10739
aS'AUTHORS'
p10740
aS'Roscioni SS, Elzinga CR, Schmidt M'
p10741
aS'TITLE'
p10742
aS'Epac: effectors and biological functions.'
p10743
aS'JOURNAL'
p10744
aS'Naunyn Schmiedebergs Arch Pharmacol 377:345-57 (2008)'
p10745
aS'PMID:24450633'
p10746
ag10746
aS'AUTHORS'
p10747
aS'Roberts OL, Dart C'
p10748
aS'TITLE'
p10749
aS'cAMP signalling in the vasculature: the role of Epac (exchange protein directly activated by cAMP).'
p10750
aS'JOURNAL'
p10751
aS'Biochem Soc Trans 42:89-97 (2014)'
p10752
aS'PMID:16765984'
p10753
ag10753
aS'AUTHORS'
p10754
aS'Schaub MC, Hefti MA, Zaugg M'
p10755
aS'TITLE'
p10756
aS'Integration of calcium with the signaling network in cardiac myocytes.'
p10757
aS'JOURNAL'
p10758
aS'J Mol Cell Cardiol 41:183-214 (2006)'
p10759
aS'PMID:19874988'
p10760
ag10760
aS'AUTHORS'
p10761
aS'Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J'
p10762
aS'TITLE'
p10763
aS'The sympathetic nervous system in heart failure physiology, pathophysiology, and'
p10764
aS'clinical implications.'
p10765
aS'JOURNAL'
p10766
aS'J Am Coll Cardiol 54:1747-62 (2009)'
p10767
aS'PMID:15142747'
p10768
ag10768
aS'AUTHORS'
p10769
aS'Saucerman JJ, McCulloch AD'
p10770
aS'TITLE'
p10771
aS'Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation.'
p10772
aS'JOURNAL'
p10773
aS'Prog Biophys Mol Biol 85:261-78 (2004)'
p10774
aS'PMID:21212391'
p10775
ag10775
aS'AUTHORS'
p10776
aS'Yang JH, Saucerman JJ'
p10777
aS'TITLE'
p10778
aS'Computational models reduce complexity and accelerate insight into cardiac signaling networks.'
p10779
aS'JOURNAL'
p10780
aS'Circ Res 108:85-97 (2011)'
p10781
aS'PMID:22022314'
p10782
ag10782
aS'AUTHORS'
p10783
aS'Taggart P, Boyett MR, Logantha S, Lambiase PD'
p10784
aS'TITLE'
p10785
aS'Anger, emotion, and arrhythmias: from brain to heart.'
p10786
aS'JOURNAL'
p10787
aS'Front Physiol 2:67 (2011)'
p10788
aS'PMID:21852968'
p10789
ag10789
aS'AUTHORS'
p10790
aS'Bozzi Y, Dunleavy M, Henshall DC'
p10791
aS'TITLE'
p10792
aS'Cell signaling underlying epileptic behavior.'
p10793
aS'JOURNAL'
p10794
aS'Front Behav Neurosci 5:45 (2011)'
p10795
aS'PMID:10880354'
p10796
ag10796
aS'AUTHORS'
p10797
aS'Lizcano JM, Morrice N, Cohen P'
p10798
aS'TITLE'
p10799
aS'Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155.'
p10800
aS'JOURNAL'
p10801
aS'Biochem J 349:547-57 (2000)'
p10802
aS'PMID:21744067'
p10803
ag10803
aS'AUTHORS'
p10804
aS'Gerlo S, Kooijman R, Beck IM, Kolmus K, Spooren A, Haegeman G'
p10805
aS'TITLE'
p10806
aS'Cyclic AMP: a selective modulator of NF-kappaB action.'
p10807
aS'JOURNAL'
p10808
aS'Cell Mol Life Sci 68:3823-41 (2011)'
p10809
aS'PMID:7688165'
p10810
ag10810
aS'AUTHORS'
p10811
aS'Lauder JM'
p10812
aS'TITLE'
p10813
aS'Neurotransmitters as growth regulatory signals: role of receptors and second messengers.'
p10814
aS'JOURNAL'
p10815
aS'Trends Neurosci 16:233-40 (1993)'
p10816
aS'PMID:17077866'
p10817
ag10817
aS'AUTHORS'
p10818
aS'Voglis G, Tavernarakis N'
p10819
aS'TITLE'
p10820
aS'The role of synaptic ion channels in synaptic plasticity.'
p10821
aS'JOURNAL'
p10822
aS'EMBO Rep 7:1104-10 (2006)'
p10823
aS'PMID:21346730'
p10824
ag10824
aS'AUTHORS'
p10825
aS'Altarejos JY, Montminy M'
p10826
aS'TITLE'
p10827
aS'CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.'
p10828
aS'JOURNAL'
p10829
aS'Nat Rev Mol Cell Biol 12:141-51 (2011)'
p10830
aS'PMID:24062645'
p10831
ag10831
aS'AUTHORS'
p10832
aS'Bozzi Y, Borrelli E'
p10833
aS'TITLE'
p10834
aS'The role of dopamine signaling in epileptogenesis.'
p10835
aS'JOURNAL'
p10836
aS'Front Cell Neurosci 7:157 (2013)'
p10837
aS'PMID:14715909'
p10838
ag10838
aS'AUTHORS'
p10839
aS'Ceulemans H, Bollen M'
p10840
aS'TITLE'
p10841
aS'Functional diversity of protein phosphatase-1, a cellular economizer and reset button.'
p10842
aS'JOURNAL'
p10843
aS'Physiol Rev 84:1-39 (2004)'
p10844
aS'PMID:16571352'
p10845
ag10845
aS'AUTHORS'
p10846
aS'Lipinski RJ, Gipp JJ, Zhang J, Doles JD, Bushman W'
p10847
aS'TITLE'
p10848
aS'Unique and complimentary activities of the Gli transcription factors in Hedgehog'
p10849
aS'signaling.'
p10850
aS'JOURNAL'
p10851
aS'Exp Cell Res 312:1925-38 (2006)'
p10852
aS'PMID:21693691'
p10853
ag10853
aS'AUTHORS'
p10854
aS'Lasala C, Schteingart HF, Arouche N, Bedecarras P, Grinspon RP, Picard JY, Josso N, di Clemente N, Rey RA'
p10855
aS'TITLE'
p10856
aS'SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Mullerian gene expression in the testicular prepubertal Sertoli cell line SMAT1.'
p10857
aS'JOURNAL'
p10858
aS'Am J Physiol Endocrinol Metab 301:E539-47 (2011)'
p10859
aS'PMID:19460777'
p10860
ag10860
aS'AUTHORS'
p10861
aS'Rosenkranz AC, Rauch BH, Freidel K, Schror K'
p10862
aS'TITLE'
p10863
aS'Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT.'
p10864
aS'JOURNAL'
p10865
aS'Cardiovasc Res 83:778-84 (2009)'
p10866
aS'PMID:11117527'
p10867
ag10867
aS'AUTHORS'
p10868
aS'Lazennec G, Canaple L, Saugy D, Wahli W'
p10869
aS'TITLE'
p10870
aS'Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.'
p10871
aS'JOURNAL'
p10872
aS'Mol Endocrinol 14:1962-75 (2000)'
p10873
aS'PMID:16460276'
p10874
ag10874
aS'AUTHORS'
p10875
aS'Murthy KS'
p10876
aS'TITLE'
p10877
aS'Signaling for contraction and relaxation in smooth muscle of the gut.'
p10878
aS'JOURNAL'
p10879
aS'Annu Rev Physiol 68:345-74 (2006)'
p10880
aS'PMID:18064650'
p10881
ag10881
aS'AUTHORS'
p10882
aS'Birukova AA, Zagranichnaya T, Alekseeva E, Bokoch GM, Birukov KG'
p10883
aS'TITLE'
p10884
aS'Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.'
p10885
aS'JOURNAL'
p10886
aS'J Cell Physiol 215:715-24 (2008)'
p10887
aS'PMID:9204709'
p10888
ag10888
aS'AUTHORS'
p10889
aS'Houslay MD, Milligan G'
p10890
aS'TITLE'
p10891
aS'Tailoring cAMP-signalling responses through isoform multiplicity.'
p10892
aS'JOURNAL'
p10893
aS'Trends Biochem Sci 22:217-24 (1997)'
p10894
asS'KO_PATHWAY'
p10895
(lp10896
S'ko04024'
p10897
asS'PATHWAY_MAP'
p10898
(lp10899
S'map04024'
p10900
asS'MODULE'
p10901
(lp10902
S'M00695'
p10903
aS'cAMP signaling [PATH:map04024]'
p10904
asS'DBLINKS'
p10905
(lp10906
S'GO: 0019933'
p10907
asS'ENTRY'
p10908
(lp10909
S'map04024'
p10910
aS'Pathway'
p10911
asS'CLASS'
p10912
(lp10913
S'Environmental Information Processing Signal transduction'
p10914
asS'DESCRIPTION'
p10915
(lp10916
S'cAMP is one of the most common and universal second messengers, and its formation is promoted by adenylyl cyclase (AC) activation after ligation of G protein-coupled receptors (GPCRs) by ligands including hormones, neurotransmitters, and other signaling molecules. cAMP regulates pivotal physiologic processes including metabolism, secretion, calcium homeostasis, muscle contraction, cell fate, and gene transcription. cAMP acts directly on three main targets: protein kinase A (PKA), the exchange protein activated by cAMP (Epac), and cyclic nucleotide-gated ion channels (CNGCs). PKA modulates, via phosphorylation, a number of cellular substrates, including transcription factors, ion channels, transporters, exchangers, intracellular Ca2+ -handling proteins, and the contractile machinery. Epac proteins function as guanine nucleotide exchange factors (GEFs) for both Rap1 and Rap2. Various effector proteins, including adaptor proteins implicated in modulation of the actin cytoskeleton, regulators of G proteins of the Rho family, and phospholipases, relay signaling downstream from Rap.'
p10917
assS'path:map01501'
p10918
(dp10919
S'NAME'
p10920
(lp10921
S'beta-Lactam resistance'
p10922
asS'REFERENCE'
p10923
(lp10924
S'PMID:23034325'
p10925
ag10925
aS'AUTHORS'
p10926
aS'Fernandez L, Hancock RE'
p10927
aS'TITLE'
p10928
aS'Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.'
p10929
aS'JOURNAL'
p10930
aS'Clin Microbiol Rev 25:661-81 (2012)'
p10931
aS'PMID:21149619'
p10932
ag10932
aS'AUTHORS'
p10933
aS'Muller C, Plesiat P, Jeannot K'
p10934
aS'TITLE'
p10935
aS'A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and beta-lactams in Pseudomonas aeruginosa.'
p10936
aS'JOURNAL'
p10937
aS'Antimicrob Agents Chemother 55:1211-21 (2011)'
p10938
aS'PMID:20351243'
p10939
ag10939
aS'AUTHORS'
p10940
aS'Tanabe M, Nimigean CM, Iverson TM'
p10941
aS'TITLE'
p10942
aS'Structural basis for solute transport, nucleotide regulation, and immunological recognition of Neisseria meningitidis PorB.'
p10943
aS'JOURNAL'
p10944
aS'Proc Natl Acad Sci U S A 107:6811-6 (2010)'
p10945
aS'PMID:9797206'
p10946
ag10946
aS'AUTHORS'
p10947
aS'Gill MJ, Simjee S, Al-Hattawi K, Robertson BD, Easmon CS, Ison CA'
p10948
aS'TITLE'
p10949
aS'Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop'
p10950
aS'3 of the porin encoded at the penB locus.'
p10951
aS'JOURNAL'
p10952
aS'Antimicrob Agents Chemother 42:2799-803 (1998)'
p10953
aS'PMID:23163477'
p10954
ag10954
aS'AUTHORS'
p10955
aS'Johnson JW, Fisher JF, Mobashery S'
p10956
aS'TITLE'
p10957
aS'Bacterial cell-wall recycling.'
p10958
aS'JOURNAL'
p10959
aS'Ann N Y Acad Sci 1277:54-75 (2013)'
p10960
aS'PMID:22438804'
p10961
ag10961
aS'AUTHORS'
p10962
aS'Amoroso A, Boudet J, Berzigotti S, Duval V, Teller N, Mengin-Lecreulx D, Luxen A, Simorre JP, Joris B'
p10963
aS'TITLE'
p10964
aS'A peptidoglycan fragment triggers beta-lactam resistance in Bacillus licheniformis.'
p10965
aS'JOURNAL'
p10966
aS'PLoS Pathog 8:e1002571 (2012)'
p10967
aS'PMID:19154333'
p10968
ag10968
aS'AUTHORS'
p10969
aS'Sala C, Haouz A, Saul FA, Miras I, Rosenkrands I, Alzari PM, Cole ST'
p10970
aS'TITLE'
p10971
aS'Genome-wide regulon and crystal structure of BlaI (Rv1846c) from Mycobacterium tuberculosis.'
p10972
aS'JOURNAL'
p10973
aS'Mol Microbiol 71:1102-16 (2009)'
p10974
aS'PMID:18248419'
p10975
ag10975
aS'AUTHORS'
p10976
aS'Zapun A, Contreras-Martel C, Vernet T'
p10977
aS'TITLE'
p10978
aS'Penicillin-binding proteins and beta-lactam resistance.'
p10979
aS'JOURNAL'
p10980
aS'FEMS Microbiol Rev 32:361-85 (2008)'
p10981
aS'PMID:19258280'
p10982
ag10982
aS'AUTHORS'
p10983
aS'Vettoretti L, Plesiat P, Muller C, El Garch F, Phan G, Attree I, Ducruix A, Llanes C'
p10984
aS'TITLE'
p10985
aS'Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.'
p10986
aS'JOURNAL'
p10987
aS'Antimicrob Agents Chemother 53:1987-97 (2009)'
p10988
aS'PMID:15387820'
p10989
ag10989
aS'AUTHORS'
p10990
aS'Cao L, Srikumar R, Poole K'
p10991
aS'TITLE'
p10992
aS'MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719.'
p10993
aS'JOURNAL'
p10994
aS'Mol Microbiol 53:1423-36 (2004)'
p10995
aS'PMID:11895293'
p10996
ag10996
aS'AUTHORS'
p10997
aS'Poole K, Srikumar R'
p10998
aS'TITLE'
p10999
aS'Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance.'
p11000
aS'JOURNAL'
p11001
aS'Curr Top Med Chem 1:59-71 (2001)'
p11002
aS'PMID:15855496'
p11003
ag11003
aS'AUTHORS'
p11004
aS'Sobel ML, Hocquet D, Cao L, Plesiat P, Poole K'
p11005
aS'TITLE'
p11006
aS'Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug'
p11007
aS'resistance in laboratory and clinical isolates of Pseudomonas aeruginosa.'
p11008
aS'JOURNAL'
p11009
aS'Antimicrob Agents Chemother 49:1782-6 (2005)'
p11010
aS'PMID:15105114'
p11011
ag11011
aS'AUTHORS'
p11012
aS'Kaczmarek FS, Gootz TD, Dib-Hajj F, Shang W, Hallowell S, Cronan M'
p11013
aS'TITLE'
p11014
aS'Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin.'
p11015
aS'JOURNAL'
p11016
aS'Antimicrob Agents Chemother 48:1630-9 (2004)'
p11017
aS'PMID:16048914'
p11018
ag11018
aS'AUTHORS'
p11019
aS'Dean CR, Narayan S, Daigle DM, Dzink-Fox JL, Puyang X, Bracken KR, Dean KE, Weidmann B, Yuan Z, Jain R, Ryder NS'
p11020
aS'TITLE'
p11021
aS'Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415.'
p11022
aS'JOURNAL'
p11023
aS'Antimicrob Agents Chemother 49:3129-35 (2005)'
p11024
aS'PMID:22371895'
p11025
ag11025
aS'AUTHORS'
p11026
aS'Rosenfeld N, Bouchier C, Courvalin P, Perichon B'
p11027
aS'TITLE'
p11028
aS'Expression of the resistance-nodulation-cell division pump AdeIJK in Acinetobacter baumannii is regulated by AdeN, a TetR-type regulator.'
p11029
aS'JOURNAL'
p11030
aS'Antimicrob Agents Chemother 56:2504-10 (2012)'
p11031
aS'PMID:21173183'
p11032
ag11032
aS'AUTHORS'
p11033
aS'Coyne S, Courvalin P, Perichon B'
p11034
aS'TITLE'
p11035
aS'Efflux-mediated antibiotic resistance in Acinetobacter spp.'
p11036
aS'JOURNAL'
p11037
aS'Antimicrob Agents Chemother 55:947-53 (2011)'
p11038
aS'PMID:19026770'
p11039
ag11039
aS'AUTHORS'
p11040
aS'Nikaido H, Takatsuka Y'
p11041
aS'TITLE'
p11042
aS'Mechanisms of RND multidrug efflux pumps.'
p11043
aS'JOURNAL'
p11044
aS'Biochim Biophys Acta 1794:769-81 (2009)'
p11045
aS'PMID:17277059'
p11046
ag11046
aS'AUTHORS'
p11047
aS'Truong-Bolduc QC, Hooper DC'
p11048
aS'TITLE'
p11049
aS'The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus.'
p11050
aS'JOURNAL'
p11051
aS'J Bacteriol 189:2996-3005 (2007)'
p11052
aS'PMID:12222968'
p11053
ag11053
aS'AUTHORS'
p11054
aS'Sauvage E, Kerff F, Fonze E, Herman R, Schoot B, Marquette JP, Taburet Y, Prevost D, Dumas J, Leonard G, Stefanic P, Coyette J, Charlier P'
p11055
aS'TITLE'
p11056
aS'The 2.4-A crystal structure of the penicillin-resistant penicillin-binding protein PBP5fm from Enterococcus faecium in complex with benzylpenicillin.'
p11057
aS'JOURNAL'
p11058
aS'Cell Mol Life Sci 59:1223-32 (2002)'
p11059
aS'PMID:16143832'
p11060
ag11060
aS'AUTHORS'
p11061
aS'Fuda CC, Fisher JF, Mobashery S'
p11062
aS'TITLE'
p11063
aS'Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome.'
p11064
aS'JOURNAL'
p11065
aS'Cell Mol Life Sci 62:2617-33 (2005)'
p11066
asS'KO_PATHWAY'
p11067
(lp11068
S'ko01501'
p11069
asS'PATHWAY_MAP'
p11070
(lp11071
S'map01501'
p11072
asS'MODULE'
p11073
(lp11074
S'M00625'
p11075
aS'Methicillin resistance [PATH:map01501]'
p11076
ag11075
ag11076
aS'M00627'
p11077
aS'beta-Lactam resistance, Bla system [PATH:map01501]'
p11078
aS'M00628'
p11079
aS'beta-Lactam resistance, AmpC system [PATH:map01501]'
p11080
aS'M00649'
p11081
aS'Multidrug resistance, efflux pump AdeABC [PATH:map01501]'
p11082
aS'M00654'
p11083
aS'ParS-ParR (polymyxin-adaptive resistance) two-component regulatory system [PATH:map01501]'
p11084
aS'M00655'
p11085
aS'AdeS-AdeR two-component regulatory system [PATH:map01501]'
p11086
asS'ENTRY'
p11087
(lp11088
S'map01501'
p11089
aS'Global'
p11090
aS'Pathway'
p11091
asS'CLASS'
p11092
(lp11093
S'Human Diseases Drug resistance'
p11094
asS'DESCRIPTION'
p11095
(lp11096
S'The beta-lactam antibiotics are the most widely used group of antibiotics, which exert their effect by interfering with the structural crosslinking of peptidoglycans in bacterial cell walls. Over the past decades, a rapid increase in the number of beta-lactam-resistant clinical isolates is observed. Bacterial resistance to beta-lactam antibiotics can be achieved by any of the following strategies: producing inactivating enzymes called beta-lactamases, altering the beta-lactam targets of penicillin-binding proteins (PBPs), reducing transport of beta-lactams into the periplasmic space via changes in porins, and using the mechanisms for exclusion of beta-lactams by way of efflux pumps. Resistance may result from intrinsic properties of organisms, through gene mutations, and through plasmid- and transposon-specified genes.'
p11097
assS'path:map01502'
p11098
(dp11099
S'NAME'
p11100
(lp11101
S'Vancomycin resistance'
p11102
asS'REFERENCE'
p11103
(lp11104
S'PMID:16323116'
p11105
ag11105
aS'AUTHORS'
p11106
aS'Courvalin P'
p11107
aS'TITLE'
p11108
aS'Vancomycin resistance in gram-positive cocci.'
p11109
aS'JOURNAL'
p11110
aS'Clin Infect Dis 42 Suppl 1:S25-34 (2006)'
p11111
aS'PMID:22913355'
p11112
ag11112
aS'AUTHORS'
p11113
aS'Chancey ST, Zahner D, Stephens DS'
p11114
aS'TITLE'
p11115
aS'Acquired inducible antimicrobial resistance in Gram-positive bacteria.'
p11116
aS'JOURNAL'
p11117
aS'Future Microbiol 7:959-78 (2012)'
p11118
aS'PMID:8899966'
p11119
ag11119
aS'AUTHORS'
p11120
aS'Arthur M, Reynolds P, Courvalin P'
p11121
aS'TITLE'
p11122
aS'Glycopeptide resistance in enterococci.'
p11123
aS'JOURNAL'
p11124
aS'Trends Microbiol 4:401-7 (1996)'
p11125
aS'PMID:11023964'
p11126
ag11126
aS'AUTHORS'
p11127
aS'Cetinkaya Y, Falk P, Mayhall CG'
p11128
aS'TITLE'
p11129
aS'Vancomycin-resistant enterococci.'
p11130
aS'JOURNAL'
p11131
aS'Clin Microbiol Rev 13:686-707 (2000)'
p11132
aS'PMID:7854121'
p11133
ag11133
aS'AUTHORS'
p11134
aS'Reynolds PE, Depardieu F, Dutka-Malen S, Arthur M, Courvalin P'
p11135
aS'TITLE'
p11136
aS'Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.'
p11137
aS'JOURNAL'
p11138
aS'Mol Microbiol 13:1065-70 (1994)'
p11139
aS'PMID:8631706'
p11140
ag11140
aS'AUTHORS'
p11141
aS'Evers S, Courvalin P'
p11142
aS'TITLE'
p11143
aS'Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583.'
p11144
aS'JOURNAL'
p11145
aS'J Bacteriol 178:1302-9 (1996)'
p11146
aS'PMID:10564477'
p11147
ag11147
aS'AUTHORS'
p11148
aS'Reynolds PE, Arias CA, Courvalin P'
p11149
aS'TITLE'
p11150
aS'Gene vanXYC encodes D,D -dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174.'
p11151
aS'JOURNAL'
p11152
aS'Mol Microbiol 34:341-9 (1999)'
p11153
aS'PMID:12047383'
p11154
ag11154
aS'AUTHORS'
p11155
aS'Podmore AH, Reynolds PE'
p11156
aS'TITLE'
p11157
aS'Purification and characterization of VanXY(C), a D,D-dipeptidase/D,D-carboxypeptidase in vancomycin-resistant Enterococcus gallinarum BM4174.'
p11158
aS'JOURNAL'
p11159
aS'Eur J Biochem 269:2740-6 (2002)'
p11160
aS'PMID:15616270'
p11161
ag11161
aS'AUTHORS'
p11162
aS'Reynolds PE, Courvalin P'
p11163
aS'TITLE'
p11164
aS'Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine.'
p11165
aS'JOURNAL'
p11166
aS'Antimicrob Agents Chemother 49:21-5 (2005)'
p11167
aS'PMID:10878136'
p11168
ag11168
aS'AUTHORS'
p11169
aS'Arias CA, Weisner J, Blackburn JM, Reynolds PE'
p11170
aS'TITLE'
p11171
aS'Serine and alanine racemase activities of VanT: a protein necessary for vancomycin resistance in Enterococcus gallinarum BM4174.'
p11172
aS'JOURNAL'
p11173
aS'Microbiology 146 ( Pt 7):1727-34 (2000)'
p11174
aS'PMID:18792691'
p11175
ag11175
aS'AUTHORS'
p11176
aS'Hong HJ, Hutchings MI, Buttner MJ'
p11177
aS'TITLE'
p11178
aS'Vancomycin resistance VanS/VanR two-component systems.'
p11179
aS'JOURNAL'
p11180
aS'Adv Exp Med Biol 631:200-13 (2008)'
p11181
aS'PMID:14617152'
p11182
ag11182
aS'AUTHORS'
p11183
aS'Depardieu F, Bonora MG, Reynolds PE, Courvalin P'
p11184
aS'TITLE'
p11185
aS'The vanG glycopeptide resistance operon from Enterococcus faecalis revisited.'
p11186
aS'JOURNAL'
p11187
aS'Mol Microbiol 50:931-48 (2003)'
p11188
aS'PMID:11036060'
p11189
ag11189
aS'AUTHORS'
p11190
aS'McKessar SJ, Berry AM, Bell JM, Turnidge JD, Paton JC'
p11191
aS'TITLE'
p11192
aS'Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis.'
p11193
aS'JOURNAL'
p11194
aS'Antimicrob Agents Chemother 44:3224-8 (2000)'
p11195
aS'PMID:23836175'
p11196
ag11196
aS'AUTHORS'
p11197
aS'Kwun MJ, Novotna G, Hesketh AR, Hill L, Hong HJ'
p11198
aS'TITLE'
p11199
aS'In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall.'
p11200
aS'JOURNAL'
p11201
aS'Antimicrob Agents Chemother 57:4470-80 (2013)'
p11202
aS'PMID:15130128'
p11203
ag11203
aS'AUTHORS'
p11204
aS'Hong HJ, Hutchings MI, Neu JM, Wright GD, Paget MS, Buttner MJ'
p11205
aS'TITLE'
p11206
aS'Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.'
p11207
aS'JOURNAL'
p11208
aS'Mol Microbiol 52:1107-21 (2004)'
p11209
aS'PMID:15632111'
p11210
ag11210
aS'AUTHORS'
p11211
aS'Hong HJ, Hutchings MI, Hill LM, Buttner MJ'
p11212
aS'TITLE'
p11213
aS'The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor.'
p11214
aS'JOURNAL'
p11215
aS'J Biol Chem 280:13055-61 (2005)'
p11216
aS'PMID:16420361'
p11217
ag11217
aS'AUTHORS'
p11218
aS'Hutchings MI, Hong HJ, Buttner MJ'
p11219
aS'TITLE'
p11220
aS'The vancomycin resistance VanRS two-component signal transduction system of Streptomyces coelicolor.'
p11221
aS'JOURNAL'
p11222
aS'Mol Microbiol 59:923-35 (2006)'
p11223
aS'PMID:21569315'
p11224
ag11224
aS'AUTHORS'
p11225
aS'Hesketh A, Hill C, Mokhtar J, Novotna G, Tran N, Bibb M, Hong HJ'
p11226
aS'TITLE'
p11227
aS'Genome-wide dynamics of a bacterial response to antibiotics that target the cell'
p11228
aS'envelope.'
p11229
aS'JOURNAL'
p11230
aS'BMC Genomics 12:226 (2011)'
p11231
aS'PMID:20383152'
p11232
ag11232
aS'AUTHORS'
p11233
aS'Koteva K, Hong HJ, Wang XD, Nazi I, Hughes D, Naldrett MJ, Buttner MJ, Wright GD'
p11234
aS'TITLE'
p11235
aS'A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor.'
p11236
aS'JOURNAL'
p11237
aS'Nat Chem Biol 6:327-9 (2010)'
p11238
asS'KO_PATHWAY'
p11239
(lp11240
S'ko01502'
p11241
asS'PATHWAY_MAP'
p11242
(lp11243
S'map01502'
p11244
asS'DESCRIPTION Vancomycin (VCM) is a glycopeptide antibiotic agent that inhibits the synthesis of peptidolgycan in the production of bacterial cell walls. It is active in most Gram-positive bacteria and acts by binding to the D-Ala-D-Ala C-terminus of pentapeptide, thus blocking the addition of subunits to the peptidoglycan backbone. The resistance to VCM was first described among enterococci in the late 1980s in Europe. Subsequently, vancomycin-resistant enteococci (VRE) have been observed in many countries. The genes encoding resistance are carried on plasmids that can tranfer themselves from cell to cell and on tranponsons that can jump from plamids to the chromosome. Up to now, at least six resistance operon types are characterized, namely VanA, VanB, VanC, VanD, VanE and VanG. The VanA and VanB operons are detected on plasmids or in the chromosome, whereas the rest are found in the chromosome. In addition, Streptomyces, which is non-pathogenic, non-glycopeptide-producing actinomycete, also shows high-level resistance to'
p11245
(lp11246
S'VCM. In Streptomyces, novel genes (vanK and vanJ) are characterized with no counterparts found in the resistance clusters of pathogenic bacteria.'
p11247
aS'The expression of vancomycin resistance pathway is induced by the VanS-VanR two component system, and D-Ala-D-Lac or D-Ala-D-Ser dipsipeptides are formed in place of D-Ala-D-Ala dipeptide. Thus, VCM cannot bind to pentadepsipeptide[D-Lac] or pentadepsipeptide[D-Ser]. The D-Ala-D-Lac variation shows high levels of resistance to VCM, especially in VanA type, wheras the D-Ala-D-Ser variation shows low levels of resistance. The modified pepidoglycan can interact with cross-linking enzymes (PBPs), thus cell wall is successfully formed.'
p11248
asS'ENTRY'
p11249
(lp11250
S'map01502'
p11251
aS'Global'
p11252
aS'Pathway'
p11253
asS'CLASS'
p11254
(lp11255
S'Human Diseases Drug resistance'
p11256
asS'DESCRIPTION'
p11257
(lp11258
S'Vancomycin (VCM) is a glycopeptide antibiotic agent that inhibits the synthesis of peptidolgycan in the production of bacterial cell walls. It is active in most Gram-positive bacteria and acts by binding to the D-Ala-D-Ala C-terminus of pentapeptide, thus blocking the addition of subunits to the peptidoglycan backbone. The resistance to VCM was first described among enterococci in the late 1980s in Europe. Subsequently, vancomycin-resistant enteococci (VRE) have been observed in many countries. The genes encoding resistance are carried on plasmids that can tranfer themselves from cell to cell and on tranponsons that can jump from plamids to the chromosome. Up to now, at least six resistance operon types are characterized, namely VanA, VanB, VanC, VanD, VanE and VanG. The VanA and VanB operons are detected on plasmids or in the chromosome, whereas the rest are found in the chromosome. In addition, Streptomyces, which is non-pathogenic, non-glycopeptide-producing actinomycete, also shows high-level resistance to'
p11259
assS'path:map05221'
p11260
(dp11261
S'NAME'
p11262
(lp11263
S'Acute myeloid leukemia'
p11264
asS'REFERENCE'
p11265
(lp11266
S'PMID:16236521'
p11267
ag11267
aS'AUTHORS'
p11268
aS'Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.'
p11269
aS'TITLE'
p11270
aS'The molecular pathogenesis of acute myeloid leukemia.'
p11271
aS'JOURNAL'
p11272
aS'Crit Rev Oncol Hematol 56:195-221 (2005)'
p11273
aS'PMID:12563308'
p11274
ag11274
aS'AUTHORS'
p11275
aS'Tenen DG.'
p11276
aS'TITLE'
p11277
aS'Disruption of differentiation in human cancer: AML shows the way.'
p11278
aS'JOURNAL'
p11279
aS'Nat Rev Cancer 3:89-101 (2003)'
p11280
aS'PMID:16146838'
p11281
ag11281
aS'AUTHORS'
p11282
aS'Choudhary C, Muller-Tidow C, Berdel WE, Serve H.'
p11283
aS'TITLE'
p11284
aS'Signal transduction of oncogenic Flt3.'
p11285
aS'JOURNAL'
p11286
aS'Int J Hematol 82:93-9 (2005)'
p11287
aS'PMID:12951584'
p11288
ag11288
aS'AUTHORS'
p11289
aS'Stirewalt DL, Radich JP.'
p11290
aS'TITLE'
p11291
aS'The role of FLT3 in haematopoietic malignancies.'
p11292
aS'JOURNAL'
p11293
aS'Nat Rev Cancer 3:650-65 (2003)'
p11294
aS'PMID:16642045'
p11295
ag11295
aS'AUTHORS'
p11296
aS'Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.'
p11297
aS'TITLE'
p11298
aS'Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.'
p11299
aS'JOURNAL'
p11300
aS'Leukemia 20:911-28 (2006)'
p11301
aS'PMID:15625120'
p11302
ag11302
aS'AUTHORS'
p11303
aS'Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.'
p11304
aS'TITLE'
p11305
aS'Normal and oncogenic forms of the receptor tyrosine kinase kit.'
p11306
aS'JOURNAL'
p11307
aS'Stem Cells 23:16-43 (2005)'
p11308
aS'PMID:11721960'
p11309
ag11309
aS'AUTHORS'
p11310
aS'Lorsbach RB, Downing JR.'
p11311
aS'TITLE'
p11312
aS'The role of the AML1 transcription factor in leukemogenesis.'
p11313
aS'JOURNAL'
p11314
aS'Int J Hematol 74:258-65 (2001)'
p11315
aS'PMID:12468433'
p11316
ag11316
aS'AUTHORS'
p11317
aS'Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.'
p11318
aS'TITLE'
p11319
aS'Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.'
p11320
aS'JOURNAL'
p11321
aS'Blood 101:3164-73 (2003)'
p11322
aS'PMID:17554387'
p11323
ag11323
aS'AUTHORS'
p11324
aS'Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.'
p11325
aS'TITLE'
p11326
aS'The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.'
p11327
aS'JOURNAL'
p11328
aS'Leukemia : (2007)'
p11329
aS'PMID:16352814'
p11330
ag11330
aS'AUTHORS'
p11331
aS'Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.'
p11332
aS'TITLE'
p11333
aS'ATRA resolves the differentiation block in t(1517) acute myeloid leukemia by restoring PU.1 expression.'
p11334
aS'JOURNAL'
p11335
aS'Blood 107:3330-8 (2006)'
p11336
asS'KO_PATHWAY'
p11337
(lp11338
S'ko05221'
p11339
asS'PATHWAY_MAP'
p11340
(lp11341
S'map05221'
p11342
asS'DISEASE'
p11343
(lp11344
S'H00003'
p11345
aS'Acute myeloid leukemia (AML)'
p11346
asS'ENTRY'
p11347
(lp11348
S'map05221'
p11349
aS'Pathway'
p11350
asS'CLASS'
p11351
(lp11352
S'Human Diseases Cancers'
p11353
asS'DESCRIPTION'
p11354
(lp11355
S'Acute myeloid leukemia (AML) is a disease that is characterized by uncontrolled proliferation of clonal neoplastic cells and accumulation in the bone marrow of blasts with an impaired differentiation program. AML accounts for approximately 80% of all adult leukemias and remains the most common cause of leukemia death. Two major types of genetic events have been described that are crucial for leukemic transformation. A proposed necessary first event is disordered cell growth and upregulation of cell survival genes. The most common of these activating events were observed in the RTK Flt3, in N-Ras and K-Ras, in Kit, and sporadically in other RTKs. Alterations in myeloid transcription factors governing hematopoietic differentiation provide second necessary event for leukemogenesis. Transcription factor fusion proteins such as AML-ETO, PML-RARalpha or PLZF-RARalpha block myeloid cell differentiation by repressing target genes. In other cases,'
p11356
assS'path:map00190'
p11357
(dp11358
S'NAME'
p11359
(lp11360
S'Oxidative phosphorylation'
p11361
asS'REFERENCE'
p11362
(lp11363
S'PMID:16469879'
p11364
ag11364
aS'AUTHORS'
p11365
aS'Sazanov LA, Hinchliffe P.'
p11366
aS'TITLE'
p11367
aS'Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus.'
p11368
aS'JOURNAL'
p11369
aS'Science 311:1430-6 (2006)'
p11370
aS'PMID:16584177'
p11371
ag11371
aS'AUTHORS'
p11372
aS'Hinchliffe P, Carroll J, Sazanov LA.'
p11373
aS'TITLE'
p11374
aS'Identification of a novel subunit of respiratory complex I from Thermus thermophilus.'
p11375
aS'JOURNAL'
p11376
aS'Biochemistry 45:4413-20 (2006)'
p11377
asS'KO_PATHWAY'
p11378
(lp11379
S'ko00190'
p11380
asS'PATHWAY_MAP'
p11381
(lp11382
S'map00190'
p11383
asS'DISEASE'
p11384
(lp11385
S'H00068'
p11386
aS'Leber optic atrophy'
p11387
ag11386
ag11387
aS'H00473'
p11388
aS'Mitochondrial respiratory chain deficiencies (MRCD)'
p11389
aS'H00920'
p11390
aS'Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis'
p11391
aS'H01177'
p11392
aS'Infantile bilateral striatal necrosis (IBSN)'
p11393
aS'H01200'
p11394
aS'Fatal infantile cardioencephalomyopathy'
p11395
aS'H01222'
p11396
aS'Cowden-like syndrome'
p11397
aS'H01347'
p11398
aS'MELAS Syndrome'
p11399
aS'H01354'
p11400
aS'Leigh syndrome'
p11401
aS'H01355'
p11402
aS'Kearns-Sayre Syndrome'
p11403
aS'H01356'
p11404
aS'Myoclonic Epilepsy and Ragged-Red Fiber Disease'
p11405
aS'H01363'
p11406
aS'NARP syndrome'
p11407
aS'H01365'
p11408
aS'Leber hereditary optic neuropathy and dystonia (LDYT)'
p11409
aS'H01368'
p11410
aS'Cytochrome c oxidase (COX) deficiency'
p11411
aS'H01369'
p11412
aS'ATP synthase deficiency'
p11413
asS'MODULE'
p11414
(lp11415
S'M00142'
p11416
aS'NADH:ubiquinone oxidoreductase, mitochondria [PATH:map00190]'
p11417
ag11416
ag11417
aS'M00143'
p11418
aS'NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria [PATH:map00190]'
p11419
aS'M00144'
p11420
aS'NADH:quinone oxidoreductase, prokaryotes [PATH:map00190]'
p11421
aS'M00145'
p11422
aS'NAD(P)H:quinone oxidoreductase, chloroplasts and cyanobacteria [PATH:map00190]'
p11423
aS'M00146'
p11424
aS'NADH dehydrogenase (ubiquinone) 1 alpha subcomplex [PATH:map00190]'
p11425
aS'M00147'
p11426
aS'NADH dehydrogenase (ubiquinone) 1 beta subcomplex [PATH:map00190]'
p11427
aS'M00148'
p11428
aS'Succinate dehydrogenase (ubiquinone) [PATH:map00190]'
p11429
aS'M00149'
p11430
aS'Succinate dehydrogenase, prokaryotes [PATH:map00190]'
p11431
aS'M00150'
p11432
aS'Fumarate reductase, prokaryotes [PATH:map00190]'
p11433
aS'M00151'
p11434
aS'Cytochrome bc1 complex respiratory unit [PATH:map00190]'
p11435
aS'M00152'
p11436
aS'Cytochrome bc1 complex [PATH:map00190]'
p11437
aS'M00153'
p11438
aS'Cytochrome d ubiquinol oxidase [PATH:map00190]'
p11439
aS'M00154'
p11440
aS'Cytochrome c oxidase [PATH:map00190]'
p11441
aS'M00155'
p11442
aS'Cytochrome c oxidase, prokaryotes [PATH:map00190]'
p11443
aS'M00156'
p11444
aS'Cytochrome c oxidase, cbb3-type [PATH:map00190]'
p11445
aS'M00157'
p11446
aS'F-type ATPase, prokaryotes and chloroplasts [PATH:map00190]'
p11447
aS'M00158'
p11448
aS'F-type ATPase, eukaryotes [PATH:map00190]'
p11449
aS'M00159'
p11450
aS'V/A-type ATPase, prokaryotes [PATH:map00190]'
p11451
aS'M00160'
p11452
aS'V-type ATPase, eukaryotes [PATH:map00190]'
p11453
aS'M00416'
p11454
aS'Cytochrome aa3-600 menaquinol oxidase [PATH:map00190]'
p11455
aS'M00417'
p11456
aS'Cytochrome o ubiquinol oxidase [PATH:map00190]'
p11457
asS'ENTRY'
p11458
(lp11459
S'map00190'
p11460
aS'Pathway'
p11461
asS'CLASS'
p11462
(lp11463
S'Metabolism Energy metabolism'
p11464
assS'path:map05220'
p11465
(dp11466
S'NAME'
p11467
(lp11468
S'Chronic myeloid leukemia'
p11469
asS'REFERENCE'
p11470
(lp11471
S'PMID:15719031'
p11472
ag11472
aS'AUTHORS'
p11473
aS'Ren R.'
p11474
aS'TITLE'
p11475
aS'Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.'
p11476
aS'JOURNAL'
p11477
aS'Nat Rev Cancer 5:172-83 (2005)'
p11478
aS'PMID:11071626'
p11479
ag11479
aS'AUTHORS'
p11480
aS'Deininger MW, Goldman JM, Melo JV.'
p11481
aS'TITLE'
p11482
aS'The molecular biology of chronic myeloid leukemia.'
p11483
aS'JOURNAL'
p11484
aS'Blood 96:3343-56 (2000)'
p11485
aS'PMID:14982876'
p11486
ag11486
aS'AUTHORS'
p11487
aS'Calabretta B, Perrotti D.'
p11488
aS'TITLE'
p11489
aS'The biology of CML blast crisis.'
p11490
aS'JOURNAL'
p11491
aS'Blood 103:4010-22 (2004)'
p11492
aS'PMID:10403855'
p11493
ag11493
aS'AUTHORS'
p11494
aS"Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM."
p11495
aS'TITLE'
p11496
aS'The biology of chronic myeloid leukemia.'
p11497
aS'JOURNAL'
p11498
aS'N Engl J Med 341:164-72 (1999)'
p11499
aS'PMID:15156182'
p11500
ag11500
aS'AUTHORS'
p11501
aS'Mitani K.'
p11502
aS'TITLE'
p11503
aS'Molecular mechanisms of leukemogenesis by AML1/EVI-1.'
p11504
aS'JOURNAL'
p11505
aS'Oncogene 23:4263-9 (2004)'
p11506
aS'PMID:16484590'
p11507
ag11507
aS'AUTHORS'
p11508
aS'Dong M, Blobe GC.'
p11509
aS'TITLE'
p11510
aS'Role of transforming growth factor-beta in hematologic malignancies.'
p11511
aS'JOURNAL'
p11512
aS'Blood 107:4589-96 (2006)'
p11513
aS'PMID:9834202'
p11514
ag11514
aS'AUTHORS'
p11515
aS'Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.'
p11516
aS'TITLE'
p11517
aS'The t(321) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.'
p11518
aS'JOURNAL'
p11519
aS'Blood 92:4003-12 (1998)'
p11520
aS'PMID:12801837'
p11521
ag11521
aS'AUTHORS'
p11522
aS'Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.'
p11523
aS'TITLE'
p11524
aS'p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.'
p11525
aS'JOURNAL'
p11526
aS'Haematologica 88:622-30 (2003)'
p11527
aS'PMID:11160144'
p11528
ag11528
aS'AUTHORS'
p11529
aS'Baldwin AS.'
p11530
aS'TITLE'
p11531
aS'Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.'
p11532
aS'JOURNAL'
p11533
aS'J Clin Invest 107:241-6 (2001)'
p11534
aS'PMID:12244301'
p11535
ag11535
aS'AUTHORS'
p11536
aS'Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.'
p11537
aS'TITLE'
p11538
aS'PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.'
p11539
aS'JOURNAL'
p11540
aS'Nat Med 8:1145-52 (2002)'
p11541
aS'PMID:22286129'
p11542
ag11542
aS'AUTHORS'
p11543
aS'Hantschel O, Warsch W, Eckelhart E, Kaupe I, Grebien F, Wagner KU, Superti-Furga G, Sexl V'
p11544
aS'TITLE'
p11545
aS'BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia.'
p11546
aS'JOURNAL'
p11547
aS'Nat Chem Biol 8:285-93 (2012)'
p11548
asS'KO_PATHWAY'
p11549
(lp11550
S'ko05220'
p11551
asS'PATHWAY_MAP'
p11552
(lp11553
S'map05220'
p11554
asS'DISEASE'
p11555
(lp11556
S'H00004'
p11557
aS'Chronic myeloid leukemia (CML)'
p11558
asS'ENTRY'
p11559
(lp11560
S'map05220'
p11561
aS'Pathway'
p11562
asS'CLASS'
p11563
(lp11564
S'Human Diseases Cancers'
p11565
asS'DESCRIPTION'
p11566
(lp11567
S'Chronic myelogenous leukemia (CML) originates in a pluripotent hematopoetic stem cell of the bone marrow and is characterized by greatly increased numbers of granulocytes in the blood. Myeloid and other hematopoetic cell lineages are involved in the process of clonal proliferation and differentiation. On the cellular level, CML is associated with a specific chromosome abnormality, the t(9 22) reciprocal translocation that forms the Philadelphia (Ph) chromosome. The Ph chromosome is the result of a molecular rearrangement between the c-ABL proto-oncogene on chromosome 9 and the BCR (breakpoint cluster region) gene on chromosome 22.'
p11568
assS'path:map00402'
p11569
(dp11570
S'NAME'
p11571
(lp11572
S'Benzoxazinoid biosynthesis'
p11573
asS'REFERENCE'
p11574
(lp11575
S'PMID:11106389'
p11576
ag11576
aS'AUTHORS'
p11577
aS'Frey M, Stettner C, Pare PW, Schmelz EA, Tumlinson JH, Gierl A.'
p11578
aS'TITLE'
p11579
aS'An herbivore elicitor activates the gene for indole emission in maize.'
p11580
aS'JOURNAL'
p11581
aS'Proc Natl Acad Sci U S A 97:14801-6 (2000)'
p11582
aS'PMID:11556781'
p11583
ag11583
aS'AUTHORS'
p11584
aS'Gierl A, Frey M.'
p11585
aS'TITLE'
p11586
aS'Evolution of benzoxazinone biosynthesis and indole production in maize.'
p11587
aS'JOURNAL'
p11588
aS'Planta 213:493-8 (2001)'
p11589
aS'PMID:16260753'
p11590
ag11590
aS'AUTHORS'
p11591
aS'Nomura T, Ishihara A, Yanagita RC, Endo TR, Iwamura H.'
p11592
aS'TITLE'
p11593
aS'Three genomes differentially contribute to the biosynthesis of benzoxazinones in hexaploid wheat.'
p11594
aS'JOURNAL'
p11595
aS'Proc Natl Acad Sci U S A 102:16490-5 (2005)'
p11596
aS'PMID:9235894'
p11597
ag11597
aS'AUTHORS'
p11598
aS'Frey M, Chomet P, Glawischnig E, Stettner C, Grun S, Winklmair A, Eisenreich W, Bacher A, Meeley RB, Briggs SP, Simcox K, Gierl A.'
p11599
aS'TITLE'
p11600
aS'Analysis of a chemical plant defense mechanism in grasses.'
p11601
aS'JOURNAL'
p11602
aS'Science 277:696-9 (1997)'
p11603
aS'PMID:12620350'
p11604
ag11604
aS'AUTHORS'
p11605
aS'Frey M, Huber K, Park WJ, Sicker D, Lindberg P, Meeley RB, Simmons CR, Yalpani N, Gierl A.'
p11606
aS'TITLE'
p11607
aS'A 2-oxoglutarate-dependent dioxygenase is integrated in DIMBOA-biosynthesis.'
p11608
aS'JOURNAL'
p11609
aS'Phytochemistry 62:371-6 (2003)'
p11610
aS'PMID:11851909'
p11611
ag11611
aS'AUTHORS'
p11612
aS'von Rad U, Huttl R, Lottspeich F, Gierl A, Frey M.'
p11613
aS'TITLE'
p11614
aS'Two glucosyltransferases are involved in detoxification of benzoxazinoids in maize.'
p11615
aS'JOURNAL'
p11616
aS'Plant J 28:633-42 (2001)'
p11617
aS'PMID:16666853'
p11618
ag11618
aS'AUTHORS'
p11619
aS'Bailey BA, Larson RL'
p11620
aS'TITLE'
p11621
aS'Hydroxamic Acid glucosyltransferases from maize seedlings.'
p11622
aS'JOURNAL'
p11623
aS'Plant Physiol 90:1071-6 (1989)'
p11624
aS'PMID:18192444'
p11625
ag11625
aS'AUTHORS'
p11626
aS'Jonczyk R, Schmidt H, Osterrieder A, Fiesselmann A, Schullehner K, Haslbeck M, Sicker D, Hofmann D, Yalpani N, Simmons C, Frey M, Gierl A'
p11627
aS'TITLE'
p11628
aS'Elucidation of the final reactions of DIMBOA-glucoside biosynthesis in maize: characterization of Bx6 and Bx7.'
p11629
aS'JOURNAL'
p11630
aS'Plant Physiol 146:1053-63 (2008)'
p11631
aS'PMID:19577780'
p11632
ag11632
aS'AUTHORS'
p11633
aS'Frey M, Schullehner K, Dick R, Fiesselmann A, Gierl A'
p11634
aS'TITLE'
p11635
aS'Benzoxazinoid biosynthesis, a model for evolution of secondary metabolic pathways in plants.'
p11636
aS'JOURNAL'
p11637
aS'Phytochemistry 70:1645-51 (2009)'
p11638
asS'KO_PATHWAY'
p11639
(lp11640
S'ko00402'
p11641
asS'ENTRY'
p11642
(lp11643
S'map00402'
p11644
aS'Pathway'
p11645
asS'PATHWAY_MAP'
p11646
(lp11647
S'map00402'
p11648
asS'CLASS'
p11649
(lp11650
S'Metabolism Biosynthesis of other secondary metabolites'
p11651
asS'DESCRIPTION'
p11652
(lp11653
S'Benzoxazinoids (hydroxamic acids) are plant secondary metabolites that serve as important factors for host resistance against microbial pathogens and insects and for allelopathic effects. They are found in grass family and some eudicot families. The predominant benzoxazinoids are DIBOA and its 7-methoxy derivative DIMBOA, which are stored as glucosides in vacuoles. In maize, benzoxazinoid biosynthesis branches off from tryptophan biosynthesis at indole-3-glycerol phosphate, which is converted to indole by indole-3-glycerol phosphate lyase, BX1. Subsequently four cytochrome P450 monooxygenases (BX2-BX5) catalyze the introduction of four oxygen atoms into the indole moiety, yielding DIBOA. After glucosylation by UDP-glucosyltransferase (BX8/BX9), the glucoside is further modified by hydroxylation and O-methylation at C-7 to form DIMBOA-glucoside.'
p11654
assS'path:map03420'
p11655
(dp11656
S'NAME'
p11657
(lp11658
S'Nucleotide excision repair'
p11659
asS'REFERENCE'
p11660
(lp11661
S'PMID:11436314'
p11662
ag11662
aS'AUTHORS'
p11663
aS'Sugasawa K.'
p11664
aS'TITLE'
p11665
aS'[Molecular mechanism of mammalian nucleotide excision repair] Japanese'
p11666
aS'JOURNAL'
p11667
aS'Tanpakushitsu Kakusan Koso 46:893-901 (2001)'
p11668
aS'PMID:11436316'
p11669
ag11669
aS'AUTHORS'
p11670
aS'Nakatsu Y.'
p11671
aS'TITLE'
p11672
aS'[Transcription-coupled repair and Cockayne syndrome] Japanese'
p11673
aS'JOURNAL'
p11674
aS'Tanpakushitsu Kakusan Koso 46:908-15 (2001)'
p11675
aS'PMID:11436323'
p11676
ag11676
aS'AUTHORS'
p11677
aS'Nakagawa N, Masui R, Kuramitsu S.'
p11678
aS'TITLE'
p11679
aS'[Structure and function of DNA repair enzyme UvrB from Thermus thermophilus HB8] Japanese'
p11680
aS'JOURNAL'
p11681
aS'Tanpakushitsu Kakusan Koso 46:968-75 (2001)'
p11682
aS'PMID:17276014'
p11683
ag11683
aS'AUTHORS'
p11684
aS'Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ.'
p11685
aS'TITLE'
p11686
aS'Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship.'
p11687
aS'JOURNAL'
p11688
aS'Neuroscience 145:1388-96 (2007)'
p11689
aS'PMID:17884153'
p11690
ag11690
aS'AUTHORS'
p11691
aS'Saldivar JS, Wu X, Follen M, Gershenson D.'
p11692
aS'TITLE'
p11693
aS'Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity.'
p11694
aS'JOURNAL'
p11695
aS'Gynecol Oncol 107:S56-71 (2007)'
p11696
aS'PMID:16922398'
p11697
ag11697
aS'AUTHORS'
p11698
aS'Sugasawa K.'
p11699
aS'TITLE'
p11700
aS'[DNA repair pathways involving Cul4A ubiquitin ligases] Japanese'
p11701
aS'JOURNAL'
p11702
aS'Tanpakushitsu Kakusan Koso 51:1339-44 (2006)'
p11703
aS'PMID:18018633'
p11704
ag11704
aS'AUTHORS'
p11705
aS'Ito S, Ando D, Tanaka K.'
p11706
aS'TITLE'
p11707
aS'[Cross-talk between DNA repair and transcription: molecular mechanism and disorders] Japanese'
p11708
aS'JOURNAL'
p11709
aS'Tanpakushitsu Kakusan Koso 52:1823-31 (2007)'
p11710
asS'KO_PATHWAY'
p11711
(lp11712
S'ko03420'
p11713
asS'PATHWAY_MAP'
p11714
(lp11715
S'map03420'
p11716
asS'DISEASE'
p11717
(lp11718
S'H00076'
p11719
aS'Cockayne syndrome'
p11720
ag11719
ag11720
aS'H00403'
p11721
aS'Disorders of nucleotide excision repair'
p11722
aS'H00658'
p11723
aS'Syndromic X-linked mental retardation'
p11724
aS'H00821'
p11725
aS'Macular degeneration'
p11726
asS'MODULE'
p11727
(lp11728
S'M00262'
p11729
aS'DNA polymerase delta complex [PATH:map03420]'
p11730
ag11729
ag11730
aS'M00288'
p11731
aS'RPA complex [PATH:map03420]'
p11732
aS'M00289'
p11733
aS'RF-C complex [PATH:map03420]'
p11734
aS'M00290'
p11735
aS'Holo-TFIIH complex [PATH:map03420]'
p11736
aS'M00385'
p11737
aS'Cul4-DDB1-DDB2 complex [PATH:map03420]'
p11738
aS'M00386'
p11739
aS'Cul4-DDB1-CSA complex [PATH:map03420]'
p11740
asS'DBLINKS'
p11741
(lp11742
S'GO: 0006289'
p11743
asS'ENTRY'
p11744
(lp11745
S'map03420'
p11746
aS'Pathway'
p11747
asS'CLASS'
p11748
(lp11749
S'Genetic Information Processing Replication and repair'
p11750
asS'DESCRIPTION'
p11751
(lp11752
S'Nucleotide excision repair (NER) is a mechanism to recognize and repair bulky DNA damage caused by compounds, environmental carcinogens, and exposure to UV-light. In humans hereditary defects in the NER pathway are linked to at least three diseases: xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD). The repair of damaged DNA involves at least 30 polypeptides within two different sub-pathways of NER known as transcription-coupled repair (TCR-NER) and global genome repair (GGR-NER). TCR refers to the expedited repair of lesions located in the actively transcribed strand of genes by RNA polymerase II (RNAP II). In GGR-NER the first step of damage recognition involves XPC-hHR23B complex together with XPE complex (in prokaryotes, uvrAB complex). The following steps of GGR-NER and TCR-NER are similar.'
p11753
assS'path:map05332'
p11754
(dp11755
S'NAME'
p11756
(lp11757
S'Graft-versus-host disease'
p11758
asS'REFERENCE'
p11759
(lp11760
S'PMID:16412784'
p11761
ag11761
aS'AUTHORS'
p11762
aS'Ferrara JL, Reddy P.'
p11763
aS'TITLE'
p11764
aS'Pathophysiology of graft-versus-host disease.'
p11765
aS'JOURNAL'
p11766
aS'Semin Hematol 43:3-10 (2006)'
p11767
aS'PMID:14735553'
p11768
ag11768
aS'AUTHORS'
p11769
aS'Reddy P.'
p11770
aS'TITLE'
p11771
aS'Pathophysiology of acute graft-versus-host disease.'
p11772
aS'JOURNAL'
p11773
aS'Hematol Oncol 21:149-61 (2003)'
p11774
aS'PMID:17900507'
p11775
ag11775
aS'AUTHORS'
p11776
aS'Sun Y, Tawara I, Toubai T, Reddy P.'
p11777
aS'TITLE'
p11778
aS'Pathophysiology of acute graft-versus-host disease: recent advances.'
p11779
aS'JOURNAL'
p11780
aS'Transl Res 150:197-214 (2007)'
p11781
aS'PMID:15882431'
p11782
ag11782
aS'AUTHORS'
p11783
aS'Jaksch M, Mattsson J.'
p11784
aS'TITLE'
p11785
aS'The pathophysiology of acute graft-versus-host disease.'
p11786
aS'JOURNAL'
p11787
aS'Scand J Immunol 61:398-409 (2005)'
p11788
aS'PMID:12359826'
p11789
ag11789
aS'AUTHORS'
p11790
aS'Vogelsang GB, Lee L, Bensen-Kennedy DM.'
p11791
aS'TITLE'
p11792
aS'Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.'
p11793
aS'JOURNAL'
p11794
aS'Annu Rev Med 54:29-52 (2003)'
p11795
aS'PMID:14556773'
p11796
ag11796
aS'AUTHORS'
p11797
aS'Reddy P, Ferrara JL.'
p11798
aS'TITLE'
p11799
aS'Immunobiology of acute graft-versus-host disease.'
p11800
aS'JOURNAL'
p11801
aS'Blood Rev 17:187-94 (2003)'
p11802
aS'PMID:16147539'
p11803
ag11803
aS'AUTHORS'
p11804
aS'Blazar BR, Murphy WJ.'
p11805
aS'TITLE'
p11806
aS'Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).'
p11807
aS'JOURNAL'
p11808
aS'Philos Trans R Soc Lond B Biol Sci 360:1747-67 (2005)'
p11809
aS'PMID:15372473'
p11810
ag11810
aS'AUTHORS'
p11811
aS'Couriel D, Caldera H, Champlin R, Komanduri K.'
p11812
aS'TITLE'
p11813
aS'Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.'
p11814
aS'JOURNAL'
p11815
aS'Cancer 101:1936-46 (2004)'
p11816
aS'PMID:17784964'
p11817
ag11817
aS'AUTHORS'
p11818
aS'Jacobsohn DA, Vogelsang GB.'
p11819
aS'TITLE'
p11820
aS'Acute graft versus host disease.'
p11821
aS'JOURNAL'
p11822
aS'Orphanet J Rare Dis 2:35 (2007)'
p11823
asS'KO_PATHWAY'
p11824
(lp11825
S'ko05332'
p11826
asS'PATHWAY_MAP'
p11827
(lp11828
S'map05332'
p11829
asS'DISEASE'
p11830
(lp11831
S'H00084'
p11832
aS'Graft-versus-host disease'
p11833
asS'ENTRY'
p11834
(lp11835
S'map05332'
p11836
aS'Pathway'
p11837
asS'CLASS'
p11838
(lp11839
S'Human Diseases Immune diseases'
p11840
asS'DESCRIPTION'
p11841
(lp11842
S'Graft-versus-host disease (GVHD) is a lethal complication of allogeneic hematopoietic stem cell transplantation (HSCT) where immunocompetent donor T cells attack the genetically disparate host cells. GVHD pathophysiology can be summerized in a three-step process. Step 1 involves the development of an inflammatory milieu resulting from damage in the host tissues induced by the preparative chemotherapy or radiotherapy regimen. Damaged tissues secrete inflammatory cytokines, including interleukin 1 (IL-1), and tumor necrosis factor (TNF-alpha ). During step 2, antigen-presenting cells (APCs) trigger the activation of donor-derived T cells, which induce further T-cell expansion, induce cytotoxic T lymphocytes (CTL) and natural killer (NK) cells responses and prime additional mononuclear phagocytes to produce TNF-alpha and IL-1. Also, nitric oxide (NO) is produced by activated macrophages, and it may contribute to the tissue damage seen during step 3. During step 3, the effector phase, activated CTL and NK cells mediate cytotoxicity against target host cells through Fas-Fas ligand interactions and perforin-granzyme B.'
p11843
assS'path:map05330'
p11844
(dp11845
S'NAME'
p11846
(lp11847
S'Allograft rejection'
p11848
asS'REFERENCE'
p11849
(lp11850
S'PMID:10746853'
p11851
ag11851
aS'AUTHORS'
p11852
aS'Arakelov A, Lakkis FG.'
p11853
aS'TITLE'
p11854
aS'The alloimmune response and effector mechanisms of allograft rejection.'
p11855
aS'JOURNAL'
p11856
aS'Semin Nephrol 20:95-102 (2000)'
p11857
aS'PMID:12023610'
p11858
ag11858
aS'AUTHORS'
p11859
aS'Le Moine A, Goldman M, Abramowicz D.'
p11860
aS'TITLE'
p11861
aS'Multiple pathways to allograft rejection.'
p11862
aS'JOURNAL'
p11863
aS'Transplantation 73:1373-81 (2002)'
p11864
aS'PMID:17445565'
p11865
ag11865
aS'AUTHORS'
p11866
aS'Trivedi HL.'
p11867
aS'TITLE'
p11868
aS'Immunobiology of rejection and adaptation.'
p11869
aS'JOURNAL'
p11870
aS'Transplant Proc 39:647-52 (2007)'
p11871
aS'PMID:14710779'
p11872
ag11872
aS'AUTHORS'
p11873
aS'Pietra BA.'
p11874
aS'TITLE'
p11875
aS'Transplantation immunology 2003: simplified approach.'
p11876
aS'JOURNAL'
p11877
aS'Pediatr Clin North Am 50:1233-59 (2003)'
p11878
aS'PMID:8835634'
p11879
ag11879
aS'AUTHORS'
p11880
aS'Oka T, Yoshimura N.'
p11881
aS'TITLE'
p11882
aS'Immunosuppression in organ transplantation.'
p11883
aS'JOURNAL'
p11884
aS'Jpn J Pharmacol 71:89-100 (1996)'
p11885
aS'PMID:10571983'
p11886
ag11886
aS'AUTHORS'
p11887
aS'Sayegh MH.'
p11888
aS'TITLE'
p11889
aS'Why do we reject a graft? Role of indirect allorecognition in graft rejection.'
p11890
aS'JOURNAL'
p11891
aS'Kidney Int 56:1967-79 (1999)'
p11892
aS'PMID:10331992'
p11893
ag11893
aS'AUTHORS'
p11894
aS'Benichou G.'
p11895
aS'TITLE'
p11896
aS'Direct and indirect antigen recognition: the pathways to allograft immune rejection.'
p11897
aS'JOURNAL'
p11898
aS'Front Biosci 4:D476-80 (1999)'
p11899
aS'PMID:10667806'
p11900
ag11900
aS'AUTHORS'
p11901
aS'Turvey SE, Wood KJ.'
p11902
aS'TITLE'
p11903
aS'Immunobiology of solid organ transplantation.'
p11904
aS'JOURNAL'
p11905
aS'Int Surg 84:279-90 (1999)'
p11906
ag22
ag22
aS'AUTHORS'
p11907
aS'Janeway CA, Travers P, Walport M, Shlomchik MJ.'
p11908
aS'TITLE'
p11909
aS'Immunobiology 6th edition'
p11910
aS'JOURNAL'
p11911
aS'Garland Science Publishing (2005)'
p11912
aS'PMID:12216939'
p11913
ag11913
aS'AUTHORS'
p11914
aS'Game DS, Lechler RI.'
p11915
aS'TITLE'
p11916
aS'Pathways of allorecognition: implications for transplantation tolerance.'
p11917
aS'JOURNAL'
p11918
aS'Transpl Immunol 10:101-8 (2002)'
p11919
aS'PMID:12563298'
p11920
ag11920
aS'AUTHORS'
p11921
aS'Lechler RI, Garden OA, Turka LA.'
p11922
aS'TITLE'
p11923
aS'The complementary roles of deletion and regulation in transplantation tolerance.'
p11924
aS'JOURNAL'
p11925
aS'Nat Rev Immunol 3:147-58 (2003)'
p11926
asS'KO_PATHWAY'
p11927
(lp11928
S'ko05330'
p11929
asS'PATHWAY_MAP'
p11930
(lp11931
S'map05330'
p11932
asS'DISEASE'
p11933
(lp11934
S'H00083'
p11935
aS'Allograft rejection'
p11936
asS'ENTRY'
p11937
(lp11938
S'map05330'
p11939
aS'Pathway'
p11940
asS'CLASS'
p11941
(lp11942
S'Human Diseases Immune diseases'
p11943
asS'DESCRIPTION'
p11944
(lp11945
S"Allograft rejection is the consequence of the recipient's alloimmune response to nonself antigens expressed by donor tissues. After transplantation of organ allografts, there are two pathways of antigen presentation. In the direct pathway, recipient T cells react to intact allogeneic MHC molecules expressed on the surface of donor cells. This pathway would activate host CD4 or CD8 T cells. In contrast, donor MHC molecules (and all other proteins) shed from the graft can be taken up by host APCs and presented to recipient T cells in the context of self-MHC molecules - the indirect pathway. Such presentation activates predominantly CD4 T cells. A direct cytotoxic T-cell attack on graft cells can be made only by T cells that recognize the graft MHC molecules directly. Nontheless, T cells with indirect allospecificity can contribute to graft rejection by activating macrophages, which cause tissue injury and fibrosis, and are also likely to be important in the development of an alloantibody response to graft."
p11946
assS'path:map04022'
p11947
(dp11948
S'NAME'
p11949
(lp11950
S'cGMP-PKG signaling pathway'
p11951
asS'REFERENCE'
p11952
(lp11953
S'PMID:20716671'
p11954
ag11954
aS'AUTHORS'
p11955
aS'Francis SH, Busch JL, Corbin JD, Sibley D'
p11956
aS'TITLE'
p11957
aS'cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.'
p11958
aS'JOURNAL'
p11959
aS'Pharmacol Rev 62:525-63 (2010)'
p11960
aS'PMID:16439998'
p11961
ag11961
aS'AUTHORS'
p11962
aS'Feil R, Kemp-Harper B'
p11963
aS'TITLE'
p11964
aS'cGMP signalling: from bench to bedside. Conference on cGMP generators, effectors'
p11965
aS'and therapeutic implications.'
p11966
aS'JOURNAL'
p11967
aS'EMBO Rep 7:149-53 (2006)'
p11968
aS'PMID:22785374'
p11969
ag11969
aS'AUTHORS'
p11970
aS'Takimoto E'
p11971
aS'TITLE'
p11972
aS'Cyclic GMP-dependent signaling in cardiac myocytes.'
p11973
aS'JOURNAL'
p11974
aS'Circ J 76:1819-25 (2012)'
p11975
aS'PMID:16371594'
p11976
ag11976
aS'AUTHORS'
p11977
aS'Hofmann F, Feil R, Kleppisch T, Schlossmann J'
p11978
aS'TITLE'
p11979
aS'Function of cGMP-dependent protein kinases as revealed by gene deletion.'
p11980
aS'JOURNAL'
p11981
aS'Physiol Rev 86:1-23 (2006)'
p11982
aS'PMID:21685243'
p11983
ag11983
aS'AUTHORS'
p11984
aS'Kuebler WM'
p11985
aS'TITLE'
p11986
aS'The Janus-faced regulation of endothelial permeability by cyclic GMP.'
p11987
aS'JOURNAL'
p11988
aS'Am J Physiol Lung Cell Mol Physiol 301:L157-60 (2011)'
p11989
aS'PMID:21666108'
p11990
ag11990
aS'AUTHORS'
p11991
aS'Schlossmann J, Desch M'
p11992
aS'TITLE'
p11993
aS'IRAG and novel PKG targeting in the cardiovascular system.'
p11994
aS'JOURNAL'
p11995
aS'Am J Physiol Heart Circ Physiol 301:H672-82 (2011)'
p11996
aS'PMID:16460276'
p11997
ag11997
aS'AUTHORS'
p11998
aS'Murthy KS'
p11999
aS'TITLE'
p12000
aS'Signaling for contraction and relaxation in smooth muscle of the gut.'
p12001
aS'JOURNAL'
p12002
aS'Annu Rev Physiol 68:345-74 (2006)'
p12003
aS'PMID:22965426'
p12004
ag12004
aS'AUTHORS'
p12005
aS'Sanders KM, Koh SD, Ro S, Ward SM'
p12006
aS'TITLE'
p12007
aS'Regulation of gastrointestinal motility--insights from smooth muscle biology.'
p12008
aS'JOURNAL'
p12009
aS'Nat Rev Gastroenterol Hepatol 9:633-45 (2012)'
p12010
aS'PMID:20024580'
p12011
ag12011
aS'AUTHORS'
p12012
aS'Gao Y'
p12013
aS'TITLE'
p12014
aS'The multiple actions of NO.'
p12015
aS'JOURNAL'
p12016
aS'Pflugers Arch 459:829-39 (2010)'
p12017
aS'PMID:9003029'
p12018
ag12018
aS'AUTHORS'
p12019
aS'Wang X, Robinson PJ'
p12020
aS'TITLE'
p12021
aS'Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system.'
p12022
aS'JOURNAL'
p12023
aS'J Neurochem 68:443-56 (1997)'
p12024
aS'PMID:19306895'
p12025
ag12025
aS'AUTHORS'
p12026
aS'Tsai EJ, Kass DA'
p12027
aS'TITLE'
p12028
aS'Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.'
p12029
aS'JOURNAL'
p12030
aS'Pharmacol Ther 122:216-38 (2009)'
p12031
aS'PMID:20388537'
p12032
ag12032
aS'AUTHORS'
p12033
aS'Villanueva C, Giulivi C'
p12034
aS'TITLE'
p12035
aS'Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease.'
p12036
aS'JOURNAL'
p12037
aS'Free Radic Biol Med 49:307-16 (2010)'
p12038
aS'PMID:15894227'
p12039
ag12039
aS'AUTHORS'
p12040
aS'Schlossmann J, Hofmann F'
p12041
aS'TITLE'
p12042
aS'cGMP-dependent protein kinases in drug discovery.'
p12043
aS'JOURNAL'
p12044
aS'Drug Discov Today 10:627-34 (2005)'
p12045
aS'PMID:18040025'
p12046
ag12046
aS'AUTHORS'
p12047
aS'Kass DA, Champion HC, Beavo JA'
p12048
aS'TITLE'
p12049
aS'Phosphodiesterase type 5: expanding roles in cardiovascular regulation.'
p12050
aS'JOURNAL'
p12051
aS'Circ Res 101:1084-95 (2007)'
p12052
aS'PMID:16815627'
p12053
ag12053
aS'AUTHORS'
p12054
aS'Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG'
p12055
aS'TITLE'
p12056
aS'Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future.'
p12057
aS'JOURNAL'
p12058
aS'Eur Urol 50:1194-207 discussion 1207 (2006)'
p12059
aS'PMID:12524221'
p12060
ag12060
aS'AUTHORS'
p12061
aS'Yan C, Kim D, Aizawa T, Berk BC'
p12062
aS'TITLE'
p12063
aS'Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator.'
p12064
aS'JOURNAL'
p12065
aS'Arterioscler Thromb Vasc Biol 23:26-36 (2003)'
p12066
aS'PMID:17643091'
p12067
ag12067
aS'AUTHORS'
p12068
aS'McKinsey TA, Kass DA'
p12069
aS'TITLE'
p12070
aS'Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface.'
p12071
aS'JOURNAL'
p12072
aS'Nat Rev Drug Discov 6:617-35 (2007)'
p12073
aS'PMID:19961855'
p12074
ag12074
aS'AUTHORS'
p12075
aS'Koitabashi N, Aiba T, Hesketh GG, Rowell J, Zhang M, Takimoto E, Tomaselli GF, Kass DA'
p12076
aS'TITLE'
p12077
aS'Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.'
p12078
aS'JOURNAL'
p12079
aS'J Mol Cell Cardiol 48:713-24 (2010)'
p12080
aS'PMID:18006449'
p12081
ag12081
aS'AUTHORS'
p12082
aS'Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD'
p12083
aS'TITLE'
p12084
aS'cGMP signalling in pre- and post-conditioning: the role of mitochondria.'
p12085
aS'JOURNAL'
p12086
aS'Cardiovasc Res 77:344-52 (2008)'
p12087
aS'PMID:19176601'
p12088
ag12088
aS'AUTHORS'
p12089
aS'Boengler K, Schulz R, Heusch G'
p12090
aS'TITLE'
p12091
aS'Loss of cardioprotection with ageing.'
p12092
aS'JOURNAL'
p12093
aS'Cardiovasc Res 83:247-61 (2009)'
p12094
aS'PMID:18757523'
p12095
ag12095
aS'AUTHORS'
p12096
aS'Gao Y, Portugal AD, Liu J, Negash S, Zhou W, Tian J, Xiang R, Longo LD, Raj JU'
p12097
aS'TITLE'
p12098
aS'Preservation of cGMP-induced relaxation of pulmonary veins of fetal lambs exposed to chronic high altitude hypoxia: role of PKG and Rho kinase.'
p12099
aS'JOURNAL'
p12100
aS'Am J Physiol Lung Cell Mol Physiol 295:L889-96 (2008)'
p12101
aS'PMID:11522789'
p12102
ag12102
aS'AUTHORS'
p12103
aS'Li Z, Xi X, Du X'
p12104
aS'TITLE'
p12105
aS'A mitogen-activated protein kinase-dependent signaling pathway in the activation'
p12106
aS'of platelet integrin alpha IIbbeta3.'
p12107
aS'JOURNAL'
p12108
aS'J Biol Chem 276:42226-32 (2001)'
p12109
aS'PMID:23212367'
p12110
ag12110
aS'AUTHORS'
p12111
aS'Xie J, Cha SK, An SW, Kuro-O M, Birnbaumer L, Huang CL'
p12112
aS'TITLE'
p12113
aS'Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse'
p12114
aS'heart.'
p12115
aS'JOURNAL'
p12116
aS'Nat Commun 3:1238 (2012)'
p12117
asS'KO_PATHWAY'
p12118
(lp12119
S'ko04022'
p12120
asS'PATHWAY_MAP'
p12121
(lp12122
S'map04022'
p12123
asS'MODULE'
p12124
(lp12125
S'M00694'
p12126
aS'cGMP signaling [PATH:map04022]'
p12127
asS'DBLINKS'
p12128
(lp12129
S'GO: 0070305'
p12130
asS'ENTRY'
p12131
(lp12132
S'map04022'
p12133
aS'Pathway'
p12134
asS'CLASS'
p12135
(lp12136
S'Environmental Information Processing Signal transduction'
p12137
asS'DESCRIPTION'
p12138
(lp12139
S"Cyclic GMP (cGMP) is the intracellular second messenger that mediates the action of nitric oxide (NO) and natriuretic peptides (NPs), regulating a broad array of physiologic processes. The elevated intracellular cGMP level exerts its physiological action through two forms of cGMP-dependent protein kinase (PKG), cGMP-regulated phosphodiesterases (PDE2, PDE3) and cGMP-gated cation channels, among which PKGs might be the primary mediator. PKG1 isoform-specific activation of established substrates leads to reduction of cytosolic calcium concentration and/or decrease in the sensitivity of myofilaments to Ca2+ (Ca2+-desensitization), resulting in smooth muscle relaxation. In cardiac myocyte, PKG directly phosphorylates a member of the transient potential receptor canonical channel family, TRPC6, suppressing this nonselective ion channel's Ca2+ conductance, G-alpha-q agonist-induced NFAT activation, and myocyte hypertrophic responses. PKG also opens mitochondrial ATP-sensitive K+ (mitoKATP) channels and subsequent release of ROS triggers cardioprotection."
p12140
assS'path:map04530'
p12141
(dp12142
S'NAME'
p12143
(lp12144
S'Tight junction'
p12145
asS'REFERENCE'
p12146
(lp12147
S'PMID:15151915'
p12148
ag12148
aS'AUTHORS'
p12149
aS'Schneeberger EE, Lynch RD.'
p12150
aS'TITLE'
p12151
aS'The tight junction: a multifunctional complex.'
p12152
aS'JOURNAL'
p12153
aS'Am J Physiol Cell Physiol 286:C1213-28 (2004)'
p12154
aS'PMID:15269339'
p12155
ag12155
aS'AUTHORS'
p12156
aS'Bazzoni G, Dejana E.'
p12157
aS'TITLE'
p12158
aS'Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis.'
p12159
aS'JOURNAL'
p12160
aS'Physiol Rev 84:869-901 (2004)'
p12161
aS'PMID:12612641'
p12162
ag12162
aS'AUTHORS'
p12163
aS'Matter K, Balda MS.'
p12164
aS'TITLE'
p12165
aS'Signalling to and from tight junctions.'
p12166
aS'JOURNAL'
p12167
aS'Nat Rev Mol Cell Biol 4:225-36 (2003)'
p12168
aS'PMID:11283726'
p12169
ag12169
aS'AUTHORS'
p12170
aS'Tsukita S, Furuse M, Itoh M.'
p12171
aS'TITLE'
p12172
aS'Multifunctional strands in tight junctions.'
p12173
aS'JOURNAL'
p12174
aS'Nat Rev Mol Cell Biol 2:285-93 (2001)'
p12175
aS'PMID:12475568'
p12176
ag12176
aS'AUTHORS'
p12177
aS'Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE.'
p12178
aS'TITLE'
p12179
aS'Tight junction proteins.'
p12180
aS'JOURNAL'
p12181
aS'Prog Biophys Mol Biol 81:1-44 (2003)'
p12182
aS'PMID:12270945'
p12183
ag12183
aS'AUTHORS'
p12184
aS'Cheng CY, Mruk DD.'
p12185
aS'TITLE'
p12186
aS'Cell junction dynamics in the testis: Sertoli-germ cell interactions and male contraceptive development.'
p12187
aS'JOURNAL'
p12188
aS'Physiol Rev 82:825-74 (2002)'
p12189
aS'PMID:15551862'
p12190
ag12190
aS'AUTHORS'
p12191
aS'Nakanishi H, Takai Y.'
p12192
aS'TITLE'
p12193
aS'Roles of nectins in cell adhesion, migration and polarization.'
p12194
aS'JOURNAL'
p12195
aS'Biol Chem 385:885-92 (2004)'
p12196
aS'PMID:12791297'
p12197
ag12197
aS'AUTHORS'
p12198
aS'Balda MS, Matter K.'
p12199
aS'TITLE'
p12200
aS'Epithelial cell adhesion and the regulation of gene expression.'
p12201
aS'JOURNAL'
p12202
aS'Trends Cell Biol 13:310-8 (2003)'
p12203
asS'KO_PATHWAY'
p12204
(lp12205
S'ko04530'
p12206
asS'PATHWAY_MAP'
p12207
(lp12208
S'map04530'
p12209
asS'DISEASE'
p12210
(lp12211
S'H00578'
p12212
aS'MYH9-related kidney diseases'
p12213
ag12212
ag12213
aS'H00594'
p12214
aS'Distal muscular dystrophies'
p12215
aS'H00606'
p12216
aS'Early infantile epileptic encephalopathy'
p12217
aS'H00626'
p12218
aS'Nephrotic syndrome and focal segmental glomerulosclerosis'
p12219
aS'H00656'
p12220
aS'Scapuloperoneal myopathy (SPM)'
p12221
aS'H00703'
p12222
aS'Myosin storage myopathy (MSM)'
p12223
aS'H00742'
p12224
aS'Neonatal ichthyosis-sclerosing cholangitis (NISCH) syndrome'
p12225
aS'H00801'
p12226
aS'Familial thoracic aortic aneurysm and dissection (TAAD)'
p12227
aS'H00811'
p12228
aS'Distal arthrogryposis (DA)'
p12229
aS'H00840'
p12230
aS'Band-like calcification with simplified gyration and polymicrogyria (BLC-PMG)'
p12231
aS'H00872'
p12232
aS'Trismus-pseudocamptodactyly syndrome'
p12233
aS'H00894'
p12234
aS'FG syndrome (FGS)'
p12235
aS'H00947'
p12236
aS'Pilomatricoma'
p12237
aS'H01195'
p12238
aS'VACTERL/VATER association'
p12239
aS'H01210'
p12240
aS'Hypomagnesemia'
p12241
aS'H01229'
p12242
aS'Inclusion body myopathy 3 (IBM3)'
p12243
aS'H01255'
p12244
aS'Juvenile-onset dystonia'
p12245
aS'H01301'
p12246
aS'Hemorrhagic destruction of the brain, subependymal calcification, and cataracts'
p12247
asS'DBLINKS'
p12248
(lp12249
S'GO: 0005923'
p12250
asS'ENTRY'
p12251
(lp12252
S'map04530'
p12253
aS'Pathway'
p12254
asS'CLASS'
p12255
(lp12256
S'Cellular Processes Cellular commiunity'
p12257
asS'DESCRIPTION'
p12258
(lp12259
S"Epithelial tight junctions (TJs) are composed of at least three types of transmembrane protein -occludin, claudin and junctional adhesion molecules (JAMs)- and a cytoplasmic 'plaque' consisting of many different proteins that form large complexes. The transmembrane proteins mediate cell adhesion and are thought to constitute the intramembrane and paracellular diffusion barriers. The cytoplasmic 'plaque' contains three major multi-protein complexes consisting largely of scaffolding proteins, the ZO protein complex, the CRB3-Pals1-PATJ complex and the PAR-3-aPKC-PAR-6 complex. The ZO protein complex appears to organize the transmembrane proteins and couple them to other cytoplasmic proteins and to actin microfilaments. Two evolutionarily conserved protein complexes, the CRB3 and PAR complexes are involved in the establishment and maintenance of epithelial cell polarity. Besides these three protein complexes which seem to be constitutively associated at TJs, a number of proteins with different functions has been identified at TJs. These include additional scaffolding proteins like MUPP1 and MAGI-1, adaptor proteins, transcription regulators and RNA processing factors, regulatory proteins like small GTPases and G-proteins, kinases and phosphatases, and heat shock proteins. These are proposed to be involved in junction assembly, barrier regulation, gene transcription, and perhaps other, presently undefined pathways."
p12260
assS'path:map04120'
p12261
(dp12262
S'NAME'
p12263
(lp12264
S'Ubiquitin mediated proteolysis'
p12265
asS'REFERENCE'
p12266
(lp12267
S'PMID:16922370 (Japanese)'
p12268
ag12268
aS'AUTHORS'
p12269
aS'Kamura T.'
p12270
aS'TITLE'
p12271
aS'[Cullin-based E3 family] Japanese'
p12272
aS'JOURNAL'
p12273
aS'Tanpakushitsu Kakusan Koso 51:1167-72 (2006)'
p12274
aS'PMID:16922408 (Japanese)'
p12275
ag12275
aS'AUTHORS'
p12276
aS'Matsuda N.'
p12277
aS'TITLE'
p12278
aS'[Overview: hereditary disorders caused by dysfunction of ubiquitylation]'
p12279
aS'JOURNAL'
p12280
aS'Tanpakushitsu Kakusan Koso 51:1402-7 (2006)'
p12281
aS'PMID:16922367 (Japanese)'
p12282
ag12282
aS'AUTHORS'
p12283
aS'Tokunaga F.'
p12284
aS'TITLE'
p12285
aS'[E2 ubiquitin-conjugating enzymes: structures and functions]'
p12286
aS'JOURNAL'
p12287
aS'Tanpakushitsu Kakusan Koso 51:1150-6 (2006)'
p12288
aS'PMID:16816840'
p12289
ag12289
aS'AUTHORS'
p12290
aS'Nalepa G, Rolfe M, Harper JW.'
p12291
aS'TITLE'
p12292
aS'Drug discovery in the ubiquitin-proteasome system.'
p12293
aS'JOURNAL'
p12294
aS'Nat Rev Drug Discov 5:596-613 (2006)'
p12295
aS'PMID:16405856'
p12296
ag12296
aS'AUTHORS'
p12297
aS'Hsu YJ, Goodman SR.'
p12298
aS'TITLE'
p12299
aS'Spectrin and ubiquitination: a review.'
p12300
aS'JOURNAL'
p12301
aS'Cell Mol Biol (Noisy-le-grand) Suppl 51:OL801-7 (2005)'
p12302
aS'PMID:12944364'
p12303
ag12303
aS'AUTHORS'
p12304
aS'Hatakeyama S, Nakayama KI.'
p12305
aS'TITLE'
p12306
aS'Ubiquitylation as a quality control system for intracellular proteins.'
p12307
aS'JOURNAL'
p12308
aS'J Biochem 134:1-8 (2003)'
p12309
aS'PMID:17588513'
p12310
ag12310
aS'AUTHORS'
p12311
aS'Lee J, Zhou P.'
p12312
aS'TITLE'
p12313
aS'DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase.'
p12314
aS'JOURNAL'
p12315
aS'Mol Cell 26:775-80 (2007)'
p12316
asS'KO_PATHWAY'
p12317
(lp12318
S'ko04120'
p12319
asS'PATHWAY_MAP'
p12320
(lp12321
S'map04120'
p12322
asS'DISEASE'
p12323
(lp12324
S'H00478'
p12325
aS'Prader-Willi and Angelman syndromes'
p12326
ag12325
ag12326
aS'H00509'
p12327
aS'3M syndrome'
p12328
aS'H00559'
p12329
aS'von Hippel-Lindau syndrome'
p12330
aS'H00583'
p12331
aS'Opitz-GBBB syndrome'
p12332
aS'H00593'
p12333
aS'Limb-girdle muscular dystrophy (LGMD)'
p12334
aS'H00658'
p12335
aS'Syndromic X-linked mental retardation'
p12336
aS'H00810'
p12337
aS'Progressive myoclonic epilepsy (PME/ EPM)'
p12338
aS'H01232'
p12339
aS'Syndromic multisystem autoimmune disease'
p12340
aS'H01289'
p12341
aS'Mulibrey nanism'
p12342
asS'MODULE'
p12343
(lp12344
S'M00379'
p12345
aS'SCF-MET30 complex [PATH:map04120]'
p12346
ag12345
ag12346
aS'M00380'
p12347
aS'SCF-BTRC complex [PATH:map04120]'
p12348
aS'M00381'
p12349
aS'SCF-SKP2 complex [PATH:map04120]'
p12350
aS'M00382'
p12351
aS'SCF-FBS complex [PATH:map04120]'
p12352
aS'M00383'
p12353
aS'ECV complex [PATH:map04120]'
p12354
aS'M00384'
p12355
aS'Cul3-SPOP complex [PATH:map04120]'
p12356
aS'M00385'
p12357
aS'Cul4-DDB1-DDB2 complex [PATH:map04120]'
p12358
aS'M00386'
p12359
aS'Cul4-DDB1-CSA complex [PATH:map04120]'
p12360
aS'M00387'
p12361
aS'SCF-FBW7 complex [PATH:map04120]'
p12362
aS'M00388'
p12363
aS'ECS complex [PATH:map04120]'
p12364
aS'M00389'
p12365
aS'APC/C complex [PATH:map04120]'
p12366
aS'M00407'
p12367
aS'SCF-CDC4 complex [PATH:map04120]'
p12368
aS'M00411'
p12369
aS'SCF-GRR1 complex [PATH:map04120]'
p12370
asS'DBLINKS'
p12371
(lp12372
S'GO: 0016567'
p12373
asS'ENTRY'
p12374
(lp12375
S'map04120'
p12376
aS'Pathway'
p12377
asS'CLASS'
p12378
(lp12379
S'Genetic Information Processing Folding, sorting and degradation'
p12380
asS'DESCRIPTION'
p12381
(lp12382
S'Protein ubiquitination plays an important role in eukaryotic cellular processes. It mainly functions as a signal for 26S proteasome dependent protein degradation. The addition of ubiquitin to proteins being degraded is performed by a reaction cascade consisting of three enzymes, named E1 (ubiquitin activating enzyme), E2 (ubiquitin conjugating enzyme), and E3 (ubiquitin ligase). Each E3 has specificity to its substrate, or proteins to be targeted by ubiquitination. Many E3s are discovered in eukaryotes and they are classified into four types: HECT type, U-box type, single RING-finger type, and multi-subunit RING-finger type. Multi-subunit RING-finger E3s are exemplified by cullin-Rbx E3s and APC/C. They consist of a RING-finger-containing subunit (RBX1 or RBX2) that functions to bind E2s, a scaffold-like cullin molecule, adaptor proteins, and a target recognizing subunit that binds substrates.'
p12383
assS'path:map04122'
p12384
(dp12385
S'NAME'
p12386
(lp12387
S'Sulfur relay system'
p12388
asS'REFERENCE'
p12389
(lp12390
S'PMID:19151091'
p12391
ag12391
aS'AUTHORS'
p12392
aS'Noma A, Sakaguchi Y, Suzuki T'
p12393
aS'TITLE'
p12394
aS'Mechanistic characterization of the sulfur-relay system for eukaryotic 2-thiouridine biogenesis at tRNA wobble positions.'
p12395
aS'JOURNAL'
p12396
aS'Nucleic Acids Res 37:1335-52 (2009)'
p12397
aS'PMID:16859499'
p12398
ag12398
aS'AUTHORS'
p12399
aS'Iyer LM, Burroughs AM, Aravind L'
p12400
aS'TITLE'
p12401
aS'The prokaryotic antecedents of the ubiquitin-signaling system and the early evolution of ubiquitin-like beta-grasp domains.'
p12402
aS'JOURNAL'
p12403
aS'Genome Biol 7:R60 (2006)'
p12404
aS'PMID:19675644'
p12405
ag12405
aS'AUTHORS'
p12406
aS'Schwarz G, Mendel RR, Ribbe MW'
p12407
aS'TITLE'
p12408
aS'Molybdenum cofactors, enzymes and pathways.'
p12409
aS'JOURNAL'
p12410
aS'Nature 460:839-47 (2009)'
p12411
asS'KO_PATHWAY'
p12412
(lp12413
S'ko04122'
p12414
asS'PATHWAY_MAP'
p12415
(lp12416
S'map04122'
p12417
asS'DISEASE'
p12418
(lp12419
S'H00192'
p12420
aS'Xanthinuria'
p12421
ag12420
ag12421
aS'H01367'
p12422
aS'Infantile liver failure'
p12423
asS'ENTRY'
p12424
(lp12425
S'map04122'
p12426
aS'Pathway'
p12427
asS'CLASS'
p12428
(lp12429
S'Genetic Information Processing Folding, sorting and degradation'
p12430
asS'DESCRIPTION'
p12431
(lp12432
S'Ubiquitin and ubiquitin-like proteins (Ubls) are signalling messengers that control many cellular functions, such as cell proliferation, apoptosis, and DNA repair. It is suggested that Ub-protein modification evolved from prokaryotic sulfurtransfer systems. Molybdenum cofactor (Moco) and thiamin are sulfur-containing cofactors whose biosynthesis includes a key sulfur transfer step that uses unique sulfur carrier proteins, MoaD and ThiS. Ubiquitin, MoaD, and ThiS are all structurally related proteins whose C-termini are activated through adenylation by homologous E1-like enzymes. s2T biosynthesis may share similar chemistry with Moco and thiamin synthesis. In Saccharomyces cerevisiae, Urm1 and Uba4 function as part of a ubl protein conjugation system, though they have sequence homology to bacterial sulfur-transfer enzymes and the ability to function in sulfur transfer.'
p12433
assS'path:map04080'
p12434
(dp12435
S'NAME'
p12436
(lp12437
S'Neuroactive ligand-receptor interaction'
p12438
asS'KO_PATHWAY'
p12439
(lp12440
S'ko04080'
p12441
asS'ENTRY'
p12442
(lp12443
S'map04080'
p12444
aS'Pathway'
p12445
asS'PATHWAY_MAP'
p12446
(lp12447
S'map04080'
p12448
asS'DISEASE'
p12449
(lp12450
S'H00249'
p12451
aS'Thyroid hormone resistance syndrome'
p12452
ag12451
ag12452
aS'H00255'
p12453
aS'Hypogonadotropic hypogonadism'
p12454
aS'H00577'
p12455
aS'Syndromic X-linked mental retardation with epilepsy or seizures'
p12456
aS'H00608'
p12457
aS'46,XY disorders of sex development (Disorders in androgen synthesis or action)'
p12458
aS'H00609'
p12459
aS'46,XY disorders of sex development (Other)'
p12460
aS'H00627'
p12461
aS'Premature ovarian failure'
p12462
aS'H00667'
p12463
aS'Woolly hair'
p12464
aS'H00680'
p12465
aS'Primary failure of tooth eruption'
p12466
aS'H00759'
p12467
aS'Waardenburg syndrome (WS)'
p12468
aS'H00768'
p12469
aS'Nonsyndromic autosomal recessive mental retardation (NS-ARMR)'
p12470
aS'H00769'
p12471
aS'Hyperekplexia'
p12472
aS'H00770'
p12473
aS'Congenital myasthenic syndrome'
p12474
aS'H00783'
p12475
aS'Febrile seizures'
p12476
aS'H00787'
p12477
aS'Congenital stationary night blindness (CSNB)'
p12478
aS'H00807'
p12479
aS'Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)'
p12480
aS'H00808'
p12481
aS'Idiopathic generalized epilepsies (IGEs)'
p12482
aS'H00823'
p12483
aS'ABCD syndrome'
p12484
aS'H00910'
p12485
aS'Hirschsprung disease (HD)'
p12486
aS'H00937'
p12487
aS'Precocious puberty'
p12488
aS'H00986'
p12489
aS'Multiple pterygium syndrome'
p12490
aS'H01039'
p12491
aS'Ovarian hyperstimulation syndrome (OHSS)'
p12492
aS'H01206'
p12493
aS'Plasminogen deficiency'
p12494
aS'H01253'
p12495
aS'Isolated follicle-stimulating hormone deficiency (IFSHD)'
p12496
aS'H01294'
p12497
aS'Nephrogenic syndrome of inappropriate antidiuresis (NSIAD)'
p12498
asS'CLASS'
p12499
(lp12500
S'Environmental Information Processing Signaling molecules and interaction'
p12501
assS'path:map02010'
p12502
(dp12503
S'NAME'
p12504
(lp12505
S'ABC transporters'
p12506
asS'REFERENCE'
p12507
(lp12508
S'PMID:9799792'
p12509
ag12509
aS'AUTHORS'
p12510
aS'Tomii K, Kanehisa M.'
p12511
aS'TITLE'
p12512
aS'A comparative analysis of ABC transporters in complete microbial genomes.'
p12513
aS'JOURNAL'
p12514
aS'Genome Res 8:1048-59 (1998)'
p12515
aS'PMID:18424520'
p12516
ag12516
aS'AUTHORS'
p12517
aS'Sperandeo P, Lau FK, Carpentieri A, De Castro C, Molinaro A, Deho G, Silhavy TJ, Polissi A'
p12518
aS'TITLE'
p12519
aS'Functional analysis of the protein machinery required for transport of lipopolysaccharide to the outer membrane of Escherichia coli.'
p12520
aS'JOURNAL'
p12521
aS'J Bacteriol 190:4460-9 (2008)'
p12522
aS'PMID:18375759'
p12523
ag12523
aS'AUTHORS'
p12524
aS'Ruiz N, Gronenberg LS, Kahne D, Silhavy TJ'
p12525
aS'TITLE'
p12526
aS'Identification of two inner-membrane proteins required for the transport of lipopolysaccharide to the outer membrane of Escherichia coli.'
p12527
aS'JOURNAL'
p12528
aS'Proc Natl Acad Sci U S A 105:5537-42 (2008)'
p12529
aS'PMID:10557362'
p12530
ag12530
aS'AUTHORS'
p12531
aS'Omata T, Price GD, Badger MR, Okamura M, Gohta S, Ogawa T'
p12532
aS'TITLE'
p12533
aS'Identification of an ATP-binding cassette transporter involved in bicarbonate uptake in the cyanobacterium Synechococcus sp. strain PCC 7942.'
p12534
aS'JOURNAL'
p12535
aS'Proc Natl Acad Sci U S A 96:13571-6 (1999)'
p12536
aS'PMID:11731493'
p12537
ag12537
aS'AUTHORS'
p12538
aS'Quintero MJ, Montesinos ML, Herrero A, Flores E'
p12539
aS'TITLE'
p12540
aS'Identification of genes encoding amino acid permeases by inactivation of selected ORFs from the Synechocystis genomic sequence.'
p12541
aS'JOURNAL'
p12542
aS'Genome Res 11:2034-40 (2001)'
p12543
aS'PMID:16135226'
p12544
ag12544
aS'AUTHORS'
p12545
aS'Picossi S, Montesinos ML, Pernil R, Lichtle C, Herrero A, Flores E'
p12546
aS'TITLE'
p12547
aS'ABC-type neutral amino acid permease N-I is required for optimal diazotrophic growth and is repressed in the heterocysts of Anabaena sp. strain PCC 7120.'
p12548
aS'JOURNAL'
p12549
aS'Mol Microbiol 57:1582-92 (2005)'
p12550
aS'PMID:11929526'
p12551
ag12551
aS'AUTHORS'
p12552
aS'Valladares A, Montesinos ML, Herrero A, Flores E.'
p12553
aS'TITLE'
p12554
aS'An ABC-type, high-affinity urea permease identified in cyanobacteria.'
p12555
aS'JOURNAL'
p12556
aS'Mol Microbiol 43:703-15 (2002)'
p12557
aS'PMID:18326572'
p12558
ag12558
aS'AUTHORS'
p12559
aS'Richard-Fogal CL, Frawley ER, Kranz RG'
p12560
aS'TITLE'
p12561
aS'Topology and function of CcmD in cytochrome c maturation.'
p12562
aS'JOURNAL'
p12563
aS'J Bacteriol 190:3489-93 (2008)'
p12564
aS'PMID:16109926'
p12565
ag12565
aS'AUTHORS'
p12566
aS'Suzuki H, Koyanagi T, Izuka S, Onishi A, Kumagai H'
p12567
aS'TITLE'
p12568
aS'The yliA, -B, -C, and -D genes of Escherichia coli K-12 encode a novel glutathione importer with an ATP-binding cassette.'
p12569
aS'JOURNAL'
p12570
aS'J Bacteriol 187:5861-7 (2005)'
p12571
aS'PMID:17873039'
p12572
ag12572
aS'AUTHORS'
p12573
aS'Novikova M, Metlitskaya A, Datsenko K, Kazakov T, Kazakov A, Wanner B, Severinov K'
p12574
aS'TITLE'
p12575
aS'The Escherichia coli Yej transporter is required for the uptake of translation inhibitor microcin C.'
p12576
aS'JOURNAL'
p12577
aS'J Bacteriol 189:8361-5 (2007)'
p12578
aS'PMID:17214741'
p12579
ag12579
aS'AUTHORS'
p12580
aS'Tikhonova EB, Devroy VK, Lau SY, Zgurskaya HI'
p12581
aS'TITLE'
p12582
aS'Reconstitution of the Escherichia coli macrolide transporter: the periplasmic membrane fusion protein MacA stimulates the ATPase activity of MacB.'
p12583
aS'JOURNAL'
p12584
aS'Mol Microbiol 63:895-910 (2007)'
p12585
aS'PMID:18805970'
p12586
ag12586
aS'AUTHORS'
p12587
aS'Yamanaka H, Kobayashi H, Takahashi E, Okamoto K'
p12588
aS'TITLE'
p12589
aS'MacAB is involved in the secretion of Escherichia coli heat-stable enterotoxin II.'
p12590
aS'JOURNAL'
p12591
aS'J Bacteriol 190:7693-8 (2008)'
p12592
asS'KO_PATHWAY'
p12593
(lp12594
S'ko02010'
p12595
asS'PATHWAY_MAP'
p12596
(lp12597
S'map02010'
p12598
asS'DISEASE'
p12599
(lp12600
S'H00152'
p12601
aS'Sitosterolemia'
p12602
ag12601
ag12602
aS'H00159'
p12603
aS'Tangier disease'
p12604
aS'H00176'
p12605
aS'Adrenoleukodystrophy (ALD)'
p12606
aS'H00208'
p12607
aS'Hyperbilirubinemia'
p12608
aS'H00217'
p12609
aS'Pulmonary surfactant metabolism dysfunction (SMDP)'
p12610
aS'H00218'
p12611
aS'Cystic fibrosis (CF)'
p12612
aS'H00560'
p12613
aS'Pseudoxanthoma elasticum'
p12614
aS'H00624'
p12615
aS'Familial cholestasis'
p12616
aS'H00733'
p12617
aS'Harlequin ichthyosis'
p12618
aS'H00734'
p12619
aS'Lamellar ichthyosis (LI) and Non-bullous congenital ichthyosiform erythroderma (NBCIE)'
p12620
aS'H00819'
p12621
aS'Stargardt disease (STGD)'
p12622
aS'H00821'
p12623
aS'Macular degeneration'
p12624
aS'H00930'
p12625
aS'Hypoalphalipoproteinemia'
p12626
aS'H00984'
p12627
aS'Bare lymphocyte syndrome (BLS) type1'
p12628
aS'H01033'
p12629
aS'Congenital bilateral absence of vas deferens'
p12630
aS'H01213'
p12631
aS'Gallbladder disease'
p12632
aS'H01267'
p12633
aS'Familial hyperinsulinemic hypoglycemia (HHF)'
p12634
asS'MODULE'
p12635
(lp12636
S'M00185'
p12637
aS'Sulfate transport system [PATH:map02010]'
p12638
ag12637
ag12638
aS'M00186'
p12639
aS'Tungstate transport system [PATH:map02010]'
p12640
aS'M00189'
p12641
aS'Molybdate transport system [PATH:map02010]'
p12642
aS'M00190'
p12643
aS'Iron(III) transport system [PATH:map02010]'
p12644
aS'M00191'
p12645
aS'Thiamine transport system [PATH:map02010]'
p12646
aS'M00194'
p12647
aS'Maltose/maltodextrin transport system [PATH:map02010]'
p12648
aS'M00196'
p12649
aS'Raffinose/stachyose/melibiose transport system [PATH:map02010]'
p12650
aS'M00198'
p12651
aS'Putative sn-glycerol-phosphate transport system [PATH:map02010]'
p12652
aS'M00199'
p12653
aS'L-Arabinose/lactose transport system [PATH:map02010]'
p12654
aS'M00200'
p12655
aS'Putative sorbitol/mannitol transport system [PATH:map02010]'
p12656
aS'M00201'
p12657
aS'alpha-Glucoside transport system [PATH:map02010]'
p12658
aS'M00202'
p12659
aS'Oligogalacturonide transport system [PATH:map02010]'
p12660
aS'M00203'
p12661
aS'Glucose/arabinose transport system [PATH:map02010]'
p12662
aS'M00204'
p12663
aS'Trehalose/maltose transport system [PATH:map02010]'
p12664
aS'M00205'
p12665
aS'N-Acetylglucosamine transport system [PATH:map02010]'
p12666
aS'M00206'
p12667
aS'Cellobiose transport system [PATH:map02010]'
p12668
aS'M00208'
p12669
aS'Glycine betaine/proline transport system [PATH:map02010]'
p12670
aS'M00209'
p12671
aS'Osmoprotectant transport system [PATH:map02010]'
p12672
aS'M00210'
p12673
aS'Phospholipid transport system [PATH:map02010]'
p12674
aS'M00212'
p12675
aS'Ribose transport system [PATH:map02010]'
p12676
aS'M00213'
p12677
aS'L-Arabinose transport system [PATH:map02010]'
p12678
aS'M00214'
p12679
aS'Methyl-galactoside transport system [PATH:map02010]'
p12680
aS'M00215'
p12681
aS'D-Xylose transport system [PATH:map02010]'
p12682
aS'M00216'
p12683
aS'Multiple sugar transport system [PATH:map02010]'
p12684
aS'M00217'
p12685
aS'D-Allose transport system [PATH:map02010]'
p12686
aS'M00218'
p12687
aS'Fructose transport system [PATH:map02010]'
p12688
aS'M00219'
p12689
aS'AI-2 transport system [PATH:map02010]'
p12690
aS'M00220'
p12691
aS'Rhamnose transport system [PATH:map02010]'
p12692
aS'M00222'
p12693
aS'Phosphate transport system [PATH:map02010]'
p12694
aS'M00223'
p12695
aS'Phosphonate transport system [PATH:map02010]'
p12696
aS'M00224'
p12697
aS'Fluoroquinolones transport system [PATH:map02010]'
p12698
aS'M00225'
p12699
aS'Lysine/arginine/ornithine transport system [PATH:map02010]'
p12700
aS'M00226'
p12701
aS'Histidine transport system [PATH:map02010]'
p12702
aS'M00227'
p12703
aS'Glutamine transport system [PATH:map02010]'
p12704
aS'M00228'
p12705
aS'Putative glutamine transport system [PATH:map02010]'
p12706
aS'M00229'
p12707
aS'Arginine transport system [PATH:map02010]'
p12708
aS'M00230'
p12709
aS'Glutamate/aspartate transport system [PATH:map02010]'
p12710
aS'M00231'
p12711
aS'Octopine/nopaline transport system [PATH:map02010]'
p12712
aS'M00232'
p12713
aS'General L-amino acid transport system [PATH:map02010]'
p12714
aS'M00233'
p12715
aS'Glutamate transport system [PATH:map02010]'
p12716
aS'M00234'
p12717
aS'Cystine transport system [PATH:map02010]'
p12718
aS'M00235'
p12719
aS'Arginine/ornithine transport system [PATH:map02010]'
p12720
aS'M00237'
p12721
aS'Branched-chain amino acid transport system [PATH:map02010]'
p12722
aS'M00238'
p12723
aS'D-Methionine transport system [PATH:map02010]'
p12724
aS'M00239'
p12725
aS'Peptides/nickel transport system [PATH:map02010]'
p12726
aS'M00240'
p12727
aS'Iron complex transport system [PATH:map02010]'
p12728
aS'M00241'
p12729
aS'Vitamin B12 transport system [PATH:map02010]'
p12730
aS'M00242'
p12731
aS'Zinc transport system [PATH:map02010]'
p12732
aS'M00245'
p12733
aS'Cobalt/nickel transport system [PATH:map02010]'
p12734
aS'M00246'
p12735
aS'Nickel transport system [PATH:map02010]'
p12736
aS'M00249'
p12737
aS'Capsular polysaccharide transport system [PATH:map02010]'
p12738
aS'M00250'
p12739
aS'Lipopolysaccharide transport system [PATH:map02010]'
p12740
aS'M00251'
p12741
aS'Teichoic acid transport system [PATH:map02010]'
p12742
aS'M00252'
p12743
aS'Lipooligosaccharide transport system [PATH:map02010]'
p12744
aS'M00253'
p12745
aS'Sodium transport system [PATH:map02010]'
p12746
aS'M00255'
p12747
aS'Lipoprotein-releasing system [PATH:map02010]'
p12748
aS'M00256'
p12749
aS'Cell division transport system [PATH:map02010]'
p12750
aS'M00257'
p12751
aS'Hemin transport system [PATH:map02010]'
p12752
aS'M00259'
p12753
aS'Heme transport system [PATH:map02010]'
p12754
aS'M00298'
p12755
aS'Multidrug/hemolysin transport system [PATH:map02010]'
p12756
aS'M00299'
p12757
aS'Spermidine/putrescine transport system [PATH:map02010]'
p12758
aS'M00300'
p12759
aS'Putrescine transport system [PATH:map02010]'
p12760
aS'M00301'
p12761
aS'Mannopine transport system [PATH:map02010]'
p12762
aS'M00302'
p12763
aS'2-Aminoethylphosphonate transport system [PATH:map02010]'
p12764
aS'M00314'
p12765
aS'Bacitracin transport system [PATH:map02010]'
p12766
aS'M00316'
p12767
aS'Manganese transport system [PATH:map02010]'
p12768
aS'M00317'
p12769
aS'Manganese/iron transport system [PATH:map02010]'
p12770
aS'M00318'
p12771
aS'Iron/zinc/copper transport system [PATH:map02010]'
p12772
aS'M00319'
p12773
aS'Manganese/zinc/iron transport system [PATH:map02010]'
p12774
aS'M00320'
p12775
aS'Lipopolysaccharide export system [PATH:map02010]'
p12776
aS'M00321'
p12777
aS'Bicarbonate transport system [PATH:map02010]'
p12778
aS'M00322'
p12779
aS'Neutral amino acid transport system [PATH:map02010]'
p12780
aS'M00323'
p12781
aS'Urea transport system [PATH:map02010]'
p12782
aS'M00324'
p12783
aS'Dipeptide transport system [PATH:map02010]'
p12784
aS'M00325'
p12785
aS'alpha-Hemolysin/cyclolysin transport system [PATH:map02010]'
p12786
aS'M00348'
p12787
aS'Glutathione transport system [PATH:map02010]'
p12788
aS'M00349'
p12789
aS'Microcin C transport system [PATH:map02010]'
p12790
aS'M00423'
p12791
aS'Molybdate/tungstate transport system [PATH:map02010]'
p12792
aS'M00435'
p12793
aS'Taurine transport system [PATH:map02010]'
p12794
aS'M00436'
p12795
aS'Sulfonate transport system [PATH:map02010]'
p12796
aS'M00437'
p12797
aS'Phthalate transport system [PATH:map02010]'
p12798
aS'M00438'
p12799
aS'Nitrate/nitrite transport system [PATH:map02010]'
p12800
aS'M00439'
p12801
aS'Oligopeptide transport system [PATH:map02010]'
p12802
aS'M00440'
p12803
aS'Nickel transport system [PATH:map02010]'
p12804
aS'M00442'
p12805
aS'Putative hydroxymethylpyrimidine transport system [PATH:map02010]'
p12806
aS'M00491'
p12807
aS'arabinogalactan oligomer/maltooligosaccharide transport system [PATH:map02010]'
p12808
aS'M00566'
p12809
aS'Dipeptide transport system, Firmicutes [PATH:map02010]'
p12810
aS'M00581'
p12811
aS'Biotin transport system [PATH:map02010]'
p12812
aS'M00582'
p12813
aS'Energy-coupling factor transport system [PATH:map02010]'
p12814
aS'M00583'
p12815
aS'Putative peptide transport system [PATH:map02010]'
p12816
aS'M00584'
p12817
aS'Acetoin utilization transport system [PATH:map02010]'
p12818
aS'M00585'
p12819
aS'L-Cystine transport system [PATH:map02010]'
p12820
aS'M00586'
p12821
aS'Putative amino-acid transport system [PATH:map02010]'
p12822
aS'M00587'
p12823
aS'Arginine/lysine/histidine/glutamine transport system [PATH:map02010]'
p12824
aS'M00589'
p12825
aS'Putative lysine transport system [PATH:map02010]'
p12826
aS'M00590'
p12827
aS'Erythritol transport system [PATH:map02010]'
p12828
aS'M00591'
p12829
aS'Putative xylitol transport system [PATH:map02010]'
p12830
aS'M00592'
p12831
aS'Inositol transport system [PATH:map02010]'
p12832
aS'M00593'
p12833
aS'Inositol transport system [PATH:map02010]'
p12834
aS'M00599'
p12835
aS'Inositol-phosphate transport system [PATH:map02010]'
p12836
aS'M00600'
p12837
aS'alpha-1,4-Digalacturonate transport system [PATH:map02010]'
p12838
aS'M00601'
p12839
aS'Putative chitobiose transport system [PATH:map02010]'
p12840
aS'M00602'
p12841
aS'Arabinosaccharide transport system [PATH:map02010]'
p12842
aS'M00603'
p12843
aS'Putative aldouronate transport system [PATH:map02010]'
p12844
aS'M00604'
p12845
aS'Trehalose transport system [PATH:map02010]'
p12846
aS'M00605'
p12847
aS'Glucose/mannose transport system [PATH:map02010]'
p12848
aS'M00606'
p12849
aS"N,N'-Diacetylchitobiose transport system [PATH:map02010]"
p12850
aS'M00607'
p12851
aS'Glycerol transport system [PATH:map02010]'
p12852
aS'M00619'
p12853
aS'Xylobiose transport system [PATH:map02010]'
p12854
aS'M00634'
p12855
aS'Oleandomycin transport system [PATH:map02010]'
p12856
aS'M00635'
p12857
aS'Tetracycline resistance, TetAB(46) transporter [PATH:map02010]'
p12858
asS'DBLINKS'
p12859
(lp12860
S'GO: 0043190 0043191 0043192'
p12861
ag12861
aS'TC: 3.A.1'
p12862
asS'ENTRY'
p12863
(lp12864
S'map02010'
p12865
aS'Pathway'
p12866
asS'CLASS'
p12867
(lp12868
S'Environmental Information Processing Membrane transport'
p12869
asS'DESCRIPTION'
p12870
(lp12871
S'The ATP-binding cassette (ABC) transporters form one of the largest known protein families, and are widespread in bacteria, archaea, and eukaryotes. They couple ATP hydrolysis to active transport of a wide variety of substrates such as ions, sugars, lipids, sterols, peptides, proteins, and drugs. The structure of a prokaryotic ABC transporter usually consists of three components typically two integral membrane proteins each having six transmembrane segments, two peripheral proteins that bind and hydrolyze ATP, and a periplasmic (or lipoprotein) substrate-binding protein. Many of the genes for the three components form operons as in fact observed in many bacterial and archaeal genomes. On the other hand, in a typical eukaryotic ABC transporter, the membrane spanning protein and the ATP-binding protein are fused, forming a multi-domain protein with the membrane-spanning domain (MSD) and the nucleotide-binding domain (NBD).'
p12872
assS'path:map07227'
p12873
(dp12874
S'ENTRY'
p12875
(lp12876
S'map07227'
p12877
aS'Drug'
p12878
aS'Pathway'
p12879
asS'PATHWAY_MAP'
p12880
(lp12881
S'map07227'
p12882
asS'NAME'
p12883
(lp12884
S'Histamine H2/H3 receptor agonists/antagonists'
p12885
asS'REFERENCE'
p12886
(lp12887
g22
ag22
aS'AUTHORS'
p12888
aS'Yamakawa K., Kanaoka Y., Iwasawa Y.'
p12889
aS'TITLE'
p12890
aS'[Medicinal Chemistry (5th ed)] (In Japanase)'
p12891
aS'JOURNAL'
p12892
aS'Kodansha Scientific'
p12893
asS'COMPOUND'
p12894
(lp12895
S'C00388'
p12896
aS'Histamine'
p12897
ag12896
ag12897
aS'C07448'
p12898
aS'Burimamide'
p12899
aS'C07454'
p12900
aS'N-Guanylhistamine'
p12901
aS'C11800'
p12902
aS'Thiaburimamide'
p12903
aS'C17929'
p12904
aS'4-Methylhistamine'
p12905
aS'C17930'
p12906
aS'Dimaprit'
p12907
aS'C17931'
p12908
aS'Imetit'
p12909
aS'C17932'
p12910
aS'Immepip'
p12911
aS'C17933'
p12912
aS'Thioperamide'
p12913
aS'C17934'
p12914
aS'Clobenpropit'
p12915
aS'D00295'
p12916
aS'Cimetidine (JP16/USP/INN)'
p12917
aS'D00318'
p12918
aS'Famotidine (JP16/USP/INN)'
p12919
aS'D00422'
p12920
aS'Ranitidine (USAN/INN)'
p12921
aS'D00440'
p12922
aS'Nizatidine (JP16/USP/INN)'
p12923
aS'D00673'
p12924
aS'Ranitidine hydrochloride (JP16/USP)'
p12925
aS'D01131'
p12926
aS'Lafutidine (JP16/INN)'
p12927
aS'D01467'
p12928
aS'Roxatidine acetate hydrochloride (JP16/USAN)'
p12929
aS'D03503'
p12930
aS'Cimetidine hydrochloride (USP)'
p12931
aS'D04517'
p12932
aS'Impromidine hydrochloride (USAN)'
p12933
aS'D05004'
p12934
aS'Metiamide (USAN/INN)'
p12935
aS'D05699'
p12936
aS'Ranitidine bismuth citrate (USAN)'
p12937
aS'D06157'
p12938
aS'Tiotidine (USAN/INN)'
p12939
aS'D07072'
p12940
aS'Niperotidine (INN)'
p12941
aS'D08494'
p12942
aS'Roxatidine (INN)'
p12943
aS'D08495'
p12944
aS'Roxatidine acetate (BAN)'
p12945
assS'path:map07226'
p12946
(dp12947
S'ENTRY'
p12948
(lp12949
S'map07226'
p12950
aS'Drug'
p12951
aS'Pathway'
p12952
asS'PATHWAY_MAP'
p12953
(lp12954
S'map07226'
p12955
asS'NAME'
p12956
(lp12957
S'Progesterone, androgen and estrogen receptor agonists/antagonists'
p12958
asS'REFERENCE'
p12959
(lp12960
g22
ag22
aS'AUTHORS'
p12961
aS'Yamakawa K., Kanaoka Y., Iwasawa Y.'
p12962
aS'TITLE'
p12963
aS'[Medicinal Chemistry (5th ed)] (In Japanase)'
p12964
aS'JOURNAL'
p12965
aS'Kodansha Scientific'
p12966
ag22
ag22
aS'AUTHORS'
p12967
aS'Tanaka C., Kato R. (eds)'
p12968
aS'TITLE'
p12969
aS'[New pharmacology (revision 5th ed)] (In Japanese)'
p12970
aS'JOURNAL'
p12971
aS'Nankodo'
p12972
asS'COMPOUND'
p12973
(lp12974
S'C00410'
p12975
aS'Progesterone'
p12976
ag12975
ag12976
aS'C00468'
p12977
aS'Estrone'
p12978
aS'C00535'
p12979
aS'Testosterone'
p12980
aS'C00951'
p12981
aS'Estradiol-17beta'
p12982
aS'C05141'
p12983
aS'Estriol'
p12984
aS'D00066'
p12985
aS'Progesterone (JP16/USP/INN)'
p12986
aS'D00067'
p12987
aS'Estrone (JAN/USP/INN)'
p12988
aS'D00075'
p12989
aS'Testosterone (JAN/USP)'
p12990
aS'D00105'
p12991
aS'Estradiol (JAN/USP/INN)'
p12992
aS'D00182'
p12993
aS'Norethisterone (JP16)'
p12994
aS'D00185'
p12995
aS'Estriol (JP16/USP)'
p12996
aS'D00289'
p12997
aS'Danazol (JP16/USP/INN)'
p12998
aS'D00312'
p12999
aS'Estrone sodium sulfate'
p13000
aS'D00327'
p13001
aS'Fluoxymesterone (JP16/USP/INN)'
p13002
aS'D00408'
p13003
aS'Methyltestosterone (JP16/USP/INN)'
p13004
aS'D00444'
p13005
aS'Stanozolol (JAN/USP/INN)'
p13006
aS'D00462'
p13007
aS'Oxandrolone (JAN/USP/INN)'
p13008
aS'D00554'
p13009
aS'Ethinylestradiol (JP16/INN)'
p13010
aS'D00575'
p13011
aS'Mestranol (JP16/USP/INN)'
p13012
aS'D00577'
p13013
aS'Diethylstilbestrol (USP/INN)'
p13014
aS'D00585'
p13015
aS'Mifepristone (USAN/INN)'
p13016
aS'D00586'
p13017
aS'Flutamide (JP16/USP/INN)'
p13018
aS'D00946'
p13019
aS'Fosfestrol (JAN/INN)'
p13020
aS'D00949'
p13021
aS'Hydroxyprogesterone caproate (JAN/USP/INN)'
p13022
aS'D00951'
p13023
aS'Medroxyprogesterone acetate (JAN/USP)'
p13024
aS'D00953'
p13025
aS'Norethisterone acetate (JAN)'
p13026
aS'D00957'
p13027
aS'Testosterone cypionate (USP)'
p13028
aS'D00958'
p13029
aS'Testosterone enanthate (JP16/USP)'
p13030
aS'D00959'
p13031
aS'Testosterone propionate (JP16/USP)'
p13032
aS'D00961'
p13033
aS'Bicalutamide (JAN/USP/INN)'
p13034
aS'D00962'
p13035
aS'Clomifene citrate (JP16)'
p13036
aS'D00965'
p13037
aS'Nilutamide (USAN/INN)'
p13038
aS'D00966'
p13039
aS'Tamoxifen citrate (JP16/USP)'
p13040
aS'D00967'
p13041
aS'Toremifene citrate (JAN/USAN)'
p13042
aS'D01159'
p13043
aS'Gestonorone caproate (JAN/USAN)'
p13044
aS'D01161'
p13045
aS'Fulvestrant (JAN/USAN/INN)'
p13046
aS'D01217'
p13047
aS'Dydrogesterone (JP16/USP/INN)'
p13048
aS'D01265'
p13049
aS'Epitiostanol (JAN/INN)'
p13050
aS'D01281'
p13051
aS'Cyclofenil (JAN/INN)'
p13052
aS'D01299'
p13053
aS'Chlormadinone acetate (JP16/USAN)'
p13054
aS'D01329'
p13055
aS'Oxendolone (JAN/USAN/INN)'
p13056
aS'D01368'
p13057
aS'Cyproterone acetate (JAN/USAN)'
p13058
aS'D01413'
p13059
aS'Estradiol valerate (JAN/USP/INN)'
p13060
aS'D01602'
p13061
aS'Mepitiostane (JP16/INN)'
p13062
aS'D01617'
p13063
aS'Estradiol dipropionate (JAN)'
p13064
aS'D01953'
p13065
aS'Estradiol benzoate (JP16)'
p13066
aS'D01986'
p13067
aS'Estriol tripropionate (JAN)'
p13068
aS'D01989'
p13069
aS'Estriol diacetate benzoate (JAN)'
p13070
aS'D02367'
p13071
aS'Desogestrel (USAN/INN)'
p13072
aS'D02996'
p13073
aS'Asoprisnil (USAN/INN)'
p13074
aS'D03675'
p13075
aS'Delmadinone acetate (USAN)'
p13076
aS'D04061'
p13077
aS'Estradiol acetate (USAN)'
p13078
aS'D04063'
p13079
aS'Estradiol cypionate (USP)'
p13080
aS'D04064'
p13081
aS'Estradiol enanthate (USAN)'
p13082
aS'D04065'
p13083
aS'Estradiol undecylate (USAN/INN)'
p13084
aS'D04316'
p13085
aS'Gestodene (USAN/INN)'
p13086
aS'D05209'
p13087
aS'Norgestimate (USP/INN)'
p13088
aS'D06085'
p13089
aS'Testosterone ketolaurate (USAN/INN)'
p13090
aS'D06086'
p13091
aS'Testosterone phenylacetate (USAN)'
p13092
aS'D06087'
p13093
aS'Testosterone undecanoate (USAN)'
p13094
aS'D07434'
p13095
aS'Polyestradiol phosphate (INN)'
p13096
aS'D07670'
p13097
aS'Chlormadinone (INN)'
p13098
aS'D07726'
p13099
aS'Clomifene (INN)'
p13100
aS'D07766'
p13101
aS'Cyproterone (INN)'
p13102
aS'D07783'
p13103
aS'Delmadinone (INN)'
p13104
aS'D07826'
p13105
aS'Hexestrol diphosphate sodium'
p13106
aS'D07918'
p13107
aS'Estradiol hemihydrate'
p13108
aS'D07919'
p13109
aS'Estradiol 17 beta-hemisuccinate'
p13110
aS'D07920'
p13111
aS'Estriol succinate'
p13112
aS'D07921'
p13113
aS'Estriol sodium succinate (BAN)'
p13114
aS'D07928'
p13115
aS'Ethinylestradiol propanesulfonate'
p13116
aS'D08052'
p13117
aS'Hydroxyprogesterone (INN)'
p13118
aS'D08053'
p13119
aS'Hydroxyprogesterone 17alfa-acetate'
p13120
aS'D08166'
p13121
aS'Medroxyprogesterone (INN)'
p13122
aS'D08285'
p13123
aS'Norethisterone enantate'
p13124
aS'D08465'
p13125
aS'Raloxifene (INN)'
p13126
aS'D08559'
p13127
aS'Tamoxifen (INN)'
p13128
aS'D08573'
p13129
aS'Testosterone decanoate'
p13130
aS'D08574'
p13131
aS'Testosterone phenylpropionate'
p13132
aS'D08620'
p13133
aS'Toremifene (INN)'
p13134
aS'D09571'
p13135
aS'Onapristone (INN)'
p13136
assS'path:map07225'
p13137
(dp13138
S'ENTRY'
p13139
(lp13140
S'map07225'
p13141
aS'Drug'
p13142
aS'Pathway'
p13143
asS'PATHWAY_MAP'
p13144
(lp13145
S'map07225'
p13146
asS'NAME'
p13147
(lp13148
S'Glucocorticoid and meneralocorticoid receptor agonists/antagonists'
p13149
asS'REFERENCE'
p13150
(lp13151
g22
ag22
aS'AUTHORS'
p13152
aS'Yamakawa K., Kanaoka Y., Iwasawa Y.'
p13153
aS'TITLE'
p13154
aS'[Medicinal Chemistry (5th ed)] (In Japanase)'
p13155
aS'JOURNAL'
p13156
aS'Kodansha Scientific'
p13157
ag22
ag22
aS'AUTHORS'
p13158
aS'Tanaka C., Kato R. (eds)'
p13159
aS'TITLE'
p13160
aS'[New pharmacology (revision 5th ed)] (In Japanese)'
p13161
aS'JOURNAL'
p13162
aS'Nankodo'
p13163
asS'COMPOUND'
p13164
(lp13165
S'C00410'
p13166
aS'Progesterone'
p13167
ag13166
ag13167
aS'C00735'
p13168
aS'Cortisol'
p13169
aS'C00762'
p13170
aS'Cortisone'
p13171
aS'C01780'
p13172
aS'Aldosterone'
p13173
aS'D00066'
p13174
aS'Progesterone (JP16/USP/INN)'
p13175
aS'D00088'
p13176
aS'Hydrocortisone (JP16/USP/INN)'
p13177
aS'D00165'
p13178
aS'Hydrocortisone acetate (JP16/USP)'
p13179
aS'D00244'
p13180
aS'Betamethasone (JP16/USP/INN)'
p13181
aS'D00292'
p13182
aS'Dexamethasone (JP16/USP/INN)'
p13183
aS'D00325'
p13184
aS'Fluocinonide (JP16/USP/INN)'
p13185
aS'D00385'
p13186
aS'Triamcinolone (JP16/USP/INN)'
p13187
aS'D00407'
p13188
aS'Methylprednisolone (JP16/USP/INN)'
p13189
aS'D00443'
p13190
aS'Spironolactone (JP16/USP/INN)'
p13191
aS'D00472'
p13192
aS'Prednisolone (JP16/USP/INN)'
p13193
aS'D00689'
p13194
aS'Beclometasone dipropionate (JP16)'
p13195
aS'D00751'
p13196
aS'Methylprednisolone sodium succinate (JAN/USP)'
p13197
aS'D00972'
p13198
aS'Betamethasone sodium phosphate (JP16/USP)'
p13199
aS'D00973'
p13200
aS'Cortisone acetate (JP16/USP)'
p13201
aS'D00975'
p13202
aS'Dexamethasone sodium phosphate (JAN/USP)'
p13203
aS'D00976'
p13204
aS'Hydrocortisone cypionate'
p13205
aS'D00977'
p13206
aS'Hydrocortisone sodium phosphate (JP16/USP)'
p13207
aS'D00978'
p13208
aS'Hydrocortisone sodium succinate (JP16/USP)'
p13209
aS'D00979'
p13210
aS'Methylprednisolone acetate (JAN/USP)'
p13211
aS'D00980'
p13212
aS'Prednisolone acetate (JP16/USP/INN)'
p13213
aS'D00981'
p13214
aS'Prednisolone sodium phosphate (JP16/USP)'
p13215
aS'D00982'
p13216
aS'Prednisolone tebutate (JAN/USP)'
p13217
aS'D00983'
p13218
aS'Triamcinolone acetonide (JP16/USP)'
p13219
aS'D00984'
p13220
aS'Triamcinolone diacetate (JAN/USP)'
p13221
aS'D00985'
p13222
aS'Triamcinolone hexacetonide (USP/INN)'
p13223
aS'D00986'
p13224
aS'Fludrocortisone acetate (JP16/USP)'
p13225
aS'D01115'
p13226
aS'Eplerenone (JAN/USAN/INN)'
p13227
aS'D01229'
p13228
aS'Paramethasone acetate (JAN/USP)'
p13229
aS'D01239'
p13230
aS'Prednisolone sodium succinate (JP16/USP)'
p13231
aS'D01299'
p13232
aS'Chlormadinone acetate (JP16/USAN)'
p13233
aS'D01357'
p13234
aS'Betamethasone valerate (JP16/USP)'
p13235
aS'D01387'
p13236
aS'Amcinonide (JAN/USP/INN)'
p13237
aS'D01402'
p13238
aS'Betamethasone acetate (JAN/USP)'
p13239
aS'D01442'
p13240
aS'Hydrocortisone succinate (JP16)'
p13241
aS'D01510'
p13242
aS'Dexamethasone metasulfobenzoate sodium (JAN)'
p13243
aS'D01615'
p13244
aS'Dexamethasone palmitate (JAN)'
p13245
aS'D01619'
p13246
aS'Hydrocortisone butyrate (JP16/USP)'
p13247
aS'D01632'
p13248
aS'Dexamethasone propionate (JAN)'
p13249
aS'D01637'
p13250
aS'Betamethasone dipropionate (JP16/USP)'
p13251
aS'D01708'
p13252
aS'Fluticasone propionate (JAN/USAN)'
p13253
aS'D01825'
p13254
aS'Fluocinolone acetonide (JP16/USP/INN)'
p13255
aS'D01886'
p13256
aS'Hydrocortisone butyrate propionate (JAN)'
p13257
aS'D01943'
p13258
aS'Potassium canrenoate (JP16)'
p13259
aS'D01948'
p13260
aS'Dexamethasone valerate (JAN)'
p13261
aS'D01998'
p13262
aS'Prednisolone farnesylate (JAN)'
p13263
aS'D02032'
p13264
aS'Betamethasone butyrate propionate (JAN)'
p13265
aS'D02156'
p13266
aS'Prednisolone succinate (JP16)'
p13267
aS'D02174'
p13268
aS'Dexamethasone acetate (JAN/USP)'
p13269
aS'D02286'
p13270
aS'Betamethasone benzoate (USP)'
p13271
aS'D02288'
p13272
aS'Hydrocortisone valerate (USP)'
p13273
aS'D02591'
p13274
aS'Dexamethasone acefurate (USAN/INN)'
p13275
aS'D02592'
p13276
aS'Dexamethasone beloxil (USAN)'
p13277
aS'D03301'
p13278
aS'Prednisolone valerate acetate (JAN)'
p13279
aS'D03363'
p13280
aS'Canrenone (USAN)'
p13281
aS'D03698'
p13282
aS'Desoxycorticosterone acetate (USP)'
p13283
aS'D03699'
p13284
aS'Desoxycorticosterone pivalate (USP)'
p13285
aS'D03792'
p13286
aS'Dicirenone (USAN)'
p13287
aS'D03917'
p13288
aS'Drospirenone (JAN/USP/INN)'
p13289
aS'D04467'
p13290
aS'Hydrocortisone hemisuccinate (USP)'
p13291
aS'D05000'
p13292
aS'Methylprednisolone succinate (JP16)'
p13293
aS'D05001'
p13294
aS'Methylprednisolone sodium phosphate (USAN)'
p13295
aS'D05002'
p13296
aS'Methylprednisolone suleptanate (USAN/INN)'
p13297
aS'D05020'
p13298
aS'Mexrenoate potassium (USAN)'
p13299
aS'D05640'
p13300
aS'Prorenoate potassium (USAN/INN)'
p13301
aS'D06216'
p13302
aS'Triamcinolone acetonide sodium phosphate (USAN)'
p13303
aS'D06315'
p13304
aS'Fluticasone furoate (JAN/USAN/INN)'
p13305
aS'D06876'
p13306
aS'Hydrocortisone aceponate (INN)'
p13307
aS'D07073'
p13308
aS'Dexamethasone cipecilate (JAN/INN)'
p13309
aS'D07203'
p13310
aS'Methylprednisolone aceponate (INN)'
p13311
aS'D07464'
p13312
aS'Paramethasone (INN)'
p13313
aS'D07495'
p13314
aS'Beclometasone (INN)'
p13315
aS'D07670'
p13316
aS'Chlormadinone (INN)'
p13317
aS'D07749'
p13318
aS'Cortisone (INN)'
p13319
aS'D07792'
p13320
aS'Desoxycortone (INN)'
p13321
aS'D07796'
p13322
aS'Dexamethasone 21-acetate'
p13323
aS'D07797'
p13324
aS'Dexamethasone isonicotinate'
p13325
aS'D07798'
p13326
aS'Dexamethasone sodium hemisulfate'
p13327
aS'D07799'
p13328
aS'Dexamethasone 21-tebutate'
p13329
aS'D07800'
p13330
aS'Dexamethasone 21-valerate'
p13331
aS'D07801'
p13332
aS'Dexamethasone phenylpropionate'
p13333
aS'D07802'
p13334
aS'Dexamethasone phosphate'
p13335
aS'D07967'
p13336
aS'Fludrocortisone (INN)'
p13337
aS'D07981'
p13338
aS'Fluticasone (INN)'
p13339
aS'D08412'
p13340
aS'Prednisolone pivalate'
p13341
aS'D08413'
p13342
aS'Prednisolone sodium metazoate (USAN)'
p13343
aS'D08414'
p13344
aS'Prednisolone 21-(sodium tetrahydrophthalate)'
p13345
aS'D08415'
p13346
aS'Prednisolone steaglate (BAN)'
p13347
assS'path:map00540'
p13348
(dp13349
S'NAME'
p13350
(lp13351
S'Lipopolysaccharide biosynthesis'
p13352
asS'REFERENCE'
p13353
(lp13354
S'PMID:9791168'
p13355
ag13355
aS'AUTHORS'
p13356
aS'Heinrichs DE, Yethon JA, Whitfield C.'
p13357
aS'TITLE'
p13358
aS'Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica.'
p13359
aS'JOURNAL'
p13360
aS'Mol Microbiol 30:221-32 (1998)'
p13361
aS'PMID:11751812'
p13362
ag13362
aS'AUTHORS'
p13363
aS'Kneidinger B, Marolda C, Graninger M, Zamyatina A, McArthur F, Kosma P, Valvano MA, Messner P.'
p13364
aS'TITLE'
p13365
aS'Biosynthesis pathway of ADP-L-glycero-beta-D-manno-heptose in Escherichia coli.'
p13366
aS'JOURNAL'
p13367
aS'J Bacteriol 184:363-9 (2002)'
p13368
aS'PMID:9587193'
p13369
ag13369
aS'AUTHORS'
p13370
aS'Wyckoff TJ, Raetz CR, Jackman JE.'
p13371
aS'TITLE'
p13372
aS'Antibacterial and anti-inflammatory agents that target endotoxin.'
p13373
aS'JOURNAL'
p13374
aS'Trends Microbiol 6:154-9 (1998)'
p13375
aS'PMID:9765561'
p13376
ag13376
aS'AUTHORS'
p13377
aS'Shibayama K, Ohsuka S, Tanaka T, Arakawa Y, Ohta M.'
p13378
aS'TITLE'
p13379
aS'Conserved structural regions involved in the catalytic mechanism of Escherichia coli K-12 WaaO (RfaI).'
p13380
aS'JOURNAL'
p13381
aS'J Bacteriol 180:5313-8 (1998)'
p13382
asS'KO_PATHWAY'
p13383
(lp13384
S'ko00540'
p13385
asS'PATHWAY_MAP'
p13386
(lp13387
S'map00540'
p13388
asS'MODULE'
p13389
(lp13390
S'M00060'
p13391
aS'Lipopolysaccharide biosynthesis, KDO2-lipid A [PATH:map00540]'
p13392
ag13391
ag13392
aS'M00063'
p13393
aS'CMP-KDO biosynthesis [PATH:map00540]'
p13394
aS'M00064'
p13395
aS'ADP-L-glycero-D-manno-heptose biosynthesis [PATH:map00540]'
p13396
aS'M00080'
p13397
aS'Lipopolysaccharide biosynthesis, inner core => outer core => O-antigen [PATH:map00540]'
p13398
asS'DBLINKS'
p13399
(lp13400
S'GO: 0009103'
p13401
asS'ENTRY'
p13402
(lp13403
S'map00540'
p13404
aS'Pathway'
p13405
asS'CLASS'
p13406
(lp13407
S'Metabolism Glycan biosynthesis and metabolism'
p13408
assS'path:map07223'
p13409
(dp13410
S'ENTRY'
p13411
(lp13412
S'map07223'
p13413
aS'Drug'
p13414
aS'Pathway'
p13415
asS'PATHWAY_MAP'
p13416
(lp13417
S'map07223'
p13418
asS'NAME'
p13419
(lp13420
S'Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists'
p13421
asS'REFERENCE'
p13422
(lp13423
S'PMID:18622097'
p13424
ag13424
aS'AUTHORS'
p13425
aS'Kagechika H'
p13426
aS'TITLE'
p13427
aS'[Chemical biology research on nuclear receptors]'
p13428
aS'JOURNAL'
p13429
aS'Nippon Yakurigaku Zasshi 132:11-7 (2008)'
p13430
asS'COMPOUND'
p13431
(lp13432
S'D00094'
p13433
aS'Tretinoin (JAN/USP/INN)'
p13434
ag13433
ag13434
aS'D00164'
p13435
aS'Retinol palmitate (JP16)'
p13436
aS'D00316'
p13437
aS'Etretinate (JAN/USAN/INN)'
p13438
aS'D00348'
p13439
aS'Isotretinoin (USP)'
p13440
aS'D01112'
p13441
aS'Adapalene (JAN/USAN/INN)'
p13442
aS'D01132'
p13443
aS'Tazarotene (JAN/USAN/INN)'
p13444
aS'D01418'
p13445
aS'Tamibarotene (JAN/INN)'
p13446
aS'D01621'
p13447
aS'Retinol acetate (JP16)'
p13448
aS'D02754'
p13449
aS'Acitretin (USP/INN)'
p13450
aS'D02815'
p13451
aS'Alitretinoin (USAN)'
p13452
aS'D03106'
p13453
aS'Bexarotene (JAN/USAN/INN)'
p13454
aS'D04636'
p13455
aS'Isotretinoin anisatil (USAN)'
p13456
aS'D05082'
p13457
aS'Motretinide (USAN/INN)'
p13458
aS'D06543'
p13459
aS'Vitamin A (USP)'
p13460
aS'D08477'
p13461
aS'Retinol propionate'
p13462
assS'path:map07222'
p13463
(dp13464
S'ENTRY'
p13465
(lp13466
S'map07222'
p13467
aS'Drug'
p13468
aS'Pathway'
p13469
asS'PATHWAY_MAP'
p13470
(lp13471
S'map07222'
p13472
asS'NAME'
p13473
(lp13474
S'Peroxisome proliferator-activated receptor (PPAR) agonists'
p13475
asS'REFERENCE'
p13476
(lp13477
g22
ag22
aS'AUTHORS'
p13478
aS'Yamakawa K., Kanaoka Y., Iwasawa Y.'
p13479
aS'TITLE'
p13480
aS'[Medicinal Chemistry (5th ed)] (In Japanase)'
p13481
aS'JOURNAL'
p13482
aS'Kodansha Scientific'
p13483
asS'COMPOUND'
p13484
(lp13485
S'C17302'
p13486
aS'AL-294'
p13487
ag13486
ag13487
aS'C17303'
p13488
aS'AL-321'
p13489
aS'D00279'
p13490
aS'Clofibrate (JP16/USP/INN)'
p13491
aS'D00334'
p13492
aS'Gemfibrozil (JAN/USP/INN)'
p13493
aS'D00395'
p13494
aS'Troglitazone (JAN/USAN/INN)'
p13495
aS'D00565'
p13496
aS'Fenofibrate (JAN/INN)'
p13497
aS'D00596'
p13498
aS'Rosiglitazone maleate (JAN/USAN)'
p13499
aS'D00945'
p13500
aS'Pioglitazone hydrochloride (JP16/USP)'
p13501
aS'D01208'
p13502
aS'Aluminum clofibrate (JAN/INN)'
p13503
aS'D01212'
p13504
aS'Simfibrate (JAN/INN)'
p13505
aS'D01300'
p13506
aS'Clinofibrate (JP16/INN)'
p13507
aS'D01366'
p13508
aS'Bezafibrate (JP16/USAN/INN)'
p13509
aS'D03493'
p13510
aS'Ciglitazone (USAN/INN)'
p13511
aS'D03521'
p13512
aS'Ciprofibrate (USAN/INN)'
p13513
aS'D03653'
p13514
aS'Darglitazone sodium (USAN)'
p13515
aS'D05091'
p13516
aS'Muraglitazar (USAN/INN)'
p13517
aS'D05150'
p13518
aS'Netoglitazone (USAN/INN)'
p13519
aS'D05739'
p13520
aS'Rivoglitazone (USAN/INN)'
p13521
aS'D07186'
p13522
aS'Ronifibrate (INN)'
p13523
aS'D07187'
p13524
aS'Etofibrate (INN)'
p13525
aS'D07188'
p13526
aS'Clofibride (INN)'
p13527
aS'D07529'
p13528
aS'Binifibrate (INN)'
p13529
aS'D07723'
p13530
aS'Clofibric acid (INN)'
p13531
aS'D07724'
p13532
aS'Magnesium clofibrate (INN)'
p13533
aS'D08378'
p13534
aS'Pioglitazone (INN)'
p13535
aS'D08491'
p13536
aS'Rosiglitazone (INN)'
p13537
assS'path:map07221'
p13538
(dp13539
S'ENTRY'
p13540
(lp13541
S'map07221'
p13542
aS'Drug'
p13543
aS'Pathway'
p13544
asS'PATHWAY_MAP'
p13545
(lp13546
S'map07221'
p13547
asS'NAME'
p13548
(lp13549
S'Nicotinic cholinergic receptor antagonists'
p13550
asS'REFERENCE'
p13551
(lp13552
g22
ag22
aS'AUTHORS'
p13553
aS'David AW, Thomas LL, William OF.'
p13554
aS'TITLE'
p13555
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p13556
aS'JOURNAL'
p13557
aS'Lippincott Williams & Wilkins (2002)'
p13558
ag22
ag22
aS'AUTHORS'
p13559
aS'Sano T, Naito T, Kubo T (eds).'
p13560
aS'TITLE'
p13561
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p13562
aS'JOURNAL'
p13563
aS'Nankodo (2002)'
p13564
ag22
ag22
aS'AUTHORS'
p13565
aS'Tanaka C, Kato R (eds).'
p13566
aS'TITLE'
p13567
aS'[New Pharmacology (4th ed)] (In Japanese)'
p13568
aS'JOURNAL'
p13569
aS'Nankodo (2002)'
p13570
aS'PMID:16402115'
p13571
ag13571
aS'AUTHORS'
p13572
aS'Bowman WC.'
p13573
aS'TITLE'
p13574
aS'Neuromuscular block.'
p13575
aS'JOURNAL'
p13576
aS'Br J Pharmacol 147 Suppl 1:S277-86 (2006)'
p13577
asS'COMPOUND'
p13578
(lp13579
S'C07547'
p13580
aS'Tubocurarine'
p13581
ag13580
ag13581
aS'C07548'
p13582
aS'Atracurium'
p13583
aS'C07550'
p13584
aS'Mivacurium'
p13585
aS'C07919'
p13586
aS'Metocurine'
p13587
aS'C11733'
p13588
aS'Decamethonium'
p13589
aS'D00492'
p13590
aS'Pancuronium bromide (JP16/USAN/INN)'
p13591
aS'D00758'
p13592
aS'Atracurium besylate (USP)'
p13593
aS'D00761'
p13594
aS'Metocurine iodide (USAN)'
p13595
aS'D00763'
p13596
aS'Mivacurium chloride (USAN/INN)'
p13597
aS'D00764'
p13598
aS'Pipecuronium bromide (USAN/INN)'
p13599
aS'D00765'
p13600
aS'Rocuronium bromide (JAN/USAN/INN)'
p13601
aS'D00766'
p13602
aS'Succinylcholine chloride (USP)'
p13603
aS'D00767'
p13604
aS'Vecuronium bromide (JAN/USAN/INN)'
p13605
aS'D02204'
p13606
aS'Hexamethonium bromide (JAN/INN)'
p13607
aS'D02207'
p13608
aS'Tubocurarine chloride hydrate (JAN)'
p13609
aS'D02275'
p13610
aS'Suxamethonium chloride hydrate (JP16)'
p13611
aS'D02292'
p13612
aS'Gallamine triethiodide (USP)'
p13613
aS'D07272'
p13614
aS'Dimethyltubocurarine (BAN)'
p13615
aS'D08655'
p13616
aS'Tubocurarine chloride (INN)'
p13617
assS'path:map00982'
p13618
(dp13619
S'NAME'
p13620
(lp13621
S'Drug metabolism - cytochrome P450'
p13622
asS'REFERENCE'
p13623
(lp13624
g22
ag22
aS'AUTHORS'
p13625
aS'Kato R, Kamatari T (eds).'
p13626
aS'TITLE'
p13627
aS'[Drug Metabolism] (In Japanese)'
p13628
aS'JOURNAL'
p13629
aS'Tokyo Kagaku Dojin (2000)'
p13630
aS'PMID:16038189'
p13631
ag13631
aS'AUTHORS'
p13632
aS'Gjerde J, Kisanga ER, Hauglid M, Holm PI, Mellgren G, Lien EA.'
p13633
aS'TITLE'
p13634
aS'Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.'
p13635
aS'JOURNAL'
p13636
aS'J Chromatogr A 1082:6-14 (2005)'
p13637
aS'PMID:18043895'
p13638
ag13638
aS'AUTHORS'
p13639
aS'Buck MB, Coller JK, Murdter TE, Eichelbaum M, Knabbe C.'
p13640
aS'TITLE'
p13641
aS'TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells.'
p13642
aS'JOURNAL'
p13643
aS'Breast Cancer Res Treat 107:15-24 (2008)'
p13644
aS'PMID:16550168'
p13645
ag13645
aS'AUTHORS'
p13646
aS'Rodriguez-Antona C, Ingelman-Sundberg M.'
p13647
aS'TITLE'
p13648
aS'Cytochrome P450 pharmacogenetics and cancer.'
p13649
aS'JOURNAL'
p13650
aS'Oncogene 25:1679-91 (2006)'
p13651
aS'PMID:16393888'
p13652
ag13652
aS'AUTHORS'
p13653
aS'Zhang J, Tian Q, Yung Chan S, Chuen Li S, Zhou S, Duan W, Zhu YZ.'
p13654
aS'TITLE'
p13655
aS'Metabolism and transport of oxazaphosphorines and the clinical implications.'
p13656
aS'JOURNAL'
p13657
aS'Drug Metab Rev 37:611-703 (2005)'
p13658
aS'PMID:11226815'
p13659
ag13659
aS'AUTHORS'
p13660
aS'Kosel M, Amey M, Aubert AC, Baumann P.'
p13661
aS'TITLE'
p13662
aS'In vitro metabolism of citalopram by monoamine oxidase B in human blood.'
p13663
aS'JOURNAL'
p13664
aS'Eur Neuropsychopharmacol 11:75-8 (2001)'
p13665
aS'PMID:10575324'
p13666
ag13666
aS'AUTHORS'
p13667
aS'Olesen OV, Linnet K.'
p13668
aS'TITLE'
p13669
aS'Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes.'
p13670
aS'JOURNAL'
p13671
aS'Pharmacology 59:298-309 (1999)'
p13672
aS'PMID:9698084'
p13673
ag13673
aS'AUTHORS'
p13674
aS'Rochat B, Kosel M, Boss G, Testa B, Gillet M, Baumann P.'
p13675
aS'TITLE'
p13676
aS'Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver.'
p13677
aS'JOURNAL'
p13678
aS'Biochem Pharmacol 56:15-23 (1998)'
p13679
ag22
ag22
aS'AUTHORS'
p13680
aS'David AW, Thomas LL, William OF.'
p13681
aS'TITLE'
p13682
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p13683
aS'JOURNAL'
p13684
aS'Lippincott Williams & Wilkins (2002)'
p13685
aS'PMID:11504799'
p13686
ag13686
aS'AUTHORS'
p13687
aS'Oda Y, Kharasch ED.'
p13688
aS'TITLE'
p13689
aS'Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation.'
p13690
aS'JOURNAL'
p13691
aS'J Pharmacol Exp Ther 298:1021-32 (2001)'
p13692
aS'PMID:10901707'
p13693
ag13693
aS'AUTHORS'
p13694
aS'Wang JS, Backman JT, Taavitsainen P, Neuvonen PJ, Kivisto KT.'
p13695
aS'TITLE'
p13696
aS'Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans.'
p13697
aS'JOURNAL'
p13698
aS'Drug Metab Dispos 28:959-65 (2000)'
p13699
aS'PMID:12399158'
p13700
ag13700
aS'AUTHORS'
p13701
aS'Dieckhaus CM, Thompson CD, Roller SG, Macdonald TL.'
p13702
aS'TITLE'
p13703
aS'Mechanisms of idiosyncratic drug reactions: the case of felbamate.'
p13704
aS'JOURNAL'
p13705
aS'Chem Biol Interact 142:99-117 (2002)'
p13706
aS'PMID:18463198'
p13707
ag13707
aS'AUTHORS'
p13708
aS'Pearce RE, Lu W, Wang Y, Uetrecht JP, Correia MA, Leeder JS'
p13709
aS'TITLE'
p13710
aS'Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.'
p13711
aS'JOURNAL'
p13712
aS'Drug Metab Dispos 36:1637-49 (2008)'
p13713
aS'PMID:12386121'
p13714
ag13714
aS'AUTHORS'
p13715
aS'Pearce RE, Vakkalagadda GR, Leeder JS.'
p13716
aS'TITLE'
p13717
aS'Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites.'
p13718
aS'JOURNAL'
p13719
aS'Drug Metab Dispos 30:1170-9 (2002)'
p13720
aS'PMID:10859160'
p13721
ag13721
aS'AUTHORS'
p13722
aS'Kumar S, Wong H, Yeung SA, Riggs KW, Abbott FS, Rurak DW.'
p13723
aS'TITLE'
p13724
aS'Disposition of valproic acid in maternal, fetal, and newborn sheep. II: metabolism and renal elimination.'
p13725
aS'JOURNAL'
p13726
aS'Drug Metab Dispos 28:857-64 (2000)'
p13727
ag22
ag22
aS'AUTHORS'
p13728
aS'Bernad T, Joachim M.'
p13729
aS'TITLE'
p13730
aS'Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology'
p13731
aS'JOURNAL'
p13732
aS'Wiley-VCH (2003)'
p13733
asS'KO_PATHWAY'
p13734
(lp13735
S'ko00982'
p13736
asS'ENTRY'
p13737
(lp13738
S'map00982'
p13739
aS'Pathway'
p13740
asS'PATHWAY_MAP'
p13741
(lp13742
S'map00982'
p13743
asS'DISEASE'
p13744
(lp13745
S'H01171'
p13746
aS'Poor drug metabolism (PM)'
p13747
ag13746
ag13747
aS'H01205'
p13748
aS'Coumarin resistance'
p13749
aS'H01234'
p13750
aS'Trimethylaminuria (TMAU)'
p13751
asS'CLASS'
p13752
(lp13753
S'Metabolism Xenobiotics biodegradation and metabolism'
p13754
assS'path:map00981'
p13755
(dp13756
S'NAME'
p13757
(lp13758
S'Insect hormone biosynthesis'
p13759
asS'REFERENCE'
p13760
(lp13761
S'PMID:15355237'
p13762
ag13762
aS'AUTHORS'
p13763
aS'Belles X, Martin D, Piulachs MD.'
p13764
aS'TITLE'
p13765
aS'The mevalonate pathway and the synthesis of juvenile hormone in insects.'
p13766
aS'JOURNAL'
p13767
aS'Annu Rev Entomol 50:181-99 (2005)'
p13768
aS'PMID:15026169'
p13769
ag13769
aS'AUTHORS'
p13770
aS'Gilbert LI.'
p13771
aS'TITLE'
p13772
aS'Halloween genes encode P450 enzymes that mediate steroid hormone biosynthesis in Drosophila melanogaster.'
p13773
aS'JOURNAL'
p13774
aS'Mol Cell Endocrinol 215:1-10 (2004)'
p13775
aS'PMID:15350618'
p13776
ag13776
aS'AUTHORS'
p13777
aS"Warren JT, Petryk A, Marques G, Parvy JP, Shinoda T, Itoyama K, Kobayashi J, Jarcho M, Li Y, O'Connor MB, Dauphin-Villemant C, Gilbert LI."
p13778
aS'TITLE'
p13779
aS'Phantom encodes the 25-hydroxylase of Drosophila melanogaster and Bombyx mori: a P450 enzyme critical in ecdysone biosynthesis.'
p13780
aS'JOURNAL'
p13781
aS'Insect Biochem Mol Biol 34:991-1010 (2004)'
p13782
ag22
ag22
aS'AUTHORS'
p13783
aS'Omura T, Ishimura Y, Fujii Y (eds).'
p13784
aS'TITLE'
p13785
aS'[Molecular Biology of P450] (In Japanese)'
p13786
aS'JOURNAL'
p13787
aS'Kodansya (2003)'
p13788
asS'KO_PATHWAY'
p13789
(lp13790
S'ko00981'
p13791
asS'ENTRY'
p13792
(lp13793
S'map00981'
p13794
aS'Pathway'
p13795
asS'PATHWAY_MAP'
p13796
(lp13797
S'map00981'
p13798
asS'CLASS'
p13799
(lp13800
S'Metabolism Metabolism of terpenoids and polyketides'
p13801
assS'path:map07229'
p13802
(dp13803
S'ENTRY'
p13804
(lp13805
S'map07229'
p13806
aS'Drug'
p13807
aS'Pathway'
p13808
asS'PATHWAY_MAP'
p13809
(lp13810
S'map07229'
p13811
asS'NAME'
p13812
(lp13813
S'Angiotensin receptor and endothelin receptor antagonists'
p13814
asS'COMPOUND'
p13815
(lp13816
S'C02135'
p13817
aS'Angiotensin II'
p13818
ag13817
ag13818
aS'C15551'
p13819
aS'CV 2961'
p13820
aS'C15552'
p13821
aS'PD 123177'
p13822
aS'C15553'
p13823
aS'PD 123319'
p13824
aS'D00357'
p13825
aS'Losartan potassium (JP16/USAN)'
p13826
aS'D00400'
p13827
aS'Valsartan (JP16/USAN/INN)'
p13828
aS'D00522'
p13829
aS'Candesartan (USAN/INN)'
p13830
aS'D00523'
p13831
aS'Irbesartan (JAN/USAN/INN)'
p13832
aS'D00626'
p13833
aS'Candesartan cilexetil (JP16/USAN)'
p13834
aS'D00627'
p13835
aS'Telmisartan (JP16/USAN/INN)'
p13836
aS'D01204'
p13837
aS'Olmesartan medoxomil (JP16/USAN)'
p13838
aS'D01227'
p13839
aS'Bosentan hydrate (JAN)'
p13840
aS'D02082'
p13841
aS'Eprosartan mesylate (USAN)'
p13842
aS'D04040'
p13843
aS'Eprosartan (USAN/INN)'
p13844
aS'D04126'
p13845
aS'Saralasin acetate (USAN)'
p13846
aS'D05246'
p13847
aS'Olmesartan (USAN/INN)'
p13848
aS'D07077'
p13849
aS'Ambrisentan (JAN/INN)'
p13850
aS'D07538'
p13851
aS'Bosentan (INN)'
p13852
aS'D08146'
p13853
aS'Losartan (INN)'
p13854
assS'path:map07228'
p13855
(dp13856
S'ENTRY'
p13857
(lp13858
S'map07228'
p13859
aS'Drug'
p13860
aS'Pathway'
p13861
asS'PATHWAY_MAP'
p13862
(lp13863
S'map07228'
p13864
asS'NAME'
p13865
(lp13866
S'Eicosanoid receptor agonists/antagonists'
p13867
asS'REFERENCE'
p13868
(lp13869
g22
ag22
aS'AUTHORS'
p13870
aS'Tanaka C., Kato R. (eds)'
p13871
aS'TITLE'
p13872
aS'[New pharmacology (revision 5th ed)] (In Japanese)'
p13873
aS'JOURNAL'
p13874
aS'Nankodo'
p13875
ag22
ag22
aS'AUTHORS'
p13876
aS'Brunton LL, Lazo JS, Parker KL.'
p13877
aS'TITLE'
p13878
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics, eleventh edition"
p13879
aS'JOURNAL'
p13880
aS'McGraw-Hill (2005)'
p13881
ag22
ag22
aS'AUTHORS'
p13882
aS'Watanabe T., Kamisaki Y.'
p13883
aS'TITLE'
p13884
aS'[Molecular Targeting Pharmacology 2nd Ed)] (In Japanase)'
p13885
aS'JOURNAL'
p13886
aS'Ishiyaku Publishers'
p13887
asS'COMPOUND'
p13888
(lp13889
S'D00079'
p13890
aS'Dinoprostone (JAN/USP/INN)'
p13891
ag13890
ag13891
aS'D00081'
p13892
aS'Dinoprost (JP16/USAN/INN)'
p13893
aS'D00106'
p13894
aS'Epoprostenol (USAN/INN)'
p13895
aS'D00180'
p13896
aS'Alprostadil (JP16/USP/INN)'
p13897
aS'D00356'
p13898
aS'Latanoprost (JAN/USAN/INN)'
p13899
aS'D00411'
p13900
aS'Zafirlukast (JAN/USAN/INN)'
p13901
aS'D00419'
p13902
aS'Misoprostol (JAN/USAN/INN)'
p13903
aS'D00529'
p13904
aS'Montelukast sodium (JAN/USAN)'
p13905
aS'D00682'
p13906
aS'Carboprost tromethamine (USP)'
p13907
aS'D01123'
p13908
aS'Seratrodast (JAN/USAN/INN)'
p13909
aS'D01128'
p13910
aS'Ramatroban (JAN/INN)'
p13911
aS'D01188'
p13912
aS'Pimilprost (JAN/INN)'
p13913
aS'D01337'
p13914
aS'Epoprostenol sodium (JAN/USAN)'
p13915
aS'D01352'
p13916
aS'Dinoprost tromethamine (JAN/USP)'
p13917
aS'D01385'
p13918
aS'Ibudilast (JP16/INN)'
p13919
aS'D01452'
p13920
aS'Isopropyl unoprostone (JAN)'
p13921
aS'D01551'
p13922
aS'Beraprost sodium (JP16/USAN)'
p13923
aS'D01869'
p13924
aS'Ornoprostil (JAN/INN)'
p13925
aS'D01891'
p13926
aS'Enprostil (JAN/USAN/INN)'
p13927
aS'D01964'
p13928
aS'Travoprost (JAN/USAN/INN)'
p13929
aS'D02048'
p13930
aS'Clinprost (JAN/INN)'
p13931
aS'D02073'
p13932
aS'Gemeprost (JAN/USAN/INN)'
p13933
aS'D02343'
p13934
aS'Carboprost (USAN/INN)'
p13935
aS'D02705'
p13936
aS'Alprostadil alfadex (JP16)'
p13937
aS'D02719'
p13938
aS'Rosaprostol (INN)'
p13939
aS'D02720'
p13940
aS'Beraprost (USAN)'
p13941
aS'D02721'
p13942
aS'Iloprost (USAN/INN)'
p13943
aS'D02722'
p13944
aS'Limaprost (INN)'
p13945
aS'D02724'
p13946
aS'Bimatoprost (JAN/USAN/INN)'
p13947
aS'D02725'
p13948
aS'Sulprostone (USAN/INN)'
p13949
aS'D02732'
p13950
aS'Pranlukast hydrate (JP16)'
p13951
aS'D02860'
p13952
aS'Limaprost alfadex (JP16)'
p13953
aS'D03187'
p13954
aS'Butaprost (USAN/INN)'
p13955
aS'D03269'
p13956
aS'Dinoprostone betadex (JAN)'
p13957
aS'D03399'
p13958
aS'Carboprost methyl (USAN)'
p13959
aS'D05732'
p13960
aS'Rioprostil (USAN/INN)'
p13961
aS'D06213'
p13962
aS'Treprostinil (JAN/USAN/INN)'
p13963
aS'D06274'
p13964
aS'Tafluprost (JAN/USAN/INN)'
p13965
aS'D08065'
p13966
aS'Iloprost tromethamine'
p13967
aS'D08229'
p13968
aS'Montelukast (INN)'
p13969
aS'D08408'
p13970
aS'Pranlukast (INN)'
p13971
aS'D08628'
p13972
aS'Treprostinil monosodium salt'
p13973
aS'D08661'
p13974
aS'Unoprostone (INN)'
p13975
assS'path:map05206'
p13976
(dp13977
S'NAME'
p13978
(lp13979
S'MicroRNAs in cancer'
p13980
asS'REFERENCE'
p13981
(lp13982
S'PMID:18817506'
p13983
ag13983
aS'AUTHORS'
p13984
aS'Lee YS, Dutta A'
p13985
aS'TITLE'
p13986
aS'MicroRNAs in cancer.'
p13987
aS'JOURNAL'
p13988
aS'Annu Rev Pathol 4:199-227 (2009)'
p13989
aS'PMID:21402473'
p13990
ag13990
aS'AUTHORS'
p13991
aS'Babashah S, Soleimani M'
p13992
aS'TITLE'
p13993
aS'The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.'
p13994
aS'JOURNAL'
p13995
aS'Eur J Cancer 47:1127-37 (2011)'
p13996
aS'PMID:19630570'
p13997
ag13997
aS'AUTHORS'
p13998
aS'Garzon R, Calin GA, Croce CM'
p13999
aS'TITLE'
p14000
aS'MicroRNAs in Cancer.'
p14001
aS'JOURNAL'
p14002
aS'Annu Rev Med 60:167-79 (2009)'
p14003
aS'PMID:23075324'
p14004
ag14004
aS'AUTHORS'
p14005
aS'Chen PS, Su JL, Hung MC'
p14006
aS'TITLE'
p14007
aS'Dysregulation of microRNAs in cancer.'
p14008
aS'JOURNAL'
p14009
aS'J Biomed Sci 19:90 (2012)'
p14010
aS'PMID:22035854'
p14011
ag14011
aS'AUTHORS'
p14012
aS'Ling H, Zhang W, Calin GA'
p14013
aS'TITLE'
p14014
aS'Principles of microRNA involvement in human cancers.'
p14015
aS'JOURNAL'
p14016
aS'Chin J Cancer 30:739-48 (2011)'
p14017
aS'PMID:22351564'
p14018
ag14018
aS'AUTHORS'
p14019
aS'Iorio MV, Croce CM'
p14020
aS'TITLE'
p14021
aS'MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.'
p14022
aS'JOURNAL'
p14023
aS'EMBO Mol Med 4:143-59 (2012)'
p14024
aS'PMID:21742789'
p14025
ag14025
aS'AUTHORS'
p14026
aS'Sayed D, Abdellatif M'
p14027
aS'TITLE'
p14028
aS'MicroRNAs in development and disease.'
p14029
aS'JOURNAL'
p14030
aS'Physiol Rev 91:827-87 (2011)'
p14031
aS'PMID:22345301'
p14032
ag14032
aS'AUTHORS'
p14033
aS'Wang Q, Wang S, Wang H, Li P, Ma Z'
p14034
aS'TITLE'
p14035
aS'MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.'
p14036
aS'JOURNAL'
p14037
aS'Exp Biol Med (Maywood) 237:227-35 (2012)'
p14038
aS'PMID:22580099'
p14039
ag14039
aS'AUTHORS'
p14040
aS'Song JH, Meltzer SJ'
p14041
aS'TITLE'
p14042
aS'MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.'
p14043
aS'JOURNAL'
p14044
aS'Gastroenterology 143:35-47.e2 (2012)'
p14045
aS'PMID:23462054'
p14046
ag14046
aS'AUTHORS'
p14047
aS'Chu Y, Zhu H, Lv L, Zhou Y, Huo J'
p14048
aS'TITLE'
p14049
aS'MiRNA s in oesophageal squamous cancer.'
p14050
aS'JOURNAL'
p14051
aS'Neth J Med 71:69-75 (2013)'
p14052
aS'PMID:19773200'
p14053
ag14053
aS'AUTHORS'
p14054
aS'Kan T, Meltzer SJ'
p14055
aS'TITLE'
p14056
aS"MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma."
p14057
aS'JOURNAL'
p14058
aS'Curr Opin Pharmacol 9:727-32 (2009)'
p14059
aS'PMID:20128019'
p14060
ag14060
aS'AUTHORS'
p14061
aS'Smith CM, Watson DI, Michael MZ, Hussey DJ'
p14062
aS'TITLE'
p14063
aS"MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma."
p14064
aS'JOURNAL'
p14065
aS'World J Gastroenterol 16:531-7 (2010)'
p14066
aS'PMID:23165235'
p14067
ag14067
aS'AUTHORS'
p14068
aS'Song S, Ajani JA'
p14069
aS'TITLE'
p14070
aS'The role of microRNAs in cancers of the upper gastrointestinal tract.'
p14071
aS'JOURNAL'
p14072
aS'Nat Rev Gastroenterol Hepatol 10:109-18 (2013)'
p14073
aS'PMID:21565290'
p14074
ag14074
aS'AUTHORS'
p14075
aS'Liu WH, Yeh SH, Chen PJ'
p14076
aS'TITLE'
p14077
aS'Role of microRNAs in hepatitis B virus replication and pathogenesis.'
p14078
aS'JOURNAL'
p14079
aS'Biochim Biophys Acta 1809:678-85 (2011)'
p14080
aS'PMID:23091478'
p14081
ag14081
aS'AUTHORS'
p14082
aS'Hrasovec S, Glavac D'
p14083
aS'TITLE'
p14084
aS'MicroRNAs as Novel Biomarkers in Colorectal Cancer.'
p14085
aS'JOURNAL'
p14086
aS'Front Genet 3:180 (2012)'
p14087
aS'PMID:22926415'
p14088
ag14088
aS'AUTHORS'
p14089
aS'Liu H'
p14090
aS'TITLE'
p14091
aS'MicroRNAs in breast cancer initiation and progression.'
p14092
aS'JOURNAL'
p14093
aS'Cell Mol Life Sci 69:3587-99 (2012)'
p14094
aS'PMID:20345848'
p14095
ag14095
aS'AUTHORS'
p14096
aS'Li SD, Zhang JR, Wang YQ, Wan XP'
p14097
aS'TITLE'
p14098
aS'The role of microRNAs in ovarian cancer initiation and progression.'
p14099
aS'JOURNAL'
p14100
aS'J Cell Mol Med 14:2240-9 (2010)'
p14101
aS'PMID:23316212'
p14102
ag14102
aS'AUTHORS'
p14103
aS'Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA'
p14104
aS'TITLE'
p14105
aS'Characteristic patterns of microRNA expression in human bladder cancer.'
p14106
aS'JOURNAL'
p14107
aS'Front Genet 3:310 (2012)'
p14108
aS'PMID:20221895'
p14109
ag14109
aS'AUTHORS'
p14110
aS'Saini S, Majid S, Dahiya R'
p14111
aS'TITLE'
p14112
aS'Diet, microRNAs and prostate cancer.'
p14113
aS'JOURNAL'
p14114
aS'Pharm Res 27:1014-26 (2010)'
p14115
asS'KO_PATHWAY'
p14116
(lp14117
S'ko05206'
p14118
asS'PATHWAY_MAP'
p14119
(lp14120
S'map05206'
p14121
asS'DISEASE'
p14122
(lp14123
S'H00013'
p14124
aS'Small cell lung cancer'
p14125
ag14124
ag14125
aS'H00014'
p14126
aS'Non-small cell lung cancer'
p14127
aS'H00017'
p14128
aS'Esophageal cancer'
p14129
aS'H00020'
p14130
aS'Colorectal cancer'
p14131
aS'H00022'
p14132
aS'Bladder cancer'
p14133
aS'H00024'
p14134
aS'Prostate cancer'
p14135
aS'H00027'
p14136
aS'Ovarian cancer'
p14137
aS'H00031'
p14138
aS'Breast cancer'
p14139
aS'H00042'
p14140
aS'Glioma'
p14141
aS'H00048'
p14142
aS'Hepatocellular carcinoma'
p14143
asS'ENTRY'
p14144
(lp14145
S'map05206'
p14146
aS'Pathway'
p14147
asS'CLASS'
p14148
(lp14149
S'Human Diseases Cancers'
p14150
asS'DESCRIPTION'
p14151
(lp14152
S'MicroRNA (miRNA) is a cluster of small non-encoding RNA molecules of 21 - 23 nucleotides in length, which controls gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Using high-throughput profiling, dysregulation of miRNAs has been widely observed in different stages of cancer. The upregulation (overexpression) of specific miRNAs could lead to the repression of tumor suppressor gene expression, and conversely the downregulation of specific miRNAs could result in an increase of oncogene expression both these situations induce subsequent malignant effects on cell proliferation, differentiation, and apoptosis that lead to tumor growth and progress. The miRNA signatures of cancer observed in various studies differ significantly. These inconsistencies occur due to the differences in the study populations and methodologies used. This pathway map shows the summarized results from various studies in 9 cancers, each of which is presented in a review article.'
p14153
assS'path:map05205'
p14154
(dp14155
S'NAME'
p14156
(lp14157
S'Proteoglycans in cancer'
p14158
asS'REFERENCE'
p14159
(lp14160
S'PMID:18450475'
p14161
ag14161
aS'AUTHORS'
p14162
aS'Bourguignon LY'
p14163
aS'TITLE'
p14164
aS'Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.'
p14165
aS'JOURNAL'
p14166
aS'Semin Cancer Biol 18:251-9 (2008)'
p14167
aS'PMID:12729888'
p14168
ag14168
aS'AUTHORS'
p14169
aS'Briggs MW, Sacks DB'
p14170
aS'TITLE'
p14171
aS'IQGAP1 as signal integrator: Ca2+, calmodulin, Cdc42 and the cytoskeleton.'
p14172
aS'JOURNAL'
p14173
aS'FEBS Lett 542:7-11 (2003)'
p14174
aS'PMID:12748184'
p14175
ag14175
aS'AUTHORS'
p14176
aS'Bourguignon LY, Singleton PA, Zhu H, Diedrich F'
p14177
aS'TITLE'
p14178
aS'Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.'
p14179
aS'JOURNAL'
p14180
aS'J Biol Chem 278:29420-34 (2003)'
p14181
aS'PMID:15655247'
p14182
ag14182
aS'AUTHORS'
p14183
aS'Bourguignon LY, Gilad E, Rothman K, Peyrollier K'
p14184
aS'TITLE'
p14185
aS'Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.'
p14186
aS'JOURNAL'
p14187
aS'J Biol Chem 280:11961-72 (2005)'
p14188
aS'PMID:11717317'
p14189
ag14189
aS'AUTHORS'
p14190
aS'Turley EA, Noble PW, Bourguignon LY'
p14191
aS'TITLE'
p14192
aS'Signaling properties of hyaluronan receptors.'
p14193
aS'JOURNAL'
p14194
aS'J Biol Chem 277:4589-92 (2002)'
p14195
aS'PMID:9346940'
p14196
ag14196
aS'AUTHORS'
p14197
aS'Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC'
p14198
aS'TITLE'
p14199
aS'Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.'
p14200
aS'JOURNAL'
p14201
aS'J Biol Chem 272:27913-8 (1997)'
p14202
aS'PMID:22735579'
p14203
ag14203
aS'AUTHORS'
p14204
aS'Neill T, Schaefer L, Iozzo RV'
p14205
aS'TITLE'
p14206
aS'Decorin: a guardian from the matrix.'
p14207
aS'JOURNAL'
p14208
aS'Am J Pathol 181:380-7 (2012)'
p14209
aS'PMID:22194599'
p14210
ag14210
aS'AUTHORS'
p14211
aS'Neill T, Painter H, Buraschi S, Owens RT, Lisanti MP, Schaefer L, Iozzo RV'
p14212
aS'TITLE'
p14213
aS'Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.'
p14214
aS'JOURNAL'
p14215
aS'J Biol Chem 287:5492-506 (2012)'
p14216
aS'PMID:19433454'
p14217
ag14217
aS'AUTHORS'
p14218
aS'Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ, Ireton K, Iozzo RV'
p14219
aS'TITLE'
p14220
aS'Decorin is a novel antagonistic ligand of the Met receptor.'
p14221
aS'JOURNAL'
p14222
aS'J Cell Biol 185:743-54 (2009)'
p14223
aS'PMID:15994311'
p14224
ag14224
aS'AUTHORS'
p14225
aS'Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV'
p14226
aS'TITLE'
p14227
aS'Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis.'
p14228
aS'JOURNAL'
p14229
aS'J Biol Chem 280:32468-79 (2005)'
p14230
aS'PMID:20974860'
p14231
ag14231
aS'AUTHORS'
p14232
aS'Buraschi S, Pal N, Tyler-Rubinstein N, Owens RT, Neill T, Iozzo RV'
p14233
aS'TITLE'
p14234
aS'Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.'
p14235
aS'JOURNAL'
p14236
aS'J Biol Chem 285:42075-85 (2010)'
p14237
aS'PMID:18798267'
p14238
ag14238
aS'AUTHORS'
p14239
aS'Goldoni S, Iozzo RV'
p14240
aS'TITLE'
p14241
aS'Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.'
p14242
aS'JOURNAL'
p14243
aS'Int J Cancer 123:2473-9 (2008)'
p14244
aS'PMID:23058688'
p14245
ag14245
aS'AUTHORS'
p14246
aS'Sofeu Feugaing DD, Gotte M, Viola M'
p14247
aS'TITLE'
p14248
aS'More than matrix: the multifaceted role of decorin in cancer.'
p14249
aS'JOURNAL'
p14250
aS'Eur J Cell Biol 92:1-11 (2013)'
p14251
aS'PMID:22087031'
p14252
ag14252
aS'AUTHORS'
p14253
aS'Merline R, Moreth K, Beckmann J, Nastase MV, Zeng-Brouwers J, Tralhao JG, Lemarchand P, Pfeilschifter J, Schaefer RM, Iozzo RV, Schaefer L'
p14254
aS'TITLE'
p14255
aS'Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21.'
p14256
aS'JOURNAL'
p14257
aS'Sci Signal 4:ra75 (2011)'
p14258
aS'PMID:22033227'
p14259
ag14259
aS'AUTHORS'
p14260
aS'Teng YH, Aquino RS, Park PW'
p14261
aS'TITLE'
p14262
aS'Molecular functions of syndecan-1 in disease.'
p14263
aS'JOURNAL'
p14264
aS'Matrix Biol 31:3-16 (2012)'
p14265
aS'PMID:11830493'
p14266
ag14266
aS'AUTHORS'
p14267
aS'Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST'
p14268
aS'TITLE'
p14269
aS'Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.'
p14270
aS'JOURNAL'
p14271
aS'Blood 99:1405-10 (2002)'
p14272
aS'PMID:19733083'
p14273
ag14273
aS'AUTHORS'
p14274
aS'Fux L, Ilan N, Sanderson RD, Vlodavsky I'
p14275
aS'TITLE'
p14276
aS'Heparanase: busy at the cell surface.'
p14277
aS'JOURNAL'
p14278
aS'Trends Biochem Sci 34:511-9 (2009)'
p14279
aS'PMID:18812315'
p14280
ag14280
aS'AUTHORS'
p14281
aS'Purushothaman A, Chen L, Yang Y, Sanderson RD'
p14282
aS'TITLE'
p14283
aS'Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.'
p14284
aS'JOURNAL'
p14285
aS'J Biol Chem 283:32628-36 (2008)'
p14286
aS'PMID:19255147'
p14287
ag14287
aS'AUTHORS'
p14288
aS'Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC'
p14289
aS'TITLE'
p14290
aS'Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.'
p14291
aS'JOURNAL'
p14292
aS'J Exp Med 206:691-705 (2009)'
p14293
aS'PMID:20655987'
p14294
ag14294
aS'AUTHORS'
p14295
aS'Mahtouk K, Tjin EP, Spaargaren M, Pals ST'
p14296
aS'TITLE'
p14297
aS'The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.'
p14298
aS'JOURNAL'
p14299
aS'Biochim Biophys Acta 1806:208-19 (2010)'
p14300
aS'PMID:11931647'
p14301
ag14301
aS'AUTHORS'
p14302
aS'Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M'
p14303
aS'TITLE'
p14304
aS'The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis'
p14305
aS'lung carcinoma-derived metastatic clones.'
p14306
aS'JOURNAL'
p14307
aS'Biochem J 363:201-9 (2002)'
p14308
aS'PMID:10687947'
p14309
ag14309
aS'AUTHORS'
p14310
aS'Nugent MA, Iozzo RV'
p14311
aS'TITLE'
p14312
aS'Fibroblast growth factor-2.'
p14313
aS'JOURNAL'
p14314
aS'Int J Biochem Cell Biol 32:115-20 (2000)'
p14315
aS'PMID:10633082'
p14316
ag14316
aS'AUTHORS'
p14317
aS'Baciu PC, Saoncella S, Lee SH, Denhez F, Leuthardt D, Goetinck PF'
p14318
aS'TITLE'
p14319
aS'Syndesmos, a protein that interacts with the cytoplasmic domain of syndecan-4, mediates cell spreading and actin cytoskeletal organization.'
p14320
aS'JOURNAL'
p14321
aS'J Cell Sci 113 Pt 2:315-24 (2000)'
p14322
aS'PMID:12509413'
p14323
ag14323
aS'AUTHORS'
p14324
aS'Thodeti CK, Albrechtsen R, Grauslund M, Asmar M, Larsson C, Takada Y, Mercurio AM, Couchman JR, Wewer UM'
p14325
aS'TITLE'
p14326
aS'ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA.'
p14327
aS'JOURNAL'
p14328
aS'J Biol Chem 278:9576-84 (2003)'
p14329
aS'PMID:14711376'
p14330
ag14330
aS'AUTHORS'
p14331
aS'Beauvais DM, Rapraeger AC'
p14332
aS'TITLE'
p14333
aS'Syndecans in tumor cell adhesion and signaling.'
p14334
aS'JOURNAL'
p14335
aS'Reprod Biol Endocrinol 2:3 (2004)'
p14336
aS'PMID:17971838'
p14337
ag14337
aS'AUTHORS'
p14338
aS'Morgan MR, Humphries MJ, Bass MD'
p14339
aS'TITLE'
p14340
aS'Synergistic control of cell adhesion by integrins and syndecans.'
p14341
aS'JOURNAL'
p14342
aS'Nat Rev Mol Cell Biol 8:957-69 (2007)'
p14343
aS'PMID:18505598'
p14344
ag14344
aS'AUTHORS'
p14345
aS'Filmus J, Capurro M, Rast J'
p14346
aS'TITLE'
p14347
aS'Glypicans.'
p14348
aS'JOURNAL'
p14349
aS'Genome Biol 9:224 (2008)'
p14350
aS'PMID:23305321'
p14351
ag14351
aS'AUTHORS'
p14352
aS'Filmus J, Capurro M'
p14353
aS'TITLE'
p14354
aS'Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.'
p14355
aS'JOURNAL'
p14356
aS'FEBS J 280:2471-6 (2013)'
p14357
aS'PMID:22563565'
p14358
ag14358
aS'AUTHORS'
p14359
aS'Gao W, Ho M'
p14360
aS'TITLE'
p14361
aS'The role of glypican-3 in regulating Wnt in hepatocellular carcinomas.'
p14362
aS'JOURNAL'
p14363
aS'Cancer Rep 1:14-19 (2011)'
p14364
aS'PMID:18413366'
p14365
ag14365
aS'AUTHORS'
p14366
aS'Cheng W, Tseng CJ, Lin TT, Cheng I, Pan HW, Hsu HC, Lee YM'
p14367
aS'TITLE'
p14368
aS'Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.'
p14369
aS'JOURNAL'
p14370
aS'Carcinogenesis 29:1319-26 (2008)'
p14371
aS'PMID:21155971'
p14372
ag14372
aS'AUTHORS'
p14373
aS'Iozzo RV, Sanderson RD'
p14374
aS'TITLE'
p14375
aS'Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.'
p14376
aS'JOURNAL'
p14377
aS'J Cell Mol Med 15:1013-31 (2011)'
p14378
aS'PMID:18949819'
p14379
ag14379
aS'AUTHORS'
p14380
aS'Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN'
p14381
aS'TITLE'
p14382
aS'Lumican, a small leucine-rich proteoglycan.'
p14383
aS'JOURNAL'
p14384
aS'IUBMB Life 60:818-23 (2008)'
p14385
asS'KO_PATHWAY'
p14386
(lp14387
S'ko05205'
p14388
asS'ENTRY'
p14389
(lp14390
S'map05205'
p14391
aS'Pathway'
p14392
asS'PATHWAY_MAP'
p14393
(lp14394
S'map05205'
p14395
asS'CLASS'
p14396
(lp14397
S'Human Diseases Cancers'
p14398
asS'DESCRIPTION'
p14399
(lp14400
S'Many proteoglycans (PGs) in the tumor microenvironment have been shown to be key macromolecules that contribute to biology of various types of cancer including proliferation, adhesion, angiogenesis and metastasis, affecting tumor progress. The four main types of proteoglycans include hyaluronan (HA), which does not occur as a PG but in free form, heparan sulfate proteoglycans (HSPGs), chondroitin sulfate proteoglycans (CSPGs), dematan sulfate proteoglycans (DSPG) and keratan sulfate proteoglycans (KSPGs) [BR:00535]. Among these proteoglycans such as HA, acting with CD44, promotes tumor cell growth and migration, whereas other proteoglycans such as syndecans (-1~-4), glypican (-1, -3) and perlecan may interact with growth factors, cytokines, morphogens and enzymes through HS chains [BR: 00536], also leading to tumor growth and invasion. In contrast, some of the small leucine-rich proteolgycans, such as decorin and lumican, can function as tumor repressors, and modulate the signaling pathways by the interaction of their core proteins and multiple receptors.'
p14401
assS'path:map05204'
p14402
(dp14403
S'NAME'
p14404
(lp14405
S'Chemical carcinogenesis'
p14406
asS'REFERENCE'
p14407
(lp14408
S'PMID:15660110'
p14409
ag14409
aS'AUTHORS'
p14410
aS'Luch A.'
p14411
aS'TITLE'
p14412
aS'Nature and nurture - lessons from chemical carcinogenesis.'
p14413
aS'JOURNAL'
p14414
aS'Nat Rev Cancer 5:113-25 (2005)'
p14415
aS'PMID:14570033'
p14416
ag14416
aS'AUTHORS'
p14417
aS'Hecht SS'
p14418
aS'TITLE'
p14419
aS'Tobacco carcinogens, their biomarkers and tobacco-induced cancer.'
p14420
aS'JOURNAL'
p14421
aS'Nat Rev Cancer 3:733-44 (2003)'
p14422
aS'PMID:18066431'
p14423
ag14423
aS'AUTHORS'
p14424
aS'Oliveira PA, Colaco A, Chaves R, Guedes-Pinto H, De-La-Cruz P LF, Lopes C'
p14425
aS'TITLE'
p14426
aS'Chemical carcinogenesis.'
p14427
aS'JOURNAL'
p14428
aS'An Acad Bras Cienc 79:593-616 (2007)'
p14429
aS'PMID:15489140'
p14430
ag14430
aS'AUTHORS'
p14431
aS'Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA.'
p14432
aS'TITLE'
p14433
aS'Environmental and chemical carcinogenesis.'
p14434
aS'JOURNAL'
p14435
aS'Semin Cancer Biol 14:473-86 (2004)'
p14436
aS'PMID:21234336'
p14437
ag14437
aS'AUTHORS'
p14438
aS'Hang B'
p14439
aS'TITLE'
p14440
aS'Formation and repair of tobacco carcinogen-derived bulky DNA adducts.'
p14441
aS'JOURNAL'
p14442
aS'J Nucleic Acids 2010:709521 (2010)'
p14443
aS'PMID:12928348'
p14444
ag14444
aS'AUTHORS'
p14445
aS'Tsuneoka Y, Dalton TP, Miller ML, Clay CD, Shertzer HG, Talaska G, Medvedovic M, Nebert DW'
p14446
aS'TITLE'
p14447
aS'4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice.'
p14448
aS'JOURNAL'
p14449
aS'J Natl Cancer Inst 95:1227-37 (2003)'
p14450
aS'PMID:11978484'
p14451
ag14451
aS'AUTHORS'
p14452
aS'Kawanishi S, Hiraku Y, Murata M, Oikawa S'
p14453
aS'TITLE'
p14454
aS'The role of metals in site-specific DNA damage with reference to carcinogenesis.'
p14455
aS'JOURNAL'
p14456
aS'Free Radic Biol Med 32:822-32 (2002)'
p14457
aS'PMID:11275476'
p14458
ag14458
aS'AUTHORS'
p14459
aS'Murata M, Tamura A, Tada M, Kawanishi S'
p14460
aS'TITLE'
p14461
aS'Mechanism of oxidative DNA damage induced by carcinogenic 4-aminobiphenyl.'
p14462
aS'JOURNAL'
p14463
aS'Free Radic Biol Med 30:765-73 (2001)'
p14464
aS'PMID:20232918'
p14465
ag14465
aS'AUTHORS'
p14466
aS'Patterson AD, Gonzalez FJ, Idle JR'
p14467
aS'TITLE'
p14468
aS'Xenobiotic metabolism: a view through the metabolometer.'
p14469
aS'JOURNAL'
p14470
aS'Chem Res Toxicol 23:851-60 (2010)'
p14471
aS'PMID:9202760'
p14472
ag14472
aS'AUTHORS'
p14473
aS'Turesky RJ, Box RM, Markovic J, Gremaud E, Snyderwine EG'
p14474
aS'TITLE'
p14475
aS'Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline in the rat and nonhuman primates.'
p14476
aS'JOURNAL'
p14477
aS'Mutat Res 376:235-41 (1997)'
p14478
aS'PMID:20570348'
p14479
ag14479
aS'AUTHORS'
p14480
aS'Immonen E, Kummu M, Petsalo A, Pihlaja T, Mathiesen L, Nielsen JK, Knudsen LE, Vahakangas K, Myllynen P'
p14481
aS'TITLE'
p14482
aS'Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected'
p14483
aS'by ABCG2 or xenobiotic metabolism.'
p14484
aS'JOURNAL'
p14485
aS'Placenta 31:641-8 (2010)'
p14486
aS'PMID:8702479'
p14487
ag14487
aS'AUTHORS'
p14488
aS'Solomon MS, Morgenthaler PM, Turesky RJ, Essigmann JM'
p14489
aS'TITLE'
p14490
aS'Mutational and DNA binding specificity of the carcinogen 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline.'
p14491
aS'JOURNAL'
p14492
aS'J Biol Chem 271:18368-74 (1996)'
p14493
aS'PMID:21456541'
p14494
ag14494
aS'AUTHORS'
p14495
aS'Nauwelaers G, Bessette EE, Gu D, Tang Y, Rageul J, Fessard V, Yuan JM, Yu MC, Langouet S, Turesky RJ'
p14496
aS'TITLE'
p14497
aS'DNA adduct formation of 4-aminobiphenyl and heterocyclic aromatic amines in human hepatocytes.'
p14498
aS'JOURNAL'
p14499
aS'Chem Res Toxicol 24:913-25 (2011)'
p14500
aS'PMID:20669524'
p14501
ag14501
aS'AUTHORS'
p14502
ag22
aS'TITLE'
p14503
ag22
aS'JOURNAL'
p14504
aS'(2006)'
p14505
aS'PMID:17445838'
p14506
ag14506
aS'AUTHORS'
p14507
aS'Singh R, Sram RJ, Binkova B, Kalina I, Popov TA, Georgieva T, Garte S, Taioli E, Farmer PB'
p14508
aS'TITLE'
p14509
aS'The relationship between biomarkers of oxidative DNA damage, polycyclic aromatic'
p14510
aS'hydrocarbon DNA adducts, antioxidant status and genetic susceptibility following'
p14511
aS'exposure to environmental air pollution in humans.'
p14512
aS'JOURNAL'
p14513
aS'Mutat Res 620:83-92 (2007)'
p14514
aS'PMID:15298956'
p14515
ag14515
aS'AUTHORS'
p14516
aS'Lodovici M, Luceri C, Guglielmi F, Bacci C, Akpan V, Fonnesu ML, Boddi V, Dolara P.'
p14517
aS'TITLE'
p14518
aS'Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.'
p14519
aS'JOURNAL'
p14520
aS'Cancer Epidemiol Biomarkers Prev 13:1342-8 (2004)'
p14521
aS'PMID:19531241'
p14522
ag14522
aS'AUTHORS'
p14523
aS'Androutsopoulos VP, Tsatsakis AM, Spandidos DA'
p14524
aS'TITLE'
p14525
aS'Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.'
p14526
aS'JOURNAL'
p14527
aS'BMC Cancer 9:187 (2009)'
p14528
aS'PMID:11376689'
p14529
ag14529
aS'AUTHORS'
p14530
aS'Gonzalez FJ, Kimura S'
p14531
aS'TITLE'
p14532
aS'Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using'
p14533
aS'gene knockout mice.'
p14534
aS'JOURNAL'
p14535
aS'Mutat Res 477:79-87 (2001)'
p14536
aS'PMID:11467078'
p14537
ag14537
aS'AUTHORS'
p14538
aS'Banoglu E'
p14539
aS'TITLE'
p14540
aS'Current status of the cytosolic sulfotransferases in the metabolic activation of'
p14541
aS'promutagens and procarcinogens.'
p14542
aS'JOURNAL'
p14543
aS'Curr Drug Metab 1:1-30 (2000)'
p14544
aS'PMID:15532073'
p14545
ag14545
aS'AUTHORS'
p14546
aS'Lehner AF, Horn J, Flesher JW'
p14547
aS'TITLE'
p14548
aS'Mass spectrometric analysis of 7-sulfoxymethyl-12-methylbenz[a]anthracene and related electrophilic polycyclic aromatic hydrocarbon metabolites.'
p14549
aS'JOURNAL'
p14550
aS'J Mass Spectrom 39:1366-78 (2004)'
p14551
aS'PMID:21217854'
p14552
ag14552
aS'AUTHORS'
p14553
aS'Stiborova M, Martinek V, Semanska M, Hodek P, Dracinsky M, Cvacka J, Schmeiser HH, Frei E'
p14554
aS'TITLE'
p14555
aS'Oxidation of the carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxy-naphthalene'
p14556
aS'(Sudan I) by cytochromes P450 and peroxidases: a comparative study.'
p14557
aS'JOURNAL'
p14558
aS'Interdiscip Toxicol 2:195-200 (2009)'
p14559
aS'PMID:10913381'
p14560
ag14560
aS'AUTHORS'
p14561
aS'Maanen MJ, Smeets CJ, Beijnen JH'
p14562
aS'TITLE'
p14563
aS'Chemistry, pharmacology and pharmacokinetics of N,N\',N" -triethylenethiophosphoramide (ThioTEPA).'
p14564
aS'JOURNAL'
p14565
aS'Cancer Treat Rev 26:257-68 (2000)'
p14566
aS'PMID:11092599'
p14567
ag14567
aS'AUTHORS'
p14568
aS'Hoes I, Van Dongen W, Lemiere F, Esmans EL, Van Bockstaele D, Berneman ZN'
p14569
aS'TITLE'
p14570
aS'Comparison between capillary and nano liquid chromatography-electrospray mass spectrometry for the analysis of minor DNA-melphalan adducts.'
p14571
aS'JOURNAL'
p14572
aS'J Chromatogr B Biomed Sci Appl 748:197-212 (2000)'
p14573
aS'PMID:22705365'
p14574
ag14574
aS'AUTHORS'
p14575
aS'Lee JC, Son YO, Pratheeshkumar P, Shi X'
p14576
aS'TITLE'
p14577
aS'Oxidative stress and metal carcinogenesis.'
p14578
aS'JOURNAL'
p14579
aS'Free Radic Biol Med 53:742-57 (2012)'
p14580
aS'PMID:12435844'
p14581
ag14581
aS'AUTHORS'
p14582
aS'Wild CP, Turner PC'
p14583
aS'TITLE'
p14584
aS'The toxicology of aflatoxins as a basis for public health decisions.'
p14585
aS'JOURNAL'
p14586
aS'Mutagenesis 17:471-81 (2002)'
p14587
aS'PMID:9275165'
p14588
ag14588
aS'AUTHORS'
p14589
aS'Kobertz WR, Wang D, Wogan GN, Essigmann JM'
p14590
aS'TITLE'
p14591
aS'An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot.'
p14592
aS'JOURNAL'
p14593
aS'Proc Natl Acad Sci U S A 94:9579-84 (1997)'
p14594
aS'PMID:8759017'
p14595
ag14595
aS'AUTHORS'
p14596
aS'Bailey EA, Iyer RS, Harris TM, Essigmann JM'
p14597
aS'TITLE'
p14598
aS'A viral genome containing an unstable aflatoxin B1-N7-guanine DNA adduct situated at a unique site.'
p14599
aS'JOURNAL'
p14600
aS'Nucleic Acids Res 24:2821-8 (1996)'
p14601
aS'PMID:21473878'
p14602
ag14602
aS'AUTHORS'
p14603
aS'Chiang HC, Wang CY, Lee HL, Tsou TC'
p14604
aS'TITLE'
p14605
aS'Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.'
p14606
aS'JOURNAL'
p14607
aS'Toxicol Appl Pharmacol 253:145-52 (2011)'
p14608
aS'PMID:21154658'
p14609
ag14609
aS'AUTHORS'
p14610
aS'Bhat SH, Gelhaus SL, Mesaros C, Vachani A, Blair IA'
p14611
aS'TITLE'
p14612
aS'A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.'
p14613
aS'JOURNAL'
p14614
aS'Rapid Commun Mass Spectrom 25:115-21 (2011)'
p14615
aS'PMID:20159989'
p14616
ag14616
aS'AUTHORS'
p14617
aS'Maertens LA, Upadhyaya P, Hecht SS, Zimmerman CL'
p14618
aS'TITLE'
p14619
aS'Formation and distribution of NNK metabolites in an isolated perfused rat lung.'
p14620
aS'JOURNAL'
p14621
aS'Drug Metab Dispos 38:752-60 (2010)'
p14622
aS'PMID:17459420'
p14623
ag14623
aS'AUTHORS'
p14624
aS'Schuller HM'
p14625
aS'TITLE'
p14626
aS'Nitrosamines as nicotinic receptor ligands.'
p14627
aS'JOURNAL'
p14628
aS'Life Sci 80:2274-80 (2007)'
p14629
aS'PMID:22178655'
p14630
ag14630
aS'AUTHORS'
p14631
aS'Shen J, Xu L, Owonikoko TK, Sun SY, Khuri FR, Curran WJ, Deng X'
p14632
aS'TITLE'
p14633
aS'NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCiota/FAK loop.'
p14634
aS'JOURNAL'
p14635
aS'Cancer Lett 318:106-13 (2012)'
p14636
aS'PMID:8951235'
p14637
ag14637
aS'AUTHORS'
p14638
aS'Lee VM, Keefer LK, Archer MC'
p14639
aS'TITLE'
p14640
aS'An evaluation of the roles of metabolic denitrosation and alpha-hydroxylation in'
p14641
aS'the hepatotoxicity of N-Nitrosodimethylamine.'
p14642
aS'JOURNAL'
p14643
aS'Chem Res Toxicol 9:1319-24 (1996)'
p14644
aS'PMID:21163908'
p14645
ag14645
aS'AUTHORS'
p14646
aS'Swenberg JA, Lu K, Moeller BC, Gao L, Upton PB, Nakamura J, Starr TB'
p14647
aS'TITLE'
p14648
aS'Endogenous versus exogenous DNA adducts: their role in carcinogenesis, epidemiology, and risk assessment.'
p14649
aS'JOURNAL'
p14650
aS'Toxicol Sci 120 Suppl 1:S130-45 (2011)'
p14651
aS'PMID:10753215'
p14652
ag14652
aS'AUTHORS'
p14653
aS'Yang Y, Nair J, Barbin A, Bartsch H'
p14654
aS'TITLE'
p14655
aS'Immunohistochemical detection of 1,N(6)-ethenodeoxyadenosine, a promutagenic DNA'
p14656
aS'adduct, in liver of rats exposed to vinyl chloride or an iron overload.'
p14657
aS'JOURNAL'
p14658
aS'Carcinogenesis 21:777-81 (2000)'
p14659
aS'PMID:15582261'
p14660
ag14660
aS'AUTHORS'
p14661
aS'Bartsch H, Nair J'
p14662
aS'TITLE'
p14663
aS'Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis.'
p14664
aS'JOURNAL'
p14665
aS'Cancer Detect Prev 28:385-91 (2004)'
p14666
aS'PMID:19657920'
p14667
ag14667
aS'AUTHORS'
p14668
aS'Tabrez S, Ahmad M'
p14669
aS'TITLE'
p14670
aS'Toxicity, biomarkers, genotoxicity, and carcinogenicity of trichloroethylene and'
p14671
aS'its metabolites: a review.'
p14672
aS'JOURNAL'
p14673
aS'J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 27:178-96 (2009)'
p14674
aS'PMID:16421178'
p14675
ag14675
aS'AUTHORS'
p14676
aS'Lock EA, Reed CJ'
p14677
aS'TITLE'
p14678
aS'Trichloroethylene: mechanisms of renal toxicity and renal cancer and relevance to risk assessment.'
p14679
aS'JOURNAL'
p14680
aS'Toxicol Sci 91:313-31 (2006)'
p14681
aS'PMID:16959879'
p14682
ag14682
aS'AUTHORS'
p14683
aS'Kim D, Ghanayem BI'
p14684
aS'TITLE'
p14685
aS'Comparative metabolism and disposition of trichloroethylene in Cyp2e1-/-and wild-type mice.'
p14686
aS'JOURNAL'
p14687
aS'Drug Metab Dispos 34:2020-7 (2006)'
p14688
aS'PMID:11222868'
p14689
ag14689
aS'AUTHORS'
p14690
aS'Cummings BS, Parker JC, Lash LH'
p14691
aS'TITLE'
p14692
aS'Cytochrome p450-dependent metabolism of trichloroethylene in rat kidney.'
p14693
aS'JOURNAL'
p14694
aS'Toxicol Sci 60:11-9 (2001)'
p14695
aS'PMID:9356303'
p14696
ag14696
aS'AUTHORS'
p14697
aS'Abbas R, Fisher JW'
p14698
aS'TITLE'
p14699
aS'A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.'
p14700
aS'JOURNAL'
p14701
aS'Toxicol Appl Pharmacol 147:15-30 (1997)'
p14702
aS'PMID:9152590'
p14703
ag14703
aS'AUTHORS'
p14704
aS'Stenner RD, Merdink JL, Stevens DK, Springer DL, Bull RJ'
p14705
aS'TITLE'
p14706
aS'Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid. Metabolites of trichloroethylene.'
p14707
aS'JOURNAL'
p14708
aS'Drug Metab Dispos 25:529-35 (1997)'
p14709
aS'PMID:21255676'
p14710
ag14710
aS'AUTHORS'
p14711
aS'Gwinn MR, Johns DO, Bateson TF, Guyton KZ'
p14712
aS'TITLE'
p14713
aS'A review of the genotoxicity of 1,2-dichloroethane (EDC).'
p14714
aS'JOURNAL'
p14715
aS'Mutat Res 727:42-53 (2011)'
p14716
aS'PMID:16084004'
p14717
ag14717
aS'AUTHORS'
p14718
aS'Kehe K, Szinicz L'
p14719
aS'TITLE'
p14720
aS'Medical aspects of sulphur mustard poisoning.'
p14721
aS'JOURNAL'
p14722
aS'Toxicology 214:198-209 (2005)'
p14723
aS'PMID:17292678'
p14724
ag14724
aS'AUTHORS'
p14725
aS'Matijasevic Z, Volkert MR'
p14726
aS'TITLE'
p14727
aS'Base excision repair sensitizes cells to sulfur mustard and chloroethyl ethyl sulfide.'
p14728
aS'JOURNAL'
p14729
aS'DNA Repair (Amst) 6:733-41 (2007)'
p14730
asS'KO_PATHWAY'
p14731
(lp14732
S'ko05204'
p14733
asS'ENTRY'
p14734
(lp14735
S'map05204'
p14736
aS'Pathway'
p14737
asS'PATHWAY_MAP'
p14738
(lp14739
S'map05204'
p14740
asS'CLASS'
p14741
(lp14742
S'Human Diseases Cancers'
p14743
asS'DESCRIPTION'
p14744
(lp14745
S'It has been estimated that exposure to environmental chemical carcinogens may contribute significantly to the causation of a sizable fraction, perhaps a majority, of human cancers. Human carcinogens act through a variety of genotoxic and non-genotoxic mechanisms. Genotoxic carcinogens can attack biological macromolecules such as DNA and RNA either directly or indirectly through metabolism, resulting in the formation of adducts with these macromolecules. If DNA adducts escape cellular repair mechanisms and persist, they may lead to miscoding, resulting in permanent mutations. Non-genotoxic carcinogens act by the mechanisms such as induction of inflammation, immunosuppression, formation of reactive oxygen species, activation of receptors, and epigenetic silencing. Together, these genotoxic and non-genotoxic mechanisms can alter signal-transduction pathways that finally result in hypermutability, genomic instability, loss of proliferation control, and resistance to apoptosis - some of the characteristic features of cancer cells.'
p14746
assS'path:map05203'
p14747
(dp14748
S'NAME'
p14749
(lp14750
S'Viral carcinogenesis'
p14751
asS'REFERENCE'
p14752
(lp14753
S'PMID:18201576'
p14754
ag14754
aS'AUTHORS'
p14755
aS'McLaughlin-Drubin ME, Munger K'
p14756
aS'TITLE'
p14757
aS'Viruses associated with human cancer.'
p14758
aS'JOURNAL'
p14759
aS'Biochim Biophys Acta 1782:127-50 (2008)'
p14760
aS'PMID:21102637'
p14761
ag14761
aS'AUTHORS'
p14762
aS'Moore PS, Chang Y'
p14763
aS'TITLE'
p14764
aS'Why do viruses cause cancer? Highlights of the first century of human tumour virology.'
p14765
aS'JOURNAL'
p14766
aS'Nat Rev Cancer 10:878-89 (2010)'
p14767
aS'PMID:19400863'
p14768
ag14768
aS'AUTHORS'
p14769
aS'Kalland KH, Ke XS, Oyan AM'
p14770
aS'TITLE'
p14771
aS'Tumour virology--history, status and future challenges.'
p14772
aS'JOURNAL'
p14773
aS'APMIS 117:382-99 (2009)'
p14774
aS'PMID:17979705'
p14775
ag14775
aS'AUTHORS'
p14776
aS'Boccardo E, Villa LL'
p14777
aS'TITLE'
p14778
aS'Viral origins of human cancer.'
p14779
aS'JOURNAL'
p14780
aS'Curr Med Chem 14:2526-39 (2007)'
p14781
aS'PMID:21084867'
p14782
ag14782
aS'AUTHORS'
p14783
aS'Saha A, Kaul R, Murakami M, Robertson ES'
p14784
aS'TITLE'
p14785
aS'Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.'
p14786
aS'JOURNAL'
p14787
aS'Cancer Biol Ther 10:961-78 (2010)'
p14788
aS'PMID:21152115'
p14789
ag14789
aS'AUTHORS'
p14790
aS'Zheng ZM'
p14791
aS'TITLE'
p14792
aS'Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.'
p14793
aS'JOURNAL'
p14794
aS'Int J Biol Sci 6:730-55 (2010)'
p14795
aS'PMID:19956178'
p14796
ag14796
aS'AUTHORS'
p14797
aS'Martin D, Gutkind JS'
p14798
aS'TITLE'
p14799
aS'Human tumor-associated viruses and new insights into the molecular mechanisms of'
p14800
aS'cancer.'
p14801
aS'JOURNAL'
p14802
aS'Oncogene 27 Suppl 2:S31-42 (2008)'
p14803
aS'PMID:16459163'
p14804
ag14804
aS'AUTHORS'
p14805
aS'Zhang X, Zhang H, Ye L'
p14806
aS'TITLE'
p14807
aS'Effects of hepatitis B virus X protein on the development of liver cancer.'
p14808
aS'JOURNAL'
p14809
aS'J Lab Clin Med 147:58-66 (2006)'
p14810
aS'PMID:12686421'
p14811
ag14811
aS'AUTHORS'
p14812
aS'Panteva M, Korkaya H, Jameel S'
p14813
aS'TITLE'
p14814
aS'Hepatitis viruses and the MAPK pathway: is this a survival strategy?'
p14815
aS'JOURNAL'
p14816
aS'Virus Res 92:131-40 (2003)'
p14817
aS'PMID:21647825'
p14818
ag14818
aS'AUTHORS'
p14819
aS'Ng SA, Lee C.'
p14820
aS'TITLE'
p14821
aS'Hepatitis B virus X gene and hepatocarcinogenesis.'
p14822
aS'JOURNAL'
p14823
aS'J Gastroenterol 46:974-990 (2011)'
p14824
aS'PMID:21966251'
p14825
ag14825
aS'AUTHORS'
p14826
aS'Nishida N, Goel A'
p14827
aS'TITLE'
p14828
aS'Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.'
p14829
aS'JOURNAL'
p14830
aS'Curr Genomics 12:130-7 (2011)'
p14831
aS'PMID:19854353'
p14832
ag14832
aS'AUTHORS'
p14833
aS'Benhenda S, Cougot D, Buendia MA, Neuveut C'
p14834
aS'TITLE'
p14835
aS'Hepatitis B virus X protein molecular functions and its role in virus life cycle'
p14836
aS'and pathogenesis.'
p14837
aS'JOURNAL'
p14838
aS'Adv Cancer Res 103:75-109 (2009)'
p14839
aS'PMID:18251977'
p14840
ag14840
aS'AUTHORS'
p14841
aS'Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ'
p14842
aS'TITLE'
p14843
aS'Viral hepatocarcinogenesis: from infection to cancer.'
p14844
aS'JOURNAL'
p14845
aS'Liver Int 28:175-88 (2008)'
p14846
aS'PMID:9343405'
p14847
ag14847
aS'AUTHORS'
p14848
aS'Klein NP, Schneider RJ'
p14849
aS'TITLE'
p14850
aS'Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.'
p14851
aS'JOURNAL'
p14852
aS'Mol Cell Biol 17:6427-36 (1997)'
p14853
aS'PMID:16039586'
p14854
ag14854
aS'AUTHORS'
p14855
aS'Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC'
p14856
aS'TITLE'
p14857
aS'Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.'
p14858
aS'JOURNAL'
p14859
aS'Mol Cell 19:159-70 (2005)'
p14860
aS'PMID:21994562'
p14861
ag14861
aS'AUTHORS'
p14862
aS'Benhenda S, Cougot D, Neuveut C, Buendia MA'
p14863
aS'TITLE'
p14864
aS'Liver cell transformation in chronic HBV infection.'
p14865
aS'JOURNAL'
p14866
aS'Viruses 1:630-46 (2009)'
p14867
aS'PMID:11099494'
p14868
ag14868
aS'AUTHORS'
p14869
aS'Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD'
p14870
aS'TITLE'
p14871
aS'X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated'
p14872
aS'with up-regulation of the SAPK/JNK pathway.'
p14873
aS'JOURNAL'
p14874
aS'J Biol Chem 276:8328-40 (2001)'
p14875
aS'PMID:10824878'
p14876
ag14876
aS'AUTHORS'
p14877
aS'Arbuthnot P, Capovilla A, Kew M'
p14878
aS'TITLE'
p14879
aS'Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on'
p14880
aS'apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.'
p14881
aS'JOURNAL'
p14882
aS'J Gastroenterol Hepatol 15:357-68 (2000)'
p14883
aS'PMID:9837909'
p14884
ag14884
aS'AUTHORS'
p14885
aS'Gottlob K, Fulco M, Levrero M, Graessmann A'
p14886
aS'TITLE'
p14887
aS'The hepatitis B virus HBx protein inhibits caspase 3 activity.'
p14888
aS'JOURNAL'
p14889
aS'J Biol Chem 273:33347-53 (1998)'
p14890
aS'PMID:15614436'
p14891
ag14891
aS'AUTHORS'
p14892
aS'Zhang JL, Zhao WG, Wu KL, Wang K, Zhang X, Gu CF, Li Y, Zhu Y, Wu JG'
p14893
aS'TITLE'
p14894
aS'Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin.'
p14895
aS'JOURNAL'
p14896
aS'Arch Virol 150:721-41 (2005)'
p14897
aS'PMID:15105524'
p14898
ag14898
aS'AUTHORS'
p14899
aS'Cooray S'
p14900
aS'TITLE'
p14901
aS'The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival.'
p14902
aS'JOURNAL'
p14903
aS'J Gen Virol 85:1065-76 (2004)'
p14904
aS'PMID:16939421'
p14905
ag14905
aS'AUTHORS'
p14906
aS'Mukherji A, Janbandhu VC, Kumar V'
p14907
aS'TITLE'
p14908
aS'HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1.'
p14909
aS'JOURNAL'
p14910
aS'Biochem J 401:247-56 (2007)'
p14911
aS'PMID:15173177'
p14912
ag14912
aS'AUTHORS'
p14913
aS'Yoo YG, Lee MO'
p14914
aS'TITLE'
p14915
aS'Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.'
p14916
aS'JOURNAL'
p14917
aS'J Biol Chem 279:36242-9 (2004)'
p14918
aS'PMID:11604508'
p14919
ag14919
aS'AUTHORS'
p14920
aS'Waris G, Huh KW, Siddiqui A'
p14921
aS'TITLE'
p14922
aS'Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress.'
p14923
aS'JOURNAL'
p14924
aS'Mol Cell Biol 21:7721-30 (2001)'
p14925
aS'PMID:17894800'
p14926
ag14926
aS'AUTHORS'
p14927
aS'Kasprzak A, Adamek A'
p14928
aS'TITLE'
p14929
aS'Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis.'
p14930
aS'JOURNAL'
p14931
aS'Hepatol Res 38:1-26 (2008)'
p14932
aS'PMID:9882379'
p14933
ag14933
aS'AUTHORS'
p14934
aS'You LR, Chen CM, Lee YH'
p14935
aS'TITLE'
p14936
aS'Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha.'
p14937
aS'JOURNAL'
p14938
aS'J Virol 73:1672-81 (1999)'
p14939
aS'PMID:16581947'
p14940
ag14940
aS'AUTHORS'
p14941
aS'Sato Y, Kato J, Takimoto R, Takada K, Kawano Y, Miyanishi K, Kobune M, Sato Y, Takayama T, Matunaga T, Niitsu Y'
p14942
aS'TITLE'
p14943
aS'Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.'
p14944
aS'JOURNAL'
p14945
aS'Gut 55:1801-8 (2006)'
p14946
aS'PMID:14559998'
p14947
ag14947
aS'AUTHORS'
p14948
aS'Watashi K, Hijikata M, Tagawa A, Doi T, Marusawa H, Shimotohno K'
p14949
aS'TITLE'
p14950
aS'Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.'
p14951
aS'JOURNAL'
p14952
aS'Mol Cell Biol 23:7498-509 (2003)'
p14953
aS'PMID:9651361'
p14954
ag14954
aS'AUTHORS'
p14955
aS'Hsieh TY, Matsumoto M, Chou HC, Schneider R, Hwang SB, Lee AS, Lai MM'
p14956
aS'TITLE'
p14957
aS'Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K.'
p14958
aS'JOURNAL'
p14959
aS'J Biol Chem 273:17651-9 (1998)'
p14960
aS'PMID:10873631'
p14961
ag14961
aS'AUTHORS'
p14962
aS'Wang F, Yoshida I, Takamatsu M, Ishido S, Fujita T, Oka K, Hotta H'
p14963
aS'TITLE'
p14964
aS'Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1.'
p14965
aS'JOURNAL'
p14966
aS'Biochem Biophys Res Commun 273:479-84 (2000)'
p14967
aS'PMID:10074132'
p14968
ag14968
aS'AUTHORS'
p14969
aS'You LR, Chen CM, Yeh TS, Tsai TY, Mai RT, Lin CH, Lee YH'
p14970
aS'TITLE'
p14971
aS'Hepatitis C virus core protein interacts with cellular putative RNA helicase.'
p14972
aS'JOURNAL'
p14973
aS'J Virol 73:2841-53 (1999)'
p14974
aS'PMID:10644344'
p14975
ag14975
aS'AUTHORS'
p14976
aS'Aoki H, Hayashi J, Moriyama M, Arakawa Y, Hino O'
p14977
aS'TITLE'
p14978
aS'Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1.'
p14979
aS'JOURNAL'
p14980
aS'J Virol 74:1736-41 (2000)'
p14981
aS'PMID:17267064'
p14982
ag14982
aS'AUTHORS'
p14983
aS'Yan XB, Battaglia S, Boucreux D, Chen Z, Brechot C, Pavio N'
p14984
aS'TITLE'
p14985
aS'Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR.'
p14986
aS'JOURNAL'
p14987
aS'Virus Res 125:79-87 (2007)'
p14988
aS'PMID:9060639'
p14989
ag14989
aS'AUTHORS'
p14990
aS'Borowski P, Oehlmann K, Heiland M, Laufs R'
p14991
aS'TITLE'
p14992
aS'Nonstructural protein 3 of hepatitis C virus blocks the distribution of the free'
p14993
aS'catalytic subunit of cyclic AMP-dependent protein kinase.'
p14994
aS'JOURNAL'
p14995
aS'J Virol 71:2838-43 (1997)'
p14996
aS'PMID:10405893'
p14997
ag14997
aS'AUTHORS'
p14998
aS'Borowski P, Kuhl R, Laufs R, Schulze zur Wiesch J, Heiland M'
p14999
aS'TITLE'
p15000
aS'Identification and characterization of a histone binding site of the non-structural protein 3 of hepatitis C virus.'
p15001
aS'JOURNAL'
p15002
aS'J Clin Virol 13:61-9 (1999)'
p15003
aS'PMID:12101418'
p15004
ag15004
aS'AUTHORS'
p15005
aS'Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD'
p15006
aS'TITLE'
p15007
aS'HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.'
p15008
aS'JOURNAL'
p15009
aS'Oncogene 21:4801-11 (2002)'
p15010
aS'PMID:12925958'
p15011
ag15011
aS'AUTHORS'
p15012
aS'Chung YL, Sheu ML, Yen SH'
p15013
aS'TITLE'
p15014
aS'Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma.'
p15015
aS'JOURNAL'
p15016
aS'Int J Cancer 107:65-73 (2003)'
p15017
aS'PMID:10400746'
p15018
ag15018
aS'AUTHORS'
p15019
aS'Gale M Jr, Kwieciszewski B, Dossett M, Nakao H, Katze MG'
p15020
aS'TITLE'
p15021
aS'Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.'
p15022
aS'JOURNAL'
p15023
aS'J Virol 73:6506-16 (1999)'
p15024
aS'PMID:12186904'
p15025
ag15025
aS'AUTHORS'
p15026
aS'He Y, Nakao H, Tan SL, Polyak SJ, Neddermann P, Vijaysri S, Jacobs BL, Katze MG'
p15027
aS'TITLE'
p15028
aS'Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase.'
p15029
aS'JOURNAL'
p15030
aS'J Virol 76:9207-17 (2002)'
p15031
aS'PMID:15795286'
p15032
ag15032
aS'AUTHORS'
p15033
aS'Street A, Macdonald A, McCormick C, Harris M'
p15034
aS'TITLE'
p15035
aS'Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription.'
p15036
aS'JOURNAL'
p15037
aS'J Virol 79:5006-16 (2005)'
p15038
aS'PMID:11886269'
p15039
ag15039
aS'AUTHORS'
p15040
aS'Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, Ray RB'
p15041
aS'TITLE'
p15042
aS'Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.'
p15043
aS'JOURNAL'
p15044
aS'Virology 294:94-105 (2002)'
p15045
aS'PMID:11278402'
p15046
ag15046
aS'AUTHORS'
p15047
aS'Arima N, Kao CY, Licht T, Padmanabhan R, Sasaguri Y, Padmanabhan R'
p15048
aS'TITLE'
p15049
aS'Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A.'
p15050
aS'JOURNAL'
p15051
aS'J Biol Chem 276:12675-84 (2001)'
p15052
aS'PMID:21250384'
p15053
ag15053
aS'AUTHORS'
p15054
aS'He Y, Staschke KA, Tan SL'
p15055
aS'TITLE'
p15056
aS'HCV NS5A: A Multifunctional Regulator of Cellular Pathways and Virus Replication'
p15057
aS'JOURNAL'
p15058
aS'(2006)'
p15059
aS'PMID:12379483'
p15060
ag15060
aS'AUTHORS'
p15061
aS'Qadri I, Iwahashi M, Simon F'
p15062
aS'TITLE'
p15063
aS'Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3.'
p15064
aS'JOURNAL'
p15065
aS'Biochim Biophys Acta 1592:193-204 (2002)'
p15066
aS'PMID:22110506'
p15067
ag15067
aS'AUTHORS'
p15068
aS'Spender LC, Inman GJ'
p15069
aS'TITLE'
p15070
aS'Inhibition of germinal centre apoptotic programmes by epstein-barr virus.'
p15071
aS'JOURNAL'
p15072
aS'Adv Hematol 2011:829525 (2011)'
p15073
aS'PMID:20494113'
p15074
ag15074
aS'AUTHORS'
p15075
aS'Klein G, Klein E, Kashuba E'
p15076
aS'TITLE'
p15077
aS'Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.'
p15078
aS'JOURNAL'
p15079
aS'Biochem Biophys Res Commun 396:67-73 (2010)'
p15080
aS'PMID:21372216'
p15081
ag15081
aS'AUTHORS'
p15082
aS'Saha A, Robertson ES'
p15083
aS'TITLE'
p15084
aS'Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.'
p15085
aS'JOURNAL'
p15086
aS'Clin Cancer Res 17:3056-63 (2011)'
p15087
aS'PMID:15510157'
p15088
ag15088
aS'AUTHORS'
p15089
aS'Young LS, Rickinson AB.'
p15090
aS'TITLE'
p15091
aS'Epstein-Barr virus: 40 years on.'
p15092
aS'JOURNAL'
p15093
aS'Nat Rev Cancer 4:757-68 (2004)'
p15094
aS'PMID:14506283'
p15095
ag15095
aS'AUTHORS'
p15096
aS'Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L'
p15097
aS'TITLE'
p15098
aS'Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.'
p15099
aS'JOURNAL'
p15100
aS'J Biol Chem 278:47753-61 (2003)'
p15101
aS'PMID:11160754'
p15102
ag15102
aS'AUTHORS'
p15103
aS'Harada S, Yalamanchili R, Kieff E'
p15104
aS'TITLE'
p15105
aS'Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association.'
p15106
aS'JOURNAL'
p15107
aS'J Virol 75:2482-7 (2001)'
p15108
aS'PMID:15452270'
p15109
ag15109
aS'AUTHORS'
p15110
aS'Peng CW, Zhao B, Kieff E'
p15111
aS'TITLE'
p15112
aS'Four EBNA2 domains are important for EBNALP coactivation.'
p15113
aS'JOURNAL'
p15114
aS'J Virol 78:11439-42 (2004)'
p15115
aS'PMID:15767449'
p15116
ag15116
aS'AUTHORS'
p15117
aS'Peng R, Moses SC, Tan J, Kremmer E, Ling PD'
p15118
aS'TITLE'
p15119
aS'The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated'
p15120
aS'stimulation of latent membrane proteins expressed from the viral divergent promoter.'
p15121
aS'JOURNAL'
p15122
aS'J Virol 79:4492-505 (2005)'
p15123
aS'PMID:21177815'
p15124
ag15124
aS'AUTHORS'
p15125
aS'Saha A, Bamidele A, Murakami M, Robertson ES'
p15126
aS'TITLE'
p15127
aS'EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.'
p15128
aS'JOURNAL'
p15129
aS'J Virol 85:2079-88 (2011)'
p15130
aS'PMID:21347341'
p15131
ag15131
aS'AUTHORS'
p15132
aS'Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES'
p15133
aS'TITLE'
p15134
aS'Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing'
p15135
aS'and enhancing the function of cyclin D1.'
p15136
aS'JOURNAL'
p15137
aS'PLoS Pathog 7:e1001275 (2011)'
p15138
aS'PMID:15542638'
p15139
ag15139
aS'AUTHORS'
p15140
aS'Knight JS, Sharma N, Kalman DE, Robertson ES'
p15141
aS'TITLE'
p15142
aS'A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds'
p15143
aS'cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.'
p15144
aS'JOURNAL'
p15145
aS'J Virol 78:12857-67 (2004)'
p15146
aS'PMID:14747563'
p15147
ag15147
aS'AUTHORS'
p15148
aS'Knight JS, Robertson ES'
p15149
aS'TITLE'
p15150
aS'Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity.'
p15151
aS'JOURNAL'
p15152
aS'J Virol 78:1981-91 (2004)'
p15153
aS'PMID:16352731'
p15154
ag15154
aS'AUTHORS'
p15155
aS'Knight JS, Sharma N, Robertson ES'
p15156
aS'TITLE'
p15157
aS'Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.'
p15158
aS'JOURNAL'
p15159
aS'Proc Natl Acad Sci U S A 102:18562-6 (2005)'
p15160
aS'PMID:18391203'
p15161
ag15161
aS'AUTHORS'
p15162
aS'Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Isaguliants M, Szekely L, Klein G'
p15163
aS'TITLE'
p15164
aS'EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes.'
p15165
aS'JOURNAL'
p15166
aS'Proc Natl Acad Sci U S A 105:5489-94 (2008)'
p15167
aS'PMID:11091847'
p15168
ag15168
aS'AUTHORS'
p15169
aS'Young LS, Dawson CW, Eliopoulos AG'
p15170
aS'TITLE'
p15171
aS'The expression and function of Epstein-Barr virus encoded latent genes.'
p15172
aS'JOURNAL'
p15173
aS'Mol Pathol 53:238-47 (2000)'
p15174
aS'PMID:19078975'
p15175
ag15175
aS'AUTHORS'
p15176
aS'Kuppers R'
p15177
aS'TITLE'
p15178
aS"The biology of Hodgkin's lymphoma."
p15179
aS'JOURNAL'
p15180
aS'Nat Rev Cancer 9:15-27 (2009)'
p15181
aS'PMID:17049016'
p15182
ag15182
aS'AUTHORS'
p15183
aS'Pattle SB, Farrell PJ'
p15184
aS'TITLE'
p15185
aS'The role of Epstein-Barr virus in cancer.'
p15186
aS'JOURNAL'
p15187
aS'Expert Opin Biol Ther 6:1193-205 (2006)'
p15188
aS'PMID:11905817'
p15189
ag15189
aS'AUTHORS'
p15190
aS'Thorley-Lawson DA'
p15191
aS'TITLE'
p15192
aS'Epstein-Barr virus: exploiting the immune system.'
p15193
aS'JOURNAL'
p15194
aS'Nat Rev Immunol 1:75-82 (2001)'
p15195
aS'PMID:11669605'
p15196
ag15196
aS'AUTHORS'
p15197
aS'Eliopoulos AG, Young LS'
p15198
aS'TITLE'
p15199
aS'LMP1 structure and signal transduction.'
p15200
aS'JOURNAL'
p15201
aS'Semin Cancer Biol 11:435-44 (2001)'
p15202
aS'PMID:11766888'
p15203
ag15203
aS'AUTHORS'
p15204
aS'Dell G, Gaston K'
p15205
aS'TITLE'
p15206
aS'Human papillomaviruses and their role in cervical cancer.'
p15207
aS'JOURNAL'
p15208
aS'Cell Mol Life Sci 58:1923-42 (2001)'
p15209
aS'PMID:10793105'
p15210
ag15210
aS'AUTHORS'
p15211
aS'zur Hausen H'
p15212
aS'TITLE'
p15213
aS'Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.'
p15214
aS'JOURNAL'
p15215
aS'J Natl Cancer Inst 92:690-8 (2000)'
p15216
aS'PMID:19156753'
p15217
ag15217
aS'AUTHORS'
p15218
aS'Yugawa T, Kiyono T'
p15219
aS'TITLE'
p15220
aS'Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.'
p15221
aS'JOURNAL'
p15222
aS'Rev Med Virol 19:97-113 (2009)'
p15223
aS'PMID:17645777'
p15224
ag15224
aS'AUTHORS'
p15225
aS'Narisawa-Saito M, Kiyono T'
p15226
aS'TITLE'
p15227
aS'Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles'
p15228
aS'of E6 and E7 proteins.'
p15229
aS'JOURNAL'
p15230
aS'Cancer Sci 98:1505-11 (2007)'
p15231
aS'PMID:15342967'
p15232
ag15232
aS'AUTHORS'
p15233
aS'Motoyama S, Ladines-Llave CA, Luis Villanueva S, Maruo T'
p15234
aS'TITLE'
p15235
aS'The role of human papilloma virus in the molecular biology of cervical carcinogenesis.'
p15236
aS'JOURNAL'
p15237
aS'Kobe J Med Sci 50:9-19 (2004)'
p15238
aS'PMID:20592731'
p15239
ag15239
aS'AUTHORS'
p15240
aS'Moody CA, Laimins LA'
p15241
aS'TITLE'
p15242
aS'Human papillomavirus oncoproteins: pathways to transformation.'
p15243
aS'JOURNAL'
p15244
aS'Nat Rev Cancer 10:550-60 (2010)'
p15245
aS'PMID:15956361'
p15246
ag15246
aS'AUTHORS'
p15247
aS'McCance DJ'
p15248
aS'TITLE'
p15249
aS'Human papillomaviruses and cell signaling.'
p15250
aS'JOURNAL'
p15251
aS'Sci STKE 2005:pe29 (2005)'
p15252
aS'PMID:18385245'
p15253
ag15253
aS'AUTHORS'
p15254
aS'Wade R, Brimer N, Vande Pol S'
p15255
aS'TITLE'
p15256
aS'Transformation by bovine papillomavirus type 1 E6 requires paxillin.'
p15257
aS'JOURNAL'
p15258
aS'J Virol 82:5962-6 (2008)'
p15259
aS'PMID:9374493'
p15260
ag15260
aS'AUTHORS'
p15261
aS'Berezutskaya E, Bagchi S'
p15262
aS'TITLE'
p15263
aS'The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome.'
p15264
aS'JOURNAL'
p15265
aS'J Biol Chem 272:30135-40 (1997)'
p15266
aS'PMID:16381817'
p15267
ag15267
aS'AUTHORS'
p15268
aS'Zhang B, Chen W, Roman A'
p15269
aS'TITLE'
p15270
aS'The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.'
p15271
aS'JOURNAL'
p15272
aS'Proc Natl Acad Sci U S A 103:437-42 (2006)'
p15273
aS'PMID:12970441'
p15274
ag15274
aS'AUTHORS'
p15275
aS'He W, Staples D, Smith C, Fisher C'
p15276
aS'TITLE'
p15277
aS'Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.'
p15278
aS'JOURNAL'
p15279
aS'J Virol 77:10566-74 (2003)'
p15280
aS'PMID:9349482'
p15281
ag15281
aS'AUTHORS'
p15282
aS'Massimi P, Pim D, Banks L'
p15283
aS'TITLE'
p15284
aS'Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.'
p15285
aS'JOURNAL'
p15286
aS'J Gen Virol 78 ( Pt 10):2607-13 (1997)'
p15287
aS'PMID:8617242'
p15288
ag15288
aS'AUTHORS'
p15289
aS'Antinore MJ, Birrer MJ, Patel D, Nader L, McCance DJ'
p15290
aS'TITLE'
p15291
aS'The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors.'
p15292
aS'JOURNAL'
p15293
aS'EMBO J 15:1950-60 (1996)'
p15294
aS'PMID:9990017'
p15295
ag15295
aS'AUTHORS'
p15296
aS'Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P'
p15297
aS'TITLE'
p15298
aS'Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.'
p15299
aS'JOURNAL'
p15300
aS'Proc Natl Acad Sci U S A 96:1291-6 (1999)'
p15301
aS'PMID:17384582'
p15302
ag15302
aS'AUTHORS'
p15303
aS'Matsuoka M, Jeang KT'
p15304
aS'TITLE'
p15305
aS'Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.'
p15306
aS'JOURNAL'
p15307
aS'Nat Rev Cancer 7:270-80 (2007)'
p15308
aS'PMID:15310405'
p15309
ag15309
aS'AUTHORS'
p15310
aS'Azran I, Schavinsky-Khrapunsky Y, Aboud M'
p15311
aS'TITLE'
p15312
aS'Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity.'
p15313
aS'JOURNAL'
p15314
aS'Retrovirology 1:20 (2004)'
p15315
aS'PMID:12910250'
p15316
ag15316
aS'AUTHORS'
p15317
aS'Matsuoka M'
p15318
aS'TITLE'
p15319
aS'Human T-cell leukemia virus type I and adult T-cell leukemia.'
p15320
aS'JOURNAL'
p15321
aS'Oncogene 22:5131-40 (2003)'
p15322
aS'PMID:11244044'
p15323
ag15323
aS'AUTHORS'
p15324
aS'Yoshida M'
p15325
aS'TITLE'
p15326
aS'Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.'
p15327
aS'JOURNAL'
p15328
aS'Annu Rev Immunol 19:475-96 (2001)'
p15329
aS'PMID:18702816'
p15330
ag15330
aS'AUTHORS'
p15331
aS'Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L'
p15332
aS'TITLE'
p15333
aS'The HTLV-1 Tax interactome.'
p15334
aS'JOURNAL'
p15335
aS'Retrovirology 5:76 (2008)'
p15336
aS'PMID:8223437'
p15337
ag15337
aS'AUTHORS'
p15338
aS'Caron C, Rousset R, Beraud C, Moncollin V, Egly JM, Jalinot P'
p15339
aS'TITLE'
p15340
aS'Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP.'
p15341
aS'JOURNAL'
p15342
aS'EMBO J 12:4269-78 (1993)'
p15343
aS'PMID:8756622'
p15344
ag15344
aS'AUTHORS'
p15345
aS'Clemens KE, Piras G, Radonovich MF, Choi KS, Duvall JF, DeJong J, Roeder R, Brady JN'
p15346
aS'TITLE'
p15347
aS'Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA.'
p15348
aS'JOURNAL'
p15349
aS'Mol Cell Biol 16:4656-64 (1996)'
p15350
aS'PMID:16036567'
p15351
ag15351
aS'AUTHORS'
p15352
aS'Harhaj EW, Harhaj NS'
p15353
aS'TITLE'
p15354
aS'Mechanisms of persistent NF-kappaB activation by HTLV-I tax.'
p15355
aS'JOURNAL'
p15356
aS'IUBMB Life 57:83-91 (2005)'
p15357
aS'PMID:21743832'
p15358
ag15358
aS'AUTHORS'
p15359
aS'Qu Z, Xiao G'
p15360
aS'TITLE'
p15361
aS'Human T-cell lymphotropic virus: a model of NF-kappaB-associated tumorigenesis.'
p15362
aS'JOURNAL'
p15363
aS'Viruses 3:714-49 (2011)'
p15364
aS'PMID:16155601'
p15365
ag15365
aS'AUTHORS'
p15366
aS'Kashanchi F, Brady JN'
p15367
aS'TITLE'
p15368
aS'Transcriptional and post-transcriptional gene regulation of HTLV-1.'
p15369
aS'JOURNAL'
p15370
aS'Oncogene 24:5938-51 (2005)'
p15371
aS'PMID:14530271'
p15372
ag15372
aS'AUTHORS'
p15373
aS'Wu K, Bottazzi ME, de la Fuente C, Deng L, Gitlin SD, Maddukuri A, Dadgar S, Li H, Vertes A, Pumfery A, Kashanchi F'
p15374
aS'TITLE'
p15375
aS'Protein profile of tax-associated complexes.'
p15376
aS'JOURNAL'
p15377
aS'J Biol Chem 279:495-508 (2004)'
p15378
aS'PMID:16155604'
p15379
ag15379
aS'AUTHORS'
p15380
aS'Grassmann R, Aboud M, Jeang KT'
p15381
aS'TITLE'
p15382
aS'Molecular mechanisms of cellular transformation by HTLV-1 Tax.'
p15383
aS'JOURNAL'
p15384
aS'Oncogene 24:5976-85 (2005)'
p15385
aS'PMID:16308315'
p15386
ag15386
aS'AUTHORS'
p15387
aS'Tabakin-Fix Y, Azran I, Schavinky-Khrapunsky Y, Levy O, Aboud M'
p15388
aS'TITLE'
p15389
aS'Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.'
p15390
aS'JOURNAL'
p15391
aS'Carcinogenesis 27:673-81 (2006)'
p15392
aS'PMID:16760382'
p15393
ag15393
aS'AUTHORS'
p15394
aS'Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ'
p15395
aS'TITLE'
p15396
aS"Kaposi's sarcoma-associated herpesvirus immune modulation: an overview."
p15397
aS'JOURNAL'
p15398
aS'J Gen Virol 87:1781-804 (2006)'
p15399
aS'PMID:17457345'
p15400
ag15400
aS'AUTHORS'
p15401
aS'Coscoy L'
p15402
aS'TITLE'
p15403
aS"Immune evasion by Kaposi's sarcoma-associated herpesvirus."
p15404
aS'JOURNAL'
p15405
aS'Nat Rev Immunol 7:391-401 (2007)'
p15406
aS'PMID:21040832'
p15407
ag15407
aS'AUTHORS'
p15408
aS'Cai Q, Verma SC, Lu J, Robertson ES'
p15409
aS'TITLE'
p15410
aS"Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis."
p15411
aS'JOURNAL'
p15412
aS'Adv Virus Res 78:87-142 (2010)'
p15413
aS'PMID:16828973'
p15414
ag15414
aS'AUTHORS'
p15415
aS'Jarviluoma A, Ojala PM'
p15416
aS'TITLE'
p15417
aS'Cell signaling pathways engaged by KSHV.'
p15418
aS'JOURNAL'
p15419
aS'Biochim Biophys Acta 1766:140-58 (2006)'
p15420
aS'PMID:18948197'
p15421
ag15421
aS'AUTHORS'
p15422
aS'Liang C, Lee JS, Jung JU'
p15423
aS'TITLE'
p15424
aS"Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis."
p15425
aS'JOURNAL'
p15426
aS'Semin Cancer Biol 18:423-36 (2008)'
p15427
aS'PMID:19715458'
p15428
ag15428
aS'AUTHORS'
p15429
aS'Lee HR, Kim MH, Lee JS, Liang C, Jung JU'
p15430
aS'TITLE'
p15431
aS'Viral interferon regulatory factors.'
p15432
aS'JOURNAL'
p15433
aS'J Interferon Cytokine Res 29:621-7 (2009)'
p15434
aS'PMID:22566809'
p15435
ag15435
aS'AUTHORS'
p15436
aS'Jacobs SR, Damania B'
p15437
aS'TITLE'
p15438
aS'The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?'
p15439
aS'JOURNAL'
p15440
aS'Front Immunol 2:19 (2011)'
p15441
aS'PMID:19651473'
p15442
ag15442
aS'AUTHORS'
p15443
aS'Wen KW, Damania B'
p15444
aS'TITLE'
p15445
aS'Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.'
p15446
aS'JOURNAL'
p15447
aS'Cancer Lett 289:140-50 (2010)'
p15448
aS'PMID:15967719'
p15449
ag15449
aS'AUTHORS'
p15450
aS'Wang HW, Boshoff C'
p15451
aS'TITLE'
p15452
aS'Linking Kaposi virus to cancer-associated cytokines.'
p15453
aS'JOURNAL'
p15454
aS'Trends Mol Med 11:309-12 (2005)'
p15455
aS'PMID:15692053'
p15456
ag15456
aS'AUTHORS'
p15457
aS'McCormick C, Ganem D'
p15458
aS'TITLE'
p15459
aS'The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.'
p15460
aS'JOURNAL'
p15461
aS'Science 307:739-41 (2005)'
p15462
aS'PMID:12770701'
p15463
ag15463
aS'AUTHORS'
p15464
aS'Verma SC, Robertson ES'
p15465
aS'TITLE'
p15466
aS'Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.'
p15467
aS'JOURNAL'
p15468
aS'FEMS Microbiol Lett 222:155-63 (2003)'
p15469
aS'PMID:10354594'
p15470
ag15470
aS'AUTHORS'
p15471
aS'Schulz TF, Moore PS'
p15472
aS'TITLE'
p15473
aS"Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how?"
p15474
aS'JOURNAL'
p15475
aS'Trends Microbiol 7:196-200 (1999)'
p15476
aS'PMID:10855768'
p15477
ag15477
aS'AUTHORS'
p15478
aS'Schulz TF'
p15479
aS'TITLE'
p15480
aS"Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis."
p15481
aS'JOURNAL'
p15482
aS'J Antimicrob Chemother 45 Suppl T3:15-27 (2000)'
p15483
aS'PMID:9594662'
p15484
ag15484
aS'AUTHORS'
p15485
aS'Moore PS, Chang Y'
p15486
aS'TITLE'
p15487
aS'Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV.'
p15488
aS'JOURNAL'
p15489
aS'Trends Genet 14:144-50 (1998)'
p15490
aS'PMID:20534855'
p15491
ag15491
aS'AUTHORS'
p15492
aS'Pietrek M, Brinkmann MM, Glowacka I, Enlund A, Havemeier A, Dittrich-Breiholz O, Kracht M, Lewitzky M, Saksela K, Feller SM, Schulz TF'
p15493
aS'TITLE'
p15494
aS"Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation."
p15495
aS'JOURNAL'
p15496
aS'J Virol 84:8231-40 (2010)'
p15497
aS'PMID:21421561'
p15498
ag15498
aS'AUTHORS'
p15499
aS'Bagneris C, Briggs LC, Savva R, Ebrahimi B, Barrett TE'
p15500
aS'TITLE'
p15501
aS'Crystal structure of a KSHV-SOX-DNA complex: insights into the molecular mechanisms underlying DNase activity and host shutoff.'
p15502
aS'JOURNAL'
p15503
aS'Nucleic Acids Res 39:5744-56 (2011)'
p15504
aS'PMID:15919895'
p15505
ag15505
aS'AUTHORS'
p15506
aS'Glaunsinger B, Chavez L, Ganem D'
p15507
aS'TITLE'
p15508
aS"The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable."
p15509
aS'JOURNAL'
p15510
aS'J Virol 79:7396-401 (2005)'
p15511
asS'KO_PATHWAY'
p15512
(lp15513
S'ko05203'
p15514
asS'PATHWAY_MAP'
p15515
(lp15516
S'map05203'
p15517
asS'DISEASE'
p15518
(lp15519
S'H00007'
p15520
aS'Hodgkin lymphoma'
p15521
ag15520
ag15521
aS'H00008'
p15522
aS'Burkitt lymphoma'
p15523
aS'H00009'
p15524
aS'Adult T-cell leukemia'
p15525
aS'H00025'
p15526
aS'Penile cancer'
p15527
aS'H00030'
p15528
aS'Cervical cancer'
p15529
aS'H00041'
p15530
aS"Kaposi's sarcoma"
p15531
aS'H00044'
p15532
aS'Cancer of the anal canal'
p15533
aS'H00048'
p15534
aS'Hepatocellular carcinoma'
p15535
aS'H00054'
p15536
aS'Nasopharyngeal cancer'
p15537
asS'ENTRY'
p15538
(lp15539
S'map05203'
p15540
aS'Pathway'
p15541
asS'CLASS'
p15542
(lp15543
S'Human Diseases Cancers'
p15544
asS'DESCRIPTION'
p15545
(lp15546
S"There is a strong association between viruses and the development of human malignancies. We now know that at least six human viruses, Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), human papilloma virus (HPV), human T-cell lymphotropic virus (HTLV-1) and Kaposi's associated sarcoma virus (KSHV) contribute to 10-15% of the cancers worldwide. Via expression of many potent oncoproteins, these tumor viruses promote an aberrant cell-proliferation via modulating cellular cell-signaling pathways and escape from cellular defense system such as blocking apoptosis. Human tumor virus oncoproteins can also disrupt pathways that are necessary for the maintenance of the integrity of host cellular genome. Viruses that encode such activities can contribute to initiation as well as progression of human cancers."
p15547
assS'path:map05202'
p15548
(dp15549
S'NAME'
p15550
(lp15551
S'Transcriptional misregulation in cancer'
p15552
asS'REFERENCE'
p15553
(lp15554
S'PMID:11607818'
p15555
ag15555
aS'AUTHORS'
p15556
aS'Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M, Pelicci PG'
p15557
aS'TITLE'
p15558
aS'Common themes in the pathogenesis of acute myeloid leukemia.'
p15559
aS'JOURNAL'
p15560
aS'Oncogene 20:5680-94 (2001)'
p15561
aS'PMID:12032780'
p15562
ag15562
aS'AUTHORS'
p15563
aS'Scandura JM, Boccuni P, Cammenga J, Nimer SD'
p15564
aS'TITLE'
p15565
aS'Transcription factor fusions in acute leukemia: variations on a theme.'
p15566
aS'JOURNAL'
p15567
aS'Oncogene 21:3422-44 (2002)'
p15568
aS'PMID:12529654'
p15569
ag15569
aS'AUTHORS'
p15570
aS'Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C'
p15571
aS'TITLE'
p15572
aS'New mechanisms of AML1 gene alteration in hematological malignancies.'
p15573
aS'JOURNAL'
p15574
aS'Leukemia 17:9-16 (2003)'
p15575
aS'PMID:10717473'
p15576
ag15576
aS'AUTHORS'
p15577
aS'Lutterbach B, Hiebert SW'
p15578
aS'TITLE'
p15579
aS'Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation.'
p15580
aS'JOURNAL'
p15581
aS'Gene 245:223-35 (2000)'
p15582
aS'PMID:19075268'
p15583
ag15583
aS'AUTHORS'
p15584
aS'Koschmieder S, Halmos B, Levantini E, Tenen DG'
p15585
aS'TITLE'
p15586
aS'Dysregulation of the C/EBPalpha differentiation pathway in human cancer.'
p15587
aS'JOURNAL'
p15588
aS'J Clin Oncol 27:619-28 (2009)'
p15589
aS'PMID:11340171'
p15590
ag15590
aS'AUTHORS'
p15591
aS'Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR, Tenen DG'
p15592
aS'TITLE'
p15593
aS'c-Myc is a critical target for c/EBPalpha in granulopoiesis.'
p15594
aS'JOURNAL'
p15595
aS'Mol Cell Biol 21:3789-806 (2001)'
p15596
aS'PMID:15985538'
p15597
ag15597
aS'AUTHORS'
p15598
aS'Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP'
p15599
aS'TITLE'
p15600
aS'Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in'
p15601
aS'myeloid leukemia.'
p15602
aS'JOURNAL'
p15603
aS'Blood 106:2827-36 (2005)'
p15604
aS'PMID:12393465'
p15605
ag15605
aS'AUTHORS'
p15606
aS'Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G'
p15607
aS'TITLE'
p15608
aS'The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(821) myeloid leukemia.'
p15609
aS'JOURNAL'
p15610
aS'Blood 101:270-7 (2003)'
p15611
aS'PMID:12130514'
p15612
ag15612
aS'AUTHORS'
p15613
aS'Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD, Behre G, Hiddemann W, Ito Y, Tenen DG'
p15614
aS'TITLE'
p15615
aS'Heterozygous PU.1 mutations are associated with acute myeloid leukemia.'
p15616
aS'JOURNAL'
p15617
aS'Blood 100:998-1007 (2002)'
p15618
aS'PMID:15160934'
p15619
ag15619
aS'AUTHORS'
p15620
aS'Jing Y'
p15621
aS'TITLE'
p15622
aS'The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.'
p15623
aS'JOURNAL'
p15624
aS'Leuk Lymphoma 45:639-48 (2004)'
p15625
aS'PMID:15024077'
p15626
ag15626
aS'AUTHORS'
p15627
aS'Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Kohler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H'
p15628
aS'TITLE'
p15629
aS'Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.'
p15630
aS'JOURNAL'
p15631
aS'Mol Cell Biol 24:2890-904 (2004)'
p15632
aS'PMID:19855079'
p15633
ag15633
aS'AUTHORS'
p15634
aS'Rice KL, Hormaeche I, Doulatov S, Flatow JM, Grimwade D, Mills KI, Leiva M, Ablain J, Ambardekar C, McConnell MJ, Dick JE, Licht JD'
p15635
aS'TITLE'
p15636
aS'Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.'
p15637
aS'JOURNAL'
p15638
aS'Blood 114:5499-511 (2009)'
p15639
aS'PMID:10500199'
p15640
ag15640
aS'AUTHORS'
p15641
aS'McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C'
p15642
aS'TITLE'
p15643
aS'Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia.'
p15644
aS'JOURNAL'
p15645
aS'Proc Natl Acad Sci U S A 96:11464-9 (1999)'
p15646
aS'PMID:15156184'
p15647
ag15647
aS'AUTHORS'
p15648
aS'Zelent A, Greaves M, Enver T'
p15649
aS'TITLE'
p15650
aS'Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia.'
p15651
aS'JOURNAL'
p15652
aS'Oncogene 23:4275-83 (2004)'
p15653
aS'PMID:14630078'
p15654
ag15654
aS'AUTHORS'
p15655
aS'Sawinska M, Ladon D'
p15656
aS'TITLE'
p15657
aS'Mechanism, detection and clinical significance of the reciprocal translocation t(1221)(p12q22) in the children suffering from acute lymphoblastic leukaemia.'
p15658
aS'JOURNAL'
p15659
aS'Leuk Res 28:35-42 (2004)'
p15660
aS'PMID:19141473'
p15661
ag15661
aS'AUTHORS'
p15662
aS'Guenther MG, Lawton LN, Rozovskaia T, Frampton GM, Levine SS, Volkert TL, Croce CM, Nakamura T, Canaani E, Young RA'
p15663
aS'TITLE'
p15664
aS'Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage'
p15665
aS'leukemia.'
p15666
aS'JOURNAL'
p15667
aS'Genes Dev 22:3403-8 (2008)'
p15668
aS'PMID:16169901'
p15669
ag15669
aS'AUTHORS'
p15670
aS'Xia ZB, Popovic R, Chen J, Theisler C, Stuart T, Santillan DA, Erfurth F, Diaz MO, Zeleznik-Le NJ'
p15671
aS'TITLE'
p15672
aS'The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B'
p15673
aS'(p27kip1) expression.'
p15674
aS'JOURNAL'
p15675
aS'Proc Natl Acad Sci U S A 102:14028-33 (2005)'
p15676
aS'PMID:21518926'
p15677
ag15677
aS'AUTHORS'
p15678
aS'Wang QF, Wu G, Mi S, He F, Wu J, Dong J, Luo RT, Mattison R, Kaberlein JJ, Prabhakar S, Ji H, Thirman MJ'
p15679
aS'TITLE'
p15680
aS'MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.'
p15681
aS'JOURNAL'
p15682
aS'Blood 117:6895-905 (2011)'
p15683
aS'PMID:14701735'
p15684
ag15684
aS'AUTHORS'
p15685
aS'Zeisig BB, Milne T, Garcia-Cuellar MP, Schreiner S, Martin ME, Fuchs U, Borkhardt A, Chanda SK, Walker J, Soden R, Hess JL, Slany RK'
p15686
aS'TITLE'
p15687
aS'Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.'
p15688
aS'JOURNAL'
p15689
aS'Mol Cell Biol 24:617-28 (2004)'
p15690
aS'PMID:19133982'
p15691
ag15691
aS'AUTHORS'
p15692
aS'Riz I, Hawley TS, Johnston H, Hawley RG'
p15693
aS'TITLE'
p15694
aS'Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.'
p15695
aS'JOURNAL'
p15696
aS'Br J Haematol 145:140-3 (2009)'
p15697
aS'PMID:12511414'
p15698
ag15698
aS'AUTHORS'
p15699
aS'Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G, Parwaresch RM, Lichter P, Siebert R, Mooller P'
p15700
aS'TITLE'
p15701
aS'Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.'
p15702
aS'JOURNAL'
p15703
aS'Blood 101:3681-6 (2003)'
p15704
aS'PMID:11313274'
p15705
ag15705
aS'AUTHORS'
p15706
aS'Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C'
p15707
aS'TITLE'
p15708
aS'Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.'
p15709
aS'JOURNAL'
p15710
aS'Blood 97:2798-807 (2001)'
p15711
aS'PMID:12670461'
p15712
ag15712
aS'AUTHORS'
p15713
aS'Zuzel M, Cawley JC.'
p15714
aS'TITLE'
p15715
aS'The biology of hairy cells.'
p15716
aS'JOURNAL'
p15717
aS'Best Pract Res Clin Haematol 16:1-13 (2003)'
p15718
aS'PMID:14998494'
p15719
ag15719
aS'AUTHORS'
p15720
aS'Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM'
p15721
aS'TITLE'
p15722
aS'Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.'
p15723
aS'JOURNAL'
p15724
aS'Cancer Cell 5:191-9 (2004)'
p15725
aS'PMID:20974671'
p15726
ag15726
aS'AUTHORS'
p15727
aS'Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, Levens DL, Kelleher NL, Licht JD'
p15728
aS'TITLE'
p15729
aS'The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(414) multiple myeloma cells.'
p15730
aS'JOURNAL'
p15731
aS'Blood 117:211-20 (2011)'
p15732
aS'PMID:19059936'
p15733
ag15733
aS'AUTHORS'
p15734
aS'Brito JL, Walker B, Jenner M, Dickens NJ, Brown NJ, Ross FM, Avramidou A, Irving JA, Gonzalez D, Davies FE, Morgan GJ'
p15735
aS'TITLE'
p15736
aS'MMSET deregulation affects cell cycle progression and adhesion regulons in t(414) myeloma plasma cells.'
p15737
aS'JOURNAL'
p15738
aS'Haematologica 94:78-86 (2009)'
p15739
aS'PMID:10350329'
p15740
ag15740
aS'AUTHORS'
p15741
aS'Iida S, Rao PH, Ueda R, Chaganti RS, Dalla-Favera R'
p15742
aS'TITLE'
p15743
aS'Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(914)(p13q32).'
p15744
aS'JOURNAL'
p15745
aS'Leuk Lymphoma 34:25-33 (1999)'
p15746
aS'PMID:10784387'
p15747
ag15747
aS'AUTHORS'
p15748
aS'Ohno H, Ueda C, Akasaka T'
p15749
aS'TITLE'
p15750
aS"The t(914)(p13q32) translocation in B-cell non-Hodgkin's lymphoma."
p15751
aS'JOURNAL'
p15752
aS'Leuk Lymphoma 36:435-45 (2000)'
p15753
aS'PMID:19233641'
p15754
ag15754
aS'AUTHORS'
p15755
aS'Prensner JR, Chinnaiyan AM'
p15756
aS'TITLE'
p15757
aS'Oncogenic gene fusions in epithelial carcinomas.'
p15758
aS'JOURNAL'
p15759
aS'Curr Opin Genet Dev 19:82-91 (2009)'
p15760
aS'PMID:19406209'
p15761
ag15761
aS'AUTHORS'
p15762
aS'Brenner JC, Chinnaiyan AM'
p15763
aS'TITLE'
p15764
aS'Translocations in epithelial cancers.'
p15765
aS'JOURNAL'
p15766
aS'Biochim Biophys Acta 1796:201-15 (2009)'
p15767
aS'PMID:16946003'
p15768
ag15768
aS'AUTHORS'
p15769
aS'Reddi HV, McIver B, Grebe SK, Eberhardt NL.'
p15770
aS'TITLE'
p15771
aS'THE PAX8/PPAR{gamma} ONCOGENE IN THYROID TUMORIGENESIS.'
p15772
aS'JOURNAL'
p15773
aS'Endocrinology : (2006)'
p15774
aS'PMID:19422821'
p15775
ag15775
aS'AUTHORS'
p15776
aS'Medendorp K, van Groningen JJ, Vreede L, Hetterschijt L, Brugmans L, van den Hurk WH, van Kessel AG'
p15777
aS'TITLE'
p15778
aS'The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.'
p15779
aS'JOURNAL'
p15780
aS'Exp Cell Res 315:2399-409 (2009)'
p15781
aS'PMID:18563191'
p15782
ag15782
aS'AUTHORS'
p15783
aS'Kumar-Sinha C, Tomlins SA, Chinnaiyan AM'
p15784
aS'TITLE'
p15785
aS'Recurrent gene fusions in prostate cancer.'
p15786
aS'JOURNAL'
p15787
aS'Nat Rev Cancer 8:497-511 (2008)'
p15788
aS'PMID:20478527'
p15789
ag15789
aS'AUTHORS'
p15790
aS'Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM'
p15791
aS'TITLE'
p15792
aS'An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.'
p15793
aS'JOURNAL'
p15794
aS'Cancer Cell 17:443-54 (2010)'
p15795
aS'PMID:21747944'
p15796
ag15796
aS'AUTHORS'
p15797
aS'Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R'
p15798
aS'TITLE'
p15799
aS'TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.'
p15800
aS'JOURNAL'
p15801
aS'PLoS One 6:e21650 (2011)'
p15802
aS'PMID:17505060'
p15803
ag15803
aS'AUTHORS'
p15804
aS'Cai C, Hsieh CL, Omwancha J, Zheng Z, Chen SY, Baert JL, Shemshedini L'
p15805
aS'TITLE'
p15806
aS'ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.'
p15807
aS'JOURNAL'
p15808
aS'Mol Endocrinol 21:1835-46 (2007)'
p15809
aS'PMID:18172298'
p15810
ag15810
aS'AUTHORS'
p15811
aS'Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM'
p15812
aS'TITLE'
p15813
aS'Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.'
p15814
aS'JOURNAL'
p15815
aS'Cancer Res 68:73-80 (2008)'
p15816
aS'PMID:21849159'
p15817
ag15817
aS'AUTHORS'
p15818
aS'Westermark UK, Wilhelm M, Frenzel A, Henriksson MA'
p15819
aS'TITLE'
p15820
aS'The MYCN oncogene and differentiation in neuroblastoma.'
p15821
aS'JOURNAL'
p15822
aS'Semin Cancer Biol 21:256-66 (2011)'
p15823
aS'PMID:20153925'
p15824
ag15824
aS'AUTHORS'
p15825
aS'Bell E, Chen L, Liu T, Marshall GM, Lunec J, Tweddle DA'
p15826
aS'TITLE'
p15827
aS'MYCN oncoprotein targets and their therapeutic potential.'
p15828
aS'JOURNAL'
p15829
aS'Cancer Lett 293:144-57 (2010)'
p15830
aS'PMID:15644444'
p15831
ag15831
aS'AUTHORS'
p15832
aS'Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A, Shohet JM'
p15833
aS'TITLE'
p15834
aS'The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.'
p15835
aS'JOURNAL'
p15836
aS'Proc Natl Acad Sci U S A 102:731-6 (2005)'
p15837
aS'PMID:20190806'
p15838
ag15838
aS'AUTHORS'
p15839
aS'Ochiai H, Takenobu H, Nakagawa A, Yamaguchi Y, Kimura M, Ohira M, Okimoto Y, Fujimura Y, Koseki H, Kohno Y, Nakagawara A, Kamijo T'
p15840
aS'TITLE'
p15841
aS'Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.'
p15842
aS'JOURNAL'
p15843
aS'Oncogene 29:2681-90 (2010)'
p15844
aS'PMID:20145147'
p15845
ag15845
aS'AUTHORS'
p15846
aS'Chen L, Iraci N, Gherardi S, Gamble LD, Wood KM, Perini G, Lunec J, Tweddle DA'
p15847
aS'TITLE'
p15848
aS'p53 is a direct transcriptional target of MYCN in neuroblastoma.'
p15849
aS'JOURNAL'
p15850
aS'Cancer Res 70:1377-88 (2010)'
p15851
aS'PMID:17327229'
p15852
ag15852
aS'AUTHORS'
p15853
aS'Beierle EA, Trujillo A, Nagaram A, Kurenova EV, Finch R, Ma X, Vella J, Cance WG, Golubovskaya VM'
p15854
aS'TITLE'
p15855
aS'N-MYC regulates focal adhesion kinase expression in human neuroblastoma.'
p15856
aS'JOURNAL'
p15857
aS'J Biol Chem 282:12503-16 (2007)'
p15858
aS'PMID:21123453'
p15859
ag15859
aS'AUTHORS'
p15860
aS'Iraci N, Diolaiti D, Papa A, Porro A, Valli E, Gherardi S, Herold S, Eilers M, Bernardoni R, Della Valle G, Perini G'
p15861
aS'TITLE'
p15862
aS'A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF.'
p15863
aS'JOURNAL'
p15864
aS'Cancer Res 71:404-12 (2011)'
p15865
aS'PMID:17024155'
p15866
ag15866
aS'AUTHORS'
p15867
aS'Dreijerink KM, Hoppener JW, Timmers HM, Lips CJ'
p15868
aS'TITLE'
p15869
aS'Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.'
p15870
aS'JOURNAL'
p15871
aS'Nat Clin Pract Endocrinol Metab 2:562-70 (2006)'
p15872
aS'PMID:19075677'
p15873
ag15873
aS'AUTHORS'
p15874
aS'Wu X, Hua X'
p15875
aS'TITLE'
p15876
aS'Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.'
p15877
aS'JOURNAL'
p15878
aS'Curr Mol Med 8:805-15 (2008)'
p15879
aS'PMID:19564705'
p15880
ag15880
aS'AUTHORS'
p15881
aS'Sakurai A, Murakami A, Sano K, Uchino S, Fukushima Y'
p15882
aS'TITLE'
p15883
aS'Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1.'
p15884
aS'JOURNAL'
p15885
aS'Endocr J 56:887-95 (2009)'
p15886
aS'PMID:17222504'
p15887
ag15887
aS'AUTHORS'
p15888
aS'Yang Y, Hua X'
p15889
aS'TITLE'
p15890
aS'In search of tumor suppressing functions of menin.'
p15891
aS'JOURNAL'
p15892
aS'Mol Cell Endocrinol 265-266:34-41 (2007)'
p15893
aS'PMID:15826838'
p15894
ag15894
aS'AUTHORS'
p15895
aS'Aman P'
p15896
aS'TITLE'
p15897
aS'Fusion oncogenes in tumor development.'
p15898
aS'JOURNAL'
p15899
aS'Semin Cancer Biol 15:236-43 (2005)'
p15900
aS'PMID:12527902'
p15901
ag15901
aS'AUTHORS'
p15902
aS'Fukuma M, Okita H, Hata J, Umezawa A'
p15903
aS'TITLE'
p15904
aS'Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.'
p15905
aS'JOURNAL'
p15906
aS'Oncogene 22:1-9 (2003)'
p15907
aS'PMID:18648544'
p15908
ag15908
aS'AUTHORS'
p15909
aS'Cironi L, Riggi N, Provero P, Wolf N, Suva ML, Suva D, Kindler V, Stamenkovic I'
p15910
aS'TITLE'
p15911
aS"IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells."
p15912
aS'JOURNAL'
p15913
aS'PLoS One 3:e2634 (2008)'
p15914
aS'PMID:17250957'
p15915
ag15915
aS'AUTHORS'
p15916
aS'Riggi N, Stamenkovic I.'
p15917
aS'TITLE'
p15918
aS'The Biology of Ewing sarcoma.'
p15919
aS'JOURNAL'
p15920
aS'Cancer Lett 254:1-10 (2007)'
p15921
aS'PMID:20490326'
p15922
ag15922
aS'AUTHORS'
p15923
aS'Jedlicka P'
p15924
aS'TITLE'
p15925
aS'Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.'
p15926
aS'JOURNAL'
p15927
aS'Int J Clin Exp Pathol 3:338-47 (2010)'
p15928
aS'PMID:19738075'
p15929
ag15929
aS'AUTHORS'
p15930
aS'Ordonez JL, Osuna D, Herrero D, de Alava E, Madoz-Gurpide J'
p15931
aS'TITLE'
p15932
aS"Advances in Ewing's sarcoma research: where are we now and what lies ahead?"
p15933
aS'JOURNAL'
p15934
aS'Cancer Res 69:7140-50 (2009)'
p15935
aS'PMID:12527906'
p15936
ag15936
aS'AUTHORS'
p15937
aS'Jishage M, Fujino T, Yamazaki Y, Kuroda H, Nakamura T'
p15938
aS'TITLE'
p15939
aS'Identification of target genes for EWS/ATF-1 chimeric transcription factor.'
p15940
aS'JOURNAL'
p15941
aS'Oncogene 22:41-9 (2003)'
p15942
aS'PMID:15826834'
p15943
ag15943
aS'AUTHORS'
p15944
aS'Gerald WL, Haber DA'
p15945
aS'TITLE'
p15946
aS'The EWS-WT1 gene fusion in desmoplastic small round cell tumor.'
p15947
aS'JOURNAL'
p15948
aS'Semin Cancer Biol 15:197-205 (2005)'
p15949
aS'PMID:18855877'
p15950
ag15950
aS'AUTHORS'
p15951
aS'Filion C, Motoi T, Olshen AB, Lae M, Emnett RJ, Gutmann DH, Perry A, Ladanyi M, Labelle Y'
p15952
aS'TITLE'
p15953
aS'The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.'
p15954
aS'JOURNAL'
p15955
aS'J Pathol 217:83-93 (2009)'
p15956
aS'PMID:18330902'
p15957
ag15957
aS'AUTHORS'
p15958
aS'Kim S, Lee HJ, Jun HJ, Kim J'
p15959
aS'TITLE'
p15960
aS'The hTAF II 68-TEC fusion protein functions as a strong transcriptional activator.'
p15961
aS'JOURNAL'
p15962
aS'Int J Cancer 122:2446-53 (2008)'
p15963
aS'PMID:10537274'
p15964
ag15964
aS'AUTHORS'
p15965
aS'Sjogren H, Meis-Kindblom J, Kindblom LG, Aman P, Stenman G'
p15966
aS'TITLE'
p15967
aS'Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.'
p15968
aS'JOURNAL'
p15969
aS'Cancer Res 59:5064-7 (1999)'
p15970
aS'PMID:15688424'
p15971
ag15971
aS'AUTHORS'
p15972
aS'Goransson M, Elias E, Stahlberg A, Olofsson A, Andersson C, Aman P'
p15973
aS'TITLE'
p15974
aS'Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.'
p15975
aS'JOURNAL'
p15976
aS'Int J Cancer 115:556-60 (2005)'
p15977
aS'PMID:18850010'
p15978
ag15978
aS'AUTHORS'
p15979
aS'Goransson M, Andersson MK, Forni C, Stahlberg A, Andersson C, Olofsson A, Mantovani R, Aman P'
p15980
aS'TITLE'
p15981
aS'The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target'
p15982
aS'genes by interaction with NFKBIZ.'
p15983
aS'JOURNAL'
p15984
aS'Oncogene 28:270-8 (2009)'
p15985
aS'PMID:20863376'
p15986
ag15986
aS'AUTHORS'
p15987
aS'Willems SM, Schrage YM, Bruijn IH, Szuhai K, Hogendoorn PC, Bovee JV'
p15988
aS'TITLE'
p15989
aS'Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity'
p15990
aS'and casein kinase II inhibition as a potential treatment option.'
p15991
aS'JOURNAL'
p15992
aS'Mol Cancer 9:257 (2010)'
p15993
aS'PMID:18457914'
p15994
ag15994
aS'AUTHORS'
p15995
aS'Linardic CM'
p15996
aS'TITLE'
p15997
aS'PAX3-FOXO1 fusion gene in rhabdomyosarcoma.'
p15998
aS'JOURNAL'
p15999
aS'Cancer Lett 270:10-8 (2008)'
p16000
aS'PMID:11863357'
p16001
ag16001
aS'AUTHORS'
p16002
aS'Barber TD, Barber MC, Tomescu O, Barr FG, Ruben S, Friedman TB'
p16003
aS'TITLE'
p16004
aS'Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma.'
p16005
aS'JOURNAL'
p16006
aS'Genomics 79:278-84 (2002)'
p16007
aS'PMID:17101797'
p16008
ag16008
aS'AUTHORS'
p16009
aS'Ishida M, Miyamoto M, Naitoh S, Tatsuda D, Hasegawa T, Nemoto T, Yokozeki H, Nishioka K, Matsukage A, Ohki M, Ohta T'
p16010
aS'TITLE'
p16011
aS'The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x18) synovial sarcoma.'
p16012
aS'JOURNAL'
p16013
aS'Mol Cell Biol 27:1348-55 (2007)'
p16014
aS'PMID:19472090'
p16015
ag16015
aS'AUTHORS'
p16016
aS'Jun HJ, Lee J, Lim do H, Park JO, Ahn G, Seo SW, Sung KS, Lim do H, Yoo KH, Choi YL'
p16017
aS'TITLE'
p16018
aS'Expression of MET in alveolar soft part sarcoma.'
p16019
aS'JOURNAL'
p16020
aS'Med Oncol 27:459-65 (2010)'
p16021
aS'PMID:21779514'
p16022
ag16022
aS'AUTHORS'
p16023
aS'Rivlin N, Brosh R, Oren M, Rotter V'
p16024
aS'TITLE'
p16025
aS'Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.'
p16026
aS'JOURNAL'
p16027
aS'Genes Cancer 2:466-74 (2011)'
p16028
aS'PMID:21765642'
p16029
ag16029
aS'AUTHORS'
p16030
aS'Suzuki K, Matsubara H'
p16031
aS'TITLE'
p16032
aS'Recent advances in p53 research and cancer treatment.'
p16033
aS'JOURNAL'
p16034
aS'J Biomed Biotechnol 2011:978312 (2011)'
p16035
asS'KO_PATHWAY'
p16036
(lp16037
S'ko05202'
p16038
asS'ENTRY'
p16039
(lp16040
S'map05202'
p16041
aS'Pathway'
p16042
asS'PATHWAY_MAP'
p16043
(lp16044
S'map05202'
p16045
asS'DISEASE'
p16046
(lp16047
S'H00001'
p16048
aS'Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)'
p16049
ag16048
ag16049
aS'H00002'
p16050
aS'Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)'
p16051
aS'H00003'
p16052
aS'Acute myeloid leukemia (AML)'
p16053
aS'H00006'
p16054
aS'Hairy-cell leukemia'
p16055
aS'H00007'
p16056
aS'Hodgkin lymphoma'
p16057
aS'H00010'
p16058
aS'Multiple myeloma'
p16059
aS'H00011'
p16060
aS'Lymphoplasmacytic lymphoma'
p16061
aS'H00021'
p16062
aS'Renal cell carcinoma'
p16063
aS'H00024'
p16064
aS'Prostate cancer'
p16065
aS'H00032'
p16066
aS'Thyroid cancer'
p16067
aS'H00034'
p16068
aS'Carcinoid'
p16069
aS'H00035'
p16070
aS"Ewing's sarcoma"
p16071
aS'H00037'
p16072
aS'Alveolar rhabdomyosarcoma'
p16073
aS'H00043'
p16074
aS'Neuroblastoma'
p16075
aS'H00049'
p16076
aS'Myxoid liposarcoma'
p16077
aS'H00050'
p16078
aS'Synovial sarcoma'
p16079
aS'H00051'
p16080
aS'Alveolar soft part sarcoma'
p16081
aS'H00052'
p16082
aS'Clear cell sarcoma of soft tissue'
p16083
aS'H00053'
p16084
aS'Extraskeletal myxoid chondrosarcoma'
p16085
aS'H01102'
p16086
aS'Pituitary adenomas'
p16087
asS'CLASS'
p16088
(lp16089
S'Human Diseases Cancers'
p16090
assS'path:map05200'
p16091
(dp16092
S'NAME'
p16093
(lp16094
S'Pathways in cancer'
p16095
asS'REFERENCE'
p16096
(lp16097
g22
ag22
aS'AUTHORS'
p16098
aS'Weinberg RA.'
p16099
aS'TITLE'
p16100
aS'The biology of cancer'
p16101
aS'JOURNAL'
p16102
aS'Garland Science, Taylor & Francis Group, LLC (2007)'
p16103
aS'PMID:10647931'
p16104
ag16104
aS'AUTHORS'
p16105
aS'Hanahan D, Weinberg RA'
p16106
aS'TITLE'
p16107
aS'The hallmarks of cancer.'
p16108
aS'JOURNAL'
p16109
aS'Cell 100:57-70 (2000)'
p16110
aS'PMID:15000146'
p16111
ag16111
aS'AUTHORS'
p16112
aS'Grady WM.'
p16113
aS'TITLE'
p16114
aS'Genomic instability and colon cancer.'
p16115
aS'JOURNAL'
p16116
aS'Cancer Metastasis Rev 23:11-27 (2004)'
p16117
aS'PMID:16555243'
p16118
ag16118
aS'AUTHORS'
p16119
aS'Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.'
p16120
aS'TITLE'
p16121
aS'Microsatellite instability in colorectal cancer.'
p16122
aS'JOURNAL'
p16123
aS'Br J Surg 93:395-406 (2006)'
p16124
aS'PMID:11078609'
p16125
ag16125
aS'AUTHORS'
p16126
aS'Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.'
p16127
aS'TITLE'
p16128
aS'Hereditary non-polyposis colorectal cancer: an updated review.'
p16129
aS'JOURNAL'
p16130
aS'Eur J Surg Oncol 26:635-45 (2000)'
p16131
aS'PMID:16699851'
p16132
ag16132
aS'AUTHORS'
p16133
aS'Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.'
p16134
aS'TITLE'
p16135
aS'Colorectal cancer: genetics of development and metastasis.'
p16136
aS'JOURNAL'
p16137
aS'J Gastroenterol 41:185-92 (2006)'
p16138
aS'PMID:12621137'
p16139
ag16139
aS'AUTHORS'
p16140
aS'Lynch HT, de la Chapelle A.'
p16141
aS'TITLE'
p16142
aS'Hereditary colorectal cancer.'
p16143
aS'JOURNAL'
p16144
aS'N Engl J Med 348:919-32 (2003)'
p16145
aS'PMID:12951588'
p16146
ag16146
aS'AUTHORS'
p16147
aS'Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.'
p16148
aS'TITLE'
p16149
aS'The significance of unstable chromosomes in colorectal cancer.'
p16150
aS'JOURNAL'
p16151
aS'Nat Rev Cancer 3:695-701 (2003)'
p16152
aS'PMID:10505543'
p16153
ag16153
aS'AUTHORS'
p16154
aS'Behrens J.'
p16155
aS'TITLE'
p16156
aS'Cadherins and catenins: role in signal transduction and tumor progression.'
p16157
aS'JOURNAL'
p16158
aS'Cancer Metastasis Rev 18:15-30 (1999)'
p16159
aS'PMID:16042571'
p16160
ag16160
aS'AUTHORS'
p16161
aS'Behrens J.'
p16162
aS'TITLE'
p16163
aS'The role of the Wnt signalling pathway in colorectal tumorigenesis.'
p16164
aS'JOURNAL'
p16165
aS'Biochem Soc Trans 33:672-5 (2005)'
p16166
aS'PMID:15349822'
p16167
ag16167
aS'AUTHORS'
p16168
aS'Behrens J, Lustig B.'
p16169
aS'TITLE'
p16170
aS'The Wnt connection to tumorigenesis.'
p16171
aS'JOURNAL'
p16172
aS'Int J Dev Biol 48:477-87 (2004)'
p16173
aS'PMID:9196022'
p16174
ag16174
aS'AUTHORS'
p16175
aS'Polakis P.'
p16176
aS'TITLE'
p16177
aS'The adenomatous polyposis coli (APC) tumor suppressor.'
p16178
aS'JOURNAL'
p16179
aS'Biochim Biophys Acta 1332:F127-47 (1997)'
p16180
aS'PMID:12737309'
p16181
ag16181
aS'AUTHORS'
p16182
aS'Janssen KP.'
p16183
aS'TITLE'
p16184
aS'Murine models of colorectal cancer: studying the role of oncogenic K-ras.'
p16185
aS'JOURNAL'
p16186
aS'Cell Mol Life Sci 60:495-506 (2003)'
p16187
aS'PMID:11459867'
p16188
ag16188
aS'AUTHORS'
p16189
aS'Adjei AA.'
p16190
aS'TITLE'
p16191
aS'Blocking oncogenic Ras signaling for cancer therapy.'
p16192
aS'JOURNAL'
p16193
aS'J Natl Cancer Inst 93:1062-74 (2001)'
p16194
aS'PMID:15573119'
p16195
ag16195
aS'AUTHORS'
p16196
aS'Arakawa H.'
p16197
aS'TITLE'
p16198
aS'Netrin-1 and its receptors in tumorigenesis.'
p16199
aS'JOURNAL'
p16200
aS'Nat Rev Cancer 4:978-87 (2004)'
p16201
aS'PMID:15310786'
p16202
ag16202
aS'AUTHORS'
p16203
aS'Mehlen P, Fearon ER.'
p16204
aS'TITLE'
p16205
aS'Role of the dependence receptor DCC in colorectal cancer pathogenesis.'
p16206
aS'JOURNAL'
p16207
aS'J Clin Oncol 22:3420-8 (2004)'
p16208
aS'PMID:11223406'
p16209
ag16209
aS'AUTHORS'
p16210
aS'Peltomaki P.'
p16211
aS'TITLE'
p16212
aS'DNA mismatch repair and cancer.'
p16213
aS'JOURNAL'
p16214
aS'Mutat Res 488:77-85 (2001)'
p16215
aS'PMID:15711891'
p16216
ag16216
aS'AUTHORS'
p16217
aS'Li F, Cao Y, Townsend CM Jr, Ko TC.'
p16218
aS'TITLE'
p16219
aS'TGF-beta signaling in colon cancer cells.'
p16220
aS'JOURNAL'
p16221
aS'World J Surg 29:306-11 (2005)'
p16222
aS'PMID:11170304'
p16223
ag16223
aS'AUTHORS'
p16224
aS'Roman C, Saha D, Beauchamp R.'
p16225
aS'TITLE'
p16226
aS'TGF-beta and colorectal carcinogenesis.'
p16227
aS'JOURNAL'
p16228
aS'Microsc Res Tech 52:450-7 (2001)'
p16229
aS'PMID:16326109'
p16230
ag16230
aS'AUTHORS'
p16231
aS'Watson AJ.'
p16232
aS'TITLE'
p16233
aS'An overview of apoptosis and the prevention of colorectal cancer.'
p16234
aS'JOURNAL'
p16235
aS'Crit Rev Oncol Hematol 57:107-21 (2006)'
p16236
aS'PMID:15479695'
p16237
ag16237
aS'AUTHORS'
p16238
aS'Watson AJ.'
p16239
aS'TITLE'
p16240
aS'Apoptosis and colorectal cancer.'
p16241
aS'JOURNAL'
p16242
aS'Gut 53:1701-9 (2004)'
p16243
aS'PMID:11477132'
p16244
ag16244
aS'AUTHORS'
p16245
aS'Houlston RS.'
p16246
aS'TITLE'
p16247
aS'What we could do now: molecular pathology of colorectal cancer.'
p16248
aS'JOURNAL'
p16249
aS'Mol Pathol 54:206-14 (2001)'
p16250
ag22
ag22
aS'AUTHORS'
p16251
ag22
aS'TITLE'
p16252
ag22
aS'JOURNAL'
p16253
ag22
ag22
ag22
aS'AUTHORS'
p16254
aS'Niitsu Y, Yokota J (ed).'
p16255
aS'TITLE'
p16256
aS'[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)'
p16257
aS'JOURNAL'
p16258
aS'Nankodo (1999)'
p16259
aS'PMID:12459728'
p16260
ag16260
aS'AUTHORS'
p16261
aS'Bardeesy N, DePinho RA.'
p16262
aS'TITLE'
p16263
aS'Pancreatic cancer biology and genetics.'
p16264
aS'JOURNAL'
p16265
aS'Nat Rev Cancer 2:897-909 (2002)'
p16266
aS'PMID:11407945'
p16267
ag16267
aS'AUTHORS'
p16268
aS'Bardeesy N, Sharpless NE, DePinho RA, Merlino G.'
p16269
aS'TITLE'
p16270
aS'The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.'
p16271
aS'JOURNAL'
p16272
aS'Semin Cancer Biol 11:201-18 (2001)'
p16273
aS'PMID:12946833'
p16274
ag16274
aS'AUTHORS'
p16275
aS'Cowgill SM, Muscarella P.'
p16276
aS'TITLE'
p16277
aS'The genetics of pancreatic cancer.'
p16278
aS'JOURNAL'
p16279
aS'Am J Surg 186:279-86 (2003)'
p16280
aS'PMID:16702400'
p16281
ag16281
aS'AUTHORS'
p16282
aS'Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.'
p16283
aS'TITLE'
p16284
aS'Genetics and biology of pancreatic ductal adenocarcinoma.'
p16285
aS'JOURNAL'
p16286
aS'Genes Dev 20:1218-49 (2006)'
p16287
aS'PMID:10740269'
p16288
ag16288
aS'AUTHORS'
p16289
aS'Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.'
p16290
aS'TITLE'
p16291
aS"Understanding Ras: 'it ain't over 'til it's over'."
p16292
aS'JOURNAL'
p16293
aS'Trends Cell Biol 10:147-54 (2000)'
p16294
aS'PMID:12648469'
p16295
ag16295
aS'AUTHORS'
p16296
aS'Holbro T, Civenni G, Hynes NE.'
p16297
aS'TITLE'
p16298
aS'The ErbB receptors and their role in cancer progression.'
p16299
aS'JOURNAL'
p16300
aS'Exp Cell Res 284:99-110 (2003)'
p16301
aS'PMID:14967450'
p16302
ag16302
aS'AUTHORS'
p16303
aS'Marmor MD, Skaria KB, Yarden Y.'
p16304
aS'TITLE'
p16305
aS'Signal transduction and oncogenesis by ErbB/HER receptors.'
p16306
aS'JOURNAL'
p16307
aS'Int J Radiat Oncol Biol Phys 58:903-13 (2004)'
p16308
aS'PMID:14586404'
p16309
ag16309
aS'AUTHORS'
p16310
aS'DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.'
p16311
aS'TITLE'
p16312
aS'Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.'
p16313
aS'JOURNAL'
p16314
aS'Oncogene 22:7781-95 (2003)'
p16315
aS'PMID:12545153'
p16316
ag16316
aS'AUTHORS'
p16317
aS'Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.'
p16318
aS'TITLE'
p16319
aS'Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.'
p16320
aS'JOURNAL'
p16321
aS'Oncogene 22:319-29 (2003)'
p16322
aS'PMID:14580692'
p16323
ag16323
aS'AUTHORS'
p16324
aS'Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.'
p16325
aS'TITLE'
p16326
aS'Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.'
p16327
aS'JOURNAL'
p16328
aS'Cancer Lett 201:107-16 (2003)'
p16329
aS'PMID:12079267'
p16330
ag16330
aS'AUTHORS'
p16331
aS'Schmid RM.'
p16332
aS'TITLE'
p16333
aS'Genetic basis of pancreatic cancer.'
p16334
aS'JOURNAL'
p16335
aS'Best Pract Res Clin Gastroenterol 16:421-33 (2002)'
p16336
aS'PMID:15774796'
p16337
ag16337
aS'AUTHORS'
p16338
aS'Elliott RL, Blobe GC.'
p16339
aS'TITLE'
p16340
aS'Role of transforming growth factor Beta in human cancer.'
p16341
aS'JOURNAL'
p16342
aS'J Clin Oncol 23:2078-93 (2005)'
p16343
aS'PMID:15823750'
p16344
ag16344
aS'AUTHORS'
p16345
aS'Rudkin TM, Foulkes WD.'
p16346
aS'TITLE'
p16347
aS'BRCA2: breaks, mistakes and failed separations.'
p16348
aS'JOURNAL'
p16349
aS'Trends Mol Med 11:145-8 (2005)'
p16350
aS'PMID:11707511'
p16351
ag16351
aS'AUTHORS'
p16352
aS'Venkitaraman AR.'
p16353
aS'TITLE'
p16354
aS'Functions of BRCA1 and BRCA2 in the biological response to DNA damage.'
p16355
aS'JOURNAL'
p16356
aS'J Cell Sci 114:3591-8 (2001)'
p16357
aS'PMID:15639402'
p16358
ag16358
aS'AUTHORS'
p16359
aS'Soni D, King JA, Kaye AH, Hovens CM.'
p16360
aS'TITLE'
p16361
aS'Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.'
p16362
aS'JOURNAL'
p16363
aS'J Clin Neurosci 12:1-5 (2005)'
p16364
aS'PMID:12154354'
p16365
ag16365
aS'AUTHORS'
p16366
aS'Zhu Y, Parada LF.'
p16367
aS'TITLE'
p16368
aS'The molecular and genetic basis of neurological tumours.'
p16369
aS'JOURNAL'
p16370
aS'Nat Rev Cancer 2:616-26 (2002)'
p16371
aS'PMID:11253051'
p16372
ag16372
aS'AUTHORS'
p16373
aS'Holland EC.'
p16374
aS'TITLE'
p16375
aS'Gliomagenesis: genetic alterations and mouse models.'
p16376
aS'JOURNAL'
p16377
aS'Nat Rev Genet 2:120-9 (2001)'
p16378
aS'PMID:16700615'
p16379
ag16379
aS'AUTHORS'
p16380
aS'Bansal K, Liang ML, Rutka JT.'
p16381
aS'TITLE'
p16382
aS'Molecular biology of human gliomas.'
p16383
aS'JOURNAL'
p16384
aS'Technol Cancer Res Treat 5:185-94 (2006)'
p16385
ag22
ag22
aS'AUTHORS'
p16386
aS'Tabuchi K (ed).'
p16387
aS'TITLE'
p16388
aS'[Gliomas: Research and therapy] (In Japanese)'
p16389
aS'JOURNAL'
p16390
aS'Springer-Verlag Tokyo (2006)'
p16391
aS'PMID:12762887'
p16392
ag16392
aS'AUTHORS'
p16393
aS"Kapoor GS, O'Rourke DM."
p16394
aS'TITLE'
p16395
aS'Mitogenic signaling cascades in glial tumors.'
p16396
aS'JOURNAL'
p16397
aS'Neurosurgery 52:1425-34 discussion 1434-5 (2003)'
p16398
aS'PMID:16095998'
p16399
ag16399
aS'AUTHORS'
p16400
aS'Hulleman E, Helin K.'
p16401
aS'TITLE'
p16402
aS'Molecular mechanisms in gliomagenesis.'
p16403
aS'JOURNAL'
p16404
aS'Adv Cancer Res 94:1-27 (2005)'
p16405
aS'PMID:11057895'
p16406
ag16406
aS'AUTHORS'
p16407
aS'Schlessinger J.'
p16408
aS'TITLE'
p16409
aS'Cell signaling by receptor tyrosine kinases.'
p16410
aS'JOURNAL'
p16411
aS'Cell 103:211-25 (2000)'
p16412
aS'PMID:9643506'
p16413
ag16413
aS'AUTHORS'
p16414
aS'Ng HK, Lam PY.'
p16415
aS'TITLE'
p16416
aS'The molecular genetics of central nervous system tumors.'
p16417
aS'JOURNAL'
p16418
aS'Pathology 30:196-202 (1998)'
p16419
aS'PMID:12084351'
p16420
ag16420
aS'AUTHORS'
p16421
aS'Knobbe CB, Merlo A, Reifenberger G.'
p16422
aS'TITLE'
p16423
aS'Pten signaling in gliomas.'
p16424
aS'JOURNAL'
p16425
aS'Neuro-oncol 4:196-211 (2002)'
p16426
aS'PMID:16557281'
p16427
ag16427
aS'AUTHORS'
p16428
aS'Kondo T, Ezzat S, Asa SL.'
p16429
aS'TITLE'
p16430
aS'Pathogenetic mechanisms in thyroid follicular-cell neoplasia.'
p16431
aS'JOURNAL'
p16432
aS'Nat Rev Cancer 6:292-306 (2006)'
p16433
aS'PMID:16551846'
p16434
ag16434
aS'AUTHORS'
p16435
aS'Chiloeches A, Marais R.'
p16436
aS'TITLE'
p16437
aS"Is BRAF the Achilles' Heel of thyroid cancer?"
p16438
aS'JOURNAL'
p16439
aS'Clin Cancer Res 12:1661-4 (2006)'
p16440
aS'PMID:16946003'
p16441
ag16441
aS'AUTHORS'
p16442
aS'Reddi HV, McIver B, Grebe SK, Eberhardt NL.'
p16443
aS'TITLE'
p16444
aS'THE PAX8/PPAR{gamma} ONCOGENE IN THYROID TUMORIGENESIS.'
p16445
aS'JOURNAL'
p16446
aS'Endocrinology : (2006)'
p16447
aS'PMID:17062879'
p16448
ag16448
aS'AUTHORS'
p16449
aS'Santoro M, Melillo RM, Fusco A.'
p16450
aS'TITLE'
p16451
aS'RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.'
p16452
aS'JOURNAL'
p16453
aS'Eur J Endocrinol 155:645-653 (2006)'
p16454
aS'PMID:16242838'
p16455
ag16455
aS'AUTHORS'
p16456
aS'Pierotti MA, Greco A.'
p16457
aS'TITLE'
p16458
aS'Oncogenic rearrangements of the NTRK1/NGF receptor.'
p16459
aS'JOURNAL'
p16460
aS'Cancer Lett 232:90-8 (2006)'
p16461
aS'PMID:16189702'
p16462
ag16462
aS'AUTHORS'
p16463
aS'Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.'
p16464
aS'TITLE'
p16465
aS'Molecular pathology of well-differentiated thyroid carcinomas.'
p16466
aS'JOURNAL'
p16467
aS'Virchows Arch 447:787-93 (2005)'
p16468
aS'PMID:11165748'
p16469
ag16469
aS'AUTHORS'
p16470
aS'Gimm O.'
p16471
aS'TITLE'
p16472
aS'Thyroid cancer.'
p16473
aS'JOURNAL'
p16474
aS'Cancer Lett 163:143-56 (2001)'
p16475
aS'PMID:12094241'
p16476
ag16476
aS'AUTHORS'
p16477
aS'Williams D.'
p16478
aS'TITLE'
p16479
aS'Cancer after nuclear fallout: lessons from the Chernobyl accident.'
p16480
aS'JOURNAL'
p16481
aS'Nat Rev Cancer 2:543-9 (2002)'
p16482
aS'PMID:16236521'
p16483
ag16483
aS'AUTHORS'
p16484
aS'Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.'
p16485
aS'TITLE'
p16486
aS'The molecular pathogenesis of acute myeloid leukemia.'
p16487
aS'JOURNAL'
p16488
aS'Crit Rev Oncol Hematol 56:195-221 (2005)'
p16489
aS'PMID:12563308'
p16490
ag16490
aS'AUTHORS'
p16491
aS'Tenen DG.'
p16492
aS'TITLE'
p16493
aS'Disruption of differentiation in human cancer: AML shows the way.'
p16494
aS'JOURNAL'
p16495
aS'Nat Rev Cancer 3:89-101 (2003)'
p16496
aS'PMID:16146838'
p16497
ag16497
aS'AUTHORS'
p16498
aS'Choudhary C, Muller-Tidow C, Berdel WE, Serve H.'
p16499
aS'TITLE'
p16500
aS'Signal transduction of oncogenic Flt3.'
p16501
aS'JOURNAL'
p16502
aS'Int J Hematol 82:93-9 (2005)'
p16503
aS'PMID:12951584'
p16504
ag16504
aS'AUTHORS'
p16505
aS'Stirewalt DL, Radich JP.'
p16506
aS'TITLE'
p16507
aS'The role of FLT3 in haematopoietic malignancies.'
p16508
aS'JOURNAL'
p16509
aS'Nat Rev Cancer 3:650-65 (2003)'
p16510
aS'PMID:16642045'
p16511
ag16511
aS'AUTHORS'
p16512
aS'Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.'
p16513
aS'TITLE'
p16514
aS'Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.'
p16515
aS'JOURNAL'
p16516
aS'Leukemia 20:911-28 (2006)'
p16517
aS'PMID:15625120'
p16518
ag16518
aS'AUTHORS'
p16519
aS'Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.'
p16520
aS'TITLE'
p16521
aS'Normal and oncogenic forms of the receptor tyrosine kinase kit.'
p16522
aS'JOURNAL'
p16523
aS'Stem Cells 23:16-43 (2005)'
p16524
aS'PMID:11721960'
p16525
ag16525
aS'AUTHORS'
p16526
aS'Lorsbach RB, Downing JR.'
p16527
aS'TITLE'
p16528
aS'The role of the AML1 transcription factor in leukemogenesis.'
p16529
aS'JOURNAL'
p16530
aS'Int J Hematol 74:258-65 (2001)'
p16531
aS'PMID:12468433'
p16532
ag16532
aS'AUTHORS'
p16533
aS'Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.'
p16534
aS'TITLE'
p16535
aS'Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.'
p16536
aS'JOURNAL'
p16537
aS'Blood 101:3164-73 (2003)'
p16538
aS'PMID:17554387'
p16539
ag16539
aS'AUTHORS'
p16540
aS'Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.'
p16541
aS'TITLE'
p16542
aS'The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.'
p16543
aS'JOURNAL'
p16544
aS'Leukemia : (2007)'
p16545
aS'PMID:16352814'
p16546
ag16546
aS'AUTHORS'
p16547
aS'Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.'
p16548
aS'TITLE'
p16549
aS'ATRA resolves the differentiation block in t(1517) acute myeloid leukemia by restoring PU.1 expression.'
p16550
aS'JOURNAL'
p16551
aS'Blood 107:3330-8 (2006)'
p16552
aS'PMID:15719031'
p16553
ag16553
aS'AUTHORS'
p16554
aS'Ren R.'
p16555
aS'TITLE'
p16556
aS'Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.'
p16557
aS'JOURNAL'
p16558
aS'Nat Rev Cancer 5:172-83 (2005)'
p16559
aS'PMID:11071626'
p16560
ag16560
aS'AUTHORS'
p16561
aS'Deininger MW, Goldman JM, Melo JV.'
p16562
aS'TITLE'
p16563
aS'The molecular biology of chronic myeloid leukemia.'
p16564
aS'JOURNAL'
p16565
aS'Blood 96:3343-56 (2000)'
p16566
aS'PMID:14982876'
p16567
ag16567
aS'AUTHORS'
p16568
aS'Calabretta B, Perrotti D.'
p16569
aS'TITLE'
p16570
aS'The biology of CML blast crisis.'
p16571
aS'JOURNAL'
p16572
aS'Blood 103:4010-22 (2004)'
p16573
aS'PMID:10403855'
p16574
ag16574
aS'AUTHORS'
p16575
aS"Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM."
p16576
aS'TITLE'
p16577
aS'The biology of chronic myeloid leukemia.'
p16578
aS'JOURNAL'
p16579
aS'N Engl J Med 341:164-72 (1999)'
p16580
aS'PMID:15156182'
p16581
ag16581
aS'AUTHORS'
p16582
aS'Mitani K.'
p16583
aS'TITLE'
p16584
aS'Molecular mechanisms of leukemogenesis by AML1/EVI-1.'
p16585
aS'JOURNAL'
p16586
aS'Oncogene 23:4263-9 (2004)'
p16587
aS'PMID:16484590'
p16588
ag16588
aS'AUTHORS'
p16589
aS'Dong M, Blobe GC.'
p16590
aS'TITLE'
p16591
aS'Role of transforming growth factor-beta in hematologic malignancies.'
p16592
aS'JOURNAL'
p16593
aS'Blood 107:4589-96 (2006)'
p16594
aS'PMID:9834202'
p16595
ag16595
aS'AUTHORS'
p16596
aS'Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.'
p16597
aS'TITLE'
p16598
aS'The t(321) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.'
p16599
aS'JOURNAL'
p16600
aS'Blood 92:4003-12 (1998)'
p16601
aS'PMID:12801837'
p16602
ag16602
aS'AUTHORS'
p16603
aS'Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.'
p16604
aS'TITLE'
p16605
aS'p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.'
p16606
aS'JOURNAL'
p16607
aS'Haematologica 88:622-30 (2003)'
p16608
aS'PMID:11160144'
p16609
ag16609
aS'AUTHORS'
p16610
aS'Baldwin AS.'
p16611
aS'TITLE'
p16612
aS'Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.'
p16613
aS'JOURNAL'
p16614
aS'J Clin Invest 107:241-6 (2001)'
p16615
aS'PMID:12244301'
p16616
ag16616
aS'AUTHORS'
p16617
aS'Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.'
p16618
aS'TITLE'
p16619
aS'PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.'
p16620
aS'JOURNAL'
p16621
aS'Nat Med 8:1145-52 (2002)'
p16622
aS'PMID:15948971'
p16623
ag16623
aS'AUTHORS'
p16624
aS'Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.'
p16625
aS'TITLE'
p16626
aS'Molecular aetiology and pathogenesis of basal cell carcinoma.'
p16627
aS'JOURNAL'
p16628
aS'Br J Dermatol 152:1108-24 (2005)'
p16629
aS'PMID:12588368'
p16630
ag16630
aS'AUTHORS'
p16631
aS'Saldanha G, Fletcher A, Slater DN.'
p16632
aS'TITLE'
p16633
aS'Basal cell carcinoma: a dermatopathological and molecular biological update.'
p16634
aS'JOURNAL'
p16635
aS'Br J Dermatol 148:195-202 (2003)'
p16636
aS'PMID:15978322'
p16637
ag16637
aS'AUTHORS'
p16638
aS'Daya-Grosjean L, Couve-Privat S.'
p16639
aS'TITLE'
p16640
aS'Sonic hedgehog signaling in basal cell carcinomas.'
p16641
aS'JOURNAL'
p16642
aS'Cancer Lett 225:181-92 (2005)'
p16643
aS'PMID:15468170'
p16644
ag16644
aS'AUTHORS'
p16645
aS'Tsai KY, Tsao H.'
p16646
aS'TITLE'
p16647
aS'The genetics of skin cancer.'
p16648
aS'JOURNAL'
p16649
aS'Am J Med Genet C Semin Med Genet 131C:82-92 (2004)'
p16650
aS'PMID:16881963'
p16651
ag16651
aS'AUTHORS'
p16652
aS'Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.'
p16653
aS'TITLE'
p16654
aS'Hedgehog signalling in skin development and cancer.'
p16655
aS'JOURNAL'
p16656
aS'Exp Dermatol 15:667-77 (2006)'
p16657
aS'PMID:16306523'
p16658
ag16658
aS'AUTHORS'
p16659
aS'Rubin AI, Chen EH, Ratner D.'
p16660
aS'TITLE'
p16661
aS'Basal-cell carcinoma.'
p16662
aS'JOURNAL'
p16663
aS'N Engl J Med 353:2262-9 (2005)'
p16664
aS'PMID:11276000'
p16665
ag16665
aS'AUTHORS'
p16666
aS'Saldanha G.'
p16667
aS'TITLE'
p16668
aS'The Hedgehog signalling pathway and cancer.'
p16669
aS'JOURNAL'
p16670
aS'J Pathol 193:427-32 (2001)'
p16671
aS'PMID:15270885'
p16672
ag16672
aS'AUTHORS'
p16673
aS'Saldanha G, Ghura V, Potter L, Fletcher A.'
p16674
aS'TITLE'
p16675
aS'Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.'
p16676
aS'JOURNAL'
p16677
aS'Br J Dermatol 151:157-64 (2004)'
p16678
aS'PMID:14737121'
p16679
ag16679
aS'AUTHORS'
p16680
aS'Pasca di Magliano M, Hebrok M.'
p16681
aS'TITLE'
p16682
aS'Hedgehog signalling in cancer formation and maintenance.'
p16683
aS'JOURNAL'
p16684
aS'Nat Rev Cancer 3:903-11 (2003)'
p16685
aS'PMID:15656799'
p16686
ag16686
aS'AUTHORS'
p16687
aS'Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.'
p16688
aS'TITLE'
p16689
aS'Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.'
p16690
aS'JOURNAL'
p16691
aS'Br J Dermatol 152:43-51 (2005)'
p16692
aS'PMID:14556242'
p16693
ag16693
aS'AUTHORS'
p16694
aS'Cohen MM Jr.'
p16695
aS'TITLE'
p16696
aS'The hedgehog signaling network.'
p16697
aS'JOURNAL'
p16698
aS'Am J Med Genet A 123:5-28 (2003)'
p16699
aS'PMID:11736900'
p16700
ag16700
aS'AUTHORS'
p16701
aS'Yamazaki F, Aragane Y, Kawada A, Tezuka T.'
p16702
aS'TITLE'
p16703
aS'Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.'
p16704
aS'JOURNAL'
p16705
aS'Br J Dermatol 145:771-7 (2001)'
p16706
aS'PMID:16054233'
p16707
ag16707
aS'AUTHORS'
p16708
aS'Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.'
p16709
aS'TITLE'
p16710
aS'Role of apoptosis in basal cell and squamous cell carcinoma formation.'
p16711
aS'JOURNAL'
p16712
aS'Immunol Lett 100:68-72 (2005)'
p16713
aS'PMID:11130178'
p16714
ag16714
aS'AUTHORS'
p16715
aS'Toftgard R.'
p16716
aS'TITLE'
p16717
aS'Hedgehog signalling in cancer.'
p16718
aS'JOURNAL'
p16719
aS'Cell Mol Life Sci 57:1720-31 (2000)'
p16720
aS'PMID:16822996'
p16721
ag16721
aS'AUTHORS'
p16722
aS'Miller AJ, Mihm MC Jr.'
p16723
aS'TITLE'
p16724
aS'Melanoma.'
p16725
aS'JOURNAL'
p16726
aS'N Engl J Med 355:51-65 (2006)'
p16727
aS'PMID:12894244'
p16728
ag16728
aS'AUTHORS'
p16729
aS'Chin L.'
p16730
aS'TITLE'
p16731
aS'The genetics of malignant melanoma: lessons from mouse and man.'
p16732
aS'JOURNAL'
p16733
aS'Nat Rev Cancer 3:559-70 (2003)'
p16734
aS'PMID:16750612'
p16735
ag16735
aS'AUTHORS'
p16736
aS'Takata M, Saida T.'
p16737
aS'TITLE'
p16738
aS'Genetic alterations in melanocytic tumors.'
p16739
aS'JOURNAL'
p16740
aS'J Dermatol Sci 43:1-10 (2006)'
p16741
aS'PMID:15841168'
p16742
ag16742
aS'AUTHORS'
p16743
aS'Chudnovsky Y, Khavari PA, Adams AE.'
p16744
aS'TITLE'
p16745
aS'Melanoma genetics and the development of rational therapeutics.'
p16746
aS'JOURNAL'
p16747
aS'J Clin Invest 115:813-24 (2005)'
p16748
aS'PMID:16001050'
p16749
ag16749
aS'AUTHORS'
p16750
aS'Merlino G.'
p16751
aS'TITLE'
p16752
aS'Cancer biology: the weakest link?'
p16753
aS'JOURNAL'
p16754
aS'Nature 436:33-5 (2005)'
p16755
aS'PMID:16001072'
p16756
ag16756
aS'AUTHORS'
p16757
aS'Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.'
p16758
aS'TITLE'
p16759
aS'Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.'
p16760
aS'JOURNAL'
p16761
aS'Nature 436:117-22 (2005)'
p16762
aS'PMID:16899407'
p16763
ag16763
aS'AUTHORS'
p16764
aS'Levy C, Khaled M, Fisher DE.'
p16765
aS'TITLE'
p16766
aS'MITF: master regulator of melanocyte development and melanoma oncogene.'
p16767
aS'JOURNAL'
p16768
aS'Trends Mol Med 12:406-14 (2006)'
p16769
aS'PMID:15009714'
p16770
ag16770
aS'AUTHORS'
p16771
aS'Tsao H, Goel V, Wu H, Yang G, Haluska FG.'
p16772
aS'TITLE'
p16773
aS'Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.'
p16774
aS'JOURNAL'
p16775
aS'J Invest Dermatol 122:337-41 (2004)'
p16776
aS'PMID:11224709'
p16777
ag16777
aS'AUTHORS'
p16778
aS'Gruss C, Herlyn M.'
p16779
aS'TITLE'
p16780
aS'Role of cadherins and matrixins in melanoma.'
p16781
aS'JOURNAL'
p16782
aS'Curr Opin Oncol 13:117-23 (2001)'
p16783
aS'PMID:15721476'
p16784
ag16784
aS'AUTHORS'
p16785
aS'Thompson JF, Scolyer RA, Kefford RF.'
p16786
aS'TITLE'
p16787
aS'Cutaneous melanoma.'
p16788
aS'JOURNAL'
p16789
aS'Lancet 365:687-701 (2005)'
p16790
aS'PMID:14695152'
p16791
ag16791
aS'AUTHORS'
p16792
aS'Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.'
p16793
aS'TITLE'
p16794
aS'NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.'
p16795
aS'JOURNAL'
p16796
aS'Clin Cancer Res 9:6483-8 (2003)'
p16797
aS'PMID:15557758'
p16798
ag16798
aS'AUTHORS'
p16799
aS'Hussein MR.'
p16800
aS'TITLE'
p16801
aS'The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?'
p16802
aS'JOURNAL'
p16803
aS'Tumour Biol 25:200-7 (2004)'
p16804
aS'PMID:10843728'
p16805
ag16805
aS'AUTHORS'
p16806
aS'Lazar-Molnar E, Hegyesi H, Toth S, Falus A.'
p16807
aS'TITLE'
p16808
aS'Autocrine and paracrine regulation by cytokines and growth factors in melanoma.'
p16809
aS'JOURNAL'
p16810
aS'Cytokine 12:547-54 (2000)'
p16811
aS'PMID:16339096'
p16812
ag16812
aS'AUTHORS'
p16813
aS'Cohen HT, McGovern FJ.'
p16814
aS'TITLE'
p16815
aS'Renal-cell carcinoma.'
p16816
aS'JOURNAL'
p16817
aS'N Engl J Med 353:2477-90 (2005)'
p16818
aS'PMID:15122209'
p16819
ag16819
aS'AUTHORS'
p16820
aS'Pavlovich CP, Schmidt LS.'
p16821
aS'TITLE'
p16822
aS'Searching for the hereditary causes of renal-cell carcinoma.'
p16823
aS'JOURNAL'
p16824
aS'Nat Rev Cancer 4:381-93 (2004)'
p16825
aS'PMID:14634372'
p16826
ag16826
aS'AUTHORS'
p16827
aS'Linehan WM, Walther MM, Zbar B.'
p16828
aS'TITLE'
p16829
aS'The genetic basis of cancer of the kidney.'
p16830
aS'JOURNAL'
p16831
aS'J Urol 170:2163-72 (2003)'
p16832
aS'PMID:14685170'
p16833
ag16833
aS'AUTHORS'
p16834
aS'Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.'
p16835
aS'TITLE'
p16836
aS'Met, metastasis, motility and more.'
p16837
aS'JOURNAL'
p16838
aS'Nat Rev Mol Cell Biol 4:915-25 (2003)'
p16839
aS'PMID:15611513'
p16840
ag16840
aS'AUTHORS'
p16841
aS'Kim WY, Kaelin WG.'
p16842
aS'TITLE'
p16843
aS'Role of VHL gene mutation in human cancer.'
p16844
aS'JOURNAL'
p16845
aS'J Clin Oncol 22:4991-5004 (2004)'
p16846
aS'PMID:17211469'
p16847
ag16847
aS'AUTHORS'
p16848
aS'Sudarshan S, Linehan WM, Neckers L.'
p16849
aS'TITLE'
p16850
aS'HIF and fumarate hydratase in renal cancer.'
p16851
aS'JOURNAL'
p16852
aS'Br J Cancer 96:403-7 (2007)'
p16853
aS'PMID:17287871'
p16854
ag16854
aS'AUTHORS'
p16855
aS'Sudarshan S, Pinto PA, Neckers L, Linehan WM.'
p16856
aS'TITLE'
p16857
aS'Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.'
p16858
aS'JOURNAL'
p16859
aS'Nat Clin Pract Urol 4:104-10 (2007)'
p16860
aS'PMID:12351585'
p16861
ag16861
aS'AUTHORS'
p16862
aS'Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.'
p16863
aS'TITLE'
p16864
aS'Understanding familial and non-familial renal cell cancer.'
p16865
aS'JOURNAL'
p16866
aS'Hum Mol Genet 11:2489-98 (2002)'
p16867
aS'PMID:17158541'
p16868
ag16868
aS'AUTHORS'
p16869
aS'Mitra AP, Datar RH, Cote RJ.'
p16870
aS'TITLE'
p16871
aS'Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.'
p16872
aS'JOURNAL'
p16873
aS'J Clin Oncol 24:5552-64 (2006)'
p16874
aS'PMID:16474624'
p16875
ag16875
aS'AUTHORS'
p16876
aS'Wolff EM, Liang G, Jones PA.'
p16877
aS'TITLE'
p16878
aS'Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.'
p16879
aS'JOURNAL'
p16880
aS'Nat Clin Pract Urol 2:502-10 (2005)'
p16881
aS'PMID:16110317'
p16882
ag16882
aS'AUTHORS'
p16883
aS'Wu XR.'
p16884
aS'TITLE'
p16885
aS'Urothelial tumorigenesis: a tale of divergent pathways.'
p16886
aS'JOURNAL'
p16887
aS'Nat Rev Cancer 5:713-25 (2005)'
p16888
aS'PMID:11103787'
p16889
ag16889
aS'AUTHORS'
p16890
aS'Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.'
p16891
aS'TITLE'
p16892
aS'Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.'
p16893
aS'JOURNAL'
p16894
aS'Cancer Res 60:6298-302 (2000)'
p16895
aS'PMID:12850530'
p16896
ag16896
aS'AUTHORS'
p16897
aS'Bellmunt J, Hussain M, Dinney CP.'
p16898
aS'TITLE'
p16899
aS'Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.'
p16900
aS'JOURNAL'
p16901
aS'Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)'
p16902
aS'PMID:17149381'
p16903
ag16903
aS'AUTHORS'
p16904
aS'Sugano K, Kakizoe T.'
p16905
aS'TITLE'
p16906
aS'Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.'
p16907
aS'JOURNAL'
p16908
aS'Nat Clin Pract Urol 3:642-52 (2006)'
p16909
aS'PMID:15746962'
p16910
ag16910
aS'AUTHORS'
p16911
aS'Dunn KL, Espino PS, Drobic B, He S, Davie JR.'
p16912
aS'TITLE'
p16913
aS'The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.'
p16914
aS'JOURNAL'
p16915
aS'Biochem Cell Biol 83:1-14 (2005)'
p16916
aS'PMID:15551095'
p16917
ag16917
aS'AUTHORS'
p16918
aS'Williams SG, Stein JP.'
p16919
aS'TITLE'
p16920
aS'Molecular pathways in bladder cancer.'
p16921
aS'JOURNAL'
p16922
aS'Urol Res 32:373-85 (2004)'
p16923
aS'PMID:12878745'
p16924
ag16924
aS'AUTHORS'
p16925
aS'Nelson WG, De Marzo AM, Isaacs WB.'
p16926
aS'TITLE'
p16927
aS'Prostate cancer.'
p16928
aS'JOURNAL'
p16929
aS'N Engl J Med 349:366-81 (2003)'
p16930
aS'PMID:15724144'
p16931
ag16931
aS'AUTHORS'
p16932
aS'Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.'
p16933
aS'TITLE'
p16934
aS'The emerging role of the PI3-K-Akt pathway in prostate cancer progression.'
p16935
aS'JOURNAL'
p16936
aS'Prostate Cancer Prostatic Dis 8:108-18 (2005)'
p16937
aS'PMID:16551847'
p16938
ag16938
aS'AUTHORS'
p16939
aS'Pienta KJ, Bradley D.'
p16940
aS'TITLE'
p16941
aS'Mechanisms underlying the development of androgen-independent prostate cancer.'
p16942
aS'JOURNAL'
p16943
aS'Clin Cancer Res 12:1665-71 (2006)'
p16944
aS'PMID:11900250'
p16945
ag16945
aS'AUTHORS'
p16946
aS'Feldman BJ, Feldman D.'
p16947
aS'TITLE'
p16948
aS'The development of androgen-independent prostate cancer.'
p16949
aS'JOURNAL'
p16950
aS'Nat Rev Cancer 1:34-45 (2001)'
p16951
aS'PMID:15082523'
p16952
ag16952
aS'AUTHORS'
p16953
aS'Heinlein CA, Chang C.'
p16954
aS'TITLE'
p16955
aS'Androgen receptor in prostate cancer.'
p16956
aS'JOURNAL'
p16957
aS'Endocr Rev 25:276-308 (2004)'
p16958
aS'PMID:9422516'
p16959
ag16959
aS'AUTHORS'
p16960
aS'Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.'
p16961
aS'TITLE'
p16962
aS'Androgen receptor gene and hormonal therapy failure of prostate cancer.'
p16963
aS'JOURNAL'
p16964
aS'Am J Pathol 152:1-9 (1998)'
p16965
aS'PMID:10835690'
p16966
ag16966
aS'AUTHORS'
p16967
aS'Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.'
p16968
aS'TITLE'
p16969
aS'Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.'
p16970
aS'JOURNAL'
p16971
aS'Nat Med 6:703-6 (2000)'
p16972
aS'PMID:10453277'
p16973
ag16973
aS'AUTHORS'
p16974
aS'Macri E, Loda M.'
p16975
aS'TITLE'
p16976
aS'Role of p27 in prostate carcinogenesis.'
p16977
aS'JOURNAL'
p16978
aS'Cancer Metastasis Rev 17:337-44 (1998)'
p16979
aS'PMID:11750244'
p16980
ag16980
aS'AUTHORS'
p16981
aS'Steers WD.'
p16982
aS'TITLE'
p16983
aS'5alpha-reductase activity in the prostate.'
p16984
aS'JOURNAL'
p16985
aS'Urology 58:17-24 discussion 24 (2001)'
p16986
aS'PMID:8069858'
p16987
ag16987
aS'AUTHORS'
p16988
aS'Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.'
p16989
aS'TITLE'
p16990
aS'Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.'
p16991
aS'JOURNAL'
p16992
aS'Cancer Res 54:4920-6 (1994)'
p16993
aS'PMID:11527574'
p16994
ag16994
aS'AUTHORS'
p16995
aS'Grimes CA, Jope RS.'
p16996
aS'TITLE'
p16997
aS'The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.'
p16998
aS'JOURNAL'
p16999
aS'Prog Neurobiol 65:391-426 (2001)'
p17000
aS'PMID:15947972'
p17001
ag17001
aS'AUTHORS'
p17002
aS'Ryan AJ, Susil B, Jobling TW, Oehler MK.'
p17003
aS'TITLE'
p17004
aS'Endometrial cancer.'
p17005
aS'JOURNAL'
p17006
aS'Cell Tissue Res 322:53-61 (2005)'
p17007
aS'PMID:14747944'
p17008
ag17008
aS'AUTHORS'
p17009
aS'Lax SF.'
p17010
aS'TITLE'
p17011
aS'Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.'
p17012
aS'JOURNAL'
p17013
aS'Virchows Arch 444:213-23 (2004)'
p17014
aS'PMID:16508724'
p17015
ag17015
aS'AUTHORS'
p17016
aS'Shiozawa T, Konishi I.'
p17017
aS'TITLE'
p17018
aS'Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.'
p17019
aS'JOURNAL'
p17020
aS'Int J Clin Oncol 11:13-21 (2006)'
p17021
aS'PMID:17028294'
p17022
ag17022
aS'AUTHORS'
p17023
aS'Hecht JL, Mutter GL.'
p17024
aS'TITLE'
p17025
aS'Molecular and pathologic aspects of endometrial carcinogenesis.'
p17026
aS'JOURNAL'
p17027
aS'J Clin Oncol 24:4783-91 (2006)'
p17028
aS'PMID:11431710'
p17029
ag17029
aS'AUTHORS'
p17030
aS'Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.'
p17031
aS'TITLE'
p17032
aS'Molecular pathology of endometrial hyperplasia and carcinoma.'
p17033
aS'JOURNAL'
p17034
aS'Hum Pathol 32:569-77 (2001)'
p17035
aS'PMID:15284264'
p17036
ag17036
aS'AUTHORS'
p17037
aS'Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.'
p17038
aS'TITLE'
p17039
aS'Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.'
p17040
aS'JOURNAL'
p17041
aS'J Clin Oncol 22:3126-32 (2004)'
p17042
aS'PMID:7585656'
p17043
ag17043
aS'AUTHORS'
p17044
aS'Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.'
p17045
aS'TITLE'
p17046
aS'Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.'
p17047
aS'JOURNAL'
p17048
aS'Cancer Res 55:5693-8 (1995)'
p17049
aS'PMID:16248975'
p17050
ag17050
aS'AUTHORS'
p17051
aS'Kim D, Chung J.'
p17052
aS'TITLE'
p17053
aS'Akt: versatile mediator of cell survival and beyond.'
p17054
aS'JOURNAL'
p17055
aS'J Biochem Mol Biol 35:106-15 (2002)'
p17056
aS'PMID:12711111'
p17057
ag17057
aS'AUTHORS'
p17058
aS'Sanchez-Cespedes M.'
p17059
aS'TITLE'
p17060
aS'Dissecting the genetic alterations involved in lung carcinogenesis.'
p17061
aS'JOURNAL'
p17062
aS'Lung Cancer 40:111-21 (2003)'
p17063
aS'PMID:11720739'
p17064
ag17064
aS'AUTHORS'
p17065
aS'Kaye FJ.'
p17066
aS'TITLE'
p17067
aS'Molecular biology of lung cancer.'
p17068
aS'JOURNAL'
p17069
aS'Lung Cancer 34 Suppl 2:S35-41 (2001)'
p17070
aS'PMID:12616528'
p17071
ag17071
aS'AUTHORS'
p17072
aS'Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.'
p17073
aS'TITLE'
p17074
aS'Apoptosis and lung cancer: a review.'
p17075
aS'JOURNAL'
p17076
aS'J Cell Biochem 88:885-98 (2003)'
p17077
aS'PMID:11807782'
p17078
ag17078
aS'AUTHORS'
p17079
aS'Sartorius UA, Krammer PH.'
p17080
aS'TITLE'
p17081
aS'Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.'
p17082
aS'JOURNAL'
p17083
aS'Int J Cancer 97:584-92 (2002)'
p17084
aS'PMID:16064138'
p17085
ag17085
aS'AUTHORS'
p17086
aS'Adhikary S, Eilers M.'
p17087
aS'TITLE'
p17088
aS'Transcriptional regulation and transformation by Myc proteins.'
p17089
aS'JOURNAL'
p17090
aS'Nat Rev Mol Cell Biol 6:635-45 (2005)'
p17091
aS'PMID:11463388'
p17092
ag17092
aS'AUTHORS'
p17093
aS'Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.'
p17094
aS'TITLE'
p17095
aS'A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.'
p17096
aS'JOURNAL'
p17097
aS'Mol Cell 7:639-50 (2001)'
p17098
aS'PMID:15109562'
p17099
ag17099
aS'AUTHORS'
p17100
aS'Buttery RC, Rintoul RC, Sethi T.'
p17101
aS'TITLE'
p17102
aS'Small cell lung cancer: the importance of the extracellular matrix.'
p17103
aS'JOURNAL'
p17104
aS'Int J Biochem Cell Biol 36:1154-60 (2004)'
p17105
aS'PMID:11559746'
p17106
ag17106
aS'AUTHORS'
p17107
aS'Yamada KM, Araki M.'
p17108
aS'TITLE'
p17109
aS'Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.'
p17110
aS'JOURNAL'
p17111
aS'J Cell Sci 114:2375-82 (2001)'
p17112
aS'PMID:11905738'
p17113
ag17113
aS'AUTHORS'
p17114
aS'Rintoul RC, Sethi T.'
p17115
aS'TITLE'
p17116
aS'The role of extracellular matrix in small-cell lung cancer.'
p17117
aS'JOURNAL'
p17118
aS'Lancet Oncol 2:437-42 (2001)'
p17119
aS'PMID:12243753'
p17120
ag17120
aS'AUTHORS'
p17121
aS'Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.'
p17122
aS'TITLE'
p17123
aS'Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.'
p17124
aS'JOURNAL'
p17125
aS'Exp Cell Res 279:277-90 (2002)'
p17126
aS'PMID:12379883'
p17127
ag17127
aS'AUTHORS'
p17128
aS'Osada H, Takahashi T.'
p17129
aS'TITLE'
p17130
aS'Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.'
p17131
aS'JOURNAL'
p17132
aS'Oncogene 21:7421-34 (2002)'
p17133
aS'PMID:12741677'
p17134
ag17134
aS'AUTHORS'
p17135
aS'Yokota J, Nishioka M, Tani M, Kohno T.'
p17136
aS'TITLE'
p17137
aS'Genetic alterations responsible for metastatic phenotypes of lung cancer cells.'
p17138
aS'JOURNAL'
p17139
aS'Clin Exp Metastasis 20:189-93 (2003)'
p17140
aS'PMID:16870043'
p17141
ag17141
aS'AUTHORS'
p17142
aS'Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.'
p17143
aS'TITLE'
p17144
aS'K-ras mutations in non-small-cell lung carcinoma: a review.'
p17145
aS'JOURNAL'
p17146
aS'Clin Lung Cancer 8:30-8 (2006)'
p17147
aS'PMID:15948711'
p17148
ag17148
aS'AUTHORS'
p17149
aS'Pfeifer GP, Dammann R.'
p17150
aS'TITLE'
p17151
aS'Methylation of the tumor suppressor gene RASSF1A in human tumors.'
p17152
aS'JOURNAL'
p17153
aS'Biochemistry (Mosc) 70:576-83 (2005)'
p17154
aS'PMID:11902573'
p17155
ag17155
aS'AUTHORS'
p17156
aS'Altucci L, Gronemeyer H.'
p17157
aS'TITLE'
p17158
aS'The promise of retinoids to fight against cancer.'
p17159
aS'JOURNAL'
p17160
aS'Nat Rev Cancer 1:181-93 (2001)'
p17161
aS'PMID:10944551'
p17162
ag17162
aS'AUTHORS'
p17163
aS'Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.'
p17164
aS'TITLE'
p17165
aS'Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.'
p17166
aS'JOURNAL'
p17167
aS'J Natl Cancer Inst 92:1303-7 (2000)'
p17168
aS'PMID:12867060'
p17169
ag17169
aS'AUTHORS'
p17170
aS'Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.'
p17171
aS'TITLE'
p17172
aS'Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.'
p17173
aS'JOURNAL'
p17174
aS'Lung Cancer 41 Suppl 1:S29-42 (2003)'
p17175
aS'PMID:16112428'
p17176
ag17176
aS'AUTHORS'
p17177
aS'Panani AD, Roussos C.'
p17178
aS'TITLE'
p17179
aS'Cytogenetic and molecular aspects of lung cancer.'
p17180
aS'JOURNAL'
p17181
aS'Cancer Lett 239:1-9 (2006)'
p17182
aS'PMID:12407699'
p17183
ag17183
aS'AUTHORS'
p17184
aS'Mitsuuchi Y, Testa JR.'
p17185
aS'TITLE'
p17186
aS'Cytogenetics and molecular genetics of lung cancer.'
p17187
aS'JOURNAL'
p17188
aS'Am J Med Genet 115:183-8 (2002)'
p17189
aS'PMID:15942304'
p17190
ag17190
aS'AUTHORS'
p17191
aS'Breuer RH, Postmus PE, Smit EF.'
p17192
aS'TITLE'
p17193
aS'Molecular pathology of non-small-cell lung cancer.'
p17194
aS'JOURNAL'
p17195
aS'Respiration 72:313-30 (2005)'
p17196
aS'PMID:11895903'
p17197
ag17197
aS'AUTHORS'
p17198
aS'Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.'
p17199
aS'TITLE'
p17200
aS'Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.'
p17201
aS'JOURNAL'
p17202
aS'Clin Cancer Res 8:734-44 (2002)'
p17203
aS'PMID:16189154'
p17204
ag17204
aS'AUTHORS'
p17205
aS'Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.'
p17206
aS'TITLE'
p17207
aS'Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.'
p17208
aS'JOURNAL'
p17209
aS'J Clin Pathol 58:1076-80 (2005)'
p17210
aS'PMID:21193867'
p17211
ag17211
aS'AUTHORS'
p17212
aS'Lappano R, Maggiolini M'
p17213
aS'TITLE'
p17214
aS'G protein-coupled receptors: novel targets for drug discovery in cancer.'
p17215
aS'JOURNAL'
p17216
aS'Nat Rev Drug Discov 10:47-60 (2011)'
p17217
aS'PMID:24508914'
p17218
ag17218
aS'AUTHORS'
p17219
aS"O'Hayre M, Degese MS, Gutkind JS"
p17220
aS'TITLE'
p17221
aS'Novel insights into G protein and G protein-coupled receptor signaling in cancer.'
p17222
aS'JOURNAL'
p17223
aS'Curr Opin Cell Biol 27:126-35 (2014)'
p17224
aS'PMID:17251915'
p17225
ag17225
aS'AUTHORS'
p17226
aS'Dorsam RT, Gutkind JS'
p17227
aS'TITLE'
p17228
aS'G-protein-coupled receptors and cancer.'
p17229
aS'JOURNAL'
p17230
aS'Nat Rev Cancer 7:79-94 (2007)'
p17231
asS'KO_PATHWAY'
p17232
(lp17233
S'ko05200'
p17234
asS'ENTRY'
p17235
(lp17236
S'map05200'
p17237
aS'Pathway'
p17238
asS'PATHWAY_MAP'
p17239
(lp17240
S'map05200'
p17241
asS'DISEASE'
p17242
(lp17243
S'H00559'
p17244
aS'von Hippel-Lindau syndrome'
p17245
ag17244
ag17245
aS'H00646'
p17246
aS'Odontoonychodermal dysplasia'
p17247
aS'H00857'
p17248
aS'Oligodontia-colorectal cancer syndrome'
p17249
aS'H00881'
p17250
aS'Li-Fraumeni syndrome'
p17251
aS'H00895'
p17252
aS'Basal cell nevus syndrome'
p17253
aS'H00947'
p17254
aS'Pilomatricoma'
p17255
aS'H01007'
p17256
aS'Choroid plexus papilloma'
p17257
aS'H01023'
p17258
aS'Juvenile polyposis syndrome'
p17259
aS'H01025'
p17260
aS'Familial adenomatous polyposis'
p17261
asS'CLASS'
p17262
(lp17263
S'Human Diseases Cancers'
p17264
assS'path:map04330'
p17265
(dp17266
S'NAME'
p17267
(lp17268
S'Notch signaling pathway'
p17269
asS'REFERENCE'
p17270
(lp17271
S'PMID:15288257'
p17272
ag17272
aS'AUTHORS'
p17273
aS'Hansson EM, Lendahl U, Chapman G.'
p17274
aS'TITLE'
p17275
aS'Notch signaling in development and disease.'
p17276
aS'JOURNAL'
p17277
aS'Semin Cancer Biol 14:320-8 (2004)'
p17278
aS'PMID:15300010'
p17279
ag17279
aS'AUTHORS'
p17280
aS'Callahan R, Egan SE.'
p17281
aS'TITLE'
p17282
aS'Notch signaling in mammary development and oncogenesis.'
p17283
aS'JOURNAL'
p17284
aS'J Mammary Gland Biol Neoplasia 9:145-63 (2004)'
p17285
aS'PMID:15288258'
p17286
ag17286
aS'AUTHORS'
p17287
aS'Zweidler-McKay PA, Pear WS.'
p17288
aS'TITLE'
p17289
aS'Notch and T cell malignancy.'
p17290
aS'JOURNAL'
p17291
aS'Semin Cancer Biol 14:329-40 (2004)'
p17292
aS'PMID:15288260'
p17293
ag17293
aS'AUTHORS'
p17294
aS'Wu L, Griffin JD.'
p17295
aS'TITLE'
p17296
aS'Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis.'
p17297
aS'JOURNAL'
p17298
aS'Semin Cancer Biol 14:348-56 (2004)'
p17299
aS'PMID:15585829'
p17300
ag17300
aS'AUTHORS'
p17301
aS'Tsukumo S, Yasutomo K.'
p17302
aS'TITLE'
p17303
aS'Notch governing mature T cell differentiation.'
p17304
aS'JOURNAL'
p17305
aS'J Immunol 173:7109-13 (2004)'
p17306
aS'PMID:12464310'
p17307
ag17307
aS'AUTHORS'
p17308
aS'Haltiwanger RS.'
p17309
aS'TITLE'
p17310
aS'Regulation of signal transduction pathways in development by glycosylation.'
p17311
aS'JOURNAL'
p17312
aS'Curr Opin Struct Biol 12:593-8 (2002)'
p17313
aS'PMID:15272268'
p17314
ag17314
aS'AUTHORS'
p17315
aS'Koo EH, Kopan R.'
p17316
aS'TITLE'
p17317
aS'Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration.'
p17318
aS'JOURNAL'
p17319
aS'Nat Med 10 Suppl:S26-33 (2004)'
p17320
aS'PMID:11896183'
p17321
ag17321
aS'AUTHORS'
p17322
aS'Okano H, Imai T, Okabe M.'
p17323
aS'TITLE'
p17324
aS'Musashi: a translational regulator of cell fate.'
p17325
aS'JOURNAL'
p17326
aS'J Cell Sci 115:1355-9 (2002)'
p17327
aS'PMID:12417415'
p17328
ag17328
aS'AUTHORS'
p17329
aS'Haltiwanger RS, Stanley P.'
p17330
aS'TITLE'
p17331
aS'Modulation of receptor signaling by glycosylation: fringe is an O-fucose-beta1,3-N-acetylglucosaminyltransferase.'
p17332
aS'JOURNAL'
p17333
aS'Biochim Biophys Acta 1573:328-35 (2002)'
p17334
aS'PMID:12015972'
p17335
ag17335
aS'AUTHORS'
p17336
aS'Das G, Reynolds-Kenneally J, Mlodzik M.'
p17337
aS'TITLE'
p17338
aS'The atypical cadherin Flamingo links Frizzled and Notch signaling in planar polarity establishment in the Drosophila eye.'
p17339
aS'JOURNAL'
p17340
aS'Dev Cell 2:655-66 (2002)'
p17341
aS'PMID:10028969'
p17342
ag17342
aS'AUTHORS'
p17343
aS'Cooper MT, Bray SJ.'
p17344
aS'TITLE'
p17345
aS'Frizzled regulation of Notch signalling polarizes cell fate in the Drosophila eye.'
p17346
aS'JOURNAL'
p17347
aS'Nature 397:526-30 (1999)'
p17348
aS'PMID:12681948'
p17349
ag17349
aS'AUTHORS'
p17350
aS'Tanigaki K, Kuroda K, Han H, Honjo T.'
p17351
aS'TITLE'
p17352
aS'Regulation of B cell development by Notch/RBP-J signaling.'
p17353
aS'JOURNAL'
p17354
aS'Semin Immunol 15:113-9 (2003)'
p17355
asS'KO_PATHWAY'
p17356
(lp17357
S'ko04330'
p17358
asS'PATHWAY_MAP'
p17359
(lp17360
S'map04330'
p17361
asS'DISEASE'
p17362
(lp17363
S'H00078'
p17364
aS'Frontotemporal lobar degeneration (FTLD)'
p17365
ag17364
ag17365
aS'H00409'
p17366
aS'Type II diabetes mellitus'
p17367
aS'H00517'
p17368
aS'Spondylocostal dysostosis (SCD)'
p17369
aS'H00536'
p17370
aS'Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL)'
p17371
aS'H00549'
p17372
aS'Tetralogy of Fallot'
p17373
aS'H00551'
p17374
aS'Alagille syndrome'
p17375
aS'H00554'
p17376
aS'Bicuspid aortic valve'
p17377
aS'H00623'
p17378
aS'Hajdu-Cheney syndrome'
p17379
aS'H00681'
p17380
aS'Acne inversa'
p17381
asS'MODULE'
p17382
(lp17383
S'M00682'
p17384
aS'Notch signaling [PATH:map04330]'
p17385
asS'DBLINKS'
p17386
(lp17387
S'GO: 0007219'
p17388
asS'ENTRY'
p17389
(lp17390
S'map04330'
p17391
aS'Pathway'
p17392
asS'CLASS'
p17393
(lp17394
S'Environmental Information Processing Signal transduction'
p17395
asS'DESCRIPTION'
p17396
(lp17397
S'The Notch signaling pathway is an evolutionarily conserved, intercellular signaling mechanism essential for proper embryonic development in all metazoan organisms in the Animal kingdom. The Notch proteins (Notch1-Notch4 in vertebrates) are single-pass receptors that are activated by the Delta (or Delta-like) and Jagged/Serrate families of membrane-bound ligands. They are transported to the plasma membrane as cleaved, but otherwise intact polypeptides. Interaction with ligand leads to two additional proteolytic cleavages that liberate the Notch intracellular domain (NICD) from the plasma membrane. The NICD translocates to the nucleus, where it forms a complex with the DNA binding protein CSL, displacing a histone deacetylase (HDAc)-co-repressor (CoR) complex from CSL. Components of an activation complex, such as MAML1 and histone acetyltransferases (HATs), are recruited to the NICD-CSL complex, leading to the transcriptional activation of Notch target genes.'
p17398
assS'path:map00140'
p17399
(dp17400
S'NAME'
p17401
(lp17402
S'Steroid hormone biosynthesis'
p17403
asS'REFERENCE'
p17404
(lp17405
S'PMID:10998348'
p17406
ag17406
aS'AUTHORS'
p17407
aS'Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K'
p17408
aS'TITLE'
p17409
aS'Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.'
p17410
aS'JOURNAL'
p17411
aS'Biochem J 351:67-77 (2000)'
p17412
aS'PMID:11469811'
p17413
ag17413
aS'AUTHORS'
p17414
aS'Tomlinson JW, Stewart PM'
p17415
aS'TITLE'
p17416
aS'Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.'
p17417
aS'JOURNAL'
p17418
aS'Best Pract Res Clin Endocrinol Metab 15:61-78 (2001)'
p17419
aS'PMID:12604236'
p17420
ag17420
aS'AUTHORS'
p17421
aS'Higaki Y, Usami N, Shintani S, Ishikura S, El-Kabbani O, Hara A'
p17422
aS'TITLE'
p17423
aS'Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone.'
p17424
aS'JOURNAL'
p17425
aS'Chem Biol Interact 143-144:503-13 (2003)'
p17426
aS'PMID:12832414'
p17427
ag17427
aS'AUTHORS'
p17428
aS'Thomas JL, Duax WL, Addlagatta A, Brandt S, Fuller RR, Norris W'
p17429
aS'TITLE'
p17430
aS'Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1 3 beta-hydroxysteroid dehydrogenase/isomerase.'
p17431
aS'JOURNAL'
p17432
aS'J Biol Chem 278:35483-90 (2003)'
p17433
aS'PMID:15642792'
p17434
ag17434
aS'AUTHORS'
p17435
aS'Cavigelli SA, Monfort SL, Whitney TK, Mechref YS, Novotny M, McClintock MK'
p17436
aS'TITLE'
p17437
aS'Frequent serial fecal corticoid measures from rats reflect circadian and ovarian'
p17438
aS'corticosterone rhythms.'
p17439
aS'JOURNAL'
p17440
aS'J Endocrinol 184:153-63 (2005)'
p17441
aS'PMID:16413106'
p17442
ag17442
aS'AUTHORS'
p17443
aS'Holmes MC, Seckl JR'
p17444
aS'TITLE'
p17445
aS'The role of 11beta-hydroxysteroid dehydrogenases in the brain.'
p17446
aS'JOURNAL'
p17447
aS'Mol Cell Endocrinol 248:9-14 (2006)'
p17448
aS'PMID:16547389'
p17449
ag17449
aS'AUTHORS'
p17450
aS'Matsunaga T, Shintani S, Hara A'
p17451
aS'TITLE'
p17452
aS'Multiplicity of mammalian reductases for xenobiotic carbonyl compounds.'
p17453
aS'JOURNAL'
p17454
aS'Drug Metab Pharmacokinet 21:1-18 (2006)'
p17455
aS'PMID:17459698'
p17456
ag17456
aS'AUTHORS'
p17457
aS'Morris DJ, Latif SA, Hardy MP, Brem AS'
p17458
aS'TITLE'
p17459
aS'Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.'
p17460
aS'JOURNAL'
p17461
aS'J Steroid Biochem Mol Biol 104:161-8 (2007)'
p17462
aS'PMID:17475203'
p17463
ag17463
aS'AUTHORS'
p17464
aS'Sanai M, Endo S, Matsunaga T, Ishikura S, Tajima K, El-Kabbani O, Hara A'
p17465
aS'TITLE'
p17466
aS'Rat NAD+-dependent 3alpha-hydroxysteroid dehydrogenase (AKR1C17): a member of the aldo-keto reductase family highly expressed in kidney cytosol.'
p17467
aS'JOURNAL'
p17468
aS'Arch Biochem Biophys 464:122-9 (2007)'
p17469
aS'PMID:17926129'
p17470
ag17470
aS'AUTHORS'
p17471
aS'Ghayee HK, Auchus RJ'
p17472
aS'TITLE'
p17473
aS'Basic concepts and recent developments in human steroid hormone biosynthesis.'
p17474
aS'JOURNAL'
p17475
aS'Rev Endocr Metab Disord 8:289-300 (2007)'
p17476
asS'KO_PATHWAY'
p17477
(lp17478
S'ko00140'
p17479
asS'PATHWAY_MAP'
p17480
(lp17481
S'map00140'
p17482
asS'DISEASE'
p17483
(lp17484
S'H00134'
p17485
aS'X-linked ichthyosis (XLI)'
p17486
ag17485
ag17486
aS'H00216'
p17487
aS'Congenital adrenal hyperplasia (CAH)'
p17488
aS'H00258'
p17489
aS'Aldosterone synthase deficiency'
p17490
aS'H00259'
p17491
aS'Apparent mineralocorticoid excess syndrome'
p17492
aS'H00599'
p17493
aS'46,XX disorders of sex development (Disorders related to androgen excess)'
p17494
aS'H00602'
p17495
aS'Glucocorticoid-remediable aldosteronism (GRA)'
p17496
aS'H00608'
p17497
aS'46,XY disorders of sex development (Disorders in androgen synthesis or action)'
p17498
aS'H00628'
p17499
aS'Congenital bile acid synthesis defect (CBAS)'
p17500
aS'H00794'
p17501
aS'Aromatase excess syndrome'
p17502
aS'H01075'
p17503
aS'Peters anomaly'
p17504
aS'H01111'
p17505
aS'Cortisone reductase deficiency (CRD)'
p17506
aS'H01203'
p17507
aS'Primary congenital glaucoma (PCG)'
p17508
asS'MODULE'
p17509
(lp17510
S'M00107'
p17511
aS'Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone [PATH:map00140]'
p17512
ag17511
ag17512
aS'M00108'
p17513
aS'C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone [PATH:map00140]'
p17514
aS'M00109'
p17515
aS'C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone [PATH:map00140]'
p17516
aS'M00110'
p17517
aS'C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone [PATH:map00140]'
p17518
asS'DBLINKS'
p17519
(lp17520
S'GO: 0034754'
p17521
asS'ENTRY'
p17522
(lp17523
S'map00140'
p17524
aS'Pathway'
p17525
asS'CLASS'
p17526
(lp17527
S'Metabolism Lipid metabolism'
p17528
asS'DESCRIPTION'
p17529
(lp17530
S'Steroid hormones derived from cholesterol are a class of biologically active compounds in vertebrates. The cholesterol side-chain cleavage enzyme CYP11A1 catalyzes conversion of cholesterol, a C27 compound, to the first C21 steroid, pregnenolone, which is converted by a bifunctional enzyme complex to the gestagen hormone, progesterone [MD:M00107]. Pregnenolone and progesterone are the starting materials for the three groups of steroids: C21 steroids of glucocorticoids and mineralocorticoids, C19 steroids of androgens, and C18 steroids of estrogens. (i) Progesterone is converted by hydroxylations at carbons 21 and 11 to corticosterone, which is further modified by hydroxylation and oxydoreduction at carbon 18 to yield aldosterone, a mineralcorticoid [MD:M00108]. Cortisol, the main glucocorticoid, is formed from 17alpha-hydroxyprogesterone with 11-deoxycortisol as an intermediate [MD:M00109]. (ii) Male hormone testosterone is formed from pregnenolone by two pathways, delta5 pathway via dehydroepiandrosterone and delta4 pathway via androstenedione [MD:M00110]. The enzyme CYP17A1 is responsible for the 17,20 lyase and 17alpha-hydroxylase activities in respective pathways. (iii) Female hormones estrone and estradiol are formed from testosterone and 4-androstene-3,17-dione by oxidative removal of the C19 methyl group and subsequent aromatization of ring A [MD:M00111]. In addition to these three groups, recent studies show that there is another group, termed neurosteroids, synthesized in the brain rather than the peripheral endocrine gland.'
p17531
assS'path:map03008'
p17532
(dp17533
S'NAME'
p17534
(lp17535
S'Ribosome biogenesis in eukaryotes'
p17536
asS'REFERENCE'
p17537
(lp17538
S'PMID:20174677'
p17539
ag17539
aS'AUTHORS'
p17540
aS'Freed EF, Bleichert F, Dutca LM, Baserga SJ'
p17541
aS'TITLE'
p17542
aS'When ribosomes go bad: diseases of ribosome biogenesis.'
p17543
aS'JOURNAL'
p17544
aS'Mol Biosyst 6:481-93 (2010)'
p17545
aS'PMID:17515605'
p17546
ag17546
aS'AUTHORS'
p17547
aS'Perez-Fernandez J, Roman A, De Las Rivas J, Bustelo XR, Dosil M'
p17548
aS'TITLE'
p17549
aS'The 90S preribosome is a multimodular structure that is assembled through a hierarchical mechanism.'
p17550
aS'JOURNAL'
p17551
aS'Mol Cell Biol 27:5414-29 (2007)'
p17552
aS'PMID:19850913'
p17553
ag17553
aS'AUTHORS'
p17554
aS'Strunk BS, Karbstein K'
p17555
aS'TITLE'
p17556
aS'Powering through ribosome assembly.'
p17557
aS'JOURNAL'
p17558
aS'RNA 15:2083-104 (2009)'
p17559
aS'PMID:15120992'
p17560
ag17560
aS'AUTHORS'
p17561
aS'Granneman S, Baserga SJ'
p17562
aS'TITLE'
p17563
aS'Ribosome biogenesis: of knobs and RNA processing.'
p17564
aS'JOURNAL'
p17565
aS'Exp Cell Res 296:43-50 (2004)'
p17566
aS'PMID:19879902'
p17567
ag17567
aS'AUTHORS'
p17568
aS'Kressler D, Hurt E, Bassler J'
p17569
aS'TITLE'
p17570
aS'Driving ribosome assembly.'
p17571
aS'JOURNAL'
p17572
aS'Biochim Biophys Acta 1803:673-83 (2010)'
p17573
asS'KO_PATHWAY'
p17574
(lp17575
S'ko03008'
p17576
asS'PATHWAY_MAP'
p17577
(lp17578
S'map03008'
p17579
asS'DISEASE'
p17580
(lp17581
S'H00063'
p17582
aS'Spinocerebellar ataxia (SCA)'
p17583
ag17582
ag17583
aS'H00439'
p17584
aS'Shwachman-Diamond syndrome (SDS)'
p17585
aS'H00507'
p17586
aS'Dyskeratosis congenita (DC)'
p17587
aS'H00518'
p17588
aS'RMRP related disorders'
p17589
aS'H00610'
p17590
aS'Treacher Collins syndrome'
p17591
aS'H00612'
p17592
aS'Primary open angle glaucoma'
p17593
aS'H00616'
p17594
aS'Bowen-Conradi syndrome (BCS)'
p17595
aS'H00621'
p17596
aS'Alopecia neurologic defects and endocrinopathy syndrome (ANE syndrome)'
p17597
aS'H00624'
p17598
aS'Familial cholestasis'
p17599
aS'H00788'
p17600
aS'Hoyeraal-Hreidarsson syndrome'
p17601
asS'MODULE'
p17602
(lp17603
S'M00425'
p17604
aS'H/ACA ribonucleoprotein complex [PATH:map03008]'
p17605
asS'ENTRY'
p17606
(lp17607
S'map03008'
p17608
aS'Pathway'
p17609
asS'CLASS'
p17610
(lp17611
S'Genetic Information Processing Translation'
p17612
asS'DESCRIPTION'
p17613
(lp17614
S'Ribosomes are the cellular factories responsible for making proteins. In eukaryotes, ribosome biogenesis involves the production and correct assembly of four rRNAs and about 80 ribosomal proteins. It requires hundreds of factors not present in the mature particle. In the absence of these proteins, ribosome biogenesis is stalled and cell growth is terminated even under optimal growth conditions. The primary pre-rRNA transcript is'
p17615
assS'path:map00061'
p17616
(dp17617
S'NAME'
p17618
(lp17619
S'Fatty acid biosynthesis'
p17620
asS'REFERENCE'
p17621
(lp17622
S'PMID:12061798'
p17623
ag17623
aS'AUTHORS'
p17624
aS'Salas JJ, Ohlrogge JB.'
p17625
aS'TITLE'
p17626
aS'Characterization of substrate specificity of plant FatA and FatB acyl-ACP thioesterases.'
p17627
aS'JOURNAL'
p17628
aS'Arch Biochem Biophys 403:25-34 (2002)'
p17629
aS'PMID:12518017'
p17630
ag17630
aS'AUTHORS'
p17631
aS'Zhang YM, Marrakchi H, White SW, Rock CO.'
p17632
aS'TITLE'
p17633
aS'The application of computational methods to explore the diversity and structure of bacterial fatty acid synthase.'
p17634
aS'JOURNAL'
p17635
aS'J Lipid Res 44:1-10 (2003)'
p17636
aS'PMID:11337402'
p17637
ag17637
aS'AUTHORS'
p17638
aS'Voelker T, Kinney AJ.'
p17639
aS'TITLE'
p17640
aS'VARIATIONS IN THE BIOSYNTHESIS OF SEED-STORAGE LIPIDS.'
p17641
aS'JOURNAL'
p17642
aS'Annu Rev Plant Physiol Plant Mol Biol 52:335-361 (2001)'
p17643
aS'PMID:17573542'
p17644
ag17644
aS'AUTHORS'
p17645
aS'Barker GC, Larson TR, Graham IA, Lynn JR, King GJ.'
p17646
aS'TITLE'
p17647
aS'Novel insights into seed fatty acid synthesis and modification pathways from genetic diversity and quantitative trait Loci analysis of the Brassica C genome.'
p17648
aS'JOURNAL'
p17649
aS'Plant Physiol 144:1827-42 (2007)'
p17650
asS'KO_PATHWAY'
p17651
(lp17652
S'ko00061'
p17653
asS'ENTRY'
p17654
(lp17655
S'map00061'
p17656
aS'Pathway'
p17657
asS'PATHWAY_MAP'
p17658
(lp17659
S'map00061'
p17660
asS'CLASS'
p17661
(lp17662
S'Metabolism Lipid metabolism'
p17663
asS'MODULE'
p17664
(lp17665
S'M00082'
p17666
aS'Fatty acid biosynthesis, initiation [PATH:map00061]'
p17667
ag17666
ag17667
aS'M00083'
p17668
aS'Fatty acid biosynthesis, elongation [PATH:map00061]'
p17669
assS'path:map00062'
p17670
(dp17671
S'NAME'
p17672
(lp17673
S'Fatty acid elongation'
p17674
asS'REFERENCE'
p17675
(lp17676
S'PMID:4387390'
p17677
ag17677
aS'AUTHORS'
p17678
aS'Seubert W, Lamberts I, Kramer R, Ohly B'
p17679
aS'TITLE'
p17680
aS'On the mechanism of malonyl-CoA-independent fatty acid synthesis. I. The mechanism of elongation of long-chain fatty acids by acetyl-CoA.'
p17681
aS'JOURNAL'
p17682
aS'Biochim Biophys Acta 164:498-517 (1968)'
p17683
aS'PMID:7150615'
p17684
ag17684
aS'AUTHORS'
p17685
aS'El-Fakhri M, Middleton B'
p17686
aS'TITLE'
p17687
aS'The existence of an inner-membrane-bound, long acyl-chain-specific 3-hydroxyacyl-CoA dehydrogenase in mammalian mitochondria.'
p17688
aS'JOURNAL'
p17689
aS'Biochim Biophys Acta 713:270-9 (1982)'
p17690
aS'PMID:8190743'
p17691
ag17691
aS'AUTHORS'
p17692
aS'Cassagne C, Lessire R, Bessoule JJ, Moreau P, Creach A, Schneider F, Sturbois B'
p17693
aS'TITLE'
p17694
aS'Biosynthesis of very long chain fatty acids in higher plants.'
p17695
aS'JOURNAL'
p17696
aS'Prog Lipid Res 33:55-69 (1994)'
p17697
aS'PMID:16564093'
p17698
ag17698
aS'AUTHORS'
p17699
aS'Jakobsson A, Westerberg R, Jacobsson A.'
p17700
aS'TITLE'
p17701
aS'Fatty acid elongases in mammals: their regulation and roles in metabolism.'
p17702
aS'JOURNAL'
p17703
aS'Prog Lipid Res 45:237-49 (2006)'
p17704
aS'PMID:16765910'
p17705
ag17705
aS'AUTHORS'
p17706
aS'Blacklock BJ, Jaworski JG'
p17707
aS'TITLE'
p17708
aS'Substrate specificity of Arabidopsis 3-ketoacyl-CoA synthases.'
p17709
aS'JOURNAL'
p17710
aS'Biochem Biophys Res Commun 346:583-90 (2006)'
p17711
aS'PMID:16866954'
p17712
ag17712
aS'AUTHORS'
p17713
aS'Shepherd T, Wynne Griffiths D'
p17714
aS'TITLE'
p17715
aS'The effects of stress on plant cuticular waxes.'
p17716
aS'JOURNAL'
p17717
aS'New Phytol 171:469-99 (2006)'
p17718
aS'PMID:17719534'
p17719
ag17719
aS'AUTHORS'
p17720
aS'Riezman H'
p17721
aS'TITLE'
p17722
aS'The long and short of fatty acid synthesis.'
p17723
aS'JOURNAL'
p17724
aS'Cell 130:587-8 (2007)'
p17725
aS'PMID:19649180'
p17726
ag17726
aS'AUTHORS'
p17727
aS'Raffaele S, Leger A, Roby D'
p17728
aS'TITLE'
p17729
aS'Very long chain fatty acid and lipid signaling in the response of plants to pathogens.'
p17730
aS'JOURNAL'
p17731
aS'Plant Signal Behav 4:94-9 (2009)'
p17732
asS'KO_PATHWAY'
p17733
(lp17734
S'ko00062'
p17735
asS'PATHWAY_MAP'
p17736
(lp17737
S'map00062'
p17738
asS'DISEASE'
p17739
(lp17740
S'H00149'
p17741
aS'Neuronal ceroid lipofuscinosis'
p17742
ag17741
ag17742
aS'H00186'
p17743
aS'Hyperargininemia'
p17744
aS'H00810'
p17745
aS'Progressive myoclonic epilepsy (PME/ EPM)'
p17746
aS'H00819'
p17747
aS'Stargardt disease (STGD)'
p17748
aS'H01364'
p17749
aS'3-Hydroxyacyl-CoA dehydrogenase deficiency'
p17750
asS'MODULE'
p17751
(lp17752
S'M00085'
p17753
aS'Fatty acid biosynthesis, elongation, mitochondria [PATH:map00062]'
p17754
ag17753
ag17754
aS'M00415'
p17755
aS'Fatty acid biosynthesis, elongation, endoplasmic reticulum [PATH:map00062]'
p17756
asS'ENTRY'
p17757
(lp17758
S'map00062'
p17759
aS'Pathway'
p17760
asS'CLASS'
p17761
(lp17762
S'Metabolism Lipid metabolism'
p17763
assS'path:map00240'
p17764
(dp17765
S'NAME'
p17766
(lp17767
S'Pyrimidine metabolism'
p17768
asS'KO_PATHWAY'
p17769
(lp17770
S'ko00240'
p17771
asS'PATHWAY_MAP'
p17772
(lp17773
S'map00240'
p17774
asS'DISEASE'
p17775
(lp17776
S'H00193'
p17777
aS'Dihydropyrimidine dehydrogenase deficiency'
p17778
ag17777
ag17778
aS'H00198'
p17779
aS'Orotic aciduria'
p17780
aS'H00199'
p17781
aS'Dihydropyrimidinase deficiency'
p17782
aS'H00200'
p17783
aS'Beta-ureidopropionase deficiency'
p17784
aS'H00469'
p17785
aS'Mitochondrial DNA depletion syndrome (MDS)'
p17786
aS'H00494'
p17787
aS'Desbuquois syndrome'
p17788
aS'H00674'
p17789
aS'Anemia due to disorders of nucleotide metabolism'
p17790
aS'H00824'
p17791
aS'Calcification of joints and arteries'
p17792
aS'H01118'
p17793
aS'Progressive external ophthalmoplegia (PEO)'
p17794
aS'H01376'
p17795
aS'Acrofacial dysostosis'
p17796
aS'H01390'
p17797
aS'Mitochondrial neurogastrointestinal encephalomyopathy'
p17798
asS'MODULE'
p17799
(lp17800
S'M00046'
p17801
aS'Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate [PATH:map00240]'
p17802
ag17801
ag17802
aS'M00051'
p17803
aS'Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP [PATH:map00240]'
p17804
aS'M00052'
p17805
aS'Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP [PATH:map00240]'
p17806
aS'M00053'
p17807
aS'Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP [PATH:map00240]'
p17808
asS'DBLINKS'
p17809
(lp17810
S'GO: 0006220'
p17811
asS'ENTRY'
p17812
(lp17813
S'map00240'
p17814
aS'Pathway'
p17815
asS'CLASS'
p17816
(lp17817
S'Metabolism Nucleotide metabolism'
p17818
assS'path:map00710'
p17819
(dp17820
S'NAME'
p17821
(lp17822
S'Carbon fixation in photosynthetic organisms'
p17823
asS'KO_PATHWAY'
p17824
(lp17825
S'ko00710'
p17826
asS'ENTRY'
p17827
(lp17828
S'map00710'
p17829
aS'Pathway'
p17830
asS'PATHWAY_MAP'
p17831
(lp17832
S'map00710'
p17833
asS'CLASS'
p17834
(lp17835
S'Metabolism Energy metabolism'
p17836
asS'MODULE'
p17837
(lp17838
S'M00165'
p17839
aS'Reductive pentose phosphate cycle (Calvin cycle) [PATH:map00710]'
p17840
ag17839
ag17840
aS'M00166'
p17841
aS'Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P [PATH:map00710]'
p17842
aS'M00167'
p17843
aS'Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P [PATH:map00710]'
p17844
aS'M00168'
p17845
aS'CAM (Crassulacean acid metabolism), dark [PATH:map00710]'
p17846
aS'M00169'
p17847
aS'CAM (Crassulacean acid metabolism), light [PATH:map00710]'
p17848
aS'M00170'
p17849
aS'C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type [PATH:map00710]'
p17850
aS'M00171'
p17851
aS'C4-dicarboxylic acid cycle, NAD - malic enzyme type [PATH:map00710]'
p17852
aS'M00172'
p17853
aS'C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map00710]'
p17854
assS'path:map04622'
p17855
(dp17856
S'NAME'
p17857
(lp17858
S'RIG-I-like receptor signaling pathway'
p17859
asS'REFERENCE'
p17860
(lp17861
S'PMID:15208624'
p17862
ag17862
aS'AUTHORS'
p17863
aS'Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T'
p17864
aS'TITLE'
p17865
aS'The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.'
p17866
aS'JOURNAL'
p17867
aS'Nat Immunol 5:730-7 (2004)'
p17868
aS'PMID:18272355'
p17869
ag17869
aS'AUTHORS'
p17870
aS'Takeuchi O, Akira S'
p17871
aS'TITLE'
p17872
aS'MDA5/RIG-I and virus recognition.'
p17873
aS'JOURNAL'
p17874
aS'Curr Opin Immunol 20:17-22 (2008)'
p17875
aS'PMID:19120475'
p17876
ag17876
aS'AUTHORS'
p17877
aS'Yoneyama M, Fujita T'
p17878
aS'TITLE'
p17879
aS'RNA recognition and signal transduction by RIG-I-like receptors.'
p17880
aS'JOURNAL'
p17881
aS'Immunol Rev 227:54-65 (2009)'
p17882
aS'PMID:19539500'
p17883
ag17883
aS'AUTHORS'
p17884
aS'Nakhaei P, Genin P, Civas A, Hiscott J'
p17885
aS'TITLE'
p17886
aS'RIG-I-like receptors: sensing and responding to RNA virus infection.'
p17887
aS'JOURNAL'
p17888
aS'Semin Immunol 21:215-22 (2009)'
p17889
aS'PMID:18549796'
p17890
ag17890
aS'AUTHORS'
p17891
aS'Moore CB, Ting JP'
p17892
aS'TITLE'
p17893
aS'Regulation of mitochondrial antiviral signaling pathways.'
p17894
aS'JOURNAL'
p17895
aS'Immunity 28:735-9 (2008)'
p17896
aS'PMID:19615405'
p17897
ag17897
aS'AUTHORS'
p17898
aS'Barral PM, Sarkar D, Su ZZ, Barber GN, DeSalle R, Racaniello VR, Fisher PB'
p17899
aS'TITLE'
p17900
aS'Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.'
p17901
aS'JOURNAL'
p17902
aS'Pharmacol Ther 124:219-34 (2009)'
p17903
aS'PMID:19120476'
p17904
ag17904
aS'AUTHORS'
p17905
aS'Schlee M, Hartmann E, Coch C, Wimmenauer V, Janke M, Barchet W, Hartmann G'
p17906
aS'TITLE'
p17907
aS'Approaching the RNA ligand for RIG-I?'
p17908
aS'JOURNAL'
p17909
aS'Immunol Rev 227:66-74 (2009)'
p17910
aS'PMID:18591413'
p17911
ag17911
aS'AUTHORS'
p17912
aS'Saito T, Gale M Jr'
p17913
aS'TITLE'
p17914
aS'Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity.'
p17915
aS'JOURNAL'
p17916
aS'J Exp Med 205:1523-7 (2008)'
p17917
aS'PMID:19076341'
p17918
ag17918
aS'AUTHORS'
p17919
aS'Kawai T, Akira S'
p17920
aS'TITLE'
p17921
aS'Toll-like receptor and RIG-I-like receptor signaling.'
p17922
aS'JOURNAL'
p17923
aS'Ann N Y Acad Sci 1143:1-20 (2008)'
p17924
aS'PMID:18439848'
p17925
ag17925
aS'AUTHORS'
p17926
aS'Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J, Poeck H, Bscheider M, Hartmann G, Konig M, Kalinke U, Pasparakis M, Tschopp J'
p17927
aS'TITLE'
p17928
aS'TRADD protein is an essential component of the RIG-like helicase antiviral pathway.'
p17929
aS'JOURNAL'
p17930
aS'Immunity 28:651-61 (2008)'
p17931
aS'PMID:18984593'
p17932
ag17932
aS'AUTHORS'
p17933
aS'Yoshida R, Takaesu G, Yoshida H, Okamoto F, Yoshioka T, Choi Y, Akira S, Kawai T, Yoshimura A, Kobayashi T'
p17934
aS'TITLE'
p17935
aS'TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway.'
p17936
aS'JOURNAL'
p17937
aS'J Biol Chem 283:36211-20 (2008)'
p17938
aS'PMID:19224920'
p17939
ag17939
aS'AUTHORS'
p17940
aS'Mikkelsen SS, Jensen SB, Chiliveru S, Melchjorsen J, Julkunen I, Gaestel M, Arthur JS, Flavell RA, Ghosh S, Paludan SR'
p17941
aS'TITLE'
p17942
aS'RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1.'
p17943
aS'JOURNAL'
p17944
aS'J Biol Chem 284:10774-82 (2009)'
p17945
asS'KO_PATHWAY'
p17946
(lp17947
S'ko04622'
p17948
asS'PATHWAY_MAP'
p17949
(lp17950
S'map04622'
p17951
asS'DISEASE'
p17952
(lp17953
S'H00827'
p17954
aS'Brooke-Spiegler syndrome'
p17955
ag17954
ag17955
aS'H00882'
p17956
aS'Cocoon syndrome'
p17957
asS'ENTRY'
p17958
(lp17959
S'map04622'
p17960
aS'Pathway'
p17961
asS'CLASS'
p17962
(lp17963
S'Organismal Systems Immune system'
p17964
asS'DESCRIPTION'
p17965
(lp17966
S'Specific families of pattern recognition receptors are responsible for detecting viral pathogens and generating innate immune responses. Non-self RNA appearing in a cell as a result of intracellular viral replication is recognized by a family of cytosolic RNA helicases termed RIG-I-like receptors (RLRs). The RLR proteins include RIG-I, MDA5, and LGP2 and are expressed in both immune and nonimmune cells. Upon recognition of viral nucleic acids, RLRs recruit specific intracellular adaptor proteins to initiate signaling pathways that lead to the synthesis of type I interferon and other inflammatory cytokines, which are important for eliminating viruses.'
p17967
assS'path:map04623'
p17968
(dp17969
S'NAME'
p17970
(lp17971
S'Cytosolic DNA-sensing pathway'
p17972
asS'REFERENCE'
p17973
(lp17974
S'PMID:19362700'
p17975
ag17975
aS'AUTHORS'
p17976
aS'Yanai H, Savitsky D, Tamura T, Taniguchi T'
p17977
aS'TITLE'
p17978
aS'Regulation of the cytosolic DNA-sensing system in innate immunity: a current view.'
p17979
aS'JOURNAL'
p17980
aS'Curr Opin Immunol 21:17-22 (2009)'
p17981
aS'PMID:19497760'
p17982
ag17982
aS'AUTHORS'
p17983
aS'Vilaysane A, Muruve DA'
p17984
aS'TITLE'
p17985
aS'The innate immune response to DNA.'
p17986
aS'JOURNAL'
p17987
aS'Semin Immunol 21:208-14 (2009)'
p17988
aS'PMID:18573338'
p17989
ag17989
aS'AUTHORS'
p17990
aS'Takeshita F, Ishii KJ'
p17991
aS'TITLE'
p17992
aS'Intracellular DNA sensors in immunity.'
p17993
aS'JOURNAL'
p17994
aS'Curr Opin Immunol 20:383-8 (2008)'
p17995
aS'PMID:19122387'
p17996
ag17996
aS'AUTHORS'
p17997
aS'Takaoka A, Shinohara S'
p17998
aS'TITLE'
p17999
aS'DNA sensors in innate immune system.'
p18000
aS'JOURNAL'
p18001
aS'Uirusu 58:37-46 (2008)'
p18002
aS'PMID:18280611'
p18003
ag18003
aS'AUTHORS'
p18004
aS'Takaoka A, Taniguchi T'
p18005
aS'TITLE'
p18006
aS'Cytosolic DNA recognition for triggering innate immune responses.'
p18007
aS'JOURNAL'
p18008
aS'Adv Drug Deliv Rev 60:847-57 (2008)'
p18009
aS'PMID:18941233'
p18010
ag18010
aS'AUTHORS'
p18011
aS'Kaiser WJ, Upton JW, Mocarski ES'
p18012
aS'TITLE'
p18013
aS'Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors.'
p18014
aS'JOURNAL'
p18015
aS'J Immunol 181:6427-34 (2008)'
p18016
aS'PMID:19590578'
p18017
ag18017
aS'AUTHORS'
p18018
aS'Rebsamen M, Heinz LX, Meylan E, Michallet MC, Schroder K, Hofmann K, Vazquez J, Benedict CA, Tschopp J'
p18019
aS'TITLE'
p18020
aS'DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB.'
p18021
aS'JOURNAL'
p18022
aS'EMBO Rep 10:916-22 (2009)'
p18023
aS'PMID:18375758'
p18024
ag18024
aS'AUTHORS'
p18025
aS'Wang Z, Choi MK, Ban T, Yanai H, Negishi H, Lu Y, Tamura T, Takaoka A, Nishikura K, Taniguchi T'
p18026
aS'TITLE'
p18027
aS'Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules.'
p18028
aS'JOURNAL'
p18029
aS'Proc Natl Acad Sci U S A 105:5477-82 (2008)'
p18030
aS'PMID:18724932'
p18031
ag18031
aS'AUTHORS'
p18032
aS'Stetson DB, Ko JS, Heidmann T, Medzhitov R'
p18033
aS'TITLE'
p18034
aS'Trex1 prevents cell-intrinsic initiation of autoimmunity.'
p18035
aS'JOURNAL'
p18036
aS'Cell 134:587-98 (2008)'
p18037
aS'PMID:19321146'
p18038
ag18038
aS'AUTHORS'
p18039
aS'Schroder K, Muruve DA, Tschopp J'
p18040
aS'TITLE'
p18041
aS'Innate immunity: cytoplasmic DNA sensing by the AIM2 inflammasome.'
p18042
aS'JOURNAL'
p18043
aS'Curr Biol 19:R262-5 (2009)'
p18044
aS'PMID:19567913'
p18045
ag18045
aS'AUTHORS'
p18046
aS'Krieg AM'
p18047
aS'TITLE'
p18048
aS'AIMing 2 detect foreign DNA.'
p18049
aS'JOURNAL'
p18050
aS'Sci Signal 2:pe39 (2009)'
p18051
aS'PMID:19665965'
p18052
ag18052
aS'AUTHORS'
p18053
aS"O'Neill LA"
p18054
aS'TITLE'
p18055
aS'DNA makes RNA makes innate immunity.'
p18056
aS'JOURNAL'
p18057
aS'Cell 138:428-30 (2009)'
p18058
aS'PMID:16286919'
p18059
ag18059
aS'AUTHORS'
p18060
aS'Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, Sato S, Yamamoto M, Uematsu S, Kawai T, Takeuchi O, Akira S'
p18061
aS'TITLE'
p18062
aS'A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.'
p18063
aS'JOURNAL'
p18064
aS'Nat Immunol 7:40-8 (2006)'
p18065
aS'PMID:19767723'
p18066
ag18066
aS'AUTHORS'
p18067
aS'Cao X'
p18068
aS'TITLE'
p18069
aS'New DNA-sensing pathway feeds RIG-I with RNA.'
p18070
aS'JOURNAL'
p18071
aS'Nat Immunol 10:1049-51 (2009)'
p18072
aS'PMID:23258413'
p18073
ag18073
aS'AUTHORS'
p18074
aS'Sun L, Wu J, Du F, Chen X, Chen ZJ'
p18075
aS'TITLE'
p18076
aS'Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.'
p18077
aS'JOURNAL'
p18078
aS'Science 339:786-91 (2013)'
p18079
asS'KO_PATHWAY'
p18080
(lp18081
S'ko04623'
p18082
asS'PATHWAY_MAP'
p18083
(lp18084
S'map04623'
p18085
asS'DISEASE'
p18086
(lp18087
S'H00290'
p18088
aS'Aicardi-Goutieres Syndrome (AGS)'
p18089
ag18088
ag18089
aS'H00291'
p18090
aS'Familial chilblain lupus (FCL)'
p18091
aS'H00880'
p18092
aS'Dyschromatosis symmetrica hereditaria'
p18093
aS'H00882'
p18094
aS'Cocoon syndrome'
p18095
aS'H01000'
p18096
aS'Retinal vasculopathy with cerebral leukodystrophy (RVCL)'
p18097
asS'MODULE'
p18098
(lp18099
S'M00181'
p18100
aS'RNA polymerase III, eukaryotes [PATH:map04623]'
p18101
asS'ENTRY'
p18102
(lp18103
S'map04623'
p18104
aS'Pathway'
p18105
asS'CLASS'
p18106
(lp18107
S'Organismal Systems Immune system'
p18108
asS'DESCRIPTION'
p18109
(lp18110
S'Specific families of pattern recognition receptors are responsible for detecting foreign DNA from invading microbes or host cells and generating innate immune responses. DAI is the first identified sensor of cytosolic DNA which activates the IRF and NF-{kappa}B transcription factors, leading to production of type I interferon and other cytokines. The second type of cytoplasmic DNA sensor is AIM2. Upon sensing DNA, AIM2 triggers the assembly of the inflammasome, culminating in interleukin maturation. In addition to these receptors, there is a mechanism to sense foreign DNA, with the host RNA polymerase III converting the DNA into RNA for recognition by the RNA sensor RIG-I. These pathways provide various means to alert the cell.'
p18111
assS'path:map04620'
p18112
(dp18113
S'NAME'
p18114
(lp18115
S'Toll-like receptor signaling pathway'
p18116
asS'REFERENCE'
p18117
(lp18118
S'PMID:17275323'
p18119
ag18119
aS'AUTHORS'
p18120
aS'Kawai T, Akira S.'
p18121
aS'TITLE'
p18122
aS'TLR signaling.'
p18123
aS'JOURNAL'
p18124
aS'Semin Immunol 19:24-32 (2007)'
p18125
aS'PMID:17457343'
p18126
ag18126
aS'AUTHORS'
p18127
aS"O'Neill LA, Bowie AG."
p18128
aS'TITLE'
p18129
aS'The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.'
p18130
aS'JOURNAL'
p18131
aS'Nat Rev Immunol 7:353-64 (2007)'
p18132
aS'PMID:16932750'
p18133
ag18133
aS'AUTHORS'
p18134
aS'Honda K, Taniguchi T.'
p18135
aS'TITLE'
p18136
aS'IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.'
p18137
aS'JOURNAL'
p18138
aS'Nat Rev Immunol 6:644-58 (2006)'
p18139
aS'PMID:17395581'
p18140
ag18140
aS'AUTHORS'
p18141
aS'Uematsu S, Akira S.'
p18142
aS'TITLE'
p18143
aS'Toll-like receptors and Type I interferons.'
p18144
aS'JOURNAL'
p18145
aS'J Biol Chem 282:15319-23 (2007)'
p18146
aS'PMID:16497588'
p18147
ag18147
aS'AUTHORS'
p18148
aS'Akira S, Uematsu S, Takeuchi O.'
p18149
aS'TITLE'
p18150
aS'Pathogen recognition and innate immunity.'
p18151
aS'JOURNAL'
p18152
aS'Cell 124:783-801 (2006)'
p18153
aS'PMID:14698224'
p18154
ag18154
aS'AUTHORS'
p18155
aS'Yamamoto M, Takeda K, Akira S.'
p18156
aS'TITLE'
p18157
aS'TIR domain-containing adaptors define the specificity of TLR signaling.'
p18158
aS'JOURNAL'
p18159
aS'Mol Immunol 40:861-8 (2004)'
p18160
ag22
ag22
aS'AUTHORS'
p18161
aS'Matsumoto M, Oshiumi H, Seya T.'
p18162
aS'TITLE'
p18163
aS'[TICAM-1, an adaptor molecule that participates in Toll-like receptor-mediated type1 interferon production.] (In Japanese)'
p18164
aS'JOURNAL'
p18165
aS'Molecular Medicine 40:194-200 (2003)'
p18166
aS'PMID:12734364'
p18167
ag18167
aS'AUTHORS'
p18168
aS'Means TK, Hayashi F, Smith KD, Aderem A, Luster AD.'
p18169
aS'TITLE'
p18170
aS'The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.'
p18171
aS'JOURNAL'
p18172
aS'J Immunol 170:5165-75 (2003)'
p18173
aS'PMID:14751764'
p18174
ag18174
aS'AUTHORS'
p18175
aS'Aderem A, Smith KD.'
p18176
aS'TITLE'
p18177
aS'A systems approach to dissecting immunity and inflammation.'
p18178
aS'JOURNAL'
p18179
aS'Semin Immunol 16:55-67 (2004)'
p18180
aS'PMID:17637696'
p18181
ag18181
aS'AUTHORS'
p18182
aS'Banerjee A, Gerondakis S.'
p18183
aS'TITLE'
p18184
aS'Coordinating TLR-activated signaling pathways in cells of the immune system.'
p18185
aS'JOURNAL'
p18186
aS'Immunol Cell Biol : (2007)'
p18187
aS'PMID:17507094'
p18188
ag18188
aS'AUTHORS'
p18189
aS'Loniewski KJ, Patial S, Parameswaran N.'
p18190
aS'TITLE'
p18191
aS'Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.'
p18192
aS'JOURNAL'
p18193
aS'Mol Immunol 44:3715-23 (2007)'
p18194
aS'PMID:11101877'
p18195
ag18195
aS'AUTHORS'
p18196
aS'Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG.'
p18197
aS'TITLE'
p18198
aS'Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway.'
p18199
aS'JOURNAL'
p18200
aS'Nat Immunol 1:533-40 (2000)'
p18201
aS'PMID:16924467'
p18202
ag18202
aS'AUTHORS'
p18203
aS'Uematsu S, Akira S.'
p18204
aS'TITLE'
p18205
aS'Toll-like receptors and innate immunity.'
p18206
aS'JOURNAL'
p18207
aS'J Mol Med 84:712-25 (2006)'
p18208
asS'KO_PATHWAY'
p18209
(lp18210
S'ko04620'
p18211
asS'PATHWAY_MAP'
p18212
(lp18213
S'map04620'
p18214
asS'DISEASE'
p18215
(lp18216
S'H00096'
p18217
aS'Defects of toll-like receptor signaling'
p18218
ag18217
ag18218
aS'H00273'
p18219
aS'Pycnodysostosis'
p18220
aS'H00344'
p18221
aS'Leprosy'
p18222
aS'H00425'
p18223
aS'Lysosomal cysteine protease deficiencies'
p18224
aS'H00721'
p18225
aS'Pyogenic bacterial infections, recurrent, due to MYD88 deficiency'
p18226
aS'H00821'
p18227
aS'Macular degeneration'
p18228
aS'H00882'
p18229
aS'Cocoon syndrome'
p18230
aS'H01109'
p18231
aS'Chronic mucocutaneous candidiasis (CMC)'
p18232
asS'MODULE'
p18233
(lp18234
S'M00686'
p18235
aS'Toll-like receptor signaling [PATH:map04620]'
p18236
asS'ENTRY'
p18237
(lp18238
S'map04620'
p18239
aS'Pathway'
p18240
asS'CLASS'
p18241
(lp18242
S'Organismal Systems Immune system'
p18243
asS'DESCRIPTION'
p18244
(lp18245
S'Specific families of pattern recognition receptors are responsible for detecting microbial pathogens and generating innate immune responses. Toll-like receptors (TLRs) are membrane-bound receptors identified as homologs of Toll in Drosophila. Mammalian TLRs are expressed on innate immune cells, such as macrophages and dendritic cells, and respond to the membrane components of Gram-positive or Gram-negative bacteria. Pathogen recognition by TLRs provokes rapid activation of innate immunity by inducing production of proinflammatory cytokines and upregulation of costimulatory molecules. TLR signaling pathways are separated into two groups: a MyD88-dependent pathway that leads to the production of proinflammatory cytokines with quick activation of NF-{kappa}B and MAPK, and a MyD88-independent pathway associated with the induction of IFN-beta and IFN-inducible genes, and maturation of dendritic cells with slow activation of NF-{kappa}B and MAPK.'
p18246
assS'path:map04621'
p18247
(dp18248
S'NAME'
p18249
(lp18250
S'NOD-like receptor signaling pathway'
p18251
asS'REFERENCE'
p18252
(lp18253
S'PMID:18585455'
p18254
ag18254
aS'AUTHORS'
p18255
aS'Shaw MH, Reimer T, Kim YG, Nunez G'
p18256
aS'TITLE'
p18257
aS'NOD-like receptors (NLRs): bona fide intracellular microbial sensors.'
p18258
aS'JOURNAL'
p18259
aS'Curr Opin Immunol 20:377-82 (2008)'
p18260
aS'PMID:17967410'
p18261
ag18261
aS'AUTHORS'
p18262
aS'Kanneganti TD, Lamkanfi M, Nunez G'
p18263
aS'TITLE'
p18264
aS'Intracellular NOD-like receptors in host defense and disease.'
p18265
aS'JOURNAL'
p18266
aS'Immunity 27:549-59 (2007)'
p18267
aS'PMID:19120480'
p18268
ag18268
aS'AUTHORS'
p18269
aS'Franchi L, Warner N, Viani K, Nunez G'
p18270
aS'TITLE'
p18271
aS'Function of Nod-like receptors in microbial recognition and host defense.'
p18272
aS'JOURNAL'
p18273
aS'Immunol Rev 227:106-28 (2009)'
p18274
aS'PMID:17690884'
p18275
ag18275
aS'AUTHORS'
p18276
aS'Tattoli I, Travassos LH, Carneiro LA, Magalhaes JG, Girardin SE'
p18277
aS'TITLE'
p18278
aS'The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.'
p18279
aS'JOURNAL'
p18280
aS'Semin Immunopathol 29:289-301 (2007)'
p18281
aS'PMID:17186025'
p18282
ag18282
aS'AUTHORS'
p18283
aS'da Silva Correia J, Miranda Y, Leonard N, Hsu J, Ulevitch RJ'
p18284
aS'TITLE'
p18285
aS'Regulation of Nod1-mediated signaling pathways.'
p18286
aS'JOURNAL'
p18287
aS'Cell Death Differ 14:830-9 (2007)'
p18288
aS'PMID:19538923'
p18289
ag18289
aS'AUTHORS'
p18290
aS'Reardon C, Mak TW'
p18291
aS'TITLE'
p18292
aS'cIAP proteins: keystones in NOD receptor signal transduction.'
p18293
aS'JOURNAL'
p18294
aS'Immunity 30:755-6 (2009)'
p18295
aS'PMID:17110941'
p18296
ag18296
aS'AUTHORS'
p18297
aS'Fritz JH, Ferrero RL, Philpott DJ, Girardin SE'
p18298
aS'TITLE'
p18299
aS'Nod-like proteins in immunity, inflammation and disease.'
p18300
aS'JOURNAL'
p18301
aS'Nat Immunol 7:1250-7 (2006)'
p18302
aS'PMID:18487086'
p18303
ag18303
aS'AUTHORS'
p18304
aS'Rietdijk ST, Burwell T, Bertin J, Coyle AJ'
p18305
aS'TITLE'
p18306
aS'Sensing intracellular pathogens-NOD-like receptors.'
p18307
aS'JOURNAL'
p18308
aS'Curr Opin Pharmacol 8:261-6 (2008)'
p18309
aS'PMID:17187069'
p18310
ag18310
aS'AUTHORS'
p18311
aS'Hsu YM, Zhang Y, You Y, Wang D, Li H, Duramad O, Qin XF, Dong C, Lin X'
p18312
aS'TITLE'
p18313
aS'The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens.'
p18314
aS'JOURNAL'
p18315
aS'Nat Immunol 8:198-205 (2007)'
p18316
aS'PMID:16714539'
p18317
ag18317
aS'AUTHORS'
p18318
aS'Kufer TA, Kremmer E, Banks DJ, Philpott DJ'
p18319
aS'TITLE'
p18320
aS'Role for erbin in bacterial activation of Nod2.'
p18321
aS'JOURNAL'
p18322
aS'Infect Immun 74:3115-24 (2006)'
p18323
aS'PMID:19221555'
p18324
ag18324
aS'AUTHORS'
p18325
aS'Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G'
p18326
aS'TITLE'
p18327
aS'The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis.'
p18328
aS'JOURNAL'
p18329
aS'Nat Immunol 10:241-7 (2009)'
p18330
aS'PMID:17703304'
p18331
ag18331
aS'AUTHORS'
p18332
aS'Martinon F, Gaide O, Petrilli V, Mayor A, Tschopp J'
p18333
aS'TITLE'
p18334
aS'NALP inflammasomes: a central role in innate immunity.'
p18335
aS'JOURNAL'
p18336
aS'Semin Immunopathol 29:213-29 (2007)'
p18337
aS'PMID:15163405'
p18338
ag18338
aS'AUTHORS'
p18339
aS'Martinon F, Tschopp J'
p18340
aS'TITLE'
p18341
aS'Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases.'
p18342
aS'JOURNAL'
p18343
aS'Cell 117:561-74 (2004)'
p18344
aS'PMID:19302040'
p18345
ag18345
aS'AUTHORS'
p18346
aS'Martinon F, Mayor A, Tschopp J'
p18347
aS'TITLE'
p18348
aS'The inflammasomes: guardians of the body.'
p18349
aS'JOURNAL'
p18350
aS'Annu Rev Immunol 27:229-65 (2009)'
p18351
aS'PMID:19120479'
p18352
ag18352
aS'AUTHORS'
p18353
aS'Lamkanfi M, Dixit VM'
p18354
aS'TITLE'
p18355
aS'Inflammasomes: guardians of cytosolic sanctity.'
p18356
aS'JOURNAL'
p18357
aS'Immunol Rev 227:95-105 (2009)'
p18358
aS'PMID:18715799'
p18359
ag18359
aS'AUTHORS'
p18360
aS'Benko S, Philpott DJ, Girardin SE'
p18361
aS'TITLE'
p18362
aS'The microbial and danger signals that activate Nod-like receptors.'
p18363
aS'JOURNAL'
p18364
aS'Cytokine 43:368-73 (2008)'
p18365
asS'KO_PATHWAY'
p18366
(lp18367
S'ko04621'
p18368
asS'PATHWAY_MAP'
p18369
(lp18370
S'map04621'
p18371
asS'DISEASE'
p18372
(lp18373
S'H00282'
p18374
aS'Cryopyrin associated periodic syndrome (CAPS)'
p18375
ag18374
ag18375
aS'H00285'
p18376
aS'Blau syndrome'
p18377
aS'H00286'
p18378
aS"Crohn's disease"
p18379
aS'H00287'
p18380
aS'Pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome'
p18381
aS'H00288'
p18382
aS'Familial Mediterranean fever (FMF)'
p18383
aS'H00882'
p18384
aS'Cocoon syndrome'
p18385
aS'H01109'
p18386
aS'Chronic mucocutaneous candidiasis (CMC)'
p18387
aS'H01309'
p18388
aS'Sarcoidosis, early-onset'
p18389
aS'H01372'
p18390
aS'Vitiligo'
p18391
asS'ENTRY'
p18392
(lp18393
S'map04621'
p18394
aS'Pathway'
p18395
asS'CLASS'
p18396
(lp18397
S'Organismal Systems Immune system'
p18398
asS'DESCRIPTION'
p18399
(lp18400
S'Specific families of pattern recognition receptors are responsible for detecting various pathogens and generating innate immune responses. The intracellular NOD-like receptor (NLR) family contains more than 20 members in mammals and plays a pivotal role in the recognition of intracellular ligands. NOD1 and NOD2, two prototypic NLRs, sense the cytosolic presence of the bacterial peptidoglycan fragments that escaped from endosomal compartments, driving the activation of NF-{kappa}B and MAPK, cytokine production and apoptosis. On the other hand, a different set of NLRs induces caspase-1 activation through the assembly of multiprotein complexes called inflammasomes. These NLRs include NALP1, NALP3 and Ipaf. The inflammasomes are critical for generating mature proinflammatory cytokines in concert with Toll-like receptor signaling pathway.'
p18401
assS'path:map04626'
p18402
(dp18403
S'NAME'
p18404
(lp18405
S'Plant-pathogen interaction'
p18406
asS'REFERENCE'
p18407
(lp18408
S'PMID:18206360'
p18409
ag18409
aS'AUTHORS'
p18410
aS'Zipfel C'
p18411
aS'TITLE'
p18412
aS'Pattern-recognition receptors in plant innate immunity.'
p18413
aS'JOURNAL'
p18414
aS'Curr Opin Immunol 20:10-6 (2008)'
p18415
aS'PMID:19748302'
p18416
ag18416
aS'AUTHORS'
p18417
aS'Chinchilla D, Shan L, He P, de Vries S, Kemmerling B'
p18418
aS'TITLE'
p18419
aS'One for all: the receptor-associated kinase BAK1.'
p18420
aS'JOURNAL'
p18421
aS'Trends Plant Sci 14:535-41 (2009)'
p18422
aS'PMID:19423812'
p18423
ag18423
aS'AUTHORS'
p18424
aS'Boller T, He SY'
p18425
aS'TITLE'
p18426
aS'Innate immunity in plants: an arms race between pattern recognition receptors in'
p18427
aS'plants and effectors in microbial pathogens.'
p18428
aS'JOURNAL'
p18429
aS'Science 324:742-4 (2009)'
p18430
aS'PMID:19794842'
p18431
ag18431
aS'AUTHORS'
p18432
aS'Ma W, Smigel A, Verma R, Berkowitz GA'
p18433
aS'TITLE'
p18434
aS'Cyclic nucleotide gated channels and related signaling components in plant innate immunity.'
p18435
aS'JOURNAL'
p18436
aS'Plant Signal Behav 4:277-82 (2009)'
p18437
aS'PMID:11875555'
p18438
ag18438
aS'AUTHORS'
p18439
aS'Asai T, Tena G, Plotnikova J, Willmann MR, Chiu WL, Gomez-Gomez L, Boller T, Ausubel FM, Sheen J'
p18440
aS'TITLE'
p18441
aS'MAP kinase signalling cascade in Arabidopsis innate immunity.'
p18442
aS'JOURNAL'
p18443
aS'Nature 415:977-83 (2002)'
p18444
aS'PMID:15922649'
p18445
ag18445
aS'AUTHORS'
p18446
aS'Zipfel C, Felix G'
p18447
aS'TITLE'
p18448
aS'Plants and animals: a different taste for microbes?'
p18449
aS'JOURNAL'
p18450
aS'Curr Opin Plant Biol 8:353-60 (2005)'
p18451
aS'PMID:17451411'
p18452
ag18452
aS'AUTHORS'
p18453
aS'He P, Shan L, Sheen J'
p18454
aS'TITLE'
p18455
aS'Elicitation and suppression of microbe-associated molecular pattern-triggered immunity in plant-microbe interactions.'
p18456
aS'JOURNAL'
p18457
aS'Cell Microbiol 9:1385-96 (2007)'
p18458
aS'PMID:17876517'
p18459
ag18459
aS'AUTHORS'
p18460
aS'de Wit PJ'
p18461
aS'TITLE'
p18462
aS'How plants recognize pathogens and defend themselves.'
p18463
aS'JOURNAL'
p18464
aS'Cell Mol Life Sci 64:2726-32 (2007)'
p18465
aS'PMID:16497589'
p18466
ag18466
aS'AUTHORS'
p18467
aS'Chisholm ST, Coaker G, Day B, Staskawicz BJ'
p18468
aS'TITLE'
p18469
aS'Host-microbe interactions: shaping the evolution of the plant immune response.'
p18470
aS'JOURNAL'
p18471
aS'Cell 124:803-14 (2006)'
p18472
aS'PMID:16677430'
p18473
ag18473
aS'AUTHORS'
p18474
aS'McHale L, Tan X, Koehl P, Michelmore RW'
p18475
aS'TITLE'
p18476
aS'Plant NBS-LRR proteins: adaptable guards.'
p18477
aS'JOURNAL'
p18478
aS'Genome Biol 7:212 (2006)'
p18479
aS'PMID:11459065'
p18480
ag18480
aS'AUTHORS'
p18481
aS'Dangl JL, Jones JD'
p18482
aS'TITLE'
p18483
aS'Plant pathogens and integrated defence responses to infection.'
p18484
aS'JOURNAL'
p18485
aS'Nature 411:826-33 (2001)'
p18486
aS'PMID:17108957'
p18487
ag18487
aS'AUTHORS'
p18488
aS'Jones JD, Dangl JL'
p18489
aS'TITLE'
p18490
aS'The plant immune system.'
p18491
aS'JOURNAL'
p18492
aS'Nature 444:323-9 (2006)'
p18493
aS'PMID:16697674'
p18494
ag18494
aS'AUTHORS'
p18495
aS'da Cunha L, McFall AJ, Mackey D'
p18496
aS'TITLE'
p18497
aS'Innate immunity in plants: a continuum of layered defenses.'
p18498
aS'JOURNAL'
p18499
aS'Microbes Infect 8:1372-81 (2006)'
p18500
aS'PMID:15862106'
p18501
ag18501
aS'AUTHORS'
p18502
aS'Mudgett MB'
p18503
aS'TITLE'
p18504
aS'New insights to the function of phytopathogenic bacterial type III effectors in plants.'
p18505
aS'JOURNAL'
p18506
aS'Annu Rev Plant Biol 56:509-31 (2005)'
p18507
aS'PMID:17714518'
p18508
ag18508
aS'AUTHORS'
p18509
aS'Ma W, Berkowitz GA'
p18510
aS'TITLE'
p18511
aS'The grateful dead: calcium and cell death in plant innate immunity.'
p18512
aS'JOURNAL'
p18513
aS'Cell Microbiol 9:2571-85 (2007)'
p18514
aS'PMID:14711430'
p18515
ag18515
aS'AUTHORS'
p18516
aS'Schulze-Lefert P'
p18517
aS'TITLE'
p18518
aS'Plant immunity: the origami of receptor activation.'
p18519
aS'JOURNAL'
p18520
aS'Curr Biol 14:R22-4 (2004)'
p18521
aS'PMID:9868361'
p18522
ag18522
aS'AUTHORS'
p18523
aS'Van der Biezen EA, Jones JD'
p18524
aS'TITLE'
p18525
aS'Plant disease-resistance proteins and the gene-for-gene concept.'
p18526
aS'JOURNAL'
p18527
aS'Trends Biochem Sci 23:454-6 (1998)'
p18528
aS'PMID:16936700'
p18529
ag18529
aS'AUTHORS'
p18530
aS'Abramovitch RB, Anderson JC, Martin GB'
p18531
aS'TITLE'
p18532
aS'Bacterial elicitation and evasion of plant innate immunity.'
p18533
aS'JOURNAL'
p18534
aS'Nat Rev Mol Cell Biol 7:601-11 (2006)'
p18535
asS'KO_PATHWAY'
p18536
(lp18537
S'ko04626'
p18538
asS'PATHWAY_MAP'
p18539
(lp18540
S'map04626'
p18541
asS'MODULE'
p18542
(lp18543
S'M00339'
p18544
aS'RaxAB-RaxC type I secretion system [PATH:map04626]'
p18545
asS'ENTRY'
p18546
(lp18547
S'map04626'
p18548
aS'Pathway'
p18549
asS'CLASS'
p18550
(lp18551
S'Organismal Systems Environmental adaptation'
p18552
asS'DESCRIPTION'
p18553
(lp18554
S'Plants lack animal-like adaptive immunity mechanisms, and therefore have evolved a specific system with multiple layers against invading pathogens. The primary response includes the perception of pathogens by cell-surface pattern-recognition receptors (PRRs) and is referred to as PAMP-triggered immunity (PTI). Activation of FLS2 and EFR triggers MAPK signaling pathway that activates defense genes for antimictobial compounds. The increase in the cytosolic Ca2+ concentration is also a regulator for production of reactive oxygen species and localized programmed cell death/hypersensitive response. The secondary response is called effector-triggered immunity (ETI). Pathogens can acquire the ability to suppress PTI by directly injecting effector proteins into the plant cell through secretion systems. In addition, pathogens can manipulate plant hormone signaling pathways to evade host immune responses using coronatine toxin. Some plants possess specific intracellular surveillance proteins (R proteins) to monitor the presence of pathogen virulence proteins. This ETI occurs with localized programmed cell death to arrest pathogen growth, resulting in cultivar-specific disease resistance.'
p18555
assS'path:map05111'
p18556
(dp18557
S'NAME'
p18558
(lp18559
S'Vibrio cholerae pathogenic cycle'
p18560
asS'DESCRIPTION The dual life style of Vibrio cholerae, in the aquatic environment or in the human host, is supported by appropriate gene expression of various factors. During exponential phase, quorum sensing systems mediate degradation of the virulence repressor HapR, which, together with the control of ToxR regulon, in turn leads to induction of virulence factors such as toxin coregulated pilus (TCP) and cholera toxin (CTX), essential for colonization of the host and enterotoxicity, respectively. Contrastively, during conditions of stationary phase, HapR is upregulated and induces hemagglutinin/protease (HapA) production, which will be involved in detachment of V. cholerae from epithelial cells of the host intestine.'
p18561
(lp18562
S'On the other hand, flagellar and chemotaxis gene transcription is organized into a hierarchy of four classes of genes controlled by some sigma factors.'
p18563
asS'KO_PATHWAY'
p18564
(lp18565
S'ko05111'
p18566
asS'PATHWAY_MAP'
p18567
(lp18568
S'map05111'
p18569
asS'MODULE'
p18570
(lp18571
S'M00513'
p18572
aS'LuxQN/CqsS-LuxU-LuxO (quorum sensing) two-component regulatory system [PATH:map05111]'
p18573
ag18572
ag18573
aS'M00515'
p18574
aS'FlrB-FlrC (polar flagellar synthesis) two-component regulatory system [PATH:map05111]'
p18575
asS'REFERENCE'
p18576
(lp18577
S'PMID:9224875'
p18578
ag18578
aS'AUTHORS'
p18579
aS'Manning PA.'
p18580
aS'TITLE'
p18581
aS'The tcp gene cluster of Vibrio cholerae.'
p18582
aS'JOURNAL'
p18583
aS'Gene 192:63-70 (1997)'
p18584
aS'PMID:9632254'
p18585
ag18585
aS'AUTHORS'
p18586
aS'Klose KE, Mekalanos JJ.'
p18587
aS'TITLE'
p18588
aS'Distinct roles of an alternative sigma factor during both free-swimming and colonizing phases of the Vibrio cholerae pathogenic cycle.'
p18589
aS'JOURNAL'
p18590
aS'Mol Microbiol 28:501-20 (1998)'
p18591
aS'PMID:9721317'
p18592
ag18592
aS'AUTHORS'
p18593
aS'Pfau JD, Taylor RK.'
p18594
aS'TITLE'
p18595
aS'Mutations in toxR and toxS that separate transcriptional activation from DNA binding at the cholera toxin gene promoter.'
p18596
aS'JOURNAL'
p18597
aS'J Bacteriol 180:4724-33 (1998)'
p18598
aS'PMID:11528005'
p18599
ag18599
aS'AUTHORS'
p18600
aS'McCarter LL.'
p18601
aS'TITLE'
p18602
aS'Polar flagellar motility of the Vibrionaceae.'
p18603
aS'JOURNAL'
p18604
aS'Microbiol Mol Biol Rev 65:445-62, table of contents (2001)'
p18605
aS'PMID:12117994'
p18606
ag18606
aS'AUTHORS'
p18607
aS'Sarkar A, Nandy RK, Nair GB, Ghose AC.'
p18608
aS'TITLE'
p18609
aS'Vibrio pathogenicity island and cholera toxin genetic element-associated virulence genes and their expression in non-O1 non-O139 strains of Vibrio cholerae.'
p18610
aS'JOURNAL'
p18611
aS'Infect Immun 70:4735-42 (2002)'
p18612
aS'PMID:11260476'
p18613
ag18613
aS'AUTHORS'
p18614
aS'Prouty MG, Correa NE, Klose KE.'
p18615
aS'TITLE'
p18616
aS'The novel sigma54- and sigma28-dependent flagellar gene transcription hierarchy of Vibrio cholerae.'
p18617
aS'JOURNAL'
p18618
aS'Mol Microbiol 39:1595-609 (2001)'
p18619
aS'PMID:17661707'
p18620
ag18620
aS'AUTHORS'
p18621
aS'Childers BM, Klose KE.'
p18622
aS'TITLE'
p18623
aS'Regulation of virulence in Vibrio cholerae: the ToxR regulon.'
p18624
aS'JOURNAL'
p18625
aS'Future Microbiol 2:335-44 (2007)'
p18626
aS'PMID:17768239'
p18627
ag18627
aS'AUTHORS'
p18628
aS'Liang W, Pascual-Montano A, Silva AJ, Benitez JA.'
p18629
aS'TITLE'
p18630
aS'The cyclic AMP receptor protein modulates quorum sensing, motility and multiple genes that affect intestinal colonization in Vibrio cholerae.'
p18631
aS'JOURNAL'
p18632
aS'Microbiology 153:2964-75 (2007)'
p18633
aS'PMID:15375117'
p18634
ag18634
aS'AUTHORS'
p18635
aS'Silva AJ, Benitez JA.'
p18636
aS'TITLE'
p18637
aS'Transcriptional regulation of Vibrio cholerae hemagglutinin/protease by the cyclic AMP receptor protein and RpoS.'
p18638
aS'JOURNAL'
p18639
aS'J Bacteriol 186:6374-82 (2004)'
p18640
aS'PMID:11952906'
p18641
ag18641
aS'AUTHORS'
p18642
aS'Li CC, Merrell DS, Camilli A, Kaper JB.'
p18643
aS'TITLE'
p18644
aS'ToxR interferes with CRP-dependent transcriptional activation of ompT in Vibrio cholerae.'
p18645
aS'JOURNAL'
p18646
aS'Mol Microbiol 43:1577-89 (2002)'
p18647
aS'PMID:17054394'
p18648
ag18648
aS'AUTHORS'
p18649
aS'Nielsen AT, Dolganov NA, Otto G, Miller MC, Wu CY, Schoolnik GK.'
p18650
aS'TITLE'
p18651
aS'RpoS controls the Vibrio cholerae mucosal escape response.'
p18652
aS'JOURNAL'
p18653
aS'PLoS Pathog 2:e109 (2006)'
p18654
aS'PMID:16983078'
p18655
ag18655
aS'AUTHORS'
p18656
aS'Hsiao A, Liu Z, Joelsson A, Zhu J.'
p18657
aS'TITLE'
p18658
aS'Vibrio cholerae virulence regulator-coordinated evasion of host immunity.'
p18659
aS'JOURNAL'
p18660
aS'Proc Natl Acad Sci U S A 103:14542-7 (2006)'
p18661
aS'PMID:18179420'
p18662
ag18662
aS'AUTHORS'
p18663
aS'Hsiao A, Toscano K, Zhu J.'
p18664
aS'TITLE'
p18665
aS'Post-transcriptional cross-talk between pro- and anti-colonization pili biosynthesis systems in Vibrio cholerae.'
p18666
aS'JOURNAL'
p18667
aS'Mol Microbiol 67:849-60 (2008)'
p18668
asS'ENTRY'
p18669
(lp18670
S'map05111'
p18671
aS'Pathway'
p18672
asS'CLASS'
p18673
(lp18674
S'Human Diseases Infectious diseases'
p18675
asS'DESCRIPTION'
p18676
(lp18677
S'The dual life style of Vibrio cholerae, in the aquatic environment or in the human host, is supported by appropriate gene expression of various factors. During exponential phase, quorum sensing systems mediate degradation of the virulence repressor HapR, which, together with the control of ToxR regulon, in turn leads to induction of virulence factors such as toxin coregulated pilus (TCP) and cholera toxin (CTX), essential for colonization of the host and enterotoxicity, respectively. Contrastively, during conditions of stationary phase, HapR is upregulated and induces hemagglutinin/protease (HapA) production, which will be involved in detachment of V. cholerae from epithelial cells of the host intestine.'
p18678
assS'path:map05110'
p18679
(dp18680
S'NAME'
p18681
(lp18682
S'Vibrio cholerae infection'
p18683
asS'REFERENCE'
p18684
(lp18685
S'PMID:10942706'
p18686
ag18686
aS'AUTHORS'
p18687
aS'Trucksis M, Conn TL, Wasserman SS, Sears CL.'
p18688
aS'TITLE'
p18689
aS'Vibrio cholerae ACE stimulates Ca(2+)-dependent Cl(-)/HCO(3)(-) secretion in T84 cells in vitro.'
p18690
aS'JOURNAL'
p18691
aS'Am J Physiol Cell Physiol 279:C567-77 (2000)'
p18692
aS'PMID:11032799'
p18693
ag18693
aS'AUTHORS'
p18694
aS'Fullner KJ, Mekalanos JJ.'
p18695
aS'TITLE'
p18696
aS'In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin.'
p18697
aS'JOURNAL'
p18698
aS'EMBO J 19:5315-23 (2000)'
p18699
aS'PMID:11292584'
p18700
ag18700
aS'AUTHORS'
p18701
aS'Lencer WI.'
p18702
aS'TITLE'
p18703
aS'Microbes and microbial Toxins: paradigms for microbial-mucosal toxins. V. Cholera: invasion of the intestinal epithelial barrier by a stably folded protein toxin.'
p18704
aS'JOURNAL'
p18705
aS'Am J Physiol Gastrointest Liver Physiol 280:G781-6 (2001)'
p18706
aS'PMID:12102686'
p18707
ag18707
aS'AUTHORS'
p18708
aS'Moschioni M, Tombola F, de Bernard M, Coelho A, Zitzer A, Zoratti M, Montecucco C.'
p18709
aS'TITLE'
p18710
aS'The Vibrio cholerae haemolysin anion channel is required for cell vacuolation and death.'
p18711
aS'JOURNAL'
p18712
aS'Cell Microbiol 4:397-409 (2002)'
p18713
aS'PMID:12403808'
p18714
ag18714
aS'AUTHORS'
p18715
aS'Tsai B, Rapoport TA.'
p18716
aS'TITLE'
p18717
aS'Unfolded cholera toxin is transferred to the ER membrane and released from protein disulfide isomerase upon oxidation by Ero1.'
p18718
aS'JOURNAL'
p18719
aS'J Cell Biol 159:207-16 (2002)'
p18720
aS'PMID:13679513'
p18721
ag18721
aS'AUTHORS'
p18722
aS'Fujinaga Y, Wolf AA, Rodighiero C, Wheeler H, Tsai B, Allen L, Jobling MG, Rapoport T, Holmes RK, Lencer WI.'
p18723
aS'TITLE'
p18724
aS'Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulm.'
p18725
aS'JOURNAL'
p18726
aS'Mol Biol Cell 14:4783-93 (2003)'
p18727
aS'PMID:11953326'
p18728
ag18728
aS'AUTHORS'
p18729
aS'Fasano A.'
p18730
aS'TITLE'
p18731
aS'Toxins and the gut: role in human disease.'
p18732
aS'JOURNAL'
p18733
aS'Gut 50 Suppl 3:III9-14 (2002)'
p18734
aS'PMID:11207565'
p18735
ag18735
aS'AUTHORS'
p18736
aS'Uzzau S, Fasano A.'
p18737
aS'TITLE'
p18738
aS'Cross-talk between enteric pathogens and the intestine.'
p18739
aS'JOURNAL'
p18740
aS'Cell Microbiol 2:83-9 (2000)'
p18741
aS'PMID:11349009'
p18742
ag18742
aS'AUTHORS'
p18743
aS'Sandkvist M.'
p18744
aS'TITLE'
p18745
aS'Type II secretion and pathogenesis.'
p18746
aS'JOURNAL'
p18747
aS'Infect Immun 69:3523-35 (2001)'
p18748
aS'PMID:12671039'
p18749
ag18749
aS'AUTHORS'
p18750
aS'Field M.'
p18751
aS'TITLE'
p18752
aS'Intestinal ion transport and the pathophysiology of diarrhea.'
p18753
aS'JOURNAL'
p18754
aS'J Clin Invest 111:931-43 (2003)'
p18755
aS'PMID:14659695'
p18756
ag18756
aS'AUTHORS'
p18757
aS'Lencer WI, Tsai B.'
p18758
aS'TITLE'
p18759
aS'The intracellular voyage of cholera toxin: going retro.'
p18760
aS'JOURNAL'
p18761
aS'Trends Biochem Sci 28:639-45 (2003)'
p18762
aS'PMID:15204437'
p18763
ag18763
aS'AUTHORS'
p18764
aS'De Haan L, Hirst TR.'
p18765
aS'TITLE'
p18766
aS'Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review).'
p18767
aS'JOURNAL'
p18768
aS'Mol Membr Biol 21:77-92 (2004)'
p18769
aS'PMID:17156122'
p18770
ag18770
aS'AUTHORS'
p18771
aS'Chinnapen DJ, Chinnapen H, Saslowsky D, Lencer WI.'
p18772
aS'TITLE'
p18773
aS'Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER.'
p18774
aS'JOURNAL'
p18775
aS'FEMS Microbiol Lett 266:129-37 (2007)'
p18776
aS'PMID:17464284'
p18777
ag18777
aS'AUTHORS'
p18778
aS'Sheahan KL, Cordero CL, Satchell KJ.'
p18779
aS'TITLE'
p18780
aS'Autoprocessing of the Vibrio cholerae RTX toxin by the cysteine protease domain.'
p18781
aS'JOURNAL'
p18782
aS'EMBO J 26:2552-61 (2007)'
p18783
aS'PMID:11454785'
p18784
ag18784
aS'AUTHORS'
p18785
aS'Fasano A.'
p18786
aS'TITLE'
p18787
aS'Intestinal zonulin: open sesame!'
p18788
aS'JOURNAL'
p18789
aS'Gut 49:159-62 (2001)'
p18790
asS'KO_PATHWAY'
p18791
(lp18792
S'ko05110'
p18793
asS"DESCRIPTION Cholera toxin (CTX) is one of the main virulence factors of Vibrio cholerae. Once secreted, CTX B-chain (CTXB) binds to ganglioside GM1 on the surface of the host's cells. After binding takes place, the entire CTX complex is carried from plasma membrane (PM) to endoplasmic reticulum (ER). In the ER, the A-chain (CTXA) is recognized by protein disulfide isomerase (PDI), unfolded, and delivered to the membrane where the membrane-associated ER-oxidase, Ero1, oxidizes PDI to release the CTXA into the protein-conducting channel, Sec61. CTXA is then retro-translocated to the cytosol and induces water and electrolyte secretion by increasing cAMP levels via adenylate cyclase (AC) to exert toxicity."
p18794
(lp18795
S'Other than CTX, Vibrio cholerae generates several toxins that are perilous to eukaryotic cells. Zonula occludens toxin (ZOT) causes tight junction disruption through protein kinase C-dependent actin polymerization. RTX toxin (RtxA) causes actin depolymerization by covalently cross-linking actin monomers into dimers, trimers, and higher multimers. Vibrio cholerae cytolysin (VCC) is an important pore-forming toxin. The assembly of VCC anion channels in cells cause vacuolization and lysis.'
p18796
asS'PATHWAY_MAP'
p18797
(lp18798
S'map05110'
p18799
asS'DISEASE'
p18800
(lp18801
S'H00110'
p18802
aS'Cholera'
p18803
asS'MODULE'
p18804
(lp18805
S'M00401'
p18806
aS'Sec61 complex [PATH:map05110]'
p18807
asS'ENTRY'
p18808
(lp18809
S'map05110'
p18810
aS'Pathway'
p18811
asS'CLASS'
p18812
(lp18813
S'Human Diseases Infectious diseases'
p18814
asS'DESCRIPTION'
p18815
(lp18816
S"Cholera toxin (CTX) is one of the main virulence factors of Vibrio cholerae. Once secreted, CTX B-chain (CTXB) binds to ganglioside GM1 on the surface of the host's cells. After binding takes place, the entire CTX complex is carried from plasma membrane (PM) to endoplasmic reticulum (ER). In the ER, the A-chain (CTXA) is recognized by protein disulfide isomerase (PDI), unfolded, and delivered to the membrane where the membrane-associated ER-oxidase, Ero1, oxidizes PDI to release the CTXA into the protein-conducting channel, Sec61. CTXA is then retro-translocated to the cytosol and induces water and electrolyte secretion by increasing cAMP levels via adenylate cyclase (AC) to exert toxicity."
p18817
assS'path:map00660'
p18818
(dp18819
S'ENTRY'
p18820
(lp18821
S'map00660'
p18822
aS'Pathway'
p18823
asS'PATHWAY_MAP'
p18824
(lp18825
S'map00660'
p18826
asS'CLASS'
p18827
(lp18828
S'Metabolism Carbohydrate metabolism'
p18829
asS'NAME'
p18830
(lp18831
S'C5-Branched dibasic acid metabolism'
p18832
asS'KO_PATHWAY'
p18833
(lp18834
S'ko00660'
p18835
assS'path:map07047'
p18836
(dp18837
S'ENTRY'
p18838
(lp18839
S'map07047'
p18840
aS'Drug'
p18841
aS'Pathway'
p18842
asS'PATHWAY_MAP'
p18843
(lp18844
S'map07047'
p18845
asS'NAME'
p18846
(lp18847
S'Osteoporosis drugs'
p18848
asS'COMPOUND'
p18849
(lp18850
S'D00100'
p18851
aS'Menatetrenone (JP16/INN)'
p18852
ag18851
ag18852
aS'D00105'
p18853
aS'Estradiol (JAN/USP/INN)'
p18854
aS'D00129'
p18855
aS'Calcitriol (JAN/USP/INN)'
p18856
aS'D00185'
p18857
aS'Estriol (JP16/USP)'
p18858
aS'D00249'
p18859
aS'Calcitonin salmon (JP16/USAN/INN)'
p18860
aS'D00314'
p18861
aS'Etidronate disodium (JP16/USP)'
p18862
aS'D00937'
p18863
aS'Dibasic calcium phosphate hydrate (JP16)'
p18864
aS'D00939'
p18865
aS'Alendronate sodium hydrate (JP16)'
p18866
aS'D00941'
p18867
aS'Pamidronate disodium hydrate (JAN)'
p18868
aS'D00942'
p18869
aS'Risedronate sodium (USP)'
p18870
aS'D00955'
p18871
aS'Nandrolone decanoate (JAN/USP)'
p18872
aS'D00956'
p18873
aS'Nandrolone phenylpropionate (JAN)'
p18874
aS'D01301'
p18875
aS'Metenolone enanthate (JP16)'
p18876
aS'D01338'
p18877
aS'Ipriflavone (JP16/INN)'
p18878
aS'D01375'
p18879
aS'Metenolone acetate (JP16)'
p18880
aS'D01518'
p18881
aS'Alfacalcidol (JAN/INN)'
p18882
aS'D01533'
p18883
aS'Mestanolone (JAN/INN)'
p18884
aS'D01598'
p18885
aS'Calcium L-aspartate hydrate (JAN)'
p18886
aS'D01968'
p18887
aS'Zoledronic acid hydrate (JAN)'
p18888
aS'D02217'
p18889
aS'Raloxifene hydrochloride (JAN/USP)'
p18890
aS'D02285'
p18891
aS'Tiludronate disodium (USAN)'
p18892
aS'D02373'
p18893
aS'Etidronic acid (USAN/INN)'
p18894
aS'D03062'
p18895
aS'Bazedoxifene acetate (JAN/USAN)'
p18896
aS'D03234'
p18897
aS'Sodium risedronate hydrate (JP16)'
p18898
aS'D03287'
p18899
aS'Elcatonin (JP16/INN)'
p18900
aS'D03302'
p18901
aS'Dibasic calcium phosphate, anhydrous (JAN)'
p18902
aS'D03358'
p18903
aS'Teriparatide acetate (JAN)'
p18904
aS'D03544'
p18905
aS'Sodium clodronate hydrate (JAN)'
p18906
aS'D03545'
p18907
aS'Clodronic acid (USAN/INN)'
p18908
aS'D04486'
p18909
aS'Ibandronate sodium hydrate (JAN)'
p18910
aS'D04672'
p18911
aS'Lasofoxifene tartrate (JAN/USAN)'
p18912
aS'D06078'
p18913
aS'Teriparatide (genetical recombination) (JAN)'
p18914
aS'D06378'
p18915
aS'Zoledronate disodium (USAN)'
p18916
aS'D06379'
p18917
aS'Zoledronate trisodium (USAN)'
p18918
aS'D06437'
p18919
aS'Anhydrous dibasic calcium phosphate (JP16)'
p18920
aS'D07119'
p18921
aS'Alendronic acid (INN)'
p18922
aS'D07281'
p18923
aS'Pamidronic acid (INN)'
p18924
aS'D07578'
p18925
aS'Eldecalcitol (JAN/INN)'
p18926
aS'D07720'
p18927
aS'Clodronic acid disodium salt'
p18928
aS'D08056'
p18929
aS'Ibandronic acid (INN)'
p18930
aS'D08193'
p18931
aS'Metenolone (INN)'
p18932
aS'D08465'
p18933
aS'Raloxifene (INN)'
p18934
aS'D08467'
p18935
aS'Ranelic acid (INN)'
p18936
aS'D08468'
p18937
aS'Strontium ranelate'
p18938
aS'D08484'
p18939
aS'Risedronic acid (INN)'
p18940
aS'D08599'
p18941
aS'Tiludronic acid (INN)'
p18942
aS'D08689'
p18943
aS'Zoledronic acid (INN)'
p18944
aS'D09198'
p18945
aS'Minodronic acid hydrate (JAN)'
p18946
assS'path:map01120'
p18947
(dp18948
S'ENTRY'
p18949
(lp18950
S'map01120'
p18951
aS'Global'
p18952
aS'Pathway'
p18953
asS'PATHWAY_MAP'
p18954
(lp18955
S'map01120'
p18956
asS'NAME'
p18957
(lp18958
S'Microbial metabolism in diverse environments'
p18959
asS'KO_PATHWAY'
p18960
(lp18961
S'ko01120'
p18962
assS'path:map00300'
p18963
(dp18964
S'NAME'
p18965
(lp18966
S'Lysine biosynthesis'
p18967
asS'REFERENCE'
p18968
(lp18969
S'PMID:10074354'
p18970
ag18970
aS'AUTHORS'
p18971
aS'Ledwidge R, Blanchard JS.'
p18972
aS'TITLE'
p18973
aS'The dual biosynthetic capability of N-acetylornithine aminotransferase in arginine and lysine biosynthesis.'
p18974
aS'JOURNAL'
p18975
aS'Biochemistry 38:3019-3024 (1999)'
p18976
aS'PMID:10850974'
p18977
ag18977
aS'AUTHORS'
p18978
aS'Fuchs TM, Schneider B, Krumbach K, Eggeling L, Gross R.'
p18979
aS'TITLE'
p18980
aS'Characterization of a bordetella pertussis diaminopimelate (DAP) biosynthesis locus identifies dapC, a novel gene coding for an N-succinyl-L,L-DAP aminotransferase.'
p18981
aS'JOURNAL'
p18982
aS'J Bacteriol 182:3626-3631 (2000)'
p18983
aS'PMID:10714900'
p18984
ag18984
aS'AUTHORS'
p18985
aS'Zabriskie TM, Jackson MD.'
p18986
aS'TITLE'
p18987
aS'Lysine biosynthesis and metabolism in fungi.'
p18988
aS'JOURNAL'
p18989
aS'Nat Prod Rep 17:85-97 (2000)'
p18990
aS'PMID:14627808'
p18991
ag18991
aS'AUTHORS'
p18992
aS'Rodionov DA, Vitreschak AG, Mironov AA, Gelfand MS.'
p18993
aS'TITLE'
p18994
aS'Regulation of lysine biosynthesis and transport genes in bacteria: yet another RNA riboswitch?'
p18995
aS'JOURNAL'
p18996
aS'Nucleic Acids Res 31:6748-57 (2003)'
p18997
aS'PMID:12355264'
p18998
ag18998
aS'AUTHORS'
p18999
aS'Velasco AM, Leguina JI, Lazcano A.'
p19000
aS'TITLE'
p19001
aS'Molecular evolution of the lysine biosynthetic pathways.'
p19002
aS'JOURNAL'
p19003
aS'J Mol Evol 55:445-59 (2002)'
p19004
aS'PMID:15256574'
p19005
ag19005
aS'AUTHORS'
p19006
aS'Miyazaki T, Miyazaki J, Yamane H, Nishiyama M.'
p19007
aS'TITLE'
p19008
aS'alpha-Aminoadipate aminotransferase from an extremely thermophilic bacterium, Thermus thermophilus.'
p19009
aS'JOURNAL'
p19010
aS'Microbiology 150:2327-34 (2004)'
p19011
aS'PMID:12126930'
p19012
ag19012
aS'AUTHORS'
p19013
aS'Goh DL, Patel A, Thomas GH, Salomons GS, Schor DS, Jakobs C, Geraghty MT.'
p19014
aS'TITLE'
p19015
aS'Characterization of the human gene encoding alpha-aminoadipate aminotransferase (AADAT).'
p19016
aS'JOURNAL'
p19017
aS'Mol Genet Metab 76:172-80 (2002)'
p19018
aS'PMID:15160885'
p19019
ag19019
aS'AUTHORS'
p19020
aS'Nishiyama M.'
p19021
aS'TITLE'
p19022
aS'[Novel lysine biosynthesis: a key to elucidate evolution of metabolic and biosynthetic pathways]'
p19023
aS'JOURNAL'
p19024
aS'Tanpakushitsu Kakusan Koso 49:758-63 (2004)'
p19025
aS'PMID:10613839'
p19026
ag19026
aS'AUTHORS'
p19027
aS'Nishida H, Nishiyama M, Kobashi N, Kosuge T, Hoshino T, Yamane H.'
p19028
aS'TITLE'
p19029
aS'A prokaryotic gene cluster involved in synthesis of lysine through the amino adipate pathway: a key to the evolution of amino acid biosynthesis.'
p19030
aS'JOURNAL'
p19031
aS'Genome Res 9:1175-83 (1999)'
p19032
aS'PMID:12963379'
p19033
ag19033
aS'AUTHORS'
p19034
aS'Sakai H, Vassylyeva MN, Matsuura T, Sekine S, Gotoh K, Nishiyama M, Terada T, Shirouzu M, Kuramitsu S, Vassylyev DG, Yokoyama S.'
p19035
aS'TITLE'
p19036
aS'Crystal structure of a lysine biosynthesis enzyme, LysX, from Thermus thermophilus HB8.'
p19037
aS'JOURNAL'
p19038
aS'J Mol Biol 332:729-40 (2003)'
p19039
aS'PMID:16361515'
p19040
ag19040
aS'AUTHORS'
p19041
aS'Hudson AO, Singh BK, Leustek T, Gilvarg C.'
p19042
aS'TITLE'
p19043
aS'An LL-diaminopimelate aminotransferase defines a novel variant of the lysine biosynthesis pathway in plants.'
p19044
aS'JOURNAL'
p19045
aS'Plant Physiol 140:292-301 (2006)'
p19046
aS'PMID:19620981'
p19047
ag19047
aS'AUTHORS'
p19048
aS'Horie A, Tomita T, Saiki A, Kono H, Taka H, Mineki R, Fujimura T, Nishiyama C, Kuzuyama T, Nishiyama M'
p19049
aS'TITLE'
p19050
aS'Discovery of proteinaceous N-modification in lysine biosynthesis of Thermus thermophilus.'
p19051
aS'JOURNAL'
p19052
aS'Nat Chem Biol 5:673-9 (2009)'
p19053
aS'PMID:21547300'
p19054
ag19054
aS'AUTHORS'
p19055
aS'Dairi T, Kuzuyama T, Nishiyama M, Fujii I'
p19056
aS'TITLE'
p19057
aS'Convergent strategies in biosynthesis.'
p19058
aS'JOURNAL'
p19059
aS'Nat Prod Rep 28:1054-86 (2011)'
p19060
aS'PMID:21550296'
p19061
ag19061
aS'AUTHORS'
p19062
aS'Gaston MA, Jiang R, Krzycki JA'
p19063
aS'TITLE'
p19064
aS'Functional context, biosynthesis, and genetic encoding of pyrrolysine.'
p19065
aS'JOURNAL'
p19066
aS'Curr Opin Microbiol 14:342-9 (2011)'
p19067
asS'KO_PATHWAY'
p19068
(lp19069
S'ko00300'
p19070
asS'PATHWAY_MAP'
p19071
(lp19072
S'map00300'
p19073
asS'DISEASE'
p19074
(lp19075
S'H00188'
p19076
aS'Hyperlysinemia'
p19077
asS'MODULE'
p19078
(lp19079
S'M00016'
p19080
aS'Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine [PATH:map00300]'
p19081
ag19080
ag19081
aS'M00030'
p19082
aS'Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine [PATH:map00300]'
p19083
aS'M00031'
p19084
aS'Lysine biosynthesis, 2-aminoadipate => lysine [PATH:map00300]'
p19085
aS'M00433'
p19086
aS'Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate [PATH:map00300]'
p19087
aS'M00525'
p19088
aS'Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine [PATH:map00300]'
p19089
aS'M00526'
p19090
aS'Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine [PATH:map00300]'
p19091
aS'M00527'
p19092
aS'Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine [PATH:map00300]'
p19093
asS'DBLINKS'
p19094
(lp19095
S'GO: 0009085'
p19096
asS'ENTRY'
p19097
(lp19098
S'map00300'
p19099
aS'Pathway'
p19100
asS'CLASS'
p19101
(lp19102
S'Metabolism Amino acid metabolism'
p19103
assS'path:map00430'
p19104
(dp19105
S'NAME'
p19106
(lp19107
S'Taurine and hypotaurine metabolism'
p19108
asS'REFERENCE'
p19109
(lp19110
S'PMID:12471498'
p19111
ag19111
aS'AUTHORS'
p19112
aS'Cook AM, Denger K.'
p19113
aS'TITLE'
p19114
aS'Dissimilation of the C2 sulfonates.'
p19115
aS'JOURNAL'
p19116
aS'Arch Microbiol 179:1-6 (2002)'
p19117
aS'PMID:11082195'
p19118
ag19118
aS'AUTHORS'
p19119
aS'Laue H, Cook AM.'
p19120
aS'TITLE'
p19121
aS'Biochemical and molecular characterization of taurine:pyruvate aminotransferase from the anaerobe Bilophila wadsworthia.'
p19122
aS'JOURNAL'
p19123
aS'Eur J Biochem 267:6841-8 (2000)'
p19124
aS'PMID:12358600'
p19125
ag19125
aS'AUTHORS'
p19126
aS'Ruff J, Denger K, Cook AM.'
p19127
aS'TITLE'
p19128
aS'Sulphoacetaldehyde acetyltransferase yields acetyl phosphate: purification from Alcaligenes defragrans and gene clusters in taurine degradation.'
p19129
aS'JOURNAL'
p19130
aS'Biochem J 369:275-85 (2003)'
p19131
aS'PMID:15073291'
p19132
ag19132
aS'AUTHORS'
p19133
aS'Bruggemann C, Denger K, Cook AM, Ruff J.'
p19134
aS'TITLE'
p19135
aS'Enzymes and genes of taurine and isethionate dissimilation in Paracoccus denitrificans.'
p19136
aS'JOURNAL'
p19137
aS'Microbiology 150:805-16 (2004)'
p19138
aS'PMID:15340795'
p19139
ag19139
aS'AUTHORS'
p19140
aS'Denger K, Weinitschke S, Hollemeyer K, Cook AM.'
p19141
aS'TITLE'
p19142
aS'Sulfoacetate generated by Rhodopseudomonas palustris from taurine.'
p19143
aS'JOURNAL'
p19144
aS'Arch Microbiol 182:254-8 (2004)'
p19145
aS'PMID:15184572'
p19146
ag19146
aS'AUTHORS'
p19147
aS'Denger K, Ruff J, Schleheck D, Cook AM.'
p19148
aS'TITLE'
p19149
aS'Rhodococcus opacus expresses the xsc gene to utilize taurine as a carbon source or as a nitrogen source but not as a sulfur source.'
p19150
aS'JOURNAL'
p19151
aS'Microbiology 150:1859-67 (2004)'
p19152
aS'PMID:15883781'
p19153
ag19153
aS'AUTHORS'
p19154
aS'Styp von Rekowski K, Denger K, Cook AM.'
p19155
aS'TITLE'
p19156
aS'Isethionate as a product from taurine during nitrogen-limited growth of Klebsiella oxytoca TauN1.'
p19157
aS'JOURNAL'
p19158
aS'Arch Microbiol 183:325-30 (2005)'
p19159
aS'PMID:4297098'
p19160
ag19160
aS'AUTHORS'
p19161
aS'Jacobsen JG, Smith LH'
p19162
aS'TITLE'
p19163
aS'Biochemistry and physiology of taurine and taurine derivatives.'
p19164
aS'JOURNAL'
p19165
aS'Physiol Rev 48:424-511 (1968)'
p19166
asS'KO_PATHWAY'
p19167
(lp19168
S'ko00430'
p19169
asS'PATHWAY_MAP'
p19170
(lp19171
S'map00430'
p19172
asS'DISEASE'
p19173
(lp19174
S'H01097'
p19175
aS'Cerebral palsy'
p19176
asS'DBLINKS'
p19177
(lp19178
S'GO: 0019530'
p19179
asS'ENTRY'
p19180
(lp19181
S'map00430'
p19182
aS'Pathway'
p19183
asS'CLASS'
p19184
(lp19185
S'Metabolism Metabolism of other amino acids'
p19186
assS'path:map03430'
p19187
(dp19188
S'NAME'
p19189
(lp19190
S'Mismatch repair'
p19191
asS'REFERENCE'
p19192
(lp19193
S'PMID:16612326'
p19194
ag19194
aS'AUTHORS'
p19195
aS'Jiricny J.'
p19196
aS'TITLE'
p19197
aS'The multifaceted mismatch-repair system.'
p19198
aS'JOURNAL'
p19199
aS'Nat Rev Mol Cell Biol 7:335-46 (2006)'
p19200
aS'PMID:18157157'
p19201
ag19201
aS'AUTHORS'
p19202
aS'Li GM.'
p19203
aS'TITLE'
p19204
aS'Mechanisms and functions of DNA mismatch repair.'
p19205
aS'JOURNAL'
p19206
aS'Cell Res 18:85-98 (2008)'
p19207
aS'PMID:11920679'
p19208
ag19208
aS'AUTHORS'
p19209
aS'Marti TM, Kunz C, Fleck O.'
p19210
aS'TITLE'
p19211
aS'DNA mismatch repair and mutation avoidance pathways.'
p19212
aS'JOURNAL'
p19213
aS'J Cell Physiol 191:28-41 (2002)'
p19214
aS'PMID:11436301'
p19215
ag19215
aS'AUTHORS'
p19216
aS'Ikejima M, Shimada T.'
p19217
aS'TITLE'
p19218
aS'[Molecular mechanism of mismatch repair] Japanese'
p19219
aS'JOURNAL'
p19220
aS'Tanpakushitsu Kakusan Koso 46:1124-9 (2001)'
p19221
aS'(Japanese )'
p19222
ag19222
aS'AUTHORS'
p19223
aS'Hanaoka F.'
p19224
aS'TITLE'
p19225
aS'[DNA Replication and Repair] (In Japanese)'
p19226
aS'JOURNAL'
p19227
aS'Yodosha (2004)'
p19228
asS'KO_PATHWAY'
p19229
(lp19230
S'ko03430'
p19231
asS'PATHWAY_MAP'
p19232
(lp19233
S'map03430'
p19234
asS'DISEASE'
p19235
(lp19236
S'H00876'
p19237
aS'Mismatch repair deficiency'
p19238
asS'MODULE'
p19239
(lp19240
S'M00260'
p19241
aS'DNA polymerase III complex, bacteria [PATH:map03430]'
p19242
ag19241
ag19242
aS'M00288'
p19243
aS'RPA complex [PATH:map03430]'
p19244
aS'M00289'
p19245
aS'RF-C complex [PATH:map03430]'
p19246
aS'M00295'
p19247
aS'BRCA1-associated genome surveillance complex (BASC) [PATH:map03430]'
p19248
asS'DESCRIPTION DNA mismatch repair (MMR) is a highly conserved biological pathway that plays a key role in maintaining genomic stability. MMR corrects DNA mismatches generated during DNA replication, thereby preventing mutations from becoming permanent in dividing cells. MMR also suppresses homologous recombination and was recently shown to play a role in DNA damage signaling. Defects in MMR are associated with genome-wide instability, predisposition to certain types of cancer including HNPCC, resistance to certain chemotherapeutic agents, and abnormalities in meiosis and sterility in mammalian systems.'
p19249
(lp19250
S'The Escherichia coli MMR pathway has been extensively studied and is well characterized. In E. coli, the mismatch-activated MutS-MutL-ATP complex licenses MutH to incise the nearest unmethylated GATC sequence. UvrD and an exonuclease generate a gap. This gap is filled by pol III and DNA ligase. The GATC sites are then methylated by Dam. Several human MMR proteins have been identified based on their homology to E. coli MMR proteins. These include human homologs of MutS and MutL. Although E. coli MutS and MutL proteins are homodimers, human MutS and MutL homologs are heterodimers. The role of hemimethylated dGATC sites as a signal for strand discrimination is not conserved from E. coli to human. Human MMR is presumed to be nick-directed in vivo, and is thought to discriminate daughter and template strands using a strand-specific nick.'
p19251
asS'DBLINKS'
p19252
(lp19253
S'GO: 0006298'
p19254
asS'ENTRY'
p19255
(lp19256
S'map03430'
p19257
aS'Pathway'
p19258
asS'CLASS'
p19259
(lp19260
S'Genetic Information Processing Replication and repair'
p19261
asS'DESCRIPTION'
p19262
(lp19263
S'DNA mismatch repair (MMR) is a highly conserved biological pathway that plays a key role in maintaining genomic stability. MMR corrects DNA mismatches generated during DNA replication, thereby preventing mutations from becoming permanent in dividing cells. MMR also suppresses homologous recombination and was recently shown to play a role in DNA damage signaling. Defects in MMR are associated with genome-wide instability, predisposition to certain types of cancer including HNPCC, resistance to certain chemotherapeutic agents, and abnormalities in meiosis and sterility in mammalian systems.'
p19264
assS'path:map07014'
p19265
(dp19266
S'ENTRY'
p19267
(lp19268
S'map07014'
p19269
aS'Drug'
p19270
aS'Pathway'
p19271
asS'PATHWAY_MAP'
p19272
(lp19273
S'map07014'
p19274
asS'NAME'
p19275
(lp19276
S'Quinolones'
p19277
asS'REFERENCE'
p19278
(lp19279
S'(Japanese)'
p19280
ag19280
aS'AUTHORS'
p19281
aS'Sano T, Naito T, Kubo T (eds).'
p19282
aS'TITLE'
p19283
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p19284
aS'JOURNAL'
p19285
aS'Nankodo (2002)'
p19286
aS'(Japanese)'
p19287
ag19287
aS'AUTHORS'
p19288
aS'Fukai S.'
p19289
aS'TITLE'
p19290
aS'[New Drugs Today (6th ed)] (In Japanese)'
p19291
aS'JOURNAL'
p19292
aS'Jiho (1995)'
p19293
aS'(Japanese)'
p19294
ag19294
aS'AUTHORS'
p19295
aS'Japan Pharmaceutical Association (ed).'
p19296
aS'TITLE'
p19297
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p19298
aS'JOURNAL'
p19299
aS'Yakuji Nippo (1999)'
p19300
aS'(Japanese)'
p19301
ag19301
aS'AUTHORS'
p19302
aS'Noguchi S, Hibino S (eds).'
p19303
aS'TITLE'
p19304
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p19305
aS'JOURNAL'
p19306
aS'Hirokawa (2002)'
p19307
aS'(Japanese)'
p19308
ag19308
aS'AUTHORS'
p19309
aS'Sakurai J.'
p19310
aS'TITLE'
p19311
aS'[Illustrated Microbiology (2nd ed)] (In Japanese)'
p19312
aS'JOURNAL'
p19313
aS'Nanzando'
p19314
aS'PMID:2546585'
p19315
ag19315
aS'AUTHORS'
p19316
aS"Shen LL, Mitscher LA, Sharma PN, O'Donnell TJ, Chu DW, Cooper CS, Rosen T, Pernet AG."
p19317
aS'TITLE'
p19318
aS'Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.'
p19319
aS'JOURNAL'
p19320
aS'Biochemistry 28:3886-94 (1989)'
p19321
aS'PMID:10997595'
p19322
ag19322
aS'AUTHORS'
p19323
aS'Ball P.'
p19324
aS'TITLE'
p19325
aS'Quinolone generations: natural history or natural selection?'
p19326
aS'JOURNAL'
p19327
aS'J Antimicrob Chemother 46 Suppl T1:17-24 (2000)'
p19328
aS'PMID:12702699'
p19329
ag19329
aS'AUTHORS'
p19330
aS'Emmerson AM, Jones AM.'
p19331
aS'TITLE'
p19332
aS'The quinolones: decades of development and use.'
p19333
aS'JOURNAL'
p19334
aS'J Antimicrob Chemother 51 Suppl 1:13-20 (2003)'
p19335
aS'PMID:15760423'
p19336
ag19336
aS'AUTHORS'
p19337
aS'Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM'
p19338
aS'TITLE'
p19339
aS'Quinolones in 2005: an update.'
p19340
aS'JOURNAL'
p19341
aS'Clin Microbiol Infect 11:256-80 (2005)'
p19342
asS'COMPOUND'
p19343
(lp19344
S'C14492'
p19345
aS'Ulifloxacin'
p19346
ag19345
ag19346
aS'D00183'
p19347
aS'Nalidixic acid (JP16/USP/INN)'
p19348
aS'D00186'
p19349
aS'Ciprofloxacin (JAN/USP/INN)'
p19350
aS'D00210'
p19351
aS'Norfloxacin (JP16/USP/INN)'
p19352
aS'D00310'
p19353
aS'Enoxacin (USAN/INN)'
p19354
aS'D00453'
p19355
aS'Ofloxacin (JP16/USP/INN)'
p19356
aS'D00589'
p19357
aS'Gatifloxacin hydrate (JAN)'
p19358
aS'D00590'
p19359
aS'Sparfloxacin (JAN/USAN/INN)'
p19360
aS'D00872'
p19361
aS'Cinoxacin (JP16/USP/INN)'
p19362
aS'D00874'
p19363
aS'Moxifloxacin hydrochloride (JAN/USAN)'
p19364
aS'D01144'
p19365
aS'Prulifloxacin (JAN/INN)'
p19366
aS'D01431'
p19367
aS'Piromidic acid (JAN/INN)'
p19368
aS'D01531'
p19369
aS'Pipemidic acid hydrate (JP16)'
p19370
aS'D01996'
p19371
aS'Tosufloxacin tosylate hydrate (JP16)'
p19372
aS'D02123'
p19373
aS'Trovafloxacin mesylate (USAN)'
p19374
aS'D02178'
p19375
aS'Grepafloxacin hydrochloride (JAN/USAN)'
p19376
aS'D02216'
p19377
aS'Ciprofloxacin hydrochloride (JAN/USP)'
p19378
aS'D02301'
p19379
aS'Oxolinic acid (USAN/INN)'
p19380
aS'D02302'
p19381
aS'Flumequine (USAN/INN)'
p19382
aS'D02303'
p19383
aS'Miloxacin (INN)'
p19384
aS'D02305'
p19385
aS'Rosoxacin (USAN/INN)'
p19386
aS'D02317'
p19387
aS'Tosufloxacin (USAN)'
p19388
aS'D02467'
p19389
aS'Droxacin sodium (USAN)'
p19390
aS'D02471'
p19391
aS'Gemifloxacin mesylate (USAN)'
p19392
aS'D02475'
p19393
aS'Sitafloxacin hydrate (JAN)'
p19394
aS'D02539'
p19395
aS'Clinafloxacin hydrochloride (USAN)'
p19396
aS'D02540'
p19397
aS'Garenoxacin mesilate hydrate (JAN)'
p19398
aS'D05461'
p19399
aS'Enoxacin hydrate (JP16)'
p19400
aS'D07702'
p19401
aS'Ciprofloxacin lactate'
p19402
aS'D08011'
p19403
aS'Gatifloxacin (INN)'
p19404
aS'D08012'
p19405
aS'Gemifloxacin (INN)'
p19406
aS'D08237'
p19407
aS'Moxifloxacin (INN)'
p19408
aS'D08287'
p19409
aS'Norfloxacin nicotinate'
p19410
aS'D08291'
p19411
aS'Ofloxacin hydrochloride'
p19412
aS'D08379'
p19413
aS'Pipemidic acid (INN)'
p19414
aS'D08654'
p19415
aS'Trovafloxacin (INN)'
p19416
assS'path:map03020'
p19417
(dp19418
S'NAME'
p19419
(lp19420
S'RNA polymerase'
p19421
asS'REFERENCE'
p19422
(lp19423
S'PMID:10499798'
p19424
ag19424
aS'AUTHORS'
p19425
aS'Zhang G, Campbell EA, Minakhin L, Richter C, Severinov K, Darst SA.'
p19426
aS'TITLE'
p19427
aS'Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 A resolution.'
p19428
aS'JOURNAL'
p19429
aS'Cell 98:811-824 (1999)'
p19430
aS'PMID:10784442'
p19431
ag19431
aS'AUTHORS'
p19432
aS'Cramer P, Bushnell DA, Fu J, Gnatt AL, Maier-Davis B, Thompson NE, Burgess RR, Edwards AM, David PR, Kornberg RD.'
p19433
aS'TITLE'
p19434
aS'Architecture of RNA polymerase II and implications for the transcription mechanism.'
p19435
aS'JOURNAL'
p19436
aS'Science 288:640-649 (2000)'
p19437
aS'PMID:19880312'
p19438
ag19438
aS'AUTHORS'
p19439
aS'Hirata A, Murakami KS'
p19440
aS'TITLE'
p19441
aS'Archaeal RNA polymerase.'
p19442
aS'JOURNAL'
p19443
aS'Curr Opin Struct Biol 19:724-31 (2009)'
p19444
aS'PMID:18573085'
p19445
ag19445
aS'AUTHORS'
p19446
aS'Cramer P, Armache KJ, Baumli S, Benkert S, Brueckner F, Buchen C, Damsma GE, Dengl S, Geiger SR, Jasiak AJ, Jawhari A, Jennebach S, Kamenski T, Kettenberger H, Kuhn CD, Lehmann E, Leike K, Sydow JF, Vannini A'
p19447
aS'TITLE'
p19448
aS'Structure of eukaryotic RNA polymerases.'
p19449
aS'JOURNAL'
p19450
aS'Annu Rev Biophys 37:337-52 (2008)'
p19451
asS'KO_PATHWAY'
p19452
(lp19453
S'ko03020'
p19454
asS'PATHWAY_MAP'
p19455
(lp19456
S'map03020'
p19457
asS'DISEASE'
p19458
(lp19459
S'H00610'
p19460
aS'Treacher Collins syndrome'
p19461
asS'MODULE'
p19462
(lp19463
S'M00180'
p19464
aS'RNA polymerase II, eukaryotes [PATH:map03020]'
p19465
ag19464
ag19465
aS'M00181'
p19466
aS'RNA polymerase III, eukaryotes [PATH:map03020]'
p19467
aS'M00182'
p19468
aS'RNA polymerase I, eukaryotes [PATH:map03020]'
p19469
aS'M00183'
p19470
aS'RNA polymerase, bacteria [PATH:map03020]'
p19471
aS'M00184'
p19472
aS'RNA polymerase, archaea [PATH:map03020]'
p19473
asS'DBLINKS'
p19474
(lp19475
S'GO: 0000428'
p19476
asS'ENTRY'
p19477
(lp19478
S'map03020'
p19479
aS'Pathway'
p19480
asS'CLASS'
p19481
(lp19482
S'Genetic Information Processing Transcription'
p19483
assS'path:map07016'
p19484
(dp19485
S'ENTRY'
p19486
(lp19487
S'map07016'
p19488
aS'Drug'
p19489
aS'Pathway'
p19490
asS'PATHWAY_MAP'
p19491
(lp19492
S'map07016'
p19493
asS'NAME'
p19494
(lp19495
S'Sulfonamide derivatives - sulfa drugs'
p19496
asS'REFERENCE'
p19497
(lp19498
g22
ag22
aS'AUTHORS'
p19499
aS'Sano T, Naito T, Kubo T (eds).'
p19500
aS'TITLE'
p19501
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p19502
aS'JOURNAL'
p19503
aS'Nankodo (2002)'
p19504
ag22
ag22
aS'AUTHORS'
p19505
aS'Fukai S.'
p19506
aS'TITLE'
p19507
aS'[New Drugs Today (6th ed)] (In Japanese)'
p19508
aS'JOURNAL'
p19509
aS'Jiho (1995)'
p19510
ag22
ag22
aS'AUTHORS'
p19511
aS'Walter S.'
p19512
aS'TITLE'
p19513
aS'Drug Discovery: A History'
p19514
aS'JOURNAL'
p19515
aS'Wiley (2005)'
p19516
asS'COMPOUND'
p19517
(lp19518
S'C06530'
p19519
aS'Cupreine'
p19520
ag19519
ag19520
aS'C14617'
p19521
aS'Chrysoidine free base'
p19522
aS'D00285'
p19523
aS'Co-Trimoxazole (BAN)'
p19524
aS'D00433'
p19525
aS'Sulfadiazine silver (JP16)'
p19526
aS'D00447'
p19527
aS'Sulfamethoxazole (JP16/USP/INN)'
p19528
aS'D00448'
p19529
aS'Salazosulfapyridine (JP16)'
p19530
aS'D00450'
p19531
aS'Sulfisoxazole (JP16/USP)'
p19532
aS'D00580'
p19533
aS'Sulfadoxine (JAN/USP/INN)'
p19534
aS'D00587'
p19535
aS'Sulfadiazine (JAN/USP/INN)'
p19536
aS'D00870'
p19537
aS'Sulfamethizole (JP16/USP/INN)'
p19538
aS'D00871'
p19539
aS'Sulfacetamide sodium (USP)'
p19540
aS'D01047'
p19541
aS'Sulfathiazole (USP/INN)'
p19542
aS'D01141'
p19543
aS'Sulfamonomethoxine (JAN/USAN/INN)'
p19544
aS'D01142'
p19545
aS'Sulfadimethoxine (JAN/USP)'
p19546
aS'D01216'
p19547
aS'Sulfamethopyrazine (JAN)'
p19548
aS'D01526'
p19549
aS'Sulfisomidine (JAN)'
p19550
aS'D01954'
p19551
aS'Sulfaphenazole (JAN/INN)'
p19552
aS'D02001'
p19553
aS'Sulfamonomethoxine sodium (JAN)'
p19554
aS'D02261'
p19555
aS'Quinine hydrochloride hydrate (JP16)'
p19556
aS'D02262'
p19557
aS'Quinine sulfate hydrate (JP16)'
p19558
aS'D02433'
p19559
aS'Optochin hydrochloride'
p19560
aS'D02434'
p19561
aS'Sulfapyridine (USP/INN)'
p19562
aS'D02435'
p19563
aS'Sulfamerazine (INN)'
p19564
aS'D02436'
p19565
aS'Sulfamethazine (USP)'
p19566
aS'D02437'
p19567
aS'Sulfaguanidine (INN)'
p19568
aS'D02439'
p19569
aS'Sulfamethoxypyridazine (INN)'
p19570
aS'D02440'
p19571
aS'Phthalylsulfathiazole (INN)'
p19572
aS'D02447'
p19573
aS'Succinylsulfathiazole'
p19574
aS'D05023'
p19575
aS'Sulfamonomethoxine hydrate (JP16)'
p19576
aS'D05681'
p19577
aS'Quinine ascorbate (USAN)'
p19578
aS'D05947'
p19579
aS'Sulfacetamide (USP/INN)'
p19580
aS'D05949'
p19581
aS'Sulfadiazine sodium (USP)'
p19582
aS'D05957'
p19583
aS'Sulfisoxazole diolamine (USAN)'
p19584
aS'D07060'
p19585
aS'Succinylsulfathiazole (INN)'
p19586
aS'D08460'
p19587
aS'Quinine (BAN)'
p19588
aS'D08461'
p19589
aS'Quinine dihydrochloride'
p19590
aS'D08538'
p19591
aS'Sulfadimethoxine sodium (USP)'
p19592
aS'D08539'
p19593
aS'Sulfadimidine sodium'
p19594
aS'D08540'
p19595
aS'Sulfamethoxypyridazine sodium salt'
p19596
aS'D08542'
p19597
aS'Sulfamidochrysoidine'
p19598
aS'D08543'
p19599
aS'Sulfanilamide (INN)'
p19600
assS'path:map03022'
p19601
(dp19602
S'DBLINKS'
p19603
(lp19604
S'GO: 0005668 0005669 0005672 0005673 0005674 0005675'
p19605
asS'NAME'
p19606
(lp19607
S'Basal transcription factors'
p19608
asS'REFERENCE'
p19609
(lp19610
S'PMID:16858867'
p19611
ag19611
aS'AUTHORS'
p19612
aS'Thomas MC, Chiang CM'
p19613
aS'TITLE'
p19614
aS'The general transcription machinery and general cofactors.'
p19615
aS'JOURNAL'
p19616
aS'Crit Rev Biochem Mol Biol 41:105-78 (2006)'
p19617
aS'PMID:12516863'
p19618
ag19618
aS'AUTHORS'
p19619
aS'Martinez E'
p19620
aS'TITLE'
p19621
aS'Multi-protein complexes in eukaryotic gene transcription.'
p19622
aS'JOURNAL'
p19623
aS'Plant Mol Biol 50:925-47 (2002)'
p19624
aS'PMID:19308322'
p19625
ag19625
aS'AUTHORS'
p19626
aS'Cler E, Papai G, Schultz P, Davidson I'
p19627
aS'TITLE'
p19628
aS'Recent advances in understanding the structure and function of general transcription factor TFIID.'
p19629
aS'JOURNAL'
p19630
aS'Cell Mol Life Sci 66:2123-34 (2009)'
p19631
aS'PMID:10838567'
p19632
ag19632
aS'AUTHORS'
p19633
aS'Malik S, Roeder RG.'
p19634
aS'TITLE'
p19635
aS'Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells.'
p19636
aS'JOURNAL'
p19637
aS'Trends Biochem Sci 25:277-283 (2000)'
p19638
asS'KO_PATHWAY'
p19639
(lp19640
S'ko03022'
p19641
asS'ENTRY'
p19642
(lp19643
S'map03022'
p19644
aS'Pathway'
p19645
asS'PATHWAY_MAP'
p19646
(lp19647
S'map03022'
p19648
asS'CLASS'
p19649
(lp19650
S'Genetic Information Processing Transcription'
p19651
assS'path:map07011'
p19652
(dp19653
S'ENTRY'
p19654
(lp19655
S'map07011'
p19656
aS'Drug'
p19657
aS'Pathway'
p19658
asS'PATHWAY_MAP'
p19659
(lp19660
S'map07011'
p19661
asS'NAME'
p19662
(lp19663
S'Penicillins'
p19664
asS'REFERENCE'
p19665
(lp19666
g22
ag22
aS'AUTHORS'
p19667
aS'Sano T, Naito T, Kubo T (eds).'
p19668
aS'TITLE'
p19669
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p19670
aS'JOURNAL'
p19671
aS'Nankodo (2002)'
p19672
ag22
ag22
aS'AUTHORS'
p19673
aS'Fukai S.'
p19674
aS'TITLE'
p19675
aS'[New Drugs Today (6th ed)] (In Japanese)'
p19676
aS'JOURNAL'
p19677
aS'Jiho (1995)'
p19678
ag22
ag22
aS'AUTHORS'
p19679
aS'Walter S.'
p19680
aS'TITLE'
p19681
aS'Drug Discovery: A History'
p19682
aS'JOURNAL'
p19683
aS'Wiley (2005)'
p19684
ag22
ag22
aS'AUTHORS'
p19685
aS'Japan Pharmaceutical Association (ed).'
p19686
aS'TITLE'
p19687
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p19688
aS'JOURNAL'
p19689
aS'Yakuji Nippo (1999)'
p19690
aS'PMID:3547627'
p19691
ag19691
aS'AUTHORS'
p19692
aS'Sjovall J, Huitfeldt B, Magni L, Nord CE.'
p19693
aS'TITLE'
p19694
aS'Effect of beta-lactam prodrugs on human intestinal microflora.'
p19695
aS'JOURNAL'
p19696
aS'Scand J Infect Dis Suppl 49:73-84 (1986)'
p19697
asS'COMPOUND'
p19698
(lp19699
S'C02954'
p19700
aS'6-Aminopenicillanate'
p19701
ag19700
ag19701
aS'C06662'
p19702
aS'Clavulanic acid'
p19703
aS'D00204'
p19704
aS'Anhydrous ampicillin (JP16)'
p19705
aS'D00229'
p19706
aS'Amoxicillin hydrate (JP16)'
p19707
aS'D00230'
p19708
aS'Amoxicillin - potassium clavulanate combination'
p19709
aS'D00466'
p19710
aS'Piperacillin sodium (JP16/USP)'
p19711
aS'D00497'
p19712
aS'Phenoxymethylpenicillin potassium (JAN)'
p19713
aS'D00660'
p19714
aS'Tazobactam (JP16/USAN/INN)'
p19715
aS'D00927'
p19716
aS'Bacampicillin hydrochloride (JP16/USP)'
p19717
aS'D00929'
p19718
aS'Oxacillin sodium (JAN/USP)'
p19719
aS'D01053'
p19720
aS'Benzylpenicillin potassium (JP16)'
p19721
aS'D01074'
p19722
aS'Hetacillin (USAN/INN)'
p19723
aS'D01178'
p19724
aS'Phenethicillin potassium (JP16)'
p19725
aS'D01249'
p19726
aS'Flucloxacillin sodium (JAN)'
p19727
aS'D01251'
p19728
aS'Ampicillin hydrate (JP16)'
p19729
aS'D01283'
p19730
aS'Carindacillin sodium (JAN)'
p19731
aS'D01334'
p19732
aS'Ciclacillin (JP16/INN)'
p19733
aS'D01489'
p19734
aS'Sulbenicillin sodium (JP16)'
p19735
aS'D01499'
p19736
aS'Pivmecillinam hydrochloride (JP16)'
p19737
aS'D01649'
p19738
aS'Propicillin potassium (JAN)'
p19739
aS'D01668'
p19740
aS'Sultamicillin tosilate hydrate (JP16)'
p19741
aS'D01696'
p19742
aS'Lenampicillin hydrochloride (JP16)'
p19743
aS'D02119'
p19744
aS'Ampicillin sodium (JP16/USP)'
p19745
aS'D02137'
p19746
aS'Dicloxacillin sodium hydrate (JP16)'
p19747
aS'D02190'
p19748
aS'Carbenicillin sodium (JAN)'
p19749
aS'D02196'
p19750
aS'Meticillin sodium (JAN)'
p19751
aS'D02199'
p19752
aS'Carfecillin sodium (JAN)'
p19753
aS'D02201'
p19754
aS'Talampicillin hydrochloride (JP16/USAN)'
p19755
aS'D02203'
p19756
aS'Hetacillin potassium (JAN/USAN)'
p19757
aS'D02221'
p19758
aS'Mezlocillin sodium (JAN)'
p19759
aS'D02223'
p19760
aS'Sulbactam sodium (JP16/USP)'
p19761
aS'D02231'
p19762
aS'Cloxacillin sodium hydrate (JP16)'
p19763
aS'D02241'
p19764
aS'Ticarcillin sodium (JAN)'
p19765
aS'D02251'
p19766
aS'Piperacillin hydrate (JP16)'
p19767
aS'D02336'
p19768
aS'Benzylpenicillin (INN)'
p19769
aS'D02339'
p19770
aS'Azlocillin (USAN/INN)'
p19771
aS'D02348'
p19772
aS'Dicloxacillin (USAN/INN)'
p19773
aS'D02370'
p19774
aS'Clavulanate potassium (JP16/USP)'
p19775
aS'D02504'
p19776
aS'Aspoxicillin hydrate (JP16)'
p19777
aS'D02505'
p19778
aS'Tazobactam and piperacillin for injection (JP16)'
p19779
aS'D02508'
p19780
aS'Pivampicillin hydrochloride (USAN)'
p19781
aS'D02889'
p19782
aS'Amdinocillin pivoxil (USAN)'
p19783
aS'D02925'
p19784
aS'Amoxicillin sodium (USAN)'
p19785
aS'D03387'
p19786
aS'Carbenicillin potassium (USAN)'
p19787
aS'D03707'
p19788
aS'Tazobactam sodium (USAN)'
p19789
aS'D04196'
p19790
aS'Floxacillin (USAN)'
p19791
aS'D05021'
p19792
aS'Mezlocillin (USAN/INN)'
p19793
aS'D05022'
p19794
aS'Mezlocillin sodium (USP)'
p19795
aS'D05220'
p19796
aS'Octanoic acid (USAN/INN)'
p19797
aS'D05221'
p19798
aS'Octazamide (USAN/INN)'
p19799
aS'D05408'
p19800
aS'Penicillin G sodium (USP)'
p19801
aS'D05411'
p19802
aS'Penicillin V (USP)'
p19803
aS'D05972'
p19804
aS'Sultamicillin (USAN/INN)'
p19805
aS'D06137'
p19806
aS'Ticarcillin cresyl sodium (USAN)'
p19807
aS'D06138'
p19808
aS'Ticarcillin monosodium (USP)'
p19809
aS'D07452'
p19810
aS'Amoxicillin (INN)'
p19811
aS'D07469'
p19812
aS'Aspoxicillin (JAN/INN)'
p19813
aS'D07487'
p19814
aS'Bacampicillin (INN)'
p19815
aS'D07614'
p19816
aS'Carbenicillin (INN)'
p19817
aS'D07621'
p19818
aS'Carindacillin (INN)'
p19819
aS'D07711'
p19820
aS'Clavulanic acid (INN)'
p19821
aS'D07733'
p19822
aS'Cloxacillin (INN)'
p19823
aS'D07965'
p19824
aS'Flucloxacillin sodium salt'
p19825
aS'D08110'
p19826
aS'Lenampicillin (INN)'
p19827
aS'D08307'
p19828
aS'Oxacillin (INN)'
p19829
aS'D08350'
p19830
aS'Pheneticillin (INN)'
p19831
aS'D08360'
p19832
aS'Phenoxymethylpenicillin calcium'
p19833
aS'D08380'
p19834
aS'Piperacillin (INN)'
p19835
aS'D08396'
p19836
aS'Pivampicillin (INN)'
p19837
aS'D08438'
p19838
aS'Propicillin (BAN)'
p19839
aS'D08533'
p19840
aS'Sulbactam (INN)'
p19841
aS'D08534'
p19842
aS'Sulbenicillin (INN)'
p19843
aS'D08557'
p19844
aS'Talampicillin (INN)'
p19845
aS'D08593'
p19846
aS'Ticarcillin (INN)'
p19847
assS'path:map07012'
p19848
(dp19849
S'ENTRY'
p19850
(lp19851
S'map07012'
p19852
aS'Drug'
p19853
aS'Pathway'
p19854
asS'PATHWAY_MAP'
p19855
(lp19856
S'map07012'
p19857
asS'NAME'
p19858
(lp19859
S'Cephalosporins - parenteral agents'
p19860
asS'REFERENCE'
p19861
(lp19862
g22
ag22
aS'AUTHORS'
p19863
aS'Fukai S.'
p19864
aS'TITLE'
p19865
aS'[New Drugs Today (6th ed)] (In Japanese)'
p19866
aS'JOURNAL'
p19867
aS'Jiho (1995)'
p19868
ag22
ag22
aS'AUTHORS'
p19869
aS'Sano T, Naito T, Kubo T (eds).'
p19870
aS'TITLE'
p19871
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p19872
aS'JOURNAL'
p19873
aS'Nankodo (2002)'
p19874
ag22
ag22
aS'AUTHORS'
p19875
aS'Japan Pharmaceutical Association (ed).'
p19876
aS'TITLE'
p19877
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p19878
aS'JOURNAL'
p19879
aS'Yakuji Nippo (1999)'
p19880
aS'PMID:3072926'
p19881
ag19881
aS'AUTHORS'
p19882
aS'Curtis NA, Eisenstadt RL, East SJ, Cornford RJ, Walker LA, White AJ'
p19883
aS'TITLE'
p19884
aS'Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of'
p19885
aS'action of catechol-substituted cephalosporins.'
p19886
aS'JOURNAL'
p19887
aS'Antimicrob Agents Chemother 32:1879-86 (1988)'
p19888
asS'COMPOUND'
p19889
(lp19890
S'C00916'
p19891
aS'Cephalosporin C'
p19892
ag19891
ag19892
aS'C01941'
p19893
aS'Nocardicin A'
p19894
aS'C02954'
p19895
aS'6-Aminopenicillanate'
p19896
aS'C06566'
p19897
aS'Cephamycin C'
p19898
aS'D00240'
p19899
aS'Aztreonam (JP16/USP/INN)'
p19900
aS'D00260'
p19901
aS'Cefotetan (JP16/USP/INN)'
p19902
aS'D00262'
p19903
aS'Cefuroxime (USAN/INN)'
p19904
aS'D00466'
p19905
aS'Piperacillin sodium (JP16/USP)'
p19906
aS'D00905'
p19907
aS'Cefazolin sodium (JP16/USP)'
p19908
aS'D00907'
p19909
aS'Cefalotin sodium (JP16)'
p19910
aS'D00908'
p19911
aS'Cefapirin sodium (JAN)'
p19912
aS'D00910'
p19913
aS'Cefmetazole (USP/INN)'
p19914
aS'D00911'
p19915
aS'Cefmetazole sodium (JP16/USP)'
p19916
aS'D00913'
p19917
aS'Cefoxitin sodium (JAN/USP)'
p19918
aS'D00914'
p19919
aS'Cefuroxime axetil (JP16/USP/INN)'
p19920
aS'D00915'
p19921
aS'Cefuroxime sodium (JAN/USP)'
p19922
aS'D00918'
p19923
aS'Cefoperazone sodium (JP16/USP)'
p19924
aS'D00919'
p19925
aS'Cefotaxime sodium (JP16/USP)'
p19926
aS'D00921'
p19927
aS'Ceftazidime hydrate (JP16)'
p19928
aS'D00923'
p19929
aS'Ceftizoxime sodium (JP16/USP)'
p19930
aS'D00924'
p19931
aS'Ceftriaxone sodium hydrate (JP16)'
p19932
aS'D01075'
p19933
aS'Cefaloridine (JAN/INN)'
p19934
aS'D01415'
p19935
aS'Cefotiam hexetil hydrochloride (JP16)'
p19936
aS'D01489'
p19937
aS'Sulbenicillin sodium (JP16)'
p19938
aS'D01560'
p19939
aS'Carumonam sodium (JP16/USAN)'
p19940
aS'D01568'
p19941
aS'Cefpimizole sodium (JAN/USAN)'
p19942
aS'D01736'
p19943
aS'Cefbuperazone sodium (JP16)'
p19944
aS'D01739'
p19945
aS'Cefmenoxime hydrochloride (JP16/USP)'
p19946
aS'D01819'
p19947
aS'Cefotiam hydrochloride (JP16/USP)'
p19948
aS'D01863'
p19949
aS'Cefodizime sodium (JP16)'
p19950
aS'D01904'
p19951
aS'Cefpiramide sodium (JP16/USAN)'
p19952
aS'D01909'
p19953
aS'Cefminox sodium hydrate (JP16)'
p19954
aS'D02005'
p19955
aS'Cefsulodin sodium (JP16/USAN)'
p19956
aS'D02191'
p19957
aS'Cefamandole sodium (JAN)'
p19958
aS'D02226'
p19959
aS'Cefazolin sodium hydrate (JP16)'
p19960
aS'D02228'
p19961
aS'Cefotetan sodium (JAN)'
p19962
aS'D02251'
p19963
aS'Piperacillin hydrate (JP16)'
p19964
aS'D02299'
p19965
aS'Cefazolin (USP)'
p19966
aS'D02344'
p19967
aS'Cefamandole (USAN/INN)'
p19968
aS'D02345'
p19969
aS'Cefoxitin (USAN/INN)'
p19970
aS'D03423'
p19971
aS'Cefbuperazone (USAN/INN)'
p19972
aS'D03427'
p19973
aS'Cefpimizole (USAN/INN)'
p19974
aS'D03428'
p19975
aS'Cefpiramide (USP/INN)'
p19976
aS'D06558'
p19977
aS'Aztreonam lysine (USAN)'
p19978
aS'D07625'
p19979
aS'Carumonam (INN)'
p19980
aS'D07635'
p19981
aS'Cefalotin (BAN)'
p19982
aS'D07636'
p19983
aS'Cefapirin (BAN)'
p19984
aS'D07637'
p19985
aS'Cephapirin benzathine (USP)'
p19986
aS'D07641'
p19987
aS'Cefmenoxime (INN)'
p19988
aS'D07642'
p19989
aS'Cefminox (INN)'
p19990
aS'D07643'
p19991
aS'Cefodizime (INN)'
p19992
aS'D07645'
p19993
aS'Cefoperazone (INN)'
p19994
aS'D07647'
p19995
aS'Cefotaxime (INN)'
p19996
aS'D07648'
p19997
aS'Cefotiam (INN)'
p19998
aS'D07653'
p19999
aS'Cefsulodin (INN)'
p20000
aS'D07654'
p20001
aS'Ceftazidime (INN)'
p20002
aS'D07658'
p20003
aS'Ceftizoxime (INN)'
p20004
aS'D07659'
p20005
aS'Ceftriaxone (INN)'
p20006
aS'D08380'
p20007
aS'Piperacillin (INN)'
p20008
aS'D08534'
p20009
aS'Sulbenicillin (INN)'
p20010
assS'path:map07013'
p20011
(dp20012
S'ENTRY'
p20013
(lp20014
S'map07013'
p20015
aS'Drug'
p20016
aS'Pathway'
p20017
asS'PATHWAY_MAP'
p20018
(lp20019
S'map07013'
p20020
asS'NAME'
p20021
(lp20022
S'Cephalosporins - oral agents'
p20023
asS'REFERENCE'
p20024
(lp20025
g22
ag22
aS'AUTHORS'
p20026
aS'Fukai S.'
p20027
aS'TITLE'
p20028
aS'[New Drugs Today (6th ed)] (In Japanese)'
p20029
aS'JOURNAL'
p20030
aS'Jiho (1995)'
p20031
ag22
ag22
aS'AUTHORS'
p20032
aS'Walter S.'
p20033
aS'TITLE'
p20034
aS'Drug Discovery: A History'
p20035
aS'JOURNAL'
p20036
aS'Wiley (2005)'
p20037
ag22
ag22
aS'AUTHORS'
p20038
aS'Bertram GK (ed).'
p20039
aS'TITLE'
p20040
aS'Basic & Clinical Pharmacology (9th ed)'
p20041
aS'JOURNAL'
p20042
aS'Lange (2004)'
p20043
aS'(ISBN:4753212955)'
p20044
ag20044
aS'AUTHORS'
p20045
aS'Matsumoto K.'
p20046
aS'TITLE'
p20047
aS'[Cephem Antibiotics] (In Japanese)'
p20048
aS'JOURNAL'
p20049
aS'Iyaku journal (1991)'
p20050
aS'PMID:3501757'
p20051
ag20051
aS'AUTHORS'
p20052
aS'Jones RN, Barry AL.'
p20053
aS'TITLE'
p20054
aS'Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.'
p20055
aS'JOURNAL'
p20056
aS'Eur J Clin Microbiol 6:570-1 (1987)'
p20057
asS'COMPOUND'
p20058
(lp20059
S'C00916'
p20060
aS'Cephalosporin C'
p20061
ag20060
ag20061
aS'D00256'
p20062
aS'Cefaclor (JP16)'
p20063
aS'D00257'
p20064
aS'Cefadroxil (JP16)'
p20065
aS'D00258'
p20066
aS'Cefixime (JAN/USP/INN)'
p20067
aS'D00261'
p20068
aS'Cefprozil (USP)'
p20069
aS'D00263'
p20070
aS'Cefalexin (JP16)'
p20071
aS'D00264'
p20072
aS'Cefradine (JAN/INN)'
p20073
aS'D00906'
p20074
aS'Cephalexin (USP)'
p20075
aS'D00914'
p20076
aS'Cefuroxime axetil (JP16/USP/INN)'
p20077
aS'D00916'
p20078
aS'Loracarbef (USP)'
p20079
aS'D00917'
p20080
aS'Cefdinir (JP16/USAN/INN)'
p20081
aS'D00920'
p20082
aS'Cefpodoxime proxetil (JP16/USP)'
p20083
aS'D00922'
p20084
aS'Ceftibuten (USAN/INN)'
p20085
aS'D00923'
p20086
aS'Ceftizoxime sodium (JP16/USP)'
p20087
aS'D01415'
p20088
aS'Cefotiam hexetil hydrochloride (JP16)'
p20089
aS'D01628'
p20090
aS'Cefditoren pivoxil (JP16)'
p20091
aS'D01629'
p20092
aS'Cefetamet pivoxil hydrochloride (JAN)'
p20093
aS'D01680'
p20094
aS'Cefcapene pivoxil hydrochloride hydrate (JP16)'
p20095
aS'D01686'
p20096
aS'Cefteram pivoxil (JP16)'
p20097
aS'D01949'
p20098
aS'Cefaloglycin (JAN)'
p20099
aS'D02121'
p20100
aS'Ceftibuten hydrate (JP16)'
p20101
aS'D02352'
p20102
aS'Cefaclor (USP)'
p20103
aS'D02353'
p20104
aS'Cefadroxil (USP)'
p20105
aS'D03438'
p20106
aS'Cephalexin hydrochloride (USP)'
p20107
aS'D07640'
p20108
aS'Cefixime hydrate (JP16)'
p20109
aS'D07651'
p20110
aS'Cefprozil (INN)'
p20111
aS'D07658'
p20112
aS'Ceftizoxime (INN)'
p20113
aS'D08143'
p20114
aS'Loracarbef (INN)'
p20115
assS'path:map07018'
p20116
(dp20117
S'ENTRY'
p20118
(lp20119
S'map07018'
p20120
aS'Drug'
p20121
aS'Pathway'
p20122
asS'PATHWAY_MAP'
p20123
(lp20124
S'map07018'
p20125
asS'NAME'
p20126
(lp20127
S'Sulfonamide derivatives - hypoglycemic agents'
p20128
asS'REFERENCE'
p20129
(lp20130
g22
ag22
aS'AUTHORS'
p20131
aS'Sano T, Naito T, Kubo T (eds).'
p20132
aS'TITLE'
p20133
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p20134
aS'JOURNAL'
p20135
aS'Nankodo (2002)'
p20136
ag22
ag22
aS'AUTHORS'
p20137
aS'Fukai S.'
p20138
aS'TITLE'
p20139
aS'[New Drugs Today (6th ed)] (In Japanese)'
p20140
aS'JOURNAL'
p20141
aS'Jiho (1995)'
p20142
ag22
ag22
aS'AUTHORS'
p20143
aS'Walter S.'
p20144
aS'TITLE'
p20145
aS'Drug Discovery: A History'
p20146
aS'JOURNAL'
p20147
aS'Wiley (2005)'
p20148
ag22
ag22
aS'AUTHORS'
p20149
aS'Japan Pharmaceutical Association (ed).'
p20150
aS'TITLE'
p20151
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p20152
aS'JOURNAL'
p20153
aS'Yakuji Nippo (1999)'
p20154
asS'COMPOUND'
p20155
(lp20156
S'D00219'
p20157
aS'Acetohexamide (JP16/USP/INN)'
p20158
ag20157
ag20158
aS'D00271'
p20159
aS'Chlorpropamide (JP16/USP/INN)'
p20160
aS'D00335'
p20161
aS'Glipizide (USP/INN)'
p20162
aS'D00336'
p20163
aS'Glibenclamide (JP16/INN)'
p20164
aS'D00379'
p20165
aS'Tolazamide (JP16/USP/INN)'
p20166
aS'D00380'
p20167
aS'Tolbutamide (JP16/USP/INN)'
p20168
aS'D00593'
p20169
aS'Glimepiride (JP16/USP/INN)'
p20170
aS'D01210'
p20171
aS'Glybuzole (JAN/INN)'
p20172
aS'D01356'
p20173
aS'Glymidine sodium (JAN/USAN/INN)'
p20174
aS'D01599'
p20175
aS'Gliclazide (JP16/INN)'
p20176
aS'D01799'
p20177
aS'Glyclopyramide (JAN/INN)'
p20178
aS'D02424'
p20179
aS'Glyprothiazol (INN)'
p20180
aS'D02425'
p20181
aS'Carbutamide (INN)'
p20182
aS'D02426'
p20183
aS'Glycyclamide (INN)'
p20184
aS'D02427'
p20185
aS'Glibornuride (USAN/INN)'
p20186
aS'D02431'
p20187
aS'Gliflumide (USAN)'
p20188
aS'D02432'
p20189
aS'Glicetanile sodium (USAN)'
p20190
aS'D02462'
p20191
aS'Glybuthiazol (INN)'
p20192
aS'D08543'
p20193
aS'Sulfanilamide (INN)'
p20194
assS'path:map07019'
p20195
(dp20196
S'ENTRY'
p20197
(lp20198
S'map07019'
p20199
aS'Drug'
p20200
aS'Pathway'
p20201
asS'PATHWAY_MAP'
p20202
(lp20203
S'map07019'
p20204
asS'NAME'
p20205
(lp20206
S'Tetracyclines'
p20207
asS'REFERENCE'
p20208
(lp20209
S'(Japanese)'
p20210
ag20210
aS'AUTHORS'
p20211
aS'Fukai S.'
p20212
aS'TITLE'
p20213
aS'[New Drugs Today (6th ed)] (In Japanese)'
p20214
aS'JOURNAL'
p20215
aS'Jiho (1995)'
p20216
ag22
ag22
aS'AUTHORS'
p20217
aS'Walter S.'
p20218
aS'TITLE'
p20219
aS'Drug Discovery: A History'
p20220
aS'JOURNAL'
p20221
aS'Wiley (2005)'
p20222
aS'(Japanese)'
p20223
ag20223
aS'AUTHORS'
p20224
aS'Japan Pharmaceutical Association (ed).'
p20225
aS'TITLE'
p20226
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p20227
aS'JOURNAL'
p20228
aS'Yakuji Nippo (1999)'
p20229
ag22
ag22
aS'AUTHORS'
p20230
aS'Zimmerman TJ, Kooner K, Sharir M, Fechtner RD (eds).'
p20231
aS'TITLE'
p20232
aS'Textbook of Ocular Pharmacology (1997)'
p20233
aS'JOURNAL'
p20234
aS'Lippincott Williams & Wilkins (1997)'
p20235
ag22
ag22
aS'AUTHORS'
p20236
aS'Hunter IS, Hill RA.'
p20237
aS'TITLE'
p20238
aS'Tetracyclines.'
p20239
aS'JOURNAL'
p20240
aS'Drugs and the Pharmaceutical Sciences 82:659-682 (1997)'
p20241
ag22
ag22
aS'AUTHORS'
p20242
aS'Nelson ML.'
p20243
aS'TITLE'
p20244
aS'The chemistry and biology of the tetracyclines.'
p20245
aS'JOURNAL'
p20246
aS'Annual Reports in Medicinal Chemistry 37:105-114 (2002)'
p20247
aS'PMID:2280462 (Japanese)'
p20248
ag20248
aS'AUTHORS'
p20249
aS'Kobayashi Y.'
p20250
aS'TITLE'
p20251
aS'[Tetracyclines]'
p20252
aS'JOURNAL'
p20253
aS'Nippon Rinsho 48:2184-8 (1990)'
p20254
aS'PMID:7628979'
p20255
ag20255
aS'AUTHORS'
p20256
aS'Tally FT, Ellestad GA, Testa RT.'
p20257
aS'TITLE'
p20258
aS'Glycylcyclines: a new generation of tetracyclines.'
p20259
aS'JOURNAL'
p20260
aS'J Antimicrob Chemother 35:449-52 (1995)'
p20261
aS'PMID:12237079'
p20262
ag20262
aS'AUTHORS'
p20263
aS'Chopra I.'
p20264
aS'TITLE'
p20265
aS'New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors.'
p20266
aS'JOURNAL'
p20267
aS'Drug Resist Updat 5:119-25 (2002)'
p20268
aS'PMID:16249141'
p20269
ag20269
aS'AUTHORS'
p20270
aS'Scheinfeld N.'
p20271
aS'TITLE'
p20272
aS'Tigecycline: a review of a new glycylcycline antibiotic.'
p20273
aS'JOURNAL'
p20274
aS'J Dermatolog Treat 16:207-12 (2005)'
p20275
asS'COMPOUND'
p20276
(lp20277
S'D00201'
p20278
aS'Tetracycline (JAN/USP/INN)'
p20279
ag20278
ag20279
aS'D00205'
p20280
aS'Oxytetracycline (JAN/USP/INN)'
p20281
aS'D00290'
p20282
aS'Demethylchlortetracycline hydrochloride (JP16)'
p20283
aS'D00307'
p20284
aS'Doxycycline (USP)'
p20285
aS'D00849'
p20286
aS'Methacycline hydrochloride (JAN/USP)'
p20287
aS'D00850'
p20288
aS'Minocycline hydrochloride (JP16/USP)'
p20289
aS'D01079'
p20290
aS'Tigecycline (JAN/USAN)'
p20291
aS'D01596'
p20292
aS'Oxytetracycline hydrochloride (JP16/USP)'
p20293
aS'D02122'
p20294
aS'Tetracycline hydrochloride (JP16/USP)'
p20295
aS'D02129'
p20296
aS'Doxycycline hydrochloride hydrate (JP16)'
p20297
aS'D02255'
p20298
aS'Chlortetracycline hydrochloride (JAN/USP)'
p20299
aS'D03477'
p20300
aS'Chlortetracycline bisulfate (USP)'
p20301
aS'D03680'
p20302
aS'Demethylchlortetracycline (JAN)'
p20303
aS'D03903'
p20304
aS'Doxycycline calcium (USP)'
p20305
aS'D04972'
p20306
aS'Methacycline (USAN)'
p20307
aS'D05045'
p20308
aS'Minocycline (USAN/INN)'
p20309
aS'D05322'
p20310
aS'Oxytetracycline calcium (USP)'
p20311
aS'D07689'
p20312
aS'Chlortetracycline (INN)'
p20313
aS'D07876'
p20314
aS'Doxycycline (INN)'
p20315
aS'D07877'
p20316
aS'Doxycycline hydrochloride'
p20317
assS'path:map01230'
p20318
(dp20319
S'NAME'
p20320
(lp20321
S'Biosynthesis of amino acids'
p20322
asS'KO_PATHWAY'
p20323
(lp20324
S'ko01230'
p20325
asS'ENTRY'
p20326
(lp20327
S'map01230'
p20328
aS'Global'
p20329
aS'Pathway'
p20330
asS'PATHWAY_MAP'
p20331
(lp20332
S'map01230'
p20333
asS'CLASS'
p20334
(lp20335
S'Metabolism Overview'
p20336
asS'MODULE'
p20337
(lp20338
S'M00002'
p20339
aS'Glycolysis, core module involving three-carbon compounds [PATH:map01230]'
p20340
ag20339
ag20340
aS'M00005'
p20341
aS'PRPP biosynthesis, ribose 5P => PRPP [PATH:map01230]'
p20342
aS'M00007'
p20343
aS'Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map01230]'
p20344
aS'M00010'
p20345
aS'Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map01230]'
p20346
aS'M00015'
p20347
aS'Proline biosynthesis, glutamate => proline [PATH:map01230]'
p20348
aS'M00016'
p20349
aS'Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine [PATH:map01230]'
p20350
aS'M00017'
p20351
aS'Methionine biosynthesis, apartate => homoserine => methionine [PATH:map01230]'
p20352
aS'M00018'
p20353
aS'Threonine biosynthesis, aspartate => homoserine => threonine [PATH:map01230]'
p20354
aS'M00019'
p20355
aS'Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map01230]'
p20356
aS'M00020'
p20357
aS'Serine biosynthesis, glycerate-3P => serine [PATH:map01230]'
p20358
aS'M00021'
p20359
aS'Cysteine biosynthesis, serine => cysteine [PATH:map01230]'
p20360
aS'M00022'
p20361
aS'Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map01230]'
p20362
aS'M00023'
p20363
aS'Tryptophan biosynthesis, chorismate => tryptophan [PATH:map01230]'
p20364
aS'M00024'
p20365
aS'Phenylalanine biosynthesis, chorismate => phenylalanine [PATH:map01230]'
p20366
aS'M00025'
p20367
aS'Tyrosine biosynthesis, chorismate => tyrosine [PATH:map01230]'
p20368
aS'M00026'
p20369
aS'Histidine biosynthesis, PRPP => histidine [PATH:map01230]'
p20370
aS'M00028'
p20371
aS'Ornithine biosynthesis, glutamate => ornithine [PATH:map01230]'
p20372
aS'M00029'
p20373
aS'Urea cycle [PATH:map01230]'
p20374
aS'M00030'
p20375
aS'Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine [PATH:map01230]'
p20376
aS'M00031'
p20377
aS'Lysine biosynthesis, 2-aminoadipate => lysine [PATH:map01230]'
p20378
aS'M00033'
p20379
aS'Ectoine biosynthesis, aspartate => ectoine [PATH:map01230]'
p20380
aS'M00040'
p20381
aS'Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine [PATH:map01230]'
p20382
aS'M00338'
p20383
aS'Cysteine biosynthesis, homocysteine + serine => cysteine [PATH:map01230]'
p20384
aS'M00432'
p20385
aS'Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map01230]'
p20386
aS'M00433'
p20387
aS'Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate [PATH:map01230]'
p20388
aS'M00525'
p20389
aS'Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine [PATH:map01230]'
p20390
aS'M00526'
p20391
aS'Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine [PATH:map01230]'
p20392
aS'M00527'
p20393
aS'Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine [PATH:map01230]'
p20394
aS'M00535'
p20395
aS'Isoleucine biosynthesis, pyruvate => 2-oxobutanoate [PATH:map01230]'
p20396
aS'M00570'
p20397
aS'Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine [PATH:map01230]'
p20398
aS'M00580'
p20399
aS'Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map01230]'
p20400
aS'M00609'
p20401
aS'Cysteine biosynthesis, methionine => cysteine [PATH:map01230]'
p20402
asS'DESCRIPTION'
p20403
(lp20404
S'This map presents a modular architecture of the biosynthesis pathways of twenty amino acids, which may be viewed as consisting of the core part and its extensions. The core part is the KEGG module for conversion of three-carbon compounds from glyceraldehyde-3P to pyruvate [MD:M00002], together with the pathways around serine and glycine. This KEGG module is the most conserved one in the KEGG MODULE database and is found in almost all the completely sequenced genomes. The extensions are the pathways containing the reaction modules RM001, RM033, RM032, and RM002 for biosynthesis of branched-chain amino acids (left) and basic amino acids (bottom), and the pathways for biosynthesis of histidine and aromatic amino acids (top right). It is interesting to note that the so-called essential amino acids that cannot be synthesized in human and other organisms generally appear in these extensions. Furthermore, the bottom extension of basic amino acids appears to be most divergent containing multiple pathways for lysine biosynthesis and multiple gene sets for arginine biosynthesis.'
p20405
assS'path:map01058'
p20406
(dp20407
S'NAME'
p20408
(lp20409
S'Acridone alkaloid biosynthesis'
p20410
asS'REFERENCE'
p20411
(lp20412
g22
ag22
aS'AUTHORS'
p20413
aS'Funayama S.'
p20414
aS'TITLE'
p20415
aS'[Arukaroido -Doku to Kusuri no Houko-] (In Japanese)'
p20416
aS'JOURNAL'
p20417
aS'Kyouritu shuppan kabusikikaisya:183-187 (1998)'
p20418
ag22
ag22
aS'AUTHORS'
p20419
aS'Paul M Dewick.'
p20420
aS'TITLE'
p20421
aS'Medicinal Natural Products -A Biosynthetic Approach- (2nd ed)'
p20422
aS'JOURNAL'
p20423
aS'John Wiley and Sons, LTD:376-379 (2001)'
p20424
ag22
ag22
aS'AUTHORS'
p20425
aS'Jeffrey B, Herbert B, Gerard P.'
p20426
aS'TITLE'
p20427
aS'Phytochemical Dictionary-A Handbook of Bioactive Compounds from Plants (2nd ed)'
p20428
aS'JOURNAL'
p20429
aS'Taylor and Francis:301-316 (1999)'
p20430
aS'PMID:10217426'
p20431
ag20431
aS'AUTHORS'
p20432
aS'Lukacin R, Springob K, Urbanke C, Ernwein C, Schroder G, Schroder J, Matern U.'
p20433
aS'TITLE'
p20434
aS'Native acridone synthases I and II from Ruta graveolens L. form homodimers'
p20435
aS'JOURNAL'
p20436
aS'FEBS Lett 448:135-40 (1999)'
p20437
asS'KO_PATHWAY'
p20438
(lp20439
S'ko01058'
p20440
asS'ENTRY'
p20441
(lp20442
S'map01058'
p20443
aS'Pathway'
p20444
asS'PATHWAY_MAP'
p20445
(lp20446
S'map01058'
p20447
asS'CLASS'
p20448
(lp20449
S'Metabolism Biosynthesis of other secondary metabolites'
p20450
asS'DESCRIPTION'
p20451
(lp20452
S'Acridone alkaloids are anthranillic acid-derived plant alkaloids found in Rutaceae (rue family). Compounds in this class have been tested for antitumor and antimicrobial activities.'
p20453
assS'path:map01056'
p20454
(dp20455
S'NAME'
p20456
(lp20457
S'Biosynthesis of type II polyketide backbone'
p20458
asS'REFERENCE'
p20459
(lp20460
S'PMID:10467738'
p20461
ag20461
aS'AUTHORS'
p20462
aS'Rawlings BJ'
p20463
aS'TITLE'
p20464
aS'Biosynthesis of polyketides (other than actinomycete macrolides).'
p20465
aS'JOURNAL'
p20466
aS'Nat Prod Rep 16:425-84 (1999)'
p20467
aS'PMID:17268612'
p20468
ag20468
aS'AUTHORS'
p20469
aS'Hertweck C, Luzhetskyy A, Rebets Y, Bechthold A'
p20470
aS'TITLE'
p20471
aS'Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork.'
p20472
aS'JOURNAL'
p20473
aS'Nat Prod Rep 24:162-90 (2007)'
p20474
aS'PMID:11902441'
p20475
ag20475
aS'AUTHORS'
p20476
aS'Moore BS, Hertweck C'
p20477
aS'TITLE'
p20478
aS'Biosynthesis and attachment of novel bacterial polyketide synthase starter units.'
p20479
aS'JOURNAL'
p20480
aS'Nat Prod Rep 19:70-99 (2002)'
p20481
aS'PMID:15286722'
p20482
ag20482
aS'AUTHORS'
p20483
aS'Keatinge-Clay AT, Maltby DA, Medzihradszky KF, Khosla C, Stroud RM'
p20484
aS'TITLE'
p20485
aS'An antibiotic factory caught in action.'
p20486
aS'JOURNAL'
p20487
aS'Nat Struct Mol Biol 11:888-93 (2004)'
p20488
aS'PMID:18250311'
p20489
ag20489
aS'AUTHORS'
p20490
aS'Ridley CP, Lee HY, Khosla C'
p20491
aS'TITLE'
p20492
aS'Evolution of polyketide synthases in bacteria.'
p20493
aS'JOURNAL'
p20494
aS'Proc Natl Acad Sci U S A 105:4595-600 (2008)'
p20495
aS'PMID:20522541'
p20496
ag20496
aS'AUTHORS'
p20497
aS'Pickens LB, Tang Y'
p20498
aS'TITLE'
p20499
aS'Oxytetracycline biosynthesis.'
p20500
aS'JOURNAL'
p20501
aS'J Biol Chem 285:27509-15 (2010)'
p20502
aS'PMID:10551844'
p20503
ag20503
aS'AUTHORS'
p20504
aS'Petkovic H, Thamchaipenet A, Zhou LH, Hranueli D, Raspor P, Waterman PG, Hunter IS'
p20505
aS'TITLE'
p20506
aS'Disruption of an aromatase/cyclase from the oxytetracycline gene cluster of Streptomyces rimosus results in production of novel polyketides with shorter chain lengths.'
p20507
aS'JOURNAL'
p20508
aS'J Biol Chem 274:32829-34 (1999)'
p20509
aS'PMID:20358042'
p20510
ag20510
aS'AUTHORS'
p20511
aS'Zhou H, Li Y, Tang Y'
p20512
aS'TITLE'
p20513
aS'Cyclization of aromatic polyketides from bacteria and fungi.'
p20514
aS'JOURNAL'
p20515
aS'Nat Prod Rep 27:839-68 (2010)'
p20516
aS'PMID:18205400'
p20517
ag20517
aS'AUTHORS'
p20518
aS'Korman TP, Tan YH, Wong J, Luo R, Tsai SC'
p20519
aS'TITLE'
p20520
aS'Inhibition kinetics and emodin cocrystal structure of a type II polyketide ketoreductase.'
p20521
aS'JOURNAL'
p20522
aS'Biochemistry 47:1837-47 (2008)'
p20523
aS'PMID:9375253'
p20524
ag20524
aS'AUTHORS'
p20525
aS'Kantola J, Blanco G, Hautala A, Kunnari T, Hakala J, Mendez C, Ylihonko K, Mantsala P, Salas J'
p20526
aS'TITLE'
p20527
aS'Folding of the polyketide chain is not dictated by minimal polyketide synthase in the biosynthesis of mithramycin and anthracycline.'
p20528
aS'JOURNAL'
p20529
aS'Chem Biol 4:751-5 (1997)'
p20530
aS'PMID:10509907'
p20531
ag20531
aS'AUTHORS'
p20532
aS'Kunnari T, Ylihonko K, Hautala A, Klika KD, Mantsala P, Hakala J'
p20533
aS'TITLE'
p20534
aS'Incorrectly folded aromatic polyketides from polyketide reductase deficient mutants.'
p20535
aS'JOURNAL'
p20536
aS'Bioorg Med Chem Lett 9:2639-42 (1999)'
p20537
aS'PMID:19362634'
p20538
ag20538
aS'AUTHORS'
p20539
aS'Tsai SC, Ames BD'
p20540
aS'TITLE'
p20541
aS'Structural enzymology of polyketide synthases.'
p20542
aS'JOURNAL'
p20543
aS'Methods Enzymol 459:17-47 (2009)'
p20544
aS'PMID:15544323'
p20545
ag20545
aS'AUTHORS'
p20546
aS'Korman TP, Hill JA, Vu TN, Tsai SC'
p20547
aS'TITLE'
p20548
aS'Structural analysis of actinorhodin polyketide ketoreductase: cofactor binding and substrate specificity.'
p20549
aS'JOURNAL'
p20550
aS'Biochemistry 43:14529-38 (2004)'
p20551
aS'PMID:15458634'
p20552
ag20552
aS'AUTHORS'
p20553
aS'Hadfield AT, Limpkin C, Teartasin W, Simpson TJ, Crosby J, Crump MP'
p20554
aS'TITLE'
p20555
aS'The crystal structure of the actIII actinorhodin polyketide reductase: proposed mechanism for ACP and polyketide binding.'
p20556
aS'JOURNAL'
p20557
aS'Structure 12:1865-75 (2004)'
p20558
aS'PMID:10658662'
p20559
ag20559
aS'AUTHORS'
p20560
aS'Kantola J, Kunnari T, Hautala A, Hakala J, Ylihonko K, Mantsala P'
p20561
aS'TITLE'
p20562
aS'Elucidation of anthracyclinone biosynthesis by stepwise cloning of genes for anthracyclines from three different Streptomyces spp.'
p20563
aS'JOURNAL'
p20564
aS'Microbiology 146 ( Pt 1):155-63 (2000)'
p20565
aS'PMID:2394677'
p20566
ag20566
aS'AUTHORS'
p20567
aS'Bartel PL, Zhu CB, Lampel JS, Dosch DC, Connors NC, Strohl WR, Beale JM Jr, Floss HG'
p20568
aS'TITLE'
p20569
aS'Biosynthesis of anthraquinones by interspecies cloning of actinorhodin biosynthesis genes in streptomycetes: clarification of actinorhodin gene functions.'
p20570
aS'JOURNAL'
p20571
aS'J Bacteriol 172:4816-26 (1990)'
p20572
aS'PMID:16793516'
p20573
ag20573
aS'AUTHORS'
p20574
aS'Arthur CJ, Szafranska AE, Long J, Mills J, Cox RJ, Findlow SC, Simpson TJ, Crump MP, Crosby J'
p20575
aS'TITLE'
p20576
aS'The malonyl transferase activity of type II polyketide synthase acyl carrier proteins.'
p20577
aS'JOURNAL'
p20578
aS'Chem Biol 13:587-96 (2006)'
p20579
aS'PMID:16263270'
p20580
ag20580
aS'AUTHORS'
p20581
aS'Schneider G'
p20582
aS'TITLE'
p20583
aS'Enzymes in the biosynthesis of aromatic polyketide antibiotics.'
p20584
aS'JOURNAL'
p20585
aS'Curr Opin Struct Biol 15:629-36 (2005)'
p20586
aS'PMID:1548230'
p20587
ag20587
aS'AUTHORS'
p20588
aS'Summers RG, Wendt-Pienkowski E, Motamedi H, Hutchinson CR'
p20589
aS'TITLE'
p20590
aS'Nucleotide sequence of the tcmII-tcmIV region of the tetracenomycin C biosynthetic gene cluster of Streptomyces glaucescens and evidence that the tcmN'
p20591
aS'gene encodes a multifunctional cyclase-dehydratase-O-methyl transferase.'
p20592
aS'JOURNAL'
p20593
aS'J Bacteriol 174:1810-20 (1992)'
p20594
aS'PMID:18388203'
p20595
ag20595
aS'AUTHORS'
p20596
aS'Ames BD, Korman TP, Zhang W, Smith P, Vu T, Tang Y, Tsai SC'
p20597
aS'TITLE'
p20598
aS'Crystal structure and functional analysis of tetracenomycin ARO/CYC: implications for cyclization specificity of aromatic polyketides.'
p20599
aS'JOURNAL'
p20600
aS'Proc Natl Acad Sci U S A 105:5349-54 (2008)'
p20601
aS'PMID:17013601'
p20602
ag20602
aS'AUTHORS'
p20603
aS'Lombo F, Menendez N, Salas JA, Mendez C'
p20604
aS'TITLE'
p20605
aS'The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.'
p20606
aS'JOURNAL'
p20607
aS'Appl Microbiol Biotechnol 73:1-14 (2006)'
p20608
ag22
ag22
aS'AUTHORS'
p20609
aS'Krohn K (ed).'
p20610
aS'TITLE'
p20611
aS'Anthracycline Chemistry and Biology I : Biological Occurence and Biosynthesis, Synthesis and Chemistry'
p20612
aS'JOURNAL'
p20613
aS'Topics in Current Chemistry 282 (2008)'
p20614
asS'KO_PATHWAY'
p20615
(lp20616
S'ko01056'
p20617
asS'ENTRY'
p20618
(lp20619
S'map01056'
p20620
aS'Pathway'
p20621
asS'PATHWAY_MAP'
p20622
(lp20623
S'map01056'
p20624
asS'CLASS'
p20625
(lp20626
S'Metabolism Metabolism of terpenoids and polyketides'
p20627
assS'path:map01057'
p20628
(dp20629
S'NAME'
p20630
(lp20631
S'Biosynthesis of type II polyketide products'
p20632
asS'REFERENCE'
p20633
(lp20634
S'PMID:17227452'
p20635
ag20635
aS'AUTHORS'
p20636
aS'Taguchi T, Okamoto S, Lezhava A, Li A, Ochi K, Ebizuka Y, Ichinose K'
p20637
aS'TITLE'
p20638
aS'Possible involvement of ActVI-ORFA in transcriptional regulation of actVI tailoring-step genes for actinorhodin biosynthesis.'
p20639
aS'JOURNAL'
p20640
aS'FEMS Microbiol Lett 269:234-9 (2007)'
p20641
aS'PMID:12855716'
p20642
ag20642
aS'AUTHORS'
p20643
aS'Ichinose K, Ozawa M, Itou K, Kunieda K, Ebizuka Y'
p20644
aS'TITLE'
p20645
aS'Cloning, sequencing and heterologous expression of the medermycin biosynthetic gene cluster of Streptomyces sp. AM-7161: towards comparative analysis of the benzoisochromanequinone gene clusters.'
p20646
aS'JOURNAL'
p20647
aS'Microbiology 149:1633-45 (2003)'
p20648
aS'PMID:16169737'
p20649
ag20649
aS'AUTHORS'
p20650
aS'Li A, Itoh T, Taguchi T, Xiang T, Ebizuka Y, Ichinose K'
p20651
aS'TITLE'
p20652
aS'Functional studies on a ketoreductase gene from Streptomyces sp. AM-7161 to control the stereochemistry in medermycin biosynthesis.'
p20653
aS'JOURNAL'
p20654
aS'Bioorg Med Chem 13:6856-63 (2005)'
p20655
aS'PMID:9831526'
p20656
ag20656
aS'AUTHORS'
p20657
aS'Ichinose K, Bedford DJ, Tornus D, Bechthold A, Bibb MJ, Revill WP, Floss HG, Hopwood DA'
p20658
aS'TITLE'
p20659
aS'The granaticin biosynthetic gene cluster of Streptomyces violaceoruber Tu22: sequence analysis and expression in a heterologous host.'
p20660
aS'JOURNAL'
p20661
aS'Chem Biol 5:647-59 (1998)'
p20662
aS'PMID:11851466'
p20663
ag20663
aS'AUTHORS'
p20664
aS'Hopwood DA'
p20665
aS'TITLE'
p20666
aS'Genetic Contributions to Understanding Polyketide Synthases.'
p20667
aS'JOURNAL'
p20668
aS'Chem Rev 97:2465-2498 (1997)'
p20669
aS'PMID:7929165'
p20670
ag20670
aS'AUTHORS'
p20671
aS'Fernandez-Moreno MA, Martinez E, Caballero JL, Ichinose K, Hopwood DA, Malpartida F'
p20672
aS'TITLE'
p20673
aS'DNA sequence and functions of the actVI region of the actinorhodin biosynthetic gene cluster of Streptomyces coelicolor A3(2).'
p20674
aS'JOURNAL'
p20675
aS'J Biol Chem 269:24854-63 (1994)'
p20676
aS'PMID:17579485'
p20677
ag20677
aS'AUTHORS'
p20678
aS'Itoh T, Taguchi T, Kimberley MR, Booker-Milburn KI, Stephenson GR, Ebizuka Y, Ichinose K'
p20679
aS'TITLE'
p20680
aS'Actinorhodin biosynthesis: structural requirements for post-PKS tailoring intermediates revealed by functional analysis of ActVI-ORF1 reductase.'
p20681
aS'JOURNAL'
p20682
aS'Biochemistry 46:8181-8 (2007)'
p20683
aS'PMID:11325954'
p20684
ag20684
aS'AUTHORS'
p20685
aS'Ichinose K, Taguchi T, Bedford DJ, Ebizuka Y, Hopwood DA'
p20686
aS'TITLE'
p20687
aS'Functional complementation of pyran ring formation in actinorhodin biosynthesis in Streptomyces coelicolor A3(2) by ketoreductase genes for granaticin biosynthesis.'
p20688
aS'JOURNAL'
p20689
aS'J Bacteriol 183:3247-50 (2001)'
p20690
aS'PMID:11707113'
p20691
ag20691
aS'AUTHORS'
p20692
aS'Taguchi T, Ebizuka Y, Hopwood DA, Ichinose K'
p20693
aS'TITLE'
p20694
aS'A new mode of stereochemical control revealed by analysis of the biosynthesis of'
p20695
aS'dihydrogranaticin in Streptomyces violaceoruber Tu22.'
p20696
aS'JOURNAL'
p20697
aS'J Am Chem Soc 123:11376-80 (2001)'
p20698
aS'PMID:15498668'
p20699
ag20699
aS'AUTHORS'
p20700
aS'Taguchi T, Kunieda K, Takeda-Shitaka M, Takaya D, Kawano N, Kimberley MR, Booker-Milburn KI, Stephenson GR, Umeyama H, Ebizuka Y, Ichinose K'
p20701
aS'TITLE'
p20702
aS'Remarkably different structures and reaction mechanisms of ketoreductases for the opposite stereochemical control in the biosynthesis of BIQ antibiotics.'
p20703
aS'JOURNAL'
p20704
aS'Bioorg Med Chem 12:5917-27 (2004)'
p20705
aS'PMID:19246012'
p20706
ag20706
aS'AUTHORS'
p20707
aS'Okamoto S, Taguchi T, Ochi K, Ichinose K'
p20708
aS'TITLE'
p20709
aS'Biosynthesis of actinorhodin and related antibiotics: discovery of alternative routes for quinone formation encoded in the act gene cluster.'
p20710
aS'JOURNAL'
p20711
aS'Chem Biol 16:226-36 (2009)'
p20712
aS'PMID:18245777'
p20713
ag20713
aS'AUTHORS'
p20714
aS'Valton J, Mathevon C, Fontecave M, Niviere V, Ballou DP'
p20715
aS'TITLE'
p20716
aS'Mechanism and regulation of the Two-component FMN-dependent monooxygenase ActVA-ActVB from Streptomyces coelicolor.'
p20717
aS'JOURNAL'
p20718
aS'J Biol Chem 283:10287-96 (2008)'
p20719
aS'PMID:16267053'
p20720
ag20720
aS'AUTHORS'
p20721
aS'Valton J, Fontecave M, Douki T, Kendrew SG, Niviere V'
p20722
aS'TITLE'
p20723
aS'An aromatic hydroxylation reaction catalyzed by a two-component FMN-dependent Monooxygenase. The ActVA-ActVB system from Streptomyces coelicolor.'
p20724
aS'JOURNAL'
p20725
aS'J Biol Chem 281:27-35 (2006)'
p20726
aS'PMID:15297451'
p20727
ag20727
aS'AUTHORS'
p20728
aS'Valton J, Filisetti L, Fontecave M, Niviere V'
p20729
aS'TITLE'
p20730
aS'A two-component flavin-dependent monooxygenase involved in actinorhodin biosynthesis in Streptomyces coelicolor.'
p20731
aS'JOURNAL'
p20732
aS'J Biol Chem 279:44362-9 (2004)'
p20733
aS'PMID:20193654'
p20734
ag20734
aS'AUTHORS'
p20735
aS'Ellis HR'
p20736
aS'TITLE'
p20737
aS'The FMN-dependent two-component monooxygenase systems.'
p20738
aS'JOURNAL'
p20739
aS'Arch Biochem Biophys 497:1-12 (2010)'
p20740
aS'PMID:12417584'
p20741
ag20741
aS'AUTHORS'
p20742
aS'Filisetti L, Fontecave M, Niviere V'
p20743
aS'TITLE'
p20744
aS'Mechanism and substrate specificity of the flavin reductase ActVB from Streptomyces coelicolor.'
p20745
aS'JOURNAL'
p20746
aS'J Biol Chem 278:296-303 (2003)'
p20747
aS'PMID:9209048'
p20748
ag20748
aS'AUTHORS'
p20749
aS'Kendrew SG, Hopwood DA, Marsh EN'
p20750
aS'TITLE'
p20751
aS'Identification of a monooxygenase from Streptomyces coelicolor A3(2) involved in'
p20752
aS'biosynthesis of actinorhodin: purification and characterization of the recombinant enzyme.'
p20753
aS'JOURNAL'
p20754
aS'J Bacteriol 179:4305-10 (1997)'
p20755
aS'PMID:12514126'
p20756
ag20756
aS'AUTHORS'
p20757
aS'Sciara G, Kendrew SG, Miele AE, Marsh NG, Federici L, Malatesta F, Schimperna G, Savino C, Vallone B'
p20758
aS'TITLE'
p20759
aS'The structure of ActVA-Orf6, a novel type of monooxygenase involved in actinorhodin biosynthesis.'
p20760
aS'JOURNAL'
p20761
aS'EMBO J 22:205-15 (2003)'
p20762
aS'PMID:20157809'
p20763
ag20763
aS'AUTHORS'
p20764
aS'Fetzner S, Steiner RA'
p20765
aS'TITLE'
p20766
aS'Cofactor-independent oxidases and oxygenases.'
p20767
aS'JOURNAL'
p20768
aS'Appl Microbiol Biotechnol 86:791-804 (2010)'
p20769
ag22
ag22
aS'AUTHORS'
p20770
aS'Krohn K (ed).'
p20771
aS'TITLE'
p20772
aS'Anthracycline Chemistry and Biology I : Biological Occurence and Biosynthesis, Synthesis and Chemistry'
p20773
aS'JOURNAL'
p20774
aS'Topics in Current Chemistry 282 (2008)'
p20775
aS'PMID:11683270'
p20776
ag20776
aS'AUTHORS'
p20777
aS'Torkkell S, Kunnari T, Palmu K, Mantsala P, Hakala J, Ylihonko K'
p20778
aS'TITLE'
p20779
aS'The entire nogalamycin biosynthetic gene cluster of Streptomyces nogalater: characterization of a 20-kb DNA region and generation of hybrid structures.'
p20780
aS'JOURNAL'
p20781
aS'Mol Genet Genomics 266:276-88 (2001)'
p20782
aS'PMID:20052967'
p20783
ag20783
aS'AUTHORS'
p20784
aS'Grocholski T, Koskiniemi H, Lindqvist Y, Mantsala P, Niemi J, Schneider G'
p20785
aS'TITLE'
p20786
aS'Crystal structure of the cofactor-independent monooxygenase SnoaB from Streptomyces nogalater: implications for the reaction mechanism.'
p20787
aS'JOURNAL'
p20788
aS'Biochemistry 49:934-44 (2010)'
p20789
aS'PMID:19255477'
p20790
ag20790
aS'AUTHORS'
p20791
aS'Koskiniemi H, Grocholski T, Schneider G, Niemi J'
p20792
aS'TITLE'
p20793
aS'Expression, purification and crystallization of the cofactor-independent monooxygenase SnoaB from the nogalamycin biosynthetic pathway.'
p20794
aS'JOURNAL'
p20795
aS'Acta Crystallogr Sect F Struct Biol Cryst Commun 65:256-9 (2009)'
p20796
aS'PMID:12399480'
p20797
ag20797
aS'AUTHORS'
p20798
aS'Chung JY, Fujii I, Harada S, Sankawa U, Ebizuka Y'
p20799
aS'TITLE'
p20800
aS'Expression, purification, and characterization of AknX anthrone oxygenase, which'
p20801
aS'is involved in aklavinone biosynthesis in Streptomyces galilaeus.'
p20802
aS'JOURNAL'
p20803
aS'J Bacteriol 184:6115-22 (2002)'
p20804
aS'PMID:7836284'
p20805
ag20805
aS'AUTHORS'
p20806
aS'Dickens ML, Ye J, Strohl WR'
p20807
aS'TITLE'
p20808
aS'Analysis of clustered genes encoding both early and late steps in daunomycin biosynthesis by Streptomyces sp. strain C5.'
p20809
aS'JOURNAL'
p20810
aS'J Bacteriol 177:536-43 (1995)'
p20811
aS'PMID:10639368'
p20812
ag20812
aS'AUTHORS'
p20813
aS'Torkkell S, Kunnari T, Palmu K, Hakala J, Mantsala P, Ylihonko K'
p20814
aS'TITLE'
p20815
aS'Identification of a cyclase gene dictating the C-9 stereochemistry of anthracyclines from Streptomyces nogalater.'
p20816
aS'JOURNAL'
p20817
aS'Antimicrob Agents Chemother 44:396-9 (2000)'
p20818
aS'PMID:15071504'
p20819
ag20819
aS'AUTHORS'
p20820
aS'Sultana A, Kallio P, Jansson A, Wang JS, Niemi J, Mantsala P, Schneider G'
p20821
aS'TITLE'
p20822
aS'Structure of the polyketide cyclase SnoaL reveals a novel mechanism for enzymatic aldol condensation.'
p20823
aS'JOURNAL'
p20824
aS'EMBO J 23:1911-21 (2004)'
p20825
aS'PMID:16414075'
p20826
ag20826
aS'AUTHORS'
p20827
aS'Kallio P, Sultana A, Niemi J, Mantsala P, Schneider G'
p20828
aS'TITLE'
p20829
aS'Crystal structure of the polyketide cyclase AknH with bound substrate and product analogue: implications for catalytic mechanism and product stereoselectivity.'
p20830
aS'JOURNAL'
p20831
aS'J Mol Biol 357:210-20 (2006)'
p20832
aS'PMID:8655529'
p20833
ag20833
aS'AUTHORS'
p20834
aS'Dickens ML, Ye J, Strohl WR'
p20835
aS'TITLE'
p20836
aS'Cloning, sequencing, and analysis of aklaviketone reductase from Streptomyces sp. strain C5.'
p20837
aS'JOURNAL'
p20838
aS'J Bacteriol 178:3384-8 (1996)'
p20839
aS'PMID:17685523'
p20840
ag20840
aS'AUTHORS'
p20841
aS'Leimkuhler C, Fridman M, Lupoli T, Walker S, Walsh CT, Kahne D'
p20842
aS'TITLE'
p20843
aS'Characterization of rhodosaminyl transfer by the AknS/AknT glycosylation complex'
p20844
aS'and its use in reconstituting the biosynthetic pathway of aclacinomycin A.'
p20845
aS'JOURNAL'
p20846
aS'J Am Chem Soc 129:10546-50 (2007)'
p20847
aS'PMID:15911373'
p20848
ag20848
aS'AUTHORS'
p20849
aS'Lu W, Leimkuhler C, Gatto GJ Jr, Kruger RG, Oberthur M, Kahne D, Walsh CT'
p20850
aS'TITLE'
p20851
aS'AknT is an activating protein for the glycosyltransferase AknS in L-aminodeoxysugar transfer to the aglycone of aclacinomycin A.'
p20852
aS'JOURNAL'
p20853
aS'Chem Biol 12:527-34 (2005)'
p20854
aS'PMID:15078101'
p20855
ag20855
aS'AUTHORS'
p20856
aS'Lu W, Leimkuhler C, Oberthur M, Kahne D, Walsh CT'
p20857
aS'TITLE'
p20858
aS'AknK is an L-2-deoxyfucosyltransferase in the biosynthesis of the anthracycline aclacinomycin A.'
p20859
aS'JOURNAL'
p20860
aS'Biochemistry 43:4548-58 (2004)'
p20861
aS'PMID:17395717'
p20862
ag20862
aS'AUTHORS'
p20863
aS'Alexeev I, Sultana A, Mantsala P, Niemi J, Schneider G'
p20864
aS'TITLE'
p20865
aS'Aclacinomycin oxidoreductase (AknOx) from the biosynthetic pathway of the antibiotic aclacinomycin is an unusual flavoenzyme with a dual active site.'
p20866
aS'JOURNAL'
p20867
aS'Proc Natl Acad Sci U S A 104:6170-5 (2007)'
p20868
aS'PMID:19744497'
p20869
ag20869
aS'AUTHORS'
p20870
aS'Lindqvist Y, Koskiniemi H, Jansson A, Sandalova T, Schnell R, Liu Z, Mantsala P, Niemi J, Schneider G'
p20871
aS'TITLE'
p20872
aS'Structural basis for substrate recognition and specificity in aklavinone-11-hydroxylase from rhodomycin biosynthesis.'
p20873
aS'JOURNAL'
p20874
aS'J Mol Biol 393:966-77 (2009)'
p20875
aS'PMID:20116225'
p20876
ag20876
aS'AUTHORS'
p20877
aS'Malla S, Niraula NP, Singh B, Liou K, Sohng JK'
p20878
aS'TITLE'
p20879
aS'Limitations in doxorubicin production from Streptomyces peucetius.'
p20880
aS'JOURNAL'
p20881
aS'Microbiol Res 165:427-35 (2010)'
p20882
aS'PMID:7592454'
p20883
ag20883
aS'AUTHORS'
p20884
aS'Otten SL, Liu X, Ferguson J, Hutchinson CR'
p20885
aS'TITLE'
p20886
aS'Cloning and characterization of the Streptomyces peucetius dnrQS genes encoding a daunosamine biosynthesis enzyme and a glycosyl transferase involved in daunorubicin biosynthesis.'
p20887
aS'JOURNAL'
p20888
aS'J Bacteriol 177:6688-92 (1995)'
p20889
aS'PMID:19619853'
p20890
ag20890
aS'AUTHORS'
p20891
aS'Malla S, Niraula NP, Liou K, Sohng JK'
p20892
aS'TITLE'
p20893
aS'Enhancement of doxorubicin production by expression of structural sugar biosynthesis and glycosyltransferase genes in Streptomyces peucetius.'
p20894
aS'JOURNAL'
p20895
aS'J Biosci Bioeng 108:92-8 (2009)'
p20896
aS'PMID:9098063'
p20897
ag20897
aS'AUTHORS'
p20898
aS'Dickens ML, Priestley ND, Strohl WR'
p20899
aS'TITLE'
p20900
aS'In vivo and in vitro bioconversion of epsilon-rhodomycinone glycoside to doxorubicin: functions of DauP, DauK, and DoxA.'
p20901
aS'JOURNAL'
p20902
aS'J Bacteriol 179:2641-50 (1997)'
p20903
aS'PMID:9864344'
p20904
ag20904
aS'AUTHORS'
p20905
aS'Lomovskaya N, Otten SL, Doi-Katayama Y, Fonstein L, Liu XC, Takatsu T, Inventi-Solari A, Filippini S, Torti F, Colombo AL, Hutchinson CR'
p20906
aS'TITLE'
p20907
aS'Doxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene.'
p20908
aS'JOURNAL'
p20909
aS'J Bacteriol 181:305-18 (1999)'
p20910
aS'PMID:15548527'
p20911
ag20911
aS'AUTHORS'
p20912
aS'Jansson A, Koskiniemi H, Erola A, Wang J, Mantsala P, Schneider G, Niemi J'
p20913
aS'TITLE'
p20914
aS'Aclacinomycin 10-hydroxylase is a novel substrate-assisted hydroxylase requiring'
p20915
aS'S-adenosyl-L-methionine as cofactor.'
p20916
aS'JOURNAL'
p20917
aS'J Biol Chem 280:3636-44 (2005)'
p20918
aS'PMID:11520231'
p20919
ag20919
aS'AUTHORS'
p20920
aS'Wohlert SE, Wendt-Pienkowski E, Bao W, Hutchinson CR'
p20921
aS'TITLE'
p20922
aS'Production of aromatic minimal polyketides by the daunorubicin polyketide synthase genes reveals the incompatibility of the heterologous DpsY and JadI cyclases.'
p20923
aS'JOURNAL'
p20924
aS'J Nat Prod 64:1077-80 (2001)'
p20925
aS'PMID:20358042'
p20926
ag20926
aS'AUTHORS'
p20927
aS'Zhou H, Li Y, Tang Y'
p20928
aS'TITLE'
p20929
aS'Cyclization of aromatic polyketides from bacteria and fungi.'
p20930
aS'JOURNAL'
p20931
aS'Nat Prod Rep 27:839-68 (2010)'
p20932
aS'PMID:17268612'
p20933
ag20933
aS'AUTHORS'
p20934
aS'Hertweck C, Luzhetskyy A, Rebets Y, Bechthold A'
p20935
aS'TITLE'
p20936
aS'Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork.'
p20937
aS'JOURNAL'
p20938
aS'Nat Prod Rep 24:162-90 (2007)'
p20939
aS'PMID:20422670'
p20940
ag20940
aS'AUTHORS'
p20941
aS'Chen Y, Fan K, He Y, Xu X, Peng Y, Yu T, Jia C, Yang K'
p20942
aS'TITLE'
p20943
aS'Characterization of JadH as an FAD- and NAD(P)H-dependent bifunctional hydroxylase/dehydrase in jadomycin biosynthesis.'
p20944
aS'JOURNAL'
p20945
aS'Chembiochem 11:1055-60 (2010)'
p20946
aS'PMID:15776503'
p20947
ag20947
aS'AUTHORS'
p20948
aS'Rix U, Wang C, Chen Y, Lipata FM, Remsing Rix LL, Greenwell LM, Vining LC, Yang K, Rohr J'
p20949
aS'TITLE'
p20950
aS'The oxidative ring cleavage in jadomycin biosynthesis: a multistep oxygenation cascade in a biosynthetic black box.'
p20951
aS'JOURNAL'
p20952
aS'Chembiochem 6:838-45 (2005)'
p20953
aS'PMID:15817470'
p20954
ag20954
aS'AUTHORS'
p20955
aS'Chen YH, Wang CC, Greenwell L, Rix U, Hoffmeister D, Vining LC, Rohr J, Yang KQ'
p20956
aS'TITLE'
p20957
aS'Functional analyses of oxygenases in jadomycin biosynthesis and identification of JadH as a bifunctional oxygenase/dehydrase.'
p20958
aS'JOURNAL'
p20959
aS'J Biol Chem 280:22508-14 (2005)'
p20960
aS'PMID:17570722'
p20961
ag20961
aS'AUTHORS'
p20962
aS'Borissow CN, Graham CL, Syvitski RT, Reid TR, Blay J, Jakeman DL'
p20963
aS'TITLE'
p20964
aS'Stereochemical integrity of oxazolone ring-containing jadomycins.'
p20965
aS'JOURNAL'
p20966
aS'Chembiochem 8:1198-203 (2007)'
p20967
aS'PMID:17640665'
p20968
ag20968
aS'AUTHORS'
p20969
aS'Mittler M, Bechthold A, Schulz GE'
p20970
aS'TITLE'
p20971
aS'Structure and action of the C-C bond-forming glycosyltransferase UrdGT2 involved'
p20972
aS'in the biosynthesis of the antibiotic urdamycin.'
p20973
aS'JOURNAL'
p20974
aS'J Mol Biol 372:67-76 (2007)'
p20975
aS'PMID:10662691'
p20976
ag20976
aS'AUTHORS'
p20977
aS'Trefzer A, Hoffmeister D, Kunzel E, Stockert S, Weitnauer G, Westrich L, Rix U, Fuchser J, Bindseil KU, Rohr J, Bechthold A'
p20978
aS'TITLE'
p20979
aS'Function of glycosyltransferase genes involved in urdamycin A biosynthesis.'
p20980
aS'JOURNAL'
p20981
aS'Chem Biol 7:133-42 (2000)'
p20982
aS'PMID:11410375'
p20983
ag20983
aS'AUTHORS'
p20984
aS'Hoffmeister D, Ichinose K, Bechthold A'
p20985
aS'TITLE'
p20986
aS'Two sequence elements of glycosyltransferases involved in urdamycin biosynthesis'
p20987
aS'are responsible for substrate specificity and enzymatic activity.'
p20988
aS'JOURNAL'
p20989
aS'Chem Biol 8:557-67 (2001)'
p20990
ag22
ag22
aS'AUTHORS'
p20991
aS'Rohr J, Schonewolf M, Udvarnoki G, Eckardt K, Schumann G, Wagner C, Beale JM, Sorey SD'
p20992
aS'TITLE'
p20993
aS'Investigations on the biosynthesis of the angucycline group antibiotics aquayamycin and the urdamycins A and B. Results from the structural analysis of novel blocked mutant products.'
p20994
aS'JOURNAL'
p20995
aS'J Org Chem 58:2547-51 (1993)'
p20996
aS'PMID:15651811'
p20997
ag20997
aS'AUTHORS'
p20998
aS'Zhu L, Ostash B, Rix U, Nur-E-Alam M, Mayers A, Luzhetskyy A, Mendez C, Salas JA, Bechthold A, Fedorenko V, Rohr J'
p20999
aS'TITLE'
p21000
aS'Identification of the function of gene lndM2 encoding a bifunctional oxygenase-reductase involved in the biosynthesis of the antitumor antibiotic landomycin E by Streptomyces globisporus 1912 supports the originally assigned structure for landomycinone.'
p21001
aS'JOURNAL'
p21002
aS'J Org Chem 70:631-8 (2005)'
p21003
aS'PMID:17061307'
p21004
ag21004
aS'AUTHORS'
p21005
aS'Baig I, Kharel M, Kobylyanskyy A, Zhu L, Rebets Y, Ostash B, Luzhetskyy A, Bechthold A, Fedorenko VA, Rohr J'
p21006
aS'TITLE'
p21007
aS'On the acceptor substrate of C-glycosyltransferase UrdGT2: three prejadomycin C-Glycosides from an engineered mutant of Streptomyces globisporus 1912 DeltalndE(urdGT2).'
p21008
aS'JOURNAL'
p21009
aS'Angew Chem Int Ed Engl 45:7842-6 (2006)'
p21010
aS'PMID:15123249'
p21011
ag21011
aS'AUTHORS'
p21012
aS'Ostash B, Rix U, Rix LL, Liu T, Lombo F, Luzhetskyy A, Gromyko O, Wang C, Brana AF, Mendez C, Salas JA, Fedorenko V, Rohr J'
p21013
aS'TITLE'
p21014
aS'Generation of new landomycins by combinatorial biosynthetic manipulation of the LndGT4 gene of the landomycin E cluster in S. globisporus.'
p21015
aS'JOURNAL'
p21016
aS'Chem Biol 11:547-55 (2004)'
p21017
aS'PMID:17013601'
p21018
ag21018
aS'AUTHORS'
p21019
aS'Lombo F, Menendez N, Salas JA, Mendez C'
p21020
aS'TITLE'
p21021
aS'The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.'
p21022
aS'JOURNAL'
p21023
aS'Appl Microbiol Biotechnol 73:1-14 (2006)'
p21024
aS'PMID:12022840'
p21025
ag21025
aS'AUTHORS'
p21026
aS'Trefzer A, Blanco G, Remsing L, Kunzel E, Rix U, Lipata F, Brana AF, Mendez C, Rohr J, Bechthold A, Salas JA'
p21027
aS'TITLE'
p21028
aS'Rationally designed glycosylated premithramycins: hybrid aromatic polyketides using genes from three different biosynthetic pathways.'
p21029
aS'JOURNAL'
p21030
aS'J Am Chem Soc 124:6056-62 (2002)'
p21031
aS'PMID:10652287'
p21032
ag21032
aS'AUTHORS'
p21033
aS'Lozano MJ, Remsing LL, Quiros LM, Brana AF, Fernandez E, Sanchez C, Mendez C, Rohr J, Salas JA'
p21034
aS'TITLE'
p21035
aS'Characterization of two polyketide methyltransferases involved in the biosynthesis of the antitumor drug mithramycin by Streptomyces argillaceus.'
p21036
aS'JOURNAL'
p21037
aS'J Biol Chem 275:3065-74 (2000)'
p21038
aS'PMID:10660060'
p21039
ag21039
aS'AUTHORS'
p21040
aS'Blanco G, Fernandez E, Fernandez MJ, Brana AF, Weissbach U, Kunzel E, Rohr J, Mendez C, Salas JA'
p21041
aS'TITLE'
p21042
aS'Characterization of two glycosyltransferases involved in early glycosylation steps during biosynthesis of the antitumor polyketide mithramycin by Streptomyces argillaceus.'
p21043
aS'JOURNAL'
p21044
aS'Mol Gen Genet 262:991-1000 (2000)'
p21045
aS'PMID:15712316'
p21046
ag21046
aS'AUTHORS'
p21047
aS'Nur-e-Alam M, Mendez C, Salas JA, Rohr J'
p21048
aS'TITLE'
p21049
aS'Elucidation of the glycosylation sequence of mithramycin biosynthesis: isolation'
p21050
aS'of 3A-deolivosylpremithramycin B and its conversion to premithramycin B by glycosyltransferase MtmGII.'
p21051
aS'JOURNAL'
p21052
aS'Chembiochem 6:632-6 (2005)'
p21053
aS'PMID:9733697'
p21054
ag21054
aS'AUTHORS'
p21055
aS'Fernandez E, Weissbach U, Sanchez Reillo C, Brana AF, Mendez C, Rohr J, Salas JA'
p21056
aS'TITLE'
p21057
aS'Identification of two genes from Streptomyces argillaceus encoding glycosyltransferases involved in transfer of a disaccharide during biosynthesis of the antitumor drug mithramycin.'
p21058
aS'JOURNAL'
p21059
aS'J Bacteriol 180:4929-37 (1998)'
p21060
aS'PMID:19364090'
p21061
ag21061
aS'AUTHORS'
p21062
aS'Beam MP, Bosserman MA, Noinaj N, Wehenkel M, Rohr J'
p21063
aS'TITLE'
p21064
aS'Crystal structure of Baeyer-Villiger monooxygenase MtmOIV, the key enzyme of the'
p21065
aS'mithramycin biosynthetic pathway .'
p21066
aS'JOURNAL'
p21067
aS'Biochemistry 48:4476-87 (2009)'
p21068
aS'PMID:16511225'
p21069
ag21069
aS'AUTHORS'
p21070
aS'Wang C, Gibson M, Rohr J, Oliveira MA'
p21071
aS'TITLE'
p21072
aS'Crystallization and X-ray diffraction properties of Baeyer-Villiger monooxygenase MtmOIV from the mithramycin biosynthetic pathway in Streptomyces argillaceus.'
p21073
aS'JOURNAL'
p21074
aS'Acta Crystallogr Sect F Struct Biol Cryst Commun 61:1023-6 (2005)'
p21075
aS'PMID:12813091'
p21076
ag21076
aS'AUTHORS'
p21077
aS'Rodriguez D, Quiros LM, Brana AF, Salas JA'
p21078
aS'TITLE'
p21079
aS'Purification and characterization of a monooxygenase involved in the biosynthetic pathway of the antitumor drug mithramycin.'
p21080
aS'JOURNAL'
p21081
aS'J Bacteriol 185:3962-5 (2003)'
p21082
aS'PMID:11851469'
p21083
ag21083
aS'AUTHORS'
p21084
aS'Hutchinson CR'
p21085
aS'TITLE'
p21086
aS'Biosynthetic Studies of Daunorubicin and Tetracenomycin C.'
p21087
aS'JOURNAL'
p21088
aS'Chem Rev 97:2525-2536 (1997)'
p21089
aS'PMID:8244926'
p21090
ag21090
aS'AUTHORS'
p21091
aS'Summers RG, Wendt-Pienkowski E, Motamedi H, Hutchinson CR'
p21092
aS'TITLE'
p21093
aS'The tcmVI region of the tetracenomycin C biosynthetic gene cluster of Streptomyces glaucescens encodes the tetracenomycin F1 monooxygenase, tetracenomycin F2 cyclase, and, most likely, a second cyclase.'
p21094
aS'JOURNAL'
p21095
aS'J Bacteriol 175:7571-80 (1993)'
p21096
aS'PMID:8218177'
p21097
ag21097
aS'AUTHORS'
p21098
aS'Shen B, Hutchinson CR'
p21099
aS'TITLE'
p21100
aS'Tetracenomycin F2 cyclase: intramolecular aldol condensation in the biosynthesis'
p21101
aS'of tetracenomycin C in Streptomyces glaucescens.'
p21102
aS'JOURNAL'
p21103
aS'Biochemistry 32:11149-54 (1993)'
p21104
aS'PMID:8329392'
p21105
ag21105
aS'AUTHORS'
p21106
aS'Shen B, Hutchinson CR'
p21107
aS'TITLE'
p21108
aS'Tetracenomycin F1 monooxygenase: oxidation of a naphthacenone to a naphthacenequinone in the biosynthesis of tetracenomycin C in Streptomyces glaucescens.'
p21109
aS'JOURNAL'
p21110
aS'Biochemistry 32:6656-63 (1993)'
p21111
aS'PMID:1548230'
p21112
ag21112
aS'AUTHORS'
p21113
aS'Summers RG, Wendt-Pienkowski E, Motamedi H, Hutchinson CR'
p21114
aS'TITLE'
p21115
aS'Nucleotide sequence of the tcmII-tcmIV region of the tetracenomycin C biosynthetic gene cluster of Streptomyces glaucescens and evidence that the tcmN'
p21116
aS'gene encodes a multifunctional cyclase-dehydratase-O-methyl transferase.'
p21117
aS'JOURNAL'
p21118
aS'J Bacteriol 174:1810-20 (1992)'
p21119
aS'PMID:18388203'
p21120
ag21120
aS'AUTHORS'
p21121
aS'Ames BD, Korman TP, Zhang W, Smith P, Vu T, Tang Y, Tsai SC'
p21122
aS'TITLE'
p21123
aS'Crystal structure and functional analysis of tetracenomycin ARO/CYC: implications for cyclization specificity of aromatic polyketides.'
p21124
aS'JOURNAL'
p21125
aS'Proc Natl Acad Sci U S A 105:5349-54 (2008)'
p21126
aS'PMID:11009387'
p21127
ag21127
aS'AUTHORS'
p21128
aS'Rafanan ER Jr, Hutchinson CR, Shen B'
p21129
aS'TITLE'
p21130
aS'Triple hydroxylation of tetracenomycin A2 to tetracenomycin C involving two molecules of O(2) and one molecule of H(2)O.'
p21131
aS'JOURNAL'
p21132
aS'Org Lett 2:3225-7 (2000)'
p21133
aS'PMID:18310024'
p21134
ag21134
aS'AUTHORS'
p21135
aS'Ramos A, Lombo F, Brana AF, Rohr J, Mendez C, Salas JA'
p21136
aS'TITLE'
p21137
aS'Biosynthesis of elloramycin in Streptomyces olivaceus requires glycosylation by enzymes encoded outside the aglycon cluster.'
p21138
aS'JOURNAL'
p21139
aS'Microbiology 154:781-8 (2008)'
p21140
aS'PMID:11376004'
p21141
ag21141
aS'AUTHORS'
p21142
aS'Patallo EP, Blanco G, Fischer C, Brana AF, Rohr J, Mendez C, Salas JA'
p21143
aS'TITLE'
p21144
aS'Deoxysugar methylation during biosynthesis of the antitumor polyketide elloramycin by Streptomyces olivaceus. Characterization of three methyltransferase genes.'
p21145
aS'JOURNAL'
p21146
aS'J Biol Chem 276:18765-74 (2001)'
p21147
asS'KO_PATHWAY'
p21148
(lp21149
S'ko01057'
p21150
asS'ENTRY'
p21151
(lp21152
S'map01057'
p21153
aS'Pathway'
p21154
asS'PATHWAY_MAP'
p21155
(lp21156
S'map01057'
p21157
asS'CLASS'
p21158
(lp21159
S'Metabolism Metabolism of terpenoids and polyketides'
p21160
assS'path:map01054'
p21161
(dp21162
S'NAME'
p21163
(lp21164
S'Nonribosomal peptide structures'
p21165
asS'REFERENCE'
p21166
(lp21167
S'PMID:9864322'
p21168
ag21168
aS'AUTHORS'
p21169
aS'Konz D, Doekel S, Marahiel MA.'
p21170
aS'TITLE'
p21171
aS'Molecular and biochemical characterization of the protein template controlling biosynthesis of the lipopeptide lichenysin.'
p21172
aS'JOURNAL'
p21173
aS'J Bacteriol 181:133-40 (1999)'
p21174
aS'PMID:15109718'
p21175
ag21175
aS'AUTHORS'
p21176
aS'Moyne AL, Cleveland TE, Tuzun S.'
p21177
aS'TITLE'
p21178
aS'Molecular characterization and analysis of the operon encoding the antifungal lipopeptide bacillomycin D.'
p21179
aS'JOURNAL'
p21180
aS'FEMS Microbiol Lett 234:43-9 (2004)'
p21181
aS'PMID:9830033'
p21182
ag21182
aS'AUTHORS'
p21183
aS'Guenzi E, Galli G, Grgurina I, Gross DC, Grandi G.'
p21184
aS'TITLE'
p21185
aS'Characterization of the syringomycin synthetase gene cluster. A link between prokaryotic and eukaryotic peptide synthetases.'
p21186
aS'JOURNAL'
p21187
aS'J Biol Chem 273:32857-63 (1998)'
p21188
aS'PMID:9303382'
p21189
ag21189
aS'AUTHORS'
p21190
aS'de Crecy-Lagard V, Saurin W, Thibaut D, Gil P, Naudin L, Crouzet J, Blanc V'
p21191
aS'TITLE'
p21192
aS'Streptogramin B biosynthesis in Streptomyces pristinaespiralis and Streptomyces virginiae: molecular characterization of the last structural peptide synthetase gene.'
p21193
aS'JOURNAL'
p21194
aS'Antimicrob Agents Chemother 41:1904-9 (1997)'
p21195
aS'PMID:11048953'
p21196
ag21196
aS'AUTHORS'
p21197
aS'Du L, Sanchez C, Chen M, Edwards DJ, Shen B.'
p21198
aS'TITLE'
p21199
aS'The biosynthetic gene cluster for the antitumor drug bleomycin from Streptomyces verticillus ATCC15003 supporting functional interactions between nonribosomal peptide synthetases and a polyketide synthase.'
p21200
aS'JOURNAL'
p21201
aS'Chem Biol 7:623-42 (2000)'
p21202
aS'PMID:14766543'
p21203
ag21203
aS'AUTHORS'
p21204
aS'Rouhiainen L, Vakkilainen T, Siemer BL, Buikema W, Haselkorn R, Sivonen K'
p21205
aS'TITLE'
p21206
aS'Genes coding for hepatotoxic heptapeptides (microcystins) in the cyanobacterium Anabaena strain 90.'
p21207
aS'JOURNAL'
p21208
aS'Appl Environ Microbiol 70:686-92 (2004)'
p21209
aS'PMID:11001063'
p21210
ag21210
aS'AUTHORS'
p21211
aS'Trauger JW, Kohli RM, Mootz HD, Marahiel MA, Walsh CT.'
p21212
aS'TITLE'
p21213
aS'Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase.'
p21214
aS'JOURNAL'
p21215
aS'Nature 407:215-8 (2000)'
p21216
asS'KO_PATHWAY'
p21217
(lp21218
S'ko01054'
p21219
asS'ENTRY'
p21220
(lp21221
S'map01054'
p21222
aS'Pathway'
p21223
asS'PATHWAY_MAP'
p21224
(lp21225
S'map01054'
p21226
asS'CLASS'
p21227
(lp21228
S'Metabolism Metabolism of terpenoids and polyketides'
p21229
assS'path:map01055'
p21230
(dp21231
S'NAME'
p21232
(lp21233
S'Biosynthesis of vancomycin group antibiotics'
p21234
asS'REFERENCE'
p21235
(lp21236
S'PMID:24884615'
p21237
ag21237
aS'AUTHORS'
p21238
aS'Xu L, Huang H, Wei W, Zhong Y, Tang B, Yuan H, Zhu L, Huang W, Ge M, Yang S, Zheng H, Jiang W, Chen D, Zhao GP, Zhao W'
p21239
aS'TITLE'
p21240
aS'Complete genome sequence and comparative genomic analyses of the vancomycin-producing Amycolatopsis orientalis.'
p21241
aS'JOURNAL'
p21242
aS'BMC Genomics 15:363 (2014)'
p21243
aS'PMID:12596194'
p21244
ag21244
aS'AUTHORS'
p21245
aS'Hubbard BK, Walsh CT.'
p21246
aS'TITLE'
p21247
aS"Vancomycin assembly: nature's way."
p21248
aS'JOURNAL'
p21249
aS'Angew Chem Int Ed Engl 42:730-65 (2003)'
p21250
aS'PMID:11035791'
p21251
ag21251
aS'AUTHORS'
p21252
aS'Chen H, Thomas MG, Hubbard BK, Losey HC, Walsh CT, Burkart MD.'
p21253
aS'TITLE'
p21254
aS'Deoxysugars in glycopeptide antibiotics: enzymatic synthesis of TDP-L-epivancosamine in chloroeremomycin biosynthesis.'
p21255
aS'JOURNAL'
p21256
aS'Proc Natl Acad Sci U S A 97:11942-7 (2000)'
p21257
aS'PMID:9545426'
p21258
ag21258
aS'AUTHORS'
p21259
aS'van Wageningen AM, Kirkpatrick PN, Williams DH, Harris BR, Kershaw JK, Lennard NJ, Jones M, Jones SJ, Solenberg PJ.'
p21260
aS'TITLE'
p21261
aS'Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic.'
p21262
aS'JOURNAL'
p21263
aS'Chem Biol 5:155-62 (1998)'
p21264
asS'KO_PATHWAY'
p21265
(lp21266
S'ko01055'
p21267
asS'ENTRY'
p21268
(lp21269
S'map01055'
p21270
aS'Pathway'
p21271
asS'PATHWAY_MAP'
p21272
(lp21273
S'map01055'
p21274
asS'CLASS'
p21275
(lp21276
S'Metabolism Metabolism of terpenoids and polyketides'
p21277
assS'path:map01052'
p21278
(dp21279
S'ENTRY'
p21280
(lp21281
S'map01052'
p21282
aS'Pathway'
p21283
asS'PATHWAY_MAP'
p21284
(lp21285
S'map01052'
p21286
asS'CLASS'
p21287
(lp21288
S'Metabolism Metabolism of terpenoids and polyketides'
p21289
asS'NAME'
p21290
(lp21291
S'Type I polyketide structures'
p21292
asS'KO_PATHWAY'
p21293
(lp21294
S'ko01052'
p21295
assS'path:map01053'
p21296
(dp21297
S'NAME'
p21298
(lp21299
S'Biosynthesis of siderophore group nonribosomal peptides'
p21300
asS'REFERENCE'
p21301
(lp21302
S'PMID:12040125'
p21303
ag21303
aS'AUTHORS'
p21304
aS'Crosa JH, Walsh CT.'
p21305
aS'TITLE'
p21306
aS'Genetics and assembly line enzymology of siderophore biosynthesis in bacteria.'
p21307
aS'JOURNAL'
p21308
aS'Microbiol Mol Biol Rev 66:223-49 (2002)'
p21309
aS'PMID:9818149'
p21310
ag21310
aS'AUTHORS'
p21311
aS'Gehring AM, DeMoll E, Fetherston JD, Mori I, Mayhew GF, Blattner FR, Walsh CT, Perry RD.'
p21312
aS'TITLE'
p21313
aS'Iron acquisition in plague: modular logic in enzymatic biogenesis of yersiniabactin by Yersinia pestis.'
p21314
aS'JOURNAL'
p21315
aS'Chem Biol 5:573-86 (1998)'
p21316
aS'PMID:11029592'
p21317
ag21317
aS'AUTHORS'
p21318
aS'Silakowski B, Kunze B, Nordsiek G, Blocker H, Hofle G, Muller R.'
p21319
aS'TITLE'
p21320
aS'The myxochelin iron transport regulon of the myxobacterium Stigmatella aurantiaca Sg a15.'
p21321
aS'JOURNAL'
p21322
aS'Eur J Biochem 267:6476-85 (2000)'
p21323
aS'PMID:11112537'
p21324
ag21324
aS'AUTHORS'
p21325
aS'Keating TA, Marshall CG, Walsh CT.'
p21326
aS'TITLE'
p21327
aS'Vibriobactin biosynthesis in Vibrio cholerae: VibH is an amide synthase homologous to nonribosomal peptide synthetase condensation domains.'
p21328
aS'JOURNAL'
p21329
aS'Biochemistry 39:15513-21 (2000)'
p21330
aS'PMID:10692387'
p21331
ag21331
aS'AUTHORS'
p21332
aS'Hantash FM, Earhart CF.'
p21333
aS'TITLE'
p21334
aS'Membrane association of the Escherichia coli enterobactin synthase proteins EntB/G, EntE, and EntF.'
p21335
aS'JOURNAL'
p21336
aS'J Bacteriol 182:1768-73 (2000)'
p21337
asS'KO_PATHWAY'
p21338
(lp21339
S'ko01053'
p21340
asS'ENTRY'
p21341
(lp21342
S'map01053'
p21343
aS'Pathway'
p21344
asS'PATHWAY_MAP'
p21345
(lp21346
S'map01053'
p21347
asS'CLASS'
p21348
(lp21349
S'Metabolism Metabolism of terpenoids and polyketides'
p21350
assS'path:map01051'
p21351
(dp21352
S'NAME'
p21353
(lp21354
S'Biosynthesis of ansamycins'
p21355
asS'REFERENCE'
p21356
(lp21357
S'PMID:22193711'
p21358
ag21358
aS'AUTHORS'
p21359
aS'Kang Q, Shen Y, Bai L'
p21360
aS'TITLE'
p21361
aS'Biosynthesis of 3,5-AHBA-derived natural products.'
p21362
aS'JOURNAL'
p21363
aS'Nat Prod Rep 29:243-63 (2012)'
p21364
aS'PMID:21081954'
p21365
ag21365
aS'AUTHORS'
p21366
aS'Floss HG, Yu TW, Arakawa K'
p21367
aS'TITLE'
p21368
aS'The biosynthesis of 3-amino-5-hydroxybenzoic acid (AHBA), the precursor of mC7N units in ansamycin and mitomycin antibiotics: a review.'
p21369
aS'JOURNAL'
p21370
aS'J Antibiot (Tokyo) 64:35-44 (2011)'
p21371
aS'PMID:12207504'
p21372
ag21372
aS'AUTHORS'
p21373
aS'Guo J, Frost JW'
p21374
aS'TITLE'
p21375
aS"Kanosamine biosynthesis: a likely source of the aminoshikimate pathway's nitrogen atom."
p21376
aS'JOURNAL'
p21377
aS'J Am Chem Soc 124:10642-3 (2002)'
p21378
aS'PMID:17076505'
p21379
ag21379
aS'AUTHORS'
p21380
aS'Wenzel SC, Williamson RM, Grunanger C, Xu J, Gerth K, Martinez RA, Moss SJ, Carroll BJ, Grond S, Unkefer CJ, Muller R, Floss HG'
p21381
aS'TITLE'
p21382
aS'On the biosynthetic origin of methoxymalonyl-acyl carrier protein, the substrate'
p21383
aS'for incorporation of "glycolate" units into ansamitocin and soraphen A.'
p21384
aS'JOURNAL'
p21385
aS'J Am Chem Soc 128:14325-36 (2006)'
p21386
aS'PMID:11996558'
p21387
ag21387
aS'AUTHORS'
p21388
aS'Kato Y, Bai L, Xue Q, Revill WP, Yu TW, Floss HG'
p21389
aS'TITLE'
p21390
aS'Functional expression of genes involved in the biosynthesis of the novel polyketide chain extension unit, methoxymalonyl-acyl carrier protein, and engineered biosynthesis of 2-desmethyl-2-methoxy-6-deoxyerythronolide B.'
p21391
aS'JOURNAL'
p21392
aS'J Am Chem Soc 124:5268-9 (2002)'
p21393
aS'PMID:12060743'
p21394
ag21394
aS'AUTHORS'
p21395
aS'Yu TW, Bai L, Clade D, Hoffmann D, Toelzer S, Trinh KQ, Xu J, Moss SJ, Leistner E, Floss HG'
p21396
aS'TITLE'
p21397
aS'The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum.'
p21398
aS'JOURNAL'
p21399
aS'Proc Natl Acad Sci U S A 99:7968-73 (2002)'
p21400
aS'PMID:14624546'
p21401
ag21401
aS'AUTHORS'
p21402
aS'Spiteller P, Bai L, Shang G, Carroll BJ, Yu TW, Floss HG'
p21403
aS'TITLE'
p21404
aS'The post-polyketide synthase modification steps in the biosynthesis of the antitumor agent ansamitocin by Actinosynnema pretiosum.'
p21405
aS'JOURNAL'
p21406
aS'J Am Chem Soc 125:14236-7 (2003)'
p21407
aS'PMID:19292483'
p21408
ag21408
aS'AUTHORS'
p21409
aS'Taft F, Brunjes M, Knobloch T, Floss HG, Kirschning A'
p21410
aS'TITLE'
p21411
aS'Timing of the Delta(10,12)-Delta(11,13) double bond migration during ansamitocin'
p21412
aS'biosynthesis in Actinosynnema pretiosum.'
p21413
aS'JOURNAL'
p21414
aS'J Am Chem Soc 131:3812-3 (2009)'
p21415
aS'PMID:22195559'
p21416
ag21416
aS'AUTHORS'
p21417
aS'Li Y, Zhao P, Kang Q, Ma J, Bai L, Deng Z'
p21418
aS'TITLE'
p21419
aS'Dual carbamoylations on the polyketide and glycosyl moiety by asm21 result in extended ansamitocin biosynthesis.'
p21420
aS'JOURNAL'
p21421
aS'Chem Biol 18:1571-80 (2011)'
p21422
aS'PMID:21681880'
p21423
ag21423
aS'AUTHORS'
p21424
aS'Wu Y, Kang Q, Shang G, Spiteller P, Carroll B, Yu TW, Su W, Bai L, Floss HG'
p21425
aS'TITLE'
p21426
aS'N-methylation of the amide bond by methyltransferase asm10 in ansamitocin biosynthesis.'
p21427
aS'JOURNAL'
p21428
aS'Chembiochem 12:1759-66 (2011)'
p21429
aS'PMID:18721757'
p21430
ag21430
aS'AUTHORS'
p21431
aS'Zhao P, Bai L, Ma J, Zeng Y, Li L, Zhang Y, Lu C, Dai H, Wu Z, Li Y, Wu X, Chen G, Hao X, Shen Y, Deng Z, Floss HG'
p21432
aS'TITLE'
p21433
aS'Amide N-glycosylation by Asm25, an N-glycosyltransferase of ansamitocins.'
p21434
aS'JOURNAL'
p21435
aS'Chem Biol 15:863-74 (2008)'
p21436
aS'PMID:12207505'
p21437
ag21437
aS'AUTHORS'
p21438
aS'Arakawa K, Muller R, Mahmud T, Yu TW, Floss HG'
p21439
aS'TITLE'
p21440
aS'Characterization of the early stage aminoshikimate pathway in the formation of 3-amino-5-hydroxybenzoic acid: the RifN protein specifically converts kanosamine'
p21441
aS'into kanosamine 6-phosphate.'
p21442
aS'JOURNAL'
p21443
aS'J Am Chem Soc 124:10644-5 (2002)'
p21444
aS'PMID:12888623'
p21445
ag21445
aS'AUTHORS'
p21446
aS'Watanabe K, Rude MA, Walsh CT, Khosla C'
p21447
aS'TITLE'
p21448
aS'Engineered biosynthesis of an ansamycin polyketide precursor in Escherichia coli.'
p21449
aS'JOURNAL'
p21450
aS'Proc Natl Acad Sci U S A 100:9774-8 (2003)'
p21451
aS'PMID:15700959'
p21452
ag21452
aS'AUTHORS'
p21453
aS'Floss HG, Yu TW.'
p21454
aS'TITLE'
p21455
aS'Rifamycin-mode of action, resistance, and biosynthesis.'
p21456
aS'JOURNAL'
p21457
aS'Chem Rev 105:621-32 (2005)'
p21458
aS'PMID:12623077'
p21459
ag21459
aS'AUTHORS'
p21460
aS'Xu J, Mahmud T, Floss HG'
p21461
aS'TITLE'
p21462
aS'Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.'
p21463
aS'JOURNAL'
p21464
aS'Arch Biochem Biophys 411:277-88 (2003)'
p21465
aS'PMID:15791687'
p21466
ag21466
aS'AUTHORS'
p21467
aS'Xiong Y, Wu X, Mahmud T'
p21468
aS'TITLE'
p21469
aS'A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.'
p21470
aS'JOURNAL'
p21471
aS'Chembiochem 6:834-7 (2005)'
p21472
aS'PMID:16079331'
p21473
ag21473
aS'AUTHORS'
p21474
aS'Xu J, Wan E, Kim CJ, Floss HG, Mahmud T'
p21475
aS'TITLE'
p21476
aS'Identification of tailoring genes involved in the modification of the polyketide'
p21477
aS'backbone of rifamycin B by Amycolatopsis mediterranei S699.'
p21478
aS'JOURNAL'
p21479
aS'Microbiology 151:2515-28 (2005)'
p21480
asS'KO_PATHWAY'
p21481
(lp21482
S'ko01051'
p21483
asS'ENTRY'
p21484
(lp21485
S'map01051'
p21486
aS'Pathway'
p21487
asS'PATHWAY_MAP'
p21488
(lp21489
S'map01051'
p21490
asS'CLASS'
p21491
(lp21492
S'Metabolism Metabolism of terpenoids and polyketides'
p21493
assS'path:map07044'
p21494
(dp21495
S'ENTRY'
p21496
(lp21497
S'map07044'
p21498
aS'Drug'
p21499
aS'Pathway'
p21500
asS'PATHWAY_MAP'
p21501
(lp21502
S'map07044'
p21503
asS'NAME'
p21504
(lp21505
S'Antiviral agents'
p21506
asS'REFERENCE'
p21507
(lp21508
g22
ag22
aS'AUTHORS'
p21509
aS'Fukai S.'
p21510
aS'TITLE'
p21511
aS'[New Drugs Today (6th ed)] (In Japanese)'
p21512
aS'JOURNAL'
p21513
aS'Jiho (1995)'
p21514
ag22
ag22
aS'AUTHORS'
p21515
aS'David AW, Thomas LL, William OF.'
p21516
aS'TITLE'
p21517
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p21518
aS'JOURNAL'
p21519
aS'Lippincott Williams & Wilkins (2002)'
p21520
ag22
ag22
aS'AUTHORS'
p21521
aS'Walter S.'
p21522
aS'TITLE'
p21523
aS'Drug Discovery: A History'
p21524
aS'JOURNAL'
p21525
aS'Wiley (2005)'
p21526
ag22
ag22
aS'AUTHORS'
p21527
aS'Bertram GK (ed).'
p21528
aS'TITLE'
p21529
aS'Basic & Clinical Pharmacology (9th ed)'
p21530
aS'JOURNAL'
p21531
aS'Lange (2004)'
p21532
aS'PMID:16308532'
p21533
ag21533
aS'AUTHORS'
p21534
aS'Baba M.'
p21535
aS'TITLE'
p21536
aS'[Advances in antiviral chemotherapy]'
p21537
aS'JOURNAL'
p21538
aS'Uirusu 55:69-75 (2005)'
p21539
aS'PMID:12187768'
p21540
ag21540
aS'AUTHORS'
p21541
aS'Watabe T, Ogura K, Nishiyama T.'
p21542
aS'TITLE'
p21543
aS'[Molecular toxicological mechanism of the lethal interactions of the new antiviral drug, sorivudine, with 5-fluorouracil prodrugs and genetic deficiency of dihydropyrimidine dehydrogenase]'
p21544
aS'JOURNAL'
p21545
aS'Yakugaku Zasshi 122:527-35 (2002)'
p21546
aS'PMID:16421366'
p21547
ag21547
aS'AUTHORS'
p21548
aS'Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, Lu B, McColl D, Chuck S, Enejosa J, Toole JJ, Cheng AK.'
p21549
aS'TITLE'
p21550
aS'Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.'
p21551
aS'JOURNAL'
p21552
aS'N Engl J Med 354:251-60 (2006)'
p21553
aS'PMID:16641430'
p21554
ag21554
aS'AUTHORS'
p21555
aS'Lim SG, Krastev Z, Ng TM, Mechkov G, Kotzev IA, Chan S, Mondou E, Snow A, Sorbel J, Rousseau F'
p21556
aS'TITLE'
p21557
aS'Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B.'
p21558
aS'JOURNAL'
p21559
aS'Antimicrob Agents Chemother 50:1642-8 (2006)'
p21560
asS'COMPOUND'
p21561
(lp21562
S'D00222'
p21563
aS'Aciclovir (JP16/INN)'
p21564
ag21563
ag21564
aS'D00273'
p21565
aS'Cidofovir (USAN/INN)'
p21566
aS'D00296'
p21567
aS'Didanosine (JAN/USAN/INN)'
p21568
aS'D00317'
p21569
aS'Famciclovir (JAN/USAN/INN)'
p21570
aS'D00333'
p21571
aS'Ganciclovir (JAN/USP/INN)'
p21572
aS'D00342'
p21573
aS'Idoxuridine (JP16/USP/INN)'
p21574
aS'D00353'
p21575
aS'Lamivudine (JAN/USP/INN)'
p21576
aS'D00391'
p21577
aS'Trifluridine (JAN/USP/INN)'
p21578
aS'D00398'
p21579
aS'Valaciclovir hydrochloride (JAN)'
p21580
aS'D00406'
p21581
aS'Vidarabine (USP)'
p21582
aS'D00412'
p21583
aS'Zalcitabine (JAN/USP/INN)'
p21584
aS'D00413'
p21585
aS'Zidovudine (JP16/USP/INN)'
p21586
aS'D00423'
p21587
aS'Ribavirin (JAN/USP/INN)'
p21588
aS'D00445'
p21589
aS'Sanilvudine (JAN)'
p21590
aS'D00579'
p21591
aS'Foscarnet sodium (USAN/INN)'
p21592
aS'D00777'
p21593
aS'Amantadine hydrochloride (JP16/USP)'
p21594
aS'D00891'
p21595
aS'Abacavir sulfate (JAN/USAN)'
p21596
aS'D00900'
p21597
aS'Oseltamivir phosphate (JAN/USAN)'
p21598
aS'D00901'
p21599
aS'Rimantadine hydrochloride (USAN)'
p21600
aS'D00902'
p21601
aS'Zanamivir (USAN/INN)'
p21602
aS'D01655'
p21603
aS'Adefovir pivoxil (JAN)'
p21604
aS'D01734'
p21605
aS'Sorivudine (JAN/USAN/INN)'
p21606
aS'D01907'
p21607
aS'Fludarabine phosphate (JAN/USP)'
p21608
aS'D01937'
p21609
aS'Zanamivir hydrate (JAN)'
p21610
aS'D01982'
p21611
aS'Tenofovir disoproxil fumarate (JAN/USAN)'
p21612
aS'D02124'
p21613
aS'Penciclovir sodium (USAN)'
p21614
aS'D02267'
p21615
aS'Foscarnet sodium hydrate (JAN)'
p21616
aS'D02495'
p21617
aS'Valganciclovir (INN)'
p21618
aS'D02734'
p21619
aS'Abacavir succinate (USAN)'
p21620
aS'D02736'
p21621
aS'Fomivirsen sodium (USAN)'
p21622
aS'D02737'
p21623
aS'Palivizumab (genetical recombination) (JAN)'
p21624
aS'D02744'
p21625
aS'Interferon alfacon-1 (genetical recombination) (JAN)'
p21626
aS'D02745'
p21627
aS'Interferon alfa-2b (genetical recombination) (JAN)'
p21628
aS'D02747'
p21629
aS'Peginterferon alfa-2a (genetical recombination) (JAN)'
p21630
aS'D02748'
p21631
aS'Peginterferon alfa-2b (generical recombination) (JAN)'
p21632
aS'D02764'
p21633
aS'Acyclovir sodium (USAN)'
p21634
aS'D02781'
p21635
aS'Acemannan (USAN/INN)'
p21636
aS'D03256'
p21637
aS'Valganciclovir hydrochloride (JAN/USAN)'
p21638
aS'D03304'
p21639
aS'Interferon beta (JAN)'
p21640
aS'D03305'
p21641
aS'Interferon alfa (BALL-1) (JAN)'
p21642
aS'D03433'
p21643
aS'Celgosivir hydrochloride (USAN)'
p21644
aS'D03537'
p21645
aS'Clevudine (USAN)'
p21646
aS'D03829'
p21647
aS'Peramivir hydrate (JAN)'
p21648
aS'D03884'
p21649
aS'Docosanol (USAN)'
p21650
aS'D03956'
p21651
aS'Edoxudine (USAN/INN)'
p21652
aS'D04008'
p21653
aS'Entecavir hydrate (JAN)'
p21654
aS'D04301'
p21655
aS'Ganciclovir sodium (USAN)'
p21656
aS'D04432'
p21657
aS'Hepatitis B virus vaccine inactivated (USP XXX)'
p21658
aS'D04536'
p21659
aS'Influenza virus vaccine (USP)'
p21660
aS'D04757'
p21661
aS'Lobucavir (USAN/INN)'
p21662
aS'D04859'
p21663
aS'Maribavir (USAN/INN)'
p21664
aS'D04866'
p21665
aS'Freeze-dried live attenuated measles vaccine (JP16)'
p21666
aS'D05089'
p21667
aS'Freeze-dried live attenuated mumps vaccine (JP16)'
p21668
aS'D05182'
p21669
aS'Influenza HA vaccine (JP16)'
p21670
aS'D05248'
p21671
aS'Freeze-dried inactivated tissue culture ravies vaccine (JP16)'
p21672
aS'D05295'
p21673
aS'Smallpox vaccine (USP)'
p21674
aS'D05313'
p21675
aS'Japanese encephalitis vaccine (JP16)'
p21676
aS'D05324'
p21677
aS'Adsorbed hepatitis B vaccine (huGK-14 cell origin) (JAN)'
p21678
aS'D05362'
p21679
aS'Rubella virus vaccine live (USP)'
p21680
aS'D05407'
p21681
aS'Penciclovir (USAN/INN)'
p21682
aS'D05543'
p21683
aS'Poliovirus vaccine inactivated (USP)'
p21684
aS'D05544'
p21685
aS'Live oral polimyelitis vaccine (JP16)'
p21686
aS'D06298'
p21687
aS'Vidarabine (JAN)'
p21688
aS'D06299'
p21689
aS'Vidarabine phosphate (USAN)'
p21690
aS'D06300'
p21691
aS'Vidarabine sodium phosphate (USAN)'
p21692
aS'D06347'
p21693
aS'Yellow fever vaccine (USP)'
p21694
aS'D06475'
p21695
aS'Adsorbed hepatitis B vaccine (JP16)'
p21696
aS'D06486'
p21697
aS'Mumps virus vaccine live (USP)'
p21698
aS'D06510'
p21699
aS'Freeze-dried smallpox vaccine (JP16)'
p21700
aS'D06511'
p21701
aS'Freeze-dried smallpox vaccine prepared in cell culture (JP16)'
p21702
aS'D06512'
p21703
aS'Freeze-dried live attenuated rubella vaccine (JP16)'
p21704
aS'D06651'
p21705
aS'Taribavirin hydrochloride (USAN)'
p21706
aS'D06675'
p21707
aS'Telbivudine (USAN/INN)'
p21708
aS'D06806'
p21709
aS'Measles virus vaccine live (USP)'
p21710
aS'D07057'
p21711
aS'Abacavir (INN)'
p21712
aS'D07249'
p21713
aS'Brivudine (INN)'
p21714
aS'D07441'
p21715
aS'Amantadine (INN)'
p21716
aS'D07896'
p21717
aS'Entecavir (INN)'
p21718
aS'D07989'
p21719
aS'Fomivirsen (INN)'
p21720
aS'D08306'
p21721
aS'Oseltamivir (INN)'
p21722
aS'D08483'
p21723
aS'Rimantadine (INN)'
p21724
aS'D08664'
p21725
aS'Valaciclovir (INN)'
p21726
aS'D08777'
p21727
aS'Freeze-dried live attenuated varicella vaccine'
p21728
aS'D08778'
p21729
aS'Freeze-dried, inactivated hepatitis A vaccine (JAN)'
p21730
aS'D09410'
p21731
aS'Laninamivir (INN)'
p21732
aS'D09547'
p21733
aS'Laninamivir octanoate hydrate (JAN)'
p21734
aS'D09725'
p21735
aS'Emulsified influenza HA vaccine (A/H1N1)'
p21736
aS'D09884'
p21737
aS'Danoprevir (USAN/INN)'
p21738
aS'D09885'
p21739
aS'Danoprevir sodium (USAN)'
p21740
aS'D09987'
p21741
aS'Vaniprevir (JAN/USAN/INN)'
p21742
aS'D10093'
p21743
aS'Asunaprevir (JAN/USAN)'
p21744
aS'D10192'
p21745
aS'Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin)'
p21746
aS'D10193'
p21747
aS'Live attenuated human rota virus vaccine, oral'
p21748
aS'D10211'
p21749
aS'Rotavirus vaccine, live, oral, pentavalent'
p21750
assS'path:map00930'
p21751
(dp21752
S'DBLINKS'
p21753
(lp21754
S'GO: 0019384'
p21755
ag21755
aS'UMBBD: cap chx'
p21756
asS'NAME'
p21757
(lp21758
S'Caprolactam degradation'
p21759
asS'REFERENCE'
p21760
(lp21761
S'PMID:11571189'
p21762
ag21762
aS'AUTHORS'
p21763
aS'Parke D, Garcia MA, Ornston LN'
p21764
aS'TITLE'
p21765
aS'Cloning and genetic characterization of dca genes required for beta-oxidation of'
p21766
aS'straight-chain dicarboxylic acids in Acinetobacter sp. strain ADP1.'
p21767
aS'JOURNAL'
p21768
aS'Appl Environ Microbiol 67:4817-27 (2001)'
p21769
aS'PMID:12535077'
p21770
ag21770
aS'AUTHORS'
p21771
aS'Campbell JW, Morgan-Kiss RM, Cronan JE Jr'
p21772
aS'TITLE'
p21773
aS'A new Escherichia coli metabolic competency: growth on fatty acids by a novel anaerobic beta-oxidation pathway.'
p21774
aS'JOURNAL'
p21775
aS'Mol Microbiol 47:793-805 (2003)'
p21776
aS'PMID:15658985'
p21777
ag21777
aS'AUTHORS'
p21778
aS'Brzostowicz PC, Walters DM, Jackson RE, Halsey KH, Ni H, Rouviere PE'
p21779
aS'TITLE'
p21780
aS'Proposed involvement of a soluble methane monooxygenase homologue in the cyclohexane-dependent growth of a new Brachymonas species.'
p21781
aS'JOURNAL'
p21782
aS'Environ Microbiol 7:179-90 (2005)'
p21783
asS'KO_PATHWAY'
p21784
(lp21785
S'ko00930'
p21786
asS'ENTRY'
p21787
(lp21788
S'map00930'
p21789
aS'Pathway'
p21790
asS'PATHWAY_MAP'
p21791
(lp21792
S'map00930'
p21793
asS'CLASS'
p21794
(lp21795
S'Metabolism Xenobiotics biodegradation and metabolism'
p21796
assS'path:map04964'
p21797
(dp21798
S'NAME'
p21799
(lp21800
S'Proximal tubule bicarbonate reclamation'
p21801
asS'REFERENCE'
p21802
(lp21803
S'PMID:19948674'
p21804
ag21804
aS'AUTHORS'
p21805
aS'Koeppen BM'
p21806
aS'TITLE'
p21807
aS'The kidney and acid-base regulation.'
p21808
aS'JOURNAL'
p21809
aS'Adv Physiol Educ 33:275-81 (2009)'
p21810
aS'PMID:16914536'
p21811
ag21811
aS'AUTHORS'
p21812
aS'Boron WF'
p21813
aS'TITLE'
p21814
aS'Acid-base transport by the renal proximal tubule.'
p21815
aS'JOURNAL'
p21816
aS'J Am Soc Nephrol 17:2368-82 (2006)'
p21817
aS'PMID:9550618'
p21818
ag21818
aS'AUTHORS'
p21819
aS'Hayashi M'
p21820
aS'TITLE'
p21821
aS'Physiology and pathophysiology of acid-base homeostasis in the kidney.'
p21822
aS'JOURNAL'
p21823
aS'Intern Med 37:221-5 (1998)'
p21824
aS'PMID:16352913'
p21825
ag21825
aS'AUTHORS'
p21826
aS'Wagner CA, Kovacikova J, Stehberger PA, Winter C, Benabbas C, Mohebbi N'
p21827
aS'TITLE'
p21828
aS'Renal acid-base transport: old and new players.'
p21829
aS'JOURNAL'
p21830
aS'Nephron Physiol 103:p1-6 (2006)'
p21831
aS'PMID:17557941'
p21832
ag21832
aS'AUTHORS'
p21833
aS'Fry AC, Karet FE'
p21834
aS'TITLE'
p21835
aS'Inherited renal acidoses.'
p21836
aS'JOURNAL'
p21837
aS'Physiology (Bethesda) 22:202-11 (2007)'
p21838
aS'PMID:19721811'
p21839
ag21839
aS'AUTHORS'
p21840
aS'Pereira PC, Miranda DM, Oliveira EA, Silva AC'
p21841
aS'TITLE'
p21842
aS'Molecular pathophysiology of renal tubular acidosis.'
p21843
aS'JOURNAL'
p21844
aS'Curr Genomics 10:51-9 (2009)'
p21845
aS'PMID:12138151'
p21846
ag21846
aS'AUTHORS'
p21847
aS'Igarashi T, Sekine T, Inatomi J, Seki G'
p21848
aS'TITLE'
p21849
aS'Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis.'
p21850
aS'JOURNAL'
p21851
aS'J Am Soc Nephrol 13:2171-7 (2002)'
p21852
aS'PMID:11826292'
p21853
ag21853
aS'AUTHORS'
p21854
aS'Alper SL'
p21855
aS'TITLE'
p21856
aS'Genetic diseases of acid-base transporters.'
p21857
aS'JOURNAL'
p21858
aS'Annu Rev Physiol 64:899-923 (2002)'
p21859
aS'PMID:11385088'
p21860
ag21860
aS'AUTHORS'
p21861
aS'Unwin RJ, Capasso G'
p21862
aS'TITLE'
p21863
aS'The renal tubular acidoses.'
p21864
aS'JOURNAL'
p21865
aS'J R Soc Med 94:221-5 (2001)'
p21866
aS'PMID:11045400'
p21867
ag21867
aS'AUTHORS'
p21868
aS'Rodriguez-Soriano J'
p21869
aS'TITLE'
p21870
aS'New insights into the pathogenesis of renal tubular acidosis--from functional to'
p21871
aS'molecular studies.'
p21872
aS'JOURNAL'
p21873
aS'Pediatr Nephrol 14:1121-36 (2000)'
p21874
aS'PMID:18056784'
p21875
ag21875
aS'AUTHORS'
p21876
aS'Nowik M, Lecca MR, Velic A, Rehrauer H, Brandli AW, Wagner CA'
p21877
aS'TITLE'
p21878
aS'Genome-wide gene expression profiling reveals renal genes regulated during metabolic acidosis.'
p21879
aS'JOURNAL'
p21880
aS'Physiol Genomics 32:322-34 (2008)'
p21881
aS'PMID:11533299'
p21882
ag21882
aS'AUTHORS'
p21883
aS'Curthoys NP'
p21884
aS'TITLE'
p21885
aS'Role of mitochondrial glutaminase in rat renal glutamine metabolism.'
p21886
aS'JOURNAL'
p21887
aS'J Nutr 131:2491S-5S discussion 2496S-7S (2001)'
p21888
asS'KO_PATHWAY'
p21889
(lp21890
S'ko04964'
p21891
asS'PATHWAY_MAP'
p21892
(lp21893
S'map04964'
p21894
asS'DISEASE'
p21895
(lp21896
S'H00241'
p21897
aS'Combined proximal and distal renal tubular acidosis (RTA type 3)'
p21898
ag21897
ag21898
aS'H00429'
p21899
aS'Proximal renal tubular acidosis (RTA type 2)'
p21900
aS'H00998'
p21901
aS'Alternating hemiplegia of childhood'
p21902
asS'ENTRY'
p21903
(lp21904
S'map04964'
p21905
aS'Pathway'
p21906
asS'CLASS'
p21907
(lp21908
S'Organismal Systems Excretory system'
p21909
asS'DESCRIPTION'
p21910
(lp21911
S'One of the major tasks of the renal proximal tubule (PT) is to secrete acid into the tubule lumen, thereby reabsorbing approximately 80% of the filtered bicarbonate (HCO3(-)), as well as generating "new HCO3(-)" for regulating blood pH. In the tubular lumen, filtered HCO3(-) combines with H(+) in a reaction catalyzed by CA IV. The CO2 thus produced rapidly diffuses into the tubular cells and is combined with water to produce intracellular H(+) and HCO3(-), catalyzed by soluble cytoplasmic CA II. HCO3(-) is then cotransported with Na(+) into blood via the NBC-1. The intracellular H(+) produced by CA II is secreted into the tubular lumen predominantly via the NHE-3. The PT creates the "new HCO3(-)" by taking glutamine and metabolizing it to two molecules each of NH4(+) and HCO3(-). The NH4(+) is excreted into the tubular lumen, and the HCO3(-) , which is "new HCO3(-) ," is returned to the blood, where it replaces the HCO3(-) lost earlier in the titration of nonvolatile acids.'
p21912
assS'path:map00232'
p21913
(dp21914
S'DBLINKS'
p21915
(lp21916
S'UMBBD: caf caf2'
p21917
asS'NAME'
p21918
(lp21919
S'Caffeine metabolism'
p21920
asS'REFERENCE'
p21921
(lp21922
S'PMID:9705852'
p21923
ag21923
aS'AUTHORS'
p21924
aS'Madyastha KM, Sridhar GR.'
p21925
aS'TITLE'
p21926
aS'A novel pathway for the metabolism of caffeine by a mixed culture consortium.'
p21927
aS'JOURNAL'
p21928
aS'Biochem Biophys Res Commun 249:178-81 (1998)'
p21929
aS'PMID:14977550'
p21930
ag21930
aS'AUTHORS'
p21931
aS'Mazzafera P.'
p21932
aS'TITLE'
p21933
aS'Catabolism of caffeine in plants and microorganisms.'
p21934
aS'JOURNAL'
p21935
aS'Front Biosci 9:1348-59 (2004)'
p21936
aS'PMID:11393735'
p21937
ag21937
aS'AUTHORS'
p21938
aS'Nyeki A, Biollaz J, Kesselring UW, Decosterd LA.'
p21939
aS'TITLE'
p21940
aS'Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment.'
p21941
aS'JOURNAL'
p21942
aS'J Chromatogr B Biomed Sci Appl 755:73-84 (2001)'
p21943
aS'PMID:11544129'
p21944
ag21944
aS'AUTHORS'
p21945
aS'Ashihara H, Crozier A.'
p21946
aS'TITLE'
p21947
aS'Caffeine: a well known but little mentioned compound in plant science.'
p21948
aS'JOURNAL'
p21949
aS'Trends Plant Sci 6:407-13 (2001)'
p21950
aS'PMID:16333668'
p21951
ag21951
aS'AUTHORS'
p21952
aS'Yoneyama N, Morimoto H, Ye CX, Ashihara H, Mizuno K, Kato M.'
p21953
aS'TITLE'
p21954
aS'Substrate specificity of N-methyltransferase involved in purine alkaloids synthesis is dependent upon one amino acid residue of the enzyme.'
p21955
aS'JOURNAL'
p21956
aS'Mol Genet Genomics 275:125-35 (2006)'
p21957
asS'KO_PATHWAY'
p21958
(lp21959
S'ko00232'
p21960
asS'ENTRY'
p21961
(lp21962
S'map00232'
p21963
aS'Pathway'
p21964
asS'PATHWAY_MAP'
p21965
(lp21966
S'map00232'
p21967
asS'CLASS'
p21968
(lp21969
S'Metabolism Biosynthesis of other secondary metabolites'
p21970
assS'path:map04370'
p21971
(dp21972
S'NAME'
p21973
(lp21974
S'VEGF signaling pathway'
p21975
asS'REFERENCE'
p21976
(lp21977
S'PMID:13678960'
p21978
ag21978
aS'AUTHORS'
p21979
aS'Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L.'
p21980
aS'TITLE'
p21981
aS'VEGF-receptor signal transduction.'
p21982
aS'JOURNAL'
p21983
aS'Trends Biochem Sci 28:488-94 (2003)'
p21984
aS'PMID:11741095'
p21985
ag21985
aS'AUTHORS'
p21986
aS'Matsumoto T, Claesson-Welsh L.'
p21987
aS'TITLE'
p21988
aS'VEGF receptor signal transduction.'
p21989
aS'JOURNAL'
p21990
aS'Sci STKE 2001:RE21 (2001)'
p21991
aS'PMID:15602010'
p21992
ag21992
aS'AUTHORS'
p21993
aS'Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA.'
p21994
aS'TITLE'
p21995
aS'Vascular endothelial growth factor and angiogenesis.'
p21996
aS'JOURNAL'
p21997
aS'Pharmacol Rev 56:549-80 (2004)'
p21998
aS'PMID:16104843'
p21999
ag21999
aS'AUTHORS'
p22000
aS'Takahashi H, Shibuya M.'
p22001
aS'TITLE'
p22002
aS'The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.'
p22003
aS'JOURNAL'
p22004
aS'Clin Sci (Lond) 109:227-41 (2005)'
p22005
aS'PMID:14641020'
p22006
ag22006
aS'AUTHORS'
p22007
aS'Zachary I.'
p22008
aS'TITLE'
p22009
aS'VEGF signalling: integration and multi-tasking in endothelial cell biology.'
p22010
aS'JOURNAL'
p22011
aS'Biochem Soc Trans 31:1171-7 (2003)'
p22012
aS'PMID:15338053'
p22013
ag22013
aS'AUTHORS'
p22014
aS'Munoz-Chapuli R, Quesada AR, Angel Medina M.'
p22015
aS'TITLE'
p22016
aS'Angiogenesis and signal transduction in endothelial cells.'
p22017
aS'JOURNAL'
p22018
aS'Cell Mol Life Sci 61:2224-43 (2004)'
p22019
aS'PMID:14724572'
p22020
ag22020
aS'AUTHORS'
p22021
aS'Lamalice L, Houle F, Jourdan G, Huot J.'
p22022
aS'TITLE'
p22023
aS'Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.'
p22024
aS'JOURNAL'
p22025
aS'Oncogene 23:434-45 (2004)'
p22026
aS'PMID:12391145'
p22027
ag22027
aS'AUTHORS'
p22028
aS'Shu X, Wu W, Mosteller RD, Broek D.'
p22029
aS'TITLE'
p22030
aS'Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases.'
p22031
aS'JOURNAL'
p22032
aS'Mol Cell Biol 22:7758-68 (2002)'
p22033
asS'KO_PATHWAY'
p22034
(lp22035
S'ko04370'
p22036
asS'PATHWAY_MAP'
p22037
(lp22038
S'map04370'
p22039
asS'DISEASE'
p22040
(lp22041
S'H00539'
p22042
aS'PTEN hamartoma tumor syndrome (PHTS)'
p22043
ag22042
ag22043
aS'H00856'
p22044
aS'Distal hereditary motor neuropathies (dHMN)'
p22045
asS'DBLINKS'
p22046
(lp22047
S'GO: 0048010'
p22048
asS'ENTRY'
p22049
(lp22050
S'map04370'
p22051
aS'Pathway'
p22052
asS'CLASS'
p22053
(lp22054
S'Environmental Information Processing Signal transduction'
p22055
asS'DESCRIPTION'
p22056
(lp22057
S"There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells and it is considered to be a crucial signal transducer in both physiologic and pathologic angiogenesis. The binding of VEGF to VEGFR-2 leads to a cascade of different signaling pathways, resulting in the up-regulation of genes involved in mediating the proliferation and migration of endothelial cells and promoting their survival and vascular permeability. For example, the binding of VEGF to VEGFR-2 leads to dimerization of the receptor, followed by intracellular activation of the PLCgammaPKC-Raf kinase-MEK-mitogen-activated protein kinase (MAPK) pathway and subsequent initiation of DNA synthesis and cell growth, whereas activation of the phosphatidylinositol 3' -kinase (PI3K)-Akt pathway leads to increased endothelial-cell survival. Activation of PI3K, FAK, and p38 MAPK is implicated in cell migration signaling."
p22058
assS'path:map04612'
p22059
(dp22060
S'NAME'
p22061
(lp22062
S'Antigen processing and presentation'
p22063
asS'REFERENCE'
p22064
(lp22065
S'PMID:15771591'
p22066
ag22066
aS'AUTHORS'
p22067
aS'Trombetta ES, Mellman I.'
p22068
aS'TITLE'
p22069
aS'Cell biology of antigen processing in vitro and in vivo.'
p22070
aS'JOURNAL'
p22071
aS'Annu Rev Immunol 23:975-1028 (2005)'
p22072
aS'PMID:15814328'
p22073
ag22073
aS'AUTHORS'
p22074
aS'Inaba K, Inaba M.'
p22075
aS'TITLE'
p22076
aS'Antigen recognition and presentation by dendritic cells.'
p22077
aS'JOURNAL'
p22078
aS'Int J Hematol 81:181-7 (2005)'
p22079
aS'PMID:11905820'
p22080
ag22080
aS'AUTHORS'
p22081
aS'Heath WR, Carbone FR.'
p22082
aS'TITLE'
p22083
aS'Cross-presentation in viral immunity and self-tolerance.'
p22084
aS'JOURNAL'
p22085
aS'Nat Rev Immunol 1:126-34 (2001)'
p22086
aS'PMID:15304636'
p22087
ag22087
aS'AUTHORS'
p22088
aS'Abele R, Tampe R.'
p22089
aS'TITLE'
p22090
aS'The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing.'
p22091
aS'JOURNAL'
p22092
aS'Physiology (Bethesda) 19:216-24 (2004)'
p22093
aS'PMID:16200082'
p22094
ag22094
aS'AUTHORS'
p22095
aS'Reith W, LeibundGut-Landmann S, Waldburger JM.'
p22096
aS'TITLE'
p22097
aS'Regulation of MHC class II gene expression by the class II transactivator.'
p22098
aS'JOURNAL'
p22099
aS'Nat Rev Immunol 5:793-806 (2005)'
p22100
aS'PMID:12776207'
p22101
ag22101
aS'AUTHORS'
p22102
aS'Honey K, Rudensky AY.'
p22103
aS'TITLE'
p22104
aS'Lysosomal cysteine proteases regulate antigen presentation.'
p22105
aS'JOURNAL'
p22106
aS'Nat Rev Immunol 3:472-82 (2003)'
p22107
aS'PMID:12974477'
p22108
ag22108
aS'AUTHORS'
p22109
aS'Sercarz EE, Maverakis E.'
p22110
aS'TITLE'
p22111
aS'Mhc-guided processing: binding of large antigen fragments.'
p22112
aS'JOURNAL'
p22113
aS'Nat Rev Immunol 3:621-9 (2003)'
p22114
aS'PMID:15224093'
p22115
ag22115
aS'AUTHORS'
p22116
aS'Ackerman AL, Cresswell P.'
p22117
aS'TITLE'
p22118
aS'Cellular mechanisms governing cross-presentation of exogenous antigens.'
p22119
aS'JOURNAL'
p22120
aS'Nat Immunol 5:678-84 (2004)'
p22121
aS'PMID:16181333'
p22122
ag22122
aS'AUTHORS'
p22123
aS'Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA.'
p22124
aS'TITLE'
p22125
aS'Mechanisms of MHC class I-restricted antigen processing and cross-presentation.'
p22126
aS'JOURNAL'
p22127
aS'Immunol Rev 207:145-57 (2005)'
p22128
aS'PMID:15653312'
p22129
ag22129
aS'AUTHORS'
p22130
aS'Zika E, Ting JP.'
p22131
aS'TITLE'
p22132
aS'Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes.'
p22133
aS'JOURNAL'
p22134
aS'Curr Opin Immunol 17:58-64 (2005)'
p22135
aS'PMID:11244040'
p22136
ag22136
aS'AUTHORS'
p22137
aS'Reith W, Mach B.'
p22138
aS'TITLE'
p22139
aS'The bare lymphocyte syndrome and the regulation of MHC expression.'
p22140
aS'JOURNAL'
p22141
aS'Annu Rev Immunol 19:331-73 (2001)'
p22142
aS'PMID:15745856'
p22143
ag22143
aS'AUTHORS'
p22144
aS'Lizee G, Basha G, Jefferies WA.'
p22145
aS'TITLE'
p22146
aS'Tails of wonder: endocytic-sorting motifs key for exogenous antigen presentation.'
p22147
aS'JOURNAL'
p22148
aS'Trends Immunol 26:141-9 (2005)'
p22149
aS'PMID:15224094'
p22150
ag22150
aS'AUTHORS'
p22151
aS'Watts C.'
p22152
aS'TITLE'
p22153
aS'The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.'
p22154
aS'JOURNAL'
p22155
aS'Nat Immunol 5:685-92 (2004)'
p22156
aS'PMID:15653315'
p22157
ag22157
aS'AUTHORS'
p22158
aS'Kaufmann SH, Schaible UE.'
p22159
aS'TITLE'
p22160
aS'Antigen presentation and recognition in bacterial infections.'
p22161
aS'JOURNAL'
p22162
aS'Curr Opin Immunol 17:79-87 (2005)'
p22163
aS'PMID:20010787'
p22164
ag22164
aS'AUTHORS'
p22165
aS'Groettrup M, Kirk CJ, Basler M'
p22166
aS'TITLE'
p22167
aS'Proteasomes in immune cells: more than peptide producers?'
p22168
aS'JOURNAL'
p22169
aS'Nat Rev Immunol 10:73-8 (2010)'
p22170
asS'KO_PATHWAY'
p22171
(lp22172
S'ko04612'
p22173
asS'PATHWAY_MAP'
p22174
(lp22175
S'map04612'
p22176
asS'DISEASE'
p22177
(lp22178
S'H00344'
p22179
aS'Leprosy'
p22180
ag22179
ag22180
aS'H00425'
p22181
aS'Lysosomal cysteine protease deficiencies'
p22182
aS'H00932'
p22183
aS'Tropical calcific pancreatitis'
p22184
aS'H00984'
p22185
aS'Bare lymphocyte syndrome (BLS) type1'
p22186
aS'H00985'
p22187
aS'Bare lymphocyte syndrome (BLS) type2'
p22188
aS'H01132'
p22189
aS'Aplastic anemia (AA)'
p22190
aS'H01303'
p22191
aS'Hypercatabolic hypoproteinemia'
p22192
asS'DBLINKS'
p22193
(lp22194
S'GO: 0019885 0019886 0042591'
p22195
asS'ENTRY'
p22196
(lp22197
S'map04612'
p22198
aS'Pathway'
p22199
asS'CLASS'
p22200
(lp22201
S'Organismal Systems Immune system'
p22202
assS'path:map00020'
p22203
(dp22204
S'NAME'
p22205
(lp22206
S'Citrate cycle (TCA cycle)'
p22207
asS'REFERENCE'
p22208
(lp22209
S'(map 2)'
p22210
ag22210
aS'AUTHORS'
p22211
aS'Nishizuka Y (ed).'
p22212
aS'TITLE'
p22213
aS'[Metabolic Maps] (In Japanese)'
p22214
aS'JOURNAL'
p22215
aS'Tokyo Kagaku Dojin (1980)'
p22216
aS'(map 3)'
p22217
ag22217
aS'AUTHORS'
p22218
aS'Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).'
p22219
aS'TITLE'
p22220
aS'[Cellular Functions and Metabolic Maps] (In Japanese)'
p22221
aS'JOURNAL'
p22222
aS'Tokyo Kagaku Dojin (1997)'
p22223
ag22
ag22
aS'AUTHORS'
p22224
aS'Michal G.'
p22225
aS'TITLE'
p22226
aS'Biochemical Pathways'
p22227
aS'JOURNAL'
p22228
aS'Wiley (1999)'
p22229
asS'KO_PATHWAY'
p22230
(lp22231
S'ko00020'
p22232
asS'PATHWAY_MAP'
p22233
(lp22234
S'map00020'
p22235
asS'DISEASE'
p22236
(lp22237
S'H00073'
p22238
aS'Pyruvate carboxylase deficiency'
p22239
ag22238
ag22239
aS'H00469'
p22240
aS'Mitochondrial DNA depletion syndrome (MDS)'
p22241
aS'H00804'
p22242
aS'Multiple cutaneous and uterine leiomyomata'
p22243
aS'H01022'
p22244
aS'Diseases of the tricarboxylic acid cycle'
p22245
aS'H01222'
p22246
aS'Cowden-like syndrome'
p22247
aS'H01225'
p22248
aS'D-2-hydroxyglutaric aciduria (D-2-HGA)'
p22249
asS'MODULE'
p22250
(lp22251
S'M00003'
p22252
aS'Gluconeogenesis, oxaloacetate => fructose-6P [PATH:map00020]'
p22253
ag22252
ag22253
aS'M00009'
p22254
aS'Citrate cycle (TCA cycle, Krebs cycle) [PATH:map00020]'
p22255
aS'M00010'
p22256
aS'Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map00020]'
p22257
aS'M00011'
p22258
aS'Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:map00020]'
p22259
aS'M00307'
p22260
aS'Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map00020]'
p22261
asS'DBLINKS'
p22262
(lp22263
S'GO: 0006099'
p22264
asS'ENTRY'
p22265
(lp22266
S'map00020'
p22267
aS'Pathway'
p22268
asS'CLASS'
p22269
(lp22270
S'Metabolism Carbohydrate metabolism'
p22271
asS'DESCRIPTION'
p22272
(lp22273
S'The citrate cycle (TCA cycle, Krebs cycle) is an important aerobic pathway for the final steps of the oxidation of carbohydrates and fatty acids. The cycle starts with acetyl-CoA, the activated form of acetate, derived from glycolysis and pyruvate oxidation for carbohydrates and from beta oxidation of fatty acids. The two-carbon acetyl group in acetyl-CoA is transferred to the four-carbon compound of oxaloacetate to form the six-carbon compound of citrate. In a series of reactions two carbons in citrate are oxidized to CO2 and the reaction pathway supplies NADH for use in the oxidative phosphorylation and other metabolic processes. The pathway also supplies important precursor metabolites including 2-oxoglutarate. At the end of the cycle the remaining four-carbon part is transformed back to oxaloacetate. According to the genome sequence data, many organisms seem to lack genes for the full cycle [MD:M00009], but contain genes for specific segments [MD:M00010 M00011].'
p22274
assS'path:map04270'
p22275
(dp22276
S'NAME'
p22277
(lp22278
S'Vascular smooth muscle contraction'
p22279
asS'REFERENCE'
p22280
(lp22281
S'PMID:17458653'
p22282
ag22282
aS'AUTHORS'
p22283
aS'Akata T'
p22284
aS'TITLE'
p22285
aS'Cellular and molecular mechanisms regulating vascular tone. Part 2: regulatory mechanisms modulating Ca2+ mobilization and/or myofilament Ca2+ sensitivity in vascular smooth muscle cells.'
p22286
aS'JOURNAL'
p22287
aS'J Anesth 21:232-42 (2007)'
p22288
aS'PMID:12689814'
p22289
ag22289
aS'AUTHORS'
p22290
aS'Ogut O, Brozovich FV'
p22291
aS'TITLE'
p22292
aS'Regulation of force in vascular smooth muscle.'
p22293
aS'JOURNAL'
p22294
aS'J Mol Cell Cardiol 35:347-55 (2003)'
p22295
aS'PMID:16339747'
p22296
ag22296
aS'AUTHORS'
p22297
aS'Hilgers RH, Webb RC'
p22298
aS'TITLE'
p22299
aS'Molecular aspects of arterial smooth muscle contraction: focus on Rho.'
p22300
aS'JOURNAL'
p22301
aS'Exp Biol Med (Maywood) 230:829-35 (2005)'
p22302
aS'PMID:12693609'
p22303
ag22303
aS'AUTHORS'
p22304
aS'Schlossmann J, Feil R, Hofmann F'
p22305
aS'TITLE'
p22306
aS'Signaling through NO and cGMP-dependent protein kinases.'
p22307
aS'JOURNAL'
p22308
aS'Ann Med 35:21-7 (2003)'
p22309
aS'PMID:16870827'
p22310
ag22310
aS'AUTHORS'
p22311
aS'Mehta PK, Griendling KK'
p22312
aS'TITLE'
p22313
aS'Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.'
p22314
aS'JOURNAL'
p22315
aS'Am J Physiol Cell Physiol 292:C82-97 (2007)'
p22316
aS'PMID:19120701'
p22317
ag22317
aS'AUTHORS'
p22318
aS'Kim HR, Appel S, Vetterkind S, Gangopadhyay SS, Morgan KG'
p22319
aS'TITLE'
p22320
aS'Smooth muscle signalling pathways in health and disease.'
p22321
aS'JOURNAL'
p22322
aS'J Cell Mol Med 12:2165-80 (2008)'
p22323
aS'PMID:11165670'
p22324
ag22324
aS'AUTHORS'
p22325
aS'Fukata Y, Amano M, Kaibuchi K'
p22326
aS'TITLE'
p22327
aS'Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.'
p22328
aS'JOURNAL'
p22329
aS'Trends Pharmacol Sci 22:32-9 (2001)'
p22330
aS'PMID:17158339'
p22331
ag22331
aS'AUTHORS'
p22332
aS'Dimopoulos GJ, Semba S, Kitazawa K, Eto M, Kitazawa T'
p22333
aS'TITLE'
p22334
aS'Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.'
p22335
aS'JOURNAL'
p22336
aS'Circ Res 100:121-9 (2007)'
p22337
aS'PMID:17200683'
p22338
ag22338
aS'AUTHORS'
p22339
aS'Hynynen MM, Khalil RA'
p22340
aS'TITLE'
p22341
aS'The vascular endothelin system in hypertension--recent patents and discoveries.'
p22342
aS'JOURNAL'
p22343
aS'Recent Pat Cardiovasc Drug Discov 1:95-108 (2006)'
p22344
aS'PMID:15269340'
p22345
ag22345
aS'AUTHORS'
p22346
aS'Brain SD, Grant AD'
p22347
aS'TITLE'
p22348
aS'Vascular actions of calcitonin gene-related peptide and adrenomedullin.'
p22349
aS'JOURNAL'
p22350
aS'Physiol Rev 84:903-34 (2004)'
p22351
aS'PMID:11773611'
p22352
ag22352
aS'AUTHORS'
p22353
aS'Roman RJ'
p22354
aS'TITLE'
p22355
aS'P-450 metabolites of arachidonic acid in the control of cardiovascular function.'
p22356
aS'JOURNAL'
p22357
aS'Physiol Rev 82:131-85 (2002)'
p22358
aS'PMID:18040024'
p22359
ag22359
aS'AUTHORS'
p22360
aS'Surks HK'
p22361
aS'TITLE'
p22362
aS'cGMP-dependent protein kinase I and smooth muscle relaxation: a tale of two isoforms.'
p22363
aS'JOURNAL'
p22364
aS'Circ Res 101:1078-80 (2007)'
p22365
aS'PMID:15026027'
p22366
ag22366
aS'AUTHORS'
p22367
aS'Vanhoutte PM'
p22368
aS'TITLE'
p22369
aS'Endothelium-dependent hyperpolarizations: the history.'
p22370
aS'JOURNAL'
p22371
aS'Pharmacol Res 49:503-8 (2004)'
p22372
aS'PMID:10221985'
p22373
ag22373
aS'AUTHORS'
p22374
aS'Davis MJ, Hill MA'
p22375
aS'TITLE'
p22376
aS'Signaling mechanisms underlying the vascular myogenic response.'
p22377
aS'JOURNAL'
p22378
aS'Physiol Rev 79:387-423 (1999)'
p22379
aS'PMID:11679404'
p22380
ag22380
aS'AUTHORS'
p22381
aS'Fleming I.'
p22382
aS'TITLE'
p22383
aS'Cytochrome p450 and vascular homeostasis.'
p22384
aS'JOURNAL'
p22385
aS'Circ Res 89:753-62 (2001)'
p22386
aS'PMID:10911373'
p22387
ag22387
aS'AUTHORS'
p22388
aS'Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP'
p22389
aS'TITLE'
p22390
aS'Molecular mechanism of cGMP-mediated smooth muscle relaxation.'
p22391
aS'JOURNAL'
p22392
aS'J Cell Physiol 184:409-20 (2000)'
p22393
aS'PMID:18552454'
p22394
ag22394
aS'AUTHORS'
p22395
aS'Ko EA, Han J, Jung ID, Park WS'
p22396
aS'TITLE'
p22397
aS'Physiological roles of K+ channels in vascular smooth muscle cells.'
p22398
aS'JOURNAL'
p22399
aS'J Smooth Muscle Res 44:65-81 (2008)'
p22400
aS'PMID:18703404'
p22401
ag22401
aS'AUTHORS'
p22402
aS'Woodard GE, Rosado JA'
p22403
aS'TITLE'
p22404
aS'Natriuretic peptides in vascular physiology and pathology.'
p22405
aS'JOURNAL'
p22406
aS'Int Rev Cell Mol Biol 268:59-93 (2008)'
p22407
aS'PMID:11709400'
p22408
ag22408
aS'AUTHORS'
p22409
aS'Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG'
p22410
aS'TITLE'
p22411
aS'Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide.'
p22412
aS'JOURNAL'
p22413
aS'Am J Physiol Heart Circ Physiol 281:H2337-65 (2001)'
p22414
aS'PMID:15725705'
p22415
ag22415
aS'AUTHORS'
p22416
aS'Hirano K, Hirano M, Kanaide H'
p22417
aS'TITLE'
p22418
aS'Regulation of myosin phosphorylation and myofilament Ca2+ sensitivity in vascular smooth muscle.'
p22419
aS'JOURNAL'
p22420
aS'J Smooth Muscle Res 40:219-36 (2004)'
p22421
aS'PMID:9458738'
p22422
ag22422
aS'AUTHORS'
p22423
aS'Freeman EJ, Ruehr ML, Dorman RV'
p22424
aS'TITLE'
p22425
aS'ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells.'
p22426
aS'JOURNAL'
p22427
aS'Am J Physiol 274:C282-8 (1998)'
p22428
aS'PMID:12060106'
p22429
ag22429
aS'AUTHORS'
p22430
aS'Murphy TV, Spurrell BE, Hill MA'
p22431
aS'TITLE'
p22432
aS'Cellular signalling in arteriolar myogenic constriction: involvement of tyrosine phosphorylation pathways.'
p22433
aS'JOURNAL'
p22434
aS'Clin Exp Pharmacol Physiol 29:612-9 (2002)'
p22435
asS'KO_PATHWAY'
p22436
(lp22437
S'ko04270'
p22438
asS'PATHWAY_MAP'
p22439
(lp22440
S'map04270'
p22441
asS'DISEASE'
p22442
(lp22443
S'H00728'
p22444
aS'Brugada syndrome (BRS)'
p22445
ag22444
ag22445
aS'H00731'
p22446
aS'Atrial fibrillation'
p22447
aS'H00746'
p22448
aS'Hypokalemic periodic paralysis (HypoPP)'
p22449
aS'H00801'
p22450
aS'Familial thoracic aortic aneurysm and dissection (TAAD)'
p22451
aS'H01258'
p22452
aS'Generalized epilepsy and paroxysmal dyskinesia (GEPD)'
p22453
aS'H01396'
p22454
aS'Moyamoya Disease'
p22455
asS'DESCRIPTION The vascular smooth muscle cell (VSMC) is a highly specialized cell whose principal function is contraction. On contraction, VSMCs shorten, thereby decreasing the diameter of a blood vessel to regulate the blood flow and pressure.'
p22456
(lp22457
S'The principal mechanisms that regulate the contractile state of VSMCs are changes in cytosolic Ca2+ concentration ([Ca2+]c). In response to vasoconstrictor stimuli, Ca2+ is mobilized from intracellular stores and/or the extracellular space to increase [Ca2+]c in VSMCs. The increase in [Ca2+]c, in turn, activates the Ca2+-CaM-MLCK pathway and stimulates MLC20 phosphorylation, leading to myosin-actin interactions and, hence, the development of contractile force. The sensitivity of contractile myofilaments or MLC20 phosphorylation to Ca2+ can be secondarily modulated by other signaling pathways. During receptor stimulation, the contractile force is greatly enhanced by the inhibition of myosin phosphatase. Rho/Rho kinase, PKC, and arachidonic acid have been proposed to play a pivotal role in this enhancement.'
p22458
aS'The signaling events that mediate relaxation include the removal of a contractile agonist (passive relaxation) and activation of cyclic nucleotide-dependent signaling pathways in the continued presence of a contractile agonist (active relaxation). Active relaxation occurs through the inhibition of both Ca2+ mobilization and myofilament Ca2+ sensitivity in VSMCs.'
p22459
asS'DBLINKS'
p22460
(lp22461
S'GO: 0014829'
p22462
asS'ENTRY'
p22463
(lp22464
S'map04270'
p22465
aS'Pathway'
p22466
asS'CLASS'
p22467
(lp22468
S'Organismal Systems Circulatory system'
p22469
asS'DESCRIPTION'
p22470
(lp22471
S'The vascular smooth muscle cell (VSMC) is a highly specialized cell whose principal function is contraction. On contraction, VSMCs shorten, thereby decreasing the diameter of a blood vessel to regulate the blood flow and pressure.'
p22472
assS'path:map04962'
p22473
(dp22474
S'NAME'
p22475
(lp22476
S'Vasopressin-regulated water reabsorption'
p22477
asS'REFERENCE'
p22478
(lp22479
S'PMID:18431594'
p22480
ag22480
aS'AUTHORS'
p22481
aS'Boone M, Deen PM'
p22482
aS'TITLE'
p22483
aS'Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption.'
p22484
aS'JOURNAL'
p22485
aS'Pflugers Arch 456:1005-24 (2008)'
p22486
aS'PMID:18566824'
p22487
ag22487
aS'AUTHORS'
p22488
aS'Takata K, Matsuzaki T, Tajika Y, Ablimit A, Hasegawa T'
p22489
aS'TITLE'
p22490
aS'Localization and trafficking of aquaporin 2 in the kidney.'
p22491
aS'JOURNAL'
p22492
aS'Histochem Cell Biol 130:197-209 (2008)'
p22493
aS'PMID:10073616'
p22494
ag22494
aS'AUTHORS'
p22495
aS'Nielsen S, Kwon TH, Christensen BM, Promeneur D, Frokiaer J, Marples D'
p22496
aS'TITLE'
p22497
aS'Physiology and pathophysiology of renal aquaporins.'
p22498
aS'JOURNAL'
p22499
aS'J Am Soc Nephrol 10:647-63 (1999)'
p22500
aS'PMID:10070156'
p22501
ag22501
aS'AUTHORS'
p22502
aS'Marples D, Frokiaer J, Nielsen S'
p22503
aS'TITLE'
p22504
aS'Long-term regulation of aquaporins in the kidney.'
p22505
aS'JOURNAL'
p22506
aS'Am J Physiol 276:F331-9 (1999)'
p22507
aS'PMID:10099706'
p22508
ag22508
aS'AUTHORS'
p22509
aS'Ward DT, Hammond TG, Harris HW'
p22510
aS'TITLE'
p22511
aS'Modulation of vasopressin-elicited water transport by trafficking of aquaporin2-containing vesicles.'
p22512
aS'JOURNAL'
p22513
aS'Annu Rev Physiol 61:683-97 (1999)'
p22514
aS'PMID:18655910'
p22515
ag22515
aS'AUTHORS'
p22516
aS'Fenton RA, Moeller HB'
p22517
aS'TITLE'
p22518
aS'Recent discoveries in vasopressin-regulated aquaporin-2 trafficking.'
p22519
aS'JOURNAL'
p22520
aS'Prog Brain Res 170:571-9 (2008)'
p22521
aS'PMID:11773613'
p22522
ag22522
aS'AUTHORS'
p22523
aS'Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA'
p22524
aS'TITLE'
p22525
aS'Aquaporins in the kidney: from molecules to medicine.'
p22526
aS'JOURNAL'
p22527
aS'Physiol Rev 82:205-44 (2002)'
p22528
aS'PMID:11001488'
p22529
ag22529
aS'AUTHORS'
p22530
aS'Deen PM, van Balkom BW, Kamsteeg EJ'
p22531
aS'TITLE'
p22532
aS'Routing of the aquaporin-2 water channel in health and disease.'
p22533
aS'JOURNAL'
p22534
aS'Eur J Cell Biol 79:523-30 (2000)'
p22535
aS'PMID:15522987'
p22536
ag22536
aS'AUTHORS'
p22537
aS'Bonilla-Felix M'
p22538
aS'TITLE'
p22539
aS'Development of water transport in the collecting duct.'
p22540
aS'JOURNAL'
p22541
aS'Am J Physiol Renal Physiol 287:F1093-101 (2004)'
p22542
aS'PMID:17956998'
p22543
ag22543
aS'AUTHORS'
p22544
aS'Uawithya P, Pisitkun T, Ruttenberg BE, Knepper MA'
p22545
aS'TITLE'
p22546
aS'Transcriptional profiling of native inner medullary collecting duct cells from rat kidney.'
p22547
aS'JOURNAL'
p22548
aS'Physiol Genomics 32:229-53 (2008)'
p22549
aS'PMID:14586738'
p22550
ag22550
aS'AUTHORS'
p22551
aS'Nguyen MK, Nielsen S, Kurtz I'
p22552
aS'TITLE'
p22553
aS'Molecular pathogenesis of nephrogenic diabetes insipidus.'
p22554
aS'JOURNAL'
p22555
aS'Clin Exp Nephrol 7:9-17 (2003)'
p22556
asS'KO_PATHWAY'
p22557
(lp22558
S'ko04962'
p22559
asS'PATHWAY_MAP'
p22560
(lp22561
S'map04962'
p22562
asS'DISEASE'
p22563
(lp22564
S'H00252'
p22565
aS'Congenital nephrogenic diabetes insipidus (NDI)'
p22566
ag22565
ag22566
aS'H00751'
p22567
aS'Asphyxiating thoracic dystrophy'
p22568
aS'H00856'
p22569
aS'Distal hereditary motor neuropathies (dHMN)'
p22570
aS'H01294'
p22571
aS'Nephrogenic syndrome of inappropriate antidiuresis (NSIAD)'
p22572
asS'ENTRY'
p22573
(lp22574
S'map04962'
p22575
aS'Pathway'
p22576
asS'CLASS'
p22577
(lp22578
S'Organismal Systems Excretory system'
p22579
asS'DESCRIPTION'
p22580
(lp22581
S'In the kidney, the antidiuretic hormone vasopressin (AVP) is a critical regulator of water homeostasis by controlling the water movement from lumen to the interstitium for water reabsorption and adjusting the urinary water excretion. In normal physiology, AVP is secreted into the circulation by the posterior pituitary gland, in response to an increase in serum osmolality or a decrease in effective circulating volume. When reaching the kidney, AVP binds to V2 receptors on the basolateral surface of the collecting duct epithelium, triggering a G-protein-linked signaling cascade, which leads to water channel aquaporin-2 (AQP2) vesicle insertion into the apical plasma membrane. This results in higher water permeability in the collecting duct and, driven by an osmotic gradient, pro-urinary water then passes the membrane through AQP2 and leaves the cell on the basolateral side via AQP3 and AQP4 water channels, which are constitutively expressed on the basolateral side of these cells. When isotonicity is restored, reduced blood AVP levels results in AQP2 internalization, leaving the apical membrane watertight again.'
p22582
assS'path:map02040'
p22583
(dp22584
S'NAME'
p22585
(lp22586
S'Flagellar assembly'
p22587
asS'REFERENCE'
p22588
(lp22589
S'PMID:11520608'
p22590
ag22590
aS'AUTHORS'
p22591
aS'Aizawa SI.'
p22592
aS'TITLE'
p22593
aS'Bacterial flagella and type III secretion systems.'
p22594
aS'JOURNAL'
p22595
aS'FEMS Microbiol Lett 202:157-64 (2001)'
p22596
aS'PMID:11934612'
p22597
ag22597
aS'AUTHORS'
p22598
aS'Aldridge P, Hughes KT.'
p22599
aS'TITLE'
p22600
aS'Regulation of flagellar assembly.'
p22601
aS'JOURNAL'
p22602
aS'Curr Opin Microbiol 5:160-5 (2002)'
p22603
aS'PMID:15060055'
p22604
ag22604
aS'AUTHORS'
p22605
aS'Van Arnam JS, McMurry JL, Kihara M, Macnab RM'
p22606
aS'TITLE'
p22607
aS'Analysis of an engineered Salmonella flagellar fusion protein, FliR-FlhB.'
p22608
aS'JOURNAL'
p22609
aS'J Bacteriol 186:2495-8 (2004)'
p22610
asS'KO_PATHWAY'
p22611
(lp22612
S'ko02040'
p22613
asS'ENTRY'
p22614
(lp22615
S'map02040'
p22616
aS'Pathway'
p22617
asS'PATHWAY_MAP'
p22618
(lp22619
S'map02040'
p22620
asS'CLASS'
p22621
(lp22622
S'Cellular Processes Cell motility'
p22623
assS'path:map00590'
p22624
(dp22625
S'NAME'
p22626
(lp22627
S'Arachidonic acid metabolism'
p22628
asS'REFERENCE'
p22629
(lp22630
S'PMID:14636671'
p22631
ag22631
aS'AUTHORS'
p22632
aS'Spector AA, Fang X, Snyder GD, Weintraub NL.'
p22633
aS'TITLE'
p22634
aS'Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.'
p22635
aS'JOURNAL'
p22636
aS'Prog Lipid Res 43:55-90 (2004)'
p22637
aS'PMID:15292194'
p22638
ag22638
aS'AUTHORS'
p22639
aS'Harman CA, Rieke CJ, Garavito RM, Smith WL.'
p22640
aS'TITLE'
p22641
aS'Crystal structure of arachidonic acid bound to a mutant of prostaglandin endoperoxide H synthase-1 that forms predominantly 11-hydroperoxyeicosatetraenoic acid.'
p22642
aS'JOURNAL'
p22643
aS'J Biol Chem 279:42929-35 (2004)'
p22644
aS'PMID:15205388'
p22645
ag22645
aS'AUTHORS'
p22646
aS'Poloyac SM, Tortorici MA, Przychodzin DI, Reynolds RB, Xie W, Frye RF, Zemaitis MA.'
p22647
aS'TITLE'
p22648
aS'The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney.'
p22649
aS'JOURNAL'
p22650
aS'Drug Metab Dispos 32:727-33 (2004)'
p22651
aS'PMID:14660610'
p22652
ag22652
aS'AUTHORS'
p22653
aS'Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, Korczak B.'
p22654
aS'TITLE'
p22655
aS'CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids.'
p22656
aS'JOURNAL'
p22657
aS'J Biol Chem 279:6305-14 (2004)'
p22658
aS'PMID:14626496'
p22659
ag22659
aS'AUTHORS'
p22660
aS'Sacerdoti D, Gatta A, McGiff JC.'
p22661
aS'TITLE'
p22662
aS'Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.'
p22663
aS'JOURNAL'
p22664
aS'Prostaglandins Other Lipid Mediat 72:51-71 (2003)'
p22665
aS'PMID:14622984'
p22666
ag22666
aS'AUTHORS'
p22667
aS'Pfister SL, Spitzbarth N, Zeldin DC, Lafite P, Mansuy D, Campbell WB.'
p22668
aS'TITLE'
p22669
aS'Rabbit aorta converts 15-HPETE to trihydroxyeicosatrienoic acids: potential role of cytochrome P450.'
p22670
aS'JOURNAL'
p22671
aS'Arch Biochem Biophys 420:142-52 (2003)'
p22672
aS'PMID:11679404'
p22673
ag22673
aS'AUTHORS'
p22674
aS'Fleming I.'
p22675
aS'TITLE'
p22676
aS'Cytochrome p450 and vascular homeostasis.'
p22677
aS'JOURNAL'
p22678
aS'Circ Res 89:753-62 (2001)'
p22679
aS'PMID:11328810'
p22680
ag22680
aS'AUTHORS'
p22681
aS'Qu W, Bradbury JA, Tsao CC, Maronpot R, Harry GJ, Parker CE, Davis LS, Breyer MD, Waalkes MP, Falck JR, Chen J, Rosenberg RL, Zeldin DC.'
p22682
aS'TITLE'
p22683
aS'Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain.'
p22684
aS'JOURNAL'
p22685
aS'J Biol Chem 276:25467-79 (2001)'
p22686
aS'PMID:10908295'
p22687
ag22687
aS'AUTHORS'
p22688
aS'Tsao CC, Foley J, Coulter SJ, Maronpot R, Zeldin DC, Goldstein JA.'
p22689
aS'TITLE'
p22690
aS'CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract.'
p22691
aS'JOURNAL'
p22692
aS'Mol Pharmacol 58:279-87 (2000)'
p22693
aS'PMID:9812980'
p22694
ag22694
aS'AUTHORS'
p22695
aS'Pfister SL, Spitzbarth N, Nithipatikom K, Edgemond WS, Falck JR, Campbell WB.'
p22696
aS'TITLE'
p22697
aS'Identification of the 11,14,15- and 11,12, 15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta.'
p22698
aS'JOURNAL'
p22699
aS'J Biol Chem 273:30879-87 (1998)'
p22700
asS'KO_PATHWAY'
p22701
(lp22702
S'ko00590'
p22703
asS'PATHWAY_MAP'
p22704
(lp22705
S'map00590'
p22706
asS'DISEASE'
p22707
(lp22708
S'H00490'
p22709
aS'Diaphyseal dysplasia with anemia (Ghosal)'
p22710
ag22709
ag22710
aS'H00734'
p22711
aS'Lamellar ichthyosis (LI) and Non-bullous congenital ichthyosiform erythroderma (NBCIE)'
p22712
aS'H00833'
p22713
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p22714
asS'DBLINKS'
p22715
(lp22716
S'GO: 0019369'
p22717
asS'ENTRY'
p22718
(lp22719
S'map00590'
p22720
aS'Pathway'
p22721
asS'CLASS'
p22722
(lp22723
S'Metabolism Lipid metabolism'
p22724
assS'path:map00591'
p22725
(dp22726
S'NAME'
p22727
(lp22728
S'Linoleic acid metabolism'
p22729
asS'REFERENCE'
p22730
(lp22731
S'PMID:14757320'
p22732
ag22732
aS'AUTHORS'
p22733
aS'Nowak G, Grant DF, Moran JH.'
p22734
aS'TITLE'
p22735
aS'Linoleic acid epoxide promotes the maintenance of mitochondrial function and active Na+ transport following hypoxia.'
p22736
aS'JOURNAL'
p22737
aS'Toxicol Lett 147:161-75 (2004)'
p22738
aS'PMID:12909723'
p22739
ag22739
aS'AUTHORS'
p22740
aS'Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman SM.'
p22741
aS'TITLE'
p22742
aS'The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells.'
p22743
aS'JOURNAL'
p22744
aS'Proc Natl Acad Sci U S A 100:9968-73 (2003)'
p22745
aS'PMID:12324235'
p22746
ag22746
aS'AUTHORS'
p22747
aS'Spiteller G.'
p22748
aS'TITLE'
p22749
aS'Do changes in the cell membrane structure induce the generation of lipid peroxidation products which serve as first signalling molecules in cell to cell communication?'
p22750
aS'JOURNAL'
p22751
aS'Prostaglandins Leukot Essent Fatty Acids 67:151-62 (2002)'
p22752
aS'PMID:11302930'
p22753
ag22753
aS'AUTHORS'
p22754
aS'Jude AR, Little JM, Bull AW, Podgorski I, Radominska-Pandya A.'
p22755
aS'TITLE'
p22756
aS'13-hydroxy- and 13-oxooctadecadienoic acids: novel substrates for human UDP-glucuronosyltransferases.'
p22757
aS'JOURNAL'
p22758
aS'Drug Metab Dispos 29:652-5 (2001)'
p22759
aS'PMID:9694817'
p22760
ag22760
aS'AUTHORS'
p22761
aS'Su C, Sahlin M, Oliw EH.'
p22762
aS'TITLE'
p22763
aS'A protein radical and ferryl intermediates are generated by linoleate diol synthase, a ferric hemeprotein with dioxygenase and hydroperoxide isomerase activities.'
p22764
aS'JOURNAL'
p22765
aS'J Biol Chem 273:20744-51 (1998)'
p22766
aS'PMID:1634517'
p22767
ag22767
aS'AUTHORS'
p22768
aS'Brodowsky ID, Hamberg M, Oliw EH.'
p22769
aS'TITLE'
p22770
aS'A linoleic acid (8R)-dioxygenase and hydroperoxide isomerase of the fungus Gaeumannomyces graminis. Biosynthesis of (8R)-hydroxylinoleic acid and (7S,8S)-dihydroxylinoleic acid from (8R)-hydroperoxylinoleic acid.'
p22771
aS'JOURNAL'
p22772
aS'J Biol Chem 267:14738-45 (1992)'
p22773
aS'PMID:12226220'
p22774
ag22774
aS'AUTHORS'
p22775
aS'Hamberg M, Hamberg G.'
p22776
aS'TITLE'
p22777
aS'Peroxygenase-Catalyzed Fatty Acid Epoxidation in Cereal Seeds (Sequential Oxidation of Linoleic Acid into 9(S),12(S),13(S)-Trihydroxy-10(E)-Octadecenoic Acid).'
p22778
aS'JOURNAL'
p22779
aS'Plant Physiol 110:807-815 (1996)'
p22780
aS'PMID:8765137'
p22781
ag22781
aS'AUTHORS'
p22782
aS'Moghaddam M, Motoba K, Borhan B, Pinot F, Hammock BD.'
p22783
aS'TITLE'
p22784
aS'Novel metabolic pathways for linoleic and arachidonic acid metabolism.'
p22785
aS'JOURNAL'
p22786
aS'Biochim Biophys Acta 1290:327-39 (1996)'
p22787
asS'KO_PATHWAY'
p22788
(lp22789
S'ko00591'
p22790
asS'ENTRY'
p22791
(lp22792
S'map00591'
p22793
aS'Pathway'
p22794
asS'PATHWAY_MAP'
p22795
(lp22796
S'map00591'
p22797
asS'DISEASE'
p22798
(lp22799
S'H00833'
p22800
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p22801
asS'CLASS'
p22802
(lp22803
S'Metabolism Lipid metabolism'
p22804
assS'path:map00592'
p22805
(dp22806
S'NAME'
p22807
(lp22808
S'alpha-Linolenic acid metabolism'
p22809
asS'REFERENCE'
p22810
(lp22811
S'PMID:17172287'
p22812
ag22812
aS'AUTHORS'
p22813
aS'Schilmiller AL, Koo AJ, Howe GA.'
p22814
aS'TITLE'
p22815
aS'Functional diversification of acyl-coenzyme A oxidases in jasmonic acid biosynthesis and action.'
p22816
aS'JOURNAL'
p22817
aS'Plant Physiol 143:812-24 (2007)'
p22818
aS'PMID:15141068'
p22819
ag22819
aS'AUTHORS'
p22820
aS'Cruz Castillo M, Martinez C, Buchala A, Metraux JP, Leon J.'
p22821
aS'TITLE'
p22822
aS'Gene-specific involvement of beta-oxidation in wound-activated responses in Arabidopsis.'
p22823
aS'JOURNAL'
p22824
aS'Plant Physiol 135:85-94 (2004)'
p22825
aS'PMID:17215350'
p22826
ag22826
aS'AUTHORS'
p22827
aS'Truman W, Bennett MH, Kubigsteltig I, Turnbull C, Grant M.'
p22828
aS'TITLE'
p22829
aS'Arabidopsis systemic immunity uses conserved defense signaling pathways and is mediated by jasmonates.'
p22830
aS'JOURNAL'
p22831
aS'Proc Natl Acad Sci U S A 104:1075-80 (2007)'
p22832
aS'PMID:16116284'
p22833
ag22833
aS'AUTHORS'
p22834
aS'Kuroda H, Oshima T, Kaneda H, Takashio M.'
p22835
aS'TITLE'
p22836
aS'Identification and functional analyses of two cDNAs that encode fatty acid 9-/13-hydroperoxide lyase (CYP74C) in rice.'
p22837
aS'JOURNAL'
p22838
aS'Biosci Biotechnol Biochem 69:1545-54 (2005)'
p22839
aS'PMID:15670154'
p22840
ag22840
aS'AUTHORS'
p22841
aS'Hamberg M.'
p22842
aS'TITLE'
p22843
aS'Hidden stereospecificity in the biosynthesis of divinyl ether fatty acids.'
p22844
aS'JOURNAL'
p22845
aS'FEBS J 272:736-43 (2005)'
p22846
aS'PMID:14522973'
p22847
ag22847
aS'AUTHORS'
p22848
aS'Hamberg M, Sanz A, Rodriguez MJ, Calvo AP, Castresana C.'
p22849
aS'TITLE'
p22850
aS'Activation of the fatty acid alpha-dioxygenase pathway during bacterial infection of tobacco leaves. Formation of oxylipins protecting against cell death.'
p22851
aS'JOURNAL'
p22852
aS'J Biol Chem 278:51796-805 (2003)'
p22853
ag22
ag22
aS'AUTHORS'
p22854
aS'Creelman RA, Mulpuri R.'
p22855
aS'TITLE'
p22856
aS'The Oxylipin Pathway in Arabidopsis'
p22857
aS'JOURNAL'
p22858
aS'The Arabidopsis Book'
p22859
asS'KO_PATHWAY'
p22860
(lp22861
S'ko00592'
p22862
asS'PATHWAY_MAP'
p22863
(lp22864
S'map00592'
p22865
asS'DISEASE'
p22866
(lp22867
S'H00407'
p22868
aS'Peroxisomal beta-oxidation enzyme deficiency'
p22869
asS'MODULE'
p22870
(lp22871
S'M00113'
p22872
aS'Jasmonic acid biosynthesis [PATH:map00592]'
p22873
asS'ENTRY'
p22874
(lp22875
S'map00592'
p22876
aS'Pathway'
p22877
asS'CLASS'
p22878
(lp22879
S'Metabolism Lipid metabolism'
p22880
assS'path:map05152'
p22881
(dp22882
S'NAME'
p22883
(lp22884
S'Tuberculosis'
p22885
asS'REFERENCE'
p22886
(lp22887
S'PMID:21274449'
p22888
ag22888
aS'AUTHORS'
p22889
aS'Saiga H, Shimada Y, Takeda K'
p22890
aS'TITLE'
p22891
aS'Innate immune effectors in mycobacterial infection.'
p22892
aS'JOURNAL'
p22893
aS'Clin Dev Immunol 2011:347594 (2011)'
p22894
aS'PMID:20415982'
p22895
ag22895
aS'AUTHORS'
p22896
aS'Dheda K, Schwander SK, Zhu B, van Zyl-Smit RN, Zhang Y'
p22897
aS'TITLE'
p22898
aS'The immunology of tuberculosis: from bench to bedside.'
p22899
aS'JOURNAL'
p22900
aS'Respirology 15:433-50 (2010)'
p22901
aS'PMID:11932234'
p22902
ag22902
aS'AUTHORS'
p22903
aS'van Crevel R, Ottenhoff TH, van der Meer JW'
p22904
aS'TITLE'
p22905
aS'Innate immunity to Mycobacterium tuberculosis.'
p22906
aS'JOURNAL'
p22907
aS'Clin Microbiol Rev 15:294-309 (2002)'
p22908
aS'PMID:18288961'
p22909
ag22909
aS'AUTHORS'
p22910
aS'Torrelles JB, Azad AK, Henning LN, Carlson TK, Schlesinger LS'
p22911
aS'TITLE'
p22912
aS'Role of C-type lectins in mycobacterial infections.'
p22913
aS'JOURNAL'
p22914
aS'Curr Drug Targets 9:102-12 (2008)'
p22915
aS'PMID:17359235'
p22916
ag22916
aS'AUTHORS'
p22917
aS'Jo EK, Yang CS, Choi CH, Harding CV'
p22918
aS'TITLE'
p22919
aS'Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors.'
p22920
aS'JOURNAL'
p22921
aS'Cell Microbiol 9:1087-98 (2007)'
p22922
aS'PMID:21274433'
p22923
ag22923
aS'AUTHORS'
p22924
aS'Marakalala MJ, Graham LM, Brown GD'
p22925
aS'TITLE'
p22926
aS'The role of Syk/CARD9-coupled C-type lectin receptors in immunity to Mycobacterium tuberculosis infections.'
p22927
aS'JOURNAL'
p22928
aS'Clin Dev Immunol 2010:567571 (2010)'
p22929
aS'PMID:15083155'
p22930
ag22930
aS'AUTHORS'
p22931
aS'Koul A, Herget T, Klebl B, Ullrich A'
p22932
aS'TITLE'
p22933
aS'Interplay between mycobacteria and host signalling pathways.'
p22934
aS'JOURNAL'
p22935
aS'Nat Rev Microbiol 2:189-202 (2004)'
p22936
aS'PMID:20199890'
p22937
ag22937
aS'AUTHORS'
p22938
aS'Torrelles JB, Schlesinger LS'
p22939
aS'TITLE'
p22940
aS'Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host.'
p22941
aS'JOURNAL'
p22942
aS'Tuberculosis (Edinb) 90:84-93 (2010)'
p22943
aS'PMID:15228522'
p22944
ag22944
aS'AUTHORS'
p22945
aS'Briken V, Porcelli SA, Besra GS, Kremer L'
p22946
aS'TITLE'
p22947
aS'Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.'
p22948
aS'JOURNAL'
p22949
aS'Mol Microbiol 53:391-403 (2004)'
p22950
aS'PMID:19563525'
p22951
ag22951
aS'AUTHORS'
p22952
aS'Baena A, Porcelli SA'
p22953
aS'TITLE'
p22954
aS'Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.'
p22955
aS'JOURNAL'
p22956
aS'Tissue Antigens 74:189-204 (2009)'
p22957
aS'PMID:19369951'
p22958
ag22958
aS'AUTHORS'
p22959
aS'Flannagan RS, Cosio G, Grinstein S'
p22960
aS'TITLE'
p22961
aS'Antimicrobial mechanisms of phagocytes and bacterial evasion strategies.'
p22962
aS'JOURNAL'
p22963
aS'Nat Rev Microbiol 7:355-66 (2009)'
p22964
aS'PMID:18541216'
p22965
ag22965
aS'AUTHORS'
p22966
aS'Pieters J'
p22967
aS'TITLE'
p22968
aS'Mycobacterium tuberculosis and the macrophage: maintaining a balance.'
p22969
aS'JOURNAL'
p22970
aS'Cell Host Microbe 3:399-407 (2008)'
p22971
aS'PMID:19634703'
p22972
ag22972
aS'AUTHORS'
p22973
aS'Scherr N, Jayachandran R, Mueller P, Pieters J'
p22974
aS'TITLE'
p22975
aS'Interference of Mycobacterium tuberculosis with macrophage responses.'
p22976
aS'JOURNAL'
p22977
aS'Indian J Exp Biol 47:401-6 (2009)'
p22978
aS'PMID:16200082'
p22979
ag22979
aS'AUTHORS'
p22980
aS'Reith W, LeibundGut-Landmann S, Waldburger JM.'
p22981
aS'TITLE'
p22982
aS'Regulation of MHC class II gene expression by the class II transactivator.'
p22983
aS'JOURNAL'
p22984
aS'Nat Rev Immunol 5:793-806 (2005)'
p22985
aS'PMID:17785780'
p22986
ag22986
aS'AUTHORS'
p22987
aS'Rothfuchs AG, Bafica A, Feng CG, Egen JG, Williams DL, Brown GD, Sher A'
p22988
aS'TITLE'
p22989
aS'Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells.'
p22990
aS'JOURNAL'
p22991
aS'J Immunol 179:3463-71 (2007)'
p22992
aS'PMID:18407066'
p22993
ag22993
aS'AUTHORS'
p22994
aS'Master SS, Rampini SK, Davis AS, Keller C, Ehlers S, Springer B, Timmins GS, Sander P, Deretic V'
p22995
aS'TITLE'
p22996
aS'Mycobacterium tuberculosis prevents inflammasome activation.'
p22997
aS'JOURNAL'
p22998
aS'Cell Host Microbe 3:224-32 (2008)'
p22999
aS'PMID:11378475'
p23000
ag23000
aS'AUTHORS'
p23001
aS'Shtrichman R, Samuel CE'
p23002
aS'TITLE'
p23003
aS'The role of gamma interferon in antimicrobial immunity.'
p23004
aS'JOURNAL'
p23005
aS'Curr Opin Microbiol 4:251-9 (2001)'
p23006
asS'KO_PATHWAY'
p23007
(lp23008
S'ko05152'
p23009
asS'PATHWAY_MAP'
p23010
(lp23011
S'map05152'
p23012
asS'DISEASE'
p23013
(lp23014
S'H00342'
p23015
aS'Tuberculosis'
p23016
asS'ENTRY'
p23017
(lp23018
S'map05152'
p23019
aS'Pathway'
p23020
asS'CLASS'
p23021
(lp23022
S'Human Diseases Infectious diseases'
p23023
asS'DESCRIPTION'
p23024
(lp23025
S"Tuberculosis, or TB, is an infectious disease caused by Mycobacterium tuberculosis. One third of the world's population is thought to be infected with TB. About 90% of those infected result in latent infections, and about 10% of latent infections develop active diseases when their immune system is impaired due to the age, other diseases such as AIDS or exposure to immunosuppressive drugs. TB is transmitted through the air and primarily attacks the lungs, then it can spread by the circulatory system to other parts of body. Once TB bacilli have entered the host by the respiratory route and infected macrophages in the lungs, they interfere with phagosomal maturation, antigen presentation, apoptosis and host immune system to establish persistent or latent infection."
p23026
assS'path:map05150'
p23027
(dp23028
S'NAME'
p23029
(lp23030
S'Staphylococcus aureus infection'
p23031
asS'REFERENCE'
p23032
(lp23033
S'PMID:20178484'
p23034
ag23034
aS'AUTHORS'
p23035
aS'Foster TJ'
p23036
aS'TITLE'
p23037
aS'Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion.'
p23038
aS'JOURNAL'
p23039
aS'Vet Dermatol 20:456-70 (2009)'
p23040
aS'PMID:16322743'
p23041
ag23041
aS'AUTHORS'
p23042
aS'Foster TJ'
p23043
aS'TITLE'
p23044
aS'Immune evasion by staphylococci.'
p23045
aS'JOURNAL'
p23046
aS'Nat Rev Microbiol 3:948-58 (2005)'
p23047
aS'PMID:20062962'
p23048
ag23048
aS'AUTHORS'
p23049
aS'Laarman A, Milder F, van Strijp J, Rooijakkers S'
p23050
aS'TITLE'
p23051
aS'Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.'
p23052
aS'JOURNAL'
p23053
aS'J Mol Med 88:115-20 (2010)'
p23054
aS'PMID:16242332'
p23055
ag23055
aS'AUTHORS'
p23056
aS'Rooijakkers SH, van Kessel KP, van Strijp JA'
p23057
aS'TITLE'
p23058
aS'Staphylococcal innate immune evasion.'
p23059
aS'JOURNAL'
p23060
aS'Trends Microbiol 13:596-601 (2005)'
p23061
aS'PMID:16679003'
p23062
ag23062
aS'AUTHORS'
p23063
aS'Iwatsuki K, Yamasaki O, Morizane S, Oono T'
p23064
aS'TITLE'
p23065
aS'Staphylococcal cutaneous infections: invasion, evasion and aggression.'
p23066
aS'JOURNAL'
p23067
aS'J Dermatol Sci 42:203-14 (2006)'
p23068
aS'PMID:11361034'
p23069
ag23069
aS'AUTHORS'
p23070
aS'Torres BA, Kominsky S, Perrin GQ, Hobeika AC, Johnson HM'
p23071
aS'TITLE'
p23072
aS'Superantigens: the good, the bad, and the ugly.'
p23073
aS'JOURNAL'
p23074
aS'Exp Biol Med (Maywood) 226:164-76 (2001)'
p23075
aS'PMID:18061675'
p23076
ag23076
aS'AUTHORS'
p23077
aS'Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins AT, Feil EJ, van den Elsen JM'
p23078
aS'TITLE'
p23079
aS'S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.'
p23080
aS'JOURNAL'
p23081
aS'Mol Immunol 45:1600-11 (2008)'
p23082
aS'PMID:16724100'
p23083
ag23083
aS'AUTHORS'
p23084
aS'Silverman GJ, Goodyear CS'
p23085
aS'TITLE'
p23086
aS'Confounding B-cell defences: lessons from a staphylococcal superantigen.'
p23087
aS'JOURNAL'
p23088
aS'Nat Rev Immunol 6:465-75 (2006)'
p23089
aS'PMID:15273292'
p23090
ag23090
aS'AUTHORS'
p23091
aS'Goodyear CS, Silverman GJ'
p23092
aS'TITLE'
p23093
aS'Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.'
p23094
aS'JOURNAL'
p23095
aS'Proc Natl Acad Sci U S A 101:11392-7 (2004)'
p23096
aS'PMID:19112495'
p23097
ag23097
aS'AUTHORS'
p23098
aS'Haupt K, Reuter M, van den Elsen J, Burman J, Halbich S, Richter J, Skerka C, Zipfel PF'
p23099
aS'TITLE'
p23100
aS'The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a'
p23101
aS'tripartite complex with host complement Factor H and C3b.'
p23102
aS'JOURNAL'
p23103
aS'PLoS Pathog 4:e1000250 (2008)'
p23104
aS'PMID:16111912'
p23105
ag23105
aS'AUTHORS'
p23106
aS'Bokarewa MI, Jin T, Tarkowski A'
p23107
aS'TITLE'
p23108
aS'Staphylococcus aureus: Staphylokinase.'
p23109
aS'JOURNAL'
p23110
aS'Int J Biochem Cell Biol 38:504-9 (2006)'
p23111
aS'PMID:16086019'
p23112
ag23112
aS'AUTHORS'
p23113
aS'Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA'
p23114
aS'TITLE'
p23115
aS'Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.'
p23116
aS'JOURNAL'
p23117
aS'Nat Immunol 6:920-7 (2005)'
p23118
aS'PMID:19503103'
p23119
ag23119
aS'AUTHORS'
p23120
aS'Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P'
p23121
aS'TITLE'
p23122
aS'Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.'
p23123
aS'JOURNAL'
p23124
aS'Nat Immunol 10:721-7 (2009)'
p23125
aS'PMID:17893203'
p23126
ag23126
aS'AUTHORS'
p23127
aS'Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH'
p23128
aS'TITLE'
p23129
aS'Staphylococcal complement evasion by various convertase-blocking molecules.'
p23130
aS'JOURNAL'
p23131
aS'J Exp Med 204:2461-71 (2007)'
p23132
aS'PMID:18544012'
p23133
ag23133
aS'AUTHORS'
p23134
aS'Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM'
p23135
aS'TITLE'
p23136
aS'Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.'
p23137
aS'JOURNAL'
p23138
aS'J Infect Dis 198:125-33 (2008)'
p23139
aS'PMID:16640587'
p23140
ag23140
aS'AUTHORS'
p23141
aS'Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ'
p23142
aS'TITLE'
p23143
aS'Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.'
p23144
aS'JOURNAL'
p23145
aS'FEMS Microbiol Lett 258:290-6 (2006)'
p23146
aS'PMID:20133685'
p23147
ag23147
aS'AUTHORS'
p23148
aS'Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B, Spillner E, Christensen JB, Jensen M, Fredslund F, Bjerre M, Sottrup-Jensen L, Fraser JD, Andersen GR'
p23149
aS'TITLE'
p23150
aS'Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.'
p23151
aS'JOURNAL'
p23152
aS'Proc Natl Acad Sci U S A 107:3681-6 (2010)'
p23153
aS'PMID:17848512'
p23154
ag23154
aS'AUTHORS'
p23155
aS'Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD'
p23156
aS'TITLE'
p23157
aS'Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.'
p23158
aS'JOURNAL'
p23159
aS'Proc Natl Acad Sci U S A 104:15051-6 (2007)'
p23160
aS'PMID:14993252'
p23161
ag23161
aS'AUTHORS'
p23162
aS'de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA'
p23163
aS'TITLE'
p23164
aS'Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.'
p23165
aS'JOURNAL'
p23166
aS'J Exp Med 199:687-95 (2004)'
p23167
aS'PMID:17114475'
p23168
ag23168
aS'AUTHORS'
p23169
aS'Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP'
p23170
aS'TITLE'
p23171
aS'A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.'
p23172
aS'JOURNAL'
p23173
aS'J Immunol 177:8017-26 (2006)'
p23174
aS'PMID:17132726'
p23175
ag23175
aS'AUTHORS'
p23176
aS'Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ'
p23177
aS'TITLE'
p23178
aS'Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated'
p23179
aS'neutrophil rolling.'
p23180
aS'JOURNAL'
p23181
aS'Blood 109:2936-43 (2007)'
p23182
aS'PMID:18045383'
p23183
ag23183
aS'AUTHORS'
p23184
aS'Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD'
p23185
aS'TITLE'
p23186
aS'The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.'
p23187
aS'JOURNAL'
p23188
aS'Mol Microbiol 66:1342-55 (2007)'
p23189
aS'PMID:12091905'
p23190
ag23190
aS'AUTHORS'
p23191
aS'Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT'
p23192
aS'TITLE'
p23193
aS'Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes.'
p23194
aS'JOURNAL'
p23195
aS'Nat Med 8:687-93 (2002)'
p23196
aS'PMID:17517597'
p23197
ag23197
aS'AUTHORS'
p23198
aS'Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M'
p23199
aS'TITLE'
p23200
aS'Gram-positive three-component antimicrobial peptide-sensing system.'
p23201
aS'JOURNAL'
p23202
aS'Proc Natl Acad Sci U S A 104:9469-74 (2007)'
p23203
aS'PMID:15561843'
p23204
ag23204
aS'AUTHORS'
p23205
aS'Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J'
p23206
aS'TITLE'
p23207
aS'Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.'
p23208
aS'JOURNAL'
p23209
aS'Antimicrob Agents Chemother 48:4673-9 (2004)'
p23210
aS'PMID:18837785'
p23211
ag23211
aS'AUTHORS'
p23212
aS'Fraser JD, Proft T'
p23213
aS'TITLE'
p23214
aS'The bacterial superantigen and superantigen-like proteins.'
p23215
aS'JOURNAL'
p23216
aS'Immunol Rev 225:226-43 (2008)'
p23217
aS'PMID:12228315'
p23218
ag23218
aS'AUTHORS'
p23219
aS'Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, Takata T, Ohara M, Komatsuzawa H, Amagai M, Sugai M'
p23220
aS'TITLE'
p23221
aS'Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.'
p23222
aS'JOURNAL'
p23223
aS'Infect Immun 70:5835-45 (2002)'
p23224
aS'PMID:16710608'
p23225
ag23225
aS'AUTHORS'
p23226
aS'Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J'
p23227
aS'TITLE'
p23228
aS'Human beta-defensins.'
p23229
aS'JOURNAL'
p23230
aS'Cell Mol Life Sci 63:1294-313 (2006)'
p23231
aS'PMID:16184199'
p23232
ag23232
aS'AUTHORS'
p23233
aS'Zhang Q, Mousdicas N, Yi Q, Al-Hassani M, Billings SD, Perkins SM, Howard KM, Ishii S, Shimizu T, Travers JB'
p23234
aS'TITLE'
p23235
aS'Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.'
p23236
aS'JOURNAL'
p23237
aS'J Clin Invest 115:2855-61 (2005)'
p23238
aS'PMID:15372083'
p23239
ag23239
aS'AUTHORS'
p23240
aS'Lehrer RI'
p23241
aS'TITLE'
p23242
aS'Primate defensins.'
p23243
aS'JOURNAL'
p23244
aS'Nat Rev Microbiol 2:727-38 (2004)'
p23245
asS'KO_PATHWAY'
p23246
(lp23247
S'ko05150'
p23248
asS'PATHWAY_MAP'
p23249
(lp23250
S'map05150'
p23251
asS'DISEASE'
p23252
(lp23253
S'H00330'
p23254
aS'Methicillin-resistant Staphylococcal aureus (MRSA) infection'
p23255
ag23254
ag23255
aS'H00331'
p23256
aS'Vancomycin-resistant Staphylococcal aureus (VRSA) infection'
p23257
aS'H01409'
p23258
aS'Methicillin-sensitive Staphylococcus aureus (MSSA) infection'
p23259
asS'ENTRY'
p23260
(lp23261
S'map05150'
p23262
aS'Pathway'
p23263
asS'CLASS'
p23264
(lp23265
S'Human Diseases Infectious diseases'
p23266
asS'DESCRIPTION'
p23267
(lp23268
S'Staphylococcus aureus can cause multiple forms of infections ranging from superficial skin infections to food poisoning and life-threatening infections. The organism has several ways to divert the effectiveness of the immune system: secreting immune modulating proteins that inhibit complement activation and neutrophil chemotaxis or lysis, modulating the sensitivity to cationic antimicrobial peptides (such as defensin) by increasing the positive net charge of its cytoplasmic membrane, and expression of superantigens that prevent development of a normal immune response or cause an emetic response when ingested.'
p23269
assS'path:map00290'
p23270
(dp23271
S'NAME'
p23272
(lp23273
S'Valine, leucine and isoleucine biosynthesis'
p23274
asS'REFERENCE'
p23275
(lp23276
S'PMID:15292141'
p23277
ag23277
aS'AUTHORS'
p23278
aS'Xu H, Zhang Y, Guo X, Ren S, Staempfli AA, Chiao J, Jiang W, Zhao G.'
p23279
aS'TITLE'
p23280
aS'Isoleucine biosynthesis in Leptospira interrogans serotype lai strain 56601 proceeds via a threonine-independent pathway.'
p23281
aS'JOURNAL'
p23282
aS'J Bacteriol 186:5400-9 (2004)'
p23283
asS'KO_PATHWAY'
p23284
(lp23285
S'ko00290'
p23286
asS'PATHWAY_MAP'
p23287
(lp23288
S'map00290'
p23289
asS'MODULE'
p23290
(lp23291
S'M00019'
p23292
aS'Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map00290]'
p23293
ag23292
ag23293
aS'M00432'
p23294
aS'Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map00290]'
p23295
aS'M00535'
p23296
aS'Isoleucine biosynthesis, pyruvate => 2-oxobutanoate [PATH:map00290]'
p23297
aS'M00570'
p23298
aS'Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine [PATH:map00290]'
p23299
asS'DBLINKS'
p23300
(lp23301
S'GO: 0009097 0009098 0009099'
p23302
asS'ENTRY'
p23303
(lp23304
S'map00290'
p23305
aS'Pathway'
p23306
asS'CLASS'
p23307
(lp23308
S'Metabolism Amino acid metabolism'
p23309
assS'path:map00051'
p23310
(dp23311
S'NAME'
p23312
(lp23313
S'Fructose and mannose metabolism'
p23314
asS'KO_PATHWAY'
p23315
(lp23316
S'ko00051'
p23317
asS'PATHWAY_MAP'
p23318
(lp23319
S'map00051'
p23320
asS'DISEASE'
p23321
(lp23322
S'H00118'
p23323
aS'Congenital disorders of glycosylation (CDG) type I'
p23324
asS'MODULE'
p23325
(lp23326
S'M00114'
p23327
aS'Ascorbate biosynthesis, plants, glucose-6P => ascorbate [PATH:map00051]'
p23328
ag23327
ag23328
aS'M00273'
p23329
aS'PTS system, fructose-specific II component [PATH:map00051]'
p23330
aS'M00274'
p23331
aS'PTS system, mannitol-specific II component [PATH:map00051]'
p23332
aS'M00276'
p23333
aS'PTS system, mannose-specific II component [PATH:map00051]'
p23334
aS'M00278'
p23335
aS'PTS system, sorbose-specific II component [PATH:map00051]'
p23336
aS'M00280'
p23337
aS'PTS system, glucitol/sorbitol-specific II component [PATH:map00051]'
p23338
asS'DBLINKS'
p23339
(lp23340
S'GO: 0006000 0006013'
p23341
asS'ENTRY'
p23342
(lp23343
S'map00051'
p23344
aS'Pathway'
p23345
asS'CLASS'
p23346
(lp23347
S'Metabolism Carbohydrate metabolism'
p23348
assS'path:map00053'
p23349
(dp23350
S'NAME'
p23351
(lp23352
S'Ascorbate and aldarate metabolism'
p23353
asS'REFERENCE'
p23354
(lp23355
S'PMID:17222174'
p23356
ag23356
aS'AUTHORS'
p23357
aS'Linster CL, Van Schaftingen E'
p23358
aS'TITLE'
p23359
aS'Vitamin C. Biosynthesis, recycling and degradation in mammals.'
p23360
aS'JOURNAL'
p23361
aS'FEBS J 274:1-22 (2007)'
p23362
aS'PMID:15564123'
p23363
ag23363
aS'AUTHORS'
p23364
aS'Valpuesta V, Botella MA.'
p23365
aS'TITLE'
p23366
aS'Biosynthesis of L-ascorbic acid in plants: new pathways for an old antioxidant.'
p23367
aS'JOURNAL'
p23368
aS'Trends Plant Sci 9:573-7 (2004)'
p23369
aS'PMID:10517845'
p23370
ag23370
aS'AUTHORS'
p23371
aS'Davey MW, Gilot C, Persiau G, Ostergaard J, Han Y, Bauw GC, Van Montagu MC.'
p23372
aS'TITLE'
p23373
aS'Ascorbate biosynthesis in Arabidopsis cell suspension culture.'
p23374
aS'JOURNAL'
p23375
aS'Plant Physiol 121:535-43 (1999)'
p23376
aS'PMID:16595667'
p23377
ag23377
aS'AUTHORS'
p23378
aS'Conklin PL, Gatzek S, Wheeler GL, Dowdle J, Raymond MJ, Rolinski S, Isupov M, Littlechild JA, Smirnoff N.'
p23379
aS'TITLE'
p23380
aS'Arabidopsis thaliana VTC4 encodes L-galactose-1-P phosphatase, a plant ascorbic acid biosynthetic enzyme.'
p23381
aS'JOURNAL'
p23382
aS'J Biol Chem 281:15662-70 (2006)'
p23383
aS'PMID:17462988'
p23384
ag23384
aS'AUTHORS'
p23385
aS'Linster CL, Gomez TA, Christensen KC, Adler LN, Young BD, Brenner C, Clarke SG.'
p23386
aS'TITLE'
p23387
aS'Arabidopsis VTC2 Encodes a GDP-L-Galactose Phosphorylase, the Last Unknown Enzyme in the Smirnoff-Wheeler Pathway to Ascorbic Acid in Plants.'
p23388
aS'JOURNAL'
p23389
aS'J Biol Chem 282:18879-85 (2007)'
p23390
aS'PMID:14996803'
p23391
ag23391
aS'AUTHORS'
p23392
aS'Campos E, Baldoma L, Aguilar J, Badia J.'
p23393
aS'TITLE'
p23394
aS'Regulation of expression of the divergent ulaG and ulaABCDEF operons involved in LaAscorbate dissimilation in Escherichia coli.'
p23395
aS'JOURNAL'
p23396
aS'J Bacteriol 186:1720-8 (2004)'
p23397
aS'PMID:12644495'
p23398
ag23398
aS'AUTHORS'
p23399
aS'Zhang Z, Aboulwafa M, Smith MH, Saier MH Jr.'
p23400
aS'TITLE'
p23401
aS'The ascorbate transporter of Escherichia coli.'
p23402
aS'JOURNAL'
p23403
aS'J Bacteriol 185:2243-50 (2003)'
p23404
asS'KO_PATHWAY'
p23405
(lp23406
S'ko00053'
p23407
asS'PATHWAY_MAP'
p23408
(lp23409
S'map00053'
p23410
asS'MODULE'
p23411
(lp23412
S'M00114'
p23413
aS'Ascorbate biosynthesis, plants, glucose-6P => ascorbate [PATH:map00053]'
p23414
ag23413
ag23414
aS'M00129'
p23415
aS'Ascorbate biosynthesis, animals, glucose-1P => ascorbate [PATH:map00053]'
p23416
aS'M00283'
p23417
aS'PTS system, ascorbate-specific II component [PATH:map00053]'
p23418
aS'M00550'
p23419
aS'Ascorbate degradation, ascorbate => D-xylulose-5P [PATH:map00053]'
p23420
asS'DBLINKS'
p23421
(lp23422
S'GO: 0019852 0019572'
p23423
asS'ENTRY'
p23424
(lp23425
S'map00053'
p23426
aS'Pathway'
p23427
asS'CLASS'
p23428
(lp23429
S'Metabolism Carbohydrate metabolism'
p23430
assS'path:map00500'
p23431
(dp23432
S'NAME'
p23433
(lp23434
S'Starch and sucrose metabolism'
p23435
asS'KO_PATHWAY'
p23436
(lp23437
S'ko00500'
p23438
asS'PATHWAY_MAP'
p23439
(lp23440
S'map00500'
p23441
asS'DISEASE'
p23442
(lp23443
S'H00069'
p23444
aS'Glycogen storage diseases (GSD)'
p23445
ag23444
ag23445
aS'H00115'
p23446
aS'Congenital sucrase-isomaltase deficiency'
p23447
aS'H01002'
p23448
aS'Generalized arterial calcification of infancy'
p23449
aS'H01193'
p23450
aS'Familial tumoral calcinosis (FTC)'
p23451
aS'H01394'
p23452
aS'Cole disease'
p23453
asS'MODULE'
p23454
(lp23455
S'M00266'
p23456
aS'PTS system, maltose and glucose-specific II component [PATH:map00500]'
p23457
ag23456
ag23457
aS'M00269'
p23458
aS'PTS system, sucrose-specific II component [PATH:map00500]'
p23459
aS'M00270'
p23460
aS'PTS system, trehalose-specific II component [PATH:map00500]'
p23461
aS'M00565'
p23462
aS'Trehalose biosynthesis, D-glucose 1P => trehalose [PATH:map00500]'
p23463
asS'DBLINKS'
p23464
(lp23465
S'GO: 0005982 0005985'
p23466
asS'ENTRY'
p23467
(lp23468
S'map00500'
p23469
aS'Pathway'
p23470
asS'CLASS'
p23471
(lp23472
S'Metabolism Carbohydrate metabolism'
p23473
assS'path:map04712'
p23474
(dp23475
S'NAME'
p23476
(lp23477
S'Circadian rhythm - plant'
p23478
asS'REFERENCE'
p23479
(lp23480
S'PMID:11710980'
p23481
ag23481
aS'AUTHORS'
p23482
aS'McWatters HG, Roden LC, Staiger D.'
p23483
aS'TITLE'
p23484
aS'Picking out parallels: plant circadian clocks in context.'
p23485
aS'JOURNAL'
p23486
aS'Philos Trans R Soc Lond B Biol Sci 356:1735-43 (2001)'
p23487
aS'PMID:11597501'
p23488
ag23488
aS'AUTHORS'
p23489
aS'Yanovsky MJ, Kay SA.'
p23490
aS'TITLE'
p23491
aS'Signaling networks in the plant circadian system.'
p23492
aS'JOURNAL'
p23493
aS'Curr Opin Plant Biol 4:429-35 (2001)'
p23494
aS'PMID:10792828'
p23495
ag23495
aS'AUTHORS'
p23496
aS'Kim L, Kircher S, Toth R, Adam E, Schafer E, Nagy F.'
p23497
aS'TITLE'
p23498
aS'Light-induced nuclear import of phytochrome-A:GFP fusion proteins is differentially regulated in transgenic tobacco and Arabidopsis.'
p23499
aS'JOURNAL'
p23500
aS'Plant J 22:125-33 (2000)'
p23501
aS'PMID:8953247'
p23502
ag23502
aS'AUTHORS'
p23503
aS'Sakamoto K, Nagatani A.'
p23504
aS'TITLE'
p23505
aS'Nuclear localization activity of phytochrome B.'
p23506
aS'JOURNAL'
p23507
aS'Plant J 10:859-68 (1996)'
p23508
aS'PMID:11402161'
p23509
ag23509
aS'AUTHORS'
p23510
aS'Liu XL, Covington MF, Fankhauser C, Chory J, Wagner DR.'
p23511
aS'TITLE'
p23512
aS'ELF3 encodes a circadian clock-regulated nuclear protein that functions in an Arabidopsis PHYB signal transduction pathway.'
p23513
aS'JOURNAL'
p23514
aS'Plant Cell 13:1293-304 (2001)'
p23515
aS'PMID:11069292'
p23516
ag23516
aS'AUTHORS'
p23517
aS'Zhu Y, Tepperman JM, Fairchild CD, Quail PH.'
p23518
aS'TITLE'
p23519
aS'Phytochrome B binds with greater apparent affinity than phytochrome A to the basic helix-loop-helix factor PIF3 in a reaction requiring the PAS domain of PIF3.'
p23520
aS'JOURNAL'
p23521
aS'Proc Natl Acad Sci U S A 97:13419-24 (2000)'
p23522
aS'PMID:9845368'
p23523
ag23523
aS'AUTHORS'
p23524
aS'Ni M, Tepperman JM, Quail PH.'
p23525
aS'TITLE'
p23526
aS'PIF3, a phytochrome-interacting factor necessary for normal photoinduced signal transduction, is a novel basic helix-loop-helix protein.'
p23527
aS'JOURNAL'
p23528
aS'Cell 95:657-67 (1998)'
p23529
aS'PMID:11743105'
p23530
ag23530
aS'AUTHORS'
p23531
aS'Toth R, Kevei E, Hall A, Millar AJ, Nagy F, Kozma-Bognar L.'
p23532
aS'TITLE'
p23533
aS'Circadian clock-regulated expression of phytochrome and cryptochrome genes in Arabidopsis.'
p23534
aS'JOURNAL'
p23535
aS'Plant Physiol 127:1607-16 (2001)'
p23536
aS'PMID:11752379'
p23537
ag23537
aS'AUTHORS'
p23538
aS'Schultz TF, Kiyosue T, Yanovsky M, Wada M, Kay SA.'
p23539
aS'TITLE'
p23540
aS'A role for LKP2 in the circadian clock of Arabidopsis.'
p23541
aS'JOURNAL'
p23542
aS'Plant Cell 13:2659-70 (2001)'
p23543
aS'PMID:11260718'
p23544
ag23544
aS'AUTHORS'
p23545
aS'Jarillo JA, Capel J, Tang RH, Yang HQ, Alonso JM, Ecker JR, Cashmore AR.'
p23546
aS'TITLE'
p23547
aS'An Arabidopsis circadian clock component interacts with both CRY1 and phyB.'
p23548
aS'JOURNAL'
p23549
aS'Nature 410:487-90 (2001)'
p23550
aS'PMID:11828029'
p23551
ag23551
aS'AUTHORS'
p23552
aS'Matsushika A, Makino S, Kojima M, Yamashino T, Mizuno T.'
p23553
aS'TITLE'
p23554
aS'The APRR1/TOC1 quintet implicated in circadian rhythms of Arabidopsis thaliana: II. Characterization with CCA1-overexpressing plants.'
p23555
aS'JOURNAL'
p23556
aS'Plant Cell Physiol 43:118-22 (2002)'
p23557
aS'PMID:10535927'
p23558
ag23558
aS'AUTHORS'
p23559
aS'Sugano S, Andronis C, Ong MS, Green RM, Tobin EM.'
p23560
aS'TITLE'
p23561
aS'The protein kinase CK2 is involved in regulation of circadian rhythms in Arabidopsis.'
p23562
aS'JOURNAL'
p23563
aS'Proc Natl Acad Sci U S A 96:12362-6 (1999)'
p23564
aS'PMID:11089975'
p23565
ag23565
aS'AUTHORS'
p23566
aS'Mas P, Devlin PF, Panda S, Kay SA.'
p23567
aS'TITLE'
p23568
aS'Functional interaction of phytochrome B and cryptochrome 2.'
p23569
aS'JOURNAL'
p23570
aS'Nature 408:207-11 (2000)'
p23571
aS'PMID:9651577'
p23572
ag23572
aS'AUTHORS'
p23573
aS'Ahmad M, Jarillo JA, Smirnova O, Cashmore AR.'
p23574
aS'TITLE'
p23575
aS'The CRY1 blue light photoreceptor of Arabidopsis interacts with phytochrome A in vitro.'
p23576
aS'JOURNAL'
p23577
aS'Mol Cell 1:939-48 (1998)'
p23578
aS'PMID:11486091'
p23579
ag23579
aS'AUTHORS'
p23580
aS'Alabadi D, Oyama T, Yanovsky MJ, Harmon FG, Mas P, Kay SA.'
p23581
aS'TITLE'
p23582
aS'Reciprocal regulation between TOC1 and LHY/CCA1 within the Arabidopsis circadian clock.'
p23583
aS'JOURNAL'
p23584
aS'Science 293:880-3 (2001)'
p23585
aS'PMID:11148285'
p23586
ag23586
aS'AUTHORS'
p23587
aS'Borevitz JO, Xia Y, Blount J, Dixon RA, Lamb C.'
p23588
aS'TITLE'
p23589
aS'Activation tagging identifies a conserved MYB regulator of phenylpropanoid biosynthesis.'
p23590
aS'JOURNAL'
p23591
aS'Plant Cell 12:2383-2394 (2000)'
p23592
aS'PMID:12091722'
p23593
ag23593
aS'AUTHORS'
p23594
aS'Murakami-Kojima M, Nakamichi N, Yamashino T, Mizuno T.'
p23595
aS'TITLE'
p23596
aS'The APRR3 component of the clock-associated APRR1/TOC1 quintet is phosphorylated by a novel protein kinase belonging to the WNK family, the gene for which is also transcribed rhythmically in Arabidopsis thaliana.'
p23597
aS'JOURNAL'
p23598
aS'Plant Cell Physiol 43:675-83 (2002)'
p23599
aS'PMID:19386812'
p23600
ag23600
aS'AUTHORS'
p23601
aS'Pan Y, Michael TP, Hudson ME, Kay SA, Chory J, Schuler MA'
p23602
aS'TITLE'
p23603
aS'Cytochrome P450 monooxygenases as reporters for circadian-regulated pathways.'
p23604
aS'JOURNAL'
p23605
aS'Plant Physiol 150:858-78 (2009)'
p23606
aS'PMID:11118138'
p23607
ag23607
aS'AUTHORS'
p23608
aS'Harmer SL, Hogenesch JB, Straume M, Chang HS, Han B, Zhu T, Wang X, Kreps JA, Kay SA'
p23609
aS'TITLE'
p23610
aS'Orchestrated transcription of key pathways in Arabidopsis by the circadian clock.'
p23611
aS'JOURNAL'
p23612
aS'Science 290:2110-3 (2000)'
p23613
aS'PMID:12045273'
p23614
ag23614
aS'AUTHORS'
p23615
aS'Mouradov A, Cremer F, Coupland G'
p23616
aS'TITLE'
p23617
aS'Control of flowering time: interacting pathways as a basis for diversity.'
p23618
aS'JOURNAL'
p23619
aS'Plant Cell 14 Suppl:S111-30 (2002)'
p23620
aS'PMID:15568973'
p23621
ag23621
aS'AUTHORS'
p23622
aS'Chen M, Chory J, Fankhauser C'
p23623
aS'TITLE'
p23624
aS'Light signal transduction in higher plants.'
p23625
aS'JOURNAL'
p23626
aS'Annu Rev Genet 38:87-117 (2004)'
p23627
aS'PMID:16096959'
p23628
ag23628
aS'AUTHORS'
p23629
aS'Mas P'
p23630
aS'TITLE'
p23631
aS'Circadian clock signaling in Arabidopsis thaliana: from gene expression to physiology and development.'
p23632
aS'JOURNAL'
p23633
aS'Int J Dev Biol 49:491-500 (2005)'
p23634
aS'PMID:17304247'
p23635
ag23635
aS'AUTHORS'
p23636
aS'Jiao Y, Lau OS, Deng XW'
p23637
aS'TITLE'
p23638
aS'Light-regulated transcriptional networks in higher plants.'
p23639
aS'JOURNAL'
p23640
aS'Nat Rev Genet 8:217-30 (2007)'
p23641
aS'PMID:18444908'
p23642
ag23642
aS'AUTHORS'
p23643
aS'Turck F, Fornara F, Coupland G'
p23644
aS'TITLE'
p23645
aS'Regulation and identity of florigen: FLOWERING LOCUS T moves center stage.'
p23646
aS'JOURNAL'
p23647
aS'Annu Rev Plant Biol 59:573-94 (2008)'
p23648
aS'PMID:19836294'
p23649
ag23649
aS'AUTHORS'
p23650
aS'Imaizumi T'
p23651
aS'TITLE'
p23652
aS'Arabidopsis circadian clock and photoperiodism: time to think about location.'
p23653
aS'JOURNAL'
p23654
aS'Curr Opin Plant Biol 13:83-9 (2010)'
p23655
aS'PMID:20459860'
p23656
ag23656
aS'AUTHORS'
p23657
aS'McClung CR'
p23658
aS'TITLE'
p23659
aS'A modern circadian clock in the common angiosperm ancestor of monocots and eudicots.'
p23660
aS'JOURNAL'
p23661
aS'BMC Biol 8:55 (2010)'
p23662
aS'PMID:20809800'
p23663
ag23663
aS'AUTHORS'
p23664
aS'Doherty CJ, Kay SA'
p23665
aS'TITLE'
p23666
aS'Circadian control of global gene expression patterns.'
p23667
aS'JOURNAL'
p23668
aS'Annu Rev Genet 44:419-44 (2010)'
p23669
aS'PMID:20889330'
p23670
ag23670
aS'AUTHORS'
p23671
aS'McClung CR, Gutierrez RA'
p23672
aS'TITLE'
p23673
aS'Network news: prime time for systems biology of the plant circadian clock.'
p23674
aS'JOURNAL'
p23675
aS'Curr Opin Genet Dev 20:588-98 (2010)'
p23676
aS'PMID:22190341'
p23677
ag23677
aS'AUTHORS'
p23678
aS'Lu SX, Webb CJ, Knowles SM, Kim SH, Wang Z, Tobin EM'
p23679
aS'TITLE'
p23680
aS'CCA1 and ELF3 Interact in the control of hypocotyl length and flowering time in Arabidopsis.'
p23681
aS'JOURNAL'
p23682
aS'Plant Physiol 158:1079-88 (2012)'
p23683
aS'PMID:22705257'
p23684
ag23684
aS'AUTHORS'
p23685
aS'Lau OS, Deng XW'
p23686
aS'TITLE'
p23687
aS'The photomorphogenic repressors COP1 and DET1: 20 years later.'
p23688
aS'JOURNAL'
p23689
aS'Trends Plant Sci 17:584-93 (2012)'
p23690
asS'KO_PATHWAY'
p23691
(lp23692
S'ko04712'
p23693
asS'PATHWAY_MAP'
p23694
(lp23695
S'map04712'
p23696
asS'DBLINKS'
p23697
(lp23698
S'GO: 0007623'
p23699
asS'ENTRY'
p23700
(lp23701
S'map04712'
p23702
aS'Pathway'
p23703
asS'CLASS'
p23704
(lp23705
S'Organismal Systems Environmental adaptation'
p23706
asS'DESCRIPTION'
p23707
(lp23708
S'The circadian system is an endogenous rhythm with the period of about 24 hours to provide temporal organization of biological activity. In Arabidopsis the circadian oscillator at the core of this system is composed of the interlocked feedback loop formed by the major transcriptional factors CCA1 (circadian clock associated), LHY (late elongated hypocotyl) and TOC1 (timing of cab), a pseudo response regulator (PRR). The morning-expressed CCA1/LHY Myb transcription factors suppress TOC1 expression by binding to its promoter. Moreover, CCA1/LHY activates the expression of PRR7/9 in the morning and then PRR7/9 repress the transcription of CCA1/LHY during the rest of the day. By contrast, the evening-expressed TOC1 activates the expression of CCA1/LHY.'
p23709
assS'path:map07051'
p23710
(dp23711
S'ENTRY'
p23712
(lp23713
S'map07051'
p23714
aS'Drug'
p23715
aS'Pathway'
p23716
asS'PATHWAY_MAP'
p23717
(lp23718
S'map07051'
p23719
asS'NAME'
p23720
(lp23721
S'Antidiabetics'
p23722
asS'COMPOUND'
p23723
(lp23724
S'D00085'
p23725
aS'Insulin (JAN/USP)'
p23726
ag23725
ag23726
aS'D00216'
p23727
aS'Acarbose (JAN/USAN/INN)'
p23728
aS'D00336'
p23729
aS'Glibenclamide (JP16/INN)'
p23730
aS'D00380'
p23731
aS'Tolbutamide (JP16/USP/INN)'
p23732
aS'D00395'
p23733
aS'Troglitazone (JAN/USAN/INN)'
p23734
aS'D00594'
p23735
aS'Repaglinide (JAN/USP/INN)'
p23736
aS'D00595'
p23737
aS'Buformin (USAN/INN)'
p23738
aS'D00625'
p23739
aS'Miglitol (JAN/USAN/INN)'
p23740
aS'D00944'
p23741
aS'Metformin hydrochloride (JP16/USP)'
p23742
aS'D00945'
p23743
aS'Pioglitazone hydrochloride (JP16/USP)'
p23744
aS'D01111'
p23745
aS'Nateglinide (JP16/USAN/INN)'
p23746
aS'D01665'
p23747
aS'Voglibose (JP16/USAN/INN)'
p23748
aS'D01854'
p23749
aS'Mitiglinide calcium hydrate (JAN)'
p23750
aS'D02206'
p23751
aS'Buformin hydrochloride (JP16)'
p23752
aS'D03230'
p23753
aS'Insulin human (genetical recombination) (JP16)'
p23754
aS'D03250'
p23755
aS'Insulin glargine (genetical recombination) (JP16)'
p23756
aS'D04121'
p23757
aS'Exenatide (JAN/USAN/INN)'
p23758
aS'D04475'
p23759
aS'Insulin aspart (genetical recombination) (JAN)'
p23760
aS'D04477'
p23761
aS'Insulin lispro (genetical recombination) (JAN)'
p23762
aS'D04539'
p23763
aS'Insulin detemir (genetical recombination) (JAN)'
p23764
aS'D04540'
p23765
aS'Insulin glulisine (genetical recombination) (JAN)'
p23766
aS'D04541'
p23767
aS'Insulin human, isophane (USP)'
p23768
aS'D04547'
p23769
aS'Isophane insulin injection (aqueous suspension) (JAN)'
p23770
aS'D04966'
p23771
aS'Metformin (USAN/INN)'
p23772
aS'D06404'
p23773
aS'Liraglutide (genetical recombination) (JAN)'
p23774
aS'D06553'
p23775
aS'Alogliptin benzoate (JAN/USAN)'
p23776
aS'D06645'
p23777
aS'Sitagliptin phosphate hydrate (JAN)'
p23778
aS'D07080'
p23779
aS'Vildagliptin (JAN/USAN/INN)'
p23780
aS'D08378'
p23781
aS'Pioglitazone (INN)'
p23782
aS'D08516'
p23783
aS'Sitagliptin (Prop.INN)'
p23784
aS'D08897'
p23785
aS'Dapagliflozin (USAN/INN)'
p23786
aS'D08996'
p23787
aS'Saxagliptin (INN)'
p23788
aS'D09566'
p23789
aS'Linagliptin (JAN/USAN/INN)'
p23790
aS'D09592'
p23791
aS'Canagliflozin hydrate (JAN)'
p23792
aS'D09727'
p23793
aS'Insulin degludec (genetical recombination) (JAN)'
p23794
aS'D09729'
p23795
aS'Lixisenatide (JAN/INN)'
p23796
aS'D09753'
p23797
aS'Saxagliptin hydrate (JAN/USAN)'
p23798
aS'D09763'
p23799
aS'Dapagliflozin propylene glycolate hydrate (JAN)'
p23800
aS'D09978'
p23801
aS'Tofogliflozin hydrate (JAN)'
p23802
aS'D10195'
p23803
aS'Luseogliflozin hydrate (JAN)'
p23804
aS'D10196'
p23805
aS'Ipragliflozin (INN)'
p23806
aS'D10200'
p23807
aS'Ipragliflozin L-proline (JAN)'
p23808
aS'D10336'
p23809
aS'Fasiglifam (INN)'
p23810
assS'path:map04710'
p23811
(dp23812
S'NAME'
p23813
(lp23814
S'Circadian rhythm'
p23815
asS'REFERENCE'
p23816
(lp23817
S'PMID:11165242'
p23818
ag23818
aS'AUTHORS'
p23819
aS'Camacho F, Cilio M, Guo Y, Virshup DM, Patel K, Khorkova O, Styren S, Morse B, Yao Z, Keesler GA.'
p23820
aS'TITLE'
p23821
aS'Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2.'
p23822
aS'JOURNAL'
p23823
aS'FEBS Lett 489:159-65 (2001)'
p23824
aS'PMID:12015613'
p23825
ag23825
aS'AUTHORS'
p23826
aS'Panda S, Hogenesch JB, Kay SA.'
p23827
aS'TITLE'
p23828
aS'Circadian rhythms from flies to human.'
p23829
aS'JOURNAL'
p23830
aS'Nature 417:329-35 (2002)'
p23831
aS'PMID:11687489'
p23832
ag23832
aS'AUTHORS'
p23833
aS'Harmer SL, Panda S, Kay SA.'
p23834
aS'TITLE'
p23835
aS'Molecular bases of circadian rhythms.'
p23836
aS'JOURNAL'
p23837
aS'Annu Rev Cell Dev Biol 17:215-53 (2001)'
p23838
aS'PMID:11533719'
p23839
ag23839
aS'AUTHORS'
p23840
aS'Young MW, Kay SA.'
p23841
aS'TITLE'
p23842
aS'Time zones: a comparative genetics of circadian clocks.'
p23843
aS'JOURNAL'
p23844
aS'Nat Rev Genet 2:702-15 (2001)'
p23845
aS'PMID:12397359'
p23846
ag23846
aS'AUTHORS'
p23847
aS'Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, Kato Y, Honma K.'
p23848
aS'TITLE'
p23849
aS'Dec1 and Dec2 are regulators of the mammalian molecular clock.'
p23850
aS'JOURNAL'
p23851
aS'Nature 419:841-4 (2002)'
p23852
aS'PMID:12150932'
p23853
ag23853
aS'AUTHORS'
p23854
aS'Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, Schibler U.'
p23855
aS'TITLE'
p23856
aS'The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator.'
p23857
aS'JOURNAL'
p23858
aS'Cell 110:251-60 (2002)'
p23859
aS'PMID:12724733'
p23860
ag23860
aS'AUTHORS'
p23861
aS'Fu L, Lee CC.'
p23862
aS'TITLE'
p23863
aS'The circadian clock: pacemaker and tumour suppressor.'
p23864
aS'JOURNAL'
p23865
aS'Nat Rev Cancer 3:350-61 (2003)'
p23866
aS'PMID:12507418'
p23867
ag23867
aS'AUTHORS'
p23868
aS'Schibler U, Sassone-Corsi P.'
p23869
aS'TITLE'
p23870
aS'A web of circadian pacemakers.'
p23871
aS'JOURNAL'
p23872
aS'Cell 111:919-22 (2002)'
p23873
aS'PMID:10864977'
p23874
ag23874
aS'AUTHORS'
p23875
aS'Hogenesch JB, Gu YZ, Moran SM, Shimomura K, Radcliffe LA, Takahashi JS, Bradfield CA.'
p23876
aS'TITLE'
p23877
aS'The basic helix-loop-helix-PAS protein MOP9 is a brain-specific heterodimeric partner of circadian and hypoxia factors.'
p23878
aS'JOURNAL'
p23879
aS'J Neurosci 20:RC83 (2000)'
p23880
aS'PMID:15917222'
p23881
ag23881
aS'AUTHORS'
p23882
aS'Shirogane T, Jin J, Ang XL, Harper JW'
p23883
aS'TITLE'
p23884
aS'SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein.'
p23885
aS'JOURNAL'
p23886
aS'J Biol Chem 280:26863-72 (2005)'
p23887
aS'PMID:17463251'
p23888
ag23888
aS'AUTHORS'
p23889
aS'Busino L, Bassermann F, Maiolica A, Lee C, Nolan PM, Godinho SI, Draetta GF, Pagano M'
p23890
aS'TITLE'
p23891
aS'SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins.'
p23892
aS'JOURNAL'
p23893
aS'Science 316:900-4 (2007)'
p23894
aS'PMID:18802415'
p23895
ag23895
aS'AUTHORS'
p23896
aS'Takahashi JS, Hong HK, Ko CH, McDearmon EL'
p23897
aS'TITLE'
p23898
aS'The genetics of mammalian circadian order and disorder: implications for physiology and disease.'
p23899
aS'JOURNAL'
p23900
aS'Nat Rev Genet 9:764-75 (2008)'
p23901
aS'PMID:17586087'
p23902
ag23902
aS'AUTHORS'
p23903
aS'Mertens I, Husson SJ, Janssen T, Lindemans M, Schoofs L'
p23904
aS'TITLE'
p23905
aS'PACAP and PDF signaling in the regulation of mammalian and insect circadian rhythms.'
p23906
aS'JOURNAL'
p23907
aS'Peptides 28:1775-83 (2007)'
p23908
asS'KO_PATHWAY'
p23909
(lp23910
S'ko04710'
p23911
asS'PATHWAY_MAP'
p23912
(lp23913
S'map04710'
p23914
asS'DISEASE'
p23915
(lp23916
S'H00688'
p23917
aS'Familial advanced sleep phase syndrome'
p23918
asS'MODULE'
p23919
(lp23920
S'M00380'
p23921
aS'SCF-BTRC complex [PATH:map04710]'
p23922
asS'DBLINKS'
p23923
(lp23924
S'GO: 0007623'
p23925
asS'ENTRY'
p23926
(lp23927
S'map04710'
p23928
aS'Pathway'
p23929
asS'CLASS'
p23930
(lp23931
S'Organismal Systems Environmental adaptation'
p23932
asS'DESCRIPTION'
p23933
(lp23934
S'Circadian rhythm is an internal biological clock, which enables to sustain an approximately 24-hour rhythm in the absence of environmental cues. In mammals, the circadian clock mechanism consists of cell-autonomous transcription-translation feedback loops that drive rhythmic, 24-hour expression patterns of core clock components. The first negative feedback loop is a rhythmic transcription of period genes (PER1, PER2, and PER3) and chryptochrome genes (CRY1 and CRY2). PER and CRY proteins form a heterodimer, which acts on the CLOCK/BMAL1 heterodimer to repress its own transcription. PER and CRY proteins are phosphorylated by casein kinase epsilon (CKIepsilon), which leads to degradation and restarting of the cycle. The second loop is a positive feedback loop driven by the CLOCK/BMAL1 heterodimer, which initiates transcription of target genes containing E-box cis-regulatory enhancer sequences.'
p23935
assS'path:map04711'
p23936
(dp23937
S'NAME'
p23938
(lp23939
S'Circadian rhythm - fly'
p23940
asS'REFERENCE'
p23941
(lp23942
S'PMID:12015613'
p23943
ag23943
aS'AUTHORS'
p23944
aS'Panda S, Hogenesch JB, Kay SA.'
p23945
aS'TITLE'
p23946
aS'Circadian rhythms from flies to human.'
p23947
aS'JOURNAL'
p23948
aS'Nature 417:329-35 (2002)'
p23949
aS'PMID:11687489'
p23950
ag23950
aS'AUTHORS'
p23951
aS'Harmer SL, Panda S, Kay SA.'
p23952
aS'TITLE'
p23953
aS'Molecular bases of circadian rhythms.'
p23954
aS'JOURNAL'
p23955
aS'Annu Rev Cell Dev Biol 17:215-53 (2001)'
p23956
aS'PMID:11533719'
p23957
ag23957
aS'AUTHORS'
p23958
aS'Young MW, Kay SA.'
p23959
aS'TITLE'
p23960
aS'Time zones: a comparative genetics of circadian clocks.'
p23961
aS'JOURNAL'
p23962
aS'Nat Rev Genet 2:702-15 (2001)'
p23963
aS'PMID:12581523'
p23964
ag23964
aS'AUTHORS'
p23965
aS'Cyran SA, Buchsbaum AM, Reddy KL, Lin MC, Glossop NR, Hardin PE, Young MW, Storti RV, Blau J.'
p23966
aS'TITLE'
p23967
aS'vrille, Pdp1, and dClock form a second feedback loop in the Drosophila circadian clock.'
p23968
aS'JOURNAL'
p23969
aS'Cell 112:329-41 (2003)'
p23970
aS'PMID:16351879'
p23971
ag23971
aS'AUTHORS'
p23972
aS'Helfrich-Forster C'
p23973
aS'TITLE'
p23974
aS'The circadian system of Drosophila melanogaster and its light input pathways.'
p23975
aS'JOURNAL'
p23976
aS'Zoology (Jena) 105:297-312 (2002)'
p23977
aS'PMID:12486701'
p23978
ag23978
aS'AUTHORS'
p23979
aS'Stanewsky R'
p23980
aS'TITLE'
p23981
aS'Genetic analysis of the circadian system in Drosophila melanogaster and mammals.'
p23982
aS'JOURNAL'
p23983
aS'J Neurobiol 54:111-47 (2003)'
p23984
asS'KO_PATHWAY'
p23985
(lp23986
S'ko04711'
p23987
asS'PATHWAY_MAP'
p23988
(lp23989
S'map04711'
p23990
asS'DBLINKS'
p23991
(lp23992
S'GO: 0007623'
p23993
asS'ENTRY'
p23994
(lp23995
S'map04711'
p23996
aS'Pathway'
p23997
asS'CLASS'
p23998
(lp23999
S'Organismal Systems Environmental adaptation'
p24000
asS'DESCRIPTION'
p24001
(lp24002
S'Circadian rhythm is an internal biological clock, which enables to sustain an approximately 24-hour rhythm in the absence of environmental cues. In the fruit fly Drosophila melanogaster, seven genes that contribute to the central clock function are known: period (per), timeless (tim), Clock (Clk), cycle (cyc), vrille (vri), double-time (dbt), and shaggy (sgg). The core of the circadian clock consists of molecular feedback loops where per and tim gene products (PER and TIM proteins) eventually turn off their own transcription. The CLK/CYC heterodimer activates transcription of per and tim genes, while the PER and TIM repressor proteins accumulate in the cytoplasm. After nuclear entry of PER and TIM, transcription is inhibited by direct binding of the PER/TIM heterodimer to the CLK/CYC heterodimer. This shutoff lasts until the PER and TIM proteins are degraded allowing a new round of transcription to occur.'
p24003
assS'path:map07054'
p24004
(dp24005
S'ENTRY'
p24006
(lp24007
S'map07054'
p24008
aS'Drug'
p24009
aS'Pathway'
p24010
asS'PATHWAY_MAP'
p24011
(lp24012
S'map07054'
p24013
asS'NAME'
p24014
(lp24015
S'Antiglaucoma agents'
p24016
asS'COMPOUND'
p24017
(lp24018
S'D00028'
p24019
aS'Glycerin (JP16/USP)'
p24020
ag24019
ag24020
aS'D00062'
p24021
aS'D-Mannitol (JP16)'
p24022
aS'D00218'
p24023
aS'Acetazolamide (JP16/USP/INN)'
p24024
aS'D00347'
p24025
aS'Isosorbide (JP16/USP/INN)'
p24026
aS'D00356'
p24027
aS'Latanoprost (JAN/USAN/INN)'
p24028
aS'D00378'
p24029
aS'Timolol (USAN)'
p24030
aS'D00524'
p24031
aS'Carbachol (JAN/USP/INN)'
p24032
aS'D00525'
p24033
aS'Pilocarpine (JAN/USP)'
p24034
aS'D00598'
p24035
aS'Betaxolol hydrochloride (JP16/USP)'
p24036
aS'D00599'
p24037
aS'Carteolol hydrochloride (JP16/USP)'
p24038
aS'D00603'
p24039
aS'Timolol maleate (JP16/USP)'
p24040
aS'D00652'
p24041
aS'Brinzolamide (JAN/USP/INN)'
p24042
aS'D00653'
p24043
aS'Dorzolamide hydrochloride (JP16/USP)'
p24044
aS'D00655'
p24045
aS'Methazolamide (JAN/USP/INN)'
p24046
aS'D01008'
p24047
aS'Apraclonidine hydrochloride (JAN/USP)'
p24048
aS'D01017'
p24049
aS'Dipivefrin hydrochloride (JAN/USP)'
p24050
aS'D01025'
p24051
aS'Levobunolol hydrochloride (JAN/USP)'
p24052
aS'D01196'
p24053
aS'Acetazolamide sodium (JAN)'
p24054
aS'D01228'
p24055
aS'Distigmine bromide (JP16/INN)'
p24056
aS'D01452'
p24057
aS'Isopropyl unoprostone (JAN)'
p24058
aS'D01691'
p24059
aS'Nipradilol (JAN/INN)'
p24060
aS'D01887'
p24061
aS'Bunazosin hydrochloride (JP16)'
p24062
aS'D01964'
p24063
aS'Travoprost (JAN/USAN/INN)'
p24064
aS'D02076'
p24065
aS'Brimonidine tartrate (JAN/USAN)'
p24066
aS'D02081'
p24067
aS'Metipranolol hydrochloride'
p24068
aS'D02193'
p24069
aS'Ecothiopate iodide (JP16/INN)'
p24070
aS'D02200'
p24071
aS'Pilocarpine hydrochloride (JP16/USP)'
p24072
aS'D02349'
p24073
aS'Dipivefrin (USAN)'
p24074
aS'D02374'
p24075
aS'Metipranolol (USAN/INN)'
p24076
aS'D02724'
p24077
aS'Bimatoprost (JAN/USAN/INN)'
p24078
aS'D03845'
p24079
aS'Sezolamide hydrochloride (USAN)'
p24080
aS'D05478'
p24081
aS'Pilocarpine nitrate (USP)'
p24082
aS'D06274'
p24083
aS'Tafluprost (JAN/USAN/INN)'
p24084
aS'D07461'
p24085
aS'Apraclonidine (INN)'
p24086
aS'D07505'
p24087
aS'Latanoprost - timolol maleate mixt'
p24088
aS'D07526'
p24089
aS'Betaxolol (INN)'
p24090
aS'D07540'
p24091
aS'Brimonidine (INN)'
p24092
aS'D07550'
p24093
aS'Bunazosin (INN)'
p24094
aS'D07624'
p24095
aS'Carteolol (INN)'
p24096
aS'D07871'
p24097
aS'Dorzolamide (INN)'
p24098
aS'D08115'
p24099
aS'Levobunolol (INN)'
p24100
aS'D08376'
p24101
aS'Pilocarpine borate'
p24102
aS'D08493'
p24103
aS'Dorzolamide hydrochloride - timolol maleate mixt'
p24104
aS'D08600'
p24105
aS'Timolol (INN)'
p24106
aS'D08661'
p24107
aS'Unoprostone (INN)'
p24108
aS'D09815'
p24109
aS'Travoprost - timolol maleate mixt'
p24110
aS'D09962'
p24111
aS'Simenepag (USAN/INN)'
p24112
aS'D09963'
p24113
aS'Simenepag isopropyl (USAN)'
p24114
aS'D09968'
p24115
aS'Taprenepag (USAN/INN)'
p24116
aS'D09969'
p24117
aS'Taprenepag isopropyl (USAN)'
p24118
aS'D10298'
p24119
aS'Brimonidine tartrate - timolol maleate mixt'
p24120
assS'path:map00270'
p24121
(dp24122
S'NAME'
p24123
(lp24124
S'Cysteine and methionine metabolism'
p24125
asS'REFERENCE'
p24126
(lp24127
S'PMID:15102328'
p24128
ag24128
aS'AUTHORS'
p24129
aS'Sekowska A, Denervaud V, Ashida H, Michoud K, Haas D, Yokota A, Danchin A'
p24130
aS'TITLE'
p24131
aS'Bacterial variations on the methionine salvage pathway.'
p24132
aS'JOURNAL'
p24133
aS'BMC Microbiol 4:9 (2004)'
p24134
aS'PMID:14551435'
p24135
ag24135
aS'AUTHORS'
p24136
aS'Ashida H, Saito Y, Kojima C, Kobayashi K, Ogasawara N, Yokota A.'
p24137
aS'TITLE'
p24138
aS'A functional link between RuBisCO-like protein of Bacillus and photosynthetic RuBisCO.'
p24139
aS'JOURNAL'
p24140
aS'Science 302:286-90 (2003)'
p24141
aS'PMID:12022921'
p24142
ag24142
aS'AUTHORS'
p24143
aS'Sekowska A, Danchin A.'
p24144
aS'TITLE'
p24145
aS'The methionine salvage pathway in Bacillus subtilis.'
p24146
aS'JOURNAL'
p24147
aS'BMC Microbiol 2:8 (2002)'
p24148
aS'PMID:12670965'
p24149
ag24149
aS'AUTHORS'
p24150
aS'Berger BJ, English S, Chan G, Knodel MH.'
p24151
aS'TITLE'
p24152
aS'Methionine regeneration and aminotransferases in Bacillus subtilis, Bacillus cereus, and Bacillus anthracis.'
p24153
aS'JOURNAL'
p24154
aS'J Bacteriol 185:2418-31 (2003)'
p24155
aS'PMID:17169919'
p24156
ag24156
aS'AUTHORS'
p24157
aS'Goyer A, Collakova E, Shachar-Hill Y, Hanson AD'
p24158
aS'TITLE'
p24159
aS'Functional characterization of a methionine gamma-lyase in Arabidopsis and its implication in an alternative to the reverse trans-sulfuration pathway.'
p24160
aS'JOURNAL'
p24161
aS'Plant Cell Physiol 48:232-42 (2007)'
p24162
aS'PMID:17030798'
p24163
ag24163
aS'AUTHORS'
p24164
aS'Rebeille F, Jabrin S, Bligny R, Loizeau K, Gambonnet B, Van Wilder V, Douce R, Ravanel S'
p24165
aS'TITLE'
p24166
aS'Methionine catabolism in Arabidopsis cells is initiated by a gamma-cleavage process and leads to S-methylcysteine and isoleucine syntheses.'
p24167
aS'JOURNAL'
p24168
aS'Proc Natl Acad Sci U S A 103:15687-92 (2006)'
p24169
aS'PMID:18625006'
p24170
ag24170
aS'AUTHORS'
p24171
aS'Pirkov I, Norbeck J, Gustafsson L, Albers E'
p24172
aS'TITLE'
p24173
aS'A complete inventory of all enzymes in the eukaryotic methionine salvage pathway.'
p24174
aS'JOURNAL'
p24175
aS'FEBS J 275:4111-20 (2008)'
p24176
aS'PMID:18391471'
p24177
ag24177
aS'AUTHORS'
p24178
aS'Ashida H, Saito Y, Kojima C, Yokota A'
p24179
aS'TITLE'
p24180
aS'Enzymatic characterization of 5-methylthioribulose-1-phosphate dehydratase of the methionine salvage pathway in Bacillus subtilis.'
p24181
aS'JOURNAL'
p24182
aS'Biosci Biotechnol Biochem 72:959-67 (2008)'
p24183
aS'PMID:10613873'
p24184
ag24184
aS'AUTHORS'
p24185
aS'Kitabatake M, So MW, Tumbula DL, Soll D'
p24186
aS'TITLE'
p24187
aS'Cysteine biosynthesis pathway in the archaeon Methanosarcina barkeri encoded by acquired bacterial genes?'
p24188
aS'JOURNAL'
p24189
aS'J Bacteriol 182:143-5 (2000)'
p24190
aS'PMID:12644499'
p24191
ag24191
aS'AUTHORS'
p24192
aS'Mino K, Ishikawa K'
p24193
aS'TITLE'
p24194
aS'Characterization of a novel thermostable O-acetylserine sulfhydrylase from Aeropyrum pernix K1.'
p24195
aS'JOURNAL'
p24196
aS'J Bacteriol 185:2277-84 (2003)'
p24197
aS'PMID:18520135'
p24198
ag24198
aS'AUTHORS'
p24199
aS'Tanabe S'
p24200
aS'TITLE'
p24201
aS'Development of assay methods for endogenous inorganic sulfur compounds and sulfurtransferases and evaluation of the physiological functions of bound sulfur.'
p24202
aS'JOURNAL'
p24203
aS'Yakugaku Zasshi 128:881-900 (2008)'
p24204
ag22
ag22
aS'AUTHORS'
p24205
aS'Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).'
p24206
aS'TITLE'
p24207
aS'[Cellular Functions and Metabolic Maps] (In Japanese)'
p24208
aS'JOURNAL'
p24209
aS'Tokyo Kagaku Dojin (1997)'
p24210
aS'PMID:19270684'
p24211
ag24211
aS'AUTHORS'
p24212
aS'Gutierrez JA, Crowder T, Rinaldo-Matthis A, Ho MC, Almo SC, Schramm VL'
p24213
aS'TITLE'
p24214
aS"Transition state analogs of 5'-methylthioadenosine nucleosidase disrupt quorum sensing."
p24215
aS'JOURNAL'
p24216
aS'Nat Chem Biol 5:251-7 (2009)'
p24217
asS'KO_PATHWAY'
p24218
(lp24219
S'ko00270'
p24220
asS'PATHWAY_MAP'
p24221
(lp24222
S'map00270'
p24223
asS'DISEASE'
p24224
(lp24225
S'H00147'
p24226
aS'Sialuria/ Sialic acid storage disease'
p24227
ag24226
ag24227
aS'H00182'
p24228
aS'Cystathioninuria'
p24229
aS'H00183'
p24230
aS'Homocystinuria'
p24231
aS'H00184'
p24232
aS'Hypermethioninemia'
p24233
aS'H00597'
p24234
aS'Snyder-Robinson syndrome'
p24235
aS'H01285'
p24236
aS'Methylcobalamin deficiency type G (cblG)'
p24237
asS'MODULE'
p24238
(lp24239
S'M00017'
p24240
aS'Methionine biosynthesis, apartate => homoserine => methionine [PATH:map00270]'
p24241
ag24240
ag24241
aS'M00021'
p24242
aS'Cysteine biosynthesis, serine => cysteine [PATH:map00270]'
p24243
aS'M00034'
p24244
aS'Methionine salvage pathway [PATH:map00270]'
p24245
aS'M00035'
p24246
aS'Methionine degradation [PATH:map00270]'
p24247
aS'M00338'
p24248
aS'Cysteine biosynthesis, homocysteine + serine => cysteine [PATH:map00270]'
p24249
aS'M00368'
p24250
aS'Ethylene biosynthesis, methionine => ethylene [PATH:map00270]'
p24251
aS'M00609'
p24252
aS'Cysteine biosynthesis, methionine => cysteine [PATH:map00270]'
p24253
asS'DBLINKS'
p24254
(lp24255
S'GO: 0006534 0006555'
p24256
asS'ENTRY'
p24257
(lp24258
S'map00270'
p24259
aS'Pathway'
p24260
asS'CLASS'
p24261
(lp24262
S'Metabolism Amino acid metabolism'
p24263
asS'DESCRIPTION'
p24264
(lp24265
S'Cysteine and methionine are sulfur-containing amino acids. Cysteine is synthesized from serine through different pathways in different organism groups. In bacteria and plants, cysteine is converted from serine (via acetylserine) by transfer of hydrogen sulfide [MD:M00021]. In animals, methionine-derived homocysteine is used as sulfur source and its condensation product with serine (cystathionine) is converted to cysteine [MD:M00338]. Cysteine is metabolized to pyruvate in multiple routes. Methionine is an essential amino acid, which animals cannot synthesize. In bacteria and plants, methionine is synthesized from aspartate [MD:M00017]. S-Adenosylmethionine (SAM), synthesized from methionine and ATP, is a methyl group donor in many important transfer reactions including DNA methylation for regulation of gene expression. SAM may also be used to regenerate methionine in the methionine salvage pathway [MD:M00034].'
p24266
assS'path:map07056'
p24267
(dp24268
S'ENTRY'
p24269
(lp24270
S'map07056'
p24271
aS'Drug'
p24272
aS'Pathway'
p24273
asS'PATHWAY_MAP'
p24274
(lp24275
S'map07056'
p24276
asS'NAME'
p24277
(lp24278
S'Agents for Alzheimer-type dementia'
p24279
asS'COMPOUND'
p24280
(lp24281
S'D00196'
p24282
aS'Physostigmine (USP)'
p24283
ag24282
ag24283
aS'D00670'
p24284
aS'Donepezil hydrochloride (JP16/USAN)'
p24285
aS'D02068'
p24286
aS'Tacrine hydrochloride (USP)'
p24287
aS'D02173'
p24288
aS'Galantamine hydrobromide (JAN/USAN)'
p24289
aS'D02418'
p24290
aS'Physostigmine salicylate (JAN/USP)'
p24291
aS'D02558'
p24292
aS'Rivastigmine tartrate'
p24293
aS'D03822'
p24294
aS'Rivastigmine (JAN/USAN/INN)'
p24295
aS'D03826'
p24296
aS'Physostigmine sulfate (USP)'
p24297
aS'D04292'
p24298
aS'Galantamine (USAN/INN)'
p24299
aS'D04905'
p24300
aS'Memantine hydrochloride (JAN/USAN)'
p24301
aS'D06202'
p24302
aS'Tramiprosate (USAN)'
p24303
aS'D07869'
p24304
aS'Donepezil (INN)'
p24305
aS'D08174'
p24306
aS'Memantine (INN)'
p24307
aS'D08555'
p24308
aS'Tacrine (INN)'
p24309
aS'D08867'
p24310
aS'Bapineuzumab (USAN/INN)'
p24311
aS'D08869'
p24312
aS'Begacestat (USAN/INN)'
p24313
aS'D09010'
p24314
aS'Tarenflurbil (USAN/INN)'
p24315
aS'D09377'
p24316
aS'Semagacestat (USAN/INN)'
p24317
aS'D09713'
p24318
aS'Gantenerumab (USAN/INN)'
p24319
aS'D09869'
p24320
aS'Avagacestat (USAN)'
p24321
aS'D09917'
p24322
aS'Latrepirdine (USAN/INN)'
p24323
aS'D09918'
p24324
aS'Latrepirdine dihydrochloride (USAN)'
p24325
aS'D10058'
p24326
aS'Solanezumab (genetical recombination) (JAN)'
p24327
assS'path:map07057'
p24328
(dp24329
S'ENTRY'
p24330
(lp24331
S'map07057'
p24332
aS'Drug'
p24333
aS'Pathway'
p24334
asS'PATHWAY_MAP'
p24335
(lp24336
S'map07057'
p24337
asS'NAME'
p24338
(lp24339
S'Antiparkinsonian agents'
p24340
asS'COMPOUND'
p24341
(lp24342
S'D00059'
p24343
aS'Levodopa (JP16/USP/INN)'
p24344
ag24343
ag24344
aS'D00502'
p24345
aS'Pergolide mesilate (JAN)'
p24346
aS'D00538'
p24347
aS'Zonisamide (JAN/USAN/INN)'
p24348
aS'D00558'
p24349
aS'Carbidopa hydrate (JP16)'
p24350
aS'D00559'
p24351
aS'Pramipexole hydrochloride hydrate (JAN)'
p24352
aS'D00777'
p24353
aS'Amantadine hydrochloride (JP16/USP)'
p24354
aS'D00778'
p24355
aS'Benztropine mesilate (JAN)'
p24356
aS'D00779'
p24357
aS'Biperiden (JAN/USP/INN)'
p24358
aS'D00780'
p24359
aS'Bromocriptine mesilate (JP16)'
p24360
aS'D00781'
p24361
aS'Entacapone (JAN/USAN/INN)'
p24362
aS'D00784'
p24363
aS'Ropinirole hydrochloride (JAN/USAN)'
p24364
aS'D00785'
p24365
aS'Selegiline hydrochloride (JAN/USP)'
p24366
aS'D00786'
p24367
aS'Tolcapone (JAN/USAN/INN)'
p24368
aS'D00787'
p24369
aS'Trihexyphenidyl hydrochloride (JP16/USP)'
p24370
aS'D00987'
p24371
aS'Cabergoline (JAN/USAN/INN)'
p24372
aS'D01118'
p24373
aS'Profenamine hydrochloride (JAN)'
p24374
aS'D01231'
p24375
aS'Piroheptine hydrochloride (JAN)'
p24376
aS'D01277'
p24377
aS'Droxidopa (JP16/INN)'
p24378
aS'D01505'
p24379
aS'Talipexole hydrochloride (JAN)'
p24380
aS'D01653'
p24381
aS'Benserazide hydrochloride (JP16)'
p24382
aS'D01871'
p24383
aS'Metixene hydrochloride (JAN)'
p24384
aS'D02004'
p24385
aS'Apomorphine hydrochloride hydrate (JAN)'
p24386
aS'D02246'
p24387
aS'Biperiden hydrochloride (JP16/USP)'
p24388
aS'D02247'
p24389
aS'Biperiden lactate (JAN/USP)'
p24390
aS'D02562'
p24391
aS'Rasagiline mesylate (USAN)'
p24392
aS'D03082'
p24393
aS'Benserazide (USAN/INN)'
p24394
aS'D03100'
p24395
aS'Besonprodil (USAN)'
p24396
aS'D03165'
p24397
aS'Bromocriptine (USAN/INN)'
p24398
aS'D03264'
p24399
aS'Mazaticol hydrochloride hydrate (JAN)'
p24400
aS'D03276'
p24401
aS'Profenamine hibenzate (JAN)'
p24402
aS'D03731'
p24403
aS'Selegiline (USAN/INN)'
p24404
aS'D04087'
p24405
aS'Ethybenztropine (USAN)'
p24406
aS'D04641'
p24407
aS'Istradefylline (JAN/USAN/INN)'
p24408
aS'D05575'
p24409
aS'Pramipexole (USAN/INN)'
p24410
aS'D05768'
p24411
aS'Rotigotine (JAN/USAN/INN)'
p24412
aS'D07305'
p24413
aS'Piribedil (INN)'
p24414
aS'D07441'
p24415
aS'Amantadine (INN)'
p24416
aS'D07460'
p24417
aS'Apomorphine (BAN)'
p24418
aS'D07511'
p24419
aS'Benzatropine (INN)'
p24420
aS'D07835'
p24421
aS'Dihydroergocryptine'
p24422
aS'D07836'
p24423
aS'Dihydroergocryptine mesilate'
p24424
aS'D08157'
p24425
aS'Mazaticol (INN)'
p24426
aS'D08209'
p24427
aS'Metixene (INN)'
p24428
aS'D08339'
p24429
aS'Pergolide (INN)'
p24430
aS'D08395'
p24431
aS'Piroheptine (INN)'
p24432
aS'D08426'
p24433
aS'Profenamine (INN)'
p24434
aS'D08469'
p24435
aS'Rasagiline (USAN/INN)'
p24436
aS'D08489'
p24437
aS'Ropinirole (USAN/INN)'
p24438
aS'D08558'
p24439
aS'Talipexole (INN)'
p24440
aS'D08638'
p24441
aS'Trihexyphenidyl (INN)'
p24442
aS'D09991'
p24443
aS'Vipadenant (USAN/INN)'
p24444
aS'D10191'
p24445
aS'Safinamide mesylate (USAN)'
p24446
assS'path:map07110'
p24447
(dp24448
S'ENTRY'
p24449
(lp24450
S'map07110'
p24451
aS'Drug'
p24452
aS'Pathway'
p24453
asS'PATHWAY_MAP'
p24454
(lp24455
S'map07110'
p24456
asS'NAME'
p24457
(lp24458
S'Benzoic acid family'
p24459
asS'REFERENCE'
p24460
(lp24461
S'(Japanese)'
p24462
ag24462
aS'AUTHORS'
p24463
aS'Sano T, Naito T, Kubo T (eds).'
p24464
aS'TITLE'
p24465
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p24466
aS'JOURNAL'
p24467
aS'Nankodo (2002)'
p24468
asS'COMPOUND'
p24469
(lp24470
S'C00108'
p24471
aS'Anthranilate'
p24472
ag24471
ag24472
aS'C00156'
p24473
aS'4-Hydroxybenzoate'
p24474
aS'D00038'
p24475
aS'Benzoic acid (JP16/USP)'
p24476
aS'D00097'
p24477
aS'Salicylic acid (JP16/USP)'
p24478
aS'D00109'
p24479
aS'Aspirin (JP16/USP)'
p24480
aS'D00110'
p24481
aS'Cocaine (USP)'
p24482
aS'D00130'
p24483
aS'Diflunisal (JAN/USP/INN)'
p24484
aS'D00151'
p24485
aS'Mefenamic acid (JP16/USP/INN)'
p24486
aS'D00552'
p24487
aS'Ethyl aminobenzoate (JP16)'
p24488
aS'D00740'
p24489
aS'Procaine hydrochloride (JP16/USP)'
p24490
aS'D01087'
p24491
aS'Methyl salicylate (JP16/NF)'
p24492
aS'D01183'
p24493
aS'Tolfenamic acid (JAN/INN)'
p24494
aS'D01258'
p24495
aS'Iotalamic acid (JP16/INN)'
p24496
aS'D01376'
p24497
aS'Iodamide (JP16/USAN/INN)'
p24498
aS'D01400'
p24499
aS'Methyl parahydroxybenzoate (JP16)'
p24500
aS'D01420'
p24501
aS'Butyl parahydroxybenzoate (JP16)'
p24502
aS'D01422'
p24503
aS'Propyl parahydroxybenzoate (JP16)'
p24504
aS'D01581'
p24505
aS'Flufenamic acid (JAN/USAN/INN)'
p24506
aS'D01647'
p24507
aS'Ethyl parahydroxybenzoate (JP16)'
p24508
aS'D01774'
p24509
aS'Adipiodone (JAN/INN)'
p24510
aS'D01880'
p24511
aS'Sodium metrizoate (JAN/INN)'
p24512
aS'D01916'
p24513
aS'Iodipamide meglumine (USP)'
p24514
aS'D01979'
p24515
aS'Iodamide meglumine (USAN)'
p24516
aS'D02036'
p24517
aS'Meglumine sodium iodamide injection (JP16)'
p24518
aS'D02182'
p24519
aS'Cocaine hydrochloride (JP16/USP)'
p24520
aS'D02240'
p24521
aS'Amidotrizoic acid (JP16)'
p24522
aS'D02456'
p24523
aS'Aminobenzoic acid (USP)'
p24524
aS'D02457'
p24525
aS'Acetrizoic acid'
p24526
aS'D02458'
p24527
aS'Methylparaben sodium (NF)'
p24528
aS'D02459'
p24529
aS'Propylparaben sodium (NF)'
p24530
aS'D02461'
p24531
aS'Penicillin G procaine (USP)'
p24532
assS'path:map04650'
p24533
(dp24534
S'NAME'
p24535
(lp24536
S'Natural killer cell mediated cytotoxicity'
p24537
asS'REFERENCE'
p24538
(lp24539
S'PMID:15607802'
p24540
ag24540
aS'AUTHORS'
p24541
aS'Chiesa S, Tomasello E, Vivier E, Vely F.'
p24542
aS'TITLE'
p24543
aS'Coordination of activating and inhibitory signals in natural killer cells.'
p24544
aS'JOURNAL'
p24545
aS'Mol Immunol 42:477-84 (2005)'
p24546
aS'PMID:16109839'
p24547
ag24547
aS'AUTHORS'
p24548
aS'Maghazachi AA.'
p24549
aS'TITLE'
p24550
aS'Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.'
p24551
aS'JOURNAL'
p24552
aS'Pharmacol Rev 57:339-57 (2005)'
p24553
aS'PMID:15567854'
p24554
ag24554
aS'AUTHORS'
p24555
aS'Vivier E, Nunes JA, Vely F.'
p24556
aS'TITLE'
p24557
aS'Natural killer cell signaling pathways.'
p24558
aS'JOURNAL'
p24559
aS'Science 306:1517-9 (2004)'
p24560
aS'PMID:12205470'
p24561
ag24561
aS'AUTHORS'
p24562
aS'Colucci F, Di Santo JP, Leibson PJ.'
p24563
aS'TITLE'
p24564
aS'Natural killer cell activation in mice and men: different triggers for similar weapons?'
p24565
aS'JOURNAL'
p24566
aS'Nat Immunol 3:807-13 (2002)'
p24567
aS'PMID:11062493'
p24568
ag24568
aS'AUTHORS'
p24569
aS'Perussia B.'
p24570
aS'TITLE'
p24571
aS'Signaling for cytotoxicity.'
p24572
aS'JOURNAL'
p24573
aS'Nat Immunol 1:372-4 (2000)'
p24574
aS'PMID:15607806'
p24575
ag24575
aS'AUTHORS'
p24576
aS'Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.'
p24577
aS'TITLE'
p24578
aS'Activation of NK cell cytotoxicity.'
p24579
aS'JOURNAL'
p24580
aS'Mol Immunol 42:501-10 (2005)'
p24581
aS'PMID:11895890'
p24582
ag24582
aS'AUTHORS'
p24583
aS'Djeu JY, Jiang K, Wei S.'
p24584
aS'TITLE'
p24585
aS'A view to a kill: signals triggering cytotoxicity.'
p24586
aS'JOURNAL'
p24587
aS'Clin Cancer Res 8:636-40 (2002)'
p24588
aS'PMID:12530970'
p24589
ag24589
aS'AUTHORS'
p24590
aS'Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.'
p24591
aS'TITLE'
p24592
aS"Nature's TRAIL--on a path to cancer immunotherapy."
p24593
aS'JOURNAL'
p24594
aS'Immunity 18:1-6 (2003)'
p24595
aS'PMID:16177799'
p24596
ag24596
aS'AUTHORS'
p24597
aS'Colonna M.'
p24598
aS'TITLE'
p24599
aS"Fine-tuning NK cell responses: it's a family affair."
p24600
aS'JOURNAL'
p24601
aS'Nat Immunol 6:961-2 (2005)'
p24602
aS'PMID:8942070'
p24603
ag24603
aS'AUTHORS'
p24604
aS'Bonnema JD, Leibson PJ.'
p24605
aS'TITLE'
p24606
aS'Signal transduction during NK cell activation.'
p24607
aS'JOURNAL'
p24608
aS'Chem Immunol 64:28-43 (1996)'
p24609
aS'(Japanese)'
p24610
ag24610
aS'AUTHORS'
p24611
aS'Satoh T, Arase H.'
p24612
aS'TITLE'
p24613
aS'[Recognition of virus infected cells by NK cell receptor.] (In Japanese)'
p24614
aS'JOURNAL'
p24615
aS'Experimental Medicine 23(17):2685-2691 (2005)'
p24616
aS'PMID:16002670'
p24617
ag24617
aS'AUTHORS'
p24618
aS'Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.'
p24619
aS'TITLE'
p24620
aS'Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.'
p24621
aS'JOURNAL'
p24622
aS'J Immunol 175:749-54 (2005)'
p24623
aS'PMID:9143705'
p24624
ag24624
aS'AUTHORS'
p24625
aS'Rao A, Luo C, Hogan PG.'
p24626
aS'TITLE'
p24627
aS'Transcription factors of the NFAT family: regulation and function.'
p24628
aS'JOURNAL'
p24629
aS'Annu Rev Immunol 15:707-47 (1997)'
p24630
aS'PMID:14710949'
p24631
ag24631
aS'AUTHORS'
p24632
aS'Wu J, Lanier LL.'
p24633
aS'TITLE'
p24634
aS'Natural killer cells and cancer.'
p24635
aS'JOURNAL'
p24636
aS'Adv Cancer Res 90:127-56 (2003)'
p24637
aS'PMID:11905813'
p24638
ag24638
aS'AUTHORS'
p24639
aS'Cerwenka A, Lanier LL.'
p24640
aS'TITLE'
p24641
aS'Natural killer cells, viruses and cancer.'
p24642
aS'JOURNAL'
p24643
aS'Nat Rev Immunol 1:41-9 (2001)'
p24644
aS'PMID:11836514'
p24645
ag24645
aS'AUTHORS'
p24646
aS'Blott EJ, Griffiths GM.'
p24647
aS'TITLE'
p24648
aS'Secretory lysosomes.'
p24649
aS'JOURNAL'
p24650
aS'Nat Rev Mol Cell Biol 3:122-31 (2002)'
p24651
aS'PMID:12766758'
p24652
ag24652
aS'AUTHORS'
p24653
aS'Lieberman J.'
p24654
aS'TITLE'
p24655
aS'The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.'
p24656
aS'JOURNAL'
p24657
aS'Nat Rev Immunol 3:361-70 (2003)'
p24658
aS'PMID:12752668'
p24659
ag24659
aS'AUTHORS'
p24660
aS'Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.'
p24661
aS'TITLE'
p24662
aS'Granzyme B: a natural born killer.'
p24663
aS'JOURNAL'
p24664
aS'Immunol Rev 193:31-8 (2003)'
p24665
aS'PMID:15618404'
p24666
ag24666
aS'AUTHORS'
p24667
aS'Liu D, Xu L, Yang F, Li D, Gong F, Xu T.'
p24668
aS'TITLE'
p24669
aS'Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.'
p24670
aS'JOURNAL'
p24671
aS'Proc Natl Acad Sci U S A 102:123-7 (2005)'
p24672
aS'PMID:9862693'
p24673
ag24673
aS'AUTHORS'
p24674
aS'Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.'
p24675
aS'TITLE'
p24676
aS'Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.'
p24677
aS'JOURNAL'
p24678
aS'J Immunol 161:6648-56 (1998)'
p24679
aS'PMID:11390470'
p24680
ag24680
aS'AUTHORS'
p24681
aS'Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.'
p24682
aS'TITLE'
p24683
aS'Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.'
p24684
aS'JOURNAL'
p24685
aS'J Immunol 166:7219-28 (2001)'
p24686
asS'KO_PATHWAY'
p24687
(lp24688
S'ko04650'
p24689
asS'PATHWAY_MAP'
p24690
(lp24691
S'map04650'
p24692
asS'DISEASE'
p24693
(lp24694
S'H00090'
p24695
aS'NK cell defects'
p24696
ag24695
ag24696
aS'H00344'
p24697
aS'Leprosy'
p24698
aS'H01018'
p24699
aS'Metachondromatosis'
p24700
asS'DBLINKS'
p24701
(lp24702
S'GO: 0042267'
p24703
asS'ENTRY'
p24704
(lp24705
S'map04650'
p24706
aS'Pathway'
p24707
asS'CLASS'
p24708
(lp24709
S'Organismal Systems Immune system'
p24710
asS'DESCRIPTION'
p24711
(lp24712
S'Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.'
p24713
assS'path:map00680'
p24714
(dp24715
S'NAME'
p24716
(lp24717
S'Methane metabolism'
p24718
asS'REFERENCE'
p24719
(lp24720
S'PMID:11830598'
p24721
ag24721
aS'AUTHORS'
p24722
aS'Graham DE, Xu H, White RH'
p24723
aS'TITLE'
p24724
aS'Identification of coenzyme M biosynthetic phosphosulfolactate synthase: a new family of sulfonate-biosynthesizing enzymes.'
p24725
aS'JOURNAL'
p24726
aS'J Biol Chem 277:13421-9 (2002)'
p24727
aS'PMID:15168610'
p24728
ag24728
aS'AUTHORS'
p24729
aS'Deppenmeier U'
p24730
aS'TITLE'
p24731
aS'The membrane-bound electron transport system of Methanosarcina species.'
p24732
aS'JOURNAL'
p24733
aS'J Bioenerg Biomembr 36:55-64 (2004)'
p24734
aS'PMID:15353801'
p24735
ag24735
aS'AUTHORS'
p24736
aS'Hallam SJ, Putnam N, Preston CM, Detter JC, Rokhsar D, Richardson PM, DeLong EF'
p24737
aS'TITLE'
p24738
aS'Reverse methanogenesis: testing the hypothesis with environmental genomics.'
p24739
aS'JOURNAL'
p24740
aS'Science 305:1457-62 (2004)'
p24741
aS'PMID:16024727'
p24742
ag24742
aS'AUTHORS'
p24743
aS'Welander PV, Metcalf WW'
p24744
aS'TITLE'
p24745
aS'Loss of the mtr operon in Methanosarcina blocks growth on methanol, but not methanogenesis, and reveals an unknown methanogenic pathway.'
p24746
aS'JOURNAL'
p24747
aS'Proc Natl Acad Sci U S A 102:10664-9 (2005)'
p24748
aS'PMID:16278835'
p24749
ag24749
aS'AUTHORS'
p24750
aS'Yurimoto H, Kato N, Sakai Y'
p24751
aS'TITLE'
p24752
aS'Assimilation, dissimilation, and detoxification of formaldehyde, a central metabolic intermediate of methylotrophic metabolism.'
p24753
aS'JOURNAL'
p24754
aS'Chem Rec 5:367-75 (2005)'
p24755
aS'PMID:16385054'
p24756
ag24756
aS'AUTHORS'
p24757
aS'Fricke WF, Seedorf H, Henne A, Kruer M, Liesegang H, Hedderich R, Gottschalk G, Thauer RK.'
p24758
aS'TITLE'
p24759
aS'The genome sequence of Methanosphaera stadtmanae reveals why this human intestinal archaeon is restricted to methanol and H2 for methane formation and ATP synthesis.'
p24760
aS'JOURNAL'
p24761
aS'J Bacteriol 188:642-58 (2006)'
p24762
aS'PMID:16428816'
p24763
ag24763
aS'AUTHORS'
p24764
aS'Kato N, Yurimoto H, Thauer RK'
p24765
aS'TITLE'
p24766
aS'The physiological role of the ribulose monophosphate pathway in bacteria and archaea.'
p24767
aS'JOURNAL'
p24768
aS'Biosci Biotechnol Biochem 70:10-21 (2006)'
p24769
aS'PMID:18587410'
p24770
ag24770
aS'AUTHORS'
p24771
aS'Thauer RK, Kaster AK, Seedorf H, Buckel W, Hedderich R'
p24772
aS'TITLE'
p24773
aS'Methanogenic archaea: ecologically relevant differences in energy conservation.'
p24774
aS'JOURNAL'
p24775
aS'Nat Rev Microbiol 6:579-91 (2008)'
p24776
aS'PMID:20437165'
p24777
ag24777
aS'AUTHORS'
p24778
aS'Liffourrena AS, Salvano MA, Lucchesi GI'
p24779
aS'TITLE'
p24780
aS'Pseudomonas putida A ATCC 12633 oxidizes trimethylamine aerobically via two different pathways.'
p24781
aS'JOURNAL'
p24782
aS'Arch Microbiol 192:471-6 (2010)'
p24783
asS'KO_PATHWAY'
p24784
(lp24785
S'ko00680'
p24786
asS'PATHWAY_MAP'
p24787
(lp24788
S'map00680'
p24789
asS'DISEASE'
p24790
(lp24791
S'H00203'
p24792
aS'Acatalasia'
p24793
asS'MODULE'
p24794
(lp24795
S'M00174'
p24796
aS'Methane oxidation, methanotroph, methane => formaldehyde [PATH:map00680]'
p24797
ag24796
ag24797
aS'M00344'
p24798
aS'Formaldehyde assimilation, xylulose monophosphate pathway [PATH:map00680]'
p24799
aS'M00345'
p24800
aS'Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map00680]'
p24801
aS'M00346'
p24802
aS'Formaldehyde assimilation, serine pathway [PATH:map00680]'
p24803
aS'M00356'
p24804
aS'Methanogenesis, methanol => methane [PATH:map00680]'
p24805
aS'M00357'
p24806
aS'Methanogenesis, acetate => methane [PATH:map00680]'
p24807
aS'M00358'
p24808
aS'Coenzyme M biosynthesis [PATH:map00680]'
p24809
aS'M00378'
p24810
aS'F420 biosynthesis [PATH:map00680]'
p24811
aS'M00422'
p24812
aS'Acetyl-CoA pathway, CO2 => acetyl-CoA [PATH:map00680]'
p24813
aS'M00563'
p24814
aS'Methanogenesis, methylamine/dimethylamine/trimethylamine => methane [PATH:map00680]'
p24815
aS'M00567'
p24816
aS'Methanogenesis, CO2 => methane [PATH:map00680]'
p24817
aS'M00608'
p24818
aS'2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map00680]'
p24819
asS'DBLINKS'
p24820
(lp24821
S'GO: 0015947'
p24822
asS'ENTRY'
p24823
(lp24824
S'map00680'
p24825
aS'Pathway'
p24826
asS'CLASS'
p24827
(lp24828
S'Metabolism Energy metabolism'
p24829
asS'DESCRIPTION'
p24830
(lp24831
S'Methane is metabolized principally by methanotrophs and methanogens in the global carbon cycle. Methanotrophs consume methane as the only source of carbon, while methanogens produce methane as a metabolic byproduct. Methylotrophs, which are microorganisms that can obtain energy for growth by oxidizing one-carbon compounds, such as methanol and methane, are situated between methanotrophs and methanogens. Methanogens can obtain energy for growth by converting a limited number of substrates to methane under anaerobic conditions. Three types of methanogenic pathways are known: CO2 to methane [MD:M00567], methanol to methane [MD:M00356], and acetate to methane [MD:M00357]. Methanogens use 2-mercaptoethanesulfonate (CoM coenzyme M) as the terminal methyl carrier in methanogenesis and have four enzymes for CoM biosynthesis [MD:M00358]. Coenzyme B-Coenzyme M heterodisulfide reductase (Hdr), requiring for the final reaction steps of methanogenic pathway, is divided into two types: cytoplasmic HdrABC in most methanogens and membrane-bound HdrED in Methanosarcina species. In methanotrophs and methyltrophs methane is oxidized to form formaldehyde, which is at the diverging point for further oxidation to CO2 for energy source and assimilation for biosynthesis. There are three pathways that convert formaldehyde to C2 or C3 compounds: serine pathway [MD:M00346], ribulose monophosphate pathway [MD:M00345], and xylulose monophosphate pathway [MD:M00344]. The first two pathways are found in prokaryotes and the third is found in yeast. As a special case of methylotrophs, various amines can be used as carbon sources in trimethylamine metabolism [MD:M00563].'
p24832
assS'path:map07114'
p24833
(dp24834
S'ENTRY'
p24835
(lp24836
S'map07114'
p24837
aS'Drug'
p24838
aS'Pathway'
p24839
asS'PATHWAY_MAP'
p24840
(lp24841
S'map07114'
p24842
asS'NAME'
p24843
(lp24844
S'Naphthalene family'
p24845
asS'COMPOUND'
p24846
(lp24847
S'C00829'
p24848
aS'Naphthalene'
p24849
ag24848
ag24849
aS'C11713'
p24850
aS'2-Naphthol'
p24851
aS'C11714'
p24852
aS'1-Naphthol'
p24853
aS'C14082'
p24854
aS'1-Methylnaphthalene'
p24855
aS'C14098'
p24856
aS'2-Methylnaphthalene'
p24857
aS'D00118'
p24858
aS'Naproxen (JP16/USP/INN)'
p24859
aS'D00381'
p24860
aS'Tolnaftate (JP16/USP/INN)'
p24861
aS'D00425'
p24862
aS'Nabumetone (JP16/USP/INN)'
p24863
aS'D00483'
p24864
aS'Propranolol hydrochloride (JP16/USP)'
p24865
aS'D00743'
p24866
aS'Naphazoline hydrochloride (JP16/USP)'
p24867
aS'D00970'
p24868
aS'Naproxen sodium (USP)'
p24869
aS'D00990'
p24870
aS'Nafarelin acetate (JAN/USAN)'
p24871
aS'D01021'
p24872
aS'Naphazoline nitrate (JP16)'
p24873
aS'D01093'
p24874
aS'Butenafine hydrochloride (JP16/USAN)'
p24875
aS'D01342'
p24876
aS'Indocyanine green (JAN/USP)'
p24877
aS'D01558'
p24878
aS'1-Naphthylacetic acid (JAN)'
p24879
aS'D01670'
p24880
aS'Nafamostat mesilate (JP16)'
p24881
aS'D01674'
p24882
aS'Naftopidil (JP16/INN)'
p24883
aS'D02062'
p24884
aS'Chromomycin A3 (JAN)'
p24885
aS'D02219'
p24886
aS'Terbinafine hydrochloride (JP16/USP)'
p24887
aS'D02375'
p24888
aS'Terbinafine (USAN/INN)'
p24889
aS'D02549'
p24890
aS'Rifamycin (USAN/INN)'
p24891
aS'D03729'
p24892
aS'Dexpropranolol hydrochloride (USAN)'
p24893
aS'D07596'
p24894
aS'Butenafine (INN)'
p24895
aS'D08240'
p24896
aS'Nafamostat (INN)'
p24897
aS'D08241'
p24898
aS'Nafarelin (INN)'
p24899
aS'D08253'
p24900
aS'Naphazoline (INN)'
p24901
aS'D08443'
p24902
aS'Propranolol (INN)'
p24903
aS'D08480'
p24904
aS'Rifamycin sodium (USAN)'
p24905
assS'path:map07117'
p24906
(dp24907
S'ENTRY'
p24908
(lp24909
S'map07117'
p24910
aS'Drug'
p24911
aS'Pathway'
p24912
asS'PATHWAY_MAP'
p24913
(lp24914
S'map07117'
p24915
asS'NAME'
p24916
(lp24917
S'Benzodiazepine family'
p24918
asS'REFERENCE'
p24919
(lp24920
g22
ag22
aS'AUTHORS'
p24921
aS'David AW, Thomas LL, William OF.'
p24922
aS'TITLE'
p24923
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p24924
aS'JOURNAL'
p24925
aS'Lippincott Williams & Wilkins (2002)'
p24926
aS'PMID:12789687'
p24927
ag24927
aS'AUTHORS'
p24928
aS'Herranz R.'
p24929
aS'TITLE'
p24930
aS'Cholecystokinin antagonists: pharmacological and therapeutic potential.'
p24931
aS'JOURNAL'
p24932
aS'Med Res Rev 23:559-605 (2003)'
p24933
aS'PMID:12369971'
p24934
ag24934
aS'AUTHORS'
p24935
aS'Zappala M, Grasso S, Micale N, Polimeni S, De Micheli C.'
p24936
aS'TITLE'
p24937
aS'Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists.'
p24938
aS'JOURNAL'
p24939
aS'Mini Rev Med Chem 1:243-53 (2001)'
p24940
aS'PMID:11945139'
p24941
ag24941
aS'AUTHORS'
p24942
aS'Solyom S, Tarnawa I.'
p24943
aS'TITLE'
p24944
aS'Non-competitive AMPA antagonists of 2,3-benzodiazepine type.'
p24945
aS'JOURNAL'
p24946
aS'Curr Pharm Des 8:913-39 (2002)'
p24947
aS'PMID:12477342'
p24948
ag24948
aS'AUTHORS'
p24949
aS'Patchett AA.'
p24950
aS'TITLE'
p24951
aS'2002 Alfred Burger Award Address in Medicinal Chemistry. Natural products and design: interrelated approaches in drug discovery.'
p24952
aS'JOURNAL'
p24953
aS'J Med Chem 45:5609-16 (2002)'
p24954
asS'COMPOUND'
p24955
(lp24956
S'C11688'
p24957
aS'Asperlicin'
p24958
ag24957
ag24958
aS'C15026'
p24959
aS'L-365260'
p24960
aS'C15040'
p24961
aS'GYKI 52466'
p24962
aS'C15094'
p24963
aS'GYKI 52895'
p24964
aS'C15096'
p24965
aS'GV 150013X'
p24966
aS'C15104'
p24967
aS'LY-202769'
p24968
aS'D00283'
p24969
aS'Clozapine (JAN/USP/INN)'
p24970
aS'D00293'
p24971
aS'Diazepam (JP16/USP/INN)'
p24972
aS'D00454'
p24973
aS'Olanzapine (JAN/USAN/INN)'
p24974
aS'D01254'
p24975
aS'Tofisopam (JP16/INN)'
p24976
aS'D01858'
p24977
aS'Panazepide (JAN)'
p24978
aS'D02693'
p24979
aS'Devazepide (USAN/INN)'
p24980
aS'D02694'
p24981
aS'Tifluadom (INN)'
p24982
aS'D02696'
p24983
aS'Talampanel (INN)'
p24984
aS'D02710'
p24985
aS'Tarazepide (INN)'
p24986
aS'D02712'
p24987
aS'Tibezonium iodide (INN)'
p24988
assS'path:map05020'
p24989
(dp24990
S'NAME'
p24991
(lp24992
S'Prion diseases'
p24993
asS'REFERENCE'
p24994
(lp24995
S'PMID:18245809'
p24996
ag24996
aS'AUTHORS'
p24997
aS'Kovacs GG, Budka H'
p24998
aS'TITLE'
p24999
aS'Prion diseases: from protein to cell pathology.'
p25000
aS'JOURNAL'
p25001
aS'Am J Pathol 172:555-65 (2008)'
p25002
aS'PMID:15695097'
p25003
ag25003
aS'AUTHORS'
p25004
aS'Campana V, Sarnataro D, Zurzolo C'
p25005
aS'TITLE'
p25006
aS'The highways and byways of prion protein trafficking.'
p25007
aS'JOURNAL'
p25008
aS'Trends Cell Biol 15:102-11 (2005)'
p25009
aS'PMID:14661267'
p25010
ag25010
aS'AUTHORS'
p25011
aS'Nunziante M, Gilch S, Schatzl HM'
p25012
aS'TITLE'
p25013
aS'Prion diseases: from molecular biology to intervention strategies.'
p25014
aS'JOURNAL'
p25015
aS'Chembiochem 4:1268-84 (2003)'
p25016
aS'PMID:17051207'
p25017
ag25017
aS'AUTHORS'
p25018
aS'Caughey B, Baron GS'
p25019
aS'TITLE'
p25020
aS'Prions and their partners in crime.'
p25021
aS'JOURNAL'
p25022
aS'Nature 443:803-10 (2006)'
p25023
aS'PMID:18391177'
p25024
ag25024
aS'AUTHORS'
p25025
aS'Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR'
p25026
aS'TITLE'
p25027
aS'Physiology of the prion protein.'
p25028
aS'JOURNAL'
p25029
aS'Physiol Rev 88:673-728 (2008)'
p25030
aS'PMID:11592845'
p25031
ag25031
aS'AUTHORS'
p25032
aS'Chiesa R, Harris DA'
p25033
aS'TITLE'
p25034
aS'Prion diseases: what is the neurotoxic molecule?'
p25035
aS'JOURNAL'
p25036
aS'Neurobiol Dis 8:743-63 (2001)'
p25037
aS'PMID:10398674'
p25038
ag25038
aS'AUTHORS'
p25039
aS'Harris DA'
p25040
aS'TITLE'
p25041
aS'Cellular biology of prion diseases.'
p25042
aS'JOURNAL'
p25043
aS'Clin Microbiol Rev 12:429-44 (1999)'
p25044
aS'PMID:15528202'
p25045
ag25045
aS'AUTHORS'
p25046
aS'Marella M, Gaggioli C, Batoz M, Deckert M, Tartare-Deckert S, Chabry J'
p25047
aS'TITLE'
p25048
aS'Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment.'
p25049
aS'JOURNAL'
p25050
aS'J Biol Chem 280:1529-34 (2005)'
p25051
aS'PMID:15611724'
p25052
ag25052
aS'AUTHORS'
p25053
aS'Mallucci G, Collinge J'
p25054
aS'TITLE'
p25055
aS'Rational targeting for prion therapeutics.'
p25056
aS'JOURNAL'
p25057
aS'Nat Rev Neurosci 6:23-34 (2005)'
p25058
aS'PMID:12850426'
p25059
ag25059
aS'AUTHORS'
p25060
aS'Hegde RS, Rane NS'
p25061
aS'TITLE'
p25062
aS'Prion protein trafficking and the development of neurodegeneration.'
p25063
aS'JOURNAL'
p25064
aS'Trends Neurosci 26:337-9 (2003)'
p25065
aS'PMID:17085779'
p25066
ag25066
aS'AUTHORS'
p25067
aS'Fasano C, Campana V, Zurzolo C'
p25068
aS'TITLE'
p25069
aS'Prions: protein only or something more? Overview of potential prion cofactors.'
p25070
aS'JOURNAL'
p25071
aS'J Mol Neurosci 29:195-214 (2006)'
p25072
aS'PMID:14705136'
p25073
ag25073
aS'AUTHORS'
p25074
aS'Roucou X, Gains M, LeBlanc AC'
p25075
aS'TITLE'
p25076
aS'Neuroprotective functions of prion protein.'
p25077
aS'JOURNAL'
p25078
aS'J Neurosci Res 75:153-61 (2004)'
p25079
aS'PMID:15890824'
p25080
ag25080
aS'AUTHORS'
p25081
aS'Novakofski J, Brewer MS, Mateus-Pinilla N, Killefer J, McCusker RH'
p25082
aS'TITLE'
p25083
aS'Prion biology relevant to bovine spongiform encephalopathy.'
p25084
aS'JOURNAL'
p25085
aS'J Anim Sci 83:1455-76 (2005)'
p25086
aS'PMID:18558863'
p25087
ag25087
aS'AUTHORS'
p25088
aS'Aguzzi A, Baumann F, Bremer J'
p25089
aS'TITLE'
p25090
aS"The prion's elusive reason for being."
p25091
aS'JOURNAL'
p25092
aS'Annu Rev Neurosci 31:439-77 (2008)'
p25093
aS'PMID:15342004'
p25094
ag25094
aS'AUTHORS'
p25095
aS'Mabbott NA'
p25096
aS'TITLE'
p25097
aS'The complement system in prion diseases.'
p25098
aS'JOURNAL'
p25099
aS'Curr Opin Immunol 16:587-93 (2004)'
p25100
asS'KO_PATHWAY'
p25101
(lp25102
S'ko05020'
p25103
asS'PATHWAY_MAP'
p25104
(lp25105
S'map05020'
p25106
asS'DISEASE'
p25107
(lp25108
S'H00061'
p25109
aS'Prion diseases'
p25110
asS'ENTRY'
p25111
(lp25112
S'map05020'
p25113
aS'Pathway'
p25114
asS'CLASS'
p25115
(lp25116
S'Human Diseases Neurodegenerative diseases'
p25117
asS'DESCRIPTION'
p25118
(lp25119
S'Prion diseases, also termed transmissible spongiform encephalopathies (TSEs), are a group of fatal neurodegenerative diseases that affect humans and a number of other animal species. The etiology of these diseases is thought to be associated with the conversion of a normal protein, PrPC, into an infectious, pathogenic form, PrPSc. The conversion is induced by prion infections (for example, variant Creutzfeldt-Jakob disease (vCJD), iatrogenic CJD, Kuru), mutations (familial CJD, Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia (FFI)) or unknown factors (sporadic CJD (sCJD)), and is thought to occur after PrPC has reached the plasma membrane or is re-internalized for degradation. The PrPSc form shows greater protease resistance than PrPC and accumulates in affected individuals, often in the form of extracellular plaques. Pathways that may lead to neuronal death comprise oxidative stress, regulated activation of complement, ubiquitin-proteasome and endosomal-lysosomal systems, synaptic alterations and dendritic atrophy, corticosteroid response, and endoplasmic reticulum stress. In addition, the conformational transition could lead to the lost of a beneficial activity of the natively folded protein, PrPC.'
p25120
assS'path:map04115'
p25121
(dp25122
S'NAME'
p25123
(lp25124
S'p53 signaling pathway'
p25125
asS'REFERENCE'
p25126
(lp25127
S'PMID:16557269'
p25128
ag25128
aS'AUTHORS'
p25129
aS'Levine AJ, Hu W, Feng Z.'
p25130
aS'TITLE'
p25131
aS'The P53 pathway: what questions remain to be explored?'
p25132
aS'JOURNAL'
p25133
aS'Cell Death Differ 13:1027-36 (2006)'
p25134
aS'PMID:15838523'
p25135
ag25135
aS'AUTHORS'
p25136
aS'Harris SL, Levine AJ.'
p25137
aS'TITLE'
p25138
aS'The p53 pathway: positive and negative feedback loops.'
p25139
aS'JOURNAL'
p25140
aS'Oncogene 24:2899-908 (2005)'
p25141
aS'PMID:11747320'
p25142
ag25142
aS'AUTHORS'
p25143
aS'Balint E E, Vousden KH.'
p25144
aS'TITLE'
p25145
aS'Activation and activities of the p53 tumour suppressor protein.'
p25146
aS'JOURNAL'
p25147
aS'Br J Cancer 85:1813-23 (2001)'
p25148
aS'PMID:11313928'
p25149
ag25149
aS'AUTHORS'
p25150
aS'Taylor WR, Stark GR.'
p25151
aS'TITLE'
p25152
aS'Regulation of the G2/M transition by p53.'
p25153
aS'JOURNAL'
p25154
aS'Oncogene 20:1803-15 (2001)'
p25155
aS'PMID:15116721'
p25156
ag25156
aS'AUTHORS'
p25157
aS'Hofseth LJ, Hussain SP, Harris CC.'
p25158
aS'TITLE'
p25159
aS'p53: 25 years after its discovery.'
p25160
aS'JOURNAL'
p25161
aS'Trends Pharmacol Sci 25:177-81 (2004)'
p25162
aS'PMID:12505356'
p25163
ag25163
aS'AUTHORS'
p25164
aS'Pietenpol JA, Stewart ZA.'
p25165
aS'TITLE'
p25166
aS'Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.'
p25167
aS'JOURNAL'
p25168
aS'Toxicology 181-182:475-81 (2002)'
p25169
aS'PMID:10714958'
p25170
ag25170
aS'AUTHORS'
p25171
aS'Tokino T, Nakamura Y.'
p25172
aS'TITLE'
p25173
aS'The role of p53-target genes in human cancer.'
p25174
aS'JOURNAL'
p25175
aS'Crit Rev Oncol Hematol 33:1-6 (2000)'
p25176
aS'PMID:16697662'
p25177
ag25177
aS'AUTHORS'
p25178
aS'Hermeking H, Benzinger A.'
p25179
aS'TITLE'
p25180
aS'14-3-3 proteins in cell cycle regulation.'
p25181
aS'JOURNAL'
p25182
aS'Semin Cancer Biol 16:183-92 (2006)'
p25183
aS'PMID:16915296'
p25184
ag25184
aS'AUTHORS'
p25185
aS'Sherr CJ.'
p25186
aS'TITLE'
p25187
aS'Divorcing ARF and p53: an unsettled case.'
p25188
aS'JOURNAL'
p25189
aS'Nat Rev Cancer 6:663-73 (2006)'
p25190
aS'PMID:17409411'
p25191
ag25191
aS'AUTHORS'
p25192
aS'Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ.'
p25193
aS'TITLE'
p25194
aS'The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.'
p25195
aS'JOURNAL'
p25196
aS'Cancer Res 67:3043-53 (2007)'
p25197
asS'KO_PATHWAY'
p25198
(lp25199
S'ko04115'
p25200
asS'PATHWAY_MAP'
p25201
(lp25202
S'map04115'
p25203
asS'DISEASE'
p25204
(lp25205
S'H00409'
p25206
aS'Type II diabetes mellitus'
p25207
ag25206
ag25207
aS'H00848'
p25208
aS'Ataxia with ocular apraxia (AOA)'
p25209
aS'H00881'
p25210
aS'Li-Fraumeni syndrome'
p25211
aS'H00896'
p25212
aS'Lymphangioleiomyomatosis (LAM)'
p25213
aS'H00915'
p25214
aS'Tuberous sclerosis complex (TSC)'
p25215
aS'H00992'
p25216
aS'Seckel syndrome'
p25217
aS'H01007'
p25218
aS'Choroid plexus papilloma'
p25219
aS'H01106'
p25220
aS'Plasminogen activator inhibitor type 1 (PAI-1) deficiency'
p25221
aS'H01195'
p25222
aS'VACTERL/VATER association'
p25223
asS'ENTRY'
p25224
(lp25225
S'map04115'
p25226
aS'Pathway'
p25227
asS'CLASS'
p25228
(lp25229
S'Cellular Processes Cell growth and death'
p25230
asS'DESCRIPTION'
p25231
(lp25232
S'p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways.'
p25233
assS'path:map05412'
p25234
(dp25235
S'NAME'
p25236
(lp25237
S'Arrhythmogenic right ventricular cardiomyopathy (ARVC)'
p25238
asS'REFERENCE'
p25239
(lp25240
S'PMID:19205777'
p25241
ag25241
aS'AUTHORS'
p25242
aS'Herren T, Gerber PA, Duru F'
p25243
aS'TITLE'
p25244
aS'Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations.'
p25245
aS'JOURNAL'
p25246
aS'Clin Res Cardiol 98:141-58 (2009)'
p25247
aS'PMID:17413274'
p25248
ag25248
aS'AUTHORS'
p25249
aS'van Tintelen JP, Hofstra RM, Wiesfeld AC, van den Berg MP, Hauer RN, Jongbloed JD'
p25250
aS'TITLE'
p25251
aS'Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon?'
p25252
aS'JOURNAL'
p25253
aS'Curr Opin Cardiol 22:185-92 (2007)'
p25254
aS'PMID:12270949'
p25255
ag25255
aS'AUTHORS'
p25256
aS'Fatkin D, Graham RM'
p25257
aS'TITLE'
p25258
aS'Molecular mechanisms of inherited cardiomyopathies.'
p25259
aS'JOURNAL'
p25260
aS'Physiol Rev 82:945-80 (2002)'
p25261
aS'PMID:11716909'
p25262
ag25262
aS'AUTHORS'
p25263
aS'Franz WM, Muller OJ, Katus HA'
p25264
aS'TITLE'
p25265
aS'Cardiomyopathies: from genetics to the prospect of treatment.'
p25266
aS'JOURNAL'
p25267
aS'Lancet 358:1627-37 (2001)'
p25268
aS'PMID:16823481'
p25269
ag25269
aS'AUTHORS'
p25270
aS'MacRae CA, Birchmeier W, Thierfelder L'
p25271
aS'TITLE'
p25272
aS'Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism.'
p25273
aS'JOURNAL'
p25274
aS'J Clin Invest 116:1825-8 (2006)'
p25275
aS'PMID:18382419'
p25276
ag25276
aS'AUTHORS'
p25277
aS'Awad MM, Calkins H, Judge DP'
p25278
aS'TITLE'
p25279
aS'Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy.'
p25280
aS'JOURNAL'
p25281
aS'Nat Clin Pract Cardiovasc Med 5:258-67 (2008)'
p25282
aS'PMID:16101641'
p25283
ag25283
aS'AUTHORS'
p25284
aS'Sen-Chowdhry S, Syrris P, McKenna WJ'
p25285
aS'TITLE'
p25286
aS'Genetics of right ventricular cardiomyopathy.'
p25287
aS'JOURNAL'
p25288
aS'J Cardiovasc Electrophysiol 16:927-35 (2005)'
p25289
aS'PMID:16124859'
p25290
ag25290
aS'AUTHORS'
p25291
aS'Ahmad F, Seidman JG, Seidman CE'
p25292
aS'TITLE'
p25293
aS'The genetic basis for cardiac remodeling.'
p25294
aS'JOURNAL'
p25295
aS'Annu Rev Genomics Hum Genet 6:185-216 (2005)'
p25296
asS'KO_PATHWAY'
p25297
(lp25298
S'ko05412'
p25299
asS'PATHWAY_MAP'
p25300
(lp25301
S'map05412'
p25302
asS'DISEASE'
p25303
(lp25304
S'H00293'
p25305
aS'Arrhythmogenic right ventricular cardiomyopathy (ARVC)'
p25306
ag25305
ag25306
aS'H00669'
p25307
aS'Naxos disease and Carvajal syndrome'
p25308
aS'H00728'
p25309
aS'Brugada syndrome (BRS)'
p25310
asS'ENTRY'
p25311
(lp25312
S'map05412'
p25313
aS'Pathway'
p25314
asS'CLASS'
p25315
(lp25316
S'Human Diseases Cardiovascular diseases'
p25317
asS'DESCRIPTION'
p25318
(lp25319
S'Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease that may result in arrhythmia, heart failure, and sudden death. The hallmark pathological findings are progressive myocyte loss and fibrofatty replacement, with a predilection for the right ventricle. A number of genetic studies have identified mutations in various components of the cardiac desmosome that have important roles in the pathogenesis of ARVC. Disruption of desmosomal function by defective proteins might lead to death of myocytes under mechanical stress. The myocardial injury may be accompanied by inflammation. Since regeneration of cardiac myocytes is limited, repair by fibrofatty replacement occurs. Several studies have implicated that desmosome dysfunction results in the delocalization and nuclear translocation of plakoglobin. As a result, competition between plakoglobin and beta-catenin will lead to the inhibition of Wnt/beta-catenin signaling, resulting in a shift from a myocyte fate towards an adipocyte fate of cells. The ryanodine receptor plays a crucial part in electromechanical coupling by control of release of calcium from the sarcoplasmic reticulum into the cytosol. Therefore, defects in this receptor could result in an imbalance of calcium homeostasis that might trigger cell death.'
p25320
assS'path:map00750'
p25321
(dp25322
S'NAME'
p25323
(lp25324
S'Vitamin B6 metabolism'
p25325
asS'REFERENCE'
p25326
(lp25327
S'PMID:10753941'
p25328
ag25328
aS'AUTHORS'
p25329
aS'Tazoe M, Ichikawa K, Hoshino T.'
p25330
aS'TITLE'
p25331
aS'Biosynthesis of vitamin B(6) in rhizobium.'
p25332
aS'JOURNAL'
p25333
aS'J Biol Chem 275:11300-5 (2000)'
p25334
aS'PMID:9696782'
p25335
ag25335
aS'AUTHORS'
p25336
aS'Yang Y, Zhao G, Man TK, Winkler ME.'
p25337
aS'TITLE'
p25338
aS"Involvement of the gapA- and epd (gapB)-encoded dehydrogenases in pyridoxal 5'-phosphate coenzyme biosynthesis in Escherichia coli K-12."
p25339
aS'JOURNAL'
p25340
aS'J Bacteriol 180:4294-9 (1998)'
p25341
aS'PMID:12269807'
p25342
ag25342
aS'AUTHORS'
p25343
aS'Yeh JI, Du S, Pohl E, Cane DE.'
p25344
aS'TITLE'
p25345
aS"Multistate binding in pyridoxine 5'-phosphate synthase: 1.96 A crystal structure in complex with 1-deoxy-D-xylulose phosphate."
p25346
aS'JOURNAL'
p25347
aS'Biochemistry 41:11649-57 (2002)'
p25348
aS'PMID:10225425'
p25349
ag25349
aS'AUTHORS'
p25350
aS'Laber B, Maurer W, Scharf S, Stepusin K, Schmidt FS.'
p25351
aS'TITLE'
p25352
aS"Vitamin B6 biosynthesis: formation of pyridoxine 5'-phosphate from 4-(phosphohydroxy)-L-threonine and 1-deoxy-D-xylulose-5-phosphate by PdxA and PdxJ protein."
p25353
aS'JOURNAL'
p25354
aS'FEBS Lett 449:45-8 (1999)'
p25355
aS'PMID:16157873'
p25356
ag25356
aS'AUTHORS'
p25357
aS'Tambasco-Studart M, Titiz O, Raschle T, Forster G, Amrhein N, Fitzpatrick TB.'
p25358
aS'TITLE'
p25359
aS'Vitamin B6 biosynthesis in higher plants.'
p25360
aS'JOURNAL'
p25361
aS'Proc Natl Acad Sci U S A 102:13687-92 (2005)'
p25362
aS'PMID:22276911'
p25363
ag25363
aS'AUTHORS'
p25364
aS'Nagase T, Mugo AN, Chu HN, Yoshikane Y, Ohnishi K, Yagi T'
p25365
aS'TITLE'
p25366
aS'The mll6786 gene encodes a repressor protein controlling the degradation pathway'
p25367
aS'for vitamin B6 in Mesorhizobium loti.'
p25368
aS'JOURNAL'
p25369
aS'FEMS Microbiol Lett 329:116-22 (2012)'
p25370
asS'KO_PATHWAY'
p25371
(lp25372
S'ko00750'
p25373
asS'PATHWAY_MAP'
p25374
(lp25375
S'map00750'
p25376
asS'DISEASE'
p25377
(lp25378
S'H01082'
p25379
aS'Phosphoserine aminotransferase (PSAT) deficiency'
p25380
ag25379
ag25380
aS'H01124'
p25381
aS"Pyridox(am)ine-5'-phosphate oxidase (PNPO) deficiency"
p25382
asS'MODULE'
p25383
(lp25384
S'M00124'
p25385
aS'Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P [PATH:map00750]'
p25386
asS'DBLINKS'
p25387
(lp25388
S'GO: 0042816'
p25389
asS'ENTRY'
p25390
(lp25391
S'map00750'
p25392
aS'Pathway'
p25393
asS'CLASS'
p25394
(lp25395
S'Metabolism Metabolism of cofactors and vitamins'
p25396
assS'path:map04950'
p25397
(dp25398
S'DESCRIPTION About 2-5% of type II diabetic patients suffer from a monogenic disease with autosomal dominant inheritance. This monogenic form of type II diabetes is called maturity onset diabetes of the young (MODY).'
p25399
(lp25400
S'We now know that MODY is caused by heterozygous mutations in at least five genes encoding transcription factors: HNF4alpha (MODY1), HNF1alpha (MODY3), PDX1 (MODY4), HNF1beta (MODY5) and NEUROD1 (MODY6). MODY2, which is so far the only subtype not related to a transcription factor, is caused by mutations in the glucokinase gene. Mutations of MODY transcription factor genes lead to abnormal expression of genes involved in pancreatic islet development and metabolism.'
p25401
asS'NAME'
p25402
(lp25403
S'Maturity onset diabetes of the young'
p25404
asS'REFERENCE'
p25405
(lp25406
S'PMID:15298336'
p25407
ag25407
aS'AUTHORS'
p25408
aS'Servitja JM, Ferrer J.'
p25409
aS'TITLE'
p25410
aS'Transcriptional networks controlling pancreatic development and beta cell function.'
p25411
aS'JOURNAL'
p25412
aS'Diabetologia 47:597-613 (2004)'
p25413
aS'PMID:15604203'
p25414
ag25414
aS'AUTHORS'
p25415
aS'Habener JF, Kemp DM, Thomas MK.'
p25416
aS'TITLE'
p25417
aS'Minireview: transcriptional regulation in pancreatic development.'
p25418
aS'JOURNAL'
p25419
aS'Endocrinology 146:1025-34 (2005)'
p25420
aS'PMID:15028942'
p25421
ag25421
aS'AUTHORS'
p25422
aS'Ashizawa S, Brunicardi FC, Wang XP.'
p25423
aS'TITLE'
p25424
aS'PDX-1 and the pancreas.'
p25425
aS'JOURNAL'
p25426
aS'Pancreas 28:109-20 (2004)'
p25427
aS'PMID:14614204'
p25428
ag25428
aS'AUTHORS'
p25429
aS'Yamagata K.'
p25430
aS'TITLE'
p25431
aS'Regulation of pancreatic beta-cell function by the HNF transcription network: lessons from maturity-onset diabetes of the young (MODY).'
p25432
aS'JOURNAL'
p25433
aS'Endocr J 50:491-9 (2003)'
p25434
asS'KO_PATHWAY'
p25435
(lp25436
S'ko04950'
p25437
asS'PATHWAY_MAP'
p25438
(lp25439
S'map04950'
p25440
asS'DISEASE'
p25441
(lp25442
S'H00409'
p25443
aS'Type II diabetes mellitus'
p25444
ag25443
ag25444
aS'H00410'
p25445
aS'Maturity onset diabetes of the young (MODY)'
p25446
aS'H00512'
p25447
aS'Permanent neonatal diabetes mellitus (PNDM)'
p25448
aS'H00861'
p25449
aS'Pancreatic agenesis'
p25450
asS'ENTRY'
p25451
(lp25452
S'map04950'
p25453
aS'Pathway'
p25454
asS'CLASS'
p25455
(lp25456
S'Human Diseases Endocrine and metabolic diseases'
p25457
asS'DESCRIPTION'
p25458
(lp25459
S'About 2-5% of type II diabetic patients suffer from a monogenic disease with autosomal dominant inheritance. This monogenic form of type II diabetes is called maturity onset diabetes of the young (MODY).'
p25460
assS'path:map01010'
p25461
(dp25462
S'ENTRY'
p25463
(lp25464
S'map01010'
p25465
aS'Pathway'
p25466
asS'PATHWAY_MAP'
p25467
(lp25468
S'map01010'
p25469
asS'NAME'
p25470
(lp25471
S'Overview of biosynthetic pathways'
p25472
asS'KO_PATHWAY'
p25473
(lp25474
S'ko01010'
p25475
assS'path:map00604'
p25476
(dp25477
S'NAME'
p25478
(lp25479
S'Glycosphingolipid biosynthesis - ganglio series'
p25480
asS'KO_PATHWAY'
p25481
(lp25482
S'ko00604'
p25483
asS'ENTRY'
p25484
(lp25485
S'map00604'
p25486
aS'Pathway'
p25487
asS'PATHWAY_MAP'
p25488
(lp25489
S'map00604'
p25490
asS'DISEASE'
p25491
(lp25492
S'H00124'
p25493
aS'GM2 gangliosidoses'
p25494
ag25493
ag25494
aS'H00281'
p25495
aS'GM1 gangliosidosis'
p25496
aS'H00426'
p25497
aS'Defects in the degradation of ganglioside'
p25498
aS'H00996'
p25499
aS'Amish infantile epilepsy syndrome'
p25500
asS'MODULE'
p25501
(lp25502
S'M00069'
p25503
aS'Glycosphingolipid biosynthesis, ganglio series, LacCer => GT3 [PATH:map00604]'
p25504
asS'CLASS'
p25505
(lp25506
S'Metabolism Glycan biosynthesis and metabolism'
p25507
assS'path:map00970'
p25508
(dp25509
S'NAME'
p25510
(lp25511
S'Aminoacyl-tRNA biosynthesis'
p25512
asS'REFERENCE'
p25513
(lp25514
S'PMID:18252769'
p25515
ag25515
aS'AUTHORS'
p25516
aS'Sheppard K, Yuan J, Hohn MJ, Jester B, Devine KM, Soll D'
p25517
aS'TITLE'
p25518
aS'From one amino acid to another: tRNA-dependent amino acid biosynthesis.'
p25519
aS'JOURNAL'
p25520
aS'Nucleic Acids Res 36:1813-25 (2008)'
p25521
aS'PMID:15314242'
p25522
ag25522
aS'AUTHORS'
p25523
aS'Polycarpo C, Ambrogelly A, Berube A, Winbush SM, McCloskey JA, Crain PF, Wood JL, Soll D'
p25524
aS'TITLE'
p25525
aS'An aminoacyl-tRNA synthetase that specifically activates pyrrolysine.'
p25526
aS'JOURNAL'
p25527
aS'Proc Natl Acad Sci U S A 101:12450-4 (2004)'
p25528
asS'KO_PATHWAY'
p25529
(lp25530
S'ko00970'
p25531
asS'PATHWAY_MAP'
p25532
(lp25533
S'map00970'
p25534
asS'DISEASE'
p25535
(lp25536
S'H00264'
p25537
aS'Charcot-Marie-Tooth disease (CMT)'
p25538
ag25537
ag25538
aS'H00810'
p25539
aS'Progressive myoclonic epilepsy (PME/ EPM)'
p25540
aS'H00856'
p25541
aS'Distal hereditary motor neuropathies (dHMN)'
p25542
aS'H00871'
p25543
aS'Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL)'
p25544
aS'H00897'
p25545
aS'Pontocerebellar hypoplasia'
p25546
aS'H00898'
p25547
aS'Myopathy with lactic acidosis and sideroblastic anaemia (MLASA)'
p25548
aS'H01347'
p25549
aS'MELAS Syndrome'
p25550
aS'H01351'
p25551
aS'Spastic ataxia (SPAX)'
p25552
aS'H01356'
p25553
aS'Myoclonic Epilepsy and Ragged-Red Fiber Disease'
p25554
aS'H01367'
p25555
aS'Infantile liver failure'
p25556
asS'MODULE'
p25557
(lp25558
S'M00359'
p25559
aS'Aminoacyl-tRNA biosynthesis, eukaryotes [PATH:map00970]'
p25560
ag25559
ag25560
aS'M00360'
p25561
aS'Aminoacyl-tRNA biosynthesis, prokaryotes [PATH:map00970]'
p25562
asS'ENTRY'
p25563
(lp25564
S'map00970'
p25565
aS'Pathway'
p25566
asS'CLASS'
p25567
(lp25568
S'Genetic Information Processing Translation'
p25569
assS'path:map07029'
p25570
(dp25571
S'ENTRY'
p25572
(lp25573
S'map07029'
p25574
aS'Drug'
p25575
aS'Pathway'
p25576
asS'PATHWAY_MAP'
p25577
(lp25578
S'map07029'
p25579
asS'NAME'
p25580
(lp25581
S'Phenothiazines'
p25582
asS'REFERENCE'
p25583
(lp25584
S'(Japanese)'
p25585
ag25585
aS'AUTHORS'
p25586
aS'Sano T, Naito T, Kubo T (eds).'
p25587
aS'TITLE'
p25588
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p25589
aS'JOURNAL'
p25590
aS'Nankodo (2002)'
p25591
aS'(Japanese)'
p25592
ag25592
aS'AUTHORS'
p25593
aS'Fukai S.'
p25594
aS'TITLE'
p25595
aS'[New Drugs Today (6th ed)] (In Japanese)'
p25596
aS'JOURNAL'
p25597
aS'Jiho (1995)'
p25598
ag22
ag22
aS'AUTHORS'
p25599
aS'David AW, Thomas LL, William OF.'
p25600
aS'TITLE'
p25601
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p25602
aS'JOURNAL'
p25603
aS'Lippincott Williams & Wilkins (2002)'
p25604
ag22
ag22
aS'AUTHORS'
p25605
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p25606
aS'TITLE'
p25607
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p25608
aS'JOURNAL'
p25609
aS'McGraw-Hill (2001)'
p25610
ag22
ag22
aS'AUTHORS'
p25611
aS'Walter S.'
p25612
aS'TITLE'
p25613
aS'Drug Discovery: A History'
p25614
aS'JOURNAL'
p25615
aS'Wiley (2005)'
p25616
aS'PMID:5068965'
p25617
ag25617
aS'AUTHORS'
p25618
aS'Nightingale CH, Tse M, Stupak EI.'
p25619
aS'TITLE'
p25620
aS'Structure-toxicity relationships of substituted phenothiazines.'
p25621
aS'JOURNAL'
p25622
aS'J Pharm Sci 61:1498-9 (1972)'
p25623
aS'PMID:10579370'
p25624
ag25624
aS'AUTHORS'
p25625
aS'Shen WW.'
p25626
aS'TITLE'
p25627
aS'A history of antipsychotic drug development.'
p25628
aS'JOURNAL'
p25629
aS'Compr Psychiatry 40:407-14 (1999)'
p25630
aS'PMID:11383974'
p25631
ag25631
aS'AUTHORS'
p25632
aS'Ban TA.'
p25633
aS'TITLE'
p25634
aS'Pharmacotherapy of mental illness--a historical analysis.'
p25635
aS'JOURNAL'
p25636
aS'Prog Neuropsychopharmacol Biol Psychiatry 25:709-27 (2001)'
p25637
aS'PMID:12935655'
p25638
ag25638
aS'AUTHORS'
p25639
aS'Mizuno Y, Sato K, Sano T, Kurihara R, Kojima T, Yamakawa Y, Ishii A, Katsumata Y.'
p25640
aS'TITLE'
p25641
aS'Identification and characterization of 17 phenothiazine compounds by capillary high-performance liquid chromatography/fast atom bombardment mass spectrometry.'
p25642
aS'JOURNAL'
p25643
aS'Leg Med (Tokyo) 4:207-16 (2002)'
p25644
asS'COMPOUND'
p25645
(lp25646
S'D00270'
p25647
aS'Chlorpromazine (USP/INN)'
p25648
ag25647
ag25648
aS'D00373'
p25649
aS'Thioridazine (USP/INN)'
p25650
aS'D00390'
p25651
aS'Triflupromazine (USP/INN)'
p25652
aS'D00403'
p25653
aS'Levomepromazine (USAN/INN)'
p25654
aS'D00479'
p25655
aS'Prochlorperazine maleate (JP16/USP)'
p25656
aS'D00480'
p25657
aS'Promethazine hydrochloride (JP16/USP)'
p25658
aS'D00493'
p25659
aS'Prochlorperazine (JAN/USP/INN)'
p25660
aS'D00494'
p25661
aS'Promethazine (JAN/INN)'
p25662
aS'D00503'
p25663
aS'Perphenazine (JP16/USP/INN)'
p25664
aS'D00789'
p25665
aS'Chlorpromazine hydrochloride (JP16/USP)'
p25666
aS'D00791'
p25667
aS'Fluphenazine hydrochloride (JAN/USP)'
p25668
aS'D00797'
p25669
aS'Promazine hydrochloride (USP)'
p25670
aS'D00798'
p25671
aS'Thioridazine hydrochloride (JP16/USP)'
p25672
aS'D00799'
p25673
aS'Trifluoperazine hydrochloride (JAN/USP)'
p25674
aS'D00800'
p25675
aS'Triflupromazine hydrochloride (JAN/USP)'
p25676
aS'D01118'
p25677
aS'Profenamine hydrochloride (JAN)'
p25678
aS'D01130'
p25679
aS'Thietylperazine maleate (JAN)'
p25680
aS'D01143'
p25681
aS'Isothipendyl hydrochloride (JAN)'
p25682
aS'D01242'
p25683
aS'Promethazine teoclate (JAN/INN)'
p25684
aS'D01412'
p25685
aS'Perazine maleate (JAN)'
p25686
aS'D01447'
p25687
aS'Thioproperazine mesilate (JAN)'
p25688
aS'D01448'
p25689
aS'Trifluoperazine maleate (JAN)'
p25690
aS'D01520'
p25691
aS'Levomepromazine hydrochloride (JAN/USAN)'
p25692
aS'D01860'
p25693
aS'Perazine dimalonate (JAN)'
p25694
aS'D02022'
p25695
aS'Prochlorperazine mesilate (JAN)'
p25696
aS'D02037'
p25697
aS'Perphenazine maleate (JP16)'
p25698
aS'D02163'
p25699
aS'Fluphenazine maleate (JAN)'
p25700
aS'D02245'
p25701
aS'Alimemazine tartrate (JP16)'
p25702
aS'D02248'
p25703
aS'Levomepromazine maleate (JP16/USAN)'
p25704
aS'D02312'
p25705
aS'Methylene blue (USP)'
p25706
aS'D02354'
p25707
aS'Thiethylperazine (USAN/INN)'
p25708
aS'D02601'
p25709
aS'Phenothiazine (INN)'
p25710
aS'D02602'
p25711
aS'Fenethazine (INN)'
p25712
aS'D02603'
p25713
aS'Diethazine hydrochloride'
p25714
aS'D02604'
p25715
aS'Acepromazine maleate (USP)'
p25716
aS'D02605'
p25717
aS'Methoxypromazine maleate'
p25718
aS'D02606'
p25719
aS'Pipamazine (INN)'
p25720
aS'D02607'
p25721
aS'Mepazine acetate'
p25722
aS'D02608'
p25723
aS'Perazine fendizoate (JAN)'
p25724
aS'D02609'
p25725
aS'Prochlorperazine edisylate (USP)'
p25726
aS'D02610'
p25727
aS'Thietylperazine malate (JAN)'
p25728
aS'D03274'
p25729
aS'Chlorpromazine hibenzate (JAN)'
p25730
aS'D03276'
p25731
aS'Profenamine hibenzate (JAN)'
p25732
aS'D03290'
p25733
aS'Promethazine methylenedisalicylate (JAN)'
p25734
aS'D04034'
p25735
aS'Chlorpromazine phenolphthalinate (JAN)'
p25736
aS'D04038'
p25737
aS'Perphenazine fendizoate (JAN)'
p25738
aS'D04965'
p25739
aS'Perphenazine hydrochloride'
p25740
aS'D07065'
p25741
aS'Acepromazine (INN)'
p25742
aS'D07125'
p25743
aS'Alimemazine (INN)'
p25744
aS'D07977'
p25745
aS'Fluphenazine (INN)'
p25746
aS'D08091'
p25747
aS'Isothipendyl (INN)'
p25748
aS'D08426'
p25749
aS'Profenamine (INN)'
p25750
aS'D08432'
p25751
aS'Promethazine maleate'
p25752
aS'D08585'
p25753
aS'Thioproperazine (INN)'
p25754
aS'D08636'
p25755
aS'Trifluoperazine (INN)'
p25756
aS'D08768'
p25757
aS'Promethazine hibenzate'
p25758
assS'path:map07028'
p25759
(dp25760
S'ENTRY'
p25761
(lp25762
S'map07028'
p25763
aS'Drug'
p25764
aS'Pathway'
p25765
asS'PATHWAY_MAP'
p25766
(lp25767
S'map07028'
p25768
asS'NAME'
p25769
(lp25770
S'Antipsychotics'
p25771
asS'REFERENCE'
p25772
(lp25773
S'(Japanese)'
p25774
ag25774
aS'AUTHORS'
p25775
aS'Sano T, Naito T, Kubo T (eds).'
p25776
aS'TITLE'
p25777
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p25778
aS'JOURNAL'
p25779
aS'Nankodo (2002)'
p25780
aS'(Japanese)'
p25781
ag25781
aS'AUTHORS'
p25782
aS'Fukai S.'
p25783
aS'TITLE'
p25784
aS'[New Drugs Today (6th ed)] (In Japanese)'
p25785
aS'JOURNAL'
p25786
aS'Jiho (1995)'
p25787
ag22
ag22
aS'AUTHORS'
p25788
aS'David AW, Thomas LL, William OF.'
p25789
aS'TITLE'
p25790
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p25791
aS'JOURNAL'
p25792
aS'Lippincott Williams & Wilkins (2002)'
p25793
ag22
ag22
aS'AUTHORS'
p25794
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p25795
aS'TITLE'
p25796
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p25797
aS'JOURNAL'
p25798
aS'McGraw-Hill (2001)'
p25799
aS'(Japanese)'
p25800
ag25800
aS'AUTHORS'
p25801
aS'Japan Pharmaceutical Association (ed).'
p25802
aS'TITLE'
p25803
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p25804
aS'JOURNAL'
p25805
aS'Yakuji Nippo (1999)'
p25806
aS'(Japanese)'
p25807
ag25807
aS'AUTHORS'
p25808
aS'Noguchi S, Hibino S (eds).'
p25809
aS'TITLE'
p25810
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p25811
aS'JOURNAL'
p25812
aS'Hirokawa (2002)'
p25813
asS'COMPOUND'
p25814
(lp25815
S'D00136'
p25816
aS'Haloperidol (JP16/USP/INN)'
p25817
ag25816
ag25817
aS'D00228'
p25818
aS'Amoxapine (JP16/USP/INN)'
p25819
aS'D00270'
p25820
aS'Chlorpromazine (USP/INN)'
p25821
aS'D00300'
p25822
aS'Diphenhydramine (JP16/INN)'
p25823
aS'D00374'
p25824
aS'Tiotixene (JAN)'
p25825
aS'D00426'
p25826
aS'Risperidone (JP16/USAN/INN)'
p25827
aS'D00477'
p25828
aS'Procainamide hydrochloride (JP16/USP)'
p25829
aS'D00480'
p25830
aS'Promethazine hydrochloride (JP16/USP)'
p25831
aS'D00494'
p25832
aS'Promethazine (JAN/INN)'
p25833
aS'D00561'
p25834
aS'Sertindole (USAN/INN)'
p25835
aS'D00669'
p25836
aS'Diphenhydramine hydrochloride (JP16/USP)'
p25837
aS'D00726'
p25838
aS'Metoclopramide (JP16/INN)'
p25839
aS'D00789'
p25840
aS'Chlorpromazine hydrochloride (JP16/USP)'
p25841
aS'D00790'
p25842
aS'Chlorprothixene (JAN/USAN/INN)'
p25843
aS'D00796'
p25844
aS'Molindone hydrochloride (USP)'
p25845
aS'D01044'
p25846
aS'Flupentixol (INN)'
p25847
aS'D01226'
p25848
aS'Sulpiride (JP16/USAN/INN)'
p25849
aS'D01242'
p25850
aS'Promethazine teoclate (JAN/INN)'
p25851
aS'D01321'
p25852
aS'Zotepine (JAN/INN)'
p25853
aS'D01383'
p25854
aS'Pethidine hydrochloride (JP16)'
p25855
aS'D01438'
p25856
aS'Perlapine (JAN/USAN/INN)'
p25857
aS'D02091'
p25858
aS'Tripelennamine hydrochloride (USP)'
p25859
aS'D02162'
p25860
aS'Chlorprothixene hydrochloride (JAN)'
p25861
aS'D02213'
p25862
aS'Metoclopramide hydrochloride (JAN)'
p25863
aS'D02236'
p25864
aS'Flupentixol dihydrochloride (JAN)'
p25865
aS'D02419'
p25866
aS'Diphenhydramine salicylate (JAN)'
p25867
aS'D02603'
p25868
aS'Diethazine hydrochloride'
p25869
aS'D02611'
p25870
aS'Phenoperidine (INN)'
p25871
aS'D02612'
p25872
aS'Thiothixene hydrochloride (USP)'
p25873
aS'D02613'
p25874
aS'Clopenthixol (USAN)'
p25875
aS'D03274'
p25876
aS'Chlorpromazine hibenzate (JAN)'
p25877
aS'D03290'
p25878
aS'Promethazine methylenedisalicylate (JAN)'
p25879
aS'D03360'
p25880
aS'Diphenhydramine laurylsulfate (JAN)'
p25881
aS'D03556'
p25882
aS'Zuclopenthixol (INN)'
p25883
aS'D03854'
p25884
aS'Diphenhydramine citrate (USP)'
p25885
aS'D04034'
p25886
aS'Chlorpromazine phenolphthalinate (JAN)'
p25887
aS'D05008'
p25888
aS'Metoclopramide hydrochloride (USAN)'
p25889
aS'D06246'
p25890
aS'Tripelennamine citrate'
p25891
aS'D07686'
p25892
aS'Chlorprothixene acetate'
p25893
aS'D07687'
p25894
aS'Chlorprothixene citrate'
p25895
aS'D08343'
p25896
aS'Pethidine (INN)'
p25897
aS'D08432'
p25898
aS'Promethazine maleate'
p25899
aS'D08768'
p25900
aS'Promethazine hibenzate'
p25901
assS'path:map07025'
p25902
(dp25903
S'ENTRY'
p25904
(lp25905
S'map07025'
p25906
aS'Drug'
p25907
aS'Pathway'
p25908
asS'PATHWAY_MAP'
p25909
(lp25910
S'map07025'
p25911
asS'NAME'
p25912
(lp25913
S'Quinolines'
p25914
asS'REFERENCE'
p25915
(lp25916
g22
ag22
aS'AUTHORS'
p25917
aS'Sano T, Naito T, Kubo T (eds).'
p25918
aS'TITLE'
p25919
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p25920
aS'JOURNAL'
p25921
aS'Nankodo (2002)'
p25922
ag22
ag22
aS'AUTHORS'
p25923
aS'Fukai S.'
p25924
aS'TITLE'
p25925
aS'[New Drugs Today (6th ed)] (In Japanese)'
p25926
aS'JOURNAL'
p25927
aS'Jiho (1995)'
p25928
ag22
ag22
aS'AUTHORS'
p25929
aS'Wataya Y, Hye-Sook K.'
p25930
aS'TITLE'
p25931
aS'[Development of anti-mararial drugs: past, present, and future.] (In Japanese)'
p25932
aS'JOURNAL'
p25933
aS'Experimental Medicine 23(17):2741-2747 (2005)'
p25934
asS'COMPOUND'
p25935
(lp25936
S'D00642'
p25937
aS'Quinidine gluconate (USP)'
p25938
ag25937
ag25938
aS'D00643'
p25939
aS'Quinidine polygalacturonate'
p25940
aS'D00831'
p25941
aS'Mefloquine hydrochloride (JP16/USP)'
p25942
aS'D01663'
p25943
aS'Quinine ethylcarbonate (JP16)'
p25944
aS'D02125'
p25945
aS'Chloroquine phosphate (USP)'
p25946
aS'D02126'
p25947
aS'Primaquine phosphate (USP)'
p25948
aS'D02261'
p25949
aS'Quinine hydrochloride hydrate (JP16)'
p25950
aS'D02262'
p25951
aS'Quinine sulfate hydrate (JP16)'
p25952
aS'D02272'
p25953
aS'Quinidine sulfate hydrate (JP16)'
p25954
aS'D02366'
p25955
aS'Chloroquine (USP/INN)'
p25956
aS'D02485'
p25957
aS'Halofantrine hydrochloride (USAN)'
p25958
aS'D02547'
p25959
aS'Pamaquine'
p25960
aS'D02548'
p25961
aS'Mepacrine dihydrochloride'
p25962
aS'D03469'
p25963
aS'Chloroquine hydrochloride (USP)'
p25964
aS'D04895'
p25965
aS'Mefloquine (USAN/INN)'
p25966
aS'D05681'
p25967
aS'Quinine ascorbate (USAN)'
p25968
aS'D07680'
p25969
aS'Chloroquine sulfate'
p25970
aS'D08033'
p25971
aS'Halofantrine (INN)'
p25972
aS'D08179'
p25973
aS'Mepacrine (INN)'
p25974
aS'D08420'
p25975
aS'Primaquine (INN)'
p25976
aS'D08458'
p25977
aS'Quinidine (BAN)'
p25978
aS'D08459'
p25979
aS'Quinidine phenylethylbarbiturate'
p25980
aS'D08460'
p25981
aS'Quinine (BAN)'
p25982
aS'D08461'
p25983
aS'Quinine dihydrochloride'
p25984
assS'path:map07024'
p25985
(dp25986
S'NAME'
p25987
(lp25988
S'HMG-CoA reductase inhibitors'
p25989
asS'REFERENCE'
p25990
(lp25991
S'(Japanese)'
p25992
ag25992
aS'AUTHORS'
p25993
aS'Sano T, Naito T, Kubo T (eds).'
p25994
aS'TITLE'
p25995
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p25996
aS'JOURNAL'
p25997
aS'Nankodo (2002)'
p25998
aS'(Japanese)'
p25999
ag25999
aS'AUTHORS'
p26000
aS'Fukai S.'
p26001
aS'TITLE'
p26002
aS'[New Drugs Today (6th ed)] (In Japanese)'
p26003
aS'JOURNAL'
p26004
aS'Jiho (1995)'
p26005
ag22
ag22
aS'AUTHORS'
p26006
aS'Walter S.'
p26007
aS'TITLE'
p26008
aS'Drug Discovery: A History'
p26009
aS'JOURNAL'
p26010
aS'Wiley (2005)'
p26011
aS'(Japanese)'
p26012
ag26012
aS'AUTHORS'
p26013
aS'Japan Pharmaceutical Association (ed).'
p26014
aS'TITLE'
p26015
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p26016
aS'JOURNAL'
p26017
aS'Yakuji Nippo (1999)'
p26018
aS'(Japanese)'
p26019
ag26019
aS'AUTHORS'
p26020
aS'Noguchi S, Hibino S (eds).'
p26021
aS'TITLE'
p26022
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p26023
aS'JOURNAL'
p26024
aS'Hirokawa (2002)'
p26025
aS'(Japanese)'
p26026
ag26026
aS'AUTHORS'
p26027
aS'Teramoto T (ed).'
p26028
aS'TITLE'
p26029
aS'[Statins Q & A] (In Japanese)'
p26030
aS'JOURNAL'
p26031
aS'Iyaku journal (2001)'
p26032
aS'(Japanese)'
p26033
ag26033
aS'AUTHORS'
p26034
aS'Takamisawa I, Shiba M.'
p26035
aS'TITLE'
p26036
aS'[Structure, activity and metabolism of statins.] (In Japanese)'
p26037
aS'JOURNAL'
p26038
aS'Chiryogaku 36(5):35-40 (2002)'
p26039
aS'PMID:9892578'
p26040
ag26040
aS'AUTHORS'
p26041
aS'Furberg CD'
p26042
aS'TITLE'
p26043
aS'Natural statins and stroke risk.'
p26044
aS'JOURNAL'
p26045
aS'Circulation 99:185-8 (1999)'
p26046
aS'PMID:12530513'
p26047
ag26047
aS'AUTHORS'
p26048
aS'Veillard NR, Mach F.'
p26049
aS'TITLE'
p26050
aS'Statins: the new aspirin?'
p26051
aS'JOURNAL'
p26052
aS'Cell Mol Life Sci 59:1771-86 (2002)'
p26053
aS'PMID:15531278'
p26054
ag26054
aS'AUTHORS'
p26055
aS'Endo A.'
p26056
aS'TITLE'
p26057
aS'The discovery and development of HMG-CoA reductase inhibitors. 1992.'
p26058
aS'JOURNAL'
p26059
aS'Atheroscler Suppl 5:67-80 (2004)'
p26060
asS'COMPOUND'
p26061
(lp26062
S'C00356'
p26063
aS'(S)-3-Hydroxy-3-methylglutaryl-CoA'
p26064
ag26063
ag26064
aS'C13334'
p26065
aS'Pitavastatin'
p26066
aS'C13963'
p26067
aS'Mevastatin'
p26068
aS'D00359'
p26069
aS'Lovastatin (USP/INN)'
p26070
aS'D00434'
p26071
aS'Simvastatin (JP16/USP/INN)'
p26072
aS'D00887'
p26073
aS'Atorvastatin calcium (USAN)'
p26074
aS'D00889'
p26075
aS'Cerivastatin sodium (JAN/USAN)'
p26076
aS'D00892'
p26077
aS'Fluvastatin sodium (JAN/USAN)'
p26078
aS'D00893'
p26079
aS'Pravastatin sodium (JP16/USAN)'
p26080
aS'D01862'
p26081
aS'Pitavastatin calcium (JAN)'
p26082
aS'D01915'
p26083
aS'Rosuvastatin calcium (JAN/USAN)'
p26084
aS'D02258'
p26085
aS'Atorvastatin calcium hydrate (JP16)'
p26086
aS'D07474'
p26087
aS'Atorvastatin (INN)'
p26088
aS'D07661'
p26089
aS'Cerivastatin (INN)'
p26090
aS'D07983'
p26091
aS'Fluvastatin (INN)'
p26092
aS'D08410'
p26093
aS'Pravastatin (INN)'
p26094
aS'D08492'
p26095
aS'Rosuvastatin (INN)'
p26096
asS'ENTRY'
p26097
(lp26098
S'map07024'
p26099
aS'Drug'
p26100
aS'Pathway'
p26101
asS'PATHWAY_MAP'
p26102
(lp26103
S'map07024'
p26104
asS'DESCRIPTION'
p26105
(lp26106
S"HMG-CoA reductase inhibitors, also known as statins, are a class of cholesterol lowering drugs that target HMG-CoA reductase in the mevalonate pathway. In 1971 Akira Endo and his team working for the Japanese pharmaceutical company Sankyo started a project to search for microbial metabolites that would inhibit HMG-CoA reductase, the rate-limiting enzyme in the cholesterol biosynthesis, hoping that certain microorganisms would produce such inhibitors as a weapon against other microbes. After screening 6,000 microbial strains mevastatin was discovered from Penicillium citrinum, but the clinical trial of mevastatin was not completed because of its toxicity. The first successful statin was lovastatin isolated from Aspergillus terreus by Merck, which had repeated Sankyo's approach to microbial screening. Following the first generation statins that are based on natural products, the second and the third generation statins were developed using chemical synthesis."
p26107
assS'path:map07027'
p26108
(dp26109
S'ENTRY'
p26110
(lp26111
S'map07027'
p26112
aS'Drug'
p26113
aS'Pathway'
p26114
asS'PATHWAY_MAP'
p26115
(lp26116
S'map07027'
p26117
asS'NAME'
p26118
(lp26119
S'Antidepressants'
p26120
asS'REFERENCE'
p26121
(lp26122
S'(Japanese)'
p26123
ag26123
aS'AUTHORS'
p26124
aS'Sano T, Naito T, Kubo T (eds).'
p26125
aS'TITLE'
p26126
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p26127
aS'JOURNAL'
p26128
aS'Nankodo (2002)'
p26129
aS'(Japanese)'
p26130
ag26130
aS'AUTHORS'
p26131
aS'Fukai S.'
p26132
aS'TITLE'
p26133
aS'[New Drugs Today (6th ed)] (In Japanese)'
p26134
aS'JOURNAL'
p26135
aS'Jiho (1995)'
p26136
ag22
ag22
aS'AUTHORS'
p26137
aS'David AW, Thomas LL, William OF.'
p26138
aS'TITLE'
p26139
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p26140
aS'JOURNAL'
p26141
aS'Lippincott Williams & Wilkins (2002)'
p26142
ag22
ag22
aS'AUTHORS'
p26143
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p26144
aS'TITLE'
p26145
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p26146
aS'JOURNAL'
p26147
aS'McGraw-Hill (2001)'
p26148
ag22
ag22
aS'AUTHORS'
p26149
aS'Walter S.'
p26150
aS'TITLE'
p26151
aS'Drug Discovery: A History'
p26152
aS'JOURNAL'
p26153
aS'Wiley (2005)'
p26154
aS'(Japanese)'
p26155
ag26155
aS'AUTHORS'
p26156
aS'Shishikura K, Kamijima K.'
p26157
aS'TITLE'
p26158
aS'[History and prospects of antidepressants.] (In Japanese)'
p26159
aS'JOURNAL'
p26160
aS'Journal of Japanese Society of Hospital Pharmacists 37(11):25-28 (2001)'
p26161
aS'(Japanese)'
p26162
ag26162
aS'AUTHORS'
p26163
aS'Kusumi I, Koyama T.'
p26164
aS'TITLE'
p26165
aS'[Pharmacology of novel antidepressants.] (In Japanese)'
p26166
aS'JOURNAL'
p26167
aS'Igaku no Ayumi 195(8):519-522 (2000)'
p26168
aS'(Japanese)'
p26169
ag26169
aS'AUTHORS'
p26170
aS'Koyama T.'
p26171
aS'TITLE'
p26172
aS'[The history of antidepressant development.] (In Japanese)'
p26173
aS'JOURNAL'
p26174
aS'Iyaku journal 35(2):137-140 (2000)'
p26175
ag22
ag22
aS'AUTHORS'
p26176
aS'Leonard BE.'
p26177
aS'TITLE'
p26178
aS"Pharmacological properties of some ''second generation'' antidepressant drugs."
p26179
aS'JOURNAL'
p26180
aS'Neuropharmacology 19(12):1175-1183 (1980)'
p26181
aS'PMID:8471919'
p26182
ag26182
aS'AUTHORS'
p26183
aS'Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J'
p26184
aS'TITLE'
p26185
aS'Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.'
p26186
aS'JOURNAL'
p26187
aS'BMJ 306:683-7 (1993)'
p26188
aS'PMID:10511010'
p26189
ag26189
aS'AUTHORS'
p26190
aS'Domino EF.'
p26191
aS'TITLE'
p26192
aS'History of modern psychopharmacology: a personal view with an emphasis on antidepressants.'
p26193
aS'JOURNAL'
p26194
aS'Psychosom Med 61:591-8 (1999)'
p26195
aS'PMID:11478422'
p26196
ag26196
aS'AUTHORS'
p26197
aS'Ban TA.'
p26198
aS'TITLE'
p26199
aS'Pharmacotherapy of depression: a historical analysis.'
p26200
aS'JOURNAL'
p26201
aS'J Neural Transm 108:707-16 (2001)'
p26202
aS'PMID:14748749'
p26203
ag26203
aS'AUTHORS'
p26204
aS'Slattery DA, Hudson AL, Nutt DJ.'
p26205
aS'TITLE'
p26206
aS'Invited review: the evolution of antidepressant mechanisms.'
p26207
aS'JOURNAL'
p26208
aS'Fundam Clin Pharmacol 18:1-21 (2004)'
p26209
aS'PMID:15618947'
p26210
ag26210
aS'AUTHORS'
p26211
aS'Nutt DJ.'
p26212
aS'TITLE'
p26213
aS'Overview of diagnosis and drug treatments of anxiety disorders.'
p26214
aS'JOURNAL'
p26215
aS'CNS Spectr 10:49-56 (2005)'
p26216
asS'COMPOUND'
p26217
(lp26218
S'D00228'
p26219
aS'Amoxapine (JP16/USP/INN)'
p26220
ag26219
ag26220
aS'D00326'
p26221
aS'Fluoxetine (USAN/INN)'
p26222
aS'D00394'
p26223
aS'Trimipramine (USAN/INN)'
p26224
aS'D00505'
p26225
aS'Phenelzine sulfate (USP)'
p26226
aS'D00563'
p26227
aS'Mirtazapine (JAN/USAN/INN)'
p26228
aS'D00785'
p26229
aS'Selegiline hydrochloride (JAN/USP)'
p26230
aS'D00809'
p26231
aS'Amitriptyline hydrochloride (JP16/USP)'
p26232
aS'D00811'
p26233
aS'Clomipramine hydrochloride (JP16/USP)'
p26234
aS'D00812'
p26235
aS'Desipramine hydrochloride (JAN/USP)'
p26236
aS'D00815'
p26237
aS'Imipramine hydrochloride (JP16/USP)'
p26238
aS'D00816'
p26239
aS'Nortriptyline hydrochloride (JP16/USP/INN)'
p26240
aS'D00818'
p26241
aS'Maprotiline hydrochloride (JP16/USP)'
p26242
aS'D00819'
p26243
aS'Nefazodone hydrochloride (USAN)'
p26244
aS'D00820'
p26245
aS'Trazodone hydrochloride (JAN/USP)'
p26246
aS'D00821'
p26247
aS'Venlafaxine hydrochloride (JAN/USAN)'
p26248
aS'D00822'
p26249
aS'Citalopram hydrobromide (USAN)'
p26250
aS'D00823'
p26251
aS'Fluoxetine hydrochloride (JAN/USP)'
p26252
aS'D00824'
p26253
aS'Fluvoxamine maleate (JP16/USAN)'
p26254
aS'D00825'
p26255
aS'Sertraline hydrochloride (JAN/USAN)'
p26256
aS'D00826'
p26257
aS'Tranylcypromine sulfate (USP XXI)'
p26258
aS'D01107'
p26259
aS'Milnacipran hydrochloride (JAN/USAN)'
p26260
aS'D01110'
p26261
aS'Melitracen hydrochloride (JAN/USAN)'
p26262
aS'D01179'
p26263
aS'Duloxetine hydrochloride (JAN/USAN)'
p26264
aS'D01285'
p26265
aS'Lofepramine hydrochloride (JAN/USAN)'
p26266
aS'D01358'
p26267
aS'Mianserin hydrochloride (JAN/USAN)'
p26268
aS'D01546'
p26269
aS'Dosulepin hydrochloride (JAN)'
p26270
aS'D02034'
p26271
aS'Setiptiline maleate (JAN)'
p26272
aS'D02260'
p26273
aS'Paroxetine hydrochloride hydrate (JP16)'
p26274
aS'D02360'
p26275
aS'Sertraline (INN)'
p26276
aS'D02362'
p26277
aS'Paroxetine (USP/INN)'
p26278
aS'D02408'
p26279
aS'Trimipramine maleate (JAN/USAN)'
p26280
aS'D02559'
p26281
aS'Toloxatone (INN)'
p26282
aS'D02560'
p26283
aS'Brofaromine (INN)'
p26284
aS'D02561'
p26285
aS'Moclobemide (USAN/INN)'
p26286
aS'D02562'
p26287
aS'Rasagiline mesylate (USAN)'
p26288
aS'D02565'
p26289
aS'Dimetacrine (INN)'
p26290
aS'D02566'
p26291
aS'Maprotiline (USAN)'
p26292
aS'D02570'
p26293
aS'Desvenlafaxine succinate hydrate (JAN)'
p26294
aS'D02571'
p26295
aS'Sibutramine hydrochloride hydrate (JAN)'
p26296
aS'D02572'
p26297
aS'Viloxazine hydrochloride (USAN)'
p26298
aS'D02573'
p26299
aS'Reboxetine mesylate (USAN)'
p26300
aS'D02579'
p26301
aS'Iproniazid (INN)'
p26302
aS'D02580'
p26303
aS'Isocarboxazid (INN)'
p26304
aS'D03731'
p26305
aS'Selegiline (USAN/INN)'
p26306
aS'D05374'
p26307
aS'Paroxetine hydrochloride (USP)'
p26308
aS'D05375'
p26309
aS'Paroxetine mesylate (USAN)'
p26310
aS'D07448'
p26311
aS'Amitriptyline (INN)'
p26312
aS'D07704'
p26313
aS'Citalopram (USP/INN)'
p26314
aS'D07705'
p26315
aS'Citalopram hydrochloride'
p26316
aS'D07727'
p26317
aS'Clomipramine (INN)'
p26318
aS'D07791'
p26319
aS'Desipramine (INN)'
p26320
aS'D07793'
p26321
aS'Desvenlafaxine (INN)'
p26322
aS'D07872'
p26323
aS'Dosulepin (INN)'
p26324
aS'D07880'
p26325
aS'Duloxetine (INN)'
p26326
aS'D07984'
p26327
aS'Fluvoxamine (INN)'
p26328
aS'D08070'
p26329
aS'Imipramine (INN)'
p26330
aS'D08085'
p26331
aS'Iproniazid phosphate'
p26332
aS'D08140'
p26333
aS'Lofepramine (INN)'
p26334
aS'D08171'
p26335
aS'Melitracen (INN)'
p26336
aS'D08216'
p26337
aS'Mianserin (INN)'
p26338
aS'D08222'
p26339
aS'Milnacipran (INN)'
p26340
aS'D08257'
p26341
aS'Nefazodone (INN)'
p26342
aS'D08288'
p26343
aS'Nortriptyline (INN)'
p26344
aS'D08349'
p26345
aS'Phenelzine (BAN)'
p26346
aS'D08469'
p26347
aS'Rasagiline (USAN/INN)'
p26348
aS'D08472'
p26349
aS'Reboxetine (INN)'
p26350
aS'D08511'
p26351
aS'Setiptiline (INN)'
p26352
aS'D08513'
p26353
aS'Sibutramine (INN)'
p26354
aS'D08625'
p26355
aS'Tranylcypromine (INN)'
p26356
aS'D08626'
p26357
aS'Trazodone (INN)'
p26358
aS'D08670'
p26359
aS'Venlafaxine (INN)'
p26360
aS'D08673'
p26361
aS'Viloxazine (INN)'
p26362
assS'path:map07026'
p26363
(dp26364
S'ENTRY'
p26365
(lp26366
S'map07026'
p26367
aS'Drug'
p26368
aS'Pathway'
p26369
asS'PATHWAY_MAP'
p26370
(lp26371
S'map07026'
p26372
asS'NAME'
p26373
(lp26374
S'Antifungal agents'
p26375
asS'REFERENCE'
p26376
(lp26377
g22
ag22
aS'AUTHORS'
p26378
aS'David AW, Thomas LL, William OF.'
p26379
aS'TITLE'
p26380
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p26381
aS'JOURNAL'
p26382
aS'Lippincott Williams & Wilkins (2002)'
p26383
ag22
ag22
aS'AUTHORS'
p26384
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p26385
aS'TITLE'
p26386
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p26387
aS'JOURNAL'
p26388
aS'McGraw-Hill (2001)'
p26389
ag22
ag22
aS'AUTHORS'
p26390
aS'Walter S.'
p26391
aS'TITLE'
p26392
aS'Drug Discovery: A History'
p26393
aS'JOURNAL'
p26394
aS'Wiley (2005)'
p26395
aS'PMID:15047519'
p26396
ag26396
aS'AUTHORS'
p26397
aS'Petraitiene R, Petraitis V, Lyman CA, Groll AH, Mickiene D, Peter J, Bacher J, Roussillon K, Hemmings M, Armstrong D, Avila NA, Walsh TJ'
p26398
aS'TITLE'
p26399
aS'Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.'
p26400
aS'JOURNAL'
p26401
aS'Antimicrob Agents Chemother 48:1188-96 (2004)'
p26402
aS'PMID:11682237'
p26403
ag26403
aS'AUTHORS'
p26404
aS'Kim H, Kumari P, Lin CC, Nomeir AA.'
p26405
aS'TITLE'
p26406
aS'Simultaneous high-performance liquid chromatographic determination of SCH 59884 (phosphate ester prodrug of SCH 56592), SCH 207962 and SCH 56592 in dog plasma.'
p26407
aS'JOURNAL'
p26408
aS'J Pharm Biomed Anal 27:295-303 (2002)'
p26409
aS'PMID:3069196'
p26410
ag26410
aS'AUTHORS'
p26411
aS'Fromtling RA'
p26412
aS'TITLE'
p26413
aS'Overview of medically important antifungal azole derivatives.'
p26414
aS'JOURNAL'
p26415
aS'Clin Microbiol Rev 1:187-217 (1988)'
p26416
asS'COMPOUND'
p26417
(lp26418
S'C14531'
p26419
aS'Azomycin'
p26420
ag26419
ag26420
aS'C14816'
p26421
aS'Sch 59884'
p26422
aS'C14817'
p26423
aS'BMS 379224'
p26424
aS'D00202'
p26425
aS'Nystatin (JP16/USP/INN)'
p26426
aS'D00203'
p26427
aS'Amphotericin B (JP16/USP/INN)'
p26428
aS'D00209'
p26429
aS'Griseofulvin (JP16/USP/INN)'
p26430
aS'D00282'
p26431
aS'Clotrimazole (JP16/USP/INN)'
p26432
aS'D00322'
p26433
aS'Fluconazole (JP16/USAN/INN)'
p26434
aS'D00323'
p26435
aS'Flucytosine (JP16/USP/INN)'
p26436
aS'D00350'
p26437
aS'Itraconazole (JP16/USAN)'
p26438
aS'D00351'
p26439
aS'Ketoconazole (JP16/USP)'
p26440
aS'D00381'
p26441
aS'Tolnaftate (JP16/USP/INN)'
p26442
aS'D00409'
p26443
aS'Metronidazole (JP16/USP/INN)'
p26444
aS'D00416'
p26445
aS'Miconazole (JP16/USP/INN)'
p26446
aS'D00548'
p26447
aS'Etomidate (USAN/INN)'
p26448
aS'D00578'
p26449
aS'Voriconazole (JAN/USAN/INN)'
p26450
aS'D00880'
p26451
aS'Butoconazole nitrate (USP)'
p26452
aS'D00881'
p26453
aS'Econazole nitrate (JAN/USP)'
p26454
aS'D00882'
p26455
aS'Miconazole nitrate (JP16/USP)'
p26456
aS'D00883'
p26457
aS'Naftifine hydrochloride (USP)'
p26458
aS'D00884'
p26459
aS'Pimaricin (JP16)'
p26460
aS'D00885'
p26461
aS'Oxiconazole nitrate (JAN/USAN)'
p26462
aS'D00886'
p26463
aS'Sulconazole nitrate (JAN/USP)'
p26464
aS'D00888'
p26465
aS'Terconazole (USAN/INN)'
p26466
aS'D01092'
p26467
aS'Lanoconazole (JAN/INN)'
p26468
aS'D01093'
p26469
aS'Butenafine hydrochloride (JP16/USAN)'
p26470
aS'D01429'
p26471
aS'Fosfluconazole (JAN/INN)'
p26472
aS'D01480'
p26473
aS'Isoconazole nitrate (JAN)'
p26474
aS'D01550'
p26475
aS'Liranaftate (JAN/INN)'
p26476
aS'D01620'
p26477
aS'Neticonazole hydrochloride (JAN)'
p26478
aS'D01720'
p26479
aS'Amorolfine hydrochloride (JAN)'
p26480
aS'D01775'
p26481
aS'Bifonazole (JP16/USAN/INN)'
p26482
aS'D01980'
p26483
aS'Luliconazole (JAN/USAN/INN)'
p26484
aS'D02143'
p26485
aS'Trichomycin (JP16)'
p26486
aS'D02169'
p26487
aS'Croconazole hydrochloride (JP16)'
p26488
aS'D02219'
p26489
aS'Terbinafine hydrochloride (JP16/USP)'
p26490
aS'D02375'
p26491
aS'Terbinafine (USAN/INN)'
p26492
aS'D02465'
p26493
aS'Micafungin sodium (JAN/USAN)'
p26494
aS'D02501'
p26495
aS'Caspofungin acetate (JAN/USAN)'
p26496
aS'D02555'
p26497
aS'Posaconazole (USAN/INN)'
p26498
aS'D02556'
p26499
aS'Ravuconazole (prop.INN)'
p26500
aS'D02557'
p26501
aS'Chlormidazole (INN)'
p26502
aS'D02923'
p26503
aS'Amorolfine (USAN/INN)'
p26504
aS'D03211'
p26505
aS'Anidulafungin (USAN)'
p26506
aS'D03936'
p26507
aS'Econazole (USAN/INN)'
p26508
aS'D04624'
p26509
aS'Isoconazole (USAN/INN)'
p26510
aS'D06630'
p26511
aS'Pramiconazole (USAN/INN)'
p26512
aS'D07596'
p26513
aS'Butenafine (INN)'
p26514
aS'D07598'
p26515
aS'Butoconazole (INN)'
p26516
aS'D07626'
p26517
aS'Caspofungin (INN)'
p26518
aS'D07676'
p26519
aS'Chlormidazole hydrochloride'
p26520
aS'D07752'
p26521
aS'Croconazole (INN)'
p26522
aS'D08218'
p26523
aS'Micafungin (INN)'
p26524
aS'D08245'
p26525
aS'Naftifine (INN)'
p26526
aS'D08313'
p26527
aS'Oxiconazole (INN)'
p26528
aS'D08535'
p26529
aS'Sulconazole (INN)'
p26530
assS'path:map07021'
p26531
(dp26532
S'ENTRY'
p26533
(lp26534
S'map07021'
p26535
aS'Drug'
p26536
aS'Pathway'
p26537
asS'PATHWAY_MAP'
p26538
(lp26539
S'map07021'
p26540
asS'NAME'
p26541
(lp26542
S'Aminoglycosides'
p26543
asS'REFERENCE'
p26544
(lp26545
S'(Japanese)'
p26546
ag26546
aS'AUTHORS'
p26547
aS'Fukai S.'
p26548
aS'TITLE'
p26549
aS'[New Drugs Today (6th ed)] (In Japanese)'
p26550
aS'JOURNAL'
p26551
aS'Jiho (1995)'
p26552
ag22
ag22
aS'AUTHORS'
p26553
aS'Walter S.'
p26554
aS'TITLE'
p26555
aS'Drug Discovery: A History'
p26556
aS'JOURNAL'
p26557
aS'Wiley (2005)'
p26558
aS'(Japanese)'
p26559
ag26559
aS'AUTHORS'
p26560
aS'Sakurai J.'
p26561
aS'TITLE'
p26562
aS'[Illustrated Microbiology (2nd ed)] (In Japanese)'
p26563
aS'JOURNAL'
p26564
aS'Nanzando'
p26565
aS'PMID:12827054'
p26566
ag26566
aS'AUTHORS'
p26567
aS'Scuderi AC, Paladino GM, Marino C, Trombetta F.'
p26568
aS'TITLE'
p26569
aS'In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells.'
p26570
aS'JOURNAL'
p26571
aS'Cornea 22:468-72 (2003)'
p26572
asS'COMPOUND'
p26573
(lp26574
S'D00063'
p26575
aS'Tobramycin (JP16/USP)'
p26576
ag26575
ag26576
aS'D00865'
p26577
aS'Amikacin sulfate (JP16/USP)'
p26578
aS'D00866'
p26579
aS'Kanamycin monosulfate (JP16)'
p26580
aS'D00867'
p26581
aS'Netilmicin sulfate (JAN/USP)'
p26582
aS'D00868'
p26583
aS'Paromomycin sulfate (JAN/USP)'
p26584
aS'D00869'
p26585
aS'Spectinomycin hydrochloride hydrate (JP16)'
p26586
aS'D01063'
p26587
aS'Gentamicin sulfate (JP16/USP)'
p26588
aS'D01350'
p26589
aS'Streptomycin sulfate (JP16/USP)'
p26590
aS'D01523'
p26591
aS'Arbekacin sulfate (JP16)'
p26592
aS'D01618'
p26593
aS'Fradiomycin sulfate (JP16)'
p26594
aS'D01753'
p26595
aS'Dibekacin sulfate (JP16)'
p26596
aS'D01821'
p26597
aS'Micronomicin sulfate (JP16)'
p26598
aS'D01826'
p26599
aS'Isepamicin sulfate (JP16)'
p26600
aS'D01868'
p26601
aS'Bekanamycin sulfate (JP16)'
p26602
aS'D01881'
p26603
aS'Astromicin sulfate (JAN/USAN)'
p26604
aS'D02181'
p26605
aS'Sisomicin sulfate (JAN/USP)'
p26606
aS'D02209'
p26607
aS'Ribostamycin sulfate (JP16)'
p26608
aS'D02542'
p26609
aS'Tobramycin sulfate (USP)'
p26610
aS'D02543'
p26611
aS'Amikacin (USP/INN)'
p26612
aS'D02544'
p26613
aS'Sisomicin (USAN/INN)'
p26614
aS'D02545'
p26615
aS'Isepamicin (USAN/INN)'
p26616
aS'D03262'
p26617
aS'Kanamycin sulfate (JP16)'
p26618
aS'D05140'
p26619
aS'Framycetin (INN)'
p26620
aS'D07462'
p26621
aS'Arbekacin (INN)'
p26622
aS'D07467'
p26623
aS'Paromomycin (INN)'
p26624
aS'D07470'
p26625
aS'Astromicin (INN)'
p26626
aS'D07497'
p26627
aS'Bekanamycin (INN)'
p26628
aS'D07811'
p26629
aS'Dibekacin (INN)'
p26630
aS'D08219'
p26631
aS'Micronomicin (DCF)'
p26632
aS'D08268'
p26633
aS'Netilmicin (INN)'
p26634
aS'D08478'
p26635
aS'Ribostamycin (INN)'
p26636
aS'D08526'
p26637
aS'Spectinomycin (INN)'
p26638
aS'D08531'
p26639
aS'Streptomycin (INN)'
p26640
assS'path:map07020'
p26641
(dp26642
S'ENTRY'
p26643
(lp26644
S'map07020'
p26645
aS'Drug'
p26646
aS'Pathway'
p26647
asS'PATHWAY_MAP'
p26648
(lp26649
S'map07020'
p26650
asS'NAME'
p26651
(lp26652
S'Macrolides and ketolides'
p26653
asS'REFERENCE'
p26654
(lp26655
S'(Japanese)'
p26656
ag26656
aS'AUTHORS'
p26657
aS'Sano T, Naito T, Kubo T (eds).'
p26658
aS'TITLE'
p26659
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p26660
aS'JOURNAL'
p26661
aS'Nankodo (2002)'
p26662
aS'(Japanese)'
p26663
ag26663
aS'AUTHORS'
p26664
aS'Fukai S.'
p26665
aS'TITLE'
p26666
aS'[New Drugs Today (6th ed)] (In Japanese)'
p26667
aS'JOURNAL'
p26668
aS'Jiho (1995)'
p26669
ag22
ag22
aS'AUTHORS'
p26670
aS'David AW, Thomas LL, William OF.'
p26671
aS'TITLE'
p26672
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p26673
aS'JOURNAL'
p26674
aS'Lippincott Williams & Wilkins (2002)'
p26675
ag22
ag22
aS'AUTHORS'
p26676
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p26677
aS'TITLE'
p26678
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p26679
aS'JOURNAL'
p26680
aS'McGraw-Hill (2001)'
p26681
ag22
ag22
aS'AUTHORS'
p26682
aS'Walter S.'
p26683
aS'TITLE'
p26684
aS'Drug Discovery: A History'
p26685
aS'JOURNAL'
p26686
aS'Wiley (2005)'
p26687
aS'(Japanese)'
p26688
ag26688
aS'AUTHORS'
p26689
aS'Japan Pharmaceutical Association (ed).'
p26690
aS'TITLE'
p26691
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p26692
aS'JOURNAL'
p26693
aS'Yakuji Nippo (1999)'
p26694
aS'(Japanese)'
p26695
ag26695
aS'AUTHORS'
p26696
aS'Noguchi S, Hibino S (eds).'
p26697
aS'TITLE'
p26698
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p26699
aS'JOURNAL'
p26700
aS'Hirokawa (2002)'
p26701
aS'(Japanese)'
p26702
ag26702
aS'AUTHORS'
p26703
aS'Suzuki I, Maeda K.'
p26704
aS'TITLE'
p26705
aS'[Medicine Development (vol.5)] (In Japanese)'
p26706
aS'JOURNAL'
p26707
aS'Hirokawa'
p26708
aS'(Japanese)'
p26709
ag26709
aS'AUTHORS'
p26710
aS'Nasu M.'
p26711
aS'TITLE'
p26712
aS'[New macrolides.] (In Japanese)'
p26713
aS'JOURNAL'
p26714
aS'Sogo Rinsho 42(2):297-302 (1993)'
p26715
ag22
ag22
aS'AUTHORS'
p26716
aS'Hunter PA.'
p26717
aS'TITLE'
p26718
aS'Ketolides - a novel form of macrolide: the way forward?'
p26719
aS'JOURNAL'
p26720
aS'Drug Discovery Today 3(6):257-260 (1998)'
p26721
asS'COMPOUND'
p26722
(lp26723
S'D00140'
p26724
aS'Erythromycin (JP16/USP/INN)'
p26725
ag26724
ag26725
aS'D00276'
p26726
aS'Clarithromycin (JP16/USP/INN)'
p26727
aS'D00851'
p26728
aS'Erythromycin estorate (JAN)'
p26729
aS'D01078'
p26730
aS'Telithromycin (JAN/USAN/INN)'
p26731
aS'D01235'
p26732
aS'Josamycin (JP16/USAN/INN)'
p26733
aS'D01322'
p26734
aS'Triacetyloleandomycin (JAN)'
p26735
aS'D01339'
p26736
aS'Midecamycin (JP16/INN)'
p26737
aS'D01361'
p26738
aS'Erythromycin ethylsuccinate (JP16/USP)'
p26739
aS'D01614'
p26740
aS'Acetylkitasamycin (JP16)'
p26741
aS'D01636'
p26742
aS'Midecamycin acetate (JP16)'
p26743
aS'D01710'
p26744
aS'Roxithromycin (JP16/USAN/INN)'
p26745
aS'D01897'
p26746
aS'Rokitamycin (JP16/INN)'
p26747
aS'D02000'
p26748
aS'Kitasamycin tartrate (JP16)'
p26749
aS'D02009'
p26750
aS'Erythromycin lactobionate (JP16/USP)'
p26751
aS'D02134'
p26752
aS'Azithromycin hydrate (JP16)'
p26753
aS'D02184'
p26754
aS'Erythromycin stearate (JP16/USP)'
p26755
aS'D02186'
p26756
aS'Oleandomycin phosphate (JAN)'
p26757
aS'D02269'
p26758
aS'Kitasamycin (JP16/USAN)'
p26759
aS'D02391'
p26760
aS'Cethromycin (USAN/INN)'
p26761
aS'D02420'
p26762
aS'Acetylspiramycin (JP16)'
p26763
aS'D02490'
p26764
aS'Tylosin (USP/INN)'
p26765
aS'D02492'
p26766
aS'Tilmicosin (USP/INN)'
p26767
aS'D02493'
p26768
aS'Tilmicosin phosphate (USAN)'
p26769
aS'D02523'
p26770
aS'Erythromycin acistrate (USAN)'
p26771
aS'D02524'
p26772
aS'Erythromycin gluceptate (USP)'
p26773
aS'D02525'
p26774
aS'Erythromycin propionate (USAN)'
p26775
aS'D04054'
p26776
aS'Erythromycin salnacedin (USAN)'
p26777
aS'D05351'
p26778
aS'Josamycin propionate (JP16)'
p26779
aS'D05908'
p26780
aS'Spiramycin (USAN/INN)'
p26781
aS'D06390'
p26782
aS'Azithromycin (USP)'
p26783
aS'D07486'
p26784
aS'Azithromycin (INN)'
p26785
aS'D07710'
p26786
aS'Clarithromycin lactobionate'
p26787
aS'D07909'
p26788
aS'Erythromycin thiocyanate'
p26789
aS'D07910'
p26790
aS'Erythromycin stinoprate (INN)'
p26791
aS'D08527'
p26792
aS'Spiramycin adipate'
p26793
aS'D08528'
p26794
aS'Spiramycin embonate'
p26795
assS'path:map03070'
p26796
(dp26797
S'NAME'
p26798
(lp26799
S'Bacterial secretion system'
p26800
asS'REFERENCE'
p26801
(lp26802
S'PMID:11173102'
p26803
ag26803
aS'AUTHORS'
p26804
aS'Kim JF.'
p26805
aS'TITLE'
p26806
aS'Revisiting the chlamydial type III protein secretion system: clues to the origin of type III protein secretion.'
p26807
aS'JOURNAL'
p26808
aS'Trends Genet 17:65-9 (2001)'
p26809
aS'PMID:11309112'
p26810
ag26810
aS'AUTHORS'
p26811
aS'Plano GV, Day JB, Ferracci F.'
p26812
aS'TITLE'
p26813
aS'Type III export: new uses for an old pathway.'
p26814
aS'JOURNAL'
p26815
aS'Mol Microbiol 40:284-93 (2001)'
p26816
aS'PMID:11413015'
p26817
ag26817
aS'AUTHORS'
p26818
aS'Gauthier A, Finlay BB.'
p26819
aS'TITLE'
p26820
aS'Bacterial pathogenesis: the answer to virulence is in the pore.'
p26821
aS'JOURNAL'
p26822
aS'Curr Biol 11:R264-7 (2001)'
p26823
aS'PMID:10047550'
p26824
ag26824
aS'AUTHORS'
p26825
aS'Burns DL.'
p26826
aS'TITLE'
p26827
aS'Biochemistry of type IV secretion.'
p26828
aS'JOURNAL'
p26829
aS'Curr Opin Microbiol 2:25-9 (1999)'
p26830
aS'PMID:10920394'
p26831
ag26831
aS'AUTHORS'
p26832
aS'Christie PJ, Vogel JP.'
p26833
aS'TITLE'
p26834
aS'Bacterial type IV secretion: conjugation systems adapted to deliver effector molecules to host cells.'
p26835
aS'JOURNAL'
p26836
aS'Trends Microbiol 8:354-60 (2000)'
p26837
aS'PMID:11309113'
p26838
ag26838
aS'AUTHORS'
p26839
aS'Christie PJ.'
p26840
aS'TITLE'
p26841
aS'Type IV secretion: intercellular transfer of macromolecules by systems ancestrally related to conjugation machines.'
p26842
aS'JOURNAL'
p26843
aS'Mol Microbiol 40:294-305 (2001)'
p26844
aS'PMID:10481178'
p26845
ag26845
aS'AUTHORS'
p26846
aS'Nunn D.'
p26847
aS'TITLE'
p26848
aS'Bacterial type II protein export and pilus biogenesis: more than just homologies?'
p26849
aS'JOURNAL'
p26850
aS'Trends Cell Biol 9:402-8 (1999)'
p26851
aS'PMID:11309111'
p26852
ag26852
aS'AUTHORS'
p26853
aS'Sandkvist M.'
p26854
aS'TITLE'
p26855
aS'Biology of type II secretion.'
p26856
aS'JOURNAL'
p26857
aS'Mol Microbiol 40:271-83 (2001)'
p26858
aS'PMID:11349009'
p26859
ag26859
aS'AUTHORS'
p26860
aS'Sandkvist M.'
p26861
aS'TITLE'
p26862
aS'Type II secretion and pathogenesis.'
p26863
aS'JOURNAL'
p26864
aS'Infect Immun 69:3523-35 (2001)'
p26865
aS'PMID:15546664'
p26866
ag26866
aS'AUTHORS'
p26867
aS'Delepelaire P'
p26868
aS'TITLE'
p26869
aS'Type I secretion in gram-negative bacteria.'
p26870
aS'JOURNAL'
p26871
aS'Biochim Biophys Acta 1694:149-61 (2004)'
p26872
aS'PMID:18406342'
p26873
ag26873
aS'AUTHORS'
p26874
aS'Hazes B, Frost L'
p26875
aS'TITLE'
p26876
aS'Towards a systems biology approach to study type II/IV secretion systems.'
p26877
aS'JOURNAL'
p26878
aS'Biochim Biophys Acta 1778:1839-50 (2008)'
p26879
aS'PMID:16448494'
p26880
ag26880
aS'AUTHORS'
p26881
aS'Johnson TL, Abendroth J, Hol WG, Sandkvist M'
p26882
aS'TITLE'
p26883
aS'Type II secretion: from structure to function.'
p26884
aS'JOURNAL'
p26885
aS'FEMS Microbiol Lett 255:175-86 (2006)'
p26886
aS'PMID:15546665'
p26887
ag26887
aS'AUTHORS'
p26888
aS'Filloux A'
p26889
aS'TITLE'
p26890
aS'The underlying mechanisms of type II protein secretion.'
p26891
aS'JOURNAL'
p26892
aS'Biochim Biophys Acta 1694:163-79 (2004)'
p26893
aS'PMID:19396170'
p26894
ag26894
aS'AUTHORS'
p26895
aS'Spreter T, Yip CK, Sanowar S, Andre I, Kimbrough TG, Vuckovic M, Pfuetzner RA, Deng W, Yu AC, Finlay BB, Baker D, Miller SI, Strynadka NC'
p26896
aS'TITLE'
p26897
aS'A conserved structural motif mediates formation of the periplasmic rings in the type III secretion system.'
p26898
aS'JOURNAL'
p26899
aS'Nat Struct Mol Biol 16:468-76 (2009)'
p26900
aS'PMID:15590783'
p26901
ag26901
aS'AUTHORS'
p26902
aS'Ghosh P'
p26903
aS'TITLE'
p26904
aS'Process of protein transport by the type III secretion system.'
p26905
aS'JOURNAL'
p26906
aS'Microbiol Mol Biol Rev 68:771-95 (2004)'
p26907
aS'PMID:12360191'
p26908
ag26908
aS'AUTHORS'
p26909
aS'Cornelis GR'
p26910
aS'TITLE'
p26911
aS"The Yersinia Ysc-Yop 'type III' weaponry."
p26912
aS'JOURNAL'
p26913
aS'Nat Rev Mol Cell Biol 3:742-52 (2002)'
p26914
aS'PMID:17215876'
p26915
ag26915
aS'AUTHORS'
p26916
aS'Baron C'
p26917
aS'TITLE'
p26918
aS'VirB8: a conserved type IV secretion system assembly factor and drug target.'
p26919
aS'JOURNAL'
p26920
aS'Biochem Cell Biol 84:890-9 (2006)'
p26921
aS'PMID:17943123'
p26922
ag26922
aS'AUTHORS'
p26923
aS'Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, Misselwitz R, Berger J, Sewald N, Konig W, Backert S'
p26924
aS'TITLE'
p26925
aS'Helicobacter exploits integrin for type IV secretion and kinase activation.'
p26926
aS'JOURNAL'
p26927
aS'Nature 449:862-6 (2007)'
p26928
aS'PMID:16092524'
p26929
ag26929
aS'AUTHORS'
p26930
aS'Christie PJ, Cascales E'
p26931
aS'TITLE'
p26932
aS'Structural and dynamic properties of bacterial type IV secretion systems (review).'
p26933
aS'JOURNAL'
p26934
aS'Mol Membr Biol 22:51-61 (2005)'
p26935
aS'PMID:15546668'
p26936
ag26936
aS'AUTHORS'
p26937
aS'Christie PJ'
p26938
aS'TITLE'
p26939
aS'Type IV secretion: the Agrobacterium VirB/D4 and related conjugation systems.'
p26940
aS'JOURNAL'
p26941
aS'Biochim Biophys Acta 1694:219-34 (2004)'
p26942
aS'PMID:15590781'
p26943
ag26943
aS'AUTHORS'
p26944
aS"Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala'Aldeen D"
p26945
aS'TITLE'
p26946
aS'Type V protein secretion pathway: the autotransporter story.'
p26947
aS'JOURNAL'
p26948
aS'Microbiol Mol Biol Rev 68:692-744 (2004)'
p26949
aS'PMID:9778731'
p26950
ag26950
aS'AUTHORS'
p26951
aS'Henderson IR, Navarro-Garcia F, Nataro JP'
p26952
aS'TITLE'
p26953
aS'The great escape: structure and function of the autotransporter proteins.'
p26954
aS'JOURNAL'
p26955
aS'Trends Microbiol 6:370-8 (1998)'
p26956
aS'PMID:18524912'
p26957
ag26957
aS'AUTHORS'
p26958
aS'Filloux A, Hachani A, Bleves S'
p26959
aS'TITLE'
p26960
aS'The bacterial type VI secretion machine: yet another player for protein transport across membranes.'
p26961
aS'JOURNAL'
p26962
aS'Microbiology 154:1570-83 (2008)'
p26963
aS'PMID:19251641'
p26964
ag26964
aS'AUTHORS'
p26965
aS'Leiman PG, Basler M, Ramagopal UA, Bonanno JB, Sauder JM, Pukatzki S, Burley SK, Almo SC, Mekalanos JJ'
p26966
aS'TITLE'
p26967
aS'Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin.'
p26968
aS'JOURNAL'
p26969
aS'Proc Natl Acad Sci U S A 106:4154-9 (2009)'
p26970
aS'PMID:17603507'
p26971
ag26971
aS'AUTHORS'
p26972
aS'Kulasekara HD, Miller SI'
p26973
aS'TITLE'
p26974
aS'Threonine phosphorylation times bacterial secretion.'
p26975
aS'JOURNAL'
p26976
aS'Nat Cell Biol 9:734-6 (2007)'
p26977
aS'PMID:18078384'
p26978
ag26978
aS'AUTHORS'
p26979
aS'Driessen AJ, Nouwen N'
p26980
aS'TITLE'
p26981
aS'Protein translocation across the bacterial cytoplasmic membrane.'
p26982
aS'JOURNAL'
p26983
aS'Annu Rev Biochem 77:643-67 (2008)'
p26984
aS'PMID:14641032'
p26985
ag26985
aS'AUTHORS'
p26986
aS'Pool MR'
p26987
aS'TITLE'
p26988
aS'Getting to the membrane: how is co-translational protein targeting to the endoplasmic reticulum regulated?'
p26989
aS'JOURNAL'
p26990
aS'Biochem Soc Trans 31:1232-7 (2003)'
p26991
aS'PMID:19299134'
p26992
ag26992
aS'AUTHORS'
p26993
aS'Desvaux M, Hebraud M, Talon R, Henderson IR'
p26994
aS'TITLE'
p26995
aS'Secretion and subcellular localizations of bacterial proteins: a semantic awareness issue.'
p26996
aS'JOURNAL'
p26997
aS'Trends Microbiol 17:139-45 (2009)'
p26998
aS'PMID:15063851'
p26999
ag26999
aS'AUTHORS'
p27000
aS'Nakatogawa H, Murakami A, Ito K'
p27001
aS'TITLE'
p27002
aS'Control of SecA and SecM translation by protein secretion.'
p27003
aS'JOURNAL'
p27004
aS'Curr Opin Microbiol 7:145-50 (2004)'
p27005
asS'KO_PATHWAY'
p27006
(lp27007
S'ko03070'
p27008
asS'PATHWAY_MAP'
p27009
(lp27010
S'map03070'
p27011
asS'MODULE'
p27012
(lp27013
S'M00325'
p27014
aS'alpha-Hemolysin/cyclolysin transport system [PATH:map03070]'
p27015
ag27014
ag27015
aS'M00331'
p27016
aS'Type II general secretion pathway [PATH:map03070]'
p27017
aS'M00332'
p27018
aS'Type III secretion system [PATH:map03070]'
p27019
aS'M00333'
p27020
aS'Type IV secretion system [PATH:map03070]'
p27021
aS'M00334'
p27022
aS'Type VI secretion system [PATH:map03070]'
p27023
aS'M00335'
p27024
aS'Sec (secretion) system [PATH:map03070]'
p27025
aS'M00336'
p27026
aS'Twin-arginine translocation (Tat) system [PATH:map03070]'
p27027
asS'DBLINKS'
p27028
(lp27029
S'GO: 0030253 0015628 0030254 0030255 0046819 0033103 0044098 0043952 0043953'
p27030
asS'ENTRY'
p27031
(lp27032
S'map03070'
p27033
aS'Pathway'
p27034
asS'CLASS'
p27035
(lp27036
S'Environmental Information Processing Membrane transport'
p27037
asS'DESCRIPTION'
p27038
(lp27039
S'Gram-negative bacteria secrete a wide range of proteins whose functions include biogenesis of organelles, such as pilli and flagella, nutrient acquisition, virulence, and efflux of drugs and other toxins. Six distinct secretion systems have been shown to mediate protein export through the inner and outer membranes of Gram-negative bacteria. These pathways are highly conserved throughout the Gram-negative bacterial species. In Gram-positive bacteria, secreted proteins are commonly translocated across the single membrane by the Sec pathway or the two-arginine (Tat) pathway.'
p27040
assS'path:map00473'
p27041
(dp27042
S'NAME'
p27043
(lp27044
S'D-Alanine metabolism'
p27045
asS'DBLINKS'
p27046
(lp27047
S'GO: 0046436'
p27048
asS'KO_PATHWAY'
p27049
(lp27050
S'ko00473'
p27051
asS'ENTRY'
p27052
(lp27053
S'map00473'
p27054
aS'Pathway'
p27055
asS'PATHWAY_MAP'
p27056
(lp27057
S'map00473'
p27058
asS'CLASS'
p27059
(lp27060
S'Metabolism Metabolism of other amino acids'
p27061
assS'path:map00472'
p27062
(dp27063
S'ENTRY'
p27064
(lp27065
S'map00472'
p27066
aS'Pathway'
p27067
asS'PATHWAY_MAP'
p27068
(lp27069
S'map00472'
p27070
asS'CLASS'
p27071
(lp27072
S'Metabolism Metabolism of other amino acids'
p27073
asS'NAME'
p27074
(lp27075
S'D-Arginine and D-ornithine metabolism'
p27076
asS'KO_PATHWAY'
p27077
(lp27078
S'ko00472'
p27079
assS'path:map00471'
p27080
(dp27081
S'NAME'
p27082
(lp27083
S'D-Glutamine and D-glutamate metabolism'
p27084
asS'KO_PATHWAY'
p27085
(lp27086
S'ko00471'
p27087
asS'ENTRY'
p27088
(lp27089
S'map00471'
p27090
aS'Pathway'
p27091
asS'PATHWAY_MAP'
p27092
(lp27093
S'map00471'
p27094
asS'DISEASE'
p27095
(lp27096
S'H01267'
p27097
aS'Familial hyperinsulinemic hypoglycemia (HHF)'
p27098
asS'CLASS'
p27099
(lp27100
S'Metabolism Metabolism of other amino acids'
p27101
assS'path:map05320'
p27102
(dp27103
S'NAME'
p27104
(lp27105
S'Autoimmune thyroid disease'
p27106
asS'REFERENCE'
p27107
(lp27108
S'PMID:15049952'
p27109
ag27109
aS'AUTHORS'
p27110
aS'Fountoulakis S, Tsatsoulis A.'
p27111
aS'TITLE'
p27112
aS'On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis.'
p27113
aS'JOURNAL'
p27114
aS'Clin Endocrinol (Oxf) 60:397-409 (2004)'
p27115
aS'PMID:15762980'
p27116
ag27116
aS'AUTHORS'
p27117
aS'Chistiakov DA.'
p27118
aS'TITLE'
p27119
aS"Immunogenetics of Hashimoto's thyroiditis."
p27120
aS'JOURNAL'
p27121
aS'J Autoimmune Dis 2:1 (2005)'
p27122
aS'PMID:9534029'
p27123
ag27123
aS'AUTHORS'
p27124
aS'McIver B, Morris JC.'
p27125
aS'TITLE'
p27126
aS"The pathogenesis of Graves' disease."
p27127
aS'JOURNAL'
p27128
aS'Endocrinol Metab Clin North Am 27:73-89 (1998)'
p27129
aS'PMID:11913070'
p27130
ag27130
aS'AUTHORS'
p27131
aS'Stassi G, De Maria R.'
p27132
aS'TITLE'
p27133
aS'Autoimmune thyroid disease: new models of cell death in autoimmunity.'
p27134
aS'JOURNAL'
p27135
aS'Nat Rev Immunol 2:195-204 (2002)'
p27136
aS'PMID:12192541'
p27137
ag27137
aS'AUTHORS'
p27138
aS'Collins J, Gough S.'
p27139
aS'TITLE'
p27140
aS'Autoimmunity in thyroid disease.'
p27141
aS'JOURNAL'
p27142
aS'Eur J Nucl Med Mol Imaging 29 Suppl 2:S417-24 (2002)'
p27143
aS'PMID:11396701'
p27144
ag27144
aS'AUTHORS'
p27145
aS'Ruwhof C, Drexhage HA.'
p27146
aS'TITLE'
p27147
aS'Iodine and thyroid autoimmune disease in animal models.'
p27148
aS'JOURNAL'
p27149
aS'Thyroid 11:427-36 (2001)'
p27150
aS'PMID:17192582'
p27151
ag27151
aS'AUTHORS'
p27152
aS'Tsatsoulis A.'
p27153
aS'TITLE'
p27154
aS'The role of stress in the clinical expression of thyroid autoimmunity.'
p27155
aS'JOURNAL'
p27156
aS'Ann N Y Acad Sci 1088:382-95 (2006)'
p27157
aS'PMID:15132715'
p27158
ag27158
aS'AUTHORS'
p27159
aS'Prummel MF, Strieder T, Wiersinga WM.'
p27160
aS'TITLE'
p27161
aS'The environment and autoimmune thyroid diseases.'
p27162
aS'JOURNAL'
p27163
aS'Eur J Endocrinol 150:605-18 (2004)'
p27164
aS'PMID:11577986'
p27165
ag27165
aS'AUTHORS'
p27166
aS'Kopp P.'
p27167
aS'TITLE'
p27168
aS'The TSH receptor and its role in thyroid disease.'
p27169
aS'JOURNAL'
p27170
aS'Cell Mol Life Sci 58:1301-22 (2001)'
p27171
asS'KO_PATHWAY'
p27172
(lp27173
S'ko05320'
p27174
asS'PATHWAY_MAP'
p27175
(lp27176
S'map05320'
p27177
asS'DISEASE'
p27178
(lp27179
S'H00081'
p27180
aS"Hashimoto's thyroiditis"
p27181
ag27180
ag27181
aS'H00082'
p27182
aS"Graves' disease"
p27183
asS'ENTRY'
p27184
(lp27185
S'map05320'
p27186
aS'Pathway'
p27187
asS'CLASS'
p27188
(lp27189
S'Human Diseases Immune diseases'
p27190
asS'DESCRIPTION'
p27191
(lp27192
S"The classification of autoimmune throid disease (AITD) includes Hashimoto's thyroiditis (HT) or chronic autoimmune thyroiditis and its variants,"
p27193
assS'path:map05321'
p27194
(dp27195
S'NAME'
p27196
(lp27197
S'Inflammatory bowel disease (IBD)'
p27198
asS'REFERENCE'
p27199
(lp27200
S'PMID:20134493'
p27201
ag27201
aS'AUTHORS'
p27202
aS'Melmed GY, Targan SR'
p27203
aS'TITLE'
p27204
aS'Future biologic targets for IBD: potentials and pitfalls.'
p27205
aS'JOURNAL'
p27206
aS'Nat Rev Gastroenterol Hepatol 7:110-7 (2010)'
p27207
aS'PMID:18200661'
p27208
ag27208
aS'AUTHORS'
p27209
aS'Shih DQ, Targan SR'
p27210
aS'TITLE'
p27211
aS'Immunopathogenesis of inflammatory bowel disease.'
p27212
aS'JOURNAL'
p27213
aS'World J Gastroenterol 14:390-400 (2008)'
p27214
aS'PMID:17499605'
p27215
ag27215
aS'AUTHORS'
p27216
aS'Baumgart DC, Carding SR'
p27217
aS'TITLE'
p27218
aS'Inflammatory bowel disease: cause and immunobiology.'
p27219
aS'JOURNAL'
p27220
aS'Lancet 369:1627-40 (2007)'
p27221
aS'PMID:16493424'
p27222
ag27222
aS'AUTHORS'
p27223
aS'Strober W, Murray PJ, Kitani A, Watanabe T'
p27224
aS'TITLE'
p27225
aS'Signalling pathways and molecular interactions of NOD1 and NOD2.'
p27226
aS'JOURNAL'
p27227
aS'Nat Rev Immunol 6:9-20 (2006)'
p27228
aS'PMID:21487504'
p27229
ag27229
aS'AUTHORS'
p27230
aS'Matricon J, Barnich N, Ardid D'
p27231
aS'TITLE'
p27232
aS'Immunopathogenesis of inflammatory bowel disease.'
p27233
aS'JOURNAL'
p27234
aS'Self Nonself 1:299-309 (2010)'
p27235
aS'PMID:12797537'
p27236
ag27236
aS'AUTHORS'
p27237
aS"Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O'Shea JJ, Frucht DM"
p27238
aS'TITLE'
p27239
aS'Cytokines and transcription factors that regulate T helper cell differentiation:'
p27240
aS'new players and new insights.'
p27241
aS'JOURNAL'
p27242
aS'J Clin Immunol 23:147-61 (2003)'
p27243
aS'PMID:10898785'
p27244
ag27244
aS'AUTHORS'
p27245
aS'Glimcher LH, Murphy KM'
p27246
aS'TITLE'
p27247
aS'Lineage commitment in the immune system: the T helper lymphocyte grows up.'
p27248
aS'JOURNAL'
p27249
aS'Genes Dev 14:1693-711 (2000)'
p27250
aS'PMID:12042806'
p27251
ag27251
aS'AUTHORS'
p27252
aS'Neurath MF, Finotto S, Glimcher LH'
p27253
aS'TITLE'
p27254
aS'The role of Th1/Th2 polarization in mucosal immunity.'
p27255
aS'JOURNAL'
p27256
aS'Nat Med 8:567-73 (2002)'
p27257
aS'PMID:12006974'
p27258
ag27258
aS'AUTHORS'
p27259
aS'Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, Yang SY, Murphy TL, Murphy KM'
p27260
aS'TITLE'
p27261
aS'T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells.'
p27262
aS'JOURNAL'
p27263
aS'Nat Immunol 3:549-57 (2002)'
p27264
aS'PMID:18242222'
p27265
ag27265
aS'AUTHORS'
p27266
aS'Sartor RB'
p27267
aS'TITLE'
p27268
aS'Microbial influences in inflammatory bowel diseases.'
p27269
aS'JOURNAL'
p27270
aS'Gastroenterology 134:577-94 (2008)'
p27271
aS'PMID:9759857'
p27272
ag27272
aS'AUTHORS'
p27273
aS'Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K'
p27274
aS'TITLE'
p27275
aS'IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells:'
p27276
aS'synergism with IL-18 for IFN-gamma production.'
p27277
aS'JOURNAL'
p27278
aS'J Immunol 161:3400-7 (1998)'
p27279
aS'PMID:23176791'
p27280
ag27280
aS'AUTHORS'
p27281
aS'Hur SJ, Kang SH, Jung HS, Kim SC, Jeon HS, Kim IH, Lee JD'
p27282
aS'TITLE'
p27283
aS'Review of natural products actions on cytokines in inflammatory bowel disease.'
p27284
aS'JOURNAL'
p27285
aS'Nutr Res 32:801-16 (2012)'
p27286
aS'PMID:18563156'
p27287
ag27287
aS'AUTHORS'
p27288
aS'Bettelli E, Korn T, Oukka M, Kuchroo VK'
p27289
aS'TITLE'
p27290
aS'Induction and effector functions of T(H)17 cells.'
p27291
aS'JOURNAL'
p27292
aS'Nature 453:1051-7 (2008)'
p27293
aS'PMID:18053739'
p27294
ag27294
aS'AUTHORS'
p27295
aS'Ivanov II, Zhou L, Littman DR'
p27296
aS'TITLE'
p27297
aS'Transcriptional regulation of Th17 cell differentiation.'
p27298
aS'JOURNAL'
p27299
aS'Semin Immunol 19:409-17 (2007)'
p27300
aS'PMID:19322214'
p27301
ag27301
aS'AUTHORS'
p27302
aS'Di Cesare A, Di Meglio P, Nestle FO'
p27303
aS'TITLE'
p27304
aS'The IL-23/Th17 axis in the immunopathogenesis of psoriasis.'
p27305
aS'JOURNAL'
p27306
aS'J Invest Dermatol 129:1339-50 (2009)'
p27307
aS'PMID:19381306'
p27308
ag27308
aS'AUTHORS'
p27309
aS'Jetten AM'
p27310
aS'TITLE'
p27311
aS'Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism.'
p27312
aS'JOURNAL'
p27313
aS'Nucl Recept Signal 7:e003 (2009)'
p27314
aS'PMID:21681604'
p27315
ag27315
aS'AUTHORS'
p27316
aS'Bene L, Falus A, Baffy N, Fulop AK'
p27317
aS'TITLE'
p27318
aS'Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.'
p27319
aS'JOURNAL'
p27320
aS'Pathol Oncol Res 17:463-72 (2011)'
p27321
asS'KO_PATHWAY'
p27322
(lp27323
S'ko05321'
p27324
asS'PATHWAY_MAP'
p27325
(lp27326
S'map05321'
p27327
asS'DISEASE'
p27328
(lp27329
S'H01227'
p27330
aS'Inflammatory bowel disease'
p27331
asS'ENTRY'
p27332
(lp27333
S'map05321'
p27334
aS'Pathway'
p27335
asS'CLASS'
p27336
(lp27337
S'Human Diseases Immune diseases'
p27338
asS'DESCRIPTION'
p27339
(lp27340
S'Inflammatory bowel disease (IBD), which includes Crohn disease (CD) and ulcerative colitis (UC), is characterized by chronic inflammation of the gastrointestinal tract due to environmental and genetic factors, infectious microbes, and the dysregulated immune system. Although many environmental factors (for example, geographic locations, smoking, etc.) affect the development of IBD, the most crucial might be the luminal (external) environment of the epithelial cells. There are pathogens that are found in increasing frequency in IBD. The microbial components such as flagellin, peptidoglycan, and lipopolysaccharide are recognized by receptors such as toll-like receptors (TLRs) and nucleotide-binding oligomerization domain (NOD) proteins, and also by antigen-presenting cells (APCs) in genetically susceptible host. The TLR recognition triggers the activation of NF-kappaB, leading to an inflammatory response. APC-expressed gene NOD2 has been associated with Crohn disease. In case of mutations of NOD2, negative regulation of IL-12 production is reduced with the stimulation of muramyl dipeptide (MDP), leading to CD. In addition, the APC mediates the differentiation of naive T cells into effector T cells (Th1, Th17, Th2) and natural killer T (NKT) cells. Th1 and Th17 cells produce high levels of IFN-gamma and IL-17, -22, respectively, both of which promote CD. In contrast, Th2 cells produce IL-4, -5, -10, which together with IL-13 from NKT induce UC.'
p27341
assS'path:map05322'
p27342
(dp27343
S'NAME'
p27344
(lp27345
S'Systemic lupus erythematosus'
p27346
asS'REFERENCE'
p27347
(lp27348
S'PMID:18305268'
p27349
ag27349
aS'AUTHORS'
p27350
aS'Rahman A, Isenberg DA.'
p27351
aS'TITLE'
p27352
aS'Systemic lupus erythematosus.'
p27353
aS'JOURNAL'
p27354
aS'N Engl J Med 358:929-39 (2008)'
p27355
aS'PMID:12835292'
p27356
ag27356
aS'AUTHORS'
p27357
aS'Mok CC, Lau CS.'
p27358
aS'TITLE'
p27359
aS'Pathogenesis of systemic lupus erythematosus.'
p27360
aS'JOURNAL'
p27361
aS'J Clin Pathol 56:481-90 (2003)'
p27362
aS'PMID:17943287'
p27363
ag27363
aS'AUTHORS'
p27364
aS'Clatworthy MR, Smith KG.'
p27365
aS'TITLE'
p27366
aS'B cells in glomerulonephritis: focus on lupus nephritis.'
p27367
aS'JOURNAL'
p27368
aS'Semin Immunopathol 29:337-53 (2007)'
p27369
aS'PMID:8048228'
p27370
ag27370
aS'AUTHORS'
p27371
aS'Couser WG.'
p27372
aS'TITLE'
p27373
aS'New insights into mechanisms of immune glomerular injury.'
p27374
aS'JOURNAL'
p27375
aS'West J Med 160:440-6 (1994)'
p27376
aS'PMID:16932712'
p27377
ag27377
aS'AUTHORS'
p27378
aS'Cook HT, Botto M.'
p27379
aS'TITLE'
p27380
aS'Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.'
p27381
aS'JOURNAL'
p27382
aS'Nat Clin Pract Rheumatol 2:330-7 (2006)'
p27383
aS'PMID:15459673'
p27384
ag27384
aS'AUTHORS'
p27385
aS'Carroll MC.'
p27386
aS'TITLE'
p27387
aS'A protective role for innate immunity in systemic lupus erythematosus.'
p27388
aS'JOURNAL'
p27389
aS'Nat Rev Immunol 4:825-31 (2004)'
p27390
aS'PMID:15972354'
p27391
ag27391
aS'AUTHORS'
p27392
aS'Sturfelt G, Truedsson L.'
p27393
aS'TITLE'
p27394
aS'Complement and its breakdown products in SLE.'
p27395
aS'JOURNAL'
p27396
aS'Rheumatology (Oxford) 44:1227-32 (2005)'
p27397
aS'PMID:10430616'
p27398
ag27398
aS'AUTHORS'
p27399
aS'Lu L, Kaliyaperumal A, Boumpas DT, Datta SK.'
p27400
aS'TITLE'
p27401
aS'Major peptide autoepitopes for nucleosome-specific T cells of human lupus.'
p27402
aS'JOURNAL'
p27403
aS'J Clin Invest 104:345-55 (1999)'
p27404
aS'PMID:12965173'
p27405
ag27405
aS'AUTHORS'
p27406
aS'Zieve GW, Khusial PR.'
p27407
aS'TITLE'
p27408
aS'The anti-Sm immune response in autoimmunity and cell biology.'
p27409
aS'JOURNAL'
p27410
aS'Autoimmun Rev 2:235-40 (2003)'
p27411
aS'PMID:10025913'
p27412
ag27412
aS'AUTHORS'
p27413
aS'Scofield RH, Farris AD, Horsfall AC, Harley JB.'
p27414
aS'TITLE'
p27415
aS'Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins.'
p27416
aS'JOURNAL'
p27417
aS'Arthritis Rheum 42:199-209 (1999)'
p27418
aS'PMID:15380523'
p27419
ag27419
aS'AUTHORS'
p27420
aS'Hoffman RW.'
p27421
aS'TITLE'
p27422
aS'T cells in the pathogenesis of systemic lupus erythematosus.'
p27423
aS'JOURNAL'
p27424
aS'Clin Immunol 113:4-13 (2004)'
p27425
asS'KO_PATHWAY'
p27426
(lp27427
S'ko05322'
p27428
asS'PATHWAY_MAP'
p27429
(lp27430
S'map05322'
p27431
asS'DISEASE'
p27432
(lp27433
S'H00080'
p27434
aS'Systemic lupus erythematosus'
p27435
asS'ENTRY'
p27436
(lp27437
S'map05322'
p27438
aS'Pathway'
p27439
asS'CLASS'
p27440
(lp27441
S'Human Diseases Immune diseases'
p27442
asS'DESCRIPTION'
p27443
(lp27444
S'Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterised by the production of IgG autoantibodies that are specific for self-antigens, such as DNA, nuclear proteins and certain cytoplasmic components, in association with a diverse array of clinical manifestations. The primary pathological findings in patients with SLE are those of inflammation, vasculitis, immune complex deposition, and vasculopathy. Immune complexes comprising autoantibody and self-antigen is deposited particulary in the renal glomeruli and mediate a systemic inflammatory response by activating complement or via Fc{gamma}R-mediated neutrophil and macrophage activation. Activation of complement (C5) leads to injury both through formation of the membrane attack complex (C5b-9) or by generation of the anaphylatoxin and cell activator C5a. Neutrophils and macrophages cause tissue injury by the release of oxidants and proteases.'
p27445
assS'path:map05323'
p27446
(dp27447
S'NAME'
p27448
(lp27449
S'Rheumatoid arthritis'
p27450
asS'REFERENCE'
p27451
(lp27452
S'PMID:16127012'
p27453
ag27453
aS'AUTHORS'
p27454
aS'Zwerina J, Redlich K, Schett G, Smolen JS'
p27455
aS'TITLE'
p27456
aS'Pathogenesis of rheumatoid arthritis: targeting cytokines.'
p27457
aS'JOURNAL'
p27458
aS'Ann N Y Acad Sci 1051:716-29 (2005)'
p27459
aS'PMID:20036936'
p27460
ag27460
aS'AUTHORS'
p27461
aS'Szekanecz Z, Vegvari A, Szabo Z, Koch AE'
p27462
aS'TITLE'
p27463
aS'Chemokines and chemokine receptors in arthritis.'
p27464
aS'JOURNAL'
p27465
aS'Front Biosci (Schol Ed) 2:153-67 (2010)'
p27466
aS'PMID:20651747'
p27467
ag27467
aS'AUTHORS'
p27468
aS'Isaacs JD'
p27469
aS'TITLE'
p27470
aS'The changing face of rheumatoid arthritis: sustained remission for all?'
p27471
aS'JOURNAL'
p27472
aS'Nat Rev Immunol 10:605-11 (2010)'
p27473
aS'PMID:17195034'
p27474
ag27474
aS'AUTHORS'
p27475
aS'Strand V, Kimberly R, Isaacs JD'
p27476
aS'TITLE'
p27477
aS'Biologic therapies in rheumatology: lessons learned, future directions.'
p27478
aS'JOURNAL'
p27479
aS'Nat Rev Drug Discov 6:75-92 (2007)'
p27480
aS'PMID:20193003'
p27481
ag27481
aS'AUTHORS'
p27482
aS'Bartok B, Firestein GS'
p27483
aS'TITLE'
p27484
aS'Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.'
p27485
aS'JOURNAL'
p27486
aS'Immunol Rev 233:233-55 (2010)'
p27487
aS'PMID:17502360'
p27488
ag27488
aS'AUTHORS'
p27489
aS'Dai SM, Shan ZZ, Xu H, Nishioka K'
p27490
aS'TITLE'
p27491
aS'Cellular targets of interleukin-18 in rheumatoid arthritis.'
p27492
aS'JOURNAL'
p27493
aS'Ann Rheum Dis 66:1411-8 (2007)'
p27494
aS'PMID:9627005'
p27495
ag27495
aS'AUTHORS'
p27496
aS'Koch AE'
p27497
aS'TITLE'
p27498
aS'Review: angiogenesis: implications for rheumatoid arthritis.'
p27499
aS'JOURNAL'
p27500
aS'Arthritis Rheum 41:951-62 (1998)'
p27501
aS'PMID:20305562'
p27502
ag27502
aS'AUTHORS'
p27503
aS'Szekanecz Z, Besenyei T, Szentpetery A, Koch AE'
p27504
aS'TITLE'
p27505
aS'Angiogenesis and vasculogenesis in rheumatoid arthritis.'
p27506
aS'JOURNAL'
p27507
aS'Curr Opin Rheumatol 22:299-306 (2010)'
p27508
aS'PMID:15059264'
p27509
ag27509
aS'AUTHORS'
p27510
aS'Brunner-Weinzierl MC, Hoff H, Burmester GR'
p27511
aS'TITLE'
p27512
aS'Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases.'
p27513
aS'JOURNAL'
p27514
aS'Arthritis Res Ther 6:45-54 (2004)'
p27515
aS'PMID:11861618'
p27516
ag27516
aS'AUTHORS'
p27517
aS'Theill LE, Boyle WJ, Penninger JM'
p27518
aS'TITLE'
p27519
aS'RANK-L and RANK: T cells, bone loss, and mammalian evolution.'
p27520
aS'JOURNAL'
p27521
aS'Annu Rev Immunol 20:795-823 (2002)'
p27522
aS'PMID:19184540'
p27523
ag27523
aS'AUTHORS'
p27524
aS'Mensah KA, Li J, Schwarz EM'
p27525
aS'TITLE'
p27526
aS'The emerging field of osteoimmunology.'
p27527
aS'JOURNAL'
p27528
aS'Immunol Res (2009)'
p27529
aS'PMID:16313349'
p27530
ag27530
aS'AUTHORS'
p27531
aS'Takayanagi H, Sato K, Takaoka A, Taniguchi T'
p27532
aS'TITLE'
p27533
aS'Interplay between interferon and other cytokine systems in bone metabolism.'
p27534
aS'JOURNAL'
p27535
aS'Immunol Rev 208:181-93 (2005)'
p27536
aS'PMID:20392226'
p27537
ag27537
aS'AUTHORS'
p27538
aS'Takayanagi H'
p27539
aS'TITLE'
p27540
aS'New immune connections in osteoclast formation.'
p27541
aS'JOURNAL'
p27542
aS'Ann N Y Acad Sci 1192:117-23 (2010)'
p27543
aS'PMID:19585227'
p27544
ag27544
aS'AUTHORS'
p27545
aS'Nakashima T, Takayanagi H'
p27546
aS'TITLE'
p27547
aS'Osteoimmunology: crosstalk between the immune and bone systems.'
p27548
aS'JOURNAL'
p27549
aS'J Clin Immunol 29:555-67 (2009)'
p27550
aS'PMID:19455385'
p27551
ag27551
aS'AUTHORS'
p27552
aS'Nakashima T, Takayanagi H'
p27553
aS'TITLE'
p27554
aS'Osteoclasts and the immune system.'
p27555
aS'JOURNAL'
p27556
aS'J Bone Miner Metab 27:519-29 (2009)'
p27557
aS'PMID:17380158'
p27558
ag27558
aS'AUTHORS'
p27559
aS'Takayanagi H'
p27560
aS'TITLE'
p27561
aS'Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.'
p27562
aS'JOURNAL'
p27563
aS'Nat Rev Immunol 7:292-304 (2007)'
p27564
aS'PMID:20510236'
p27565
ag27565
aS'AUTHORS'
p27566
aS'Fox DA, Gizinski A, Morgan R, Lundy SK'
p27567
aS'TITLE'
p27568
aS'Cell-cell interactions in rheumatoid arthritis synovium.'
p27569
aS'JOURNAL'
p27570
aS'Rheum Dis Clin North Am 36:311-23 (2010)'
p27571
aS'PMID:15055519'
p27572
ag27572
aS'AUTHORS'
p27573
aS'Rho J, Takami M, Choi Y'
p27574
aS'TITLE'
p27575
aS'Osteoimmunology: interactions of the immune and skeletal systems.'
p27576
aS'JOURNAL'
p27577
aS'Mol Cells 17:1-9 (2004)'
p27578
asS'KO_PATHWAY'
p27579
(lp27580
S'ko05323'
p27581
asS'PATHWAY_MAP'
p27582
(lp27583
S'map05323'
p27584
asS'DISEASE'
p27585
(lp27586
S'H00436'
p27587
aS'Osteopetrosis'
p27588
ag27587
ag27588
aS'H00630'
p27589
aS'Rheumatoid arthritis'
p27590
asS'ENTRY'
p27591
(lp27592
S'map05323'
p27593
aS'Pathway'
p27594
asS'CLASS'
p27595
(lp27596
S'Human Diseases Immune diseases'
p27597
asS'DESCRIPTION'
p27598
(lp27599
S'Rheumatoid arthritis (RA) is a chronic autoimmune joint disease where persistent inflammation affects bone remodeling leading to progressive bone destruction. In RA, abnormal activation of the immune system elevates pro-inflammatory cytokines and chemokines levels, which can promote synovial angiogenesis and leukocyte infiltration. The synovium forms a hyperplastic pannus with infiltrated macrophage-like and fibroblast-like synoviocytes and invades joints by secreting proteinases and inducing osteoclast differentiation.'
p27600
assS'path:map07224'
p27601
(dp27602
S'ENTRY'
p27603
(lp27604
S'map07224'
p27605
aS'Drug'
p27606
aS'Pathway'
p27607
asS'PATHWAY_MAP'
p27608
(lp27609
S'map07224'
p27610
asS'NAME'
p27611
(lp27612
S'Opioid receptor agonists/antagonists'
p27613
asS'REFERENCE'
p27614
(lp27615
g22
ag22
aS'AUTHORS'
p27616
aS'Brunton LL, Lazo JS, Parker KL.'
p27617
aS'TITLE'
p27618
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics, eleventh edition"
p27619
aS'JOURNAL'
p27620
aS'McGraw-Hill (2005)'
p27621
ag22
ag22
aS'AUTHORS'
p27622
aS'Yamakawa K., Kanaoka Y., Iwasawa Y.'
p27623
aS'TITLE'
p27624
aS'[Medicinal Chemistry (5th ed)] (In Japanase)'
p27625
aS'JOURNAL'
p27626
aS'Kodansha Scientific'
p27627
asS'COMPOUND'
p27628
(lp27629
S'C16044'
p27630
aS'Nociceptin'
p27631
ag27630
ag27631
aS'C18010'
p27632
aS'Deltorphin A'
p27633
aS'C18095'
p27634
aS'Deltorphin B'
p27635
aS'C18097'
p27636
aS'Deltorphin C'
p27637
aS'C18128'
p27638
aS'Naltrindole'
p27639
aS'D00195'
p27640
aS'Codeine (USP)'
p27641
aS'D00320'
p27642
aS'Fentanyl (JAN/USAN/INN)'
p27643
aS'D00482'
p27644
aS'Propoxyphene hydrochloride (USP)'
p27645
aS'D00498'
p27646
aS'Pentazocine (JP16/USP/INN)'
p27647
aS'D00835'
p27648
aS'Alfentanil hydrochloride (USP)'
p27649
aS'D00836'
p27650
aS'Buprenorphine hydrochloride (JP16/USP)'
p27651
aS'D00837'
p27652
aS'Butorphanol tartrate (JAN/USP)'
p27653
aS'D00839'
p27654
aS'Hydromorphone hydrochloride (USP)'
p27655
aS'D00840'
p27656
aS'Levomethadyl acetate hydrochloride (USAN)'
p27657
aS'D00841'
p27658
aS'Levorphanol tartrate (USP)'
p27659
aS'D00842'
p27660
aS'Morphine sulfate hydrate (JP16)'
p27661
aS'D00843'
p27662
aS'Nalbuphine hydrochloride (USAN)'
p27663
aS'D00844'
p27664
aS'Oxymorphone hydrochloride (USP)'
p27665
aS'D00845'
p27666
aS'Sufentanil citrate (USP)'
p27667
aS'D00847'
p27668
aS'Oxycodone hydrochloride (USP)'
p27669
aS'D01177'
p27670
aS'Remifentanil hydrochloride (JAN/USAN)'
p27671
aS'D01340'
p27672
aS'Naloxone hydrochloride (JP16/USP)'
p27673
aS'D01355'
p27674
aS'Tramadol hydrochloride (JAN/USAN)'
p27675
aS'D01383'
p27676
aS'Pethidine hydrochloride (JP16)'
p27677
aS'D01399'
p27678
aS'Fentanyl citrate (JP16/USP)'
p27679
aS'D01481'
p27680
aS'Dihydrocodeine phosphate (JP16)'
p27681
aS'D01879'
p27682
aS'Eptazocine hydrobromide (JAN)'
p27683
aS'D02095'
p27684
aS'Naltrexone hydrochloride (USP)'
p27685
aS'D02101'
p27686
aS'Codeine phosphate hydrate (JP16)'
p27687
aS'D02102'
p27688
aS'Methadone hydrochloride (JAN/USP)'
p27689
aS'D02104'
p27690
aS'Nalmefene hydrochloride'
p27691
aS'D02111'
p27692
aS'Pentazocine lactate (USP)'
p27693
aS'D02227'
p27694
aS'Pentazocine hydrochloride (JAN/USP)'
p27695
aS'D02238'
p27696
aS'Levallorphan tartrate (JP16)'
p27697
aS'D02271'
p27698
aS'Morphine hydrochloride hydrate (JP16)'
p27699
aS'D02878'
p27700
aS'Alvimopan (USAN)'
p27701
aS'D03156'
p27702
aS'Brifentanil hydrochloride (USAN)'
p27703
aS'D03197'
p27704
aS'Butorphanol (USAN/INN)'
p27705
aS'D03405'
p27706
aS'Carfentanil citrate (USAN)'
p27707
aS'D03580'
p27708
aS'Codeine sulfate (USP)'
p27709
aS'D03618'
p27710
aS'Cyclazocine (USAN/INN)'
p27711
aS'D03725'
p27712
aS'Hydrocodone bitartrate (USP)'
p27713
aS'D03783'
p27714
aS'Oxycodone terephthalate (USP)'
p27715
aS'D03825'
p27716
aS'Dihydrocodeine bitartrate (USP)'
p27717
aS'D04461'
p27718
aS'Hydrocodone polistirex (USAN)'
p27719
aS'D04649'
p27720
aS'Ketazocine (USAN/INN)'
p27721
aS'D04716'
p27722
aS'Levomethadyl acetate (USAN)'
p27723
aS'D04764'
p27724
aS'Lofentanil oxalate (USAN)'
p27725
aS'D04973'
p27726
aS'Methadyl acetate (USAN)'
p27727
aS'D05048'
p27728
aS'Mirfentanil hydrochloride (USAN)'
p27729
aS'D05111'
p27730
aS'Nalmefene (USAN/INN)'
p27731
aS'D05113'
p27732
aS'Naltrexone (USAN/INN)'
p27733
aS'D05217'
p27734
aS'Ocfentanil hydrochloride (USAN)'
p27735
aS'D05312'
p27736
aS'Oxycodone (USAN/INN)'
p27737
aS'D05462'
p27738
aS'Oxycodone hydrochloride hydrate (JP16)'
p27739
aS'D05632'
p27740
aS'Propoxyphene napsylate (USAN)'
p27741
aS'D05907'
p27742
aS'Spiradoline mesylate (USAN)'
p27743
aS'D05938'
p27744
aS'Sufentanil (USAN/INN)'
p27745
aS'D06208'
p27746
aS'Trefentanil hydrochloride (USAN)'
p27747
aS'D06268'
p27748
aS'Trimeperidine (INN)'
p27749
aS'D06405'
p27750
aS'Nalfurafine hydrochloride (JAN)'
p27751
aS'D06618'
p27752
aS'Methylnaltrexone bromide (JAN/USAN)'
p27753
aS'D07122'
p27754
aS'Alfentanil (INN)'
p27755
aS'D07132'
p27756
aS'Buprenorphine (JAN/INN)'
p27757
aS'D07286'
p27758
aS'Diamorphine (BAN)'
p27759
aS'D07620'
p27760
aS'Carfentanil (INN)'
p27761
aS'D07740'
p27762
aS'Codeine hydrochloride'
p27763
aS'D07809'
p27764
aS'Dextropropoxyphene (INN)'
p27765
aS'D07810'
p27766
aS'Diacetylmorphine hydrochloride'
p27767
aS'D07831'
p27768
aS'Dihydrocodeine (INN)'
p27769
aS'D07832'
p27770
aS'Dihydrocodeine thiocyanate'
p27771
aS'D07863'
p27772
aS'Diprenorphine (INN)'
p27773
aS'D07864'
p27774
aS'Diprenorphine hydrochloride'
p27775
aS'D07904'
p27776
aS'Eptazocine (INN)'
p27777
aS'D08045'
p27778
aS'Hydrocodone (INN)'
p27779
aS'D08046'
p27780
aS'Hydrocodone hydrochloride'
p27781
aS'D08047'
p27782
aS'Hydromorphone (INN)'
p27783
aS'D08121'
p27784
aS'Levomethadone (INN)'
p27785
aS'D08122'
p27786
aS'Levomethadone hydrochloride'
p27787
aS'D08123'
p27788
aS'Levorphanol (INN)'
p27789
aS'D08195'
p27790
aS'Methadone (BAN)'
p27791
aS'D08233'
p27792
aS'Morphine (BAN)'
p27793
aS'D08234'
p27794
aS'Morphine tartrate'
p27795
aS'D08246'
p27796
aS'Nalbuphine (INN)'
p27797
aS'D08247'
p27798
aS'Nalorphine (INN)'
p27799
aS'D08248'
p27800
aS'Nalorphine hydrochloride (USP)'
p27801
aS'D08249'
p27802
aS'Naloxone (INN)'
p27803
aS'D08323'
p27804
aS'Oxymorphone (INN)'
p27805
aS'D08343'
p27806
aS'Pethidine (INN)'
p27807
aS'D08473'
p27808
aS'Remifentanil (INN)'
p27809
aS'D08623'
p27810
aS'Tramadol (INN)'
p27811
assS'path:map04130'
p27812
(dp27813
S'NAME'
p27814
(lp27815
S'SNARE interactions in vesicular transport'
p27816
asS'REFERENCE'
p27817
(lp27818
S'PMID:10839363'
p27819
ag27819
aS'AUTHORS'
p27820
aS'Scales SJ, Chen YA, Yoo BY, Patel SM, Doung YC, Scheller RH.'
p27821
aS'TITLE'
p27822
aS'SNAREs contribute to the specificity of membrane fusion.'
p27823
aS'JOURNAL'
p27824
aS'Neuron 26:457-64 (2000)'
p27825
aS'PMID:11737951'
p27826
ag27826
aS'AUTHORS'
p27827
aS'Teng FY, Wang Y, Tang BL.'
p27828
aS'TITLE'
p27829
aS'The syntaxins.'
p27830
aS'JOURNAL'
p27831
aS'Genome Biol 2:REVIEWS3012 (2001)'
p27832
aS'PMID:11115874'
p27833
ag27833
aS'AUTHORS'
p27834
aS'Sanderfoot AA, Assaad FF, Raikhel NV.'
p27835
aS'TITLE'
p27836
aS'The Arabidopsis genome. An abundance of soluble N-ethylmaleimide-sensitive factor adaptor protein receptors.'
p27837
aS'JOURNAL'
p27838
aS'Plant Physiol 124:1558-69 (2000)'
p27839
aS'PMID:15342965'
p27840
ag27840
aS'AUTHORS'
p27841
aS'Uemura T, Ueda T, Ohniwa RL, Nakano A, Takeyasu K, Sato MH.'
p27842
aS'TITLE'
p27843
aS'Systematic analysis of SNARE molecules in Arabidopsis: dissection of the post-Golgi network in plant cells.'
p27844
aS'JOURNAL'
p27845
aS'Cell Struct Funct 29:49-65 (2004)'
p27846
aS'PMID:10872468'
p27847
ag27847
aS'AUTHORS'
p27848
aS'Jahn R, Sudhof TC.'
p27849
aS'TITLE'
p27850
aS'Membrane fusion and exocytosis.'
p27851
aS'JOURNAL'
p27852
aS'Annu Rev Biochem 68:863-911 (1999)'
p27853
aS'PMID:11306253'
p27854
ag27854
aS'AUTHORS'
p27855
aS'Pelham HR.'
p27856
aS'TITLE'
p27857
aS'SNAREs and the specificity of membrane fusion.'
p27858
aS'JOURNAL'
p27859
aS'Trends Cell Biol 11:99-101 (2001)'
p27860
aS'PMID:11104523'
p27861
ag27861
aS'AUTHORS'
p27862
aS'Armstrong J'
p27863
aS'TITLE'
p27864
aS'Membrane traffic between genomes.'
p27865
aS'JOURNAL'
p27866
aS'Genome Biol 1:REVIEWS104 (2000)'
p27867
aS'PMID:11237004'
p27868
ag27868
aS'AUTHORS'
p27869
aS'Bock JB, Matern HT, Peden AA, Scheller RH.'
p27870
aS'TITLE'
p27871
aS'A genomic perspective on membrane compartment organization.'
p27872
aS'JOURNAL'
p27873
aS'Nature 409:839-41 (2001)'
p27874
aS'PMID:11252968'
p27875
ag27875
aS'AUTHORS'
p27876
aS'Chen YA, Scheller RH.'
p27877
aS'TITLE'
p27878
aS'SNARE-mediated membrane fusion.'
p27879
aS'JOURNAL'
p27880
aS'Nat Rev Mol Cell Biol 2:98-106 (2001)'
p27881
aS'PMID:9763449'
p27882
ag27882
aS'AUTHORS'
p27883
aS'Seron K, Tieaho V, Prescianotto-Baschong C, Aust T, Blondel MO, Guillaud P, Devilliers G, Rossanese OW, Glick BS, Riezman H, Keranen S, Haguenauer-Tsapis R.'
p27884
aS'TITLE'
p27885
aS'A yeast t-SNARE involved in endocytosis.'
p27886
aS'JOURNAL'
p27887
aS'Mol Biol Cell 9:2873-89 (1998)'
p27888
aS'PMID:10213783'
p27889
ag27889
aS'AUTHORS'
p27890
aS'Sanderfoot AA, Raikhel NV.'
p27891
aS'TITLE'
p27892
aS'The specificity of vesicle trafficking: coat proteins and SNAREs.'
p27893
aS'JOURNAL'
p27894
aS'Plant Cell 11:629-42 (1999)'
p27895
aS'PMID:9565594'
p27896
ag27896
aS'AUTHORS'
p27897
aS'Abeliovich H, Grote E, Novick P, Ferro-Novick S.'
p27898
aS'TITLE'
p27899
aS'Tlg2p, a yeast syntaxin homolog that resides on the Golgi and endocytic structures.'
p27900
aS'JOURNAL'
p27901
aS'J Biol Chem 273:11719-27 (1998)'
p27902
aS'PMID:9553086'
p27903
ag27903
aS'AUTHORS'
p27904
aS'Advani RJ, Bae HR, Bock JB, Chao DS, Doung YC, Prekeris R, Yoo JS, Scheller RH.'
p27905
aS'TITLE'
p27906
aS'Seven novel mammalian SNARE proteins localize to distinct membrane compartments.'
p27907
aS'JOURNAL'
p27908
aS'J Biol Chem 273:10317-24 (1998)'
p27909
aS'PMID:10459012'
p27910
ag27910
aS'AUTHORS'
p27911
aS'Advani RJ, Yang B, Prekeris R, Lee KC, Klumperman J, Scheller RH.'
p27912
aS'TITLE'
p27913
aS'VAMP-7 mediates vesicular transport from endosomes to lysosomes.'
p27914
aS'JOURNAL'
p27915
aS'J Cell Biol 146:765-76 (1999)'
p27916
aS'PMID:12893879'
p27917
ag27917
aS'AUTHORS'
p27918
aS'Burri L, Varlamov O, Doege CA, Hofmann K, Beilharz T, Rothman JE, Sollner TH, Lithgow T.'
p27919
aS'TITLE'
p27920
aS'A SNARE required for retrograde transport to the endoplasmic reticulum.'
p27921
aS'JOURNAL'
p27922
aS'Proc Natl Acad Sci U S A 100:9873-7 (2003)'
p27923
aS'PMID:10085287'
p27924
ag27924
aS'AUTHORS'
p27925
aS'Chao DS, Hay JC, Winnick S, Prekeris R, Klumperman J, Scheller RH.'
p27926
aS'TITLE'
p27927
aS'SNARE membrane trafficking dynamics in vivo.'
p27928
aS'JOURNAL'
p27929
aS'J Cell Biol 144:869-81 (1999)'
p27930
aS'PMID:10397773'
p27931
ag27931
aS'AUTHORS'
p27932
aS'Coe JG, Lim AC, Xu J, Hong W.'
p27933
aS'TITLE'
p27934
aS'A role for Tlg1p in the transport of proteins within the Golgi apparatus of Saccharomyces cerevisiae.'
p27935
aS'JOURNAL'
p27936
aS'Mol Biol Cell 10:2407-23 (1999)'
p27937
aS'PMID:11445562'
p27938
ag27938
aS'AUTHORS'
p27939
aS'Dilcher M, Kohler B, von Mollard GF.'
p27940
aS'TITLE'
p27941
aS'Genetic interactions with the yeast Q-SNARE VTI1 reveal novel functions for the R-SNARE YKT6.'
p27942
aS'JOURNAL'
p27943
aS'J Biol Chem 276:34537-44 (2001)'
p27944
aS'PMID:12853481'
p27945
ag27945
aS'AUTHORS'
p27946
aS'Dilcher M, Veith B, Chidambaram S, Hartmann E, Schmitt HD, Fischer von Mollard G.'
p27947
aS'TITLE'
p27948
aS'Use1p is a yeast SNARE protein required for retrograde traffic to the ER.'
p27949
aS'JOURNAL'
p27950
aS'EMBO J 22:3664-74 (2003)'
p27951
aS'PMID:9446565'
p27952
ag27952
aS'AUTHORS'
p27953
aS'Fischer von Mollard G, Stevens TH.'
p27954
aS'TITLE'
p27955
aS'A human homolog can functionally replace the yeast vesicle-associated SNARE Vti1p in two vesicle transport pathways.'
p27956
aS'JOURNAL'
p27957
aS'J Biol Chem 273:2624-30 (1998)'
p27958
aS'PMID:10359592'
p27959
ag27959
aS'AUTHORS'
p27960
aS'Fischer von Mollard G, Stevens TH.'
p27961
aS'TITLE'
p27962
aS'The Saccharomyces cerevisiae v-SNARE Vti1p is required for multiple membrane transport pathways to the vacuole.'
p27963
aS'JOURNAL'
p27964
aS'Mol Biol Cell 10:1719-32 (1999)'
p27965
aS'PMID:9614185'
p27966
ag27966
aS'AUTHORS'
p27967
aS'Galli T, Zahraoui A, Vaidyanathan VV, Raposo G, Tian JM, Karin M, Niemann H, Louvard D.'
p27968
aS'TITLE'
p27969
aS'A novel tetanus neurotoxin-insensitive vesicle-associated membrane protein in SNARE complexes of the apical plasma membrane of epithelial cells.'
p27970
aS'JOURNAL'
p27971
aS'Mol Biol Cell 9:1437-48 (1998)'
p27972
aS'PMID:11208059'
p27973
ag27973
aS'AUTHORS'
p27974
aS'Gerrard SR, Mecklem AB, Stevens TH.'
p27975
aS'TITLE'
p27976
aS'The yeast endosomal t-SNARE, Pep12p, functions in the absence of its transmembrane domain.'
p27977
aS'JOURNAL'
p27978
aS'Traffic 1:45-55 (2000)'
p27979
aS'PMID:10379359'
p27980
ag27980
aS'AUTHORS'
p27981
aS'Gerst JE.'
p27982
aS'TITLE'
p27983
aS'SNAREs and SNARE regulators in membrane fusion and exocytosis.'
p27984
aS'JOURNAL'
p27985
aS'Cell Mol Life Sci 55:707-34 (1999)'
p27986
aS'PMID:11029060'
p27987
ag27987
aS'AUTHORS'
p27988
aS'Gurunathan S, Chapman-Shimshoni D, Trajkovic S, Gerst JE.'
p27989
aS'TITLE'
p27990
aS'Yeast exocytic v-SNAREs confer endocytosis.'
p27991
aS'JOURNAL'
p27992
aS'Mol Biol Cell 11:3629-43 (2000)'
p27993
aS'PMID:10788491'
p27994
ag27994
aS'AUTHORS'
p27995
aS'Hatsuzawa K, Hirose H, Tani K, Yamamoto A, Scheller RH, Tagaya M.'
p27996
aS'TITLE'
p27997
aS'Syntaxin 18, a SNAP receptor that functions in the endoplasmic reticulum, intermediate compartment, and cis-Golgi vesicle trafficking.'
p27998
aS'JOURNAL'
p27999
aS'J Biol Chem 275:13713-20 (2000)'
p28000
aS'PMID:8621431'
p28001
ag28001
aS'AUTHORS'
p28002
aS'Hay JC, Hirling H, Scheller RH.'
p28003
aS'TITLE'
p28004
aS'Mammalian vesicle trafficking proteins of the endoplasmic reticulum and Golgi apparatus.'
p28005
aS'JOURNAL'
p28006
aS'J Biol Chem 271:5671-9 (1996)'
p28007
aS'PMID:9647643'
p28008
ag28008
aS'AUTHORS'
p28009
aS'Hay JC, Klumperman J, Oorschot V, Steegmaier M, Kuo CS, Scheller RH.'
p28010
aS'TITLE'
p28011
aS'Localization, dynamics, and protein interactions reveal distinct roles for ER and Golgi SNAREs.'
p28012
aS'JOURNAL'
p28013
aS'J Cell Biol 141:1489-502 (1998)'
p28014
aS'PMID:9427746'
p28015
ag28015
aS'AUTHORS'
p28016
aS'Holthuis JC, Nichols BJ, Dhruvakumar S, Pelham HR.'
p28017
aS'TITLE'
p28018
aS'Two syntaxin homologues in the TGN/endosomal system of yeast.'
p28019
aS'JOURNAL'
p28020
aS'EMBO J 17:113-26 (1998)'
p28021
aS'PMID:9843576'
p28022
ag28022
aS'AUTHORS'
p28023
aS'Holthuis JC, Nichols BJ, Pelham HR.'
p28024
aS'TITLE'
p28025
aS'The syntaxin Tlg1p mediates trafficking of chitin synthase III to polarized growth sites in yeast.'
p28026
aS'JOURNAL'
p28027
aS'Mol Biol Cell 9:3383-97 (1998)'
p28028
aS'PMID:12600315'
p28029
ag28029
aS'AUTHORS'
p28030
aS'Jahn R, Lang T, Sudhof TC.'
p28031
aS'TITLE'
p28032
aS'Membrane fusion.'
p28033
aS'JOURNAL'
p28034
aS'Cell 112:519-33 (2003)'
p28035
aS'PMID:10097106'
p28036
ag28036
aS'AUTHORS'
p28037
aS'Lafont F, Verkade P, Galli T, Wimmer C, Louvard D, Simons K.'
p28038
aS'TITLE'
p28039
aS'Raft association of SNAP receptors acting in apical trafficking in Madin-Darby canine kidney cells.'
p28040
aS'JOURNAL'
p28041
aS'Proc Natl Acad Sci U S A 96:3734-8 (1999)'
p28042
aS'PMID:9214619'
p28043
ag28043
aS'AUTHORS'
p28044
aS'Lewis MJ, Rayner JC, Pelham HR.'
p28045
aS'TITLE'
p28046
aS'A novel SNARE complex implicated in vesicle fusion with the endoplasmic reticulum.'
p28047
aS'JOURNAL'
p28048
aS'EMBO J 16:3017-24 (1997)'
p28049
aS'PMID:9647644'
p28050
ag28050
aS'AUTHORS'
p28051
aS'Low SH, Chapin SJ, Wimmer C, Whiteheart SW, Komuves LG, Mostov KE, Weimbs T.'
p28052
aS'TITLE'
p28053
aS'The SNARE machinery is involved in apical plasma membrane trafficking in MDCK cells.'
p28054
aS'JOURNAL'
p28055
aS'J Cell Biol 141:1503-13 (1998)'
p28056
aS'PMID:9452464'
p28057
ag28057
aS'AUTHORS'
p28058
aS'Low SH, Roche PA, Anderson HA, van Ijzendoorn SC, Zhang M, Mostov KE, Weimbs T.'
p28059
aS'TITLE'
p28060
aS'Targeting of SNAP-23 and SNAP-25 in polarized epithelial cells.'
p28061
aS'JOURNAL'
p28062
aS'J Biol Chem 273:3422-30 (1998)'
p28063
aS'PMID:12669082'
p28064
ag28064
aS'AUTHORS'
p28065
aS'Mostov K, Su T, ter Beest M.'
p28066
aS'TITLE'
p28067
aS'Polarized epithelial membrane traffic: conservation and plasticity.'
p28068
aS'JOURNAL'
p28069
aS'Nat Cell Biol 5:287-93 (2003)'
p28070
aS'PMID:10873817'
p28071
ag28071
aS'AUTHORS'
p28072
aS'Mostov KE, Verges M, Altschuler Y.'
p28073
aS'TITLE'
p28074
aS'Membrane traffic in polarized epithelial cells.'
p28075
aS'JOURNAL'
p28076
aS'Curr Opin Cell Biol 12:483-90 (2000)'
p28077
aS'PMID:10982406'
p28078
ag28078
aS'AUTHORS'
p28079
aS'Mullock BM, Smith CW, Ihrke G, Bright NA, Lindsay M, Parkinson EJ, Brooks DA, Parton RG, James DE, Luzio JP, Piper RC.'
p28080
aS'TITLE'
p28081
aS'Syntaxin 7 is localized to late endosome compartments, associates with Vamp 8, and Is required for late endosome-lysosome fusion.'
p28082
aS'JOURNAL'
p28083
aS'Mol Biol Cell 11:3137-53 (2000)'
p28084
aS'PMID:9817754'
p28085
ag28085
aS'AUTHORS'
p28086
aS'Prekeris R, Klumperman J, Chen YA, Scheller RH.'
p28087
aS'TITLE'
p28088
aS'Syntaxin 13 mediates cycling of plasma membrane proteins via tubulovesicular recycling endosomes.'
p28089
aS'JOURNAL'
p28090
aS'J Cell Biol 143:957-71 (1998)'
p28091
aS'PMID:10564279'
p28092
ag28092
aS'AUTHORS'
p28093
aS'Prekeris R, Yang B, Oorschot V, Klumperman J, Scheller RH.'
p28094
aS'TITLE'
p28095
aS'Differential roles of syntaxin 7 and syntaxin 8 in endosomal trafficking.'
p28096
aS'JOURNAL'
p28097
aS'Mol Biol Cell 10:3891-908 (1999)'
p28098
aS'PMID:9707576'
p28099
ag28099
aS'AUTHORS'
p28100
aS'Sanderfoot AA, Ahmed SU, Marty-Mazars D, Rapoport I, Kirchhausen T, Marty F, Raikhel NV.'
p28101
aS'TITLE'
p28102
aS'A putative vacuolar cargo receptor partially colocalizes with AtPEP12p on a prevacuolar compartment in Arabidopsis roots.'
p28103
aS'JOURNAL'
p28104
aS'Proc Natl Acad Sci U S A 95:9920-5 (1998)'
p28105
aS'PMID:11739776'
p28106
ag28106
aS'AUTHORS'
p28107
aS'Sanderfoot AA, Kovaleva V, Bassham DC, Raikhel NV.'
p28108
aS'TITLE'
p28109
aS'Interactions between syntaxins identify at least five SNARE complexes within the Golgi/prevacuolar system of the Arabidopsis cell.'
p28110
aS'JOURNAL'
p28111
aS'Mol Biol Cell 12:3733-43 (2001)'
p28112
aS'PMID:10557242'
p28113
ag28113
aS'AUTHORS'
p28114
aS'Sanderfoot AA, Kovaleva V, Zheng H, Raikhel NV.'
p28115
aS'TITLE'
p28116
aS'The t-SNARE AtVAM3p resides on the prevacuolar compartment in Arabidopsis root cells.'
p28117
aS'JOURNAL'
p28118
aS'Plant Physiol 121:929-38 (1999)'
p28119
aS'PMID:11251103'
p28120
ag28120
aS'AUTHORS'
p28121
aS'Sanderfoot AA, Pilgrim M, Adam L, Raikhel NV.'
p28122
aS'TITLE'
p28123
aS'Disruption of individual members of Arabidopsis syntaxin gene families indicates each has essential functions.'
p28124
aS'JOURNAL'
p28125
aS'Plant Cell 13:659-66 (2001)'
p28126
aS'PMID:9305917'
p28127
ag28127
aS'AUTHORS'
p28128
aS'Sato MH, Nakamura N, Ohsumi Y, Kouchi H, Kondo M, Hara-Nishimura I, Nishimura M, Wada Y.'
p28129
aS'TITLE'
p28130
aS'The AtVAM3 encodes a syntaxin-related molecule implicated in the vacuolar assembly in Arabidopsis thaliana.'
p28131
aS'JOURNAL'
p28132
aS'J Biol Chem 272:24530-5 (1997)'
p28133
aS'PMID:9710615'
p28134
ag28134
aS'AUTHORS'
p28135
aS'Sato TK, Darsow T, Emr SD.'
p28136
aS'TITLE'
p28137
aS'Vam7p, a SNAP-25-like molecule, and Vam3p, a syntaxin homolog, function together in yeast vacuolar protein trafficking.'
p28138
aS'JOURNAL'
p28139
aS'Mol Cell Biol 18:5308-19 (1998)'
p28140
aS'PMID:9813082'
p28141
ag28141
aS'AUTHORS'
p28142
aS'Spang A, Schekman R.'
p28143
aS'TITLE'
p28144
aS'Reconstitution of retrograde transport from the Golgi to the ER in vitro.'
p28145
aS'JOURNAL'
p28146
aS'J Cell Biol 143:589-99 (1998)'
p28147
aS'PMID:10359608'
p28148
ag28148
aS'AUTHORS'
p28149
aS'Steegmaier M, Klumperman J, Foletti DL, Yoo JS, Scheller RH.'
p28150
aS'TITLE'
p28151
aS'Vesicle-associated membrane protein 4 is implicated in trans-Golgi network vesicle trafficking.'
p28152
aS'JOURNAL'
p28153
aS'Mol Biol Cell 10:1957-72 (1999)'
p28154
aS'PMID:11208143'
p28155
ag28155
aS'AUTHORS'
p28156
aS'Steegmaier M, Lee KC, Prekeris R, Scheller RH.'
p28157
aS'TITLE'
p28158
aS'SNARE protein trafficking in polarized MDCK cells.'
p28159
aS'JOURNAL'
p28160
aS'Traffic 1:553-60 (2000)'
p28161
aS'PMID:9852078'
p28162
ag28162
aS'AUTHORS'
p28163
aS'Steegmaier M, Yang B, Yoo JS, Huang B, Shen M, Yu S, Luo Y, Scheller RH.'
p28164
aS'TITLE'
p28165
aS'Three novel proteins of the syntaxin/SNAP-25 family.'
p28166
aS'JOURNAL'
p28167
aS'J Biol Chem 273:34171-9 (1998)'
p28168
aS'PMID:10683148'
p28169
ag28169
aS'AUTHORS'
p28170
aS'Subramaniam VN, Loh E, Horstmann H, Habermann A, Xu Y, Coe J, Griffiths G, Hong W.'
p28171
aS'TITLE'
p28172
aS'Preferential association of syntaxin 8 with the early endosome.'
p28173
aS'JOURNAL'
p28174
aS'J Cell Sci 113 ( Pt 6):997-1008 (2000)'
p28175
aS'PMID:9507000'
p28176
ag28176
aS'AUTHORS'
p28177
aS'Tang BL, Tan AE, Lim LK, Lee SS, Low DY, Hong W.'
p28178
aS'TITLE'
p28179
aS'Syntaxin 12, a member of the syntaxin family localized to the endosome.'
p28180
aS'JOURNAL'
p28181
aS'J Biol Chem 273:6944-50 (1998)'
p28182
aS'PMID:9628864'
p28183
ag28183
aS'AUTHORS'
p28184
aS'Ungermann C, Wickner W.'
p28185
aS'TITLE'
p28186
aS'Vam7p, a vacuolar SNAP-25 homolog, is required for SNARE complex integrity and vacuole docking and fusion.'
p28187
aS'JOURNAL'
p28188
aS'EMBO J 17:3269-76 (1998)'
p28189
aS'PMID:10036234'
p28190
ag28190
aS'AUTHORS'
p28191
aS'Valdez AC, Cabaniols JP, Brown MJ, Roche PA.'
p28192
aS'TITLE'
p28193
aS'Syntaxin 11 is associated with SNAP-23 on late endosomes and the trans-Golgi network.'
p28194
aS'JOURNAL'
p28195
aS'J Cell Sci 112 ( Pt 6):845-54 (1999)'
p28196
aS'PMID:9199167'
p28197
ag28197
aS'AUTHORS'
p28198
aS'von Mollard GF, Nothwehr SF, Stevens TH.'
p28199
aS'TITLE'
p28200
aS'The yeast v-SNARE Vti1p mediates two vesicle transport pathways through interactions with the t-SNAREs Sed5p and Pep12p.'
p28201
aS'JOURNAL'
p28202
aS'J Cell Biol 137:1511-24 (1997)'
p28203
aS'PMID:11278762'
p28204
ag28204
aS'AUTHORS'
p28205
aS'Wade N, Bryant NJ, Connolly LM, Simpson RJ, Luzio JP, Piper RC, James DE.'
p28206
aS'TITLE'
p28207
aS'Syntaxin 7 complexes with mouse Vps10p tail interactor 1b, syntaxin 6, vesicle-associated membrane protein (VAMP)8, and VAMP7 in b16 melanoma cells.'
p28208
aS'JOURNAL'
p28209
aS'J Biol Chem 276:19820-7 (2001)'
p28210
aS'PMID:11555414'
p28211
ag28211
aS'AUTHORS'
p28212
aS'Wendler F, Tooze S.'
p28213
aS'TITLE'
p28214
aS'Syntaxin 6: the promiscuous behaviour of a SNARE protein.'
p28215
aS'JOURNAL'
p28216
aS'Traffic 2:606-11 (2001)'
p28217
aS'PMID:9614193'
p28218
ag28218
aS'AUTHORS'
p28219
aS'Wong SH, Zhang T, Xu Y, Subramaniam VN, Griffiths G, Hong W.'
p28220
aS'TITLE'
p28221
aS'Endobrevin, a novel synaptobrevin/VAMP-like protein preferentially associated with the early endosome.'
p28222
aS'JOURNAL'
p28223
aS'Mol Biol Cell 9:1549-63 (1998)'
p28224
aS'PMID:11035026'
p28225
ag28225
aS'AUTHORS'
p28226
aS'Xu D, Joglekar AP, Williams AL, Hay JC.'
p28227
aS'TITLE'
p28228
aS'Subunit structure of a mammalian ER/Golgi SNARE complex.'
p28229
aS'JOURNAL'
p28230
aS'J Biol Chem 275:39631-9 (2000)'
p28231
aS'PMID:11323436'
p28232
ag28232
aS'AUTHORS'
p28233
aS'Zhang T, Hong W.'
p28234
aS'TITLE'
p28235
aS'Ykt6 forms a SNARE complex with syntaxin 5, GS28, and Bet1 and participates in a late stage in endoplasmic reticulum-Golgi transport.'
p28236
aS'JOURNAL'
p28237
aS'J Biol Chem 276:27480-7 (2001)'
p28238
aS'PMID:12068098'
p28239
ag28239
aS'AUTHORS'
p28240
aS'Zheng H, Bednarek SY, Sanderfoot AA, Alonso J, Ecker JR, Raikhel NV.'
p28241
aS'TITLE'
p28242
aS'NPSN11 is a cell plate-associated SNARE protein that interacts with the syntaxin KNOLLE.'
p28243
aS'JOURNAL'
p28244
aS'Plant Physiol 129:530-9 (2002)'
p28245
aS'PMID:10397763'
p28246
ag28246
aS'AUTHORS'
p28247
aS'Zheng H, von Mollard GF, Kovaleva V, Stevens TH, Raikhel NV.'
p28248
aS'TITLE'
p28249
aS'The plant vesicle-associated SNARE AtVTI1a likely mediates vesicle transport from the trans-Golgi network to the prevacuolar compartment.'
p28250
aS'JOURNAL'
p28251
aS'Mol Biol Cell 10:2251-64 (1999)'
p28252
asS'KO_PATHWAY'
p28253
(lp28254
S'ko04130'
p28255
asS'ENTRY'
p28256
(lp28257
S'map04130'
p28258
aS'Pathway'
p28259
asS'PATHWAY_MAP'
p28260
(lp28261
S'map04130'
p28262
asS'DISEASE'
p28263
(lp28264
S'H00244'
p28265
aS'Pseudohypoparathyroidism'
p28266
ag28265
ag28266
aS'H00799'
p28267
aS'Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome'
p28268
asS'CLASS'
p28269
(lp28270
S'Genetic Information Processing Folding, sorting and degradation'
p28271
assS'path:map07220'
p28272
(dp28273
S'ENTRY'
p28274
(lp28275
S'map07220'
p28276
aS'Drug'
p28277
aS'Pathway'
p28278
asS'PATHWAY_MAP'
p28279
(lp28280
S'map07220'
p28281
asS'NAME'
p28282
(lp28283
S'Cholinergic and anticholinergic drugs'
p28284
asS'REFERENCE'
p28285
(lp28286
g22
ag22
aS'AUTHORS'
p28287
aS'Bertram GK (ed).'
p28288
aS'TITLE'
p28289
aS'Basic & Clinical Pharmacology (9th ed)'
p28290
aS'JOURNAL'
p28291
aS'Lange (2004)'
p28292
ag22
ag22
aS'AUTHORS'
p28293
aS'Tanaka C, Kato R (eds).'
p28294
aS'TITLE'
p28295
aS'[New Pharmacology (4th ed)] (In Japanese)'
p28296
aS'JOURNAL'
p28297
aS'Nankodo (2002)'
p28298
ag22
ag22
aS'AUTHORS'
p28299
aS'Fukai S.'
p28300
aS'TITLE'
p28301
aS'[New Drugs Today (6th ed)] (In Japanese)'
p28302
aS'JOURNAL'
p28303
aS'Jiho (1995)'
p28304
ag22
ag22
aS'AUTHORS'
p28305
aS'Noguchi S, Hibino S (eds).'
p28306
aS'TITLE'
p28307
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p28308
aS'JOURNAL'
p28309
aS'Hirokawa (2002)'
p28310
ag22
ag22
aS'AUTHORS'
p28311
aS'David AW, Thomas LL, William OF.'
p28312
aS'TITLE'
p28313
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p28314
aS'JOURNAL'
p28315
aS'Lippincott Williams & Wilkins (2002)'
p28316
asS'COMPOUND'
p28317
(lp28318
S'C07473'
p28319
aS'Muscarine'
p28320
ag28319
ag28320
aS'C11760'
p28321
aS'Amprotropine'
p28322
aS'D00043'
p28323
aS'Isoflurophate (USP)'
p28324
aS'D00113'
p28325
aS'Atropine (USP)'
p28326
aS'D00138'
p28327
aS'Scopolamine (INN)'
p28328
aS'D00196'
p28329
aS'Physostigmine (USP)'
p28330
aS'D00397'
p28331
aS'Tropicamide (JP16/USP/INN)'
p28332
aS'D00481'
p28333
aS'Propantheline bromide (JP16/USP/INN)'
p28334
aS'D00487'
p28335
aS'Pyridostigmine bromide (JP16/USP/INN)'
p28336
aS'D00524'
p28337
aS'Carbachol (JAN/USP/INN)'
p28338
aS'D00525'
p28339
aS'Pilocarpine (JAN/USP)'
p28340
aS'D00670'
p28341
aS'Donepezil hydrochloride (JP16/USAN)'
p28342
aS'D00715'
p28343
aS'Hyoscine methobromide (INN)'
p28344
aS'D00717'
p28345
aS'Dicyclomine hydrochloride (JAN/USP)'
p28346
aS'D00720'
p28347
aS'Mepenzolate bromide (JP16/INN)'
p28348
aS'D00721'
p28349
aS'Methanthelinium bromide (INN)'
p28350
aS'D00774'
p28351
aS'Orphenadrine citrate (USP)'
p28352
aS'D00778'
p28353
aS'Benztropine mesilate (JAN)'
p28354
aS'D00779'
p28355
aS'Biperiden (JAN/USP/INN)'
p28356
aS'D00787'
p28357
aS'Trihexyphenidyl hydrochloride (JP16/USP)'
p28358
aS'D00994'
p28359
aS'Edrophonium chloride (JP16/USP/INN)'
p28360
aS'D00995'
p28361
aS'Neostigmine bromide (JAN/USP/INN)'
p28362
aS'D00998'
p28363
aS'Neostigmine methylsulfate (JP16/USP)'
p28364
aS'D00999'
p28365
aS'Acetylcholine chloride (JP16/USP/INN)'
p28366
aS'D01000'
p28367
aS'Bethanechol chloride (JP16/USP)'
p28368
aS'D01001'
p28369
aS'Ambenonium chloride (JP16/INN)'
p28370
aS'D01002'
p28371
aS'Cyclopentolate hydrochloride (JP16/USP)'
p28372
aS'D01004'
p28373
aS'Homatropine hydrobromide (JP16/USP)'
p28374
aS'D01007'
p28375
aS'Propiverine hydrochloride (JP16)'
p28376
aS'D01103'
p28377
aS'Trospium chloride (JAN/USAN/INN)'
p28378
aS'D01165'
p28379
aS'Piperidolate hydrochloride (JAN)'
p28380
aS'D01201'
p28381
aS'Tiemonium iodide (JAN/INN)'
p28382
aS'D01297'
p28383
aS'Pirenzepine hydrochloride (USAN)'
p28384
aS'D01315'
p28385
aS'Methylbenactyzium bromide (JP16/INN)'
p28386
aS'D01451'
p28387
aS'Scopolamine butylbromide (JP16)'
p28388
aS'D01491'
p28389
aS'Butropium bromide (JP16/INN)'
p28390
aS'D01600'
p28391
aS'Diphenylpiperidinomethyldioxolan iodide (JAN)'
p28392
aS'D01815'
p28393
aS'Oxapium iodide (JP16/INN)'
p28394
aS'D01929'
p28395
aS'Tiotropium bromide hydrate (JAN)'
p28396
aS'D01946'
p28397
aS'Oxitropium bromide (JAN/INN)'
p28398
aS'D01976'
p28399
aS'N-Methylscopolamine methylsulfate (JAN)'
p28400
aS'D02068'
p28401
aS'Tacrine hydrochloride (USP)'
p28402
aS'D02069'
p28403
aS'Atropine sulfate (JP16/USP)'
p28404
aS'D02071'
p28405
aS'Scopolamine hydrobromide hydrate (JP16)'
p28406
aS'D02173'
p28407
aS'Galantamine hydrobromide (JAN/USAN)'
p28408
aS'D02193'
p28409
aS'Ecothiopate iodide (JP16/INN)'
p28410
aS'D02200'
p28411
aS'Pilocarpine hydrochloride (JP16/USP)'
p28412
aS'D02212'
p28413
aS'Ipratropium bromide hydrate (JP16)'
p28414
aS'D02246'
p28415
aS'Biperiden hydrochloride (JP16/USP)'
p28416
aS'D02247'
p28417
aS'Biperiden lactate (JAN/USP)'
p28418
aS'D02418'
p28419
aS'Physostigmine salicylate (JAN/USP)'
p28420
aS'D02535'
p28421
aS'Timepidium bromide hydrate (JP16)'
p28422
aS'D02558'
p28423
aS'Rivastigmine tartrate'
p28424
aS'D02599'
p28425
aS'Orphenadrine hydrochloride'
p28426
aS'D02772'
p28427
aS'Adiphenine hydrochloride (USAN)'
p28428
aS'D03822'
p28429
aS'Rivastigmine (JAN/USAN/INN)'
p28430
aS'D03826'
p28431
aS'Physostigmine sulfate (USP)'
p28432
aS'D04116'
p28433
aS'Eucatropine hydrochloride (USP XXXII)'
p28434
aS'D04292'
p28435
aS'Galantamine (USAN/INN)'
p28436
aS'D04970'
p28437
aS'Methacholine chloride (USAN/INN)'
p28438
aS'D05276'
p28439
aS'Pirenzepine hydrochloride hydrate (JP16)'
p28440
aS'D05478'
p28441
aS'Pilocarpine nitrate (USP)'
p28442
aS'D06000'
p28443
aS'Talsaclidine fumarate (USAN)'
p28444
aS'D06330'
p28445
aS'Xanomeline (USAN)'
p28446
aS'D06331'
p28447
aS'Xanomeline tartrate (USAN)'
p28448
aS'D07511'
p28449
aS'Benzatropine (INN)'
p28450
aS'D07759'
p28451
aS'Cyclopentolate (INN)'
p28452
aS'D07820'
p28453
aS'Dicycloverine (INN)'
p28454
aS'D07869'
p28455
aS'Donepezil (INN)'
p28456
aS'D08261'
p28457
aS'Neostigmine (BAN)'
p28458
aS'D08305'
p28459
aS'Orphenadrine (INN)'
p28460
aS'D08376'
p28461
aS'Pilocarpine borate'
p28462
aS'D08382'
p28463
aS'Piperidolate (INN)'
p28464
aS'D08389'
p28465
aS'Pirenzepine (INN)'
p28466
aS'D08441'
p28467
aS'Propiverine (INN)'
p28468
aS'D08555'
p28469
aS'Tacrine (INN)'
p28470
aS'D08595'
p28471
aS'Tiemonium methylsulfate'
p28472
aS'D08638'
p28473
aS'Trihexyphenidyl (INN)'
p28474
assS'path:map04914'
p28475
(dp28476
S'NAME'
p28477
(lp28478
S'Progesterone-mediated oocyte maturation'
p28479
asS'REFERENCE'
p28480
(lp28481
S'PMID:12045215'
p28482
ag28482
aS'AUTHORS'
p28483
aS'Schmitt A, Nebreda AR.'
p28484
aS'TITLE'
p28485
aS'Signalling pathways in oocyte meiotic maturation.'
p28486
aS'JOURNAL'
p28487
aS'J Cell Sci 115:2457-9 (2002)'
p28488
aS'PMID:12084906'
p28489
ag28489
aS'AUTHORS'
p28490
aS'Cato AC, Nestl A, Mink S.'
p28491
aS'TITLE'
p28492
aS'Rapid actions of steroid receptors in cellular signaling pathways.'
p28493
aS'JOURNAL'
p28494
aS'Sci STKE 2002:RE9 (2002)'
p28495
aS'PMID:11730319'
p28496
ag28496
aS'AUTHORS'
p28497
aS'Maller JL, Schwab MS, Roberts BT, Gross SD, Taieb FE, Tunquist BJ.'
p28498
aS'TITLE'
p28499
aS'The pathway of MAP kinase mediation of CSF arrest in Xenopus oocytes.'
p28500
aS'JOURNAL'
p28501
aS'Biol Cell 93:27-33 (2001)'
p28502
aS'PMID:11063930'
p28503
ag28503
aS'AUTHORS'
p28504
aS'Nebreda AR, Ferby I.'
p28505
aS'TITLE'
p28506
aS'Regulation of the meiotic cell cycle in oocytes.'
p28507
aS'JOURNAL'
p28508
aS'Curr Opin Cell Biol 12:666-75 (2000)'
p28509
aS'PMID:10497333'
p28510
ag28510
aS'AUTHORS'
p28511
aS'Ferrell JE Jr.'
p28512
aS'TITLE'
p28513
aS'Xenopus oocyte maturation: new lessons from a good egg.'
p28514
aS'JOURNAL'
p28515
aS'Bioessays 21:833-42 (1999)'
p28516
aS'PMID:12374568'
p28517
ag28517
aS'AUTHORS'
p28518
aS'Andersen CB, Sakaue H, Nedachi T, Kovacina KS, Clayberger C, Conti M, Roth RA.'
p28519
aS'TITLE'
p28520
aS'Protein kinase B/Akt is essential for the insulin- but not progesterone-stimulated resumption of meiosis in Xenopus oocytes.'
p28521
aS'JOURNAL'
p28522
aS'Biochem J 369:227-38 (2003)'
p28523
aS'PMID:12477927'
p28524
ag28524
aS'AUTHORS'
p28525
aS'Duckworth BC, Weaver JS, Ruderman JV.'
p28526
aS'TITLE'
p28527
aS'G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A.'
p28528
aS'JOURNAL'
p28529
aS'Proc Natl Acad Sci U S A 99:16794-9 (2002)'
p28530
aS'PMID:11148128'
p28531
ag28531
aS'AUTHORS'
p28532
aS'Abrieu A, Doree M, Fisher D.'
p28533
aS'TITLE'
p28534
aS'The interplay between cyclin-B-Cdc2 kinase (MPF) and MAP kinase during maturation of oocytes.'
p28535
aS'JOURNAL'
p28536
aS'J Cell Sci 114:257-67 (2001)'
p28537
asS'KO_PATHWAY'
p28538
(lp28539
S'ko04914'
p28540
asS'PATHWAY_MAP'
p28541
(lp28542
S'map04914'
p28543
asS'DISEASE'
p28544
(lp28545
S'H01274'
p28546
aS'Growth delay due to insulin-like growth factor I resistance'
p28547
asS'MODULE'
p28548
(lp28549
S'M00389'
p28550
aS'APC/C complex [PATH:map04914]'
p28551
asS'DBLINKS'
p28552
(lp28553
S'GO: 0001556'
p28554
asS'ENTRY'
p28555
(lp28556
S'map04914'
p28557
aS'Pathway'
p28558
asS'CLASS'
p28559
(lp28560
S'Organismal Systems Endocrine system'
p28561
asS'DESCRIPTION'
p28562
(lp28563
S'Xenopus oocytes are naturally arrested at G2 of meiosis I. Exposure to either insulin/IGF-1 or the steroid hormone progesterone breaks this arrest and induces resumption of the two meiotic division cycles and maturation of the oocyte into a mature, fertilizable egg. This process is termed oocyte maturation. The transition is accompanied by an increase in maturation promoting factor (MPF or Cdc2/cyclin B) which precedes germinal vesicle breakdown (GVBD). Most reports point towards the Mos-MEK1-ERK2 pathway [where ERK is an extracellular signal-related protein kinase, MEK is a MAPK/ERK kinase and Mos is a p42(MAPK) activator] and the polo-like kinase/CDC25 pathway as responsible for the activation of MPF in meiosis, most likely triggered by a decrease in cAMP.'
p28564
assS'path:map04915'
p28565
(dp28566
S'DESCRIPTION Estrogens are steroid hormones that regulate a plethora of physiological processes in mammals, including reproduction, cardiovascular protection, bone integrity, cellular homeostasis, and behavior. Estrogen mediates its cellular actions through two signaling pathways classified as'
p28567
(lp28568
S'"nuclear-initiated steroid signaling" and "membrane-initiated steroid signaling". In the "nuclear" pathway, estrogen binds either ERalpha or ERbeta, which in turn translocates to the nucleus, binds DNA at ERE elements and activates the expression of ERE-dependent genes. In "membrane" pathway, Estrogen can exert its actions through a subpopulation of ER at the plasma membrane (mER) or novel G-protein coupled E2 receptors (GPER). Upon activation of these receptors various signaling pathways (i.e. Ca2+, cAMP, protein kinase cascades) are rapidly activated and ultimately influence downstream transcription factors.'
p28569
asS'NAME'
p28570
(lp28571
S'Estrogen signaling pathway'
p28572
asS'REFERENCE'
p28573
(lp28574
S'PMID:16516516'
p28575
ag28575
aS'AUTHORS'
p28576
aS'Zhang D, Trudeau VL'
p28577
aS'TITLE'
p28578
aS'Integration of membrane and nuclear estrogen receptor signaling.'
p28579
aS'JOURNAL'
p28580
aS'Comp Biochem Physiol A Mol Integr Physiol 144:306-15 (2006)'
p28581
aS'PMID:19187465'
p28582
ag28582
aS'AUTHORS'
p28583
aS'Roepke TA, Qiu J, Bosch MA, Ronnekleiv OK, Kelly MJ'
p28584
aS'TITLE'
p28585
aS'Cross-talk between membrane-initiated and nuclear-initiated oestrogen signalling'
p28586
aS'in the hypothalamus.'
p28587
aS'JOURNAL'
p28588
aS'J Neuroendocrinol 21:263-70 (2009)'
p28589
aS'PMID:19700741'
p28590
ag28590
aS'AUTHORS'
p28591
aS'McCarthy MM'
p28592
aS'TITLE'
p28593
aS'The two faces of estradiol: effects on the developing brain.'
p28594
aS'JOURNAL'
p28595
aS'Neuroscientist 15:599-610 (2009)'
p28596
aS'PMID:18538919'
p28597
ag28597
aS'AUTHORS'
p28598
aS'Kelly MJ, Ronnekleiv OK'
p28599
aS'TITLE'
p28600
aS'Membrane-initiated estrogen signaling in hypothalamic neurons.'
p28601
aS'JOURNAL'
p28602
aS'Mol Cell Endocrinol 290:14-23 (2008)'
p28603
aS'PMID:16112267'
p28604
ag28604
aS'AUTHORS'
p28605
aS'Kelly MJ, Qiu J, Ronnekleiv OK'
p28606
aS'TITLE'
p28607
aS'Estrogen signaling in the hypothalamus.'
p28608
aS'JOURNAL'
p28609
aS'Vitam Horm 71:123-45 (2005)'
p28610
aS'PMID:18253054'
p28611
ag28611
aS'AUTHORS'
p28612
aS'Raz L, Khan MM, Mahesh VB, Vadlamudi RK, Brann DW'
p28613
aS'TITLE'
p28614
aS'Rapid estrogen signaling in the brain.'
p28615
aS'JOURNAL'
p28616
aS'Neurosignals 16:140-53 (2008)'
p28617
aS'PMID:15862823'
p28618
ag28618
aS'AUTHORS'
p28619
aS'Malyala A, Kelly MJ, Ronnekleiv OK'
p28620
aS'TITLE'
p28621
aS'Estrogen modulation of hypothalamic neurons: activation of multiple signaling pathways and gene expression changes.'
p28622
aS'JOURNAL'
p28623
aS'Steroids 70:397-406 (2005)'
p28624
aS'PMID:14573532'
p28625
ag28625
aS'AUTHORS'
p28626
aS'Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK, Kelly MJ'
p28627
aS'TITLE'
p28628
aS'Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C.'
p28629
aS'JOURNAL'
p28630
aS'J Neurosci 23:9529-40 (2003)'
p28631
aS'PMID:14993035'
p28632
ag28632
aS'AUTHORS'
p28633
aS'Kelly MJ, Qiu J, Ronnekleiv OK'
p28634
aS'TITLE'
p28635
aS'Estrogen modulation of G-protein-coupled receptor activation of potassium channels in the central nervous system.'
p28636
aS'JOURNAL'
p28637
aS'Ann N Y Acad Sci 1007:6-16 (2003)'
p28638
aS'PMID:19549587'
p28639
ag28639
aS'AUTHORS'
p28640
aS'Meyer MR, Haas E, Prossnitz ER, Barton M'
p28641
aS'TITLE'
p28642
aS'Non-genomic regulation of vascular cell function and growth by estrogen.'
p28643
aS'JOURNAL'
p28644
aS'Mol Cell Endocrinol 308:9-16 (2009)'
p28645
aS'PMID:20694192'
p28646
ag28646
aS'AUTHORS'
p28647
aS'do Nascimento GR, Barros YV, Wells AK, Khalil RA'
p28648
aS'TITLE'
p28649
aS'Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.'
p28650
aS'JOURNAL'
p28651
aS'Curr Hypertens Rev 5:283-306 (2009)'
p28652
aS'PMID:15695368'
p28653
ag28653
aS'AUTHORS'
p28654
aS'Bjornstrom L, Sjoberg M'
p28655
aS'TITLE'
p28656
aS'Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic'
p28657
aS'actions on target genes.'
p28658
aS'JOURNAL'
p28659
aS'Mol Endocrinol 19:833-42 (2005)'
p28660
aS'PMID:16270355'
p28661
ag28661
aS'AUTHORS'
p28662
aS'Manavathi B, Kumar R'
p28663
aS'TITLE'
p28664
aS'Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.'
p28665
aS'JOURNAL'
p28666
aS'J Cell Physiol 207:594-604 (2006)'
p28667
aS'PMID:21844907'
p28668
ag28668
aS'AUTHORS'
p28669
aS'Prossnitz ER, Barton M'
p28670
aS'TITLE'
p28671
aS'The G-protein-coupled estrogen receptor GPER in health and disease.'
p28672
aS'JOURNAL'
p28673
aS'Nat Rev Endocrinol 7:715-26 (2011)'
p28674
aS'PMID:21742056'
p28675
ag28675
aS'AUTHORS'
p28676
aS'Meyer MR, Prossnitz ER, Barton M'
p28677
aS'TITLE'
p28678
aS'The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.'
p28679
aS'JOURNAL'
p28680
aS'Vascul Pharmacol 55:17-25 (2011)'
p28681
aS'PMID:19767412'
p28682
ag28682
aS'AUTHORS'
p28683
aS'Maggiolini M, Picard D'
p28684
aS'TITLE'
p28685
aS'The unfolding stories of GPR30, a new membrane-bound estrogen receptor.'
p28686
aS'JOURNAL'
p28687
aS'J Endocrinol 204:105-14 (2010)'
p28688
aS'PMID:19464786'
p28689
ag28689
aS'AUTHORS'
p28690
aS'Prossnitz ER, Maggiolini M'
p28691
aS'TITLE'
p28692
aS'Mechanisms of estrogen signaling and gene expression via GPR30.'
p28693
aS'JOURNAL'
p28694
aS'Mol Cell Endocrinol 308:32-8 (2009)'
p28695
aS'PMID:12650715'
p28696
ag28696
aS'AUTHORS'
p28697
aS'Kelly MJ, Qiu J, Wagner EJ, Ronnekleiv OK'
p28698
aS'TITLE'
p28699
aS'Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS).'
p28700
aS'JOURNAL'
p28701
aS'J Steroid Biochem Mol Biol 83:187-93 (2002)'
p28702
aS'PMID:9278514'
p28703
ag28703
aS'AUTHORS'
p28704
aS'Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS'
p28705
aS'TITLE'
p28706
aS'Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.'
p28707
aS'JOURNAL'
p28708
aS'Science 277:1508-10 (1997)'
p28709
aS'PMID:12421825'
p28710
ag28710
aS'AUTHORS'
p28711
aS'Razandi M, Pedram A, Park ST, Levin ER'
p28712
aS'TITLE'
p28713
aS'Proximal events in signaling by plasma membrane estrogen receptors.'
p28714
aS'JOURNAL'
p28715
aS'J Biol Chem 278:2701-12 (2003)'
p28716
aS'PMID:18755790'
p28717
ag28717
aS'AUTHORS'
p28718
aS'Roepke TA, Xue C, Bosch MA, Scanlan TS, Kelly MJ, Ronnekleiv OK'
p28719
aS'TITLE'
p28720
aS'Genes associated with membrane-initiated signaling of estrogen and energy homeostasis.'
p28721
aS'JOURNAL'
p28722
aS'Endocrinology 149:6113-24 (2008)'
p28723
aS'PMID:21779010'
p28724
ag28724
aS'AUTHORS'
p28725
aS'Thomas C, Gustafsson JA'
p28726
aS'TITLE'
p28727
aS'The different roles of ER subtypes in cancer biology and therapy.'
p28728
aS'JOURNAL'
p28729
aS'Nat Rev Cancer 11:597-608 (2011)'
p28730
asS'KO_PATHWAY'
p28731
(lp28732
S'ko04915'
p28733
asS'PATHWAY_MAP'
p28734
(lp28735
S'map04915'
p28736
asS'DBLINKS'
p28737
(lp28738
S'GO: 0030520'
p28739
asS'ENTRY'
p28740
(lp28741
S'map04915'
p28742
aS'Pathway'
p28743
asS'CLASS'
p28744
(lp28745
S'Organismal Systems Endocrine system'
p28746
asS'DESCRIPTION'
p28747
(lp28748
S'Estrogens are steroid hormones that regulate a plethora of physiological processes in mammals, including reproduction, cardiovascular protection, bone integrity, cellular homeostasis, and behavior. Estrogen mediates its cellular actions through two signaling pathways classified as'
p28749
assS'path:map07230'
p28750
(dp28751
S'ENTRY'
p28752
(lp28753
S'map07230'
p28754
aS'Drug'
p28755
aS'Pathway'
p28756
asS'PATHWAY_MAP'
p28757
(lp28758
S'map07230'
p28759
asS'NAME'
p28760
(lp28761
S'GABA-A receptor agonists/antagonists'
p28762
asS'COMPOUND'
p28763
(lp28764
S'C07521'
p28765
aS'Thiopental'
p28766
ag28765
ag28766
aS'C09364'
p28767
aS'Bicuculline'
p28768
aS'C09529'
p28769
aS'Picrotoxinin'
p28770
aS'D00225'
p28771
aS'Alprazolam (JP16/USP/INN)'
p28772
aS'D00267'
p28773
aS'Chlordiazepoxide (JP16/USP/INN)'
p28774
aS'D00280'
p28775
aS'Clonazepam (JP16/USP/INN)'
p28776
aS'D00293'
p28777
aS'Diazepam (JP16/USP/INN)'
p28778
aS'D00311'
p28779
aS'Estazolam (JP16/USAN/INN)'
p28780
aS'D00329'
p28781
aS'Flurazepam (JAN/INN)'
p28782
aS'D00365'
p28783
aS'Lorazepam (JP16/USP/INN)'
p28784
aS'D00370'
p28785
aS'Temazepam (USP/INN)'
p28786
aS'D00387'
p28787
aS'Triazolam (JAN/USP/INN)'
p28788
aS'D00430'
p28789
aS'Secobarbital (USP/INN)'
p28790
aS'D00457'
p28791
aS'Quazepam (JAN/USP/INN)'
p28792
aS'D00464'
p28793
aS'Oxazepam (JAN/USP/INN)'
p28794
aS'D00470'
p28795
aS'Prazepam (JP16/USAN/INN)'
p28796
aS'D00474'
p28797
aS'Primidone (JP16/USP/INN)'
p28798
aS'D00499'
p28799
aS'Pentobarbital (USP/INN)'
p28800
aS'D00500'
p28801
aS'Pentobarbital sodium (JAN/USP)'
p28802
aS'D00506'
p28803
aS'Phenobarbital (JP16/USP/INN)'
p28804
aS'D00531'
p28805
aS'Nitrazepam (JP16/USAN/INN)'
p28806
aS'D00549'
p28807
aS'Propofol (JAN/USAN/INN)'
p28808
aS'D00550'
p28809
aS'Midazolam (JAN/USP/INN)'
p28810
aS'D00555'
p28811
aS'Amobarbital (JP16/INN)'
p28812
aS'D00693'
p28813
aS'Chlordiazepoxide hydrochloride (JAN/USP)'
p28814
aS'D00694'
p28815
aS'Clorazepate dipotassium (JP16/USP)'
p28816
aS'D00695'
p28817
aS'Flurazepam hydrochloride (USP)'
p28818
aS'D00696'
p28819
aS'Midazolam hydrochloride (USAN)'
p28820
aS'D00697'
p28821
aS'Flumazenil (JAN/USP/INN)'
p28822
aS'D00700'
p28823
aS'Mephobarbital (JAN/USP)'
p28824
aS'D00701'
p28825
aS'Phenobarbital sodium (JAN/USP/INN)'
p28826
aS'D00706'
p28827
aS'Zolpidem tartrate (JP16/USAN)'
p28828
aS'D00713'
p28829
aS'Thiamylal sodium (JP16)'
p28830
aS'D00714'
p28831
aS'Thiopental sodium (JP16/USP/INN)'
p28832
aS'D01071'
p28833
aS'Hexobarbital (JAN/INN)'
p28834
aS'D01230'
p28835
aS'Flunitrazepam (JP16/USAN/INN)'
p28836
aS'D01245'
p28837
aS'Bromazepam (JP16/USAN/INN)'
p28838
aS'D01254'
p28839
aS'Tofisopam (JP16/INN)'
p28840
aS'D01268'
p28841
aS'Cloxazolam (JP16/INN)'
p28842
aS'D01278'
p28843
aS'Oxazolam (JP16/INN)'
p28844
aS'D01279'
p28845
aS'Flutoprazepam (JP16/INN)'
p28846
aS'D01286'
p28847
aS'Flutazolam (JAN/INN)'
p28848
aS'D01292'
p28849
aS'Medazepam (JP16/INN)'
p28850
aS'D01293'
p28851
aS'Ethyl loflazepate (JAN/INN)'
p28852
aS'D01310'
p28853
aS'Secobarbital sodium (JAN/USP)'
p28854
aS'D01316'
p28855
aS'Mexazolam (JAN/INN)'
p28856
aS'D01328'
p28857
aS'Clotiazepam (JP16/INN)'
p28858
aS'D01354'
p28859
aS'Fludiazepam (JP16/INN)'
p28860
aS'D01372'
p28861
aS'Zopiclone (JAN/INN)'
p28862
aS'D01408'
p28863
aS'Flurazepam hydrochloride (JP16)'
p28864
aS'D01514'
p28865
aS'Etizolam (JP16/INN)'
p28866
aS'D01564'
p28867
aS'Rilmazafone hydrochloride hydrate (JAN)'
p28868
aS'D01593'
p28869
aS'Nimetazepam (JAN/INN)'
p28870
aS'D01657'
p28871
aS'Lormetazepam (JAN/USAN/INN)'
p28872
aS'D01740'
p28873
aS'Barbital (JP16/INN)'
p28874
aS'D01744'
p28875
aS'Brotizolam (JP16/USAN/INN)'
p28876
aS'D01758'
p28877
aS'Haloxazolam (JP16/INN)'
p28878
aS'D02252'
p28879
aS'Amobarbital sodium (JAN/USP)'
p28880
aS'D02253'
p28881
aS'Pentobarbital calcium (JP16)'
p28882
aS'D02618'
p28883
aS'Butobarbital (BAN)'
p28884
aS'D02624'
p28885
aS'Eszopiclone (JAN/USAN/INN)'
p28886
aS'D03562'
p28887
aS'Clorazepate monopotassium (USAN)'
p28888
aS'D04257'
p28889
aS'Fospropofol disodium (USAN)'
p28890
aS'D04882'
p28891
aS'Medazepam hydrochloride (USAN)'
p28892
aS'D05028'
p28893
aS'Midazolam maleate (USAN)'
p28894
aS'D06106'
p28895
aS'Thiamylal'
p28896
aS'D07409'
p28897
aS'Pentetrazol (INN)'
p28898
aS'D08356'
p28899
aS'Phenobarbital diethylamine'
p28900
aS'D08481'
p28901
aS'Rilmazafone (INN)'
p28902
aS'D08690'
p28903
aS'Zolpidem (INN)'
p28904
assS'path:map07231'
p28905
(dp28906
S'ENTRY'
p28907
(lp28908
S'map07231'
p28909
aS'Drug'
p28910
aS'Pathway'
p28911
asS'PATHWAY_MAP'
p28912
(lp28913
S'map07231'
p28914
asS'NAME'
p28915
(lp28916
S'Sodium channel blocking drugs'
p28917
asS'COMPOUND'
p28918
(lp28919
S'D00110'
p28920
aS'Cocaine (USP)'
p28921
ag28920
ag28921
aS'D00199'
p28922
aS'Ajmaline (JP16)'
p28923
aS'D00252'
p28924
aS'Carbamazepine (JP16/USP/INN)'
p28925
aS'D00303'
p28926
aS'Disopyramide (JP16/USAN/INN)'
p28927
aS'D00354'
p28928
aS'Lamotrigine (JAN/USAN/INN)'
p28929
aS'D00358'
p28930
aS'Lidocaine (JP16/USP/INN)'
p28931
aS'D00477'
p28932
aS'Procainamide hydrochloride (JP16/USP)'
p28933
aS'D00512'
p28934
aS'Phenytoin (JP16/USP/INN)'
p28935
aS'D00537'
p28936
aS'Topiramate (JAN/USAN/INN)'
p28937
aS'D00538'
p28938
aS'Zonisamide (JAN/USAN/INN)'
p28939
aS'D00551'
p28940
aS'Tetracaine (USP/INN)'
p28941
aS'D00552'
p28942
aS'Ethyl aminobenzoate (JP16)'
p28943
aS'D00553'
p28944
aS'Propitocaine (JAN)'
p28945
aS'D00631'
p28946
aS'Bepridil hydrochloride hydrate (JAN)'
p28947
aS'D00636'
p28948
aS'Amiodarone hydrochloride (JP16/USAN)'
p28949
aS'D00637'
p28950
aS'Disopyramide phosphate (JAN/USP)'
p28951
aS'D00638'
p28952
aS'Flecainide acetate (JP16/USP)'
p28953
aS'D00639'
p28954
aS'Mexiletine hydrochloride (JP16/USP)'
p28955
aS'D00640'
p28956
aS'Propafenone hydrochloride (JP16/USP)'
p28957
aS'D00642'
p28958
aS'Quinidine gluconate (USP)'
p28959
aS'D00643'
p28960
aS'Quinidine polygalacturonate'
p28961
aS'D00733'
p28962
aS'Dibucaine (USP)'
p28963
aS'D00738'
p28964
aS'Mepivacaine hydrochloride (JP16/USP)'
p28965
aS'D00740'
p28966
aS'Procaine hydrochloride (JP16/USP)'
p28967
aS'D00741'
p28968
aS'Tetracaine hydrochloride (JP16/USP)'
p28969
aS'D01287'
p28970
aS'Levobupivacaine hydrochloride (JAN/USAN)'
p28971
aS'D01326'
p28972
aS'Aprindine hydrochloride (JP16/USAN)'
p28973
aS'D01450'
p28974
aS'Bupivacaine hydrochloride hydrate (JP16)'
p28975
aS'D01455'
p28976
aS'Cibenzoline succinate (JP16)'
p28977
aS'D01479'
p28978
aS'Ambroxol hydrochloride (JAN)'
p28979
aS'D01554'
p28980
aS'Pilsicainide hydrochloride hydrate (JP16)'
p28981
aS'D01785'
p28982
aS'Pirmenol hydrochloride hydrate (JAN)'
p28983
aS'D02086'
p28984
aS'Lidocaine injection (JP16)'
p28985
aS'D02088'
p28986
aS'Tocainide hydrochloride (USP)'
p28987
aS'D02098'
p28988
aS'Proparacaine hydrochloride (USP)'
p28989
aS'D02103'
p28990
aS'Phenytoin sodium for injection (JP16)'
p28991
aS'D02182'
p28992
aS'Cocaine hydrochloride (JP16/USP)'
p28993
aS'D02220'
p28994
aS'Dibucaine hydrochloride (JP16/USP)'
p28995
aS'D02272'
p28996
aS'Quinidine sulfate hydrate (JP16)'
p28997
aS'D02537'
p28998
aS'Dronedarone (INN)'
p28999
aS'D02910'
p29000
aS'Amiodarone (USAN/INN)'
p29001
aS'D02969'
p29002
aS'Aprindine (USAN/INN)'
p29003
aS'D03492'
p29004
aS'Cifenline (USAN)'
p29005
aS'D03914'
p29006
aS'Dronedarone hydrochloride (USAN)'
p29007
aS'D04048'
p29008
aS'Ropivacaine hydrochloride hydrate (JAN)'
p29009
aS'D06172'
p29010
aS'Tocainide (USAN/INN)'
p29011
aS'D06517'
p29012
aS'Pirmenol hydrochloride (USAN)'
p29013
aS'D07442'
p29014
aS'Ambroxol (INN)'
p29015
aS'D07520'
p29016
aS'Bepridil (INN)'
p29017
aS'D07552'
p29018
aS'Bupivacaine (USAN/INN)'
p29019
aS'D07595'
p29020
aS'Fosphenytoin sodium hydrate (JAN)'
p29021
aS'D07962'
p29022
aS'Flecainide (INN)'
p29023
aS'D07993'
p29024
aS'Fosphenytoin (INN)'
p29025
aS'D08116'
p29026
aS'Levobupivacaine (INN)'
p29027
aS'D08127'
p29028
aS'Lidocaine hydrochloride monohydrate'
p29029
aS'D08181'
p29030
aS'Mepivacaine (INN)'
p29031
aS'D08215'
p29032
aS'Mexiletine (INN)'
p29033
aS'D08377'
p29034
aS'Pilsicainide (INN)'
p29035
aS'D08394'
p29036
aS'Pirmenol (INN)'
p29037
aS'D08421'
p29038
aS'Procainamide (INN)'
p29039
aS'D08422'
p29040
aS'Procaine (INN)'
p29041
aS'D08435'
p29042
aS'Propafenone (INN)'
p29043
aS'D08448'
p29044
aS'Proxymetacaine (INN)'
p29045
aS'D08458'
p29046
aS'Quinidine (BAN)'
p29047
aS'D08459'
p29048
aS'Quinidine phenylethylbarbiturate'
p29049
aS'D08490'
p29050
aS'Ropivacaine (INN)'
p29051
assS'path:map07232'
p29052
(dp29053
S'ENTRY'
p29054
(lp29055
S'map07232'
p29056
aS'Drug'
p29057
aS'Pathway'
p29058
asS'PATHWAY_MAP'
p29059
(lp29060
S'map07232'
p29061
asS'NAME'
p29062
(lp29063
S'Potassium channel blocking and opening drugs'
p29064
asS'REFERENCE'
p29065
(lp29066
S'PMID:16394574'
p29067
ag29067
aS'AUTHORS'
p29068
aS'Kurachi Y, Yamada M'
p29069
aS'TITLE'
p29070
aS'[Relationship between function and structure of ATP-sensitive K+ (KATP) channels].'
p29071
aS'JOURNAL'
p29072
aS'Nippon Yakurigaku Zasshi 126:311-6 (2005)'
p29073
aS'PMID:19491413'
p29074
ag29074
aS'AUTHORS'
p29075
aS'Sandhiya S, Dkhar SA'
p29076
aS'TITLE'
p29077
aS'Potassium channels in health, disease &amp development of channel modulators.'
p29078
aS'JOURNAL'
p29079
aS'Indian J Med Res 129:223-32 (2009)'
p29080
aS'PMID:18651412'
p29081
ag29081
aS'AUTHORS'
p29082
aS'Riera AR, Uchida AH, Ferreira C, Ferreira Filho C, Schapachnik E, Dubner S, Zhang L, Moffa PJ'
p29083
aS'TITLE'
p29084
aS'Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.'
p29085
aS'JOURNAL'
p29086
aS'Cardiol J 15:209-19 (2008)'
p29087
ag22
ag22
aS'AUTHORS'
p29088
aS'Kodama I, et. al'
p29089
aS'TITLE'
p29090
aS'[Guidelines for Drug Treatment of Arrhythmias (JCS 2009)] (in Japanese)'
p29091
aS'JOURNAL'
p29092
ag22
asS'COMPOUND'
p29093
(lp29094
S'C06855'
p29095
aS'Bretylium'
p29096
ag29095
ag29096
aS'C13729'
p29097
aS'Pinacidil'
p29098
aS'C13772'
p29099
aS'Clofilium'
p29100
aS'C13776'
p29101
aS'E-4031'
p29102
aS'C13777'
p29103
aS'Azimilide'
p29104
aS'C13820'
p29105
aS'Chromanol 293B'
p29106
aS'D00294'
p29107
aS'Diazoxide (JAN/USP/INN)'
p29108
aS'D00336'
p29109
aS'Glibenclamide (JP16/INN)'
p29110
aS'D00380'
p29111
aS'Tolbutamide (JP16/USP/INN)'
p29112
aS'D00418'
p29113
aS'Minoxidil (JAN/USP/INN)'
p29114
aS'D00521'
p29115
aS'Terfenadine (JAN/USAN/INN)'
p29116
aS'D00636'
p29117
aS'Amiodarone hydrochloride (JP16/USAN)'
p29118
aS'D00645'
p29119
aS'Bretylium tosylate (USP)'
p29120
aS'D00647'
p29121
aS'Dofetilide (JAN/USAN/INN)'
p29122
aS'D00648'
p29123
aS'Ibutilide fumarate (USAN)'
p29124
aS'D01026'
p29125
aS'Sotalol hydrochloride (JAN/USP)'
p29126
aS'D01810'
p29127
aS'Nicorandil (JP16/USAN/INN)'
p29128
aS'D01856'
p29129
aS'Nifekalant hydrochloride (JAN)'
p29130
aS'D02385'
p29131
aS'Levcromakalim (USAN/INN)'
p29132
aS'D02537'
p29133
aS'Dronedarone (INN)'
p29134
aS'D02910'
p29135
aS'Amiodarone (USAN/INN)'
p29136
aS'D03037'
p29137
aS'Azimilide dihydrochloride (USAN)'
p29138
aS'D03547'
p29139
aS'Clofilium phosphate (USAN/INN)'
p29140
aS'D03732'
p29141
aS'Dexsotalol hydrochloride (USAN)'
p29142
aS'D03914'
p29143
aS'Dronedarone hydrochloride (USAN)'
p29144
aS'D04955'
p29145
aS'Sematilide hydrochloride (USAN)'
p29146
aS'D05482'
p29147
aS'Pinacidil (USAN)'
p29148
aS'D06177'
p29149
aS'Tolbutamide sodium, sterile'
p29150
aS'D06652'
p29151
aS'Tedisamil (USAN)'
p29152
aS'D06653'
p29153
aS'Tedisamil sesquifumarate (USAN)'
p29154
aS'D07428'
p29155
aS'Bunaftine (INN)'
p29156
aS'D08060'
p29157
aS'Ibutilide (INN)'
p29158
aS'D08525'
p29159
aS'Sotalol (INN)'
p29160
aS'D09569'
p29161
aS'Ezogabine (USAN)'
p29162
aS'D09757'
p29163
aS'Terikalant (INN)'
p29164
assS'path:map07233'
p29165
(dp29166
S'ENTRY'
p29167
(lp29168
S'map07233'
p29169
aS'Drug'
p29170
aS'Pathway'
p29171
asS'PATHWAY_MAP'
p29172
(lp29173
S'map07233'
p29174
asS'NAME'
p29175
(lp29176
S'Ion transporter inhibitors'
p29177
asS'REFERENCE'
p29178
(lp29179
g22
ag22
aS'AUTHORS'
p29180
aS'Tanaka C., Kato R. (eds)'
p29181
aS'TITLE'
p29182
aS'[New pharmacology (revision 5th ed)] (In Japanese)'
p29183
aS'JOURNAL'
p29184
aS'Nankodo'
p29185
asS'COMPOUND'
p29186
(lp29187
S'D00112'
p29188
aS'G-Strophanthin (JAN)'
p29189
ag29188
ag29189
aS'D00247'
p29190
aS'Bumetanide (JP16/USP/INN)'
p29191
aS'D00272'
p29192
aS'Chlortalidone (JAN/INN)'
p29193
aS'D00297'
p29194
aS'Digitoxin (JP16/USP/INN)'
p29195
aS'D00298'
p29196
aS'Digoxin (JP16/USP)'
p29197
aS'D00313'
p29198
aS'Etacrynic acid (JP16/INN)'
p29199
aS'D00331'
p29200
aS'Furosemide (JP16/USP/INN)'
p29201
aS'D00340'
p29202
aS'Hydrochlorothiazide (JP16/USP/INN)'
p29203
aS'D00345'
p29204
aS'Indapamide (JP16/USP)'
p29205
aS'D00355'
p29206
aS'Lansoprazole (JAN/USP/INN)'
p29207
aS'D00382'
p29208
aS'Torasemide (JAN/INN)'
p29209
aS'D00431'
p29210
aS'Metolazone (JAN/USP/INN)'
p29211
aS'D00455'
p29212
aS'Omeprazole (JP16/USP/INN)'
p29213
aS'D00461'
p29214
aS'Quinethazone (JAN/INN)'
p29215
aS'D00519'
p29216
aS'Chlorothiazide (JAN/USP/INN)'
p29217
aS'D00658'
p29218
aS'Trichlormethiazide (JP16/USP/INN)'
p29219
aS'D00724'
p29220
aS'Sodium rabeprazole (JP16)'
p29221
aS'D01207'
p29222
aS'Omeprazole sodium (USAN)'
p29223
aS'D01240'
p29224
aS'Deslanoside (JP16/USP/INN)'
p29225
aS'D01246'
p29226
aS'Benzylhydrochlorothiazide (JAN)'
p29227
aS'D01323'
p29228
aS'Azosemide (JAN/USAN/INN)'
p29229
aS'D01379'
p29230
aS'Proscillaridin (JAN/USAN/INN)'
p29231
aS'D01605'
p29232
aS'Meticrane (JP16/INN)'
p29233
aS'D01634'
p29234
aS'Piretanide (JAN/USAN/INN)'
p29235
aS'D01877'
p29236
aS'Mefruside (JP16/USAN/INN)'
p29237
aS'D01895'
p29238
aS'Tripamide (JAN/USAN/INN)'
p29239
aS'D01920'
p29240
aS'Tenatoprazole (JAN/INN)'
p29241
aS'D01972'
p29242
aS'Lanatoside C (JP16/INN)'
p29243
aS'D01984'
p29244
aS'Esomeprazole magnesium hydrate (JAN)'
p29245
aS'D02587'
p29246
aS'Metildigoxin (JP16)'
p29247
aS'D02593'
p29248
aS'Pantoprazole Sodium Hydrate (JAN)'
p29249
aS'D04056'
p29250
aS'Esomeprazole sodium (USAN)'
p29251
aS'D04079'
p29252
aS'Ethacrynate sodium (USP)'
p29253
aS'D05093'
p29254
aS'Muzolimine (USAN/INN)'
p29255
aS'D05259'
p29256
aS'Omeprazole magnesium (USAN)'
p29257
aS'D05261'
p29258
aS'Omeprazole sodium injection (JAN)'
p29259
aS'D05353'
p29260
aS'Pantoprazole (USAN/INN)'
p29261
aS'D06401'
p29262
aS'Indapamide hydrate'
p29263
aS'D06881'
p29264
aS'Acetyldigitoxin (INN)'
p29265
aS'D07147'
p29266
aS'Gitoformate (INN)'
p29267
aS'D07555'
p29268
aS'Acetyldigoxin'
p29269
aS'D07556'
p29270
aS'beta-Acetyldigoxin'
p29271
aS'D07917'
p29272
aS'Esomeprazole (INN)'
p29273
aS'D07999'
p29274
aS'Sodium furosemide'
p29275
aS'D08001'
p29276
aS'Furosemide diolamine'
p29277
aS'D08463'
p29278
aS'Rabeprazole (INN)'
p29279
aS'D08619'
p29280
aS'Torasemide sodium'
p29281
aS'D09339'
p29282
aS'Esomeprazole potassium (USAN)'
p29283
aS'D09847'
p29284
aS'Metildigoxin (INN)'
p29285
assS'path:map07234'
p29286
(dp29287
S'ENTRY'
p29288
(lp29289
S'map07234'
p29290
aS'Drug'
p29291
aS'Pathway'
p29292
asS'PATHWAY_MAP'
p29293
(lp29294
S'map07234'
p29295
asS'NAME'
p29296
(lp29297
S'Neurotransmitter transporter inhibitors'
p29298
asS'REFERENCE'
p29299
(lp29300
g22
ag22
aS'AUTHORS'
p29301
aS'Tanaka C., Kato R. (eds)'
p29302
aS'TITLE'
p29303
aS'[New pharmacology (revision 5th ed)] (In Japanese)'
p29304
aS'JOURNAL'
p29305
aS'Nankodo'
p29306
asS'COMPOUND'
p29307
(lp29308
S'D00110'
p29309
aS'Cocaine (USP)'
p29310
ag29309
ag29310
aS'D00228'
p29311
aS'Amoxapine (JP16/USP/INN)'
p29312
aS'D00326'
p29313
aS'Fluoxetine (USAN/INN)'
p29314
aS'D00367'
p29315
aS'Mazindol (JAN/USP/INN)'
p29316
aS'D00394'
p29317
aS'Trimipramine (USAN/INN)'
p29318
aS'D00809'
p29319
aS'Amitriptyline hydrochloride (JP16/USP)'
p29320
aS'D00811'
p29321
aS'Clomipramine hydrochloride (JP16/USP)'
p29322
aS'D00812'
p29323
aS'Desipramine hydrochloride (JAN/USP)'
p29324
aS'D00815'
p29325
aS'Imipramine hydrochloride (JP16/USP)'
p29326
aS'D00816'
p29327
aS'Nortriptyline hydrochloride (JP16/USP/INN)'
p29328
aS'D00818'
p29329
aS'Maprotiline hydrochloride (JP16/USP)'
p29330
aS'D00820'
p29331
aS'Trazodone hydrochloride (JAN/USP)'
p29332
aS'D00821'
p29333
aS'Venlafaxine hydrochloride (JAN/USAN)'
p29334
aS'D00822'
p29335
aS'Citalopram hydrobromide (USAN)'
p29336
aS'D00823'
p29337
aS'Fluoxetine hydrochloride (JAN/USP)'
p29338
aS'D00824'
p29339
aS'Fluvoxamine maleate (JP16/USAN)'
p29340
aS'D00825'
p29341
aS'Sertraline hydrochloride (JAN/USAN)'
p29342
aS'D01107'
p29343
aS'Milnacipran hydrochloride (JAN/USAN)'
p29344
aS'D01179'
p29345
aS'Duloxetine hydrochloride (JAN/USAN)'
p29346
aS'D01285'
p29347
aS'Lofepramine hydrochloride (JAN/USAN)'
p29348
aS'D01546'
p29349
aS'Dosulepin hydrochloride (JAN)'
p29350
aS'D02074'
p29351
aS'Amphetamine sulfate (USP)'
p29352
aS'D02078'
p29353
aS'Dextroamphetamine sulfate (USP)'
p29354
aS'D02182'
p29355
aS'Cocaine hydrochloride (JP16/USP)'
p29356
aS'D02242'
p29357
aS'Methamphetamine hydrochloride (JP16/USP)'
p29358
aS'D02260'
p29359
aS'Paroxetine hydrochloride hydrate (JP16)'
p29360
aS'D02360'
p29361
aS'Sertraline (INN)'
p29362
aS'D02362'
p29363
aS'Paroxetine (USP/INN)'
p29364
aS'D02408'
p29365
aS'Trimipramine maleate (JAN/USAN)'
p29366
aS'D02566'
p29367
aS'Maprotiline (USAN)'
p29368
aS'D02567'
p29369
aS'Escitalopram oxalate (JAN/USAN)'
p29370
aS'D02570'
p29371
aS'Desvenlafaxine succinate hydrate (JAN)'
p29372
aS'D02573'
p29373
aS'Reboxetine mesylate (USAN)'
p29374
aS'D02574'
p29375
aS'Atomoxetine hydrochloride (JAN/USAN)'
p29376
aS'D02897'
p29377
aS'Amfonelic acid (USAN)'
p29378
aS'D03740'
p29379
aS'Dextroamphetamine (USAN)'
p29380
aS'D05173'
p29381
aS'Nisoxetine (USAN/INN)'
p29382
aS'D05200'
p29383
aS'Nomifensine maleate (USAN)'
p29384
aS'D05374'
p29385
aS'Paroxetine hydrochloride (USP)'
p29386
aS'D05375'
p29387
aS'Paroxetine mesylate (USAN)'
p29388
aS'D07334'
p29389
aS'Imipraminoxide (INN)'
p29390
aS'D07445'
p29391
aS'Amfetamine (INN)'
p29392
aS'D07448'
p29393
aS'Amitriptyline (INN)'
p29394
aS'D07449'
p29395
aS'Amitriptylinoxide (INN)'
p29396
aS'D07473'
p29397
aS'Atomoxetine (INN)'
p29398
aS'D07704'
p29399
aS'Citalopram (USP/INN)'
p29400
aS'D07705'
p29401
aS'Citalopram hydrochloride'
p29402
aS'D07727'
p29403
aS'Clomipramine (INN)'
p29404
aS'D07791'
p29405
aS'Desipramine (INN)'
p29406
aS'D07793'
p29407
aS'Desvenlafaxine (INN)'
p29408
aS'D07872'
p29409
aS'Dosulepin (INN)'
p29410
aS'D07880'
p29411
aS'Duloxetine (INN)'
p29412
aS'D07913'
p29413
aS'Escitalopram (INN)'
p29414
aS'D07984'
p29415
aS'Fluvoxamine (INN)'
p29416
aS'D08070'
p29417
aS'Imipramine (INN)'
p29418
aS'D08071'
p29419
aS'Imipramine embonate'
p29420
aS'D08140'
p29421
aS'Lofepramine (INN)'
p29422
aS'D08187'
p29423
aS'Metamfetamine (INN)'
p29424
aS'D08222'
p29425
aS'Milnacipran (INN)'
p29426
aS'D08288'
p29427
aS'Nortriptyline (INN)'
p29428
aS'D08472'
p29429
aS'Reboxetine (INN)'
p29430
aS'D08626'
p29431
aS'Trazodone (INN)'
p29432
aS'D08670'
p29433
aS'Venlafaxine (INN)'
p29434
aS'D09340'
p29435
aS'Esreboxetine (USAN/INN)'
p29436
aS'D09341'
p29437
aS'Esreboxetine succinate (USAN)'
p29438
assS'path:map07235'
p29439
(dp29440
S'ENTRY'
p29441
(lp29442
S'map07235'
p29443
aS'Drug'
p29444
aS'Pathway'
p29445
asS'PATHWAY_MAP'
p29446
(lp29447
S'map07235'
p29448
asS'NAME'
p29449
(lp29450
S'N-Metyl-D-aspartic acid receptor antagonists'
p29451
asS'COMPOUND'
p29452
(lp29453
S'C07575'
p29454
aS'Phencyclidine'
p29455
ag29454
ag29455
aS'C13737'
p29456
aS'Dizocilpine'
p29457
aS'D00711'
p29458
aS'Ketamine hydrochloride (JP16/USP)'
p29459
aS'D00777'
p29460
aS'Amantadine hydrochloride (JP16/USP)'
p29461
aS'D00848'
p29462
aS'Dextromethorphan hydrobromide hydrate (JP16)'
p29463
aS'D01445'
p29464
aS'Ifenprodil tartrate (JP16)'
p29465
aS'D02102'
p29466
aS'Methadone hydrochloride (JAN/USP)'
p29467
aS'D03100'
p29468
aS'Besonprodil (USAN)'
p29469
aS'D03742'
p29470
aS'Dextromethorphan (USP)'
p29471
aS'D03744'
p29472
aS'Dextromethorphan polistirex (USAN)'
p29473
aS'D03746'
p29474
aS'Dextrorphan hydrochloride (USAN)'
p29475
aS'D03878'
p29476
aS'Dizocilpine maleate (USAN)'
p29477
aS'D04905'
p29478
aS'Memantine hydrochloride (JAN/USAN)'
p29479
aS'D05453'
p29480
aS'Phencyclidine hydrochloride (USAN)'
p29481
aS'D06204'
p29482
aS'Traxoprodil mesylate (USAN)'
p29483
aS'D07283'
p29484
aS'Esketamine (INN)'
p29485
aS'D07441'
p29486
aS'Amantadine (INN)'
p29487
aS'D08064'
p29488
aS'Ifenprodil (INN)'
p29489
aS'D08098'
p29490
aS'Ketamine (INN)'
p29491
aS'D08121'
p29492
aS'Levomethadone (INN)'
p29493
aS'D08122'
p29494
aS'Levomethadone hydrochloride'
p29495
aS'D08174'
p29496
aS'Memantine (INN)'
p29497
aS'D08195'
p29498
aS'Methadone (BAN)'
p29499
assS'path:map04917'
p29500
(dp29501
S'NAME'
p29502
(lp29503
S'Prolactin signaling pathway'
p29504
asS'REFERENCE'
p29505
(lp29506
S'PMID:20149678'
p29507
ag29507
aS'AUTHORS'
p29508
aS'Binart N, Bachelot A, Bouilly J'
p29509
aS'TITLE'
p29510
aS'Impact of prolactin receptor isoforms on reproduction.'
p29511
aS'JOURNAL'
p29512
aS'Trends Endocrinol Metab 21:362-8 (2010)'
p29513
aS'PMID:17307904'
p29514
ag29514
aS'AUTHORS'
p29515
aS'Bachelot A, Binart N'
p29516
aS'TITLE'
p29517
aS'Reproductive role of prolactin.'
p29518
aS'JOURNAL'
p29519
aS'Reproduction 133:361-9 (2007)'
p29520
aS'PMID:16231422'
p29521
ag29521
aS'AUTHORS'
p29522
aS'Hennighausen L, Robinson GW'
p29523
aS'TITLE'
p29524
aS'Information networks in the mammary gland.'
p29525
aS'JOURNAL'
p29526
aS'Nat Rev Mol Cell Biol 6:715-25 (2005)'
p29527
aS'PMID:21664429'
p29528
ag29528
aS'AUTHORS'
p29529
aS'Bouilly J, Sonigo C, Auffret J, Gibori G, Binart N'
p29530
aS'TITLE'
p29531
aS'Prolactin signaling mechanisms in ovary.'
p29532
aS'JOURNAL'
p29533
aS'Mol Cell Endocrinol 356:80-7 (2012)'
p29534
aS'PMID:18219564'
p29535
ag29535
aS'AUTHORS'
p29536
aS'Oakes SR, Rogers RL, Naylor MJ, Ormandy CJ'
p29537
aS'TITLE'
p29538
aS'Prolactin regulation of mammary gland development.'
p29539
aS'JOURNAL'
p29540
aS'J Mammary Gland Biol Neoplasia 13:13-28 (2008)'
p29541
aS'PMID:12670737'
p29542
ag29542
aS'AUTHORS'
p29543
aS'Frasor J, Gibori G'
p29544
aS'TITLE'
p29545
aS'Prolactin regulation of estrogen receptor expression.'
p29546
aS'JOURNAL'
p29547
aS'Trends Endocrinol Metab 14:118-23 (2003)'
p29548
aS'PMID:9626554'
p29549
ag29549
aS'AUTHORS'
p29550
aS'Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA'
p29551
aS'TITLE'
p29552
aS'Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.'
p29553
aS'JOURNAL'
p29554
aS'Endocr Rev 19:225-68 (1998)'
p29555
aS'PMID:17535875'
p29556
ag29556
aS'AUTHORS'
p29557
aS'Weinhaus AJ, Stout LE, Bhagroo NV, Brelje TC, Sorenson RL'
p29558
aS'TITLE'
p29559
aS'Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy.'
p29560
aS'JOURNAL'
p29561
aS'J Endocrinol 193:367-81 (2007)'
p29562
aS'PMID:18601698'
p29563
ag29563
aS'AUTHORS'
p29564
aS'Grattan DR, Kokay IC'
p29565
aS'TITLE'
p29566
aS'Prolactin: a pleiotropic neuroendocrine hormone.'
p29567
aS'JOURNAL'
p29568
aS'J Neuroendocrinol 20:752-63 (2008)'
p29569
aS'PMID:9475379'
p29570
ag29570
aS'AUTHORS'
p29571
aS'Yu-Lee LY, Luo G, Book ML, Morris SM'
p29572
aS'TITLE'
p29573
aS'Lactogenic hormone signal transduction.'
p29574
aS'JOURNAL'
p29575
aS'Biol Reprod 58:295-301 (1998)'
p29576
aS'PMID:11606470'
p29577
ag29577
aS'AUTHORS'
p29578
aS'Tam SP, Lau P, Djiane J, Hilton DJ, Waters MJ'
p29579
aS'TITLE'
p29580
aS'Tissue-specific induction of SOCS gene expression by PRL.'
p29581
aS'JOURNAL'
p29582
aS'Endocrinology 142:5015-26 (2001)'
p29583
aS'PMID:17975019'
p29584
ag29584
aS'AUTHORS'
p29585
aS'Halperin J, Devi SY, Elizur S, Stocco C, Shehu A, Rebourcet D, Unterman TG, Leslie ND, Le J, Binart N, Gibori G'
p29586
aS'TITLE'
p29587
aS'Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect.'
p29588
aS'JOURNAL'
p29589
aS'Mol Endocrinol 22:513-22 (2008)'
p29590
aS'PMID:17519353'
p29591
ag29591
aS'AUTHORS'
p29592
aS'Sakamoto K, Creamer BA, Triplett AA, Wagner KU'
p29593
aS'TITLE'
p29594
aS'The Janus kinase 2 is required for expression and nuclear accumulation of cyclin'
p29595
aS'D1 in proliferating mammary epithelial cells.'
p29596
aS'JOURNAL'
p29597
aS'Mol Endocrinol 21:1877-92 (2007)'
p29598
aS'PMID:16677418'
p29599
ag29599
aS'AUTHORS'
p29600
aS'Oakes SR, Hilton HN, Ormandy CJ'
p29601
aS'TITLE'
p29602
aS'The alveolar switch: coordinating the proliferative cues and cell fate decisions'
p29603
aS'that drive the formation of lobuloalveoli from ductal epithelium.'
p29604
aS'JOURNAL'
p29605
aS'Breast Cancer Res 8:207 (2006)'
p29606
asS'KO_PATHWAY'
p29607
(lp29608
S'ko04917'
p29609
asS'PATHWAY_MAP'
p29610
(lp29611
S'map04917'
p29612
asS'DISEASE'
p29613
(lp29614
S'H01388'
p29615
aS'Hyperprolactinemia'
p29616
asS'DBLINKS'
p29617
(lp29618
S'GO: 0038161'
p29619
asS'ENTRY'
p29620
(lp29621
S'map04917'
p29622
aS'Pathway'
p29623
asS'CLASS'
p29624
(lp29625
S'Organismal Systems Endocrine system'
p29626
asS'DESCRIPTION'
p29627
(lp29628
S'Prolactin (PRL) is a polypeptide hormone known to be involved in a wide range of biological functions including osmoregulation, lactation, reproduction, growth and development, endocrinology and metabolism, brain and behavior, and immunomodulation. PRL mediates its action through PRLR, a transmembrane protein of the hematopoietin cytokine receptor superfamily. At the protein level, the long PRLR isoform (long-R) and several short PRLR isoforms (short-R) have been detected. Acting through the long-R, PRL activates many signaling cascades including Jak2/Stat, the major cascade, Src kinase, phosphatidylinositol-3-kinase (PI3K)/AKT, and mitogen-activated protein kinase (MAPK) pathways. PRL cannot activate Jak2/Stat5 through the short-R, but can activate pathways including MAPK and PI3K pathways.'
p29629
assS'path:map00942'
p29630
(dp29631
S'NAME'
p29632
(lp29633
S'Anthocyanin biosynthesis'
p29634
asS'REFERENCE'
p29635
(lp29636
S'PMID:17383962'
p29637
ag29637
aS'AUTHORS'
p29638
aS'Unno H, Ichimaida F, Suzuki H, Takahashi S, Tanaka Y, Saito A, Nishino T, Kusunoki M, Nakayama T.'
p29639
aS'TITLE'
p29640
aS'Structural and mutational studies of anthocyanin malonyltransferases establish the features of BAHD enzyme catalysis.'
p29641
aS'JOURNAL'
p29642
aS'J Biol Chem 282:15812-22 (2007)'
p29643
aS'PMID:16887235'
p29644
ag29644
aS'AUTHORS'
p29645
aS'Kogawa K, Kazuma K, Kato N, Noda N, Suzuki M.'
p29646
aS'TITLE'
p29647
aS'Biosynthesis of malonylated flavonoid glycosides on the basis of malonyltransferase activity in the petals of Clitoria ternatea.'
p29648
aS'JOURNAL'
p29649
aS'J Plant Physiol 164:886-94 (2007)'
p29650
aS'PMID:16945088'
p29651
ag29651
aS'AUTHORS'
p29652
aS'Tsai CJ, Harding SA, Tschaplinski TJ, Lindroth RL, Yuan Y.'
p29653
aS'TITLE'
p29654
aS'Genome-wide analysis of the structural genes regulating defense phenylpropanoid metabolism in Populus.'
p29655
aS'JOURNAL'
p29656
aS'New Phytol 172:47-62 (2006)'
p29657
aS'PMID:15944692'
p29658
ag29658
aS'AUTHORS'
p29659
aS'Ogata J, Kanno Y, Itoh Y, Tsugawa H, Suzuki M.'
p29660
aS'TITLE'
p29661
aS'Plant biochemistry: anthocyanin biosynthesis in roses.'
p29662
aS'JOURNAL'
p29663
aS'Nature 435:757-8 (2005)'
p29664
aS'PMID:15860422'
p29665
ag29665
aS'AUTHORS'
p29666
aS'Bowles D, Isayenkova J, Lim EK, Poppenberger B.'
p29667
aS'TITLE'
p29668
aS'Glycosyltransferases: managers of small molecules.'
p29669
aS'JOURNAL'
p29670
aS'Curr Opin Plant Biol 8:254-63 (2005)'
p29671
aS'PMID:15842621'
p29672
ag29672
aS'AUTHORS'
p29673
aS'Morita Y, Hoshino A, Kikuchi Y, Okuhara H, Ono E, Tanaka Y, Fukui Y, Saito N, Nitasaka E, Noguchi H, Iida S.'
p29674
aS'TITLE'
p29675
aS"Japanese morning glory dusky mutants displaying reddish-brown or purplish-gray flowers are deficient in a novel glycosylation enzyme for anthocyanin biosynthesis, UDP-glucose:anthocyanidin 3-O-glucoside-2''-O-glucosyltransferase, due to 4-bp insertions in the gene."
p29676
aS'JOURNAL'
p29677
aS'Plant J 42:353-63 (2005)'
p29678
aS'PMID:15509561'
p29679
ag29679
aS'AUTHORS'
p29680
aS'Sawada S, Suzuki H, Ichimaida F, Yamaguchi MA, Iwashita T, Fukui Y, Hemmi H, Nishino T, Nakayama T.'
p29681
aS'TITLE'
p29682
aS'UDP-glucuronic acid:anthocyanin glucuronosyltransferase from red daisy (Bellis perennis) flowers. Enzymology and phylogenetics of a novel glucuronosyltransferase involved in flower pigment biosynthesis.'
p29683
aS'JOURNAL'
p29684
aS'J Biol Chem 280:899-906 (2005)'
p29685
aS'PMID:15165190'
p29686
ag29686
aS'AUTHORS'
p29687
aS'Suzuki H, Sawada S, Watanabe K, Nagae S, Yamaguchi MA, Nakayama T, Nishino T.'
p29688
aS'TITLE'
p29689
aS'Identification and characterization of a novel anthocyanin malonyltransferase from scarlet sage (Salvia splendens) flowers: an enzyme that is phylogenetically separated from other anthocyanin acyltransferases.'
p29690
aS'JOURNAL'
p29691
aS'Plant J 38:994-1003 (2004)'
p29692
ag22
ag22
aS'AUTHORS'
p29693
aS'Suzuki H, Nakayama T, Yamaguchi M, Nishino T.'
p29694
aS'TITLE'
p29695
aS'cDNA cloning and characterization of two Dendranthema x morifolium anthocyanin malonyltransferases with different functional activities.'
p29696
aS'JOURNAL'
p29697
aS'Plant Sci 166(1):89-96 (2004)'
p29698
ag22
ag22
aS'AUTHORS'
p29699
aS'Nakayama T, Suzuki H, Nishino T.'
p29700
aS'TITLE'
p29701
aS'Anthocyanin acyltransferases: specificities, mechanism, phylogenetics, and applications.'
p29702
aS'JOURNAL'
p29703
aS'Journal of Molecular Catalysis B: Enzymatic 23(2-6):117-132 (2003)'
p29704
aS'PMID:12857844'
p29705
ag29705
aS'AUTHORS'
p29706
aS'Fukuchi-Mizutani M, Okuhara H, Fukui Y, Nakao M, Katsumoto Y, Yonekura-Sakakibara K, Kusumi T, Hase T, Tanaka Y.'
p29707
aS'TITLE'
p29708
aS"Biochemical and molecular characterization of a novel UDP-glucose:anthocyanin 3'-O-glucosyltransferase, a key enzyme for blue anthocyanin biosynthesis, from gentian."
p29709
aS'JOURNAL'
p29710
aS'Plant Physiol 132:1652-63 (2003)'
p29711
aS'PMID:12828368'
p29712
ag29712
aS'AUTHORS'
p29713
aS'Springob K, Nakajima J, Yamazaki M, Saito K.'
p29714
aS'TITLE'
p29715
aS'Recent advances in the biosynthesis and accumulation of anthocyanins.'
p29716
aS'JOURNAL'
p29717
aS'Nat Prod Rep 20:288-303 (2003)'
p29718
aS'(Manuscript M1:08444 (Revised))'
p29719
ag29719
aS'AUTHORS'
p29720
aS'Suzuki H, Nakayama T, Yonekura-Sakakibara K, Fukui Y, Nakamura N, Nakao M, Tanaka Y, Yamaguchi MA, Kusumi T, Nishino T.'
p29721
aS'TITLE'
p29722
aS"Malonyl-CoA:anthocyanin 5-O-glucoside-6'''-O-malonyltransferase from scarlet sage (Salvia splendens) flowers. Enzyme purification, gene cloning, expression, and characterization."
p29723
aS'JOURNAL'
p29724
aS'J Biol Chem (2001)'
p29725
aS'PMID:10536025'
p29726
ag29726
aS'AUTHORS'
p29727
aS'Burbulis IE, Winkel-Shirley B.'
p29728
aS'TITLE'
p29729
aS'Interactions among enzymes of the Arabidopsis flavonoid biosynthetic pathway.'
p29730
aS'JOURNAL'
p29731
aS'Proc Natl Acad Sci U S A 96:12929-34 (1999)'
p29732
aS'PMID:10504566'
p29733
ag29733
aS'AUTHORS'
p29734
aS'Brugliera F, Barri-Rewell G, Holton TA, Mason JG.'
p29735
aS'TITLE'
p29736
aS"Isolation and characterization of a flavonoid 3'-hydroxylase cDNA clone corresponding to the Ht1 locus of Petunia hybrida."
p29737
aS'JOURNAL'
p29738
aS'Plant J 19:441-51 (1999)'
p29739
aS'PMID:12226348'
p29740
ag29740
aS'AUTHORS'
p29741
aS'Boss PK, Davies C, Robinson SP.'
p29742
aS'TITLE'
p29743
aS'Analysis of the Expression of Anthocyanin Pathway Genes in Developing Vitis vinifera L. cv Shiraz Grape Berries and the Implications for Pathway Regulation.'
p29744
aS'JOURNAL'
p29745
aS'Plant Physiol 111:1059-1066 (1996)'
p29746
aS'PMID:12242398'
p29747
ag29747
aS'AUTHORS'
p29748
aS'Holton TA, Cornish EC.'
p29749
aS'TITLE'
p29750
aS'Genetics and Biochemistry of Anthocyanin Biosynthesis.'
p29751
aS'JOURNAL'
p29752
aS'Plant Cell 7:1071-1083 (1995)'
p29753
aS'PMID:8130799'
p29754
ag29754
aS'AUTHORS'
p29755
aS'Kroon J, Souer E, de Graaff A, Xue Y, Mol J, Koes R.'
p29756
aS'TITLE'
p29757
aS'Cloning and structural analysis of the anthocyanin pigmentation locus Rt of Petunia hybrida: characterization of insertion sequences in two mutant alleles.'
p29758
aS'JOURNAL'
p29759
aS'Plant J 5:69-80 (1994)'
p29760
asS'KO_PATHWAY'
p29761
(lp29762
S'ko00942'
p29763
asS'PATHWAY_MAP'
p29764
(lp29765
S'map00942'
p29766
asS'DBLINKS'
p29767
(lp29768
S'GO: 0009718'
p29769
asS'ENTRY'
p29770
(lp29771
S'map00942'
p29772
aS'Pathway'
p29773
asS'CLASS'
p29774
(lp29775
S'Metabolism Biosynthesis of other secondary metabolites'
p29776
asS'DESCRIPTION'
p29777
(lp29778
S'Anthocyanidins (aglycones) and anthocyanins (glycosides) are common plant pigments and belong to a structural subclass of flavonoids characterized by a 2-phenylbenzopyrylium unit. They are derived along the flavonoid modification pathways and further separated into three types, pelargonidin, cyanidin, and delphinidin, due to the different number of hydroxyl groups in the phenyl group.'
p29779
assS'path:map05218'
p29780
(dp29781
S'NAME'
p29782
(lp29783
S'Melanoma'
p29784
asS'REFERENCE'
p29785
(lp29786
S'PMID:16822996'
p29787
ag29787
aS'AUTHORS'
p29788
aS'Miller AJ, Mihm MC Jr.'
p29789
aS'TITLE'
p29790
aS'Melanoma.'
p29791
aS'JOURNAL'
p29792
aS'N Engl J Med 355:51-65 (2006)'
p29793
aS'PMID:12894244'
p29794
ag29794
aS'AUTHORS'
p29795
aS'Chin L.'
p29796
aS'TITLE'
p29797
aS'The genetics of malignant melanoma: lessons from mouse and man.'
p29798
aS'JOURNAL'
p29799
aS'Nat Rev Cancer 3:559-70 (2003)'
p29800
aS'PMID:16750612'
p29801
ag29801
aS'AUTHORS'
p29802
aS'Takata M, Saida T.'
p29803
aS'TITLE'
p29804
aS'Genetic alterations in melanocytic tumors.'
p29805
aS'JOURNAL'
p29806
aS'J Dermatol Sci 43:1-10 (2006)'
p29807
aS'PMID:15841168'
p29808
ag29808
aS'AUTHORS'
p29809
aS'Chudnovsky Y, Khavari PA, Adams AE.'
p29810
aS'TITLE'
p29811
aS'Melanoma genetics and the development of rational therapeutics.'
p29812
aS'JOURNAL'
p29813
aS'J Clin Invest 115:813-24 (2005)'
p29814
aS'PMID:16001050'
p29815
ag29815
aS'AUTHORS'
p29816
aS'Merlino G.'
p29817
aS'TITLE'
p29818
aS'Cancer biology: the weakest link?'
p29819
aS'JOURNAL'
p29820
aS'Nature 436:33-5 (2005)'
p29821
aS'PMID:16001072'
p29822
ag29822
aS'AUTHORS'
p29823
aS'Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.'
p29824
aS'TITLE'
p29825
aS'Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.'
p29826
aS'JOURNAL'
p29827
aS'Nature 436:117-22 (2005)'
p29828
aS'PMID:16899407'
p29829
ag29829
aS'AUTHORS'
p29830
aS'Levy C, Khaled M, Fisher DE.'
p29831
aS'TITLE'
p29832
aS'MITF: master regulator of melanocyte development and melanoma oncogene.'
p29833
aS'JOURNAL'
p29834
aS'Trends Mol Med 12:406-14 (2006)'
p29835
aS'PMID:15009714'
p29836
ag29836
aS'AUTHORS'
p29837
aS'Tsao H, Goel V, Wu H, Yang G, Haluska FG.'
p29838
aS'TITLE'
p29839
aS'Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.'
p29840
aS'JOURNAL'
p29841
aS'J Invest Dermatol 122:337-41 (2004)'
p29842
aS'PMID:11224709'
p29843
ag29843
aS'AUTHORS'
p29844
aS'Gruss C, Herlyn M.'
p29845
aS'TITLE'
p29846
aS'Role of cadherins and matrixins in melanoma.'
p29847
aS'JOURNAL'
p29848
aS'Curr Opin Oncol 13:117-23 (2001)'
p29849
aS'PMID:15721476'
p29850
ag29850
aS'AUTHORS'
p29851
aS'Thompson JF, Scolyer RA, Kefford RF.'
p29852
aS'TITLE'
p29853
aS'Cutaneous melanoma.'
p29854
aS'JOURNAL'
p29855
aS'Lancet 365:687-701 (2005)'
p29856
aS'PMID:14695152'
p29857
ag29857
aS'AUTHORS'
p29858
aS'Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.'
p29859
aS'TITLE'
p29860
aS'NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.'
p29861
aS'JOURNAL'
p29862
aS'Clin Cancer Res 9:6483-8 (2003)'
p29863
aS'PMID:15557758'
p29864
ag29864
aS'AUTHORS'
p29865
aS'Hussein MR.'
p29866
aS'TITLE'
p29867
aS'The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?'
p29868
aS'JOURNAL'
p29869
aS'Tumour Biol 25:200-7 (2004)'
p29870
aS'PMID:10843728'
p29871
ag29871
aS'AUTHORS'
p29872
aS'Lazar-Molnar E, Hegyesi H, Toth S, Falus A.'
p29873
aS'TITLE'
p29874
aS'Autocrine and paracrine regulation by cytokines and growth factors in melanoma.'
p29875
aS'JOURNAL'
p29876
aS'Cytokine 12:547-54 (2000)'
p29877
asS'KO_PATHWAY'
p29878
(lp29879
S'ko05218'
p29880
asS'PATHWAY_MAP'
p29881
(lp29882
S'map05218'
p29883
asS'DISEASE'
p29884
(lp29885
S'H00038'
p29886
aS'Malignant melanoma'
p29887
asS'ENTRY'
p29888
(lp29889
S'map05218'
p29890
aS'Pathway'
p29891
asS'CLASS'
p29892
(lp29893
S'Human Diseases Cancers'
p29894
asS'DESCRIPTION'
p29895
(lp29896
S'Melanoma is a form of skin cancer that has a poor prognosis and which is on the rise in Western populations.'
p29897
assS'path:map05219'
p29898
(dp29899
S'NAME'
p29900
(lp29901
S'Bladder cancer'
p29902
asS'REFERENCE'
p29903
(lp29904
S'PMID:17158541'
p29905
ag29905
aS'AUTHORS'
p29906
aS'Mitra AP, Datar RH, Cote RJ.'
p29907
aS'TITLE'
p29908
aS'Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.'
p29909
aS'JOURNAL'
p29910
aS'J Clin Oncol 24:5552-64 (2006)'
p29911
aS'PMID:16474624'
p29912
ag29912
aS'AUTHORS'
p29913
aS'Wolff EM, Liang G, Jones PA.'
p29914
aS'TITLE'
p29915
aS'Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.'
p29916
aS'JOURNAL'
p29917
aS'Nat Clin Pract Urol 2:502-10 (2005)'
p29918
aS'PMID:16110317'
p29919
ag29919
aS'AUTHORS'
p29920
aS'Wu XR.'
p29921
aS'TITLE'
p29922
aS'Urothelial tumorigenesis: a tale of divergent pathways.'
p29923
aS'JOURNAL'
p29924
aS'Nat Rev Cancer 5:713-25 (2005)'
p29925
aS'PMID:11103787'
p29926
ag29926
aS'AUTHORS'
p29927
aS'Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.'
p29928
aS'TITLE'
p29929
aS'Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.'
p29930
aS'JOURNAL'
p29931
aS'Cancer Res 60:6298-302 (2000)'
p29932
aS'PMID:12850530'
p29933
ag29933
aS'AUTHORS'
p29934
aS'Bellmunt J, Hussain M, Dinney CP.'
p29935
aS'TITLE'
p29936
aS'Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.'
p29937
aS'JOURNAL'
p29938
aS'Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)'
p29939
aS'PMID:17149381'
p29940
ag29940
aS'AUTHORS'
p29941
aS'Sugano K, Kakizoe T.'
p29942
aS'TITLE'
p29943
aS'Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.'
p29944
aS'JOURNAL'
p29945
aS'Nat Clin Pract Urol 3:642-52 (2006)'
p29946
aS'PMID:15746962'
p29947
ag29947
aS'AUTHORS'
p29948
aS'Dunn KL, Espino PS, Drobic B, He S, Davie JR.'
p29949
aS'TITLE'
p29950
aS'The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.'
p29951
aS'JOURNAL'
p29952
aS'Biochem Cell Biol 83:1-14 (2005)'
p29953
aS'PMID:15551095'
p29954
ag29954
aS'AUTHORS'
p29955
aS'Williams SG, Stein JP.'
p29956
aS'TITLE'
p29957
aS'Molecular pathways in bladder cancer.'
p29958
aS'JOURNAL'
p29959
aS'Urol Res 32:373-85 (2004)'
p29960
asS'KO_PATHWAY'
p29961
(lp29962
S'ko05219'
p29963
asS'PATHWAY_MAP'
p29964
(lp29965
S'map05219'
p29966
asS'DISEASE'
p29967
(lp29968
S'H00022'
p29969
aS'Bladder cancer'
p29970
asS'ENTRY'
p29971
(lp29972
S'map05219'
p29973
aS'Pathway'
p29974
asS'CLASS'
p29975
(lp29976
S'Human Diseases Cancers'
p29977
asS'DESCRIPTION'
p29978
(lp29979
S'The urothelium covers the luminal surface of almost the entire urinary tract, extending from the renal pelvis, through the ureter and bladder, to the proximal urethra. The majority of urothelial carcinoma are bladder carcinomas, and urothelial carcinomas of the renal pelvis and ureter account for only approximately 7% of the total. Urothelial tumours arise and evolve through divergent phenotypic pathways. Some tumours progress from urothelial hyperplasia to low-grade non-invasive superficial papillary tumours. More aggressive variants arise either from flat, high-grade carcinoma in situ (CIS) and progress to invasive tumours, or they arise de novo as invasive tumours. Low-grade papillary tumors frequently show a constitutive activation of the receptor tyrosine kinase-Ras pathway, exhibiting activating mutations in the HRAS and fibroblast growth factor receptor 3 (FGFR3) genes. In contrast, CIS and invasive tumors frequently show alterations in the TP53 and RB genes and pathways. Invasion and metastases are promoted by several factors that alter the tumour microenvironment, including the aberrant expression of'
p29980
assS'path:map05210'
p29981
(dp29982
S'NAME'
p29983
(lp29984
S'Colorectal cancer'
p29985
asS'REFERENCE'
p29986
(lp29987
S'PMID:15000146'
p29988
ag29988
aS'AUTHORS'
p29989
aS'Grady WM.'
p29990
aS'TITLE'
p29991
aS'Genomic instability and colon cancer.'
p29992
aS'JOURNAL'
p29993
aS'Cancer Metastasis Rev 23:11-27 (2004)'
p29994
aS'PMID:16555243'
p29995
ag29995
aS'AUTHORS'
p29996
aS'Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.'
p29997
aS'TITLE'
p29998
aS'Microsatellite instability in colorectal cancer.'
p29999
aS'JOURNAL'
p30000
aS'Br J Surg 93:395-406 (2006)'
p30001
aS'PMID:11078609'
p30002
ag30002
aS'AUTHORS'
p30003
aS'Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.'
p30004
aS'TITLE'
p30005
aS'Hereditary non-polyposis colorectal cancer: an updated review.'
p30006
aS'JOURNAL'
p30007
aS'Eur J Surg Oncol 26:635-45 (2000)'
p30008
aS'PMID:16699851'
p30009
ag30009
aS'AUTHORS'
p30010
aS'Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.'
p30011
aS'TITLE'
p30012
aS'Colorectal cancer: genetics of development and metastasis.'
p30013
aS'JOURNAL'
p30014
aS'J Gastroenterol 41:185-92 (2006)'
p30015
aS'PMID:12621137'
p30016
ag30016
aS'AUTHORS'
p30017
aS'Lynch HT, de la Chapelle A.'
p30018
aS'TITLE'
p30019
aS'Hereditary colorectal cancer.'
p30020
aS'JOURNAL'
p30021
aS'N Engl J Med 348:919-32 (2003)'
p30022
aS'PMID:12951588'
p30023
ag30023
aS'AUTHORS'
p30024
aS'Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.'
p30025
aS'TITLE'
p30026
aS'The significance of unstable chromosomes in colorectal cancer.'
p30027
aS'JOURNAL'
p30028
aS'Nat Rev Cancer 3:695-701 (2003)'
p30029
aS'PMID:10505543'
p30030
ag30030
aS'AUTHORS'
p30031
aS'Behrens J.'
p30032
aS'TITLE'
p30033
aS'Cadherins and catenins: role in signal transduction and tumor progression.'
p30034
aS'JOURNAL'
p30035
aS'Cancer Metastasis Rev 18:15-30 (1999)'
p30036
aS'PMID:16042571'
p30037
ag30037
aS'AUTHORS'
p30038
aS'Behrens J.'
p30039
aS'TITLE'
p30040
aS'The role of the Wnt signalling pathway in colorectal tumorigenesis.'
p30041
aS'JOURNAL'
p30042
aS'Biochem Soc Trans 33:672-5 (2005)'
p30043
aS'PMID:15349822'
p30044
ag30044
aS'AUTHORS'
p30045
aS'Behrens J, Lustig B.'
p30046
aS'TITLE'
p30047
aS'The Wnt connection to tumorigenesis.'
p30048
aS'JOURNAL'
p30049
aS'Int J Dev Biol 48:477-87 (2004)'
p30050
aS'PMID:9196022'
p30051
ag30051
aS'AUTHORS'
p30052
aS'Polakis P.'
p30053
aS'TITLE'
p30054
aS'The adenomatous polyposis coli (APC) tumor suppressor.'
p30055
aS'JOURNAL'
p30056
aS'Biochim Biophys Acta 1332:F127-47 (1997)'
p30057
aS'PMID:12737309'
p30058
ag30058
aS'AUTHORS'
p30059
aS'Janssen KP.'
p30060
aS'TITLE'
p30061
aS'Murine models of colorectal cancer: studying the role of oncogenic K-ras.'
p30062
aS'JOURNAL'
p30063
aS'Cell Mol Life Sci 60:495-506 (2003)'
p30064
aS'PMID:11459867'
p30065
ag30065
aS'AUTHORS'
p30066
aS'Adjei AA.'
p30067
aS'TITLE'
p30068
aS'Blocking oncogenic Ras signaling for cancer therapy.'
p30069
aS'JOURNAL'
p30070
aS'J Natl Cancer Inst 93:1062-74 (2001)'
p30071
aS'PMID:15573119'
p30072
ag30072
aS'AUTHORS'
p30073
aS'Arakawa H.'
p30074
aS'TITLE'
p30075
aS'Netrin-1 and its receptors in tumorigenesis.'
p30076
aS'JOURNAL'
p30077
aS'Nat Rev Cancer 4:978-87 (2004)'
p30078
aS'PMID:15310786'
p30079
ag30079
aS'AUTHORS'
p30080
aS'Mehlen P, Fearon ER.'
p30081
aS'TITLE'
p30082
aS'Role of the dependence receptor DCC in colorectal cancer pathogenesis.'
p30083
aS'JOURNAL'
p30084
aS'J Clin Oncol 22:3420-8 (2004)'
p30085
aS'PMID:11223406'
p30086
ag30086
aS'AUTHORS'
p30087
aS'Peltomaki P.'
p30088
aS'TITLE'
p30089
aS'DNA mismatch repair and cancer.'
p30090
aS'JOURNAL'
p30091
aS'Mutat Res 488:77-85 (2001)'
p30092
aS'PMID:15711891'
p30093
ag30093
aS'AUTHORS'
p30094
aS'Li F, Cao Y, Townsend CM Jr, Ko TC.'
p30095
aS'TITLE'
p30096
aS'TGF-beta signaling in colon cancer cells.'
p30097
aS'JOURNAL'
p30098
aS'World J Surg 29:306-11 (2005)'
p30099
aS'PMID:11170304'
p30100
ag30100
aS'AUTHORS'
p30101
aS'Roman C, Saha D, Beauchamp R.'
p30102
aS'TITLE'
p30103
aS'TGF-beta and colorectal carcinogenesis.'
p30104
aS'JOURNAL'
p30105
aS'Microsc Res Tech 52:450-7 (2001)'
p30106
aS'PMID:16326109'
p30107
ag30107
aS'AUTHORS'
p30108
aS'Watson AJ.'
p30109
aS'TITLE'
p30110
aS'An overview of apoptosis and the prevention of colorectal cancer.'
p30111
aS'JOURNAL'
p30112
aS'Crit Rev Oncol Hematol 57:107-21 (2006)'
p30113
aS'PMID:15479695'
p30114
ag30114
aS'AUTHORS'
p30115
aS'Watson AJ.'
p30116
aS'TITLE'
p30117
aS'Apoptosis and colorectal cancer.'
p30118
aS'JOURNAL'
p30119
aS'Gut 53:1701-9 (2004)'
p30120
aS'PMID:11477132'
p30121
ag30121
aS'AUTHORS'
p30122
aS'Houlston RS.'
p30123
aS'TITLE'
p30124
aS'What we could do now: molecular pathology of colorectal cancer.'
p30125
aS'JOURNAL'
p30126
aS'Mol Pathol 54:206-14 (2001)'
p30127
asS'KO_PATHWAY'
p30128
(lp30129
S'ko05210'
p30130
asS'PATHWAY_MAP'
p30131
(lp30132
S'map05210'
p30133
asS'DISEASE'
p30134
(lp30135
S'H00020'
p30136
aS'Colorectal cancer'
p30137
ag30136
ag30137
aS'H00857'
p30138
aS'Oligodontia-colorectal cancer syndrome'
p30139
aS'H00876'
p30140
aS'Mismatch repair deficiency'
p30141
aS'H01023'
p30142
aS'Juvenile polyposis syndrome'
p30143
aS'H01025'
p30144
aS'Familial adenomatous polyposis'
p30145
asS'ENTRY'
p30146
(lp30147
S'map05210'
p30148
aS'Pathway'
p30149
asS'CLASS'
p30150
(lp30151
S'Human Diseases Cancers'
p30152
asS'DESCRIPTION'
p30153
(lp30154
S'Colorectal cancer (CRC) is the second largest cause of cancer-related deaths in Western countries. CRC arises from the colorectal epithelium as a result of the accumulation of genetic alterations in defined oncogenes and tumour suppressor genes (TSG). Two major mechanisms of genomic instability have been identified in sporadic CRC progression. The first, known as chromosomal instability (CIN), results from a series of genetic changes that involve the activation of oncogenes such as K-ras and inactivation of TSG such as p53, DCC/Smad4, and APC. The second, known as'
p30155
assS'path:map05211'
p30156
(dp30157
S'NAME'
p30158
(lp30159
S'Renal cell carcinoma'
p30160
asS'REFERENCE'
p30161
(lp30162
S'PMID:16339096'
p30163
ag30163
aS'AUTHORS'
p30164
aS'Cohen HT, McGovern FJ.'
p30165
aS'TITLE'
p30166
aS'Renal-cell carcinoma.'
p30167
aS'JOURNAL'
p30168
aS'N Engl J Med 353:2477-90 (2005)'
p30169
aS'PMID:15122209'
p30170
ag30170
aS'AUTHORS'
p30171
aS'Pavlovich CP, Schmidt LS.'
p30172
aS'TITLE'
p30173
aS'Searching for the hereditary causes of renal-cell carcinoma.'
p30174
aS'JOURNAL'
p30175
aS'Nat Rev Cancer 4:381-93 (2004)'
p30176
aS'PMID:14634372'
p30177
ag30177
aS'AUTHORS'
p30178
aS'Linehan WM, Walther MM, Zbar B.'
p30179
aS'TITLE'
p30180
aS'The genetic basis of cancer of the kidney.'
p30181
aS'JOURNAL'
p30182
aS'J Urol 170:2163-72 (2003)'
p30183
aS'PMID:14685170'
p30184
ag30184
aS'AUTHORS'
p30185
aS'Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.'
p30186
aS'TITLE'
p30187
aS'Met, metastasis, motility and more.'
p30188
aS'JOURNAL'
p30189
aS'Nat Rev Mol Cell Biol 4:915-25 (2003)'
p30190
aS'PMID:15611513'
p30191
ag30191
aS'AUTHORS'
p30192
aS'Kim WY, Kaelin WG.'
p30193
aS'TITLE'
p30194
aS'Role of VHL gene mutation in human cancer.'
p30195
aS'JOURNAL'
p30196
aS'J Clin Oncol 22:4991-5004 (2004)'
p30197
aS'PMID:17211469'
p30198
ag30198
aS'AUTHORS'
p30199
aS'Sudarshan S, Linehan WM, Neckers L.'
p30200
aS'TITLE'
p30201
aS'HIF and fumarate hydratase in renal cancer.'
p30202
aS'JOURNAL'
p30203
aS'Br J Cancer 96:403-7 (2007)'
p30204
aS'PMID:17287871'
p30205
ag30205
aS'AUTHORS'
p30206
aS'Sudarshan S, Pinto PA, Neckers L, Linehan WM.'
p30207
aS'TITLE'
p30208
aS'Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.'
p30209
aS'JOURNAL'
p30210
aS'Nat Clin Pract Urol 4:104-10 (2007)'
p30211
aS'PMID:12351585'
p30212
ag30212
aS'AUTHORS'
p30213
aS'Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.'
p30214
aS'TITLE'
p30215
aS'Understanding familial and non-familial renal cell cancer.'
p30216
aS'JOURNAL'
p30217
aS'Hum Mol Genet 11:2489-98 (2002)'
p30218
asS'KO_PATHWAY'
p30219
(lp30220
S'ko05211'
p30221
asS'PATHWAY_MAP'
p30222
(lp30223
S'map05211'
p30224
asS'DISEASE'
p30225
(lp30226
S'H00021'
p30227
aS'Renal cell carcinoma'
p30228
ag30227
ag30228
aS'H00559'
p30229
aS'von Hippel-Lindau syndrome'
p30230
asS'MODULE'
p30231
(lp30232
S'M00383'
p30233
aS'ECV complex [PATH:map05211]'
p30234
asS'ENTRY'
p30235
(lp30236
S'map05211'
p30237
aS'Pathway'
p30238
asS'CLASS'
p30239
(lp30240
S'Human Diseases Cancers'
p30241
asS'DESCRIPTION'
p30242
(lp30243
S'Renal cell cancer (RCC) accounts for ~3% of human malignancies and its incidence appears to be rising. Although most cases of RCC seem to occur sporadically, an inherited predisposition to renal cancer accounts for 1-4% of cases. RCC is not a single disease, it has several morphological subtypes. Conventional RCC (clear cell RCC) accounts for ~80% of cases, followed by papillary RCC (10-15%), chromophobe RCC (5%), and collecting duct RCC (<1%). Genes potentially involved in sporadic neoplasms of each particular type are VHL, MET, BHD, and FH respectively. In the absence of VHL, hypoxia-inducible factor alpha (HIF-alpha) accumulates, leading to production of several growth factors, including vascular endothelial growth factor and platelet-derived growth factor. Activated MET mediates a number of biological effects including motility, invasion of extracellular matrix, cellular transformation, prevention of apoptosis and metastasis formation. Loss of functional FH leads to accumulation of fumarate in the cell, triggering inhibition of HPH and preventing targeted pVHL-mediated degradation of HIF-alpha. BHD mutations cause the Birt-Hogg-Dube syndrome and its associated chromophobe, hybrid oncocytic, and conventional (clear cell) RCC.'
p30244
assS'path:map05212'
p30245
(dp30246
S'NAME'
p30247
(lp30248
S'Pancreatic cancer'
p30249
asS'REFERENCE'
p30250
(lp30251
g22
ag22
aS'AUTHORS'
p30252
ag22
aS'TITLE'
p30253
ag22
aS'JOURNAL'
p30254
ag22
aS'(Japanese)'
p30255
ag30255
aS'AUTHORS'
p30256
aS'Niitsu Y, Yokota J (ed).'
p30257
aS'TITLE'
p30258
aS'[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)'
p30259
aS'JOURNAL'
p30260
aS'Nankodo (1999)'
p30261
aS'PMID:12459728'
p30262
ag30262
aS'AUTHORS'
p30263
aS'Bardeesy N, DePinho RA.'
p30264
aS'TITLE'
p30265
aS'Pancreatic cancer biology and genetics.'
p30266
aS'JOURNAL'
p30267
aS'Nat Rev Cancer 2:897-909 (2002)'
p30268
aS'PMID:11407945'
p30269
ag30269
aS'AUTHORS'
p30270
aS'Bardeesy N, Sharpless NE, DePinho RA, Merlino G.'
p30271
aS'TITLE'
p30272
aS'The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.'
p30273
aS'JOURNAL'
p30274
aS'Semin Cancer Biol 11:201-18 (2001)'
p30275
aS'PMID:12946833'
p30276
ag30276
aS'AUTHORS'
p30277
aS'Cowgill SM, Muscarella P.'
p30278
aS'TITLE'
p30279
aS'The genetics of pancreatic cancer.'
p30280
aS'JOURNAL'
p30281
aS'Am J Surg 186:279-86 (2003)'
p30282
aS'PMID:16702400'
p30283
ag30283
aS'AUTHORS'
p30284
aS'Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.'
p30285
aS'TITLE'
p30286
aS'Genetics and biology of pancreatic ductal adenocarcinoma.'
p30287
aS'JOURNAL'
p30288
aS'Genes Dev 20:1218-49 (2006)'
p30289
aS'PMID:10740269'
p30290
ag30290
aS'AUTHORS'
p30291
aS'Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.'
p30292
aS'TITLE'
p30293
aS"Understanding Ras: 'it ain't over 'til it's over'."
p30294
aS'JOURNAL'
p30295
aS'Trends Cell Biol 10:147-54 (2000)'
p30296
aS'PMID:12648469'
p30297
ag30297
aS'AUTHORS'
p30298
aS'Holbro T, Civenni G, Hynes NE.'
p30299
aS'TITLE'
p30300
aS'The ErbB receptors and their role in cancer progression.'
p30301
aS'JOURNAL'
p30302
aS'Exp Cell Res 284:99-110 (2003)'
p30303
aS'PMID:14967450'
p30304
ag30304
aS'AUTHORS'
p30305
aS'Marmor MD, Skaria KB, Yarden Y.'
p30306
aS'TITLE'
p30307
aS'Signal transduction and oncogenesis by ErbB/HER receptors.'
p30308
aS'JOURNAL'
p30309
aS'Int J Radiat Oncol Biol Phys 58:903-13 (2004)'
p30310
aS'PMID:14586404'
p30311
ag30311
aS'AUTHORS'
p30312
aS'DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.'
p30313
aS'TITLE'
p30314
aS'Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.'
p30315
aS'JOURNAL'
p30316
aS'Oncogene 22:7781-95 (2003)'
p30317
aS'PMID:12545153'
p30318
ag30318
aS'AUTHORS'
p30319
aS'Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.'
p30320
aS'TITLE'
p30321
aS'Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.'
p30322
aS'JOURNAL'
p30323
aS'Oncogene 22:319-29 (2003)'
p30324
aS'PMID:14580692'
p30325
ag30325
aS'AUTHORS'
p30326
aS'Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.'
p30327
aS'TITLE'
p30328
aS'Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.'
p30329
aS'JOURNAL'
p30330
aS'Cancer Lett 201:107-16 (2003)'
p30331
aS'PMID:12079267'
p30332
ag30332
aS'AUTHORS'
p30333
aS'Schmid RM.'
p30334
aS'TITLE'
p30335
aS'Genetic basis of pancreatic cancer.'
p30336
aS'JOURNAL'
p30337
aS'Best Pract Res Clin Gastroenterol 16:421-33 (2002)'
p30338
aS'PMID:15774796'
p30339
ag30339
aS'AUTHORS'
p30340
aS'Elliott RL, Blobe GC.'
p30341
aS'TITLE'
p30342
aS'Role of transforming growth factor Beta in human cancer.'
p30343
aS'JOURNAL'
p30344
aS'J Clin Oncol 23:2078-93 (2005)'
p30345
aS'PMID:15823750'
p30346
ag30346
aS'AUTHORS'
p30347
aS'Rudkin TM, Foulkes WD.'
p30348
aS'TITLE'
p30349
aS'BRCA2: breaks, mistakes and failed separations.'
p30350
aS'JOURNAL'
p30351
aS'Trends Mol Med 11:145-8 (2005)'
p30352
aS'PMID:11707511'
p30353
ag30353
aS'AUTHORS'
p30354
aS'Venkitaraman AR.'
p30355
aS'TITLE'
p30356
aS'Functions of BRCA1 and BRCA2 in the biological response to DNA damage.'
p30357
aS'JOURNAL'
p30358
aS'J Cell Sci 114:3591-8 (2001)'
p30359
asS'KO_PATHWAY'
p30360
(lp30361
S'ko05212'
p30362
asS'PATHWAY_MAP'
p30363
(lp30364
S'map05212'
p30365
asS'DISEASE'
p30366
(lp30367
S'H00019'
p30368
aS'Pancreatic cancer'
p30369
asS'ENTRY'
p30370
(lp30371
S'map05212'
p30372
aS'Pathway'
p30373
asS'CLASS'
p30374
(lp30375
S'Human Diseases Cancers'
p30376
asS'DESCRIPTION'
p30377
(lp30378
S"Infiltrating ductal adenocarcinoma is the most common malignancy of the pancreas. When most investigators use the term 'pancreatic cancer' they are referring to pancreatic ductal adenocarcinoma (PDA). Normal duct epithelium progresses to infiltrating cancer through a series of histologically defined precursors (PanINs). The overexpression of HER-2/neu and activating point mutations in the K-ras gene occur early, inactivation of the p16 gene at an intermediate stage, and the inactivation of p53, SMAD4, and BRCA2 occur relatively late. Activated K-ras engages multiple effector pathways."
p30379
assS'path:map05213'
p30380
(dp30381
S'NAME'
p30382
(lp30383
S'Endometrial cancer'
p30384
asS'REFERENCE'
p30385
(lp30386
S'PMID:15947972'
p30387
ag30387
aS'AUTHORS'
p30388
aS'Ryan AJ, Susil B, Jobling TW, Oehler MK.'
p30389
aS'TITLE'
p30390
aS'Endometrial cancer.'
p30391
aS'JOURNAL'
p30392
aS'Cell Tissue Res 322:53-61 (2005)'
p30393
aS'PMID:14747944'
p30394
ag30394
aS'AUTHORS'
p30395
aS'Lax SF.'
p30396
aS'TITLE'
p30397
aS'Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.'
p30398
aS'JOURNAL'
p30399
aS'Virchows Arch 444:213-23 (2004)'
p30400
aS'PMID:16508724'
p30401
ag30401
aS'AUTHORS'
p30402
aS'Shiozawa T, Konishi I.'
p30403
aS'TITLE'
p30404
aS'Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.'
p30405
aS'JOURNAL'
p30406
aS'Int J Clin Oncol 11:13-21 (2006)'
p30407
aS'PMID:17028294'
p30408
ag30408
aS'AUTHORS'
p30409
aS'Hecht JL, Mutter GL.'
p30410
aS'TITLE'
p30411
aS'Molecular and pathologic aspects of endometrial carcinogenesis.'
p30412
aS'JOURNAL'
p30413
aS'J Clin Oncol 24:4783-91 (2006)'
p30414
aS'PMID:11431710'
p30415
ag30415
aS'AUTHORS'
p30416
aS'Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.'
p30417
aS'TITLE'
p30418
aS'Molecular pathology of endometrial hyperplasia and carcinoma.'
p30419
aS'JOURNAL'
p30420
aS'Hum Pathol 32:569-77 (2001)'
p30421
aS'PMID:15284264'
p30422
ag30422
aS'AUTHORS'
p30423
aS'Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.'
p30424
aS'TITLE'
p30425
aS'Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.'
p30426
aS'JOURNAL'
p30427
aS'J Clin Oncol 22:3126-32 (2004)'
p30428
aS'PMID:7585656'
p30429
ag30429
aS'AUTHORS'
p30430
aS'Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.'
p30431
aS'TITLE'
p30432
aS'Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.'
p30433
aS'JOURNAL'
p30434
aS'Cancer Res 55:5693-8 (1995)'
p30435
aS'PMID:16248975'
p30436
ag30436
aS'AUTHORS'
p30437
aS'Kim D, Chung J.'
p30438
aS'TITLE'
p30439
aS'Akt: versatile mediator of cell survival and beyond.'
p30440
aS'JOURNAL'
p30441
aS'J Biochem Mol Biol 35:106-15 (2002)'
p30442
asS'KO_PATHWAY'
p30443
(lp30444
S'ko05213'
p30445
asS'PATHWAY_MAP'
p30446
(lp30447
S'map05213'
p30448
asS'DISEASE'
p30449
(lp30450
S'H00026'
p30451
aS'Endometrial Cancer'
p30452
ag30451
ag30452
aS'H00876'
p30453
aS'Mismatch repair deficiency'
p30454
asS'ENTRY'
p30455
(lp30456
S'map05213'
p30457
aS'Pathway'
p30458
asS'CLASS'
p30459
(lp30460
S'Human Diseases Cancers'
p30461
asS'DESCRIPTION'
p30462
(lp30463
S'Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.'
p30464
assS'path:map05214'
p30465
(dp30466
S'NAME'
p30467
(lp30468
S'Glioma'
p30469
asS'REFERENCE'
p30470
(lp30471
S'PMID:15639402'
p30472
ag30472
aS'AUTHORS'
p30473
aS'Soni D, King JA, Kaye AH, Hovens CM.'
p30474
aS'TITLE'
p30475
aS'Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.'
p30476
aS'JOURNAL'
p30477
aS'J Clin Neurosci 12:1-5 (2005)'
p30478
aS'PMID:12154354'
p30479
ag30479
aS'AUTHORS'
p30480
aS'Zhu Y, Parada LF.'
p30481
aS'TITLE'
p30482
aS'The molecular and genetic basis of neurological tumours.'
p30483
aS'JOURNAL'
p30484
aS'Nat Rev Cancer 2:616-26 (2002)'
p30485
aS'PMID:11253051'
p30486
ag30486
aS'AUTHORS'
p30487
aS'Holland EC.'
p30488
aS'TITLE'
p30489
aS'Gliomagenesis: genetic alterations and mouse models.'
p30490
aS'JOURNAL'
p30491
aS'Nat Rev Genet 2:120-9 (2001)'
p30492
aS'PMID:16700615'
p30493
ag30493
aS'AUTHORS'
p30494
aS'Bansal K, Liang ML, Rutka JT.'
p30495
aS'TITLE'
p30496
aS'Molecular biology of human gliomas.'
p30497
aS'JOURNAL'
p30498
aS'Technol Cancer Res Treat 5:185-94 (2006)'
p30499
aS'(Japanese)'
p30500
ag30500
aS'AUTHORS'
p30501
aS'Tabuchi K (ed).'
p30502
aS'TITLE'
p30503
aS'[Gliomas: Research and therapy] (In Japanese)'
p30504
aS'JOURNAL'
p30505
aS'Springer-Verlag Tokyo (2006)'
p30506
aS'PMID:12762887'
p30507
ag30507
aS'AUTHORS'
p30508
aS"Kapoor GS, O'Rourke DM."
p30509
aS'TITLE'
p30510
aS'Mitogenic signaling cascades in glial tumors.'
p30511
aS'JOURNAL'
p30512
aS'Neurosurgery 52:1425-34 discussion 1434-5 (2003)'
p30513
aS'PMID:16095998'
p30514
ag30514
aS'AUTHORS'
p30515
aS'Hulleman E, Helin K.'
p30516
aS'TITLE'
p30517
aS'Molecular mechanisms in gliomagenesis.'
p30518
aS'JOURNAL'
p30519
aS'Adv Cancer Res 94:1-27 (2005)'
p30520
aS'PMID:11057895'
p30521
ag30521
aS'AUTHORS'
p30522
aS'Schlessinger J.'
p30523
aS'TITLE'
p30524
aS'Cell signaling by receptor tyrosine kinases.'
p30525
aS'JOURNAL'
p30526
aS'Cell 103:211-25 (2000)'
p30527
aS'PMID:9643506'
p30528
ag30528
aS'AUTHORS'
p30529
aS'Ng HK, Lam PY.'
p30530
aS'TITLE'
p30531
aS'The molecular genetics of central nervous system tumors.'
p30532
aS'JOURNAL'
p30533
aS'Pathology 30:196-202 (1998)'
p30534
aS'PMID:12084351'
p30535
ag30535
aS'AUTHORS'
p30536
aS'Knobbe CB, Merlo A, Reifenberger G.'
p30537
aS'TITLE'
p30538
aS'Pten signaling in gliomas.'
p30539
aS'JOURNAL'
p30540
aS'Neuro-oncol 4:196-211 (2002)'
p30541
asS'KO_PATHWAY'
p30542
(lp30543
S'ko05214'
p30544
asS'PATHWAY_MAP'
p30545
(lp30546
S'map05214'
p30547
asS'DISEASE'
p30548
(lp30549
S'H00042'
p30550
aS'Glioma'
p30551
asS'ENTRY'
p30552
(lp30553
S'map05214'
p30554
aS'Pathway'
p30555
asS'CLASS'
p30556
(lp30557
S'Human Diseases Cancers'
p30558
asS'DESCRIPTION'
p30559
(lp30560
S'Gliomas are the most common of the primary brain tumors and account for more than 40% of all central nervous system neoplasms. Gliomas include tumours that are composed predominantly of astrocytes (astrocytomas), oligodendrocytes (oligodendrogliomas), mixtures of various glial cells (for example,oligoastrocytomas) and ependymal cells (ependymomas). The most malignant form of infiltrating astrocytoma - glioblastoma multiforme (GBM) - is one of the most aggressive human cancers. GBM may develop de novo (primary glioblastoma) or by progression from low-grade or anaplastic astrocytoma (secondary glioblastoma).'
p30561
assS'path:map05215'
p30562
(dp30563
S'NAME'
p30564
(lp30565
S'Prostate cancer'
p30566
asS'REFERENCE'
p30567
(lp30568
S'PMID:12878745'
p30569
ag30569
aS'AUTHORS'
p30570
aS'Nelson WG, De Marzo AM, Isaacs WB.'
p30571
aS'TITLE'
p30572
aS'Prostate cancer.'
p30573
aS'JOURNAL'
p30574
aS'N Engl J Med 349:366-81 (2003)'
p30575
aS'PMID:15724144'
p30576
ag30576
aS'AUTHORS'
p30577
aS'Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.'
p30578
aS'TITLE'
p30579
aS'The emerging role of the PI3-K-Akt pathway in prostate cancer progression.'
p30580
aS'JOURNAL'
p30581
aS'Prostate Cancer Prostatic Dis 8:108-18 (2005)'
p30582
aS'PMID:16551847'
p30583
ag30583
aS'AUTHORS'
p30584
aS'Pienta KJ, Bradley D.'
p30585
aS'TITLE'
p30586
aS'Mechanisms underlying the development of androgen-independent prostate cancer.'
p30587
aS'JOURNAL'
p30588
aS'Clin Cancer Res 12:1665-71 (2006)'
p30589
aS'PMID:11900250'
p30590
ag30590
aS'AUTHORS'
p30591
aS'Feldman BJ, Feldman D.'
p30592
aS'TITLE'
p30593
aS'The development of androgen-independent prostate cancer.'
p30594
aS'JOURNAL'
p30595
aS'Nat Rev Cancer 1:34-45 (2001)'
p30596
aS'PMID:15082523'
p30597
ag30597
aS'AUTHORS'
p30598
aS'Heinlein CA, Chang C.'
p30599
aS'TITLE'
p30600
aS'Androgen receptor in prostate cancer.'
p30601
aS'JOURNAL'
p30602
aS'Endocr Rev 25:276-308 (2004)'
p30603
aS'PMID:9422516'
p30604
ag30604
aS'AUTHORS'
p30605
aS'Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.'
p30606
aS'TITLE'
p30607
aS'Androgen receptor gene and hormonal therapy failure of prostate cancer.'
p30608
aS'JOURNAL'
p30609
aS'Am J Pathol 152:1-9 (1998)'
p30610
aS'PMID:10835690'
p30611
ag30611
aS'AUTHORS'
p30612
aS'Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.'
p30613
aS'TITLE'
p30614
aS'Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.'
p30615
aS'JOURNAL'
p30616
aS'Nat Med 6:703-6 (2000)'
p30617
aS'PMID:10453277'
p30618
ag30618
aS'AUTHORS'
p30619
aS'Macri E, Loda M.'
p30620
aS'TITLE'
p30621
aS'Role of p27 in prostate carcinogenesis.'
p30622
aS'JOURNAL'
p30623
aS'Cancer Metastasis Rev 17:337-44 (1998)'
p30624
aS'PMID:11750244'
p30625
ag30625
aS'AUTHORS'
p30626
aS'Steers WD.'
p30627
aS'TITLE'
p30628
aS'5alpha-reductase activity in the prostate.'
p30629
aS'JOURNAL'
p30630
aS'Urology 58:17-24 discussion 24 (2001)'
p30631
aS'PMID:8069858'
p30632
ag30632
aS'AUTHORS'
p30633
aS'Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.'
p30634
aS'TITLE'
p30635
aS'Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.'
p30636
aS'JOURNAL'
p30637
aS'Cancer Res 54:4920-6 (1994)'
p30638
aS'PMID:11527574'
p30639
ag30639
aS'AUTHORS'
p30640
aS'Grimes CA, Jope RS.'
p30641
aS'TITLE'
p30642
aS'The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.'
p30643
aS'JOURNAL'
p30644
aS'Prog Neurobiol 65:391-426 (2001)'
p30645
asS'KO_PATHWAY'
p30646
(lp30647
S'ko05215'
p30648
asS'PATHWAY_MAP'
p30649
(lp30650
S'map05215'
p30651
asS'DISEASE'
p30652
(lp30653
S'H00024'
p30654
aS'Prostate cancer'
p30655
asS'ENTRY'
p30656
(lp30657
S'map05215'
p30658
aS'Pathway'
p30659
asS'CLASS'
p30660
(lp30661
S'Human Diseases Cancers'
p30662
asS'DESCRIPTION'
p30663
(lp30664
S'Prostate cancer constitutes a major health problem in Western countries. It is the most frequently diagnosed cancer among men and the second leading cause of male cancer deaths. The identification of key molecular alterations in prostate-cancer cells implicates carcinogen defenses (GSTP1), growth-factor-signaling pathways (NKX3.1, PTEN, and p27), and androgens (AR) as critical determinants of the phenotype of prostate-cancer cells. Glutathione S-transferases (GSTP1) are detoxifying enzymes. Cells of prostatic intraepithelial neoplasia, devoid of GSTP1, undergo genomic damage mediated by carcinogens. NKX3.1, PTEN, and p27 regulate the growth and survival of prostate cells in the normal prostate. Inadequate levels of PTEN and NKX3.1 lead to a reduction in p27 levels and to increased proliferation and decreased apoptosis. Androgen receptor (AR) is a transcription factor that is normally activated by its androgen ligand. During androgen withdrawal therapy, the AR signal transduction pathway also could be activated by amplification of the AR gene, by AR gene mutations, or by altered activity of AR coactivators. Through these mechanisms, tumor cells lead to the emergence of androgen-independent prostate cancer.'
p30665
assS'path:map05216'
p30666
(dp30667
S'NAME'
p30668
(lp30669
S'Thyroid cancer'
p30670
asS'REFERENCE'
p30671
(lp30672
S'PMID:16557281'
p30673
ag30673
aS'AUTHORS'
p30674
aS'Kondo T, Ezzat S, Asa SL.'
p30675
aS'TITLE'
p30676
aS'Pathogenetic mechanisms in thyroid follicular-cell neoplasia.'
p30677
aS'JOURNAL'
p30678
aS'Nat Rev Cancer 6:292-306 (2006)'
p30679
aS'PMID:16551846'
p30680
ag30680
aS'AUTHORS'
p30681
aS'Chiloeches A, Marais R.'
p30682
aS'TITLE'
p30683
aS"Is BRAF the Achilles' Heel of thyroid cancer?"
p30684
aS'JOURNAL'
p30685
aS'Clin Cancer Res 12:1661-4 (2006)'
p30686
aS'PMID:16946003'
p30687
ag30687
aS'AUTHORS'
p30688
aS'Reddi HV, McIver B, Grebe SK, Eberhardt NL.'
p30689
aS'TITLE'
p30690
aS'THE PAX8/PPAR{gamma} ONCOGENE IN THYROID TUMORIGENESIS.'
p30691
aS'JOURNAL'
p30692
aS'Endocrinology : (2006)'
p30693
aS'PMID:17062879'
p30694
ag30694
aS'AUTHORS'
p30695
aS'Santoro M, Melillo RM, Fusco A.'
p30696
aS'TITLE'
p30697
aS'RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.'
p30698
aS'JOURNAL'
p30699
aS'Eur J Endocrinol 155:645-653 (2006)'
p30700
aS'PMID:16242838'
p30701
ag30701
aS'AUTHORS'
p30702
aS'Pierotti MA, Greco A.'
p30703
aS'TITLE'
p30704
aS'Oncogenic rearrangements of the NTRK1/NGF receptor.'
p30705
aS'JOURNAL'
p30706
aS'Cancer Lett 232:90-8 (2006)'
p30707
aS'PMID:16189702'
p30708
ag30708
aS'AUTHORS'
p30709
aS'Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.'
p30710
aS'TITLE'
p30711
aS'Molecular pathology of well-differentiated thyroid carcinomas.'
p30712
aS'JOURNAL'
p30713
aS'Virchows Arch 447:787-93 (2005)'
p30714
aS'PMID:11165748'
p30715
ag30715
aS'AUTHORS'
p30716
aS'Gimm O.'
p30717
aS'TITLE'
p30718
aS'Thyroid cancer.'
p30719
aS'JOURNAL'
p30720
aS'Cancer Lett 163:143-56 (2001)'
p30721
aS'PMID:12094241'
p30722
ag30722
aS'AUTHORS'
p30723
aS'Williams D.'
p30724
aS'TITLE'
p30725
aS'Cancer after nuclear fallout: lessons from the Chernobyl accident.'
p30726
aS'JOURNAL'
p30727
aS'Nat Rev Cancer 2:543-9 (2002)'
p30728
asS'KO_PATHWAY'
p30729
(lp30730
S'ko05216'
p30731
asS'PATHWAY_MAP'
p30732
(lp30733
S'map05216'
p30734
asS'DISEASE'
p30735
(lp30736
S'H00032'
p30737
aS'Thyroid cancer'
p30738
asS'ENTRY'
p30739
(lp30740
S'map05216'
p30741
aS'Pathway'
p30742
asS'CLASS'
p30743
(lp30744
S'Human Diseases Cancers'
p30745
asS'DESCRIPTION'
p30746
(lp30747
S'Thyroid cancer is the most common endocrine malignancy and accounts for the majority of endocrine cancer- related deaths each year. More than 95% of thyroid carcinomas are derived from follicular cells.'
p30748
assS'path:map05217'
p30749
(dp30750
S'NAME'
p30751
(lp30752
S'Basal cell carcinoma'
p30753
asS'REFERENCE'
p30754
(lp30755
S'PMID:15948971'
p30756
ag30756
aS'AUTHORS'
p30757
aS'Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.'
p30758
aS'TITLE'
p30759
aS'Molecular aetiology and pathogenesis of basal cell carcinoma.'
p30760
aS'JOURNAL'
p30761
aS'Br J Dermatol 152:1108-24 (2005)'
p30762
aS'PMID:12588368'
p30763
ag30763
aS'AUTHORS'
p30764
aS'Saldanha G, Fletcher A, Slater DN.'
p30765
aS'TITLE'
p30766
aS'Basal cell carcinoma: a dermatopathological and molecular biological update.'
p30767
aS'JOURNAL'
p30768
aS'Br J Dermatol 148:195-202 (2003)'
p30769
aS'PMID:15978322'
p30770
ag30770
aS'AUTHORS'
p30771
aS'Daya-Grosjean L, Couve-Privat S.'
p30772
aS'TITLE'
p30773
aS'Sonic hedgehog signaling in basal cell carcinomas.'
p30774
aS'JOURNAL'
p30775
aS'Cancer Lett 225:181-92 (2005)'
p30776
aS'PMID:15468170'
p30777
ag30777
aS'AUTHORS'
p30778
aS'Tsai KY, Tsao H.'
p30779
aS'TITLE'
p30780
aS'The genetics of skin cancer.'
p30781
aS'JOURNAL'
p30782
aS'Am J Med Genet C Semin Med Genet 131C:82-92 (2004)'
p30783
aS'PMID:16881963'
p30784
ag30784
aS'AUTHORS'
p30785
aS'Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.'
p30786
aS'TITLE'
p30787
aS'Hedgehog signalling in skin development and cancer.'
p30788
aS'JOURNAL'
p30789
aS'Exp Dermatol 15:667-77 (2006)'
p30790
aS'PMID:16306523'
p30791
ag30791
aS'AUTHORS'
p30792
aS'Rubin AI, Chen EH, Ratner D.'
p30793
aS'TITLE'
p30794
aS'Basal-cell carcinoma.'
p30795
aS'JOURNAL'
p30796
aS'N Engl J Med 353:2262-9 (2005)'
p30797
aS'PMID:11276000'
p30798
ag30798
aS'AUTHORS'
p30799
aS'Saldanha G.'
p30800
aS'TITLE'
p30801
aS'The Hedgehog signalling pathway and cancer.'
p30802
aS'JOURNAL'
p30803
aS'J Pathol 193:427-32 (2001)'
p30804
aS'PMID:15270885'
p30805
ag30805
aS'AUTHORS'
p30806
aS'Saldanha G, Ghura V, Potter L, Fletcher A.'
p30807
aS'TITLE'
p30808
aS'Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.'
p30809
aS'JOURNAL'
p30810
aS'Br J Dermatol 151:157-64 (2004)'
p30811
aS'PMID:14737121'
p30812
ag30812
aS'AUTHORS'
p30813
aS'Pasca di Magliano M, Hebrok M.'
p30814
aS'TITLE'
p30815
aS'Hedgehog signalling in cancer formation and maintenance.'
p30816
aS'JOURNAL'
p30817
aS'Nat Rev Cancer 3:903-11 (2003)'
p30818
aS'PMID:15656799'
p30819
ag30819
aS'AUTHORS'
p30820
aS'Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.'
p30821
aS'TITLE'
p30822
aS'Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.'
p30823
aS'JOURNAL'
p30824
aS'Br J Dermatol 152:43-51 (2005)'
p30825
aS'PMID:14556242'
p30826
ag30826
aS'AUTHORS'
p30827
aS'Cohen MM Jr.'
p30828
aS'TITLE'
p30829
aS'The hedgehog signaling network.'
p30830
aS'JOURNAL'
p30831
aS'Am J Med Genet A 123:5-28 (2003)'
p30832
aS'PMID:11736900'
p30833
ag30833
aS'AUTHORS'
p30834
aS'Yamazaki F, Aragane Y, Kawada A, Tezuka T.'
p30835
aS'TITLE'
p30836
aS'Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.'
p30837
aS'JOURNAL'
p30838
aS'Br J Dermatol 145:771-7 (2001)'
p30839
aS'PMID:16054233'
p30840
ag30840
aS'AUTHORS'
p30841
aS'Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.'
p30842
aS'TITLE'
p30843
aS'Role of apoptosis in basal cell and squamous cell carcinoma formation.'
p30844
aS'JOURNAL'
p30845
aS'Immunol Lett 100:68-72 (2005)'
p30846
aS'PMID:11130178'
p30847
ag30847
aS'AUTHORS'
p30848
aS'Toftgard R.'
p30849
aS'TITLE'
p30850
aS'Hedgehog signalling in cancer.'
p30851
aS'JOURNAL'
p30852
aS'Cell Mol Life Sci 57:1720-31 (2000)'
p30853
asS'KO_PATHWAY'
p30854
(lp30855
S'ko05217'
p30856
asS'PATHWAY_MAP'
p30857
(lp30858
S'map05217'
p30859
asS'DISEASE'
p30860
(lp30861
S'H00039'
p30862
aS'Basal cell carcinoma'
p30863
ag30862
ag30863
aS'H00895'
p30864
aS'Basal cell nevus syndrome'
p30865
asS'MODULE'
p30866
(lp30867
S'M00678'
p30868
aS'Hedgehog signaling [PATH:map05217]'
p30869
asS'ENTRY'
p30870
(lp30871
S'map05217'
p30872
aS'Pathway'
p30873
asS'CLASS'
p30874
(lp30875
S'Human Diseases Cancers'
p30876
asS'DESCRIPTION'
p30877
(lp30878
S'Cancer of the skin is the most common cancer in Caucasians and basal cell carcinomas (BCC) account for 90% of all skin cancers. The vast majority of BCC cases are sporadic, though there is a rare familial syndrome basal cell nevus syndrome (BCNS, or Gorlin syndrome) that predisposes to development of BCC. In addition, there is strong epidemiological and genetic evidence that demonstrates UV exposure as a risk factor of prime importance. The development of basal cell carcinoma is associated with constitutive activation of sonic hedgehog signaling. The mutations in SMOH, PTCH1, and SHH in BCCs result in continuous activation of target genes. At a cellular level, sonic hedgehog signaling promotes cell proliferation. Mutations in TP53 are also found with high frequency (>50%) in sporadic BCC.'
p30879
assS'path:map04340'
p30880
(dp30881
S'NAME'
p30882
(lp30883
S'Hedgehog signaling pathway'
p30884
asS'REFERENCE'
p30885
(lp30886
S'PMID:14556242'
p30887
ag30887
aS'AUTHORS'
p30888
aS'Cohen MM Jr.'
p30889
aS'TITLE'
p30890
aS'The hedgehog signaling network.'
p30891
aS'JOURNAL'
p30892
aS'Am J Med Genet A 123:5-28 (2003)'
p30893
aS'PMID:15205520'
p30894
ag30894
aS'AUTHORS'
p30895
aS'Lum L, Beachy PA.'
p30896
aS'TITLE'
p30897
aS'The Hedgehog response network: sensors, switches, and routers.'
p30898
aS'JOURNAL'
p30899
aS'Science 304:1755-9 (2004)'
p30900
aS'PMID:12495844'
p30901
ag30901
aS'AUTHORS'
p30902
aS'Mullor JL, Sanchez P, Altaba AR.'
p30903
aS'TITLE'
p30904
aS'Pathways and consequences: Hedgehog signaling in human disease.'
p30905
aS'JOURNAL'
p30906
aS'Trends Cell Biol 12:562-9 (2002)'
p30907
aS'PMID:15013214'
p30908
ag30908
aS'AUTHORS'
p30909
aS'Ruiz i Altaba A, Stecca B, Sanchez P.'
p30910
aS'TITLE'
p30911
aS'Hedgehog--Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer.'
p30912
aS'JOURNAL'
p30913
aS'Cancer Lett 204:145-57 (2004)'
p30914
aS'PMID:14530294'
p30915
ag30915
aS'AUTHORS'
p30916
aS'Nusse R.'
p30917
aS'TITLE'
p30918
aS'Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.'
p30919
aS'JOURNAL'
p30920
aS'Development 130:5297-305 (2003)'
p30921
aS'PMID:14738752'
p30922
ag30922
aS'AUTHORS'
p30923
aS'Kalderon D.'
p30924
aS'TITLE'
p30925
aS'Hedgehog signaling: Costal-2 bridges the transduction gap.'
p30926
aS'JOURNAL'
p30927
aS'Curr Biol 14:R67-9 (2004)'
p30928
aS'PMID:15549094'
p30929
ag30929
aS'AUTHORS'
p30930
aS'Beachy PA, Karhadkar SS, Berman DM.'
p30931
aS'TITLE'
p30932
aS'Tissue repair and stem cell renewal in carcinogenesis.'
p30933
aS'JOURNAL'
p30934
aS'Nature 432:324-31 (2004)'
p30935
aS'PMID:15189162'
p30936
ag30936
aS'AUTHORS'
p30937
aS'Mann RK, Beachy PA.'
p30938
aS'TITLE'
p30939
aS'Novel lipid modifications of secreted protein signals.'
p30940
aS'JOURNAL'
p30941
aS'Annu Rev Biochem 73:891-923 (2004)'
p30942
aS'PMID:12437772'
p30943
ag30943
aS'AUTHORS'
p30944
aS'Frank-Kamenetsky M, Zhang XM, Bottega S, Guicherit O, Wichterle H, Dudek H, Bumcrot D, Wang FY, Jones S, Shulok J, Rubin LL, Porter JA.'
p30945
aS'TITLE'
p30946
aS'Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists.'
p30947
aS'JOURNAL'
p30948
aS'J Biol 1:10 (2002)'
p30949
aS'PMID:11238441'
p30950
ag30950
aS'AUTHORS'
p30951
aS'Koyabu Y, Nakata K, Mizugishi K, Aruga J, Mikoshiba K.'
p30952
aS'TITLE'
p30953
aS'Physical and functional interactions between Zic and Gli proteins.'
p30954
aS'JOURNAL'
p30955
aS'J Biol Chem 276:6889-92 (2001)'
p30956
asS'KO_PATHWAY'
p30957
(lp30958
S'ko04340'
p30959
asS'PATHWAY_MAP'
p30960
(lp30961
S'map04340'
p30962
asS'DISEASE'
p30963
(lp30964
S'H00263'
p30965
aS'Acrocallosal syndrome'
p30966
ag30965
ag30966
aS'H00267'
p30967
aS'Holoprosencephaly (HPE)'
p30968
aS'H00482'
p30969
aS'Brachydactyly'
p30970
aS'H00502'
p30971
aS'Pallister-Hall syndrome'
p30972
aS'H00607'
p30973
aS'46,XY disorders of sex development (Disorders of gonadal development)'
p30974
aS'H00646'
p30975
aS'Odontoonychodermal dysplasia'
p30976
aS'H00652'
p30977
aS'Solitary median maxillary central incisor syndrome'
p30978
aS'H00675'
p30979
aS'Acrocapitofemoral dysplasia'
p30980
aS'H00855'
p30981
aS'Triphalangeal thumb'
p30982
aS'H00886'
p30983
aS'Donnai-Barrow syndrome'
p30984
aS'H00895'
p30985
aS'Basal cell nevus syndrome'
p30986
aS'H01027'
p30987
aS'Anophthalmia and microphthalmia (A/M)'
p30988
aS'H01160'
p30989
aS'Schizencephaly'
p30990
aS'H01226'
p30991
aS'GLI3 morphopathies'
p30992
asS'MODULE'
p30993
(lp30994
S'M00678'
p30995
aS'Hedgehog signaling [PATH:map04340]'
p30996
asS'ENTRY'
p30997
(lp30998
S'map04340'
p30999
aS'Pathway'
p31000
asS'CLASS'
p31001
(lp31002
S'Environmental Information Processing Signal transduction'
p31003
asS'DESCRIPTION'
p31004
(lp31005
S'The Hedgehog (Hh) family of secreted signaling proteins plays a crucial role in development of diverse animal phyla, from Drosophila to humans, regulating morphogenesis of a variety of tissues and organs. Hh signaling is also involved in control of stem cell proliferation in adult tissues and aberrant activation of the Hh pathway has been linked to multiple types of human cancer. Members of the Hh family bind to patched (ptc), thus releasing smoothened (smo) to transduce a signal. Transcriptional activation occurs through the GLI family of proteins resulting in activation of target genes.'
p31006
assS'path:map00010'
p31007
(dp31008
S'NAME'
p31009
(lp31010
S'Glycolysis / Gluconeogenesis'
p31011
asS'REFERENCE'
p31012
(lp31013
S'(map 1)'
p31014
ag31014
aS'AUTHORS'
p31015
aS'Nishizuka Y (ed).'
p31016
aS'TITLE'
p31017
aS'[Metabolic Maps] (In Japanese)'
p31018
aS'JOURNAL'
p31019
aS'Tokyo Kagaku Dojin (1980)'
p31020
aS'(map 1)'
p31021
ag31021
aS'AUTHORS'
p31022
aS'Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).'
p31023
aS'TITLE'
p31024
aS'[Cellular Functions and Metabolic Maps] (In Japanese)'
p31025
aS'JOURNAL'
p31026
aS'Tokyo Kagaku Dojin (1997)'
p31027
ag22
ag22
aS'AUTHORS'
p31028
aS'Michal G.'
p31029
aS'TITLE'
p31030
aS'Biochemical Pathways'
p31031
aS'JOURNAL'
p31032
aS'Wiley (1999)'
p31033
asS'KO_PATHWAY'
p31034
(lp31035
S'ko00010'
p31036
asS'PATHWAY_MAP'
p31037
(lp31038
S'map00010'
p31039
asS'DISEASE'
p31040
(lp31041
S'H00069'
p31042
aS'Glycogen storage diseases (GSD)'
p31043
ag31042
ag31043
aS'H00071'
p31044
aS'Hereditary fructose intolerance'
p31045
aS'H00072'
p31046
aS'Pyruvate dehydrogenase complex deficiency'
p31047
aS'H00114'
p31048
aS'Fructose-1,6-bisphosphatase deficiency'
p31049
aS'H00664'
p31050
aS'Anemia due to disorders of glycolytic enzymes'
p31051
aS'H01071'
p31052
aS'Acute alcohol sensitivity'
p31053
aS'H01096'
p31054
aS'Pyruvate kinase (PK) deficiency'
p31055
aS'H01267'
p31056
aS'Familial hyperinsulinemic hypoglycemia (HHF)'
p31057
asS'MODULE'
p31058
(lp31059
S'M00001'
p31060
aS'Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate [PATH:map00010]'
p31061
ag31060
ag31061
aS'M00002'
p31062
aS'Glycolysis, core module involving three-carbon compounds [PATH:map00010]'
p31063
aS'M00003'
p31064
aS'Gluconeogenesis, oxaloacetate => fructose-6P [PATH:map00010]'
p31065
aS'M00114'
p31066
aS'Ascorbate biosynthesis, plants, glucose-6P => ascorbate [PATH:map00010]'
p31067
aS'M00265'
p31068
aS'PTS system, glucose-specific II component [PATH:map00010]'
p31069
aS'M00266'
p31070
aS'PTS system, maltose and glucose-specific II component [PATH:map00010]'
p31071
aS'M00268'
p31072
aS'PTS system, arbutin-like II component [PATH:map00010]'
p31073
aS'M00272'
p31074
aS'PTS system, arbutin-, cellobiose-, and salicin-specific II component [PATH:map00010]'
p31075
aS'M00307'
p31076
aS'Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map00010]'
p31077
asS'DBLINKS'
p31078
(lp31079
S'GO: 0006096 0006094'
p31080
asS'ENTRY'
p31081
(lp31082
S'map00010'
p31083
aS'Pathway'
p31084
asS'CLASS'
p31085
(lp31086
S'Metabolism Carbohydrate metabolism'
p31087
asS'DESCRIPTION'
p31088
(lp31089
S'Glycolysis is the process of converting glucose into pyruvate and generating small amounts of ATP (energy) and NADH (reducing power). It is a central pathway that produces important precursor metabolites: six-carbon compounds of glucose-6P and fructose-6P and three-carbon compounds of glycerone-P, glyceraldehyde-3P, glycerate-3P, phosphoenolpyruvate, and pyruvate [MD:M00001]. Acetyl-CoA, another important precursor metabolite, is produced by oxidative decarboxylation of pyruvate [MD:M00307]. When the enzyme genes of this pathway are examined in completely sequenced genomes, the reaction steps of three-carbon compounds from glycerone-P to pyruvate form a conserved core module [MD:M00002], which is found in almost all organisms and which sometimes contains operon structures in bacterial genomes. Gluconeogenesis is a synthesis pathway of glucose from noncarbohydrate precursors. It is essentially a reversal of glycolysis with minor variations of alternative paths [MD:M00003].'
p31090
assS'path:map00231'
p31091
(dp31092
S'DBLINKS'
p31093
(lp31094
S'GO: 0043638'
p31095
asS'NAME'
p31096
(lp31097
S'Puromycin biosynthesis'
p31098
asS'REFERENCE'
p31099
(lp31100
S'PMID:8576156'
p31101
ag31101
aS'AUTHORS'
p31102
aS'Tercero JA, Espinosa JC, Lacalle RA, Jimenez A.'
p31103
aS'TITLE'
p31104
aS'The biosynthetic pathway of the aminonucleoside antibiotic puromycin, as deduced from the molecular analysis of the pur cluster of Streptomyces alboniger.'
p31105
aS'JOURNAL'
p31106
aS'J Biol Chem 271:1579-90 (1996)'
p31107
asS'KO_PATHWAY'
p31108
(lp31109
S'ko00231'
p31110
asS'ENTRY'
p31111
(lp31112
S'map00231'
p31113
aS'Pathway'
p31114
asS'PATHWAY_MAP'
p31115
(lp31116
S'map00231'
p31117
asS'CLASS'
p31118
(lp31119
S'Metabolism Biosynthesis of other secondary metabolites'
p31120
assS'path:map00230'
p31121
(dp31122
S'NAME'
p31123
(lp31124
S'Purine metabolism'
p31125
asS'REFERENCE'
p31126
(lp31127
S'PMID:10601204'
p31128
ag31128
aS'AUTHORS'
p31129
aS'Cusa E, Obradors N, Baldoma L, Badia J, Aguilar J.'
p31130
aS'TITLE'
p31131
aS'Genetic analysis of a chromosomal region containing genes required for assimilation of allantoin nitrogen and linked glyoxylate metabolism in Escherichia coli.'
p31132
aS'JOURNAL'
p31133
aS'J Bacteriol 181:7479-84 (1999)'
p31134
aS'PMID:10986234'
p31135
ag31135
aS'AUTHORS'
p31136
aS'Xi H, Schneider BL, Reitzer L.'
p31137
aS'TITLE'
p31138
aS'Purine catabolism in Escherichia coli and function of xanthine dehydrogenase in purine salvage.'
p31139
aS'JOURNAL'
p31140
aS'J Bacteriol 182:5332-41 (2000)'
p31141
asS'KO_PATHWAY'
p31142
(lp31143
S'ko00230'
p31144
asS'PATHWAY_MAP'
p31145
(lp31146
S'map00230'
p31147
asS'DISEASE'
p31148
(lp31149
S'H00192'
p31150
aS'Xanthinuria'
p31151
ag31150
ag31151
aS'H00194'
p31152
aS'Lesch-Nyhan syndrome'
p31153
aS'H00195'
p31154
aS'Adenine phosphoribosyltransferase deficiency'
p31155
aS'H00196'
p31156
aS'Phosphoribosylpyrophosphate synthetase I superactivity'
p31157
aS'H00197'
p31158
aS'Adenylosuccinate lyase deficiency'
p31159
aS'H00469'
p31160
aS'Mitochondrial DNA depletion syndrome (MDS)'
p31161
aS'H00481'
p31162
aS'Cone-rod dystrophy and cone dystrophy'
p31163
aS'H00494'
p31164
aS'Desbuquois syndrome'
p31165
aS'H00674'
p31166
aS'Anemia due to disorders of nucleotide metabolism'
p31167
aS'H00761'
p31168
aS'SEMD, Pakistani type'
p31169
aS'H00824'
p31170
aS'Calcification of joints and arteries'
p31171
aS'H00837'
p31172
aS'Leber congenital amaurosis (LCR)'
p31173
aS'H00946'
p31174
aS'Arts syndrome'
p31175
aS'H00966'
p31176
aS'AICA-ribosiduria'
p31177
aS'H01002'
p31178
aS'Generalized arterial calcification of infancy'
p31179
aS'H01096'
p31180
aS'Pyruvate kinase (PK) deficiency'
p31181
aS'H01118'
p31182
aS'Progressive external ophthalmoplegia (PEO)'
p31183
aS'H01128'
p31184
aS'Reticular dysgenesis'
p31185
aS'H01394'
p31186
aS'Cole disease'
p31187
asS'MODULE'
p31188
(lp31189
S'M00005'
p31190
aS'PRPP biosynthesis, ribose 5P => PRPP [PATH:map00230]'
p31191
ag31190
ag31191
aS'M00048'
p31192
aS'Inosine monophosphate biosynthesis, PRPP + glutamine => IMP [PATH:map00230]'
p31193
aS'M00049'
p31194
aS'Adenine ribonucleotide biosynthesis, IMP => ADP,ATP [PATH:map00230]'
p31195
aS'M00050'
p31196
aS'Guanine ribonucleotide biosynthesis IMP => GDP,GTP [PATH:map00230]'
p31197
aS'M00546'
p31198
aS'Purine degradation, xanthine => urea [PATH:map00230]'
p31199
asS'DBLINKS'
p31200
(lp31201
S'GO: 0042278'
p31202
asS'ENTRY'
p31203
(lp31204
S'map00230'
p31205
aS'Pathway'
p31206
asS'CLASS'
p31207
(lp31208
S'Metabolism Nucleotide metabolism'
p31209
assS'path:map00720'
p31210
(dp31211
S'NAME'
p31212
(lp31213
S'Carbon fixation pathways in prokaryotes'
p31214
asS'REFERENCE'
p31215
(lp31216
S'PMID:19955419'
p31217
ag31217
aS'AUTHORS'
p31218
aS'Zarzycki J, Brecht V, Muller M, Fuchs G'
p31219
aS'TITLE'
p31220
aS'Identifying the missing steps of the autotrophic 3-hydroxypropionate CO2 fixation cycle in Chloroflexus aurantiacus.'
p31221
aS'JOURNAL'
p31222
aS'Proc Natl Acad Sci U S A 106:21317-22 (2009)'
p31223
aS'PMID:19429610'
p31224
ag31224
aS'AUTHORS'
p31225
aS'Teufel R, Kung JW, Kockelkorn D, Alber BE, Fuchs G'
p31226
aS'TITLE'
p31227
aS'3-hydroxypropionyl-coenzyme A dehydratase and acryloyl-coenzyme A reductase, enzymes of the autotrophic 3-hydroxypropionate/4-hydroxybutyrate cycle in the Sulfolobales.'
p31228
aS'JOURNAL'
p31229
aS'J Bacteriol 191:4572-81 (2009)'
p31230
aS'PMID:18511565'
p31231
ag31231
aS'AUTHORS'
p31232
aS'Huber H, Gallenberger M, Jahn U, Eylert E, Berg IA, Kockelkorn D, Eisenreich W, Fuchs G'
p31233
aS'TITLE'
p31234
aS'A dicarboxylate/4-hydroxybutyrate autotrophic carbon assimilation cycle in the hyperthermophilic Archaeum Ignicoccus hospitalis.'
p31235
aS'JOURNAL'
p31236
aS'Proc Natl Acad Sci U S A 105:7851-6 (2008)'
p31237
aS'PMID:15838028'
p31238
ag31238
aS'AUTHORS'
p31239
aS'Hugler M, Wirsen CO, Fuchs G, Taylor CD, Sievert SM'
p31240
aS'TITLE'
p31241
aS'Evidence for autotrophic CO2 fixation via the reductive tricarboxylic acid cycle'
p31242
aS'by members of the epsilon subdivision of proteobacteria.'
p31243
aS'JOURNAL'
p31244
aS'J Bacteriol 187:3020-7 (2005)'
p31245
aS'PMID:11827525'
p31246
ag31246
aS'AUTHORS'
p31247
aS'Seravalli J, Kumar M, Ragsdale SW'
p31248
aS'TITLE'
p31249
aS'Rapid kinetic studies of acetyl-CoA synthesis: evidence supporting the catalytic'
p31250
aS'intermediacy of a paramagnetic NiFeC species in the autotrophic Wood-Ljungdahl pathway.'
p31251
aS'JOURNAL'
p31252
aS'Biochemistry 41:1807-19 (2002)'
p31253
aS'PMID:3096193'
p31254
ag31254
aS'AUTHORS'
p31255
aS'Ljungdahl LG'
p31256
aS'TITLE'
p31257
aS'The autotrophic pathway of acetate synthesis in acetogenic bacteria.'
p31258
aS'JOURNAL'
p31259
aS'Annu Rev Microbiol 40:415-50 (1986)'
p31260
asS'KO_PATHWAY'
p31261
(lp31262
S'ko00720'
p31263
asS'PATHWAY_MAP'
p31264
(lp31265
S'map00720'
p31266
asS'MODULE'
p31267
(lp31268
S'M00173'
p31269
aS'Reductive citrate cycle (Arnon-Buchanan cycle) [PATH:map00720]'
p31270
ag31269
ag31270
aS'M00374'
p31271
aS'Dicarboxylate-hydroxybutyrate cycle [PATH:map00720]'
p31272
aS'M00375'
p31273
aS'Hydroxypropionate-hydroxybutylate cycle [PATH:map00720]'
p31274
aS'M00376'
p31275
aS'3-Hydroxypropionate bi-cycle [PATH:map00720]'
p31276
aS'M00377'
p31277
aS'Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [PATH:map00720]'
p31278
aS'M00579'
p31279
aS'Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map00720]'
p31280
aS'M00620'
p31281
aS'Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate [PATH:map00720]'
p31282
asS'DBLINKS'
p31283
(lp31284
S'GO: 0015977'
p31285
asS'ENTRY'
p31286
(lp31287
S'map00720'
p31288
aS'Pathway'
p31289
asS'CLASS'
p31290
(lp31291
S'Metabolism Energy metabolism'
p31292
asS'DESCRIPTION'
p31293
(lp31294
S'Carbon fixation is an important pathway for autotrophs living in various environments. Plants and cyanobacteria fix CO2 as organic compounds using solar energy mainly by the reductive pentose phosphate cycle (also called Calvin cycle, Calvin-Benson cycle, or Calvin-Benson-Bassham cycle) [MD:M00165]. There are, at least, five additional carbon fixation pathways known to exist in autotrophic bacteria and archaea, which differ in reducing compounds, energy source, and oxygen sensitivity of enzymes. (i) The reductive citric acid cycle (Arnon-Buchanan cycle) [MD:M00173] is found in microaerophiles and anaerobes, such as green sulfur bacteria. In one complete turn of this cycle, four molecules of CO2 are fixed by the enzymes that are sensitive to oxygen, resulting in the production of one molecule of oxaloacetate, which is itself an intermediate of the cycle. (ii) The reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [MD:M00377] is found in strictly anaerobic bacteria and archaea (Proteobacteria, Planctomycetes, Spirochaetes, and Euryarchaeota), some of which are methane-forming. A bifunctional enzyme, carbon monoxide dehydrogenase/acetyl-CoA synthase, catalyzes the reactions from CO2 to CO and from CO2 to a methyl group, and then to generate acetyl-CoA. (iii) The 3-hydroxypropionate bicycle [MD:M00376] is found in some green non-sulphur bacteria of the family Chloroflexaceae. In one complete turn of this bicycle, three molecules of bicarbonate are converted into one molecule of pyruvate. In addition, this bicycle provides the secondary benefit of useful intermediates for biosynthesis: acetyl-CoA, glyoxylate, and succinyl-CoA. (iv) The hydroxypropionate-hydroxybutyrate cycle [MD:M00375] is found in aerobic Crenarchaeota, Acidianus, Metallosphaera, and Sulfolobales. Some of the intermediates and the carboxylation reactions are the same as in the 3-hydroxypropionate bicycle. One complete turn of this cycle generates two molecules of acetyl-CoA, one of which is reutilized in the the cycle and the other is removed for cell material biosynthesis. (v) The dicarboxylate-hydroxybutyrate cycle [MD:M00374] was named after its intermediates: succinate (a kind of dicarboxylate) and hydroxybutyrate. This cycle has been found only in Ignicoccus hospitals, a strictly anaerobic hyperthermophilic archaea. Recent genome study suggests that this cycle may exist in Desulfurococcales (to which Ignicoccus belongs) and Thermoproteales (a taxon close to the origin of archaea). The first half of the cycle, from acetyl-CoA to succinate-CoA, corresponds to the reductive citric acid cycle and the latter half of the cycle, from succinate-CoA to two molecules of acetyl-CoA, corresponds to the hydroxypropionate-hydroxybutyrate cycle.'
p31295
assS'path:map04961'
p31296
(dp31297
S'NAME'
p31298
(lp31299
S'Endocrine and other factor-regulated calcium reabsorption'
p31300
asS'REFERENCE'
p31301
(lp31302
S'PMID:18989697'
p31303
ag31303
aS'AUTHORS'
p31304
aS'Boros S, Bindels RJ, Hoenderop JG'
p31305
aS'TITLE'
p31306
aS'Active Ca(2+) reabsorption in the connecting tubule.'
p31307
aS'JOURNAL'
p31308
aS'Pflugers Arch 458:99-109 (2009)'
p31309
aS'PMID:16518325'
p31310
ag31310
aS'AUTHORS'
p31311
aS'Lambers TT, Bindels RJ, Hoenderop JG'
p31312
aS'TITLE'
p31313
aS'Coordinated control of renal Ca2+ handling.'
p31314
aS'JOURNAL'
p31315
aS'Kidney Int 69:650-4 (2006)'
p31316
aS'PMID:18596722'
p31317
ag31317
aS'AUTHORS'
p31318
aS'de Groot T, Bindels RJ, Hoenderop JG'
p31319
aS'TITLE'
p31320
aS'TRPV5: an ingeniously controlled calcium channel.'
p31321
aS'JOURNAL'
p31322
aS'Kidney Int 74:1241-6 (2008)'
p31323
aS'PMID:20969972'
p31324
ag31324
aS'AUTHORS'
p31325
aS'Markadieu N, Bindels RJ, Hoenderop JG'
p31326
aS'TITLE'
p31327
aS'The renal connecting tubule: Resolved and unresolved issues in Ca(2+) transport.'
p31328
aS'JOURNAL'
p31329
aS'Int J Biochem Cell Biol 43:1-4 (2011)'
p31330
aS'PMID:15618484'
p31331
ag31331
aS'AUTHORS'
p31332
aS'Hoenderop JG, Nilius B, Bindels RJ'
p31333
aS'TITLE'
p31334
aS'Calcium absorption across epithelia.'
p31335
aS'JOURNAL'
p31336
aS'Physiol Rev 85:373-422 (2005)'
p31337
aS'PMID:15747113'
p31338
ag31338
aS'AUTHORS'
p31339
aS'van Abel M, Hoenderop JG, Bindels RJ'
p31340
aS'TITLE'
p31341
aS'The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for'
p31342
aS'disease.'
p31343
aS'JOURNAL'
p31344
aS'Naunyn Schmiedebergs Arch Pharmacol 371:295-306 (2005)'
p31345
aS'PMID:16044309'
p31346
ag31346
aS'AUTHORS'
p31347
aS'Nijenhuis T, Hoenderop JG, Bindels RJ'
p31348
aS'TITLE'
p31349
aS'TRPV5 and TRPV6 in Ca(2+) (re)absorption: regulating Ca(2+) entry at the gate.'
p31350
aS'JOURNAL'
p31351
aS'Pflugers Arch 451:181-92 (2005)'
p31352
aS'PMID:12684797'
p31353
ag31353
aS'AUTHORS'
p31354
aS'Hoenderop JG, Nilius B, Bindels RJ'
p31355
aS'TITLE'
p31356
aS'Epithelial calcium channels: from identification to function and regulation.'
p31357
aS'JOURNAL'
p31358
aS'Pflugers Arch 446:304-8 (2003)'
p31359
aS'PMID:17006539'
p31360
ag31360
aS'AUTHORS'
p31361
aS'Gkika D, Topala CN, Chang Q, Picard N, Thebault S, Houillier P, Hoenderop JG, Bindels RJ'
p31362
aS'TITLE'
p31363
aS'Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5.'
p31364
aS'JOURNAL'
p31365
aS'EMBO J 25:4707-16 (2006)'
p31366
aS'PMID:17233615'
p31367
ag31367
aS'AUTHORS'
p31368
aS'Schoeber JP, Hoenderop JG, Bindels RJ'
p31369
aS'TITLE'
p31370
aS'Concerted action of associated proteins in the regulation of TRPV5 and TRPV6.'
p31371
aS'JOURNAL'
p31372
aS'Biochem Soc Trans 35:115-9 (2007)'
p31373
aS'PMID:18293139'
p31374
ag31374
aS'AUTHORS'
p31375
aS'Renkema KY, Alexander RT, Bindels RJ, Hoenderop JG'
p31376
aS'TITLE'
p31377
aS'Calcium and phosphate homeostasis: concerted interplay of new regulators.'
p31378
aS'JOURNAL'
p31379
aS'Ann Med 40:82-91 (2008)'
p31380
aS'PMID:19423690'
p31381
ag31381
aS'AUTHORS'
p31382
aS'de Groot T, Lee K, Langeslag M, Xi Q, Jalink K, Bindels RJ, Hoenderop JG'
p31383
aS'TITLE'
p31384
aS'Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation.'
p31385
aS'JOURNAL'
p31386
aS'J Am Soc Nephrol 20:1693-704 (2009)'
p31387
asS'KO_PATHWAY'
p31388
(lp31389
S'ko04961'
p31390
asS'PATHWAY_MAP'
p31391
(lp31392
S'map04961'
p31393
asS'DISEASE'
p31394
(lp31395
S'H00680'
p31396
aS'Primary failure of tooth eruption'
p31397
ag31396
ag31397
aS'H00700'
p31398
aS'Centronuclear myopathy'
p31399
aS'H00784'
p31400
aS'Localized autosomal recessive hypotrichosis'
p31401
aS'H00998'
p31402
aS'Alternating hemiplegia of childhood'
p31403
aS'H01143'
p31404
aS'Vitamin D-dependent rickets'
p31405
aS'H01193'
p31406
aS'Familial tumoral calcinosis (FTC)'
p31407
asS'ENTRY'
p31408
(lp31409
S'map04961'
p31410
aS'Pathway'
p31411
asS'CLASS'
p31412
(lp31413
S'Organismal Systems Excretory system'
p31414
asS'DESCRIPTION'
p31415
(lp31416
S'Calcium (Ca2+) is essential for numerous physiological functions including intracellular signalling processes, neuronal excitability, muscle contraction and bone formation. Therefore, its homeostasis is finely maintained through the coordination of intestinal absorption, renal reabsorption, and bone resorption. In kidney, the late part of the distal convoluted tubule (DCT) and the connecting tubule (CNT) are the site of active Ca2+ transport and precisely regulate Ca2+ reabsorption. Following Ca2+ entry through TRPV5, Ca2+ bound to calbindin-D28K diffuses to the basolateral side, where it is extruded into the blood compartment through NCX1 and to a lesser extent PMCA1b. In the urinary compartment, both klotho and tissue kallikrein (TK) increase the apical abundance of TRPV5. In the blood compartment, PTH, 1,25(OH)2D3 and estrogen increase the transcription and protein expression of'
p31417
assS'path:map04960'
p31418
(dp31419
S'NAME'
p31420
(lp31421
S'Aldosterone-regulated sodium reabsorption'
p31422
asS'REFERENCE'
p31423
(lp31424
S'PMID:16002531'
p31425
ag31425
aS'AUTHORS'
p31426
aS'Connell JM, Davies E'
p31427
aS'TITLE'
p31428
aS'The new biology of aldosterone.'
p31429
aS'JOURNAL'
p31430
aS'J Endocrinol 186:1-20 (2005)'
p31431
aS'PMID:11850323'
p31432
ag31432
aS'AUTHORS'
p31433
aS'Booth RE, Johnson JP, Stockand JD'
p31434
aS'TITLE'
p31435
aS'Aldosterone.'
p31436
aS'JOURNAL'
p31437
aS'Adv Physiol Educ 26:8-20 (2002)'
p31438
aS'PMID:18197893'
p31439
ag31439
aS'AUTHORS'
p31440
aS'Lee IH, Campbell CR, Cook DI, Dinudom A'
p31441
aS'TITLE'
p31442
aS'Regulation of epithelial Na+ channels by aldosterone: role of Sgk1.'
p31443
aS'JOURNAL'
p31444
aS'Clin Exp Pharmacol Physiol 35:235-41 (2008)'
p31445
aS'PMID:18174920'
p31446
ag31446
aS'AUTHORS'
p31447
aS'Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombes M'
p31448
aS'TITLE'
p31449
aS'The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology.'
p31450
aS'JOURNAL'
p31451
aS'Nucl Recept Signal 5:e012 (2007)'
p31452
aS'PMID:16286565'
p31453
ag31453
aS'AUTHORS'
p31454
aS'Fuller PJ, Young MJ'
p31455
aS'TITLE'
p31456
aS'Mechanisms of mineralocorticoid action.'
p31457
aS'JOURNAL'
p31458
aS'Hypertension 46:1227-35 (2005)'
p31459
aS'PMID:12649599'
p31460
ag31460
aS'AUTHORS'
p31461
aS'Verrey F, Loffing J, Zecevic M, Heitzmann D, Staub O'
p31462
aS'TITLE'
p31463
aS'SGK1: aldosterone-induced relay of Na+ transport regulation in distal kidney nephron cells.'
p31464
aS'JOURNAL'
p31465
aS'Cell Physiol Biochem 13:21-8 (2003)'
p31466
aS'PMID:17332888'
p31467
ag31467
aS'AUTHORS'
p31468
aS'Pearce D, Kleyman TR'
p31469
aS'TITLE'
p31470
aS'Salt, sodium channels, and SGK1.'
p31471
aS'JOURNAL'
p31472
aS'J Clin Invest 117:592-5 (2007)'
p31473
aS'PMID:19549592'
p31474
ag31474
aS'AUTHORS'
p31475
aS'Grossmann C, Gekle M'
p31476
aS'TITLE'
p31477
aS'New aspects of rapid aldosterone signaling.'
p31478
aS'JOURNAL'
p31479
aS'Mol Cell Endocrinol 308:53-62 (2009)'
p31480
aS'PMID:15590995'
p31481
ag31481
aS'AUTHORS'
p31482
aS'Vallon V, Wulff P, Huang DY, Loffing J, Volkl H, Kuhl D, Lang F'
p31483
aS'TITLE'
p31484
aS'Role of Sgk1 in salt and potassium homeostasis.'
p31485
aS'JOURNAL'
p31486
aS'Am J Physiol Regul Integr Comp Physiol 288:R4-10 (2005)'
p31487
aS'PMID:12943727'
p31488
ag31488
aS'AUTHORS'
p31489
aS'Rogerson FM, Brennan FE, Fuller PJ'
p31490
aS'TITLE'
p31491
aS'Dissecting mineralocorticoid receptor structure and function.'
p31492
aS'JOURNAL'
p31493
aS'J Steroid Biochem Mol Biol 85:389-96 (2003)'
p31494
aS'PMID:11208606'
p31495
ag31495
aS'AUTHORS'
p31496
aS'Wang J, Barbry P, Maiyar AC, Rozansky DJ, Bhargava A, Leong M, Firestone GL, Pearce D'
p31497
aS'TITLE'
p31498
aS'SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport.'
p31499
aS'JOURNAL'
p31500
aS'Am J Physiol Renal Physiol 280:F303-13 (2001)'
p31501
aS'PMID:17309947'
p31502
ag31502
aS'AUTHORS'
p31503
aS'Good DW'
p31504
aS'TITLE'
p31505
aS'Nongenomic actions of aldosterone on the renal tubule.'
p31506
aS'JOURNAL'
p31507
aS'Hypertension 49:728-39 (2007)'
p31508
asS'KO_PATHWAY'
p31509
(lp31510
S'ko04960'
p31511
asS'PATHWAY_MAP'
p31512
(lp31513
S'map04960'
p31514
asS'DISEASE'
p31515
(lp31516
S'H00239'
p31517
aS'Bartter syndrome'
p31518
ag31517
ag31518
aS'H00242'
p31519
aS'Liddle syndrome'
p31520
aS'H00243'
p31521
aS'Hyperkalemic distal renal tubular acidosis (RTA type 4)'
p31522
aS'H00603'
p31523
aS'Hypertension exacerbated in pregnancy'
p31524
aS'H00719'
p31525
aS'Leprechaunism'
p31526
aS'H00892'
p31527
aS'Bronchiectasis with or without elevated sweat chloride'
p31528
aS'H00942'
p31529
aS'Rabson-Mendenhall syndrome'
p31530
aS'H00998'
p31531
aS'Alternating hemiplegia of childhood'
p31532
aS'H01228'
p31533
aS'Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN)'
p31534
asS'ENTRY'
p31535
(lp31536
S'map04960'
p31537
aS'Pathway'
p31538
asS'CLASS'
p31539
(lp31540
S'Organismal Systems Excretory system'
p31541
asS'DESCRIPTION'
p31542
(lp31543
S'Sodium transport across the tight epithelia of Na+ reabsorbing tissues such as the distal part of the kidney nephron and colon is the major factor determining total-body Na+ levels, and thus, long-term blood pressure. Aldosterone plays a major role in sodium and potassium metabolism by binding to epithelial mineralocorticoid receptors (MR) in the renal collecting duct cells localized in the distal nephron, promoting sodium resorption and potassium excretion. Aldosterone enters a target cell and binds MR, which translocates into the nucleus and regulates gene transcription. Activation of MR leads to increased expression of Sgk-1, which phosphorylates Nedd4-2, an ubiquitin-ligase which targets ENAC to proteosomal degradation. Phosphorylated Nedd4-2 dissociates from ENAC, increasing its apical membrane abundance. Activation of MR also leads to increased expression of Na+/K+-ATPase, thus causing a net increase in sodium uptake from the renal filtrate. The specificity of MR for aldosterone is provided by 11beta-HSD2 by the rapid conversion of cortisol to cortisone in renal cortical collecting duct cells. Recently, besides genomic effects mediated by activated MR, rapid aldosterone actions that are independent of translation and transcription have been documented.'
p31544
assS'path:map04611'
p31545
(dp31546
S'NAME'
p31547
(lp31548
S'Platelet activation'
p31549
asS'REFERENCE'
p31550
(lp31551
S'PMID:21071698'
p31552
ag31552
aS'AUTHORS'
p31553
aS"Li Z, Delaney MK, O'Brien KA, Du X"
p31554
aS'TITLE'
p31555
aS'Signaling during platelet adhesion and activation.'
p31556
aS'JOURNAL'
p31557
aS'Arterioscler Thromb Vasc Biol 30:2341-9 (2010)'
p31558
aS'PMID:22119499'
p31559
ag31559
aS'AUTHORS'
p31560
aS'Broos K, De Meyer SF, Feys HB, Vanhoorelbeke K, Deckmyn H'
p31561
aS'TITLE'
p31562
aS'Blood platelet biochemistry.'
p31563
aS'JOURNAL'
p31564
aS'Thromb Res 129:245-9 (2012)'
p31565
aS'PMID:16149014'
p31566
ag31566
aS'AUTHORS'
p31567
aS'Jurk K, Kehrel BE'
p31568
aS'TITLE'
p31569
aS'Platelets: physiology and biochemistry.'
p31570
aS'JOURNAL'
p31571
aS'Semin Thromb Hemost 31:381-92 (2005)'
p31572
aS'PMID:17158345'
p31573
ag31573
aS'AUTHORS'
p31574
aS'Offermanns S'
p31575
aS'TITLE'
p31576
aS'Activation of platelet function through G protein-coupled receptors.'
p31577
aS'JOURNAL'
p31578
aS'Circ Res 99:1293-304 (2006)'
p31579
aS'PMID:18174460'
p31580
ag31580
aS'AUTHORS'
p31581
aS'Varga-Szabo D, Pleines I, Nieswandt B'
p31582
aS'TITLE'
p31583
aS'Cell adhesion mechanisms in platelets.'
p31584
aS'JOURNAL'
p31585
aS'Arterioscler Thromb Vasc Biol 28:403-12 (2008)'
p31586
aS'PMID:18550847'
p31587
ag31587
aS'AUTHORS'
p31588
aS'Yin H, Liu J, Li Z, Berndt MC, Lowell CA, Du X'
p31589
aS'TITLE'
p31590
aS'Src family tyrosine kinase Lyn mediates VWF/GPIb-IX-induced platelet activation via the cGMP signaling pathway.'
p31591
aS'JOURNAL'
p31592
aS'Blood 112:1139-46 (2008)'
p31593
aS'PMID:19630797'
p31594
ag31594
aS'AUTHORS'
p31595
aS'Bergmeier W, Stefanini L'
p31596
aS'TITLE'
p31597
aS'Novel molecules in calcium signaling in platelets.'
p31598
aS'JOURNAL'
p31599
aS'J Thromb Haemost 7 Suppl 1:187-90 (2009)'
p31600
aS'PMID:18544684'
p31601
ag31601
aS'AUTHORS'
p31602
aS'Cifuni SM, Wagner DD, Bergmeier W'
p31603
aS'TITLE'
p31604
aS'CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets.'
p31605
aS'JOURNAL'
p31606
aS'Blood 112:1696-703 (2008)'
p31607
aS'PMID:23106920'
p31608
ag31608
aS'AUTHORS'
p31609
aS'Heemskerk JW, Mattheij NJ, Cosemans JM'
p31610
aS'TITLE'
p31611
aS'Platelet-based coagulation: different populations, different functions.'
p31612
aS'JOURNAL'
p31613
aS'J Thromb Haemost 11:2-16 (2013)'
p31614
aS'PMID:19286885'
p31615
ag31615
aS'AUTHORS'
p31616
aS'Rivera J, Lozano ML, Navarro-Nunez L, Vicente V'
p31617
aS'TITLE'
p31618
aS'Platelet receptors and signaling in the dynamics of thrombus formation.'
p31619
aS'JOURNAL'
p31620
aS'Haematologica 94:700-11 (2009)'
p31621
aS'PMID:18363565'
p31622
ag31622
aS'AUTHORS'
p31623
aS'Banno A, Ginsberg MH'
p31624
aS'TITLE'
p31625
aS'Integrin activation.'
p31626
aS'JOURNAL'
p31627
aS'Biochem Soc Trans 36:229-34 (2008)'
p31628
aS'PMID:20089227'
p31629
ag31629
aS'AUTHORS'
p31630
aS'Angiolillo DJ, Ferreiro JL'
p31631
aS'TITLE'
p31632
aS'Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions.'
p31633
aS'JOURNAL'
p31634
aS'Rev Esp Cardiol 63:60-76 (2010)'
p31635
aS'PMID:22701130'
p31636
ag31636
aS'AUTHORS'
p31637
aS'Joo SJ'
p31638
aS'TITLE'
p31639
aS'Mechanisms of Platelet Activation and Integrin alphaIIbeta3.'
p31640
aS'JOURNAL'
p31641
aS'Korean Circ J 42:295-301 (2012)'
p31642
aS'PMID:20002545'
p31643
ag31643
aS'AUTHORS'
p31644
aS'Harper MT, Poole AW'
p31645
aS'TITLE'
p31646
aS'Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation.'
p31647
aS'JOURNAL'
p31648
aS'J Thromb Haemost 8:454-62 (2010)'
p31649
aS'PMID:23805129'
p31650
ag31650
aS'AUTHORS'
p31651
aS'Fitch-Tewfik JL, Flaumenhaft R'
p31652
aS'TITLE'
p31653
aS'Platelet granule exocytosis: a comparison with chromaffin cells.'
p31654
aS'JOURNAL'
p31655
aS'Front Endocrinol (Lausanne) 4:77 (2013)'
p31656
aS'PMID:18641368'
p31657
ag31657
aS'AUTHORS'
p31658
aS'Boylan B, Gao C, Rathore V, Gill JC, Newman DK, Newman PJ'
p31659
aS'TITLE'
p31660
aS'Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.'
p31661
aS'JOURNAL'
p31662
aS'Blood 112:2780-6 (2008)'
p31663
asS'KO_PATHWAY'
p31664
(lp31665
S'ko04611'
p31666
asS'PATHWAY_MAP'
p31667
(lp31668
S'map04611'
p31669
asS'DBLINKS'
p31670
(lp31671
S'GO: 0030168'
p31672
asS'ENTRY'
p31673
(lp31674
S'map04611'
p31675
aS'Pathway'
p31676
asS'CLASS'
p31677
(lp31678
S'Organismal Systems Immune system'
p31679
asS'DESCRIPTION'
p31680
(lp31681
S'Platelets play a key and beneficial role for primary hemostasis on the disruption of the integrity of vessel wall. Platelet adhesion and activation at sites of vascular wall injury is initiated by adhesion to adhesive macromolecules, such as collagen and von Willebrand factor (vWF), or by soluble platelet agonists, such as ADP, thrombin, and thromboxane A2. Different receptors are stimulated by various agonists, almost converging in increasing intracellular Ca2+ concentration that stimulate platelet shape change and granule secretion and ultimately induce the "inside-out" signaling process leading to activation of the ligand-binding function of integrin alpha IIb beta 3. Binding of alpha IIb beta 3 to its ligands, mainly fibrinogen, mediates platelet adhesion and aggregation and triggers "outside-in" signaling, resulting in platelet spreading, additional granule secretion, stabilization of platelet adhesion and aggregation, and clot retraction.'
p31682
assS'path:map04610'
p31683
(dp31684
S'NAME'
p31685
(lp31686
S'Complement and coagulation cascades'
p31687
asS'REFERENCE'
p31688
(lp31689
S'PMID:12787532'
p31690
ag31690
aS'AUTHORS'
p31691
aS'Norris LA.'
p31692
aS'TITLE'
p31693
aS'Blood coagulation.'
p31694
aS'JOURNAL'
p31695
aS'Best Pract Res Clin Obstet Gynaecol 17:369-83 (2003)'
p31696
aS'PMID:12970118'
p31697
ag31697
aS'AUTHORS'
p31698
aS'Mann KG'
p31699
aS'TITLE'
p31700
aS'Thrombin formation.'
p31701
aS'JOURNAL'
p31702
aS'Chest 124:4S-10S (2003)'
p31703
aS'PMID:12544983'
p31704
ag31704
aS'AUTHORS'
p31705
aS'Bhole D, Stahl GL.'
p31706
aS'TITLE'
p31707
aS'Therapeutic potential of targeting the complement cascade in critical care medicine.'
p31708
aS'JOURNAL'
p31709
aS'Crit Care Med 31:S97-104 (2003)'
p31710
aS'PMID:12914820'
p31711
ag31711
aS'AUTHORS'
p31712
aS'Turnberg D, Botto M.'
p31713
aS'TITLE'
p31714
aS'The regulation of the complement system: insights from genetically-engineered mice.'
p31715
aS'JOURNAL'
p31716
aS'Mol Immunol 40:145-53 (2003)'
p31717
aS'PMID:11903316'
p31718
ag31718
aS'AUTHORS'
p31719
aS'Campbell DJ.'
p31720
aS'TITLE'
p31721
aS'The kallikrein-kinin system in humans.'
p31722
aS'JOURNAL'
p31723
aS'Clin Exp Pharmacol Physiol 28:1060-5 (2001)'
p31724
aS'PMID:14501145'
p31725
ag31725
aS'AUTHORS'
p31726
aS'Ueno A, Oh-ishi S.'
p31727
aS'TITLE'
p31728
aS'Roles for the kallikrein-kinin system in inflammatory exudation and pain: lessons from studies on kininogen-deficient rats.'
p31729
aS'JOURNAL'
p31730
aS'J Pharmacol Sci 93:1-20 (2003)'
p31731
aS'PMID:12871285'
p31732
ag31732
aS'AUTHORS'
p31733
aS'Ruf W, Dorfleutner A, Riewald M.'
p31734
aS'TITLE'
p31735
aS'Specificity of coagulation factor signaling.'
p31736
aS'JOURNAL'
p31737
aS'J Thromb Haemost 1:1495-503 (2003)'
p31738
aS'PMID:14517441'
p31739
ag31739
aS'AUTHORS'
p31740
aS'Mazar AP, Henkin J, Goldfarb RH.'
p31741
aS'TITLE'
p31742
aS'The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis.'
p31743
aS'JOURNAL'
p31744
aS'Angiogenesis 3:15-32 (1999)'
p31745
aS'PMID:10644276'
p31746
ag31746
aS'AUTHORS'
p31747
aS'Markovic SN, Inwards DJ, Frigas EA, Phyliky RP.'
p31748
aS'TITLE'
p31749
aS'Acquired C1 esterase inhibitor deficiency.'
p31750
aS'JOURNAL'
p31751
aS'Ann Intern Med 132:144-50 (2000)'
p31752
aS'PMID:11956236'
p31753
ag31753
aS'AUTHORS'
p31754
aS'Schmaier AH.'
p31755
aS'TITLE'
p31756
aS'The plasma kallikrein-kinin system counterbalances the renin-angiotensin system.'
p31757
aS'JOURNAL'
p31758
aS'J Clin Invest 109:1007-9 (2002)'
p31759
aS'PMID:12927520'
p31760
ag31760
aS'AUTHORS'
p31761
aS'Velasco-Velazquez MA, Barrera D, Gonzalez-Arenas A, Rosales C, Agramonte-Hevia J.'
p31762
aS'TITLE'
p31763
aS'Macrophage--Mycobacterium tuberculosis interactions: role of complement receptor 3.'
p31764
aS'JOURNAL'
p31765
aS'Microb Pathog 35:125-31 (2003)'
p31766
aS'PMID:12727625'
p31767
ag31767
aS'AUTHORS'
p31768
aS'Kim SJ, Gershov D, Ma X, Brot N, Elkon KB'
p31769
aS'TITLE'
p31770
aS'Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses.'
p31771
aS'JOURNAL'
p31772
aS'Ann N Y Acad Sci 987:68-78 (2003)'
p31773
aS'PMID:10946292'
p31774
ag31774
aS'AUTHORS'
p31775
aS'Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T.'
p31776
aS'TITLE'
p31777
aS'Proteolytic activities of two types of mannose-binding lectin-associated serine protease.'
p31778
aS'JOURNAL'
p31779
aS'J Immunol 165:2637-42 (2000)'
p31780
asS'KO_PATHWAY'
p31781
(lp31782
S'ko04610'
p31783
asS'PATHWAY_MAP'
p31784
(lp31785
S'map04610'
p31786
asS'DISEASE'
p31787
(lp31788
S'H00102'
p31789
aS'Classic complement pathway component defects'
p31790
ag31789
ag31790
aS'H00103'
p31791
aS'Late complement pathway defects'
p31792
aS'H00104'
p31793
aS'Alternative complement pathway component defects'
p31794
aS'H00105'
p31795
aS'Mannose-binding lectin pathway component defects'
p31796
aS'H00106'
p31797
aS'Complement regulatory protein defects'
p31798
aS'H00219'
p31799
aS'Hemophilia'
p31800
aS'H00220'
p31801
aS'Factor V deficiency'
p31802
aS'H00222'
p31803
aS'Afibrinogenemia'
p31804
aS'H00223'
p31805
aS'Inherited thrombophilia'
p31806
aS'H00845'
p31807
aS'Familial amyloidosis'
p31808
aS'H00938'
p31809
aS'Factor XI deficiency'
p31810
aS'H00941'
p31811
aS'Factor XII deficiency'
p31812
aS'H00945'
p31813
aS'Factor XIII deficiency'
p31814
aS'H00983'
p31815
aS'Alpha-2-plasmin inhibitor (a2-PI) deficiency'
p31816
aS'H01006'
p31817
aS'Hereditary angioedema'
p31818
aS'H01078'
p31819
aS'Fletcher factor deficiency'
p31820
aS'H01103'
p31821
aS'Alpha-1-antitrypsin (A1AT) deficiency'
p31822
aS'H01106'
p31823
aS'Plasminogen activator inhibitor type 1 (PAI-1) deficiency'
p31824
aS'H01206'
p31825
aS'Plasminogen deficiency'
p31826
aS'H01254'
p31827
aS'Congenital prothrombin deficiency'
p31828
aS'H01381'
p31829
aS'Antithrombin III deficiency'
p31830
asS'ENTRY'
p31831
(lp31832
S'map04610'
p31833
aS'Pathway'
p31834
asS'CLASS'
p31835
(lp31836
S'Organismal Systems Immune system'
p31837
asS'DESCRIPTION'
p31838
(lp31839
S'The complement system is a proteolytic cascade in blood plasma and a mediator of innate immunity, a nonspecific defense mechanism against pathogens. There are three pathways of complement activation: the classical pathway, the lectin pathway, and the alternative pathway. All of these pathways generate a crucial enzymatic activity that, in turn, generates the effector molecules of complement. The main consequences of complement activation are the opsonization of pathogens, the recruitment of inflammatory and immunocompetent cells, and the direct killing of pathogens. Blood coagulation is another series of proenzyme-to-serine protease conversions, culminating the formation of thrombin, the enzyme responsible for the conversion of soluble fibrinogen to the insoluble fibrin clot. Protease-activated receptors, such as those activated by thrombin, are members of G protein-coupled receptors and function as a mediator of innate immunity. The kallikrein-kinin system is an endogenous metabolic cascade, triggering of which results in the release of vasoactive kinins (bradykinin-related peptides). Kinin peptides are implicated in many physiological and pathological processes including the regulation of blood pressure and sodium homeostasis, inflammatory processes, and the cardioprotective effects of preconditioning.'
p31840
assS'path:map07036'
p31841
(dp31842
S'ENTRY'
p31843
(lp31844
S'map07036'
p31845
aS'Drug'
p31846
aS'Pathway'
p31847
asS'PATHWAY_MAP'
p31848
(lp31849
S'map07036'
p31850
asS'NAME'
p31851
(lp31852
S'Calcium channel blocking drugs'
p31853
asS'REFERENCE'
p31854
(lp31855
S'PMID:16150216'
p31856
ag31856
aS'AUTHORS'
p31857
aS'Palamaras I, Kyriakis K.'
p31858
aS'TITLE'
p31859
aS'Calcium antagonists in dermatology: a review of the evidence and research-based studies.'
p31860
aS'JOURNAL'
p31861
aS'Dermatol Online J 11:8 (2005)'
p31862
ag22
ag22
aS'AUTHORS'
p31863
aS'Fukai S.'
p31864
aS'TITLE'
p31865
aS'[New Drugs Today (6th ed)] (In Japanese)'
p31866
aS'JOURNAL'
p31867
aS'Jiho (1995)'
p31868
ag22
ag22
aS'AUTHORS'
p31869
aS'Noguchi S, Hibino S (eds).'
p31870
aS'TITLE'
p31871
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p31872
aS'JOURNAL'
p31873
aS'Hirokawa (2002)'
p31874
aS'PMID:11005649'
p31875
ag31875
aS'AUTHORS'
p31876
aS'Arh M, Budihna MV.'
p31877
aS'TITLE'
p31878
aS'Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts.'
p31879
aS'JOURNAL'
p31880
aS'Pflugers Arch 440:R149-50 (2000)'
p31881
aS'PMID:16399866'
p31882
ag31882
aS'AUTHORS'
p31883
aS'Li M, Hu J, Chen Z, Meng J, Wang H, Ma X, Luo X'
p31884
aS'TITLE'
p31885
aS'Evidence for histamine as a neurotransmitter in the cardiac sympathetic nervous system.'
p31886
aS'JOURNAL'
p31887
aS'Am J Physiol Heart Circ Physiol 291:H45-51 (2006)'
p31888
aS'PMID:10373231'
p31889
ag31889
aS'AUTHORS'
p31890
aS'Sakata K, Shirotani M, Yoshida H, Nawada R, Obayashi K, Togi K, Miho N.'
p31891
aS'TITLE'
p31892
aS'Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.'
p31893
aS'JOURNAL'
p31894
aS'Hypertension 33:1447-52 (1999)'
p31895
ag22
ag22
aS'AUTHORS'
p31896
aS'Bertram GK (ed).'
p31897
aS'TITLE'
p31898
aS'Basic & Clinical Pharmacology (9th ed)'
p31899
aS'JOURNAL'
p31900
aS'Lange (2004)'
p31901
asS'COMPOUND'
p31902
(lp31903
S'D00304'
p31904
aS'Divalproex sodium (USP)'
p31905
ag31904
ag31905
aS'D00319'
p31906
aS'Felodipine (JAN/USP/INN)'
p31907
aS'D00349'
p31908
aS'Isradipine (USP/INN)'
p31909
aS'D00399'
p31910
aS'Valproic acid (USP)'
p31911
aS'D00437'
p31912
aS'Nifedipine (JP16/USP/INN)'
p31913
aS'D00438'
p31914
aS'Nimodipine (USAN/INN)'
p31915
aS'D00539'
p31916
aS'Ethosuximide (JP16/USP/INN)'
p31917
aS'D00615'
p31918
aS'Amlodipine besilate (JP16)'
p31919
aS'D00616'
p31920
aS'Diltiazem hydrochloride (JP16/USP)'
p31921
aS'D00617'
p31922
aS'Nicardipine hydrochloride (JP16/USAN)'
p31923
aS'D00618'
p31924
aS'Nisoldipine (JAN/USAN/INN)'
p31925
aS'D00619'
p31926
aS'Verapamil hydrochloride (JP16/USP)'
p31927
aS'D00629'
p31928
aS'Nitrendipine (JP16/USAN/INN)'
p31929
aS'D00631'
p31930
aS'Bepridil hydrochloride hydrate (JAN)'
p31931
aS'D00710'
p31932
aS'Sodium valproate (JP16)'
p31933
aS'D01104'
p31934
aS'Barnidipine hydrochloride (JAN)'
p31935
aS'D01145'
p31936
aS'Azelnidipine (JP16/INN)'
p31937
aS'D01173'
p31938
aS'Cilnidipine (JAN/INN)'
p31939
aS'D01295'
p31940
aS'Cinnarizine (JAN/USAN/INN)'
p31941
aS'D01303'
p31942
aS'Flunarizine hydrochloride (JAN/USAN)'
p31943
aS'D01553'
p31944
aS'Manidipine hydrochloride (JP16)'
p31945
aS'D01562'
p31946
aS'Aranidipine (JAN/INN)'
p31947
aS'D01604'
p31948
aS'Efonidipine hydrochloride ethanolate (JAN)'
p31949
aS'D01908'
p31950
aS'Nilvadipine (JP16/USAN/INN)'
p31951
aS'D01969'
p31952
aS'Gallopamil hydrochloride (JAN)'
p31953
aS'D02045'
p31954
aS'Benidipine hydrochloride (JP16)'
p31955
aS'D02356'
p31956
aS'Verapamil (USAN/INN)'
p31957
aS'D02633'
p31958
aS'Lomerizine hydrochloride (JAN)'
p31959
aS'D02914'
p31960
aS'Amlodipine maleate (USAN)'
p31961
aS'D03830'
p31962
aS'Diltiazem malate (USAN)'
p31963
aS'D04657'
p31964
aS'Lacidipine (USAN/INN)'
p31965
aS'D05024'
p31966
aS'Mibefradil dihydrochloride (USAN)'
p31967
aS'D07450'
p31968
aS'Amlodipine (USAN/INN)'
p31969
aS'D07494'
p31970
aS'Barnidipine (INN)'
p31971
aS'D07509'
p31972
aS'Benidipine (INN)'
p31973
aS'D07520'
p31974
aS'Bepridil (INN)'
p31975
aS'D07734'
p31976
aS'Cinnarizine dihydrochloride'
p31977
aS'D07845'
p31978
aS'Diltiazem (INN)'
p31979
aS'D07886'
p31980
aS'Efonidipine (INN)'
p31981
aS'D07971'
p31982
aS'Flunarizine (INN)'
p31983
aS'D08009'
p31984
aS'Gallopamil (INN)'
p31985
aS'D08155'
p31986
aS'Manidipine (INN)'
p31987
aS'D08217'
p31988
aS'Mibefradil (INN)'
p31989
aS'D08270'
p31990
aS'Nicardipine (INN)'
p31991
aS'D08667'
p31992
aS'Calcium valproate'
p31993
assS'path:map07035'
p31994
(dp31995
S'ENTRY'
p31996
(lp31997
S'map07035'
p31998
aS'Drug'
p31999
aS'Pathway'
p32000
asS'PATHWAY_MAP'
p32001
(lp32002
S'map07035'
p32003
asS'NAME'
p32004
(lp32005
S'Prostaglandins'
p32006
asS'REFERENCE'
p32007
(lp32008
S'(Japanese)'
p32009
ag32009
aS'AUTHORS'
p32010
aS'Fukai S.'
p32011
aS'TITLE'
p32012
aS'[New Drugs Today (6th ed)] (In Japanese)'
p32013
aS'JOURNAL'
p32014
aS'Jiho (1995)'
p32015
ag22
ag22
aS'AUTHORS'
p32016
aS'David AW, Thomas LL, William OF.'
p32017
aS'TITLE'
p32018
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p32019
aS'JOURNAL'
p32020
aS'Lippincott Williams & Wilkins (2002)'
p32021
ag22
ag22
aS'AUTHORS'
p32022
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p32023
aS'TITLE'
p32024
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p32025
aS'JOURNAL'
p32026
aS'McGraw-Hill (2001)'
p32027
ag22
ag22
aS'AUTHORS'
p32028
aS'Walter S.'
p32029
aS'TITLE'
p32030
aS'Drug Discovery: A History'
p32031
aS'JOURNAL'
p32032
aS'Wiley (2005)'
p32033
aS'(Japanese)'
p32034
ag32034
aS'AUTHORS'
p32035
aS'Japan Pharmaceutical Association (ed).'
p32036
aS'TITLE'
p32037
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p32038
aS'JOURNAL'
p32039
aS'Yakuji Nippo (1999)'
p32040
aS'(Japanese)'
p32041
ag32041
aS'AUTHORS'
p32042
aS'Tanaka C, Kato R (eds).'
p32043
aS'TITLE'
p32044
aS'[New Pharmacology (4th ed)] (In Japanese)'
p32045
aS'JOURNAL'
p32046
aS'Nankodo (2002)'
p32047
ag22
ag22
aS'AUTHORS'
p32048
aS'Collins PW, Djuric SW.'
p32049
aS'TITLE'
p32050
aS'Synthesis of therapeutically useful prostaglandin and prostacyclin analogs.'
p32051
aS'JOURNAL'
p32052
aS'Chemical Reviews 93(4):1533-1564 (1993)'
p32053
ag22
ag22
aS'AUTHORS'
p32054
aS'Igarashi R, Mizushima Y.'
p32055
aS'TITLE'
p32056
aS'New lipo-PGE1 using a stable prodrug of prostaglandin E1 (PGE1).'
p32057
aS'JOURNAL'
p32058
aS'Advanced Drug Delivery Reviews 20(2-3):189-194 (1996)'
p32059
aS'PMID:12556403'
p32060
ag32060
aS'AUTHORS'
p32061
aS'Sharif NA, Kelly CR, Crider JY.'
p32062
aS'TITLE'
p32063
aS'Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.'
p32064
aS'JOURNAL'
p32065
aS'Invest Ophthalmol Vis Sci 44:715-21 (2003)'
p32066
aS'PMID:15087728'
p32067
ag32067
aS'AUTHORS'
p32068
aS'Nguyen QH.'
p32069
aS'TITLE'
p32070
aS'The role of prostaglandin analogues in the treatment of glaucoma in the 21st century.'
p32071
aS'JOURNAL'
p32072
aS'Int Ophthalmol Clin 44:15-27 (2004)'
p32073
asS'COMPOUND'
p32074
(lp32075
S'C00427'
p32076
aS'Prostaglandin H2'
p32077
ag32076
ag32077
aS'C15450'
p32078
aS'S 1033'
p32079
aS'D00079'
p32080
aS'Dinoprostone (JAN/USP/INN)'
p32081
aS'D00081'
p32082
aS'Dinoprost (JP16/USAN/INN)'
p32083
aS'D00180'
p32084
aS'Alprostadil (JP16/USP/INN)'
p32085
aS'D00356'
p32086
aS'Latanoprost (JAN/USAN/INN)'
p32087
aS'D00419'
p32088
aS'Misoprostol (JAN/USAN/INN)'
p32089
aS'D00682'
p32090
aS'Carboprost tromethamine (USP)'
p32091
aS'D01352'
p32092
aS'Dinoprost tromethamine (JAN/USP)'
p32093
aS'D01452'
p32094
aS'Isopropyl unoprostone (JAN)'
p32095
aS'D01869'
p32096
aS'Ornoprostil (JAN/INN)'
p32097
aS'D01891'
p32098
aS'Enprostil (JAN/USAN/INN)'
p32099
aS'D01964'
p32100
aS'Travoprost (JAN/USAN/INN)'
p32101
aS'D02073'
p32102
aS'Gemeprost (JAN/USAN/INN)'
p32103
aS'D02343'
p32104
aS'Carboprost (USAN/INN)'
p32105
aS'D02705'
p32106
aS'Alprostadil alfadex (JP16)'
p32107
aS'D02719'
p32108
aS'Rosaprostol (INN)'
p32109
aS'D02722'
p32110
aS'Limaprost (INN)'
p32111
aS'D02723'
p32112
aS'Ecraprost (USAN/INN)'
p32113
aS'D02724'
p32114
aS'Bimatoprost (JAN/USAN/INN)'
p32115
aS'D02725'
p32116
aS'Sulprostone (USAN/INN)'
p32117
aS'D02726'
p32118
aS'Meteneprost (USAN/INN)'
p32119
aS'D02860'
p32120
aS'Limaprost alfadex (JP16)'
p32121
aS'D03269'
p32122
aS'Dinoprostone betadex (JAN)'
p32123
assS'path:map05100'
p32124
(dp32125
S'NAME'
p32126
(lp32127
S'Bacterial invasion of epithelial cells'
p32128
asS'REFERENCE'
p32129
(lp32130
S'PMID:19296488'
p32131
ag32131
aS'AUTHORS'
p32132
aS'Mostowy S, Cossart P'
p32133
aS'TITLE'
p32134
aS'Cytoskeleton rearrangements during Listeria infection: clathrin and septins as new players in the game.'
p32135
aS'JOURNAL'
p32136
aS'Cell Motil Cytoskeleton 66:816-23 (2009)'
p32137
aS'PMID:16406780'
p32138
ag32138
aS'AUTHORS'
p32139
aS'Hauck CR, Ohlsen K'
p32140
aS'TITLE'
p32141
aS'Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus.'
p32142
aS'JOURNAL'
p32143
aS'Curr Opin Microbiol 9:5-11 (2006)'
p32144
aS'PMID:17298394'
p32145
ag32145
aS'AUTHORS'
p32146
aS'Wang B, Li S, Dedhar S, Cleary PP'
p32147
aS'TITLE'
p32148
aS'Paxillin phosphorylation: bifurcation point downstream of integrin-linked kinase'
p32149
aS'(ILK) in streptococcal invasion.'
p32150
aS'JOURNAL'
p32151
aS'Cell Microbiol 9:1519-28 (2007)'
p32152
aS'PMID:19185531'
p32153
ag32153
aS'AUTHORS'
p32154
aS'Matsumoto H, Young GM'
p32155
aS'TITLE'
p32156
aS'Translocated effectors of Yersinia.'
p32157
aS'JOURNAL'
p32158
aS'Curr Opin Microbiol 12:94-100 (2009)'
p32159
aS'PMID:19157959'
p32160
ag32160
aS'AUTHORS'
p32161
aS'McGhie EJ, Brawn LC, Hume PJ, Humphreys D, Koronakis V'
p32162
aS'TITLE'
p32163
aS'Salmonella takes control: effector-driven manipulation of the host.'
p32164
aS'JOURNAL'
p32165
aS'Curr Opin Microbiol 12:117-24 (2009)'
p32166
aS'PMID:17719540'
p32167
ag32167
aS'AUTHORS'
p32168
aS'Iwai H, Kim M, Yoshikawa Y, Ashida H, Ogawa M, Fujita Y, Muller D, Kirikae T, Jackson PK, Kotani S, Sasakawa C'
p32169
aS'TITLE'
p32170
aS'A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling.'
p32171
aS'JOURNAL'
p32172
aS'Cell 130:611-23 (2007)'
p32173
ag22
ag22
aS'AUTHORS'
p32174
aS'Ohno H, Yoshimori T (eds).'
p32175
aS'TITLE'
p32176
aS'[Current Stream in Membrane Traffic] (in Japanese)'
p32177
aS'JOURNAL'
p32178
aS'Tanpakushitsu Kakusan Koso 53 (2008)'
p32179
asS'KO_PATHWAY'
p32180
(lp32181
S'ko05100'
p32182
asS'ENTRY'
p32183
(lp32184
S'map05100'
p32185
aS'Pathway'
p32186
asS'PATHWAY_MAP'
p32187
(lp32188
S'map05100'
p32189
asS'CLASS'
p32190
(lp32191
S'Human Diseases Infectious diseases'
p32192
asS'DESCRIPTION'
p32193
(lp32194
S'Many pathogenic bacteria can invade phagocytic and non-phagocytic cells and colonize them intracellularly, then become disseminated to other cells. Invasive bacteria induce their own uptake by non-phagocytic host cells (e.g. epithelial cells) using two mechanisms referred to as zipper model and trigger model. Listeria, Staphylococcus, Streptococcus, and Yersinia are examples of bacteria that enter using the zipper model. These bacteria express proteins on their surfaces that interact with cellular receptors, initiating signalling cascades that result in close apposition of the cellular membrane around the entering bacteria. Shigella and Salmonella are the examples of bacteria entering cells using the trigger model. These bacteria use type III secretion systems to inject protein effectors that interact with the actin cytoskeleton.'
p32195
assS'path:map07033'
p32196
(dp32197
S'ENTRY'
p32198
(lp32199
S'map07033'
p32200
aS'Drug'
p32201
aS'Pathway'
p32202
asS'PATHWAY_MAP'
p32203
(lp32204
S'map07033'
p32205
asS'NAME'
p32206
(lp32207
S'Anticonvulsants'
p32208
asS'REFERENCE'
p32209
(lp32210
g22
ag22
aS'AUTHORS'
p32211
aS'Sano T, Naito T, Kubo T (eds).'
p32212
aS'TITLE'
p32213
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p32214
aS'JOURNAL'
p32215
aS'Nankodo (2002)'
p32216
ag22
ag22
aS'AUTHORS'
p32217
aS'Walter S.'
p32218
aS'TITLE'
p32219
aS'Drug Discovery: A History'
p32220
aS'JOURNAL'
p32221
aS'Wiley (2005)'
p32222
ag22
ag22
aS'AUTHORS'
p32223
aS'Tanaka C, Kato R (eds).'
p32224
aS'TITLE'
p32225
aS'[New Pharmacology (4th ed)] (In Japanese)'
p32226
aS'JOURNAL'
p32227
aS'Nankodo (2002)'
p32228
aS'PMID:16382190'
p32229
ag32229
aS'AUTHORS'
p32230
aS'Stepien K, Tomaszewski M, Czuczwar SJ.'
p32231
aS'TITLE'
p32232
aS'Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs--an update.'
p32233
aS'JOURNAL'
p32234
aS'Pharmacol Rep 57:719-33 (2005)'
p32235
aS'PMID:11805728'
p32236
ag32236
aS'AUTHORS'
p32237
aS'Bialer M.'
p32238
aS'TITLE'
p32239
aS'New antiepileptic drugs currently in clinical trials: is there a strategy in their development?'
p32240
aS'JOURNAL'
p32241
aS'Ther Drug Monit 24:85-90 (2002)'
p32242
aS'PMID:11056076'
p32243
ag32243
aS'AUTHORS'
p32244
aS'Aiken SP, Brown WM.'
p32245
aS'TITLE'
p32246
aS'Treatment of epilepsy: existing therapies and future developments.'
p32247
aS'JOURNAL'
p32248
aS'Front Biosci 5:E124-52 (2000)'
p32249
aS'PMID:16922870'
p32250
ag32250
aS'AUTHORS'
p32251
aS'Loscher W, Schmidt D.'
p32252
aS'TITLE'
p32253
aS'Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs.'
p32254
aS'JOURNAL'
p32255
aS'Epilepsia 47:1253-84 (2006)'
p32256
asS'COMPOUND'
p32257
(lp32258
S'C07493'
p32259
aS'10-Hydroxycarbazepine'
p32260
ag32259
ag32260
aS'C07499'
p32261
aS'Phenylethylmalonamide'
p32262
aS'C14916'
p32263
aS'Nirvanol'
p32264
aS'C15341'
p32265
aS'Fluorofelbamate'
p32266
aS'D00218'
p32267
aS'Acetazolamide (JP16/USP/INN)'
p32268
aS'D00252'
p32269
aS'Carbamazepine (JP16/USP/INN)'
p32270
aS'D00280'
p32271
aS'Clonazepam (JP16/USP/INN)'
p32272
aS'D00293'
p32273
aS'Diazepam (JP16/USP/INN)'
p32274
aS'D00304'
p32275
aS'Divalproex sodium (USP)'
p32276
aS'D00332'
p32277
aS'Gabapentin (JAN/USAN/INN)'
p32278
aS'D00354'
p32279
aS'Lamotrigine (JAN/USAN/INN)'
p32280
aS'D00375'
p32281
aS'Mephenytoin (USP/INN)'
p32282
aS'D00392'
p32283
aS'Trimethadione (JP16/INN)'
p32284
aS'D00399'
p32285
aS'Valproic acid (USP)'
p32286
aS'D00474'
p32287
aS'Primidone (JP16/USP/INN)'
p32288
aS'D00504'
p32289
aS'Phenacemide (JAN/INN)'
p32290
aS'D00506'
p32291
aS'Phenobarbital (JP16/USP/INN)'
p32292
aS'D00512'
p32293
aS'Phenytoin (JP16/USP/INN)'
p32294
aS'D00531'
p32295
aS'Nitrazepam (JP16/USAN/INN)'
p32296
aS'D00533'
p32297
aS'Oxcarbazepine (JAN/USAN/INN)'
p32298
aS'D00535'
p32299
aS'Vigabatrin (JAN/USAN/INN)'
p32300
aS'D00536'
p32301
aS'Felbamate (USAN/INN)'
p32302
aS'D00537'
p32303
aS'Topiramate (JAN/USAN/INN)'
p32304
aS'D00538'
p32305
aS'Zonisamide (JAN/USAN/INN)'
p32306
aS'D00539'
p32307
aS'Ethosuximide (JP16/USP/INN)'
p32308
aS'D00701'
p32309
aS'Phenobarbital sodium (JAN/USP/INN)'
p32310
aS'D00708'
p32311
aS'Ethotoin (JAN/USP/INN)'
p32312
aS'D00709'
p32313
aS'Levetiracetam (JAN/USAN/INN)'
p32314
aS'D00710'
p32315
aS'Sodium valproate (JP16)'
p32316
aS'D01196'
p32317
aS'Acetazolamide sodium (JAN)'
p32318
aS'D01253'
p32319
aS'Clobazam (JAN/USAN/INN)'
p32320
aS'D01382'
p32321
aS'Metharbital (JAN/INN)'
p32322
aS'D01409'
p32323
aS'Acetylpheneturide (JAN)'
p32324
aS'D01740'
p32325
aS'Barbital (JP16/INN)'
p32326
aS'D01787'
p32327
aS'Sultiame (JP16)'
p32328
aS'D01914'
p32329
aS'Piracetam (JAN/USAN/INN)'
p32330
aS'D02096'
p32331
aS'Fosphenytoin sodium (USP)'
p32332
aS'D02097'
p32333
aS'Tiagabine hydrochloride (USP)'
p32334
aS'D02103'
p32335
aS'Phenytoin sodium for injection (JP16)'
p32336
aS'D02716'
p32337
aS'Pregabalin (JAN/USAN/INN)'
p32338
aS'D02717'
p32339
aS'Valnoctamide (USAN/INN)'
p32340
aS'D02718'
p32341
aS'Valrocemide (USAN/INN)'
p32342
aS'D02766'
p32343
aS'Valpromide (INN)'
p32344
aS'D07595'
p32345
aS'Fosphenytoin sodium hydrate (JAN)'
p32346
aS'D07993'
p32347
aS'Fosphenytoin (INN)'
p32348
aS'D08588'
p32349
aS'Tiagabine (INN)'
p32350
aS'D08667'
p32351
aS'Calcium valproate'
p32352
aS'D09539'
p32353
aS'Gabapentin enacarbil (JAN/USAN/INN)'
p32354
assS'path:map04910'
p32355
(dp32356
S'NAME'
p32357
(lp32358
S'Insulin signaling pathway'
p32359
asS'REFERENCE'
p32360
(lp32361
S'PMID:14635525'
p32362
ag32362
aS'AUTHORS'
p32363
aS'Ogawa W, Kasuga M.'
p32364
aS'TITLE'
p32365
aS'[Mechanism of insulin action and diabetes mellitus]'
p32366
aS'JOURNAL'
p32367
aS'Seikagaku 75:1332-44 (2003)'
p32368
aS'PMID:11282018'
p32369
ag32369
aS'AUTHORS'
p32370
aS'Bevan P.'
p32371
aS'TITLE'
p32372
aS'Insulin signalling.'
p32373
aS'JOURNAL'
p32374
aS'J Cell Sci 114:1429-30 (2001)'
p32375
aS'PMID:12867054'
p32376
ag32376
aS'AUTHORS'
p32377
aS'Kanzaki M, Pessin JE.'
p32378
aS'TITLE'
p32379
aS'Insulin signaling: GLUT4 vesicles exit via the exocyst.'
p32380
aS'JOURNAL'
p32381
aS'Curr Biol 13:R574-6 (2003)'
p32382
aS'PMID:10196204'
p32383
ag32383
aS'AUTHORS'
p32384
aS'Moodie SA, Alleman-Sposeto J, Gustafson TA.'
p32385
aS'TITLE'
p32386
aS'Identification of the APS protein as a novel insulin receptor substrate.'
p32387
aS'JOURNAL'
p32388
aS'J Biol Chem 274:11186-93 (1999)'
p32389
aS'PMID:15733744'
p32390
ag32390
aS'AUTHORS'
p32391
aS'Gual P, Le Marchand-Brustel Y, Tanti JF.'
p32392
aS'TITLE'
p32393
aS'Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.'
p32394
aS'JOURNAL'
p32395
aS'Biochimie 87:99-109 (2005)'
p32396
aS'PMID:9748166'
p32397
ag32397
aS'AUTHORS'
p32398
aS'Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ.'
p32399
aS'TITLE'
p32400
aS'Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1.'
p32401
aS'JOURNAL'
p32402
aS'Science 281:2042-5 (1998)'
p32403
aS'PMID:11742412'
p32404
ag32404
aS'AUTHORS'
p32405
aS'Saltiel AR, Kahn CR.'
p32406
aS'TITLE'
p32407
aS'Insulin signalling and the regulation of glucose and lipid metabolism.'
p32408
aS'JOURNAL'
p32409
aS'Nature 414:799-806 (2001)'
p32410
aS'PMID:15624019'
p32411
ag32411
aS'AUTHORS'
p32412
aS'Inoki K, Corradetti MN, Guan KL.'
p32413
aS'TITLE'
p32414
aS'Dysregulation of the TSC-mTOR pathway in human disease.'
p32415
aS'JOURNAL'
p32416
aS'Nat Genet 37:19-24 (2005)'
p32417
aS'PMID:16288289'
p32418
ag32418
aS'AUTHORS'
p32419
aS'Ruggero D, Sonenberg N.'
p32420
aS'TITLE'
p32421
aS'The Akt of translational control.'
p32422
aS'JOURNAL'
p32423
aS'Oncogene 24:7426-34 (2005)'
p32424
aS'PMID:10567225'
p32425
ag32425
aS'AUTHORS'
p32426
aS'Nave BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR.'
p32427
aS'TITLE'
p32428
aS'Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.'
p32429
aS'JOURNAL'
p32430
aS'Biochem J 344 Pt 2:427-31 (1999)'
p32431
aS'PMID:9445476'
p32432
ag32432
aS'AUTHORS'
p32433
aS'Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G.'
p32434
aS'TITLE'
p32435
aS'Phosphorylation and activation of p70s6k by PDK1.'
p32436
aS'JOURNAL'
p32437
aS'Science 279:707-10 (1998)'
p32438
aS'PMID:9609110'
p32439
ag32439
aS'AUTHORS'
p32440
aS'Ogawa W, Matozaki T, Kasuga M.'
p32441
aS'TITLE'
p32442
aS'Role of binding proteins to IRS-1 in insulin signalling.'
p32443
aS'JOURNAL'
p32444
aS'Mol Cell Biochem 182:13-22 (1998)'
p32445
aS'PMID:9609111'
p32446
ag32446
aS'AUTHORS'
p32447
aS'Ceresa BP, Pessin JE.'
p32448
aS'TITLE'
p32449
aS'Insulin regulation of the Ras activation/inactivation cycle.'
p32450
aS'JOURNAL'
p32451
aS'Mol Cell Biochem 182:23-9 (1998)'
p32452
aS'PMID:15229476'
p32453
ag32453
aS'AUTHORS'
p32454
aS'Pollak MN, Schernhammer ES, Hankinson SE.'
p32455
aS'TITLE'
p32456
aS'Insulin-like growth factors and neoplasia.'
p32457
aS'JOURNAL'
p32458
aS'Nat Rev Cancer 4:505-18 (2004)'
p32459
aS'PMID:9346240'
p32460
ag32460
aS'AUTHORS'
p32461
aS'Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME.'
p32462
aS'TITLE'
p32463
aS'Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.'
p32464
aS'JOURNAL'
p32465
aS'Cell 91:231-41 (1997)'
p32466
aS'PMID:17344645'
p32467
ag32467
aS'AUTHORS'
p32468
aS'Ferre P, Foufelle F'
p32469
aS'TITLE'
p32470
aS'SREBP-1c transcription factor and lipid homeostasis: clinical perspective.'
p32471
aS'JOURNAL'
p32472
aS'Horm Res 68:72-82 (2007)'
p32473
aS'PMID:18291668'
p32474
ag32474
aS'AUTHORS'
p32475
aS'Raghow R, Yellaturu C, Deng X, Park EA, Elam MB'
p32476
aS'TITLE'
p32477
aS'SREBPs: the crossroads of physiological and pathological lipid homeostasis.'
p32478
aS'JOURNAL'
p32479
aS'Trends Endocrinol Metab 19:65-73 (2008)'
p32480
aS'PMID:11343120'
p32481
ag32481
aS'AUTHORS'
p32482
aS'Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Le Marchand-Brustel Y, Erneux C, Hue L, Schurmans S'
p32483
aS'TITLE'
p32484
aS'The lipid phosphatase SHIP2 controls insulin sensitivity.'
p32485
aS'JOURNAL'
p32486
aS'Nature 409:92-7 (2001)'
p32487
aS'PMID:12791379'
p32488
ag32488
aS'AUTHORS'
p32489
aS'Backers K, Blero D, Paternotte N, Zhang J, Erneux C'
p32490
aS'TITLE'
p32491
aS'The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.'
p32492
aS'JOURNAL'
p32493
aS'Adv Enzyme Regul 43:15-28 (2003)'
p32494
asS'KO_PATHWAY'
p32495
(lp32496
S'ko04910'
p32497
asS'PATHWAY_MAP'
p32498
(lp32499
S'map04910'
p32500
asS'DISEASE'
p32501
(lp32502
S'H00069'
p32503
aS'Glycogen storage diseases (GSD)'
p32504
ag32503
ag32504
aS'H00410'
p32505
aS'Maturity onset diabetes of the young (MODY)'
p32506
aS'H00420'
p32507
aS'Familial partial lipodystrophy (FPL)'
p32508
aS'H00512'
p32509
aS'Permanent neonatal diabetes mellitus (PNDM)'
p32510
aS'H00719'
p32511
aS'Leprechaunism'
p32512
aS'H00896'
p32513
aS'Lymphangioleiomyomatosis (LAM)'
p32514
aS'H00915'
p32515
aS'Tuberous sclerosis complex (TSC)'
p32516
aS'H00942'
p32517
aS'Rabson-Mendenhall syndrome'
p32518
aS'H01102'
p32519
aS'Pituitary adenomas'
p32520
aS'H01154'
p32521
aS'Wolff-Parkinson-White (WPW) syndrome'
p32522
aS'H01228'
p32523
aS'Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN)'
p32524
aS'H01251'
p32525
aS'Focal cortical dysplasia of Taylor'
p32526
aS'H01267'
p32527
aS'Familial hyperinsulinemic hypoglycemia (HHF)'
p32528
asS'MODULE'
p32529
(lp32530
S'M00676'
p32531
aS'PI3K-Akt signaling [PATH:map04910]'
p32532
asS'DESCRIPTION Insulin binding to its receptor results in the tyrosine phosphorylation of insulin receptor substrates (IRS) by the insulin receptor tyrosine kinase (INSR). This allows association of IRSs with the regulatory subunit of phosphoinositide 3-kinase (PI3K). PI3K activates 3-phosphoinositide-dependent protein kinase 1 (PDK1), which activates Akt, a serine kinase. Akt in turn deactivates glycogen synthase kinase 3 (GSK-3), leading to activation of glycogen synthase (GYS) and thus glycogen synthesis. Activation of Akt also results in the translocation of GLUT4 vesicles from their intracellular pool to the plasma membrane, where they allow uptake of glucose into the cell. Akt also leads to mTOR-mediated activation of protein synthesis by eIF4 and p70S6K. The translocation of GLUT4 protein is also elicited through the CAP/Cbl/TC10 pathway, once Cbl is phosphorylated by INSR.'
p32533
(lp32534
S'Other signal transduction proteins interact with IRS including GRB2. GRB2 is part of the cascade including SOS, RAS, RAF and MEK that leads to activation of mitogen-activated protein kinase (MAPK) and mitogenic responses in the form of gene transcription. SHC is another substrate of INSR. When tyrosine phosphorylated, SHC associates with GRB2 and can thus activate the RAS/MAPK pathway independently of IRS-1.'
p32535
asS'ENTRY'
p32536
(lp32537
S'map04910'
p32538
aS'Pathway'
p32539
asS'CLASS'
p32540
(lp32541
S'Organismal Systems Endocrine system'
p32542
asS'DESCRIPTION'
p32543
(lp32544
S'Insulin binding to its receptor results in the tyrosine phosphorylation of insulin receptor substrates (IRS) by the insulin receptor tyrosine kinase (INSR). This allows association of IRSs with the regulatory subunit of phosphoinositide 3-kinase (PI3K). PI3K activates 3-phosphoinositide-dependent protein kinase 1 (PDK1), which activates Akt, a serine kinase. Akt in turn deactivates glycogen synthase kinase 3 (GSK-3), leading to activation of glycogen synthase (GYS) and thus glycogen synthesis. Activation of Akt also results in the translocation of GLUT4 vesicles from their intracellular pool to the plasma membrane, where they allow uptake of glucose into the cell. Akt also leads to mTOR-mediated activation of protein synthesis by eIF4 and p70S6K. The translocation of GLUT4 protein is also elicited through the CAP/Cbl/TC10 pathway, once Cbl is phosphorylated by INSR.'
p32545
assS'path:map04911'
p32546
(dp32547
S'NAME'
p32548
(lp32549
S'Insulin secretion'
p32550
asS'REFERENCE'
p32551
(lp32552
S'PMID:20551594'
p32553
ag32553
aS'AUTHORS'
p32554
aS'Seino S, Shibasaki T, Minami K'
p32555
aS'TITLE'
p32556
aS'Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment.'
p32557
aS'JOURNAL'
p32558
aS'Proc Jpn Acad Ser B Phys Biol Sci 86:563-77 (2010)'
p32559
aS'PMID:20225132'
p32560
ag32560
aS'AUTHORS'
p32561
aS'Jitrapakdee S, Wutthisathapornchai A, Wallace JC, MacDonald MJ'
p32562
aS'TITLE'
p32563
aS'Regulation of insulin secretion: role of mitochondrial signalling.'
p32564
aS'JOURNAL'
p32565
aS'Diabetologia 53:1019-32 (2010)'
p32566
aS'PMID:22974438'
p32567
ag32567
aS'AUTHORS'
p32568
aS'Rorsman P, Braun M'
p32569
aS'TITLE'
p32570
aS'Regulation of insulin secretion in human pancreatic islets.'
p32571
aS'JOURNAL'
p32572
aS'Annu Rev Physiol 75:155-79 (2013)'
p32573
aS'PMID:9715374'
p32574
ag32574
aS'AUTHORS'
p32575
aS'Jones PM, Persaud SJ'
p32576
aS'TITLE'
p32577
aS'Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic beta-cells.'
p32578
aS'JOURNAL'
p32579
aS'Endocr Rev 19:429-61 (1998)'
p32580
aS'PMID:21934040'
p32581
ag32581
aS'AUTHORS'
p32582
aS'MacDonald PE'
p32583
aS'TITLE'
p32584
aS'Signal integration at the level of ion channel and exocytotic function in pancreatic beta-cells.'
p32585
aS'JOURNAL'
p32586
aS'Am J Physiol Endocrinol Metab 301:E1065-9 (2011)'
p32587
aS'PMID:9914469'
p32588
ag32588
aS'AUTHORS'
p32589
aS'Lang J'
p32590
aS'TITLE'
p32591
aS'Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion.'
p32592
aS'JOURNAL'
p32593
aS'Eur J Biochem 259:3-17 (1999)'
p32594
aS'PMID:10605628'
p32595
ag32595
aS'AUTHORS'
p32596
aS'Kieffer TJ, Habener JF'
p32597
aS'TITLE'
p32598
aS'The glucagon-like peptides.'
p32599
aS'JOURNAL'
p32600
aS'Endocr Rev 20:876-913 (1999)'
p32601
aS'PMID:19036624'
p32602
ag32602
aS'AUTHORS'
p32603
aS'Girard J'
p32604
aS'TITLE'
p32605
aS'The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions.'
p32606
aS'JOURNAL'
p32607
aS'Diabetes Metab 34:550-9 (2008)'
p32608
aS'PMID:15655710'
p32609
ag32609
aS'AUTHORS'
p32610
aS'Holz GG'
p32611
aS'TITLE'
p32612
aS'New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.'
p32613
aS'JOURNAL'
p32614
aS'Horm Metab Res 36:787-94 (2004)'
p32615
aS'PMID:15271645'
p32616
ag32616
aS'AUTHORS'
p32617
aS'Holst JJ, Gromada J'
p32618
aS'TITLE'
p32619
aS'Role of incretin hormones in the regulation of insulin secretion in diabetic and'
p32620
aS'nondiabetic humans.'
p32621
aS'JOURNAL'
p32622
aS'Am J Physiol Endocrinol Metab 287:E199-206 (2004)'
p32623
aS'PMID:17306374'
p32624
ag32624
aS'AUTHORS'
p32625
aS'Doyle ME, Egan JM'
p32626
aS'TITLE'
p32627
aS'Mechanisms of action of glucagon-like peptide 1 in the pancreas.'
p32628
aS'JOURNAL'
p32629
aS'Pharmacol Ther 113:546-93 (2007)'
p32630
aS'PMID:19074620'
p32631
ag32631
aS'AUTHORS'
p32632
aS'Kim W, Egan JM'
p32633
aS'TITLE'
p32634
aS'The role of incretins in glucose homeostasis and diabetes treatment.'
p32635
aS'JOURNAL'
p32636
aS'Pharmacol Rev 60:470-512 (2008)'
p32637
aS'PMID:19817800'
p32638
ag32638
aS'AUTHORS'
p32639
aS'Seino S, Takahashi H, Fujimoto W, Shibasaki T'
p32640
aS'TITLE'
p32641
aS'Roles of cAMP signalling in insulin granule exocytosis.'
p32642
aS'JOURNAL'
p32643
aS'Diabetes Obes Metab 11 Suppl 4:180-8 (2009)'
p32644
aS'PMID:22970724'
p32645
ag32645
aS'AUTHORS'
p32646
aS'Tengholm A'
p32647
aS'TITLE'
p32648
aS'Cyclic AMP dynamics in the pancreatic beta-cell.'
p32649
aS'JOURNAL'
p32650
aS'Ups J Med Sci 117:355-69 (2012)'
p32651
aS'PMID:14693691'
p32652
ag32652
aS'AUTHORS'
p32653
aS'Holz GG'
p32654
aS'TITLE'
p32655
aS'Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell.'
p32656
aS'JOURNAL'
p32657
aS'Diabetes 53:5-13 (2004)'
p32658
aS'PMID:20055708'
p32659
ag32659
aS'AUTHORS'
p32660
aS'Gloerich M, Bos JL'
p32661
aS'TITLE'
p32662
aS'Epac: defining a new mechanism for cAMP action.'
p32663
aS'JOURNAL'
p32664
aS'Annu Rev Pharmacol Toxicol 50:355-75 (2010)'
p32665
aS'PMID:17084085'
p32666
ag32666
aS'AUTHORS'
p32667
aS'Bos JL'
p32668
aS'TITLE'
p32669
aS'Epac proteins: multi-purpose cAMP targets.'
p32670
aS'JOURNAL'
p32671
aS'Trends Biochem Sci 31:680-6 (2006)'
p32672
aS'PMID:11522660'
p32673
ag32673
aS'AUTHORS'
p32674
aS'Filipsson K, Kvist-Reimer M, Ahren B'
p32675
aS'TITLE'
p32676
aS'The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function.'
p32677
aS'JOURNAL'
p32678
aS'Diabetes 50:1959-69 (2001)'
p32679
aS'PMID:19817784'
p32680
ag32680
aS'AUTHORS'
p32681
aS'Kebede MA, Alquier T, Latour MG, Poitout V'
p32682
aS'TITLE'
p32683
aS'Lipid receptors and islet function: therapeutic implications?'
p32684
aS'JOURNAL'
p32685
aS'Diabetes Obes Metab 11 Suppl 4:10-20 (2009)'
p32686
aS'PMID:19660440'
p32687
ag32687
aS'AUTHORS'
p32688
aS'Morgan NG, Dhayal S'
p32689
aS'TITLE'
p32690
aS'G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell.'
p32691
aS'JOURNAL'
p32692
aS'Biochem Pharmacol 78:1419-27 (2009)'
p32693
asS'KO_PATHWAY'
p32694
(lp32695
S'ko04911'
p32696
asS'PATHWAY_MAP'
p32697
(lp32698
S'map04911'
p32699
asS'DISEASE'
p32700
(lp32701
S'H00409'
p32702
aS'Type II diabetes mellitus'
p32703
ag32702
ag32703
aS'H00426'
p32704
aS'Defects in the degradation of ganglioside'
p32705
asS'DBLINKS'
p32706
(lp32707
S'GO: 0030073'
p32708
asS'ENTRY'
p32709
(lp32710
S'map04911'
p32711
aS'Pathway'
p32712
asS'CLASS'
p32713
(lp32714
S'Organismal Systems Endocrine system'
p32715
asS'DESCRIPTION'
p32716
(lp32717
S'Pancreatic beta cells are specialised endocrine cells that continuously sense the levels of blood sugar and other fuels and, in response, secrete insulin to maintain normal fuel homeostasis. Glucose-induced insulin secretion and its potentiation constitute the principal mechanism of insulin release. Glucose is transported by the glucose transporter (GLUT) into the pancreatic beta-cell. Metabolism of glucose generates ATP, which inhibits ATP-sensitive K+ channels and causes voltage-dependent Ca2+ influx. Elevation of [Ca2+]i triggers exocytotic release of insulin granules. Insulin secretion is further regulated by several hormones and neurotransmitters. Peptide hormones, such as glucagon-like peptide 1 (GLP-1), increase cAMP levels and thereby potentiate insulin secretion via the combined action of PKA and Epac2. Achetylcholine (ACh), a major parasympathetic neurotransmitter, binds to Gq-coupled receptors and activates phospholipase C- (PLC-),'
p32718
assS'path:map04912'
p32719
(dp32720
S'NAME'
p32721
(lp32722
S'GnRH signaling pathway'
p32723
asS'REFERENCE'
p32724
(lp32725
S'PMID:15350605'
p32726
ag32726
aS'AUTHORS'
p32727
aS'Ruf F, Sealfon SC.'
p32728
aS'TITLE'
p32729
aS'Genomics view of gonadotrope signaling circuits.'
p32730
aS'JOURNAL'
p32731
aS'Trends Endocrinol Metab 15:331-8 (2004)'
p32732
aS'PMID:15613448'
p32733
ag32733
aS'AUTHORS'
p32734
aS'Harrison GS, Wierman ME, Nett TM, Glode LM.'
p32735
aS'TITLE'
p32736
aS'Gonadotropin-releasing hormone and its receptor in normal and malignant cells.'
p32737
aS'JOURNAL'
p32738
aS'Endocr Relat Cancer 11:725-48 (2004)'
p32739
aS'PMID:15982836'
p32740
ag32740
aS'AUTHORS'
p32741
aS'Pawson AJ, McNeilly AS.'
p32742
aS'TITLE'
p32743
aS'The pituitary effects of GnRH.'
p32744
aS'JOURNAL'
p32745
aS'Anim Reprod Sci 88:75-94 (2005)'
p32746
ag22
ag22
aS'AUTHORS'
p32747
aS'DeGroot LJ, Jameson JL (ed).'
p32748
aS'TITLE'
p32749
aS'Endocrinology (Fifth edition)'
p32750
aS'JOURNAL'
p32751
aS'Elsevier Saunders (2006)'
p32752
aS'PMID:10707049'
p32753
ag32753
aS'AUTHORS'
p32754
aS'Naor Z, Benard O, Seger R.'
p32755
aS'TITLE'
p32756
aS'Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor.'
p32757
aS'JOURNAL'
p32758
aS'Trends Endocrinol Metab 11:91-9 (2000)'
p32759
aS'PMID:14596811'
p32760
ag32760
aS'AUTHORS'
p32761
aS'Ruf F, Fink MY, Sealfon SC.'
p32762
aS'TITLE'
p32763
aS'Structure of the GnRH receptor-stimulated signaling network: insights from genomics.'
p32764
aS'JOURNAL'
p32765
aS'Front Neuroendocrinol 24:181-99 (2003)'
p32766
aS'PMID:12943720'
p32767
ag32767
aS'AUTHORS'
p32768
aS'Farshori PQ, Shah BH, Arora KK, Martinez-Fuentes A, Catt KJ.'
p32769
aS'TITLE'
p32770
aS'Activation and nuclear translocation of PKCdelta, Pyk2 and ERK1/2 by gonadotropin releasing hormone in HEK293 cells.'
p32771
aS'JOURNAL'
p32772
aS'J Steroid Biochem Mol Biol 85:337-47 (2003)'
p32773
aS'PMID:15080147'
p32774
ag32774
aS'AUTHORS'
p32775
aS'Shah BH, Catt KJ.'
p32776
aS'TITLE'
p32777
aS'Matrix metalloproteinases in reproductive endocrinology.'
p32778
aS'JOURNAL'
p32779
aS'Trends Endocrinol Metab 15:47-9 (2004)'
p32780
aS'PMID:12963732'
p32781
ag32781
aS'AUTHORS'
p32782
aS'Roelle S, Grosse R, Aigner A, Krell HW, Czubayko F, Gudermann T.'
p32783
aS'TITLE'
p32784
aS'Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone.'
p32785
aS'JOURNAL'
p32786
aS'J Biol Chem 278:47307-18 (2003)'
p32787
asS'KO_PATHWAY'
p32788
(lp32789
S'ko04912'
p32790
asS'PATHWAY_MAP'
p32791
(lp32792
S'map04912'
p32793
asS'DISEASE'
p32794
(lp32795
S'H00255'
p32796
aS'Hypogonadotropic hypogonadism'
p32797
ag32796
ag32797
aS'H00746'
p32798
aS'Hypokalemic periodic paralysis (HypoPP)'
p32799
aS'H00937'
p32800
aS'Precocious puberty'
p32801
aS'H01253'
p32802
aS'Isolated follicle-stimulating hormone deficiency (IFSHD)'
p32803
asS'ENTRY'
p32804
(lp32805
S'map04912'
p32806
aS'Pathway'
p32807
asS'CLASS'
p32808
(lp32809
S'Organismal Systems Endocrine system'
p32810
asS'DESCRIPTION'
p32811
(lp32812
S'Gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus acts upon its receptor in the anterior pituitary to regulate the production and release of the gonadotropins, LH and FSH. The GnRHR is coupled to Gq/11 proteins to activate phospholipase C which transmits its signal to diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG activates the intracellular protein kinase C (PKC) pathway and IP3 stimulates release of intracellular calcium. In addition to the classical Gq/11, coupling of Gs is occasionally observed in a cell-specific fashion. Signaling downstream of protein kinase C (PKC) leads to transactivation of the epidermal growth factor (EGF) receptor and activation of mitogen-activated protein kinases (MAPKs), including extracellular-signal-regulated kinase (ERK), Jun N-terminal kinase (JNK) and p38 MAPK. Active MAPKs translocate to the nucleus, resulting in activation of transcription factors and rapid induction of early genes.'
p32813
assS'path:map04913'
p32814
(dp32815
S'NAME'
p32816
(lp32817
S'Ovarian steroidogenesis'
p32818
asS'REFERENCE'
p32819
(lp32820
S'PMID:15541573'
p32821
ag32821
aS'AUTHORS'
p32822
aS'Havelock JC, Rainey WE, Carr BR'
p32823
aS'TITLE'
p32824
aS'Ovarian granulosa cell lines.'
p32825
aS'JOURNAL'
p32826
aS'Mol Cell Endocrinol 228:67-78 (2004)'
p32827
aS'PMID:15831519'
p32828
ag32828
aS'AUTHORS'
p32829
aS'Stocco DM, Wang X, Jo Y, Manna PR'
p32830
aS'TITLE'
p32831
aS'Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought.'
p32832
aS'JOURNAL'
p32833
aS'Mol Endocrinol 19:2647-59 (2005)'
p32834
aS'PMID:20937107'
p32835
ag32835
aS'AUTHORS'
p32836
aS'Wen X, Li D, Tozer AJ, Docherty SM, Iles RK'
p32837
aS'TITLE'
p32838
aS'Estradiol, progesterone, testosterone profiles in human follicular fluid and cultured granulosa cells from luteinized pre-ovulatory follicles.'
p32839
aS'JOURNAL'
p32840
aS'Reprod Biol Endocrinol 8:117 (2010)'
p32841
aS'PMID:11704115'
p32842
ag32842
aS'AUTHORS'
p32843
aS'Erickson GF, Shimasaki S'
p32844
aS'TITLE'
p32845
aS'The physiology of folliculogenesis: the role of novel growth factors.'
p32846
aS'JOURNAL'
p32847
aS'Fertil Steril 76:943-9 (2001)'
p32848
aS'PMID:11883103'
p32849
ag32849
aS'AUTHORS'
p32850
aS'Wood JR, Strauss JF 3rd'
p32851
aS'TITLE'
p32852
aS'Multiple signal transduction pathways regulate ovarian steroidogenesis.'
p32853
aS'JOURNAL'
p32854
aS'Rev Endocr Metab Disord 3:33-46 (2002)'
p32855
aS'PMID:16603089'
p32856
ag32856
aS'AUTHORS'
p32857
aS'Drummond AE'
p32858
aS'TITLE'
p32859
aS'The role of steroids in follicular growth.'
p32860
aS'JOURNAL'
p32861
aS'Reprod Biol Endocrinol 4:16 (2006)'
p32862
aS'PMID:21862696'
p32863
ag32863
aS'AUTHORS'
p32864
aS'Craig ZR, Wang W, Flaws JA'
p32865
aS'TITLE'
p32866
aS'Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling.'
p32867
aS'JOURNAL'
p32868
aS'Reproduction 142:633-46 (2011)'
p32869
aS'PMID:20628033'
p32870
ag32870
aS'AUTHORS'
p32871
aS'Young JM, McNeilly AS'
p32872
aS'TITLE'
p32873
aS'Theca: the forgotten cell of the ovarian follicle.'
p32874
aS'JOURNAL'
p32875
aS'Reproduction 140:489-504 (2010)'
p32876
aS'PMID:18440223'
p32877
ag32877
aS'AUTHORS'
p32878
aS'Diamanti-Kandarakis E, Argyrakopoulou G, Economou F, Kandaraki E, Koutsilieris M'
p32879
aS'TITLE'
p32880
aS'Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS).'
p32881
aS'JOURNAL'
p32882
aS'J Steroid Biochem Mol Biol 109:242-6 (2008)'
p32883
aS'PMID:11408113'
p32884
ag32884
aS'AUTHORS'
p32885
aS'Spicer LJ'
p32886
aS'TITLE'
p32887
aS'Receptors for insulin-like growth factor-I and tumor necrosis factor-alpha are hormonally regulated in bovine granulosa and thecal cells.'
p32888
aS'JOURNAL'
p32889
aS'Anim Reprod Sci 67:45-58 (2001)'
p32890
aS'PMID:10630400'
p32891
ag32891
aS'AUTHORS'
p32892
aS'Wang X, Stocco DM'
p32893
aS'TITLE'
p32894
aS'Cyclic AMP and arachidonic acid: a tale of two pathways.'
p32895
aS'JOURNAL'
p32896
aS'Mol Cell Endocrinol 158:7-12 (1999)'
p32897
aS'PMID:17003287'
p32898
ag32898
aS'AUTHORS'
p32899
aS'Wang X, Shen CL, Dyson MT, Yin X, Schiffer RB, Grammas P, Stocco DM'
p32900
aS'TITLE'
p32901
aS'The involvement of epoxygenase metabolites of arachidonic acid in cAMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression.'
p32902
aS'JOURNAL'
p32903
aS'J Endocrinol 190:871-8 (2006)'
p32904
aS'PMID:17008391'
p32905
ag32905
aS'AUTHORS'
p32906
aS'Miyoshi T, Otsuka F, Inagaki K, Otani H, Takeda M, Suzuki J, Goto J, Ogura T, Makino H'
p32907
aS'TITLE'
p32908
aS'Differential regulation of steroidogenesis by bone morphogenetic proteins in granulosa cells: involvement of extracellularly regulated kinase signaling and oocyte actions in follicle-stimulating hormone-induced estrogen production.'
p32909
aS'JOURNAL'
p32910
aS'Endocrinology 148:337-45 (2007)'
p32911
aS'PMID:11447221'
p32912
ag32912
aS'AUTHORS'
p32913
aS'Otsuka F, Moore RK, Shimasaki S'
p32914
aS'TITLE'
p32915
aS'Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary.'
p32916
aS'JOURNAL'
p32917
aS'J Biol Chem 276:32889-95 (2001)'
p32918
aS'PMID:14769828'
p32919
ag32919
aS'AUTHORS'
p32920
aS'Shimasaki S, Moore RK, Otsuka F, Erickson GF.'
p32921
aS'TITLE'
p32922
aS'The bone morphogenetic protein system in mammalian reproduction.'
p32923
aS'JOURNAL'
p32924
aS'Endocr Rev 25:72-101 (2004)'
p32925
aS'PMID:16414178'
p32926
ag32926
aS'AUTHORS'
p32927
aS'Lukacik P, Kavanagh KL, Oppermann U'
p32928
aS'TITLE'
p32929
aS'Structure and function of human 17beta-hydroxysteroid dehydrogenases.'
p32930
aS'JOURNAL'
p32931
aS'Mol Cell Endocrinol 248:61-71 (2006)'
p32932
asS'KO_PATHWAY'
p32933
(lp32934
S'ko04913'
p32935
asS'PATHWAY_MAP'
p32936
(lp32937
S'map04913'
p32938
asS'DISEASE'
p32939
(lp32940
S'H01383'
p32941
aS'LDL Receptor Disorder'
p32942
asS'DBLINKS'
p32943
(lp32944
S'GO: 0050810'
p32945
asS'ENTRY'
p32946
(lp32947
S'map04913'
p32948
aS'Pathway'
p32949
asS'CLASS'
p32950
(lp32951
S'Organismal Systems Endocrine system'
p32952
asS'DESCRIPTION'
p32953
(lp32954
S'The ovarian steroids, 17-beta estradiol (E2) and progesterone (P4), are critical for normal uterine function, establishment and maintenance of pregnancy, and mammary gland development. Furthermore, the local effects that are essential for normal ovarian physiology are dependent on the endocrine, paracrine, and autocrine actions of E2, P4, and androgens. In most mammals (including humans and mice), ovarian steroidogenesis occurs according to the two-cell/two-gonadotropin theory. This theory describes how granulosa and theca cells work together to make the ovarian steroids. Theca cells respond to LH signaling by increasing the expression of enzymes necessary for the conversion of cholesterol to androgens,'
p32955
assS'path:map00121'
p32956
(dp32957
S'NAME'
p32958
(lp32959
S'Secondary bile acid biosynthesis'
p32960
asS'REFERENCE'
p32961
(lp32962
S'PMID:18488143'
p32963
ag32963
aS'AUTHORS'
p32964
aS'Hofmann AF, Hagey LR'
p32965
aS'TITLE'
p32966
aS'Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.'
p32967
aS'JOURNAL'
p32968
aS'Cell Mol Life Sci 65:2461-83 (2008)'
p32969
aS'PMID:16299351'
p32970
ag32970
aS'AUTHORS'
p32971
aS'Ridlon JM, Kang DJ, Hylemon PB'
p32972
aS'TITLE'
p32973
aS'Bile salt biotransformations by human intestinal bacteria.'
p32974
aS'JOURNAL'
p32975
aS'J Lipid Res 47:241-59 (2006)'
p32976
aS'PMID:19464381'
p32977
ag32977
aS'AUTHORS'
p32978
aS'Ridlon JM, Kang DJ, Hylemon PB'
p32979
aS'TITLE'
p32980
aS'Isolation and characterization of a bile acid inducible 7alpha-dehydroxylating operon in Clostridium hylemonae TN271.'
p32981
aS'JOURNAL'
p32982
aS'Anaerobe 16:137-46 (2010)'
p32983
aS'PMID:18047844'
p32984
ag32984
aS'AUTHORS'
p32985
aS'Kang DJ, Ridlon JM, Moore DR 2nd, Barnes S, Hylemon PB'
p32986
aS'TITLE'
p32987
aS'Clostridium scindens baiCD and baiH genes encode stereo-specific 7alpha/7beta-hydroxy-3-oxo-delta4-cholenoic acid oxidoreductases.'
p32988
aS'JOURNAL'
p32989
aS'Biochim Biophys Acta 1781:16-25 (2008)'
p32990
aS'PMID:16061950'
p32991
ag32991
aS'AUTHORS'
p32992
aS'Moschetta A, Xu F, Hagey LR, van Berge-Henegouwen GP, van Erpecum KJ, Brouwers JF, Cohen JC, Bierman M, Hobbs HH, Steinbach JH, Hofmann AF'
p32993
aS'TITLE'
p32994
aS'A phylogenetic survey of biliary lipids in vertebrates.'
p32995
aS'JOURNAL'
p32996
aS'J Lipid Res 46:2221-32 (2005)'
p32997
asS'KO_PATHWAY'
p32998
(lp32999
S'ko00121'
p33000
asS'ENTRY'
p33001
(lp33002
S'map00121'
p33003
aS'Pathway'
p33004
asS'PATHWAY_MAP'
p33005
(lp33006
S'map00121'
p33007
asS'CLASS'
p33008
(lp33009
S'Metabolism Lipid metabolism'
p33010
asS'DESCRIPTION'
p33011
(lp33012
S'The secondary bile acids are derived from the primary bile acids by the enzymatic action of intestinal bacteria through the process of deconjugation and dehydroxylation. The secondary bile acids in humans include deoxycholic acid and lithocholic acid, formed from the 7alpha-dehydroxylation of cholic acid and chenodeoxycholic acid, respectively.'
p33013
assS'path:map00120'
p33014
(dp33015
S'NAME'
p33016
(lp33017
S'Primary bile acid biosynthesis'
p33018
asS'REFERENCE'
p33019
(lp33020
S'PMID:12543708'
p33021
ag33021
aS'AUTHORS'
p33022
aS'Russell DW'
p33023
aS'TITLE'
p33024
aS'The enzymes, regulation, and genetics of bile acid synthesis.'
p33025
aS'JOURNAL'
p33026
aS'Annu Rev Biochem 72:137-74 (2003)'
p33027
aS'PMID:17346171'
p33028
ag33028
aS'AUTHORS'
p33029
aS'Norlin M, Wikvall K'
p33030
aS'TITLE'
p33031
aS'Enzymes in the conversion of cholesterol into bile acids.'
p33032
aS'JOURNAL'
p33033
aS'Curr Mol Med 7:199-218 (2007)'
p33034
aS'PMID:10198776'
p33035
ag33035
aS'AUTHORS'
p33036
aS'Vlahcevic ZR, Pandak WM, Stravitz RT'
p33037
aS'TITLE'
p33038
aS'Regulation of bile acid biosynthesis.'
p33039
aS'JOURNAL'
p33040
aS'Gastroenterol Clin North Am 28:1-25, v (1999)'
p33041
aS'PMID:18081658'
p33042
ag33042
aS'AUTHORS'
p33043
aS'Pellicoro A, Faber KN'
p33044
aS'TITLE'
p33045
aS'Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport.'
p33046
aS'JOURNAL'
p33047
aS'Aliment Pharmacol Ther 26 Suppl 2:149-60 (2007)'
p33048
aS'PMID:18488143'
p33049
ag33049
aS'AUTHORS'
p33050
aS'Hofmann AF, Hagey LR'
p33051
aS'TITLE'
p33052
aS'Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.'
p33053
aS'JOURNAL'
p33054
aS'Cell Mol Life Sci 65:2461-83 (2008)'
p33055
aS'PMID:11067870'
p33056
ag33056
aS'AUTHORS'
p33057
aS'Schwarz M, Wright AC, Davis DL, Nazer H, Bjorkhem I, Russell DW'
p33058
aS'TITLE'
p33059
aS'The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis.'
p33060
aS'JOURNAL'
p33061
aS'J Clin Invest 106:1175-84 (2000)'
p33062
aS'PMID:16299351'
p33063
ag33063
aS'AUTHORS'
p33064
aS'Ridlon JM, Kang DJ, Hylemon PB'
p33065
aS'TITLE'
p33066
aS'Bile salt biotransformations by human intestinal bacteria.'
p33067
aS'JOURNAL'
p33068
aS'J Lipid Res 47:241-59 (2006)'
p33069
aS'PMID:9292932'
p33070
ag33070
aS'AUTHORS'
p33071
aS'Bortolini O, Medici A, Poli S'
p33072
aS'TITLE'
p33073
aS'Biotransformations on steroid nucleus of bile acids.'
p33074
aS'JOURNAL'
p33075
aS'Steroids 62:564-77 (1997)'
p33076
asS'KO_PATHWAY'
p33077
(lp33078
S'ko00120'
p33079
asS'PATHWAY_MAP'
p33080
(lp33081
S'map00120'
p33082
asS'DISEASE'
p33083
(lp33084
S'H00151'
p33085
aS'Cerebrotendinous xanthomatosis'
p33086
ag33085
ag33086
aS'H00407'
p33087
aS'Peroxisomal beta-oxidation enzyme deficiency'
p33088
aS'H00624'
p33089
aS'Familial cholestasis'
p33090
aS'H00628'
p33091
aS'Congenital bile acid synthesis defect (CBAS)'
p33092
aS'H00874'
p33093
aS'Leukoencephalopathy with dystonia and motor neuropathy'
p33094
asS'MODULE'
p33095
(lp33096
S'M00104'
p33097
aS'Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate [PATH:map00120]'
p33098
ag33097
ag33098
aS'M00106'
p33099
aS'Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate [PATH:map00120]'
p33100
asS'ENTRY'
p33101
(lp33102
S'map00120'
p33103
aS'Pathway'
p33104
asS'CLASS'
p33105
(lp33106
S'Metabolism Lipid metabolism'
p33107
asS'DESCRIPTION'
p33108
(lp33109
S'Bile acids are steroid carboxylic acids derived from cholesterol in vertebrates. The primary bile acids, cholic acid and chenodeoxycholic acid, are synthesized in the liver and conjugated with taurine or glycine before secretion via bile into the intestine. The conversion from cholesterol to cholic and chenodeoxycholic acids involves four steps: 1) the initiation of synthesis by 7alpha-hydroxylation of sterol precursors, 2) further modifications to the ring structures, 3) side-chain oxidation and shortening (cleavage) by three carbons, and 4) conjugation of the bile acid with taurine or glycine.'
p33110
assS'path:map04916'
p33111
(dp33112
S'NAME'
p33113
(lp33114
S'Melanogenesis'
p33115
asS'REFERENCE'
p33116
(lp33117
S'PMID:15383650'
p33118
ag33118
aS'AUTHORS'
p33119
aS'Slominski A, Tobin DJ, Shibahara S, Wortsman J.'
p33120
aS'TITLE'
p33121
aS'Melanin pigmentation in mammalian skin and its hormonal regulation.'
p33122
aS'JOURNAL'
p33123
aS'Physiol Rev 84:1155-228 (2004)'
p33124
aS'PMID:10841026'
p33125
ag33125
aS'AUTHORS'
p33126
aS'Busca R, Ballotti R.'
p33127
aS'TITLE'
p33128
aS'Cyclic AMP a key messenger in the regulation of skin pigmentation.'
p33129
aS'JOURNAL'
p33130
aS'Pigment Cell Res 13:60-9 (2000)'
p33131
aS'PMID:15016298'
p33132
ag33132
aS'AUTHORS'
p33133
aS'Imokawa G.'
p33134
aS'TITLE'
p33135
aS'Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders.'
p33136
aS'JOURNAL'
p33137
aS'Pigment Cell Res 17:96-110 (2004)'
p33138
aS'PMID:11023702'
p33139
ag33139
aS'AUTHORS'
p33140
aS'Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A.'
p33141
aS'TITLE'
p33142
aS'New aspects on the melanocortins and their receptors.'
p33143
aS'JOURNAL'
p33144
aS'Pharmacol Res 42:393-420 (2000)'
p33145
aS'PMID:12894244'
p33146
ag33146
aS'AUTHORS'
p33147
aS'Chin L.'
p33148
aS'TITLE'
p33149
aS'The genetics of malignant melanoma: lessons from mouse and man.'
p33150
aS'JOURNAL'
p33151
aS'Nat Rev Cancer 3:559-70 (2003)'
p33152
aS'PMID:16822996'
p33153
ag33153
aS'AUTHORS'
p33154
aS'Miller AJ, Mihm MC Jr.'
p33155
aS'TITLE'
p33156
aS'Melanoma.'
p33157
aS'JOURNAL'
p33158
aS'N Engl J Med 355:51-65 (2006)'
p33159
aS'PMID:12753399'
p33160
ag33160
aS'AUTHORS'
p33161
aS'Saito H, Yasumoto K, Takeda K, Takahashi K, Yamamoto H, Shibahara S.'
p33162
aS'TITLE'
p33163
aS'Microphthalmia-associated transcription factor in the Wnt signaling pathway.'
p33164
aS'JOURNAL'
p33165
aS'Pigment Cell Res 16:261-5 (2003)'
p33166
aS'PMID:9263329'
p33167
ag33167
aS'AUTHORS'
p33168
aS'Imokawa G, Kobayashi T, Miyagishi M, Higashi K, Yada Y.'
p33169
aS'TITLE'
p33170
aS'The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis.'
p33171
aS'JOURNAL'
p33172
aS'Pigment Cell Res 10:218-28 (1997)'
p33173
aS'PMID:10643996'
p33174
ag33174
aS'AUTHORS'
p33175
aS'Park HY, Gilchrest BA.'
p33176
aS'TITLE'
p33177
aS'Signaling pathways mediating melanogenesis.'
p33178
aS'JOURNAL'
p33179
aS'Cell Mol Biol (Noisy-le-grand) 45:919-30 (1999)'
p33180
aS'PMID:10347209'
p33181
ag33181
aS'AUTHORS'
p33182
aS'Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA.'
p33183
aS'TITLE'
p33184
aS'Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain.'
p33185
aS'JOURNAL'
p33186
aS'J Biol Chem 274:16470-8 (1999)'
p33187
aS'PMID:11602344'
p33188
ag33188
aS'AUTHORS'
p33189
aS'Sturm RA, Teasdale RD, Box NF.'
p33190
aS'TITLE'
p33191
aS'Human pigmentation genes: identification, structure and consequences of polymorphic variation.'
p33192
aS'JOURNAL'
p33193
aS'Gene 277:49-62 (2001)'
p33194
aS'PMID:11041354'
p33195
ag33195
aS'AUTHORS'
p33196
aS'Hearing VJ.'
p33197
aS'TITLE'
p33198
aS'The melanosome: the perfect model for cellular responses to the environment.'
p33199
aS'JOURNAL'
p33200
aS'Pigment Cell Res 13 Suppl 8:23-34 (2000)'
p33201
aS'PMID:16246839'
p33202
ag33202
aS'AUTHORS'
p33203
aS'Molina DM, Grewal S, Bardwell L.'
p33204
aS'TITLE'
p33205
aS'Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation.'
p33206
aS'JOURNAL'
p33207
aS'J Biol Chem 280:42051-60 (2005)'
p33208
asS'KO_PATHWAY'
p33209
(lp33210
S'ko04916'
p33211
asS'PATHWAY_MAP'
p33212
(lp33213
S'map04916'
p33214
asS'DISEASE'
p33215
(lp33216
S'H00168'
p33217
aS'Oculocutaneous albinism (OCA)'
p33218
ag33217
ag33218
aS'H00169'
p33219
aS'Ocular albinism'
p33220
aS'H00170'
p33221
aS'Piebaldism'
p33222
aS'H00646'
p33223
aS'Odontoonychodermal dysplasia'
p33224
aS'H00759'
p33225
aS'Waardenburg syndrome (WS)'
p33226
aS'H00759'
p33227
aS'Waardenburg syndrome (WS)'
p33228
aS'H00823'
p33229
aS'ABCD syndrome'
p33230
aS'H00884'
p33231
aS'Familial progressive hyperpigmentation'
p33232
aS'H00947'
p33233
aS'Pilomatricoma'
p33234
aS'H01187'
p33235
aS'Tietz syndrome'
p33236
asS'ENTRY'
p33237
(lp33238
S'map04916'
p33239
aS'Pathway'
p33240
asS'CLASS'
p33241
(lp33242
S'Organismal Systems Endocrine system'
p33243
asS'DESCRIPTION'
p33244
(lp33245
S'Cutaneous melanin pigment plays a critical role in camouflage, mimicry, social communication, and protection against harmful effects of solar radiation. Melanogenesis is under complex regulatory control by multiple agents. The most important positive regulator of melanogenesis is the MC1 receptor with its ligands melanocortic peptides. MC1R activates the cyclic AMP (cAMP) response-element binding protein (CREB). Increased expression of MITF and its activation by phosphorylation (P) stimulate the transcription of tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), and dopachrome tautomerase (DCT), which produce melanin. Melanin synthesis takes place within specialized intracellular organelles named melanosomes. Melanin-containing melanosomes then move from the perinuclear region to the dendrite tips and are transferred to keratinocytes by a still not well-characterized mechanism.'
p33246
assS'path:map00650'
p33247
(dp33248
S'NAME'
p33249
(lp33250
S'Butanoate metabolism'
p33251
asS'KO_PATHWAY'
p33252
(lp33253
S'ko00650'
p33254
asS'ENTRY'
p33255
(lp33256
S'map00650'
p33257
aS'Pathway'
p33258
asS'PATHWAY_MAP'
p33259
(lp33260
S'map00650'
p33261
asS'DISEASE'
p33262
(lp33263
S'H00179'
p33264
aS'3-Hydroxy-3-methylglutaryl-CoA lyase deficiency'
p33265
ag33264
ag33265
aS'H00835'
p33266
aS'Succinic semialdehyde dehydrogenase (SSADH) deficiency'
p33267
aS'H01097'
p33268
aS'Cerebral palsy'
p33269
aS'H01121'
p33270
aS'Succinyl CoA:3-oxoacid CoA transferase (SCOT) deficiency'
p33271
aS'H01123'
p33272
aS'HMG-CoA synthase (HMGCS) deficiency'
p33273
aS'H01280'
p33274
aS'L-2-hydroxyglutaric aciduria (L2HGA)'
p33275
aS'H01364'
p33276
aS'3-Hydroxyacyl-CoA dehydrogenase deficiency'
p33277
asS'CLASS'
p33278
(lp33279
S'Metabolism Carbohydrate metabolism'
p33280
assS'path:map04918'
p33281
(dp33282
S'NAME'
p33283
(lp33284
S'Thyroid hormone synthesis'
p33285
asS'REFERENCE'
p33286
(lp33287
S'PMID:21448409'
p33288
ag33288
aS'AUTHORS'
p33289
aS'Ahad F, Ganie SA'
p33290
aS'TITLE'
p33291
aS'Iodine, Iodine metabolism and Iodine deficiency disorders revisited.'
p33292
aS'JOURNAL'
p33293
aS'Indian J Endocrinol Metab 14:13-7 (2010)'
p33294
aS'PMID:11717564'
p33295
ag33295
aS'AUTHORS'
p33296
aS'Gillam MP, Kopp P'
p33297
aS'TITLE'
p33298
aS'Genetic defects in thyroid hormone synthesis.'
p33299
aS'JOURNAL'
p33300
aS'Curr Opin Pediatr 13:364-72 (2001)'
p33301
aS'PMID:20167242'
p33302
ag33302
aS'AUTHORS'
p33303
aS'Rokita SE, Adler JM, McTamney PM, Watson JA Jr'
p33304
aS'TITLE'
p33305
aS'Efficient use and recycling of the micronutrient iodide in mammals.'
p33306
aS'JOURNAL'
p33307
aS'Biochimie 92:1227-35 (2010)'
p33308
aS'PMID:21683758'
p33309
ag33309
aS'AUTHORS'
p33310
aS'Massart C, Hoste C, Virion A, Ruf J, Dumont JE, Van Sande J'
p33311
aS'TITLE'
p33312
aS'Cell biology of H2O2 generation in the thyroid: investigation of the control of dual oxidases (DUOX) activity in intact ex vivo thyroid tissue and cell lines.'
p33313
aS'JOURNAL'
p33314
aS'Mol Cell Endocrinol 343:32-44 (2011)'
p33315
aS'PMID:19196800'
p33316
ag33316
aS'AUTHORS'
p33317
aS'Bizhanova A, Kopp P'
p33318
aS'TITLE'
p33319
aS'Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of'
p33320
aS'the thyroid.'
p33321
aS'JOURNAL'
p33322
aS'Endocrinology 150:1084-90 (2009)'
p33323
aS'PMID:21986207'
p33324
ag33324
aS'AUTHORS'
p33325
aS'Fong P'
p33326
aS'TITLE'
p33327
aS'Thyroid iodide efflux: a team effort?'
p33328
aS'JOURNAL'
p33329
aS'J Physiol 589:5929-39 (2011)'
p33330
aS'PMID:17666482'
p33331
ag33331
aS'AUTHORS'
p33332
aS'Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, Maenhaut C, Miot F, Van Sande J, Many MC, Dumont JE'
p33333
aS'TITLE'
p33334
aS'Roles of hydrogen peroxide in thyroid physiology and disease.'
p33335
aS'JOURNAL'
p33336
aS'J Clin Endocrinol Metab 92:3764-73 (2007)'
p33337
aS'PMID:11137035'
p33338
ag33338
aS'AUTHORS'
p33339
aS'Kohn LD, Suzuki K, Nakazato M, Royaux I, Green ED'
p33340
aS'TITLE'
p33341
aS'Effects of thyroglobulin and pendrin on iodide flux through the thyrocyte.'
p33342
aS'JOURNAL'
p33343
aS'Trends Endocrinol Metab 12:10-6 (2001)'
p33344
aS'PMID:11029276'
p33345
ag33345
aS'AUTHORS'
p33346
aS'Marino M, McCluskey RT'
p33347
aS'TITLE'
p33348
aS'Role of thyroglobulin endocytic pathways in the control of thyroid hormone release.'
p33349
aS'JOURNAL'
p33350
aS'Am J Physiol Cell Physiol 279:C1295-306 (2000)'
p33351
aS'PMID:16870170'
p33352
ag33352
aS'AUTHORS'
p33353
aS'Rivolta CM, Targovnik HM'
p33354
aS'TITLE'
p33355
aS'Molecular advances in thyroglobulin disorders.'
p33356
aS'JOURNAL'
p33357
aS'Clin Chim Acta 374:8-24 (2006)'
p33358
aS'PMID:10893432'
p33359
ag33359
aS'AUTHORS'
p33360
aS'De La Vieja A, Dohan O, Levy O, Carrasco N'
p33361
aS'TITLE'
p33362
aS'Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.'
p33363
aS'JOURNAL'
p33364
aS'Physiol Rev 80:1083-105 (2000)'
p33365
aS'PMID:20407074'
p33366
ag33366
aS'AUTHORS'
p33367
aS'Ohye H, Sugawara M'
p33368
aS'TITLE'
p33369
aS'Dual oxidase, hydrogen peroxide and thyroid diseases.'
p33370
aS'JOURNAL'
p33371
aS'Exp Biol Med (Maywood) 235:424-33 (2010)'
p33372
aS'PMID:20093166'
p33373
ag33373
aS'AUTHORS'
p33374
aS'Targovnik HM, Esperante SA, Rivolta CM'
p33375
aS'TITLE'
p33376
aS'Genetics and phenomics of hypothyroidism and goiter due to thyroglobulin mutations.'
p33377
aS'JOURNAL'
p33378
aS'Mol Cell Endocrinol 322:44-55 (2010)'
p33379
aS'PMID:20122987'
p33380
ag33380
aS'AUTHORS'
p33381
aS'Grasberger H'
p33382
aS'TITLE'
p33383
aS'Defects of thyroidal hydrogen peroxide generation in congenital hypothyroidism.'
p33384
aS'JOURNAL'
p33385
aS'Mol Cell Endocrinol 322:99-106 (2010)'
p33386
aS'PMID:9086577'
p33387
ag33387
aS'AUTHORS'
p33388
aS'Arvan P, Kim PS, Kuliawat R, Prabakaran D, Muresan Z, Yoo SE, Abu Hossain S'
p33389
aS'TITLE'
p33390
aS'Intracellular protein transport to the thyrocyte plasma membrane: potential implications for thyroid physiology.'
p33391
aS'JOURNAL'
p33392
aS'Thyroid 7:89-105 (1997)'
p33393
aS'PMID:15611820'
p33394
ag33394
aS'AUTHORS'
p33395
aS'Vono-Toniolo J, Kopp P'
p33396
aS'TITLE'
p33397
aS'Thyroglobulin gene mutations and other genetic defects associated with congenital hypothyroidism.'
p33398
aS'JOURNAL'
p33399
aS'Arq Bras Endocrinol Metabol 48:70-82 (2004)'
p33400
aS'PMID:23438835'
p33401
ag33401
aS'AUTHORS'
p33402
aS'Vitale G, Salvioli S, Franceschi C'
p33403
aS'TITLE'
p33404
aS'Oxidative stress and the ageing endocrine system.'
p33405
aS'JOURNAL'
p33406
aS'Nat Rev Endocrinol 9:228-40 (2013)'
p33407
aS'PMID:20378719'
p33408
ag33408
aS'AUTHORS'
p33409
aS'Calebiro D, Nikolaev VO, Lohse MJ'
p33410
aS'TITLE'
p33411
aS'Imaging of persistent cAMP signaling by internalized G protein-coupled receptors.'
p33412
aS'JOURNAL'
p33413
aS'J Mol Endocrinol 45:1-8 (2010)'
p33414
aS'PMID:9538302'
p33415
ag33415
aS'AUTHORS'
p33416
aS'Newman CM, Price A, Davies DW, Gray TA, Weetman AP'
p33417
aS'TITLE'
p33418
aS'Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.'
p33419
aS'JOURNAL'
p33420
aS'Heart 79:121-7 (1998)'
p33421
asS'KO_PATHWAY'
p33422
(lp33423
S'ko04918'
p33424
asS'PATHWAY_MAP'
p33425
(lp33426
S'map04918'
p33427
asS'DBLINKS'
p33428
(lp33429
S'GO: 0006590'
p33430
asS'ENTRY'
p33431
(lp33432
S'map04918'
p33433
aS'Pathway'
p33434
asS'CLASS'
p33435
(lp33436
S'Organismal Systems Endocrine system'
p33437
asS'DESCRIPTION'
p33438
(lp33439
S'Thyroid hormones triiodothyronine (T3) and thyroxine (T4) are essential for normal development, growth and metabolic homeostasis in all vertebrates, and synthesized in the thyroid gland. The functional unit of the thyroid gland is the follicle, delimited by a monolayer of thyrocytes. Polarized thyrocytes surround the follicular lumen with their basal and apical surfaces facing the bloodstream and the lumen, respectively. To synthesize thyroid hormones, thyrocytes take up iodide at their basal side and concentrate it into the lumen. They also secrete in this lumen the specialized protein thyroglobulin (TG) which serves as a store for the hormones. In the follicular lumen oxidation of iodine, iodination of tyrosines (MIT, 3-monoiodotyrosine DIT, 3,5-diiodotyrosine) and coupling of iodotyrosines takes place on tyrosine residues in TG, resulting in T3 and T4 synthesis. Iodinated TG is resorbed through the apical membrane and degraded to form T3/T4 in lysosomes the T3/T4 is then secreted through the basal membrane.'
p33440
assS'path:map04919'
p33441
(dp33442
S'NAME'
p33443
(lp33444
S'Thyroid hormone signaling pathway'
p33445
asS'REFERENCE'
p33446
(lp33447
S'PMID:20051527'
p33448
ag33448
aS'AUTHORS'
p33449
aS'Cheng SY, Leonard JL, Davis PJ'
p33450
aS'TITLE'
p33451
aS'Molecular aspects of thyroid hormone actions.'
p33452
aS'JOURNAL'
p33453
aS'Endocr Rev 31:139-70 (2010)'
p33454
aS'PMID:16214361'
p33455
ag33455
aS'AUTHORS'
p33456
aS'Davis PJ, Davis FB, Cody V'
p33457
aS'TITLE'
p33458
aS'Membrane receptors mediating thyroid hormone action.'
p33459
aS'JOURNAL'
p33460
aS'Trends Endocrinol Metab 16:429-35 (2005)'
p33461
aS'PMID:18329679'
p33462
ag33462
aS'AUTHORS'
p33463
aS'Davis PJ, Davis FB, Lin HY'
p33464
aS'TITLE'
p33465
aS'Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors.'
p33466
aS'JOURNAL'
p33467
aS'Steroids 73:1013-7 (2008)'
p33468
aS'PMID:22484490'
p33469
ag33469
aS'AUTHORS'
p33470
aS'Pascual A, Aranda A'
p33471
aS'TITLE'
p33472
aS'Thyroid hormone receptors, cell growth and differentiation.'
p33473
aS'JOURNAL'
p33474
aS'Biochim Biophys Acta 1830:3908-16 (2013)'
p33475
aS'PMID:17983645'
p33476
ag33476
aS'AUTHORS'
p33477
aS'Davis PJ, Leonard JL, Davis FB'
p33478
aS'TITLE'
p33479
aS'Mechanisms of nongenomic actions of thyroid hormone.'
p33480
aS'JOURNAL'
p33481
aS'Front Neuroendocrinol 29:211-8 (2008)'
p33482
aS'PMID:19755667'
p33483
ag33483
aS'AUTHORS'
p33484
aS'Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK'
p33485
aS'TITLE'
p33486
aS'Translational implications of nongenomic actions of thyroid hormone initiated at'
p33487
aS'its integrin receptor.'
p33488
aS'JOURNAL'
p33489
aS'Am J Physiol Endocrinol Metab 297:E1238-46 (2009)'
p33490
aS'PMID:20868274'
p33491
ag33491
aS'AUTHORS'
p33492
aS'Davis PJ, Davis FB, Mousa SA, Luidens MK, Lin HY'
p33493
aS'TITLE'
p33494
aS'Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.'
p33495
aS'JOURNAL'
p33496
aS'Annu Rev Pharmacol Toxicol 51:99-115 (2011)'
p33497
aS'PMID:23021374'
p33498
ag33498
aS'AUTHORS'
p33499
aS'Lin HY, Tang HY, Davis FB, Mousa SA, Incerpi S, Luidens MK, Meng R, Davis PJ'
p33500
aS'TITLE'
p33501
aS'Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps.'
p33502
aS'JOURNAL'
p33503
aS'Discov Med 14:199-206 (2012)'
p33504
aS'PMID:21835053'
p33505
ag33505
aS'AUTHORS'
p33506
aS'Moeller LC, Broecker-Preuss M'
p33507
aS'TITLE'
p33508
aS'Transcriptional regulation by nonclassical action of thyroid hormone.'
p33509
aS'JOURNAL'
p33510
aS'Thyroid Res 4 Suppl 1:S6 (2011)'
p33511
aS'PMID:19295177'
p33512
ag33512
aS'AUTHORS'
p33513
aS'Bhargava M, Lei J, Ingbar DH'
p33514
aS'TITLE'
p33515
aS'Nongenomic actions of L-thyroxine and 3,5,3\'-triiodo-L-thyronine. Focus on "L-Thyroxine vs. 3,5,3\'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase".'
p33516
aS'JOURNAL'
p33517
aS'Am J Physiol Cell Physiol 296:C977-9 (2009)'
p33518
aS'PMID:17574003'
p33519
ag33519
aS'AUTHORS'
p33520
aS'Oetting A, Yen PM'
p33521
aS'TITLE'
p33522
aS'New insights into thyroid hormone action.'
p33523
aS'JOURNAL'
p33524
aS'Best Pract Res Clin Endocrinol Metab 21:193-208 (2007)'
p33525
aS'PMID:20005976'
p33526
ag33526
aS'AUTHORS'
p33527
aS'Ojamaa K'
p33528
aS'TITLE'
p33529
aS'Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.'
p33530
aS'JOURNAL'
p33531
aS'Vascul Pharmacol 52:113-9 (2010)'
p33532
aS'PMID:19716314'
p33533
ag33533
aS'AUTHORS'
p33534
aS'Aranda A, Martinez-Iglesias O, Ruiz-Llorente L, Garcia-Carpizo V, Zambrano A'
p33535
aS'TITLE'
p33536
aS'Thyroid receptor: roles in cancer.'
p33537
aS'JOURNAL'
p33538
aS'Trends Endocrinol Metab 20:318-24 (2009)'
p33539
aS'PMID:16951130'
p33540
ag33540
aS'AUTHORS'
p33541
aS"Otulakowski G, O'Brodovich H"
p33542
aS'TITLE'
p33543
aS'Thyroid hormone and Na+-K+-ATPase: more than simple transcription.'
p33544
aS'JOURNAL'
p33545
aS'Am J Physiol Lung Cell Mol Physiol 292:L4-5 (2007)'
p33546
aS'PMID:16051672'
p33547
ag33547
aS'AUTHORS'
p33548
aS'Moeller LC, Dumitrescu AM, Refetoff S'
p33549
aS'TITLE'
p33550
aS'Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes.'
p33551
aS'JOURNAL'
p33552
aS'Mol Endocrinol 19:2955-63 (2005)'
p33553
aS'PMID:15345678'
p33554
ag33554
aS'AUTHORS'
p33555
aS"D'Arezzo S, Incerpi S, Davis FB, Acconcia F, Marino M, Farias RN, Davis PJ"
p33556
aS'TITLE'
p33557
aS"Rapid nongenomic effects of 3,5,3'-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways."
p33558
aS'JOURNAL'
p33559
aS'Endocrinology 145:5694-703 (2004)'
p33560
asS'KO_PATHWAY'
p33561
(lp33562
S'ko04919'
p33563
asS'PATHWAY_MAP'
p33564
(lp33565
S'map04919'
p33566
asS'DBLINKS'
p33567
(lp33568
S'GO: 0002154'
p33569
asS'ENTRY'
p33570
(lp33571
S'map04919'
p33572
aS'Pathway'
p33573
asS'CLASS'
p33574
(lp33575
S'Organismal Systems Endocrine system'
p33576
asS'DESCRIPTION'
p33577
(lp33578
S"The thyroid hormones (THs) are important regulators of growth, development and metabolism. The action of TH is mainly mediated by T3 (3,5,3'-triiodo-L-thyronine). Thyroid hormones, L-thyroxine (T4) and T3 enter the cell through transporter proteins. Although the major form of TH in the blood is T4, it is converted to the more active hormone T3 within cells. T3 binds to nuclear thyroid hormone receptors (TRs), which functions as a ligand-dependent transcription factor and controls the expression of target genes (genomic action). Nongenomic mechanisms of action is initiated at the integrin receptor. The plasma membrane alpha(v)beta(3)-integrin has distinct binding sites for T3 and T4. One binding site binds only T3 and activates the phosphatidylinositol 3-kinase (PI3K) pathway. The other binding site binds both T3 and T4 and activates the ERK1/2 MAP kinase pathway."
p33579
assS'path:map00550'
p33580
(dp33581
S'NAME'
p33582
(lp33583
S'Peptidoglycan biosynthesis'
p33584
asS'REFERENCE'
p33585
(lp33586
S'PMID:18081839'
p33587
ag33587
aS'AUTHORS'
p33588
aS'Bouhss A, Trunkfield AE, Bugg TD, Mengin-Lecreulx D'
p33589
aS'TITLE'
p33590
aS'The biosynthesis of peptidoglycan lipid-linked intermediates.'
p33591
aS'JOURNAL'
p33592
aS'FEMS Microbiol Rev 32:208-33 (2008)'
p33593
aS'PMID:18077448'
p33594
ag33594
aS'AUTHORS'
p33595
aS'Lloyd AJ, Gilbey AM, Blewett AM, De Pascale G, El Zoeiby A, Levesque RC, Catherwood AC, Tomasz A, Bugg TD, Roper DI, Dowson CG'
p33596
aS'TITLE'
p33597
aS'Characterization of tRNA-dependent peptide bond formation by MurM in the synthesis of Streptococcus pneumoniae peptidoglycan.'
p33598
aS'JOURNAL'
p33599
aS'J Biol Chem 283:6402-17 (2008)'
p33600
aS'PMID:18266853'
p33601
ag33601
aS'AUTHORS'
p33602
aS'Barreteau H, Kovac A, Boniface A, Sova M, Gobec S, Blanot D'
p33603
aS'TITLE'
p33604
aS'Cytoplasmic steps of peptidoglycan biosynthesis.'
p33605
aS'JOURNAL'
p33606
aS'FEMS Microbiol Rev 32:168-207 (2008)'
p33607
aS'PMID:11699883'
p33608
ag33608
aS'AUTHORS'
p33609
aS'van Heijenoort J'
p33610
aS'TITLE'
p33611
aS'Recent advances in the formation of the bacterial peptidoglycan monomer unit.'
p33612
aS'JOURNAL'
p33613
aS'Nat Prod Rep 18:503-19 (2001)'
p33614
aS'PMID:11320055'
p33615
ag33615
aS'AUTHORS'
p33616
aS'van Heijenoort'
p33617
aS'J'
p33618
aS'TITLE'
p33619
aS'Formation of the glycan chains in the synthesis of bacterial peptidoglycan.'
p33620
aS'JOURNAL'
p33621
aS'Glycobiology 11:25R-36R (2001)'
p33622
asS'KO_PATHWAY'
p33623
(lp33624
S'ko00550'
p33625
asS'PATHWAY_MAP'
p33626
(lp33627
S'map00550'
p33628
asS'DISEASE'
p33629
(lp33630
S'H00424'
p33631
aS'Defects in the degradation of sphingomyelin'
p33632
asS'ENTRY'
p33633
(lp33634
S'map00550'
p33635
aS'Pathway'
p33636
asS'CLASS'
p33637
(lp33638
S'Metabolism Glycan biosynthesis and metabolism'
p33639
asS'DESCRIPTION'
p33640
(lp33641
S'Peptidoglycan is a macromolecule made of long aminosugar strands cross-linked by short peptides. It forms the cell wall in bacteria surrounding the cytoplasmic membrane. The glycan strands are typically comprised of repeating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) disaccharides. Each MurNAc is linked to a peptide of three to five amino acid residues. Disaccharide subunits are first assembled on the cytoplasmic side of the bacterial membrane on a polyisoprenoid anchor (lipid I and II). Polymerization of disaccharide subunits by transglycosylases and cross-linking of glycan strands by transpeptidases occur on the other side of the membrane. Bacterial cell wall biosynthesis inhibitors form a major class of antibiotics.'
p33642
assS'path:map04966'
p33643
(dp33644
S'NAME'
p33645
(lp33646
S'Collecting duct acid secretion'
p33647
asS'REFERENCE'
p33648
(lp33649
S'PMID:16352913'
p33650
ag33650
aS'AUTHORS'
p33651
aS'Wagner CA, Kovacikova J, Stehberger PA, Winter C, Benabbas C, Mohebbi N'
p33652
aS'TITLE'
p33653
aS'Renal acid-base transport: old and new players.'
p33654
aS'JOURNAL'
p33655
aS'Nephron Physiol 103:p1-6 (2006)'
p33656
aS'PMID:19277700'
p33657
ag33657
aS'AUTHORS'
p33658
aS'Wagner CA, Devuyst O, Bourgeois S, Mohebbi N'
p33659
aS'TITLE'
p33660
aS'Regulated acid-base transport in the collecting duct.'
p33661
aS'JOURNAL'
p33662
aS'Pflugers Arch 458:137-56 (2009)'
p33663
aS'PMID:19948674'
p33664
ag33664
aS'AUTHORS'
p33665
aS'Koeppen BM'
p33666
aS'TITLE'
p33667
aS'The kidney and acid-base regulation.'
p33668
aS'JOURNAL'
p33669
aS'Adv Physiol Educ 33:275-81 (2009)'
p33670
aS'PMID:9550618'
p33671
ag33671
aS'AUTHORS'
p33672
aS'Hayashi M'
p33673
aS'TITLE'
p33674
aS'Physiology and pathophysiology of acid-base homeostasis in the kidney.'
p33675
aS'JOURNAL'
p33676
aS'Intern Med 37:221-5 (1998)'
p33677
aS'PMID:17557941'
p33678
ag33678
aS'AUTHORS'
p33679
aS'Fry AC, Karet FE'
p33680
aS'TITLE'
p33681
aS'Inherited renal acidoses.'
p33682
aS'JOURNAL'
p33683
aS'Physiology (Bethesda) 22:202-11 (2007)'
p33684
aS'PMID:19721811'
p33685
ag33685
aS'AUTHORS'
p33686
aS'Pereira PC, Miranda DM, Oliveira EA, Silva AC'
p33687
aS'TITLE'
p33688
aS'Molecular pathophysiology of renal tubular acidosis.'
p33689
aS'JOURNAL'
p33690
aS'Curr Genomics 10:51-9 (2009)'
p33691
aS'PMID:11045400'
p33692
ag33692
aS'AUTHORS'
p33693
aS'Rodriguez-Soriano J'
p33694
aS'TITLE'
p33695
aS'New insights into the pathogenesis of renal tubular acidosis--from functional to'
p33696
aS'molecular studies.'
p33697
aS'JOURNAL'
p33698
aS'Pediatr Nephrol 14:1121-36 (2000)'
p33699
aS'PMID:11826292'
p33700
ag33700
aS'AUTHORS'
p33701
aS'Alper SL'
p33702
aS'TITLE'
p33703
aS'Genetic diseases of acid-base transporters.'
p33704
aS'JOURNAL'
p33705
aS'Annu Rev Physiol 64:899-923 (2002)'
p33706
asS'KO_PATHWAY'
p33707
(lp33708
S'ko04966'
p33709
asS'PATHWAY_MAP'
p33710
(lp33711
S'map04966'
p33712
asS'DISEASE'
p33713
(lp33714
S'H00241'
p33715
aS'Combined proximal and distal renal tubular acidosis (RTA type 3)'
p33716
ag33715
ag33716
aS'H00428'
p33717
aS'Distal renal tubular acidosis (RTA type 1)'
p33718
asS'ENTRY'
p33719
(lp33720
S'map04966'
p33721
aS'Pathway'
p33722
asS'CLASS'
p33723
(lp33724
S'Organismal Systems Excretory system'
p33725
asS'DESCRIPTION'
p33726
(lp33727
S'One of the important roles of the collecting duct segment of the kidney nephron is acid secretion. As daily food intake loads acid into the body, urinary acid excretion is essential, and urine pH can drop as low as 4.5. The alpha-intercalated cell of collecting duct is the main responsible for hydrogen secretion into the urine. The carbon dioxide, which is generated in the cells and enters from the blood, is changed to carbonic acid. This carbonic acid is divided into hydrogen ion and bicarbonate ion. Intracellular CA II catalyses the formation of these ions. The hydrogen ion is secreted into the lumen by the luminal H(+)-ATPase. The bicarbonate ion is transported to the blood side by the anion exchanger type 1. Hydrogen ion in the lumen is trapped by urinary buffers. These include ammonium and phosphate.'
p33728
assS'path:map00052'
p33729
(dp33730
S'NAME'
p33731
(lp33732
S'Galactose metabolism'
p33733
asS'KO_PATHWAY'
p33734
(lp33735
S'ko00052'
p33736
asS'PATHWAY_MAP'
p33737
(lp33738
S'map00052'
p33739
asS'DISEASE'
p33740
(lp33741
S'H00070'
p33742
aS'Galactosemia'
p33743
ag33742
ag33743
aS'H00116'
p33744
aS'Congenital lactase deficiency'
p33745
asS'MODULE'
p33746
(lp33747
S'M00277'
p33748
aS'PTS system, N-acetylgalactosamine-specific II component [PATH:map00052]'
p33749
ag33748
ag33749
aS'M00279'
p33750
aS'PTS system, galactitol-specific II component [PATH:map00052]'
p33751
aS'M00281'
p33752
aS'PTS system, lactose-specific II component [PATH:map00052]'
p33753
aS'M00287'
p33754
aS'PTS system, galactosamine-specific II component [PATH:map00052]'
p33755
aS'M00309'
p33756
aS'Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map00052]'
p33757
aS'M00552'
p33758
aS'D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P [PATH:map00052]'
p33759
aS'M00554'
p33760
aS'Nucleotide sugar biosynthesis, galactose => UDP-galactose [PATH:map00052]'
p33761
aS'M00632'
p33762
aS'Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P [PATH:map00052]'
p33763
aS'M00633'
p33764
aS'Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map00052]'
p33765
asS'DBLINKS'
p33766
(lp33767
S'GO: 0006012'
p33768
asS'ENTRY'
p33769
(lp33770
S'map00052'
p33771
aS'Pathway'
p33772
asS'CLASS'
p33773
(lp33774
S'Metabolism Carbohydrate metabolism'
p33775
assS'path:map00340'
p33776
(dp33777
S'NAME'
p33778
(lp33779
S'Histidine metabolism'
p33780
asS'KO_PATHWAY'
p33781
(lp33782
S'ko00340'
p33783
asS'PATHWAY_MAP'
p33784
(lp33785
S'map00340'
p33786
asS'DISEASE'
p33787
(lp33788
S'H00171'
p33789
aS'Histidinemia'
p33790
ag33789
ag33790
aS'H00548'
p33791
aS'Brunner syndrome'
p33792
aS'H00862'
p33793
aS'Tourette syndrome'
p33794
aS'H01233'
p33795
aS'Urocanase deficiency'
p33796
aS'H01262'
p33797
aS'Formiminotransferase deficiency'
p33798
asS'MODULE'
p33799
(lp33800
S'M00026'
p33801
aS'Histidine biosynthesis, PRPP => histidine [PATH:map00340]'
p33802
ag33801
ag33802
aS'M00045'
p33803
aS'Histidine degradation, histidine => N-formiminoglutamate => glutamate [PATH:map00340]'
p33804
asS'DBLINKS'
p33805
(lp33806
S'GO: 0006547'
p33807
asS'ENTRY'
p33808
(lp33809
S'map00340'
p33810
aS'Pathway'
p33811
asS'CLASS'
p33812
(lp33813
S'Metabolism Amino acid metabolism'
p33814
assS'path:map00830'
p33815
(dp33816
S'NAME'
p33817
(lp33818
S'Retinol metabolism'
p33819
asS'REFERENCE'
p33820
(lp33821
S'PMID:16968212'
p33822
ag33822
aS'AUTHORS'
p33823
aS'Travis GH, Golczak M, Moise AR, Palczewski K.'
p33824
aS'TITLE'
p33825
aS'Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.'
p33826
aS'JOURNAL'
p33827
aS'Annu Rev Pharmacol Toxicol 47:469-512 (2007)'
p33828
aS'PMID:17618621'
p33829
ag33829
aS'AUTHORS'
p33830
aS'Muniz A, Villazana-Espinoza ET, Hatch AL, Trevino SG, Allen DM, Tsin AT.'
p33831
aS'TITLE'
p33832
aS'A novel cone visual cycle in the cone-dominated retina.'
p33833
aS'JOURNAL'
p33834
aS'Exp Eye Res 85:175-84 (2007)'
p33835
aS'PMID:11093772'
p33836
ag33836
aS'AUTHORS'
p33837
aS'Marill J, Cresteil T, Lanotte M, Chabot GG.'
p33838
aS'TITLE'
p33839
aS'Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.'
p33840
aS'JOURNAL'
p33841
aS'Mol Pharmacol 58:1341-8 (2000)'
p33842
aS'PMID:17893666'
p33843
ag33843
aS'AUTHORS'
p33844
aS'Nezzar H, Chiambaretta F, Marceau G, Blanchon L, Faye B, Dechelotte P, Rigal D, Sapin V.'
p33845
aS'TITLE'
p33846
aS'Molecular and metabolic retinoid pathways in the human ocular surface.'
p33847
aS'JOURNAL'
p33848
aS'Mol Vis 13:1641-50 (2007)'
p33849
aS'PMID:16688755'
p33850
ag33850
aS'AUTHORS'
p33851
aS'Blomhoff R, Blomhoff HK.'
p33852
aS'TITLE'
p33853
aS'Overview of retinoid metabolism and function.'
p33854
aS'JOURNAL'
p33855
aS'J Neurobiol 66:606-30 (2006)'
p33856
aS'PMID:16428379'
p33857
ag33857
aS'AUTHORS'
p33858
aS'Liden M, Eriksson U.'
p33859
aS'TITLE'
p33860
aS'Understanding retinol metabolism: structure and function of retinol dehydrogenases.'
p33861
aS'JOURNAL'
p33862
aS'J Biol Chem 281:13001-4 (2006)'
p33863
asS'KO_PATHWAY'
p33864
(lp33865
S'ko00830'
p33866
asS'PATHWAY_MAP'
p33867
(lp33868
S'map00830'
p33869
asS'DISEASE'
p33870
(lp33871
S'H00527'
p33872
aS'Retinitis pigmentosa (RP)'
p33873
ag33872
ag33873
aS'H00825'
p33874
aS'Familial flecked retina syndrome'
p33875
aS'H00837'
p33876
aS'Leber congenital amaurosis (LCR)'
p33877
aS'H01266'
p33878
aS'Hypercarotenemia and vitamin A deficiency'
p33879
asS'DBLINKS'
p33880
(lp33881
S'GO: 0006776'
p33882
asS'ENTRY'
p33883
(lp33884
S'map00830'
p33885
aS'Pathway'
p33886
asS'CLASS'
p33887
(lp33888
S'Metabolism Metabolism of cofactors and vitamins'
p33889
assS'path:map03030'
p33890
(dp33891
S'NAME'
p33892
(lp33893
S'DNA replication'
p33894
asS'REFERENCE'
p33895
(lp33896
S'(Japanese)'
p33897
ag33897
aS'AUTHORS'
p33898
aS'Matsukage A, Masai H.'
p33899
aS'TITLE'
p33900
aS'[The Replication and Partitioning of Genomes] (In Japanese)'
p33901
aS'JOURNAL'
p33902
aS'Springer-Verlag Tokyo (2002)'
p33903
aS'(Japanese)'
p33904
ag33904
aS'AUTHORS'
p33905
aS'Tamura T, Yamamoto M.'
p33906
aS'TITLE'
p33907
aS'[Molecular Biology'
p33908
aS'Illustrated] (In Japanese)'
p33909
aS'JOURNAL'
p33910
aS'Yodosha (2002)'
p33911
aS'PMID:8087839'
p33912
ag33912
aS'AUTHORS'
p33913
aS'Stillman B.'
p33914
aS'TITLE'
p33915
aS'Smart machines at the DNA replication fork.'
p33916
aS'JOURNAL'
p33917
aS'Cell 78:725-8 (1994)'
p33918
aS'PMID:9759502'
p33919
ag33919
aS'AUTHORS'
p33920
aS'Waga S, Stillman B.'
p33921
aS'TITLE'
p33922
aS'The DNA replication fork in eukaryotic cells.'
p33923
aS'JOURNAL'
p33924
aS'Annu Rev Biochem 67:721-51 (1998)'
p33925
asS'KO_PATHWAY'
p33926
(lp33927
S'ko03030'
p33928
asS'PATHWAY_MAP'
p33929
(lp33930
S'map03030'
p33931
asS'MODULE'
p33932
(lp33933
S'M00260'
p33934
aS'DNA polymerase III complex, bacteria [PATH:map03030]'
p33935
ag33934
ag33935
aS'M00261'
p33936
aS'DNA polymerase alpha / primase complex [PATH:map03030]'
p33937
aS'M00262'
p33938
aS'DNA polymerase delta complex [PATH:map03030]'
p33939
aS'M00263'
p33940
aS'DNA polymerase epsilon complex [PATH:map03030]'
p33941
aS'M00285'
p33942
aS'MCM complex [PATH:map03030]'
p33943
aS'M00288'
p33944
aS'RPA complex [PATH:map03030]'
p33945
aS'M00289'
p33946
aS'RF-C complex [PATH:map03030]'
p33947
asS'ENTRY'
p33948
(lp33949
S'map03030'
p33950
aS'Pathway'
p33951
asS'CLASS'
p33952
(lp33953
S'Genetic Information Processing Replication and repair'
p33954
asS'DESCRIPTION'
p33955
(lp33956
S'A complex network of interacting proteins and enzymes is required for DNA replication. Generally, DNA replication follows a multistep enzymatic pathway. At the DNA replication fork, a DNA helicase (DnaB or MCM complex) precedes the DNA synthetic machinery and unwinds the duplex parental DNA in cooperation with the SSB or RPA. On the leading strand, replication occurs continuously in a 5 to 3 direction, whereas on the lagging strand, DNA replication occurs discontinuously by synthesis and joining of short Okazaki fragments. In prokaryotes, the leading strand replication apparatus consists of a DNA polymerase (pol III core), a sliding clamp (beta), and a clamp loader (gamma delta complex). The DNA primase (DnaG) is needed to form RNA primers. Normally, during replication of the lagging-strand DNA template, an RNA primer is removed either by an RNase H or by the 5 to 3 exonuclease activity of DNA pol I, and the DNA ligase joins the Okazaki fragments. In eukaryotes, three DNA polymerases (alpha, delta, and epsilon) have been identified. DNA primase forms a permanent complex with DNA polymerase alpha. PCNA and RFC function as a clamp and a clamp loader. FEN 1 and RNase H1 remove the RNA from the Okazaki fragments and DNA ligase I joins the DNA.'
p33957
assS'path:map01200'
p33958
(dp33959
S'NAME'
p33960
(lp33961
S'Carbon metabolism'
p33962
asS'KO_PATHWAY'
p33963
(lp33964
S'ko01200'
p33965
asS'ENTRY'
p33966
(lp33967
S'map01200'
p33968
aS'Global'
p33969
aS'Pathway'
p33970
asS'PATHWAY_MAP'
p33971
(lp33972
S'map01200'
p33973
asS'CLASS'
p33974
(lp33975
S'Metabolism Overview'
p33976
asS'MODULE'
p33977
(lp33978
S'M00001'
p33979
aS'Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate [PATH:map01200]'
p33980
ag33979
ag33980
aS'M00002'
p33981
aS'Glycolysis, core module involving three-carbon compounds [PATH:map01200]'
p33982
aS'M00004'
p33983
aS'Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map01200]'
p33984
aS'M00005'
p33985
aS'PRPP biosynthesis, ribose 5P => PRPP [PATH:map01200]'
p33986
aS'M00006'
p33987
aS'Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map01200]'
p33988
aS'M00007'
p33989
aS'Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map01200]'
p33990
aS'M00008'
p33991
aS'Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map01200]'
p33992
aS'M00009'
p33993
aS'Citrate cycle (TCA cycle, Krebs cycle) [PATH:map01200]'
p33994
aS'M00010'
p33995
aS'Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map01200]'
p33996
aS'M00011'
p33997
aS'Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:map01200]'
p33998
aS'M00012'
p33999
aS'Glyoxylate cycle [PATH:map01200]'
p34000
aS'M00013'
p34001
aS'Malonate semialdehyde pathway, propanoyl-CoA => Acetyl-CoA [PATH:map01200]'
p34002
aS'M00020'
p34003
aS'Serine biosynthesis, glycerate-3P => serine [PATH:map01200]'
p34004
aS'M00021'
p34005
aS'Cysteine biosynthesis, serine => cysteine [PATH:map01200]'
p34006
aS'M00165'
p34007
aS'Reductive pentose phosphate cycle (Calvin cycle) [PATH:map01200]'
p34008
aS'M00166'
p34009
aS'Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P [PATH:map01200]'
p34010
aS'M00167'
p34011
aS'Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P [PATH:map01200]'
p34012
aS'M00168'
p34013
aS'CAM (Crassulacean acid metabolism), dark [PATH:map01200]'
p34014
aS'M00169'
p34015
aS'CAM (Crassulacean acid metabolism), light [PATH:map01200]'
p34016
aS'M00170'
p34017
aS'C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type [PATH:map01200]'
p34018
aS'M00171'
p34019
aS'C4-dicarboxylic acid cycle, NAD - malic enzyme type [PATH:map01200]'
p34020
aS'M00172'
p34021
aS'C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map01200]'
p34022
aS'M00173'
p34023
aS'Reductive citrate cycle (Arnon-Buchanan cycle) [PATH:map01200]'
p34024
aS'M00174'
p34025
aS'Methane oxidation, methanotroph, methane => formaldehyde [PATH:map01200]'
p34026
aS'M00307'
p34027
aS'Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map01200]'
p34028
aS'M00308'
p34029
aS'Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map01200]'
p34030
aS'M00309'
p34031
aS'Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map01200]'
p34032
aS'M00344'
p34033
aS'Formaldehyde assimilation, xylulose monophosphate pathway [PATH:map01200]'
p34034
aS'M00345'
p34035
aS'Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map01200]'
p34036
aS'M00346'
p34037
aS'Formaldehyde assimilation, serine pathway [PATH:map01200]'
p34038
aS'M00356'
p34039
aS'Methanogenesis, methanol => methane [PATH:map01200]'
p34040
aS'M00357'
p34041
aS'Methanogenesis, acetate => methane [PATH:map01200]'
p34042
aS'M00374'
p34043
aS'Dicarboxylate-hydroxybutyrate cycle [PATH:map01200]'
p34044
aS'M00375'
p34045
aS'Hydroxypropionate-hydroxybutylate cycle [PATH:map01200]'
p34046
aS'M00376'
p34047
aS'3-Hydroxypropionate bi-cycle [PATH:map01200]'
p34048
aS'M00377'
p34049
aS'Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [PATH:map01200]'
p34050
aS'M00563'
p34051
aS'Methanogenesis, methylamine/dimethylamine/trimethylamine => methane [PATH:map01200]'
p34052
aS'M00567'
p34053
aS'Methanogenesis, CO2 => methane [PATH:map01200]'
p34054
aS'M00579'
p34055
aS'Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map01200]'
p34056
aS'M00580'
p34057
aS'Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map01200]'
p34058
aS'M00620'
p34059
aS'Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate [PATH:map01200]'
p34060
aS'M00633'
p34061
aS'Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map01200]'
p34062
asS'DESCRIPTION'
p34063
(lp34064
S'Carbon metabolism is the most basic aspect of life. This map presents an overall view of central carbon metabolism, where the number of carbons is shown for each compound denoted by a circle, excluding a cofactor (CoA, CoM, THF, or THMPT) that is replaced by an asterisk. The map contains carbon utilization pathways of glycolysis (map00010), pentose phosphate pathway (map00030), and citrate cycle (map00020), and six known carbon fixation pathways (map00710 and map00720) as well as some pathways of methane metabolism (map00680). The six carbon fixation pathways are: (1) reductive pentose phosphate cycle (Calvin cycle) in plants and cyanobacteria that perform oxygenic photosynthesis, (2) reductive citrate cycle in photosynthetic green sulfur bacteria and some chemolithoautotrophs, (3) 3-hydroxypropionate bi-cycle in photosynthetic green nonsulfur bacteria, two variants of 4-hydroxybutyrate pathways in Crenarchaeota called (4) hydroxypropionate-hydroxybutyrate cycle and (5) dicarboxylate-hydroxybutyrate cycle, and (6) reductive acetyl-CoA pathway in methanogenic bacteria.'
p34065
assS'path:map00330'
p34066
(dp34067
S'NAME'
p34068
(lp34069
S'Arginine and proline metabolism'
p34070
asS'REFERENCE'
p34071
(lp34072
S'PMID:5288244'
p34073
ag34073
aS'AUTHORS'
p34074
aS'Haake P, Allen GW.'
p34075
aS'TITLE'
p34076
aS'Studies on phosphorylation by phosphoroguanidinates. The mechanism of action of creatine: ATP transphosphorylase (creatine kinase).'
p34077
aS'JOURNAL'
p34078
aS'Proc Natl Acad Sci U S A 68:2691-3 (1971)'
p34079
aS'PMID:16499623'
p34080
ag34080
aS'AUTHORS'
p34081
aS'Kurihara S, Oda S, Kumagai H, Suzuki H.'
p34082
aS'TITLE'
p34083
aS'Gamma-glutamyl-gamma-aminobutyrate hydrolase in the putrescine utilization pathway of Escherichia coli K-12.'
p34084
aS'JOURNAL'
p34085
aS'FEMS Microbiol Lett 256:318-23 (2006)'
p34086
aS'PMID:15590624'
p34087
ag34087
aS'AUTHORS'
p34088
aS'Kurihara S, Oda S, Kato K, Kim HG, Koyanagi T, Kumagai H, Suzuki H.'
p34089
aS'TITLE'
p34090
aS'A novel putrescine utilization pathway involves gamma-glutamylated intermediates of Escherichia coli K-12.'
p34091
aS'JOURNAL'
p34092
aS'J Biol Chem 280:4602-8 (2005)'
p34093
asS'KO_PATHWAY'
p34094
(lp34095
S'ko00330'
p34096
asS'PATHWAY_MAP'
p34097
(lp34098
S'map00330'
p34099
asS'DISEASE'
p34100
(lp34101
S'H00164'
p34102
aS'Carbamoyl phosphate synthetase I deficiency'
p34103
ag34102
ag34103
aS'H00185'
p34104
aS'Citrullinemia (CTLN)'
p34105
aS'H00186'
p34106
aS'Hyperargininemia'
p34107
aS'H00187'
p34108
aS'Ornithine transcarbamylase deficiency'
p34109
aS'H00189'
p34110
aS'Ornithinaemia'
p34111
aS'H00190'
p34112
aS'Hyperprolinemia (HP)'
p34113
aS'H00597'
p34114
aS'Snyder-Robinson syndrome'
p34115
aS'H00834'
p34116
aS'Guanidinoacetate methyltransferase (GAMT) deficiency'
p34117
aS'H00849'
p34118
aS'Creatine deficiency syndrome'
p34119
aS'H00923'
p34120
aS'Congenital systemic glutamine deficiency (CSGD)'
p34121
aS'H01028'
p34122
aS'Argininosuccinic aciduria (ARGINSA)'
p34123
aS'H01032'
p34124
aS'N-acetylglutamate synthase (NAGS) deficiency'
p34125
aS'H01146'
p34126
aS'Aminoacylase 1 deficiency'
p34127
aS'H01398'
p34128
aS'Primary hyperammonemic disorders'
p34129
asS'MODULE'
p34130
(lp34131
S'M00015'
p34132
aS'Proline biosynthesis, glutamate => proline [PATH:map00330]'
p34133
ag34132
ag34133
aS'M00028'
p34134
aS'Ornithine biosynthesis, glutamate => ornithine [PATH:map00330]'
p34135
aS'M00029'
p34136
aS'Urea cycle [PATH:map00330]'
p34137
aS'M00047'
p34138
aS'Creatine pathway [PATH:map00330]'
p34139
aS'M00133'
p34140
aS'Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine [PATH:map00330]'
p34141
aS'M00134'
p34142
aS'Polyamine biosynthesis, arginine => ornithine => putrescine [PATH:map00330]'
p34143
aS'M00135'
p34144
aS'GABA biosynthesis, eukaryotes, putrescine => GABA [PATH:map00330]'
p34145
aS'M00136'
p34146
aS'GABA biosynthesis, prokaryotes, putrescine => GABA [PATH:map00330]'
p34147
asS'DBLINKS'
p34148
(lp34149
S'GO: 0006525 0006560'
p34150
asS'ENTRY'
p34151
(lp34152
S'map00330'
p34153
aS'Pathway'
p34154
asS'CLASS'
p34155
(lp34156
S'Metabolism Amino acid metabolism'
p34157
assS'path:map00331'
p34158
(dp34159
S'NAME'
p34160
(lp34161
S'Clavulanic acid biosynthesis'
p34162
asS'REFERENCE'
p34163
(lp34164
S'PMID:9614345'
p34165
ag34165
aS'AUTHORS'
p34166
aS'McGowan SJ, Bycroft BW, Salmond GP.'
p34167
aS'TITLE'
p34168
aS'Bacterial production of carbapenems and clavams: evolution of beta-lactam antibiotic pathways.'
p34169
aS'JOURNAL'
p34170
aS'Trends Microbiol 6:203-8 (1998)'
p34171
aS'PMID:14623876'
p34172
ag34172
aS'AUTHORS'
p34173
aS'Caines ME, Elkins JM, Hewitson KS, Schofield CJ.'
p34174
aS'TITLE'
p34175
aS'Crystal structure and mechanistic implications of N2-(2-carboxyethyl)arginine synthase, the first enzyme in the clavulanic acid biosynthesis pathway.'
p34176
aS'JOURNAL'
p34177
aS'J Biol Chem 279:5685-92 (2004)'
p34178
asS'KO_PATHWAY'
p34179
(lp34180
S'ko00331'
p34181
asS'ENTRY'
p34182
(lp34183
S'map00331'
p34184
aS'Pathway'
p34185
asS'PATHWAY_MAP'
p34186
(lp34187
S'map00331'
p34188
asS'CLASS'
p34189
(lp34190
S'Metabolism Biosynthesis of other secondary metabolites'
p34191
asS'MODULE'
p34192
(lp34193
S'M00674'
p34194
aS'Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate [PATH:map00331]'
p34195
assS'path:map00332'
p34196
(dp34197
S'NAME'
p34198
(lp34199
S'Carbapenem biosynthesis'
p34200
asS'REFERENCE'
p34201
(lp34202
S'PMID:12848554'
p34203
ag34203
aS'AUTHORS'
p34204
aS'Stapon A, Li R, Townsend CA'
p34205
aS'TITLE'
p34206
aS'Carbapenem biosynthesis: confirmation of stereochemical assignments and the role'
p34207
aS'of CarC in the ring stereoinversion process from L-proline.'
p34208
aS'JOURNAL'
p34209
aS'J Am Chem Soc 125:8486-93 (2003)'
p34210
aS'PMID:15174175'
p34211
ag34211
aS'AUTHORS'
p34212
aS'Sleeman MC, Smith P, Kellam B, Chhabra SR, Bycroft BW, Schofield CJ'
p34213
aS'TITLE'
p34214
aS'Biosynthesis of carbapenem antibiotics: new carbapenam substrates for carbapenem'
p34215
aS'synthase (CarC).'
p34216
aS'JOURNAL'
p34217
aS'Chembiochem 5:879-82 (2004)'
p34218
aS'PMID:14625287'
p34219
ag34219
aS'AUTHORS'
p34220
aS'Sleeman MC, Schofield CJ'
p34221
aS'TITLE'
p34222
aS'Carboxymethylproline synthase (CarB), an unusual carbon-carbon bond-forming enzyme of the crotonase superfamily involved in carbapenem biosynthesis.'
p34223
aS'JOURNAL'
p34224
aS'J Biol Chem 279:6730-6 (2004)'
p34225
aS'PMID:19090510'
p34226
ag34226
aS'AUTHORS'
p34227
aS'Hamed RB, Batchelar ET, Mecinovic J, Claridge TD, Schofield CJ'
p34228
aS'TITLE'
p34229
aS'Evidence that thienamycin biosynthesis proceeds via C-5 epimerization: ThnE catalyzes the formation of (2S,5S)-trans-carboxymethylproline.'
p34230
aS'JOURNAL'
p34231
aS'Chembiochem 10:246-50 (2009)'
p34232
aS'PMID:21913298'
p34233
ag34233
aS'AUTHORS'
p34234
aS'Bodner MJ, Li R, Phelan RM, Freeman MF, Moshos KA, Lloyd EP, Townsend CA'
p34235
aS'TITLE'
p34236
aS'Definition of the common and divergent steps in carbapenem beta-lactam antibiotic biosynthesis.'
p34237
aS'JOURNAL'
p34238
aS'Chembiochem 12:2159-65 (2011)'
p34239
aS'PMID:12147472'
p34240
ag34240
aS'AUTHORS'
p34241
aS'Derzelle S, Duchaud E, Kunst F, Danchin A, Bertin P'
p34242
aS'TITLE'
p34243
aS'Identification, characterization, and regulation of a cluster of genes involved in carbapenem biosynthesis in Photorhabdus luminescens.'
p34244
aS'JOURNAL'
p34245
aS'Appl Environ Microbiol 68:3780-9 (2002)'
p34246
aS'PMID:21263049'
p34247
ag34247
aS'AUTHORS'
p34248
aS'Rodriguez M, Nunez LE, Brana AF, Mendez C, Salas JA, Blanco G'
p34249
aS'TITLE'
p34250
aS'Mutational analysis of the thienamycin biosynthetic gene cluster from Streptomyces cattleya.'
p34251
aS'JOURNAL'
p34252
aS'Antimicrob Agents Chemother 55:1638-49 (2011)'
p34253
aS'PMID:3988730'
p34254
ag34254
aS'AUTHORS'
p34255
aS'Williamson JM, Inamine E, Wilson KE, Douglas AW, Liesch JM, Albers-Schonberg G'
p34256
aS'TITLE'
p34257
aS'Biosynthesis of the beta-lactam antibiotic, thienamycin, by Streptomyces cattleya.'
p34258
aS'JOURNAL'
p34259
aS'J Biol Chem 260:4637-47 (1985)'
p34260
aS'PMID:12725858'
p34261
ag34261
aS'AUTHORS'
p34262
aS'Nunez LE, Mendez C, Brana AF, Blanco G, Salas JA'
p34263
aS'TITLE'
p34264
aS'The biosynthetic gene cluster for the beta-lactam carbapenem thienamycin in Streptomyces cattleya.'
p34265
aS'JOURNAL'
p34266
aS'Chem Biol 10:301-11 (2003)'
p34267
aS'PMID:20017478'
p34268
ag34268
aS'AUTHORS'
p34269
aS'Bodner MJ, Phelan RM, Freeman MF, Li R, Townsend CA'
p34270
aS'TITLE'
p34271
aS'Non-heme iron oxygenases generate natural structural diversity in carbapenem antibiotics.'
p34272
aS'JOURNAL'
p34273
aS'J Am Chem Soc 132:12-3 (2010)'
p34274
aS'PMID:18678912'
p34275
ag34275
aS'AUTHORS'
p34276
aS'Freeman MF, Moshos KA, Bodner MJ, Li R, Townsend CA'
p34277
aS'TITLE'
p34278
aS'Four enzymes define the incorporation of coenzyme A in thienamycin biosynthesis.'
p34279
aS'JOURNAL'
p34280
aS'Proc Natl Acad Sci U S A 105:11128-33 (2008)'
p34281
aS'PMID:22706025'
p34282
ag34282
aS'AUTHORS'
p34283
aS'Buller AR, Labonte JW, Freeman MF, Wright NT, Schildbach JF, Townsend CA'
p34284
aS'TITLE'
p34285
aS'Autoproteolytic activation of ThnT results in structural reorganization necessary for substrate binding and catalysis.'
p34286
aS'JOURNAL'
p34287
aS'J Mol Biol 422:508-18 (2012)'
p34288
aS'PMID:24420617'
p34289
ag34289
aS'AUTHORS'
p34290
aS'Li R, Lloyd EP, Moshos KA, Townsend CA'
p34291
aS'TITLE'
p34292
aS'Identification and characterization of the carbapenem MM 4550 and its gene cluster in Streptomyces argenteolus ATCC 11009.'
p34293
aS'JOURNAL'
p34294
aS'Chembiochem 15:320-31 (2014)'
p34295
asS'KO_PATHWAY'
p34296
(lp34297
S'ko00332'
p34298
asS'PATHWAY_MAP'
p34299
(lp34300
S'map00332'
p34301
asS'MODULE'
p34302
(lp34303
S'M00675'
p34304
aS'Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate [PATH:map00332]'
p34305
asS'DBLINKS'
p34306
(lp34307
S'GO: 1901769'
p34308
asS'ENTRY'
p34309
(lp34310
S'map00332'
p34311
aS'Pathway'
p34312
asS'CLASS'
p34313
(lp34314
S'Metabolism Biosynthesis of other secondary metabolites'
p34315
assS'path:map01063'
p34316
(dp34317
S'ENTRY'
p34318
(lp34319
S'map01063'
p34320
aS'Pathway'
p34321
asS'PATHWAY_MAP'
p34322
(lp34323
S'map01063'
p34324
asS'NAME'
p34325
(lp34326
S'Biosynthesis of alkaloids derived from shikimate pathway'
p34327
asS'KO_PATHWAY'
p34328
(lp34329
S'ko01063'
p34330
assS'path:map01062'
p34331
(dp34332
S'ENTRY'
p34333
(lp34334
S'map01062'
p34335
aS'Pathway'
p34336
asS'PATHWAY_MAP'
p34337
(lp34338
S'map01062'
p34339
asS'NAME'
p34340
(lp34341
S'Biosynthesis of terpenoids and steroids'
p34342
asS'KO_PATHWAY'
p34343
(lp34344
S'ko01062'
p34345
assS'path:map01061'
p34346
(dp34347
S'ENTRY'
p34348
(lp34349
S'map01061'
p34350
aS'Pathway'
p34351
asS'PATHWAY_MAP'
p34352
(lp34353
S'map01061'
p34354
asS'NAME'
p34355
(lp34356
S'Biosynthesis of phenylpropanoids'
p34357
asS'KO_PATHWAY'
p34358
(lp34359
S'ko01061'
p34360
assS'path:map01060'
p34361
(dp34362
S'ENTRY'
p34363
(lp34364
S'map01060'
p34365
aS'Pathway'
p34366
asS'PATHWAY_MAP'
p34367
(lp34368
S'map01060'
p34369
asS'NAME'
p34370
(lp34371
S'Biosynthesis of plant secondary metabolites'
p34372
asS'KO_PATHWAY'
p34373
(lp34374
S'ko01060'
p34375
assS'path:map01066'
p34376
(dp34377
S'ENTRY'
p34378
(lp34379
S'map01066'
p34380
aS'Pathway'
p34381
asS'PATHWAY_MAP'
p34382
(lp34383
S'map01066'
p34384
asS'NAME'
p34385
(lp34386
S'Biosynthesis of alkaloids derived from terpenoid and polyketide'
p34387
asS'KO_PATHWAY'
p34388
(lp34389
S'ko01066'
p34390
assS'path:map01065'
p34391
(dp34392
S'ENTRY'
p34393
(lp34394
S'map01065'
p34395
aS'Pathway'
p34396
asS'PATHWAY_MAP'
p34397
(lp34398
S'map01065'
p34399
asS'NAME'
p34400
(lp34401
S'Biosynthesis of alkaloids derived from histidine and purine'
p34402
asS'KO_PATHWAY'
p34403
(lp34404
S'ko01065'
p34405
assS'path:map04540'
p34406
(dp34407
S'NAME'
p34408
(lp34409
S'Gap junction'
p34410
asS'REFERENCE'
p34411
(lp34412
S'PMID:14506308'
p34413
ag34413
aS'AUTHORS'
p34414
aS'Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC.'
p34415
aS'TITLE'
p34416
aS'Plasma membrane channels formed by connexins: their regulation and functions.'
p34417
aS'JOURNAL'
p34418
aS'Physiol Rev 83:1359-400 (2003)'
p34419
aS'PMID:15033580'
p34420
ag34420
aS'AUTHORS'
p34421
aS'Warn-Cramer BJ, Lau AF.'
p34422
aS'TITLE'
p34423
aS'Regulation of gap junctions by tyrosine protein kinases.'
p34424
aS'JOURNAL'
p34425
aS'Biochim Biophys Acta 1662:81-95 (2004)'
p34426
aS'PMID:9535909'
p34427
ag34427
aS'AUTHORS'
p34428
aS'Warn-Cramer BJ, Cottrell GT, Burt JM, Lau AF.'
p34429
aS'TITLE'
p34430
aS'Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinase.'
p34431
aS'JOURNAL'
p34432
aS'J Biol Chem 273:9188-96 (1998)'
p34433
aS'PMID:10751659'
p34434
ag34434
aS'AUTHORS'
p34435
aS'Roerig B, Feller MB.'
p34436
aS'TITLE'
p34437
aS'Neurotransmitters and gap junctions in developing neural circuits.'
p34438
aS'JOURNAL'
p34439
aS'Brain Res Brain Res Rev 32:86-114 (2000)'
p34440
aS'PMID:10873290'
p34441
ag34441
aS'AUTHORS'
p34442
aS'Hatton GI.'
p34443
aS'TITLE'
p34444
aS'Synaptic modulation of neuronal coupling.'
p34445
aS'JOURNAL'
p34446
aS'Cell Biol Int 22:765-80 (1998)'
p34447
aS'PMID:12566218'
p34448
ag34448
aS'AUTHORS'
p34449
aS'Cruciani V, Mikalsen SO.'
p34450
aS'TITLE'
p34451
aS'Connexins, gap junctional intercellular communication and kinases.'
p34452
aS'JOURNAL'
p34453
aS'Biol Cell 94:433-43 (2002)'
p34454
aS'PMID:15094344'
p34455
ag34455
aS'AUTHORS'
p34456
aS'Giepmans BN.'
p34457
aS'TITLE'
p34458
aS'Gap junctions and connexin-interacting proteins.'
p34459
aS'JOURNAL'
p34460
aS'Cardiovasc Res 62:233-45 (2004)'
p34461
aS'PMID:15955302'
p34462
ag34462
aS'AUTHORS'
p34463
aS'Laird DW.'
p34464
aS'TITLE'
p34465
aS'Connexin phosphorylation as a regulatory event linked to gap junction internalization and degradation.'
p34466
aS'JOURNAL'
p34467
aS'Biochim Biophys Acta 1711:172-82 (2005)'
p34468
aS'PMID:15033579'
p34469
ag34469
aS'AUTHORS'
p34470
aS'Peracchia C.'
p34471
aS'TITLE'
p34472
aS'Chemical gating of gap junction channels roles of calcium, pH and calmodulin.'
p34473
aS'JOURNAL'
p34474
aS'Biochim Biophys Acta 1662:61-80 (2004)'
p34475
aS'PMID:15033578'
p34476
ag34476
aS'AUTHORS'
p34477
aS'Bukauskas FF, Verselis VK.'
p34478
aS'TITLE'
p34479
aS'Gap junction channel gating.'
p34480
aS'JOURNAL'
p34481
aS'Biochim Biophys Acta 1662:42-60 (2004)'
p34482
asS'KO_PATHWAY'
p34483
(lp34484
S'ko04540'
p34485
asS'PATHWAY_MAP'
p34486
(lp34487
S'map04540'
p34488
asS'DISEASE'
p34489
(lp34490
S'H00606'
p34491
aS'Early infantile epileptic encephalopathy'
p34492
ag34491
ag34492
aS'H00838'
p34493
aS'Congenital fibrosis of the extraocular muscles (CFEOM)'
p34494
aS'H01095'
p34495
aS'Syndactyly'
p34496
aS'H01210'
p34497
aS'Hypomagnesemia'
p34498
aS'H01272'
p34499
aS'Hypoplastic left heart syndrome (HLHS)'
p34500
asS'DBLINKS'
p34501
(lp34502
S'GO: 0005921'
p34503
asS'ENTRY'
p34504
(lp34505
S'map04540'
p34506
aS'Pathway'
p34507
asS'CLASS'
p34508
(lp34509
S'Cellular Processes Cellular commiunity'
p34510
asS'DESCRIPTION'
p34511
(lp34512
S"Gap junctions contain intercellular channels that allow direct communication between the cytosolic compartments of adjacent cells. Each gap junction channel is formed by docking of two 'hemichannels', each containing six connexins, contributed by each neighboring cell. These channels permit the direct transfer of small molecules including ions, amino acids, nucleotides, second messengers and other metabolites between adjacent cells. Gap junctional communication is essential for many physiological events, including embryonic development, electrical coupling, metabolic transport, apoptosis, and tissue homeostasis. Communication through Gap Junction is sensitive to a variety of stimuli, including changes in the level of intracellular Ca2+, pH, transjunctional applied voltage and phosphorylation/dephosphorylation processes. This figure represents the possible activation routes of different protein kinases involved in Cx43 and Cx36 phosphorylation."
p34513
assS'path:map00909'
p34514
(dp34515
S'NAME'
p34516
(lp34517
S'Sesquiterpenoid and triterpenoid biosynthesis'
p34518
asS'REFERENCE'
p34519
(lp34520
S'PMID:9371761'
p34521
ag34521
aS'AUTHORS'
p34522
aS'Crock J, Wildung M, Croteau R'
p34523
aS'TITLE'
p34524
aS'Isolation and bacterial expression of a sesquiterpene synthase cDNA clone from peppermint (Mentha x piperita, L.) that produces the aphid alarm pheromone (E)-beta-farnesene.'
p34525
aS'JOURNAL'
p34526
aS'Proc Natl Acad Sci U S A 94:12833-8 (1997)'
p34527
aS'PMID:18363779'
p34528
ag34528
aS'AUTHORS'
p34529
aS'Nagegowda DA, Gutensohn M, Wilkerson CG, Dudareva N'
p34530
aS'TITLE'
p34531
aS'Two nearly identical terpene synthases catalyze the formation of nerolidol and linalool in snapdragon flowers.'
p34532
aS'JOURNAL'
p34533
aS'Plant J 55:224-39 (2008)'
p34534
aS'PMID:16579958'
p34535
ag34535
aS'AUTHORS'
p34536
aS'Bertea CM, Voster A, Verstappen FW, Maffei M, Beekwilder J, Bouwmeester HJ'
p34537
aS'TITLE'
p34538
aS'Isoprenoid biosynthesis in Artemisia annua: cloning and heterologous expression of a germacrene A synthase from a glandular trichome cDNA library.'
p34539
aS'JOURNAL'
p34540
aS'Arch Biochem Biophys 448:3-12 (2006)'
p34541
aS'PMID:12011356'
p34542
ag34542
aS'AUTHORS'
p34543
aS'de Kraker JW, Franssen MC, Joerink M, de Groot A, Bouwmeester HJ'
p34544
aS'TITLE'
p34545
aS'Biosynthesis of costunolide, dihydrocostunolide, and leucodin. Demonstration of cytochrome p450-catalyzed formation of the lactone ring present in sesquiterpene lactones of chicory.'
p34546
aS'JOURNAL'
p34547
aS'Plant Physiol 129:257-68 (2002)'
p34548
aS'PMID:17226502'
p34549
ag34549
aS'AUTHORS'
p34550
aS'Jaroszewski JW, Strom-Hansen T, Hansen SH, Thastrup O, Kofod H'
p34551
aS'TITLE'
p34552
aS'On the botanical distribution of chiral forms of gossypol.'
p34553
aS'JOURNAL'
p34554
aS'Planta Med 58:454-8 (1992)'
p34555
aS'PMID:9442047'
p34556
ag34556
aS'AUTHORS'
p34557
aS'Steele CL, Crock J, Bohlmann J, Croteau R'
p34558
aS'TITLE'
p34559
aS'Sesquiterpene synthases from grand fir (Abies grandis). Comparison of constitutive and wound-induced activities, and cDNA isolation, characterization, and bacterial expression of delta-selinene synthase and gamma-humulene synthase.'
p34560
aS'JOURNAL'
p34561
aS'J Biol Chem 273:2078-89 (1998)'
p34562
aS'PMID:19030608'
p34563
ag34563
aS'AUTHORS'
p34564
aS'Fraga BM'
p34565
aS'TITLE'
p34566
aS'Natural sesquiterpenoids.'
p34567
aS'JOURNAL'
p34568
aS'Nat Prod Rep 25:1180-209 (2008)'
p34569
aS'PMID:21876149'
p34570
ag34570
aS'AUTHORS'
p34571
aS'Field B, Fiston-Lavier AS, Kemen A, Geisler K, Quesneville H, Osbourn AE'
p34572
aS'TITLE'
p34573
aS'Formation of plant metabolic gene clusters within dynamic chromosomal regions.'
p34574
aS'JOURNAL'
p34575
aS'Proc Natl Acad Sci U S A 108:16116-21 (2011)'
p34576
aS'PMID:18356490'
p34577
ag34577
aS'AUTHORS'
p34578
aS'Field B, Osbourn AE'
p34579
aS'TITLE'
p34580
aS'Metabolic diversification--independent assembly of operon-like gene clusters in different plants.'
p34581
aS'JOURNAL'
p34582
aS'Science 320:543-7 (2008)'
p34583
aS'PMID:15148404'
p34584
ag34584
aS'AUTHORS'
p34585
aS'Qi X, Bakht S, Leggett M, Maxwell C, Melton R, Osbourn A'
p34586
aS'TITLE'
p34587
aS'A gene cluster for secondary metabolism in oat: implications for the evolution of metabolic diversity in plants.'
p34588
aS'JOURNAL'
p34589
aS'Proc Natl Acad Sci U S A 101:8233-8 (2004)'
p34590
asS'KO_PATHWAY'
p34591
(lp34592
S'ko00909'
p34593
asS'PATHWAY_MAP'
p34594
(lp34595
S'map00909'
p34596
asS'DBLINKS'
p34597
(lp34598
S'GO: 0016106 0016104'
p34599
asS'ENTRY'
p34600
(lp34601
S'map00909'
p34602
aS'Pathway'
p34603
asS'CLASS'
p34604
(lp34605
S'Metabolism Metabolism of terpenoids and polyketides'
p34606
asS'DESCRIPTION'
p34607
(lp34608
S'Sesquiterpenoids (C15 terpenoids) are a group of terpenoids consisting of three isoprene units. They are derive from farnesyl diphosphate (FPP) and can be cyclized to produce various skeletal structures. Sesquiterpenoid biosynthesis begins with the loss of diphosphate from FPP under the action of sesquiterpene synthesis enzymes, generating an allylic cation that is highly susceptible to intramolecular attacks. Cyclization of the farnesyl cation may take place onto either of the remaining double bonds with the result that 6-, 10-, or 11-membered rings may be formed. Many sesquiterpenoids have been isolated from plants, fungi, marine organisms, and Streptomyces species. This map shows a few examples of acyclic and cyclic sesquiterpenoids.'
p34609
assS'path:map00908'
p34610
(dp34611
S'NAME'
p34612
(lp34613
S'Zeatin biosynthesis'
p34614
asS'REFERENCE'
p34615
(lp34616
S'PMID:14726522'
p34617
ag34617
aS'AUTHORS'
p34618
aS'Kasahara H, Takei K, Ueda N, Hishiyama S, Yamaya T, Kamiya Y, Yamaguchi S, Sakakibara H.'
p34619
aS'TITLE'
p34620
aS'Distinct isoprenoid origins of cis- and trans-zeatin biosyntheses in Arabidopsis.'
p34621
aS'JOURNAL'
p34622
aS'J Biol Chem 279:14049-54 (2004)'
p34623
aS'PMID:11313355'
p34624
ag34624
aS'AUTHORS'
p34625
aS'Takei K, Sakakibara H, Sugiyama T.'
p34626
aS'TITLE'
p34627
aS'Identification of genes encoding adenylate isopentenyltransferase, a cytokinin biosynthesis enzyme, in Arabidopsis thaliana.'
p34628
aS'JOURNAL'
p34629
aS'J Biol Chem 276:26405-10 (2001)'
p34630
aS'PMID:11479373'
p34631
ag34631
aS'AUTHORS'
p34632
aS'Kakimoto T.'
p34633
aS'TITLE'
p34634
aS'Identification of plant cytokinin biosynthetic enzymes as dimethylallyl diphosphate:ATP/ADP isopentenyltransferases.'
p34635
aS'JOURNAL'
p34636
aS'Plant Cell Physiol 42:677-85 (2001)'
p34637
aS'PMID:15280363'
p34638
ag34638
aS'AUTHORS'
p34639
aS'Takei K, Yamaya T, Sakakibara H.'
p34640
aS'TITLE'
p34641
aS'Arabidopsis CYP735A1 and CYP735A2 encode cytokinin hydroxylases that catalyze the biosynthesis of trans-Zeatin.'
p34642
aS'JOURNAL'
p34643
aS'J Biol Chem 279:41866-72 (2004)'
p34644
aS'PMID:15342621'
p34645
ag34645
aS'AUTHORS'
p34646
aS'Hou B, Lim EK, Higgins GS, Bowles DJ.'
p34647
aS'TITLE'
p34648
aS'N-glucosylation of cytokinins by glycosyltransferases of Arabidopsis thaliana.'
p34649
aS'JOURNAL'
p34650
aS'J Biol Chem 279:47822-32 (2004)'
p34651
aS'PMID:9874810'
p34652
ag34652
aS'AUTHORS'
p34653
aS'Martin RC, Mok MC, Mok DW'
p34654
aS'TITLE'
p34655
aS'Isolation of a cytokinin gene, ZOG1, encoding zeatin O-glucosyltransferase from Phaseolus lunatus.'
p34656
aS'JOURNAL'
p34657
aS'Proc Natl Acad Sci U S A 96:284-9 (1999)'
p34658
aS'PMID:10364407'
p34659
ag34659
aS'AUTHORS'
p34660
aS'Martin RC, Mok MC, Mok DW'
p34661
aS'TITLE'
p34662
aS'A gene encoding the cytokinin enzyme zeatin O-xylosyltransferase of Phaseolus vulgaris.'
p34663
aS'JOURNAL'
p34664
aS'Plant Physiol 120:553-8 (1999)'
p34665
aS'PMID:12644686'
p34666
ag34666
aS'AUTHORS'
p34667
aS'Veach YK, Martin RC, Mok DW, Malbeck J, Vankova R, Mok MC'
p34668
aS'TITLE'
p34669
aS'O-glucosylation of cis-zeatin in maize. Characterization of genes, enzymes, and endogenous cytokinins.'
p34670
aS'JOURNAL'
p34671
aS'Plant Physiol 131:1374-80 (2003)'
p34672
aS'PMID:14555694'
p34673
ag34673
aS'AUTHORS'
p34674
aS'Werner T, Motyka V, Laucou V, Smets R, Van Onckelen H, Schmulling T'
p34675
aS'TITLE'
p34676
aS'Cytokinin-deficient transgenic Arabidopsis plants show multiple developmental alterations indicating opposite functions of cytokinins in the regulation of shoot and root meristem activity.'
p34677
aS'JOURNAL'
p34678
aS'Plant Cell 15:2532-50 (2003)'
p34679
aS'PMID:17062755'
p34680
ag34680
aS'AUTHORS'
p34681
aS'Miyawaki K, Tarkowski P, Matsumoto-Kitano M, Kato T, Sato S, Tarkowska D, Tabata S, Sandberg G, Kakimoto T'
p34682
aS'TITLE'
p34683
aS'Roles of Arabidopsis ATP/ADP isopentenyltransferases and tRNA isopentenyltransferases in cytokinin biosynthesis.'
p34684
aS'JOURNAL'
p34685
aS'Proc Natl Acad Sci U S A 103:16598-603 (2006)'
p34686
asS'KO_PATHWAY'
p34687
(lp34688
S'ko00908'
p34689
asS'PATHWAY_MAP'
p34690
(lp34691
S'map00908'
p34692
asS'DBLINKS'
p34693
(lp34694
S'GO: 0009691'
p34695
asS'ENTRY'
p34696
(lp34697
S'map00908'
p34698
aS'Pathway'
p34699
asS'CLASS'
p34700
(lp34701
S'Metabolism Metabolism of terpenoids and polyketides'
p34702
asS'DESCRIPTION'
p34703
(lp34704
S'Zeatin is a member of the cytokinin family, a class of phytohormones involved in various processes of growth and development in plants. Most abundant cytokinins are adenine-type, where the N6 position of adenine is substituted with an isoprenoid, such as in zeatin, or an aromatic side chain, such as in kinetin. Zeatin can be synthesized in two different pathways: the tRNA pathway and the AMP pathway. In the tRNA pathway zeatin is a recycled product of isopentenylated tRNAs. In the AMP pathway zeatin is synthesized from an isopentenyl donor, dimethylallyl diphosphate (DMAPP), and AMP, ADP, or ATP by isopentenyltransferases. After synthesis cytokinins can be glucosylated.'
p34705
assS'path:map00903'
p34706
(dp34707
S'NAME'
p34708
(lp34709
S'Limonene and pinene degradation'
p34710
asS'REFERENCE'
p34711
(lp34712
S'PMID:10224006'
p34713
ag34713
aS'AUTHORS'
p34714
aS'van der Werf MJ, Swarts HJ, de Bont JA'
p34715
aS'TITLE'
p34716
aS'Rhodococcus erythropolis DCL14 contains a novel degradation pathway for limonene.'
p34717
aS'JOURNAL'
p34718
aS'Appl Environ Microbiol 65:2092-102 (1999)'
p34719
aS'PMID:10832640'
p34720
ag34720
aS'AUTHORS'
p34721
aS'van der Werf MJ, Boot AM'
p34722
aS'TITLE'
p34723
aS'Metabolism of carveol and dihydrocarveol in Rhodococcus erythropolis DCL14.'
p34724
aS'JOURNAL'
p34725
aS'Microbiology 146 ( Pt 5):1129-41 (2000)'
p34726
asS'KO_PATHWAY'
p34727
(lp34728
S'ko00903'
p34729
asS'ENTRY'
p34730
(lp34731
S'map00903'
p34732
aS'Pathway'
p34733
asS'PATHWAY_MAP'
p34734
(lp34735
S'map00903'
p34736
asS'CLASS'
p34737
(lp34738
S'Metabolism Metabolism of terpenoids and polyketides'
p34739
assS'path:map00902'
p34740
(dp34741
S'NAME'
p34742
(lp34743
S'Monoterpenoid biosynthesis'
p34744
asS'REFERENCE'
p34745
(lp34746
S'PMID:15728344'
p34747
ag34747
aS'AUTHORS'
p34748
aS'Davis EM, Ringer KL, McConkey ME, Croteau R'
p34749
aS'TITLE'
p34750
aS'Monoterpene metabolism. Cloning, expression, and characterization of menthone reductases from peppermint.'
p34751
aS'JOURNAL'
p34752
aS'Plant Physiol 137:873-81 (2005)'
p34753
aS'PMID:11375201'
p34754
ag34754
aS'AUTHORS'
p34755
aS'Duetz WA, Fjallman AH, Ren S, Jourdat C, Witholt B'
p34756
aS'TITLE'
p34757
aS'Biotransformation of D-limonene to (+) trans-carveol by toluene-grown Rhodococcus opacus PWD4 cells.'
p34758
aS'JOURNAL'
p34759
aS'Appl Environ Microbiol 67:2829-32 (2001)'
p34760
aS'PMID:15299125'
p34761
ag34761
aS'AUTHORS'
p34762
aS'Chen F, Ro DK, Petri J, Gershenzon J, Bohlmann J, Pichersky E, Tholl D'
p34763
aS'TITLE'
p34764
aS'Characterization of a root-specific Arabidopsis terpene synthase responsible for the formation of the volatile monoterpene 1,8-cineole.'
p34765
aS'JOURNAL'
p34766
aS'Plant Physiol 135:1956-66 (2004)'
p34767
aS'PMID:1368150'
p34768
ag34768
aS'AUTHORS'
p34769
aS'Trudgill PW'
p34770
aS'TITLE'
p34771
aS'Microbial metabolism of monoterpenes--recent developments.'
p34772
aS'JOURNAL'
p34773
aS'Biodegradation 1:93-105 (1990)'
p34774
aS'PMID:1864846'
p34775
ag34775
aS'AUTHORS'
p34776
aS'Ikeda H, Esaki N, Nakai S, Hashimoto K, Uesato S, Soda K, Fujita T'
p34777
aS'TITLE'
p34778
aS'Acyclic monoterpene primary alcohol:NADP+ oxidoreductase of Rauwolfia serpentina cells: the key enzyme in biosynthesis of monoterpene alcohols.'
p34779
aS'JOURNAL'
p34780
aS'J Biochem 109:341-7 (1991)'
p34781
aS'PMID:10656401'
p34782
ag34782
aS'AUTHORS'
p34783
aS'Yamamoto H, Katano N, Ooi A, Inoue K.'
p34784
aS'TITLE'
p34785
aS'Secologanin synthase which catalyzes the oxidative cleavage of loganin into secologanin is a cytochrome P450.'
p34786
aS'JOURNAL'
p34787
aS'Phytochemistry 53:7-12 (2000)'
p34788
aS'PMID:11524113'
p34789
ag34789
aS'AUTHORS'
p34790
aS'Katano N, Yamamoto H, Iio R, Inoue K.'
p34791
aS'TITLE'
p34792
aS'7-Deoxyloganin 7-hydroxylase in Lonicera japonica cell cultures.'
p34793
aS'JOURNAL'
p34794
aS'Phytochemistry 58:53-8 (2001)'
p34795
asS'KO_PATHWAY'
p34796
(lp34797
S'ko00902'
p34798
asS'PATHWAY_MAP'
p34799
(lp34800
S'map00902'
p34801
asS'DBLINKS'
p34802
(lp34803
S'GO: 0016099'
p34804
asS'ENTRY'
p34805
(lp34806
S'map00902'
p34807
aS'Pathway'
p34808
asS'CLASS'
p34809
(lp34810
S'Metabolism Metabolism of terpenoids and polyketides'
p34811
asS'DESCRIPTION'
p34812
(lp34813
S'Monoterpenoids (C10 terpenoids) are a group of terpenoids consisting of two isoprene units. They are derived from geranyl diphosphate (GPP). Most monoterpenoids are volatile oils with highly distinctive aromas and flavors, such as essential oils, turpentine, and oleoresins of coniferous plants. This map shows some examples. The monoterpene ketone l-menthone is specifically converted to l-menthol and d-neomenthol in mature peppermint leaves. The iridoids constitute a family of highly oxygenated monoterpenes, mixtures of which are present in many medicinal plants, such as valerian. They are derived from geraniol or nerol via oxidation of a terminal methyl group. The cyclopentane ring of loganin can itself be cleaved in a further P450-dependent step, leading to secologanin, which provides the carbon skeleton for many powerfully bioactive secondary metabolites of indole alkaloids.'
p34814
assS'path:map00901'
p34815
(dp34816
S'DBLINKS'
p34817
(lp34818
S'GO: 0009709'
p34819
asS'NAME'
p34820
(lp34821
S'Indole alkaloid biosynthesis'
p34822
asS'REFERENCE'
p34823
(lp34824
S'PMID:9622525'
p34825
ag34825
aS'AUTHORS'
p34826
aS'Rijhwani SK, Shanks JV.'
p34827
aS'TITLE'
p34828
aS'Effect of elicitor dosage and exposure time on biosynthesis of indole alkaloids by Catharanthus roseus hairy root cultures.'
p34829
aS'JOURNAL'
p34830
aS'Biotechnol Prog 14:442-9 (1998)'
p34831
aS'PMID:4698228'
p34832
ag34832
aS'AUTHORS'
p34833
aS'Madyastha KM, Guarnaccia R, Baxter C, Coscia CJ.'
p34834
aS'TITLE'
p34835
aS'S-Adenosyl-L-methionine: loganic acid methyltransferase. A carboxyl-alkylating enzyme from Vinca rosea.'
p34836
aS'JOURNAL'
p34837
aS'J Biol Chem 248:2497-501 (1973)'
p34838
aS'PMID:510306'
p34839
ag34839
aS'AUTHORS'
p34840
aS'Treimer JF, Zenk MH.'
p34841
aS'TITLE'
p34842
aS'Purification and properties of strictosidine synthase, the key enzyme in indole alkaloid formation.'
p34843
aS'JOURNAL'
p34844
aS'Eur J Biochem 101:225-33 (1979)'
p34845
aS'PMID:10652285'
p34846
ag34846
aS'AUTHORS'
p34847
aS'Geerlings A, Ibanez MM, Memelink J, van Der Heijden R, Verpoorte R.'
p34848
aS'TITLE'
p34849
aS'Molecular cloning and analysis of strictosidine beta-D-glucosidase, an enzyme in terpenoid indole alkaloid biosynthesis in Catharanthus roseus.'
p34850
aS'JOURNAL'
p34851
aS'J Biol Chem 275:3051-6 (2000)'
p34852
aS'PMID:11128'
p34853
ag34853
aS'AUTHORS'
p34854
aS'Stockigt J, Treimer J, Zenk MH.'
p34855
aS'TITLE'
p34856
aS'Synthesis of ajmalicine and related indole alkaloids by cell free extracts of Catharanthus roseus cell suspension cultures.'
p34857
aS'JOURNAL'
p34858
aS'FEBS Lett 70:267-70 (1976)'
p34859
aS'PMID:12228585'
p34860
ag34860
aS'AUTHORS'
p34861
aS'St-Pierre B, De Luca V.'
p34862
aS'TITLE'
p34863
aS'A Cytochrome P-450 Monooxygenase Catalyzes the First Step in the Conversion of Tabersonine to Vindoline in Catharanthus roseus.'
p34864
aS'JOURNAL'
p34865
aS'Plant Physiol 109:131-139 (1995)'
p34866
aS'PMID:10481044'
p34867
ag34867
aS'AUTHORS'
p34868
aS'Schroder G, Unterbusch E, Kaltenbach M, Schmidt J, Strack D, De Luca V, Schroder J.'
p34869
aS'TITLE'
p34870
aS'Light-induced cytochrome P450-dependent enzyme in indole alkaloid biosynthesis: tabersonine 16-hydroxylase.'
p34871
aS'JOURNAL'
p34872
aS'FEBS Lett 458:97-102 (1999)'
p34873
aS'PMID:9654153'
p34874
ag34874
aS'AUTHORS'
p34875
aS'Sottomayor M, Lopez-Serrano M, DiCosmo F, Ros Barcelo A.'
p34876
aS'TITLE'
p34877
aS"Purification and characterization of alpha-3',4'-anhydrovinblastine synthase (peroxidase-like) from Catharanthus roseus (L.) G. Don."
p34878
aS'JOURNAL'
p34879
aS'FEBS Lett 428:299-303 (1998)'
p34880
aS'PMID:1368411'
p34881
ag34881
aS'AUTHORS'
p34882
aS'Furuya T, Sakamoto K, Iida K, Asada Y, Yoshikawa T, Sakai S, Aimi N.'
p34883
aS'TITLE'
p34884
aS'Biotransformation of tabersonine in cell suspension cultures of Catharanthus roseus.'
p34885
aS'JOURNAL'
p34886
aS'Phytochemistry 31:3065-8 (1992)'
p34887
aS'PMID:11154328'
p34888
ag34888
aS'AUTHORS'
p34889
aS'Laflamme P, St-Pierre B, De Luca V.'
p34890
aS'TITLE'
p34891
aS'Molecular and biochemical analysis of a madagascar periwinkle root-specific minovincinine-19-hydroxy-o-acetyltransferase.'
p34892
aS'JOURNAL'
p34893
aS'Plant Physiol 125:189-98 (2001)'
p34894
aS'PMID:12150812'
p34895
ag34895
aS'AUTHORS'
p34896
aS'Jain S, Sinha A, Bhakuni DS.'
p34897
aS'TITLE'
p34898
aS'The biosynthesis of beta-carboline and quinolizidine alkaloids of Alangium lamarckii.'
p34899
aS'JOURNAL'
p34900
aS'Phytochemistry 60:853-9 (2002)'
p34901
asS'KO_PATHWAY'
p34902
(lp34903
S'ko00901'
p34904
asS'ENTRY'
p34905
(lp34906
S'map00901'
p34907
aS'Pathway'
p34908
asS'PATHWAY_MAP'
p34909
(lp34910
S'map00901'
p34911
asS'CLASS'
p34912
(lp34913
S'Metabolism Biosynthesis of other secondary metabolites'
p34914
assS'path:map00900'
p34915
(dp34916
S'NAME'
p34917
(lp34918
S'Terpenoid backbone biosynthesis'
p34919
asS'REFERENCE'
p34920
(lp34921
S'PMID:12777052'
p34922
ag34922
aS'AUTHORS'
p34923
aS'Lange BM, Ghassemian M.'
p34924
aS'TITLE'
p34925
aS'Genome organization in Arabidopsis thaliana: a survey for genes involved in isoprenoid and chlorophyll metabolism.'
p34926
aS'JOURNAL'
p34927
aS'Plant Mol Biol 51:925-48 (2003)'
p34928
aS'PMID:16262699'
p34929
ag34929
aS'AUTHORS'
p34930
aS'Saiki R, Nagata A, Kainou T, Matsuda H, Kawamukai M'
p34931
aS'TITLE'
p34932
aS'Characterization of solanesyl and decaprenyl diphosphate synthases in mice and humans.'
p34933
aS'JOURNAL'
p34934
aS'FEBS J 272:5606-22 (2005)'
p34935
aS'PMID:9858571'
p34936
ag34936
aS'AUTHORS'
p34937
aS'Sato M, Sato K, Nishikawa S, Hirata A, Kato J, Nakano A'
p34938
aS'TITLE'
p34939
aS'The yeast RER2 gene, identified by endoplasmic reticulum protein localization mutations, encodes cis-prenyltransferase, a key enzyme in dolichol synthesis.'
p34940
aS'JOURNAL'
p34941
aS'Mol Cell Biol 19:471-83 (1999)'
p34942
aS'PMID:24375100'
p34943
ag34943
aS'AUTHORS'
p34944
aS'Vannice JC, Skaff DA, Keightley A, Addo J, Wyckoff GJ, Miziorko HM'
p34945
aS'TITLE'
p34946
aS'Identification in Haloferax volcanii of Phosphomevalonate Decarboxylase and Isopentenyl Phosphate Kinase as Catalysts of the Terminal Enzymatic Reactions in'
p34947
aS'an Archaeal Alternate Mevalonate Pathway.'
p34948
aS'JOURNAL'
p34949
aS'J Bacteriol (2013)'
p34950
asS'KO_PATHWAY'
p34951
(lp34952
S'ko00900'
p34953
asS'PATHWAY_MAP'
p34954
(lp34955
S'map00900'
p34956
asS'DISEASE'
p34957
(lp34958
S'H00206'
p34959
aS'Mevalonate kinase deficiency'
p34960
ag34959
ag34960
aS'H00663'
p34961
aS'Restrictive dermopathy'
p34962
aS'H00999'
p34963
aS'Coenzyme Q10 deficiency'
p34964
aS'H01123'
p34965
aS'HMG-CoA synthase (HMGCS) deficiency'
p34966
asS'MODULE'
p34967
(lp34968
S'M00095'
p34969
aS'C5 isoprenoid biosynthesis, mevalonate pathway [PATH:map00900]'
p34970
ag34969
ag34970
aS'M00096'
p34971
aS'C5 isoprenoid biosynthesis, non-mevalonate pathway [PATH:map00900]'
p34972
aS'M00364'
p34973
aS'C10-C20 isoprenoid biosynthesis, bacteria [PATH:map00900]'
p34974
aS'M00365'
p34975
aS'C10-C20 isoprenoid biosynthesis, archaea [PATH:map00900]'
p34976
aS'M00366'
p34977
aS'C10-C20 isoprenoid biosynthesis, plants [PATH:map00900]'
p34978
aS'M00367'
p34979
aS'C10-C20 isoprenoid biosynthesis, non-plant eukaryotes [PATH:map00900]'
p34980
asS'DBLINKS'
p34981
(lp34982
S'GO: 0009240 0016091'
p34983
asS'ENTRY'
p34984
(lp34985
S'map00900'
p34986
aS'Pathway'
p34987
asS'CLASS'
p34988
(lp34989
S'Metabolism Metabolism of terpenoids and polyketides'
p34990
asS'DESCRIPTION'
p34991
(lp34992
S'Terpenoids, also known as isoprenoids, are a large class of natural products consisting of isoprene (C5) units. There are two biosynthetic pathways, the mevalonate pathway [MD:M00095] and the non-mevalonate pathway or the MEP/DOXP pathway [MD:M00096], for the terpenoid building blocks: isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). The action of prenyltransferases then generates higher-order building blocks: geranyl diphosphate (GPP), farsenyl diphosphate (FPP), and geranylgeranyl diphosphate (GGPP), which are the precursors of monoterpenoids (C10), sesquiterpenoids (C15), and diterpenoids (C20), respectively. Condensation of these building blocks gives rise to the precursors of sterols (C30) and carotenoids (C40). The MEP/DOXP pathway is absent in higher animals and fungi, but in green plants the MEP/DOXP and mevalonate pathways co-exist in separate cellular compartments. The MEP/DOXP pathway, operating in the plastids, is responsible for the formation of essential oil monoterpenes and linalyl acetate, some sesquiterpenes, diterpenes, and carotenoids and phytol. The mevalonate pathway, operating in the cytosol, gives rise to triterpenes, sterols, and most sesquiterpenes.'
p34993
assS'path:map00906'
p34994
(dp34995
S'NAME'
p34996
(lp34997
S'Carotenoid biosynthesis'
p34998
asS'REFERENCE'
p34999
(lp35000
g22
ag22
aS'AUTHORS'
p35001
aS'Takaichi S, Mimuro M, Tomita Y.'
p35002
aS'TITLE'
p35003
aS'[Karotenoido-sono Tayousei to Seirikattsei] (In Japanese)'
p35004
aS'JOURNAL'
p35005
aS'SHOKABO:109-156 (2006)'
p35006
ag22
ag22
aS'AUTHORS'
p35007
aS'Fukuda H, Matida Y, Kamiya Y, Kakimoto T.'
p35008
aS'TITLE'
p35009
aS'[Shinpan Syokubutuhorumon no Sigunarudentatu] (In Japanese)'
p35010
aS'JOURNAL'
p35011
aS'Syujyunsya:165-186 (2004)'
p35012
ag22
ag22
aS'AUTHORS'
p35013
aS'Takaichi S.'
p35014
aS'TITLE'
p35015
aS'Distribution and biosynthesis of carotenoids in plants and photosynthetic bacteria.'
p35016
aS'JOURNAL'
p35017
aS'Foods and Food Ingredients Journal of Japan 212-7:524-531 (2007)'
p35018
aS'PMID:11804826 (Plant-Carotenoid pathway)'
p35019
ag35019
aS'AUTHORS'
p35020
aS'Seo M, Koshiba T.'
p35021
aS'TITLE'
p35022
aS'Complex regulation of ABA biosynthesis in plants.'
p35023
aS'JOURNAL'
p35024
aS'Trends Plant Sci 7:41-8 (2002)'
p35025
aS'PMID:17085635 (Plant-Carotenoid pathway)'
p35026
ag35026
aS'AUTHORS'
p35027
aS'Cunningham FX Jr, Lee H, Gantt E.'
p35028
aS'TITLE'
p35029
aS'Carotenoid biosynthesis in the primitive red alga Cyanidioschyzon merolae.'
p35030
aS'JOURNAL'
p35031
aS'Eukaryot Cell 6:533-45 (2007)'
p35032
aS'PMID:9914519 (Plant-Carotenoid pathway)'
p35033
ag35033
aS'AUTHORS'
p35034
aS'Bartley GE, Scolnik PA, Beyer P.'
p35035
aS'TITLE'
p35036
aS'Two Arabidopsis thaliana carotene desaturases, phytoene desaturase and zeta-carotene desaturase, expressed in Escherichia coli, catalyze a poly-cis pathway to yield pro-lycopene.'
p35037
aS'JOURNAL'
p35038
aS'Eur J Biochem 259:396-403 (1999)'
p35039
aS'PMID:11884677 (Plant-Carotenoid pathway)'
p35040
ag35040
aS'AUTHORS'
p35041
aS'Park H, Kreunen SS, Cuttriss AJ, DellaPenna D, Pogson BJ.'
p35042
aS'TITLE'
p35043
aS'Identification of the carotenoid isomerase provides insight into carotenoid biosynthesis, prolamellar body formation, and photomorphogenesis.'
p35044
aS'JOURNAL'
p35045
aS'Plant Cell 14:321-32 (2002)'
p35046
aS'PMID:15557094 (Plant-Carotenoid pathway)'
p35047
ag35047
aS'AUTHORS'
p35048
aS'Isaacson T, Ohad I, Beyer P, Hirschberg J.'
p35049
aS'TITLE'
p35050
aS'Analysis in vitro of the enzyme CRTISO establishes a poly-cis-carotenoid biosynthesis pathway in plants.'
p35051
aS'JOURNAL'
p35052
aS'Plant Physiol 136:4246-55 (2004)'
p35053
aS'PMID:12782726 (Plant-Carotenoid pathway)'
p35054
ag35054
aS'AUTHORS'
p35055
aS'Tian L, Magallanes-Lundback M, Musetti V, DellaPenna D.'
p35056
aS'TITLE'
p35057
aS'Functional analysis of beta- and epsilon-ring carotenoid hydroxylases in Arabidopsis.'
p35058
aS'JOURNAL'
p35059
aS'Plant Cell 15:1320-32 (2003)'
p35060
aS'PMID:14709673 (Plant-Carotenoid pathway)'
p35061
ag35061
aS'AUTHORS'
p35062
aS'Tian L, Musetti V, Kim J, Magallanes-Lundback M, DellaPenna D.'
p35063
aS'TITLE'
p35064
aS'The Arabidopsis LUT1 locus encodes a member of the cytochrome p450 family that is required for carotenoid epsilon-ring hydroxylation activity.'
p35065
aS'JOURNAL'
p35066
aS'Proc Natl Acad Sci U S A 101:402-7 (2004)'
p35067
aS'PMID:7920703 (Plant-Carotenoid pathway)'
p35068
ag35068
aS'AUTHORS'
p35069
aS"Bouvier F, Hugueney P, d'Harlingue A, Kuntz M, Camara B."
p35070
aS'TITLE'
p35071
aS'Xanthophyll biosynthesis in chromoplasts: isolation and molecular cloning of an enzyme catalyzing the conversion of 5,6-epoxycarotenoid into ketocarotenoid.'
p35072
aS'JOURNAL'
p35073
aS'Plant J 6:45-54 (1994)'
p35074
aS'PMID:9159947 (Plant-Carotenoid pathway)'
p35075
ag35075
aS'AUTHORS'
p35076
aS'Schwartz SH, Leon-Kloosterziel KM, Koornneef M, Zeevaart JA.'
p35077
aS'TITLE'
p35078
aS'Biochemical characterization of the aba2 and aba3 mutants in Arabidopsis thaliana.'
p35079
aS'JOURNAL'
p35080
aS'Plant Physiol 114:161-6 (1997)'
p35081
aS'PMID:12114582 (Plant-Carotenoid pathway)'
p35082
ag35082
aS'AUTHORS'
p35083
aS'Xu ZJ, Nakajima M, Suzuki Y, Yamaguchi I.'
p35084
aS'TITLE'
p35085
aS'Cloning and characterization of the abscisic acid-specific glucosyltransferase gene from adzuki bean seedlings.'
p35086
aS'JOURNAL'
p35087
aS'Plant Physiol 129:1285-95 (2002)'
p35088
aS'PMID:9808729 (Plant-Carotenoid pathway)'
p35089
ag35089
aS'AUTHORS'
p35090
aS'Krochko JE, Abrams GD, Loewen MK, Abrams SR, Cutler AJ.'
p35091
aS'TITLE'
p35092
aS"(+)-Abscisic acid 8'-hydroxylase is a cytochrome P450 monooxygenase"
p35093
aS'JOURNAL'
p35094
aS'Plant Physiol 118:849-60 (1998)'
p35095
aS'PMID:10851005 (Purple bacteria-canthaxanthin,spirilloxanthin pathway)'
p35096
ag35096
aS'AUTHORS'
p35097
aS"Hannibal L, Lorquin J, D'Ortoli NA, Garcia N, Chaintreuil C, Masson-Boivin C, Dreyfus B, Giraud E."
p35098
aS'TITLE'
p35099
aS'Isolation and characterization of canthaxanthin biosynthesis genes from the photosynthetic bacterium Bradyrhizobium sp. strain ORS278.'
p35100
aS'JOURNAL'
p35101
aS'J Bacteriol 182:3850-3 (2000)'
p35102
aS'PMID:12664193 (Purple bacteria-Spheroidene,spirilloxanthin pathway)'
p35103
ag35103
aS'AUTHORS'
p35104
aS'Pinta V, Ouchane S, Picaud M, Takaichi S, Astier C, Reiss-Husson F.'
p35105
aS'TITLE'
p35106
aS'Characterization of unusual hydroxy- and ketocarotenoids in Rubrivivax gelatinosus: involvement of enzyme CrtF or CrtA.'
p35107
aS'JOURNAL'
p35108
aS'Arch Microbiol 179:354-62 (2003)'
p35109
aS'PMID:7721699 (Purple bacteria-Spheroidene pathway)'
p35110
ag35110
aS'AUTHORS'
p35111
aS'Lang HP, Cogdell RJ, Takaichi S, Hunter CN.'
p35112
aS'TITLE'
p35113
aS'Complete DNA sequence, specific Tn5 insertion map, and gene assignment of the carotenoid biosynthesis pathway of Rhodobacter sphaeroides.'
p35114
aS'JOURNAL'
p35115
aS'J Bacteriol 177:2064-73 (1995)'
p35116
aS'PMID:9636041 (Purple bacteria-Unusual spirilloxanthin pathway)'
p35117
ag35117
aS'AUTHORS'
p35118
aS'Komori M, Ghosh R, Takaichi S, Hu Y, Mizoguchi T, Koyama Y, Kuki M.'
p35119
aS'TITLE'
p35120
aS'A null lesion in the rhodopin 3,4-desaturase of Rhodospirillum rubrum unmasks a cryptic branch of the carotenoid biosynthetic pathway.'
p35121
aS'JOURNAL'
p35122
aS'Biochemistry 37:8987-94 (1998)'
p35123
aS'(Purple bacteria-Spirilloxanthin pathway)'
p35124
ag35124
aS'AUTHORS'
p35125
ag22
aS'TITLE'
p35126
ag22
aS'JOURNAL'
p35127
ag22
aS'PMID:14044829 (Purple bacteria-Okenone )'
p35128
ag35128
aS'AUTHORS'
p35129
aS'SCHMIDT K, LIAAENJENSEN S, SCHLEGEL HG.'
p35130
aS'TITLE'
p35131
aS'[CAROTENOIDS IN THIORHODACEAE. I. OKENONEAS THE PRINCIPAL CAROTENOID IN CHROMATIUM OKENII PERTY.]'
p35132
aS'JOURNAL'
p35133
aS'Arch Mikrobiol 46:117-26 (1963)'
p35134
aS'PMID:4932469 (Purple bacteria-Rhodopinal )'
p35135
ag35135
aS'AUTHORS'
p35136
aS'Schmidt K.'
p35137
aS'TITLE'
p35138
aS'Carotenoids of purple nonsulfur bacteria. Composition and biosynthesis of the carotenoids of some strains of Rhodopseudomonas acidophila, Rhodospirillum tenue, and Rhodocyclus purpureus.'
p35139
aS'JOURNAL'
p35140
aS'Arch Mikrobiol 77:231-8 (1971)'
p35141
aS'PMID:2254247 (Erwinia uredovora-Carotenoid pathway)'
p35142
ag35142
aS'AUTHORS'
p35143
aS'Misawa N, Nakagawa M, Kobayashi K, Yamano S, Izawa Y, Nakamura K, Harashima K.'
p35144
aS'TITLE'
p35145
aS'Elucidation of the Erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products expressed in Escherichia coli.'
p35146
aS'JOURNAL'
p35147
aS'J Bacteriol 172:6704-12 (1990)'
p35148
aS'PMID:7588751 (Myxococcus xanthus-Carotenoid pathway)'
p35149
ag35149
aS'AUTHORS'
p35150
aS'Botella JA, Murillo FJ, Ruiz-Vazquez R.'
p35151
aS'TITLE'
p35152
aS'A cluster of structural and regulatory genes for light-induced carotenogenesis in Myxococcus xanthus.'
p35153
aS'JOURNAL'
p35154
aS'Eur J Biochem 233:238-48 (1995)'
p35155
aS'PMID:7592436 (Marine bacteria-Astaxanthin pathway)'
p35156
ag35156
aS'AUTHORS'
p35157
aS'Misawa N, Satomi Y, Kondo K, Yokoyama A, Kajiwara S, Saito T, Ohtani T, Miki W.'
p35158
aS'TITLE'
p35159
aS'Structure and functional analysis of a marine bacterial carotenoid biosynthesis gene cluster and astaxanthin biosynthetic pathway proposed at the gene level.'
p35160
aS'JOURNAL'
p35161
aS'J Bacteriol 177:6575-84 (1995)'
p35162
aS'PMID:16020541 (Heriobacteria-Diapocarotene pathway)'
p35163
ag35163
aS'AUTHORS'
p35164
aS'Pelz A, Wieland KP, Putzbach K, Hentschel P, Albert K, Gotz F.'
p35165
aS'TITLE'
p35166
aS'Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus.'
p35167
aS'JOURNAL'
p35168
aS'J Biol Chem 280:32493-8 (2005)'
p35169
aS'PMID:8002598 (Heriobacteria-Diapocarotene pathway)'
p35170
ag35170
aS'AUTHORS'
p35171
aS'Wieland B, Feil C, Gloria-Maercker E, Thumm G, Lechner M, Bravo JM, Poralla K, Gotz F.'
p35172
aS'TITLE'
p35173
aS"Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus."
p35174
aS'JOURNAL'
p35175
aS'J Bacteriol 176:7719-26 (1994)'
p35176
aS'PMID:10395965 (Streptomyces griseus-Carotenoid pathway)'
p35177
ag35177
aS'AUTHORS'
p35178
aS'Krugel H, Krubasik P, Weber K, Saluz HP, Sandmann G.'
p35179
aS'TITLE'
p35180
aS'Functional analysis of genes from Streptomyces griseus involved in the synthesis of isorenieratene, a carotenoid with aromatic end groups, revealed a novel type of carotenoid desaturase.'
p35181
aS'JOURNAL'
p35182
aS'Biochim Biophys Acta 1439:57-64 (1999)'
p35183
aS'PMID:11479383 (Cyanobacteria-Myxol pathway)'
p35184
ag35184
aS'AUTHORS'
p35185
aS'Takaichi S, Maoka T, Masamoto K.'
p35186
aS'TITLE'
p35187
aS"Myxoxanthophyll in Synechocystis sp. PCC 6803 is myxol 2'-dimethyl-fucoside, (3R,2'S)-myxol 2'-(2,4-di-O-methyl-alpha-L-fucoside), not rhamnoside."
p35188
aS'JOURNAL'
p35189
aS'Plant Cell Physiol 42:756-62 (2001)'
p35190
aS'PMID:15695449 (Cyanobacteria-Myxol pathway)'
p35191
ag35191
aS'AUTHORS'
p35192
aS'Takaichi S, Mochimaru M, Maoka T, Katoh H.'
p35193
aS'TITLE'
p35194
aS"Myxol and 4-ketomyxol 2'-fucosides, not rhamnosides, from Anabaena sp. PCC 7120 and Nostoc punctiforme PCC 73102, and proposal for the biosynthetic pathway of carotenoids."
p35195
aS'JOURNAL'
p35196
aS'Plant Cell Physiol 46:497-504 (2005)'
p35197
aS'PMID:9092504 (Cyanobacteria-Carotenoid pathway)'
p35198
ag35198
aS'AUTHORS'
p35199
aS'Fernandez-Gonzalez B, Sandmann G, Vioque A.'
p35200
aS'TITLE'
p35201
aS'A new type of asymmetrically acting beta-carotene ketolase is required for the synthesis of echinenone in the cyanobacterium Synechocystis sp. PCC 6803.'
p35202
aS'JOURNAL'
p35203
aS'J Biol Chem 272:9728-33 (1997)'
p35204
aS'PMID:16242129 (Cyanobacteria-Carotenoid pathway)'
p35205
ag35205
aS'AUTHORS'
p35206
aS'Mochimaru M, Masukawa H, Takaichi S.'
p35207
aS'TITLE'
p35208
aS'The cyanobacterium Anabaena sp. PCC 7120 has two distinct beta-carotene ketolases: CrtO for echinenone and CrtW for ketomyxol synthesis.'
p35209
aS'JOURNAL'
p35210
aS'FEBS Lett 579:6111-4 (2005)'
p35211
aS'PMID:7919981 (Cyanobacteria-Carotenoid pathway)'
p35212
ag35212
aS'AUTHORS'
p35213
aS'Cunningham FX Jr, Sun Z, Chamovitz D, Hirschberg J, Gantt E.'
p35214
aS'TITLE'
p35215
aS'Molecular structure and enzymatic function of lycopene cyclase from the cyanobacterium Synechococcus sp strain PCC7942.'
p35216
aS'JOURNAL'
p35217
aS'Plant Cell 6:1107-21 (1994)'
p35218
aS'PMID:15811329 (Cyanobacteria-Carotenoid pathway)'
p35219
ag35219
aS'AUTHORS'
p35220
aS'Tsuchiya T, Takaichi S, Misawa N, Maoka T, Miyashita H, Mimuro M.'
p35221
aS'TITLE'
p35222
aS'The cyanobacterium Gloeobacter violaceus PCC 7421 uses bacterial-type phytoene desaturase in carotenoid biosynthesis.'
p35223
aS'JOURNAL'
p35224
aS'FEBS Lett 579:2125-9 (2005)'
p35225
aS'PMID:15115301 (Green sulfer bacteria-Carotenoid pathway)'
p35226
ag35226
aS'AUTHORS'
p35227
aS'Hirabayashi H, Ishii T, Takaichi S, Inoue K, Uehara K.'
p35228
aS'TITLE'
p35229
aS'The role of carotenoids in the photoadaptation of the brown-colored sulfur bacterium Chlorobium phaeobacteroides.'
p35230
aS'JOURNAL'
p35231
aS'Photochem Photobiol 79:280-5 (2004)'
p35232
aS'PMID:16923888 (Green sulfer bacteria-Carotenoid pathway)'
p35233
ag35233
aS'AUTHORS'
p35234
aS'Maresca JA, Bryant DA.'
p35235
aS'TITLE'
p35236
aS'Two genes encoding new carotenoid-modifying enzymes in the green sulfur bacterium Chlorobium tepidum.'
p35237
aS'JOURNAL'
p35238
aS'J Bacteriol 188:6217-23 (2006)'
p35239
aS'PMID:15292122 (Green sulfer bacteria-Carotenoid pathway)'
p35240
ag35240
aS'AUTHORS'
p35241
aS'Frigaard NU, Maresca JA, Yunker CE, Jones AD, Bryant DA.'
p35242
aS'TITLE'
p35243
aS'Genetic manipulation of carotenoid biosynthesis in the green sulfur bacterium Chlorobium tepidum.'
p35244
aS'JOURNAL'
p35245
aS'J Bacteriol 186:5210-20 (2004)'
p35246
aS'PMID:9297463 (Green sulfer bacteria-Carotenoid pathway)'
p35247
ag35247
aS'AUTHORS'
p35248
aS'Takaichi S, Wang ZY, Umetsu M, Nozawa T, Shimada K, Madigan MT.'
p35249
aS'TITLE'
p35250
aS"New carotenoids from the thermophilic green sulfur bacterium Chlorobium tepidum: 1',2'-dihydro-gamma-carotene, 1',2'-dihydrochlorobactene, and OH-chlorobactene glucoside ester, and the carotenoid composition of different strains."
p35251
aS'JOURNAL'
p35252
aS'Arch Microbiol 168:270-6 (1997)'
p35253
aS'PMID:8661926 (Thermophilic bacteria-Thermocryptoxanthins)'
p35254
ag35254
aS'AUTHORS'
p35255
aS'Yokoyama A, Shizuri Y, Hoshino T, Sandmann G.'
p35256
aS'TITLE'
p35257
aS'Thermocryptoxanthins: novel intermediates in the carotenoid biosynthetic pathway of Thermus thermophilus'
p35258
aS'JOURNAL'
p35259
aS'Arch Microbiol 165:342-5 (1996)'
p35260
aS'(Sulfolobus solfataricus-Carotenoid pathway)'
p35261
ag35261
aS'AUTHORS'
p35262
aS'Hemmi H, Ikejiri S, Nakayama T, Nishio T.'
p35263
aS'TITLE'
p35264
aS'Fusion-type lycopene ?? cyclase from a thermoacidophilic archaeon Sulfolobus solfataricus.'
p35265
aS'JOURNAL'
p35266
aS'Biochemical and Biophysical Research Communications 305(3):586-591 (2003)'
p35267
asS'KO_PATHWAY'
p35268
(lp35269
S'ko00906'
p35270
asS'PATHWAY_MAP'
p35271
(lp35272
S'map00906'
p35273
asS'MODULE'
p35274
(lp35275
S'M00097'
p35276
aS'beta-Carotene biosynthesis, GGAP => beta-carotene [PATH:map00906]'
p35277
ag35276
ag35277
aS'M00372'
p35278
aS'Abscisic acid biosynthesis, beta-carotene => abscisic acid [PATH:map00906]'
p35279
asS'DBLINKS'
p35280
(lp35281
S'GO: 0016117'
p35282
asS'ENTRY'
p35283
(lp35284
S'map00906'
p35285
aS'Pathway'
p35286
asS'CLASS'
p35287
(lp35288
S'Metabolism Metabolism of terpenoids and polyketides'
p35289
assS'path:map00905'
p35290
(dp35291
S'NAME'
p35292
(lp35293
S'Brassinosteroid biosynthesis'
p35294
asS'REFERENCE'
p35295
(lp35296
g22
ag22
aS'AUTHORS'
p35297
aS'Koshiba K, Kamiya Y.'
p35298
aS'TITLE'
p35299
aS'[Atarasii Syokubutuhorumon no Kagaku] (In Japanese)'
p35300
aS'JOURNAL'
p35301
aS'Koudansya saientific:199-138 (2002)'
p35302
ag22
ag22
aS'AUTHORS'
p35303
aS'Fukuda H, Matida Y, Kamiya Y, Kakimoto T.'
p35304
aS'TITLE'
p35305
aS'[Shinpan Syokubutuhorumon no Sigunarudentatu] (In Japanese)'
p35306
aS'JOURNAL'
p35307
aS'Syujyunsya:165-186 (2004)'
p35308
aS'PMID:12529536'
p35309
ag35309
aS'AUTHORS'
p35310
aS'Shimada Y, Goda H, Nakamura A, Takatsuto S, Fujioka S, Yoshida S.'
p35311
aS'TITLE'
p35312
aS'Organ-specific expression of brassinosteroid-biosynthetic genes and distribution of endogenous brassinosteroids in Arabidopsis.'
p35313
aS'JOURNAL'
p35314
aS'Plant Physiol 131:287-97 (2003)'
p35315
ag22
ag22
aS'AUTHORS'
p35316
aS'Sunghwa C.'
p35317
aS'TITLE'
p35318
aS'Brassinosteroid biosynthesis and inactivation.'
p35319
aS'JOURNAL'
p35320
aS'Physiologia Plantarum 126:539-548 (2006)'
p35321
aS'PMID:17138693'
p35322
ag35322
aS'AUTHORS'
p35323
aS'Ohnishi T, Szatmari AM, Watanabe B, Fujita S, Bancos S, Koncz C, Lafos M, Shibata K, Yokota T, Sakata K, Szekeres M, Mizutani M'
p35324
aS'TITLE'
p35325
aS'C-23 hydroxylation by Arabidopsis CYP90C1 and CYP90D1 reveals a novel shortcut in brassinosteroid biosynthesis.'
p35326
aS'JOURNAL'
p35327
aS'Plant Cell 18:3275-88 (2006)'
p35328
aS'PMID:17693126'
p35329
ag35329
aS'AUTHORS'
p35330
aS'Bishop GJ'
p35331
aS'TITLE'
p35332
aS'Refining the plant steroid hormone biosynthesis pathway.'
p35333
aS'JOURNAL'
p35334
aS'Trends Plant Sci 12:377-80 (2007)'
p35335
aS'PMID:15710611'
p35336
ag35336
aS'AUTHORS'
p35337
aS'Nomura T, Kushiro T, Yokota T, Kamiya Y, Bishop GJ, Yamaguchi S'
p35338
aS'TITLE'
p35339
aS'The last reaction producing brassinolide is catalyzed by cytochrome P-450s, CYP85A3 in tomato and CYP85A2 in Arabidopsis.'
p35340
aS'JOURNAL'
p35341
aS'J Biol Chem 280:17873-9 (2005)'
p35342
aS'PMID:18685225'
p35343
ag35343
aS'AUTHORS'
p35344
aS'Katsumata T, Hasegawa A, Fujiwara T, Komatsu T, Notomi M, Abe H, Natsume M, Kawaide H'
p35345
aS'TITLE'
p35346
aS'Arabidopsis CYP85A2 catalyzes lactonization reactions in the biosynthesis of 2-deoxy-7-oxalactone brassinosteroids.'
p35347
aS'JOURNAL'
p35348
aS'Biosci Biotechnol Biochem 72:2110-7 (2008)'
p35349
aS'PMID:15705958'
p35350
ag35350
aS'AUTHORS'
p35351
aS'Tanabe S, Ashikari M, Fujioka S, Takatsuto S, Yoshida S, Yano M, Yoshimura A, Kitano H, Matsuoka M, Fujisawa Y, Kato H, Iwasaki Y'
p35352
aS'TITLE'
p35353
aS'A novel cytochrome P450 is implicated in brassinosteroid biosynthesis via the characterization of a rice dwarf mutant, dwarf11, with reduced seed length.'
p35354
aS'JOURNAL'
p35355
aS'Plant Cell 17:776-90 (2005)'
p35356
aS'PMID:14615594'
p35357
ag35357
aS'AUTHORS'
p35358
aS'Hong Z, Ueguchi-Tanaka M, Umemura K, Uozu S, Fujioka S, Takatsuto S, Yoshida S, Ashikari M, Kitano H, Matsuoka M'
p35359
aS'TITLE'
p35360
aS'A rice brassinosteroid-deficient mutant, ebisu dwarf (d2), is caused by a loss of function of a new member of cytochrome P450.'
p35361
aS'JOURNAL'
p35362
aS'Plant Cell 15:2900-10 (2003)'
p35363
asS'KO_PATHWAY'
p35364
(lp35365
S'ko00905'
p35366
asS'PATHWAY_MAP'
p35367
(lp35368
S'map00905'
p35369
asS'MODULE'
p35370
(lp35371
S'M00371'
p35372
aS'Castasterone biosynthesis, campesterol => castasterone [PATH:map00905]'
p35373
asS'DBLINKS'
p35374
(lp35375
S'GO: 0016132'
p35376
asS'ENTRY'
p35377
(lp35378
S'map00905'
p35379
aS'Pathway'
p35380
asS'CLASS'
p35381
(lp35382
S'Metabolism Metabolism of terpenoids and polyketides'
p35383
asS'DESCRIPTION'
p35384
(lp35385
S'Brassinosteroids are a group of plant steroid hormones that regulate growth and development. More than fifty naturally occurring brassinosteroids have been identified in a wide range of plant species. The most abundant and widely occurring brassinosteroids are C28 steroids, and among them brassinolide (BL) is the most biologically active. Plants have multiple pathways for biosynthesis of BL, which are derived from the steroid biosynthetic pathway. Two pathways from campestanol to castasterone (CS), C6 oxidation and the late-C6 oxidation pathways, operate in many plants. Another branching pathway, the early-C22 oxidation pathway, was demonstrated using a brassinosteroid-deficient mutant of Arabidopsis thaliana. Recently, a new shortcut pathway from campesterol to 6-deoxotyphasterol was demonstrated by a functional analysis of cytochrome P450 monooxygenases responsible for brassinosteroid biosynthesis. Thus, at least four pathways are involved in the biosynthesis of CS, and CS is further metabolized to BL by lactonization of the B ring.'
p35386
assS'path:map00904'
p35387
(dp35388
S'DBLINKS'
p35389
(lp35390
S'GO: 0016102'
p35391
asS'NAME'
p35392
(lp35393
S'Diterpenoid biosynthesis'
p35394
asS'REFERENCE'
p35395
(lp35396
S'PMID:16137660'
p35397
ag35397
aS'AUTHORS'
p35398
aS'Long RM, Croteau R.'
p35399
aS'TITLE'
p35400
aS"Preliminary assessment of the C13-side chain 2'-hydroxylase involved in taxol biosynthesis."
p35401
aS'JOURNAL'
p35402
aS'Biochem Biophys Res Commun 338:410-7 (2005)'
p35403
aS'PMID:12089320'
p35404
ag35404
aS'AUTHORS'
p35405
aS'Walker K, Long R, Croteau R.'
p35406
aS'TITLE'
p35407
aS'The final acylation step in taxol biosynthesis: cloning of the taxoid C13-side-chain N-benzoyltransferase from Taxus.'
p35408
aS'JOURNAL'
p35409
aS'Proc Natl Acad Sci U S A 99:9166-71 (2002)'
p35410
asS'KO_PATHWAY'
p35411
(lp35412
S'ko00904'
p35413
asS'ENTRY'
p35414
(lp35415
S'map00904'
p35416
aS'Pathway'
p35417
asS'PATHWAY_MAP'
p35418
(lp35419
S'map00904'
p35420
asS'CLASS'
p35421
(lp35422
S'Metabolism Metabolism of terpenoids and polyketides'
p35423
assS'path:map07050'
p35424
(dp35425
S'ENTRY'
p35426
(lp35427
S'map07050'
p35428
aS'Drug'
p35429
aS'Pathway'
p35430
asS'PATHWAY_MAP'
p35431
(lp35432
S'map07050'
p35433
asS'NAME'
p35434
(lp35435
S'Antirheumatics - DMARDs and biological agents'
p35436
asS'COMPOUND'
p35437
(lp35438
S'D00107'
p35439
aS'Tacrolimus hydrate (JP16)'
p35440
ag35439
ag35440
aS'D00142'
p35441
aS'Methotrexate (JP16/USP/INN)'
p35442
aS'D00237'
p35443
aS'Auranofin (JP16/USAN/INN)'
p35444
aS'D00238'
p35445
aS'Azathioprine (JP16/USP/INN)'
p35446
aS'D00287'
p35447
aS'Cyclophosphamide hydrate (JP16)'
p35448
aS'D00448'
p35449
aS'Salazosulfapyridine (JP16)'
p35450
aS'D00496'
p35451
aS'Penicillamine (JAN/USP/INN)'
p35452
aS'D00742'
p35453
aS'Etanercept (genetical recombination) (JAN)'
p35454
aS'D00749'
p35455
aS'Leflunomide (JAN/USAN/INN)'
p35456
aS'D00992'
p35457
aS'Sodium aurothiomalate (JP16)'
p35458
aS'D01146'
p35459
aS'Iguratimod (JAN/INN)'
p35460
aS'D01392'
p35461
aS'Mizoribine (JP16/INN)'
p35462
aS'D01395'
p35463
aS'Actarit (JAN/INN)'
p35464
aS'D01808'
p35465
aS'Lobenzarit sodium (JP16/USAN)'
p35466
aS'D01809'
p35467
aS'Bucillamine (JP16/INN)'
p35468
aS'D02115'
p35469
aS'Methotrexate sodium'
p35470
aS'D02596'
p35471
aS'Tocilizumab (genetical recombination) (JAN)'
p35472
aS'D02597'
p35473
aS'Adalimumab (genetical recombination) (JAN)'
p35474
aS'D02598'
p35475
aS'Infliximab (genetical recombination) (JAN)'
p35476
aS'D03033'
p35477
aS'Azathioprine sodium (USP)'
p35478
aS'D03203'
p35479
aS'Abatacept (genetical recombination) (JAN)'
p35480
aS'D03441'
p35481
aS'Certolizumab pegol (genetical recombination) (JAN)'
p35482
aS'D04358'
p35483
aS'Golimumab (genetical recombination) (JAN)'
p35484
aS'D07760'
p35485
aS'Cyclophosphamide (INN)'
p35486
aS'D08330'
p35487
aS'Penicillamine hydrochloride'
p35488
aS'D08556'
p35489
aS'Tacrolimus (INN)'
p35490
aS'D09314'
p35491
aS'Ofatumumab (genetical recombination) (JAN)'
p35492
aS'D09783'
p35493
aS'Tofacitinib citrate (JAN/USAN)'
p35494
aS'D09967'
p35495
aS'Secukinumab (genetical recombination) (JAN)'
p35496
assS'path:map07049'
p35497
(dp35498
S'ENTRY'
p35499
(lp35500
S'map07049'
p35501
aS'Drug'
p35502
aS'Pathway'
p35503
asS'PATHWAY_MAP'
p35504
(lp35505
S'map07049'
p35506
asS'NAME'
p35507
(lp35508
S'Antithrombosis agents'
p35509
asS'REFERENCE'
p35510
(lp35511
S'PMID:20702966'
p35512
ag35512
aS'AUTHORS'
p35513
aS'Morishima Y, Shibano T'
p35514
aS'TITLE'
p35515
aS'[Research and development strategy of antithrombotic agents: pharmacology of the'
p35516
aS'oral factor Xa-inhibitor edoxaban].'
p35517
aS'JOURNAL'
p35518
aS'Nihon Yakurigaku Zasshi 136:83-7 (2010)'
p35519
aS'PMID:21828942'
p35520
ag35520
aS'AUTHORS'
p35521
aS'Ohmura T, Takahashi I, Ikegami K, Encinas J'
p35522
aS'TITLE'
p35523
aS'[Pharmacological and clinical profiles of the direct thrombin inhibitor dabigatran etexilate methane sulfate (Prazaxa((R))) ].'
p35524
aS'JOURNAL'
p35525
aS'Nihon Yakurigaku Zasshi 138:79-88 (2011)'
p35526
ag22
ag22
aS'AUTHORS'
p35527
aS'Tomiyama Y.'
p35528
aS'TITLE'
p35529
aS'[Types and their mechanism of action of antiplatelet drugs] (in Japanese)'
p35530
aS'JOURNAL'
p35531
aS'CLINICIAN'
p35532
asS'COMPOUND'
p35533
(lp35534
S'D00106'
p35535
aS'Epoprostenol (USAN/INN)'
p35536
ag35535
ag35536
aS'D00109'
p35537
aS'Aspirin (JP16/USP)'
p35538
aS'D00181'
p35539
aS'Argatroban hydrate (JP16)'
p35540
aS'D00564'
p35541
aS'Warfarin sodium (USP)'
p35542
aS'D00769'
p35543
aS'Clopidogrel sulfate (JP16)'
p35544
aS'D01028'
p35545
aS'Ticlopidine hydrochloride (JP16/USAN)'
p35546
aS'D01029'
p35547
aS'Tirofiban hydrochloride (USAN)'
p35548
aS'D01280'
p35549
aS'Warfarin potassium (JP16)'
p35550
aS'D01337'
p35551
aS'Epoprostenol sodium (JAN/USAN)'
p35552
aS'D01551'
p35553
aS'Beraprost sodium (JP16/USAN)'
p35554
aS'D01624'
p35555
aS'Sarpogrelate hydrochloride (JP16)'
p35556
aS'D01670'
p35557
aS'Nafamostat mesilate (JP16)'
p35558
aS'D01672'
p35559
aS'Gabexate mesilate (JP16)'
p35560
aS'D01684'
p35561
aS'Ozagrel sodium (JP16)'
p35562
aS'D01844'
p35563
aS'Fondaparinux sodium (JAN/USAN/INN)'
p35564
aS'D01896'
p35565
aS'Cilostazol (JP16/USAN/INN)'
p35566
aS'D01981'
p35567
aS'Ximelagatran (JAN/USAN/INN)'
p35568
aS'D02112'
p35569
aS'Heparin sodium (JP16/USP/INN)'
p35570
aS'D02720'
p35571
aS'Beraprost (USAN)'
p35572
aS'D02778'
p35573
aS'Abciximab (genetical recombination) (JAN)'
p35574
aS'D02956'
p35575
aS'Anticoagulant heparin (USP)'
p35576
aS'D02980'
p35577
aS'Ardeparin sodium (USAN/INN)'
p35578
aS'D03136'
p35579
aS'Bivalirudin (USAN/INN)'
p35580
aS'D03213'
p35581
aS'Apixaban (JAN/USAN/INN)'
p35582
aS'D03324'
p35583
aS'Nasaruplase (cell culture) (JAN)'
p35584
aS'D03341'
p35585
aS'Urokinase (JP16/USAN/INN)'
p35586
aS'D03353'
p35587
aS'Dalteparin sodium (JAN/USAN/INN)'
p35588
aS'D03692'
p35589
aS'Desirudin (USAN/INN)'
p35590
aS'D03960'
p35591
aS'Aspirin - dialuminate mixt'
p35592
aS'D04427'
p35593
aS'Heparin calcium (JP16/USAN)'
p35594
aS'D05123'
p35595
aS'Nasaruplase beta (USAN/INN)'
p35596
aS'D06270'
p35597
aS'Urokinase alfa (USAN/INN)'
p35598
aS'D06571'
p35599
aS'Antithrombin III human (USP)'
p35600
aS'D06880'
p35601
aS'Lepirudin (INN)'
p35602
aS'D06888'
p35603
aS'Eptifibatide (INN)'
p35604
aS'D07082'
p35605
aS'Dabigatran etexilate methanesulfonate (JAN)'
p35606
aS'D07086'
p35607
aS'Rivaroxaban (JAN/USAN/INN)'
p35608
aS'D07144'
p35609
aS'Dabigatran etexilate (USAN/INN)'
p35610
aS'D07510'
p35611
aS'Adomiparin (USAN)'
p35612
aS'D07729'
p35613
aS'Clopidogrel (INN)'
p35614
aS'D08004'
p35615
aS'Gabexate (INN)'
p35616
aS'D08327'
p35617
aS'Ozagrel (INN)'
p35618
aS'D08508'
p35619
aS'Sarpogrelate (INN)'
p35620
aS'D08594'
p35621
aS'Ticlopidine (INN)'
p35622
aS'D08607'
p35623
aS'Tirofiban (INN)'
p35624
aS'D08682'
p35625
aS'Warfarin (INN)'
p35626
aS'D08795'
p35627
aS'Human anti-thrombin III, freeze-dried concentrated'
p35628
aS'D09546'
p35629
aS'Edoxaban tosilate hydrate (JAN)'
p35630
aS'D09710'
p35631
aS'Edoxaban (USAN/INN)'
p35632
aS'D09817'
p35633
aS'Darexaban maleate (JAN)'
p35634
assS'path:map04713'
p35635
(dp35636
S'NAME'
p35637
(lp35638
S'Circadian entrainment'
p35639
asS'REFERENCE'
p35640
(lp35641
S'PMID:17646042'
p35642
ag35642
aS'AUTHORS'
p35643
aS'Brown TM, Piggins HD'
p35644
aS'TITLE'
p35645
aS'Electrophysiology of the suprachiasmatic circadian clock.'
p35646
aS'JOURNAL'
p35647
aS'Prog Neurobiol 82:229-55 (2007)'
p35648
aS'PMID:19109992'
p35649
ag35649
aS'AUTHORS'
p35650
aS'Dickson L, Finlayson K'
p35651
aS'TITLE'
p35652
aS'VPAC and PAC receptors: From ligands to function.'
p35653
aS'JOURNAL'
p35654
aS'Pharmacol Ther 121:294-316 (2009)'
p35655
aS'PMID:20664079'
p35656
ag35656
aS'AUTHORS'
p35657
aS'Golombek DA, Rosenstein RE'
p35658
aS'TITLE'
p35659
aS'Physiology of circadian entrainment.'
p35660
aS'JOURNAL'
p35661
aS'Physiol Rev 90:1063-102 (2010)'
p35662
aS'PMID:16217123'
p35663
ag35663
aS'AUTHORS'
p35664
aS'Dubocovich ML, Markowska M'
p35665
aS'TITLE'
p35666
aS'Functional MT1 and MT2 melatonin receptors in mammals.'
p35667
aS'JOURNAL'
p35668
aS'Endocrine 27:101-10 (2005)'
p35669
aS'PMID:20605968'
p35670
ag35670
aS'AUTHORS'
p35671
aS'Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J'
p35672
aS'TITLE'
p35673
aS'International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.'
p35674
aS'JOURNAL'
p35675
aS'Pharmacol Rev 62:343-80 (2010)'
p35676
aS'PMID:19449447'
p35677
ag35677
aS'AUTHORS'
p35678
aS'Hardeland R'
p35679
aS'TITLE'
p35680
aS'Melatonin: signaling mechanisms of a pleiotropic agent.'
p35681
aS'JOURNAL'
p35682
aS'Biofactors 35:183-92 (2009)'
p35683
aS'PMID:12700026'
p35684
ag35684
aS'AUTHORS'
p35685
aS'Golombek DA, Ferreyra GA, Agostino PV, Murad AD, Rubio MF, Pizzio GA, Katz ME, Marpegan L, Bekinschtein TA'
p35686
aS'TITLE'
p35687
aS'From light to genes: moving the hands of the circadian clock.'
p35688
aS'JOURNAL'
p35689
aS'Front Biosci 8:s285-93 (2003)'
p35690
aS'PMID:17586087'
p35691
ag35691
aS'AUTHORS'
p35692
aS'Mertens I, Husson SJ, Janssen T, Lindemans M, Schoofs L'
p35693
aS'TITLE'
p35694
aS'PACAP and PDF signaling in the regulation of mammalian and insect circadian rhythms.'
p35695
aS'JOURNAL'
p35696
aS'Peptides 28:1775-83 (2007)'
p35697
aS'PMID:15813931'
p35698
ag35698
aS'AUTHORS'
p35699
aS'Kim DY, Choi HJ, Kim JS, Kim YS, Jeong DU, Shin HC, Kim MJ, Han HC, Hong SK, Kim YI'
p35700
aS'TITLE'
p35701
aS'Voltage-gated calcium channels play crucial roles in the glutamate-induced phase'
p35702
aS'shifts of the rat suprachiasmatic circadian clock.'
p35703
aS'JOURNAL'
p35704
aS'Eur J Neurosci 21:1215-22 (2005)'
p35705
aS'PMID:15016477'
p35706
ag35706
aS'AUTHORS'
p35707
aS'Agostino PV, Ferreyra GA, Murad AD, Watanabe Y, Golombek DA'
p35708
aS'TITLE'
p35709
aS'Diurnal, circadian and photic regulation of calcium/calmodulin-dependent kinase II and neuronal nitric oxide synthase in the hamster suprachiasmatic nuclei.'
p35710
aS'JOURNAL'
p35711
aS'Neurochem Int 44:617-25 (2004)'
p35712
aS'PMID:11294753'
p35713
ag35713
aS'AUTHORS'
p35714
aS'Ferreyra GA, Golombek DA'
p35715
aS'TITLE'
p35716
aS'Rhythmicity of the cGMP-related signal transduction pathway in the mammalian circadian system.'
p35717
aS'JOURNAL'
p35718
aS'Am J Physiol Regul Integr Comp Physiol 280:R1348-55 (2001)'
p35719
aS'PMID:15930378'
p35720
ag35720
aS'AUTHORS'
p35721
aS'Butcher GQ, Lee B, Cheng HY, Obrietan K'
p35722
aS'TITLE'
p35723
aS'Light stimulates MSK1 activation in the suprachiasmatic nucleus via a PACAP-ERK/MAP kinase-dependent mechanism.'
p35724
aS'JOURNAL'
p35725
aS'J Neurosci 25:5305-13 (2005)'
p35726
aS'PMID:10446325'
p35727
ag35727
aS'AUTHORS'
p35728
aS'Hamada T, Niki T, Ziging P, Sugiyama T, Watanabe S, Mikoshiba K, Ishida N'
p35729
aS'TITLE'
p35730
aS'Differential expression patterns of inositol trisphosphate receptor types 1 and 3 in the rat suprachiasmatic nucleus.'
p35731
aS'JOURNAL'
p35732
aS'Brain Res 838:131-5 (1999)'
p35733
aS'PMID:10208575'
p35734
ag35734
aS'AUTHORS'
p35735
aS'Diaz-Munoz M, Dent MA, Granados-Fuentes D, Hall AC, Hernandez-Cruz A, Harrington ME, Aguilar-Roblero R'
p35736
aS'TITLE'
p35737
aS'Circadian modulation of the ryanodine receptor type 2 in the SCN of rodents.'
p35738
aS'JOURNAL'
p35739
aS'Neuroreport 10:481-6 (1999)'
p35740
aS'PMID:11086993'
p35741
ag35741
aS'AUTHORS'
p35742
aS'Fang M, Jaffrey SR, Sawa A, Ye K, Luo X, Snyder SH'
p35743
aS'TITLE'
p35744
aS'Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON.'
p35745
aS'JOURNAL'
p35746
aS'Neuron 28:183-93 (2000)'
p35747
aS'PMID:12573527'
p35748
ag35748
aS'AUTHORS'
p35749
aS'Takahashi H, Umeda N, Tsutsumi Y, Fukumura R, Ohkaze H, Sujino M, van der Horst G, Yasui A, Inouye ST, Fujimori A, Ohhata T, Araki R, Abe M'
p35750
aS'TITLE'
p35751
aS'Mouse dexamethasone-induced RAS protein 1 gene is expressed in a circadian rhythmic manner in the suprachiasmatic nucleus.'
p35752
aS'JOURNAL'
p35753
aS'Brain Res Mol Brain Res 110:1-6 (2003)'
p35754
aS'PMID:17167088'
p35755
ag35755
aS'AUTHORS'
p35756
aS'Cheng HY, Dziema H, Papp J, Mathur DP, Koletar M, Ralph MR, Penninger JM, Obrietan K'
p35757
aS'TITLE'
p35758
aS'The molecular gatekeeper Dexras1 sculpts the photic responsiveness of the mammalian circadian clock.'
p35759
aS'JOURNAL'
p35760
aS'J Neurosci 26:12984-95 (2006)'
p35761
asS'KO_PATHWAY'
p35762
(lp35763
S'ko04713'
p35764
asS'PATHWAY_MAP'
p35765
(lp35766
S'map04713'
p35767
asS'DBLINKS'
p35768
(lp35769
S'GO: 0009649'
p35770
asS'ENTRY'
p35771
(lp35772
S'map04713'
p35773
aS'Pathway'
p35774
asS'CLASS'
p35775
(lp35776
S'Organismal Systems Environmental adaptation'
p35777
asS'DESCRIPTION'
p35778
(lp35779
S"Circadian entrainment is a fundamental property by which the period of the internal biological clock is entrained by recurring exogenous signals, such that the organism's endocrine and behavioral rhythms are synchronized to environmental cues. In mammals, a master clock is located in the suprachiasmatic nuclei (SCN) of the hypothalamus and may synchronize circadian oscillators in peripheral tissues. Light signal is the dominant synchronizer for master SCN clock. Downstream from the retina, glutamate and PACAP are released and trigger the activation of signal transduction cascades, including CamKII and nNOS activity, cAMP- and cGMP-dependent protein kinases, and mitogen-activated protein kinase (MAPK). Of non-photic entrainment, important phase shifting capabilities have been found for melatonin, which inhibits light-induced phase shifts through inhibition of adenylate cyclase (AC). Multiple entrainment pathways converge into CREB regulation. In turn, phosphorylated CREB activates clock gene expression."
p35780
assS'path:map07052'
p35781
(dp35782
S'ENTRY'
p35783
(lp35784
S'map07052'
p35785
aS'Drug'
p35786
aS'Pathway'
p35787
asS'PATHWAY_MAP'
p35788
(lp35789
S'map07052'
p35790
asS'NAME'
p35791
(lp35792
S'Antidyslipidemic agents'
p35793
asS'COMPOUND'
p35794
(lp35795
S'D00476'
p35796
aS'Probucol (JP16/USP/INN)'
p35797
ag35796
ag35797
aS'D01221'
p35798
aS'gamma Oryzanol (JAN)'
p35799
aS'D01291'
p35800
aS'Nicomol (JP16/INN)'
p35801
aS'D01754'
p35802
aS'Niceritrol (JP16/INN)'
p35803
aS'D01892'
p35804
aS'Ethyl icosapentate (JP16)'
p35805
aS'D01913'
p35806
aS'Riboflavin butyrate (JP16)'
p35807
aS'D01934'
p35808
aS'Colestimide (JP16)'
p35809
aS'D01966'
p35810
aS'Ezetimibe (JAN/USAN/INN)'
p35811
aS'D02047'
p35812
aS'Dextran sulfate sodium (JAN)'
p35813
aS'D02690'
p35814
aS'Colestyramine (JAN/INN)'
p35815
aS'D03343'
p35816
aS'Dextran sulfate sodium sulfur 5 (JP16)'
p35817
aS'D04267'
p35818
aS'Polyenephosphatidyl choline (JAN)'
p35819
aS'D04268'
p35820
aS'Elastase ES'
p35821
aS'D04269'
p35822
aS'Soysterol (JAN)'
p35823
aS'D07413'
p35824
aS'Pantothenic acid (BAN)'
p35825
aS'D08061'
p35826
aS'Icosapent (INN)'
p35827
assS'path:map01110'
p35828
(dp35829
S'ENTRY'
p35830
(lp35831
S'map01110'
p35832
aS'Global'
p35833
aS'Pathway'
p35834
asS'PATHWAY_MAP'
p35835
(lp35836
S'map01110'
p35837
asS'NAME'
p35838
(lp35839
S'Biosynthesis of secondary metabolites'
p35840
asS'KO_PATHWAY'
p35841
(lp35842
S'ko01110'
p35843
assS'path:map07053'
p35844
(dp35845
S'ENTRY'
p35846
(lp35847
S'map07053'
p35848
aS'Drug'
p35849
aS'Pathway'
p35850
asS'PATHWAY_MAP'
p35851
(lp35852
S'map07053'
p35853
asS'NAME'
p35854
(lp35855
S'Anti-HIV agents'
p35856
asS'COMPOUND'
p35857
(lp35858
S'C20266'
p35859
aS'AMD 070'
p35860
ag35859
ag35860
aS'D00296'
p35861
aS'Didanosine (JAN/USAN/INN)'
p35862
aS'D00353'
p35863
aS'Lamivudine (JAN/USP/INN)'
p35864
aS'D00412'
p35865
aS'Zalcitabine (JAN/USP/INN)'
p35866
aS'D00413'
p35867
aS'Zidovudine (JP16/USP/INN)'
p35868
aS'D00427'
p35869
aS'Ritonavir (JAN/USAN/INN)'
p35870
aS'D00429'
p35871
aS'Saquinavir (JAN/USP/INN)'
p35872
aS'D00435'
p35873
aS'Nevirapine (JAN/USP/INN)'
p35874
aS'D00445'
p35875
aS'Sanilvudine (JAN)'
p35876
aS'D00891'
p35877
aS'Abacavir sulfate (JAN/USAN)'
p35878
aS'D00894'
p35879
aS'Amprenavir (JAN/USAN/INN)'
p35880
aS'D00895'
p35881
aS'Delavirdine mesilate (JAN)'
p35882
aS'D00896'
p35883
aS'Efavirenz (JAN/INN)'
p35884
aS'D00897'
p35885
aS'Indinavir sulfate (USAN)'
p35886
aS'D00899'
p35887
aS'Nelfinavir mesilate (JAN)'
p35888
aS'D01055'
p35889
aS'Emivirine (USAN/INN)'
p35890
aS'D01160'
p35891
aS'Saquinavir mesilate (JAN)'
p35892
aS'D01199'
p35893
aS'Emtricitabine (JAN/USAN/INN)'
p35894
aS'D01276'
p35895
aS'Atazanavir sulfate (JAN/USAN)'
p35896
aS'D01425'
p35897
aS'Lopinavir (JAN/USAN/INN)'
p35898
aS'D01982'
p35899
aS'Tenofovir disoproxil fumarate (JAN/USAN)'
p35900
aS'D02497'
p35901
aS'Fosamprenavir (INN)'
p35902
aS'D02499'
p35903
aS'Enfuvirtide (USAN/INN)'
p35904
aS'D02861'
p35905
aS'Indinavir sulfate ethanolate (JAN)'
p35906
aS'D02867'
p35907
aS'Fosamprenavir calcium hydrate (JAN)'
p35908
aS'D02890'
p35909
aS'Amdoxovir (USAN/INN)'
p35910
aS'D03656'
p35911
aS'Darunavir (USAN/INN)'
p35912
aS'D03833'
p35913
aS'Indinavir (USAN)'
p35914
aS'D03835'
p35915
aS'Fosamprenavir calcium (USAN)'
p35916
aS'D03837'
p35917
aS'Fosamprenavir sodium (USAN)'
p35918
aS'D03843'
p35919
aS'Tipranavir disodium (USAN)'
p35920
aS'D03981'
p35921
aS'Elvucitabine (USAN/INN)'
p35922
aS'D04112'
p35923
aS'Etravirine (JAN/USAN/INN)'
p35924
aS'D06297'
p35925
aS'Vicriviroc maleate (USAN)'
p35926
aS'D06478'
p35927
aS'Darunavir ethanolate (JAN)'
p35928
aS'D06564'
p35929
aS'Bevirimat dimeglumine (USAN)'
p35930
aS'D06670'
p35931
aS'Maraviroc (JAN/INN)'
p35932
aS'D06676'
p35933
aS'Raltegravir (USAN/INN)'
p35934
aS'D06677'
p35935
aS'Elvitegravir (JAN/USAN)'
p35936
aS'D07133'
p35937
aS'Raltegravir potassium (JAN/USAN)'
p35938
aS'D07471'
p35939
aS'Atazanavir (INN)'
p35940
aS'D08259'
p35941
aS'Nelfinavir (INN)'
p35942
aS'D08605'
p35943
aS'Tipranavir (INN)'
p35944
aS'D09575'
p35945
aS'Ibalizumab (USAN/INN)'
p35946
aS'D09720'
p35947
aS'Rilpivirine (USAN/INN)'
p35948
aS'D09881'
p35949
aS'Cobicistat (JAN/USAN/INN)'
p35950
aS'D09958'
p35951
aS'Rilpivirine hydrochloride (JAN/USAN)'
p35952
aS'D10066'
p35953
aS'Dolutegravir (USAN)'
p35954
aS'D10113'
p35955
aS'Dolutegravir sodium (JAN/USAN)'
p35956
assS'path:map07055'
p35957
(dp35958
S'ENTRY'
p35959
(lp35960
S'map07055'
p35961
aS'Drug'
p35962
aS'Pathway'
p35963
asS'PATHWAY_MAP'
p35964
(lp35965
S'map07055'
p35966
asS'NAME'
p35967
(lp35968
S'Sulfonamide derivatives - overview'
p35969
asS'COMPOUND'
p35970
(lp35971
S'C07573'
p35972
aS'Prontosil'
p35973
ag35972
ag35973
aS'D00218'
p35974
aS'Acetazolamide (JP16/USP/INN)'
p35975
aS'D00331'
p35976
aS'Furosemide (JP16/USP/INN)'
p35977
aS'D00345'
p35978
aS'Indapamide (JP16/USP)'
p35979
aS'D00380'
p35980
aS'Tolbutamide (JP16/USP/INN)'
p35981
aS'D00518'
p35982
aS'Diclofenamide (JP16/INN)'
p35983
aS'D00519'
p35984
aS'Chlorothiazide (JAN/USP/INN)'
p35985
aS'D00653'
p35986
aS'Dorzolamide hydrochloride (JP16/USP)'
p35987
aS'D00870'
p35988
aS'Sulfamethizole (JP16/USP/INN)'
p35989
aS'D01142'
p35990
aS'Sulfadimethoxine (JAN/USP)'
p35991
aS'D01196'
p35992
aS'Acetazolamide sodium (JAN)'
p35993
aS'D02425'
p35994
aS'Carbutamide (INN)'
p35995
aS'D02434'
p35996
aS'Sulfapyridine (USP/INN)'
p35997
aS'D03471'
p35998
aS'Chlorothiazide sodium (USP)'
p35999
aS'D06177'
p36000
aS'Tolbutamide sodium, sterile'
p36001
aS'D06401'
p36002
aS'Indapamide hydrate'
p36003
aS'D07871'
p36004
aS'Dorzolamide (INN)'
p36005
aS'D07999'
p36006
aS'Sodium furosemide'
p36007
aS'D08001'
p36008
aS'Furosemide diolamine'
p36009
aS'D08538'
p36010
aS'Sulfadimethoxine sodium (USP)'
p36011
aS'D08542'
p36012
aS'Sulfamidochrysoidine'
p36013
aS'D08543'
p36014
aS'Sulfanilamide (INN)'
p36015
assS'path:map04380'
p36016
(dp36017
S'NAME'
p36018
(lp36019
S'Osteoclast differentiation'
p36020
asS'REFERENCE'
p36021
(lp36022
S'PMID:16313349'
p36023
ag36023
aS'AUTHORS'
p36024
aS'Takayanagi H, Sato K, Takaoka A, Taniguchi T'
p36025
aS'TITLE'
p36026
aS'Interplay between interferon and other cytokine systems in bone metabolism.'
p36027
aS'JOURNAL'
p36028
aS'Immunol Rev 208:181-93 (2005)'
p36029
aS'PMID:20392226'
p36030
ag36030
aS'AUTHORS'
p36031
aS'Takayanagi H'
p36032
aS'TITLE'
p36033
aS'New immune connections in osteoclast formation.'
p36034
aS'JOURNAL'
p36035
aS'Ann N Y Acad Sci 1192:117-23 (2010)'
p36036
aS'PMID:19585227'
p36037
ag36037
aS'AUTHORS'
p36038
aS'Nakashima T, Takayanagi H'
p36039
aS'TITLE'
p36040
aS'Osteoimmunology: crosstalk between the immune and bone systems.'
p36041
aS'JOURNAL'
p36042
aS'J Clin Immunol 29:555-67 (2009)'
p36043
aS'PMID:18722561'
p36044
ag36044
aS'AUTHORS'
p36045
aS'Caetano-Lopes J, Canhao H, Fonseca JE'
p36046
aS'TITLE'
p36047
aS'Osteoimmunology--the hidden immune regulation of bone.'
p36048
aS'JOURNAL'
p36049
aS'Autoimmun Rev 8:250-5 (2009)'
p36050
aS'PMID:18451259'
p36051
ag36051
aS'AUTHORS'
p36052
aS'Lorenzo J, Horowitz M, Choi Y'
p36053
aS'TITLE'
p36054
aS'Osteoimmunology: interactions of the bone and immune system.'
p36055
aS'JOURNAL'
p36056
aS'Endocr Rev 29:403-40 (2008)'
p36057
aS'PMID:17869613'
p36058
ag36058
aS'AUTHORS'
p36059
aS'David JP'
p36060
aS'TITLE'
p36061
aS'Osteoimmunology: a view from the bone.'
p36062
aS'JOURNAL'
p36063
aS'Adv Immunol 95:149-65 (2007)'
p36064
aS'PMID:16313342'
p36065
ag36065
aS'AUTHORS'
p36066
aS'Jimi E, Ghosh S'
p36067
aS'TITLE'
p36068
aS'Role of nuclear factor-kappaB in the immune system and bone.'
p36069
aS'JOURNAL'
p36070
aS'Immunol Rev 208:80-7 (2005)'
p36071
aS'PMID:12748652'
p36072
ag36072
aS'AUTHORS'
p36073
aS'Boyle WJ, Simonet WS, Lacey DL'
p36074
aS'TITLE'
p36075
aS'Osteoclast differentiation and activation.'
p36076
aS'JOURNAL'
p36077
aS'Nature 423:337-42 (2003)'
p36078
aS'PMID:17633024'
p36079
ag36079
aS'AUTHORS'
p36080
aS'Darnay BG, Besse A, Poblenz AT, Lamothe B, Jacoby JJ'
p36081
aS'TITLE'
p36082
aS'TRAFs in RANK signaling.'
p36083
aS'JOURNAL'
p36084
aS'Adv Exp Med Biol 597:152-9 (2007)'
p36085
aS'PMID:15122243'
p36086
ag36086
aS'AUTHORS'
p36087
aS'Baron R'
p36088
aS'TITLE'
p36089
aS'Arming the osteoclast.'
p36090
aS'JOURNAL'
p36091
aS'Nat Med 10:458-60 (2004)'
p36092
aS'PMID:17380158'
p36093
ag36093
aS'AUTHORS'
p36094
aS'Takayanagi H'
p36095
aS'TITLE'
p36096
aS'Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.'
p36097
aS'JOURNAL'
p36098
aS'Nat Rev Immunol 7:292-304 (2007)'
p36099
aS'PMID:20703218'
p36100
ag36100
aS'AUTHORS'
p36101
aS'Krum SA, Chang J, Miranda-Carboni G, Wang CY'
p36102
aS'TITLE'
p36103
aS'Novel functions for NFkappaB: inhibition of bone formation.'
p36104
aS'JOURNAL'
p36105
aS'Nat Rev Rheumatol 6:607-11 (2010)'
p36106
aS'PMID:15817678'
p36107
ag36107
aS'AUTHORS'
p36108
aS'Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY'
p36109
aS'TITLE'
p36110
aS'A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation.'
p36111
aS'JOURNAL'
p36112
aS'Blood 106:852-9 (2005)'
p36113
aS'PMID:18329366'
p36114
ag36114
aS'AUTHORS'
p36115
aS'Shinohara M, Koga T, Okamoto K, Sakaguchi S, Arai K, Yasuda H, Takai T, Kodama T, Morio T, Geha RS, Kitamura D, Kurosaki T, Ellmeier W, Takayanagi H'
p36116
aS'TITLE'
p36117
aS'Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK'
p36118
aS'and ITAM signals.'
p36119
aS'JOURNAL'
p36120
aS'Cell 132:794-806 (2008)'
p36121
aS'PMID:15546140'
p36122
ag36122
aS'AUTHORS'
p36123
aS'Takayanagi H, Kim S, Koga T, Taniguchi T'
p36124
aS'TITLE'
p36125
aS'Stat1-mediated cytoplasmic attenuation in osteoimmunology.'
p36126
aS'JOURNAL'
p36127
aS'J Cell Biochem 94:232-40 (2005)'
p36128
aS'PMID:18382763'
p36129
ag36129
aS'AUTHORS'
p36130
aS'Jin W, Chang M, Paul EM, Babu G, Lee AJ, Reiley W, Wright A, Zhang M, You J, Sun SC'
p36131
aS'TITLE'
p36132
aS'Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.'
p36133
aS'JOURNAL'
p36134
aS'J Clin Invest 118:1858-66 (2008)'
p36135
aS'PMID:16184196'
p36136
ag36136
aS'AUTHORS'
p36137
aS'Bai S, Kitaura H, Zhao H, Chen J, Muller JM, Schule R, Darnay B, Novack DV, Ross FP, Teitelbaum SL'
p36138
aS'TITLE'
p36139
aS'FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.'
p36140
aS'JOURNAL'
p36141
aS'J Clin Invest 115:2742-51 (2005)'
p36142
aS'PMID:12110142'
p36143
ag36143
aS'AUTHORS'
p36144
aS'Takayanagi H, Kim S, Taniguchi T'
p36145
aS'TITLE'
p36146
aS'Signaling crosstalk between RANKL and interferons in osteoclast differentiation.'
p36147
aS'JOURNAL'
p36148
aS'Arthritis Res 4 Suppl 3:S227-32 (2002)'
p36149
asS'KO_PATHWAY'
p36150
(lp36151
S'ko04380'
p36152
asS'PATHWAY_MAP'
p36153
(lp36154
S'map04380'
p36155
asS'DISEASE'
p36156
(lp36157
S'H00436'
p36158
aS'Osteopetrosis'
p36159
ag36158
ag36159
aS'H00437'
p36160
aS"Paget's disease of bone and related disorders"
p36161
aS'H00438'
p36162
aS'Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL)'
p36163
aS'H00540'
p36164
aS'Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID)'
p36165
aS'H00645'
p36166
aS'Incontinentia pigmenti'
p36167
aS'H00800'
p36168
aS'Loeys-Dietz syndrome (LDS)'
p36169
aS'H00882'
p36170
aS'Cocoon syndrome'
p36171
aS'H01132'
p36172
aS'Aplastic anemia (AA)'
p36173
aS'H01187'
p36174
aS'Tietz syndrome'
p36175
aS'H01240'
p36176
aS'Immune thrombocytopenia (ITP)'
p36177
asS'DBLINKS'
p36178
(lp36179
S'GO: 0030316'
p36180
asS'ENTRY'
p36181
(lp36182
S'map04380'
p36183
aS'Pathway'
p36184
asS'CLASS'
p36185
(lp36186
S'Organismal Systems Development'
p36187
asS'DESCRIPTION'
p36188
(lp36189
S'The osteoclasts, multinucleared cells originating from the hematopoietic monocyte-macrophage lineage, are responsible for bone resorption. Osteoclastogenesis is mainly regulated by signaling pathways activated by RANK and immune receptors, whose ligands are expressed on the surface of osteoblasts. Signaling from RANK changes gene expression patterns through transcription factors like NFATc1 and characterizes the active osteoclast.'
p36190
assS'path:map04260'
p36191
(dp36192
S'NAME'
p36193
(lp36194
S'Cardiac muscle contraction'
p36195
asS'REFERENCE'
p36196
(lp36197
S'PMID:17988210'
p36198
ag36198
aS'AUTHORS'
p36199
aS'Bers DM'
p36200
aS'TITLE'
p36201
aS'Calcium cycling and signaling in cardiac myocytes.'
p36202
aS'JOURNAL'
p36203
aS'Annu Rev Physiol 70:23-49 (2008)'
p36204
aS'PMID:11805843'
p36205
ag36205
aS'AUTHORS'
p36206
aS'Bers DM'
p36207
aS'TITLE'
p36208
aS'Cardiac excitation-contraction coupling.'
p36209
aS'JOURNAL'
p36210
aS'Nature 415:198-205 (2002)'
p36211
aS'PMID:16799263'
p36212
ag36212
aS'AUTHORS'
p36213
aS'Endoh M'
p36214
aS'TITLE'
p36215
aS'Signal transduction and Ca2+ signaling in intact myocardium.'
p36216
aS'JOURNAL'
p36217
aS'J Pharmacol Sci 100:525-37 (2006)'
p36218
aS'PMID:18981594'
p36219
ag36219
aS'AUTHORS'
p36220
aS'Endoh M'
p36221
aS'TITLE'
p36222
aS'Cardiac Ca2+ signaling and Ca2+ sensitizers.'
p36223
aS'JOURNAL'
p36224
aS'Circ J 72:1915-25 (2008)'
p36225
aS'PMID:16552170'
p36226
ag36226
aS'AUTHORS'
p36227
aS'Bers DM, Despa S'
p36228
aS'TITLE'
p36229
aS'Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts.'
p36230
aS'JOURNAL'
p36231
aS'J Pharmacol Sci 100:315-22 (2006)'
p36232
aS'PMID:10747208'
p36233
ag36233
aS'AUTHORS'
p36234
aS'Gordon AM, Homsher E, Regnier M'
p36235
aS'TITLE'
p36236
aS'Regulation of contraction in striated muscle.'
p36237
aS'JOURNAL'
p36238
aS'Physiol Rev 80:853-924 (2000)'
p36239
aS'PMID:16701909'
p36240
ag36240
aS'AUTHORS'
p36241
aS'Phrommintikul A, Chattipakorn N'
p36242
aS'TITLE'
p36243
aS'Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death.'
p36244
aS'JOURNAL'
p36245
aS'Int J Cardiol 112:142-52 (2006)'
p36246
aS'PMID:16096350'
p36247
ag36247
aS'AUTHORS'
p36248
aS'Lacinova L'
p36249
aS'TITLE'
p36250
aS'Voltage-dependent calcium channels.'
p36251
aS'JOURNAL'
p36252
aS'Gen Physiol Biophys 24 Suppl 1:1-78 (2005)'
p36253
aS'PMID:12763850'
p36254
ag36254
aS'AUTHORS'
p36255
aS"Lingrel J, Moseley A, Dostanic I, Cougnon M, He S, James P, Woo A, O'Connor K, Neumann J"
p36256
aS'TITLE'
p36257
aS'Functional roles of the alpha isoforms of the Na,K-ATPase.'
p36258
aS'JOURNAL'
p36259
aS'Ann N Y Acad Sci 986:354-9 (2003)'
p36260
aS'PMID:11294886'
p36261
ag36261
aS'AUTHORS'
p36262
aS'Berg JS, Powell BC, Cheney RE'
p36263
aS'TITLE'
p36264
aS'A millennial myosin census.'
p36265
aS'JOURNAL'
p36266
aS'Mol Biol Cell 12:780-94 (2001)'
p36267
aS'PMID:15736582'
p36268
ag36268
aS'AUTHORS'
p36269
aS'Parmacek MS, Solaro RJ'
p36270
aS'TITLE'
p36271
aS'Biology of the troponin complex in cardiac myocytes.'
p36272
aS'JOURNAL'
p36273
aS'Prog Cardiovasc Dis 47:159-76 (2004)'
p36274
aS'PMID:14659803'
p36275
ag36275
aS'AUTHORS'
p36276
aS'Yamashita H, Sugiura S, Fujita H, Yasuda S, Nagai R, Saeki Y, Sunagawa K, Sugi H'
p36277
aS'TITLE'
p36278
aS'Myosin light chain isoforms modify force-generating ability of cardiac myosin by changing the kinetics of actin-myosin interaction.'
p36279
aS'JOURNAL'
p36280
aS'Cardiovasc Res 60:580-8 (2003)'
p36281
asS'KO_PATHWAY'
p36282
(lp36283
S'ko04260'
p36284
asS'PATHWAY_MAP'
p36285
(lp36286
S'map04260'
p36287
asS'DISEASE'
p36288
(lp36289
S'H00594'
p36290
aS'Distal muscular dystrophies'
p36291
ag36290
ag36291
aS'H00656'
p36292
aS'Scapuloperoneal myopathy (SPM)'
p36293
aS'H00698'
p36294
aS'Nemaline myopathy'
p36295
aS'H00701'
p36296
aS'Congenital fiber type disproportion (CFTD)'
p36297
aS'H00702'
p36298
aS'Cap myopathy'
p36299
aS'H00703'
p36300
aS'Myosin storage myopathy (MSM)'
p36301
aS'H00728'
p36302
aS'Brugada syndrome (BRS)'
p36303
aS'H00746'
p36304
aS'Hypokalemic periodic paralysis (HypoPP)'
p36305
aS'H00749'
p36306
aS'Episodic ataxias'
p36307
aS'H00775'
p36308
aS'Familial or sporadic hemiplegic migraine'
p36309
aS'H00808'
p36310
aS'Idiopathic generalized epilepsies (IGEs)'
p36311
aS'H00811'
p36312
aS'Distal arthrogryposis (DA)'
p36313
aS'H00831'
p36314
aS'Primary dystonia'
p36315
aS'H01019'
p36316
aS'Catecholaminergic polymorphic ventricular tachycardia'
p36317
aS'H01216'
p36318
aS'Left ventricular noncompaction (LVNC)'
p36319
aS'H01219'
p36320
aS'Restrictive cardiomyopathy (RCM)'
p36321
aS'H01355'
p36322
aS'Kearns-Sayre Syndrome'
p36323
aS'H01368'
p36324
aS'Cytochrome c oxidase (COX) deficiency'
p36325
asS'DBLINKS'
p36326
(lp36327
S'GO: 0060048'
p36328
asS'ENTRY'
p36329
(lp36330
S'map04260'
p36331
aS'Pathway'
p36332
asS'CLASS'
p36333
(lp36334
S'Organismal Systems Circulatory system'
p36335
asS'DESCRIPTION'
p36336
(lp36337
S'Contraction of the heart is a complex process initiated by the electrical excitation of cardiac myocytes (excitation-contraction coupling, ECC). In cardiac myocytes, Ca2+ influx induced by activation of voltage-dependent L-type Ca channels (DHP receptors) upon membrane depolarization triggers the release of Ca2+ via Ca2+ release channels (ryanodine receptors) of sarcoplasmic reticulum (SR) through a Ca2+ -induced Ca release (CICR) mechanism. Ca2+ ions released via the CICR mechanism diffuse through the cytosolic space to contractile proteins to bind to troponinC resulting in the release of inhibition induced by troponinI. The Ca2+ binding to troponinC thereby triggers the sliding of thin and thick filaments, that is, the activation of a crossbridge and subsequent cardiac force development and/or cell shortening. Recovery occurs as Ca2+ is pumped out of the cell by the Na+/Ca2+ exchanger (NCX) or is returned to the sarcoplasmic reticulum (SR) by sarco(endo)plasmic Ca2+ -ATPase (SERCA) pumps on the non-junctional region of the SR.'
p36338
assS'path:map04261'
p36339
(dp36340
S'NAME'
p36341
(lp36342
S'Adrenergic signaling in cardiomyocytes'
p36343
asS'REFERENCE'
p36344
(lp36345
S'PMID:19883653'
p36346
ag36346
aS'AUTHORS'
p36347
aS'Grimm M, Brown JH'
p36348
aS'TITLE'
p36349
aS'Beta-adrenergic receptor signaling in the heart: role of CaMKII.'
p36350
aS'JOURNAL'
p36351
aS'J Mol Cell Cardiol 48:322-30 (2010)'
p36352
aS'PMID:21212391'
p36353
ag36353
aS'AUTHORS'
p36354
aS'Yang JH, Saucerman JJ'
p36355
aS'TITLE'
p36356
aS'Computational models reduce complexity and accelerate insight into cardiac signaling networks.'
p36357
aS'JOURNAL'
p36358
aS'Circ Res 108:85-97 (2011)'
p36359
aS'PMID:16765984'
p36360
ag36360
aS'AUTHORS'
p36361
aS'Schaub MC, Hefti MA, Zaugg M'
p36362
aS'TITLE'
p36363
aS'Integration of calcium with the signaling network in cardiac myocytes.'
p36364
aS'JOURNAL'
p36365
aS'J Mol Cell Cardiol 41:183-214 (2006)'
p36366
aS'PMID:22022314'
p36367
ag36367
aS'AUTHORS'
p36368
aS'Taggart P, Boyett MR, Logantha S, Lambiase PD'
p36369
aS'TITLE'
p36370
aS'Anger, emotion, and arrhythmias: from brain to heart.'
p36371
aS'JOURNAL'
p36372
aS'Front Physiol 2:67 (2011)'
p36373
aS'PMID:17988210'
p36374
ag36374
aS'AUTHORS'
p36375
aS'Bers DM'
p36376
aS'TITLE'
p36377
aS'Calcium cycling and signaling in cardiac myocytes.'
p36378
aS'JOURNAL'
p36379
aS'Annu Rev Physiol 70:23-49 (2008)'
p36380
aS'PMID:20923637'
p36381
ag36381
aS'AUTHORS'
p36382
aS'Soltis AR, Saucerman JJ'
p36383
aS'TITLE'
p36384
aS'Synergy between CaMKII substrates and beta-adrenergic signaling in regulation of'
p36385
aS'cardiac myocyte Ca(2+) handling.'
p36386
aS'JOURNAL'
p36387
aS'Biophys J 99:2038-47 (2010)'
p36388
aS'PMID:12439640'
p36389
ag36389
aS'AUTHORS'
p36390
aS'Wallukat G'
p36391
aS'TITLE'
p36392
aS'The beta-adrenergic receptors.'
p36393
aS'JOURNAL'
p36394
aS'Herz 27:683-90 (2002)'
p36395
aS'PMID:11604549'
p36396
ag36396
aS'AUTHORS'
p36397
aS'Xiao RP'
p36398
aS'TITLE'
p36399
aS'Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.'
p36400
aS'JOURNAL'
p36401
aS'Sci STKE 2001:re15 (2001)'
p36402
aS'PMID:10571541'
p36403
ag36403
aS'AUTHORS'
p36404
aS'Xiao RP, Cheng H, Zhou YY, Kuschel M, Lakatta EG'
p36405
aS'TITLE'
p36406
aS'Recent advances in cardiac beta(2)-adrenergic signal transduction.'
p36407
aS'JOURNAL'
p36408
aS'Circ Res 85:1092-100 (1999)'
p36409
aS'PMID:15979723'
p36410
ag36410
aS'AUTHORS'
p36411
aS'Zheng M, Zhu W, Han Q, Xiao RP'
p36412
aS'TITLE'
p36413
aS'Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling.'
p36414
aS'JOURNAL'
p36415
aS'Pharmacol Ther 108:257-68 (2005)'
p36416
aS'PMID:17826821'
p36417
ag36417
aS'AUTHORS'
p36418
aS'Kuzumoto M, Takeuchi A, Nakai H, Oka C, Noma A, Matsuoka S'
p36419
aS'TITLE'
p36420
aS'Simulation analysis of intracellular Na+ and Cl- homeostasis during beta 1-adrenergic stimulation of cardiac myocyte.'
p36421
aS'JOURNAL'
p36422
aS'Prog Biophys Mol Biol 96:171-86 (2008)'
p36423
aS'PMID:11805843'
p36424
ag36424
aS'AUTHORS'
p36425
aS'Bers DM'
p36426
aS'TITLE'
p36427
aS'Cardiac excitation-contraction coupling.'
p36428
aS'JOURNAL'
p36429
aS'Nature 415:198-205 (2002)'
p36430
aS'PMID:20658186'
p36431
ag36431
aS'AUTHORS'
p36432
aS'Ho D, Yan L, Iwatsubo K, Vatner DE, Vatner SF'
p36433
aS'TITLE'
p36434
aS'Modulation of beta-adrenergic receptor signaling in heart failure and longevity:'
p36435
aS'targeting adenylyl cyclase type 5.'
p36436
aS'JOURNAL'
p36437
aS'Heart Fail Rev 15:495-512 (2010)'
p36438
aS'PMID:15142747'
p36439
ag36439
aS'AUTHORS'
p36440
aS'Saucerman JJ, McCulloch AD'
p36441
aS'TITLE'
p36442
aS'Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation.'
p36443
aS'JOURNAL'
p36444
aS'Prog Biophys Mol Biol 85:261-78 (2004)'
p36445
aS'PMID:15765137'
p36446
ag36446
aS'AUTHORS'
p36447
aS'Yano M, Ikeda Y, Matsuzaki M'
p36448
aS'TITLE'
p36449
aS'Altered intracellular Ca2+ handling in heart failure.'
p36450
aS'JOURNAL'
p36451
aS'J Clin Invest 115:556-64 (2005)'
p36452
aS'PMID:15232578'
p36453
ag36453
aS'AUTHORS'
p36454
aS'Wehrens XH, Marks AR'
p36455
aS'TITLE'
p36456
aS'Novel therapeutic approaches for heart failure by normalizing calcium cycling.'
p36457
aS'JOURNAL'
p36458
aS'Nat Rev Drug Discov 3:565-73 (2004)'
p36459
aS'PMID:19874988'
p36460
ag36460
aS'AUTHORS'
p36461
aS'Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J'
p36462
aS'TITLE'
p36463
aS'The sympathetic nervous system in heart failure physiology, pathophysiology, and'
p36464
aS'clinical implications.'
p36465
aS'JOURNAL'
p36466
aS'J Am Coll Cardiol 54:1747-62 (2009)'
p36467
aS'PMID:18407781'
p36468
ag36468
aS'AUTHORS'
p36469
aS'Barry SP, Davidson SM, Townsend PA'
p36470
aS'TITLE'
p36471
aS'Molecular regulation of cardiac hypertrophy.'
p36472
aS'JOURNAL'
p36473
aS'Int J Biochem Cell Biol 40:2023-39 (2008)'
p36474
asS'KO_PATHWAY'
p36475
(lp36476
S'ko04261'
p36477
asS'PATHWAY_MAP'
p36478
(lp36479
S'map04261'
p36480
asS'DBLINKS'
p36481
(lp36482
S'GO: 0001997'
p36483
asS'ENTRY'
p36484
(lp36485
S'map04261'
p36486
aS'Pathway'
p36487
asS'CLASS'
p36488
(lp36489
S'Organismal Systems Circulatory system'
p36490
asS'DESCRIPTION'
p36491
(lp36492
S'Cardiac myocytes express at least six subtypes of adrenergic receptor (AR) which include three subtypes of beta-AR (beta-1, beta-2, beta-3) and three subtypes of the alpha-1-AR (alpha-1A, alpha-1B, and alpha-1C).'
p36493
assS'path:map04142'
p36494
(dp36495
S'NAME'
p36496
(lp36497
S'Lysosome'
p36498
asS'REFERENCE'
p36499
(lp36500
g22
ag22
aS'AUTHORS'
p36501
aS'Alberts B,'
p36502
aS'Johnson A, Lewis J, Raff M, Roberts K, Walter P'
p36503
aS'TITLE'
p36504
aS'Molecular Biology of the Cell 4th ed.'
p36505
aS'JOURNAL'
p36506
aS'Garland Science (2002)'
p36507
aS'PMID:12628346'
p36508
ag36508
aS'AUTHORS'
p36509
aS'Eskelinen EL, Tanaka Y, Saftig P'
p36510
aS'TITLE'
p36511
aS'At the acidic edge: emerging functions for lysosomal membrane proteins.'
p36512
aS'JOURNAL'
p36513
aS'Trends Cell Biol 13:137-45 (2003)'
p36514
aS'PMID:1883197'
p36515
ag36515
aS'AUTHORS'
p36516
aS'Neufeld EF'
p36517
aS'TITLE'
p36518
aS'Lysosomal storage diseases.'
p36519
aS'JOURNAL'
p36520
aS'Annu Rev Biochem 60:257-80 (1991)'
p36521
aS'PMID:2943218'
p36522
ag36522
aS'AUTHORS'
p36523
aS'von Figura K, Hasilik A'
p36524
aS'TITLE'
p36525
aS'Lysosomal enzymes and their receptors.'
p36526
aS'JOURNAL'
p36527
aS'Annu Rev Biochem 55:167-93 (1986)'
p36528
ag22
ag22
aS'AUTHORS'
p36529
aS'Uchiyama Y.'
p36530
aS'TITLE'
p36531
aS'[The analysis of a knockout mouse.] ( In Japanese)'
p36532
aS'JOURNAL'
p36533
aS'Cell Technology 25:1322-27 (2006)'
p36534
aS'PMID:15987739'
p36535
ag36535
aS'AUTHORS'
p36536
aS'Janvier K, Bonifacino JS'
p36537
aS'TITLE'
p36538
aS'Role of the endocytic machinery in the sorting of lysosome-associated membrane proteins.'
p36539
aS'JOURNAL'
p36540
aS'Mol Biol Cell 16:4231-42 (2005)'
p36541
aS'PMID:18635948'
p36542
ag36542
aS'AUTHORS'
p36543
aS'Vergarajauregui S, Puertollano R'
p36544
aS'TITLE'
p36545
aS'Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy.'
p36546
aS'JOURNAL'
p36547
aS'Autophagy 4:832-4 (2008)'
p36548
asS'KO_PATHWAY'
p36549
(lp36550
S'ko04142'
p36551
asS'PATHWAY_MAP'
p36552
(lp36553
S'map04142'
p36554
asS'DISEASE'
p36555
(lp36556
S'H00123'
p36557
aS'Mucopolysaccharidosis type IV (MPS4)'
p36558
ag36557
ag36558
aS'H00124'
p36559
aS'GM2 gangliosidoses'
p36560
aS'H00125'
p36561
aS'Fabry disease'
p36562
aS'H00126'
p36563
aS'Gaucher disease'
p36564
aS'H00127'
p36565
aS'Metachromatic leukodystrophy (MLD)'
p36566
aS'H00128'
p36567
aS'Mucopolysaccharidosis type I (MPS1)'
p36568
aS'H00129'
p36569
aS'Mucopolysaccharidosis type II (MPS2)'
p36570
aS'H00130'
p36571
aS'Mucopolysaccharidosis type III (MPS3)'
p36572
aS'H00131'
p36573
aS'Mucopolysaccharidosis type VI (MPS6)'
p36574
aS'H00132'
p36575
aS'Mucopolysaccharidosis type VII (MPS7)'
p36576
aS'H00133'
p36577
aS'Mucopolysaccharidosis type IX (MPS9)'
p36578
aS'H00135'
p36579
aS'Krabbe disease'
p36580
aS'H00136'
p36581
aS'Niemann-Pick disease type C (NPC)'
p36582
aS'H00137'
p36583
aS'Niemann-Pick disease (NPD) typeA and B'
p36584
aS'H00138'
p36585
aS'Farber lipogranulomatosis'
p36586
aS'H00139'
p36587
aS'alpha-Mannosidosis'
p36588
aS'H00140'
p36589
aS'beta-Mannosidosis'
p36590
aS'H00141'
p36591
aS'Fucosidosis'
p36592
aS'H00142'
p36593
aS'Sialidosis'
p36594
aS'H00143'
p36595
aS'Mucolipidosis II and III'
p36596
aS'H00144'
p36597
aS'Mucolipidosis IV'
p36598
aS'H00145'
p36599
aS'Aspartylglucosaminuria (AGU)'
p36600
aS'H00146'
p36601
aS'Alpha-N-acetylgalactosaminidase deficiency'
p36602
aS'H00147'
p36603
aS'Sialuria/ Sialic acid storage disease'
p36604
aS'H00148'
p36605
aS'Lysosomal acid lipase deficiency'
p36606
aS'H00149'
p36607
aS'Neuronal ceroid lipofuscinosis'
p36608
aS'H00150'
p36609
aS'Danon disease'
p36610
aS'H00166'
p36611
aS'Hermansky-Pudlak syndrome (HPS)'
p36612
aS'H00272'
p36613
aS'Multiple sulfatase deficiency (MSD)'
p36614
aS'H00273'
p36615
aS'Pycnodysostosis'
p36616
aS'H00274'
p36617
aS'Papillon-Lefevre syndrome'
p36618
aS'H00275'
p36619
aS'Cystinosis'
p36620
aS'H00276'
p36621
aS'Galactosialidosis'
p36622
aS'H00281'
p36623
aS'GM1 gangliosidosis'
p36624
aS'H00421'
p36625
aS'Mucopolysaccharidosis (MPS)'
p36626
aS'H00422'
p36627
aS'Glycoproteinoses'
p36628
aS'H00423'
p36629
aS'Defects in the degradation of sulfatide'
p36630
aS'H00424'
p36631
aS'Defects in the degradation of sphingomyelin'
p36632
aS'H00425'
p36633
aS'Lysosomal cysteine protease deficiencies'
p36634
aS'H00426'
p36635
aS'Defects in the degradation of ganglioside'
p36636
aS'H00696'
p36637
aS'Haim-Munk syndrome'
p36638
aS'H00810'
p36639
aS'Progressive myoclonic epilepsy (PME/ EPM)'
p36640
aS'H00932'
p36641
aS'Tropical calcific pancreatitis'
p36642
aS'H01097'
p36643
aS'Cerebral palsy'
p36644
aS'H01113'
p36645
aS'Acid phosphatase deficiency'
p36646
aS'H01196'
p36647
aS'Hypochromic microcytic anemia'
p36648
aS'H01239'
p36649
aS'Combined SAP deficiency'
p36650
asS'DBLINKS'
p36651
(lp36652
S'GO: 0005764'
p36653
asS'ENTRY'
p36654
(lp36655
S'map04142'
p36656
aS'Pathway'
p36657
asS'CLASS'
p36658
(lp36659
S'Cellular Processes Transport and catabolism'
p36660
asS'DESCRIPTION'
p36661
(lp36662
S"Lysosomes are membrane-delimited organelles in animal cells serving as the cell's main digestive compartment to which all sorts of macromolecules are delivered for degradation. They contain more than 40 hydrolases in an acidic environment (pH of about 5). After synthesis in the ER, lysosomal enzymes are decorated with mannose-6-phosphate residues, which are recognized by mannose-6-phosphate receptors in the trans-Golgi network. They are packaged into clathrin-coated vesicles and are transported to late endosomes. Substances for digestion are acquired by the lysosomes via a series of processes including endocytosis, phagocytosis, and autophagy."
p36663
assS'path:map04141'
p36664
(dp36665
S'NAME'
p36666
(lp36667
S'Protein processing in endoplasmic reticulum'
p36668
asS'REFERENCE'
p36669
(lp36670
S'PMID:19491040'
p36671
ag36671
aS'AUTHORS'
p36672
aS'Naidoo N'
p36673
aS'TITLE'
p36674
aS'ER and aging-Protein folding and the ER stress response.'
p36675
aS'JOURNAL'
p36676
aS'Ageing Res Rev 8:150-9 (2009)'
p36677
aS'PMID:18023214'
p36678
ag36678
aS'AUTHORS'
p36679
aS'Malhotra JD, Kaufman RJ'
p36680
aS'TITLE'
p36681
aS'The endoplasmic reticulum and the unfolded protein response.'
p36682
aS'JOURNAL'
p36683
aS'Semin Cell Dev Biol 18:716-31 (2007)'
p36684
aS'PMID:20347046'
p36685
ag36685
aS'AUTHORS'
p36686
aS'Maattanen P, Gehring K, Bergeron JJ, Thomas DY'
p36687
aS'TITLE'
p36688
aS'Protein quality control in the ER: the recognition of misfolded proteins.'
p36689
aS'JOURNAL'
p36690
aS'Semin Cell Dev Biol 21:500-11 (2010)'
p36691
aS'PMID:20219571'
p36692
ag36692
aS'AUTHORS'
p36693
aS'Stolz A, Wolf DH'
p36694
aS'TITLE'
p36695
aS'Endoplasmic reticulum associated protein degradation: a chaperone assisted journey to hell.'
p36696
aS'JOURNAL'
p36697
aS'Biochim Biophys Acta 1803:694-705 (2010)'
p36698
aS'PMID:20112977'
p36699
ag36699
aS'AUTHORS'
p36700
aS'Dejgaard K, Theberge JF, Heath-Engel H, Chevet E, Tremblay ML, Thomas DY'
p36701
aS'TITLE'
p36702
aS'Organization of the Sec61 translocon, studied by high resolution native electrophoresis.'
p36703
aS'JOURNAL'
p36704
aS'J Proteome Res 9:1763-71 (2010)'
p36705
asS'KO_PATHWAY'
p36706
(lp36707
S'ko04141'
p36708
asS'PATHWAY_MAP'
p36709
(lp36710
S'map04141'
p36711
asS'DISEASE'
p36712
(lp36713
S'H00078'
p36714
aS'Frontotemporal lobar degeneration (FTLD)'
p36715
ag36714
ag36715
aS'H00221'
p36716
aS'Combined deficiency of factors V and VIII (F5F8D)'
p36717
aS'H00344'
p36718
aS'Leprosy'
p36719
aS'H00409'
p36720
aS'Type II diabetes mellitus'
p36721
aS'H00545'
p36722
aS'Polycystic liver disease'
p36723
aS'H00594'
p36724
aS'Distal muscular dystrophies'
p36725
aS'H00595'
p36726
aS'Myofibrillar myopathies (MFM)'
p36727
aS'H00740'
p36728
aS'Ichthyosis follicularis, alopecia, and photophobia syndrome'
p36729
aS'H00766'
p36730
aS'Wolcott-Rallison syndrome'
p36731
aS'H00768'
p36732
aS'Nonsyndromic autosomal recessive mental retardation (NS-ARMR)'
p36733
aS'H00854'
p36734
aS'Wolfram syndrome (WFS)'
p36735
aS'H00917'
p36736
aS'Congenital dyserythropoietic anemias (CDAs)'
p36737
aS'H00927'
p36738
aS'Chylomicron retention disease (CRD)'
p36739
aS'H01105'
p36740
aS'Cranio-lenticulo-sutural dysplasia (CLSD)'
p36741
aS'H01202'
p36742
aS'Cataract'
p36743
aS'H01284'
p36744
aS'Marinesco-Sjogren syndrome'
p36745
asS'MODULE'
p36746
(lp36747
S'M00382'
p36748
aS'SCF-FBS complex [PATH:map04141]'
p36749
ag36748
ag36749
aS'M00400'
p36750
aS'p97-Ufd1-Npl4 complex [PATH:map04141]'
p36751
aS'M00401'
p36752
aS'Sec61 complex [PATH:map04141]'
p36753
aS'M00402'
p36754
aS'Translocon-associated protein (TRAP) complex [PATH:map04141]'
p36755
aS'M00403'
p36756
aS'HRD1/SEL1 ERAD complex [PATH:map04141]'
p36757
aS'M00404'
p36758
aS'COPII complex [PATH:map04141]'
p36759
asS'DBLINKS'
p36760
(lp36761
S'GO: 0030433 0034976'
p36762
asS'ENTRY'
p36763
(lp36764
S'map04141'
p36765
aS'Pathway'
p36766
asS'CLASS'
p36767
(lp36768
S'Genetic Information Processing Folding, sorting and degradation'
p36769
asS'DESCRIPTION'
p36770
(lp36771
S'The endoplasmic reticulum (ER) is a subcellular organelle where proteins are folded with the help of lumenal chaperones. Newly synthesized peptides enter the ER via the sec61 pore and are glycosylated. Correctly folded proteins are packaged into transport vesicles that shuttle them to the Golgi complex. Misfolded proteins are retained within the ER lumen in complex with molecular chaperones. Proteins that are terminally misfolded bind to BiP and are directed toward degradation through the proteasome in a process called ER-associated degradation (ERAD). Accumulation of misfolded proteins in the ER causes ER stress and activates a signaling pathway called the unfolded protein response (UPR). In certain severe situations, however, the protective mechanisms activated by the UPR are not sufficient to restore normal ER function and cells die by apoptosis.'
p36772
assS'path:map04140'
p36773
(dp36774
S'DBLINKS'
p36775
(lp36776
S'GO: 0006914'
p36777
asS'NAME'
p36778
(lp36779
S'Regulation of autophagy'
p36780
asS'REFERENCE'
p36781
(lp36782
S'PMID:15325584'
p36783
ag36783
aS'AUTHORS'
p36784
aS'Meijer AJ, Codogno P.'
p36785
aS'TITLE'
p36786
aS'Regulation and role of autophagy in mammalian cells.'
p36787
aS'JOURNAL'
p36788
aS'Int J Biochem Cell Biol 36:2445-62 (2004)'
p36789
aS'PMID:16099218'
p36790
ag36790
aS'AUTHORS'
p36791
aS'Deretic V.'
p36792
aS'TITLE'
p36793
aS'Autophagy in innate and adaptive immunity.'
p36794
aS'JOURNAL'
p36795
aS'Trends Immunol 26:523-8 (2005)'
p36796
aS'PMID:15752997'
p36797
ag36797
aS'AUTHORS'
p36798
aS'Thompson AR, Vierstra RD.'
p36799
aS'TITLE'
p36800
aS'Autophagic recycling: lessons from yeast help define the process in plants.'
p36801
aS'JOURNAL'
p36802
aS'Curr Opin Plant Biol 8:165-73 (2005)'
p36803
aS'PMID:16200202'
p36804
ag36804
aS'AUTHORS'
p36805
aS'Levine B, Yuan J.'
p36806
aS'TITLE'
p36807
aS'Autophagy in cell death: an innocent convict?'
p36808
aS'JOURNAL'
p36809
aS'J Clin Invest 115:2679-88 (2005)'
p36810
aS'PMID:15325588'
p36811
ag36811
aS'AUTHORS'
p36812
aS'Tanida I, Ueno T, Kominami E.'
p36813
aS'TITLE'
p36814
aS'LC3 conjugation system in mammalian autophagy.'
p36815
aS'JOURNAL'
p36816
aS'Int J Biochem Cell Biol 36:2503-18 (2004)'
p36817
aS'PMID:15928708'
p36818
ag36818
aS'AUTHORS'
p36819
aS'Lum JJ, DeBerardinis RJ, Thompson CB.'
p36820
aS'TITLE'
p36821
aS'Autophagy in metazoans: cell survival in the land of plenty.'
p36822
aS'JOURNAL'
p36823
aS'Nat Rev Mol Cell Biol 6:439-48 (2005)'
p36824
aS'PMID:15978794'
p36825
ag36825
aS'AUTHORS'
p36826
aS'Reggiori F, Klionsky DJ.'
p36827
aS'TITLE'
p36828
aS'Autophagosomes: biogenesis from scratch?'
p36829
aS'JOURNAL'
p36830
aS'Curr Opin Cell Biol 17:415-22 (2005)'
p36831
aS'PMID:11099404'
p36832
ag36832
aS'AUTHORS'
p36833
aS'Klionsky DJ, Emr SD.'
p36834
aS'TITLE'
p36835
aS'Autophagy as a regulated pathway of cellular degradation.'
p36836
aS'JOURNAL'
p36837
aS'Science 290:1717-21 (2000)'
p36838
aS'PMID:16125113'
p36839
ag36839
aS'AUTHORS'
p36840
aS'Bechet D, Tassa A, Taillandier D, Combaret L, Attaix D.'
p36841
aS'TITLE'
p36842
aS'Lysosomal proteolysis in skeletal muscle.'
p36843
aS'JOURNAL'
p36844
aS'Int J Biochem Cell Biol 37:2098-114 (2005)'
p36845
asS'KO_PATHWAY'
p36846
(lp36847
S'ko04140'
p36848
asS'ENTRY'
p36849
(lp36850
S'map04140'
p36851
aS'Pathway'
p36852
asS'PATHWAY_MAP'
p36853
(lp36854
S'map04140'
p36855
asS'CLASS'
p36856
(lp36857
S'Cellular Processes Transport and catabolism'
p36858
assS'path:map04146'
p36859
(dp36860
S'NAME'
p36861
(lp36862
S'Peroxisome'
p36863
asS'REFERENCE'
p36864
(lp36865
S'PMID:17055078'
p36866
ag36866
aS'AUTHORS'
p36867
aS'Wanders RJ, Waterham HR'
p36868
aS'TITLE'
p36869
aS'Peroxisomal disorders: the single peroxisomal enzyme deficiencies.'
p36870
aS'JOURNAL'
p36871
aS'Biochim Biophys Acta 1763:1707-20 (2006)'
p36872
aS'PMID:17055079'
p36873
ag36873
aS'AUTHORS'
p36874
aS'Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW'
p36875
aS'TITLE'
p36876
aS'Peroxisome biogenesis disorders.'
p36877
aS'JOURNAL'
p36878
aS'Biochim Biophys Acta 1763:1733-48 (2006)'
p36879
aS'PMID:17010456'
p36880
ag36880
aS'AUTHORS'
p36881
aS'Rottensteiner H, Theodoulou FL'
p36882
aS'TITLE'
p36883
aS'The ins and outs of peroxisomes: co-ordination of membrane transport and peroxisomal metabolism.'
p36884
aS'JOURNAL'
p36885
aS'Biochim Biophys Acta 1763:1527-40 (2006)'
p36886
aS'PMID:16631601'
p36887
ag36887
aS'AUTHORS'
p36888
aS'Iida R, Yasuda T, Tsubota E, Takatsuka H, Matsuki T, Kishi K'
p36889
aS'TITLE'
p36890
aS'Human Mpv17-like protein is localized in peroxisomes and regulates expression of'
p36891
aS'antioxidant enzymes.'
p36892
aS'JOURNAL'
p36893
aS'Biochem Biophys Res Commun 344:948-54 (2006)'
p36894
ag22
ag22
aS'AUTHORS'
p36895
aS'Kleinman R, Goulet OJ, Mieli-Vergani G, Sanderson I, Sherman P, Shneider B.'
p36896
aS'TITLE'
p36897
aS"Walker's Pediatric Gastrointestinal Disease (5th edition)"
p36898
aS'JOURNAL'
p36899
aS'B.C.Decker (2008)'
p36900
asS'KO_PATHWAY'
p36901
(lp36902
S'ko04146'
p36903
asS'PATHWAY_MAP'
p36904
(lp36905
S'map04146'
p36906
asS'DISEASE'
p36907
(lp36908
S'H00075'
p36909
aS'Refsum disease'
p36910
ag36909
ag36910
aS'H00176'
p36911
aS'Adrenoleukodystrophy (ALD)'
p36912
aS'H00177'
p36913
aS'Adrenoleukodystrophy, neonatal (NALD)'
p36914
aS'H00203'
p36915
aS'Acatalasia'
p36916
aS'H00205'
p36917
aS'Peroxisome biogenesis disorder'
p36918
aS'H00207'
p36919
aS'Rhizomelic chondrodysplasia punctata'
p36920
aS'H00407'
p36921
aS'Peroxisomal beta-oxidation enzyme deficiency'
p36922
aS'H00628'
p36923
aS'Congenital bile acid synthesis defect (CBAS)'
p36924
aS'H00874'
p36925
aS'Leukoencephalopathy with dystonia and motor neuropathy'
p36926
aS'H01155'
p36927
aS'Roussy-Levy syndrome'
p36928
aS'H01283'
p36929
aS'Malonyl-CoA decarboxylase deficiency'
p36930
aS'H01342'
p36931
aS'Zellweger syndrome (ZS)'
p36932
asS'DBLINKS'
p36933
(lp36934
S'GO: 0005777'
p36935
asS'ENTRY'
p36936
(lp36937
S'map04146'
p36938
aS'Pathway'
p36939
asS'CLASS'
p36940
(lp36941
S'Cellular Processes Transport and catabolism'
p36942
asS'DESCRIPTION'
p36943
(lp36944
S"Peroxisomes are essential organelles that play a key role in redox signalling and lipid homeostasis. They contribute to many crucial metabolic processes such as fatty acid oxidation, biosynthesis of ether lipids and free radical detoxification. The biogenesis of peroxisomes starts with the early peroxins PEX3, PEX16 and PEX19 and proceeds via several steps. The import of membrane proteins into peroxisomes needs PEX19 for recognition, targeting and insertion via docking at PEX3. Matrix proteins in the cytosol are recognized by peroxisomal targeting signals (PTS) and transported to the docking complex at the peroxisomal membrane. Peroxisomes' deficiencies lead to severe and often fatal inherited peroxisomal disorders (PD). PDs are usually classified in two groups. The first group is disorders of peroxisome biogenesis which include Zellweger syndrome, and the second group is single peroxisomal enzyme deficiencies."
p36945
assS'path:map04145'
p36946
(dp36947
S'NAME'
p36948
(lp36949
S'Phagosome'
p36950
asS'REFERENCE'
p36951
(lp36952
S'PMID:15894272'
p36953
ag36953
aS'AUTHORS'
p36954
aS'Stuart LM, Ezekowitz RA'
p36955
aS'TITLE'
p36956
aS'Phagocytosis: elegant complexity.'
p36957
aS'JOURNAL'
p36958
aS'Immunity 22:539-50 (2005)'
p36959
aS'PMID:10684585'
p36960
ag36960
aS'AUTHORS'
p36961
aS'Tjelle TE, Lovdal T, Berg T'
p36962
aS'TITLE'
p36963
aS'Phagosome dynamics and function.'
p36964
aS'JOURNAL'
p36965
aS'Bioessays 22:255-63 (2000)'
p36966
aS'PMID:18492791'
p36967
ag36967
aS'AUTHORS'
p36968
aS'Dupuy AG, Caron E'
p36969
aS'TITLE'
p36970
aS'Integrin-dependent phagocytosis: spreading from microadhesion to new concepts.'
p36971
aS'JOURNAL'
p36972
aS'J Cell Sci 121:1773-83 (2008)'
p36973
aS'PMID:15036145'
p36974
ag36974
aS'AUTHORS'
p36975
aS'Brumell JH, Grinstein S'
p36976
aS'TITLE'
p36977
aS'Salmonella redirects phagosomal maturation.'
p36978
aS'JOURNAL'
p36979
aS'Curr Opin Microbiol 7:78-84 (2004)'
p36980
aS'PMID:17245426'
p36981
ag36981
aS'AUTHORS'
p36982
aS'Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S'
p36983
aS'TITLE'
p36984
aS'LAMP proteins are required for fusion of lysosomes with phagosomes.'
p36985
aS'JOURNAL'
p36986
aS'EMBO J 26:313-24 (2007)'
p36987
aS'PMID:17637737'
p36988
ag36988
aS'AUTHORS'
p36989
aS'Luzio JP, Pryor PR, Bright NA'
p36990
aS'TITLE'
p36991
aS'Lysosomes: fusion and function.'
p36992
aS'JOURNAL'
p36993
aS'Nat Rev Mol Cell Biol 8:622-32 (2007)'
p36994
aS'PMID:18513324'
p36995
ag36995
aS'AUTHORS'
p36996
aS'Sumimoto H'
p36997
aS'TITLE'
p36998
aS'Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species.'
p36999
aS'JOURNAL'
p37000
aS'FEBS J 275:3249-77 (2008)'
p37001
asS'KO_PATHWAY'
p37002
(lp37003
S'ko04145'
p37004
asS'PATHWAY_MAP'
p37005
(lp37006
S'map04145'
p37007
asS'DISEASE'
p37008
(lp37009
S'H00265'
p37010
aS'Hereditary sensory and autonomic neuropathy (HSAN)'
p37011
ag37010
ag37011
aS'H00751'
p37012
aS'Asphyxiating thoracic dystrophy'
p37013
aS'H00821'
p37014
aS'Macular degeneration'
p37015
aS'H00838'
p37016
aS'Congenital fibrosis of the extraocular muscles (CFEOM)'
p37017
aS'H00856'
p37018
aS'Distal hereditary motor neuropathies (dHMN)'
p37019
aS'H00957'
p37020
aS'Fleck corneal dystrophy (FCD)'
p37021
aS'H00984'
p37022
aS'Bare lymphocyte syndrome (BLS) type1'
p37023
aS'H01108'
p37024
aS'CD36 deficiency'
p37025
aS'H01109'
p37026
aS'Chronic mucocutaneous candidiasis (CMC)'
p37027
aS'H01240'
p37028
aS'Immune thrombocytopenia (ITP)'
p37029
aS'H01255'
p37030
aS'Juvenile-onset dystonia'
p37031
asS'MODULE'
p37032
(lp37033
S'M00401'
p37034
aS'Sec61 complex [PATH:map04145]'
p37035
asS'DBLINKS'
p37036
(lp37037
S'GO: 0045335'
p37038
asS'ENTRY'
p37039
(lp37040
S'map04145'
p37041
aS'Pathway'
p37042
asS'CLASS'
p37043
(lp37044
S'Cellular Processes Transport and catabolism'
p37045
asS'DESCRIPTION'
p37046
(lp37047
S'Phagocytosis is the process of taking in relatively large particles by a cell, and is a central mechanism in the tissue remodeling, inflammation, and defense against infectious agents. A phagosome is formed when the specific receptors on the phagocyte surface recognize ligands on the particle surface. After formation, nascent phagosomes progressively acquire digestive characteristics. This maturation of phagosomes involves regulated interaction with the other membrane organelles, including recycling endosomes, late endosomes and lysosomes. The fusion of phagosomes and lysosomes releases toxic products that kill most bacteria and degrade them into fragments. However, some bacteria have strategies to escape the bactericidal mechanisms associated with phagocytosis and survive within host phagocytes.'
p37048
assS'path:map04144'
p37049
(dp37050
S'NAME'
p37051
(lp37052
S'Endocytosis'
p37053
asS'REFERENCE'
p37054
(lp37055
S'PMID:19007773'
p37056
ag37056
aS'AUTHORS'
p37057
aS'Acconcia F, Sigismund S, Polo S'
p37058
aS'TITLE'
p37059
aS'Ubiquitin in trafficking: the network at work.'
p37060
aS'JOURNAL'
p37061
aS'Exp Cell Res 315:1610-8 (2009)'
p37062
aS'PMID:18647649'
p37063
ag37063
aS'AUTHORS'
p37064
aS'Donaldson JG, Porat-Shliom N, Cohen LA'
p37065
aS'TITLE'
p37066
aS'Clathrin-independent endocytosis: a unique platform for cell signaling and PM remodeling.'
p37067
aS'JOURNAL'
p37068
aS'Cell Signal 21:1-6 (2009)'
p37069
aS'PMID:15261671'
p37070
ag37070
aS'AUTHORS'
p37071
aS'Sorkin A'
p37072
aS'TITLE'
p37073
aS'Cargo recognition during clathrin-mediated endocytosis: a team effort.'
p37074
aS'JOURNAL'
p37075
aS'Curr Opin Cell Biol 16:392-9 (2004)'
p37076
aS'PMID:19325624'
p37077
ag37077
aS'AUTHORS'
p37078
aS'Raiborg C, Stenmark H'
p37079
aS'TITLE'
p37080
aS'The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins.'
p37081
aS'JOURNAL'
p37082
aS'Nature 458:445-52 (2009)'
p37083
aS'(Japanese)'
p37084
ag37084
aS'AUTHORS'
p37085
aS'Ohno H, Yoshimori T (eds).'
p37086
aS'TITLE'
p37087
aS'[Current Stream in Membrane Traffic] (in Japanese)'
p37088
aS'JOURNAL'
p37089
aS'Tanpakushitsu Kakusan Koso 53 (2008)'
p37090
aS'PMID:20110990'
p37091
ag37091
aS'AUTHORS'
p37092
aS'Scita G, Di Fiore PP'
p37093
aS'TITLE'
p37094
aS'The endocytic matrix.'
p37095
aS'JOURNAL'
p37096
aS'Nature 463:464-73 (2010)'
p37097
aS'PMID:15687999'
p37098
ag37098
aS'AUTHORS'
p37099
aS'Le Roy C, Wrana JL'
p37100
aS'TITLE'
p37101
aS'Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling.'
p37102
aS'JOURNAL'
p37103
aS'Nat Rev Mol Cell Biol 6:112-26 (2005)'
p37104
aS'PMID:19924646'
p37105
ag37105
aS'AUTHORS'
p37106
aS'Jovic M, Sharma M, Rahajeng J, Caplan S'
p37107
aS'TITLE'
p37108
aS'The early endosome: a busy sorting station for proteins at the crossroads.'
p37109
aS'JOURNAL'
p37110
aS'Histol Histopathol 25:99-112 (2010)'
p37111
aS'PMID:16203612'
p37112
ag37112
aS'AUTHORS'
p37113
aS'Pietiainen VM, Marjomaki V, Heino J, Hyypia T'
p37114
aS'TITLE'
p37115
aS'Viral entry, lipid rafts and caveosomes.'
p37116
aS'JOURNAL'
p37117
aS'Ann Med 37:394-403 (2005)'
p37118
asS'KO_PATHWAY'
p37119
(lp37120
S'ko04144'
p37121
asS'PATHWAY_MAP'
p37122
(lp37123
S'map04144'
p37124
asS'DISEASE'
p37125
(lp37126
S'H00078'
p37127
aS'Frontotemporal lobar degeneration (FTLD)'
p37128
ag37127
ag37128
aS'H00155'
p37129
aS'Hypercholesterolemia'
p37130
aS'H00265'
p37131
aS'Hereditary sensory and autonomic neuropathy (HSAN)'
p37132
aS'H00567'
p37133
aS'Caveolinopathies'
p37134
aS'H00593'
p37135
aS'Limb-girdle muscular dystrophy (LGMD)'
p37136
aS'H00642'
p37137
aS'Lacrimo-auriculo-dento-digital syndrome (LADD)'
p37138
aS'H00700'
p37139
aS'Centronuclear myopathy'
p37140
aS'H00800'
p37141
aS'Loeys-Dietz syndrome (LDS)'
p37142
aS'H00865'
p37143
aS'Lethal congenital contractural syndrome (LCCS)'
p37144
aS'H01202'
p37145
aS'Cataract'
p37146
aS'H01232'
p37147
aS'Syndromic multisystem autoimmune disease'
p37148
aS'H01295'
p37149
aS'Neurodegeneration due to cerebral folate transport deficiency'
p37150
aS'H01383'
p37151
aS'LDL Receptor Disorder'
p37152
asS'MODULE'
p37153
(lp37154
S'M00408'
p37155
aS'ESCRT-0 complex [PATH:map04144]'
p37156
ag37155
ag37156
aS'M00409'
p37157
aS'ESCRT-I complex [PATH:map04144]'
p37158
aS'M00410'
p37159
aS'ESCRT-II complex [PATH:map04144]'
p37160
aS'M00412'
p37161
aS'ESCRT-III complex [PATH:map04144]'
p37162
asS'DBLINKS'
p37163
(lp37164
S'GO: 0006897'
p37165
asS'ENTRY'
p37166
(lp37167
S'map04144'
p37168
aS'Pathway'
p37169
asS'CLASS'
p37170
(lp37171
S'Cellular Processes Transport and catabolism'
p37172
asS'DESCRIPTION'
p37173
(lp37174
S'Endocytosis is a mechanism for cells to remove ligands, nutrients, and plasma membrane (PM) proteins, and lipids from the cell surface, bringing them into the cell interior. Transmembrane proteins entering through clathrin-dependent endocytosis (CDE) have sequences in their cytoplasmic domains that bind to the APs (adaptor-related protein complexes) and enable their rapid removal from the PM. In addition to APs and clathrin, there are numerous accessory proteins including dynamin. Depending on the various proteins that enter the endosome membrane, these cargoes are sorted to distinct destinations. Some cargoes, such as nutrient receptors, are recycled back to the PM. Ubiquitylated membrane proteins, such as activated growth-factor receptors, are sorted into intraluminal vesicles and eventually end up in the lysosome lumen via multivesicular endosomes (MVEs). There are distinct mechanisms of clathrin-independent endocytosis (CIE) depending upon the cargo and the cell type.'
p37175
assS'path:map07112'
p37176
(dp37177
S'ENTRY'
p37178
(lp37179
S'map07112'
p37180
aS'Drug'
p37181
aS'Pathway'
p37182
asS'PATHWAY_MAP'
p37183
(lp37184
S'map07112'
p37185
asS'NAME'
p37186
(lp37187
S'1,2-Diphenyl substitution family'
p37188
asS'REFERENCE'
p37189
(lp37190
S'PMID:12927511'
p37191
ag37191
aS'AUTHORS'
p37192
aS'Muller G.'
p37193
aS'TITLE'
p37194
aS'Medicinal chemistry of target family-directed masterkeys.'
p37195
aS'JOURNAL'
p37196
aS'Drug Discov Today 8:681-91 (2003)'
p37197
asS'COMPOUND'
p37198
(lp37199
S'C14316'
p37200
aS'SB 218655'
p37201
ag37200
ag37201
aS'C14319'
p37202
aS'SR 141716'
p37203
aS'D00463'
p37204
aS'Oxaprozin (JP16/USAN/INN)'
p37205
aS'D00510'
p37206
aS'Phenylbutazone (JP16/USP/INN)'
p37207
aS'D00567'
p37208
aS'Celecoxib (JAN/USAN/INN)'
p37209
aS'D00568'
p37210
aS'Rofecoxib (JAN/USAN/INN)'
p37211
aS'D01090'
p37212
aS'Pamicogrel (JAN/INN)'
p37213
aS'D01718'
p37214
aS'Mofezolac (JAN/INN)'
p37215
assS'path:map02030'
p37216
(dp37217
S'NAME'
p37218
(lp37219
S'Bacterial chemotaxis'
p37220
asS'REFERENCE'
p37221
(lp37222
S'PMID:12011078'
p37223
ag37223
aS'AUTHORS'
p37224
aS'Kristich CJ, Ordal GW.'
p37225
aS'TITLE'
p37226
aS'Bacillus subtilis CheD is a chemoreceptor modification enzyme required for chemotaxis.'
p37227
aS'JOURNAL'
p37228
aS'J Biol Chem 277:25356-62 (2002)'
p37229
aS'PMID:11722727'
p37230
ag37230
aS'AUTHORS'
p37231
aS'Kirby JR, Kristich CJ, Saulmon MM, Zimmer MA, Garrity LF, Zhulin IB, Ordal GW.'
p37232
aS'TITLE'
p37233
aS'CheC is related to the family of flagellar switch proteins and acts independently from CheD to control chemotaxis in Bacillus subtilis.'
p37234
aS'JOURNAL'
p37235
aS'Mol Microbiol 42:573-85 (2001)'
p37236
aS'PMID:12920116'
p37237
ag37237
aS'AUTHORS'
p37238
aS'Szurmant H, Bunn MW, Cannistraro VJ, Ordal GW.'
p37239
aS'TITLE'
p37240
aS'Bacillus subtilis hydrolyzes CheY-P at the location of its action, the flagellar switch.'
p37241
aS'JOURNAL'
p37242
aS'J Biol Chem 278:48611-6 (2003)'
p37243
aS'PMID:14749334'
p37244
ag37244
aS'AUTHORS'
p37245
aS'Szurmant H, Muff TJ, Ordal GW.'
p37246
aS'TITLE'
p37247
aS'Bacillus subtilis CheC and FliY are members of a novel class of CheY-P-hydrolyzing proteins in the chemotactic signal transduction cascade.'
p37248
aS'JOURNAL'
p37249
aS'J Biol Chem 279:21787-92 (2004)'
p37250
aS'PMID:11158445'
p37251
ag37251
aS'AUTHORS'
p37252
aS'Yoshihara S, Geng X, Okamoto S, Yura K, Murata T, Go M, Ohmori M, Ikeuchi M.'
p37253
aS'TITLE'
p37254
aS'Mutational analysis of genes involved in pilus structure, motility and transformation competency in the unicellular motile cyanobacterium Synechocystis sp. PCC 6803.'
p37255
aS'JOURNAL'
p37256
aS'Plant Cell Physiol 42:63-73 (2001)'
p37257
aS'PMID:8104179'
p37258
ag37258
aS'AUTHORS'
p37259
aS'Darzins A.'
p37260
aS'TITLE'
p37261
aS'The pilG gene product, required for Pseudomonas aeruginosa pilus production and twitching motility, is homologous to the enteric, single-domain response regulator CheY.'
p37262
aS'JOURNAL'
p37263
aS'J Bacteriol 175:5934-44 (1993)'
p37264
aS'PMID:15187186'
p37265
ag37265
aS'AUTHORS'
p37266
aS'Szurmant H, Ordal GW'
p37267
aS'TITLE'
p37268
aS'Diversity in chemotaxis mechanisms among the bacteria and archaea.'
p37269
aS'JOURNAL'
p37270
aS'Microbiol Mol Biol Rev 68:301-19 (2004)'
p37271
aS'PMID:18774298'
p37272
ag37272
aS'AUTHORS'
p37273
aS'Rao CV, Glekas GD, Ordal GW'
p37274
aS'TITLE'
p37275
aS'The three adaptation systems of Bacillus subtilis chemotaxis.'
p37276
aS'JOURNAL'
p37277
aS'Trends Microbiol 16:480-7 (2008)'
p37278
aS'PMID:18990184'
p37279
ag37279
aS'AUTHORS'
p37280
aS'Muff TJ, Ordal GW'
p37281
aS'TITLE'
p37282
aS'The diverse CheC-type phosphatases: chemotaxis and beyond.'
p37283
aS'JOURNAL'
p37284
aS'Mol Microbiol 70:1054-61 (2008)'
p37285
aS'PMID:19203648'
p37286
ag37286
aS'AUTHORS'
p37287
aS'Miller LD, Russell MH, Alexandre G'
p37288
aS'TITLE'
p37289
aS'Diversity in bacterial chemotactic responses and niche adaptation.'
p37290
aS'JOURNAL'
p37291
aS'Adv Appl Microbiol 66:53-75 (2009)'
p37292
asS'KO_PATHWAY'
p37293
(lp37294
S'ko02030'
p37295
asS'PATHWAY_MAP'
p37296
(lp37297
S'map02030'
p37298
asS'MODULE'
p37299
(lp37300
S'M00506'
p37301
aS'CheA-CheYBV (chemotaxis) two-component regulatory system [PATH:map02030]'
p37302
asS'DBLINKS'
p37303
(lp37304
S'GO: 0006935'
p37305
asS'ENTRY'
p37306
(lp37307
S'map02030'
p37308
aS'Pathway'
p37309
asS'CLASS'
p37310
(lp37311
S'Cellular Processes Cell motility'
p37312
asS'DESCRIPTION'
p37313
(lp37314
S'Chemotaxis is the process by which cells sense chemical gradients in their environment and then move towards more favorable conditions. In chemotaxis, events at the receptors control autophosphorylation of the CheA histidine kinase, and the phosphohistidine is the substrate for the response regulator CheY, which catalyzes the transfer of the phosphoryl group to a conserved aspartate. The resulting CheY-P can interact with the switch mechanism in the motor. This interaction causes a change in behavior, such as in direction or speed of rotation of flagella.'
p37315
assS'path:map00565'
p37316
(dp37317
S'NAME'
p37318
(lp37319
S'Ether lipid metabolism'
p37320
asS'REFERENCE'
p37321
(lp37322
S'PMID:11275267'
p37323
ag37323
aS'AUTHORS'
p37324
aS'Nagan N, Zoeller RA.'
p37325
aS'TITLE'
p37326
aS'Plasmalogens: biosynthesis and functions.'
p37327
aS'JOURNAL'
p37328
aS'Prog Lipid Res 40:199-229 (2001)'
p37329
aS'PMID:11015622'
p37330
ag37330
aS'AUTHORS'
p37331
aS'Montrucchio G, Alloatti G, Camussi G.'
p37332
aS'TITLE'
p37333
aS'Role of platelet-activating factor in cardiovascular pathophysiology.'
p37334
aS'JOURNAL'
p37335
aS'Physiol Rev 80:1669-99 (2000)'
p37336
aS'PMID:15788404'
p37337
ag37337
aS'AUTHORS'
p37338
aS'Sakagami H, Aoki J, Natori Y, Nishikawa K, Kakehi Y, Natori Y, Arai H.'
p37339
aS'TITLE'
p37340
aS'Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family.'
p37341
aS'JOURNAL'
p37342
aS'J Biol Chem 280:23084-93 (2005)'
p37343
asS'KO_PATHWAY'
p37344
(lp37345
S'ko00565'
p37346
asS'PATHWAY_MAP'
p37347
(lp37348
S'map00565'
p37349
asS'DISEASE'
p37350
(lp37351
S'H00207'
p37352
aS'Rhizomelic chondrodysplasia punctata'
p37353
ag37352
ag37353
aS'H00833'
p37354
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p37355
asS'MODULE'
p37356
(lp37357
S'M00067'
p37358
aS'Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid [PATH:map00565]'
p37359
asS'ENTRY'
p37360
(lp37361
S'map00565'
p37362
aS'Pathway'
p37363
asS'CLASS'
p37364
(lp37365
S'Metabolism Lipid metabolism'
p37366
assS'path:map00564'
p37367
(dp37368
S'NAME'
p37369
(lp37370
S'Glycerophospholipid metabolism'
p37371
asS'REFERENCE'
p37372
(lp37373
S'PMID:1512203'
p37374
ag37374
aS'AUTHORS'
p37375
aS'Racenis PV, Lai JL, Das AK, Mullick PC, Hajra AK, Greenberg ML.'
p37376
aS'TITLE'
p37377
aS'The acyl dihydroxyacetone phosphate pathway enzymes for glycerolipid biosynthesis are present in the yeast Saccharomyces cerevisiae.'
p37378
aS'JOURNAL'
p37379
aS'J Bacteriol 174:5702-10 (1992)'
p37380
aS'PMID:10092508'
p37381
ag37381
aS'AUTHORS'
p37382
aS'Taniyama Y, Shibata S, Kita S, Horikoshi K, Fuse H, Shirafuji H, Sumino Y, Fujino M.'
p37383
aS'TITLE'
p37384
aS'Cloning and expression of a novel lysophospholipase which structurally resembles lecithin cholesterol acyltransferase.'
p37385
aS'JOURNAL'
p37386
aS'Biochem Biophys Res Commun 257:50-6 (1999)'
p37387
aS'PMID:10542045'
p37388
ag37388
aS'AUTHORS'
p37389
aS'Athenstaedt K, Daum G.'
p37390
aS'TITLE'
p37391
aS'Phosphatidic acid, a key intermediate in lipid metabolism.'
p37392
aS'JOURNAL'
p37393
aS'Eur J Biochem 266:1-16 (1999)'
p37394
aS'PMID:12431977'
p37395
ag37395
aS'AUTHORS'
p37396
aS'Shields DJ, Lehner R, Agellon LB, Vance DE.'
p37397
aS'TITLE'
p37398
aS'Membrane topography of human phosphatidylethanolamine N-methyltransferase.'
p37399
aS'JOURNAL'
p37400
aS'J Biol Chem 278:2956-62 (2003)'
p37401
aS'PMID:14663079'
p37402
ag37402
aS'AUTHORS'
p37403
aS'Martinez-Morales F, Schobert M, Lopez-Lara IM, Geiger O.'
p37404
aS'TITLE'
p37405
aS'Pathways for phosphatidylcholine biosynthesis in bacteria.'
p37406
aS'JOURNAL'
p37407
aS'Microbiology 149:3461-71 (2003)'
p37408
aS'PMID:15522832'
p37409
ag37409
aS'AUTHORS'
p37410
aS'Burgermeister M, Birner-Grunberger R, Nebauer R, Daum G.'
p37411
aS'TITLE'
p37412
aS'Contribution of different pathways to the supply of phosphatidylethanolamine and phosphatidylcholine to mitochondrial membranes of the yeast Saccharomyces cerevisiae.'
p37413
aS'JOURNAL'
p37414
aS'Biochim Biophys Acta 1686:161-8 (2004)'
p37415
aS'PMID:1649829'
p37416
ag37416
aS'AUTHORS'
p37417
aS'Hsu L, Jackowski S, Rock CO'
p37418
aS'TITLE'
p37419
aS'Isolation and characterization of Escherichia coli K-12 mutants lacking both 2-acyl-glycerophosphoethanolamine acyltransferase and acyl-acyl carrier protein synthetase activity.'
p37420
aS'JOURNAL'
p37421
aS'J Biol Chem 266:13783-8 (1991)'
p37422
aS'PMID:10938271'
p37423
ag37423
aS'AUTHORS'
p37424
aS'Stone SJ, Vance JE.'
p37425
aS'TITLE'
p37426
aS'Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes.'
p37427
aS'JOURNAL'
p37428
aS'J Biol Chem 275:34534-40 (2000)'
p37429
asS'KO_PATHWAY'
p37430
(lp37431
S'ko00564'
p37432
asS'PATHWAY_MAP'
p37433
(lp37434
S'map00564'
p37435
asS'DISEASE'
p37436
(lp37437
S'H00158'
p37438
aS'Lecithin:cholesterol acyltransferase deficiency'
p37439
ag37438
ag37439
aS'H00207'
p37440
aS'Rhizomelic chondrodysplasia punctata'
p37441
aS'H00654'
p37442
aS'Barth syndrome (BTHS)'
p37443
aS'H00770'
p37444
aS'Congenital myasthenic syndrome'
p37445
aS'H00833'
p37446
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p37447
aS'H01117'
p37448
aS'Majeed syndrome'
p37449
aS'H01290'
p37450
aS'Acute recurrent myoglobinuria'
p37451
asS'MODULE'
p37452
(lp37453
S'M00090'
p37454
aS'Phosphatidylcholine (PC) biosynthesis, choline => PC [PATH:map00564]'
p37455
ag37454
ag37455
aS'M00091'
p37456
aS'Phosphatidylcholine (PC) biosynthesis, PE => PC [PATH:map00564]'
p37457
aS'M00092'
p37458
aS'Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE [PATH:map00564]'
p37459
aS'M00093'
p37460
aS'Phosphatidylethanolamine (PE) biosynthesis, PA => PS => PE [PATH:map00564]'
p37461
asS'DBLINKS'
p37462
(lp37463
S'GO: 0006650 0046474 0046475'
p37464
asS'ENTRY'
p37465
(lp37466
S'map00564'
p37467
aS'Pathway'
p37468
asS'CLASS'
p37469
(lp37470
S'Metabolism Lipid metabolism'
p37471
assS'path:map00561'
p37472
(dp37473
S'NAME'
p37474
(lp37475
S'Glycerolipid metabolism'
p37476
asS'REFERENCE'
p37477
(lp37478
S'PMID:8662716'
p37479
ag37479
aS'AUTHORS'
p37480
aS'Norbeck J, Pahlman AK, Akhtar N, Blomberg A, Adler L.'
p37481
aS'TITLE'
p37482
aS'Purification and characterization of two isoenzymes of DL-glycerol-3-phosphatase from Saccharomyces cerevisiae. Identification of the corresponding GPP1 and GPP2 genes and evidence for osmotic regulation of Gpp2p expression by the osmosensing mitogen-activated protein kinase signal transduction pathway.'
p37483
aS'JOURNAL'
p37484
aS'J Biol Chem 271:13875-81 (1996)'
p37485
aS'PMID:8995384'
p37486
ag37486
aS'AUTHORS'
p37487
aS'Karlsson OP, Dahlqvist A, Vikstrom S, Wieslander A.'
p37488
aS'TITLE'
p37489
aS'Lipid dependence and basic kinetics of the purified 1,2-diacylglycerol 3-glucosyltransferase from membranes of Acholeplasma laidlawii.'
p37490
aS'JOURNAL'
p37491
aS'J Biol Chem 272:929-36 (1997)'
p37492
aS'PMID:11294844'
p37493
ag37493
aS'AUTHORS'
p37494
aS'Berg S, Edman M, Li L, Wikstrom M, Wieslander A.'
p37495
aS'TITLE'
p37496
aS'Sequence properties of the 1,2-diacylglycerol 3-glucosyltransferase from Acholeplasma laidlawii membranes. Recognition of a large group of lipid glycosyltransferases in eubacteria and archaea.'
p37497
aS'JOURNAL'
p37498
aS'J Biol Chem 276:22056-63 (2001)'
p37499
asS'KO_PATHWAY'
p37500
(lp37501
S'ko00561'
p37502
asS'PATHWAY_MAP'
p37503
(lp37504
S'map00561'
p37505
asS'DISEASE'
p37506
(lp37507
S'H00154'
p37508
aS'Hyperlipoproteinemia, type I'
p37509
ag37508
ag37509
aS'H00552'
p37510
aS'Glycerol kinase deficiency (GKD)'
p37511
aS'H01117'
p37512
aS'Majeed syndrome'
p37513
aS'H01290'
p37514
aS'Acute recurrent myoglobinuria'
p37515
aS'H01333'
p37516
aS'Nonalcoholic fatty liver disease (NAFLD)'
p37517
asS'MODULE'
p37518
(lp37519
S'M00089'
p37520
aS'Triacylglycerol biosynthesis [PATH:map00561]'
p37521
ag37520
ag37521
aS'M00098'
p37522
aS'Acylglycerol degradation [PATH:map00561]'
p37523
asS'DBLINKS'
p37524
(lp37525
S'GO: 0045017 0046486 0046503'
p37526
asS'ENTRY'
p37527
(lp37528
S'map00561'
p37529
aS'Pathway'
p37530
asS'CLASS'
p37531
(lp37532
S'Metabolism Lipid metabolism'
p37533
assS'path:map00563'
p37534
(dp37535
S'NAME'
p37536
(lp37537
S'Glycosylphosphatidylinositol(GPI)-anchor biosynthesis'
p37538
asS'REFERENCE'
p37539
(lp37540
S'PMID:12655644'
p37541
ag37541
aS'AUTHORS'
p37542
aS'Eisenhaber B, Maurer-Stroh S, Novatchkova M, Schneider G, Eisenhaber F.'
p37543
aS'TITLE'
p37544
aS'Enzymes and auxiliary factors for GPI lipid anchor biosynthesis and post-translational transfer to proteins.'
p37545
aS'JOURNAL'
p37546
aS'Bioessays 25:367-85 (2003)'
p37547
aS'PMID:11102867'
p37548
ag37548
aS'AUTHORS'
p37549
aS'Kinoshita T, Inoue N.'
p37550
aS'TITLE'
p37551
aS'Dissecting and manipulating the pathway for glycosylphos-phatidylinositol-anchor biosynthesis.'
p37552
aS'JOURNAL'
p37553
aS'Curr Opin Chem Biol 4:632-8 (2000)'
p37554
aS'PMID:8253761'
p37555
ag37555
aS'AUTHORS'
p37556
aS'Fankhauser C, Homans SW, Thomas-Oates JE, McConville MJ, Desponds C, Conzelmann A, Ferguson MA.'
p37557
aS'TITLE'
p37558
aS'Structures of glycosylphosphatidylinositol membrane anchors from Saccharomyces cerevisiae.'
p37559
aS'JOURNAL'
p37560
aS'J Biol Chem 268:26365-74 (1993)'
p37561
aS'PMID:14517336'
p37562
ag37562
aS'AUTHORS'
p37563
aS'Murakami Y, Siripanyapinyo U, Hong Y, Kang JY, Ishihara S, Nakakuma H, Maeda Y, Kinoshita T.'
p37564
aS'TITLE'
p37565
aS'PIG-W is critical for inositol acylation but not for flipping of glycosylphosphatidylinositol-anchor.'
p37566
aS'JOURNAL'
p37567
aS'Mol Biol Cell 14:4285-95 (2003)'
p37568
aS'PMID:10329735'
p37569
ag37569
aS'AUTHORS'
p37570
aS'Benachour A, Sipos G, Flury I, Reggiori F, Canivenc-Gansel E, Vionnet C, Conzelmann A, Benghezal M.'
p37571
aS'TITLE'
p37572
aS'Deletion of GPI7, a yeast gene required for addition of a side chain to the glycosylphosphatidylinositol (GPI) core structure, affects GPI protein transport, remodeling, and cell wall integrity.'
p37573
aS'JOURNAL'
p37574
aS'J Biol Chem 274:15251-61 (1999)'
p37575
aS'PMID:14734546'
p37576
ag37576
aS'AUTHORS'
p37577
aS'Tanaka S, Maeda Y, Tashima Y, Kinoshita T.'
p37578
aS'TITLE'
p37579
aS'Inositol deacylation of glycosylphosphatidylinositol-anchored proteins is mediated by mammalian PGAP1 and yeast Bst1p.'
p37580
aS'JOURNAL'
p37581
aS'J Biol Chem 279:14256-63 (2004)'
p37582
aS'PMID:12802054'
p37583
ag37583
aS'AUTHORS'
p37584
aS'Hong Y, Ohishi K, Kang JY, Tanaka S, Inoue N, Nishimura J, Maeda Y, Kinoshita T.'
p37585
aS'TITLE'
p37586
aS'Human PIG-U and yeast Cdc91p are the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins.'
p37587
aS'JOURNAL'
p37588
aS'Mol Biol Cell 14:1780-9 (2003)'
p37589
aS'PMID:12807000'
p37590
ag37590
aS'AUTHORS'
p37591
aS'Tanaka S, Maeda Y, Kinoshita T.'
p37592
aS'TITLE'
p37593
aS'[Biosynthesis of GPI-anchored proteins]'
p37594
aS'JOURNAL'
p37595
aS'Tanpakushitsu Kakusan Koso 48:990-6 (2003)'
p37596
aS'PMID:15623507'
p37597
ag37597
aS'AUTHORS'
p37598
aS'Kang JY, Hong Y, Ashida H, Shishioh N, Murakami Y, Morita YS, Maeda Y, Kinoshita T.'
p37599
aS'TITLE'
p37600
aS'PIG-V involved in transferring the second mannose in glycosylphosphatidylinositol.'
p37601
aS'JOURNAL'
p37602
aS'J Biol Chem 280:9489-97 (2005)'
p37603
aS'PMID:15635094'
p37604
ag37604
aS'AUTHORS'
p37605
aS'Ashida H, Hong Y, Murakami Y, Shishioh N, Sugimoto N, Kim YU, Maeda Y, Kinoshita T.'
p37606
aS'TITLE'
p37607
aS'Mammalian PIG-X and yeast Pbn1p are the essential components of glycosylphosphatidylinositol-mannosyltransferase I.'
p37608
aS'JOURNAL'
p37609
aS'Mol Biol Cell 16:1439-48 (2005)'
p37610
asS'KO_PATHWAY'
p37611
(lp37612
S'ko00563'
p37613
asS'PATHWAY_MAP'
p37614
(lp37615
S'map00563'
p37616
asS'DISEASE'
p37617
(lp37618
S'H01053'
p37619
aS'Paroxysmal nocturnal hemoglobinuria (PNH)'
p37620
ag37619
ag37620
aS'H01127'
p37621
aS'Glycosylphosphatidylinositol (GPI) deficiency'
p37622
asS'MODULE'
p37623
(lp37624
S'M00065'
p37625
aS'GPI-anchor biosynthesis, core oligosaccharide [PATH:map00563]'
p37626
asS'DBLINKS'
p37627
(lp37628
S'GO: 0006506'
p37629
asS'ENTRY'
p37630
(lp37631
S'map00563'
p37632
aS'Pathway'
p37633
asS'CLASS'
p37634
(lp37635
S'Metabolism Glycan biosynthesis and metabolism'
p37636
asS'DESCRIPTION'
p37637
(lp37638
S'Cell surface proteins can be attached to the cell membrane via the glycolipid structure called glycosylphosphatidylinositol (GPI) anchor. Hundreds of GPI-anchored proteins have been identified in many eukaryotes ranging from protozoa and fungi to mammals. All protein-linked GPI anchors share a common core structure, characterized by the substructure Man (a1-4) GlcN (a1-6) myo-inositol-1P-lipid. Biosynthesis of GPI anchors proceeds in three stages: (i) preassembly of a GPI precursor in the ER membrane, (ii) attachment of the GPI to the C-terminus of a newly synthesized protein in the lumen of the ER, and (iii) lipid remodeling and/or carbohydrate side-chain modifications in the ER and the Golgi. Defects of GPI anchor biosynthesis gene result in a genetic disorder, paroxysmal nocturnal hemoglobinuria.'
p37639
assS'path:map00562'
p37640
(dp37641
S'NAME'
p37642
(lp37643
S'Inositol phosphate metabolism'
p37644
asS'REFERENCE'
p37645
(lp37646
S'PMID:14993306'
p37647
ag37647
aS'AUTHORS'
p37648
aS'Yoshida K, Yamaguchi M, Ikeda H, Omae K, Tsurusaki K, Fujita Y'
p37649
aS'TITLE'
p37650
aS'The fifth gene of the iol operon of Bacillus subtilis, iolE, encodes 2-keto-myo-inositol dehydratase.'
p37651
aS'JOURNAL'
p37652
aS'Microbiology 150:571-80 (2004)'
p37653
aS'PMID:18310071'
p37654
ag37654
aS'AUTHORS'
p37655
aS'Yoshida K, Yamaguchi M, Morinaga T, Kinehara M, Ikeuchi M, Ashida H, Fujita Y.'
p37656
aS'TITLE'
p37657
aS'myo-Inositol catabolism in Bacillus subtilis.'
p37658
aS'JOURNAL'
p37659
aS'J Biol Chem 283:10415-24 (2008)'
p37660
asS'KO_PATHWAY'
p37661
(lp37662
S'ko00562'
p37663
asS'PATHWAY_MAP'
p37664
(lp37665
S'map00562'
p37666
asS'DISEASE'
p37667
(lp37668
S'H00530'
p37669
aS'Joubert syndrome'
p37670
ag37669
ag37670
aS'H00692'
p37671
aS'Lowe syndrome'
p37672
aS'H00694'
p37673
aS'Dent disease'
p37674
aS'H00700'
p37675
aS'Centronuclear myopathy'
p37676
aS'H00865'
p37677
aS'Lethal congenital contractural syndrome (LCCS)'
p37678
aS'H00957'
p37679
aS'Fleck corneal dystrophy (FCD)'
p37680
aS'H01195'
p37681
aS'VACTERL/VATER association'
p37682
aS'H01387'
p37683
aS'Activated PI3K-delta syndrome (APDS)'
p37684
asS'MODULE'
p37685
(lp37686
S'M00130'
p37687
aS'Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 [PATH:map00562]'
p37688
ag37687
ag37688
aS'M00131'
p37689
aS'Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol [PATH:map00562]'
p37690
aS'M00132'
p37691
aS'Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate [PATH:map00562]'
p37692
asS'DBLINKS'
p37693
(lp37694
S'GO: 0006020'
p37695
asS'ENTRY'
p37696
(lp37697
S'map00562'
p37698
aS'Pathway'
p37699
asS'CLASS'
p37700
(lp37701
S'Metabolism Carbohydrate metabolism'
p37702
assS'path:map00624'
p37703
(dp37704
S'NAME'
p37705
(lp37706
S'Polycyclic aromatic hydrocarbon degradation'
p37707
asS'REFERENCE'
p37708
(lp37709
S'PMID:11766961'
p37710
ag37710
aS'AUTHORS'
p37711
aS'Wattiau P, Bastiaens L, van Herwijnen R, Daal L, Parsons JR, Renard ME, Springael D, Cornelis GR.'
p37712
aS'TITLE'
p37713
aS'Fluorene degradation by Sphingomonas sp. LB126 proceeds through protocatechuic acid: a genetic analysis.'
p37714
aS'JOURNAL'
p37715
aS'Res Microbiol 152:861-72 (2001)'
p37716
aS'PMID:15386141'
p37717
ag37717
aS'AUTHORS'
p37718
aS'Story SP, Kline EL, Hughes TA, Riley MB, Hayasaka SS.'
p37719
aS'TITLE'
p37720
aS'Degradation of aromatic hydrocarbons by Sphingomonas paucimobilis strain EPA505.'
p37721
aS'JOURNAL'
p37722
aS'Arch Environ Contam Toxicol 47:168-76 (2004)'
p37723
aS'PMID:15317800'
p37724
ag37724
aS'AUTHORS'
p37725
aS'Habe H, Chung JS, Kato H, Ayabe Y, Kasuga K, Yoshida T, Nojiri H, Yamane H, Omori T.'
p37726
aS'TITLE'
p37727
aS'Characterization of the upper pathway genes for fluorene metabolism in Terrabacter sp. strain DBF63.'
p37728
aS'JOURNAL'
p37729
aS'J Bacteriol 186:5938-44 (2004)'
p37730
aS'PMID:12483604'
p37731
ag37731
aS'AUTHORS'
p37732
aS'Nojiri H, Habe H, Omori T.'
p37733
aS'TITLE'
p37734
aS'Bacterial degradation of aromatic compounds via angular dioxygenation.'
p37735
aS'JOURNAL'
p37736
aS'J Gen Appl Microbiol 47:279-305 (2001)'
p37737
aS'PMID:17258432'
p37738
ag37738
aS'AUTHORS'
p37739
aS'Pagnout C, Frache G, Poupin P, Maunit B, Muller JF, Ferard JF.'
p37740
aS'TITLE'
p37741
aS'Isolation and characterization of a gene cluster involved in PAH degradation in Mycobacterium sp. strain SNP11: expression in Mycobacterium smegmatis mc(2)155.'
p37742
aS'JOURNAL'
p37743
aS'Res Microbiol 158:175-86 (2007)'
p37744
aS'PMID:11682202'
p37745
ag37745
aS'AUTHORS'
p37746
aS'Dean-Ross D, Moody JD, Freeman JP, Doerge DR, Cerniglia CE.'
p37747
aS'TITLE'
p37748
aS'Metabolism of anthracene by a Rhodococcus species.'
p37749
aS'JOURNAL'
p37750
aS'FEMS Microbiol Lett 204:205-11 (2001)'
p37751
aS'PMID:11282593'
p37752
ag37752
aS'AUTHORS'
p37753
aS'Moody JD, Freeman JP, Doerge DR, Cerniglia CE.'
p37754
aS'TITLE'
p37755
aS'Degradation of phenanthrene and anthracene by cell suspensions of Mycobacterium sp. strain PYR-1.'
p37756
aS'JOURNAL'
p37757
aS'Appl Environ Microbiol 67:1476-83 (2001)'
p37758
aS'PMID:12513994'
p37759
ag37759
aS'AUTHORS'
p37760
aS'van Herwijnen R, Springael D, Slot P, Govers HA, Parsons JR.'
p37761
aS'TITLE'
p37762
aS'Degradation of anthracene by Mycobacterium sp. strain LB501T proceeds via a novel pathway, through o-phthalic acid.'
p37763
aS'JOURNAL'
p37764
aS'Appl Environ Microbiol 69:186-90 (2003)'
p37765
aS'PMID:19442441'
p37766
ag37766
aS'AUTHORS'
p37767
aS'Haritash AK, Kaushik CP'
p37768
aS'TITLE'
p37769
aS'Biodegradation aspects of polycyclic aromatic hydrocarbons (PAHs): a review.'
p37770
aS'JOURNAL'
p37771
aS'J Hazard Mater 169:1-15 (2009)'
p37772
aS'PMID:17041157'
p37773
ag37773
aS'AUTHORS'
p37774
aS'Liang Y, Gardner DR, Miller CD, Chen D, Anderson AJ, Weimer BC, Sims RC'
p37775
aS'TITLE'
p37776
aS'Study of biochemical pathways and enzymes involved in pyrene degradation by Mycobacterium sp. strain KMS.'
p37777
aS'JOURNAL'
p37778
aS'Appl Environ Microbiol 72:7821-8 (2006)'
p37779
aS'PMID:15488584'
p37780
ag37780
aS'AUTHORS'
p37781
aS'da Silva M, Esposito E, Moody JD, Canhos VP, Cerniglia CE'
p37782
aS'TITLE'
p37783
aS'Metabolism of aromatic hydrocarbons by the filamentous fungus Cyclothyrium sp.'
p37784
aS'JOURNAL'
p37785
aS'Chemosphere 57:943-52 (2004)'
p37786
aS'PMID:17085566'
p37787
ag37787
aS'AUTHORS'
p37788
aS'Kim SJ, Kweon O, Jones RC, Freeman JP, Edmondson RD, Cerniglia CE'
p37789
aS'TITLE'
p37790
aS'Complete and integrated pyrene degradation pathway in Mycobacterium vanbaalenii PYR-1 based on systems biology.'
p37791
aS'JOURNAL'
p37792
aS'J Bacteriol 189:464-72 (2007)'
p37793
aS'PMID:9094229'
p37794
ag37794
aS'AUTHORS'
p37795
aS'Wunder T, Marr J, Kremer S, Sterner O, Anke H'
p37796
aS'TITLE'
p37797
aS'1-Methoxypyrene and 1,6-dimethoxypyrene: two novel metabolites in fungal metabolism of polycyclic aromatic hydrocarbons.'
p37798
aS'JOURNAL'
p37799
aS'Arch Microbiol 167:310-6 (1997)'
p37800
aS'PMID:8572690'
p37801
ag37801
aS'AUTHORS'
p37802
aS'Schneider J, Grosser R, Jayasimhulu K, Xue W, Warshawsky D'
p37803
aS'TITLE'
p37804
aS'Degradation of pyrene, benz[a]anthracene, and benzo[a]pyrene by Mycobacterium sp. strain RJGII-135, isolated from a former coal gasification site.'
p37805
aS'JOURNAL'
p37806
aS'Appl Environ Microbiol 62:13-9 (1996)'
p37807
aS'PMID:14711661'
p37808
ag37808
aS'AUTHORS'
p37809
aS'Moody JD, Freeman JP, Fu PP, Cerniglia CE'
p37810
aS'TITLE'
p37811
aS'Degradation of benzo[a]pyrene by Mycobacterium vanbaalenii PYR-1.'
p37812
aS'JOURNAL'
p37813
aS'Appl Environ Microbiol 70:340-5 (2004)'
p37814
aS'PMID:11371533'
p37815
ag37815
aS'AUTHORS'
p37816
aS'Eaton RW'
p37817
aS'TITLE'
p37818
aS'Plasmid-encoded phthalate catabolic pathway in Arthrobacter keyseri 12B.'
p37819
aS'JOURNAL'
p37820
aS'J Bacteriol 183:3689-703 (2001)'
p37821
asS'KO_PATHWAY'
p37822
(lp37823
S'ko00624'
p37824
asS'PATHWAY_MAP'
p37825
(lp37826
S'map00624'
p37827
asS'MODULE'
p37828
(lp37829
S'M00623'
p37830
aS'Phthalate degradation, phthalate => protocatechuate [PATH:map00624]'
p37831
ag37830
ag37831
aS'M00624'
p37832
aS'Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate [PATH:map00624]'
p37833
aS'M00636'
p37834
aS'Phthalate degradation, phthalate => protocatechuate [PATH:map00624]'
p37835
asS'DBLINKS'
p37836
(lp37837
S'UMBBD: flu ant pha pyr bap pth'
p37838
asS'ENTRY'
p37839
(lp37840
S'map00624'
p37841
aS'Pathway'
p37842
asS'CLASS'
p37843
(lp37844
S'Metabolism Xenobiotics biodegradation and metabolism'
p37845
assS'path:map05140'
p37846
(dp37847
S'NAME'
p37848
(lp37849
S'Leishmaniasis'
p37850
asS'REFERENCE'
p37851
(lp37852
S'PMID:11890722'
p37853
ag37853
aS'AUTHORS'
p37854
aS'Cunningham AC'
p37855
aS'TITLE'
p37856
aS'Parasitic adaptive mechanisms in infection by leishmania.'
p37857
aS'JOURNAL'
p37858
aS'Exp Mol Pathol 72:132-41 (2002)'
p37859
aS'PMID:10770277'
p37860
ag37860
aS'AUTHORS'
p37861
aS'Nandan D, Knutson KL, Lo R, Reiner NE'
p37862
aS'TITLE'
p37863
aS'Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis.'
p37864
aS'JOURNAL'
p37865
aS'J Leukoc Biol 67:464-70 (2000)'
p37866
aS'PMID:7591091'
p37867
ag37867
aS'AUTHORS'
p37868
aS'Nandan D, Reiner NE'
p37869
aS'TITLE'
p37870
aS'Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1.'
p37871
aS'JOURNAL'
p37872
aS'Infect Immun 63:4495-500 (1995)'
p37873
aS'PMID:10417174'
p37874
ag37874
aS'AUTHORS'
p37875
aS'Nandan D, Lo R, Reiner NE'
p37876
aS'TITLE'
p37877
aS'Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression'
p37878
aS'in macrophages infected with Leishmania donovani.'
p37879
aS'JOURNAL'
p37880
aS'Infect Immun 67:4055-63 (1999)'
p37881
aS'PMID:7916951'
p37882
ag37882
aS'AUTHORS'
p37883
aS'Reiner NE'
p37884
aS'TITLE'
p37885
aS'Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection.'
p37886
aS'JOURNAL'
p37887
aS'Immunol Today 15:374-81 (1994)'
p37888
aS'PMID:15721837'
p37889
ag37889
aS'AUTHORS'
p37890
aS'Nandan D, Reiner NE'
p37891
aS'TITLE'
p37892
aS'Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1.'
p37893
aS'JOURNAL'
p37894
aS'Clin Immunol 114:266-77 (2005)'
p37895
aS'PMID:17543969'
p37896
ag37896
aS'AUTHORS'
p37897
aS'Kima PE'
p37898
aS'TITLE'
p37899
aS'The amastigote forms of Leishmania are experts at exploiting host cell processes'
p37900
aS'to establish infection and persist.'
p37901
aS'JOURNAL'
p37902
aS'Int J Parasitol 37:1087-96 (2007)'
p37903
aS'PMID:15983048'
p37904
ag37904
aS'AUTHORS'
p37905
aS'Forget G, Gregory DJ, Olivier M'
p37906
aS'TITLE'
p37907
aS'Proteasome-mediated degradation of STAT1alpha following infection of macrophages'
p37908
aS'with Leishmania donovani.'
p37909
aS'JOURNAL'
p37910
aS'J Biol Chem 280:30542-9 (2005)'
p37911
aS'PMID:15322192'
p37912
ag37912
aS'AUTHORS'
p37913
aS'Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, Alexander J, Plevin R'
p37914
aS'TITLE'
p37915
aS'Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway.'
p37916
aS'JOURNAL'
p37917
aS'J Immunol 173:3297-304 (2004)'
p37918
aS'PMID:18070909'
p37919
ag37919
aS'AUTHORS'
p37920
aS'Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V'
p37921
aS'TITLE'
p37922
aS'Toll-like receptors and leishmaniasis.'
p37923
aS'JOURNAL'
p37924
aS'Infect Immun 76:866-72 (2008)'
p37925
aS'PMID:15039466'
p37926
ag37926
aS'AUTHORS'
p37927
aS'Kropf P, Freudenberg N, Kalis C, Modolell M, Herath S, Galanos C, Freudenberg M, Muller I'
p37928
aS'TITLE'
p37929
aS'Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a'
p37930
aS'role for Toll-like receptor 4 in the control of parasite replication.'
p37931
aS'JOURNAL'
p37932
aS'J Leukoc Biol 76:48-57 (2004)'
p37933
aS'PMID:10586030'
p37934
ag37934
aS'AUTHORS'
p37935
aS'Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY'
p37936
aS'TITLE'
p37937
aS'Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase.'
p37938
aS'JOURNAL'
p37939
aS'J Immunol 163:6403-12 (1999)'
p37940
aS'PMID:15831826'
p37941
ag37941
aS'AUTHORS'
p37942
aS'Olivier M, Gregory DJ, Forget G'
p37943
aS'TITLE'
p37944
aS'Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.'
p37945
aS'JOURNAL'
p37946
aS'Clin Microbiol Rev 18:293-305 (2005)'
p37947
aS'PMID:11298294'
p37948
ag37948
aS'AUTHORS'
p37949
aS'Matte C, Maion G, Mourad W, Olivier M'
p37950
aS'TITLE'
p37951
aS'Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis.'
p37952
aS'JOURNAL'
p37953
aS'Parasite Immunol 23:177-84 (2001)'
p37954
aS'PMID:12438359'
p37955
ag37955
aS'AUTHORS'
p37956
aS'Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, Roy S, Majumdar S'
p37957
aS'TITLE'
p37958
aS'Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase.'
p37959
aS'JOURNAL'
p37960
aS'Infect Immun 70:6828-38 (2002)'
p37961
aS'PMID:9504340'
p37962
ag37962
aS'AUTHORS'
p37963
aS'Bogdan C, Rollinghoff M'
p37964
aS'TITLE'
p37965
aS'The immune response to Leishmania: mechanisms of parasite control and evasion.'
p37966
aS'JOURNAL'
p37967
aS'Int J Parasitol 28:121-34 (1998)'
p37968
aS'PMID:18793215'
p37969
ag37969
aS'AUTHORS'
p37970
aS'Blanchette J, Abu-Dayyeh I, Hassani K, Whitcombe L, Olivier M'
p37971
aS'TITLE'
p37972
aS'Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1).'
p37973
aS'JOURNAL'
p37974
aS'Immunology 127:123-33 (2009)'
p37975
aS'PMID:10462516'
p37976
ag37976
aS'AUTHORS'
p37977
aS'Alexander J, Satoskar AR, Russell DG'
p37978
aS'TITLE'
p37979
aS'Leishmania species: models of intracellular parasitism.'
p37980
aS'JOURNAL'
p37981
aS'J Cell Sci 112 Pt 18:2993-3002 (1999)'
p37982
aS'PMID:15639739'
p37983
ag37983
aS'AUTHORS'
p37984
aS'Denkers EY, Butcher BA'
p37985
aS'TITLE'
p37986
aS'Sabotage and exploitation in macrophages parasitized by intracellular protozoans.'
p37987
aS'JOURNAL'
p37988
aS'Trends Parasitol 21:35-41 (2005)'
p37989
aS'PMID:16848789'
p37990
ag37990
aS'AUTHORS'
p37991
aS'Lodge R, Diallo TO, Descoteaux A'
p37992
aS'TITLE'
p37993
aS'Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane.'
p37994
aS'JOURNAL'
p37995
aS'Cell Microbiol 8:1922-31 (2006)'
p37996
aS'PMID:11728310'
p37997
ag37997
aS'AUTHORS'
p37998
aS'de Freitas Balanco JM, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C, Barcinski MA'
p37999
aS'TITLE'
p38000
aS'Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage'
p38001
aS'microbicidal activity.'
p38002
aS'JOURNAL'
p38003
aS'Curr Biol 11:1870-3 (2001)'
p38004
aS'PMID:10608501'
p38005
ag38005
aS'AUTHORS'
p38006
aS'Kane MM, Mosser DM'
p38007
aS'TITLE'
p38008
aS'Leishmania parasites and their ploys to disrupt macrophage activation.'
p38009
aS'JOURNAL'
p38010
aS'Curr Opin Hematol 7:26-31 (2000)'
p38011
aS'PMID:14762510'
p38012
ag38012
aS'AUTHORS'
p38013
aS'de Almeida MC, Vilhena V, Barral A, Barral-Netto M'
p38014
aS'TITLE'
p38015
aS'Leishmanial infection: analysis of its first steps. A review.'
p38016
aS'JOURNAL'
p38017
aS'Mem Inst Oswaldo Cruz 98:861-70 (2003)'
p38018
asS'KO_PATHWAY'
p38019
(lp38020
S'ko05140'
p38021
asS'PATHWAY_MAP'
p38022
(lp38023
S'map05140'
p38024
asS'DISEASE'
p38025
(lp38026
S'H00359'
p38027
aS'Leishmaniasis'
p38028
asS'ENTRY'
p38029
(lp38030
S'map05140'
p38031
aS'Pathway'
p38032
asS'CLASS'
p38033
(lp38034
S'Human Diseases Infectious diseases'
p38035
asS'DESCRIPTION'
p38036
(lp38037
S'Leishmania is an intracellular protozoan parasite of macrophages that causes visceral, mucosal, and cutaneous diseases. The parasite is transmitted to humans by sandflies, where they survive and proliferate intracellularly by deactivating the macrophage. Successful infection of Leishmania is achieved by alteration of signaling events in the host cell, leading to enhanced production of the autoinhibitory molecules like TGF-beta and decreased induction of cytokines such as IL12 for protective immunity. Nitric oxide production is also inhibited. In addition, defective expression of major histocompatibility complex (MHC) genes silences subsequent T cell activation mediated by macrophages, resulting in abnormal immune responses.'
p38038
assS'path:map05142'
p38039
(dp38040
S'NAME'
p38041
(lp38042
S'Chagas disease (American trypanosomiasis)'
p38043
asS'REFERENCE'
p38044
(lp38045
S'PMID:10234174'
p38046
ag38046
aS'AUTHORS'
p38047
aS'Bogdan C, Rollinghoff M'
p38048
aS'TITLE'
p38049
aS'How do protozoan parasites survive inside macrophages?'
p38050
aS'JOURNAL'
p38051
aS'Parasitol Today 15:22-8 (1999)'
p38052
aS'PMID:17110955'
p38053
ag38053
aS'AUTHORS'
p38054
aS'Gazzinelli RT, Denkers EY'
p38055
aS'TITLE'
p38056
aS'Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism.'
p38057
aS'JOURNAL'
p38058
aS'Nat Rev Immunol 6:895-906 (2006)'
p38059
aS'PMID:1717552'
p38060
ag38060
aS'AUTHORS'
p38061
aS'Norris KA, Bradt B, Cooper NR, So M'
p38062
aS'TITLE'
p38063
aS'Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.'
p38064
aS'JOURNAL'
p38065
aS'J Immunol 147:2240-7 (1991)'
p38066
aS'PMID:16238097'
p38067
ag38067
aS'AUTHORS'
p38068
aS'Aguilar L, Ramirez G, Valck C, Molina MC, Rojas A, Schwaeble W, Ferreira V, Ferreira A'
p38069
aS'TITLE'
p38070
aS"F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement."
p38071
aS'JOURNAL'
p38072
aS'Biol Res 38:187-95 (2005)'
p38073
aS'PMID:15223603'
p38074
ag38074
aS'AUTHORS'
p38075
aS'Campos MA, Gazzinelli RT'
p38076
aS'TITLE'
p38077
aS'Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors.'
p38078
aS'JOURNAL'
p38079
aS'Mediators Inflamm 13:139-43 (2004)'
p38080
aS'PMID:12427093'
p38081
ag38081
aS'AUTHORS'
p38082
aS'Burleigh BA, Woolsey AM'
p38083
aS'TITLE'
p38084
aS'Cell signalling and Trypanosoma cruzi invasion.'
p38085
aS'JOURNAL'
p38086
aS'Cell Microbiol 4:701-11 (2002)'
p38087
aS'PMID:17651955'
p38088
ag38088
aS'AUTHORS'
p38089
aS'Tarleton RL'
p38090
aS'TITLE'
p38091
aS'Immune system recognition of Trypanosoma cruzi.'
p38092
aS'JOURNAL'
p38093
aS'Curr Opin Immunol 19:430-4 (2007)'
p38094
aS'PMID:16175174'
p38095
ag38095
aS'AUTHORS'
p38096
aS'Andrade LO, Andrews NW'
p38097
aS'TITLE'
p38098
aS'The Trypanosoma cruzi-host-cell interplay: location, invasion, retention.'
p38099
aS'JOURNAL'
p38100
aS'Nat Rev Microbiol 3:819-23 (2005)'
p38101
aS'PMID:12377585'
p38102
ag38102
aS'AUTHORS'
p38103
aS'Tan H, Andrews NW'
p38104
aS'TITLE'
p38105
aS"Don't bother to knock--the cell invasion strategy of Trypanosoma cruzi."
p38106
aS'JOURNAL'
p38107
aS'Trends Parasitol 18:427-8 (2002)'
p38108
aS'PMID:10066513'
p38109
ag38109
aS'AUTHORS'
p38110
aS'Burleigh BA, Andrews NW'
p38111
aS'TITLE'
p38112
aS'Signaling and host cell invasion by Trypanosoma cruzi.'
p38113
aS'JOURNAL'
p38114
aS'Curr Opin Microbiol 1:461-5 (1998)'
p38115
aS'PMID:12377942'
p38116
ag38116
aS'AUTHORS'
p38117
aS'Stempin C, Giordanengo L, Gea S, Cerban F'
p38118
aS'TITLE'
p38119
aS'Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen.'
p38120
aS'JOURNAL'
p38121
aS'J Leukoc Biol 72:727-34 (2002)'
p38122
aS'PMID:16030288'
p38123
ag38123
aS'AUTHORS'
p38124
aS'Burleigh BA'
p38125
aS'TITLE'
p38126
aS'Host cell signaling and Trypanosoma cruzi invasion: do all roads lead to lysosomes?'
p38127
aS'JOURNAL'
p38128
aS'Sci STKE 2005:pe36 (2005)'
p38129
aS'PMID:1396957'
p38130
ag38130
aS'AUTHORS'
p38131
aS'Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A'
p38132
aS'TITLE'
p38133
aS'The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.'
p38134
aS'JOURNAL'
p38135
aS'Eur J Immunol 22:2501-6 (1992)'
p38136
aS'PMID:2194668'
p38137
ag38137
aS'AUTHORS'
p38138
aS'Andrews NW, Abrams CK, Slatin SL, Griffiths G'
p38139
aS'TITLE'
p38140
aS'A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH.'
p38141
aS'JOURNAL'
p38142
aS'Cell 61:1277-87 (1990)'
p38143
aS'PMID:9794425'
p38144
ag38144
aS'AUTHORS'
p38145
aS'Freire-de-Lima CG, Nunes MP, Corte-Real S, Soares MP, Previato JO, Mendonca-Previato L, DosReis GA'
p38146
aS'TITLE'
p38147
aS'Proapoptotic activity of a Trypanosoma cruzi ceramide-containing glycolipid turned on in host macrophages by IFN-gamma.'
p38148
aS'JOURNAL'
p38149
aS'J Immunol 161:4909-16 (1998)'
p38150
aS'PMID:15917295'
p38151
ag38151
aS'AUTHORS'
p38152
aS'Hashimoto M, Nakajima-Shimada J, Aoki T'
p38153
aS'TITLE'
p38154
aS'Trypanosoma cruzi posttranscriptionally up-regulates and exploits cellular FLIP for inhibition of death-inducing signal.'
p38155
aS'JOURNAL'
p38156
aS'Mol Biol Cell 16:3521-8 (2005)'
p38157
aS'PMID:12874238'
p38158
ag38158
aS'AUTHORS'
p38159
aS'Ropert C, Closel M, Chaves AC, Gazzinelli RT'
p38160
aS'TITLE'
p38161
aS'Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages.'
p38162
aS'JOURNAL'
p38163
aS'J Immunol 171:1456-65 (2003)'
p38164
aS'PMID:12055254'
p38165
ag38165
aS'AUTHORS'
p38166
aS'Ouaissi A, Guilvard E, Delneste Y, Caron G, Magistrelli G, Herbault N, Thieblemont N, Jeannin P'
p38167
aS'TITLE'
p38168
aS'The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.'
p38169
aS'JOURNAL'
p38170
aS'J Immunol 168:6366-74 (2002)'
p38171
aS'PMID:12036740'
p38172
ag38172
aS'AUTHORS'
p38173
aS'Teixeira MM, Gazzinelli RT, Silva JS'
p38174
aS'TITLE'
p38175
aS'Chemokines, inflammation and Trypanosoma cruzi infection.'
p38176
aS'JOURNAL'
p38177
aS'Trends Parasitol 18:262-5 (2002)'
p38178
aS'PMID:9190942'
p38179
ag38179
aS'AUTHORS'
p38180
aS'Camargo MM, Almeida IC, Pereira ME, Ferguson MA, Travassos LR, Gazzinelli RT'
p38181
aS'TITLE'
p38182
aS'Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages.'
p38183
aS'JOURNAL'
p38184
aS'J Immunol 158:5890-901 (1997)'
p38185
asS'KO_PATHWAY'
p38186
(lp38187
S'ko05142'
p38188
asS'PATHWAY_MAP'
p38189
(lp38190
S'map05142'
p38191
asS'DISEASE'
p38192
(lp38193
S'H00358'
p38194
aS'Chagas disease'
p38195
asS'ENTRY'
p38196
(lp38197
S'map05142'
p38198
aS'Pathway'
p38199
asS'CLASS'
p38200
(lp38201
S'Human Diseases Infectious diseases'
p38202
asS'DESCRIPTION'
p38203
(lp38204
S'Trypanosoma cruzi is an intracellular protozoan parasite that causes Chagas disease. The parasite life cycle involves hematophagous reduviid bugs as vectors. Once parasites enter the host body, they invade diverse host cells including cardiomyocytes. Establishment of infection depends on various parasite molecules such as cruzipain, oligopeptidase B, and trans-sialidase that activate Ca2+ signaling. Internalized parasites escape from the parasitophorous vacuole using secreted pore-forming TcTOX molecule and replicate in the cytosol. Multiplied parasites eventually lyse infected host cells and are released in the circulation. During these events, the parasites manipulate host innate immunity and elicit cardiomyocyte hypertrophy. T lymphocyte responses are also disturbed.'
p38205
assS'path:map05143'
p38206
(dp38207
S'NAME'
p38208
(lp38209
S'African trypanosomiasis'
p38210
asS'REFERENCE'
p38211
(lp38212
S'PMID:19168735'
p38213
ag38213
aS'AUTHORS'
p38214
aS'Antoine-Moussiaux N, Buscher P, Desmecht D'
p38215
aS'TITLE'
p38216
aS'Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.'
p38217
aS'JOURNAL'
p38218
aS'Infect Immun 77:1276-84 (2009)'
p38219
aS'PMID:12088284'
p38220
ag38220
aS'AUTHORS'
p38221
aS'Enanga B, Burchmore RJ, Stewart ML, Barrett MP'
p38222
aS'TITLE'
p38223
aS'Sleeping sickness and the brain.'
p38224
aS'JOURNAL'
p38225
aS'Cell Mol Life Sci 59:845-58 (2002)'
p38226
aS'PMID:16600243'
p38227
ag38227
aS'AUTHORS'
p38228
aS'Bisser S, Ouwe-Missi-Oukem-Boyer ON, Toure FS, Taoufiq Z, Bouteille B, Buguet A, Mazier D'
p38229
aS'TITLE'
p38230
aS'Harbouring in the brain: A focus on immune evasion mechanisms and their deleterious effects in malaria and human African trypanosomiasis.'
p38231
aS'JOURNAL'
p38232
aS'Int J Parasitol 36:529-40 (2006)'
p38233
aS'PMID:17582444'
p38234
ag38234
aS'AUTHORS'
p38235
aS'Masocha W, Rottenberg ME, Kristensson K'
p38236
aS'TITLE'
p38237
aS'Migration of African trypanosomes across the blood-brain barrier.'
p38238
aS'JOURNAL'
p38239
aS'Physiol Behav 92:110-4 (2007)'
p38240
aS'PMID:11850009'
p38241
ag38241
aS'AUTHORS'
p38242
aS'Lonsdale-Eccles JD, Grab DJ'
p38243
aS'TITLE'
p38244
aS'Trypanosome hydrolases and the blood-brain barrier.'
p38245
aS'JOURNAL'
p38246
aS'Trends Parasitol 18:17-9 (2002)'
p38247
aS'PMID:19016378'
p38248
ag38248
aS'AUTHORS'
p38249
aS'Grab DJ, Kennedy PG'
p38250
aS'TITLE'
p38251
aS'Traversal of human and animal trypanosomes across the blood-brain barrier.'
p38252
aS'JOURNAL'
p38253
aS'J Neurovirol 14:344-51 (2008)'
p38254
aS'PMID:19995590'
p38255
ag38255
aS'AUTHORS'
p38256
aS'Kristensson K, Nygard M, Bertini G, Bentivoglio M'
p38257
aS'TITLE'
p38258
aS'African trypanosome infections of the nervous system: parasite entry and effects'
p38259
aS'on sleep and synaptic functions.'
p38260
aS'JOURNAL'
p38261
aS'Prog Neurobiol 91:152-71 (2010)'
p38262
aS'PMID:19559585'
p38263
ag38263
aS'AUTHORS'
p38264
aS'Pays E, Vanhollebeke B'
p38265
aS'TITLE'
p38266
aS'Human innate immunity against African trypanosomes.'
p38267
aS'JOURNAL'
p38268
aS'Curr Opin Immunol 21:493-8 (2009)'
p38269
aS'PMID:9574925'
p38270
ag38270
aS'AUTHORS'
p38271
aS'Donelson JE, Hill KL, El-Sayed NM'
p38272
aS'TITLE'
p38273
aS'Multiple mechanisms of immune evasion by African trypanosomes.'
p38274
aS'JOURNAL'
p38275
aS'Mol Biochem Parasitol 91:51-66 (1998)'
p38276
aS'PMID:19621073'
p38277
ag38277
aS'AUTHORS'
p38278
aS'Grab DJ, Garcia-Garcia JC, Nikolskaia OV, Kim YV, Brown A, Pardo CA, Zhang Y, Becker KG, Wilson BA, de A Lima AP, Scharfstein J, Dumler JS'
p38279
aS'TITLE'
p38280
aS'Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells.'
p38281
aS'JOURNAL'
p38282
aS'PLoS Negl Trop Dis 3:e479 (2009)'
p38283
aS'PMID:20398209'
p38284
ag38284
aS'AUTHORS'
p38285
aS'Vanhollebeke B, Pays E'
p38286
aS'TITLE'
p38287
aS'The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill.'
p38288
aS'JOURNAL'
p38289
aS'Mol Microbiol 76:806-14 (2010)'
p38290
asS'KO_PATHWAY'
p38291
(lp38292
S'ko05143'
p38293
asS'PATHWAY_MAP'
p38294
(lp38295
S'map05143'
p38296
asS'DISEASE'
p38297
(lp38298
S'H00357'
p38299
aS'African trypanosomiasis'
p38300
asS'ENTRY'
p38301
(lp38302
S'map05143'
p38303
aS'Pathway'
p38304
asS'CLASS'
p38305
(lp38306
S'Human Diseases Infectious diseases'
p38307
asS'DESCRIPTION'
p38308
(lp38309
S'Trypanosoma brucei, the parasite responsible for African trypanosomiasis (sleeping sickness), are spread by the tsetse fly in sub-Saharan Africa. The parasites are able to pass through the blood-brain barrier and cause neurological damage by inducing cytokines like TNF alpha, IFN gamma, and IL1. These cytokines and other metabolites such as nitric oxide and somnogenic prostaglandin D2 disturb circadian rhythms in patients with African trypanosomiasis.'
p38310
assS'path:map05144'
p38311
(dp38312
S'NAME'
p38313
(lp38314
S'Malaria'
p38315
asS'REFERENCE'
p38316
(lp38317
S'PMID:19101208'
p38318
ag38318
aS'AUTHORS'
p38319
aS'Morahan BJ, Wang L, Coppel RL'
p38320
aS'TITLE'
p38321
aS'No TRAP, no invasion.'
p38322
aS'JOURNAL'
p38323
aS'Trends Parasitol 25:77-84 (2009)'
p38324
aS'PMID:8920859'
p38325
ag38325
aS'AUTHORS'
p38326
aS'Shakibaei M, Frevert U'
p38327
aS'TITLE'
p38328
aS'Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans.'
p38329
aS'JOURNAL'
p38330
aS'J Exp Med 184:1699-711 (1996)'
p38331
aS'PMID:15106591'
p38332
ag38332
aS'AUTHORS'
p38333
aS'Silvie O, Franetich JF, Renia L, Mazier D'
p38334
aS'TITLE'
p38335
aS'Malaria sporozoite: migrating for a living.'
p38336
aS'JOURNAL'
p38337
aS'Trends Mol Med 10:97-100 discussion 100-1 (2004)'
p38338
aS'PMID:15464448'
p38339
ag38339
aS'AUTHORS'
p38340
aS'Mota MM, Giordano S, Rodriguez A'
p38341
aS'TITLE'
p38342
aS'Targeting Plasmodium host cells: survival within hepatocytes.'
p38343
aS'JOURNAL'
p38344
aS'Trends Mol Med 10:487-92 (2004)'
p38345
aS'PMID:12364790'
p38346
ag38346
aS'AUTHORS'
p38347
aS'Cowman AF, Crabb BS'
p38348
aS'TITLE'
p38349
aS'The Plasmodium falciparum genome--a blueprint for erythrocyte invasion.'
p38350
aS'JOURNAL'
p38351
aS'Science 298:126-8 (2002)'
p38352
aS'PMID:16019257'
p38353
ag38353
aS'AUTHORS'
p38354
aS"O'Donnell RA, Blackman MJ"
p38355
aS'TITLE'
p38356
aS'The role of malaria merozoite proteases in red blood cell invasion.'
p38357
aS'JOURNAL'
p38358
aS'Curr Opin Microbiol 8:422-7 (2005)'
p38359
aS'PMID:17630968'
p38360
ag38360
aS'AUTHORS'
p38361
aS'Iyer J, Gruner AC, Renia L, Snounou G, Preiser PR'
p38362
aS'TITLE'
p38363
aS'Invasion of host cells by malaria parasites: a tale of two protein families.'
p38364
aS'JOURNAL'
p38365
aS'Mol Microbiol 65:231-49 (2007)'
p38366
aS'PMID:11224682'
p38367
ag38367
aS'AUTHORS'
p38368
aS'Chitnis CE'
p38369
aS'TITLE'
p38370
aS'Molecular insights into receptors used by malaria parasites for erythrocyte invasion.'
p38371
aS'JOURNAL'
p38372
aS'Curr Opin Hematol 8:85-91 (2001)'
p38373
aS'PMID:15094163'
p38374
ag38374
aS'AUTHORS'
p38375
aS'Rasti N, Wahlgren M, Chen Q'
p38376
aS'TITLE'
p38377
aS'Molecular aspects of malaria pathogenesis.'
p38378
aS'JOURNAL'
p38379
aS'FEMS Immunol Med Microbiol 41:9-26 (2004)'
p38380
aS'PMID:15463497'
p38381
ag38381
aS'AUTHORS'
p38382
aS'Clark IA, Rockett KA, Cowden WB'
p38383
aS'TITLE'
p38384
aS'Proposed link between cytokines, nitric oxide and human cerebral malaria.'
p38385
aS'JOURNAL'
p38386
aS'Parasitol Today 7:205-7 (1991)'
p38387
aS'PMID:18250459'
p38388
ag38388
aS'AUTHORS'
p38389
aS'Hisaeda H, Tetsutani K, Imai T, Moriya C, Tu L, Hamano S, Duan X, Chou B, Ishida H, Aramaki A, Shen J, Ishii KJ, Coban C, Akira S, Takeda K, Yasutomo K, Torii M, Himeno K'
p38390
aS'TITLE'
p38391
aS'Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells.'
p38392
aS'JOURNAL'
p38393
aS'J Immunol 180:2496-503 (2008)'
p38394
aS'PMID:10885986'
p38395
ag38395
aS'AUTHORS'
p38396
aS'Chen Q, Schlichtherle M, Wahlgren M'
p38397
aS'TITLE'
p38398
aS'Molecular aspects of severe malaria.'
p38399
aS'JOURNAL'
p38400
aS'Clin Microbiol Rev 13:439-50 (2000)'
p38401
aS'PMID:11832955'
p38402
ag38402
aS'AUTHORS'
p38403
aS'Miller LH, Baruch DI, Marsh K, Doumbo OK'
p38404
aS'TITLE'
p38405
aS'The pathogenic basis of malaria.'
p38406
aS'JOURNAL'
p38407
aS'Nature 415:673-9 (2002)'
p38408
aS'PMID:19967139'
p38409
ag38409
aS'AUTHORS'
p38410
aS'Faille D, El-Assaad F, Alessi MC, Fusai T, Combes V, Grau GE'
p38411
aS'TITLE'
p38412
aS'Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial'
p38413
aS'understanding.'
p38414
aS'JOURNAL'
p38415
aS'Thromb Haemost 102:1093-102 (2009)'
p38416
aS'PMID:16138104'
p38417
ag38417
aS'AUTHORS'
p38418
aS'Schofield L, Grau GE'
p38419
aS'TITLE'
p38420
aS'Immunological processes in malaria pathogenesis.'
p38421
aS'JOURNAL'
p38422
aS'Nat Rev Immunol 5:722-35 (2005)'
p38423
aS'PMID:14737184'
p38424
ag38424
aS'AUTHORS'
p38425
aS'Ishino T, Yano K, Chinzei Y, Yuda M'
p38426
aS'TITLE'
p38427
aS'Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer.'
p38428
aS'JOURNAL'
p38429
aS'PLoS Biol 2:E4 (2004)'
p38430
aS'PMID:16468982'
p38431
ag38431
aS'AUTHORS'
p38432
aS'Kariu T, Ishino T, Yano K, Chinzei Y, Yuda M'
p38433
aS'TITLE'
p38434
aS'CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts.'
p38435
aS'JOURNAL'
p38436
aS'Mol Microbiol 59:1369-79 (2006)'
p38437
aS'PMID:20091081'
p38438
ag38438
aS'AUTHORS'
p38439
aS'Cox D, McConkey S'
p38440
aS'TITLE'
p38441
aS'The role of platelets in the pathogenesis of cerebral malaria.'
p38442
aS'JOURNAL'
p38443
aS'Cell Mol Life Sci 67:557-68 (2010)'
p38444
asS'KO_PATHWAY'
p38445
(lp38446
S'ko05144'
p38447
asS'PATHWAY_MAP'
p38448
(lp38449
S'map05144'
p38450
asS'DISEASE'
p38451
(lp38452
S'H00361'
p38453
aS'Malaria'
p38454
asS'DESCRIPTION Plasmodium protozoa are parasites that account for malaria infection. Sporozoite forms of the parasite are injected by mosquito bites under the skin and are carried to the liver where they develop into the merozoite form.'
p38455
(lp38456
S'Sporozoite invasion of hepatocytes is mediated by parasite surface protein like CSP. Subsequent infection into red blood cells (RBCs) by merozoites causes malaria disease via aberrant cytokine production and sequestration of parasite-infected red blood cells (pRBCs) to host endothelium. Microvasculature sequestration in the brain brings about cerebral malaria that can results in death or persisting neurological impairment. PfEMP1 has been suggested as the key adhesive molecule of pRBCs.'
p38457
asS'ENTRY'
p38458
(lp38459
S'map05144'
p38460
aS'Pathway'
p38461
asS'CLASS'
p38462
(lp38463
S'Human Diseases Infectious diseases'
p38464
asS'DESCRIPTION'
p38465
(lp38466
S'Plasmodium protozoa are parasites that account for malaria infection. Sporozoite forms of the parasite are injected by mosquito bites under the skin and are carried to the liver where they develop into the merozoite form.'
p38467
assS'path:map05145'
p38468
(dp38469
S'NAME'
p38470
(lp38471
S'Toxoplasmosis'
p38472
asS'REFERENCE'
p38473
(lp38474
S'PMID:15639739'
p38475
ag38475
aS'AUTHORS'
p38476
aS'Denkers EY, Butcher BA'
p38477
aS'TITLE'
p38478
aS'Sabotage and exploitation in macrophages parasitized by intracellular protozoans.'
p38479
aS'JOURNAL'
p38480
aS'Trends Parasitol 21:35-41 (2005)'
p38481
aS'PMID:14642303'
p38482
ag38482
aS'AUTHORS'
p38483
aS'Denkers EY'
p38484
aS'TITLE'
p38485
aS'From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.'
p38486
aS'JOURNAL'
p38487
aS'FEMS Immunol Med Microbiol 39:193-203 (2003)'
p38488
aS'PMID:19744886'
p38489
ag38489
aS'AUTHORS'
p38490
aS'Pollard AM, Knoll LJ, Mordue DG'
p38491
aS'TITLE'
p38492
aS'The role of specific Toxoplasma gondii molecules in manipulation of innate immunity.'
p38493
aS'JOURNAL'
p38494
aS'Trends Parasitol 25:491-4 (2009)'
p38495
aS'PMID:19891610'
p38496
ag38496
aS'AUTHORS'
p38497
aS'Leng J, Butcher BA, Denkers EY'
p38498
aS'TITLE'
p38499
aS'Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances.'
p38500
aS'JOURNAL'
p38501
aS'Parasite Immunol 31:717-28 (2009)'
p38502
aS'PMID:18775432'
p38503
ag38503
aS'AUTHORS'
p38504
aS'Miller CM, Boulter NR, Ikin RJ, Smith NC'
p38505
aS'TITLE'
p38506
aS'The immunobiology of the innate response to Toxoplasma gondii.'
p38507
aS'JOURNAL'
p38508
aS'Int J Parasitol 39:23-39 (2009)'
p38509
aS'PMID:12580944'
p38510
ag38510
aS'AUTHORS'
p38511
aS'Denkers EY, Kim L, Butcher BA'
p38512
aS'TITLE'
p38513
aS'In the belly of the beast: subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection.'
p38514
aS'JOURNAL'
p38515
aS'Cell Microbiol 5:75-83 (2003)'
p38516
aS'PMID:17110955'
p38517
ag38517
aS'AUTHORS'
p38518
aS'Gazzinelli RT, Denkers EY'
p38519
aS'TITLE'
p38520
aS'Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism.'
p38521
aS'JOURNAL'
p38522
aS'Nat Rev Immunol 6:895-906 (2006)'
p38523
aS'PMID:17024357'
p38524
ag38524
aS'AUTHORS'
p38525
aS'Lang C, Gross U, Luder CG'
p38526
aS'TITLE'
p38527
aS'Subversion of innate and adaptive immune responses by Toxoplasma gondii.'
p38528
aS'JOURNAL'
p38529
aS'Parasitol Res 100:191-203 (2007)'
p38530
aS'PMID:19400868'
p38531
ag38531
aS'AUTHORS'
p38532
aS'Blader IJ, Saeij JP'
p38533
aS'TITLE'
p38534
aS'Communication between Toxoplasma gondii and its host: impact on parasite growth,'
p38535
aS'development, immune evasion, and virulence.'
p38536
aS'JOURNAL'
p38537
aS'APMIS 117:458-76 (2009)'
p38538
aS'PMID:18059289'
p38539
ag38539
aS'AUTHORS'
p38540
aS'Boothroyd JC, Dubremetz JF'
p38541
aS'TITLE'
p38542
aS'Kiss and spit: the dual roles of Toxoplasma rhoptries.'
p38543
aS'JOURNAL'
p38544
aS'Nat Rev Microbiol 6:79-88 (2008)'
p38545
aS'PMID:15361242'
p38546
ag38546
aS'AUTHORS'
p38547
aS'Denkers EY, Butcher BA, Del Rio L, Kim L'
p38548
aS'TITLE'
p38549
aS'Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling'
p38550
aS'cascades during intracellular Toxoplasma gondii infection.'
p38551
aS'JOURNAL'
p38552
aS'Immunol Rev 201:191-205 (2004)'
p38553
aS'PMID:18617274'
p38554
ag38554
aS'AUTHORS'
p38555
aS'Yarovinsky F'
p38556
aS'TITLE'
p38557
aS'Toll-like receptors and their role in host resistance to Toxoplasma gondii.'
p38558
aS'JOURNAL'
p38559
aS'Immunol Lett 119:17-21 (2008)'
p38560
aS'PMID:14987366'
p38561
ag38561
aS'AUTHORS'
p38562
aS'Coppens I, Joiner KA'
p38563
aS'TITLE'
p38564
aS'Parasitehost cell interactions in toxoplasmosis: new avenues for intervention?'
p38565
aS'JOURNAL'
p38566
aS'Expert Rev Mol Med 2001:1-20 (2001)'
p38567
aS'PMID:12106793'
p38568
ag38568
aS'AUTHORS'
p38569
aS'Aliberti J, Sher A'
p38570
aS'TITLE'
p38571
aS'Role of G-protein-coupled signaling in the induction and regulation of dendritic'
p38572
aS'cell function by Toxoplasma gondii.'
p38573
aS'JOURNAL'
p38574
aS'Microbes Infect 4:991-7 (2002)'
p38575
aS'PMID:12857995'
p38576
ag38576
aS'AUTHORS'
p38577
aS'Sher A, Collazzo C, Scanga C, Jankovic D, Yap G, Aliberti J'
p38578
aS'TITLE'
p38579
aS'Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii.'
p38580
aS'JOURNAL'
p38581
aS'Immunol Res 27:521-8 (2003)'
p38582
aS'PMID:10525166'
p38583
ag38583
aS'AUTHORS'
p38584
aS'Bonhomme A, Bouchot A, Pezzella N, Gomez J, Le Moal H, Pinon JM'
p38585
aS'TITLE'
p38586
aS'Signaling during the invasion of host cells by Toxoplasma gondii.'
p38587
aS'JOURNAL'
p38588
aS'FEMS Microbiol Rev 23:551-61 (1999)'
p38589
aS'PMID:18327664'
p38590
ag38590
aS'AUTHORS'
p38591
aS'Laliberte J, Carruthers VB'
p38592
aS'TITLE'
p38593
aS'Host cell manipulation by the human pathogen Toxoplasma gondii.'
p38594
aS'JOURNAL'
p38595
aS'Cell Mol Life Sci 65:1900-15 (2008)'
p38596
aS'PMID:10234174'
p38597
ag38597
aS'AUTHORS'
p38598
aS'Bogdan C, Rollinghoff M'
p38599
aS'TITLE'
p38600
aS'How do protozoan parasites survive inside macrophages?'
p38601
aS'JOURNAL'
p38602
aS'Parasitol Today 15:22-8 (1999)'
p38603
aS'PMID:16339966'
p38604
ag38604
aS'AUTHORS'
p38605
aS'Molestina RE, Sinai AP'
p38606
aS'TITLE'
p38607
aS'Host and parasite-derived IKK activities direct distinct temporal phases of NF-kappaB activation and target gene expression following Toxoplasma gondii infection.'
p38608
aS'JOURNAL'
p38609
aS'J Cell Sci 118:5785-96 (2005)'
p38610
asS'KO_PATHWAY'
p38611
(lp38612
S'ko05145'
p38613
asS'PATHWAY_MAP'
p38614
(lp38615
S'map05145'
p38616
asS'DISEASE'
p38617
(lp38618
S'H00435'
p38619
aS'Toxoplasmosis'
p38620
asS'ENTRY'
p38621
(lp38622
S'map05145'
p38623
aS'Pathway'
p38624
asS'CLASS'
p38625
(lp38626
S'Human Diseases Infectious diseases'
p38627
asS'DESCRIPTION'
p38628
(lp38629
S'Toxoplasma gondii is an obligate intracellular parasite that is prevalent worldwide. The tachyzoite form acquired by oral ingestion downmodulates proinflammatory signaling pathways via various mechanisms. During early infection, nuclear translocation of NFkB is temporally blocked and p38 MAPK phosphorylation is prevented, suppressing IL-12 production. Another pathway for IL-12 induction occurs through CCR5 dependent pathway, but parasitic induction of an eicosanoid LXA4 contributes to the downregulation of IL-12. Direct activation of STAT3 by the parasite enhance anti-inflammatory function of IL-10 and TGF beta. T. gondii can cause lifelong chronic infection by establishing an anti-apoptotic environment through induction of bcl-2 or IAPs and by redirecting LDL-mediated cholesterol transport to scavenge nutrients from the host.'
p38630
assS'path:map05146'
p38631
(dp38632
S'NAME'
p38633
(lp38634
S'Amoebiasis'
p38635
asS'REFERENCE'
p38636
(lp38637
S'PMID:11378035'
p38638
ag38638
aS'AUTHORS'
p38639
aS'Stanley SL'
p38640
aS'TITLE'
p38641
aS'Pathophysiology of amoebiasis.'
p38642
aS'JOURNAL'
p38643
aS'Trends Parasitol 17:280-5 (2001)'
p38644
aS'PMID:10756002'
p38645
ag38645
aS'AUTHORS'
p38646
aS'Espinosa-Cantellano M, Martinez-Palomo A'
p38647
aS'TITLE'
p38648
aS'Pathogenesis of intestinal amebiasis: from molecules to disease.'
p38649
aS'JOURNAL'
p38650
aS'Clin Microbiol Rev 13:318-31 (2000)'
p38651
aS'PMID:9832261'
p38652
ag38652
aS'AUTHORS'
p38653
aS'Huston CD, Petri WA Jr'
p38654
aS'TITLE'
p38655
aS'Host-pathogen interaction in amebiasis and progress in vaccine development.'
p38656
aS'JOURNAL'
p38657
aS'Eur J Clin Microbiol Infect Dis 17:601-14 (1998)'
p38658
aS'PMID:14700586'
p38659
ag38659
aS'AUTHORS'
p38660
aS'Huston CD'
p38661
aS'TITLE'
p38662
aS'Parasite and host contributions to the pathogenesis of amebic colitis.'
p38663
aS'JOURNAL'
p38664
aS'Trends Parasitol 20:23-6 (2004)'
p38665
aS'PMID:15813717'
p38666
ag38666
aS'AUTHORS'
p38667
aS'Campos-Rodriguezp R, Jarillo-Luna A'
p38668
aS'TITLE'
p38669
aS'The pathogenicity of Entamoeba histolytica is related to the capacity of evading'
p38670
aS'innate immunity.'
p38671
aS'JOURNAL'
p38672
aS'Parasite Immunol 27:1-8 (2005)'
p38673
aS'PMID:19207103'
p38674
ag38674
aS'AUTHORS'
p38675
aS'Lejeune M, Rybicka JM, Chadee K'
p38676
aS'TITLE'
p38677
aS'Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica.'
p38678
aS'JOURNAL'
p38679
aS'Future Microbiol 4:105-18 (2009)'
p38680
aS'PMID:17576362'
p38681
ag38681
aS'AUTHORS'
p38682
aS'Carrero JC, Cervantes-Rebolledo C, Aguilar-Diaz H, Diaz-Gallardo MY, Laclette JP, Morales-Montor J'
p38683
aS'TITLE'
p38684
aS'The role of the secretory immune response in the infection by Entamoeba histolytica.'
p38685
aS'JOURNAL'
p38686
aS'Parasite Immunol 29:331-8 (2007)'
p38687
aS'PMID:12660071'
p38688
ag38688
aS'AUTHORS'
p38689
aS'Stanley SL Jr'
p38690
aS'TITLE'
p38691
aS'Amoebiasis.'
p38692
aS'JOURNAL'
p38693
aS'Lancet 361:1025-34 (2003)'
p38694
aS'PMID:14502002'
p38695
ag38695
aS'AUTHORS'
p38696
aS'Stauffer W, Ravdin JI'
p38697
aS'TITLE'
p38698
aS'Entamoeba histolytica: an update.'
p38699
aS'JOURNAL'
p38700
aS'Curr Opin Infect Dis 16:479-85 (2003)'
p38701
aS'PMID:12142490'
p38702
ag38702
aS'AUTHORS'
p38703
aS'Petri WA Jr, Haque R, Mann BJ'
p38704
aS'TITLE'
p38705
aS'The bittersweet interface of parasite and host: lectin-carbohydrate interactions'
p38706
aS'during human invasion by the parasite Entamoeba histolytica.'
p38707
aS'JOURNAL'
p38708
aS'Annu Rev Microbiol 56:39-64 (2002)'
p38709
aS'PMID:18725798'
p38710
ag38710
aS'AUTHORS'
p38711
aS'Baxt LA, Singh U'
p38712
aS'TITLE'
p38713
aS'New insights into Entamoeba histolytica pathogenesis.'
p38714
aS'JOURNAL'
p38715
aS'Curr Opin Infect Dis 21:489-94 (2008)'
p38716
aS'PMID:12160867'
p38717
ag38717
aS'AUTHORS'
p38718
aS'Petri WA Jr'
p38719
aS'TITLE'
p38720
aS'Pathogenesis of amebiasis.'
p38721
aS'JOURNAL'
p38722
aS'Curr Opin Microbiol 5:443-7 (2002)'
p38723
aS'PMID:17702556'
p38724
ag38724
aS'AUTHORS'
p38725
aS'Guo X, Houpt E, Petri WA Jr'
p38726
aS'TITLE'
p38727
aS'Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies.'
p38728
aS'JOURNAL'
p38729
aS'Curr Opin Immunol 19:376-84 (2007)'
p38730
aS'PMID:20303955'
p38731
ag38731
aS'AUTHORS'
p38732
aS'Mortimer L, Chadee K'
p38733
aS'TITLE'
p38734
aS'The immunopathogenesis of Entamoeba histolytica.'
p38735
aS'JOURNAL'
p38736
aS'Exp Parasitol 126:366-80 (2010)'
p38737
aS'PMID:16380324'
p38738
ag38738
aS'AUTHORS'
p38739
aS'Meza I, Talamas-Rohana P, Vargas MA'
p38740
aS'TITLE'
p38741
aS'The cytoskeleton of Entamoeba histolytica: structure, function, and regulation by signaling pathways.'
p38742
aS'JOURNAL'
p38743
aS'Arch Med Res 37:234-43 (2006)'
p38744
aS'PMID:10637584'
p38745
ag38745
aS'AUTHORS'
p38746
aS'Meza I'
p38747
aS'TITLE'
p38748
aS'Extracellular matrix-induced signaling in Entamoeba histolytica: its role in invasiveness.'
p38749
aS'JOURNAL'
p38750
aS'Parasitol Today 16:23-8 (2000)'
p38751
aS'PMID:11352795'
p38752
ag38752
aS'AUTHORS'
p38753
aS'Stanley SL Jr, Reed SL'
p38754
aS'TITLE'
p38755
aS'Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VI.'
p38756
aS'Entamoeba histolytica: parasite-host interactions.'
p38757
aS'JOURNAL'
p38758
aS'Am J Physiol Gastrointest Liver Physiol 280:G1049-54 (2001)'
p38759
aS'PMID:20145703'
p38760
ag38760
aS'AUTHORS'
p38761
aS'Wong-Baeza I, Alcantara-Hernandez M, Mancilla-Herrera I, Ramirez-Saldivar I, Arriaga-Pizano L, Ferat-Osorio E, Lopez-Macias C, Isibasi A'
p38762
aS'TITLE'
p38763
aS'The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.'
p38764
aS'JOURNAL'
p38765
aS'J Biomed Biotechnol 2010:254521 (2010)'
p38766
asS'KO_PATHWAY'
p38767
(lp38768
S'ko05146'
p38769
asS'PATHWAY_MAP'
p38770
(lp38771
S'map05146'
p38772
asS'DISEASE'
p38773
(lp38774
S'H00360'
p38775
aS'Amoebiasis'
p38776
asS'ENTRY'
p38777
(lp38778
S'map05146'
p38779
aS'Pathway'
p38780
asS'CLASS'
p38781
(lp38782
S'Human Diseases Infectious diseases'
p38783
asS'DESCRIPTION'
p38784
(lp38785
S'Entamoeba histolytica, an extracellular protozoan parasite is a human pathogen that invades the intestinal epithelium. Infection occurs on ingestion of contaminated water and food. The pathogenesis of amoebiasis begins with parasite attachment and disruption of the intestinal mucus layer, followed by apoptosis of host epithelial cells. Intestinal tissue destruction causes severe dysentery and ulcerations in amoebic colitis. Several amoebic proteins such as lectins, cysteine proteineases, and amoebapores are associated with the invasion process. The parasite can cause extraintestinal infection like amoebic liver abscess by evading immune response.'
p38786
assS'path:map00280'
p38787
(dp38788
S'NAME'
p38789
(lp38790
S'Valine, leucine and isoleucine degradation'
p38791
asS'KO_PATHWAY'
p38792
(lp38793
S'ko00280'
p38794
asS'PATHWAY_MAP'
p38795
(lp38796
S'map00280'
p38797
asS'DISEASE'
p38798
(lp38799
S'H00172'
p38800
aS'Maple syrup urine disease (MSUD)'
p38801
ag38800
ag38801
aS'H00173'
p38802
aS'Isovaleric acidemia (IVA)'
p38803
aS'H00174'
p38804
aS'Methylmalonic aciduria (MMA)'
p38805
aS'H00175'
p38806
aS'Propionic acidemia'
p38807
aS'H00179'
p38808
aS'3-Hydroxy-3-methylglutaryl-CoA lyase deficiency'
p38809
aS'H00181'
p38810
aS'3-Methylcrotonylglycinuria'
p38811
aS'H00525'
p38812
aS'Disorders of fatty-acid oxidation'
p38813
aS'H00754'
p38814
aS'3-Methylglutaconic aciduria (MGCA)'
p38815
aS'H00925'
p38816
aS'2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency'
p38817
aS'H01076'
p38818
aS'Alpha-methylacetoacetic aciduria'
p38819
aS'H01121'
p38820
aS'Succinyl CoA:3-oxoacid CoA transferase (SCOT) deficiency'
p38821
aS'H01123'
p38822
aS'HMG-CoA synthase (HMGCS) deficiency'
p38823
aS'H01279'
p38824
aS'Isobutyryl-CoA dehydrogenase (IBD) deficiency'
p38825
aS'H01349'
p38826
aS'Methacrylic aciduria'
p38827
aS'H01364'
p38828
aS'3-Hydroxyacyl-CoA dehydrogenase deficiency'
p38829
aS'H01400'
p38830
aS'Secondary hyperammonemia'
p38831
asS'MODULE'
p38832
(lp38833
S'M00036'
p38834
aS'Leucine degradation, leucine => acetoacetate + acetyl-CoA [PATH:map00280]'
p38835
asS'DBLINKS'
p38836
(lp38837
S'GO: 0006550 0006552 0006574'
p38838
asS'ENTRY'
p38839
(lp38840
S'map00280'
p38841
aS'Pathway'
p38842
asS'CLASS'
p38843
(lp38844
S'Metabolism Amino acid metabolism'
p38845
assS'path:map00281'
p38846
(dp38847
S'DBLINKS'
p38848
(lp38849
S'UMBBD: ger cit'
p38850
asS'NAME'
p38851
(lp38852
S'Geraniol degradation'
p38853
asS'REFERENCE'
p38854
(lp38855
S'PMID:11778886'
p38856
ag38856
aS'AUTHORS'
p38857
aS'Wolken WA, van der Werf MJ.'
p38858
aS'TITLE'
p38859
aS'Geraniol biotransformation-pathway in spores of Penicillium digitatum.'
p38860
aS'JOURNAL'
p38861
aS'Appl Microbiol Biotechnol 57:731-7 (2001)'
p38862
aS'PMID:16272386'
p38863
ag38863
aS'AUTHORS'
p38864
aS'Hoschle B, Gnau V, Jendrossek D.'
p38865
aS'TITLE'
p38866
aS'Methylcrotonyl-CoA and geranyl-CoA carboxylases are involved in leucine/isovalerate utilization (Liu) and acyclic terpene utilization (Atu), and are encoded by liuB/liuD and atuC/atuF, in Pseudomonas aeruginosa.'
p38867
aS'JOURNAL'
p38868
aS'Microbiology 151:3649-56 (2005)'
p38869
aS'PMID:16820476'
p38870
ag38870
aS'AUTHORS'
p38871
aS'Forster-Fromme K, Hoschle B, Mack C, Bott M, Armbruster W, Jendrossek D'
p38872
aS'TITLE'
p38873
aS'Identification of genes and proteins necessary for catabolism of acyclic terpenes and leucine/isovalerate in Pseudomonas aeruginosa.'
p38874
aS'JOURNAL'
p38875
aS'Appl Environ Microbiol 72:4819-28 (2006)'
p38876
aS'PMID:16000717'
p38877
ag38877
aS'AUTHORS'
p38878
aS'Hoschle B, Jendrossek D.'
p38879
aS'TITLE'
p38880
aS'Utilization of geraniol is dependent on molybdenum in Pseudomonas aeruginosa: evidence for different metabolic routes for oxidation of geraniol and citronellol.'
p38881
aS'JOURNAL'
p38882
aS'Microbiology 151:2277-83 (2005)'
p38883
aS'PMID:681275'
p38884
ag38884
aS'AUTHORS'
p38885
aS'Cantwell SG, Lau EP, Watt DS, Fall RR.'
p38886
aS'TITLE'
p38887
aS'Biodegradation of acyclic isoprenoids by Pseudomonas species.'
p38888
aS'JOURNAL'
p38889
aS'J Bacteriol 135:324-33 (1978)'
p38890
aS'PMID:19597963'
p38891
ag38891
aS'AUTHORS'
p38892
aS'Chavez-Aviles M, Diaz-Perez AL, Campos-Garcia J'
p38893
aS'TITLE'
p38894
aS'The bifunctional role of LiuE from Pseudomonas aeruginosa, displays additionally'
p38895
aS'HIHG-CoA lyase enzymatic activity.'
p38896
aS'JOURNAL'
p38897
aS'Mol Biol Rep 37:1787-91 (2010)'
p38898
asS'KO_PATHWAY'
p38899
(lp38900
S'ko00281'
p38901
asS'ENTRY'
p38902
(lp38903
S'map00281'
p38904
aS'Pathway'
p38905
asS'PATHWAY_MAP'
p38906
(lp38907
S'map00281'
p38908
asS'CLASS'
p38909
(lp38910
S'Metabolism Metabolism of terpenoids and polyketides'
p38911
assS'path:map05223'
p38912
(dp38913
S'NAME'
p38914
(lp38915
S'Non-small cell lung cancer'
p38916
asS'REFERENCE'
p38917
(lp38918
S'PMID:12379883'
p38919
ag38919
aS'AUTHORS'
p38920
aS'Osada H, Takahashi T.'
p38921
aS'TITLE'
p38922
aS'Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.'
p38923
aS'JOURNAL'
p38924
aS'Oncogene 21:7421-34 (2002)'
p38925
aS'PMID:12741677'
p38926
ag38926
aS'AUTHORS'
p38927
aS'Yokota J, Nishioka M, Tani M, Kohno T.'
p38928
aS'TITLE'
p38929
aS'Genetic alterations responsible for metastatic phenotypes of lung cancer cells.'
p38930
aS'JOURNAL'
p38931
aS'Clin Exp Metastasis 20:189-93 (2003)'
p38932
aS'PMID:16870043'
p38933
ag38933
aS'AUTHORS'
p38934
aS'Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.'
p38935
aS'TITLE'
p38936
aS'K-ras mutations in non-small-cell lung carcinoma: a review.'
p38937
aS'JOURNAL'
p38938
aS'Clin Lung Cancer 8:30-8 (2006)'
p38939
aS'PMID:15948711'
p38940
ag38940
aS'AUTHORS'
p38941
aS'Pfeifer GP, Dammann R.'
p38942
aS'TITLE'
p38943
aS'Methylation of the tumor suppressor gene RASSF1A in human tumors.'
p38944
aS'JOURNAL'
p38945
aS'Biochemistry (Mosc) 70:576-83 (2005)'
p38946
aS'PMID:11902573'
p38947
ag38947
aS'AUTHORS'
p38948
aS'Altucci L, Gronemeyer H.'
p38949
aS'TITLE'
p38950
aS'The promise of retinoids to fight against cancer.'
p38951
aS'JOURNAL'
p38952
aS'Nat Rev Cancer 1:181-93 (2001)'
p38953
aS'PMID:10944551'
p38954
ag38954
aS'AUTHORS'
p38955
aS'Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.'
p38956
aS'TITLE'
p38957
aS'Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.'
p38958
aS'JOURNAL'
p38959
aS'J Natl Cancer Inst 92:1303-7 (2000)'
p38960
aS'PMID:12867060'
p38961
ag38961
aS'AUTHORS'
p38962
aS'Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.'
p38963
aS'TITLE'
p38964
aS'Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.'
p38965
aS'JOURNAL'
p38966
aS'Lung Cancer 41 Suppl 1:S29-42 (2003)'
p38967
aS'PMID:16112428'
p38968
ag38968
aS'AUTHORS'
p38969
aS'Panani AD, Roussos C.'
p38970
aS'TITLE'
p38971
aS'Cytogenetic and molecular aspects of lung cancer.'
p38972
aS'JOURNAL'
p38973
aS'Cancer Lett 239:1-9 (2006)'
p38974
aS'PMID:12407699'
p38975
ag38975
aS'AUTHORS'
p38976
aS'Mitsuuchi Y, Testa JR.'
p38977
aS'TITLE'
p38978
aS'Cytogenetics and molecular genetics of lung cancer.'
p38979
aS'JOURNAL'
p38980
aS'Am J Med Genet 115:183-8 (2002)'
p38981
aS'PMID:15942304'
p38982
ag38982
aS'AUTHORS'
p38983
aS'Breuer RH, Postmus PE, Smit EF.'
p38984
aS'TITLE'
p38985
aS'Molecular pathology of non-small-cell lung cancer.'
p38986
aS'JOURNAL'
p38987
aS'Respiration 72:313-30 (2005)'
p38988
aS'PMID:11895903'
p38989
ag38989
aS'AUTHORS'
p38990
aS'Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.'
p38991
aS'TITLE'
p38992
aS'Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.'
p38993
aS'JOURNAL'
p38994
aS'Clin Cancer Res 8:734-44 (2002)'
p38995
aS'PMID:16189154'
p38996
ag38996
aS'AUTHORS'
p38997
aS'Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.'
p38998
aS'TITLE'
p38999
aS'Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.'
p39000
aS'JOURNAL'
p39001
aS'J Clin Pathol 58:1076-80 (2005)'
p39002
aS'PMID:17625570'
p39003
ag39003
aS'AUTHORS'
p39004
aS'Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H'
p39005
aS'TITLE'
p39006
aS'Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.'
p39007
aS'JOURNAL'
p39008
aS'Nature 448:561-6 (2007)'
p39009
aS'PMID:18593892'
p39010
ag39010
aS'AUTHORS'
p39011
aS'Choi YL, Takeuchi K, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Hamada T, Haruta H, Watanabe H, Kurashina K, Hatanaka H, Ueno T, Takada S, Yamashita Y, Sugiyama Y, Ishikawa Y, Mano H'
p39012
aS'TITLE'
p39013
aS'Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.'
p39014
aS'JOURNAL'
p39015
aS'Cancer Res 68:4971-6 (2008)'
p39016
aS'PMID:19629074'
p39017
ag39017
aS'AUTHORS'
p39018
aS'Janne PA, Gray N, Settleman J'
p39019
aS'TITLE'
p39020
aS'Factors underlying sensitivity of cancers to small-molecule kinase inhibitors.'
p39021
aS'JOURNAL'
p39022
aS'Nat Rev Drug Discov 8:709-23 (2009)'
p39023
aS'PMID:23201355'
p39024
ag39024
aS'AUTHORS'
p39025
aS'Roskoski R Jr'
p39026
aS'TITLE'
p39027
aS'Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition.'
p39028
aS'JOURNAL'
p39029
aS'Pharmacol Res 68:68-94 (2013)'
p39030
aS'PMID:22154278'
p39031
ag39031
aS'AUTHORS'
p39032
aS'Reungwetwattana T, Weroha SJ, Molina JR'
p39033
aS'TITLE'
p39034
aS'Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC).'
p39035
aS'JOURNAL'
p39036
aS'Clin Lung Cancer 13:252-66 (2012)'
p39037
aS'PMID:21855164'
p39038
ag39038
aS'AUTHORS'
p39039
aS'Popat S, Gonzalez D, Min T, Swansbury J, Dainton M, Croud JG, Rice AJ, Nicholson AG'
p39040
aS'TITLE'
p39041
aS'ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma.'
p39042
aS'JOURNAL'
p39043
aS'Lung Cancer 75:300-5 (2012)'
p39044
aS'PMID:21753699'
p39045
ag39045
aS'AUTHORS'
p39046
aS'Yoshida A, Tsuta K, Nakamura H, Kohno T, Takahashi F, Asamura H, Sekine I, Fukayama M, Shibata T, Furuta K, Tsuda H'
p39047
aS'TITLE'
p39048
aS'Comprehensive histologic analysis of ALK-rearranged lung carcinomas.'
p39049
aS'JOURNAL'
p39050
aS'Am J Surg Pathol 35:1226-34 (2011)'
p39051
aS'PMID:22736493'
p39052
ag39052
aS'AUTHORS'
p39053
aS'Shaozhang Z, Xiaomei L, Aiping Z, Jianbo H, Xiangqun S, Qitao Y'
p39054
aS'TITLE'
p39055
aS'Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.'
p39056
aS'JOURNAL'
p39057
aS'Genes Chromosomes Cancer 51:925-32 (2012)'
p39058
asS'KO_PATHWAY'
p39059
(lp39060
S'ko05223'
p39061
asS'PATHWAY_MAP'
p39062
(lp39063
S'map05223'
p39064
asS'DISEASE'
p39065
(lp39066
S'H00014'
p39067
aS'Non-small cell lung cancer'
p39068
asS'ENTRY'
p39069
(lp39070
S'map05223'
p39071
aS'Pathway'
p39072
asS'CLASS'
p39073
(lp39074
S'Human Diseases Cancers'
p39075
asS'DESCRIPTION'
p39076
(lp39077
S'Lung cancer is a leading cause of cancer death among men and women in industrialized countries. Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer and represents a heterogeneous group of cancers, consisting mainly of squamous cell (SCC), adeno (AC) and large-cell carcinoma. Molecular mechanisms altered in NSCLC include activation of oncogenes, such as K-RAS, c-erbB-2 and EML4-ALK, and inactivation of tumorsuppressor genes, such as p53, p16INK4a, RAR-beta, and RASSF1. Point mutations within the K-RAS gene inactivate GTPase activity and the p21-RAS protein continuously transmits growth signals to the nucleus. Overexpression of c-erbB-2 or EGFR leads to a proliferative advantage. EML4-ALK fusion leads to constitutive ALK activation, which causes cell proliferation, invasion, and inhibition of apoptosis. Inactivating mutation of p53 can lead to more rapid proliferation and reduced apoptosis. The protein encoded by the p16INK4a'
p39078
assS'path:map05222'
p39079
(dp39080
S'NAME'
p39081
(lp39082
S'Small cell lung cancer'
p39083
asS'REFERENCE'
p39084
(lp39085
S'PMID:12379883'
p39086
ag39086
aS'AUTHORS'
p39087
aS'Osada H, Takahashi T.'
p39088
aS'TITLE'
p39089
aS'Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.'
p39090
aS'JOURNAL'
p39091
aS'Oncogene 21:7421-34 (2002)'
p39092
aS'PMID:12741677'
p39093
ag39093
aS'AUTHORS'
p39094
aS'Yokota J, Nishioka M, Tani M, Kohno T.'
p39095
aS'TITLE'
p39096
aS'Genetic alterations responsible for metastatic phenotypes of lung cancer cells.'
p39097
aS'JOURNAL'
p39098
aS'Clin Exp Metastasis 20:189-93 (2003)'
p39099
aS'PMID:12711111'
p39100
ag39100
aS'AUTHORS'
p39101
aS'Sanchez-Cespedes M.'
p39102
aS'TITLE'
p39103
aS'Dissecting the genetic alterations involved in lung carcinogenesis.'
p39104
aS'JOURNAL'
p39105
aS'Lung Cancer 40:111-21 (2003)'
p39106
aS'PMID:12407699'
p39107
ag39107
aS'AUTHORS'
p39108
aS'Mitsuuchi Y, Testa JR.'
p39109
aS'TITLE'
p39110
aS'Cytogenetics and molecular genetics of lung cancer.'
p39111
aS'JOURNAL'
p39112
aS'Am J Med Genet 115:183-8 (2002)'
p39113
aS'PMID:11720739'
p39114
ag39114
aS'AUTHORS'
p39115
aS'Kaye FJ.'
p39116
aS'TITLE'
p39117
aS'Molecular biology of lung cancer.'
p39118
aS'JOURNAL'
p39119
aS'Lung Cancer 34 Suppl 2:S35-41 (2001)'
p39120
aS'PMID:16112428'
p39121
ag39121
aS'AUTHORS'
p39122
aS'Panani AD, Roussos C.'
p39123
aS'TITLE'
p39124
aS'Cytogenetic and molecular aspects of lung cancer.'
p39125
aS'JOURNAL'
p39126
aS'Cancer Lett 239:1-9 (2006)'
p39127
aS'PMID:11902573'
p39128
ag39128
aS'AUTHORS'
p39129
aS'Altucci L, Gronemeyer H.'
p39130
aS'TITLE'
p39131
aS'The promise of retinoids to fight against cancer.'
p39132
aS'JOURNAL'
p39133
aS'Nat Rev Cancer 1:181-93 (2001)'
p39134
aS'PMID:10944551'
p39135
ag39135
aS'AUTHORS'
p39136
aS'Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.'
p39137
aS'TITLE'
p39138
aS'Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.'
p39139
aS'JOURNAL'
p39140
aS'J Natl Cancer Inst 92:1303-7 (2000)'
p39141
aS'PMID:12616528'
p39142
ag39142
aS'AUTHORS'
p39143
aS'Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.'
p39144
aS'TITLE'
p39145
aS'Apoptosis and lung cancer: a review.'
p39146
aS'JOURNAL'
p39147
aS'J Cell Biochem 88:885-98 (2003)'
p39148
aS'PMID:11807782'
p39149
ag39149
aS'AUTHORS'
p39150
aS'Sartorius UA, Krammer PH.'
p39151
aS'TITLE'
p39152
aS'Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.'
p39153
aS'JOURNAL'
p39154
aS'Int J Cancer 97:584-92 (2002)'
p39155
aS'PMID:16064138'
p39156
ag39156
aS'AUTHORS'
p39157
aS'Adhikary S, Eilers M.'
p39158
aS'TITLE'
p39159
aS'Transcriptional regulation and transformation by Myc proteins.'
p39160
aS'JOURNAL'
p39161
aS'Nat Rev Mol Cell Biol 6:635-45 (2005)'
p39162
aS'PMID:11463388'
p39163
ag39163
aS'AUTHORS'
p39164
aS'Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.'
p39165
aS'TITLE'
p39166
aS'A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.'
p39167
aS'JOURNAL'
p39168
aS'Mol Cell 7:639-50 (2001)'
p39169
aS'PMID:15109562'
p39170
ag39170
aS'AUTHORS'
p39171
aS'Buttery RC, Rintoul RC, Sethi T.'
p39172
aS'TITLE'
p39173
aS'Small cell lung cancer: the importance of the extracellular matrix.'
p39174
aS'JOURNAL'
p39175
aS'Int J Biochem Cell Biol 36:1154-60 (2004)'
p39176
aS'PMID:11559746'
p39177
ag39177
aS'AUTHORS'
p39178
aS'Yamada KM, Araki M.'
p39179
aS'TITLE'
p39180
aS'Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.'
p39181
aS'JOURNAL'
p39182
aS'J Cell Sci 114:2375-82 (2001)'
p39183
aS'PMID:11905738'
p39184
ag39184
aS'AUTHORS'
p39185
aS'Rintoul RC, Sethi T.'
p39186
aS'TITLE'
p39187
aS'The role of extracellular matrix in small-cell lung cancer.'
p39188
aS'JOURNAL'
p39189
aS'Lancet Oncol 2:437-42 (2001)'
p39190
aS'PMID:12243753'
p39191
ag39191
aS'AUTHORS'
p39192
aS'Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.'
p39193
aS'TITLE'
p39194
aS'Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.'
p39195
aS'JOURNAL'
p39196
aS'Exp Cell Res 279:277-90 (2002)'
p39197
asS'KO_PATHWAY'
p39198
(lp39199
S'ko05222'
p39200
asS'PATHWAY_MAP'
p39201
(lp39202
S'map05222'
p39203
asS'DISEASE'
p39204
(lp39205
S'H00013'
p39206
aS'Small cell lung cancer'
p39207
asS'ENTRY'
p39208
(lp39209
S'map05222'
p39210
aS'Pathway'
p39211
asS'CLASS'
p39212
(lp39213
S'Human Diseases Cancers'
p39214
asS'DESCRIPTION'
p39215
(lp39216
S'Lung cancer is a leading cause of cancer death among men and women in industrialized countries. Small cell lung carcinoma (SCLC) is a highly aggressive neoplasm, which accounts for approximately 25% of all lung cancer cases.'
p39217
assS'path:map04310'
p39218
(dp39219
S'NAME'
p39220
(lp39221
S'Wnt signaling pathway'
p39222
asS'REFERENCE'
p39223
(lp39224
S'PMID:14635791'
p39225
ag39225
aS'AUTHORS'
p39226
aS'Hatsell S, Rowlands T, Hiremath M, Cowin P.'
p39227
aS'TITLE'
p39228
aS'Beta-catenin and Tcfs in mammary development and cancer.'
p39229
aS'JOURNAL'
p39230
aS'J Mammary Gland Biol Neoplasia 8:145-58 (2003)'
p39231
aS'PMID:14745971'
p39232
ag39232
aS'AUTHORS'
p39233
aS'Yang Y.'
p39234
aS'TITLE'
p39235
aS'Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.'
p39236
aS'JOURNAL'
p39237
aS'Birth Defects Res Part C Embryo Today 69:305-17 (2003)'
p39238
aS'PMID:12446114'
p39239
ag39239
aS'AUTHORS'
p39240
aS'Kalderon D.'
p39241
aS'TITLE'
p39242
aS'Similarities between the Hedgehog and Wnt signaling pathways.'
p39243
aS'JOURNAL'
p39244
aS'Trends Cell Biol 12:523-31 (2002)'
p39245
aS'PMID:14530294'
p39246
ag39246
aS'AUTHORS'
p39247
aS'Nusse R.'
p39248
aS'TITLE'
p39249
aS'Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.'
p39250
aS'JOURNAL'
p39251
aS'Development 130:5297-305 (2003)'
p39252
aS'PMID:15102436'
p39253
ag39253
aS'AUTHORS'
p39254
aS'Jope RS, Johnson GV.'
p39255
aS'TITLE'
p39256
aS'The glamour and gloom of glycogen synthase kinase-3.'
p39257
aS'JOURNAL'
p39258
aS'Trends Biochem Sci 29:95-102 (2004)'
p39259
aS'PMID:12967557'
p39260
ag39260
aS'AUTHORS'
p39261
aS'Veeman MT, Axelrod JD, Moon RT.'
p39262
aS'TITLE'
p39263
aS'A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.'
p39264
aS'JOURNAL'
p39265
aS'Dev Cell 5:367-77 (2003)'
p39266
aS'PMID:11433294'
p39267
ag39267
aS'AUTHORS'
p39268
aS'Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.'
p39269
aS'TITLE'
p39270
aS'PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.'
p39271
aS'JOURNAL'
p39272
aS'Nat Cell Biol 3:628-36 (2001)'
p39273
aS'PMID:23256519'
p39274
ag39274
aS'AUTHORS'
p39275
aS'Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E'
p39276
aS'TITLE'
p39277
aS'The way Wnt works: Components and mechanism.'
p39278
aS'JOURNAL'
p39279
aS'Growth Factors 31:1-31 (2013)'
p39280
aS'PMID:19482104'
p39281
ag39281
aS'AUTHORS'
p39282
aS'Carethers JM'
p39283
aS'TITLE'
p39284
aS'Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.'
p39285
aS'JOURNAL'
p39286
aS'Gastroenterology 137:33-6 (2009)'
p39287
aS'PMID:18838381'
p39288
ag39288
aS'AUTHORS'
p39289
aS'Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG'
p39290
aS'TITLE'
p39291
aS'The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates'
p39292
aS'Wnt/beta-catenin signaling.'
p39293
aS'JOURNAL'
p39294
aS'J Biol Chem 283:33053-8 (2008)'
p39295
asS'KO_PATHWAY'
p39296
(lp39297
S'ko04310'
p39298
asS'PATHWAY_MAP'
p39299
(lp39300
S'map04310'
p39301
asS'DISEASE'
p39302
(lp39303
S'H00078'
p39304
aS'Frontotemporal lobar degeneration (FTLD)'
p39305
ag39304
ag39305
aS'H00409'
p39306
aS'Type II diabetes mellitus'
p39307
aS'H00450'
p39308
aS'Sclerosing bone dysplasias'
p39309
aS'H00451'
p39310
aS'Osteoporosis-pseudoglioma syndrome (OPPG)'
p39311
aS'H00589'
p39312
aS'Familial exudative vitreoretinopathy (FEVR)'
p39313
aS'H00598'
p39314
aS'46,XX disorders of sex development (Disorders of gonadal development)'
p39315
aS'H00600'
p39316
aS'46,XX disorders of sex development (Other)'
p39317
aS'H00607'
p39318
aS'46,XY disorders of sex development (Disorders of gonadal development)'
p39319
aS'H00625'
p39320
aS'Tooth agenesis'
p39321
aS'H00636'
p39322
aS'Tetra-amelia'
p39323
aS'H00646'
p39324
aS'Odontoonychodermal dysplasia'
p39325
aS'H00681'
p39326
aS'Acne inversa'
p39327
aS'H00810'
p39328
aS'Progressive myoclonic epilepsy (PME/ EPM)'
p39329
aS'H00857'
p39330
aS'Oligodontia-colorectal cancer syndrome'
p39331
aS'H00881'
p39332
aS'Li-Fraumeni syndrome'
p39333
aS'H00934'
p39334
aS'Caudal duplication anomaly'
p39335
aS'H00947'
p39336
aS'Pilomatricoma'
p39337
aS'H00949'
p39338
aS'Focal dermal hypoplasia'
p39339
aS'H00979'
p39340
aS'Caudal regression syndrome and Sirenomelia'
p39341
aS'H01007'
p39342
aS'Choroid plexus papilloma'
p39343
aS'H01023'
p39344
aS'Juvenile polyposis syndrome'
p39345
aS'H01025'
p39346
aS'Familial adenomatous polyposis'
p39347
aS'H01037'
p39348
aS'Vesicoureteral reflux'
p39349
aS'H01307'
p39350
aS'Nonsyndromic congenital nail disorder (NDNC)'
p39351
asS'MODULE'
p39352
(lp39353
S'M00380'
p39354
aS'SCF-BTRC complex [PATH:map04310]'
p39355
ag39354
ag39355
aS'M00677'
p39356
aS'Wnt signaling [PATH:map04310]'
p39357
asS'DBLINKS'
p39358
(lp39359
S'GO: 0016055'
p39360
asS'ENTRY'
p39361
(lp39362
S'map04310'
p39363
aS'Pathway'
p39364
asS'CLASS'
p39365
(lp39366
S'Environmental Information Processing Signal transduction'
p39367
asS'DESCRIPTION'
p39368
(lp39369
S'Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.'
p39370
assS'path:map00510'
p39371
(dp39372
S'NAME'
p39373
(lp39374
S'N-Glycan biosynthesis'
p39375
asS'REFERENCE'
p39376
(lp39377
S'PMID:9111134'
p39378
ag39378
aS'AUTHORS'
p39379
aS'Schutzbach JS.'
p39380
aS'TITLE'
p39381
aS'The role of the lipid matrix in the biosynthesis of dolichyl-linked oligosaccharides.'
p39382
aS'JOURNAL'
p39383
aS'Glycoconj J 14:175-82 (1997)'
p39384
aS'PMID:12200473'
p39385
ag39385
aS'AUTHORS'
p39386
aS'Oriol R, Martinez-Duncker I, Chantret I, Mollicone R, Codogno P.'
p39387
aS'TITLE'
p39388
aS'Common origin and evolution of glycosyltransferases using Dol-P-monosaccharides as donor substrate.'
p39389
aS'JOURNAL'
p39390
aS'Mol Biol Evol 19:1451-63 (2002)'
p39391
aS'PMID:12684507'
p39392
ag39392
aS'AUTHORS'
p39393
aS'Thiel C, Schwarz M, Peng J, Grzmil M, Hasilik M, Braulke T, Kohlschutter A, von Figura K, Lehle L, Korner C.'
p39394
aS'TITLE'
p39395
aS'A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis.'
p39396
aS'JOURNAL'
p39397
aS'J Biol Chem 278:22498-505 (2003)'
p39398
aS'PMID:11278778'
p39399
ag39399
aS'AUTHORS'
p39400
aS'Cipollo JF, Trimble RB, Chi JH, Yan Q, Dean N.'
p39401
aS'TITLE'
p39402
aS'The yeast ALG11 gene specifies addition of the terminal alpha 1,2-Man to the Man5GlcNAc2-PP-dolichol N-glycosylation intermediate formed on the cytosolic side of the endoplasmic reticulum.'
p39403
aS'JOURNAL'
p39404
aS'J Biol Chem 276:21828-40 (2001)'
p39405
aS'PMID:15987956'
p39406
ag39406
aS'AUTHORS'
p39407
aS'Frank CG, Aebi M.'
p39408
aS'TITLE'
p39409
aS'ALG9 mannosyltransferase is involved in two different steps of lipid-linked oligosaccharide biosynthesis.'
p39410
aS'JOURNAL'
p39411
aS'Glycobiology 15:1156-63 (2005)'
p39412
aS'PMID:16878994'
p39413
ag39413
aS'AUTHORS'
p39414
aS"O'Reilly MK, Zhang G, Imperiali B."
p39415
aS'TITLE'
p39416
aS'In vitro evidence for the dual function of Alg2 and Alg11: essential mannosyltransferases in N-linked glycoprotein biosynthesis.'
p39417
aS'JOURNAL'
p39418
aS'Biochemistry 45:9593-603 (2006)'
p39419
asS'KO_PATHWAY'
p39420
(lp39421
S'ko00510'
p39422
asS'PATHWAY_MAP'
p39423
(lp39424
S'map00510'
p39425
asS'DISEASE'
p39426
(lp39427
S'H00118'
p39428
aS'Congenital disorders of glycosylation (CDG) type I'
p39429
ag39428
ag39429
aS'H00119'
p39430
aS'Congenital disorders of glycosylation (CDG) type II'
p39431
aS'H00768'
p39432
aS'Nonsyndromic autosomal recessive mental retardation (NS-ARMR)'
p39433
asS'MODULE'
p39434
(lp39435
S'M00055'
p39436
aS'N-glycan precursor biosynthesis [PATH:map00510]'
p39437
ag39436
ag39437
aS'M00072'
p39438
aS'N-glycosylation by oligosaccharyltransferase [PATH:map00510]'
p39439
aS'M00073'
p39440
aS'N-glycan precursor trimming [PATH:map00510]'
p39441
aS'M00074'
p39442
aS'N-glycan biosynthesis, high-mannose type [PATH:map00510]'
p39443
aS'M00075'
p39444
aS'N-glycan biosynthesis, complex type [PATH:map00510]'
p39445
asS'DBLINKS'
p39446
(lp39447
S'GO: 0006487'
p39448
asS'ENTRY'
p39449
(lp39450
S'map00510'
p39451
aS'Pathway'
p39452
asS'CLASS'
p39453
(lp39454
S'Metabolism Glycan biosynthesis and metabolism'
p39455
asS'DESCRIPTION'
p39456
(lp39457
S'N-glycans or asparagine-linked glycans are major constituents of glycoproteins in eukaryotes. N-glycans are covalently attached to asparagine with the consensus sequence of Asn-X-Ser/Thr by an N-glycosidic bond, GlcNAc b1- Asn. Biosynthesis of N-glycans begins on the cytoplasmic face of the ER membrane with the transferase reaction of UDP-GlcNAc and the lipid-like precursor P-Dol (dolichol phosphate) to generate GlcNAc a1- PP-Dol. After sequential addition of monosaccharides by ALG glycosyltransferases [MD:M00055], the N-glycan precursor is attached by the OST (oligosaccharyltransferase) complex to the polypeptide chain that is being synthesized and translocated through the ER membrane. The protein-bound N-glycan precursor is subsequently trimmed, extended, and modified in the ER and Golgi by a complex series of reactions catalyzed by membrane-bound glycosidases and glycosyltransferases. N-glycans thus synthesized are classified into three types: high-mannose type, complex type, and hybrid type. Defects in N-glycan biosynthesis lead to a variety of human diseases known as congenital disorders of glycosylation [DS:H00118 H00119].'
p39458
assS'path:map00511'
p39459
(dp39460
S'NAME'
p39461
(lp39462
S'Other glycan degradation'
p39463
asS'KO_PATHWAY'
p39464
(lp39465
S'ko00511'
p39466
asS'ENTRY'
p39467
(lp39468
S'map00511'
p39469
aS'Pathway'
p39470
asS'PATHWAY_MAP'
p39471
(lp39472
S'map00511'
p39473
asS'DISEASE'
p39474
(lp39475
S'H00124'
p39476
aS'GM2 gangliosidoses'
p39477
ag39476
ag39477
aS'H00126'
p39478
aS'Gaucher disease'
p39479
aS'H00139'
p39480
aS'alpha-Mannosidosis'
p39481
aS'H00140'
p39482
aS'beta-Mannosidosis'
p39483
aS'H00141'
p39484
aS'Fucosidosis'
p39485
aS'H00142'
p39486
aS'Sialidosis'
p39487
aS'H00145'
p39488
aS'Aspartylglucosaminuria (AGU)'
p39489
aS'H00281'
p39490
aS'GM1 gangliosidosis'
p39491
aS'H00422'
p39492
aS'Glycoproteinoses'
p39493
aS'H00426'
p39494
aS'Defects in the degradation of ganglioside'
p39495
aS'H00810'
p39496
aS'Progressive myoclonic epilepsy (PME/ EPM)'
p39497
asS'CLASS'
p39498
(lp39499
S'Metabolism Glycan biosynthesis and metabolism'
p39500
assS'path:map00512'
p39501
(dp39502
S'NAME'
p39503
(lp39504
S'Mucin type O-Glycan biosynthesis'
p39505
asS'REFERENCE'
p39506
(lp39507
S'PMID:10580130'
p39508
ag39508
aS'AUTHORS'
p39509
aS'Brockhausen I.'
p39510
aS'TITLE'
p39511
aS'Pathways of O-glycan biosynthesis in cancer cells.'
p39512
aS'JOURNAL'
p39513
aS'Biochim Biophys Acta 1473:67-95 (1999)'
p39514
aS'PMID:11821425'
p39515
ag39515
aS'AUTHORS'
p39516
aS'Iwai T, Inaba N, Naundorf A, Zhang Y, Gotoh M, Iwasaki H, Kudo T, Togayachi A, Ishizuka Y, Nakanishi H, Narimatsu H.'
p39517
aS'TITLE'
p39518
aS'Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans.'
p39519
aS'JOURNAL'
p39520
aS'J Biol Chem 277:12802-9 (2002)'
p39521
aS'PMID:12626393'
p39522
ag39522
aS'AUTHORS'
p39523
aS'Korekane H, Taguchi T, Sakamoto Y, Honke K, Dohmae N, Salminen H, Toivonen S, Helin J, Takio K, Renkonen O, Taniguchi N.'
p39524
aS'TITLE'
p39525
aS'Purification and cDNA cloning of UDP-GlcNAc:GlcNAcbeta1-3Galbeta1-4Glc(NAc)-R [GlcNAc to Gal]beta1,6N-acetylglucosaminyltransferase from rat small intestine: a major carrier of dIGnT activity in rat small intestine.'
p39526
aS'JOURNAL'
p39527
aS'Glycobiology 13:387-400 (2003)'
p39528
aS'PMID:10350056'
p39529
ag39529
aS'AUTHORS'
p39530
aS'van Die I, van Tetering A, Schiphorst WE, Sato T, Furukawa K, van den Eijnden DH.'
p39531
aS'TITLE'
p39532
aS'The acceptor substrate specificity of human beta4-galactosyltransferase V indicates its potential function in O-glycosylation.'
p39533
aS'JOURNAL'
p39534
aS'FEBS Lett 450:52-6 (1999)'
p39535
asS'KO_PATHWAY'
p39536
(lp39537
S'ko00512'
p39538
asS'PATHWAY_MAP'
p39539
(lp39540
S'map00512'
p39541
asS'DISEASE'
p39542
(lp39543
S'H01188'
p39544
aS'Tn syndrome'
p39545
ag39544
ag39545
aS'H01193'
p39546
aS'Familial tumoral calcinosis (FTC)'
p39547
asS'MODULE'
p39548
(lp39549
S'M00056'
p39550
aS'O-glycan biosynthesis, mucin type core [PATH:map00512]'
p39551
asS'DBLINKS'
p39552
(lp39553
S'GO: 0006493'
p39554
asS'ENTRY'
p39555
(lp39556
S'map00512'
p39557
aS'Pathway'
p39558
asS'CLASS'
p39559
(lp39560
S'Metabolism Glycan biosynthesis and metabolism'
p39561
asS'DESCRIPTION'
p39562
(lp39563
S'O-glycans are a class of glycans that modify serine or threonine residues of proteins. Biosynthesis of O-glycans starts from the transfer of N-acetylgalactosamine (GalNAc) to serine or threonine. The first GalNAc may be extended with sugars including galactose, N-acetylglucosamine, fucose, or sialic acid, but not mannose, glucose, or xylose. Depending on the sugars added, there are four common O-glycan core structures, cores 1 through 4, and an additional four, cores 5 though 8. Mucins are highly O-glycosylated glycoproteins ubiquitous in mucous secretions on cell surfaces and in body fluids. Mucin O-glycans can be branched, and many sugars or groups of sugars are antigenic. Important modifications of mucin O-glycans include O-acetylation of sialic acid and O-sulfation of galactose and N-acetylglucosamine.'
p39564
assS'path:map00513'
p39565
(dp39566
S'NAME'
p39567
(lp39568
S'Various types of N-glycan biosynthesis'
p39569
asS'REFERENCE'
p39570
(lp39571
S'PMID:11412862'
p39572
ag39572
aS'AUTHORS'
p39573
aS'Munro S.'
p39574
aS'TITLE'
p39575
aS'What can yeast tell us about N-linked glycosylation in the Golgi apparatus?'
p39576
aS'JOURNAL'
p39577
aS'FEBS Lett 498:223-7 (2001)'
p39578
aS'PMID:9878803'
p39579
ag39579
aS'AUTHORS'
p39580
aS'Dean N.'
p39581
aS'TITLE'
p39582
aS'Asparagine-linked glycosylation in the yeast Golgi.'
p39583
aS'JOURNAL'
p39584
aS'Biochim Biophys Acta 1426:309-22 (1999)'
p39585
aS'PMID:9878780'
p39586
ag39586
aS'AUTHORS'
p39587
aS'Herscovics A.'
p39588
aS'TITLE'
p39589
aS'Processing glycosidases of Saccharomyces cerevisiae.'
p39590
aS'JOURNAL'
p39591
aS'Biochim Biophys Acta 1426:275-85 (1999)'
p39592
aS'PMID:9218445'
p39593
ag39593
aS'AUTHORS'
p39594
aS'Wang XH, Nakayama K, Shimma Y, Tanaka A, Jigami Y.'
p39595
aS'TITLE'
p39596
aS'MNN6, a member of the KRE2/MNT1 family, is the gene for mannosylphosphate transfer in Saccharomyces cerevisiae.'
p39597
aS'JOURNAL'
p39598
aS'J Biol Chem 272:18117-24 (1997)'
p39599
aS'PMID:9756928'
p39600
ag39600
aS'AUTHORS'
p39601
aS'Rayner JC, Munro S.'
p39602
aS'TITLE'
p39603
aS'Identification of the MNN2 and MNN5 mannosyltransferases required for forming and extending the mannose branches of the outer chain mannans of Saccharomyces cerevisiae.'
p39604
aS'JOURNAL'
p39605
aS'J Biol Chem 273:26836-43 (1998)'
p39606
aS'PMID:10037752'
p39607
ag39607
aS'AUTHORS'
p39608
aS'Jungmann J, Rayner JC, Munro S.'
p39609
aS'TITLE'
p39610
aS'The Saccharomyces cerevisiae protein Mnn10p/Bed1p is a subunit of a Golgi mannosyltransferase complex.'
p39611
aS'JOURNAL'
p39612
aS'J Biol Chem 274:6579-85 (1999)'
p39613
aS'PMID:8253757'
p39614
ag39614
aS'AUTHORS'
p39615
aS'Nakanishi-Shindo Y, Nakayama K, Tanaka A, Toda Y, Jigami Y.'
p39616
aS'TITLE'
p39617
aS'Structure of the N-linked oligosaccharides that show the complete loss of alpha-1,6-polymannose outer chain from och1, och1 mnn1, and och1 mnn1 alg3 mutants of Saccharomyces cerevisiae.'
p39618
aS'JOURNAL'
p39619
aS'J Biol Chem 268:26338-45 (1993)'
p39620
aS'PMID:20233335'
p39621
ag39621
aS'AUTHORS'
p39622
aS'Gomord V, Fitchette AC, Menu-Bouaouiche L, Saint-Jore-Dupas C, Plasson C, Michaud D, Faye L'
p39623
aS'TITLE'
p39624
aS'Plant-specific glycosylation patterns in the context of therapeutic protein production.'
p39625
aS'JOURNAL'
p39626
aS'Plant Biotechnol J 8:564-87 (2010)'
p39627
asS'KO_PATHWAY'
p39628
(lp39629
S'ko00513'
p39630
asS'PATHWAY_MAP'
p39631
(lp39632
S'map00513'
p39633
asS'MODULE'
p39634
(lp39635
S'M00074'
p39636
aS'N-glycan biosynthesis, high-mannose type [PATH:map00513]'
p39637
asS'DBLINKS'
p39638
(lp39639
S'GO: 0006487'
p39640
asS'ENTRY'
p39641
(lp39642
S'map00513'
p39643
aS'Pathway'
p39644
asS'CLASS'
p39645
(lp39646
S'Metabolism Glycan biosynthesis and metabolism'
p39647
assS'path:map00514'
p39648
(dp39649
S'NAME'
p39650
(lp39651
S'Other types of O-glycan biosynthesis'
p39652
asS'REFERENCE'
p39653
(lp39654
S'PMID:22669261'
p39655
ag39655
aS'AUTHORS'
p39656
aS'Kizuka Y, Oka S'
p39657
aS'TITLE'
p39658
aS'Regulated expression and neural functions of human natural killer-1 (HNK-1) carbohydrate.'
p39659
aS'JOURNAL'
p39660
aS'Cell Mol Life Sci 69:4135-47 (2012)'
p39661
aS'PMID:19429925'
p39662
ag39662
aS'AUTHORS'
p39663
aS'Lommel M, Strahl S'
p39664
aS'TITLE'
p39665
aS'Protein O-mannosylation: conserved from bacteria to humans.'
p39666
aS'JOURNAL'
p39667
aS'Glycobiology 19:816-28 (2009)'
p39668
asS'KO_PATHWAY'
p39669
(lp39670
S'ko00514'
p39671
asS'PATHWAY_MAP'
p39672
(lp39673
S'map00514'
p39674
asS'DISEASE'
p39675
(lp39676
S'H00120'
p39677
aS'Dystroglycanopathy'
p39678
ag39677
ag39678
aS'H00590'
p39679
aS'Congenital muscular dystrophies (CMD/MDC)'
p39680
aS'H00593'
p39681
aS'Limb-girdle muscular dystrophy (LGMD)'
p39682
aS'H00768'
p39683
aS'Nonsyndromic autosomal recessive mental retardation (NS-ARMR)'
p39684
aS'H01075'
p39685
aS'Peters anomaly'
p39686
aS'H01192'
p39687
aS'Lysyl hydroxylase 3 (LH3) deficiency'
p39688
asS'ENTRY'
p39689
(lp39690
S'map00514'
p39691
aS'Pathway'
p39692
asS'CLASS'
p39693
(lp39694
S'Metabolism Glycan biosynthesis and metabolism'
p39695
asS'DESCRIPTION'
p39696
(lp39697
S'O-mannosyl glycans are a type of O-glycans that are found both in eukaryotes and prokaryotes. Biosynthesis of O-mannosyl glycans is initiated by the transfer of mannose from Man-P-Dol to serine or threonine residue, which is catalyzed by protein O-mannosyltransferases POMT1 and POMT2. Defects of these genes are linked to human diseases, such as muscular dystrophies caused by reduced O-mannosylation of alpha-dystroglycan in skeletal muscles [DS:H00120].'
p39698
assS'path:map00040'
p39699
(dp39700
S'NAME'
p39701
(lp39702
S'Pentose and glucuronate interconversions'
p39703
asS'REFERENCE'
p39704
(lp39705
S'PMID:11741871'
p39706
ag39706
aS'AUTHORS'
p39707
aS'Yew WS, Gerlt JA.'
p39708
aS'TITLE'
p39709
aS'Utilization of L-ascorbate by Escherichia coli K-12: assignments of functions to products of the yjf-sga and yia-sgb operons.'
p39710
aS'JOURNAL'
p39711
aS'J Bacteriol 184:302-6 (2002)'
p39712
aS'PMID:15697206'
p39713
ag39713
aS'AUTHORS'
p39714
aS'Yew WS, Akana J, Wise EL, Rayment I, Gerlt JA'
p39715
aS'TITLE'
p39716
aS"Evolution of enzymatic activities in the orotidine 5'-monophosphate decarboxylase suprafamily: enhancing the promiscuous D-arabino-hex-3-ulose 6-phosphate synthase reaction catalyzed by 3-keto-L-gulonate 6-phosphate decarboxylase."
p39717
aS'JOURNAL'
p39718
aS'Biochemistry 44:1807-15 (2005)'
p39719
aS'PMID:10572115'
p39720
ag39720
aS'AUTHORS'
p39721
aS'Yasueda H, Kawahara Y, Sugimoto S.'
p39722
aS'TITLE'
p39723
aS'Bacillus subtilis yckG and yckF encode two key enzymes of the ribulose monophosphate pathway used by methylotrophs, and yckH is required for their expression.'
p39724
aS'JOURNAL'
p39725
aS'J Bacteriol 181:7154-60 (1999)'
p39726
aS'PMID:10913097'
p39727
ag39727
aS'AUTHORS'
p39728
aS'Ibanez E, Gimenez R, Pedraza T, Baldoma L, Aguilar J, Badia J'
p39729
aS'TITLE'
p39730
aS'Role of the yiaR and yiaS genes of Escherichia coli in metabolism of endogenously formed L-xylulose.'
p39731
aS'JOURNAL'
p39732
aS'J Bacteriol 182:4625-7 (2000)'
p39733
aS'PMID:15901685'
p39734
ag39734
aS'AUTHORS'
p39735
aS'Orita I, Yurimoto H, Hirai R, Kawarabayasi Y, Sakai Y, Kato N'
p39736
aS'TITLE'
p39737
aS'The archaeon Pyrococcus horikoshii possesses a bifunctional enzyme for formaldehyde fixation via the ribulose monophosphate pathway.'
p39738
aS'JOURNAL'
p39739
aS'J Bacteriol 187:3636-42 (2005)'
p39740
asS'KO_PATHWAY'
p39741
(lp39742
S'ko00040'
p39743
asS'PATHWAY_MAP'
p39744
(lp39745
S'map00040'
p39746
asS'DISEASE'
p39747
(lp39748
S'H01065'
p39749
aS'Pentosuria'
p39750
ag39749
ag39750
aS'H01193'
p39751
aS'Familial tumoral calcinosis (FTC)'
p39752
asS'MODULE'
p39753
(lp39754
S'M00014'
p39755
aS'Glucuronate pathway (uronate pathway) [PATH:map00040]'
p39756
ag39755
ag39756
aS'M00061'
p39757
aS'D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P [PATH:map00040]'
p39758
aS'M00081'
p39759
aS'Pectin degradation [PATH:map00040]'
p39760
aS'M00129'
p39761
aS'Ascorbate biosynthesis, animals, glucose-1P => ascorbate [PATH:map00040]'
p39762
aS'M00630'
p39763
aS'D-Galacturonate degradation (fungi), D-galacturonate => glycerol [PATH:map00040]'
p39764
aS'M00631'
p39765
aS'D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P [PATH:map00040]'
p39766
asS'ENTRY'
p39767
(lp39768
S'map00040'
p39769
aS'Pathway'
p39770
asS'CLASS'
p39771
(lp39772
S'Metabolism Carbohydrate metabolism'
p39773
assS'path:map04727'
p39774
(dp39775
S'NAME'
p39776
(lp39777
S'GABAergic synapse'
p39778
asS'REFERENCE'
p39779
(lp39780
g22
ag22
aS'AUTHORS'
p39781
aS'Davis KL, Charney D, Coyle JT, Nemeroff C (ed).'
p39782
aS'TITLE'
p39783
aS'Neuropsychopharmacology: The fifth generation of progress'
p39784
aS'JOURNAL'
p39785
aS'Lippincott Williams & Wikins (2002)'
p39786
aS'PMID:17499109'
p39787
ag39787
aS'AUTHORS'
p39788
aS'Farrant M, Kaila K'
p39789
aS'TITLE'
p39790
aS'The cellular, molecular and ionic basis of GABA(A) receptor signalling.'
p39791
aS'JOURNAL'
p39792
aS'Prog Brain Res 160:59-87 (2007)'
p39793
aS'PMID:9364667'
p39794
ag39794
aS'AUTHORS'
p39795
aS'Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa JL'
p39796
aS'TITLE'
p39797
aS"GABAA, NMDA and AMPA receptors: a developmentally regulated 'menage a trois'."
p39798
aS'JOURNAL'
p39799
aS'Trends Neurosci 20:523-9 (1997)'
p39800
aS'PMID:20655485'
p39801
ag39801
aS'AUTHORS'
p39802
aS'Pinard A, Seddik R, Bettler B'
p39803
aS'TITLE'
p39804
aS'GABAB receptors: physiological functions and mechanisms of diversity.'
p39805
aS'JOURNAL'
p39806
aS'Adv Pharmacol 58:231-55 (2010)'
p39807
aS'PMID:21376567'
p39808
ag39808
aS'AUTHORS'
p39809
aS'Chalifoux JR, Carter AG'
p39810
aS'TITLE'
p39811
aS'GABAB receptor modulation of synaptic function.'
p39812
aS'JOURNAL'
p39813
aS'Curr Opin Neurobiol 21:339-44 (2011)'
p39814
aS'PMID:20655481'
p39815
ag39815
aS'AUTHORS'
p39816
aS'Padgett CL, Slesinger PA'
p39817
aS'TITLE'
p39818
aS'GABAB receptor coupling to G-proteins and ion channels.'
p39819
aS'JOURNAL'
p39820
aS'Adv Pharmacol 58:123-47 (2010)'
p39821
aS'PMID:17499108'
p39822
ag39822
aS'AUTHORS'
p39823
aS'Emson PC'
p39824
aS'TITLE'
p39825
aS'GABA(B) receptors: structure and function.'
p39826
aS'JOURNAL'
p39827
aS'Prog Brain Res 160:43-57 (2007)'
p39828
aS'PMID:16932937'
p39829
ag39829
aS'AUTHORS'
p39830
aS'Kornau HC'
p39831
aS'TITLE'
p39832
aS'GABA(B) receptors and synaptic modulation.'
p39833
aS'JOURNAL'
p39834
aS'Cell Tissue Res 326:517-33 (2006)'
p39835
aS'PMID:18382465'
p39836
ag39836
aS'AUTHORS'
p39837
aS'Jacob TC, Moss SJ, Jurd R'
p39838
aS'TITLE'
p39839
aS'GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition.'
p39840
aS'JOURNAL'
p39841
aS'Nat Rev Neurosci 9:331-43 (2008)'
p39842
aS'PMID:12086709'
p39843
ag39843
aS'AUTHORS'
p39844
aS'Kneussel M'
p39845
aS'TITLE'
p39846
aS'Dynamic regulation of GABA(A) receptors at synaptic sites.'
p39847
aS'JOURNAL'
p39848
aS'Brain Res Brain Res Rev 39:74-83 (2002)'
p39849
aS'PMID:21555068'
p39850
ag39850
aS'AUTHORS'
p39851
aS'Luscher B, Fuchs T, Kilpatrick CL'
p39852
aS'TITLE'
p39853
aS'GABAA receptor trafficking-mediated plasticity of inhibitory synapses.'
p39854
aS'JOURNAL'
p39855
aS'Neuron 70:385-409 (2011)'
p39856
aS'PMID:19374920'
p39857
ag39857
aS'AUTHORS'
p39858
aS'Arancibia-Carcamo IL, Kittler JT'
p39859
aS'TITLE'
p39860
aS'Regulation of GABA(A) receptor membrane trafficking and synaptic localization.'
p39861
aS'JOURNAL'
p39862
aS'Pharmacol Ther 123:17-31 (2009)'
p39863
aS'(Japanese)'
p39864
ag39864
aS'AUTHORS'
p39865
aS'Kanematsu T, Terunuma M, Goto H, Kuratani A, Hirata M.'
p39866
aS'TITLE'
p39867
aS'[The life cycle of the GABAA receptor and its regulating molecules] (In Japanese)'
p39868
aS'JOURNAL'
p39869
aS'Folia Pharmacol. Jpn. (Nippon Yakurigaku Sasshi) (2004)'
p39870
aS'PMID:16787421'
p39871
ag39871
aS'AUTHORS'
p39872
aS'Bak LK, Schousboe A, Waagepetersen HS'
p39873
aS'TITLE'
p39874
aS'The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer.'
p39875
aS'JOURNAL'
p39876
aS'J Neurochem 98:641-53 (2006)'
p39877
aS'PMID:15210304'
p39878
ag39878
aS'AUTHORS'
p39879
aS'Conti F, Minelli A, Melone M'
p39880
aS'TITLE'
p39881
aS'GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications.'
p39882
aS'JOURNAL'
p39883
aS'Brain Res Brain Res Rev 45:196-212 (2004)'
p39884
aS'PMID:12888801'
p39885
ag39885
aS'AUTHORS'
p39886
aS'Brambilla P, Perez J, Barale F, Schettini G, Soares JC'
p39887
aS'TITLE'
p39888
aS'GABAergic dysfunction in mood disorders.'
p39889
aS'JOURNAL'
p39890
aS'Mol Psychiatry 8:721-37, 715 (2003)'
p39891
aS'PMID:10780899'
p39892
ag39892
aS'AUTHORS'
p39893
aS'Chebib M, Johnston GA'
p39894
aS'TITLE'
p39895
aS'GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.'
p39896
aS'JOURNAL'
p39897
aS'J Med Chem 43:1427-47 (2000)'
p39898
asS'KO_PATHWAY'
p39899
(lp39900
S'ko04727'
p39901
asS'PATHWAY_MAP'
p39902
(lp39903
S'map04727'
p39904
asS'DISEASE'
p39905
(lp39906
S'H00746'
p39907
aS'Hypokalemic periodic paralysis (HypoPP)'
p39908
ag39907
ag39908
aS'H00749'
p39909
aS'Episodic ataxias'
p39910
aS'H00775'
p39911
aS'Familial or sporadic hemiplegic migraine'
p39912
aS'H00783'
p39913
aS'Febrile seizures'
p39914
aS'H00808'
p39915
aS'Idiopathic generalized epilepsies (IGEs)'
p39916
aS'H00923'
p39917
aS'Congenital systemic glutamine deficiency (CSGD)'
p39918
aS'H01097'
p39919
aS'Cerebral palsy'
p39920
asS'DBLINKS'
p39921
(lp39922
S'GO: 0051932'
p39923
asS'ENTRY'
p39924
(lp39925
S'map04727'
p39926
aS'Pathway'
p39927
asS'CLASS'
p39928
(lp39929
S'Organismal Systems Nervous system'
p39930
asS'DESCRIPTION'
p39931
(lp39932
S'Gamma aminobutyric acid (GABA) is the most abundant inhibitory neurotransmitter in the mammalian central nervous system (CNS). When released in the synaptic cleft, GABA binds to three major classes of receptors: GABAA, GABAB, and GABAC receptors. GABAA and GABAC receptors are ionotropic and mediate fast GABA responses by triggering chloride channel openings, while GABAB receptors are metabotropic and mediate slower GABA responses by activating G-proteins and influencing second messenger systems. GABAA receptors, the major sites for fast inhibitory neurotransmission in the CNS, are regulated by phosphorylation mechanisms, affecting both their functional properties and their cell surface mobility and trafficking. GABA release by the presynaptic terminal is negatively regulated by GABAB autoreceptors, and is cleared from the extracellular space by GABA transporters (GATs) located either on the presynaptic terminal or neighboring glial cells.'
p39933
assS'path:map04726'
p39934
(dp39935
S'NAME'
p39936
(lp39937
S'Serotonergic synapse'
p39938
asS'REFERENCE'
p39939
(lp39940
S'PMID:18676031'
p39941
ag39941
aS'AUTHORS'
p39942
aS'Millan MJ, Marin P, Bockaert J, Mannoury la Cour C'
p39943
aS'TITLE'
p39944
aS'Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions.'
p39945
aS'JOURNAL'
p39946
aS'Trends Pharmacol Sci 29:454-64 (2008)'
p39947
aS'PMID:16896947'
p39948
ag39948
aS'AUTHORS'
p39949
aS'Bockaert J, Claeysen S, Becamel C, Dumuis A, Marin P'
p39950
aS'TITLE'
p39951
aS'Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling,'
p39952
aS'and roles in synaptic modulation.'
p39953
aS'JOURNAL'
p39954
aS'Cell Tissue Res 326:553-72 (2006)'
p39955
aS'PMID:11916537'
p39956
ag39956
aS'AUTHORS'
p39957
aS'Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN'
p39958
aS'TITLE'
p39959
aS'Multiplicity of mechanisms of serotonin receptor signal transduction.'
p39960
aS'JOURNAL'
p39961
aS'Pharmacol Ther 92:179-212 (2001)'
p39962
aS'PMID:15034221'
p39963
ag39963
aS'AUTHORS'
p39964
aS'Noda M, Higashida H, Aoki S, Wada K'
p39965
aS'TITLE'
p39966
aS'Multiple signal transduction pathways mediated by 5-HT receptors.'
p39967
aS'JOURNAL'
p39968
aS'Mol Neurobiol 29:31-9 (2004)'
p39969
aS'PMID:20561690'
p39970
ag39970
aS'AUTHORS'
p39971
aS'Daubert EA, Condron BG'
p39972
aS'TITLE'
p39973
aS'Serotonin: a regulator of neuronal morphology and circuitry.'
p39974
aS'JOURNAL'
p39975
aS'Trends Neurosci 33:424-34 (2010)'
p39976
aS'PMID:16826372'
p39977
ag39977
aS'AUTHORS'
p39978
aS'Chameau P, van Hooft JA'
p39979
aS'TITLE'
p39980
aS'Serotonin 5-HT(3) receptors in the central nervous system.'
p39981
aS'JOURNAL'
p39982
aS'Cell Tissue Res 326:573-81 (2006)'
p39983
aS'PMID:9651340'
p39984
ag39984
aS'AUTHORS'
p39985
aS'Tournois C, Mutel V, Manivet P, Launay JM, Kellermann O'
p39986
aS'TITLE'
p39987
aS'Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolism.'
p39988
aS'JOURNAL'
p39989
aS'J Biol Chem 273:17498-503 (1998)'
p39990
aS'PMID:19545642'
p39991
ag39991
aS'AUTHORS'
p39992
aS'Iliff JJ, Jia J, Nelson J, Goyagi T, Klaus J, Alkayed NJ'
p39993
aS'TITLE'
p39994
aS'Epoxyeicosanoid signaling in CNS function and disease.'
p39995
aS'JOURNAL'
p39996
aS'Prostaglandins Other Lipid Mediat 91:68-84 (2010)'
p39997
aS'PMID:12676358'
p39998
ag39998
aS'AUTHORS'
p39999
aS'Adayev T, Ray I, Sondhi R, Sobocki T, Banerjee P'
p40000
aS'TITLE'
p40001
aS'The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Calpha.'
p40002
aS'JOURNAL'
p40003
aS'Biochim Biophys Acta 1640:85-96 (2003)'
p40004
aS'PMID:11701344'
p40005
ag40005
aS'AUTHORS'
p40006
aS'Albert PR, Tiberi M'
p40007
aS'TITLE'
p40008
aS'Receptor signaling and structure: insights from serotonin-1 receptors.'
p40009
aS'JOURNAL'
p40010
aS'Trends Endocrinol Metab 12:453-60 (2001)'
p40011
aS'PMID:9658404'
p40012
ag40012
aS'AUTHORS'
p40013
aS'Durham PL, Russo AF'
p40014
aS'TITLE'
p40015
aS'Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.'
p40016
aS'JOURNAL'
p40017
aS'Mol Endocrinol 12:1002-9 (1998)'
p40018
aS'PMID:15710402'
p40019
ag40019
aS'AUTHORS'
p40020
aS"Robert S, Maillet M, Morel E, Launay JM, Fischmeister R, Mercken L, Lezoualc'h F"
p40021
aS'TITLE'
p40022
aS'Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and Epac.'
p40023
aS'JOURNAL'
p40024
aS'FEBS Lett 579:1136-42 (2005)'
p40025
aS'PMID:12543273'
p40026
ag40026
aS'AUTHORS'
p40027
aS"Lezoualc'h F, Robert SJ"
p40028
aS'TITLE'
p40029
aS'The serotonin 5-HT4 receptor and the amyloid precursor protein processing.'
p40030
aS'JOURNAL'
p40031
aS'Exp Gerontol 38:159-66 (2003)'
p40032
aS'PMID:11043573'
p40033
ag40033
aS'AUTHORS'
p40034
aS'Durham PL, Russo AF'
p40035
aS'TITLE'
p40036
aS'Differential regulation of mitogen-activated protein kinase-responsive genes by the duration of a calcium signal.'
p40037
aS'JOURNAL'
p40038
aS'Mol Endocrinol 14:1570-82 (2000)'
p40039
aS'PMID:9542727'
p40040
ag40040
aS'AUTHORS'
p40041
aS'Hagberg GB, Blomstrand F, Nilsson M, Tamir H, Hansson E'
p40042
aS'TITLE'
p40043
aS'Stimulation of 5-HT2A receptors on astrocytes in primary culture opens voltage-independent Ca2+ channels.'
p40044
aS'JOURNAL'
p40045
aS'Neurochem Int 32:153-62 (1998)'
p40046
ag22
ag22
aS'AUTHORS'
p40047
aS'Nestler EJ, Hyman SE, Malenka RC.'
p40048
aS'TITLE'
p40049
aS'Molecular neuropharmacology: A foundation for clinical neuroscience'
p40050
aS'JOURNAL'
p40051
aS'The McGraw-Hill Companies, Inc. (2001)'
p40052
asS'KO_PATHWAY'
p40053
(lp40054
S'ko04726'
p40055
asS'PATHWAY_MAP'
p40056
(lp40057
S'map04726'
p40058
asS'DISEASE'
p40059
(lp40060
S'H00833'
p40061
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p40062
ag40061
ag40062
aS'H01161'
p40063
aS'Aromatic L-amino acid decarboxylase (AADC) deficiency'
p40064
aS'H01185'
p40065
aS'Cerebral amyloid angiopathy (CAA)'
p40066
asS'DBLINKS'
p40067
(lp40068
S'GO: 0007210'
p40069
asS'ENTRY'
p40070
(lp40071
S'map04726'
p40072
aS'Pathway'
p40073
asS'CLASS'
p40074
(lp40075
S'Organismal Systems Nervous system'
p40076
asS'DESCRIPTION'
p40077
(lp40078
S"Serotonin (5-Hydroxytryptamine, 5-HT) is a monoamine neurotransmitter that plays important roles in physiological functions such as learning and memory, emotion, sleep, pain, motor function and endocrine secretion, as well as in pathological states including abnormal mood and cognition. Once released from presynaptic axonal terminals, 5-HT binds to receptors, which have been divided into 7 subfamilies on the basis of conserved structures and signaling mechanisms. These families include the ionotropic 5-HT3 receptors and G-protein-coupled 5-HT receptors, the 5-HT1 (Gi /Go -coupled), 5-HT2(Gq-coupled), 5-HT4/6/7 (Gs-coupled) and 5-HT5 receptors. Presynaptically localized 5-HT1B receptors are thought to be the autoreceptors that suppress excess 5-HT release. 5-HT's actions are terminated by transporter- mediated reuptake into neurons, leading to catabolism by monoamine oxidase."
p40079
assS'path:map04725'
p40080
(dp40081
S'NAME'
p40082
(lp40083
S'Cholinergic synapse'
p40084
asS'REFERENCE'
p40085
(lp40086
g22
ag22
aS'AUTHORS'
p40087
aS'Nestler EJ, Hyman SE, Malenka RC.'
p40088
aS'TITLE'
p40089
aS'Molecular neuropharmacology: A foundation for clinical neuroscience'
p40090
aS'JOURNAL'
p40091
aS'The McGraw-Hill Companies, Inc. (2001)'
p40092
ag22
ag22
aS'AUTHORS'
p40093
aS'Nicholls JG, Martin AR, Wallace BG, Fuchs PA.'
p40094
aS'TITLE'
p40095
aS'From neuron to brain, 4th ed.'
p40096
aS'JOURNAL'
p40097
aS'Sunderland, MA: Sinauer associates (2001)'
p40098
aS'PMID:15165747'
p40099
ag40099
aS'AUTHORS'
p40100
aS'Dajas-Bailador F, Wonnacott S'
p40101
aS'TITLE'
p40102
aS'Nicotinic acetylcholine receptors and the regulation of neuronal signalling.'
p40103
aS'JOURNAL'
p40104
aS'Trends Pharmacol Sci 25:317-24 (2004)'
p40105
aS'PMID:19712465'
p40106
ag40106
aS'AUTHORS'
p40107
aS'Resende RR, Adhikari A'
p40108
aS'TITLE'
p40109
aS'Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.'
p40110
aS'JOURNAL'
p40111
aS'Cell Commun Signal 7:20 (2009)'
p40112
aS'PMID:19378880'
p40113
ag40113
aS'AUTHORS'
p40114
aS'Origlia N, Kuczewski N, Pesavento E, Aztiria E, Domenici L'
p40115
aS'TITLE'
p40116
aS'The role of cholinergic system in neuronal plasticity: focus on visual cortex and muscarinic receptors.'
p40117
aS'JOURNAL'
p40118
aS'Arch Ital Biol 146:165-88 (2008)'
p40119
aS'PMID:21550798'
p40120
ag40120
aS'AUTHORS'
p40121
aS'Oldenburg IA, Ding JB'
p40122
aS'TITLE'
p40123
aS'Cholinergic modulation of synaptic integration and dendritic excitability in the'
p40124
aS'striatum.'
p40125
aS'JOURNAL'
p40126
aS'Curr Opin Neurobiol 21:425-32 (2011)'
p40127
aS'PMID:12893537'
p40128
ag40128
aS'AUTHORS'
p40129
aS'Lanzafame AA, Christopoulos A, Mitchelson F'
p40130
aS'TITLE'
p40131
aS'Cellular signaling mechanisms for muscarinic acetylcholine receptors.'
p40132
aS'JOURNAL'
p40133
aS'Receptors Channels 9:241-60 (2003)'
p40134
aS'PMID:20446119'
p40135
ag40135
aS'AUTHORS'
p40136
aS'Brown DA'
p40137
aS'TITLE'
p40138
aS'Muscarinic acetylcholine receptors (mAChRs) in the nervous system: some functions and mechanisms.'
p40139
aS'JOURNAL'
p40140
aS'J Mol Neurosci 41:340-6 (2010)'
p40141
aS'PMID:11738031'
p40142
ag40142
aS'AUTHORS'
p40143
aS'Chang KT, Berg DK'
p40144
aS'TITLE'
p40145
aS'Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons.'
p40146
aS'JOURNAL'
p40147
aS'Neuron 32:855-65 (2001)'
p40148
aS'PMID:11283752'
p40149
ag40149
aS'AUTHORS'
p40150
aS'Soreq H, Seidman S'
p40151
aS'TITLE'
p40152
aS'Acetylcholinesterase--new roles for an old actor.'
p40153
aS'JOURNAL'
p40154
aS'Nat Rev Neurosci 2:294-302 (2001)'
p40155
aS'PMID:12436417'
p40156
ag40156
aS'AUTHORS'
p40157
aS'Sharma G, Vijayaraghavan S'
p40158
aS'TITLE'
p40159
aS'Nicotinic receptor signaling in nonexcitable cells.'
p40160
aS'JOURNAL'
p40161
aS'J Neurobiol 53:524-34 (2002)'
p40162
aS'PMID:11923408'
p40163
ag40163
aS'AUTHORS'
p40164
aS'Araque A, Martin ED, Perea G, Arellano JI, Buno W'
p40165
aS'TITLE'
p40166
aS'Synaptically released acetylcholine evokes Ca2+ elevations in astrocytes in hippocampal slices.'
p40167
aS'JOURNAL'
p40168
aS'J Neurosci 22:2443-50 (2002)'
p40169
aS'PMID:12690458'
p40170
ag40170
aS'AUTHORS'
p40171
aS'Lucas-Meunier E, Fossier P, Baux G, Amar M'
p40172
aS'TITLE'
p40173
aS'Cholinergic modulation of the cortical neuronal network.'
p40174
aS'JOURNAL'
p40175
aS'Pflugers Arch 446:17-29 (2003)'
p40176
aS'PMID:20060019'
p40177
ag40177
aS'AUTHORS'
p40178
aS'Abreu-Villaca Y, Filgueiras CC, Manhaes AC'
p40179
aS'TITLE'
p40180
aS'Developmental aspects of the cholinergic system.'
p40181
aS'JOURNAL'
p40182
aS'Behav Brain Res 221:367-78 (2011)'
p40183
asS'KO_PATHWAY'
p40184
(lp40185
S'ko04725'
p40186
asS'PATHWAY_MAP'
p40187
(lp40188
S'map04725'
p40189
asS'DISEASE'
p40190
(lp40191
S'H00215'
p40192
aS'Periodic paralysis'
p40193
ag40192
ag40193
aS'H00606'
p40194
aS'Early infantile epileptic encephalopathy'
p40195
aS'H00746'
p40196
aS'Hypokalemic periodic paralysis (HypoPP)'
p40197
aS'H00748'
p40198
aS'Andersen-Tawil syndrome (ATS)'
p40199
aS'H00749'
p40200
aS'Episodic ataxias'
p40201
aS'H00770'
p40202
aS'Congenital myasthenic syndrome'
p40203
aS'H00775'
p40204
aS'Familial or sporadic hemiplegic migraine'
p40205
aS'H00806'
p40206
aS'Benign familial neonatal and infantile epilepsies'
p40207
aS'H00807'
p40208
aS'Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)'
p40209
asS'DBLINKS'
p40210
(lp40211
S'GO: 0032222'
p40212
asS'ENTRY'
p40213
(lp40214
S'map04725'
p40215
aS'Pathway'
p40216
asS'CLASS'
p40217
(lp40218
S'Organismal Systems Nervous system'
p40219
asS'DESCRIPTION'
p40220
(lp40221
S'Acetylcholine (ACh) is a neurotransmitter widely distributed in the central (and also peripheral, autonomic and enteric) nervous system (CNS). In the CNS, ACh facilitates many functions, such as learning, memory, attention and motor control. When released in the synaptic cleft, ACh binds to two distinct types of receptors: Ionotropic nicotinic acetylcholine receptors (nAChR) and metabotropic muscarinic acetylcholine receptors (mAChRs). The activation of nAChR by ACh leads to the rapid influx of Na+ and Ca2+ and subsequent cellular depolarization. Activation of mAChRs is relatively slow (milliseconds to seconds) and, depending on the subtypes present (M1-M5), they directly alter cellular homeostasis of phospholipase C, inositol trisphosphate, cAMP, and free calcium. In the cleft, ACh may also be hydrolyzed by acetylcholinesterase (AChE) into choline and acetate. The choline derived from ACh hydrolysis is recovered by a presynaptic high-affinity choline transporter (CHT).'
p40222
assS'path:map04724'
p40223
(dp40224
S'NAME'
p40225
(lp40226
S'Glutamatergic synapse'
p40227
asS'REFERENCE'
p40228
(lp40229
S'PMID:20055706'
p40230
ag40230
aS'AUTHORS'
p40231
aS'Niswender CM, Conn PJ'
p40232
aS'TITLE'
p40233
aS'Metabotropic glutamate receptors: physiology, pharmacology, and disease.'
p40234
aS'JOURNAL'
p40235
aS'Annu Rev Pharmacol Toxicol 50:295-322 (2010)'
p40236
aS'PMID:19112153'
p40237
ag40237
aS'AUTHORS'
p40238
aS'Ferraguti F, Crepaldi L, Nicoletti F'
p40239
aS'TITLE'
p40240
aS'Metabotropic glutamate 1 receptor: current concepts and perspectives.'
p40241
aS'JOURNAL'
p40242
aS'Pharmacol Rev 60:536-81 (2008)'
p40243
aS'PMID:11672421'
p40244
ag40244
aS'AUTHORS'
p40245
aS'Hermans E, Challiss RA'
p40246
aS'TITLE'
p40247
aS'Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors.'
p40248
aS'JOURNAL'
p40249
aS'Biochem J 359:465-84 (2001)'
p40250
aS'PMID:17663464'
p40251
ag40251
aS'AUTHORS'
p40252
aS'Kim CH, Lee J, Lee JY, Roche KW'
p40253
aS'TITLE'
p40254
aS'Metabotropic glutamate receptors: phosphorylation and receptor signaling.'
p40255
aS'JOURNAL'
p40256
aS'J Neurosci Res 86:1-10 (2008)'
p40257
aS'PMID:14684436'
p40258
ag40258
aS'AUTHORS'
p40259
aS'Meador-Woodruff JH, Clinton SM, Beneyto M, McCullumsmith RE'
p40260
aS'TITLE'
p40261
aS'Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia.'
p40262
aS'JOURNAL'
p40263
aS'Ann N Y Acad Sci 1003:75-93 (2003)'
p40264
aS'PMID:18425072'
p40265
ag40265
aS'AUTHORS'
p40266
aS'Sanacora G, Zarate CA, Krystal JH, Manji HK'
p40267
aS'TITLE'
p40268
aS'Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.'
p40269
aS'JOURNAL'
p40270
aS'Nat Rev Drug Discov 7:426-37 (2008)'
p40271
aS'PMID:17706608'
p40272
ag40272
aS'AUTHORS'
p40273
aS'Gass JT, Olive MF'
p40274
aS'TITLE'
p40275
aS'Glutamatergic substrates of drug addiction and alcoholism.'
p40276
aS'JOURNAL'
p40277
aS'Biochem Pharmacol 75:218-65 (2008)'
p40278
aS'PMID:9665875'
p40279
ag40279
aS'AUTHORS'
p40280
aS'Palmada M, Centelles JJ'
p40281
aS'TITLE'
p40282
aS'Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain.'
p40283
aS'JOURNAL'
p40284
aS'Front Biosci 3:d701-18 (1998)'
p40285
aS'PMID:11561058'
p40286
ag40286
aS'AUTHORS'
p40287
aS'Schoepp DD'
p40288
aS'TITLE'
p40289
aS'Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.'
p40290
aS'JOURNAL'
p40291
aS'J Pharmacol Exp Ther 299:12-20 (2001)'
p40292
aS'PMID:19559598'
p40293
ag40293
aS'AUTHORS'
p40294
aS'de Jong AP, Verhage M'
p40295
aS'TITLE'
p40296
aS'Presynaptic signal transduction pathways that modulate synaptic transmission.'
p40297
aS'JOURNAL'
p40298
aS'Curr Opin Neurobiol 19:245-53 (2009)'
p40299
aS'PMID:18464791'
p40300
ag40300
aS'AUTHORS'
p40301
aS'Pinheiro PS, Mulle C'
p40302
aS'TITLE'
p40303
aS'Presynaptic glutamate receptors: physiological functions and mechanisms of action.'
p40304
aS'JOURNAL'
p40305
aS'Nat Rev Neurosci 9:423-36 (2008)'
p40306
aS'PMID:19110202'
p40307
ag40307
aS'AUTHORS'
p40308
aS'Byrnes KR, Loane DJ, Faden AI'
p40309
aS'TITLE'
p40310
aS'Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders.'
p40311
aS'JOURNAL'
p40312
aS'Neurotherapeutics 6:94-107 (2009)'
p40313
aS'PMID:10481192'
p40314
ag40314
aS'AUTHORS'
p40315
aS'Conti F, Weinberg RJ'
p40316
aS'TITLE'
p40317
aS'Shaping excitation at glutamatergic synapses.'
p40318
aS'JOURNAL'
p40319
aS'Trends Neurosci 22:451-8 (1999)'
p40320
aS'PMID:12399578'
p40321
ag40321
aS'AUTHORS'
p40322
aS'Sheng M, Kim MJ'
p40323
aS'TITLE'
p40324
aS'Postsynaptic signaling and plasticity mechanisms.'
p40325
aS'JOURNAL'
p40326
aS'Science 298:776-80 (2002)'
p40327
asS'KO_PATHWAY'
p40328
(lp40329
S'ko04724'
p40330
asS'PATHWAY_MAP'
p40331
(lp40332
S'map04724'
p40333
asS'DISEASE'
p40334
(lp40335
S'H00577'
p40336
aS'Syndromic X-linked mental retardation with epilepsy or seizures'
p40337
ag40336
ag40337
aS'H00749'
p40338
aS'Episodic ataxias'
p40339
aS'H00768'
p40340
aS'Nonsyndromic autosomal recessive mental retardation (NS-ARMR)'
p40341
aS'H00775'
p40342
aS'Familial or sporadic hemiplegic migraine'
p40343
aS'H00787'
p40344
aS'Congenital stationary night blindness (CSNB)'
p40345
aS'H00911'
p40346
aS'Dicarboxylic aminoaciduria'
p40347
aS'H00923'
p40348
aS'Congenital systemic glutamine deficiency (CSGD)'
p40349
aS'H01238'
p40350
aS'Phelan-McDermid syndrome'
p40351
asS'DBLINKS'
p40352
(lp40353
S'GO: 0051966'
p40354
asS'ENTRY'
p40355
(lp40356
S'map04724'
p40357
aS'Pathway'
p40358
asS'CLASS'
p40359
(lp40360
S'Organismal Systems Nervous system'
p40361
asS'DESCRIPTION'
p40362
(lp40363
S'Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system(CNS). Glutamate is packaged into synaptic vesicles in the presynaptic terminal. Once released into the synaptic cleft,'
p40364
assS'path:map04723'
p40365
(dp40366
S'NAME'
p40367
(lp40368
S'Retrograde endocannabinoid signaling'
p40369
asS'REFERENCE'
p40370
(lp40371
S'PMID:17419048'
p40372
ag40372
aS'AUTHORS'
p40373
aS'Hashimotodani Y, Ohno-Shosaku T, Kano M'
p40374
aS'TITLE'
p40375
aS'Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities.'
p40376
aS'JOURNAL'
p40377
aS'Curr Opin Neurobiol 17:360-5 (2007)'
p40378
aS'PMID:21531987'
p40379
ag40379
aS'AUTHORS'
p40380
aS'Ohno-Shosaku T, Tanimura A, Hashimotodani Y, Kano M'
p40381
aS'TITLE'
p40382
aS'Endocannabinoids and retrograde modulation of synaptic transmission.'
p40383
aS'JOURNAL'
p40384
aS'Neuroscientist 18:119-32 (2012)'
p40385
aS'PMID:18084639'
p40386
ag40386
aS'AUTHORS'
p40387
aS'Basavarajappa BS'
p40388
aS'TITLE'
p40389
aS'Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.'
p40390
aS'JOURNAL'
p40391
aS'Curr Neuropharmacol 5:81-97 (2007)'
p40392
aS'PMID:16968947'
p40393
ag40393
aS'AUTHORS'
p40394
aS'Pacher P, Batkai S, Kunos G'
p40395
aS'TITLE'
p40396
aS'The endocannabinoid system as an emerging target of pharmacotherapy.'
p40397
aS'JOURNAL'
p40398
aS'Pharmacol Rev 58:389-462 (2006)'
p40399
aS'PMID:15340387'
p40400
ag40400
aS'AUTHORS'
p40401
aS'Di Marzo V, Bifulco M, De Petrocellis L'
p40402
aS'TITLE'
p40403
aS'The endocannabinoid system and its therapeutic exploitation.'
p40404
aS'JOURNAL'
p40405
aS'Nat Rev Drug Discov 3:771-84 (2004)'
p40406
aS'PMID:17404373'
p40407
ag40407
aS'AUTHORS'
p40408
aS'Hashimotodani Y, Ohno-Shosaku T, Kano M'
p40409
aS'TITLE'
p40410
aS'Endocannabinoids and synaptic function in the CNS.'
p40411
aS'JOURNAL'
p40412
aS'Neuroscientist 13:127-37 (2007)'
p40413
aS'PMID:19126760'
p40414
ag40414
aS'AUTHORS'
p40415
aS'Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M'
p40416
aS'TITLE'
p40417
aS'Endocannabinoid-mediated control of synaptic transmission.'
p40418
aS'JOURNAL'
p40419
aS'Physiol Rev 89:309-80 (2009)'
p40420
aS'PMID:19640475'
p40421
ag40421
aS'AUTHORS'
p40422
aS'Regehr WG, Carey MR, Best AR'
p40423
aS'TITLE'
p40424
aS'Activity-dependent regulation of synapses by retrograde messengers.'
p40425
aS'JOURNAL'
p40426
aS'Neuron 63:154-70 (2009)'
p40427
aS'PMID:17636069'
p40428
ag40428
aS'AUTHORS'
p40429
aS'Benarroch E'
p40430
aS'TITLE'
p40431
aS'Endocannabinoids in basal ganglia circuits: implications for Parkinson disease.'
p40432
aS'JOURNAL'
p40433
aS'Neurology 69:306-9 (2007)'
p40434
aS'PMID:16085309'
p40435
ag40435
aS'AUTHORS'
p40436
aS'Ohno-Shosaku T, Hashimotodani Y, Maejima T, Kano M'
p40437
aS'TITLE'
p40438
aS'Calcium signaling and synaptic modulation: regulation of endocannabinoid-mediated synaptic modulation by calcium.'
p40439
aS'JOURNAL'
p40440
aS'Cell Calcium 38:369-74 (2005)'
p40441
aS'PMID:18801434'
p40442
ag40442
aS'AUTHORS'
p40443
aS'Harkany T, Mackie K, Doherty P'
p40444
aS'TITLE'
p40445
aS'Wiring and firing neuronal networks: endocannabinoids take center stage.'
p40446
aS'JOURNAL'
p40447
aS'Curr Opin Neurobiol 18:338-45 (2008)'
p40448
aS'PMID:18515270'
p40449
ag40449
aS'AUTHORS'
p40450
aS'Hosking RD, Zajicek JP'
p40451
aS'TITLE'
p40452
aS'Therapeutic potential of cannabis in pain medicine.'
p40453
aS'JOURNAL'
p40454
aS'Br J Anaesth 101:59-68 (2008)'
p40455
aS'PMID:21187849'
p40456
ag40456
aS'AUTHORS'
p40457
aS'Di Marzo V'
p40458
aS'TITLE'
p40459
aS'Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.'
p40460
aS'JOURNAL'
p40461
aS'Nat Neurosci 14:9-15 (2011)'
p40462
aS'PMID:18948642'
p40463
ag40463
aS'AUTHORS'
p40464
aS'McPartland JM'
p40465
aS'TITLE'
p40466
aS'The endocannabinoid system: an osteopathic perspective.'
p40467
aS'JOURNAL'
p40468
aS'J Am Osteopath Assoc 108:586-600 (2008)'
p40469
aS'PMID:17553427'
p40470
ag40470
aS'AUTHORS'
p40471
aS'Chevaleyre V, Heifets BD, Kaeser PS, Sudhof TC, Castillo PE'
p40472
aS'TITLE'
p40473
aS'Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha.'
p40474
aS'JOURNAL'
p40475
aS'Neuron 54:801-12 (2007)'
p40476
aS'PMID:19553483'
p40477
ag40477
aS'AUTHORS'
p40478
aS'Lafourcade CA'
p40479
aS'TITLE'
p40480
aS'Presynaptic mechanisms of endocannabinoid-mediated long-term depression in the hippocampus.'
p40481
aS'JOURNAL'
p40482
aS'J Neurophysiol 102:2009-12 (2009)'
p40483
aS'PMID:21117095'
p40484
ag40484
aS'AUTHORS'
p40485
aS'Ueda N, Tsuboi K, Uyama T, Ohnishi T'
p40486
aS'TITLE'
p40487
aS'Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.'
p40488
aS'JOURNAL'
p40489
aS'Biofactors (2010)'
p40490
aS'PMID:14978245'
p40491
ag40491
aS'AUTHORS'
p40492
aS'Guo J, Ikeda SR'
p40493
aS'TITLE'
p40494
aS'Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly'
p40495
aS'rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.'
p40496
aS'JOURNAL'
p40497
aS'Mol Pharmacol 65:665-74 (2004)'
p40498
asS'KO_PATHWAY'
p40499
(lp40500
S'ko04723'
p40501
asS'PATHWAY_MAP'
p40502
(lp40503
S'map04723'
p40504
asS'DISEASE'
p40505
(lp40506
S'H00577'
p40507
aS'Syndromic X-linked mental retardation with epilepsy or seizures'
p40508
asS'DBLINKS'
p40509
(lp40510
S'GO: 0071926'
p40511
asS'ENTRY'
p40512
(lp40513
S'map04723'
p40514
aS'Pathway'
p40515
asS'CLASS'
p40516
(lp40517
S'Organismal Systems Nervous system'
p40518
asS'DESCRIPTION'
p40519
(lp40520
S'Endogenous cannabinoids (endocannabinoids) serve as retrograde messengers at synapses in various regions of the brain. The family of endocannabinoids includes at least five derivatives of arachidonic acid the two best characterized are arachydonoyl ethanolamide (anandamide, AEA) and 2-arachydonoil glycerol (2AG). They are released from postsynaptic neurons upon postsynaptic depolarization and/or receptor activation. The released endocannabinoids then activate the CB1 receptors (CB1R) at presynaptic terminals and suppress the release of inhibitory transmitter GABA (depolarization-induced suppression of inhibition, DSI) or excitatory transmitter glutamate (depolarization-induced suppression of excitation, DSE) by inhibiting Ca2+ channels. Whereas DSI and DSE result in short-term synaptic plasticity, endocannabinoids also mediate long-term synaptic changes (eCB-LTD). Persistent activation of CB1 receptors over a period of minutes triggers eCB-LTD by a RIM1alpha-dependent mechanism.'
p40521
assS'path:map04722'
p40522
(dp40523
S'NAME'
p40524
(lp40525
S'Neurotrophin signaling pathway'
p40526
asS'REFERENCE'
p40527
(lp40528
S'PMID:12676795'
p40529
ag40529
aS'AUTHORS'
p40530
aS'Huang EJ, Reichardt LF.'
p40531
aS'TITLE'
p40532
aS'Trk receptors: roles in neuronal signal transduction.'
p40533
aS'JOURNAL'
p40534
aS'Annu Rev Biochem 72:609-42 (2003)'
p40535
aS'PMID:11399424'
p40536
ag40536
aS'AUTHORS'
p40537
aS'Patapoutian A, Reichardt LF'
p40538
aS'TITLE'
p40539
aS'Trk receptors: mediators of neurotrophin action.'
p40540
aS'JOURNAL'
p40541
aS'Curr Opin Neurobiol 11:272-80 (2001)'
p40542
aS'PMID:16699811'
p40543
ag40543
aS'AUTHORS'
p40544
aS'Arevalo JC, Wu SH'
p40545
aS'TITLE'
p40546
aS'Neurotrophin signaling: many exciting surprises!'
p40547
aS'JOURNAL'
p40548
aS'Cell Mol Life Sci 63:1523-37 (2006)'
p40549
aS'PMID:14704852'
p40550
ag40550
aS'AUTHORS'
p40551
aS'Teng KK, Hempstead BL'
p40552
aS'TITLE'
p40553
aS'Neurotrophins and their receptors: signaling trios in complex biological systems.'
p40554
aS'JOURNAL'
p40555
aS'Cell Mol Life Sci 61:35-48 (2004)'
p40556
aS'PMID:11529497'
p40557
ag40557
aS'AUTHORS'
p40558
aS'Miller FD, Kaplan DR'
p40559
aS'TITLE'
p40560
aS'Neurotrophin signalling pathways regulating neuronal apoptosis.'
p40561
aS'JOURNAL'
p40562
aS'Cell Mol Life Sci 58:1045-53 (2001)'
p40563
aS'PMID:10851172'
p40564
ag40564
aS'AUTHORS'
p40565
aS'Kaplan DR, Miller FD'
p40566
aS'TITLE'
p40567
aS'Neurotrophin signal transduction in the nervous system.'
p40568
aS'JOURNAL'
p40569
aS'Curr Opin Neurobiol 10:381-91 (2000)'
p40570
aS'PMID:16939974'
p40571
ag40571
aS'AUTHORS'
p40572
aS'Reichardt LF'
p40573
aS'TITLE'
p40574
aS'Neurotrophin-regulated signalling pathways.'
p40575
aS'JOURNAL'
p40576
aS'Philos Trans R Soc Lond B Biol Sci 361:1545-64 (2006)'
p40577
aS'PMID:16856873'
p40578
ag40578
aS'AUTHORS'
p40579
aS'Zampieri N, Chao MV'
p40580
aS'TITLE'
p40581
aS'Mechanisms of neurotrophin receptor signalling.'
p40582
aS'JOURNAL'
p40583
aS'Biochem Soc Trans 34:607-11 (2006)'
p40584
aS'PMID:15499580'
p40585
ag40585
aS'AUTHORS'
p40586
aS'Rose CR, Blum R, Kafitz KW, Kovalchuk Y, Konnerth A'
p40587
aS'TITLE'
p40588
aS'From modulator to mediator: rapid effects of BDNF on ion channels.'
p40589
aS'JOURNAL'
p40590
aS'Bioessays 26:1185-94 (2004)'
p40591
aS'PMID:10812966'
p40592
ag40592
aS'AUTHORS'
p40593
aS'Yano H, Chao MV'
p40594
aS'TITLE'
p40595
aS'Neurotrophin receptor structure and interactions.'
p40596
aS'JOURNAL'
p40597
aS'Pharm Acta Helv 74:253-60 (2000)'
p40598
aS'PMID:10764727'
p40599
ag40599
aS'AUTHORS'
p40600
aS'Mukai J, Hachiya T, Shoji-Hoshino S, Kimura MT, Nadano D, Suvanto P, Hanaoka T, Li Y, Irie S, Greene LA, Sato TA'
p40601
aS'TITLE'
p40602
aS'NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR.'
p40603
aS'JOURNAL'
p40604
aS'J Biol Chem 275:17566-70 (2000)'
p40605
aS'PMID:10985348'
p40606
ag40606
aS'AUTHORS'
p40607
aS'Salehi AH, Roux PP, Kubu CJ, Zeindler C, Bhakar A, Tannis LL, Verdi JM, Barker PA'
p40608
aS'TITLE'
p40609
aS'NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis.'
p40610
aS'JOURNAL'
p40611
aS'Neuron 27:279-88 (2000)'
p40612
asS'KO_PATHWAY'
p40613
(lp40614
S'ko04722'
p40615
asS'PATHWAY_MAP'
p40616
(lp40617
S'map04722'
p40618
asS'DISEASE'
p40619
(lp40620
S'H00078'
p40621
aS'Frontotemporal lobar degeneration (FTLD)'
p40622
ag40621
ag40622
aS'H00265'
p40623
aS'Hereditary sensory and autonomic neuropathy (HSAN)'
p40624
aS'H00408'
p40625
aS'Type I diabetes mellitus'
p40626
aS'H00681'
p40627
aS'Acne inversa'
p40628
aS'H00916'
p40629
aS'Congenital central hypoventilation syndrome (CCHS)'
p40630
aS'H01007'
p40631
aS'Choroid plexus papilloma'
p40632
aS'H01018'
p40633
aS'Metachondromatosis'
p40634
asS'ENTRY'
p40635
(lp40636
S'map04722'
p40637
aS'Pathway'
p40638
asS'CLASS'
p40639
(lp40640
S'Organismal Systems Nervous system'
p40641
asS'DESCRIPTION'
p40642
(lp40643
S'Neurotrophins are a family of trophic factors involved in differentiation and survival of neural cells. The neurotrophin family consists of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4 (NT-4). Neurotrophins exert their functions through engagement of Trk tyrosine kinase receptors or p75 neurotrophin receptor (p75NTR). Neurotrophin/Trk signaling is regulated by connecting a variety of intracellular signaling cascades, which include MAPK pathway, PI-3 kinase pathway, and PLC pathway, transmitting positive signals like enhanced survival and growth. On the other hand, p75NTR transmits both positive and nagative signals. These signals play an important role for neural development and additional higher-order activities such as learning and memory.'
p40644
assS'path:map04721'
p40645
(dp40646
S'NAME'
p40647
(lp40648
S'Synaptic vesicle cycle'
p40649
asS'REFERENCE'
p40650
(lp40651
S'PMID:12827282'
p40652
ag40652
aS'AUTHORS'
p40653
aS'Li L, Chin LS'
p40654
aS'TITLE'
p40655
aS'The molecular machinery of synaptic vesicle exocytosis.'
p40656
aS'JOURNAL'
p40657
aS'Cell Mol Life Sci 60:942-60 (2003)'
p40658
ag22
ag22
aS'AUTHORS'
p40659
aS'Nestler EJ, Hyman SE, Malenka RC.'
p40660
aS'TITLE'
p40661
aS'Molecular neuropharmacology: A foundation for clinical neuroscience'
p40662
aS'JOURNAL'
p40663
aS'The McGraw-Hill Companies, Inc. (2001)'
p40664
aS'PMID:18275379'
p40665
ag40665
aS'AUTHORS'
p40666
aS'Chapman ER'
p40667
aS'TITLE'
p40668
aS'How does synaptotagmin trigger neurotransmitter release?'
p40669
aS'JOURNAL'
p40670
aS'Annu Rev Biochem 77:615-41 (2008)'
p40671
aS'PMID:10212473'
p40672
ag40672
aS'AUTHORS'
p40673
aS'Benfenati F, Onofri F, Giovedi S'
p40674
aS'TITLE'
p40675
aS'Protein-protein interactions and protein modules in the control of neurotransmitter release.'
p40676
aS'JOURNAL'
p40677
aS'Philos Trans R Soc Lond B Biol Sci 354:243-57 (1999)'
p40678
aS'PMID:20634814'
p40679
ag40679
aS'AUTHORS'
p40680
aS'de Saint Basile G, Menasche G, Fischer A'
p40681
aS'TITLE'
p40682
aS'Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules.'
p40683
aS'JOURNAL'
p40684
aS'Nat Rev Immunol 10:568-79 (2010)'
p40685
aS'PMID:17767192'
p40686
ag40686
aS'AUTHORS'
p40687
aS'Carr CM, Munson M'
p40688
aS'TITLE'
p40689
aS'Tag team action at the synapse.'
p40690
aS'JOURNAL'
p40691
aS'EMBO Rep 8:834-8 (2007)'
p40692
aS'PMID:15217342'
p40693
ag40693
aS'AUTHORS'
p40694
aS'Sudhof TC'
p40695
aS'TITLE'
p40696
aS'The synaptic vesicle cycle.'
p40697
aS'JOURNAL'
p40698
aS'Annu Rev Neurosci 27:509-47 (2004)'
p40699
aS'PMID:12563290'
p40700
ag40700
aS'AUTHORS'
p40701
aS'Gundelfinger ED, Kessels MM, Qualmann B'
p40702
aS'TITLE'
p40703
aS'Temporal and spatial coordination of exocytosis and endocytosis.'
p40704
aS'JOURNAL'
p40705
aS'Nat Rev Mol Cell Biol 4:127-39 (2003)'
p40706
aS'PMID:16990140'
p40707
ag40707
aS'AUTHORS'
p40708
aS'Tang J, Maximov A, Shin OH, Dai H, Rizo J, Sudhof TC'
p40709
aS'TITLE'
p40710
aS'A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis.'
p40711
aS'JOURNAL'
p40712
aS'Cell 126:1175-87 (2006)'
p40713
aS'PMID:12094216'
p40714
ag40714
aS'AUTHORS'
p40715
aS'Chapman ER'
p40716
aS'TITLE'
p40717
aS'Synaptotagmin: a Ca(2+) sensor that triggers exocytosis?'
p40718
aS'JOURNAL'
p40719
aS'Nat Rev Mol Cell Biol 3:498-508 (2002)'
p40720
aS'PMID:7791897'
p40721
ag40721
aS'AUTHORS'
p40722
aS'Sudhof TC'
p40723
aS'TITLE'
p40724
aS'The synaptic vesicle cycle: a cascade of protein-protein interactions.'
p40725
aS'JOURNAL'
p40726
aS'Nature 375:645-53 (1995)'
p40727
aS'PMID:12154365'
p40728
ag40728
aS'AUTHORS'
p40729
aS'Rizo J, Sudhof TC'
p40730
aS'TITLE'
p40731
aS'Snares and Munc18 in synaptic vesicle fusion.'
p40732
aS'JOURNAL'
p40733
aS'Nat Rev Neurosci 3:641-53 (2002)'
p40734
aS'PMID:18726177'
p40735
ag40735
aS'AUTHORS'
p40736
aS'Malsam J, Kreye S, Sollner TH'
p40737
aS'TITLE'
p40738
aS'Membrane fusion: SNAREs and regulation.'
p40739
aS'JOURNAL'
p40740
aS'Cell Mol Life Sci 65:2814-32 (2008)'
p40741
asS'KO_PATHWAY'
p40742
(lp40743
S'ko04721'
p40744
asS'PATHWAY_MAP'
p40745
(lp40746
S'map04721'
p40747
asS'DISEASE'
p40748
(lp40749
S'H00606'
p40750
aS'Early infantile epileptic encephalopathy'
p40751
ag40750
ag40751
aS'H00700'
p40752
aS'Centronuclear myopathy'
p40753
aS'H00749'
p40754
aS'Episodic ataxias'
p40755
aS'H00775'
p40756
aS'Familial or sporadic hemiplegic migraine'
p40757
asS'DBLINKS'
p40758
(lp40759
S'GO: 0016079 0048488'
p40760
asS'ENTRY'
p40761
(lp40762
S'map04721'
p40763
aS'Pathway'
p40764
asS'CLASS'
p40765
(lp40766
S'Organismal Systems Nervous system'
p40767
asS'DESCRIPTION'
p40768
(lp40769
S'Communication between neurons is mediated by the release of neurotransmitter from synaptic vesicles (SVs). At the nerve terminal, SVs cycle through repetitive episodes of exocytosis and endocytosis. SVs are filled with neurotransmitters by active transport. The loaded SVs are then docked at a specialized region of the presynaptic plasma membrane known as the active zone, where they undergo a priming reaction. Upon arrival of an action potential, Ca2+ enters through voltage-gated channels and neurotransmitter is released by exocytosis, usually in less than a millisecond. After fusion, the vesicle is retrieved by endocytosis and reloaded for another round of exocytosis.'
p40770
assS'path:map04720'
p40771
(dp40772
S'NAME'
p40773
(lp40774
S'Long-term potentiation'
p40775
asS'REFERENCE'
p40776
(lp40777
S'PMID:15652868'
p40778
ag40778
aS'AUTHORS'
p40779
aS'Blitzer RD, Iyengar R, Landau EM.'
p40780
aS'TITLE'
p40781
aS'Postsynaptic signaling networks: cellular cogwheels underlying long-term plasticity.'
p40782
aS'JOURNAL'
p40783
aS'Biol Psychiatry 57:113-9 (2005)'
p40784
aS'PMID:10652548'
p40785
ag40785
aS'AUTHORS'
p40786
aS'Soderling TR, Derkach VA.'
p40787
aS'TITLE'
p40788
aS'Postsynaptic protein phosphorylation and LTP.'
p40789
aS'JOURNAL'
p40790
aS'Trends Neurosci 23:75-80 (2000)'
p40791
aS'PMID:11378299'
p40792
ag40792
aS'AUTHORS'
p40793
aS'Poser S, Storm DR.'
p40794
aS'TITLE'
p40795
aS'Role of Ca2+-stimulated adenylyl cyclases in LTP and memory formation.'
p40796
aS'JOURNAL'
p40797
aS'Int J Dev Neurosci 19:387-94 (2001)'
p40798
aS'PMID:15803158'
p40799
ag40799
aS'AUTHORS'
p40800
aS'Xia Z, Storm DR.'
p40801
aS'TITLE'
p40802
aS'The role of calmodulin as a signal integrator for synaptic plasticity.'
p40803
aS'JOURNAL'
p40804
aS'Nat Rev Neurosci 6:267-76 (2005)'
p40805
ag22
ag22
aS'AUTHORS'
p40806
aS'Purves D, Augustine GJ (ed).'
p40807
aS'TITLE'
p40808
aS'Neuroscience'
p40809
aS'JOURNAL'
p40810
aS'Sunderland, Mass.:Sinauer Associates (2004)'
p40811
aS'(Japanese)'
p40812
ag40812
aS'AUTHORS'
p40813
aS'Futai K, Hayashi Y.'
p40814
aS'TITLE'
p40815
aS'[Molecular mechanisms of hippocampal long-term potentiation.] (In Japanese)'
p40816
aS'JOURNAL'
p40817
aS'Experimental Medicine 21(17):2361-2369 (2003)'
p40818
aS'PMID:14715912'
p40819
ag40819
aS'AUTHORS'
p40820
aS'Lynch MA.'
p40821
aS'TITLE'
p40822
aS'Long-term potentiation and memory.'
p40823
aS'JOURNAL'
p40824
aS'Physiol Rev 84:87-136 (2004)'
p40825
aS'PMID:15857686'
p40826
ag40826
aS'AUTHORS'
p40827
aS'Kelly PT, Mackinnon RL 2nd, Dietz RV, Maher BJ, Wang J.'
p40828
aS'TITLE'
p40829
aS'Postsynaptic IP3 receptor-mediated Ca2+ release modulates synaptic transmission in hippocampal neurons.'
p40830
aS'JOURNAL'
p40831
aS'Brain Res Mol Brain Res 135:232-48 (2005)'
p40832
aS'PMID:9697848'
p40833
ag40833
aS'AUTHORS'
p40834
aS'Berridge MJ.'
p40835
aS'TITLE'
p40836
aS'Neuronal calcium signaling.'
p40837
aS'JOURNAL'
p40838
aS'Neuron 21:13-26 (1998)'
p40839
asS'KO_PATHWAY'
p40840
(lp40841
S'ko04720'
p40842
asS'PATHWAY_MAP'
p40843
(lp40844
S'map04720'
p40845
asS'DBLINKS'
p40846
(lp40847
S'GO: 0048169'
p40848
asS'ENTRY'
p40849
(lp40850
S'map04720'
p40851
aS'Pathway'
p40852
asS'CLASS'
p40853
(lp40854
S'Organismal Systems Nervous system'
p40855
asS'DESCRIPTION'
p40856
(lp40857
S'Hippocampal long-term potentiation (LTP), a long-lasting increase in synaptic efficacy, is the molecular basis for learning and memory. Tetanic stimulation of afferents in the CA1 region of the hippocampus induces glutamate release and activation of glutamate receptors in dendritic spines. A large increase in [Ca2+]i resulting from influx through NMDA receptors leads to constitutive activation of CaM kinase II (CaM KII) . Constitutively active CaM kinase II phosphorylates AMPA receptors, resulting in potentiation of the ionic conductance of AMPA receptors. Early-phase LTP (E-LTP) expression is due, in part, to this phosphorylation of the AMPA receptor. It is hypothesized that postsynaptic Ca2+ increases generated through NMDA receptors activate several signal transduction pathways including the Erk/MAP kinase and cAMP regulatory pathways. The convergence of these pathways at the level of the CREB/CRE transcriptional pathway may increase expression of a family of genes required for late-phase LTP (L-LTP).'
p40858
assS'path:map04640'
p40859
(dp40860
S'NAME'
p40861
(lp40862
S'Hematopoietic cell lineage'
p40863
asS'REFERENCE'
p40864
(lp40865
g22
ag22
aS'AUTHORS'
p40866
aS'Janeway CA Jr, Travers P, Walport M, Shlomchik MJ'
p40867
aS'TITLE'
p40868
aS'Immunobiology - International editon: The immune system in health and disease'
p40869
aS'JOURNAL'
p40870
aS'Harcourt Publishers Ltd, a subsidiary of Harcourt International Ltd (2001)'
p40871
aS'(Japanese)'
p40872
ag40872
aS'AUTHORS'
p40873
aS'Abe T'
p40874
aS'TITLE'
p40875
aS'[Atlas of malignancies in hematopoietic organ - Morphology, immunology, chromosome and gene] (Japanese)'
p40876
aS'JOURNAL'
p40877
aS'Nihonijishinhousya (2000)'
p40878
aS'PMID:15771582'
p40879
ag40879
aS'AUTHORS'
p40880
aS'Rothenberg EV, Taghon T.'
p40881
aS'TITLE'
p40882
aS'Molecular genetics of T cell development.'
p40883
aS'JOURNAL'
p40884
aS'Annu Rev Immunol 23:601-49 (2005)'
p40885
aS'PMID:12415312'
p40886
ag40886
aS'AUTHORS'
p40887
aS'Ceredig R, Rolink T.'
p40888
aS'TITLE'
p40889
aS'A positive look at double-negative thymocytes.'
p40890
aS'JOURNAL'
p40891
aS'Nat Rev Immunol 2:888-97 (2002)'
p40892
aS'PMID:15156179'
p40893
ag40893
aS'AUTHORS'
p40894
aS'de Bruijn MF, Speck NA.'
p40895
aS'TITLE'
p40896
aS'Core-binding factors in hematopoiesis and immune function.'
p40897
aS'JOURNAL'
p40898
aS'Oncogene 23:4238-48 (2004)'
p40899
aS'PMID:14985712'
p40900
ag40900
aS'AUTHORS'
p40901
aS'Radtke F, Wilson A, Mancini SJ, MacDonald HR.'
p40902
aS'TITLE'
p40903
aS'Notch regulation of lymphocyte development and function.'
p40904
aS'JOURNAL'
p40905
aS'Nat Immunol 5:247-53 (2004)'
p40906
aS'PMID:12360214'
p40907
ag40907
aS'AUTHORS'
p40908
aS'Spits H.'
p40909
aS'TITLE'
p40910
aS'Development of alphabeta T cells in the human thymus.'
p40911
aS'JOURNAL'
p40912
aS'Nat Rev Immunol 2:760-72 (2002)'
p40913
aS'PMID:9927518'
p40914
ag40914
aS'AUTHORS'
p40915
aS'Di Santo JP, Aifantis I, Rosmaraki E, Garcia C, Feinberg J, Fehling HJ, Fischer A, von Boehmer H, Rocha B.'
p40916
aS'TITLE'
p40917
aS'The common cytokine receptor gamma chain and the pre-T cell receptor provide independent but critically overlapping signals in early alpha/beta T cell development.'
p40918
aS'JOURNAL'
p40919
aS'J Exp Med 189:563-74 (1999)'
p40920
aS'PMID:11905810'
p40921
ag40921
aS'AUTHORS'
p40922
aS'Mak TW, Penninger JM, Ohashi PS.'
p40923
aS'TITLE'
p40924
aS'Knockout mice: a paradigm shift in modern immunology.'
p40925
aS'JOURNAL'
p40926
aS'Nat Rev Immunol 1:11-9 (2001)'
p40927
aS'PMID:15738953'
p40928
ag40928
aS'AUTHORS'
p40929
aS'Shapiro-Shelef M, Calame K.'
p40930
aS'TITLE'
p40931
aS'Regulation of plasma-cell development.'
p40932
aS'JOURNAL'
p40933
aS'Nat Rev Immunol 5:230-42 (2005)'
p40934
aS'PMID:14670296'
p40935
ag40935
aS'AUTHORS'
p40936
aS'Maillard I, Adler SH, Pear WS.'
p40937
aS'TITLE'
p40938
aS'Notch and the immune system.'
p40939
aS'JOURNAL'
p40940
aS'Immunity 19:781-91 (2003)'
p40941
aS'PMID:15629410'
p40942
ag40942
aS'AUTHORS'
p40943
aS'Alpdogan O, van den Brink MR.'
p40944
aS'TITLE'
p40945
aS'IL-7 and IL-15: therapeutic cytokines for immunodeficiency.'
p40946
aS'JOURNAL'
p40947
aS'Trends Immunol 26:56-64 (2005)'
p40948
asS'KO_PATHWAY'
p40949
(lp40950
S'ko04640'
p40951
asS'PATHWAY_MAP'
p40952
(lp40953
S'map04640'
p40954
asS'DISEASE'
p40955
(lp40956
S'H00219'
p40957
aS'Hemophilia'
p40958
ag40957
ag40958
aS'H00224'
p40959
aS'Bernard-Soulier syndrome'
p40960
asS'ENTRY'
p40961
(lp40962
S'map04640'
p40963
aS'Pathway'
p40964
asS'CLASS'
p40965
(lp40966
S'Organismal Systems Immune system'
p40967
asS'DESCRIPTION'
p40968
(lp40969
S'Blood-cell development progresses from a hematopoietic stem cell (HSC), which can undergo either self-renewal or differentiation into a multilineage committed progenitor cell: a common lymphoid progenitor (CLP) or a common myeloid progenitor (CMP). A CLP gives rise to the lymphoid lineage of white blood cells or leukocytes-the natural killer (NK) cells and the T and B lymphocytes. A CMP gives rise to the myeloid lineage, which comprises the rest of the leukocytes, the erythrocytes (red blood cells), and the megakaryocytes that produce platelets important in blood clotting. Cells undergoing these differentiation process express a stage- and lineage-specific set of surface markers. Therefore cellular stages are identified by the specific expression patterns of these genes.'
p40970
assS'path:map00260'
p40971
(dp40972
S'NAME'
p40973
(lp40974
S'Glycine, serine and threonine metabolism'
p40975
asS'REFERENCE'
p40976
(lp40977
g22
ag22
aS'AUTHORS'
p40978
aS'Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).'
p40979
aS'TITLE'
p40980
aS'[Cellular Functions and Metabolic Maps] (In Japanese)'
p40981
aS'JOURNAL'
p40982
aS'Tokyo Kagaku Dojin (1997)'
p40983
aS'PMID:11823218'
p40984
ag40984
aS'AUTHORS'
p40985
aS'Kuhlmann AU, Bremer E.'
p40986
aS'TITLE'
p40987
aS'Osmotically regulated synthesis of the compatible solute ectoine in Bacillus pasteurii and related Bacillus spp.'
p40988
aS'JOURNAL'
p40989
aS'Appl Environ Microbiol 68:772-83 (2002)'
p40990
aS'PMID:10473374'
p40991
ag40991
aS'AUTHORS'
p40992
aS'Canovas D, Borges N, Vargas C, Ventosa A, Nieto JJ, Santos H.'
p40993
aS'TITLE'
p40994
aS'Role of Ngamma-acetyldiaminobutyrate as an enzyme stabilizer and an intermediate in the biosynthesis of hydroxyectoine.'
p40995
aS'JOURNAL'
p40996
aS'Appl Environ Microbiol 65:3774-9 (1999)'
p40997
aS'PMID:17636255'
p40998
ag40998
aS'AUTHORS'
p40999
aS'Bursy J, Pierik AJ, Pica N, Bremer E.'
p41000
aS'TITLE'
p41001
aS'Osmotically induced synthesis of the compatible solute hydroxyectoine is mediated by an evolutionarily conserved ectoine hydroxylase.'
p41002
aS'JOURNAL'
p41003
aS'J Biol Chem 282:31147-55 (2007)'
p41004
aS'PMID:16707670'
p41005
ag41005
aS'AUTHORS'
p41006
aS'Garcia-Estepa R, Argandona M, Reina-Bueno M, Capote N, Iglesias-Guerra F, Nieto JJ, Vargas C.'
p41007
aS'TITLE'
p41008
aS'The ectD gene, which is involved in the synthesis of the compatible solute hydroxyectoine, is essential for thermoprotection of the halophilic bacterium Chromohalobacter salexigens.'
p41009
aS'JOURNAL'
p41010
aS'J Bacteriol 188:3774-84 (2006)'
p41011
aS'PMID:15470257'
p41012
ag41012
aS'AUTHORS'
p41013
aS'Arevalo-Rodriguez M, Pan X, Boeke JD, Heitman J'
p41014
aS'TITLE'
p41015
aS'FKBP12 controls aspartate pathway flux in Saccharomyces cerevisiae to prevent toxic intermediate accumulation.'
p41016
aS'JOURNAL'
p41017
aS'Eukaryot Cell 3:1287-96 (2004)'
p41018
aS'PMID:7639721'
p41019
ag41019
aS'AUTHORS'
p41020
aS'Rees WD, Hay SM'
p41021
aS'TITLE'
p41022
aS'The biosynthesis of threonine by mammalian cells: expression of a complete bacterial biosynthetic pathway in an animal cell.'
p41023
aS'JOURNAL'
p41024
aS'Biochem J 309 ( Pt 3):999-1007 (1995)'
p41025
aS'PMID:11341914'
p41026
ag41026
aS'AUTHORS'
p41027
aS'Jacques SL, Nieman C, Bareich D, Broadhead G, Kinach R, Honek JF, Wright GD'
p41028
aS'TITLE'
p41029
aS'Characterization of yeast homoserine dehydrogenase, an antifungal target: the invariant histidine 309 is important for enzyme integrity.'
p41030
aS'JOURNAL'
p41031
aS'Biochim Biophys Acta 1544:28-41 (2001)'
p41032
aS'PMID:15520012'
p41033
ag41033
aS'AUTHORS'
p41034
aS'Chen X, Jhee KH, Kruger WD'
p41035
aS'TITLE'
p41036
aS'Production of the neuromodulator H2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine.'
p41037
aS'JOURNAL'
p41038
aS'J Biol Chem 279:52082-6 (2004)'
p41039
asS'KO_PATHWAY'
p41040
(lp41041
S'ko00260'
p41042
asS'PATHWAY_MAP'
p41043
(lp41044
S'map00260'
p41045
asS'DISEASE'
p41046
(lp41047
S'H00117'
p41048
aS'Primary hyperoxaluria (HP)'
p41049
ag41048
ag41049
aS'H00182'
p41050
aS'Cystathioninuria'
p41051
aS'H00183'
p41052
aS'Homocystinuria'
p41053
aS'H00184'
p41054
aS'Hypermethioninemia'
p41055
aS'H00191'
p41056
aS'Nonketotic hyperglycinemia'
p41057
aS'H00834'
p41058
aS'Guanidinoacetate methyltransferase (GAMT) deficiency'
p41059
aS'H00849'
p41060
aS'Creatine deficiency syndrome'
p41061
aS'H01003'
p41062
aS'Dimethylglycine dehydrogenase deficiency (DMGDHD)'
p41063
aS'H01079'
p41064
aS'3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency'
p41065
aS'H01082'
p41066
aS'Phosphoserine aminotransferase (PSAT) deficiency'
p41067
asS'MODULE'
p41068
(lp41069
S'M00018'
p41070
aS'Threonine biosynthesis, aspartate => homoserine => threonine [PATH:map00260]'
p41071
ag41070
ag41071
aS'M00020'
p41072
aS'Serine biosynthesis, glycerate-3P => serine [PATH:map00260]'
p41073
aS'M00033'
p41074
aS'Ectoine biosynthesis, aspartate => ectoine [PATH:map00260]'
p41075
aS'M00555'
p41076
aS'Betaine biosynthesis, choline => betaine [PATH:map00260]'
p41077
asS'DBLINKS'
p41078
(lp41079
S'GO: 0006544 0006563 0070178 0006566'
p41080
asS'ENTRY'
p41081
(lp41082
S'map00260'
p41083
aS'Pathway'
p41084
asS'CLASS'
p41085
(lp41086
S'Metabolism Amino acid metabolism'
p41087
asS'DESCRIPTION'
p41088
(lp41089
S'Serine is derived from 3-phospho-D-glycerate, an intermediate of glycolysis [MD:M00020], and glycine is derived from serine. Threonine is an essential amino acid, which animals cannot synthesize. In bacteria and plants, threonine is derived from aspartate [MD:M00018].'
p41090
assS'path:map04728'
p41091
(dp41092
S'NAME'
p41093
(lp41094
S'Dopaminergic synapse'
p41095
asS'REFERENCE'
p41096
(lp41097
S'PMID:21303898'
p41098
ag41098
aS'AUTHORS'
p41099
aS'Beaulieu JM, Gainetdinov RR'
p41100
aS'TITLE'
p41101
aS'The physiology, signaling, and pharmacology of dopamine receptors.'
p41102
aS'JOURNAL'
p41103
aS'Pharmacol Rev 63:182-217 (2011)'
p41104
aS'PMID:15521361'
p41105
ag41105
aS'AUTHORS'
p41106
aS'Neve KA, Seamans JK, Trantham-Davidson H'
p41107
aS'TITLE'
p41108
aS'Dopamine receptor signaling.'
p41109
aS'JOURNAL'
p41110
aS'J Recept Signal Transduct Res 24:165-205 (2004)'
p41111
aS'PMID:17408758'
p41112
ag41112
aS'AUTHORS'
p41113
aS'Surmeier DJ, Ding J, Day M, Wang Z, Shen W'
p41114
aS'TITLE'
p41115
aS'D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.'
p41116
aS'JOURNAL'
p41117
aS'Trends Neurosci 30:228-35 (2007)'
p41118
aS'PMID:20224735'
p41119
ag41119
aS'AUTHORS'
p41120
aS'Knab AM, Lightfoot JT'
p41121
aS'TITLE'
p41122
aS'Does the difference between physically active and couch potato lie in the dopamine system?'
p41123
aS'JOURNAL'
p41124
aS'Int J Biol Sci 6:133-50 (2010)'
p41125
aS'PMID:10433257'
p41126
ag41126
aS'AUTHORS'
p41127
aS'Greengard P, Allen PB, Nairn AC'
p41128
aS'TITLE'
p41129
aS'Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.'
p41130
aS'JOURNAL'
p41131
aS'Neuron 23:435-47 (1999)'
p41132
aS'PMID:15590733'
p41133
ag41133
aS'AUTHORS'
p41134
aS'Hu XT, Dong Y, Zhang XF, White FJ'
p41135
aS'TITLE'
p41136
aS'Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium'
p41137
aS'currents in rat nucleus accumbens neurons.'
p41138
aS'JOURNAL'
p41139
aS'J Neurophysiol 93:1406-17 (2005)'
p41140
aS'PMID:17349698'
p41141
ag41141
aS'AUTHORS'
p41142
aS'Beaulieu JM, Gainetdinov RR, Caron MG'
p41143
aS'TITLE'
p41144
aS'The Akt-GSK-3 signaling cascade in the actions of dopamine.'
p41145
aS'JOURNAL'
p41146
aS'Trends Pharmacol Sci 28:166-72 (2007)'
p41147
aS'PMID:19138563'
p41148
ag41148
aS'AUTHORS'
p41149
aS'De Mei C, Ramos M, Iitaka C, Borrelli E'
p41150
aS'TITLE'
p41151
aS'Getting specialized: presynaptic and postsynaptic dopamine D2 receptors.'
p41152
aS'JOURNAL'
p41153
aS'Curr Opin Pharmacol 9:53-8 (2009)'
p41154
aS'PMID:15381316'
p41155
ag41155
aS'AUTHORS'
p41156
aS'Seamans JK, Yang CR'
p41157
aS'TITLE'
p41158
aS'The principal features and mechanisms of dopamine modulation in the prefrontal cortex.'
p41159
aS'JOURNAL'
p41160
aS'Prog Neurobiol 74:1-58 (2004)'
p41161
aS'PMID:18353279'
p41162
ag41162
aS'AUTHORS'
p41163
aS'Yao WD, Spealman RD, Zhang J'
p41164
aS'TITLE'
p41165
aS'Dopaminergic signaling in dendritic spines.'
p41166
aS'JOURNAL'
p41167
aS'Biochem Pharmacol 75:2055-69 (2008)'
p41168
aS'PMID:20727368'
p41169
ag41169
aS'AUTHORS'
p41170
aS'Li YC, Gao WJ'
p41171
aS'TITLE'
p41172
aS'GSK-3beta activity and hyperdopamine-dependent behaviors.'
p41173
aS'JOURNAL'
p41174
aS'Neurosci Biobehav Rev 35:645-54 (2011)'
p41175
aS'PMID:15292232'
p41176
ag41176
aS'AUTHORS'
p41177
aS'Tang TS, Bezprozvanny I'
p41178
aS'TITLE'
p41179
aS'Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons.'
p41180
aS'JOURNAL'
p41181
aS'J Biol Chem 279:42082-94 (2004)'
p41182
aS'PMID:12967774'
p41183
ag41183
aS'AUTHORS'
p41184
aS'Bergson C, Levenson R, Goldman-Rakic PS, Lidow MS'
p41185
aS'TITLE'
p41186
aS'Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling.'
p41187
aS'JOURNAL'
p41188
aS'Trends Pharmacol Sci 24:486-92 (2003)'
p41189
aS'PMID:9457173'
p41190
ag41190
aS'AUTHORS'
p41191
aS'Missale C, Nash SR, Robinson SW, Jaber M, Caron MG'
p41192
aS'TITLE'
p41193
aS'Dopamine receptors: from structure to function.'
p41194
aS'JOURNAL'
p41195
aS'Physiol Rev 78:189-225 (1998)'
p41196
aS'PMID:19251795'
p41197
ag41197
aS'AUTHORS'
p41198
aS'Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ'
p41199
aS'TITLE'
p41200
aS'Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?'
p41201
aS'JOURNAL'
p41202
aS'Eur Respir J 33:468-80 (2009)'
p41203
asS'KO_PATHWAY'
p41204
(lp41205
S'ko04728'
p41206
asS'PATHWAY_MAP'
p41207
(lp41208
S'map04728'
p41209
asS'DISEASE'
p41210
(lp41211
S'H00548'
p41212
aS'Brunner syndrome'
p41213
ag41212
ag41213
aS'H00577'
p41214
aS'Syndromic X-linked mental retardation with epilepsy or seizures'
p41215
aS'H00749'
p41216
aS'Episodic ataxias'
p41217
aS'H00775'
p41218
aS'Familial or sporadic hemiplegic migraine'
p41219
aS'H00783'
p41220
aS'Febrile seizures'
p41221
aS'H00831'
p41222
aS'Primary dystonia'
p41223
aS'H01161'
p41224
aS'Aromatic L-amino acid decarboxylase (AADC) deficiency'
p41225
asS'DBLINKS'
p41226
(lp41227
S'GO: 0001963'
p41228
asS'ENTRY'
p41229
(lp41230
S'map04728'
p41231
aS'Pathway'
p41232
asS'CLASS'
p41233
(lp41234
S'Organismal Systems Nervous system'
p41235
asS'DESCRIPTION'
p41236
(lp41237
S'Dopamine (DA) is'
p41238
assS'path:map05034'
p41239
(dp41240
S'NAME'
p41241
(lp41242
S'Alcoholism'
p41243
asS'REFERENCE'
p41244
(lp41245
S'PMID:19342616'
p41246
ag41246
aS'AUTHORS'
p41247
aS'Spanagel R'
p41248
aS'TITLE'
p41249
aS'Alcoholism: a systems approach from molecular physiology to addictive behavior.'
p41250
aS'JOURNAL'
p41251
aS'Physiol Rev 89:649-705 (2009)'
p41252
aS'PMID:16102840'
p41253
ag41253
aS'AUTHORS'
p41254
aS'Newton PM, Messing RO'
p41255
aS'TITLE'
p41256
aS'Intracellular signaling pathways that regulate behavioral responses to ethanol.'
p41257
aS'JOURNAL'
p41258
aS'Pharmacol Ther 109:227-37 (2006)'
p41259
aS'PMID:14729391'
p41260
ag41260
aS'AUTHORS'
p41261
aS'Mailliard WS, Diamond I'
p41262
aS'TITLE'
p41263
aS'Recent advances in the neurobiology of alcoholism: the role of adenosine.'
p41264
aS'JOURNAL'
p41265
aS'Pharmacol Ther 101:39-46 (2004)'
p41266
aS'PMID:16278489'
p41267
ag41267
aS'AUTHORS'
p41268
aS'Ron D, Jurd R'
p41269
aS'TITLE'
p41270
aS'The "ups and downs" of signaling cascades in addiction.'
p41271
aS'JOURNAL'
p41272
aS'Sci STKE 2005:re14 (2005)'
p41273
aS'PMID:12605085'
p41274
ag41274
aS'AUTHORS'
p41275
aS'Diana M, Brodie M, Muntoni A, Puddu MC, Pillolla G, Steffensen S, Spiga S, Little HJ'
p41276
aS'TITLE'
p41277
aS'Enduring effects of chronic ethanol in the CNS: basis for alcoholism.'
p41278
aS'JOURNAL'
p41279
aS'Alcohol Clin Exp Res 27:354-61 (2003)'
p41280
aS'PMID:19756388'
p41281
ag41281
aS'AUTHORS'
p41282
aS'Moonat S, Starkman BG, Sakharkar A, Pandey SC'
p41283
aS'TITLE'
p41284
aS'Neuroscience of alcoholism: molecular and cellular mechanisms.'
p41285
aS'JOURNAL'
p41286
aS'Cell Mol Life Sci 67:73-88 (2010)'
p41287
aS'PMID:15500908'
p41288
ag41288
aS'AUTHORS'
p41289
aS'Pandey SC'
p41290
aS'TITLE'
p41291
aS'The gene transcription factor cyclic AMP-responsive element binding protein: role in positive and negative affective states of alcohol addiction.'
p41292
aS'JOURNAL'
p41293
aS'Pharmacol Ther 104:47-58 (2004)'
p41294
aS'PMID:16764827'
p41295
ag41295
aS'AUTHORS'
p41296
aS'Zhang TA, Maldve RE, Morrisett RA'
p41297
aS'TITLE'
p41298
aS'Coincident signaling in mesolimbic structures underlying alcohol reinforcement.'
p41299
aS'JOURNAL'
p41300
aS'Biochem Pharmacol 72:919-27 (2006)'
p41301
aS'PMID:12068305'
p41302
ag41302
aS'AUTHORS'
p41303
aS'Maldve RE, Zhang TA, Ferrani-Kile K, Schreiber SS, Lippmann MJ, Snyder GL, Fienberg AA, Leslie SW, Gonzales RA, Morrisett RA'
p41304
aS'TITLE'
p41305
aS'DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens.'
p41306
aS'JOURNAL'
p41307
aS'Nat Neurosci 5:641-8 (2002)'
p41308
aS'PMID:12085089'
p41309
ag41309
aS'AUTHORS'
p41310
aS'Lovinger DM'
p41311
aS'TITLE'
p41312
aS'NMDA receptors lose their inhibitions.'
p41313
aS'JOURNAL'
p41314
aS'Nat Neurosci 5:614-6 (2002)'
p41315
aS'PMID:16776597'
p41316
ag41316
aS'AUTHORS'
p41317
aS'Hyman SE, Malenka RC, Nestler EJ'
p41318
aS'TITLE'
p41319
aS'Neural mechanisms of addiction: the role of reward-related learning and memory.'
p41320
aS'JOURNAL'
p41321
aS'Annu Rev Neurosci 29:565-98 (2006)'
p41322
aS'PMID:10774721'
p41323
ag41323
aS'AUTHORS'
p41324
aS'Berke JD, Hyman SE'
p41325
aS'TITLE'
p41326
aS'Addiction, dopamine, and the molecular mechanisms of memory.'
p41327
aS'JOURNAL'
p41328
aS'Neuron 25:515-32 (2000)'
p41329
aS'PMID:20729980'
p41330
ag41330
aS'AUTHORS'
p41331
aS'Clapp P, Bhave SV, Hoffman PL'
p41332
aS'TITLE'
p41333
aS'How Adaptation of the Brain to Alcohol Leads to Dependence: A Pharmacological Perspective.'
p41334
aS'JOURNAL'
p41335
aS'Alcohol Res Health 31:310-339 (2008)'
p41336
aS'PMID:20947635'
p41337
ag41337
aS'AUTHORS'
p41338
aS'Jeanes ZM, Buske TR, Morrisett RA'
p41339
aS'TITLE'
p41340
aS'In vivo chronic intermittent ethanol exposure reverses the polarity of synaptic plasticity in the nucleus accumbens shell.'
p41341
aS'JOURNAL'
p41342
aS'J Pharmacol Exp Ther 336:155-64 (2011)'
p41343
aS'PMID:18991950'
p41344
ag41344
aS'AUTHORS'
p41345
aS'Lee AM, Messing RO'
p41346
aS'TITLE'
p41347
aS'Protein kinases and addiction.'
p41348
aS'JOURNAL'
p41349
aS'Ann N Y Acad Sci 1141:22-57 (2008)'
p41350
aS'PMID:17270154'
p41351
ag41351
aS'AUTHORS'
p41352
aS'Repunte-Canonigo V, Lutjens R, van der Stap LD, Sanna PP'
p41353
aS'TITLE'
p41354
aS'Increased expression of protein kinase A inhibitor alpha (PKI-alpha) and decreased PKA-regulated genes in chronic intermittent alcohol exposure.'
p41355
aS'JOURNAL'
p41356
aS'Brain Res 1138:48-56 (2007)'
p41357
aS'PMID:18310464'
p41358
ag41358
aS'AUTHORS'
p41359
aS'Logrip ML, Janak PH, Ron D'
p41360
aS'TITLE'
p41361
aS'Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake.'
p41362
aS'JOURNAL'
p41363
aS'FASEB J 22:2393-404 (2008)'
p41364
aS'PMID:18616668'
p41365
ag41365
aS'AUTHORS'
p41366
aS'Shukla SD, Velazquez J, French SW, Lu SC, Ticku MK, Zakhari S'
p41367
aS'TITLE'
p41368
aS'Emerging role of epigenetics in the actions of alcohol.'
p41369
aS'JOURNAL'
p41370
aS'Alcohol Clin Exp Res 32:1525-34 (2008)'
p41371
aS'PMID:19077056'
p41372
ag41372
aS'AUTHORS'
p41373
aS'Pascual M, Boix J, Felipo V, Guerri C'
p41374
aS'TITLE'
p41375
aS'Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in'
p41376
aS'the adult rat.'
p41377
aS'JOURNAL'
p41378
aS'J Neurochem 108:920-31 (2009)'
p41379
aS'PMID:20626732'
p41380
ag41380
aS'AUTHORS'
p41381
aS'Li J, Cheng Y, Bian W, Liu X, Zhang C, Ye JH'
p41382
aS'TITLE'
p41383
aS'Region-specific induction of FosB/DeltaFosB by voluntary alcohol intake: effects'
p41384
aS'of naltrexone.'
p41385
aS'JOURNAL'
p41386
aS'Alcohol Clin Exp Res 34:1742-50 (2010)'
p41387
asS'KO_PATHWAY'
p41388
(lp41389
S'ko05034'
p41390
asS'PATHWAY_MAP'
p41391
(lp41392
S'map05034'
p41393
asS'DBLINKS'
p41394
(lp41395
S'GO: 0045471'
p41396
asS'ENTRY'
p41397
(lp41398
S'map05034'
p41399
aS'Pathway'
p41400
asS'CLASS'
p41401
(lp41402
S'Human Diseases Substance dependence'
p41403
asS'DESCRIPTION'
p41404
(lp41405
S'Alcoholism, also called dependence on alcohol (ethanol), is a chronic relapsing disorder that is progressive and has serious detrimental health outcomes. As one of the primary mediators of the rewarding effects of alcohol, dopaminergic ventral tegmental area (VTA) projections to the nucleus accumbens (NAc) have been identified. Acute exposure to alcohol stimulates dopamine release into the NAc, which activates D1 receptors, stimulating PKA signaling and subsequent CREB-mediated gene expression,'
p41406
assS'path:map05030'
p41407
(dp41408
S'NAME'
p41409
(lp41410
S'Cocaine addiction'
p41411
asS'REFERENCE'
p41412
(lp41413
S'PMID:16278489'
p41414
ag41414
aS'AUTHORS'
p41415
aS'Ron D, Jurd R'
p41416
aS'TITLE'
p41417
aS'The "ups and downs" of signaling cascades in addiction.'
p41418
aS'JOURNAL'
p41419
aS'Sci STKE 2005:re14 (2005)'
p41420
aS'PMID:18440072'
p41421
ag41421
aS'AUTHORS'
p41422
aS'Cunha-Oliveira T, Rego AC, Oliveira CR'
p41423
aS'TITLE'
p41424
aS'Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.'
p41425
aS'JOURNAL'
p41426
aS'Brain Res Rev 58:192-208 (2008)'
p41427
aS'PMID:19403004'
p41428
ag41428
aS'AUTHORS'
p41429
aS'Chen JC, Chen PC, Chiang YC'
p41430
aS'TITLE'
p41431
aS'Molecular mechanisms of psychostimulant addiction.'
p41432
aS'JOURNAL'
p41433
aS'Chang Gung Med J 32:148-54 (2009)'
p41434
aS'PMID:16251986'
p41435
ag41435
aS'AUTHORS'
p41436
aS'Nestler EJ'
p41437
aS'TITLE'
p41438
aS'Is there a common molecular pathway for addiction?'
p41439
aS'JOURNAL'
p41440
aS'Nat Neurosci 8:1445-9 (2005)'
p41441
aS'PMID:15091342'
p41442
ag41442
aS'AUTHORS'
p41443
aS'Bowers MS, McFarland K, Lake RW, Peterson YK, Lapish CC, Gregory ML, Lanier SM, Kalivas PW'
p41444
aS'TITLE'
p41445
aS'Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking.'
p41446
aS'JOURNAL'
p41447
aS'Neuron 42:269-81 (2004)'
p41448
aS'PMID:12818179'
p41449
ag41449
aS'AUTHORS'
p41450
aS'Rahman Z, Schwarz J, Gold SJ, Zachariou V, Wein MN, Choi KH, Kovoor A, Chen CK, DiLeone RJ, Schwarz SC, Selley DE, Sim-Selley LJ, Barrot M, Luedtke RR, Self D, Neve RL, Lester HA, Simon MI, Nestler EJ'
p41451
aS'TITLE'
p41452
aS'RGS9 modulates dopamine signaling in the basal ganglia.'
p41453
aS'JOURNAL'
p41454
aS'Neuron 38:941-52 (2003)'
p41455
aS'PMID:10234039'
p41456
ag41456
aS'AUTHORS'
p41457
aS'Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR'
p41458
aS'TITLE'
p41459
aS'Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor.'
p41460
aS'JOURNAL'
p41461
aS'J Neurosci 19:4110-22 (1999)'
p41462
aS'PMID:12064476'
p41463
ag41463
aS'AUTHORS'
p41464
aS'Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S'
p41465
aS'TITLE'
p41466
aS'Dopamine transport function is elevated in cocaine users.'
p41467
aS'JOURNAL'
p41468
aS'J Neurochem 81:292-300 (2002)'
p41469
aS'PMID:14566342'
p41470
ag41470
aS'AUTHORS'
p41471
aS'McClung CA, Nestler EJ'
p41472
aS'TITLE'
p41473
aS'Regulation of gene expression and cocaine reward by CREB and DeltaFosB.'
p41474
aS'JOURNAL'
p41475
aS'Nat Neurosci 6:1208-15 (2003)'
p41476
aS'PMID:15582154'
p41477
ag41477
aS'AUTHORS'
p41478
aS'McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ'
p41479
aS'TITLE'
p41480
aS'DeltaFosB: a molecular switch for long-term adaptation in the brain.'
p41481
aS'JOURNAL'
p41482
aS'Brain Res Mol Brain Res 132:146-54 (2004)'
p41483
aS'PMID:11595774'
p41484
ag41484
aS'AUTHORS'
p41485
aS'Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E, Nestler EJ'
p41486
aS'TITLE'
p41487
aS'Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration.'
p41488
aS'JOURNAL'
p41489
aS'J Neurochem 79:221-4 (2001)'
p41490
aS'PMID:11268215'
p41491
ag41491
aS'AUTHORS'
p41492
aS'Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P'
p41493
aS'TITLE'
p41494
aS'Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.'
p41495
aS'JOURNAL'
p41496
aS'Nature 410:376-80 (2001)'
p41497
aS'PMID:14746512'
p41498
ag41498
aS'AUTHORS'
p41499
aS'Chao J, Nestler EJ'
p41500
aS'TITLE'
p41501
aS'Molecular neurobiology of drug addiction.'
p41502
aS'JOURNAL'
p41503
aS'Annu Rev Med 55:113-32 (2004)'
p41504
asS'KO_PATHWAY'
p41505
(lp41506
S'ko05030'
p41507
asS'PATHWAY_MAP'
p41508
(lp41509
S'map05030'
p41510
asS'DBLINKS'
p41511
(lp41512
S'GO: 0042220'
p41513
asS'ENTRY'
p41514
(lp41515
S'map05030'
p41516
aS'Pathway'
p41517
asS'CLASS'
p41518
(lp41519
S'Human Diseases Substance dependence'
p41520
asS'DESCRIPTION'
p41521
(lp41522
S'Drug addiction is a chronic, relapsing disorder in which compulsive drug-seeking and drug-taking behavior persists despite serious negative consequences.There is strong evidence that the dopaminergic system that projects from the ventral tegmental area (VTA) of the midbrain to the nucleus accumbens (NAc), and to other forebrain sites, is the major substrate of reward and reinforcement for both natural rewards and addictive drugs. Cocaine binds strongly to the dopamine-reuptake transporter, preventing the reuptake of dopamine into the nerve terminal. Because of this blocking effect, dopamine remains at high concentrations in the synapse and continues to affect adjacent neurons, producing the characteristic cocaine "high." Activated D1 receptor activates the PKA signaling pathway, and this pathway plays a critical role in mediating the behavioral responses to cocaine administration. Cocaine-induced neuroadaptations, including dopamine depletion, may underlie craving and hedonic dysregulation.'
p41523
assS'path:map05031'
p41524
(dp41525
S'NAME'
p41526
(lp41527
S'Amphetamine addiction'
p41528
asS'REFERENCE'
p41529
(lp41530
S'PMID:16724157'
p41531
ag41531
aS'AUTHORS'
p41532
aS'Rajadhyaksha AM, Kosofsky BE'
p41533
aS'TITLE'
p41534
aS'Psychostimulants, Protein phosphorylation and Gene expression: a growing role of'
p41535
aS'L-type calcium channels.'
p41536
aS'JOURNAL'
p41537
aS'Cellscience 2:127-144 (2005)'
p41538
aS'PMID:18440072'
p41539
ag41539
aS'AUTHORS'
p41540
aS'Cunha-Oliveira T, Rego AC, Oliveira CR'
p41541
aS'TITLE'
p41542
aS'Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.'
p41543
aS'JOURNAL'
p41544
aS'Brain Res Rev 58:192-208 (2008)'
p41545
aS'PMID:16776597'
p41546
ag41546
aS'AUTHORS'
p41547
aS'Hyman SE, Malenka RC, Nestler EJ'
p41548
aS'TITLE'
p41549
aS'Neural mechanisms of addiction: the role of reward-related learning and memory.'
p41550
aS'JOURNAL'
p41551
aS'Annu Rev Neurosci 29:565-98 (2006)'
p41552
aS'PMID:16151049'
p41553
ag41553
aS'AUTHORS'
p41554
aS'Rajadhyaksha AM, Kosofsky BE'
p41555
aS'TITLE'
p41556
aS'Psychostimulants, L-type calcium channels, kinases, and phosphatases.'
p41557
aS'JOURNAL'
p41558
aS'Neuroscientist 11:494-502 (2005)'
p41559
aS'PMID:14622123'
p41560
ag41560
aS'AUTHORS'
p41561
aS'Dudman JT, Eaton ME, Rajadhyaksha A, Macias W, Taher M, Barczak A, Kameyama K, Huganir R, Konradi C'
p41562
aS'TITLE'
p41563
aS'Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1.'
p41564
aS'JOURNAL'
p41565
aS'J Neurochem 87:922-34 (2003)'
p41566
aS'PMID:10414964'
p41567
ag41567
aS'AUTHORS'
p41568
aS'Rajadhyaksha A, Barczak A, Macias W, Leveque JC, Lewis SE, Konradi C'
p41569
aS'TITLE'
p41570
aS'L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation'
p41571
aS'and c-fos gene expression in striatal neurons.'
p41572
aS'JOURNAL'
p41573
aS'J Neurosci 19:6348-59 (1999)'
p41574
aS'PMID:8753884'
p41575
ag41575
aS'AUTHORS'
p41576
aS'Konradi C, Leveque JC, Hyman SE'
p41577
aS'TITLE'
p41578
aS'Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.'
p41579
aS'JOURNAL'
p41580
aS'J Neurosci 16:4231-9 (1996)'
p41581
aS'PMID:10774721'
p41582
ag41582
aS'AUTHORS'
p41583
aS'Berke JD, Hyman SE'
p41584
aS'TITLE'
p41585
aS'Addiction, dopamine, and the molecular mechanisms of memory.'
p41586
aS'JOURNAL'
p41587
aS'Neuron 25:515-32 (2000)'
p41588
aS'PMID:17728700'
p41589
ag41589
aS'AUTHORS'
p41590
aS'McClung CA, Nestler EJ'
p41591
aS'TITLE'
p41592
aS'Neuroplasticity mediated by altered gene expression.'
p41593
aS'JOURNAL'
p41594
aS'Neuropsychopharmacology 33:3-17 (2008)'
p41595
aS'PMID:14746512'
p41596
ag41596
aS'AUTHORS'
p41597
aS'Chao J, Nestler EJ'
p41598
aS'TITLE'
p41599
aS'Molecular neurobiology of drug addiction.'
p41600
aS'JOURNAL'
p41601
aS'Annu Rev Med 55:113-32 (2004)'
p41602
aS'PMID:19199083'
p41603
ag41603
aS'AUTHORS'
p41604
aS'Robertson SD, Matthies HJ, Galli A'
p41605
aS'TITLE'
p41606
aS'A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.'
p41607
aS'JOURNAL'
p41608
aS'Mol Neurobiol 39:73-80 (2009)'
p41609
aS'PMID:18617632'
p41610
ag41610
aS'AUTHORS'
p41611
aS'Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, Fog JU, Zhang M, Sen N, Colbran RJ, Gnegy ME, Gether U, Javitch JA, Erreger K, Galli A'
p41612
aS'TITLE'
p41613
aS'Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.'
p41614
aS'JOURNAL'
p41615
aS'Mol Pharmacol 74:1101-8 (2008)'
p41616
aS'PMID:21338876'
p41617
ag41617
aS'AUTHORS'
p41618
aS'Sulzer D'
p41619
aS'TITLE'
p41620
aS'How addictive drugs disrupt presynaptic dopamine neurotransmission.'
p41621
aS'JOURNAL'
p41622
aS'Neuron 69:628-49 (2011)'
p41623
aS'PMID:8630246'
p41624
ag41624
aS'AUTHORS'
p41625
aS'Hyman SE'
p41626
aS'TITLE'
p41627
aS'Addiction to cocaine and amphetamine.'
p41628
aS'JOURNAL'
p41629
aS'Neuron 16:901-4 (1996)'
p41630
aS'PMID:18632938'
p41631
ag41631
aS'AUTHORS'
p41632
aS'Renthal W, Carle TL, Maze I, Covington HE 3rd, Truong HT, Alibhai I, Kumar A, Montgomery RL, Olson EN, Nestler EJ'
p41633
aS'TITLE'
p41634
aS'Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure.'
p41635
aS'JOURNAL'
p41636
aS'J Neurosci 28:7344-9 (2008)'
p41637
aS'PMID:21989194'
p41638
ag41638
aS'AUTHORS'
p41639
aS'Robison AJ, Nestler EJ'
p41640
aS'TITLE'
p41641
aS'Transcriptional and epigenetic mechanisms of addiction.'
p41642
aS'JOURNAL'
p41643
aS'Nat Rev Neurosci 12:623-37 (2011)'
p41644
aS'PMID:14529709'
p41645
ag41645
aS'AUTHORS'
p41646
aS'Snyder GL, Galdi S, Fienberg AA, Allen P, Nairn AC, Greengard P'
p41647
aS'TITLE'
p41648
aS'Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists.'
p41649
aS'JOURNAL'
p41650
aS'Neuropharmacology 45:703-13 (2003)'
p41651
aS'PMID:19222557'
p41652
ag41652
aS'AUTHORS'
p41653
aS'Banerjee PS, Aston J, Khundakar AA, Zetterstrom TS'
p41654
aS'TITLE'
p41655
aS'Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and'
p41656
aS'adult brain.'
p41657
aS'JOURNAL'
p41658
aS'Eur J Neurosci 29:465-76 (2009)'
p41659
asS'KO_PATHWAY'
p41660
(lp41661
S'ko05031'
p41662
asS'PATHWAY_MAP'
p41663
(lp41664
S'map05031'
p41665
asS'DBLINKS'
p41666
(lp41667
S'GO: 0001975'
p41668
asS'ENTRY'
p41669
(lp41670
S'map05031'
p41671
aS'Pathway'
p41672
asS'CLASS'
p41673
(lp41674
S'Human Diseases Substance dependence'
p41675
asS'DESCRIPTION'
p41676
(lp41677
S'Amphetamine is a psychostimulant drug that exerts persistent addictive effects. Most addictive drugs increase extracellular concentrations of dopamine (DA) in nucleus accumbens (NAc) and medial prefrontal cortex (mPFC), projection areas of mesocorticolimbic DA neurons and key components of the "brain reward circuit". Amphetamine achieves this elevation in extracellular levels of DA by promoting efflux from synaptic terminals. Acute administration of amphetamine induces phosphorylation of cAMP response element-binding protein (CREB) and expression of a number of immediate early genes (IEGs), such as c-fos. The IEGs is likely to initiate downstream molecular events, which may have important roles in the induction and maintenance of addictive states. Chronic exposure to amphetamine induces a unique transcription factor delta FosB, which plays an essential role in long-term adaptive changes in the brain.'
p41678
assS'path:map05032'
p41679
(dp41680
S'NAME'
p41681
(lp41682
S'Morphine addiction'
p41683
asS'REFERENCE'
p41684
(lp41685
S'PMID:15661627'
p41686
ag41686
aS'AUTHORS'
p41687
aS'Bailey CP, Connor M'
p41688
aS'TITLE'
p41689
aS'Opioids: cellular mechanisms of tolerance and physical dependence.'
p41690
aS'JOURNAL'
p41691
aS'Curr Opin Pharmacol 5:60-8 (2005)'
p41692
aS'PMID:11152760'
p41693
ag41693
aS'AUTHORS'
p41694
aS'Williams JT, Christie MJ, Manzoni O'
p41695
aS'TITLE'
p41696
aS'Cellular and synaptic adaptations mediating opioid dependence.'
p41697
aS'JOURNAL'
p41698
aS'Physiol Rev 81:299-343 (2001)'
p41699
aS'PMID:16581089'
p41700
ag41700
aS'AUTHORS'
p41701
aS'Gintzler AR, Chakrabarti S'
p41702
aS'TITLE'
p41703
aS'Post-opioid receptor adaptations to chronic morphine altered functionality and associations of signaling molecules.'
p41704
aS'JOURNAL'
p41705
aS'Life Sci 79:717-22 (2006)'
p41706
aS'PMID:8785060'
p41707
ag41707
aS'AUTHORS'
p41708
aS'Bonci A, Williams JT'
p41709
aS'TITLE'
p41710
aS'A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine.'
p41711
aS'JOURNAL'
p41712
aS'Neuron 16:631-9 (1996)'
p41713
aS'PMID:11750924'
p41714
ag41714
aS'AUTHORS'
p41715
aS'Liu JG, Anand KJ'
p41716
aS'TITLE'
p41717
aS'Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence.'
p41718
aS'JOURNAL'
p41719
aS'Brain Res Brain Res Rev 38:1-19 (2001)'
p41720
aS'PMID:10066284'
p41721
ag41721
aS'AUTHORS'
p41722
aS'Shoji Y, Delfs J, Williams JT'
p41723
aS'TITLE'
p41724
aS'Presynaptic inhibition of GABA(B)-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal.'
p41725
aS'JOURNAL'
p41726
aS'J Neurosci 19:2347-55 (1999)'
p41727
aS'PMID:18349442'
p41728
ag41728
aS'AUTHORS'
p41729
aS'Zhang Y, Chen Q, Yu LC'
p41730
aS'TITLE'
p41731
aS'Morphine: a protective or destructive role in neurons?'
p41732
aS'JOURNAL'
p41733
aS'Neuroscientist 14:561-70 (2008)'
p41734
aS'PMID:12859419'
p41735
ag41735
aS'AUTHORS'
p41736
aS'Tso PH, Wong YH'
p41737
aS'TITLE'
p41738
aS'Molecular basis of opioid dependence: role of signal regulation by G-proteins.'
p41739
aS'JOURNAL'
p41740
aS'Clin Exp Pharmacol Physiol 30:307-16 (2003)'
p41741
aS'PMID:1346804'
p41742
ag41742
aS'AUTHORS'
p41743
aS'Johnson SW, North RA'
p41744
aS'TITLE'
p41745
aS'Opioids excite dopamine neurons by hyperpolarization of local interneurons.'
p41746
aS'JOURNAL'
p41747
aS'J Neurosci 12:483-8 (1992)'
p41748
aS'PMID:20962224'
p41749
ag41749
aS'AUTHORS'
p41750
aS'Madhavan A, Bonci A, Whistler JL'
p41751
aS'TITLE'
p41752
aS'Opioid-Induced GABA potentiation after chronic morphine attenuates the rewarding'
p41753
aS'effects of opioids in the ventral tegmental area.'
p41754
aS'JOURNAL'
p41755
aS'J Neurosci 30:14029-35 (2010)'
p41756
aS'PMID:8987801'
p41757
ag41757
aS'AUTHORS'
p41758
aS'Bonci A, Williams JT'
p41759
aS'TITLE'
p41760
aS'Increased probability of GABA release during withdrawal from morphine.'
p41761
aS'JOURNAL'
p41762
aS'J Neurosci 17:796-803 (1997)'
p41763
aS'PMID:21872647'
p41764
ag41764
aS'AUTHORS'
p41765
aS'Morikawa H, Paladini CA'
p41766
aS'TITLE'
p41767
aS'Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms.'
p41768
aS'JOURNAL'
p41769
aS'Neuroscience 198:95-111 (2011)'
p41770
aS'PMID:12217944'
p41771
ag41771
aS'AUTHORS'
p41772
aS'Xi ZX, Stein EA'
p41773
aS'TITLE'
p41774
aS'GABAergic mechanisms of opiate reinforcement .'
p41775
aS'JOURNAL'
p41776
aS'Alcohol Alcohol 37:485-94 (2002)'
p41777
aS'PMID:8096779'
p41778
ag41778
aS'AUTHORS'
p41779
aS'Kalivas PW'
p41780
aS'TITLE'
p41781
aS'Neurotransmitter regulation of dopamine neurons in the ventral tegmental area.'
p41782
aS'JOURNAL'
p41783
aS'Brain Res Brain Res Rev 18:75-113 (1993)'
p41784
aS'PMID:21930931'
p41785
ag41785
aS'AUTHORS'
p41786
aS'Jalabert M, Bourdy R, Courtin J, Veinante P, Manzoni OJ, Barrot M, Georges F'
p41787
aS'TITLE'
p41788
aS'Neuronal circuits underlying acute morphine action on dopamine neurons.'
p41789
aS'JOURNAL'
p41790
aS'Proc Natl Acad Sci U S A 108:16446-50 (2011)'
p41791
aS'PMID:14625081'
p41792
ag41792
aS'AUTHORS'
p41793
aS'Chakrabarti S, Gintzler AR'
p41794
aS'TITLE'
p41795
aS'Phosphorylation of Gbeta is augmented by chronic morphine and enhances Gbetagamma stimulation of adenylyl cyclase activity.'
p41796
aS'JOURNAL'
p41797
aS'Brain Res Mol Brain Res 119:144-51 (2003)'
p41798
aS'PMID:14969742'
p41799
ag41799
aS'AUTHORS'
p41800
aS'Ferrer-Alcon M, La Harpe R, Garcia-Sevilla JA'
p41801
aS'TITLE'
p41802
aS'Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts.'
p41803
aS'JOURNAL'
p41804
aS'Brain Res Mol Brain Res 121:114-22 (2004)'
p41805
asS'KO_PATHWAY'
p41806
(lp41807
S'ko05032'
p41808
asS'PATHWAY_MAP'
p41809
(lp41810
S'map05032'
p41811
asS'DBLINKS'
p41812
(lp41813
S'GO: 0043278'
p41814
asS'ENTRY'
p41815
(lp41816
S'map05032'
p41817
aS'Pathway'
p41818
asS'CLASS'
p41819
(lp41820
S'Human Diseases Substance dependence'
p41821
asS'DESCRIPTION'
p41822
(lp41823
S'Morphine is an alkaloid from the plant extracts of opium poppy. Although morphine is highly effective for the treatment of pain, it is also known to be intensely addictive. We now know that the most important brain-reward circuit involves dopamine (DA) -containing neurons in the ventral tegmental area (VTA) of the midbrain and their target areas in the limbic forebrain, in particular, the nucleus accumbens (NAc) and frontal regions of cerebral cortex. Morphine can cause indirect excitation of VTA dopamine neurons by reducing inhibitory synaptic transmission mediated by GABAergic neurons. The chronic use of morphine is characterized by adaptive changes in neurons and neuronal communication'
p41824
assS'path:map05033'
p41825
(dp41826
S'NAME'
p41827
(lp41828
S'Nicotine addiction'
p41829
asS'REFERENCE'
p41830
(lp41831
S'PMID:12436424'
p41832
ag41832
aS'AUTHORS'
p41833
aS'Mansvelder HD, McGehee DS'
p41834
aS'TITLE'
p41835
aS'Cellular and synaptic mechanisms of nicotine addiction.'
p41836
aS'JOURNAL'
p41837
aS'J Neurobiol 53:606-17 (2002)'
p41838
aS'PMID:15661626'
p41839
ag41839
aS'AUTHORS'
p41840
aS'Wonnacott S, Sidhpura N, Balfour DJ'
p41841
aS'TITLE'
p41842
aS'Nicotine: from molecular mechanisms to behaviour.'
p41843
aS'JOURNAL'
p41844
aS'Curr Opin Pharmacol 5:53-9 (2005)'
p41845
aS'PMID:19669944'
p41846
ag41846
aS'AUTHORS'
p41847
aS'Mao D, McGehee DS'
p41848
aS'TITLE'
p41849
aS'Nicotine and behavioral sensitization.'
p41850
aS'JOURNAL'
p41851
aS'J Mol Neurosci 40:154-63 (2010)'
p41852
aS'PMID:19184650'
p41853
ag41853
aS'AUTHORS'
p41854
aS'Barik J, Wonnacott S'
p41855
aS'TITLE'
p41856
aS'Molecular and cellular mechanisms of action of nicotine in the CNS.'
p41857
aS'JOURNAL'
p41858
aS'Handb Exp Pharmacol 173-207 (2009)'
p41859
aS'PMID:19498417'
p41860
ag41860
aS'AUTHORS'
p41861
aS'Yang KC, Jin GZ, Wu J'
p41862
aS'TITLE'
p41863
aS'Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.'
p41864
aS'JOURNAL'
p41865
aS'Acta Pharmacol Sin 30:740-51 (2009)'
p41866
aS'PMID:14747518'
p41867
ag41867
aS'AUTHORS'
p41868
aS'Pidoplichko VI, Noguchi J, Areola OO, Liang Y, Peterson J, Zhang T, Dani JA'
p41869
aS'TITLE'
p41870
aS'Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction.'
p41871
aS'JOURNAL'
p41872
aS'Learn Mem 11:60-9 (2004)'
p41873
aS'PMID:12716925'
p41874
ag41874
aS'AUTHORS'
p41875
aS'Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA'
p41876
aS'TITLE'
p41877
aS'Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas.'
p41878
aS'JOURNAL'
p41879
aS'J Neurosci 23:3176-85 (2003)'
p41880
aS'PMID:19434058'
p41881
ag41881
aS'AUTHORS'
p41882
aS'Xi ZX, Spiller K, Gardner EL'
p41883
aS'TITLE'
p41884
aS'Mechanism-based medication development for the treatment of nicotine dependence.'
p41885
aS'JOURNAL'
p41886
aS'Acta Pharmacol Sin 30:723-39 (2009)'
p41887
aS'PMID:14708004'
p41888
ag41888
aS'AUTHORS'
p41889
aS'Laviolette SR, van der Kooy D'
p41890
aS'TITLE'
p41891
aS'The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour.'
p41892
aS'JOURNAL'
p41893
aS'Nat Rev Neurosci 5:55-65 (2004)'
p41894
aS'PMID:20485364'
p41895
ag41895
aS'AUTHORS'
p41896
aS'Changeux JP'
p41897
aS'TITLE'
p41898
aS'Nicotine addiction and nicotinic receptors: lessons from genetically modified mice.'
p41899
aS'JOURNAL'
p41900
aS'Nat Rev Neurosci 11:389-401 (2010)'
p41901
aS'PMID:17009926'
p41902
ag41902
aS'AUTHORS'
p41903
aS'Dani JA, Bertrand D'
p41904
aS'TITLE'
p41905
aS'Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.'
p41906
aS'JOURNAL'
p41907
aS'Annu Rev Pharmacol Toxicol 47:699-729 (2007)'
p41908
aS'PMID:11906697'
p41909
ag41909
aS'AUTHORS'
p41910
aS'Mansvelder HD, Keath JR, McGehee DS'
p41911
aS'TITLE'
p41912
aS'Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas.'
p41913
aS'JOURNAL'
p41914
aS'Neuron 33:905-19 (2002)'
p41915
aS'PMID:18723034'
p41916
ag41916
aS'AUTHORS'
p41917
aS"O'Dell LE"
p41918
aS'TITLE'
p41919
aS'A psychobiological framework of the substrates that mediate nicotine use during adolescence.'
p41920
aS'JOURNAL'
p41921
aS'Neuropharmacology 56 Suppl 1:263-78 (2009)'
p41922
aS'PMID:20833261'
p41923
ag41923
aS'AUTHORS'
p41924
aS'Ortells MO, Arias HR'
p41925
aS'TITLE'
p41926
aS'Neuronal networks of nicotine addiction.'
p41927
aS'JOURNAL'
p41928
aS'Int J Biochem Cell Biol 42:1931-5 (2010)'
p41929
aS'PMID:16251989'
p41930
ag41930
aS'AUTHORS'
p41931
aS'Dani JA, Harris RA'
p41932
aS'TITLE'
p41933
aS'Nicotine addiction and comorbidity with alcohol abuse and mental illness.'
p41934
aS'JOURNAL'
p41935
aS'Nat Neurosci 8:1465-70 (2005)'
p41936
aS'PMID:18640919'
p41937
ag41937
aS'AUTHORS'
p41938
aS'Markou A'
p41939
aS'TITLE'
p41940
aS'Review. Neurobiology of nicotine dependence.'
p41941
aS'JOURNAL'
p41942
aS'Philos Trans R Soc Lond B Biol Sci 363:3159-68 (2008)'
p41943
aS'PMID:15165747'
p41944
ag41944
aS'AUTHORS'
p41945
aS'Dajas-Bailador F, Wonnacott S'
p41946
aS'TITLE'
p41947
aS'Nicotinic acetylcholine receptors and the regulation of neuronal signalling.'
p41948
aS'JOURNAL'
p41949
aS'Trends Pharmacol Sci 25:317-24 (2004)'
p41950
asS'KO_PATHWAY'
p41951
(lp41952
S'ko05033'
p41953
asS'PATHWAY_MAP'
p41954
(lp41955
S'map05033'
p41956
asS'DBLINKS'
p41957
(lp41958
S'GO: 0035094'
p41959
asS'ENTRY'
p41960
(lp41961
S'map05033'
p41962
aS'Pathway'
p41963
asS'CLASS'
p41964
(lp41965
S'Human Diseases Substance dependence'
p41966
asS'DESCRIPTION'
p41967
(lp41968
S'Nicotine is one of the main psychoactive ingredients in tobacco that contributes to the harmful tobacco smoking habit. A common feature of addictive drugs, including nicotine, is that they increase dopamine (DA) release in the nucleus accumbens (NAc). The principal dopaminergic projections to NAc arise from neurons in the ventral tegmental area (VTA). In the VTA, alpha6- and alpha4beta2-containing nAChRs (alpha6*-AChRs and alpha4beta2*-AChRs, respectively) are located on GABAergic terminals and provide inhibitory inputs onto DAergic neuons, while alpha7*-nAChRs are located on glutamatergic terminals and activation of these receptors enhances glutamate release and increases excitability of DAergic neurons. Nicotine acts as an agonist to activate and desensitize these nicotinic acetylcholine receptors (nAChRs). After a short exposure to nicotine, alpha6*- and alpha4beta2*- nAChRs on GABAergic afferents are desensitized, decreasing GABA release and decreasing local inhibition of DA neurons. But the alpha7*-nAChRs on glutamatergic afferents remain active and enhance glutamate excitation of the DA neurons, leading to increased DA release in the NAc -and so facilitate the reinforcing effects of nicotine.'
p41969
assS'path:map05134'
p41970
(dp41971
S'NAME'
p41972
(lp41973
S'Legionellosis'
p41974
asS'REFERENCE'
p41975
(lp41976
S'PMID:20375353'
p41977
ag41977
aS'AUTHORS'
p41978
aS'Newton HJ, Ang DK, van Driel IR, Hartland EL'
p41979
aS'TITLE'
p41980
aS'Molecular pathogenesis of infections caused by Legionella pneumophila.'
p41981
aS'JOURNAL'
p41982
aS'Clin Microbiol Rev 23:274-98 (2010)'
p41983
aS'PMID:18363881'
p41984
ag41984
aS'AUTHORS'
p41985
aS'Shin S, Roy CR'
p41986
aS'TITLE'
p41987
aS'Host cell processes that influence the intracellular survival of Legionella pneumophila.'
p41988
aS'JOURNAL'
p41989
aS'Cell Microbiol 10:1209-20 (2008)'
p41990
aS'PMID:19157961'
p41991
ag41991
aS'AUTHORS'
p41992
aS'Ensminger AW, Isberg RR'
p41993
aS'TITLE'
p41994
aS'Legionella pneumophila Dot/Icm translocated substrates: a sum of parts.'
p41995
aS'JOURNAL'
p41996
aS'Curr Opin Microbiol 12:67-73 (2009)'
p41997
aS'PMID:15972519'
p41998
ag41998
aS'AUTHORS'
p41999
aS'Chang B, Kura F, Amemura-Maekawa J, Koizumi N, Watanabe H'
p42000
aS'TITLE'
p42001
aS'Identification of a novel adhesion molecule involved in the virulence of Legionella pneumophila.'
p42002
aS'JOURNAL'
p42003
aS'Infect Immun 73:4272-80 (2005)'
p42004
aS'PMID:18549456'
p42005
ag42005
aS'AUTHORS'
p42006
aS'Liu M, Conover GM, Isberg RR'
p42007
aS'TITLE'
p42008
aS'Legionella pneumophila EnhC is required for efficient replication in tumour necrosis factor alpha-stimulated macrophages.'
p42009
aS'JOURNAL'
p42010
aS'Cell Microbiol 10:1906-23 (2008)'
p42011
aS'PMID:19021631'
p42012
ag42012
aS'AUTHORS'
p42013
aS'Weber SS, Ragaz C, Hilbi H'
p42014
aS'TITLE'
p42015
aS'The inositol polyphosphate 5-phosphatase OCRL1 restricts intracellular growth of'
p42016
aS'Legionella, localizes to the replicative vacuole and binds to the bacterial effector LpnE.'
p42017
aS'JOURNAL'
p42018
aS'Cell Microbiol 11:442-60 (2009)'
p42019
aS'PMID:16495539'
p42020
ag42020
aS'AUTHORS'
p42021
aS'Newton HJ, Sansom FM, Bennett-Wood V, Hartland EL'
p42022
aS'TITLE'
p42023
aS'Identification of Legionella pneumophila-specific genes by genomic subtractive hybridization with Legionella micdadei and identification of lpnE, a gene required for efficient host cell entry.'
p42024
aS'JOURNAL'
p42025
aS'Infect Immun 74:1683-91 (2006)'
p42026
aS'PMID:18048909'
p42027
ag42027
aS'AUTHORS'
p42028
aS'De Buck E, Anne J, Lammertyn E'
p42029
aS'TITLE'
p42030
aS'The role of protein secretion systems in the virulence of the intracellular pathogen Legionella pneumophila.'
p42031
aS'JOURNAL'
p42032
aS'Microbiology 153:3948-53 (2007)'
p42033
aS'PMID:19687203'
p42034
ag42034
aS'AUTHORS'
p42035
aS'Chong A, Lima CA, Allan DS, Nasrallah GK, Garduno RA'
p42036
aS'TITLE'
p42037
aS'The purified and recombinant Legionella pneumophila chaperonin alters mitochondrial trafficking and microfilament organization.'
p42038
aS'JOURNAL'
p42039
aS'Infect Immun 77:4724-39 (2009)'
p42040
aS'PMID:1721820'
p42041
ag42041
aS'AUTHORS'
p42042
aS'Cooper NR'
p42043
aS'TITLE'
p42044
aS'Complement evasion strategies of microorganisms.'
p42045
aS'JOURNAL'
p42046
aS'Immunol Today 12:327-31 (1991)'
p42047
aS'PMID:16824952'
p42048
ag42048
aS'AUTHORS'
p42049
aS'Machner MP, Isberg RR'
p42050
aS'TITLE'
p42051
aS'Targeting of host Rab GTPase function by the intravacuolar pathogen Legionella pneumophila.'
p42052
aS'JOURNAL'
p42053
aS'Dev Cell 11:47-56 (2006)'
p42054
aS'PMID:12427954'
p42055
ag42055
aS'AUTHORS'
p42056
aS'Neumeister B, Faigle M, Lauber K, Northoff H, Wesselborg S'
p42057
aS'TITLE'
p42058
aS'Legionella pneumophila induces apoptosis via the mitochondrial death pathway.'
p42059
aS'JOURNAL'
p42060
aS'Microbiology 148:3639-50 (2002)'
p42061
aS'PMID:17124169'
p42062
ag42062
aS'AUTHORS'
p42063
aS'Laguna RK, Creasey EA, Li Z, Valtz N, Isberg RR'
p42064
aS'TITLE'
p42065
aS'A Legionella pneumophila-translocated substrate that is required for growth within macrophages and protection from host cell death.'
p42066
aS'JOURNAL'
p42067
aS'Proc Natl Acad Sci U S A 103:18745-50 (2006)'
p42068
aS'PMID:19666608'
p42069
ag42069
aS'AUTHORS'
p42070
aS'Ge J, Xu H, Li T, Zhou Y, Zhang Z, Li S, Liu L, Shao F'
p42071
aS'TITLE'
p42072
aS'A Legionella type IV effector activates the NF-kappaB pathway by phosphorylating'
p42073
aS'the IkappaB family of inhibitors.'
p42074
aS'JOURNAL'
p42075
aS'Proc Natl Acad Sci U S A 106:13725-30 (2009)'
p42076
aS'PMID:18284575'
p42077
ag42077
aS'AUTHORS'
p42078
aS'Kubori T, Hyakutake A, Nagai H'
p42079
aS'TITLE'
p42080
aS'Legionella translocates an E3 ubiquitin ligase that has multiple U-boxes with distinct functions.'
p42081
aS'JOURNAL'
p42082
aS'Mol Microbiol 67:1307-19 (2008)'
p42083
aS'PMID:19386084'
p42084
ag42084
aS'AUTHORS'
p42085
aS'Shen X, Banga S, Liu Y, Xu L, Gao P, Shamovsky I, Nudler E, Luo ZQ'
p42086
aS'TITLE'
p42087
aS'Targeting eEF1A by a Legionella pneumophila effector leads to inhibition of protein synthesis and induction of host stress response.'
p42088
aS'JOURNAL'
p42089
aS'Cell Microbiol 11:911-26 (2009)'
p42090
aS'PMID:19478083'
p42091
ag42091
aS'AUTHORS'
p42092
aS'Belyi Y, Stahl M, Sovkova I, Kaden P, Luy B, Aktories K'
p42093
aS'TITLE'
p42094
aS'Region of elongation factor 1A1 involved in substrate recognition by Legionella pneumophila glucosyltransferase Lgt1: identification of Lgt1 as a retaining glucosyltransferase.'
p42095
aS'JOURNAL'
p42096
aS'J Biol Chem 284:20167-74 (2009)'
p42097
aS'PMID:18281405'
p42098
ag42098
aS'AUTHORS'
p42099
aS'Belyi Y, Tabakova I, Stahl M, Aktories K'
p42100
aS'TITLE'
p42101
aS'Lgt: a family of cytotoxic glucosyltransferases produced by Legionella pneumophila.'
p42102
aS'JOURNAL'
p42103
aS'J Bacteriol 190:3026-35 (2008)'
p42104
aS'PMID:19343209'
p42105
ag42105
aS'AUTHORS'
p42106
aS'Akhter A, Gavrilin MA, Frantz L, Washington S, Ditty C, Limoli D, Day C, Sarkar A, Newland C, Butchar J, Marsh CB, Wewers MD, Tridandapani S, Kanneganti TD, Amer AO'
p42107
aS'TITLE'
p42108
aS'Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection.'
p42109
aS'JOURNAL'
p42110
aS'PLoS Pathog 5:e1000361 (2009)'
p42111
aS'PMID:20941588'
p42112
ag42112
aS'AUTHORS'
p42113
aS'Palusinska-Szysz M, Janczarek M'
p42114
aS'TITLE'
p42115
aS'Innate immunity to Legionella and toll-like receptors - review.'
p42116
aS'JOURNAL'
p42117
aS'Folia Microbiol (Praha) 55:508-14 (2010)'
p42118
asS'KO_PATHWAY'
p42119
(lp42120
S'ko05134'
p42121
asS"DESCRIPTION Legionellosis is a potentially fatal infectious disease caused by the bacterium Legionella pneumophila and other legionella species. Two distinct clinical and epidemiological syndromes are associated with Legionella species: Legionnaires' disease is the more severe form of the infection, which may involve pneumonia, and Pontiac fever is a milder respiratory illness."
p42122
(lp42123
S"The pathogenesis of L. pneumophila is derived from its growth within lung macrophages. One of the L. pneumophila's type IV secretion systems, the Dot/Icm secretion system, is of critical importance for its ability to replicate and to cause disease. The Dot/Icm substrates modulate multiple host cell processes and in particular, redirect trafficking of the L. pneumophila phagosome and mediate its conversion into an ER-derived organelle competent for intracellular bacterial replication. L. pneumophila also manipulates host cell death and survival pathways in a way that allows continued intracellular replication."
p42124
asS'PATHWAY_MAP'
p42125
(lp42126
S'map05134'
p42127
asS'DISEASE'
p42128
(lp42129
S'H00311'
p42130
aS'Legionellosis'
p42131
asS'ENTRY'
p42132
(lp42133
S'map05134'
p42134
aS'Pathway'
p42135
asS'CLASS'
p42136
(lp42137
S'Human Diseases Infectious diseases'
p42138
asS'DESCRIPTION'
p42139
(lp42140
S"Legionellosis is a potentially fatal infectious disease caused by the bacterium Legionella pneumophila and other legionella species. Two distinct clinical and epidemiological syndromes are associated with Legionella species: Legionnaires' disease is the more severe form of the infection, which may involve pneumonia, and Pontiac fever is a milder respiratory illness."
p42141
assS'path:map05131'
p42142
(dp42143
S'NAME'
p42144
(lp42145
S'Shigellosis'
p42146
asS'REFERENCE'
p42147
(lp42148
S'PMID:18202440'
p42149
ag42149
aS'AUTHORS'
p42150
aS'Schroeder GN, Hilbi H'
p42151
aS'TITLE'
p42152
aS'Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.'
p42153
aS'JOURNAL'
p42154
aS'Clin Microbiol Rev 21:134-56 (2008)'
p42155
aS'PMID:18059288'
p42156
ag42156
aS'AUTHORS'
p42157
aS'Ogawa M, Handa Y, Ashida H, Suzuki M, Sasakawa C'
p42158
aS'TITLE'
p42159
aS'The versatility of Shigella effectors.'
p42160
aS'JOURNAL'
p42161
aS'Nat Rev Microbiol 6:11-6 (2008)'
p42162
aS'PMID:7591128'
p42163
ag42163
aS'AUTHORS'
p42164
aS'Nataro JP, Seriwatana J, Fasano A, Maneval DR, Guers LD, Noriega F, Dubovsky F, Levine MM, Morris JG Jr'
p42165
aS'TITLE'
p42166
aS'Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains.'
p42167
aS'JOURNAL'
p42168
aS'Infect Immun 63:4721-8 (1995)'
p42169
aS'PMID:7665485'
p42170
ag42170
aS'AUTHORS'
p42171
aS'Nakayama S, Watanabe H'
p42172
aS'TITLE'
p42173
aS'Involvement of cpxA, a sensor of a two-component regulatory system, in the pH-dependent regulation of expression of Shigella sonnei virF gene.'
p42174
aS'JOURNAL'
p42175
aS'J Bacteriol 177:5062-9 (1995)'
p42176
aS'PMID:8376337'
p42177
ag42177
aS'AUTHORS'
p42178
aS'Menard R, Sansonetti PJ, Parsot C'
p42179
aS'TITLE'
p42180
aS'Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells.'
p42181
aS'JOURNAL'
p42182
aS'J Bacteriol 175:5899-906 (1993)'
p42183
aS'PMID:8642302'
p42184
ag42184
aS'AUTHORS'
p42185
aS'Watarai M, Funato S, Sasakawa C'
p42186
aS'TITLE'
p42187
aS'Interaction of Ipa proteins of Shigella flexneri with alpha5beta1 integrin promotes entry of the bacteria into mammalian cells.'
p42188
aS'JOURNAL'
p42189
aS'J Exp Med 183:991-9 (1996)'
p42190
aS'PMID:9176079'
p42191
ag42191
aS'AUTHORS'
p42192
aS'Fasano A, Noriega FR, Liao FM, Wang W, Levine MM'
p42193
aS'TITLE'
p42194
aS'Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo.'
p42195
aS'JOURNAL'
p42196
aS'Gut 40:505-11 (1997)'
p42197
aS'PMID:10369666'
p42198
ag42198
aS'AUTHORS'
p42199
aS'Tran Van Nhieu G, Caron E, Hall A, Sansonetti PJ'
p42200
aS'TITLE'
p42201
aS'IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells.'
p42202
aS'JOURNAL'
p42203
aS'EMBO J 18:3249-62 (1999)'
p42204
aS'PMID:10491394'
p42205
ag42205
aS'AUTHORS'
p42206
aS'Egile C, Loisel TP, Laurent V, Li R, Pantaloni D, Sansonetti PJ, Carlier MF'
p42207
aS'TITLE'
p42208
aS'Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility.'
p42209
aS'JOURNAL'
p42210
aS'J Cell Biol 146:1319-32 (1999)'
p42211
aS'PMID:11207560'
p42212
ag42212
aS'AUTHORS'
p42213
aS'Skoudy A, Mounier J, Aruffo A, Ohayon H, Gounon P, Sansonetti P, Tran Van Nhieu G'
p42214
aS'TITLE'
p42215
aS'CD44 binds to the Shigella IpaB protein and participates in bacterial invasion of epithelial cells.'
p42216
aS'JOURNAL'
p42217
aS'Cell Microbiol 2:19-33 (2000)'
p42218
aS'PMID:11379633'
p42219
ag42219
aS'AUTHORS'
p42220
aS'Pantaloni D, Le Clainche C, Carlier MF'
p42221
aS'TITLE'
p42222
aS'Mechanism of actin-based motility.'
p42223
aS'JOURNAL'
p42224
aS'Science 292:1502-6 (2001)'
p42225
aS'PMID:12065406'
p42226
ag42226
aS'AUTHORS'
p42227
aS'Yoshida S, Katayama E, Kuwae A, Mimuro H, Suzuki T, Sasakawa C'
p42228
aS'TITLE'
p42229
aS'Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization.'
p42230
aS'JOURNAL'
p42231
aS'EMBO J 21:2923-35 (2002)'
p42232
aS'PMID:12356723'
p42233
ag42233
aS'AUTHORS'
p42234
aS'Niebuhr K, Giuriato S, Pedron T, Philpott DJ, Gaits F, Sable J, Sheetz MP, Parsot C, Sansonetti PJ, Payrastre B'
p42235
aS'TITLE'
p42236
aS'Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology.'
p42237
aS'JOURNAL'
p42238
aS'EMBO J 21:5069-78 (2002)'
p42239
aS'PMID:12828640'
p42240
ag42240
aS'AUTHORS'
p42241
aS'Hume PJ, McGhie EJ, Hayward RD, Koronakis V'
p42242
aS'TITLE'
p42243
aS'The purified Shigella IpaB and Salmonella SipB translocators share biochemical properties and membrane topology.'
p42244
aS'JOURNAL'
p42245
aS'Mol Microbiol 49:425-39 (2003)'
p42246
aS'PMID:12856283'
p42247
ag42247
aS'AUTHORS'
p42248
aS'Sossey-Alaoui K, Head K, Nowak N, Cowell JK'
p42249
aS'TITLE'
p42250
aS'Genomic organization and expression profile of the human and mouse WAVE gene family.'
p42251
aS'JOURNAL'
p42252
aS'Mamm Genome 14:314-22 (2003)'
p42253
aS'PMID:14638419'
p42254
ag42254
aS'AUTHORS'
p42255
aS'Cherla RP, Lee SY, Tesh VL'
p42256
aS'TITLE'
p42257
aS'Shiga toxins and apoptosis.'
p42258
aS'JOURNAL'
p42259
aS'FEMS Microbiol Lett 228:159-66 (2003)'
p42260
aS'PMID:15073367'
p42261
ag42261
aS'AUTHORS'
p42262
aS'Cossart P, Sansonetti PJ'
p42263
aS'TITLE'
p42264
aS'Bacterial invasion: the paradigms of enteroinvasive pathogens.'
p42265
aS'JOURNAL'
p42266
aS'Science 304:242-8 (2004)'
p42267
aS'PMID:15318166'
p42268
ag42268
aS'AUTHORS'
p42269
aS'Matsuzawa T, Kuwae A, Yoshida S, Sasakawa C, Abe A.'
p42270
aS'TITLE'
p42271
aS'Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1.'
p42272
aS'JOURNAL'
p42273
aS'EMBO J 23:3570-82 (2004)'
p42274
aS'PMID:15694852'
p42275
ag42275
aS'AUTHORS'
p42276
aS'Nhieu GT, Enninga J, Sansonetti P, Grompone G'
p42277
aS'TITLE'
p42278
aS'Tyrosine kinase signaling and type III effectors orchestrating Shigella invasion.'
p42279
aS'JOURNAL'
p42280
aS'Curr Opin Microbiol 8:16-20 (2005)'
p42281
aS'PMID:15731041'
p42282
ag42282
aS'AUTHORS'
p42283
aS'Picking WL, Nishioka H, Hearn PD, Baxter MA, Harrington AT, Blocker A, Picking WD'
p42284
aS'TITLE'
p42285
aS'IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.'
p42286
aS'JOURNAL'
p42287
aS'Infect Immun 73:1432-40 (2005)'
p42288
aS'PMID:15950937'
p42289
ag42289
aS'AUTHORS'
p42290
aS'Okuda J, Toyotome T, Kataoka N, Ohno M, Abe H, Shimura Y, Seyedarabi A, Pickersgill R, Sasakawa C'
p42291
aS'TITLE'
p42292
aS'Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses.'
p42293
aS'JOURNAL'
p42294
aS'Biochem Biophys Res Commun 333:531-9 (2005)'
p42295
aS'PMID:16162672'
p42296
ag42296
aS'AUTHORS'
p42297
aS'Kim DW, Lenzen G, Page AL, Legrain P, Sansonetti PJ, Parsot C'
p42298
aS'TITLE'
p42299
aS'The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes.'
p42300
aS'JOURNAL'
p42301
aS'Proc Natl Acad Sci U S A 102:14046-51 (2005)'
p42302
aS'PMID:16413487'
p42303
ag42303
aS'AUTHORS'
p42304
aS'Alto NM, Shao F, Lazar CS, Brost RL, Chua G, Mattoo S, McMahon SA, Ghosh P, Hughes TR, Boone C, Dixon JE'
p42305
aS'TITLE'
p42306
aS'Identification of a bacterial type III effector family with G protein mimicry functions.'
p42307
aS'JOURNAL'
p42308
aS'Cell 124:133-45 (2006)'
p42309
aS'PMID:16441429'
p42310
ag42310
aS'AUTHORS'
p42311
aS'Ogawa M, Sasakawa C'
p42312
aS'TITLE'
p42313
aS'Intracellular survival of Shigella.'
p42314
aS'JOURNAL'
p42315
aS'Cell Microbiol 8:177-84 (2006)'
p42316
aS'PMID:16622194'
p42317
ag42317
aS'AUTHORS'
p42318
aS'Miura M, Terajima J, Izumiya H, Mitobe J, Komano T, Watanabe H'
p42319
aS'TITLE'
p42320
aS'OspE2 of Shigella sonnei is required for the maintenance of cell architecture of'
p42321
aS'bacterium-infected cells.'
p42322
aS'JOURNAL'
p42323
aS'Infect Immun 74:2587-95 (2006)'
p42324
aS'PMID:16939534'
p42325
ag42325
aS'AUTHORS'
p42326
aS'Hilbi H'
p42327
aS'TITLE'
p42328
aS'Modulation of phosphoinositide metabolism by pathogenic bacteria.'
p42329
aS'JOURNAL'
p42330
aS'Cell Microbiol 8:1697-706 (2006)'
p42331
aS'PMID:17060328'
p42332
ag42332
aS'AUTHORS'
p42333
aS'Demali KA, Jue AL, Burridge K'
p42334
aS'TITLE'
p42335
aS'IpaA targets beta1 integrins and rho to promote actin cytoskeleton rearrangements necessary for Shigella entry.'
p42336
aS'JOURNAL'
p42337
aS'J Biol Chem 281:39534-41 (2006)'
p42338
aS'PMID:17095701'
p42339
ag42339
aS'AUTHORS'
p42340
aS'Yoshida S, Handa Y, Suzuki T, Ogawa M, Suzuki M, Tamai A, Abe A, Katayama E, Sasakawa C'
p42341
aS'TITLE'
p42342
aS'Microtubule-severing activity of Shigella is pivotal for intercellular spreading.'
p42343
aS'JOURNAL'
p42344
aS'Science 314:985-9 (2006)'
p42345
aS'PMID:17173036'
p42346
ag42346
aS'AUTHORS'
p42347
aS'Handa Y, Suzuki M, Ohya K, Iwai H, Ishijima N, Koleske AJ, Fukui Y, Sasakawa C'
p42348
aS'TITLE'
p42349
aS'Shigella IpgB1 promotes bacterial entry through the ELMO-Dock180 machinery.'
p42350
aS'JOURNAL'
p42351
aS'Nat Cell Biol 9:121-8 (2007)'
p42352
aS'PMID:17662586'
p42353
ag42353
aS'AUTHORS'
p42354
aS'Mattoo S, Lee YM, Dixon JE'
p42355
aS'TITLE'
p42356
aS'Interactions of bacterial effector proteins with host proteins.'
p42357
aS'JOURNAL'
p42358
aS'Curr Opin Immunol 19:392-401 (2007)'
p42359
aS'PMID:17719540'
p42360
ag42360
aS'AUTHORS'
p42361
aS'Iwai H, Kim M, Yoshikawa Y, Ashida H, Ogawa M, Fujita Y, Muller D, Kirikae T, Jackson PK, Kotani S, Sasakawa C'
p42362
aS'TITLE'
p42363
aS'A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling.'
p42364
aS'JOURNAL'
p42365
aS'Cell 130:611-23 (2007)'
p42366
aS'PMID:18005683'
p42367
ag42367
aS'AUTHORS'
p42368
aS'Rohde JR, Breitkreutz A, Chenal A, Sansonetti PJ, Parsot C'
p42369
aS'TITLE'
p42370
aS'Type III secretion effectors of the IpaH family are E3 ubiquitin ligases.'
p42371
aS'JOURNAL'
p42372
aS'Cell Host Microbe 1:77-83 (2007)'
p42373
aS'PMID:18005697'
p42374
ag42374
aS'AUTHORS'
p42375
aS'Zhang J, Shao F, Li Y, Cui H, Chen L, Li H, Zou Y, Long C, Lan L, Chai J, Chen S, Tang X, Zhou JM'
p42376
aS'TITLE'
p42377
aS'A Pseudomonas syringae effector inactivates MAPKs to suppress PAMP-induced immunity in plants.'
p42378
aS'JOURNAL'
p42379
aS'Cell Host Microbe 1:175-85 (2007)'
p42380
aS'PMID:19165331'
p42381
ag42381
aS'AUTHORS'
p42382
aS'Mounier J, Popoff MR, Enninga J, Frame MC, Sansonetti PJ, Van Nhieu GT'
p42383
aS'TITLE'
p42384
aS'The IpaC carboxyterminal effector domain mediates Src-dependent actin polymerization during Shigella invasion of epithelial cells.'
p42385
aS'JOURNAL'
p42386
aS'PLoS Pathog 5:e1000271 (2009)'
p42387
asS'KO_PATHWAY'
p42388
(lp42389
S'ko05131'
p42390
asS'PATHWAY_MAP'
p42391
(lp42392
S'map05131'
p42393
asS'DISEASE'
p42394
(lp42395
S'H00299'
p42396
aS'Shigellosis'
p42397
asS'MODULE'
p42398
(lp42399
S'M00363'
p42400
aS'EHEC pathogenicity signature, Shiga toxin [PATH:map05131]'
p42401
asS'ENTRY'
p42402
(lp42403
S'map05131'
p42404
aS'Pathway'
p42405
asS'CLASS'
p42406
(lp42407
S'Human Diseases Infectious diseases'
p42408
asS'DESCRIPTION'
p42409
(lp42410
S'Shigellosis, or bacillary dysentery, is an intestinal infection caused by Shigella, a genus of enterobacteria. Shigella are potential food-borne pathogens that are capable of colonizing the intestinal epithelium by exploiting epithelial-cell functions and circumventing the host innate immune response. During basolateral entry into the host-cell cytoplasm, Shigella deliver a subset of effectors into the host cells through the type III secretion system. The effectors induce membrane ruffling through the stimulation of the Rac1-WAVE-Arp2/3 pathway, enabling bacterial entry into the epithelial cells. During multiplication within the cells, Shigella secrete another subset of effectors. VirG induces actin polymerization at one pole of the bacteria, allowing the bacteria to spread intracellularly and to infect adjacent cells. OspF, OspG and IpaH(9.8) downregulate the production of proinflammatory cytokines such as IL-8, helping bacteria circumvent the innate immune response.'
p42411
assS'path:map05130'
p42412
(dp42413
S'NAME'
p42414
(lp42415
S'Pathogenic Escherichia coli infection'
p42416
asS'REFERENCE'
p42417
(lp42418
S'PMID:15040260'
p42419
ag42419
aS'AUTHORS'
p42420
aS'Kaper JB, Nataro JP, Mobley HL.'
p42421
aS'TITLE'
p42422
aS'Pathogenic Escherichia coli.'
p42423
aS'JOURNAL'
p42424
aS'Nat Rev Microbiol 2:123-40 (2004)'
p42425
aS'PMID:15618137'
p42426
ag42426
aS'AUTHORS'
p42427
aS'Torres AG, Zhou X, Kaper JB.'
p42428
aS'TITLE'
p42429
aS'Adherence of diarrheagenic Escherichia coli strains to epithelial cells.'
p42430
aS'JOURNAL'
p42431
aS'Infect Immun 73:18-29 (2005)'
p42432
aS'PMID:15694854'
p42433
ag42433
aS'AUTHORS'
p42434
aS'Dean P, Maresca M, Kenny B.'
p42435
aS'TITLE'
p42436
aS"EPEC's weapons of mass subversion."
p42437
aS'JOURNAL'
p42438
aS'Curr Opin Microbiol 8:28-34 (2005)'
p42439
aS'PMID:15845459'
p42440
ag42440
aS'AUTHORS'
p42441
aS'Garmendia J, Frankel G, Crepin VF.'
p42442
aS'TITLE'
p42443
aS'Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.'
p42444
aS'JOURNAL'
p42445
aS'Infect Immun 73:2573-85 (2005)'
p42446
aS'PMID:16448495'
p42447
ag42447
aS'AUTHORS'
p42448
aS'Spears KJ, Roe AJ, Gally DL.'
p42449
aS'TITLE'
p42450
aS'A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis.'
p42451
aS'JOURNAL'
p42452
aS'FEMS Microbiol Lett 255:187-202 (2006)'
p42453
aS'PMID:12101285'
p42454
ag42454
aS'AUTHORS'
p42455
aS'Kenny B.'
p42456
aS'TITLE'
p42457
aS'Enteropathogenic Escherichia coli (EPEC)-- a crafty subversive little bug.'
p42458
aS'JOURNAL'
p42459
aS'Microbiology 148:1967-78 (2002)'
p42460
aS'PMID:16582930'
p42461
ag42461
aS'AUTHORS'
p42462
aS'Hayward RD, Leong JM, Koronakis V, Campellone KG.'
p42463
aS'TITLE'
p42464
aS'Exploiting pathogenic Escherichia coli to model transmembrane receptor signalling.'
p42465
aS'JOURNAL'
p42466
aS'Nat Rev Microbiol 4:358-70 (2006)'
p42467
aS'PMID:15318166'
p42468
ag42468
aS'AUTHORS'
p42469
aS'Matsuzawa T, Kuwae A, Yoshida S, Sasakawa C, Abe A.'
p42470
aS'TITLE'
p42471
aS'Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1.'
p42472
aS'JOURNAL'
p42473
aS'EMBO J 23:3570-82 (2004)'
p42474
aS'PMID:19144561'
p42475
ag42475
aS'AUTHORS'
p42476
aS'Dean P, Kenny B'
p42477
aS'TITLE'
p42478
aS'The effector repertoire of enteropathogenic E. coli: ganging up on the host cell.'
p42479
aS'JOURNAL'
p42480
aS'Curr Opin Microbiol 12:101-9 (2009)'
p42481
asS'KO_PATHWAY'
p42482
(lp42483
S'ko05130'
p42484
asS'PATHWAY_MAP'
p42485
(lp42486
S'map05130'
p42487
asS'DISEASE'
p42488
(lp42489
S'H00277'
p42490
aS'Enterohemorrhagic Escherichia coli (EHEC) infection'
p42491
ag42490
ag42491
aS'H00278'
p42492
aS'Enteropathogenic Escherichia coli (EPEC) infection'
p42493
asS'MODULE'
p42494
(lp42495
S'M00363'
p42496
aS'EHEC pathogenicity signature, Shiga toxin [PATH:map05130]'
p42497
ag42496
ag42497
aS'M00542'
p42498
aS'EHEC/EPEC pathogenicity signature, T3SS and effectors [PATH:map05130]'
p42499
asS'ENTRY'
p42500
(lp42501
S'map05130'
p42502
aS'Pathway'
p42503
asS'CLASS'
p42504
(lp42505
S'Human Diseases Infectious diseases'
p42506
asS'DESCRIPTION'
p42507
(lp42508
S"Enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli (EHEC) are closely related pathogenic strains of Escherichia coli. The hallmark of EPEC/EHEC infections [DS:H00278 H00277] is induction of attaching and effacing (A/E) lesions that damage intestinal epithelial cells. The capacity to form A/E lesions is encoded mainly by the locus of enterocyte effacement (LEE) pathogenicity island. Tir, Map, EspF, EspG are known LEE-encoded effector proteins secreted via the type III secretion system, which is also LEE-encoded, into the host cell. EPEC and EHEC Tir's link the extracellular bacterium to the cell cytoskeleton. Map and EspF are involved in mitochondrion membrane permeabilization. EspG interacts with tubulins and stimulates microtubule destabilization. LEE-encoded adhesin or intimin (Eae) is exported via the general secretory pathway to the periplasm, where it is inserted into the outer membrane. In addition to Tir, two potential host cell-carried intimin receptors, beta1 integrin (ITGB1) and nucleolin (NCL), have so far been identified. The distinguishing feature of EHEC is the elaboration of Shiga-like toxin (Stx). Stx cleaves ribosomal RNA, thereby disrupting protein synthesis and killing the intoxicated epithelial or endothelial cells."
p42509
assS'path:map05133'
p42510
(dp42511
S'DESCRIPTION Pertussis, also known as whooping cough, is an acute respiratory infectious disease caused by a bacteria called Bordetella Pertussis. The characteristic symptoms are paroxysmal cough, inspiratory wheezing and post-tussive vomiting.'
p42512
(lp42513
S'Following the inhalation of respiratory secretions from an infected individual, bacteria enter the upper respiratory tract and adhere to epithelial cells. Several adhesion factors have been implicated: the filamentous hemagglutinin (FHA), fimbriae, and pertactin (Prn).'
p42514
aS'Pertussis toxin (Ptx) and adenylate cyclase toxin (ACT) have been identified so far as major protein toxins of B. pertussis. PTX is a hexameric AB5-type exotoxin. Catalytic A subunit catalyzes the ADP-ribosylation of the Gi subunits of the heterotrimeric G protein, then inhibits multiple downstream pathways. ACT is able to penetrate the cytoplasmic membrane of host cells and becomes activated through the cleavage and the binding of calmodulin (CaM). Activated ACT converts ATP to cyclic AMP and subverts cellular signaling pathways.'
p42515
asS'NAME'
p42516
(lp42517
S'Pertussis'
p42518
asS'REFERENCE'
p42519
(lp42520
S'PMID:21204863'
p42521
ag42521
aS'AUTHORS'
p42522
aS'de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR'
p42523
aS'TITLE'
p42524
aS'Pertussis: a matter of immune modulation.'
p42525
aS'JOURNAL'
p42526
aS'FEMS Microbiol Rev 35:441-74 (2011)'
p42527
aS'PMID:20210554'
p42528
ag42528
aS'AUTHORS'
p42529
aS'Carbonetti NH'
p42530
aS'TITLE'
p42531
aS'Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella'
p42532
aS'pertussis and cell biology tools.'
p42533
aS'JOURNAL'
p42534
aS'Future Microbiol 5:455-69 (2010)'
p42535
aS'PMID:10540218'
p42536
ag42536
aS'AUTHORS'
p42537
aS'van den Berg BM, van Furth R, Hazenbos WL'
p42538
aS'TITLE'
p42539
aS'Activation of complement receptor 3 on human monocytes by cross-linking of very-late antigen-5 is mediated via protein tyrosine kinases.'
p42540
aS'JOURNAL'
p42541
aS'Immunology 98:197-202 (1999)'
p42542
aS'PMID:16999837'
p42543
ag42543
aS'AUTHORS'
p42544
aS'Mazar J, Cotter PA'
p42545
aS'TITLE'
p42546
aS'Topology and maturation of filamentous haemagglutinin suggest a new model for two-partner secretion.'
p42547
aS'JOURNAL'
p42548
aS'Mol Microbiol 62:641-54 (2006)'
p42549
aS'PMID:16390441'
p42550
ag42550
aS'AUTHORS'
p42551
aS'Hewlett EL, Donato GM, Gray MC'
p42552
aS'TITLE'
p42553
aS'Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP!'
p42554
aS'JOURNAL'
p42555
aS'Mol Microbiol 59:447-59 (2006)'
p42556
aS'PMID:20610650'
p42557
ag42557
aS'AUTHORS'
p42558
aS'Dunne A, Ross PJ, Pospisilova E, Masin J, Meaney A, Sutton CE, Iwakura Y, Tschopp J, Sebo P, Mills KH'
p42559
aS'TITLE'
p42560
aS'Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis.'
p42561
aS'JOURNAL'
p42562
aS'J Immunol 185:1711-9 (2010)'
p42563
aS'PMID:18401006'
p42564
ag42564
aS'AUTHORS'
p42565
aS'Hickey FB, Brereton CF, Mills KH'
p42566
aS'TITLE'
p42567
aS'Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation'
p42568
aS'in dendritic cells.'
p42569
aS'JOURNAL'
p42570
aS'J Leukoc Biol 84:234-43 (2008)'
p42571
aS'PMID:16622221'
p42572
ag42572
aS'AUTHORS'
p42573
aS'Spensieri F, Fedele G, Fazio C, Nasso M, Stefanelli P, Mastrantonio P, Ausiello CM'
p42574
aS'TITLE'
p42575
aS'Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction.'
p42576
aS'JOURNAL'
p42577
aS'Infect Immun 74:2831-8 (2006)'
p42578
aS'PMID:17148436'
p42579
ag42579
aS'AUTHORS'
p42580
aS'Fiser R, Masin J, Basler M, Krusek J, Spulakova V, Konopasek I, Sebo P'
p42581
aS'TITLE'
p42582
aS'Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b+ monocytes independently of the catalytic and hemolytic activities.'
p42583
aS'JOURNAL'
p42584
aS'J Biol Chem 282:2808-20 (2007)'
p42585
aS'PMID:16863919'
p42586
ag42586
aS'AUTHORS'
p42587
aS'Wang ZY, Yang D, Chen Q, Leifer CA, Segal DM, Su SB, Caspi RR, Howard ZO, Oppenheim JJ'
p42588
aS'TITLE'
p42589
aS'Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways.'
p42590
aS'JOURNAL'
p42591
aS'Exp Hematol 34:1115-24 (2006)'
p42592
aS'PMID:15201703'
p42593
ag42593
aS'AUTHORS'
p42594
aS'Fan H, Peck OM, Tempel GE, Halushka PV, Cook JA'
p42595
aS'TITLE'
p42596
aS'Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation.'
p42597
aS'JOURNAL'
p42598
aS'Shock 22:57-62 (2004)'
p42599
aS'PMID:17328678'
p42600
ag42600
aS'AUTHORS'
p42601
aS'Lee MS, Kim YJ'
p42602
aS'TITLE'
p42603
aS'Signaling pathways downstream of pattern-recognition receptors and their cross talk.'
p42604
aS'JOURNAL'
p42605
aS'Annu Rev Biochem 76:447-80 (2007)'
p42606
aS'PMID:20404851'
p42607
ag42607
aS'AUTHORS'
p42608
aS'Kawai T, Akira S'
p42609
aS'TITLE'
p42610
aS'The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.'
p42611
aS'JOURNAL'
p42612
aS'Nat Immunol 11:373-84 (2010)'
p42613
aS'PMID:12701623'
p42614
ag42614
aS'AUTHORS'
p42615
aS'Ferlito M, Romanenko OG, Guyton K, Ashton S, Squadrito F, Halushka PV, Cook JA'
p42616
aS'TITLE'
p42617
aS'Implication of Galpha i proteins and Src tyrosine kinases in endotoxin-induced signal transduction events and mediator production.'
p42618
aS'JOURNAL'
p42619
aS'J Endotoxin Res 8:427-35 (2002)'
p42620
aS'PMID:21423776'
p42621
ag42621
aS'AUTHORS'
p42622
aS'Han HJ, Kuwae A, Abe A, Arakawa Y, Kamachi K'
p42623
aS'TITLE'
p42624
aS'Differential expression of type III effector BteA protein due to IS481 insertion'
p42625
aS'in Bordetella pertussis.'
p42626
aS'JOURNAL'
p42627
aS'PLoS One 6:e17797 (2011)'
p42628
aS'PMID:16481212'
p42629
ag42629
aS'AUTHORS'
p42630
aS'Beier D, Gross R'
p42631
aS'TITLE'
p42632
aS'Regulation of bacterial virulence by two-component systems.'
p42633
aS'JOURNAL'
p42634
aS'Curr Opin Microbiol 9:143-52 (2006)'
p42635
aS'PMID:12915094'
p42636
ag42636
aS'AUTHORS'
p42637
aS'Cotter PA, Jones AM'
p42638
aS'TITLE'
p42639
aS'Phosphorelay control of virulence gene expression in Bordetella.'
p42640
aS'JOURNAL'
p42641
aS'Trends Microbiol 11:367-73 (2003)'
p42642
asS'KO_PATHWAY'
p42643
(lp42644
S'ko05133'
p42645
asS'PATHWAY_MAP'
p42646
(lp42647
S'map05133'
p42648
asS'DISEASE'
p42649
(lp42650
S'H00319'
p42651
aS'Pertussis'
p42652
asS'MODULE'
p42653
(lp42654
S'M00574'
p42655
aS'Pertussis pathogenicity signature 1, pertussis toxin [PATH:map05133]'
p42656
ag42655
ag42656
aS'M00575'
p42657
aS'Pertussis pathogenicity signature 2, T1SS [PATH:map05133]'
p42658
asS'ENTRY'
p42659
(lp42660
S'map05133'
p42661
aS'Pathway'
p42662
asS'CLASS'
p42663
(lp42664
S'Human Diseases Infectious diseases'
p42665
asS'DESCRIPTION'
p42666
(lp42667
S'Pertussis, also known as whooping cough, is an acute respiratory infectious disease caused by a bacteria called Bordetella Pertussis. The characteristic symptoms are paroxysmal cough, inspiratory wheezing and post-tussive vomiting.'
p42668
assS'path:map05132'
p42669
(dp42670
S'NAME'
p42671
(lp42672
S'Salmonella infection'
p42673
asS'REFERENCE'
p42674
(lp42675
S'PMID:20526845'
p42676
ag42676
aS'AUTHORS'
p42677
aS'Trebichavsky I, Splichal I, Splichalova A'
p42678
aS'TITLE'
p42679
aS'Innate immune response in the gut against Salmonella - review.'
p42680
aS'JOURNAL'
p42681
aS'Folia Microbiol (Praha) 55:295-300 (2010)'
p42682
aS'PMID:19930040'
p42683
ag42683
aS'AUTHORS'
p42684
aS'Talbot S, Totemeyer S, Yamamoto M, Akira S, Hughes K, Gray D, Barr T, Mastroeni P, Maskell DJ, Bryant CE'
p42685
aS'TITLE'
p42686
aS'Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella'
p42687
aS'enterica serovar typhimurium infection, but not for the initiation of bacterial clearance.'
p42688
aS'JOURNAL'
p42689
aS'Immunology 128:472-83 (2009)'
p42690
aS'PMID:19775254'
p42691
ag42691
aS'AUTHORS'
p42692
aS'Ibarra JA, Steele-Mortimer O'
p42693
aS'TITLE'
p42694
aS'Salmonella--the ultimate insider. Salmonella virulence factors that modulate intracellular survival.'
p42695
aS'JOURNAL'
p42696
aS'Cell Microbiol 11:1579-86 (2009)'
p42697
aS'PMID:11489966'
p42698
ag42698
aS'AUTHORS'
p42699
aS'Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL'
p42700
aS'TITLE'
p42701
aS'Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression.'
p42702
aS'JOURNAL'
p42703
aS'J Immunol 167:1882-5 (2001)'
p42704
aS'PMID:17071592'
p42705
ag42705
aS'AUTHORS'
p42706
aS'Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, King TP, Kelly D, Gewirtz AT, Neish AS'
p42707
aS'TITLE'
p42708
aS'Flagellin suppresses epithelial apoptosis and limits disease during enteric infection.'
p42709
aS'JOURNAL'
p42710
aS'Am J Pathol 169:1686-700 (2006)'
p42711
aS'PMID:17690885'
p42712
ag42712
aS'AUTHORS'
p42713
aS'Miao EA, Andersen-Nissen E, Warren SE, Aderem A'
p42714
aS'TITLE'
p42715
aS'TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system.'
p42716
aS'JOURNAL'
p42717
aS'Semin Immunopathol 29:275-88 (2007)'
p42718
aS'PMID:20158475'
p42719
ag42719
aS'AUTHORS'
p42720
aS'Bueno SM, Riedel CA, Carreno LJ, Kalergis AM'
p42721
aS'TITLE'
p42722
aS'Virulence mechanisms displayed by Salmonella to impair dendritic cell function.'
p42723
aS'JOURNAL'
p42724
aS'Curr Med Chem 17:1156-66 (2010)'
p42725
aS'PMID:18026123'
p42726
ag42726
aS'AUTHORS'
p42727
aS'Haraga A, Ohlson MB, Miller SI'
p42728
aS'TITLE'
p42729
aS'Salmonellae interplay with host cells.'
p42730
aS'JOURNAL'
p42731
aS'Nat Rev Microbiol 6:53-66 (2008)'
p42732
aS'PMID:11825778'
p42733
ag42733
aS'AUTHORS'
p42734
aS'Kimbrough TG, Miller SI'
p42735
aS'TITLE'
p42736
aS'Assembly of the type III secretion needle complex of Salmonella typhimurium.'
p42737
aS'JOURNAL'
p42738
aS'Microbes Infect 4:75-82 (2002)'
p42739
aS'PMID:17074883'
p42740
ag42740
aS'AUTHORS'
p42741
aS'Patel JC, Galan JE'
p42742
aS'TITLE'
p42743
aS'Differential activation and function of Rho GTPases during Salmonella-host cell interactions.'
p42744
aS'JOURNAL'
p42745
aS'J Cell Biol 175:453-63 (2006)'
p42746
aS'PMID:20123714'
p42747
ag42747
aS'AUTHORS'
p42748
aS'Bulgin R, Raymond B, Garnett JA, Frankel G, Crepin VF, Berger CN, Arbeloa A'
p42749
aS'TITLE'
p42750
aS'Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors.'
p42751
aS'JOURNAL'
p42752
aS'Infect Immun 78:1417-25 (2010)'
p42753
aS'PMID:18778407'
p42754
ag42754
aS'AUTHORS'
p42755
aS'Bakowski MA, Braun V, Brumell JH'
p42756
aS'TITLE'
p42757
aS'Salmonella-containing vacuoles: directing traffic and nesting to grow.'
p42758
aS'JOURNAL'
p42759
aS'Traffic 9:2022-31 (2008)'
p42760
aS'PMID:18411289'
p42761
ag42761
aS'AUTHORS'
p42762
aS'Wasylnka JA, Bakowski MA, Szeto J, Ohlson MB, Trimble WS, Miller SI, Brumell JH'
p42763
aS'TITLE'
p42764
aS'Role for myosin II in regulating positioning of Salmonella-containing vacuoles and intracellular replication.'
p42765
aS'JOURNAL'
p42766
aS'Infect Immun 76:2722-35 (2008)'
p42767
aS'PMID:11567004'
p42768
ag42768
aS'AUTHORS'
p42769
aS'Nikolaus T, Deiwick J, Rappl C, Freeman JA, Schroder W, Miller SI, Hensel M'
p42770
aS'TITLE'
p42771
aS'SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon.'
p42772
aS'JOURNAL'
p42773
aS'J Bacteriol 183:6036-45 (2001)'
p42774
aS'PMID:11755407'
p42775
ag42775
aS'AUTHORS'
p42776
aS'Eckmann L, Kagnoff MF'
p42777
aS'TITLE'
p42778
aS'Cytokines in host defense against Salmonella.'
p42779
aS'JOURNAL'
p42780
aS'Microbes Infect 3:1191-200 (2001)'
p42781
aS'PMID:10499590'
p42782
ag42782
aS'AUTHORS'
p42783
aS'Fu Y, Galan JE'
p42784
aS'TITLE'
p42785
aS'A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion.'
p42786
aS'JOURNAL'
p42787
aS'Nature 401:293-7 (1999)'
p42788
aS'PMID:19779561'
p42789
ag42789
aS'AUTHORS'
p42790
aS'Du F, Galan JE'
p42791
aS'TITLE'
p42792
aS'Selective inhibition of type III secretion activated signaling by the Salmonella'
p42793
aS'effector AvrA.'
p42794
aS'JOURNAL'
p42795
aS'PLoS Pathog 5:e1000595 (2009)'
p42796
aS'PMID:18407067'
p42797
ag42797
aS'AUTHORS'
p42798
aS'Jones RM, Wu H, Wentworth C, Luo L, Collier-Hyams L, Neish AS'
p42799
aS'TITLE'
p42800
aS'Salmonella AvrA Coordinates Suppression of Host Immune and Apoptotic Defenses via JNK Pathway Blockade.'
p42801
aS'JOURNAL'
p42802
aS'Cell Host Microbe 3:233-44 (2008)'
p42803
aS'PMID:16611232'
p42804
ag42804
aS'AUTHORS'
p42805
aS'Haraga A, Miller SI'
p42806
aS'TITLE'
p42807
aS'A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1.'
p42808
aS'JOURNAL'
p42809
aS'Cell Microbiol 8:837-46 (2006)'
p42810
aS'PMID:16800847'
p42811
ag42811
aS'AUTHORS'
p42812
aS'Abrahams GL, Muller P, Hensel M'
p42813
aS'TITLE'
p42814
aS'Functional dissection of SseF, a type III effector protein involved in positioning the salmonella-containing vacuole.'
p42815
aS'JOURNAL'
p42816
aS'Traffic 7:950-65 (2006)'
p42817
aS'PMID:16938850'
p42818
ag42818
aS'AUTHORS'
p42819
aS'Henry T, Couillault C, Rockenfeller P, Boucrot E, Dumont A, Schroeder N, Hermant A, Knodler LA, Lecine P, Steele-Mortimer O, Borg JP, Gorvel JP, Meresse S'
p42820
aS'TITLE'
p42821
aS'The Salmonella effector protein PipB2 is a linker for kinesin-1.'
p42822
aS'JOURNAL'
p42823
aS'Proc Natl Acad Sci U S A 103:13497-502 (2006)'
p42824
aS'PMID:12675800'
p42825
ag42825
aS'AUTHORS'
p42826
aS'Miao EA, Brittnacher M, Haraga A, Jeng RL, Welch MD, Miller SI'
p42827
aS'TITLE'
p42828
aS'Salmonella effectors translocated across the vacuolar membrane interact with the'
p42829
aS'actin cytoskeleton.'
p42830
aS'JOURNAL'
p42831
aS'Mol Microbiol 48:401-15 (2003)'
p42832
aS'PMID:20943123'
p42833
ag42833
aS'AUTHORS'
p42834
aS'Prior K, Hautefort I, Hinton JC, Richardson DJ, Rowley G'
p42835
aS'TITLE'
p42836
aS'All stressed out. Salmonella pathogenesis and reactive nitrogen species.'
p42837
aS'JOURNAL'
p42838
aS'Adv Microb Physiol 56:1-28 (2009)'
p42839
asS'KO_PATHWAY'
p42840
(lp42841
S'ko05132'
p42842
asS'PATHWAY_MAP'
p42843
(lp42844
S'map05132'
p42845
asS'DISEASE'
p42846
(lp42847
S'H00111'
p42848
aS'Typhoid fever'
p42849
asS'DESCRIPTION Salmonella infection usually presents as a self-limiting gastroenteritis or the more severe typhoid fever and bacteremia. The common disease-causing Salmonella species in human is a single species, Salmonella enterica, which has numerous serovars.'
p42850
(lp42851
S'Following intestinal colonization Salmonella inject effector proteins into the host cells using a type III secretion system (T3SS), T3SS1. Then a small group of effector proteins induce rearrangement of the actin cytoskeleton resulting in membrane ruffles and rapid internalization of the bacteria.The T3SS2 is responsible for translocating effector proteins that direct Salmonella-containing vacuole (SCV) maturation. The majority of the bacteria are known to survive and replicate in SCV.'
p42852
asS'ENTRY'
p42853
(lp42854
S'map05132'
p42855
aS'Pathway'
p42856
asS'CLASS'
p42857
(lp42858
S'Human Diseases Infectious diseases'
p42859
asS'DESCRIPTION'
p42860
(lp42861
S'Salmonella infection usually presents as a self-limiting gastroenteritis or the more severe typhoid fever and bacteremia. The common disease-causing Salmonella species in human is a single species, Salmonella enterica, which has numerous serovars.'
p42862
assS'path:map00760'
p42863
(dp42864
S'NAME'
p42865
(lp42866
S'Nicotinate and nicotinamide metabolism'
p42867
asS'REFERENCE'
p42868
(lp42869
S'PMID:13475371'
p42870
ag42870
aS'AUTHORS'
p42871
aS'BEHRMAN EJ, STANIER RY.'
p42872
aS'TITLE'
p42873
aS'The bacterial oxidation of nicotinic acid.'
p42874
aS'JOURNAL'
p42875
aS'J Biol Chem 228:923-45 (1957)'
p42876
aS'PMID:16894175'
p42877
ag42877
aS'AUTHORS'
p42878
aS'Alhapel A, Darley DJ, Wagener N, Eckel E, Elsner N, Pierik AJ.'
p42879
aS'TITLE'
p42880
aS'Molecular and functional analysis of nicotinate catabolism in Eubacterium barkeri.'
p42881
aS'JOURNAL'
p42882
aS'Proc Natl Acad Sci U S A 103:12341-6 (2006)'
p42883
aS'PMID:11514508'
p42884
ag42884
aS'AUTHORS'
p42885
aS'Baitsch D, Sandu C, Brandsch R, Igloi GL.'
p42886
aS'TITLE'
p42887
aS'Gene cluster on pAO1 of Arthrobacter nicotinovorans involved in degradation of the plant alkaloid nicotine: cloning, purification, and characterization of 2,6-dihydroxypyridine 3-hydroxylase.'
p42888
aS'JOURNAL'
p42889
aS'J Bacteriol 183:5262-7 (2001)'
p42890
aS'PMID:16321959'
p42891
ag42891
aS'AUTHORS'
p42892
aS'Sachelaru P, Schiltz E, Igloi GL, Brandsch R.'
p42893
aS'TITLE'
p42894
aS'An alpha/beta-fold C--C bond hydrolase is involved in a central step of nicotine catabolism by Arthrobacter nicotinovorans.'
p42895
aS'JOURNAL'
p42896
aS'J Bacteriol 187:8516-9 (2005)'
p42897
aS'PMID:5835946'
p42898
ag42898
aS'AUTHORS'
p42899
aS'Gherna RL, Richardson SH, Rittenberg SC'
p42900
aS'TITLE'
p42901
aS'The bacterial oxidation of nicotine. VI. The metabolism of 2,6-dihydroxypseudooxynicotine.'
p42902
aS'JOURNAL'
p42903
aS'J Biol Chem 240:3669-74 (1965)'
p42904
aS'PMID:21953451'
p42905
ag42905
aS'AUTHORS'
p42906
aS'Galeazzi L, Bocci P, Amici A, Brunetti L, Ruggieri S, Romine M, Reed S, Osterman AL, Rodionov DA, Sorci L, Raffaelli N'
p42907
aS'TITLE'
p42908
aS'Identification of nicotinamide mononucleotide deamidase of the bacterial pyridine nucleotide cycle reveals a novel broadly conserved amidohydrolase family.'
p42909
aS'JOURNAL'
p42910
aS'J Biol Chem 286:40365-75 (2011)'
p42911
asS'KO_PATHWAY'
p42912
(lp42913
S'ko00760'
p42914
asS'PATHWAY_MAP'
p42915
(lp42916
S'map00760'
p42917
asS'DISEASE'
p42918
(lp42919
S'H00824'
p42920
aS'Calcification of joints and arteries'
p42921
ag42920
ag42921
aS'H01002'
p42922
aS'Generalized arterial calcification of infancy'
p42923
aS'H01394'
p42924
aS'Cole disease'
p42925
asS'MODULE'
p42926
(lp42927
S'M00115'
p42928
aS'NAD biosynthesis, aspartate => NAD [PATH:map00760]'
p42929
ag42928
ag42929
aS'M00622'
p42930
aS'Nicotinate degradation, nicotinate => fumarate [PATH:map00760]'
p42931
asS'DBLINKS'
p42932
(lp42933
S'UMBBD: nic'
p42934
ag42934
aS'GO: 0006769'
p42935
asS'ENTRY'
p42936
(lp42937
S'map00760'
p42938
aS'Pathway'
p42939
asS'CLASS'
p42940
(lp42941
S'Metabolism Metabolism of cofactors and vitamins'
p42942
assS'path:map04921'
p42943
(dp42944
S'NAME'
p42945
(lp42946
S'Oxytocin signaling pathway'
p42947
asS'REFERENCE'
p42948
(lp42949
S'PMID:18655881'
p42950
ag42950
aS'AUTHORS'
p42951
aS'Devost D, Wrzal P, Zingg HH'
p42952
aS'TITLE'
p42953
aS'Oxytocin receptor signalling.'
p42954
aS'JOURNAL'
p42955
aS'Prog Brain Res 170:167-76 (2008)'
p42956
aS'PMID:20626426'
p42957
ag42957
aS'AUTHORS'
p42958
aS'Viero C, Shibuya I, Kitamura N, Verkhratsky A, Fujihara H, Katoh A, Ueta Y, Zingg HH, Chvatal A, Sykova E, Dayanithi G'
p42959
aS'TITLE'
p42960
aS'REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy.'
p42961
aS'JOURNAL'
p42962
aS'CNS Neurosci Ther 16:e138-56 (2010)'
p42963
aS'PMID:21981277'
p42964
ag42964
aS'AUTHORS'
p42965
aS'Gutkowska J, Jankowski M'
p42966
aS'TITLE'
p42967
aS'Oxytocin revisited: its role in cardiovascular regulation.'
p42968
aS'JOURNAL'
p42969
aS'J Neuroendocrinol 24:599-608 (2012)'
p42970
aS'PMID:22190926'
p42971
ag42971
aS'AUTHORS'
p42972
aS'Vrachnis N, Malamas FM, Sifakis S, Deligeoroglou E, Iliodromiti Z'
p42973
aS'TITLE'
p42974
aS'The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents.'
p42975
aS'JOURNAL'
p42976
aS'Int J Endocrinol 2011:350546 (2011)'
p42977
aS'PMID:19840865'
p42978
ag42978
aS'AUTHORS'
p42979
aS'Tom N, Assinder SJ'
p42980
aS'TITLE'
p42981
aS'Oxytocin in health and disease.'
p42982
aS'JOURNAL'
p42983
aS'Int J Biochem Cell Biol 42:202-5 (2010)'
p42984
aS'PMID:9575824'
p42985
ag42985
aS'AUTHORS'
p42986
aS'Strakova Z, Copland JA, Lolait SJ, Soloff MS'
p42987
aS'TITLE'
p42988
aS'ERK2 mediates oxytocin-stimulated PGE2 synthesis.'
p42989
aS'JOURNAL'
p42990
aS'Am J Physiol 274:E634-41 (1998)'
p42991
aS'PMID:12009385'
p42992
ag42992
aS'AUTHORS'
p42993
aS'Slater DM, Zervou S, Thornton S'
p42994
aS'TITLE'
p42995
aS'Prostaglandins and prostanoid receptors in human pregnancy and parturition.'
p42996
aS'JOURNAL'
p42997
aS'J Soc Gynecol Investig 9:118-24 (2002)'
p42998
aS'PMID:16787565'
p42999
ag42999
aS'AUTHORS'
p43000
aS'Shmygol A, Gullam J, Blanks A, Thornton S'
p43001
aS'TITLE'
p43002
aS'Multiple mechanisms involved in oxytocin-induced modulation of myometrial contractility.'
p43003
aS'JOURNAL'
p43004
aS'Acta Pharmacol Sin 27:827-32 (2006)'
p43005
aS'PMID:11861513'
p43006
ag43006
aS'AUTHORS'
p43007
aS'Tahara M, Morishige K, Sawada K, Ikebuchi Y, Kawagishi R, Tasaka K, Murata Y'
p43008
aS'TITLE'
p43009
aS'RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction.'
p43010
aS'JOURNAL'
p43011
aS'Endocrinology 143:920-9 (2002)'
p43012
aS'PMID:12433531'
p43013
ag43013
aS'AUTHORS'
p43014
aS'Slattery MM, Morrison JJ'
p43015
aS'TITLE'
p43016
aS'Preterm delivery.'
p43017
aS'JOURNAL'
p43018
aS'Lancet 360:1489-97 (2002)'
p43019
aS'PMID:22902539'
p43020
ag43020
aS'AUTHORS'
p43021
aS'Pont JN, McArdle CA, Lopez Bernal A'
p43022
aS'TITLE'
p43023
aS'Oxytocin-stimulated NFAT transcriptional activation in human myometrial cells.'
p43024
aS'JOURNAL'
p43025
aS'Mol Endocrinol 26:1743-56 (2012)'
p43026
aS'PMID:9326674'
p43027
ag43027
aS'AUTHORS'
p43028
aS'Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM'
p43029
aS'TITLE'
p43030
aS'Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart.'
p43031
aS'JOURNAL'
p43032
aS'Proc Natl Acad Sci U S A 94:11704-9 (1997)'
p43033
aS'PMID:14715914'
p43034
ag43034
aS'AUTHORS'
p43035
aS'Antunes-Rodrigues J, de Castro M, Elias LL, Valenca MM, McCann SM'
p43036
aS'TITLE'
p43037
aS'Neuroendocrine control of body fluid metabolism.'
p43038
aS'JOURNAL'
p43039
aS'Physiol Rev 84:169-208 (2004)'
p43040
aS'PMID:18555543'
p43041
ag43041
aS'AUTHORS'
p43042
aS'Lee ES, Uhm KO, Lee YM, Kwon J, Park SH, Soo KH'
p43043
aS'TITLE'
p43044
aS'Oxytocin stimulates glucose uptake in skeletal muscle cells through the calcium-CaMKK-AMPK pathway.'
p43045
aS'JOURNAL'
p43046
aS'Regul Pept 151:71-4 (2008)'
p43047
aS'PMID:9219843'
p43048
ag43048
aS'AUTHORS'
p43049
aS'Cassoni P, Sapino A, Fortunati N, Munaron L, Chini B, Bussolati G'
p43050
aS'TITLE'
p43051
aS'Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A.'
p43052
aS'JOURNAL'
p43053
aS'Int J Cancer 72:340-4 (1997)'
p43054
aS'PMID:23356278'
p43055
ag43055
aS'AUTHORS'
p43056
aS'Busnelli M, Peverelli E, Mantovani G, Spada A, Chini B'
p43057
aS'TITLE'
p43058
aS'Deciphering the specific role of G(alphai/o) isoforms: functional selective oxytocin ligands and somatostatin SST5 receptor mutants.'
p43059
aS'JOURNAL'
p43060
aS'Biochem Soc Trans 41:166-71 (2013)'
p43061
aS'PMID:16966388'
p43062
ag43062
aS'AUTHORS'
p43063
aS'Reversi A, Rimoldi V, Brambillasca S, Chini B'
p43064
aS'TITLE'
p43065
aS'Effects of cholesterol manipulation on the signaling of the human oxytocin receptor.'
p43066
aS'JOURNAL'
p43067
aS'Am J Physiol Regul Integr Comp Physiol 291:R861-9 (2006)'
p43068
aS'PMID:20141572'
p43069
ag43069
aS'AUTHORS'
p43070
aS'Salmina AB, Lopatina O, Ekimova MV, Mikhutkina SV, Higashida H'
p43071
aS'TITLE'
p43072
aS'CD38/cyclic ADP-ribose system: a new player for oxytocin secretion and regulation of social behaviour.'
p43073
aS'JOURNAL'
p43074
aS'J Neuroendocrinol 22:380-92 (2010)'
p43075
aS'PMID:22227279'
p43076
ag43076
aS'AUTHORS'
p43077
aS'Higashida H, Yokoyama S, Kikuchi M, Munesue T'
p43078
aS'TITLE'
p43079
aS'CD38 and its role in oxytocin secretion and social behavior.'
p43080
aS'JOURNAL'
p43081
aS'Horm Behav 61:351-8 (2012)'
p43082
aS'PMID:23335873'
p43083
ag43083
aS'AUTHORS'
p43084
aS'Lopatina O, Inzhutova A, Salmina AB, Higashida H'
p43085
aS'TITLE'
p43086
aS'The roles of oxytocin and CD38 in social or parental behaviors.'
p43087
aS'JOURNAL'
p43088
aS'Front Neurosci 6:182 (2012)'
p43089
aS'PMID:16156781'
p43090
ag43090
aS'AUTHORS'
p43091
aS'Guse AH'
p43092
aS'TITLE'
p43093
aS'Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR).'
p43094
aS'JOURNAL'
p43095
aS'FEBS J 272:4590-7 (2005)'
p43096
asS'KO_PATHWAY'
p43097
(lp43098
S'ko04921'
p43099
asS'ENTRY'
p43100
(lp43101
S'map04921'
p43102
aS'Pathway'
p43103
asS'PATHWAY_MAP'
p43104
(lp43105
S'map04921'
p43106
asS'CLASS'
p43107
(lp43108
S'Organismal Systems Endocrine system'
p43109
asS'DESCRIPTION'
p43110
(lp43111
S'Oxytocin (OT) is a nonapeptide synthesized by the magno-cellular neurons located in the supraoptic (SON) and paraventricular (PVN) nuclei of the hypothalamus. It exerts a wide variety of central and peripheral effects.'
p43112
assS'path:map04920'
p43113
(dp43114
S'NAME'
p43115
(lp43116
S'Adipocytokine signaling pathway'
p43117
asS'REFERENCE'
p43118
(lp43119
S'PMID:15733744'
p43120
ag43120
aS'AUTHORS'
p43121
aS'Gual P, Le Marchand-Brustel Y, Tanti JF.'
p43122
aS'TITLE'
p43123
aS'Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.'
p43124
aS'JOURNAL'
p43125
aS'Biochimie 87:99-109 (2005)'
p43126
aS'PMID:12829246'
p43127
ag43127
aS'AUTHORS'
p43128
aS'Hardie DG, Scott JW, Pan DA, Hudson ER.'
p43129
aS'TITLE'
p43130
aS'Management of cellular energy by the AMP-activated protein kinase system.'
p43131
aS'JOURNAL'
p43132
aS'FEBS Lett 546:113-20 (2003)'
p43133
aS'PMID:15980064'
p43134
ag43134
aS'AUTHORS'
p43135
aS'Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA.'
p43136
aS'TITLE'
p43137
aS'The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases.'
p43138
aS'JOURNAL'
p43139
aS'J Biol Chem 280:29060-6 (2005)'
p43140
aS'PMID:10766253'
p43141
ag43141
aS'AUTHORS'
p43142
aS'Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG.'
p43143
aS'TITLE'
p43144
aS'Central nervous system control of food intake.'
p43145
aS'JOURNAL'
p43146
aS'Nature 404:661-71 (2000)'
p43147
aS'PMID:15856064'
p43148
ag43148
aS'AUTHORS'
p43149
aS'Munzberg H, Myers MG Jr.'
p43150
aS'TITLE'
p43151
aS'Molecular and anatomical determinants of central leptin resistance.'
p43152
aS'JOURNAL'
p43153
aS'Nat Neurosci 8:566-70 (2005)'
p43154
aS'PMID:12754525'
p43155
ag43155
aS'AUTHORS'
p43156
aS'Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM.'
p43157
aS'TITLE'
p43158
aS'Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.'
p43159
aS'JOURNAL'
p43160
aS'Nature 423:550-5 (2003)'
p43161
aS'PMID:11557972'
p43162
ag43162
aS'AUTHORS'
p43163
aS'Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM.'
p43164
aS'TITLE'
p43165
aS'Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.'
p43166
aS'JOURNAL'
p43167
aS'Nature 413:131-8 (2001)'
p43168
aS'PMID:14716305'
p43169
ag43169
aS'AUTHORS'
p43170
aS'Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M.'
p43171
aS'TITLE'
p43172
aS'Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.'
p43173
aS'JOURNAL'
p43174
aS'Nat Med 10:168-74 (2004)'
p43175
aS'PMID:9671776'
p43176
ag43176
aS'AUTHORS'
p43177
aS'Zhou YT, Shimabukuro M, Wang MY, Lee Y, Higa M, Milburn JL, Newgard CB, Unger RH.'
p43178
aS'TITLE'
p43179
aS'Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells.'
p43180
aS'JOURNAL'
p43181
aS'Proc Natl Acad Sci U S A 95:8898-903 (1998)'
p43182
aS'PMID:10905472'
p43183
ag43183
aS'AUTHORS'
p43184
aS'Kelley DE, Mandarino LJ.'
p43185
aS'TITLE'
p43186
aS'Fuel selection in human skeletal muscle in insulin resistance: a reexamination.'
p43187
aS'JOURNAL'
p43188
aS'Diabetes 49:677-83 (2000)'
p43189
aS'PMID:12368907'
p43190
ag43190
aS'AUTHORS'
p43191
aS'Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T.'
p43192
aS'TITLE'
p43193
aS'Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.'
p43194
aS'JOURNAL'
p43195
aS'Nat Med 8:1288-95 (2002)'
p43196
aS'PMID:11479627'
p43197
ag43197
aS'AUTHORS'
p43198
aS'Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T.'
p43199
aS'TITLE'
p43200
aS'The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.'
p43201
aS'JOURNAL'
p43202
aS'Nat Med 7:941-6 (2001)'
p43203
aS'PMID:15058305'
p43204
ag43204
aS'AUTHORS'
p43205
aS'Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB.'
p43206
aS'TITLE'
p43207
aS'AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.'
p43208
aS'JOURNAL'
p43209
aS'Nature 428:569-74 (2004)'
p43210
aS'PMID:14679176'
p43211
ag43211
aS'AUTHORS'
p43212
aS'Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr.'
p43213
aS'TITLE'
p43214
aS'Obesity is associated with macrophage accumulation in adipose tissue.'
p43215
aS'JOURNAL'
p43216
aS'J Clin Invest 112:1796-808 (2003)'
p43217
asS'KO_PATHWAY'
p43218
(lp43219
S'ko04920'
p43220
asS'PATHWAY_MAP'
p43221
(lp43222
S'map04920'
p43223
asS'DISEASE'
p43224
(lp43225
S'H00645'
p43226
aS'Incontinentia pigmenti'
p43227
ag43226
ag43227
aS'H00666'
p43228
aS'Peutz-Jeghers syndrome'
p43229
aS'H00831'
p43230
aS'Primary dystonia'
p43231
aS'H00836'
p43232
aS'GLUT1 deficiency syndrome (GLUT1DS)'
p43233
aS'H00882'
p43234
aS'Cocoon syndrome'
p43235
aS'H00967'
p43236
aS'Adiponectin deficiency'
p43237
aS'H01018'
p43238
aS'Metachondromatosis'
p43239
aS'H01108'
p43240
aS'CD36 deficiency'
p43241
aS'H01154'
p43242
aS'Wolff-Parkinson-White (WPW) syndrome'
p43243
asS'DESCRIPTION Increased adipocyte volume and number are positively correlated with leptin production, and negatively correlated with production of adiponectin.'
p43244
(lp43245
S'Leptin is an important regulator of energy intake and metabolic rate primarily by acting at hypothalamic nuclei. Leptin exerts its anorectic effects by modulating the levels of neuropeptides such as NPY, AGRP, and alpha-MSH. This leptin action is through the JAK kinase, STAT3 phosphorylation, and nuclear transcriptional effect.'
p43246
aS'Adiponectin lowers plasma glucose and FFAs. These effects are partly accounted for by adiponectin-induced AMPK activation, which in turn stimulates skeletal muscle fatty acid oxidation and glucose uptake. Furthermore, activation of AMPK by adiponectin suppresses endogenous glucose production, concomitantly with inhibition of PEPCK and G6Pase expression.'
p43247
aS'The proinflammatory cytokine TNFalpha has been implicated as a link between obesity and insulin resistance. TNFalpha interferes with early steps of insulin signaling. Several data have shown that TNFalpha inhibits IRS1 tyrosine phosphorylation by promoting its serine phosphorylation. Among the serine/threonine kinases activated by TNFalpha, JNK, mTOR and IKK have been shown to be involved in this phosphorylation.'
p43248
asS'ENTRY'
p43249
(lp43250
S'map04920'
p43251
aS'Pathway'
p43252
asS'CLASS'
p43253
(lp43254
S'Organismal Systems Endocrine system'
p43255
asS'DESCRIPTION'
p43256
(lp43257
S'Increased adipocyte volume and number are positively correlated with leptin production, and negatively correlated with production of adiponectin.'
p43258
assS'path:map00600'
p43259
(dp43260
S'NAME'
p43261
(lp43262
S'Sphingolipid metabolism'
p43263
asS'REFERENCE'
p43264
(lp43265
S'PMID:12011104'
p43266
ag43266
aS'AUTHORS'
p43267
aS'Merrill AH Jr.'
p43268
aS'TITLE'
p43269
aS'De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway.'
p43270
aS'JOURNAL'
p43271
aS'J Biol Chem 277:25843-6 (2002)'
p43272
aS'PMID:10652340'
p43273
ag43273
aS'AUTHORS'
p43274
aS'Tani M, Okino N, Mitsutake S, Tanigawa T, Izu H, Ito M.'
p43275
aS'TITLE'
p43276
aS'Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized.'
p43277
aS'JOURNAL'
p43278
aS'J Biol Chem 275:3462-8 (2000)'
p43279
aS'PMID:11305904'
p43280
ag43280
aS'AUTHORS'
p43281
aS'Hannun YA, Luberto C, Argraves KM.'
p43282
aS'TITLE'
p43283
aS'Enzymes of sphingolipid metabolism: from modular to integrative signaling.'
p43284
aS'JOURNAL'
p43285
aS'Biochemistry 40:4893-903 (2001)'
p43286
aS'PMID:1495423'
p43287
ag43287
aS'AUTHORS'
p43288
aS'Merrill AH Jr, Wang E.'
p43289
aS'TITLE'
p43290
aS'Enzymes of ceramide biosynthesis.'
p43291
aS'JOURNAL'
p43292
aS'Methods Enzymol 209:427-37 (1992)'
p43293
aS'PMID:8457204'
p43294
ag43294
aS'AUTHORS'
p43295
aS'Hirschberg K, Rodger J, Futerman AH.'
p43296
aS'TITLE'
p43297
aS'The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver.'
p43298
aS'JOURNAL'
p43299
aS'Biochem J 290 ( Pt 3):751-7 (1993)'
p43300
aS'PMID:10366774'
p43301
ag43301
aS'AUTHORS'
p43302
aS'Dickson RC, Lester RL.'
p43303
aS'TITLE'
p43304
aS'Metabolism and selected functions of sphingolipids in the yeast Saccharomyces cerevisiae.'
p43305
aS'JOURNAL'
p43306
aS'Biochim Biophys Acta 1438:305-21 (1999)'
p43307
asS'KO_PATHWAY'
p43308
(lp43309
S'ko00600'
p43310
asS'PATHWAY_MAP'
p43311
(lp43312
S'map00600'
p43313
asS'DISEASE'
p43314
(lp43315
S'H00125'
p43316
aS'Fabry disease'
p43317
ag43316
ag43317
aS'H00126'
p43318
aS'Gaucher disease'
p43319
aS'H00127'
p43320
aS'Metachromatic leukodystrophy (MLD)'
p43321
aS'H00135'
p43322
aS'Krabbe disease'
p43323
aS'H00137'
p43324
aS'Niemann-Pick disease (NPD) typeA and B'
p43325
aS'H00138'
p43326
aS'Farber lipogranulomatosis'
p43327
aS'H00142'
p43328
aS'Sialidosis'
p43329
aS'H00265'
p43330
aS'Hereditary sensory and autonomic neuropathy (HSAN)'
p43331
aS'H00276'
p43332
aS'Galactosialidosis'
p43333
aS'H00281'
p43334
aS'GM1 gangliosidosis'
p43335
aS'H00423'
p43336
aS'Defects in the degradation of sulfatide'
p43337
aS'H00424'
p43338
aS'Defects in the degradation of sphingomyelin'
p43339
aS'H00426'
p43340
aS'Defects in the degradation of ganglioside'
p43341
aS'H00810'
p43342
aS'Progressive myoclonic epilepsy (PME/ EPM)'
p43343
asS'MODULE'
p43344
(lp43345
S'M00066'
p43346
aS'Lactosylceramide biosynthesis [PATH:map00600]'
p43347
ag43346
ag43347
aS'M00067'
p43348
aS'Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid [PATH:map00600]'
p43349
aS'M00094'
p43350
aS'Ceramide biosynthesis [PATH:map00600]'
p43351
aS'M00099'
p43352
aS'Sphingosine biosynthesis [PATH:map00600]'
p43353
aS'M00100'
p43354
aS'Sphingosine degradation [PATH:map00600]'
p43355
asS'DBLINKS'
p43356
(lp43357
S'GO: 0006665 0030148'
p43358
asS'ENTRY'
p43359
(lp43360
S'map00600'
p43361
aS'Pathway'
p43362
asS'CLASS'
p43363
(lp43364
S'Metabolism Lipid metabolism'
p43365
assS'path:map00601'
p43366
(dp43367
S'NAME'
p43368
(lp43369
S'Glycosphingolipid biosynthesis - lacto and neolacto series'
p43370
asS'KO_PATHWAY'
p43371
(lp43372
S'ko00601'
p43373
asS'ENTRY'
p43374
(lp43375
S'map00601'
p43376
aS'Pathway'
p43377
asS'PATHWAY_MAP'
p43378
(lp43379
S'map00601'
p43380
asS'DISEASE'
p43381
(lp43382
S'H00768'
p43383
aS'Nonsyndromic autosomal recessive mental retardation (NS-ARMR)'
p43384
ag43383
ag43384
aS'H01013'
p43385
aS'Adult i phenotype'
p43386
aS'H01202'
p43387
aS'Cataract'
p43388
asS'MODULE'
p43389
(lp43390
S'M00070'
p43391
aS'Glycosphingolipid biosynthesis, lacto-series, LacCer => Lc4Cer [PATH:map00601]'
p43392
ag43391
ag43392
aS'M00071'
p43393
aS'Glycosphingolipid biosynthesis, neolacto-series, LacCer => nLc4Cer [PATH:map00601]'
p43394
asS'CLASS'
p43395
(lp43396
S'Metabolism Glycan biosynthesis and metabolism'
p43397
assS'path:map00603'
p43398
(dp43399
S'NAME'
p43400
(lp43401
S'Glycosphingolipid biosynthesis - globo series'
p43402
asS'REFERENCE'
p43403
(lp43404
S'PMID:12716912'
p43405
ag43405
aS'AUTHORS'
p43406
aS'Saito S, Aoki H, Ito A, Ueno S, Wada T, Mitsuzuka K, Satoh M, Arai Y, Miyagi T.'
p43407
aS'TITLE'
p43408
aS'Human alpha2,3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase.'
p43409
aS'JOURNAL'
p43410
aS'J Biol Chem 278:26474-9 (2003)'
p43411
aS'PMID:10837462'
p43412
ag43412
aS'AUTHORS'
p43413
aS'Zhou D, Henion TR, Jungalwala FB, Berger EG, Hennet T.'
p43414
aS'TITLE'
p43415
aS'The beta 1,3-galactosyltransferase beta 3GalT-V is a stage-specific embryonic antigen-3 (SSEA-3) synthase.'
p43416
aS'JOURNAL'
p43417
aS'J Biol Chem 275:22631-4 (2000)'
p43418
aS'PMID:10748143'
p43419
ag43419
aS'AUTHORS'
p43420
aS'Kojima Y, Fukumoto S, Furukawa K, Okajima T, Wiels J, Yokoyama K, Suzuki Y, Urano T, Ohta M, Furukawa K.'
p43421
aS'TITLE'
p43422
aS'Molecular cloning of globotriaosylceramide/CD77 synthase, aglycosyltransferase that initiates the synthesis of globo seriesglycosphingolipids.'
p43423
aS'JOURNAL'
p43424
aS'J Biol Chem 275:15152-6 (2000)'
p43425
aS'PMID:10854428'
p43426
ag43426
aS'AUTHORS'
p43427
aS'Keusch JJ, Manzella SM, Nyame KA, Cummings RD, Baenziger JU.'
p43428
aS'TITLE'
p43429
aS'Cloning of Gb3 synthase, the key enzyme in globo-series glycosphingolipidsynthesis, predicts a family of alpha 1, 4-glycosyltransferases conservedin plants, insects, and mammals.'
p43430
aS'JOURNAL'
p43431
aS'J Biol Chem 275:25315-21 (2000)'
p43432
asS'KO_PATHWAY'
p43433
(lp43434
S'ko00603'
p43435
asS'PATHWAY_MAP'
p43436
(lp43437
S'map00603'
p43438
asS'DISEASE'
p43439
(lp43440
S'H00124'
p43441
aS'GM2 gangliosidoses'
p43442
ag43441
ag43442
aS'H00125'
p43443
aS'Fabry disease'
p43444
aS'H00146'
p43445
aS'Alpha-N-acetylgalactosaminidase deficiency'
p43446
aS'H00422'
p43447
aS'Glycoproteinoses'
p43448
asS'MODULE'
p43449
(lp43450
S'M00068'
p43451
aS'Glycosphingolipid biosynthesis, globo-series, LacCer => Gb4Cer [PATH:map00603]'
p43452
asS'ENTRY'
p43453
(lp43454
S'map00603'
p43455
aS'Pathway'
p43456
asS'CLASS'
p43457
(lp43458
S'Metabolism Glycan biosynthesis and metabolism'
p43459
assS'path:map00627'
p43460
(dp43461
S'NAME'
p43462
(lp43463
S'Aminobenzoate degradation'
p43464
asS'REFERENCE'
p43465
(lp43466
S'PMID:3078743'
p43467
ag43467
aS'AUTHORS'
p43468
aS'Fewson CA'
p43469
aS'TITLE'
p43470
aS'Microbial metabolism of mandelate: a microcosm of diversity.'
p43471
aS'JOURNAL'
p43472
aS'FEMS Microbiol Rev 4:85-110 (1988)'
p43473
aS'PMID:12670968'
p43474
ag43474
aS'AUTHORS'
p43475
aS'McLeish MJ, Kneen MM, Gopalakrishna KN, Koo CW, Babbitt PC, Gerlt JA, Kenyon GL'
p43476
aS'TITLE'
p43477
aS'Identification and characterization of a mandelamide hydrolase and an NAD(P)+-dependent benzaldehyde dehydrogenase from Pseudomonas putida ATCC 12633.'
p43478
aS'JOURNAL'
p43479
aS'J Bacteriol 185:2451-6 (2003)'
p43480
aS'PMID:8782397'
p43481
ag43481
aS'AUTHORS'
p43482
aS'Shimao M, Nakamura T, Okuda A, Harayama S.'
p43483
aS'TITLE'
p43484
aS'Characteristics of transposon insertion mutants of mandelic acid-utilizing Pseudomonas putida strain A10L.'
p43485
aS'JOURNAL'
p43486
aS'Biosci Biotechnol Biochem 60:1051-5 (1996)'
p43487
aS'PMID:11344134'
p43488
ag43488
aS'AUTHORS'
p43489
aS'Naidu D, Ragsdale SW.'
p43490
aS'TITLE'
p43491
aS'Characterization of a three-component vanillate O-demethylase from Moorella thermoacetica.'
p43492
aS'JOURNAL'
p43493
aS'J Bacteriol 183:3276-81 (2001)'
p43494
aS'PMID:14711645'
p43495
ag43495
aS'AUTHORS'
p43496
aS'Toraya T, Oka T, Ando M, Yamanishi M, Nishihara H.'
p43497
aS'TITLE'
p43498
aS'Novel pathway for utilization of cyclopropanecarboxylate by Rhodococcus rhodochrous.'
p43499
aS'JOURNAL'
p43500
aS'Appl Environ Microbiol 70:224-8 (2004)'
p43501
asS'KO_PATHWAY'
p43502
(lp43503
S'ko00627'
p43504
asS'PATHWAY_MAP'
p43505
(lp43506
S'map00627'
p43507
asS'MODULE'
p43508
(lp43509
S'M00637'
p43510
aS'Anthranilate degradation, anthranilate => catechol [PATH:map00627]'
p43511
asS'DBLINKS'
p43512
(lp43513
S'GO: 0043421'
p43514
ag43514
aS'UMBBD: dcz 2,4-d pcp 2,4,5-t box dca'
p43515
asS'ENTRY'
p43516
(lp43517
S'map00627'
p43518
aS'Pathway'
p43519
asS'CLASS'
p43520
(lp43521
S'Metabolism Xenobiotics biodegradation and metabolism'
p43522
assS'path:map00945'
p43523
(dp43524
S'NAME'
p43525
(lp43526
S'Stilbenoid, diarylheptanoid and gingerol biosynthesis'
p43527
asS'REFERENCE'
p43528
(lp43529
S'PMID:19258320'
p43530
ag43530
aS'AUTHORS'
p43531
aS'Katsuyama Y, Kita T, Funa N, Horinouchi S'
p43532
aS'TITLE'
p43533
aS'Curcuminoid biosynthesis by two type III polyketide synthases in the herb Curcuma longa.'
p43534
aS'JOURNAL'
p43535
aS'J Biol Chem 284:11160-70 (2009)'
p43536
aS'PMID:16890967'
p43537
ag43537
aS'AUTHORS'
p43538
aS'Ramirez-Ahumada Mdel C, Timmermann BN, Gang DR'
p43539
aS'TITLE'
p43540
aS'Biosynthesis of curcuminoids and gingerols in turmeric (Curcuma longa) and ginger (Zingiber officinale): identification of curcuminoid synthase and hydroxycinnamoyl-CoA thioesterases.'
p43541
aS'JOURNAL'
p43542
aS'Phytochemistry 67:2017-29 (2006)'
p43543
aS'PMID:17509574'
p43544
ag43544
aS'AUTHORS'
p43545
aS'Masada S, Terasaka K, Mizukami H'
p43546
aS'TITLE'
p43547
aS'A single amino acid in the PSPG-box plays an important role in the catalytic function of CaUGT2 (Curcumin glucosyltransferase), a Group D Family 1 glucosyltransferase from Catharanthus roseus.'
p43548
aS'JOURNAL'
p43549
aS'FEBS Lett 581:2605-10 (2007)'
p43550
asS'KO_PATHWAY'
p43551
(lp43552
S'ko00945'
p43553
asS'ENTRY'
p43554
(lp43555
S'map00945'
p43556
aS'Pathway'
p43557
asS'PATHWAY_MAP'
p43558
(lp43559
S'map00945'
p43560
asS'CLASS'
p43561
(lp43562
S'Metabolism Biosynthesis of other secondary metabolites'
p43563
asS'DESCRIPTION'
p43564
(lp43565
S'Stilbenoids are a group of phenolic compounds, biosynthetically interrelated through their common origin from a C6-C2-C6 intermediate, such as resveratol found in grapes. Stilbenoids can also exist as glycosides (e.g., piceid). Combretastatins are potentially useful stilbenoid natural products with known antitumor activity. Diarylheptanoid is a compound group having phenyl rings at 1,7 positions of n-heptane (C6-C7-C6), such as curcumin found in the ginger family. [6]-Gingerol is a major active component of ginger and has diverse pharmacologic effects.'
p43566
assS'path:map00944'
p43567
(dp43568
S'NAME'
p43569
(lp43570
S'Flavone and flavonol biosynthesis'
p43571
asS'REFERENCE'
p43572
(lp43573
S'PMID:3994393'
p43574
ag43574
aS'AUTHORS'
p43575
aS'De Luca V, Ibrahim RK'
p43576
aS'TITLE'
p43577
aS"Enzymatic synthesis of polymethylated flavonols in Chrysosplenium americanum. I. Partial purification and some properties of S-adenosyl-L-methionine:flavonol 3-, 6-, 7-, and 4'-O-methyltransferases."
p43578
aS'JOURNAL'
p43579
aS'Arch Biochem Biophys 238:596-605 (1985)'
p43580
aS'PMID:6462109'
p43581
ag43581
aS'AUTHORS'
p43582
aS'Jourdan PS, Mansell RL'
p43583
aS'TITLE'
p43584
aS'Isolation and partial characterization of three glucosyl transferases involved in the biosynthesis of flavonol triglucosides in Pisum sativum L.'
p43585
aS'JOURNAL'
p43586
aS'Arch Biochem Biophys 213:434-43 (1982)'
p43587
aS'PMID:10567367'
p43588
ag43588
aS'AUTHORS'
p43589
aS'Miller KD, Guyon V, Evans JN, Shuttleworth WA, Taylor LP'
p43590
aS'TITLE'
p43591
aS'Purification, cloning, and heterologous expression of a catalytically efficient flavonol 3-O-galactosyltransferase expressed in the male gametophyte of Petunia hybrida.'
p43592
aS'JOURNAL'
p43593
aS'J Biol Chem 274:34011-9 (1999)'
p43594
aS'PMID:12482447'
p43595
ag43595
aS'AUTHORS'
p43596
aS'Cacace S, Schroder G, Wehinger E, Strack D, Schmidt J, Schroder J'
p43597
aS'TITLE'
p43598
aS'A flavonol O-methyltransferase from Catharanthus roseus performing two sequential methylations.'
p43599
aS'JOURNAL'
p43600
aS'Phytochemistry 62:127-37 (2003)'
p43601
aS'PMID:15807784'
p43602
ag43602
aS'AUTHORS'
p43603
aS'Tohge T, Nishiyama Y, Hirai MY, Yano M, Nakajima J, Awazuhara M, Inoue E, Takahashi H, Goodenowe DB, Kitayama M, Noji M, Yamazaki M, Saito K'
p43604
aS'TITLE'
p43605
aS'Functional genomics by integrated analysis of metabolome and transcriptome of Arabidopsis plants over-expressing an MYB transcription factor.'
p43606
aS'JOURNAL'
p43607
aS'Plant J 42:218-35 (2005)'
p43608
aS'PMID:17277900'
p43609
ag43609
aS'AUTHORS'
p43610
aS'Kubo H, Nawa N, Lupsea SA'
p43611
aS'TITLE'
p43612
aS'Anthocyaninless1 gene of Arabidopsis thaliana encodes a UDP-glucose:flavonoid-3-O-glucosyltransferase.'
p43613
aS'JOURNAL'
p43614
aS'J Plant Res 120:445-9 (2007)'
p43615
ag22
ag22
aS'AUTHORS'
p43616
aS'Knogge W, Weissenbock G.'
p43617
aS'TITLE'
p43618
aS'Tissue-distribution of secondary phenolic biosynthesis in developing primary leaves of Avena sativa L.'
p43619
aS'JOURNAL'
p43620
aS'Planta 167:196-205 (1986)'
p43621
ag22
ag22
aS'AUTHORS'
p43622
aS'Anhalt S, Weissenbock G.'
p43623
aS'TITLE'
p43624
aS'Subcellular localization of luteolin glucuronides and related enzymes in rye mesophyll.'
p43625
aS'JOURNAL'
p43626
aS'Planta 187:83-88 (1992)'
p43627
ag22
ag22
aS'AUTHORS'
p43628
aS'Suzuki H, Nakayama T, Nagae S, Yamaguchi M, Iwashita T, Fukui Y, Nishino T.'
p43629
aS'TITLE'
p43630
aS"cDNA cloning and functional characterization of flavonol 3-O-glucoside-6''-O-malonyltransferases from flowers of Verbena hybrida and Lamium purpureum."
p43631
aS'JOURNAL'
p43632
aS'J Mol Catal B 28:87-93 (2004)'
p43633
asS'KO_PATHWAY'
p43634
(lp43635
S'ko00944'
p43636
asS'ENTRY'
p43637
(lp43638
S'map00944'
p43639
aS'Pathway'
p43640
asS'PATHWAY_MAP'
p43641
(lp43642
S'map00944'
p43643
asS'CLASS'
p43644
(lp43645
S'Metabolism Biosynthesis of other secondary metabolites'
p43646
asS'DESCRIPTION'
p43647
(lp43648
S'Flavones and flavonols (3-hydroxyflavones) are common flavonoids in the plant kingdom. They are synthesized as part of the flavonoid modification pathways in aglycone and glucoside forms.'
p43649
assS'path:map00943'
p43650
(dp43651
S'NAME'
p43652
(lp43653
S'Isoflavonoid biosynthesis'
p43654
asS'REFERENCE'
p43655
(lp43656
S'PMID:11027686'
p43657
ag43657
aS'AUTHORS'
p43658
aS'Latunde-Dada AO, Cabello-Hurtado F, Czittrich N, Didierjean L, Schopfer C, Hertkorn N, Werck-Reichhart D, Ebel J.'
p43659
aS'TITLE'
p43660
aS'Flavonoid 6-hydroxylase from soybean (Glycine max L.), a novel plant P-450 monooxygenase.'
p43661
aS'JOURNAL'
p43662
aS'J Biol Chem 276:1688-95 (2001)'
p43663
aS'PMID:12179983'
p43664
ag43664
aS'AUTHORS'
p43665
aS'Baggett BR, Cooper JD, Hogan ET, Carper J, Paiva NL, Smith JT.'
p43666
aS'TITLE'
p43667
aS'Profiling isoflavonoids found in legume root extracts using capillary electrophoresis.'
p43668
aS'JOURNAL'
p43669
aS'Electrophoresis 23:1642-51 (2002)'
p43670
aS'PMID:16996502'
p43671
ag43671
aS'AUTHORS'
p43672
aS'Akashi T, Koshimizu S, Aoki T, Ayabe S.'
p43673
aS'TITLE'
p43674
aS'Identification of cDNAs encoding pterocarpan reductase involved in isoflavan phytoalexin biosynthesis in Lotus japonicus by EST mining.'
p43675
aS'JOURNAL'
p43676
aS'FEBS Lett 580:5666-70 (2006)'
p43677
aS'PMID:14617078'
p43678
ag43678
aS'AUTHORS'
p43679
aS'Liu CJ, Huhman D, Sumner LW, Dixon RA.'
p43680
aS'TITLE'
p43681
aS'Regiospecific hydroxylation of isoflavones by cytochrome p450 81E enzymes from Medicago truncatula.'
p43682
aS'JOURNAL'
p43683
aS'Plant J 36:471-84 (2003)'
p43684
aS'PMID:15082922'
p43685
ag43685
aS'AUTHORS'
p43686
aS'Dhaubhadel S, McGarvey BD, Williams R, Gijzen M.'
p43687
aS'TITLE'
p43688
aS'Isoflavonoid biosynthesis and accumulation in developing soybean seeds.'
p43689
aS'JOURNAL'
p43690
aS'Plant Mol Biol 53:733-43 (2003)'
p43691
aS'PMID:11164575'
p43692
ag43692
aS'AUTHORS'
p43693
aS'Shimada N, Akashi T, Aoki T, Ayabe S.'
p43694
aS'TITLE'
p43695
aS'Induction of isoflavonoid pathway in the model legume Lotus japonicus: molecular characterization of enzymes involved in phytoalexin biosynthesis.'
p43696
aS'JOURNAL'
p43697
aS'Plant Sci 160:37-47 (2000)'
p43698
aS'PMID:16667851'
p43699
ag43699
aS'AUTHORS'
p43700
aS'Preisig CL, Bell JN, Sun Y, Hrazdina G, Matthews DE, Vanetten HD'
p43701
aS'TITLE'
p43702
aS'Biosynthesis of the Phytoalexin Pisatin : Isoflavone Reduction and Further Metabolism of the Product Sophorol by Extracts of Pisum sativum.'
p43703
aS'JOURNAL'
p43704
aS'Plant Physiol 94:1444-8 (1990)'
p43705
aS'PMID:17452423'
p43706
ag43706
aS'AUTHORS'
p43707
aS'Shimada N, Sato S, Akashi T, Nakamura Y, Tabata S, Ayabe S, Aoki T'
p43708
aS'TITLE'
p43709
aS'Genome-wide analyses of the structural gene families involved in the legume-specific 5-deoxyisoflavonoid biosynthesis of Lotus japonicus.'
p43710
aS'JOURNAL'
p43711
aS'DNA Res 14:25-36 (2007)'
p43712
aS'PMID:16924535'
p43713
ag43713
aS'AUTHORS'
p43714
aS'Lozovaya VV, Lygin AV, Zernova OV, Ulanov AV, Li S, Hartman GL, Widholm JM.'
p43715
aS'TITLE'
p43716
aS'Modification of phenolic metabolism in soybean hairy roots through down regulation of chalcone synthase or isoflavone synthase.'
p43717
aS'JOURNAL'
p43718
aS'Planta 225:665-79 (2007)'
p43719
aS'PMID:12207646'
p43720
ag43720
aS'AUTHORS'
p43721
aS'Sawada Y, Kinoshita K, Akashi T, Aoki T, Ayabe S.'
p43722
aS'TITLE'
p43723
aS'Key amino acid residues required for aryl migration catalysed by the cytochrome P450 2-hydroxyisoflavanone synthase.'
p43724
aS'JOURNAL'
p43725
aS'Plant J 31:555-64 (2002)'
p43726
ag22
ag22
aS'AUTHORS'
p43727
aS'Deavours BE, Dixon RA.'
p43728
aS'TITLE'
p43729
aS'Metabolic engineering of isoflavonoid biosynthesis in Alfalfa.'
p43730
aS'JOURNAL'
p43731
aS'Plant Physiology 138:2245-2259 (2005)'
p43732
ag22
ag22
aS'AUTHORS'
p43733
aS'Hinderer W, Flentje U, Barz W.'
p43734
aS'TITLE'
p43735
aS"Microsomal isoflavone 2'- and 3'-hydroxylases from chickpea (Cicer arietinum L.) cell suspensions induced for pterocarpan phytoalexin formation."
p43736
aS'JOURNAL'
p43737
aS'FEBS letters 214(1):101-106 (1987)'
p43738
ag22
ag22
aS'AUTHORS'
p43739
aS'Aoki T, Akashi T, Ayabe S.'
p43740
aS'TITLE'
p43741
aS'Flavonoids of leguminous plants: structure, biological activity, and biosynthesis.'
p43742
aS'JOURNAL'
p43743
aS'Journal of Plant Research 113(4):475-488 (2000)'
p43744
ag22
ag22
aS'AUTHORS'
p43745
aS'Barz W, Mackenbrock U.'
p43746
aS'TITLE'
p43747
aS'Constitutive and elicitation induced metabolism of isoflavones and pterocarpans in chickpea (Cicer arietinum) cell suspension cultures.'
p43748
aS'JOURNAL'
p43749
aS'Plant Cell, Tissue and Organ Culture 38(2-3):199-211 (1994)'
p43750
ag22
ag22
aS'AUTHORS'
p43751
aS'Fischer D, Ebenau-Jehle C, Grisebach H.'
p43752
aS'TITLE'
p43753
aS'Purification and characterization of pterocarpan synthase from elicitor-challenged soybean cell cultures.'
p43754
aS'JOURNAL'
p43755
aS'Phytochemistry 29(9):2879-2882 (1990)'
p43756
ag22
ag22
aS'AUTHORS'
p43757
aS'Ayabe S, Akashi T.'
p43758
aS'TITLE'
p43759
aS'Cytochrome P450s in flavonoid metabolism.'
p43760
aS'JOURNAL'
p43761
aS'Phytochemistry Reviews 5(2-3):271-282 (2006)'
p43762
ag22
ag22
aS'AUTHORS'
p43763
aS'Daniel S, Tiemann K, Wittkampf U, Bless W, Hinderer W, Barz W.'
p43764
aS'TITLE'
p43765
aS'Elicitor-induced metabolic changes in cell cultures of chickpea (Cicer arietinum L.) cultivars resistant and susceptible to Ascochyta rabiei.'
p43766
aS'JOURNAL'
p43767
aS'Planta 182(2):270-278 (1990)'
p43768
asS'KO_PATHWAY'
p43769
(lp43770
S'ko00943'
p43771
asS'ENTRY'
p43772
(lp43773
S'map00943'
p43774
aS'Pathway'
p43775
asS'PATHWAY_MAP'
p43776
(lp43777
S'map00943'
p43778
asS'CLASS'
p43779
(lp43780
S'Metabolism Biosynthesis of other secondary metabolites'
p43781
asS'DESCRIPTION'
p43782
(lp43783
S'Isoflavonoids are biologically active compounds, such as phytoestrogens, produced by pea family plants. While flavonoids (in the narrow sense) have the 2-phenylchromen-4-one backbone, isoflavonoids have the 3-phenylchromen-4-one backbone with no hydroxyl group substitution at position 2. Isoflavonoids are derived from the flavonoid biosynthesis pathway via liquiritigenin or naringenin.'
p43784
assS'path:map00410'
p43785
(dp43786
S'NAME'
p43787
(lp43788
S'beta-Alanine metabolism'
p43789
asS'DBLINKS'
p43790
(lp43791
S'GO: 0019482'
p43792
asS'KO_PATHWAY'
p43793
(lp43794
S'ko00410'
p43795
asS'ENTRY'
p43796
(lp43797
S'map00410'
p43798
aS'Pathway'
p43799
asS'PATHWAY_MAP'
p43800
(lp43801
S'map00410'
p43802
asS'DISEASE'
p43803
(lp43804
S'H00597'
p43805
aS'Snyder-Robinson syndrome'
p43806
ag43805
ag43806
aS'H01097'
p43807
aS'Cerebral palsy'
p43808
aS'H01283'
p43809
aS'Malonyl-CoA decarboxylase deficiency'
p43810
asS'CLASS'
p43811
(lp43812
S'Metabolism Metabolism of other amino acids'
p43813
assS'path:map00941'
p43814
(dp43815
S'NAME'
p43816
(lp43817
S'Flavonoid biosynthesis'
p43818
asS'REFERENCE'
p43819
(lp43820
S'PMID:16945088'
p43821
ag43821
aS'AUTHORS'
p43822
aS'Tsai CJ, Harding SA, Tschaplinski TJ, Lindroth RL, Yuan Y.'
p43823
aS'TITLE'
p43824
aS'Genome-wide analysis of the structural genes regulating defense phenylpropanoid metabolism in Populus.'
p43825
aS'JOURNAL'
p43826
aS'New Phytol 172:47-62 (2006)'
p43827
aS'PMID:16367960'
p43828
ag43828
aS'AUTHORS'
p43829
aS'Ono E, Hatayama M, Isono Y, Sato T, Watanabe R, Yonekura-Sakakibara K, Fukuchi-Mizutani M, Tanaka Y, Kusumi T, Nishino T, Nakayama T.'
p43830
aS'TITLE'
p43831
aS'Localization of a flavonoid biosynthetic polyphenol oxidase in vacuoles.'
p43832
aS'JOURNAL'
p43833
aS'Plant J 45:133-43 (2006)'
p43834
aS'PMID:16774647'
p43835
ag43835
aS'AUTHORS'
p43836
aS'Morreel K, Goeminne G, Storme V, Sterck L, Ralph J, Coppieters W, Breyne P, Steenackers M, Georges M, Messens E, Boerjan W.'
p43837
aS'TITLE'
p43838
aS'Genetical metabolomics of flavonoid biosynthesis in Populus: a case study.'
p43839
aS'JOURNAL'
p43840
aS'Plant J 47:224-37 (2006)'
p43841
aS'PMID:16832053'
p43842
ag43842
aS'AUTHORS'
p43843
aS'Ono E, Fukuchi-Mizutani M, Nakamura N, Fukui Y, Yonekura-Sakakibara K, Yamaguchi M, Nakayama T, Tanaka T, Kusumi T, Tanaka Y.'
p43844
aS'TITLE'
p43845
aS'Yellow flowers generated by expression of the aurone biosynthetic pathway.'
p43846
aS'JOURNAL'
p43847
aS'Proc Natl Acad Sci U S A 103:11075-80 (2006)'
p43848
ag22
ag22
aS'AUTHORS'
p43849
aS'Halbwirth H, Martens S, Wienand U, Forkmann G, Stich K.'
p43850
aS'TITLE'
p43851
aS'Synthesis of (14C)-labeled 5-deoxyflavonoids and their application in the study of dihydroflavonol/leucoanthocyanidin interconversion by dihydroflavonol 4-reductase.'
p43852
aS'JOURNAL'
p43853
aS'Plant Science 170(3): 587-595 (2006)'
p43854
aS'PMID:15231405'
p43855
ag43855
aS'AUTHORS'
p43856
aS'Stevens JF, Page JE.'
p43857
aS'TITLE'
p43858
aS'Xanthohumol and related prenylflavonoids from hops and beer: to your good health!'
p43859
aS'JOURNAL'
p43860
aS'Phytochemistry 65:1317-30 (2004)'
p43861
ag22
ag22
aS'AUTHORS'
p43862
aS'Ogata J, Itoh Y, Ishida M, Yoshida H, Ozeki Y.'
p43863
aS'TITLE'
p43864
aS'Cloning and heterologous expression of cDNAs encoding flavonoid glucosyltransferases from Dianthus caryophyllus.'
p43865
aS'JOURNAL'
p43866
aS'Plant Biotechnology 21(5):367-375 (2004)'
p43867
aS'PMID:12828368'
p43868
ag43868
aS'AUTHORS'
p43869
aS'Springob K, Nakajima J, Yamazaki M, Saito K.'
p43870
aS'TITLE'
p43871
aS'Recent advances in the biosynthesis and accumulation of anthocyanins.'
p43872
aS'JOURNAL'
p43873
aS'Nat Prod Rep 20:288-303 (2003)'
p43874
aS'PMID:12644647'
p43875
ag43875
aS'AUTHORS'
p43876
aS'Shimada N, Aoki T, Sato S, Nakamura Y, Tabata S, Ayabe S.'
p43877
aS'TITLE'
p43878
aS'A cluster of genes encodes the two types of chalcone isomerase involved in the biosynthesis of general flavonoids and legume-specific 5-deoxy(iso)flavonoids in Lotus japonicus.'
p43879
aS'JOURNAL'
p43880
aS'Plant Physiol 131:941-51 (2003)'
p43881
ag22
ag22
aS'AUTHORS'
p43882
aS'Halbwirth H, Martens S, Wienand U, Forkmann G, Stich K.'
p43883
aS'TITLE'
p43884
aS'Biochemical formation of anthocyanins in silk tissue of Zea mays.'
p43885
aS'JOURNAL'
p43886
aS'Plant Science 164(4):489-495 (2003)'
p43887
ag22
ag22
aS'AUTHORS'
p43888
aS'Martens S, Knott J, Seitz CA, Janvari L, Yu SN, Forkmann G.'
p43889
aS'TITLE'
p43890
aS'Impact of biochemical pre-studies on specific metabolic engineering strategies of flavonoid biosynthesis in plant tissues.'
p43891
aS'JOURNAL'
p43892
aS'Biochemical Engineering Journal 14(3):227-235 (2003)'
p43893
aS'PMID:11073455'
p43894
ag43894
aS'AUTHORS'
p43895
aS'Nakayama T, Yonekura-Sakakibara K, Sato T, Kikuchi S, Fukui Y, Fukuchi-Mizutani M, Ueda T, Nakao M, Tanaka Y, Kusumi T, Nishino T.'
p43896
aS'TITLE'
p43897
aS'Aureusidin synthase: a polyphenol oxidase homolog responsible for flower coloration.'
p43898
aS'JOURNAL'
p43899
aS'Science 290:1163-6 (2000)'
p43900
aS'PMID:16667183'
p43901
ag43901
aS'AUTHORS'
p43902
aS'Lewinsohn E, Britsch L, Mazur Y, Gressel J'
p43903
aS'TITLE'
p43904
aS'Flavanone Glycoside Biosynthesis in Citrus: Chalcone Synthase, UDP-Glucose:Flavanone-7-O-Glucosyl-Transferase and -Rhamnosyl-Transferase Activities in Cell-Free Extracts.'
p43905
aS'JOURNAL'
p43906
aS'Plant Physiol 91:1323-8 (1989)'
p43907
asS'KO_PATHWAY'
p43908
(lp43909
S'ko00941'
p43910
asS'PATHWAY_MAP'
p43911
(lp43912
S'map00941'
p43913
asS'MODULE'
p43914
(lp43915
S'M00137'
p43916
aS'Flavanone biosynthesis, phenylalanine => naringenin [PATH:map00941]'
p43917
ag43916
ag43917
aS'M00138'
p43918
aS'Flavonoid biosynthesis, naringenin => pelargonidin [PATH:map00941]'
p43919
asS'DBLINKS'
p43920
(lp43921
S'GO: 0009813'
p43922
asS'ENTRY'
p43923
(lp43924
S'map00941'
p43925
aS'Pathway'
p43926
asS'CLASS'
p43927
(lp43928
S'Metabolism Biosynthesis of other secondary metabolites'
p43929
asS'DESCRIPTION'
p43930
(lp43931
S'Flavonoids are a major class of plant secondary metabolites that serves a multitude of functions including pigments and antioxidant activity. Flavonoids are synthesized from phenylpropanoid derivatives by condensation with malonyl-CoA. For example, condensation of p-coumaroyl-CoA (C6-C3) with three malonyl-CoA (C3) molecules results in naringenin chalcone with a diphenylpropane (C6-C3-C6) unit, which is converted to naringenin with the flavone (2-phenylchromen-4-one) backbone by conjugate ring closure. These and further modifications yield a variety of structural forms including chalcones, flavanones, dihyroflavonols, and flavans, anthocyanins, flavones and flavonols, and isoflavonoids.'
p43932
assS'path:map00940'
p43933
(dp43934
S'NAME'
p43935
(lp43936
S'Phenylpropanoid biosynthesis'
p43937
asS'REFERENCE'
p43938
(lp43939
S'PMID:14729911'
p43940
ag43940
aS'AUTHORS'
p43941
aS'Nair RB, Bastress KL, Ruegger MO, Denault JW, Chapple C.'
p43942
aS'TITLE'
p43943
aS'The Arabidopsis thaliana REDUCED EPIDERMAL FLUORESCENCE1 gene encodes an aldehyde dehydrogenase involved in ferulic acid and sinapic acid biosynthesis.'
p43944
aS'JOURNAL'
p43945
aS'Plant Cell 16:544-54 (2004)'
p43946
aS'PMID:14551235'
p43947
ag43947
aS'AUTHORS'
p43948
aS'Baucher M, Halpin C, Petit-Conil M, Boerjan W.'
p43949
aS'TITLE'
p43950
aS'Lignin: genetic engineering and impact on pulping.'
p43951
aS'JOURNAL'
p43952
aS'Crit Rev Biochem Mol Biol 38:305-50 (2003)'
p43953
aS'PMID:15878986'
p43954
ag43954
aS'AUTHORS'
p43955
aS'Rogers LA, Dubos C, Cullis IF, Surman C, Poole M, Willment J, Mansfield SD, Campbell MM.'
p43956
aS'TITLE'
p43957
aS'Light, the circadian clock, and sugar perception in the control of lignin biosynthesis.'
p43958
aS'JOURNAL'
p43959
aS'J Exp Bot 56:1651-63 (2005)'
p43960
aS'PMID:12242395'
p43961
ag43961
aS'AUTHORS'
p43962
aS'Whetten R, Sederoff R.'
p43963
aS'TITLE'
p43964
aS'Lignin Biosynthesis.'
p43965
aS'JOURNAL'
p43966
aS'Plant Cell 7:1001-1013 (1995)'
p43967
aS'PMID:8972602'
p43968
ag43968
aS'AUTHORS'
p43969
aS'Lorenzen M, Racicot V, Strack D, Chapple C.'
p43970
aS'TITLE'
p43971
aS'Sinapic acid ester metabolism in wild type and a sinapoylglucose-accumulating mutant of arabidopsis.'
p43972
aS'JOURNAL'
p43973
aS'Plant Physiol 112:1625-30 (1996)'
p43974
aS'PMID:1477555'
p43975
ag43975
aS'AUTHORS'
p43976
aS'Chapple CC, Vogt T, Ellis BE, Somerville CR.'
p43977
aS'TITLE'
p43978
aS'An Arabidopsis mutant defective in the general phenylpropanoid pathway.'
p43979
aS'JOURNAL'
p43980
aS'Plant Cell 4:1413-24 (1992)'
p43981
aS'PMID:14612585'
p43982
ag43982
aS'AUTHORS'
p43983
aS'Raes J, Rohde A, Christensen JH, Van de Peer Y, Boerjan W.'
p43984
aS'TITLE'
p43985
aS'Genome-wide characterization of the lignification toolbox in Arabidopsis.'
p43986
aS'JOURNAL'
p43987
aS'Plant Physiol 133:1051-71 (2003)'
p43988
aS'PMID:14568076'
p43989
ag43989
aS'AUTHORS'
p43990
aS'Costa MA, Collins RE, Anterola AM, Cochrane FC, Davin LB, Lewis NG.'
p43991
aS'TITLE'
p43992
aS'An in silico assessment of gene function and organization of the phenylpropanoid pathway metabolic networks in Arabidopsis thaliana and limitations thereof.'
p43993
aS'JOURNAL'
p43994
aS'Phytochemistry 64:1097-112 (2003)'
p43995
aS'PMID:10934215'
p43996
ag43996
aS'AUTHORS'
p43997
aS'Meyermans H, Morreel K, Lapierre C, Pollet B, De Bruyn A, Busson R, Herdewijn P, Devreese B, Van Beeumen J, Marita JM, Ralph J, Chen C, Burggraeve B, Van Montagu M, Messens E, Boerjan W.'
p43998
aS'TITLE'
p43999
aS'Modifications in lignin and accumulation of phenolic glucosides in poplar xylem upon down-regulation of caffeoyl-coenzyme A O-methyltransferase, an enzyme involved in lignin biosynthesis.'
p44000
aS'JOURNAL'
p44001
aS'J Biol Chem 275:36899-909 (2000)'
p44002
aS'PMID:16027976'
p44003
ag44003
aS'AUTHORS'
p44004
aS'Gachon CM, Langlois-Meurinne M, Henry Y, Saindrenan P.'
p44005
aS'TITLE'
p44006
aS'Transcriptional co-regulation of secondary metabolism enzymes in Arabidopsis: functional and evolutionary implications.'
p44007
aS'JOURNAL'
p44008
aS'Plant Mol Biol 58:229-45 (2005)'
p44009
aS'PMID:10692459'
p44010
ag44010
aS'AUTHORS'
p44011
aS'Li L, Popko JL, Umezawa T, Chiang VL.'
p44012
aS'TITLE'
p44013
aS'5-hydroxyconiferyl aldehyde modulates enzymatic methylation for syringyl monolignol formation, a new view of monolignol biosynthesis in angiosperms.'
p44014
aS'JOURNAL'
p44015
aS'J Biol Chem 275:6537-45 (2000)'
p44016
aS'PMID:12009990'
p44017
ag44017
aS'AUTHORS'
p44018
aS'Yamauchi K, Yasuda S, Fukushima K.'
p44019
aS'TITLE'
p44020
aS'Evidence for the biosynthetic pathway from sinapic acid to syringyl lignin using labeled sinapic acid with stable isotope at both methoxy groups in Robinia pseudoacacia and Nerium indicum.'
p44021
aS'JOURNAL'
p44022
aS'J Agric Food Chem 50:3222-7 (2002)'
p44023
aS'PMID:12084820'
p44024
ag44024
aS'AUTHORS'
p44025
aS'Eckardt NA.'
p44026
aS'TITLE'
p44027
aS'Probing the mysteries of lignin biosynthesis: the crystal structure of caffeic acid/5-hydroxyferulic acid 3/5-O-methyltransferase provides new insights.'
p44028
aS'JOURNAL'
p44029
aS'Plant Cell 14:1185-9 (2002)'
p44030
asS'KO_PATHWAY'
p44031
(lp44032
S'ko00940'
p44033
asS'PATHWAY_MAP'
p44034
(lp44035
S'map00940'
p44036
asS'MODULE'
p44037
(lp44038
S'M00039'
p44039
aS'Monolignol biosynthesis, phenylalanine/tyrosine'
p44040
aS'=> monolignol [PATH:map00940]'
p44041
ag44039
ag44040
ag44041
aS'M00137'
p44042
aS'Flavanone biosynthesis, phenylalanine => naringenin [PATH:map00940]'
p44043
asS'DBLINKS'
p44044
(lp44045
S'GO: 0009699'
p44046
asS'ENTRY'
p44047
(lp44048
S'map00940'
p44049
aS'Pathway'
p44050
asS'CLASS'
p44051
(lp44052
S'Metabolism Biosynthesis of other secondary metabolites'
p44053
asS'DESCRIPTION'
p44054
(lp44055
S'Phenylpropanoids are a group of plant secondary metabolites derived from phenylalanine and having a wide variety of functions both as structural and signaling molecules. Phenylalanine is first converted to cinnamic acid by deamination. It is followed by hydroxylation and frequent methylation to generate coumaric acid and other acids with a phenylpropane (C6-C3) unit. Reduction of the CoA-activated carboxyl groups of these acids results in the corresponding aldehydes and alcohols. The alcohols are called monolignols, the starting compounds for biosynthesis of lignin.'
p44056
assS'path:map00625'
p44057
(dp44058
S'DBLINKS'
p44059
(lp44060
S'UMBBD: tce tce2 tca atl dcm dce cpr caa'
p44061
asS'NAME'
p44062
(lp44063
S'Chloroalkane and chloroalkene degradation'
p44064
asS'REFERENCE'
p44065
(lp44066
S'PMID:15294827'
p44067
ag44067
aS'AUTHORS'
p44068
aS'Muller JA, Rosner BM, Von Abendroth G, Meshulam-Simon G, McCarty PL, Spormann AM.'
p44069
aS'TITLE'
p44070
aS'Molecular identification of the catabolic vinyl chloride reductase from Dehalococcoides sp. strain VS and its environmental distribution.'
p44071
aS'JOURNAL'
p44072
aS'Appl Environ Microbiol 70:4880-8 (2004)'
p44073
aS'PMID:16957242'
p44074
ag44074
aS'AUTHORS'
p44075
aS'Lee PK, Johnson DR, Holmes VF, He J, Alvarez-Cohen L.'
p44076
aS'TITLE'
p44077
aS'Reductive dehalogenase gene expression as a biomarker for physiological activity of Dehalococcoides spp.'
p44078
aS'JOURNAL'
p44079
aS'Appl Environ Microbiol 72:6161-8 (2006)'
p44080
aS'PMID:15865156'
p44081
ag44081
aS'AUTHORS'
p44082
aS'Torz M, Beschkov V'
p44083
aS'TITLE'
p44084
aS'Biodegradation of monochloroacetic acid used as a sole carbon and energy source by Xanthobacter autotrophicus GJ10 strain in batch and continuous culture.'
p44085
aS'JOURNAL'
p44086
aS'Biodegradation 16:423-33 (2005)'
p44087
aS'PMID:10347028'
p44088
ag44088
aS'AUTHORS'
p44089
aS'Hage JC, Hartmans S'
p44090
aS'TITLE'
p44091
aS'Monooxygenase-mediated 1,2-dichloroethane degradation by Pseudomonas sp. strain DCA1.'
p44092
aS'JOURNAL'
p44093
aS'Appl Environ Microbiol 65:2466-70 (1999)'
p44094
aS'PMID:9687453'
p44095
ag44095
aS'AUTHORS'
p44096
aS'Poelarends GJ, Wilkens M, Larkin MJ, van Elsas JD, Janssen DB.'
p44097
aS'TITLE'
p44098
aS'Degradation of 1,3-dichloropropene by pseudomonas cichorii 170.'
p44099
aS'JOURNAL'
p44100
aS'Appl Environ Microbiol 64:2931-6 (1998)'
p44101
aS'PMID:12411705'
p44102
ag44102
aS'AUTHORS'
p44103
aS'Sun B, Griffin BM, Ayala-del-Rio HL, Hashsham SA, Tiedje JM'
p44104
aS'TITLE'
p44105
aS'Microbial dehalorespiration with 1,1,1-trichloroethane.'
p44106
aS'JOURNAL'
p44107
aS'Science 298:1023-5 (2002)'
p44108
aS'PMID:11999413'
p44109
ag44109
aS'AUTHORS'
p44110
aS'Hashimoto A, Iwasaki K, Nakasugi N, Nakajima M, Yagi O'
p44111
aS'TITLE'
p44112
aS'Degradation pathways of trichloroethylene and 1,1,1-trichloroethane by Mycobacterium sp. TA27.'
p44113
aS'JOURNAL'
p44114
aS'Biosci Biotechnol Biochem 66:385-90 (2002)'
p44115
aS'PMID:1768109'
p44116
ag44116
aS'AUTHORS'
p44117
aS'Newman LM, Wackett LP'
p44118
aS'TITLE'
p44119
aS'Fate of 2,2,2-trichloroacetaldehyde (chloral hydrate) produced during trichloroethylene oxidation by methanotrophs.'
p44120
aS'JOURNAL'
p44121
aS'Appl Environ Microbiol 57:2399-402 (1991)'
p44122
aS'PMID:8981984'
p44123
ag44123
aS'AUTHORS'
p44124
aS'Newman LM, Wackett LP'
p44125
aS'TITLE'
p44126
aS'Trichloroethylene oxidation by purified toluene 2-monooxygenase: products, kinetics, and turnover-dependent inactivation.'
p44127
aS'JOURNAL'
p44128
aS'J Bacteriol 179:90-6 (1997)'
p44129
asS'KO_PATHWAY'
p44130
(lp44131
S'ko00625'
p44132
asS'ENTRY'
p44133
(lp44134
S'map00625'
p44135
aS'Pathway'
p44136
asS'PATHWAY_MAP'
p44137
(lp44138
S'map00625'
p44139
asS'CLASS'
p44140
(lp44141
S'Metabolism Xenobiotics biodegradation and metabolism'
p44142
assS'path:map00860'
p44143
(dp44144
S'NAME'
p44145
(lp44146
S'Porphyrin and chlorophyll metabolism'
p44147
asS'REFERENCE'
p44148
(lp44149
S'PMID:9461500'
p44150
ag44150
aS'AUTHORS'
p44151
aS'Woodcock SC, Raux E, Levillayer F, Thermes C, Rambach A, Warren MJ.'
p44152
aS'TITLE'
p44153
aS'Effect of mutations in the transmethylase and dehydrogenase/chelatase domains of sirohaem synthase (CysG) on sirohaem and cobalamin biosynthesis.'
p44154
aS'JOURNAL'
p44155
aS'Biochem J 330:121-9 (1998)'
p44156
aS'PMID:10217486'
p44157
ag44157
aS'AUTHORS'
p44158
aS'Johansson P, Hederstedt L'
p44159
aS'TITLE'
p44160
aS'Organization of genes for tetrapyrrole biosynthesis in gram--positive bacteria.'
p44161
aS'JOURNAL'
p44162
aS'Microbiology 145 ( Pt 3):529-38 (1999)'
p44163
aS'PMID:10518530'
p44164
ag44164
aS'AUTHORS'
p44165
aS'Maggio-Hall LA, Escalante-Semerena JC.'
p44166
aS'TITLE'
p44167
aS'In vitro synthesis of the nucleotide loop of cobalamin by Salmonella typhimurium enzymes.'
p44168
aS'JOURNAL'
p44169
aS'Proc Natl Acad Sci USA 96:11798-803 (1999)'
p44170
aS'PMID:11007789'
p44171
ag44171
aS'AUTHORS'
p44172
aS'Roper JM, Raux E, Brindley AA, Schubert HL, Gharbia SE, Shah HN, Warren MJ.'
p44173
aS'TITLE'
p44174
aS'The enigma of cobalamin (Vitamin B12) biosynthesis in Porphyromonas gingivalis. Identification and characterization of a functional corrin pathway.'
p44175
aS'JOURNAL'
p44176
aS'J Biol Chem 275:40316-23 (2000)'
p44177
aS'PMID:12196148'
p44178
ag44178
aS'AUTHORS'
p44179
aS'Scott AI, Roessner CA.'
p44180
aS'TITLE'
p44181
aS'Biosynthesis of cobalamin (vitamin B(12)).'
p44182
aS'JOURNAL'
p44183
aS'Biochem Soc Trans 30:613-20 (2002)'
p44184
aS'PMID:12195810'
p44185
ag44185
aS'AUTHORS'
p44186
aS'Warren MJ, Raux E, Schubert HL, Escalante-Semerena JC.'
p44187
aS'TITLE'
p44188
aS'The biosynthesis of adenosylcobalamin (vitamin B12).'
p44189
aS'JOURNAL'
p44190
aS'Nat Prod Rep 19:390-412 (2002)'
p44191
aS'PMID:12055304'
p44192
ag44192
aS'AUTHORS'
p44193
aS'Roessner CA, Huang KX, Warren MJ, Raux E, Scott AI.'
p44194
aS'TITLE'
p44195
aS'Isolation and characterization of 14 additional genes specifying the anaerobic biosynthesis of cobalamin (vitamin B12) in Propionibacterium freudenreichii (P. shermanii).'
p44196
aS'JOURNAL'
p44197
aS'Microbiology 148:1845-53 (2002)'
p44198
aS'PMID:11283349'
p44199
ag44199
aS'AUTHORS'
p44200
aS'Frankenberg N, Mukougawa K, Kohchi T, Lagarias JC.'
p44201
aS'TITLE'
p44202
aS'Functional genomic analysis of the HY2 family of ferredoxin-dependent bilin reductases from oxygenic photosynthetic organisms.'
p44203
aS'JOURNAL'
p44204
aS'Plant Cell 13:965-78 (2001)'
p44205
aS'PMID:17506685'
p44206
ag44206
aS'AUTHORS'
p44207
aS'Chew AG, Bryant DA'
p44208
aS'TITLE'
p44209
aS'Chlorophyll biosynthesis in bacteria: the origins of structural and functional diversity.'
p44210
aS'JOURNAL'
p44211
aS'Annu Rev Microbiol 61:113-29 (2007)'
p44212
aS'PMID:16245042'
p44213
ag44213
aS'AUTHORS'
p44214
aS'Frigaard NU, Chew AG, Li H, Maresca JA, Bryant DA'
p44215
aS'TITLE'
p44216
aS'Chlorobium tepidum: insights into the structure, physiology, and metabolism of a'
p44217
aS'green sulfur bacterium derived from the complete genome sequence.'
p44218
aS'JOURNAL'
p44219
aS'Photosynth Res 78:93-117 (2003)'
p44220
aS'PMID:23042036'
p44221
ag44221
aS'AUTHORS'
p44222
aS'Deery E, Schroeder S, Lawrence AD, Taylor SL, Seyedarabi A, Waterman J, Wilson KS, Brown D, Geeves MA, Howard MJ, Pickersgill RW, Warren MJ'
p44223
aS'TITLE'
p44224
aS'An enzyme-trap approach allows isolation of intermediates in cobalamin biosynthesis.'
p44225
aS'JOURNAL'
p44226
aS'Nat Chem Biol 8:933-40 (2012)'
p44227
aS'PMID:23922391'
p44228
ag44228
aS'AUTHORS'
p44229
aS'Moore SJ, Lawrence AD, Biedendieck R, Deery E, Frank S, Howard MJ, Rigby SE, Warren MJ'
p44230
aS'TITLE'
p44231
aS'Elucidation of the anaerobic pathway for the corrin component of cobalamin (vitamin B12).'
p44232
aS'JOURNAL'
p44233
aS'Proc Natl Acad Sci U S A 110:14906-11 (2013)'
p44234
asS'KO_PATHWAY'
p44235
(lp44236
S'ko00860'
p44237
asS'PATHWAY_MAP'
p44238
(lp44239
S'map00860'
p44240
asS'DISEASE'
p44241
(lp44242
S'H00201'
p44243
aS'Erythropoietic porphyria (EP)'
p44244
ag44243
ag44244
aS'H00202'
p44245
aS'Hepatic porphyria'
p44246
aS'H00208'
p44247
aS'Hyperbilirubinemia'
p44248
aS'H00833'
p44249
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p44250
aS'H01027'
p44251
aS'Anophthalmia and microphthalmia (A/M)'
p44252
aS'H01202'
p44253
aS'Cataract'
p44254
aS'H01368'
p44255
aS'Cytochrome c oxidase (COX) deficiency'
p44256
asS'MODULE'
p44257
(lp44258
S'M00121'
p44259
aS'Heme biosynthesis, glutamate => protoheme/siroheme [PATH:map00860]'
p44260
ag44259
ag44260
aS'M00122'
p44261
aS'Cobalamin biosynthesis, cobinamide => cobalamin [PATH:map00860]'
p44262
asS'DBLINKS'
p44263
(lp44264
S'GO: 0006778'
p44265
asS'ENTRY'
p44266
(lp44267
S'map00860'
p44268
aS'Pathway'
p44269
asS'CLASS'
p44270
(lp44271
S'Metabolism Metabolism of cofactors and vitamins'
p44272
assS'path:map07038'
p44273
(dp44274
S'ENTRY'
p44275
(lp44276
S'map07038'
p44277
aS'Drug'
p44278
aS'Pathway'
p44279
asS'PATHWAY_MAP'
p44280
(lp44281
S'map07038'
p44282
asS'NAME'
p44283
(lp44284
S'Antiulcer drugs'
p44285
asS'REFERENCE'
p44286
(lp44287
g22
ag22
aS'AUTHORS'
p44288
aS'Fukai S.'
p44289
aS'TITLE'
p44290
aS'[New Drugs Today (6th ed)] (In Japanese)'
p44291
aS'JOURNAL'
p44292
aS'Jiho (1995)'
p44293
ag22
ag22
aS'AUTHORS'
p44294
aS'David AW, Thomas LL, William OF.'
p44295
aS'TITLE'
p44296
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p44297
aS'JOURNAL'
p44298
aS'Lippincott Williams & Wilkins (2002)'
p44299
ag22
ag22
aS'AUTHORS'
p44300
aS'Walter S.'
p44301
aS'TITLE'
p44302
aS'Drug Discovery: A History'
p44303
aS'JOURNAL'
p44304
aS'Wiley (2005)'
p44305
ag22
ag22
aS'AUTHORS'
p44306
aS'Japan Pharmaceutical Association (ed).'
p44307
aS'TITLE'
p44308
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p44309
aS'JOURNAL'
p44310
aS'Yakuji Nippo (1999)'
p44311
ag22
ag22
aS'AUTHORS'
p44312
aS'Noguchi S, Hibino S (eds).'
p44313
aS'TITLE'
p44314
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p44315
aS'JOURNAL'
p44316
aS'Hirokawa (2002)'
p44317
ag22
ag22
aS'AUTHORS'
p44318
aS'Tanaka C, Kato R (eds).'
p44319
aS'TITLE'
p44320
aS'[New Pharmacology (4th ed)] (In Japanese)'
p44321
aS'JOURNAL'
p44322
aS'Nankodo (2002)'
p44323
aS'PMID:16700898'
p44324
ag44324
aS'AUTHORS'
p44325
aS'Sachs G, Shin JM, Howden CW'
p44326
aS'TITLE'
p44327
aS'Review article: the clinical pharmacology of proton pump inhibitors.'
p44328
aS'JOURNAL'
p44329
aS'Aliment Pharmacol Ther 23 Suppl 2:2-8 (2006)'
p44330
aS'PMID:16700900'
p44331
ag44331
aS'AUTHORS'
p44332
aS'Scarpignato C, Pelosini I'
p44333
aS'TITLE'
p44334
aS'Review article: the opportunities and benefits of extended acid suppression.'
p44335
aS'JOURNAL'
p44336
aS'Aliment Pharmacol Ther 23 Suppl 2:23-34 (2006)'
p44337
aS'PMID:14603076'
p44338
ag44338
aS'AUTHORS'
p44339
aS'Der G.'
p44340
aS'TITLE'
p44341
aS'An overview of proton pump inhibitors.'
p44342
aS'JOURNAL'
p44343
aS'Gastroenterol Nurs 26:182-90 (2003)'
p44344
asS'COMPOUND'
p44345
(lp44346
S'D00295'
p44347
aS'Cimetidine (JP16/USP/INN)'
p44348
ag44347
ag44348
aS'D00318'
p44349
aS'Famotidine (JP16/USP/INN)'
p44350
aS'D00355'
p44351
aS'Lansoprazole (JAN/USP/INN)'
p44352
aS'D00419'
p44353
aS'Misoprostol (JAN/USAN/INN)'
p44354
aS'D00422'
p44355
aS'Ranitidine (USAN/INN)'
p44356
aS'D00440'
p44357
aS'Nizatidine (JP16/USP/INN)'
p44358
aS'D00446'
p44359
aS'Sucralfate hydrate (JP16)'
p44360
aS'D00455'
p44361
aS'Omeprazole (JP16/USP/INN)'
p44362
aS'D00481'
p44363
aS'Propantheline bromide (JP16/USP/INN)'
p44364
aS'D00673'
p44365
aS'Ranitidine hydrochloride (JP16/USP)'
p44366
aS'D00724'
p44367
aS'Sodium rabeprazole (JP16)'
p44368
aS'D00731'
p44369
aS'Magnesium hydroxide (JAN/USP)'
p44370
aS'D00932'
p44371
aS'Precipitated calcium carbonate (JP16)'
p44372
aS'D01121'
p44373
aS'Rebamipide (JP16/INN)'
p44374
aS'D01131'
p44375
aS'Lafutidine (JP16/INN)'
p44376
aS'D01152'
p44377
aS'Oxethazaine (JP16/USAN)'
p44378
aS'D01165'
p44379
aS'Piperidolate hydrochloride (JAN)'
p44380
aS'D01167'
p44381
aS'Magnesium oxide (JP16/USP)'
p44382
aS'D01203'
p44383
aS'Sodium bicarbonate (JP16/USP)'
p44384
aS'D01207'
p44385
aS'Omeprazole sodium (USAN)'
p44386
aS'D01297'
p44387
aS'Pirenzepine hydrochloride (USAN)'
p44388
aS'D01377'
p44389
aS'Prifinium bromide (JAN/INN)'
p44390
aS'D01451'
p44391
aS'Scopolamine butylbromide (JP16)'
p44392
aS'D01467'
p44393
aS'Roxatidine acetate hydrochloride (JP16/USAN)'
p44394
aS'D01491'
p44395
aS'Butropium bromide (JP16/INN)'
p44396
aS'D01611'
p44397
aS'Polaprezinc (JAN/INN)'
p44398
aS'D01658'
p44399
aS'Irsogladine maleate (JP16)'
p44400
aS'D01803'
p44401
aS'Plaunotol (JAN/INN)'
p44402
aS'D01815'
p44403
aS'Oxapium iodide (JP16/INN)'
p44404
aS'D01818'
p44405
aS'Proglumide (JP16/USAN/INN)'
p44406
aS'D01827'
p44407
aS'Teprenone (JP16/INN)'
p44408
aS'D01869'
p44409
aS'Ornoprostil (JAN/INN)'
p44410
aS'D01875'
p44411
aS'Tiquizium bromide (JAN/INN)'
p44412
aS'D01891'
p44413
aS'Enprostil (JAN/USAN/INN)'
p44414
aS'D01920'
p44415
aS'Tenatoprazole (JAN/INN)'
p44416
aS'D01956'
p44417
aS'Sofalcone (JAN)'
p44418
aS'D01984'
p44419
aS'Esomeprazole magnesium hydrate (JAN)'
p44420
aS'D01991'
p44421
aS'Ecabet sodium hydrate (JP16)'
p44422
aS'D02075'
p44423
aS'Sodium gualenate (INN)'
p44424
aS'D02266'
p44425
aS'Cetraxate hydrochloride (JP16/USAN)'
p44426
aS'D02416'
p44427
aS'Dried aluminum hydroxide gel (JP16)'
p44428
aS'D02535'
p44429
aS'Timepidium bromide hydrate (JP16)'
p44430
aS'D02593'
p44431
aS'Pantoprazole Sodium Hydrate (JAN)'
p44432
aS'D02706'
p44433
aS'Sodium gualenate hydrate (JAN)'
p44434
aS'D03236'
p44435
aS'Synthetic aluminum silicate (JP16)'
p44436
aS'D03237'
p44437
aS'Natural aluminum silicate (JP16)'
p44438
aS'D03238'
p44439
aS'Hydrotalcite (JAN/INN)'
p44440
aS'D03271'
p44441
aS'Magnesium trisilicate (USP)'
p44442
aS'D03503'
p44443
aS'Cimetidine hydrochloride (USP)'
p44444
aS'D04056'
p44445
aS'Esomeprazole sodium (USAN)'
p44446
aS'D04839'
p44447
aS'Magnesium silicate (JP16/NF)'
p44448
aS'D05259'
p44449
aS'Omeprazole magnesium (USAN)'
p44450
aS'D05261'
p44451
aS'Omeprazole sodium injection (JAN)'
p44452
aS'D05276'
p44453
aS'Pirenzepine hydrochloride hydrate (JP16)'
p44454
aS'D05353'
p44455
aS'Pantoprazole (USAN/INN)'
p44456
aS'D05699'
p44457
aS'Ranitidine bismuth citrate (USAN)'
p44458
aS'D05900'
p44459
aS'Timoprazole (INN)'
p44460
aS'D05901'
p44461
aS'Picoprazole (INN)'
p44462
aS'D05906'
p44463
aS'Leminoprazole (INN)'
p44464
aS'D07663'
p44465
aS'Cetraxate (INN)'
p44466
aS'D07885'
p44467
aS'Ecabet (INN)'
p44468
aS'D07917'
p44469
aS'Esomeprazole (INN)'
p44470
aS'D08087'
p44471
aS'Irsogladine (INN)'
p44472
aS'D08382'
p44473
aS'Piperidolate (INN)'
p44474
aS'D08389'
p44475
aS'Pirenzepine (INN)'
p44476
aS'D08463'
p44477
aS'Rabeprazole (INN)'
p44478
assS'path:map07039'
p44479
(dp44480
S'ENTRY'
p44481
(lp44482
S'map07039'
p44483
aS'Drug'
p44484
aS'Pathway'
p44485
asS'PATHWAY_MAP'
p44486
(lp44487
S'map07039'
p44488
asS'NAME'
p44489
(lp44490
S'Opioid analgesics'
p44491
asS'REFERENCE'
p44492
(lp44493
g22
ag22
aS'AUTHORS'
p44494
aS'Sano T, Naito T, Kubo T (eds).'
p44495
aS'TITLE'
p44496
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p44497
aS'JOURNAL'
p44498
aS'Nankodo (2002)'
p44499
ag22
ag22
aS'AUTHORS'
p44500
aS'David AW, Thomas LL, William OF.'
p44501
aS'TITLE'
p44502
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p44503
aS'JOURNAL'
p44504
aS'Lippincott Williams & Wilkins (2002)'
p44505
ag22
ag22
aS'AUTHORS'
p44506
aS'Japan Pharmaceutical Association (ed).'
p44507
aS'TITLE'
p44508
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p44509
aS'JOURNAL'
p44510
aS'Yakuji Nippo (1999)'
p44511
aS'PMID:8390660'
p44512
ag44512
aS'AUTHORS'
p44513
aS'Brownstein MJ.'
p44514
aS'TITLE'
p44515
aS'A brief history of opiates, opioid peptides, and opioid receptors.'
p44516
aS'JOURNAL'
p44517
aS'Proc Natl Acad Sci U S A 90:5391-3 (1993)'
p44518
asS'COMPOUND'
p44519
(lp44520
S'C06173'
p44521
aS'Thebaine'
p44522
ag44521
ag44522
aS'C11790'
p44523
aS'Phenazocine'
p44524
aS'C11791'
p44525
aS'Bremazocine'
p44526
aS'D00195'
p44527
aS'Codeine (USP)'
p44528
aS'D00320'
p44529
aS'Fentanyl (JAN/USAN/INN)'
p44530
aS'D00482'
p44531
aS'Propoxyphene hydrochloride (USP)'
p44532
aS'D00498'
p44533
aS'Pentazocine (JP16/USP/INN)'
p44534
aS'D00835'
p44535
aS'Alfentanil hydrochloride (USP)'
p44536
aS'D00836'
p44537
aS'Buprenorphine hydrochloride (JP16/USP)'
p44538
aS'D00837'
p44539
aS'Butorphanol tartrate (JAN/USP)'
p44540
aS'D00839'
p44541
aS'Hydromorphone hydrochloride (USP)'
p44542
aS'D00840'
p44543
aS'Levomethadyl acetate hydrochloride (USAN)'
p44544
aS'D00841'
p44545
aS'Levorphanol tartrate (USP)'
p44546
aS'D00842'
p44547
aS'Morphine sulfate hydrate (JP16)'
p44548
aS'D00843'
p44549
aS'Nalbuphine hydrochloride (USAN)'
p44550
aS'D00844'
p44551
aS'Oxymorphone hydrochloride (USP)'
p44552
aS'D00845'
p44553
aS'Sufentanil citrate (USP)'
p44554
aS'D00847'
p44555
aS'Oxycodone hydrochloride (USP)'
p44556
aS'D01340'
p44557
aS'Naloxone hydrochloride (JP16/USP)'
p44558
aS'D01383'
p44559
aS'Pethidine hydrochloride (JP16)'
p44560
aS'D01399'
p44561
aS'Fentanyl citrate (JP16/USP)'
p44562
aS'D02095'
p44563
aS'Naltrexone hydrochloride (USP)'
p44564
aS'D02101'
p44565
aS'Codeine phosphate hydrate (JP16)'
p44566
aS'D02102'
p44567
aS'Methadone hydrochloride (JAN/USP)'
p44568
aS'D02111'
p44569
aS'Pentazocine lactate (USP)'
p44570
aS'D02227'
p44571
aS'Pentazocine hydrochloride (JAN/USP)'
p44572
aS'D02238'
p44573
aS'Levallorphan tartrate (JP16)'
p44574
aS'D02271'
p44575
aS'Morphine hydrochloride hydrate (JP16)'
p44576
aS'D03197'
p44577
aS'Butorphanol (USAN/INN)'
p44578
aS'D03580'
p44579
aS'Codeine sulfate (USP)'
p44580
aS'D03725'
p44581
aS'Hydrocodone bitartrate (USP)'
p44582
aS'D03783'
p44583
aS'Oxycodone terephthalate (USP)'
p44584
aS'D04716'
p44585
aS'Levomethadyl acetate (USAN)'
p44586
aS'D05113'
p44587
aS'Naltrexone (USAN/INN)'
p44588
aS'D05312'
p44589
aS'Oxycodone (USAN/INN)'
p44590
aS'D05462'
p44591
aS'Oxycodone hydrochloride hydrate (JP16)'
p44592
aS'D05632'
p44593
aS'Propoxyphene napsylate (USAN)'
p44594
aS'D05938'
p44595
aS'Sufentanil (USAN/INN)'
p44596
aS'D06268'
p44597
aS'Trimeperidine (INN)'
p44598
aS'D07122'
p44599
aS'Alfentanil (INN)'
p44600
aS'D07132'
p44601
aS'Buprenorphine (JAN/INN)'
p44602
aS'D07286'
p44603
aS'Diamorphine (BAN)'
p44604
aS'D07740'
p44605
aS'Codeine hydrochloride'
p44606
aS'D07809'
p44607
aS'Dextropropoxyphene (INN)'
p44608
aS'D07810'
p44609
aS'Diacetylmorphine hydrochloride'
p44610
aS'D07863'
p44611
aS'Diprenorphine (INN)'
p44612
aS'D07864'
p44613
aS'Diprenorphine hydrochloride'
p44614
aS'D08045'
p44615
aS'Hydrocodone (INN)'
p44616
aS'D08046'
p44617
aS'Hydrocodone hydrochloride'
p44618
aS'D08047'
p44619
aS'Hydromorphone (INN)'
p44620
aS'D08123'
p44621
aS'Levorphanol (INN)'
p44622
aS'D08195'
p44623
aS'Methadone (BAN)'
p44624
aS'D08233'
p44625
aS'Morphine (BAN)'
p44626
aS'D08246'
p44627
aS'Nalbuphine (INN)'
p44628
aS'D08247'
p44629
aS'Nalorphine (INN)'
p44630
aS'D08248'
p44631
aS'Nalorphine hydrochloride (USP)'
p44632
aS'D08249'
p44633
aS'Naloxone (INN)'
p44634
aS'D08323'
p44635
aS'Oxymorphone (INN)'
p44636
aS'D08343'
p44637
aS'Pethidine (INN)'
p44638
assS'path:map00785'
p44639
(dp44640
S'DBLINKS'
p44641
(lp44642
S'GO: 0000273'
p44643
asS'NAME'
p44644
(lp44645
S'Lipoic acid metabolism'
p44646
asS'REFERENCE'
p44647
(lp44648
S'PMID:16246025'
p44649
ag44649
aS'AUTHORS'
p44650
aS'Gunther S, McMillan PJ, Wallace LJ, Muller S.'
p44651
aS'TITLE'
p44652
aS'Plasmodium falciparum possesses organelle-specific alpha-keto acid dehydrogenase complexes and lipoylation pathways.'
p44653
aS'JOURNAL'
p44654
aS'Biochem Soc Trans 33:977-80 (2005)'
p44655
aS'PMID:10103005'
p44656
ag44656
aS'AUTHORS'
p44657
aS'Fujiwara K, Suzuki M, Okumachi Y, Okamura-Ikeda K, Fujiwara T, Takahashi E, Motokawa Y.'
p44658
aS'TITLE'
p44659
aS'Molecular cloning, structural characterization and chromosomal localization of human lipoyltransferase gene.'
p44660
aS'JOURNAL'
p44661
aS'Eur J Biochem 260:761-7 (1999)'
p44662
aS'PMID:8206978'
p44663
ag44663
aS'AUTHORS'
p44664
aS'Fujiwara K, Okamura-Ikeda K, Motokawa Y.'
p44665
aS'TITLE'
p44666
aS'Purification and characterization of lipoyl-AMP:N epsilon-lysine lipoyltransferase from bovine liver mitochondria.'
p44667
aS'JOURNAL'
p44668
aS'J Biol Chem 269:16605-9 (1994)'
p44669
aS'PMID:9405389'
p44670
ag44670
aS'AUTHORS'
p44671
aS'Fujiwara K, Okamura-Ikeda K, Motokawa Y.'
p44672
aS'TITLE'
p44673
aS'Cloning and expression of a cDNA encoding bovine lipoyltransferase.'
p44674
aS'JOURNAL'
p44675
aS'J Biol Chem 272:31974-8 (1997)'
p44676
aS'PMID:11382754'
p44677
ag44677
aS'AUTHORS'
p44678
aS'Fujiwara K, Takeuchi S, Okamura-Ikeda K, Motokawa Y.'
p44679
aS'TITLE'
p44680
aS'Purification, characterization, and cDNA cloning of lipoate-activating enzyme from bovine liver.'
p44681
aS'JOURNAL'
p44682
aS'J Biol Chem 276:28819-23 (2001)'
p44683
aS'PMID:16043486'
p44684
ag44684
aS'AUTHORS'
p44685
aS'Fujiwara K, Toma S, Okamura-Ikeda K, Motokawa Y, Nakagawa A, Taniguchi H.'
p44686
aS'TITLE'
p44687
aS'Crystal structure of lipoate-protein ligase A from Escherichia coli. Determination of the lipoic acid-binding site.'
p44688
aS'JOURNAL'
p44689
aS'J Biol Chem 280:33645-51 (2005)'
p44690
aS'PMID:9808738'
p44691
ag44691
aS'AUTHORS'
p44692
aS'Yasuno R, Wada H.'
p44693
aS'TITLE'
p44694
aS'Biosynthesis of lipoic acid in Arabidopsis: cloning and characterization of the cDNA for lipoic acid synthase.'
p44695
aS'JOURNAL'
p44696
aS'Plant Physiol 118:935-43 (1998)'
p44697
aS'PMID:10671542'
p44698
ag44698
aS'AUTHORS'
p44699
aS'Gueguen V, Macherel D, Jaquinod M, Douce R, Bourguignon J.'
p44700
aS'TITLE'
p44701
aS'Fatty acid and lipoic acid biosynthesis in higher plant mitochondria.'
p44702
aS'JOURNAL'
p44703
aS'J Biol Chem 275:5016-25 (2000)'
p44704
aS'PMID:11427685'
p44705
ag44705
aS'AUTHORS'
p44706
aS'Wada M, Yasuno R, Jordan SW, Cronan JE Jr, Wada H.'
p44707
aS'TITLE'
p44708
aS'Lipoic acid metabolism in Arabidopsis thaliana: cloning and characterization of a cDNA encoding lipoyltransferase.'
p44709
aS'JOURNAL'
p44710
aS'Plant Cell Physiol 42:650-6 (2001)'
p44711
aS'PMID:8206909'
p44712
ag44712
aS'AUTHORS'
p44713
aS'Morris TW, Reed KE, Cronan JE Jr.'
p44714
aS'TITLE'
p44715
aS'Identification of the gene encoding lipoate-protein ligase A of Escherichia coli. Molecular cloning and characterization of the lplA gene and gene product.'
p44716
aS'JOURNAL'
p44717
aS'J Biol Chem 269:16091-100 (1994)'
p44718
aS'PMID:14700636'
p44719
ag44719
aS'AUTHORS'
p44720
aS'Zhao X, Miller JR, Jiang Y, Marletta MA, Cronan JE.'
p44721
aS'TITLE'
p44722
aS'Assembly of the covalent linkage between lipoic acid and its cognate enzymes.'
p44723
aS'JOURNAL'
p44724
aS'Chem Biol 10:1293-302 (2003)'
p44725
aS'PMID:15642479'
p44726
ag44726
aS'AUTHORS'
p44727
aS'Nesbitt NM, Baleanu-Gogonea C, Cicchillo RM, Goodson K, Iwig DF, Broadwater JA, Haas JA, Fox BG, Booker SJ.'
p44728
aS'TITLE'
p44729
aS'Expression, purification, and physical characterization of Escherichia coli lipoyl(octanoyl)transferase.'
p44730
aS'JOURNAL'
p44731
aS'Protein Expr Purif 39:269-82 (2005)'
p44732
asS'KO_PATHWAY'
p44733
(lp44734
S'ko00785'
p44735
asS'ENTRY'
p44736
(lp44737
S'map00785'
p44738
aS'Pathway'
p44739
asS'PATHWAY_MAP'
p44740
(lp44741
S'map00785'
p44742
asS'CLASS'
p44743
(lp44744
S'Metabolism Metabolism of cofactors and vitamins'
p44745
assS'path:map07037'
p44746
(dp44747
S'ENTRY'
p44748
(lp44749
S'map07037'
p44750
aS'Drug'
p44751
aS'Pathway'
p44752
asS'PATHWAY_MAP'
p44753
(lp44754
S'map07037'
p44755
asS'NAME'
p44756
(lp44757
S'Antiarrhythmic drugs'
p44758
asS'REFERENCE'
p44759
(lp44760
g22
ag22
aS'AUTHORS'
p44761
aS'Fukai S.'
p44762
aS'TITLE'
p44763
aS'[New Drugs Today (6th ed)] (In Japanese)'
p44764
aS'JOURNAL'
p44765
aS'Jiho (1995)'
p44766
ag22
ag22
aS'AUTHORS'
p44767
aS'Tanaka C, Kato R (eds).'
p44768
aS'TITLE'
p44769
aS'[New Pharmacology (4th ed)] (In Japanese)'
p44770
aS'JOURNAL'
p44771
aS'Nankodo (2002)'
p44772
aS'PMID:11916001'
p44773
ag44773
aS'AUTHORS'
p44774
aS'Castro A, Bianconi L, Santini M.'
p44775
aS'TITLE'
p44776
aS'New antiarrhythmic drugs for the treatment of atrial fibrillation.'
p44777
aS'JOURNAL'
p44778
aS'Pacing Clin Electrophysiol 25:249-59 (2002)'
p44779
aS'PMID:2447771'
p44780
ag44780
aS'AUTHORS'
p44781
aS'Woosley RL, Funck-Brentano C'
p44782
aS'TITLE'
p44783
aS'Overview of the clinical pharmacology of antiarrhythmic drugs.'
p44784
aS'JOURNAL'
p44785
aS'Am J Cardiol 61:61A-69A (1988)'
p44786
asS'COMPOUND'
p44787
(lp44788
S'C06855'
p44789
aS'Bretylium'
p44790
ag44789
ag44790
aS'C13772'
p44791
aS'Clofilium'
p44792
aS'C13777'
p44793
aS'Azimilide'
p44794
aS'D00235'
p44795
aS'Atenolol (JP16/USP/INN)'
p44796
aS'D00303'
p44797
aS'Disopyramide (JP16/USAN/INN)'
p44798
aS'D00358'
p44799
aS'Lidocaine (JP16/USP/INN)'
p44800
aS'D00477'
p44801
aS'Procainamide hydrochloride (JP16/USP)'
p44802
aS'D00483'
p44803
aS'Propranolol hydrochloride (JP16/USP)'
p44804
aS'D00513'
p44805
aS'Pindolol (JP16/USP/INN)'
p44806
aS'D00601'
p44807
aS'Metoprolol tartrate (JP16/USP)'
p44808
aS'D00616'
p44809
aS'Diltiazem hydrochloride (JP16/USP)'
p44810
aS'D00619'
p44811
aS'Verapamil hydrochloride (JP16/USP)'
p44812
aS'D00631'
p44813
aS'Bepridil hydrochloride hydrate (JAN)'
p44814
aS'D00635'
p44815
aS'Metoprolol succinate (USP)'
p44816
aS'D00636'
p44817
aS'Amiodarone hydrochloride (JP16/USAN)'
p44818
aS'D00637'
p44819
aS'Disopyramide phosphate (JAN/USP)'
p44820
aS'D00638'
p44821
aS'Flecainide acetate (JP16/USP)'
p44822
aS'D00639'
p44823
aS'Mexiletine hydrochloride (JP16/USP)'
p44824
aS'D00640'
p44825
aS'Propafenone hydrochloride (JP16/USP)'
p44826
aS'D00642'
p44827
aS'Quinidine gluconate (USP)'
p44828
aS'D00643'
p44829
aS'Quinidine polygalacturonate'
p44830
aS'D00645'
p44831
aS'Bretylium tosylate (USP)'
p44832
aS'D00647'
p44833
aS'Dofetilide (JAN/USAN/INN)'
p44834
aS'D00648'
p44835
aS'Ibutilide fumarate (USAN)'
p44836
aS'D00740'
p44837
aS'Procaine hydrochloride (JP16/USP)'
p44838
aS'D01026'
p44839
aS'Sotalol hydrochloride (JAN/USP)'
p44840
aS'D01182'
p44841
aS'Alprenolol hydrochloride (JP16/USAN)'
p44842
aS'D01326'
p44843
aS'Aprindine hydrochloride (JP16/USAN)'
p44844
aS'D01554'
p44845
aS'Pilsicainide hydrochloride hydrate (JP16)'
p44846
aS'D01785'
p44847
aS'Pirmenol hydrochloride hydrate (JAN)'
p44848
aS'D01833'
p44849
aS'Benziodarone (JAN/INN)'
p44850
aS'D01856'
p44851
aS'Nifekalant hydrochloride (JAN)'
p44852
aS'D02086'
p44853
aS'Lidocaine injection (JP16)'
p44854
aS'D02088'
p44855
aS'Tocainide hydrochloride (USP)'
p44856
aS'D02272'
p44857
aS'Quinidine sulfate hydrate (JP16)'
p44858
aS'D02356'
p44859
aS'Verapamil (USAN/INN)'
p44860
aS'D02358'
p44861
aS'Metoprolol (USAN/INN)'
p44862
aS'D02537'
p44863
aS'Dronedarone (INN)'
p44864
aS'D02746'
p44865
aS'Acecainide hydrochloride (USAN)'
p44866
aS'D02910'
p44867
aS'Amiodarone (USAN/INN)'
p44868
aS'D02969'
p44869
aS'Aprindine (USAN/INN)'
p44870
aS'D03037'
p44871
aS'Azimilide dihydrochloride (USAN)'
p44872
aS'D03547'
p44873
aS'Clofilium phosphate (USAN/INN)'
p44874
aS'D03732'
p44875
aS'Dexsotalol hydrochloride (USAN)'
p44876
aS'D03830'
p44877
aS'Diltiazem malate (USAN)'
p44878
aS'D03914'
p44879
aS'Dronedarone hydrochloride (USAN)'
p44880
aS'D03991'
p44881
aS'Encainide hydrochloride (USAN)'
p44882
aS'D04955'
p44883
aS'Sematilide hydrochloride (USAN)'
p44884
aS'D05011'
p44885
aS'Metoprolol fumarate (USP)'
p44886
aS'D05587'
p44887
aS'Practolol (USAN)'
p44888
aS'D06172'
p44889
aS'Tocainide (USAN/INN)'
p44890
aS'D06517'
p44891
aS'Pirmenol hydrochloride (USAN)'
p44892
aS'D07156'
p44893
aS'Alprenolol (INN)'
p44894
aS'D07520'
p44895
aS'Bepridil (INN)'
p44896
aS'D07845'
p44897
aS'Diltiazem (INN)'
p44898
aS'D07894'
p44899
aS'Encainide (INN)'
p44900
aS'D07962'
p44901
aS'Flecainide (INN)'
p44902
aS'D08060'
p44903
aS'Ibutilide (INN)'
p44904
aS'D08127'
p44905
aS'Lidocaine hydrochloride monohydrate'
p44906
aS'D08215'
p44907
aS'Mexiletine (INN)'
p44908
aS'D08377'
p44909
aS'Pilsicainide (INN)'
p44910
aS'D08394'
p44911
aS'Pirmenol (INN)'
p44912
aS'D08421'
p44913
aS'Procainamide (INN)'
p44914
aS'D08422'
p44915
aS'Procaine (INN)'
p44916
aS'D08435'
p44917
aS'Propafenone (INN)'
p44918
aS'D08443'
p44919
aS'Propranolol (INN)'
p44920
aS'D08458'
p44921
aS'Quinidine (BAN)'
p44922
aS'D08459'
p44923
aS'Quinidine phenylethylbarbiturate'
p44924
aS'D08525'
p44925
aS'Sotalol (INN)'
p44926
assS'path:map07034'
p44927
(dp44928
S'ENTRY'
p44929
(lp44930
S'map07034'
p44931
aS'Drug'
p44932
aS'Pathway'
p44933
asS'PATHWAY_MAP'
p44934
(lp44935
S'map07034'
p44936
asS'NAME'
p44937
(lp44938
S'Eicosanoids'
p44939
asS'REFERENCE'
p44940
(lp44941
S'(Japanese)'
p44942
ag44942
aS'AUTHORS'
p44943
aS'Fukai S.'
p44944
aS'TITLE'
p44945
aS'[New Drugs Today (6th ed)] (In Japanese)'
p44946
aS'JOURNAL'
p44947
aS'Jiho (1995)'
p44948
ag22
ag22
aS'AUTHORS'
p44949
aS'David AW, Thomas LL, William OF.'
p44950
aS'TITLE'
p44951
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p44952
aS'JOURNAL'
p44953
aS'Lippincott Williams & Wilkins (2002)'
p44954
ag22
ag22
aS'AUTHORS'
p44955
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p44956
aS'TITLE'
p44957
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p44958
aS'JOURNAL'
p44959
aS'McGraw-Hill (2001)'
p44960
ag22
ag22
aS'AUTHORS'
p44961
aS'Walter S.'
p44962
aS'TITLE'
p44963
aS'Drug Discovery: A History'
p44964
aS'JOURNAL'
p44965
aS'Wiley (2005)'
p44966
aS'(Japanese)'
p44967
ag44967
aS'AUTHORS'
p44968
aS'Japan Pharmaceutical Association (ed).'
p44969
aS'TITLE'
p44970
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p44971
aS'JOURNAL'
p44972
aS'Yakuji Nippo (1999)'
p44973
aS'(Japanese)'
p44974
ag44974
aS'AUTHORS'
p44975
aS'Tanaka C, Kato R (eds).'
p44976
aS'TITLE'
p44977
aS'[New Pharmacology (4th ed)] (In Japanese)'
p44978
aS'JOURNAL'
p44979
aS'Nankodo (2002)'
p44980
ag22
ag22
aS'AUTHORS'
p44981
aS'Collins PW, Djuric SW.'
p44982
aS'TITLE'
p44983
aS'Synthesis of therapeutically useful prostaglandin and prostacyclin analogs.'
p44984
aS'JOURNAL'
p44985
aS'Chemical Reviews 93(4):1533-1564 (1993)'
p44986
aS'PMID:11829716'
p44987
ag44987
aS'AUTHORS'
p44988
aS'Dogne JM, de Leval X, Benoit P, Rolin S, Pirotte B, Masereel B.'
p44989
aS'TITLE'
p44990
aS'Therapeutic potential of thromboxane inhibitors in asthma.'
p44991
aS'JOURNAL'
p44992
aS'Expert Opin Investig Drugs 11:275-81 (2002)'
p44993
aS'PMID:12052325'
p44994
ag44994
aS'AUTHORS'
p44995
aS'McMillan RM.'
p44996
aS'TITLE'
p44997
aS'Leukotrienes in respiratory disease.'
p44998
aS'JOURNAL'
p44999
aS'Paediatr Respir Rev 2:238-44 (2001)'
p45000
asS'COMPOUND'
p45001
(lp45002
S'C00219'
p45003
aS'Arachidonate'
p45004
ag45003
ag45004
aS'C00427'
p45005
aS'Prostaglandin H2'
p45006
aS'C00909'
p45007
aS'Leukotriene A4'
p45008
aS'C02165'
p45009
aS'Leukotriene B4'
p45010
aS'C02198'
p45011
aS'Thromboxane A2'
p45012
aS'C05356'
p45013
aS'5(S)-HPETE'
p45014
aS'C05956'
p45015
aS'Prostaglandin G2'
p45016
aS'D00106'
p45017
aS'Epoprostenol (USAN/INN)'
p45018
aS'D00411'
p45019
aS'Zafirlukast (JAN/USAN/INN)'
p45020
aS'D00529'
p45021
aS'Montelukast sodium (JAN/USAN)'
p45022
aS'D01123'
p45023
aS'Seratrodast (JAN/USAN/INN)'
p45024
aS'D01128'
p45025
aS'Ramatroban (JAN/INN)'
p45026
aS'D01337'
p45027
aS'Epoprostenol sodium (JAN/USAN)'
p45028
aS'D01551'
p45029
aS'Beraprost sodium (JP16/USAN)'
p45030
aS'D01683'
p45031
aS'Ozagrel hydrochloride hydrate (JAN)'
p45032
aS'D01684'
p45033
aS'Ozagrel sodium (JP16)'
p45034
aS'D02720'
p45035
aS'Beraprost (USAN)'
p45036
aS'D02721'
p45037
aS'Iloprost (USAN/INN)'
p45038
aS'D02732'
p45039
aS'Pranlukast hydrate (JP16)'
p45040
aS'D08065'
p45041
aS'Iloprost tromethamine'
p45042
aS'D08229'
p45043
aS'Montelukast (INN)'
p45044
aS'D08327'
p45045
aS'Ozagrel (INN)'
p45046
aS'D08408'
p45047
aS'Pranlukast (INN)'
p45048
assS'path:map03040'
p45049
(dp45050
S'NAME'
p45051
(lp45052
S'Spliceosome'
p45053
asS'REFERENCE'
p45054
(lp45055
S'PMID:19239890'
p45056
ag45056
aS'AUTHORS'
p45057
aS'Wahl MC, Will CL, Luhrmann R'
p45058
aS'TITLE'
p45059
aS'The spliceosome: design principles of a dynamic RNP machine.'
p45060
aS'JOURNAL'
p45061
aS'Cell 136:701-18 (2009)'
p45062
aS'PMID:10978320'
p45063
ag45063
aS'AUTHORS'
p45064
aS'Morris DP, Greenleaf AL'
p45065
aS'TITLE'
p45066
aS'The splicing factor, Prp40, binds the phosphorylated carboxyl-terminal domain of RNA polymerase II.'
p45067
aS'JOURNAL'
p45068
aS'J Biol Chem 275:39935-43 (2000)'
p45069
aS'PMID:17537823'
p45070
ag45070
aS'AUTHORS'
p45071
aS'Chen YI, Moore RE, Ge HY, Young MK, Lee TD, Stevens SW'
p45072
aS'TITLE'
p45073
aS'Proteomic analysis of in vivo-assembled pre-mRNA splicing complexes expands the catalog of participating factors.'
p45074
aS'JOURNAL'
p45075
aS'Nucleic Acids Res 35:3928-44 (2007)'
p45076
aS'PMID:19733268'
p45077
ag45077
aS'AUTHORS'
p45078
aS'Ritchie DB, Schellenberg MJ, MacMillan AM'
p45079
aS'TITLE'
p45080
aS'Spliceosome structure: piece by piece.'
p45081
aS'JOURNAL'
p45082
aS'Biochim Biophys Acta 1789:624-33 (2009)'
p45083
asS'KO_PATHWAY'
p45084
(lp45085
S'ko03040'
p45086
asS'PATHWAY_MAP'
p45087
(lp45088
S'map03040'
p45089
asS'DISEASE'
p45090
(lp45091
S'H00527'
p45092
aS'Retinitis pigmentosa (RP)'
p45093
ag45092
ag45093
aS'H01376'
p45094
aS'Acrofacial dysostosis'
p45095
asS'MODULE'
p45096
(lp45097
S'M00351'
p45098
aS'Spliceosome, U1-snRNP [PATH:map03040]'
p45099
ag45098
ag45099
aS'M00352'
p45100
aS'Spliceosome, U2-snRNP [PATH:map03040]'
p45101
aS'M00353'
p45102
aS'Spliceosome, Prp19/CDC5L complex [PATH:map03040]'
p45103
aS'M00354'
p45104
aS'Spliceosome, U4/U6.U5 tri-snRNP [PATH:map03040]'
p45105
aS'M00355'
p45106
aS'Spliceosome, 35S U5-snRNP [PATH:map03040]'
p45107
aS'M00396'
p45108
aS'Lsm 2-8 complex [PATH:map03040]'
p45109
aS'M00398'
p45110
aS'Sm core complex [PATH:map03040]'
p45111
aS'M00399'
p45112
aS'Cap binding complex [PATH:map03040]'
p45113
aS'M00405'
p45114
aS'THC complex [PATH:map03040]'
p45115
aS'M00406'
p45116
aS'TREX complex [PATH:map03040]'
p45117
aS'M00430'
p45118
aS'Exon junction complex (EJC) [PATH:map03040]'
p45119
asS'DBLINKS'
p45120
(lp45121
S'GO: 0005681'
p45122
asS'ENTRY'
p45123
(lp45124
S'map03040'
p45125
aS'Pathway'
p45126
asS'CLASS'
p45127
(lp45128
S'Genetic Information Processing Transcription'
p45129
asS'DESCRIPTION'
p45130
(lp45131
S'After transcription, eukaryotic mRNA precursors contain protein-coding exons and noncoding introns. In the following splicing, introns are excised and exons are joined by a macromolecular complex, the spliceosome. The standard spliceosome is made up of five small nuclear ribonucleoproteins (snRNPs), U1, U2, U4, U5, and U6 snRNPs, and several spliceosome-associated proteins (SAPs). Spliceosomes are not a simple stable complex, but a dynamic family of particles that assemble on the mRNA precursor and help fold it into a conformation that allows transesterification to proceed. Various spliceosome forms (e.g. A-, B- and C-complexes) have been identified.'
p45132
assS'path:map07032'
p45133
(dp45134
S'ENTRY'
p45135
(lp45136
S'map07032'
p45137
aS'Drug'
p45138
aS'Pathway'
p45139
asS'PATHWAY_MAP'
p45140
(lp45141
S'map07032'
p45142
asS'NAME'
p45143
(lp45144
S'Hypnotics'
p45145
asS'REFERENCE'
p45146
(lp45147
S'(Japanese)'
p45148
ag45148
aS'AUTHORS'
p45149
aS'Sano T, Naito T, Kubo T (eds).'
p45150
aS'TITLE'
p45151
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p45152
aS'JOURNAL'
p45153
aS'Nankodo (2002)'
p45154
aS'(Japanese)'
p45155
ag45155
aS'AUTHORS'
p45156
aS'Tanaka C, Kato R (eds).'
p45157
aS'TITLE'
p45158
aS'[New Pharmacology (4th ed)] (In Japanese)'
p45159
aS'JOURNAL'
p45160
aS'Nankodo (2002)'
p45161
ag22
ag22
aS'AUTHORS'
p45162
aS'Bertram GK (ed).'
p45163
aS'TITLE'
p45164
aS'Basic & Clinical Pharmacology (9th ed)'
p45165
aS'JOURNAL'
p45166
aS'Lange (2004)'
p45167
aS'PMID:16185169'
p45168
ag45168
aS'AUTHORS'
p45169
aS'Neubauer DN.'
p45170
aS'TITLE'
p45171
aS'Indiplon: the development of a new hypnotic.'
p45172
aS'JOURNAL'
p45173
aS'Expert Opin Investig Drugs 14:1269-76 (2005)'
p45174
aS'PMID:34039'
p45175
ag45175
aS'AUTHORS'
p45176
aS'Sternbach LH.'
p45177
aS'TITLE'
p45178
aS'The benzodiazepine story.'
p45179
aS'JOURNAL'
p45180
aS'J Med Chem 22:1-7 (1979)'
p45181
aS'PMID:16373464'
p45182
ag45182
aS'AUTHORS'
p45183
aS'Halas CJ'
p45184
aS'TITLE'
p45185
aS'Eszopiclone.'
p45186
aS'JOURNAL'
p45187
aS'Am J Health Syst Pharm 63:41-8 (2006)'
p45188
asS'COMPOUND'
p45189
(lp45190
S'C07490'
p45191
aS'Trichloroethanol'
p45192
ag45191
ag45192
aS'D00023'
p45193
aS'Urea (JP16/USP)'
p45194
aS'D00265'
p45195
aS'Chloral hydrate (JP16/USP)'
p45196
aS'D00293'
p45197
aS'Diazepam (JP16/USP/INN)'
p45198
aS'D00300'
p45199
aS'Diphenhydramine (JP16/INN)'
p45200
aS'D00311'
p45201
aS'Estazolam (JP16/USAN/INN)'
p45202
aS'D00329'
p45203
aS'Flurazepam (JAN/INN)'
p45204
aS'D00370'
p45205
aS'Temazepam (USP/INN)'
p45206
aS'D00387'
p45207
aS'Triazolam (JAN/USP/INN)'
p45208
aS'D00388'
p45209
aS'Triclofos sodium (JP16/USAN)'
p45210
aS'D00430'
p45211
aS'Secobarbital (USP/INN)'
p45212
aS'D00457'
p45213
aS'Quazepam (JAN/USP/INN)'
p45214
aS'D00480'
p45215
aS'Promethazine hydrochloride (JP16/USP)'
p45216
aS'D00494'
p45217
aS'Promethazine (JAN/INN)'
p45218
aS'D00499'
p45219
aS'Pentobarbital (USP/INN)'
p45220
aS'D00500'
p45221
aS'Pentobarbital sodium (JAN/USP)'
p45222
aS'D00506'
p45223
aS'Phenobarbital (JP16/USP/INN)'
p45224
aS'D00530'
p45225
aS'Zaleplon (JAN/USAN/INN)'
p45226
aS'D00531'
p45227
aS'Nitrazepam (JP16/USAN/INN)'
p45228
aS'D00532'
p45229
aS'Glutethimide (JAN/INN)'
p45230
aS'D00550'
p45231
aS'Midazolam (JAN/USP/INN)'
p45232
aS'D00555'
p45233
aS'Amobarbital (JP16/INN)'
p45234
aS'D00574'
p45235
aS'Aminoglutethimide (USP/INN)'
p45236
aS'D00669'
p45237
aS'Diphenhydramine hydrochloride (JP16/USP)'
p45238
aS'D00672'
p45239
aS'Hydroxyzine hydrochloride (JP16/USP)'
p45240
aS'D00695'
p45241
aS'Flurazepam hydrochloride (USP)'
p45242
aS'D00696'
p45243
aS'Midazolam hydrochloride (USAN)'
p45244
aS'D00701'
p45245
aS'Phenobarbital sodium (JAN/USP/INN)'
p45246
aS'D00706'
p45247
aS'Zolpidem tartrate (JP16/USAN)'
p45248
aS'D00754'
p45249
aS'Thalidomide (JAN/USP/INN)'
p45250
aS'D01096'
p45251
aS'Hydroxyzine pamoate (JP16/USP)'
p45252
aS'D01150'
p45253
aS'Methyprylon (JAN/INN)'
p45254
aS'D01230'
p45255
aS'Flunitrazepam (JP16/USAN/INN)'
p45256
aS'D01242'
p45257
aS'Promethazine teoclate (JAN/INN)'
p45258
aS'D01310'
p45259
aS'Secobarbital sodium (JAN/USP)'
p45260
aS'D01372'
p45261
aS'Zopiclone (JAN/INN)'
p45262
aS'D01391'
p45263
aS'Bromovalerylurea (JP16)'
p45264
aS'D01408'
p45265
aS'Flurazepam hydrochloride (JP16)'
p45266
aS'D01438'
p45267
aS'Perlapine (JAN/USAN/INN)'
p45268
aS'D01498'
p45269
aS'Butoctamide semisuccinate (JAN)'
p45270
aS'D01514'
p45271
aS'Etizolam (JP16/INN)'
p45272
aS'D01564'
p45273
aS'Rilmazafone hydrochloride hydrate (JAN)'
p45274
aS'D01593'
p45275
aS'Nimetazepam (JAN/INN)'
p45276
aS'D01657'
p45277
aS'Lormetazepam (JAN/USAN/INN)'
p45278
aS'D01740'
p45279
aS'Barbital (JP16/INN)'
p45280
aS'D01744'
p45281
aS'Brotizolam (JP16/USAN/INN)'
p45282
aS'D01758'
p45283
aS'Haloxazolam (JP16/INN)'
p45284
aS'D02252'
p45285
aS'Amobarbital sodium (JAN/USP)'
p45286
aS'D02253'
p45287
aS'Pentobarbital calcium (JP16)'
p45288
aS'D02419'
p45289
aS'Diphenhydramine salicylate (JAN)'
p45290
aS'D02618'
p45291
aS'Butobarbital (BAN)'
p45292
aS'D02619'
p45293
aS'Carbromal (INN)'
p45294
aS'D02624'
p45295
aS'Eszopiclone (JAN/USAN/INN)'
p45296
aS'D02640'
p45297
aS'Indiplon (USAN/INN)'
p45298
aS'D02689'
p45299
aS'Ramelteon (JAN/USAN/INN)'
p45300
aS'D03285'
p45301
aS'Diphenhydramine tannate (JP16)'
p45302
aS'D03290'
p45303
aS'Promethazine methylenedisalicylate (JAN)'
p45304
aS'D03360'
p45305
aS'Diphenhydramine laurylsulfate (JAN)'
p45306
aS'D03854'
p45307
aS'Diphenhydramine citrate (USP)'
p45308
aS'D05028'
p45309
aS'Midazolam maleate (USAN)'
p45310
aS'D08054'
p45311
aS'Hydroxyzine (INN)'
p45312
aS'D08356'
p45313
aS'Phenobarbital diethylamine'
p45314
aS'D08432'
p45315
aS'Promethazine maleate'
p45316
aS'D08481'
p45317
aS'Rilmazafone (INN)'
p45318
aS'D08634'
p45319
aS'Triclofos (INN)'
p45320
aS'D08690'
p45321
aS'Zolpidem (INN)'
p45322
aS'D08768'
p45323
aS'Promethazine hibenzate'
p45324
assS'path:map00780'
p45325
(dp45326
S'NAME'
p45327
(lp45328
S'Biotin metabolism'
p45329
asS'REFERENCE'
p45330
(lp45331
S'PMID:21437340'
p45332
ag45332
aS'AUTHORS'
p45333
aS'Lin S, Cronan JE'
p45334
aS'TITLE'
p45335
aS'Closing in on complete pathways of biotin biosynthesis.'
p45336
aS'JOURNAL'
p45337
aS'Mol Biosyst 7:1811-21 (2011)'
p45338
aS'PMID:22965231'
p45339
ag45339
aS'AUTHORS'
p45340
aS'Lin S, Cronan JE'
p45341
aS'TITLE'
p45342
aS'The BioC O-methyltransferase catalyzes methyl esterification of malonyl-acyl carrier protein, an essential step in biotin synthesis.'
p45343
aS'JOURNAL'
p45344
aS'J Biol Chem 287:37010-20 (2012)'
p45345
aS'PMID:20693992'
p45346
ag45346
aS'AUTHORS'
p45347
aS'Lin S, Hanson RE, Cronan JE'
p45348
aS'TITLE'
p45349
aS'Biotin synthesis begins by hijacking the fatty acid synthetic pathway.'
p45350
aS'JOURNAL'
p45351
aS'Nat Chem Biol 6:682-8 (2010)'
p45352
aS'PMID:21435937'
p45353
ag45353
aS'AUTHORS'
p45354
aS'Cronan JE, Lin S'
p45355
aS'TITLE'
p45356
aS'Synthesis of the alpha,omega-dicarboxylic acid precursor of biotin by the canonical fatty acid biosynthetic pathway.'
p45357
aS'JOURNAL'
p45358
aS'Curr Opin Chem Biol 15:407-13 (2011)'
p45359
aS'PMID:11368323'
p45360
ag45360
aS'AUTHORS'
p45361
aS'Stok JE, De Voss J'
p45362
aS'TITLE'
p45363
aS'Expression, purification, and characterization of BioI: a carbon-carbon bond cleaving cytochrome P450 involved in biotin biosynthesis in Bacillus subtilis.'
p45364
aS'JOURNAL'
p45365
aS'Arch Biochem Biophys 384:351-60 (2000)'
p45366
aS'PMID:18838690'
p45367
ag45367
aS'AUTHORS'
p45368
aS'Cryle MJ, Schlichting I'
p45369
aS'TITLE'
p45370
aS'Structural insights from a P450 Carrier Protein complex reveal how specificity is achieved in the P450(BioI) ACP complex.'
p45371
aS'JOURNAL'
p45372
aS'Proc Natl Acad Sci U S A 105:15696-701 (2008)'
p45373
aS'PMID:8763940'
p45374
ag45374
aS'AUTHORS'
p45375
aS'Bower S, Perkins JB, Yocum RR, Howitt CL, Rahaim P, Pero J'
p45376
aS'TITLE'
p45377
aS'Cloning, sequencing, and characterization of the Bacillus subtilis biotin biosynthetic operon.'
p45378
aS'JOURNAL'
p45379
aS'J Bacteriol 178:4122-30 (1996)'
p45380
aS'PMID:1445232'
p45381
ag45381
aS'AUTHORS'
p45382
aS'Ploux O, Soularue P, Marquet A, Gloeckler R, Lemoine Y'
p45383
aS'TITLE'
p45384
aS'Investigation of the first step of biotin biosynthesis in Bacillus sphaericus. Purification and characterization of the pimeloyl-CoA synthase, and uptake of pimelate.'
p45385
aS'JOURNAL'
p45386
aS'Biochem J 287 ( Pt 3):685-90 (1992)'
p45387
aS'PMID:12368242'
p45388
ag45388
aS'AUTHORS'
p45389
aS'Rodionov DA, Mironov AA, Gelfand MS'
p45390
aS'TITLE'
p45391
aS'Conservation of the biotin regulon and the BirA regulatory signal in Eubacteria and Archaea.'
p45392
aS'JOURNAL'
p45393
aS'Genome Res 12:1507-16 (2002)'
p45394
aS'PMID:11320134'
p45395
ag45395
aS'AUTHORS'
p45396
aS'Sullivan JT, Brown SD, Yocum RR, Ronson CW'
p45397
aS'TITLE'
p45398
aS'The bio operon on the acquired symbiosis island of Mesorhizobium sp. strain R7A includes a novel gene involved in pimeloyl-CoA synthesis.'
p45399
aS'JOURNAL'
p45400
aS'Microbiology 147:1315-22 (2001)'
p45401
aS'PMID:12039741'
p45402
ag45402
aS'AUTHORS'
p45403
aS'Entcheva P, Phillips DA, Streit WR'
p45404
aS'TITLE'
p45405
aS'Functional analysis of Sinorhizobium meliloti genes involved in biotin synthesis'
p45406
aS'and transport.'
p45407
aS'JOURNAL'
p45408
aS'Appl Environ Microbiol 68:2843-8 (2002)'
p45409
aS'PMID:19319844'
p45410
ag45410
aS'AUTHORS'
p45411
aS'Zempleni J, Wijeratne SS, Hassan YI'
p45412
aS'TITLE'
p45413
aS'Biotin.'
p45414
aS'JOURNAL'
p45415
aS'Biofactors 35:36-46 (2009)'
p45416
aS'PMID:9022537'
p45417
ag45417
aS'AUTHORS'
p45418
aS'Zempleni J, McCormick DB, Mock DM'
p45419
aS'TITLE'
p45420
aS'Identification of biotin sulfone, bisnorbiotin methyl ketone, and tetranorbiotin-l-sulfoxide in human urine.'
p45421
aS'JOURNAL'
p45422
aS'Am J Clin Nutr 65:508-11 (1997)'
p45423
aS'PMID:5775781'
p45424
ag45424
aS'AUTHORS'
p45425
aS'Iwahara S, McCormick DB, Wright LD, Li HC'
p45426
aS'TITLE'
p45427
aS'Bacterial degradation of biotin. 3. Metabolism of 14C-carbonyl-labeled biotin.'
p45428
aS'JOURNAL'
p45429
aS'J Biol Chem 244:1393-8 (1969)'
p45430
aS'PMID:2180922'
p45431
ag45431
aS'AUTHORS'
p45432
aS'Pierson DE, Campbell A'
p45433
aS'TITLE'
p45434
aS'Cloning and nucleotide sequence of bisC, the structural gene for biotin sulfoxide reductase in Escherichia coli.'
p45435
aS'JOURNAL'
p45436
aS'J Bacteriol 172:2194-8 (1990)'
p45437
aS'PMID:15601707'
p45438
ag45438
aS'AUTHORS'
p45439
aS'Ezraty B, Bos J, Barras F, Aussel L'
p45440
aS'TITLE'
p45441
aS'Methionine sulfoxide reduction and assimilation in Escherichia coli: new role for the biotin sulfoxide reductase BisC.'
p45442
aS'JOURNAL'
p45443
aS'J Bacteriol 187:231-7 (2005)'
p45444
aS'PMID:374979'
p45445
ag45445
aS'AUTHORS'
p45446
aS'del Campillo-Campbell A, Dykhuizen D, Cleary PP'
p45447
aS'TITLE'
p45448
aS'Enzymic reduction of d-biotin d-sulfoxide to d-biotin.'
p45449
aS'JOURNAL'
p45450
aS'Methods Enzymol 62:379-85 (1979)'
p45451
aS'PMID:9013576'
p45452
ag45452
aS'AUTHORS'
p45453
aS'Pollock VV, Barber MJ'
p45454
aS'TITLE'
p45455
aS'Biotin sulfoxide reductase. Heterologous expression and characterization of a functional molybdopterin guanine dinucleotide-containing enzyme.'
p45456
aS'JOURNAL'
p45457
aS'J Biol Chem 272:3355-62 (1997)'
p45458
aS'PMID:15366932'
p45459
ag45459
aS'AUTHORS'
p45460
aS'Nelson KJ, Rajagopalan KV'
p45461
aS'TITLE'
p45462
aS'Studies on the interaction of NADPH with Rhodobacter sphaeroides biotin sulfoxide reductase.'
p45463
aS'JOURNAL'
p45464
aS'Biochemistry 43:11226-37 (2004)'
p45465
aS'PMID:16299174'
p45466
ag45466
aS'AUTHORS'
p45467
aS'Pinon V, Ravanel S, Douce R, Alban C'
p45468
aS'TITLE'
p45469
aS'Biotin synthesis in plants. The first committed step of the pathway is catalyzed'
p45470
aS'by a cytosolic 7-keto-8-aminopelargonic acid synthase.'
p45471
aS'JOURNAL'
p45472
aS'Plant Physiol 139:1666-76 (2005)'
p45473
asS'KO_PATHWAY'
p45474
(lp45475
S'ko00780'
p45476
asS'PATHWAY_MAP'
p45477
(lp45478
S'map00780'
p45479
asS'DISEASE'
p45480
(lp45481
S'H00180'
p45482
aS'Holocarboxylase synthetase deficiency'
p45483
ag45482
ag45483
aS'H00548'
p45484
aS'Brunner syndrome'
p45485
aS'H01182'
p45486
aS'Biotinidase deficiency'
p45487
asS'MODULE'
p45488
(lp45489
S'M00123'
p45490
aS'Biotin biosynthesis, pimeloyl-ACP/CoA => biotin [PATH:map00780]'
p45491
ag45490
ag45491
aS'M00572'
p45492
aS'Pimeloyl-ACP biosynthesis, BioC-BioH pathway, malonyl-ACP => pimeloyl-ACP [PATH:map00780]'
p45493
aS'M00573'
p45494
aS'Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin [PATH:map00780]'
p45495
aS'M00577'
p45496
aS'Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin [PATH:map00780]'
p45497
asS'DBLINKS'
p45498
(lp45499
S'GO: 0006768'
p45500
asS'ENTRY'
p45501
(lp45502
S'map00780'
p45503
aS'Pathway'
p45504
asS'CLASS'
p45505
(lp45506
S'Metabolism Metabolism of cofactors and vitamins'
p45507
asS'DESCRIPTION'
p45508
(lp45509
S'Biotin (vitamin H or vitamin B7) is the essential cofactor of biotin-dependent carboxylases, such as pyruvate carboxylase and acetyl-CoA carboxylase. Mammals cannot synthesize biotin, while in bacteria, fungi, and plants it is synthesized from pimelate thioester through different pathways. In E. coli and many organisms, pimelate thioester is derived from malonyl-ACP. The pathway starts with the methylation to malonyl-ACP methyl ester, followed by the fatty acid chain elongation cycle to form pimeloyl-ACP methyl ester, which is then demethylated to form pimeloyl-ACP [MD:M00572]. Pimeloyl-ACP is converted to biotin through the final four steps in the biotin bicyclic ring assembly, which are conserved among biotin-producing organisms [MD:M00123]. In B. subtilis, biotin is derived from pimeloyl-ACP formed by oxidative cleavage of long-chain acyl-ACPs [MD:M00573]. Some bacteria synthesize biotin from pimeloyl-CoA derived from pimelate [MD:M00577]. Biotin is covalently attached to biotin-dependent carboxylase by biotin protein ligase, also known as holocarboxylase synthase in mammals, to form an active holocarboxylase. After degradation of the biotinylated carboxylase into biocytin, it is further degraded by biotinidase to release free biotin, which is recycled in holocarboxylase synthesis. Biotin is catabolized by beta-oxidation of the valeric acid side chain or oxidation of sulfur in the heterocyclic ring.'
p45510
assS'path:map07030'
p45511
(dp45512
S'ENTRY'
p45513
(lp45514
S'map07030'
p45515
aS'Drug'
p45516
aS'Pathway'
p45517
asS'PATHWAY_MAP'
p45518
(lp45519
S'map07030'
p45520
asS'NAME'
p45521
(lp45522
S'Anxiolytics'
p45523
asS'REFERENCE'
p45524
(lp45525
g22
ag22
aS'AUTHORS'
p45526
aS'Sano T, Naito T, Kubo T (eds).'
p45527
aS'TITLE'
p45528
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p45529
aS'JOURNAL'
p45530
aS'Nankodo (2002)'
p45531
ag22
ag22
aS'AUTHORS'
p45532
aS'Walter S.'
p45533
aS'TITLE'
p45534
aS'Drug Discovery: A History'
p45535
aS'JOURNAL'
p45536
aS'Wiley (2005)'
p45537
ag22
ag22
aS'AUTHORS'
p45538
aS'Bertram GK (ed).'
p45539
aS'TITLE'
p45540
aS'Basic & Clinical Pharmacology (9th ed)'
p45541
aS'JOURNAL'
p45542
aS'Lange (2004)'
p45543
aS'PMID:10653203'
p45544
ag45544
aS'AUTHORS'
p45545
aS'Rickels K, DeMartinis N, Aufdembrinke B.'
p45546
aS'TITLE'
p45547
aS'A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder.'
p45548
aS'JOURNAL'
p45549
aS'J Clin Psychopharmacol 20:12-8 (2000)'
p45550
aS'PMID:34039'
p45551
ag45551
aS'AUTHORS'
p45552
aS'Sternbach LH.'
p45553
aS'TITLE'
p45554
aS'The benzodiazepine story.'
p45555
aS'JOURNAL'
p45556
aS'J Med Chem 22:1-7 (1979)'
p45557
aS'PMID:8783370'
p45558
ag45558
aS'AUTHORS'
p45559
aS'Johnston GA.'
p45560
aS'TITLE'
p45561
aS'GABAA receptor pharmacology.'
p45562
aS'JOURNAL'
p45563
aS'Pharmacol Ther 69:173-98 (1996)'
p45564
aS'PMID:15969894'
p45565
ag45565
aS'AUTHORS'
p45566
aS'Michael Kaplan E, DuPont RL.'
p45567
aS'TITLE'
p45568
aS'Benzodiazepines and anxiety disorders: a review for the practicing physician.'
p45569
aS'JOURNAL'
p45570
aS'Curr Med Res Opin 21:941-50 (2005)'
p45571
aS'PMID:12625036'
p45572
ag45572
aS'AUTHORS'
p45573
aS'Bateson A.'
p45574
aS'TITLE'
p45575
aS'Pagoclone Indevus.'
p45576
aS'JOURNAL'
p45577
aS'Curr Opin Investig Drugs 4:91-5 (2003)'
p45578
asS'COMPOUND'
p45579
(lp45580
S'C14838'
p45581
aS'Y 23684'
p45582
ag45581
ag45582
aS'D00225'
p45583
aS'Alprazolam (JP16/USP/INN)'
p45584
aS'D00267'
p45585
aS'Chlordiazepoxide (JP16/USP/INN)'
p45586
aS'D00293'
p45587
aS'Diazepam (JP16/USP/INN)'
p45588
aS'D00365'
p45589
aS'Lorazepam (JP16/USP/INN)'
p45590
aS'D00370'
p45591
aS'Temazepam (USP/INN)'
p45592
aS'D00376'
p45593
aS'Meprobamate (JAN/USP/INN)'
p45594
aS'D00464'
p45595
aS'Oxazepam (JAN/USP/INN)'
p45596
aS'D00672'
p45597
aS'Hydroxyzine hydrochloride (JP16/USP)'
p45598
aS'D00693'
p45599
aS'Chlordiazepoxide hydrochloride (JAN/USP)'
p45600
aS'D00694'
p45601
aS'Clorazepate dipotassium (JP16/USP)'
p45602
aS'D00702'
p45603
aS'Buspirone hydrochloride (USP)'
p45604
aS'D00768'
p45605
aS'Carisoprodol (JAN/USP/INN)'
p45606
aS'D01096'
p45607
aS'Hydroxyzine pamoate (JP16/USP)'
p45608
aS'D01254'
p45609
aS'Tofisopam (JP16/INN)'
p45610
aS'D01268'
p45611
aS'Cloxazolam (JP16/INN)'
p45612
aS'D01286'
p45613
aS'Flutazolam (JAN/INN)'
p45614
aS'D01293'
p45615
aS'Ethyl loflazepate (JAN/INN)'
p45616
aS'D01316'
p45617
aS'Mexazolam (JAN/INN)'
p45618
aS'D01328'
p45619
aS'Clotiazepam (JP16/INN)'
p45620
aS'D01514'
p45621
aS'Etizolam (JP16/INN)'
p45622
aS'D01657'
p45623
aS'Lormetazepam (JAN/USAN/INN)'
p45624
aS'D01992'
p45625
aS'Tandospirone citrate (JAN/USAN)'
p45626
aS'D02594'
p45627
aS'Abecarnil (INN)'
p45628
aS'D02595'
p45629
aS'Mephenesin (INN)'
p45630
aS'D02616'
p45631
aS'Pagoclone (USAN/INN)'
p45632
aS'D02617'
p45633
aS'Ocinaplon (USAN/INN)'
p45634
aS'D03562'
p45635
aS'Clorazepate monopotassium (USAN)'
p45636
aS'D07593'
p45637
aS'Buspirone (INN)'
p45638
aS'D08054'
p45639
aS'Hydroxyzine (INN)'
p45640
aS'D08283'
p45641
aS'Nordazepam (INN)'
p45642
aS'D08561'
p45643
aS'Tandospirone (INN)'
p45644
assS'path:map07031'
p45645
(dp45646
S'ENTRY'
p45647
(lp45648
S'map07031'
p45649
aS'Drug'
p45650
aS'Pathway'
p45651
asS'PATHWAY_MAP'
p45652
(lp45653
S'map07031'
p45654
asS'NAME'
p45655
(lp45656
S'Butyrophenones'
p45657
asS'REFERENCE'
p45658
(lp45659
S'(Japanese)'
p45660
ag45660
aS'AUTHORS'
p45661
aS'Sano T, Naito T, Kubo T (eds).'
p45662
aS'TITLE'
p45663
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p45664
aS'JOURNAL'
p45665
aS'Nankodo (2002)'
p45666
aS'(Japanese)'
p45667
ag45667
aS'AUTHORS'
p45668
aS'Fukai S.'
p45669
aS'TITLE'
p45670
aS'[New Drugs Today (6th ed)] (In Japanese)'
p45671
aS'JOURNAL'
p45672
aS'Jiho (1995)'
p45673
ag22
ag22
aS'AUTHORS'
p45674
aS'David AW, Thomas LL, William OF.'
p45675
aS'TITLE'
p45676
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p45677
aS'JOURNAL'
p45678
aS'Lippincott Williams & Wilkins (2002)'
p45679
ag22
ag22
aS'AUTHORS'
p45680
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p45681
aS'TITLE'
p45682
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p45683
aS'JOURNAL'
p45684
aS'McGraw-Hill (2001)'
p45685
ag22
ag22
aS'AUTHORS'
p45686
aS'Walter S.'
p45687
aS'TITLE'
p45688
aS'Drug Discovery: A History'
p45689
aS'JOURNAL'
p45690
aS'Wiley (2005)'
p45691
ag22
ag22
aS'AUTHORS'
p45692
aS'Gestel SV, Schuermans V.'
p45693
aS'TITLE'
p45694
aS'Thirty-three years of drug discovery and research with Dr. Paul Janssen.'
p45695
aS'JOURNAL'
p45696
aS'Drug Development Research 8(1-4):1-13 (1986)'
p45697
asS'COMPOUND'
p45698
(lp45699
S'D00136'
p45700
aS'Haloperidol (JP16/USP/INN)'
p45701
ag45700
ag45701
aS'D00308'
p45702
aS'Droperidol (JP16/USP/INN)'
p45703
aS'D00560'
p45704
aS'Pimozide (JP16/USP/INN)'
p45705
aS'D01051'
p45706
aS'Spiperone (JAN/USAN)'
p45707
aS'D01101'
p45708
aS'Bromperidol (JAN/USAN/INN)'
p45709
aS'D01105'
p45710
aS'Moperone hydrochloride (JAN)'
p45711
aS'D01482'
p45712
aS'Pipamperone hydrochloride (JAN)'
p45713
aS'D01898'
p45714
aS'Haloperidol decanoate (JAN/USAN)'
p45715
aS'D02035'
p45716
aS'Timiperone (JAN)'
p45717
aS'D02620'
p45718
aS'Azaperone (USP/INN)'
p45719
aS'D02621'
p45720
aS'Fluanisone (INN)'
p45721
aS'D02622'
p45722
aS'Pipamperone (USAN/INN)'
p45723
aS'D02623'
p45724
aS'Moperone (INN)'
p45725
aS'D02625'
p45726
aS'Trifluperidol (USAN/INN)'
p45727
aS'D02626'
p45728
aS'Bromperidol decanoate (USAN)'
p45729
aS'D02627'
p45730
aS'Benperidol (USAN/INN)'
p45731
aS'D02628'
p45732
aS'Milenperone (USAN/INN)'
p45733
aS'D02629'
p45734
aS'Fluspirilene (USAN/INN)'
p45735
aS'D02630'
p45736
aS'Penfluridol (USAN/INN)'
p45737
aS'D08035'
p45738
aS'Haloperidol lactate'
p45739
aS'D08637'
p45740
aS'Trifluperidol hydrochloride'
p45741
assS'path:map00460'
p45742
(dp45743
S'NAME'
p45744
(lp45745
S'Cyanoamino acid metabolism'
p45746
asS'REFERENCE'
p45747
(lp45748
S'PMID:11575729'
p45749
ag45749
aS'AUTHORS'
p45750
aS'Maruyama A, Saito K, Ishizawa K'
p45751
aS'TITLE'
p45752
aS'Beta-cyanoalanine synthase and cysteine synthase from potato: molecular cloning,'
p45753
aS'biochemical characterization, and spatial and hormonal regulation.'
p45754
aS'JOURNAL'
p45755
aS'Plant Mol Biol 46:749-60 (2001)'
p45756
aS'PMID:10636899'
p45757
ag45757
aS'AUTHORS'
p45758
aS'Andersen MD, Busk PK, Svendsen I, Moller BL'
p45759
aS'TITLE'
p45760
aS'Cytochromes P-450 from cassava (Manihot esculenta Crantz) catalyzing the first steps in the biosynthesis of the cyanogenic glucosides linamarin and lotaustralin. Cloning, functional expression in Pichia pastoris, and substrate specificity of the isolated recombinant enzymes.'
p45761
aS'JOURNAL'
p45762
aS'J Biol Chem 275:1966-75 (2000)'
p45763
ag22
ag22
aS'AUTHORS'
p45764
aS'Andrea H, Meinhard H, Herfried G.'
p45765
aS'TITLE'
p45766
aS'Hydroxynitrile lyases: Functions and properties'
p45767
aS'JOURNAL'
p45768
aS'Physiologia Plantarum 98(4):891-898 (2006)'
p45769
asS'KO_PATHWAY'
p45770
(lp45771
S'ko00460'
p45772
asS'PATHWAY_MAP'
p45773
(lp45774
S'map00460'
p45775
asS'MODULE'
p45776
(lp45777
S'M00369'
p45778
aS'Cyanogenic glycoside biosynthesis, tyrosine => dhurrin [PATH:map00460]'
p45779
asS'DBLINKS'
p45780
(lp45781
S'GO: 0033052 0019756'
p45782
asS'ENTRY'
p45783
(lp45784
S'map00460'
p45785
aS'Pathway'
p45786
asS'CLASS'
p45787
(lp45788
S'Metabolism Metabolism of other amino acids'
p45789
assS'path:map03440'
p45790
(dp45791
S'NAME'
p45792
(lp45793
S'Homologous recombination'
p45794
asS'REFERENCE'
p45795
(lp45796
S'PMID:18086882'
p45797
ag45797
aS'AUTHORS'
p45798
aS'Maloisel L, Fabre F, Gangloff S.'
p45799
aS'TITLE'
p45800
aS'DNA polymerase delta is preferentially recruited during homologous recombination to promote heteroduplex DNA extension.'
p45801
aS'JOURNAL'
p45802
aS'Mol Cell Biol 28:1373-82 (2008)'
p45803
aS'PMID:17571595'
p45804
ag45804
aS'AUTHORS'
p45805
aS'Haruta-Takahashi N, Iwasaki H.'
p45806
aS'TITLE'
p45807
aS'[Recombination mediators] Japanese'
p45808
aS'JOURNAL'
p45809
aS'Seikagaku 79:449-53 (2007)'
p45810
aS'PMID:18430459'
p45811
ag45811
aS'AUTHORS'
p45812
aS'Ouyang KJ, Woo LL, Ellis NA.'
p45813
aS'TITLE'
p45814
aS'Homologous recombination and maintenance of genome integrity: Cancer and aging through the prism of human RecQ helicases.'
p45815
aS'JOURNAL'
p45816
aS'Mech Ageing Dev 129:425-40 (2008)'
p45817
aS'PMID:15902993'
p45818
ag45818
aS'AUTHORS'
p45819
aS'Kawabata M, Kawabata T, Nishibori M.'
p45820
aS'TITLE'
p45821
aS'Role of recA/RAD51 family proteins in mammals.'
p45822
aS'JOURNAL'
p45823
aS'Acta Med Okayama 59:1-9 (2005)'
p45824
aS'PMID:12589470'
p45825
ag45825
aS'AUTHORS'
p45826
aS'Prado F, Cortes-Ledesma F, Huertas P, Aguilera A.'
p45827
aS'TITLE'
p45828
aS'Mitotic recombination in Saccharomyces cerevisiae.'
p45829
aS'JOURNAL'
p45830
aS'Curr Genet 42:185-98 (2003)'
p45831
aS'PMID:16935872'
p45832
ag45832
aS'AUTHORS'
p45833
aS'Heyer WD, Li X, Rolfsmeier M, Zhang XP.'
p45834
aS'TITLE'
p45835
aS'Rad54: the Swiss Army knife of homologous recombination?'
p45836
aS'JOURNAL'
p45837
aS'Nucleic Acids Res 34:4115-25 (2006)'
p45838
aS'PMID:17395553'
p45839
ag45839
aS'AUTHORS'
p45840
aS'Michel B, Boubakri H, Baharoglu Z, LeMasson M, Lestini R.'
p45841
aS'TITLE'
p45842
aS'Recombination proteins and rescue of arrested replication forks.'
p45843
aS'JOURNAL'
p45844
aS'DNA Repair (Amst) 6:967-80 (2007)'
p45845
ag22
ag22
aS'AUTHORS'
p45846
aS'Hanaoka F.'
p45847
aS'TITLE'
p45848
aS'[DNA Replication and Repair] (In Japanese)'
p45849
aS'JOURNAL'
p45850
aS'Yodosha (2004)'
p45851
ag22
ag22
aS'AUTHORS'
p45852
aS'Ohashi E, Ohmori H.'
p45853
aS'TITLE'
p45854
aS'[The cross talk of the DNA replication and repair in Escherichia coli.] ( In Japanese)'
p45855
aS'JOURNAL'
p45856
aS'Cell Technology 19:1449-53 (2000)'
p45857
asS'KO_PATHWAY'
p45858
(lp45859
S'ko03440'
p45860
asS'PATHWAY_MAP'
p45861
(lp45862
S'map03440'
p45863
asS'DISEASE'
p45864
(lp45865
S'H00094'
p45866
aS'Immunodeficiency associated with DNA repair defects'
p45867
ag45866
ag45867
aS'H00296'
p45868
aS'Defects in RecQ helicases'
p45869
aS'H00848'
p45870
aS'Ataxia with ocular apraxia (AOA)'
p45871
aS'H01287'
p45872
aS'Congenital mirror movements (CMM)'
p45873
aS'H01344'
p45874
aS'Nijmegen Breakage Syndrome'
p45875
aS'H01346'
p45876
aS'Bloom syndrome'
p45877
asS'MODULE'
p45878
(lp45879
S'M00260'
p45880
aS'DNA polymerase III complex, bacteria [PATH:map03440]'
p45881
ag45880
ag45881
aS'M00288'
p45882
aS'RPA complex [PATH:map03440]'
p45883
aS'M00291'
p45884
aS'MRN complex [PATH:map03440]'
p45885
aS'M00292'
p45886
aS'MRX complex [PATH:map03440]'
p45887
aS'M00295'
p45888
aS'BRCA1-associated genome surveillance complex (BASC) [PATH:map03440]'
p45889
asS'DBLINKS'
p45890
(lp45891
S'GO: 0000724'
p45892
asS'ENTRY'
p45893
(lp45894
S'map03440'
p45895
aS'Pathway'
p45896
asS'CLASS'
p45897
(lp45898
S'Genetic Information Processing Replication and repair'
p45899
asS'DESCRIPTION'
p45900
(lp45901
S'Homologous recombination (HR) is essential for the accurate repair of DNA double-strand breaks (DSBs), potentially lethal lesions. HR takes place in the late S-G2 phase of the cell cycle and involves the generation of a single-stranded region of DNA, followed by strand invasion, formation of a Holliday junction, DNA synthesis using the intact strand as a template, branch migration and resolution. It is investigated that RecA/Rad51 family proteins play a central role. The breast cancer susceptibility protein Brca2 and the RecQ helicase BLM (Bloom syndrome mutated) are tumor suppressors that maintain genome integrity, at least in part, through HR.'
p45902
assS'path:map02060'
p45903
(dp45904
S'NAME'
p45905
(lp45906
S'Phosphotransferase system (PTS)'
p45907
asS'REFERENCE'
p45908
(lp45909
S'PMID:11361076'
p45910
ag45910
aS'AUTHORS'
p45911
aS'Darbon E, Galinier A, Le Coq D, Deutscher J.'
p45912
aS'TITLE'
p45913
aS'Phosphotransfer functions mutated Bacillus subtilis HPr-like protein Crh carrying a histidine in the active site.'
p45914
aS'JOURNAL'
p45915
aS'J Mol Microbiol Biotechnol 3:439-44 (2001)'
p45916
aS'PMID:15060041'
p45917
ag45917
aS'AUTHORS'
p45918
aS'Dahl U, Jaeger T, Nguyen BT, Sattler JM, Mayer C.'
p45919
aS'TITLE'
p45920
aS'Identification of a phosphotransferase system of Escherichia coli required for growth on N-acetylmuramic acid.'
p45921
aS'JOURNAL'
p45922
aS'J Bacteriol 186:2385-92 (2004)'
p45923
aS'PMID:2117666'
p45924
ag45924
aS'AUTHORS'
p45925
aS'Martin-Verstraete I, Debarbouille M, Klier A, Rapoport G'
p45926
aS'TITLE'
p45927
aS'Levanase operon of Bacillus subtilis includes a fructose-specific phosphotransferase system regulating the expression of the operon.'
p45928
aS'JOURNAL'
p45929
aS'J Mol Biol 214:657-71 (1990)'
p45930
aS'PMID:12603740'
p45931
ag45931
aS'AUTHORS'
p45932
aS'Kristich CJ, Glekas GD, Ordal GW.'
p45933
aS'TITLE'
p45934
aS'The conserved cytoplasmic module of the transmembrane chemoreceptor McpC mediates carbohydrate chemotaxis in Bacillus subtilis.'
p45935
aS'JOURNAL'
p45936
aS'Mol Microbiol 47:1353-66 (2003)'
p45937
aS'PMID:14645248'
p45938
ag45938
aS'AUTHORS'
p45939
aS'Sampaio MM, Chevance F, Dippel R, Eppler T, Schlegel A, Boos W, Lu YJ, Rock CO.'
p45940
aS'TITLE'
p45941
aS'Phosphotransferase-mediated transport of the osmolyte 2-O-alpha-mannosyl-D-glycerate in Escherichia coli occurs by the product of the mngA (hrsA) gene and is regulated by the mngR (farR) gene product acting as repressor.'
p45942
aS'JOURNAL'
p45943
aS'J Biol Chem 279:5537-48 (2004)'
p45944
aS'PMID:15608210'
p45945
ag45945
aS'AUTHORS'
p45946
aS'Keseler IM, Collado-Vides J, Gama-Castro S, Ingraham J, Paley S, Paulsen IT, Peralta-Gil M, Karp PD.'
p45947
aS'TITLE'
p45948
aS'EcoCyc: a comprehensive database resource for Escherichia coli.'
p45949
aS'JOURNAL'
p45950
aS'Nucleic Acids Res 33:D334-7 (2005)'
p45951
aS'PMID:18156259'
p45952
ag45952
aS'AUTHORS'
p45953
aS'Mukherjee A, Mammel MK, LeClerc JE, Cebula TA.'
p45954
aS'TITLE'
p45955
aS'Altered utilization of N-acetyl-D-galactosamine by Escherichia coli O157:H7 from the 2006 spinach outbreak.'
p45956
aS'JOURNAL'
p45957
aS'J Bacteriol 190:1710-7 (2008)'
p45958
aS'PMID:10931310'
p45959
ag45959
aS'AUTHORS'
p45960
aS'Brinkkotter A, Kloss H, Alpert C, Lengeler JW.'
p45961
aS'TITLE'
p45962
aS'Pathways for the utilization of N-acetyl-galactosamine and galactosamine in Escherichia coli.'
p45963
aS'JOURNAL'
p45964
aS'Mol Microbiol 37:125-35 (2000)'
p45965
aS'PMID:11361063'
p45966
ag45966
aS'AUTHORS'
p45967
aS'Tchieu JH, Norris V, Edwards JS, Saier MH Jr.'
p45968
aS'TITLE'
p45969
aS'The complete phosphotranferase system in Escherichia coli.'
p45970
aS'JOURNAL'
p45971
aS'J Mol Microbiol Biotechnol 3:329-46 (2001)'
p45972
aS'PMID:16233138'
p45973
ag45973
aS'AUTHORS'
p45974
aS'Kotrba P, Inui M, Yukawa H.'
p45975
aS'TITLE'
p45976
aS'Bacterial phosphotransferase system (PTS) in carbohydrate uptake and control of carbon metabolism.'
p45977
aS'JOURNAL'
p45978
aS'J Biosci Bioeng 92:502-17 (2001)'
p45979
asS'KO_PATHWAY'
p45980
(lp45981
S'ko02060'
p45982
asS'PATHWAY_MAP'
p45983
(lp45984
S'map02060'
p45985
asS'MODULE'
p45986
(lp45987
S'M00265'
p45988
aS'PTS system, glucose-specific II component [PATH:map02060]'
p45989
ag45988
ag45989
aS'M00266'
p45990
aS'PTS system, maltose and glucose-specific II component [PATH:map02060]'
p45991
aS'M00267'
p45992
aS'PTS system, N-acetylglucosamine-specific II component [PATH:map02060]'
p45993
aS'M00268'
p45994
aS'PTS system, arbutin-like II component [PATH:map02060]'
p45995
aS'M00269'
p45996
aS'PTS system, sucrose-specific II component [PATH:map02060]'
p45997
aS'M00270'
p45998
aS'PTS system, trehalose-specific II component [PATH:map02060]'
p45999
aS'M00271'
p46000
aS'PTS system, beta-glucosides-specific II component [PATH:map02060]'
p46001
aS'M00272'
p46002
aS'PTS system, arbutin-, cellobiose-, and salicin-specific II component [PATH:map02060]'
p46003
aS'M00273'
p46004
aS'PTS system, fructose-specific II component [PATH:map02060]'
p46005
aS'M00274'
p46006
aS'PTS system, mannitol-specific II component [PATH:map02060]'
p46007
aS'M00275'
p46008
aS'PTS system, cellobiose-specific II component [PATH:map02060]'
p46009
aS'M00276'
p46010
aS'PTS system, mannose-specific II component [PATH:map02060]'
p46011
aS'M00277'
p46012
aS'PTS system, N-acetylgalactosamine-specific II component [PATH:map02060]'
p46013
aS'M00278'
p46014
aS'PTS system, sorbose-specific II component [PATH:map02060]'
p46015
aS'M00279'
p46016
aS'PTS system, galactitol-specific II component [PATH:map02060]'
p46017
aS'M00280'
p46018
aS'PTS system, glucitol/sorbitol-specific II component [PATH:map02060]'
p46019
aS'M00281'
p46020
aS'PTS system, lactose-specific II component [PATH:map02060]'
p46021
aS'M00282'
p46022
aS'PTS system, D-glucosamine-specific II component [PATH:map02060]'
p46023
aS'M00283'
p46024
aS'PTS system, ascorbate-specific II component [PATH:map02060]'
p46025
aS'M00287'
p46026
aS'PTS system, galactosamine-specific II component [PATH:map02060]'
p46027
aS'M00303'
p46028
aS'PTS system, N-acetylmuramic acid-specific II component [PATH:map02060]'
p46029
aS'M00304'
p46030
aS'PTS system, fructose-specific II component [PATH:map02060]'
p46031
aS'M00305'
p46032
aS'PTS system, 2-O-A-mannosyl-D-glycerate-specific II component [PATH:map02060]'
p46033
aS'M00610'
p46034
aS'PTS system, D-glucosaminate-specific II component [PATH:map02060]'
p46035
asS'DBLINKS'
p46036
(lp46037
S'GO: 0009401'
p46038
ag46038
aS'TC: 4.A'
p46039
asS'ENTRY'
p46040
(lp46041
S'map02060'
p46042
aS'Pathway'
p46043
asS'CLASS'
p46044
(lp46045
S'Environmental Information Processing Membrane transport'
p46046
asS'DESCRIPTION'
p46047
(lp46048
S'The phosphoenolpyruvate (PEP)-dependent phosphotransferase system (PTS) is a major mechanism used by bacteria for uptake of carbohydrates, particularly hexoses, hexitols, and disaccharides, where the source of energy is from PEP. The PTS consists of two general components, enzyme I (EI) and histidine phosphocarrier protein (HPr), and of membrane-bound sugar specific permeases (enzymes II). Each enzyme II (EII) complex consists of one or two hydrophobic integral membrane domains (domains C and D) and two hydrophilic domains (domains A and B). EII complexes may exist as distinct proteins or as a single multidomain protein. The PTS catalyzes the uptake of carbohydrates and their conversion into their respective phosphoesters during transport. There are four successive phosphoryl transfers in the PTS. Initial autophosphorylation of EI, using PEP as a substrate, is followed by transfer of the phosphoryl group from EI to HPr. EIIA catalyzes the self-phosphoryl transfer from HPr after which the phosphoryl group is transferred to histidine or cysteine residues of EIIB. The sugar is transported through the membrane-bound EIIC and is phosphorylated by the appropriate sugar-specific EIIB.'
p46049
assS'path:map04810'
p46050
(dp46051
S'NAME'
p46052
(lp46053
S'Regulation of actin cytoskeleton'
p46054
asS'REFERENCE'
p46055
(lp46056
S'PMID:14744429'
p46057
ag46057
aS'AUTHORS'
p46058
aS'Burridge K, Wennerberg K.'
p46059
aS'TITLE'
p46060
aS'Rho and Rac take center stage.'
p46061
aS'JOURNAL'
p46062
aS'Cell 116:167-79 (2004)'
p46063
aS'PMID:11082269'
p46064
ag46064
aS'AUTHORS'
p46065
aS'Schmitz AA, Govek EE, Bottner B, Van Aelst L.'
p46066
aS'TITLE'
p46067
aS'Rho GTPases: signaling, migration, and invasion.'
p46068
aS'JOURNAL'
p46069
aS'Exp Cell Res 261:1-12 (2000)'
p46070
aS'PMID:11152757'
p46071
ag46071
aS'AUTHORS'
p46072
aS'Takai Y, Sasaki T, Matozaki T.'
p46073
aS'TITLE'
p46074
aS'Small GTP-binding proteins.'
p46075
aS'JOURNAL'
p46076
aS'Physiol Rev 81:153-208 (2001)'
p46077
aS'PMID:12700767'
p46078
ag46078
aS'AUTHORS'
p46079
aS'Pollard TD.'
p46080
aS'TITLE'
p46081
aS'The cytoskeleton, cellular motility and the reductionist agenda.'
p46082
aS'JOURNAL'
p46083
aS'Nature 422:741-5 (2003)'
p46084
aS'PMID:14657486'
p46085
ag46085
aS'AUTHORS'
p46086
aS'Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR.'
p46087
aS'TITLE'
p46088
aS'Cell migration: integrating signals from front to back.'
p46089
aS'JOURNAL'
p46090
aS'Science 302:1704-9 (2003)'
p46091
aS'PMID:11082272'
p46092
ag46092
aS'AUTHORS'
p46093
aS'Sastry SK, Burridge K.'
p46094
aS'TITLE'
p46095
aS'Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics.'
p46096
aS'JOURNAL'
p46097
aS'Exp Cell Res 261:25-36 (2000)'
p46098
aS'PMID:10574699'
p46099
ag46099
aS'AUTHORS'
p46100
aS'Fukata M, Nakagawa M, Kuroda S, Kaibuchi K.'
p46101
aS'TITLE'
p46102
aS'Cell adhesion and Rho small GTPases.'
p46103
aS'JOURNAL'
p46104
aS'J Cell Sci 112 ( Pt 24):4491-500 (1999)'
p46105
asS'KO_PATHWAY'
p46106
(lp46107
S'ko04810'
p46108
asS'PATHWAY_MAP'
p46109
(lp46110
S'map04810'
p46111
asS'DISEASE'
p46112
(lp46113
S'H00255'
p46114
aS'Hypogonadotropic hypogonadism'
p46115
ag46114
ag46115
aS'H00480'
p46116
aS'Non-syndromic X-linked mental retardation'
p46117
aS'H00484'
p46118
aS'Other brachydactylies'
p46119
aS'H00569'
p46120
aS'Aarskog-Scott syndrome'
p46121
aS'H00578'
p46122
aS'MYH9-related kidney diseases'
p46123
aS'H00586'
p46124
aS'Epidermolysis bullosa, junctional'
p46125
aS'H00590'
p46126
aS'Congenital muscular dystrophies (CMD/MDC)'
p46127
aS'H00626'
p46128
aS'Nephrotic syndrome and focal segmental glomerulosclerosis'
p46129
aS'H00627'
p46130
aS'Premature ovarian failure'
p46131
aS'H00642'
p46132
aS'Lacrimo-auriculo-dento-digital syndrome (LADD)'
p46133
aS'H00698'
p46134
aS'Nemaline myopathy'
p46135
aS'H00801'
p46136
aS'Familial thoracic aortic aneurysm and dissection (TAAD)'
p46137
aS'H00845'
p46138
aS'Familial amyloidosis'
p46139
aS'H00865'
p46140
aS'Lethal congenital contractural syndrome (LCCS)'
p46141
aS'H00956'
p46142
aS'Lattice corneal dystrophies (LCD)'
p46143
aS'H00957'
p46144
aS'Fleck corneal dystrophy (FCD)'
p46145
aS'H00997'
p46146
aS'CATSHL syndrome'
p46147
aS'H01025'
p46148
aS'Familial adenomatous polyposis'
p46149
aS'H01193'
p46150
aS'Familial tumoral calcinosis (FTC)'
p46151
aS'H01207'
p46152
aS'Trigonocephaly'
p46153
aS'H01255'
p46154
aS'Juvenile-onset dystonia'
p46155
aS'H01260'
p46156
aS'Glomerulopathy with fibronectin deposits (GFND)'
p46157
asS'DBLINKS'
p46158
(lp46159
S'GO: 0030036'
p46160
asS'ENTRY'
p46161
(lp46162
S'map04810'
p46163
aS'Pathway'
p46164
asS'CLASS'
p46165
(lp46166
S'Cellular Processes Cell motility'
p46167
assS'path:map04514'
p46168
(dp46169
S'NAME'
p46170
(lp46171
S'Cell adhesion molecules (CAMs)'
p46172
asS'REFERENCE'
p46173
(lp46174
S'PMID:14690046'
p46175
ag46175
aS'AUTHORS'
p46176
aS'Barclay AN.'
p46177
aS'TITLE'
p46178
aS'Membrane proteins with immunoglobulin-like domains--a master superfamily of interaction molecules.'
p46179
aS'JOURNAL'
p46180
aS'Semin Immunol 15:215-23 (2003)'
p46181
aS'PMID:11910893'
p46182
ag46182
aS'AUTHORS'
p46183
aS'Sharpe AH, Freeman GJ.'
p46184
aS'TITLE'
p46185
aS'The B7-CD28 superfamily.'
p46186
aS'JOURNAL'
p46187
aS'Nat Rev Immunol 2:116-26 (2002)'
p46188
aS'PMID:9597126'
p46189
ag46189
aS'AUTHORS'
p46190
aS'Grewal IS, Flavell RA.'
p46191
aS'TITLE'
p46192
aS'CD40 and CD154 in cell-mediated immunity.'
p46193
aS'JOURNAL'
p46194
aS'Annu Rev Immunol 16:111-35 (1998)'
p46195
aS'PMID:16034094'
p46196
ag46196
aS'AUTHORS'
p46197
aS'Dardalhon V, Schubart AS, Reddy J, Meyers JH, Monney L, Sabatos CA, Ahuja R, Nguyen K, Freeman GJ, Greenfield EA, Sobel RA, Kuchroo VK.'
p46198
aS'TITLE'
p46199
aS'CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions.'
p46200
aS'JOURNAL'
p46201
aS'J Immunol 175:1558-65 (2005)'
p46202
aS'PMID:12234363'
p46203
ag46203
aS'AUTHORS'
p46204
aS'Montoya MC, Sancho D, Vicente-Manzanares M, Sanchez-Madrid F.'
p46205
aS'TITLE'
p46206
aS'Cell adhesion and polarity during immune interactions.'
p46207
aS'JOURNAL'
p46208
aS'Immunol Rev 186:68-82 (2002)'
p46209
aS'PMID:15071551'
p46210
ag46210
aS'AUTHORS'
p46211
aS'Dejana E.'
p46212
aS'TITLE'
p46213
aS'Endothelial cell-cell junctions: happy together.'
p46214
aS'JOURNAL'
p46215
aS'Nat Rev Mol Cell Biol 5:261-70 (2004)'
p46216
aS'PMID:14519386'
p46217
ag46217
aS'AUTHORS'
p46218
aS'Bazzoni G.'
p46219
aS'TITLE'
p46220
aS'The JAM family of junctional adhesion molecules.'
p46221
aS'JOURNAL'
p46222
aS'Curr Opin Cell Biol 15:525-30 (2003)'
p46223
aS'PMID:10798271'
p46224
ag46224
aS'AUTHORS'
p46225
aS'Becker BF, Heindl B, Kupatt C, Zahler S.'
p46226
aS'TITLE'
p46227
aS'Endothelial function and hemostasis.'
p46228
aS'JOURNAL'
p46229
aS'Z Kardiol 89:160-7 (2000)'
p46230
aS'PMID:9150551'
p46231
ag46231
aS'AUTHORS'
p46232
aS'Elangbam CS, Qualls CW Jr, Dahlgren RR.'
p46233
aS'TITLE'
p46234
aS'Cell adhesion molecules--update.'
p46235
aS'JOURNAL'
p46236
aS'Vet Pathol 34:61-73 (1997)'
p46237
aS'PMID:12810109'
p46238
ag46238
aS'AUTHORS'
p46239
aS'Muller WA.'
p46240
aS'TITLE'
p46241
aS'Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response.'
p46242
aS'JOURNAL'
p46243
aS'Trends Immunol 24:327-34 (2003)'
p46244
aS'PMID:14519398'
p46245
ag46245
aS'AUTHORS'
p46246
aS'Yamagata M, Sanes JR, Weiner JA.'
p46247
aS'TITLE'
p46248
aS'Synaptic adhesion molecules.'
p46249
aS'JOURNAL'
p46250
aS'Curr Opin Cell Biol 15:621-32 (2003)'
p46251
aS'PMID:15882774'
p46252
ag46252
aS'AUTHORS'
p46253
aS'Ethell IM, Pasquale EB.'
p46254
aS'TITLE'
p46255
aS'Molecular mechanisms of dendritic spine development and remodeling.'
p46256
aS'JOURNAL'
p46257
aS'Prog Neurobiol 75:161-205 (2005)'
p46258
aS'PMID:11050419'
p46259
ag46259
aS'AUTHORS'
p46260
aS'Benson DL, Schnapp LM, Shapiro L, Huntley GW.'
p46261
aS'TITLE'
p46262
aS'Making memories stick: cell-adhesion molecules in synaptic plasticity.'
p46263
aS'JOURNAL'
p46264
aS'Trends Cell Biol 10:473-82 (2000)'
p46265
aS'PMID:11860281'
p46266
ag46266
aS'AUTHORS'
p46267
aS'Rosdahl JA, Mourton TL, Brady-Kalnay SM.'
p46268
aS'TITLE'
p46269
aS'Protein kinase C delta (PKCdelta) is required for protein tyrosine phosphatase mu (PTPmu)-dependent neurite outgrowth.'
p46270
aS'JOURNAL'
p46271
aS'Mol Cell Neurosci 19:292-306 (2002)'
p46272
aS'PMID:10964748'
p46273
ag46273
aS'AUTHORS'
p46274
aS'Dunican DJ, Doherty P.'
p46275
aS'TITLE'
p46276
aS'The generation of localized calcium rises mediated by cell adhesion molecules and their role in neuronal growth cone motility.'
p46277
aS'JOURNAL'
p46278
aS'Mol Cell Biol Res Commun 3:255-63 (2000)'
p46279
aS'PMID:12367625'
p46280
ag46280
aS'AUTHORS'
p46281
aS'Girault JA, Peles E.'
p46282
aS'TITLE'
p46283
aS'Development of nodes of Ranvier.'
p46284
aS'JOURNAL'
p46285
aS'Curr Opin Neurobiol 12:476-85 (2002)'
p46286
aS'PMID:10664064'
p46287
ag46287
aS'AUTHORS'
p46288
aS'Arroyo EJ, Scherer SS.'
p46289
aS'TITLE'
p46290
aS'On the molecular architecture of myelinated fibers.'
p46291
aS'JOURNAL'
p46292
aS'Histochem Cell Biol 113:1-18 (2000)'
p46293
aS'PMID:14556710'
p46294
ag46294
aS'AUTHORS'
p46295
aS'Salzer JL.'
p46296
aS'TITLE'
p46297
aS'Polarized domains of myelinated axons.'
p46298
aS'JOURNAL'
p46299
aS'Neuron 40:297-318 (2003)'
p46300
aS'PMID:15561584'
p46301
ag46301
aS'AUTHORS'
p46302
aS'Irie K, Shimizu K, Sakisaka T, Ikeda W, Takai Y.'
p46303
aS'TITLE'
p46304
aS'Roles and modes of action of nectins in cell-cell adhesion.'
p46305
aS'JOURNAL'
p46306
aS'Semin Cell Dev Biol 15:643-56 (2004)'
p46307
aS'PMID:15551862'
p46308
ag46308
aS'AUTHORS'
p46309
aS'Nakanishi H, Takai Y.'
p46310
aS'TITLE'
p46311
aS'Roles of nectins in cell adhesion, migration and polarization.'
p46312
aS'JOURNAL'
p46313
aS'Biol Chem 385:885-92 (2004)'
p46314
aS'PMID:15115723'
p46315
ag46315
aS'AUTHORS'
p46316
aS'Siu MK, Cheng CY.'
p46317
aS'TITLE'
p46318
aS'Extracellular matrix: recent advances on its role in junction dynamics in the seminiferous epithelium during spermatogenesis.'
p46319
aS'JOURNAL'
p46320
aS'Biol Reprod 71:375-91 (2004)'
p46321
aS'PMID:15056568'
p46322
ag46322
aS'AUTHORS'
p46323
aS'Lee NP, Cheng CY.'
p46324
aS'TITLE'
p46325
aS'Adaptors, junction dynamics, and spermatogenesis.'
p46326
aS'JOURNAL'
p46327
aS'Biol Reprod 71:392-404 (2004)'
p46328
aS'PMID:15728677'
p46329
ag46329
aS'AUTHORS'
p46330
aS'Inagaki M, Irie K, Ishizaki H, Tanaka-Okamoto M, Morimoto K, Inoue E, Ohtsuka T, Miyoshi J, Takai Y.'
p46331
aS'TITLE'
p46332
aS'Roles of cell-adhesion molecules nectin 1 and nectin 3 in ciliary body development.'
p46333
aS'JOURNAL'
p46334
aS'Development 132:1525-37 (2005)'
p46335
aS'PMID:12500939'
p46336
ag46336
aS'AUTHORS'
p46337
aS'Marthiens V, Gavard J, Lambert M, Mege RM.'
p46338
aS'TITLE'
p46339
aS'Cadherin-based cell adhesion in neuromuscular development.'
p46340
aS'JOURNAL'
p46341
aS'Biol Cell 94:315-26 (2002)'
p46342
aS'PMID:15923648'
p46343
ag46343
aS'AUTHORS'
p46344
aS'Krauss RS, Cole F, Gaio U, Takaesu G, Zhang W, Kang JS.'
p46345
aS'TITLE'
p46346
aS'Close encounters: regulation of vertebrate skeletal myogenesis by cell-cell contact.'
p46347
aS'JOURNAL'
p46348
aS'J Cell Sci 118:2355-62 (2005)'
p46349
asS'KO_PATHWAY'
p46350
(lp46351
S'ko04514'
p46352
asS'PATHWAY_MAP'
p46353
(lp46354
S'map04514'
p46355
asS'DISEASE'
p46356
(lp46357
S'H00577'
p46358
aS'Syndromic X-linked mental retardation with epilepsy or seizures'
p46359
ag46358
ag46359
aS'H00586'
p46360
aS'Epidermolysis bullosa, junctional'
p46361
aS'H00639'
p46362
aS'Ectodermal dysplasia, ectrodactyly, and macular dystrophy (EEM syndrome)'
p46363
aS'H00742'
p46364
aS'Neonatal ichthyosis-sclerosing cholangitis (NISCH) syndrome'
p46365
aS'H00756'
p46366
aS'Pitt-Hopkins syndrome'
p46367
aS'H00773'
p46368
aS'Autosomal dominant mental retardation'
p46369
aS'H00785'
p46370
aS'Congenital hypotrichosis with juvenile macular dystrophy'
p46371
aS'H00805'
p46372
aS'Vitreoretinal degeneration'
p46373
aS'H00840'
p46374
aS'Band-like calcification with simplified gyration and polymicrogyria (BLC-PMG)'
p46375
aS'H01034'
p46376
aS'L1 syndrome'
p46377
aS'H01155'
p46378
aS'Roussy-Levy syndrome'
p46379
aS'H01210'
p46380
aS'Hypomagnesemia'
p46381
asS'DBLINKS'
p46382
(lp46383
S'GO: 0050839'
p46384
asS'ENTRY'
p46385
(lp46386
S'map04514'
p46387
aS'Pathway'
p46388
asS'CLASS'
p46389
(lp46390
S'Environmental Information Processing Signaling molecules and interaction'
p46391
asS'DESCRIPTION'
p46392
(lp46393
S'Cell adhesion molecules are (glyco)proteins expressed on the cell surface and play a critical role in a wide array of biologic processes that include hemostasis, the immune response, inflammation, embryogenesis, and development of neuronal tissue. There are four main groups: the integrin family, the immunoglobulin superfamily, selectins, and cadherins. Membrane proteins that mediate immune cell&#8211cell interactions fall into different categories, namely those involved in antigen recognition, costimulation and cellular adhesion. Furthermore cell-cell adhesions are important for brain morphology and highly coordinated brain functions such as memory and learning. During early development of the nervous system, neurons elongate their axons towards their targets and establish and maintain synapses through formation of cell-cell adhesions. Cell-cell adhesions also underpin axon-axon contacts and link neurons with supporting schwann cells and oligodendrocytes.'
p46394
assS'path:map04510'
p46395
(dp46396
S'NAME'
p46397
(lp46398
S'Focal adhesion'
p46399
asS'REFERENCE'
p46400
(lp46401
S'PMID:14756624'
p46402
ag46402
aS'AUTHORS'
p46403
aS'Berman AE, Kozlova NI, Morozevich GE.'
p46404
aS'TITLE'
p46405
aS'Integrins: structure and signaling.'
p46406
aS'JOURNAL'
p46407
aS'Biochemistry (Mosc) 68:1284-99 (2003)'
p46408
aS'PMID:15179030'
p46409
ag46409
aS'AUTHORS'
p46410
aS'Lee JW, Juliano R.'
p46411
aS'TITLE'
p46412
aS'Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways.'
p46413
aS'JOURNAL'
p46414
aS'Mol Cells 17:188-202 (2004)'
p46415
aS'PMID:11573199'
p46416
ag46416
aS'AUTHORS'
p46417
aS'Danen EH, Yamada KM.'
p46418
aS'TITLE'
p46419
aS'Fibronectin, integrins, and growth control.'
p46420
aS'JOURNAL'
p46421
aS'J Cell Physiol 189:1-13 (2001)'
p46422
aS'PMID:15459662'
p46423
ag46423
aS'AUTHORS'
p46424
aS'Guo W, Giancotti FG.'
p46425
aS'TITLE'
p46426
aS'Integrin signalling during tumour progression.'
p46427
aS'JOURNAL'
p46428
aS'Nat Rev Mol Cell Biol 5:816-26 (2004)'
p46429
aS'PMID:11229600'
p46430
ag46430
aS'AUTHORS'
p46431
aS'Petit V, Thiery JP.'
p46432
aS'TITLE'
p46433
aS'Focal adhesions: structure and dynamics.'
p46434
aS'JOURNAL'
p46435
aS'Biol Cell 92:477-94 (2000)'
p46436
aS'PMID:12235283'
p46437
ag46437
aS'AUTHORS'
p46438
aS'Stupack DG, Cheresh DA.'
p46439
aS'TITLE'
p46440
aS'Get a ligand, get a life: integrins, signaling and cell survival.'
p46441
aS'JOURNAL'
p46442
aS'J Cell Sci 115:3729-38 (2002)'
p46443
aS'PMID:12640026'
p46444
ag46444
aS'AUTHORS'
p46445
aS'Parsons JT.'
p46446
aS'TITLE'
p46447
aS'Focal adhesion kinase: the first ten years.'
p46448
aS'JOURNAL'
p46449
aS'J Cell Sci 116:1409-16 (2003)'
p46450
aS'PMID:15688067'
p46451
ag46451
aS'AUTHORS'
p46452
aS'Mitra SK, Hanson DA, Schlaepfer DD.'
p46453
aS'TITLE'
p46454
aS'Focal adhesion kinase: in command and control of cell motility.'
p46455
aS'JOURNAL'
p46456
aS'Nat Rev Mol Cell Biol 6:56-68 (2005)'
p46457
aS'PMID:14519391'
p46458
ag46458
aS'AUTHORS'
p46459
aS'Comoglio PM, Boccaccio C, Trusolino L.'
p46460
aS'TITLE'
p46461
aS'Interactions between growth factor receptors and adhesion molecules: breaking the rules.'
p46462
aS'JOURNAL'
p46463
aS'Curr Opin Cell Biol 15:565-71 (2003)'
p46464
aS'PMID:15108811'
p46465
ag46465
aS'AUTHORS'
p46466
aS'Schlaepfer DD, Mitra SK.'
p46467
aS'TITLE'
p46468
aS'Multiple connections link FAK to cell motility and invasion.'
p46469
aS'JOURNAL'
p46470
aS'Curr Opin Genet Dev 14:92-101 (2004)'
p46471
aS'PMID:14744429'
p46472
ag46472
aS'AUTHORS'
p46473
aS'Burridge K, Wennerberg K.'
p46474
aS'TITLE'
p46475
aS'Rho and Rac take center stage.'
p46476
aS'JOURNAL'
p46477
aS'Cell 116:167-79 (2004)'
p46478
aS'PMID:11082269'
p46479
ag46479
aS'AUTHORS'
p46480
aS'Schmitz AA, Govek EE, Bottner B, Van Aelst L.'
p46481
aS'TITLE'
p46482
aS'Rho GTPases: signaling, migration, and invasion.'
p46483
aS'JOURNAL'
p46484
aS'Exp Cell Res 261:1-12 (2000)'
p46485
aS'PMID:10698680'
p46486
ag46486
aS'AUTHORS'
p46487
aS'Vanhaesebroeck B, Alessi DR.'
p46488
aS'TITLE'
p46489
aS'The PI3K-PDK1 connection: more than just a road to PKB.'
p46490
aS'JOURNAL'
p46491
aS'Biochem J 346 Pt 3:561-76 (2000)'
p46492
aS'PMID:11882383'
p46493
ag46493
aS'AUTHORS'
p46494
aS'Nicholson KM, Anderson NG.'
p46495
aS'TITLE'
p46496
aS'The protein kinase B/Akt signalling pathway in human malignancy.'
p46497
aS'JOURNAL'
p46498
aS'Cell Signal 14:381-95 (2002)'
p46499
aS'PMID:15053919'
p46500
ag46500
aS'AUTHORS'
p46501
aS'Oloumi A, McPhee T, Dedhar S.'
p46502
aS'TITLE'
p46503
aS'Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase.'
p46504
aS'JOURNAL'
p46505
aS'Biochim Biophys Acta 1691:1-15 (2004)'
p46506
aS'PMID:11146675'
p46507
ag46507
aS'AUTHORS'
p46508
aS'Turner CE.'
p46509
aS'TITLE'
p46510
aS'Paxillin and focal adhesion signalling.'
p46511
aS'JOURNAL'
p46512
aS'Nat Cell Biol 2:E231-6 (2000)'
p46513
aS'PMID:15034601'
p46514
ag46514
aS'AUTHORS'
p46515
aS'Hlobilkova A, Knillova J, Bartek J, Lukas J, Kolar Z.'
p46516
aS'TITLE'
p46517
aS'The mechanism of action of the tumour suppressor gene PTEN.'
p46518
aS'JOURNAL'
p46519
aS'Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147:19-25 (2003)'
p46520
asS'KO_PATHWAY'
p46521
(lp46522
S'ko04510'
p46523
asS'PATHWAY_MAP'
p46524
(lp46525
S'map04510'
p46526
asS'DISEASE'
p46527
(lp46528
S'H00226'
p46529
aS'Glanzmann thrombasthenia'
p46530
ag46529
ag46530
aS'H00539'
p46531
aS'PTEN hamartoma tumor syndrome (PHTS)'
p46532
aS'H00567'
p46533
aS'Caveolinopathies'
p46534
aS'H00576'
p46535
aS'Pierson syndrome'
p46536
aS'H00577'
p46537
aS'Syndromic X-linked mental retardation with epilepsy or seizures'
p46538
aS'H00579'
p46539
aS'Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC)'
p46540
aS'H00581'
p46541
aS'Alport syndrome'
p46542
aS'H00582'
p46543
aS'Benign familial hematuria'
p46544
aS'H00585'
p46545
aS'Epidermolysis bullosa, hemidesmosomal'
p46546
aS'H00586'
p46547
aS'Epidermolysis bullosa, junctional'
p46548
aS'H00590'
p46549
aS'Congenital muscular dystrophies (CMD/MDC)'
p46550
aS'H00593'
p46551
aS'Limb-girdle muscular dystrophy (LGMD)'
p46552
aS'H00595'
p46553
aS'Myofibrillar myopathies (MFM)'
p46554
aS'H00626'
p46555
aS'Nephrotic syndrome and focal segmental glomerulosclerosis'
p46556
aS'H00801'
p46557
aS'Familial thoracic aortic aneurysm and dissection (TAAD)'
p46558
aS'H00802'
p46559
aS'Ehlers-Danlos syndrome (EDS)'
p46560
aS'H00805'
p46561
aS'Vitreoretinal degeneration'
p46562
aS'H00813'
p46563
aS'Laryngo onycho cutaneous syndrome'
p46564
aS'H00839'
p46565
aS'Porencephaly'
p46566
aS'H00865'
p46567
aS'Lethal congenital contractural syndrome (LCCS)'
p46568
aS'H00877'
p46569
aS'Brain small vessel disease with Axenfeld-Rieger anomaly'
p46570
aS'H00894'
p46571
aS'FG syndrome (FGS)'
p46572
aS'H00947'
p46573
aS'Pilomatricoma'
p46574
aS'H01195'
p46575
aS'VACTERL/VATER association'
p46576
aS'H01210'
p46577
aS'Hypomagnesemia'
p46578
aS'H01255'
p46579
aS'Juvenile-onset dystonia'
p46580
aS'H01260'
p46581
aS'Glomerulopathy with fibronectin deposits (GFND)'
p46582
aS'H01274'
p46583
aS'Growth delay due to insulin-like growth factor I resistance'
p46584
aS'H01276'
p46585
aS'X-linked chronic idiopathic intestinal pseudo-obstruction'
p46586
aS'H01338'
p46587
aS'Myosclerosis'
p46588
aS'H01340'
p46589
aS'Bethlem myopathy'
p46590
aS'H01341'
p46591
aS'Collagen VI myopathy'
p46592
asS'DBLINKS'
p46593
(lp46594
S'GO: 0005925'
p46595
asS'ENTRY'
p46596
(lp46597
S'map04510'
p46598
aS'Pathway'
p46599
asS'CLASS'
p46600
(lp46601
S'Cellular Processes Cellular commiunity'
p46602
asS'DESCRIPTION'
p46603
(lp46604
S'Cell-matrix adhesions play essential roles in important biological processes including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival. At the cell-extracellular matrix contact points, specialized structures are formed and termed focal adhesions, where bundles of actin filaments are anchored to transmembrane receptors of the integrin family through a multi-molecular complex of junctional plaque proteins. Some of the constituents of focal adhesions participate in the structural link between membrane receptors and the actin cytoskeleton, while others are signalling molecules, including different protein kinases and phosphatases, their substrates, and various adapter proteins. Integrin signaling is dependent upon the non-receptor tyrosine kinase activities of the FAK and src proteins as well as the adaptor protein functions of FAK, src and Shc to initiate downstream signaling events. These signalling events culminate in reorganization of the actin cytoskeleton a prerequisite for changes in cell shape and motility, and gene expression. Similar morphological alterations and modulation of gene expression are initiated by the binding of growth factors to their respective receptors, emphasizing the considerable crosstalk between adhesion- and growth factor-mediated signalling.'
p46605
assS'path:map04512'
p46606
(dp46607
S'NAME'
p46608
(lp46609
S'ECM-receptor interaction'
p46610
asS'REFERENCE'
p46611
(lp46612
S'PMID:11572082'
p46613
ag46613
aS'AUTHORS'
p46614
aS'van der Flier A, Sonnenberg A.'
p46615
aS'TITLE'
p46616
aS'Function and interactions of integrins.'
p46617
aS'JOURNAL'
p46618
aS'Cell Tissue Res 305:285-98 (2001)'
p46619
aS'PMID:12921709'
p46620
ag46620
aS'AUTHORS'
p46621
aS'Reddy KV, Mangale SS.'
p46622
aS'TITLE'
p46623
aS'Integrin receptors: the dynamic modulators of endometrial function.'
p46624
aS'JOURNAL'
p46625
aS'Tissue Cell 35:260-73 (2003)'
p46626
aS'PMID:12125070'
p46627
ag46627
aS'AUTHORS'
p46628
aS'Milner R, Campbell IL.'
p46629
aS'TITLE'
p46630
aS'The integrin family of cell adhesion molecules has multiple functions within the CNS.'
p46631
aS'JOURNAL'
p46632
aS'J Neurosci Res 69:286-91 (2002)'
p46633
aS'PMID:12796473'
p46634
ag46634
aS'AUTHORS'
p46635
aS'Cichy J, Pure E.'
p46636
aS'TITLE'
p46637
aS'The liberation of CD44.'
p46638
aS'JOURNAL'
p46639
aS'J Cell Biol 161:839-43 (2003)'
p46640
aS'PMID:7698997'
p46641
ag46641
aS'AUTHORS'
p46642
aS'Elenius K, Jalkanen M.'
p46643
aS'TITLE'
p46644
aS'Function of the syndecans--a family of cell surface proteoglycans.'
p46645
aS'JOURNAL'
p46646
aS'J Cell Sci 107 ( Pt 11):2975-82 (1994)'
p46647
aS'PMID:10617638'
p46648
ag46648
aS'AUTHORS'
p46649
aS'Son YJ, Scranton TW, Sunderland WJ, Baek SJ, Miner JH, Sanes JR, Carlson SS.'
p46650
aS'TITLE'
p46651
aS'The synaptic vesicle protein SV2 is complexed with an alpha5-containing laminin on the nerve terminal surface.'
p46652
aS'JOURNAL'
p46653
aS'J Biol Chem 275:451-60 (2000)'
p46654
aS'PMID:15036264'
p46655
ag46655
aS'AUTHORS'
p46656
aS'Sid B, Sartelet H, Bellon G, El Btaouri H, Rath G, Delorme N, Haye B, Martiny L.'
p46657
aS'TITLE'
p46658
aS'Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth.'
p46659
aS'JOURNAL'
p46660
aS'Crit Rev Oncol Hematol 49:245-58 (2004)'
p46661
aS'PMID:15381249'
p46662
ag46662
aS'AUTHORS'
p46663
aS'Canobbio I, Balduini C, Torti M.'
p46664
aS'TITLE'
p46665
aS'Signalling through the platelet glycoprotein Ib-V-IX complex.'
p46666
aS'JOURNAL'
p46667
aS'Cell Signal 16:1329-44 (2004)'
p46668
aS'PMID:11331578'
p46669
ag46669
aS'AUTHORS'
p46670
aS'Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fassler R.'
p46671
aS'TITLE'
p46672
aS'Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen.'
p46673
aS'JOURNAL'
p46674
aS'EMBO J 20:2120-30 (2001)'
p46675
aS'PMID:12736199'
p46676
ag46676
aS'AUTHORS'
p46677
aS'Martin PT.'
p46678
aS'TITLE'
p46679
aS'Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.'
p46680
aS'JOURNAL'
p46681
aS'Glycobiology 13:55R-66R (2003)'
p46682
aS'PMID:15229478'
p46683
ag46683
aS'AUTHORS'
p46684
aS'Toole BP.'
p46685
aS'TITLE'
p46686
aS'Hyaluronan: from extracellular glue to pericellular cue.'
p46687
aS'JOURNAL'
p46688
aS'Nat Rev Cancer 4:528-39 (2004)'
p46689
aS'PMID:12845610'
p46690
ag46690
aS'AUTHORS'
p46691
aS'Bosman FT, Stamenkovic I.'
p46692
aS'TITLE'
p46693
aS'Functional structure and composition of the extracellular matrix.'
p46694
aS'JOURNAL'
p46695
aS'J Pathol 200:423-8 (2003)'
p46696
asS'KO_PATHWAY'
p46697
(lp46698
S'ko04512'
p46699
asS'PATHWAY_MAP'
p46700
(lp46701
S'map04512'
p46702
asS'DISEASE'
p46703
(lp46704
S'H00219'
p46705
aS'Hemophilia'
p46706
ag46705
ag46706
aS'H00224'
p46707
aS'Bernard-Soulier syndrome'
p46708
aS'H00226'
p46709
aS'Glanzmann thrombasthenia'
p46710
aS'H00576'
p46711
aS'Pierson syndrome'
p46712
aS'H00579'
p46713
aS'Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC)'
p46714
aS'H00581'
p46715
aS'Alport syndrome'
p46716
aS'H00582'
p46717
aS'Benign familial hematuria'
p46718
aS'H00585'
p46719
aS'Epidermolysis bullosa, hemidesmosomal'
p46720
aS'H00586'
p46721
aS'Epidermolysis bullosa, junctional'
p46722
aS'H00770'
p46723
aS'Congenital myasthenic syndrome'
p46724
aS'H00802'
p46725
aS'Ehlers-Danlos syndrome (EDS)'
p46726
aS'H00805'
p46727
aS'Vitreoretinal degeneration'
p46728
aS'H00813'
p46729
aS'Laryngo onycho cutaneous syndrome'
p46730
aS'H00839'
p46731
aS'Porencephaly'
p46732
aS'H00877'
p46733
aS'Brain small vessel disease with Axenfeld-Rieger anomaly'
p46734
aS'H01260'
p46735
aS'Glomerulopathy with fibronectin deposits (GFND)'
p46736
aS'H01338'
p46737
aS'Myosclerosis'
p46738
aS'H01340'
p46739
aS'Bethlem myopathy'
p46740
aS'H01341'
p46741
aS'Collagen VI myopathy'
p46742
asS'DBLINKS'
p46743
(lp46744
S'GO: 0005201'
p46745
asS'ENTRY'
p46746
(lp46747
S'map04512'
p46748
aS'Pathway'
p46749
asS'CLASS'
p46750
(lp46751
S'Environmental Information Processing Signaling molecules and interaction'
p46752
asS'DESCRIPTION'
p46753
(lp46754
S'The extracellular matrix (ECM) consists of a complex mixture of structural and functional macromolecules and serves an important role in tissue and organ morphogenesis and in the maintenance of cell and tissue structure and function. Specific interactions between cells and the ECM are mediated by transmembrane molecules, mainly integrins and perhaps also proteoglycans, CD36, or other cell-surface-associated components. These interactions lead to a direct or indirect control of cellular activities such as adhesion, migration, differentiation, proliferation, and apoptosis. In addition, integrins function as mechanoreceptors and provide a force-transmitting physical link between the ECM and the cytoskeleton. Integrins are a family of glycosylated, heterodimeric transmembrane adhesion receptors that consist of noncovalently bound alpha- and beta-subunits.'
p46755
assS'path:map01064'
p46756
(dp46757
S'ENTRY'
p46758
(lp46759
S'map01064'
p46760
aS'Pathway'
p46761
asS'PATHWAY_MAP'
p46762
(lp46763
S'map01064'
p46764
asS'NAME'
p46765
(lp46766
S'Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid'
p46767
asS'KO_PATHWAY'
p46768
(lp46769
S'ko01064'
p46770
assS'path:map07219'
p46771
(dp46772
S'ENTRY'
p46773
(lp46774
S'map07219'
p46775
aS'Drug'
p46776
aS'Pathway'
p46777
asS'PATHWAY_MAP'
p46778
(lp46779
S'map07219'
p46780
asS'NAME'
p46781
(lp46782
S'Cyclooxygenase inhibitors'
p46783
asS'REFERENCE'
p46784
(lp46785
g22
ag22
aS'AUTHORS'
p46786
aS'Fukai S.'
p46787
aS'TITLE'
p46788
aS'[New Drugs Today (6th ed)] (In Japanese)'
p46789
aS'JOURNAL'
p46790
aS'Jiho (1995)'
p46791
ag22
ag22
aS'AUTHORS'
p46792
aS'Tanaka C, Kato R (eds).'
p46793
aS'TITLE'
p46794
aS'[New Pharmacology (4th ed)] (In Japanese)'
p46795
aS'JOURNAL'
p46796
aS'Nankodo (2002)'
p46797
ag22
ag22
aS'AUTHORS'
p46798
aS'Japan Pharmaceutical Association (ed).'
p46799
aS'TITLE'
p46800
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p46801
aS'JOURNAL'
p46802
aS'Yakuji Nippo (1999)'
p46803
ag22
ag22
aS'AUTHORS'
p46804
aS'Noguchi S, Hibino S (eds).'
p46805
aS'TITLE'
p46806
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p46807
aS'JOURNAL'
p46808
aS'Hirokawa (2002)'
p46809
ag22
ag22
aS'AUTHORS'
p46810
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p46811
aS'TITLE'
p46812
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p46813
aS'JOURNAL'
p46814
aS'McGraw-Hill (2001)'
p46815
ag22
ag22
aS'AUTHORS'
p46816
aS'Walter S.'
p46817
aS'TITLE'
p46818
aS'Drug Discovery: A History'
p46819
aS'JOURNAL'
p46820
aS'Wiley (2005)'
p46821
ag22
ag22
aS'AUTHORS'
p46822
aS'David AW, Thomas LL, William OF.'
p46823
aS'TITLE'
p46824
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p46825
aS'JOURNAL'
p46826
aS'Lippincott Williams & Wilkins (2002)'
p46827
ag22
ag22
aS'AUTHORS'
p46828
aS'Bertram GK (ed).'
p46829
aS'TITLE'
p46830
aS'Basic & Clinical Pharmacology (9th ed)'
p46831
aS'JOURNAL'
p46832
aS'Lange (2004)'
p46833
asS'COMPOUND'
p46834
(lp46835
S'D00109'
p46836
aS'Aspirin (JP16/USP)'
p46837
ag46836
ag46837
aS'D00118'
p46838
aS'Naproxen (JP16/USP/INN)'
p46839
aS'D00120'
p46840
aS'Sulindac (JP16/USP/INN)'
p46841
aS'D00126'
p46842
aS'Ibuprofen (JP16/USP/INN)'
p46843
aS'D00127'
p46844
aS'Piroxicam (JP16/USP/INN)'
p46845
aS'D00130'
p46846
aS'Diflunisal (JAN/USP/INN)'
p46847
aS'D00132'
p46848
aS'Ketoprofen (JP16/USP/INN)'
p46849
aS'D00141'
p46850
aS'Indometacin (JP16/INN)'
p46851
aS'D00151'
p46852
aS'Mefenamic acid (JP16/USP/INN)'
p46853
aS'D00158'
p46854
aS'Tolmetin sodium (JAN/USP)'
p46855
aS'D00169'
p46856
aS'Meclofenamate sodium (USP)'
p46857
aS'D00217'
p46858
aS'Acetaminophen (JP16/USP)'
p46859
aS'D00315'
p46860
aS'Etodolac (JP16/USP/INN)'
p46861
aS'D00330'
p46862
aS'Flurbiprofen (JP16/USP/INN)'
p46863
aS'D00425'
p46864
aS'Nabumetone (JP16/USP/INN)'
p46865
aS'D00463'
p46866
aS'Oxaprozin (JP16/USAN/INN)'
p46867
aS'D00566'
p46868
aS'Sodium salicylate (JP16/USP)'
p46869
aS'D00567'
p46870
aS'Celecoxib (JAN/USAN/INN)'
p46871
aS'D00568'
p46872
aS'Rofecoxib (JAN/USAN/INN)'
p46873
aS'D00903'
p46874
aS'Diclofenac potassium (USAN)'
p46875
aS'D00904'
p46876
aS'Diclofenac sodium (JP16/USP)'
p46877
aS'D00968'
p46878
aS'Fenoprofen calcium (JAN/USP)'
p46879
aS'D00969'
p46880
aS'Meloxicam (JAN/USAN/INN)'
p46881
aS'D00970'
p46882
aS'Naproxen sodium (USP)'
p46883
aS'D01122'
p46884
aS'Ibuprofen piconol (JP16/USAN)'
p46885
aS'D01183'
p46886
aS'Tolfenamic acid (JAN/INN)'
p46887
aS'D01325'
p46888
aS'Tiaprofenic acid (JAN/INN)'
p46889
aS'D01397'
p46890
aS'Ampiroxicam (JAN/INN)'
p46891
aS'D01475'
p46892
aS'Flurbiprofen axetil (JAN)'
p46893
aS'D01547'
p46894
aS'Zaltoprofen (JP16/INN)'
p46895
aS'D01565'
p46896
aS'Indometacin farnesil (JAN)'
p46897
aS'D01578'
p46898
aS'Pranoprofen (JP16/INN)'
p46899
aS'D01581'
p46900
aS'Flufenamic acid (JAN/USAN/INN)'
p46901
aS'D01582'
p46902
aS'Acemetacin (JP16/INN)'
p46903
aS'D01709'
p46904
aS'Loxoprofen sodium hydrate (JP16)'
p46905
aS'D01718'
p46906
aS'Mofezolac (JAN/INN)'
p46907
aS'D01765'
p46908
aS'Proglumetacin maleate (JAN)'
p46909
aS'D01767'
p46910
aS'Tenoxicam (JAN/USAN/INN)'
p46911
aS'D01788'
p46912
aS'Amfenac sodium hydrate (JAN)'
p46913
aS'D01811'
p46914
aS'Salicylamide (JAN/USP/INN)'
p46915
aS'D01866'
p46916
aS'Lornoxicam (JAN/USAN/INN)'
p46917
aS'D02110'
p46918
aS'Indometacin sodium (JAN)'
p46919
aS'D02290'
p46920
aS'Flurbiprofen sodium (USP)'
p46921
aS'D02341'
p46922
aS'Meclofenamic acid (USAN/INN)'
p46923
aS'D02350'
p46924
aS'Fenoprofen (USAN/INN)'
p46925
aS'D02355'
p46926
aS'Tolmetin (USAN/INN)'
p46927
aS'D02709'
p46928
aS'Valdecoxib (USAN/INN)'
p46929
aS'D03254'
p46930
aS'Flufenamate aluminum (JAN)'
p46931
aS'D03710'
p46932
aS'Etoricoxib (USAN/INN)'
p46933
aS'D03715'
p46934
aS'Dexibuprofen (USAN/INN)'
p46935
aS'D03718'
p46936
aS'Dexibuprofen lysine (USAN)'
p46937
aS'D05511'
p46938
aS'Piroxicam betadex (USAN)'
p46939
aS'D05513'
p46940
aS'Piroxicam olamine (USAN)'
p46941
aS'D06606'
p46942
aS'Ibuprofen lysine (USAN)'
p46943
aS'D07443'
p46944
aS'Amfenac (INN)'
p46945
assS'path:map04350'
p46946
(dp46947
S'NAME'
p46948
(lp46949
S'TGF-beta signaling pathway'
p46950
asS'REFERENCE'
p46951
(lp46952
S'PMID:12809600'
p46953
ag46953
aS'AUTHORS'
p46954
aS'Shi Y, Massague J.'
p46955
aS'TITLE'
p46956
aS'Mechanisms of TGF-beta signaling from cell membrane to the nucleus.'
p46957
aS'JOURNAL'
p46958
aS'Cell 113:685-700 (2003)'
p46959
aS'PMID:14534577'
p46960
ag46960
aS'AUTHORS'
p46961
aS'Derynck R, Zhang YE.'
p46962
aS'TITLE'
p46963
aS'Smad-dependent and Smad-independent pathways in TGF-beta family signalling.'
p46964
aS'JOURNAL'
p46965
aS'Nature 425:577-84 (2003)'
p46966
aS'PMID:11252892'
p46967
ag46967
aS'AUTHORS'
p46968
aS'Massague J.'
p46969
aS'TITLE'
p46970
aS'How cells read TGF-beta signals.'
p46971
aS'JOURNAL'
p46972
aS'Nat Rev Mol Cell Biol 1:169-78 (2000)'
p46973
aS'PMID:14557817'
p46974
ag46974
aS'AUTHORS'
p46975
aS'Siegel PM, Massague J.'
p46976
aS'TITLE'
p46977
aS'Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.'
p46978
aS'JOURNAL'
p46979
aS'Nat Rev Cancer 3:807-21 (2003)'
p46980
aS'PMID:14769828'
p46981
ag46981
aS'AUTHORS'
p46982
aS'Shimasaki S, Moore RK, Otsuka F, Erickson GF.'
p46983
aS'TITLE'
p46984
aS'The bone morphogenetic protein system in mammalian reproduction.'
p46985
aS'JOURNAL'
p46986
aS'Endocr Rev 25:72-101 (2004)'
p46987
aS'PMID:11252746'
p46988
ag46988
aS'AUTHORS'
p46989
aS'De Robertis EM, Larrain J, Oelgeschlager M, Wessely O.'
p46990
aS'TITLE'
p46991
aS"The establishment of Spemann's organizer and patterning of the vertebrate embryo."
p46992
aS'JOURNAL'
p46993
aS'Nat Rev Genet 1:171-81 (2000)'
p46994
aS'PMID:12163231'
p46995
ag46995
aS'AUTHORS'
p46996
aS'Gumienny TL, Padgett RW.'
p46997
aS'TITLE'
p46998
aS'The other side of TGF-beta superfamily signal regulation: thinking outside the cell.'
p46999
aS'JOURNAL'
p47000
aS'Trends Endocrinol Metab 13:295-9 (2002)'
p47001
aS'PMID:11836504'
p47002
ag47002
aS'AUTHORS'
p47003
aS'Hamada H, Meno C, Watanabe D, Saijoh Y.'
p47004
aS'TITLE'
p47005
aS'Establishment of vertebrate left-right asymmetry.'
p47006
aS'JOURNAL'
p47007
aS'Nat Rev Genet 3:103-13 (2002)'
p47008
aS'PMID:12466190'
p47009
ag47009
aS'AUTHORS'
p47010
aS'Chang H, Brown CW, Matzuk MM.'
p47011
aS'TITLE'
p47012
aS'Genetic analysis of the mammalian transforming growth factor-beta superfamily.'
p47013
aS'JOURNAL'
p47014
aS'Endocr Rev 23:787-823 (2002)'
p47015
aS'PMID:10021351'
p47016
ag47016
aS'AUTHORS'
p47017
aS'Morita K, Chow KL, Ueno N.'
p47018
aS'TITLE'
p47019
aS'Regulation of body length and male tail ray pattern formation of Caenorhabditis elegans by a member of TGF-beta family.'
p47020
aS'JOURNAL'
p47021
aS'Development 126:1337-47 (1999)'
p47022
aS'PMID:9847239'
p47023
ag47023
aS'AUTHORS'
p47024
aS'Krishna S, Maduzia LL, Padgett RW.'
p47025
aS'TITLE'
p47026
aS'Specificity of TGFbeta signaling is conferred by distinct type I receptors and their associated SMAD proteins in Caenorhabditis elegans.'
p47027
aS'JOURNAL'
p47028
aS'Development 126:251-60 (1999)'
p47029
aS'PMID:15063168'
p47030
ag47030
aS'AUTHORS'
p47031
aS'Chen Y, Mironova E, Whitaker LL, Edwards L, Yost HJ, Ramsdell AF.'
p47032
aS'TITLE'
p47033
aS'ALK4 functions as a receptor for multiple TGF beta-related ligands to regulate left-right axis determination and mesoderm induction in Xenopus.'
p47034
aS'JOURNAL'
p47035
aS'Dev Biol 268:280-94 (2004)'
p47036
aS'PMID:10519551'
p47037
ag47037
aS'AUTHORS'
p47038
aS'Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J, Niehrs C'
p47039
aS'TITLE'
p47040
aS'Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.'
p47041
aS'JOURNAL'
p47042
aS'Nature 401:480-5 (1999)'
p47043
aS'PMID:19758997'
p47044
ag47044
aS'AUTHORS'
p47045
aS'Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y, Chen YG'
p47046
aS'TITLE'
p47047
aS'Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling.'
p47048
aS'JOURNAL'
p47049
aS'J Biol Chem 284:30097-104 (2009)'
p47050
asS'KO_PATHWAY'
p47051
(lp47052
S'ko04350'
p47053
asS'PATHWAY_MAP'
p47054
(lp47055
S'map04350'
p47056
asS'DISEASE'
p47057
(lp47058
S'H00409'
p47059
aS'Type II diabetes mellitus'
p47060
ag47059
ag47060
aS'H00430'
p47061
aS'Fibrodysplasia ossificans progressiva (FOP)'
p47062
aS'H00431'
p47063
aS'Ossification of the posterior longitudinal ligament of spine (OPLL)'
p47064
aS'H00434'
p47065
aS'Camurati-Engelmann disease'
p47066
aS'H00466'
p47067
aS'Grebe dysplasia'
p47068
aS'H00467'
p47069
aS'Fibular hypoplasia and complex brachydactyly'
p47070
aS'H00468'
p47071
aS'Acromesomelic dysplasia with genital anomalies'
p47072
aS'H00482'
p47073
aS'Brachydactyly'
p47074
aS'H00483'
p47075
aS'Brachydactyly'
p47076
aS'H00484'
p47077
aS'Other brachydactylies'
p47078
aS'H00533'
p47079
aS'Hereditary hemorrhagic telangiectasia (HHT)'
p47080
aS'H00609'
p47081
aS'46,XY disorders of sex development (Other)'
p47082
aS'H00620'
p47083
aS'Axenfeld-Rieger syndrome (ARS)'
p47084
aS'H00632'
p47085
aS'Heterotaxy'
p47086
aS'H00778'
p47087
aS'Tarsal-carpal coalition syndrome'
p47088
aS'H00800'
p47089
aS'Loeys-Dietz syndrome (LDS)'
p47090
aS'H00801'
p47091
aS'Familial thoracic aortic aneurysm and dissection (TAAD)'
p47092
aS'H00852'
p47093
aS'Klippel-Feil syndrome(KFS)'
p47094
aS'H00868'
p47095
aS'Stapes ankylosis with broad thumb and toes'
p47096
aS'H00958'
p47097
aS'Congenital stromal corneal dystrophy (CSCD)'
p47098
aS'H01023'
p47099
aS'Juvenile polyposis syndrome'
p47100
aS'H01024'
p47101
aS'Hereditary mixed polyposis syndrome'
p47102
aS'H01027'
p47103
aS'Anophthalmia and microphthalmia (A/M)'
p47104
aS'H01075'
p47105
aS'Peters anomaly'
p47106
aS'H01149'
p47107
aS'Ring dermoid of cornea'
p47108
aS'H01300'
p47109
aS'Primary pulmonary hypertension (PPH)'
p47110
aS'H01385'
p47111
aS'Rienhoff syndrome'
p47112
asS'MODULE'
p47113
(lp47114
S'M00679'
p47115
aS'BMP signaling [PATH:map04350]'
p47116
ag47115
ag47116
aS'M00680'
p47117
aS'TGF-beta signaling [PATH:map04350]'
p47118
aS'M00681'
p47119
aS'Activin signaling [PATH:map04350]'
p47120
asS'DBLINKS'
p47121
(lp47122
S'GO: 0007179'
p47123
asS'ENTRY'
p47124
(lp47125
S'map04350'
p47126
aS'Pathway'
p47127
asS'CLASS'
p47128
(lp47129
S'Environmental Information Processing Signal transduction'
p47130
asS'DESCRIPTION'
p47131
(lp47132
S'The transforming growth factor-beta (TGF-beta) family members, which include TGF-betas, activins and bone morphogenetic proteins (BMPs), are structurally related secreted cytokines found in species ranging from worms and insects to mammals. A wide spectrum of cellular functions such as proliferation, apoptosis, differentiation and migration are regulated by TGF-beta family members. TGF-beta family member binds to the Type II receptor and recruits Type I, whereby Type II receptor phosphorylates and activates Type I. The Type I receptor, in turn, phosphorylates receptor-activated Smads ( R-Smads: Smad1, Smad2, Smad3, Smad5, and Smad8). Once phosphorylated, R-Smads associate with the co-mediator Smad, Smad4, and the heteromeric complex then translocates into the nucleus. In the nucleus, Smad complexes activate specific genes through cooperative interactions with other DNA-binding and coactivator (or co-repressor) proteins.'
p47133
assS'path:map04210'
p47134
(dp47135
S'NAME'
p47136
(lp47137
S'Apoptosis'
p47138
asS'REFERENCE'
p47139
(lp47140
S'(Japanese)'
p47141
ag47141
aS'AUTHORS'
p47142
aS'Murakawa M, Yonehara S.'
p47143
aS'TITLE'
p47144
aS'[Apoptosis induced by death receptors.] (In Japanese)'
p47145
aS'JOURNAL'
p47146
aS'Experimental Medicine 19(13):1690-1694 (2001)'
p47147
aS'PMID:14663476'
p47148
ag47148
aS'AUTHORS'
p47149
aS'Kucharczak J, Simmons MJ, Fan Y, Gelinas C.'
p47150
aS'TITLE'
p47151
aS'To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis.'
p47152
aS'JOURNAL'
p47153
aS'Oncogene 22:8961-82 (2003)'
p47154
aS'PMID:14996498'
p47155
ag47155
aS'AUTHORS'
p47156
aS'Donovan M, Cotter TG.'
p47157
aS'TITLE'
p47158
aS'Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death.'
p47159
aS'JOURNAL'
p47160
aS'Biochim Biophys Acta 1644:133-47 (2004)'
p47161
aS'PMID:14996497'
p47162
ag47162
aS'AUTHORS'
p47163
aS'Sprick MR, Walczak H.'
p47164
aS'TITLE'
p47165
aS'The interplay between the Bcl-2 family and death receptor-mediated apoptosis.'
p47166
aS'JOURNAL'
p47167
aS'Biochim Biophys Acta 1644:125-32 (2004)'
p47168
aS'PMID:10690403'
p47169
ag47169
aS'AUTHORS'
p47170
aS'Nagata S.'
p47171
aS'TITLE'
p47172
aS'Fas ligand-induced apoptosis.'
p47173
aS'JOURNAL'
p47174
aS'Annu Rev Genet 33:29-55 (1999)'
p47175
aS'(Japanese)'
p47176
ag47176
aS'AUTHORS'
p47177
aS'Suda T.'
p47178
aS'TITLE'
p47179
aS'[The apoptosis is Kin to the inflammation.] (In Japanese)'
p47180
aS'JOURNAL'
p47181
aS'Experimental Medicine 19(13):1790-1797 (2001)'
p47182
aS'PMID:11048732'
p47183
ag47183
aS'AUTHORS'
p47184
aS'Yuan J, Yankner BA.'
p47185
aS'TITLE'
p47186
aS'Apoptosis in the nervous system.'
p47187
aS'JOURNAL'
p47188
aS'Nature 407:802-9 (2000)'
p47189
aS'PMID:14556717'
p47190
ag47190
aS'AUTHORS'
p47191
aS'Yuan J, Lipinski M, Degterev A.'
p47192
aS'TITLE'
p47193
aS'Diversity in the mechanisms of neuronal cell death.'
p47194
aS'JOURNAL'
p47195
aS'Neuron 40:401-13 (2003)'
p47196
aS'PMID:14737178'
p47197
ag47197
aS'AUTHORS'
p47198
aS'Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA.'
p47199
aS'TITLE'
p47200
aS'JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.'
p47201
aS'JOURNAL'
p47202
aS'Leukemia 18:189-218 (2004)'
p47203
aS'PMID:10692573'
p47204
ag47204
aS'AUTHORS'
p47205
aS'Martinon F, Holler N, Richard C, Tschopp J.'
p47206
aS'TITLE'
p47207
aS'Activation of a pro-apoptotic amplification loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of RIP.'
p47208
aS'JOURNAL'
p47209
aS'FEBS Lett 468:134-6 (2000)'
p47210
aS'PMID:11290317'
p47211
ag47211
aS'AUTHORS'
p47212
aS'Goyal L.'
p47213
aS'TITLE'
p47214
aS'Cell death inhibition: keeping caspases in check.'
p47215
aS'JOURNAL'
p47216
aS'Cell 104:805-8 (2001)'
p47217
aS'PMID:10195903'
p47218
ag47218
aS'AUTHORS'
p47219
aS'Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF, Reed JC.'
p47220
aS'TITLE'
p47221
aS'Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.'
p47222
aS'JOURNAL'
p47223
aS'Science 284:339-43 (1999)'
p47224
aS'PMID:14656699'
p47225
ag47225
aS'AUTHORS'
p47226
aS'Remillard CV, Yuan JX.'
p47227
aS'TITLE'
p47228
aS'Activation of K+ channels: an essential pathway in programmed cell death.'
p47229
aS'JOURNAL'
p47230
aS'Am J Physiol Lung Cell Mol Physiol 286:L49-67 (2004)'
p47231
aS'PMID:9670005'
p47232
ag47232
aS'AUTHORS'
p47233
aS'Gross A, Jockel J, Wei MC, Korsmeyer SJ.'
p47234
aS'TITLE'
p47235
aS'Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis.'
p47236
aS'JOURNAL'
p47237
aS'EMBO J 17:3878-85 (1998)'
p47238
asS'KO_PATHWAY'
p47239
(lp47240
S'ko04210'
p47241
asS'PATHWAY_MAP'
p47242
(lp47243
S'map04210'
p47244
asS'DISEASE'
p47245
(lp47246
S'H00108'
p47247
aS'Autoimmune lymphoproliferative syndromes (ALPS)'
p47248
ag47247
ag47248
aS'H00265'
p47249
aS'Hereditary sensory and autonomic neuropathy (HSAN)'
p47250
aS'H00539'
p47251
aS'PTEN hamartoma tumor syndrome (PHTS)'
p47252
aS'H00540'
p47253
aS'Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID)'
p47254
aS'H00645'
p47255
aS'Incontinentia pigmenti'
p47256
aS'H00721'
p47257
aS'Pyogenic bacterial infections, recurrent, due to MYD88 deficiency'
p47258
aS'H00848'
p47259
aS'Ataxia with ocular apraxia (AOA)'
p47260
aS'H00881'
p47261
aS'Li-Fraumeni syndrome'
p47262
aS'H00882'
p47263
aS'Cocoon syndrome'
p47264
aS'H00912'
p47265
aS'Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)'
p47266
aS'H01007'
p47267
aS'Choroid plexus papilloma'
p47268
aS'H01102'
p47269
aS'Pituitary adenomas'
p47270
asS'MODULE'
p47271
(lp47272
S'M00685'
p47273
aS'Apoptotic machinery [PATH:map04210]'
p47274
asS'DBLINKS'
p47275
(lp47276
S'GO: 0006915'
p47277
asS'ENTRY'
p47278
(lp47279
S'map04210'
p47280
aS'Pathway'
p47281
asS'CLASS'
p47282
(lp47283
S'Cellular Processes Cell growth and death'
p47284
asS'DESCRIPTION'
p47285
(lp47286
S'Apoptosis is a genetically controlled mechanisms of cell death involved in the regulation of tissue homeostasis. The 2 major pathways of apoptosis are the extrinsic (Fas and other TNFR superfamily members and ligands) and the intrinsic (mitochondria-associated) pathways, both of which are found in the cytoplasm. The extrinsic pathway is triggered by death receptor engagement, which initiates a signaling cascade mediated by caspase-8 activation. Caspase-8 both feeds directly into caspase-3 activation and stimulates the release of cytochrome c by the mitochondria. Caspase-3 activation leads to the degradation of cellular proteins necessary to maintain cell survival and integrity. The intrinsic pathway occurs when various apoptotic stimuli trigger the release of cytochrome c from the mitochondria (independently of caspase-8 activation). Cytochrome c interacts with Apaf-1 and caspase-9 to promote the activation of caspase-3. Recent studies point to the ER as a third subcellular compartment implicated in apoptotic execution. Alterations in Ca2+ homeostasis and accumulation of misfolded proteins in the ER cause ER stress. Prolonged ER stress can result in the activation of BAD and/or caspase-12, and execute apoptosis.'
p47287
assS'path:map04068'
p47288
(dp47289
S'NAME'
p47290
(lp47291
S'FoxO signaling pathway'
p47292
asS'REFERENCE'
p47293
(lp47294
S'PMID:17470511'
p47295
ag47295
aS'AUTHORS'
p47296
aS'Glauser DA, Schlegel W'
p47297
aS'TITLE'
p47298
aS'The emerging role of FOXO transcription factors in pancreatic beta cells.'
p47299
aS'JOURNAL'
p47300
aS'J Endocrinol 193:195-207 (2007)'
p47301
aS'PMID:17522590'
p47302
ag47302
aS'AUTHORS'
p47303
aS'van der Horst A, Burgering BM'
p47304
aS'TITLE'
p47305
aS'Stressing the role of FoxO proteins in lifespan and disease.'
p47306
aS'JOURNAL'
p47307
aS'Nat Rev Mol Cell Biol 8:440-50 (2007)'
p47308
aS'PMID:21440011'
p47309
ag47309
aS'AUTHORS'
p47310
aS'Zhang X, Tang N, Hadden TJ, Rishi AK'
p47311
aS'TITLE'
p47312
aS'Akt, FoxO and regulation of apoptosis.'
p47313
aS'JOURNAL'
p47314
aS'Biochim Biophys Acta 1813:1978-86 (2011)'
p47315
aS'PMID:23325358'
p47316
ag47316
aS'AUTHORS'
p47317
aS'Eijkelenboom A, Burgering BM'
p47318
aS'TITLE'
p47319
aS'FOXOs: signalling integrators for homeostasis maintenance.'
p47320
aS'JOURNAL'
p47321
aS'Nat Rev Mol Cell Biol 14:83-97 (2013)'
p47322
aS'PMID:17569704'
p47323
ag47323
aS'AUTHORS'
p47324
aS'Daitoku H, Fukamizu A'
p47325
aS'TITLE'
p47326
aS'FOXO transcription factors in the regulatory networks of longevity.'
p47327
aS'JOURNAL'
p47328
aS'J Biochem 141:769-74 (2007)'
p47329
aS'PMID:19701188'
p47330
ag47330
aS'AUTHORS'
p47331
aS'Hedrick SM'
p47332
aS'TITLE'
p47333
aS'The cunning little vixen: Foxo and the cycle of life and death.'
p47334
aS'JOURNAL'
p47335
aS'Nat Immunol 10:1057-63 (2009)'
p47336
aS'PMID:15516968'
p47337
ag47337
aS'AUTHORS'
p47338
aS'Coffer PJ, Burgering BM'
p47339
aS'TITLE'
p47340
aS'Forkhead-box transcription factors and their role in the immune system.'
p47341
aS'JOURNAL'
p47342
aS'Nat Rev Immunol 4:889-99 (2004)'
p47343
aS'PMID:22902436'
p47344
ag47344
aS'AUTHORS'
p47345
aS'Ro SH, Liu D, Yeo H, Paik JH'
p47346
aS'TITLE'
p47347
aS'FoxOs in neural stem cell fate decision.'
p47348
aS'JOURNAL'
p47349
aS'Arch Biochem Biophys 534:55-63 (2013)'
p47350
aS'PMID:18403263'
p47351
ag47351
aS'AUTHORS'
p47352
aS'Maiese K, Chong ZZ, Shang YC'
p47353
aS'TITLE'
p47354
aS'OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.'
p47355
aS'JOURNAL'
p47356
aS'Trends Mol Med 14:219-27 (2008)'
p47357
aS'PMID:23801966'
p47358
ag47358
aS'AUTHORS'
p47359
aS'Hagenbuchner J, Ausserlechner MJ'
p47360
aS'TITLE'
p47361
aS'Mitochondria and FOXO3: breath or die.'
p47362
aS'JOURNAL'
p47363
aS'Front Physiol 4:147 (2013)'
p47364
aS'PMID:18045156'
p47365
ag47365
aS'AUTHORS'
p47366
aS'Maiese K, Chong ZZ, Shang YC'
p47367
aS'TITLE'
p47368
aS'"Sly as a FOXO": new paths with Forkhead signaling in the brain.'
p47369
aS'JOURNAL'
p47370
aS'Curr Neurovasc Res 4:295-302 (2007)'
p47371
aS'PMID:22761423'
p47372
ag47372
aS'AUTHORS'
p47373
aS'Oh HM, Yu CR, Dambuza I, Marrero B, Egwuagu CE'
p47374
aS'TITLE'
p47375
aS'STAT3 protein interacts with Class O Forkhead transcription factors in the cytoplasm and regulates nuclear/cytoplasmic localization of FoxO1 and FoxO3a proteins in CD4(+) T cells.'
p47376
aS'JOURNAL'
p47377
aS'J Biol Chem 287:30436-43 (2012)'
p47378
aS'PMID:21238503'
p47379
ag47379
aS'AUTHORS'
p47380
aS'Huang H, Tindall DJ'
p47381
aS'TITLE'
p47382
aS'Regulation of FOXO protein stability via ubiquitination and proteasome degradation.'
p47383
aS'JOURNAL'
p47384
aS'Biochim Biophys Acta 1813:1961-4 (2011)'
p47385
aS'PMID:16288288'
p47386
ag47386
aS'AUTHORS'
p47387
aS'Greer EL, Brunet A'
p47388
aS'TITLE'
p47389
aS'FOXO transcription factors at the interface between longevity and tumor suppression.'
p47390
aS'JOURNAL'
p47391
aS'Oncogene 24:7410-25 (2005)'
p47392
aS'PMID:15084259'
p47393
ag47393
aS'AUTHORS'
p47394
aS'Seoane J, Le HV, Shen L, Anderson SA, Massague J'
p47395
aS'TITLE'
p47396
aS'Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.'
p47397
aS'JOURNAL'
p47398
aS'Cell 117:211-23 (2004)'
p47399
aS'PMID:18951090'
p47400
ag47400
aS'AUTHORS'
p47401
aS'Yamagata K, Daitoku H, Takahashi Y, Namiki K, Hisatake K, Kako K, Mukai H, Kasuya Y, Fukamizu A'
p47402
aS'TITLE'
p47403
aS'Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.'
p47404
aS'JOURNAL'
p47405
aS'Mol Cell 32:221-31 (2008)'
p47406
aS'PMID:16964248'
p47407
ag47407
aS'AUTHORS'
p47408
aS'van der Horst A, de Vries-Smits AM, Brenkman AB, van Triest MH, van den Broek N, Colland F, Maurice MM, Burgering BM'
p47409
aS'TITLE'
p47410
aS'FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP.'
p47411
aS'JOURNAL'
p47412
aS'Nat Cell Biol 8:1064-73 (2006)'
p47413
aS'PMID:21613825'
p47414
ag47414
aS'AUTHORS'
p47415
aS'Zhang Y, Gan B, Liu D, Paik JH'
p47416
aS'TITLE'
p47417
aS'FoxO family members in cancer.'
p47418
aS'JOURNAL'
p47419
aS'Cancer Biol Ther 12:253-9 (2011)'
p47420
aS'PMID:15005655'
p47421
ag47421
aS'AUTHORS'
p47422
aS'Van Der Heide LP, Hoekman MF, Smidt MP'
p47423
aS'TITLE'
p47424
aS'The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.'
p47425
aS'JOURNAL'
p47426
aS'Biochem J 380:297-309 (2004)'
p47427
asS'KO_PATHWAY'
p47428
(lp47429
S'ko04068'
p47430
asS'PATHWAY_MAP'
p47431
(lp47432
S'map04068'
p47433
asS'DISEASE'
p47434
(lp47435
S'H01385'
p47436
aS'Rienhoff syndrome'
p47437
asS'MODULE'
p47438
(lp47439
S'M00676'
p47440
aS'PI3K-Akt signaling [PATH:map04068]'
p47441
asS'DBLINKS'
p47442
(lp47443
S'GO: 0009267'
p47444
asS'ENTRY'
p47445
(lp47446
S'map04068'
p47447
aS'Pathway'
p47448
asS'CLASS'
p47449
(lp47450
S'Environmental Information Processing Signal transduction'
p47451
asS'DESCRIPTION'
p47452
(lp47453
S'The forkhead box O (FOXO) family of transcription factors regulates the expression of genes in cellular physiological events including apoptosis, cell-cycle control, glucose metabolism, oxidative stress resistance, and longevity. A central regulatory mechanism of FOXO proteins is phosphorylation by the serine-threonine kinase Akt/protein kinase B (Akt/PKB), downstream of phosphatidylinositol 3-kinase (PI3K), in response to insulin or several growth factors. Phosphorylation at three conserved residues results in the export of FOXO proteins from the nucleus to the cytoplasm, thereby decreasing expression of FOXO target genes. In contrast, the stress-activated c-Jun N-terminal kinase (JNK) and the energy sensing AMP-activated protein kinase (AMPK), upon oxidative and nutrient stress stimuli phosphorylate and activate FoxOs. Aside from PKB, JNK and AMPK, FOXOs are regulated by multiple players through several post-translational modifications, including phosphorylation, but also acetylation, methylation and ubiquitylation.'
p47454
assS'path:map03320'
p47455
(dp47456
S'NAME'
p47457
(lp47458
S'PPAR signaling pathway'
p47459
asS'REFERENCE'
p47460
(lp47461
S'PMID:15828220'
p47462
ag47462
aS'AUTHORS'
p47463
aS'Takahashi N, Goto T, Kusudo T, Moriyama T, Kawada T.'
p47464
aS'TITLE'
p47465
aS'[The structures and functions of peroxisome proliferator-activated receptors (PPARs)]'
p47466
aS'JOURNAL'
p47467
aS'Nippon Rinsho 63:557-64 (2005)'
p47468
aS'PMID:15828221'
p47469
ag47469
aS'AUTHORS'
p47470
aS'Fujii H.'
p47471
aS'TITLE'
p47472
aS'[PPARs-mediated intracellular signal transduction]'
p47473
aS'JOURNAL'
p47474
aS'Nippon Rinsho 63:565-71 (2005)'
p47475
aS'PMID:15828222'
p47476
ag47476
aS'AUTHORS'
p47477
aS'Takada I, Kato S.'
p47478
aS'TITLE'
p47479
aS'[PPARs target genes]'
p47480
aS'JOURNAL'
p47481
aS'Nippon Rinsho 63:573-7 (2005)'
p47482
aS'PMID:15828223'
p47483
ag47483
aS'AUTHORS'
p47484
aS'Inoue H.'
p47485
aS'TITLE'
p47486
aS'[Endogenous ligands for PPARs]'
p47487
aS'JOURNAL'
p47488
aS'Nippon Rinsho 63:578-83 (2005)'
p47489
aS'PMID:16476485'
p47490
ag47490
aS'AUTHORS'
p47491
aS'Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W.'
p47492
aS'TITLE'
p47493
aS'From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.'
p47494
aS'JOURNAL'
p47495
aS'Prog Lipid Res 45:120-59 (2006)'
p47496
aS'PMID:16601267'
p47497
ag47497
aS'AUTHORS'
p47498
aS'Desvergne B, Michalik L, Wahli W.'
p47499
aS'TITLE'
p47500
aS'Transcriptional regulation of metabolism.'
p47501
aS'JOURNAL'
p47502
aS'Physiol Rev 86:465-514 (2006)'
p47503
aS'PMID:14999402'
p47504
ag47504
aS'AUTHORS'
p47505
aS'Mandard S, Muller M, Kersten S.'
p47506
aS'TITLE'
p47507
aS'Peroxisome proliferator-activated receptor alpha target genes.'
p47508
aS'JOURNAL'
p47509
aS'Cell Mol Life Sci 61:393-416 (2004)'
p47510
aS'PMID:10529898'
p47511
ag47511
aS'AUTHORS'
p47512
aS'Desvergne B, Wahli W.'
p47513
aS'TITLE'
p47514
aS'Peroxisome proliferator-activated receptors: nuclear control of metabolism.'
p47515
aS'JOURNAL'
p47516
aS'Endocr Rev 20:649-88 (1999)'
p47517
aS'PMID:15673477'
p47518
ag47518
aS'AUTHORS'
p47519
aS'Savage DB.'
p47520
aS'TITLE'
p47521
aS'PPARgamma as a metabolic regulator: insights from genomics and pharmacology.'
p47522
aS'JOURNAL'
p47523
aS'Expert Rev Mol Med 2005:1-16 (2005)'
p47524
aS'PMID:16511590'
p47525
ag47525
aS'AUTHORS'
p47526
aS"Semple RK, Chatterjee VK, O'Rahilly S."
p47527
aS'TITLE'
p47528
aS'PPAR gamma and human metabolic disease.'
p47529
aS'JOURNAL'
p47530
aS'J Clin Invest 116:581-9 (2006)'
p47531
aS'PMID:16360030'
p47532
ag47532
aS'AUTHORS'
p47533
aS'Lehrke M, Lazar MA.'
p47534
aS'TITLE'
p47535
aS'The many faces of PPARgamma.'
p47536
aS'JOURNAL'
p47537
aS'Cell 123:993-9 (2005)'
p47538
aS'PMID:11921433'
p47539
ag47539
aS'AUTHORS'
p47540
aS'Hauner H.'
p47541
aS'TITLE'
p47542
aS'The mode of action of thiazolidinediones.'
p47543
aS'JOURNAL'
p47544
aS'Diabetes Metab Res Rev 18 Suppl 2:S10-5 (2002)'
p47545
asS'KO_PATHWAY'
p47546
(lp47547
S'ko03320'
p47548
asS'PATHWAY_MAP'
p47549
(lp47550
S'map03320'
p47551
asS'DISEASE'
p47552
(lp47553
S'H00151'
p47554
aS'Cerebrotendinous xanthomatosis'
p47555
ag47554
ag47555
aS'H00154'
p47556
aS'Hyperlipoproteinemia, type I'
p47557
aS'H00157'
p47558
aS'Hyperlipoproteinemia, type V'
p47559
aS'H00407'
p47560
aS'Peroxisomal beta-oxidation enzyme deficiency'
p47561
aS'H00409'
p47562
aS'Type II diabetes mellitus'
p47563
aS'H00420'
p47564
aS'Familial partial lipodystrophy (FPL)'
p47565
aS'H00552'
p47566
aS'Glycerol kinase deficiency (GKD)'
p47567
aS'H00874'
p47568
aS'Leukoencephalopathy with dystonia and motor neuropathy'
p47569
aS'H00930'
p47570
aS'Hypoalphalipoproteinemia'
p47571
aS'H00967'
p47572
aS'Adiponectin deficiency'
p47573
aS'H01108'
p47574
aS'CD36 deficiency'
p47575
aS'H01199'
p47576
aS'Hyperalphalipoproteinemia'
p47577
asS'ENTRY'
p47578
(lp47579
S'map03320'
p47580
aS'Pathway'
p47581
asS'CLASS'
p47582
(lp47583
S'Organismal Systems Endocrine system'
p47584
asS'DESCRIPTION'
p47585
(lp47586
S'Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that are activated by fatty acids and their derivatives. PPAR has three subtypes (PPARalpha, beta/delta, and gamma) showing different expression patterns in vertebrates. Each of them is encoded in a separate gene and binds fatty acids and eicosanoids. PPARalpha plays a role in the clearance of circulating or cellular lipids via the regulation of gene expression involved in lipid metabolism in liver and skeletal muscle. PPARbeta/delta is involved in lipid oxidation and cell proliferation. PPARgamma promotes adipocyte differentiation to enhance blood glucose uptake.'
p47587
assS'path:map04976'
p47588
(dp47589
S'NAME'
p47590
(lp47591
S'Bile secretion'
p47592
asS'REFERENCE'
p47593
(lp47594
S'PMID:11826283'
p47595
ag47595
aS'AUTHORS'
p47596
aS'Meier PJ, Stieger B'
p47597
aS'TITLE'
p47598
aS'Bile salt transporters.'
p47599
aS'JOURNAL'
p47600
aS'Annu Rev Physiol 64:635-61 (2002)'
p47601
aS'PMID:10728790'
p47602
ag47602
aS'AUTHORS'
p47603
aS'Kullak-Ublick GA, Beuers U, Paumgartner G'
p47604
aS'TITLE'
p47605
aS'Hepatobiliary transport.'
p47606
aS'JOURNAL'
p47607
aS'J Hepatol 32:3-18 (2000)'
p47608
aS'PMID:18668439'
p47609
ag47609
aS'AUTHORS'
p47610
aS'Kosters A, Karpen SJ'
p47611
aS'TITLE'
p47612
aS'Bile acid transporters in health and disease.'
p47613
aS'JOURNAL'
p47614
aS'Xenobiotica 38:1043-71 (2008)'
p47615
aS'PMID:14999673'
p47616
ag47616
aS'AUTHORS'
p47617
aS'Anwer MS'
p47618
aS'TITLE'
p47619
aS'Cellular regulation of hepatic bile acid transport in health and cholestasis.'
p47620
aS'JOURNAL'
p47621
aS'Hepatology 39:581-90 (2004)'
p47622
aS'PMID:17404808'
p47623
ag47623
aS'AUTHORS'
p47624
aS'Alrefai WA, Gill RK'
p47625
aS'TITLE'
p47626
aS'Bile acid transporters: structure, function, regulation and pathophysiological implications.'
p47627
aS'JOURNAL'
p47628
aS'Pharm Res 24:1803-23 (2007)'
p47629
aS'PMID:12663868'
p47630
ag47630
aS'AUTHORS'
p47631
aS'Trauner M, Boyer JL'
p47632
aS'TITLE'
p47633
aS'Bile salt transporters: molecular characterization, function, and regulation.'
p47634
aS'JOURNAL'
p47635
aS'Physiol Rev 83:633-71 (2003)'
p47636
aS'PMID:20103563'
p47637
ag47637
aS'AUTHORS'
p47638
aS'Klaassen CD, Aleksunes LM'
p47639
aS'TITLE'
p47640
aS'Xenobiotic, bile acid, and cholesterol transporters: function and regulation.'
p47641
aS'JOURNAL'
p47642
aS'Pharmacol Rev 62:1-96 (2010)'
p47643
aS'PMID:15758646'
p47644
ag47644
aS'AUTHORS'
p47645
aS'Trauner M, Wagner M, Fickert P, Zollner G'
p47646
aS'TITLE'
p47647
aS'Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.'
p47648
aS'JOURNAL'
p47649
aS'J Clin Gastroenterol 39:S111-24 (2005)'
p47650
aS'PMID:14659471'
p47651
ag47651
aS'AUTHORS'
p47652
ag22
aS'TITLE'
p47653
ag22
aS'JOURNAL'
p47654
ag22
aS'PMID:18837079'
p47655
ag47655
aS'AUTHORS'
p47656
aS'Esteller A'
p47657
aS'TITLE'
p47658
aS'Physiology of bile secretion.'
p47659
aS'JOURNAL'
p47660
aS'World J Gastroenterol 14:5641-9 (2008)'
p47661
aS'PMID:12483266'
p47662
ag47662
aS'AUTHORS'
p47663
aS'Takikawa H'
p47664
aS'TITLE'
p47665
aS'Hepatobiliary transport of bile acids and organic anions.'
p47666
aS'JOURNAL'
p47667
aS'J Hepatobiliary Pancreat Surg 9:443-7 (2002)'
p47668
aS'PMID:11316487'
p47669
ag47669
aS'AUTHORS'
p47670
aS'St-Pierre MV, Kullak-Ublick GA, Hagenbuch B, Meier PJ'
p47671
aS'TITLE'
p47672
aS'Transport of bile acids in hepatic and non-hepatic tissues.'
p47673
aS'JOURNAL'
p47674
aS'J Exp Biol 204:1673-86 (2001)'
p47675
aS'PMID:18670431'
p47676
ag47676
aS'AUTHORS'
p47677
aS'Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K'
p47678
aS'TITLE'
p47679
aS'Targeting bile-acid signalling for metabolic diseases.'
p47680
aS'JOURNAL'
p47681
aS'Nat Rev Drug Discov 7:678-93 (2008)'
p47682
aS'PMID:15975683'
p47683
ag47683
aS'AUTHORS'
p47684
aS'Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ'
p47685
aS'TITLE'
p47686
aS'Enterohepatic transport of bile salts and genetics of cholestasis.'
p47687
aS'JOURNAL'
p47688
aS'J Hepatol 43:342-57 (2005)'
p47689
aS'PMID:18081658'
p47690
ag47690
aS'AUTHORS'
p47691
aS'Pellicoro A, Faber KN'
p47692
aS'TITLE'
p47693
aS'Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport.'
p47694
aS'JOURNAL'
p47695
aS'Aliment Pharmacol Ther 26 Suppl 2:149-60 (2007)'
p47696
aS'PMID:19482594'
p47697
ag47697
aS'AUTHORS'
p47698
aS'Jonker JW, Stedman CA, Liddle C, Downes M'
p47699
aS'TITLE'
p47700
aS'Hepatobiliary ABC transporters: physiology, regulation and implications for disease.'
p47701
aS'JOURNAL'
p47702
aS'Front Biosci 14:4904-20 (2009)'
p47703
aS'PMID:19273385'
p47704
ag47704
aS'AUTHORS'
p47705
aS'Modica S, Bellafante E, Moschetta A'
p47706
aS'TITLE'
p47707
aS'Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio.'
p47708
aS'JOURNAL'
p47709
aS'Front Biosci 14:4719-45 (2009)'
p47710
aS'PMID:16706681'
p47711
ag47711
aS'AUTHORS'
p47712
aS'Cai SY, Boyer JL'
p47713
aS'TITLE'
p47714
aS'FXR: a target for cholestatic syndromes?'
p47715
aS'JOURNAL'
p47716
aS'Expert Opin Ther Targets 10:409-21 (2006)'
p47717
aS'PMID:19273238'
p47718
ag47718
aS'AUTHORS'
p47719
aS'Ballatori N, Li N, Fang F, Boyer JL, Christian WV, Hammond CL'
p47720
aS'TITLE'
p47721
aS'OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids.'
p47722
aS'JOURNAL'
p47723
aS'Front Biosci 14:2829-44 (2009)'
p47724
aS'PMID:18377365'
p47725
ag47725
aS'AUTHORS'
p47726
aS'Roma MG, Crocenzi FA, Sanchez Pozzi EA'
p47727
aS'TITLE'
p47728
aS'Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects.'
p47729
aS'JOURNAL'
p47730
aS'Clin Sci (Lond) 114:567-88 (2008)'
p47731
aS'PMID:18371245'
p47732
ag47732
aS'AUTHORS'
p47733
aS'Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ'
p47734
aS'TITLE'
p47735
aS'Molecular pathogenesis of intrahepatic cholestasis of pregnancy.'
p47736
aS'JOURNAL'
p47737
aS'Expert Rev Mol Med 10:e9 (2008)'
p47738
asS'KO_PATHWAY'
p47739
(lp47740
S'ko04976'
p47741
asS'PATHWAY_MAP'
p47742
(lp47743
S'map04976'
p47744
asS'DISEASE'
p47745
(lp47746
S'H00208'
p47747
aS'Hyperbilirubinemia'
p47748
ag47747
ag47748
aS'H00624'
p47749
aS'Familial cholestasis'
p47750
aS'H00831'
p47751
aS'Primary dystonia'
p47752
aS'H00836'
p47753
aS'GLUT1 deficiency syndrome (GLUT1DS)'
p47754
aS'H00933'
p47755
aS'Hereditary pancreatitis'
p47756
aS'H01016'
p47757
aS'Primary bile acid malabsorption'
p47758
aS'H01213'
p47759
aS'Gallbladder disease'
p47760
aS'H01383'
p47761
aS'LDL Receptor Disorder'
p47762
asS'DBLINKS'
p47763
(lp47764
S'GO: 0032782'
p47765
asS'ENTRY'
p47766
(lp47767
S'map04976'
p47768
aS'Pathway'
p47769
asS'CLASS'
p47770
(lp47771
S'Organismal Systems Digestive system'
p47772
asS'DESCRIPTION'
p47773
(lp47774
S'Bile is a vital secretion, essential for digestion and absorption of fats and fat-soluble vitamins in the small intestine. Moreover, bile is an important route of elimination for excess cholesterol and many waste product, bilirubin, drugs and toxic compounds. Bile secretion depends on the function of membrane transport systems in hepatocytes and cholangiocytes and on the structural and functional integrity of the biliary tree. The hepatocytes generate the so-called primary bile in their canaliculi.'
p47775
assS'path:map04977'
p47776
(dp47777
S'NAME'
p47778
(lp47779
S'Vitamin digestion and absorption'
p47780
asS'REFERENCE'
p47781
(lp47782
S'PMID:16462170'
p47783
ag47783
aS'AUTHORS'
p47784
aS'Said HM, Mohammed ZM'
p47785
aS'TITLE'
p47786
aS'Intestinal absorption of water-soluble vitamins: an update.'
p47787
aS'JOURNAL'
p47788
aS'Curr Opin Gastroenterol 22:140-6 (2006)'
p47789
aS'PMID:14642860'
p47790
ag47790
aS'AUTHORS'
p47791
aS'Basu TK, Donaldson D'
p47792
aS'TITLE'
p47793
aS'Intestinal absorption in health and disease: micronutrients.'
p47794
aS'JOURNAL'
p47795
aS'Best Pract Res Clin Gastroenterol 17:957-79 (2003)'
p47796
aS'PMID:14977409'
p47797
ag47797
aS'AUTHORS'
p47798
aS'Said HM'
p47799
aS'TITLE'
p47800
aS'Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins.'
p47801
aS'JOURNAL'
p47802
aS'Annu Rev Physiol 66:419-46 (2004)'
p47803
aS'PMID:16206251'
p47804
ag47804
aS'AUTHORS'
p47805
aS'Reidling JC, Nabokina SM, Balamurugan K, Said HM'
p47806
aS'TITLE'
p47807
aS'Developmental maturation of intestinal and renal thiamin uptake: studies in wild-type and transgenic mice carrying human THTR-1 and 2 promoters.'
p47808
aS'JOURNAL'
p47809
aS'J Cell Physiol 206:371-7 (2006)'
p47810
aS'PMID:20724488'
p47811
ag47811
aS'AUTHORS'
p47812
aS'Fujimura M, Yamamoto S, Murata T, Yasujima T, Inoue K, Ohta KY, Yuasa H'
p47813
aS'TITLE'
p47814
aS'Functional characteristics of the human ortholog of riboflavin transporter 2 and'
p47815
aS'riboflavin-responsive expression of its rat ortholog in the small intestine indicate its involvement in riboflavin absorption.'
p47816
aS'JOURNAL'
p47817
aS'J Nutr 140:1722-7 (2010)'
p47818
aS'PMID:19056639'
p47819
ag47819
aS'AUTHORS'
p47820
aS'Said HM'
p47821
aS'TITLE'
p47822
aS'Cell and molecular aspects of human intestinal biotin absorption.'
p47823
aS'JOURNAL'
p47824
aS'J Nutr 139:158-62 (2009)'
p47825
aS'PMID:20185591'
p47826
ag47826
aS'AUTHORS'
p47827
aS'Green R'
p47828
aS'TITLE'
p47829
aS'Ins and outs of cellular cobalamin transport.'
p47830
aS'JOURNAL'
p47831
aS'Blood 115:1476-7 (2010)'
p47832
aS'PMID:19173758'
p47833
ag47833
aS'AUTHORS'
p47834
aS'Zhao R, Matherly LH, Goldman ID'
p47835
aS'TITLE'
p47836
aS'Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.'
p47837
aS'JOURNAL'
p47838
aS'Expert Rev Mol Med 11:e4 (2009)'
p47839
aS'PMID:11984580'
p47840
ag47840
aS'AUTHORS'
p47841
aS'Hediger MA'
p47842
aS'TITLE'
p47843
aS'New view at C.'
p47844
aS'JOURNAL'
p47845
aS'Nat Med 8:445-6 (2002)'
p47846
aS'PMID:11340090'
p47847
ag47847
aS'AUTHORS'
p47848
aS'Harrison EH, Hussain MM'
p47849
aS'TITLE'
p47850
aS'Mechanisms involved in the intestinal digestion and absorption of dietary vitamin A.'
p47851
aS'JOURNAL'
p47852
aS'J Nutr 131:1405-8 (2001)'
p47853
aS'PMID:16688755'
p47854
ag47854
aS'AUTHORS'
p47855
aS'Blomhoff R, Blomhoff HK.'
p47856
aS'TITLE'
p47857
aS'Overview of retinoid metabolism and function.'
p47858
aS'JOURNAL'
p47859
aS'J Neurobiol 66:606-30 (2006)'
p47860
aS'PMID:20166147'
p47861
ag47861
aS'AUTHORS'
p47862
aS'Lemaire-Ewing S, Desrumaux C, Neel D, Lagrost L'
p47863
aS'TITLE'
p47864
aS'Vitamin E transport, membrane incorporation and cell metabolism: Is alpha-tocopherol in lipid rafts an oar in the lifeboat?'
p47865
aS'JOURNAL'
p47866
aS'Mol Nutr Food Res 54:631-40 (2010)'
p47867
aS'PMID:18841274'
p47868
ag47868
aS'AUTHORS'
p47869
aS'Shearer MJ, Newman P'
p47870
aS'TITLE'
p47871
aS'Metabolism and cell biology of vitamin K.'
p47872
aS'JOURNAL'
p47873
aS'Thromb Haemost 100:530-47 (2008)'
p47874
asS'KO_PATHWAY'
p47875
(lp47876
S'ko04977'
p47877
asS'PATHWAY_MAP'
p47878
(lp47879
S'map04977'
p47880
asS'DISEASE'
p47881
(lp47882
S'H00845'
p47883
aS'Familial amyloidosis'
p47884
ag47883
ag47884
aS'H00930'
p47885
aS'Hypoalphalipoproteinemia'
p47886
aS'H01182'
p47887
aS'Biotinidase deficiency'
p47888
aS'H01190'
p47889
aS'Transcobalamin II deficiency'
p47890
aS'H01231'
p47891
aS'Biotin-responsive basal ganglia disease (BBGD)'
p47892
aS'H01252'
p47893
aS'Hereditary folate malabsorption (HFM)'
p47894
aS'H01270'
p47895
aS'Familial hypobetalipoproteinemia (FHBL)'
p47896
aS'H01277'
p47897
aS'Vitamin B12 deficiency anaemia'
p47898
asS'DBLINKS'
p47899
(lp47900
S'GO: 0051180'
p47901
asS'ENTRY'
p47902
(lp47903
S'map04977'
p47904
aS'Pathway'
p47905
asS'CLASS'
p47906
(lp47907
S'Organismal Systems Digestive system'
p47908
asS'DESCRIPTION'
p47909
(lp47910
S'Vitamins are a diverse and chemically unrelated group of organic substances that share a common feature of being essential for normal health and well-being. They catalyze numerous biochemical reactions. Because humans and other mammals cannot synthesize these compounds (except for some synthesis of niacin), they must obtain them from exogenous sources via intestinal absorption. Vitamins'
p47911
assS'path:map04974'
p47912
(dp47913
S'NAME'
p47914
(lp47915
S'Protein digestion and absorption'
p47916
asS'REFERENCE'
p47917
(lp47918
S'PMID:18195088'
p47919
ag47919
aS'AUTHORS'
p47920
aS'Broer S'
p47921
aS'TITLE'
p47922
aS'Amino acid transport across mammalian intestinal and renal epithelia.'
p47923
aS'JOURNAL'
p47924
aS'Physiol Rev 88:249-86 (2008)'
p47925
aS'PMID:15772300'
p47926
ag47926
aS'AUTHORS'
p47927
aS'Palacin M, Nunes V, Font-Llitjos M, Jimenez-Vidal M, Fort J, Gasol E, Pineda M, Feliubadalo L, Chillaron J, Zorzano A'
p47928
aS'TITLE'
p47929
aS'The genetics of heteromeric amino acid transporters.'
p47930
aS'JOURNAL'
p47931
aS'Physiology (Bethesda) 20:112-24 (2005)'
p47932
aS'PMID:20522896'
p47933
ag47933
aS'AUTHORS'
p47934
aS'Goodman BE'
p47935
aS'TITLE'
p47936
aS'Insights into digestion and absorption of major nutrients in humans.'
p47937
aS'JOURNAL'
p47938
aS'Adv Physiol Educ 34:44-53 (2010)'
p47939
aS'PMID:11546643'
p47940
ag47940
aS'AUTHORS'
p47941
aS'Wagner CA, Lang F, Broer S'
p47942
aS'TITLE'
p47943
aS'Function and structure of heterodimeric amino acid transporters.'
p47944
aS'JOURNAL'
p47945
aS'Am J Physiol Cell Physiol 281:C1077-93 (2001)'
p47946
aS'PMID:18400692'
p47947
ag47947
aS'AUTHORS'
p47948
aS'Broer S'
p47949
aS'TITLE'
p47950
aS'Apical transporters for neutral amino acids: physiology and pathophysiology.'
p47951
aS'JOURNAL'
p47952
aS'Physiology (Bethesda) 23:95-103 (2008)'
p47953
aS'PMID:9687539'
p47954
ag47954
aS'AUTHORS'
p47955
aS'Wu G'
p47956
aS'TITLE'
p47957
aS'Intestinal mucosal amino acid catabolism.'
p47958
aS'JOURNAL'
p47959
aS'J Nutr 128:1249-52 (1998)'
p47960
aS'PMID:14977407'
p47961
ag47961
aS'AUTHORS'
p47962
aS'Daniel H'
p47963
aS'TITLE'
p47964
aS'Molecular and integrative physiology of intestinal peptide transport.'
p47965
aS'JOURNAL'
p47966
aS'Annu Rev Physiol 66:361-84 (2004)'
p47967
aS'PMID:12237156'
p47968
ag47968
aS'AUTHORS'
p47969
aS'Rubio-Aliaga I, Daniel H'
p47970
aS'TITLE'
p47971
aS'Mammalian peptide transporters as targets for drug delivery.'
p47972
aS'JOURNAL'
p47973
aS'Trends Pharmacol Sci 23:434-40 (2002)'
p47974
aS'PMID:7937532'
p47975
ag47975
aS'AUTHORS'
p47976
aS'Bai JP'
p47977
aS'TITLE'
p47978
aS'Distribution of brush-border membrane peptidases along the rat intestine.'
p47979
aS'JOURNAL'
p47980
aS'Pharm Res 11:897-900 (1994)'
p47981
aS'PMID:12583961'
p47982
ag47982
aS'AUTHORS'
p47983
aS'Guarner F, Malagelada JR'
p47984
aS'TITLE'
p47985
aS'Gut flora in health and disease.'
p47986
aS'JOURNAL'
p47987
aS'Lancet 361:512-9 (2003)'
p47988
aS'PMID:16887608'
p47989
ag47989
aS'AUTHORS'
p47990
aS'Smith EA, Macfarlane GT'
p47991
aS'TITLE'
p47992
aS'Dissimilatory amino Acid metabolism in human colonic bacteria.'
p47993
aS'JOURNAL'
p47994
aS'Anaerobe 3:327-37 (1997)'
p47995
aS'PMID:20093818'
p47996
ag47996
aS'AUTHORS'
p47997
aS'Schepers E, Glorieux G, Vanholder R'
p47998
aS'TITLE'
p47999
aS'The gut: the forgotten organ in uremia?'
p48000
aS'JOURNAL'
p48001
aS'Blood Purif 29:130-6 (2010)'
p48002
ag22
ag22
aS'AUTHORS'
p48003
aS'John H.Cummings'
p48004
aS'TITLE'
p48005
aS'The large intestine in nutrition and disease'
p48006
aS'JOURNAL'
p48007
aS'Institut Danone'
p48008
aS'PMID:18626068'
p48009
ag48009
aS'AUTHORS'
p48010
aS'Heitzmann D, Warth R'
p48011
aS'TITLE'
p48012
aS'Physiology and pathophysiology of potassium channels in gastrointestinal epithelia.'
p48013
aS'JOURNAL'
p48014
aS'Physiol Rev 88:1119-82 (2008)'
p48015
asS'KO_PATHWAY'
p48016
(lp48017
S'ko04974'
p48018
asS'PATHWAY_MAP'
p48019
(lp48020
S'map04974'
p48021
asS'DISEASE'
p48022
(lp48023
S'H00843'
p48024
aS'Hartnup disorder'
p48025
ag48024
ag48025
aS'H00899'
p48026
aS'Lysinuric protein intolerance (LPI)'
p48027
aS'H00901'
p48028
aS'Cystinuria'
p48029
aS'H00905'
p48030
aS'Iminoglycinuria'
p48031
aS'H00911'
p48032
aS'Dicarboxylic aminoaciduria'
p48033
aS'H00933'
p48034
aS'Hereditary pancreatitis'
p48035
aS'H01304'
p48036
aS'Hyperglycinuria'
p48037
asS'DBLINKS'
p48038
(lp48039
S'GO: 0044256 0050892'
p48040
asS'ENTRY'
p48041
(lp48042
S'map04974'
p48043
aS'Pathway'
p48044
asS'CLASS'
p48045
(lp48046
S'Organismal Systems Digestive system'
p48047
asS'DESCRIPTION'
p48048
(lp48049
S'Protein is a dietary component essential for nutritional homeostasis in humans. Normally, ingested protein undergoes a complex series of degradative processes following the action of gastric, pancreatic and small intestinal enzymes. The result of this proteolytic activity is a mixture of amino acids and small peptides. Amino acids (AAs) are transported into the enterocyte (intestinal epithelial cell) by a variety of AA transporters that are specific for cationic (basic) AA, neutral AA, and anionic (acidic) AA. Small peptides are absorbed into enterocytes by the PEPT1 transporter. Inside enterocytes peptides are hydrolyzed, and the resulting amino acids are released together with those absorbed by AA transporters into blood via multiple, basolateral, AA transporters. Hydrolysis-resistant peptides, however, are transported out of the cells by a basolateral peptide transporter that has not been identified molecularly.'
p48050
assS'path:map04975'
p48051
(dp48052
S'NAME'
p48053
(lp48054
S'Fat digestion and absorption'
p48055
asS'REFERENCE'
p48056
(lp48057
S'PMID:19158321'
p48058
ag48058
aS'AUTHORS'
p48059
aS'Iqbal J, Hussain MM'
p48060
aS'TITLE'
p48061
aS'Intestinal lipid absorption.'
p48062
aS'JOURNAL'
p48063
aS'Am J Physiol Endocrinol Metab 296:E1183-94 (2009)'
p48064
aS'PMID:20522896'
p48065
ag48065
aS'AUTHORS'
p48066
aS'Goodman BE'
p48067
aS'TITLE'
p48068
aS'Insights into digestion and absorption of major nutrients in humans.'
p48069
aS'JOURNAL'
p48070
aS'Adv Physiol Educ 34:44-53 (2010)'
p48071
aS'PMID:19280719'
p48072
ag48072
aS'AUTHORS'
p48073
aS'Niot I, Poirier H, Tran TT, Besnard P'
p48074
aS'TITLE'
p48075
aS'Intestinal absorption of long-chain fatty acids: evidence and uncertainties.'
p48076
aS'JOURNAL'
p48077
aS'Prog Lipid Res 48:101-15 (2009)'
p48078
aS'PMID:15286736'
p48079
ag48079
aS'AUTHORS'
p48080
aS'Shi Y, Burn P'
p48081
aS'TITLE'
p48082
aS'Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.'
p48083
aS'JOURNAL'
p48084
aS'Nat Rev Drug Discov 3:695-710 (2004)'
p48085
aS'PMID:20148678'
p48086
ag48086
aS'AUTHORS'
p48087
aS'Mansbach CM, Siddiqi SA'
p48088
aS'TITLE'
p48089
aS'The biogenesis of chylomicrons.'
p48090
aS'JOURNAL'
p48091
aS'Annu Rev Physiol 72:315-33 (2010)'
p48092
aS'PMID:19116371'
p48093
ag48093
aS'AUTHORS'
p48094
aS'Shi Y, Cheng D'
p48095
aS'TITLE'
p48096
aS'Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism.'
p48097
aS'JOURNAL'
p48098
aS'Am J Physiol Endocrinol Metab 297:E10-8 (2009)'
p48099
aS'PMID:10924713'
p48100
ag48100
aS'AUTHORS'
p48101
aS'Ros E'
p48102
aS'TITLE'
p48103
aS'Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk.'
p48104
aS'JOURNAL'
p48105
aS'Atherosclerosis 151:357-79 (2000)'
p48106
aS'PMID:12621063'
p48107
ag48107
aS'AUTHORS'
p48108
aS'Yen CL, Farese RV Jr'
p48109
aS'TITLE'
p48110
aS'MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine.'
p48111
aS'JOURNAL'
p48112
aS'J Biol Chem 278:18532-7 (2003)'
p48113
aS'PMID:17495606'
p48114
ag48114
aS'AUTHORS'
p48115
aS'Levy E, Spahis S, Sinnett D, Peretti N, Maupas-Schwalm F, Delvin E, Lambert M, Lavoie MA'
p48116
aS'TITLE'
p48117
aS'Intestinal cholesterol transport proteins: an update and beyond.'
p48118
aS'JOURNAL'
p48119
aS'Curr Opin Lipidol 18:310-8 (2007)'
p48120
aS'PMID:18830418'
p48121
ag48121
aS'AUTHORS'
p48122
aS'Williams KJ'
p48123
aS'TITLE'
p48124
aS'Molecular processes that handle -- and mishandle -- dietary lipids.'
p48125
aS'JOURNAL'
p48126
aS'J Clin Invest 118:3247-59 (2008)'
p48127
aS'PMID:11504671'
p48128
ag48128
aS'AUTHORS'
p48129
aS'Lu K, Lee MH, Patel SB'
p48130
aS'TITLE'
p48131
aS'Dietary cholesterol absorption more than just bile.'
p48132
aS'JOURNAL'
p48133
aS'Trends Endocrinol Metab 12:314-20 (2001)'
p48134
aS'PMID:14976303'
p48135
ag48135
aS'AUTHORS'
p48136
aS'Klett EL, Patel SB'
p48137
aS'TITLE'
p48138
aS'Biomedicine. Will the real cholesterol transporter please stand up.'
p48139
aS'JOURNAL'
p48140
aS'Science 303:1149-50 (2004)'
p48141
aS'PMID:17002594'
p48142
ag48142
aS'AUTHORS'
p48143
aS'Wang DQ'
p48144
aS'TITLE'
p48145
aS'Regulation of intestinal cholesterol absorption.'
p48146
aS'JOURNAL'
p48147
aS'Annu Rev Physiol 69:221-48 (2007)'
p48148
aS'PMID:19663632'
p48149
ag48149
aS'AUTHORS'
p48150
aS'Patel JP, Brocks DR'
p48151
aS'TITLE'
p48152
aS'The effect of oral lipids and circulating lipoproteins on the metabolism of drugs.'
p48153
aS'JOURNAL'
p48154
aS'Expert Opin Drug Metab Toxicol 5:1385-98 (2009)'
p48155
aS'PMID:15891388'
p48156
ag48156
aS'AUTHORS'
p48157
aS'Hussain MM, Fatma S, Pan X, Iqbal J'
p48158
aS'TITLE'
p48159
aS'Intestinal lipoprotein assembly.'
p48160
aS'JOURNAL'
p48161
aS'Curr Opin Lipidol 16:281-5 (2005)'
p48162
aS'PMID:20493784'
p48163
ag48163
aS'AUTHORS'
p48164
aS'Kindel T, Lee DM, Tso P'
p48165
aS'TITLE'
p48166
aS'The mechanism of the formation and secretion of chylomicrons.'
p48167
aS'JOURNAL'
p48168
aS'Atheroscler Suppl 11:11-6 (2010)'
p48169
asS'KO_PATHWAY'
p48170
(lp48171
S'ko04975'
p48172
asS'PATHWAY_MAP'
p48173
(lp48174
S'map04975'
p48175
asS'DISEASE'
p48176
(lp48177
S'H00845'
p48178
aS'Familial amyloidosis'
p48179
ag48178
ag48179
aS'H00930'
p48180
aS'Hypoalphalipoproteinemia'
p48181
aS'H01108'
p48182
aS'CD36 deficiency'
p48183
aS'H01213'
p48184
aS'Gallbladder disease'
p48185
aS'H01270'
p48186
aS'Familial hypobetalipoproteinemia (FHBL)'
p48187
asS'DBLINKS'
p48188
(lp48189
S'GO: 0044241 0030299'
p48190
asS'ENTRY'
p48191
(lp48192
S'map04975'
p48193
aS'Pathway'
p48194
asS'CLASS'
p48195
(lp48196
S'Organismal Systems Digestive system'
p48197
asS'DESCRIPTION'
p48198
(lp48199
S'Fat is an important energy source from food. More than 95% of dietary fat is long-chain triacylglycerols (TAG), the remaining being phospholipids (4.5%) and sterols. In the small intestine lumen, dietary TAG is hydrolyzed to fatty acids (FA) and monoacylglycerols (MAG) by pancreatic lipase. These products are then emulsified with the help of phospholipids (PL) and bile acids (BA) present in bile to form micelles. Free FAs and MAGs are taken up by the enterocyte where they are rapidly resynthesized in endoplasmic reticulum (ER) to form TAG. PLs from the diet as well as bile - mainly LPA - too are absorbed by the enterocyte and are acylated to form phosphatidic acid (PA), which is also converted into TAG. Absorbed cholesterol (CL) is acylated to cholesterol esters (CE). Within the ER, TAG joins CE and apolipoprotein B (ApoB) to form chylomicrons that enter circulation through the lymph.'
p48200
assS'path:map04972'
p48201
(dp48202
S'NAME'
p48203
(lp48204
S'Pancreatic secretion'
p48205
asS'REFERENCE'
p48206
(lp48207
S'PMID:17850212'
p48208
ag48208
aS'AUTHORS'
p48209
aS'Petersen OH, Tepikin AV'
p48210
aS'TITLE'
p48211
aS'Polarized calcium signaling in exocrine gland cells.'
p48212
aS'JOURNAL'
p48213
aS'Annu Rev Physiol 70:273-99 (2008)'
p48214
aS'PMID:20625287'
p48215
ag48215
aS'AUTHORS'
p48216
aS'Williams JA'
p48217
aS'TITLE'
p48218
aS'Regulation of acinar cell function in the pancreas.'
p48219
aS'JOURNAL'
p48220
aS'Curr Opin Gastroenterol 26:478-83 (2010)'
p48221
aS'PMID:16891880'
p48222
ag48222
aS'AUTHORS'
p48223
aS'Williams JA'
p48224
aS'TITLE'
p48225
aS'Regulation of pancreatic acinar cell function.'
p48226
aS'JOURNAL'
p48227
aS'Curr Opin Gastroenterol 22:498-504 (2006)'
p48228
aS'PMID:15689674'
p48229
ag48229
aS'AUTHORS'
p48230
aS'Bi Y, Williams JA'
p48231
aS'TITLE'
p48232
aS'Receptor biology and signal transduction in pancreatic acinar cells.'
p48233
aS'JOURNAL'
p48234
aS'Curr Opin Gastroenterol 20:427-34 (2004)'
p48235
aS'PMID:14660554'
p48236
ag48236
aS'AUTHORS'
p48237
aS'Yamasaki M, Masgrau R, Morgan AJ, Churchill GC, Patel S, Ashcroft SJ, Galione A'
p48238
aS'TITLE'
p48239
aS'Organelle selection determines agonist-specific Ca2+ signals in pancreatic acinar and beta cells.'
p48240
aS'JOURNAL'
p48241
aS'J Biol Chem 279:7234-40 (2004)'
p48242
aS'PMID:9548666'
p48243
ag48243
aS'AUTHORS'
p48244
aS'Kanno T'
p48245
aS'TITLE'
p48246
aS'Ca2+ signaling in the pancreatic acinus.'
p48247
aS'JOURNAL'
p48248
aS'Pancreas 16:273-6 (1998)'
p48249
aS'PMID:18626068'
p48250
ag48250
aS'AUTHORS'
p48251
aS'Heitzmann D, Warth R'
p48252
aS'TITLE'
p48253
aS'Physiology and pathophysiology of potassium channels in gastrointestinal epithelia.'
p48254
aS'JOURNAL'
p48255
aS'Physiol Rev 88:1119-82 (2008)'
p48256
aS'PMID:14637169'
p48257
ag48257
aS'AUTHORS'
p48258
aS'Konturek SJ, Zabielski R, Konturek JW, Czarnecki J'
p48259
aS'TITLE'
p48260
aS'Neuroendocrinology of the pancreas role of brain-gut axis in pancreatic secretion.'
p48261
aS'JOURNAL'
p48262
aS'Eur J Pharmacol 481:1-14 (2003)'
p48263
aS'PMID:16888148'
p48264
ag48264
aS'AUTHORS'
p48265
aS'Chu JY, Yung WH, Chow BK'
p48266
aS'TITLE'
p48267
aS'Secretin: a pleiotrophic hormone.'
p48268
aS'JOURNAL'
p48269
aS'Ann N Y Acad Sci 1070:27-50 (2006)'
p48270
aS'PMID:16930743'
p48271
ag48271
aS'AUTHORS'
p48272
aS'Siu FK, Lam IP, Chu JY, Chow BK'
p48273
aS'TITLE'
p48274
aS'Signaling mechanisms of secretin receptor.'
p48275
aS'JOURNAL'
p48276
aS'Regul Pept 137:95-104 (2006)'
p48277
aS'PMID:15709963'
p48278
ag48278
aS'AUTHORS'
p48279
aS'Steward MC, Ishiguro H, Case RM'
p48280
aS'TITLE'
p48281
aS'Mechanisms of bicarbonate secretion in the pancreatic duct.'
p48282
aS'JOURNAL'
p48283
aS'Annu Rev Physiol 67:377-409 (2005)'
p48284
aS'PMID:20224219'
p48285
ag48285
aS'AUTHORS'
p48286
aS'Kim D, Steward MC'
p48287
aS'TITLE'
p48288
aS'The role of CFTR in bicarbonate secretion by pancreatic duct and airway epithelia.'
p48289
aS'JOURNAL'
p48290
aS'J Med Invest 56 Suppl:336-42 (2009)'
p48291
aS'PMID:17205399'
p48292
ag48292
aS'AUTHORS'
p48293
aS'Whitcomb DC, Lowe ME'
p48294
aS'TITLE'
p48295
aS'Human pancreatic digestive enzymes.'
p48296
aS'JOURNAL'
p48297
aS'Dig Dis Sci 52:1-17 (2007)'
p48298
aS'PMID:10835353'
p48299
ag48299
aS'AUTHORS'
p48300
aS'Cancela JM, Gerasimenko OV, Gerasimenko JV, Tepikin AV, Petersen OH'
p48301
aS'TITLE'
p48302
aS'Two different but converging messenger pathways to intracellular Ca(2+) release:'
p48303
aS'the roles of nicotinic acid adenine dinucleotide phosphate, cyclic ADP-ribose and inositol trisphosphate.'
p48304
aS'JOURNAL'
p48305
aS'EMBO J 19:2549-57 (2000)'
p48306
aS'PMID:10078532'
p48307
ag48307
aS'AUTHORS'
p48308
aS'Cancela JM, Churchill GC, Galione A'
p48309
aS'TITLE'
p48310
aS'Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells.'
p48311
aS'JOURNAL'
p48312
aS'Nature 398:74-6 (1999)'
p48313
aS'PMID:11087843'
p48314
ag48314
aS'AUTHORS'
p48315
aS'Parekh AB'
p48316
aS'TITLE'
p48317
aS'Calcium signaling and acute pancreatitis: specific response to a promiscuous messenger.'
p48318
aS'JOURNAL'
p48319
aS'Proc Natl Acad Sci U S A 97:12933-4 (2000)'
p48320
aS'PMID:19088252'
p48321
ag48321
aS'AUTHORS'
p48322
aS'Williams JA, Chen X, Sabbatini ME'
p48323
aS'TITLE'
p48324
aS'Small G proteins as key regulators of pancreatic digestive enzyme secretion.'
p48325
aS'JOURNAL'
p48326
aS'Am J Physiol Endocrinol Metab 296:E405-14 (2009)'
p48327
asS'KO_PATHWAY'
p48328
(lp48329
S'ko04972'
p48330
asS'PATHWAY_MAP'
p48331
(lp48332
S'map04972'
p48333
asS'DISEASE'
p48334
(lp48335
S'H00409'
p48336
aS'Type II diabetes mellitus'
p48337
ag48336
ag48337
aS'H00933'
p48338
aS'Hereditary pancreatitis'
p48339
asS'DBLINKS'
p48340
(lp48341
S'GO: 0030157'
p48342
asS'ENTRY'
p48343
(lp48344
S'map04972'
p48345
aS'Pathway'
p48346
asS'CLASS'
p48347
(lp48348
S'Organismal Systems Digestive system'
p48349
asS'DESCRIPTION'
p48350
(lp48351
S'The pancreas performs both exocrine and endocrine functions.'
p48352
assS'path:map04973'
p48353
(dp48354
S'NAME'
p48355
(lp48356
S'Carbohydrate digestion and absorption'
p48357
asS'REFERENCE'
p48358
(lp48359
S'PMID:16586532'
p48360
ag48360
aS'AUTHORS'
p48361
aS'Drozdowski LA, Thomson AB'
p48362
aS'TITLE'
p48363
aS'Intestinal sugar transport.'
p48364
aS'JOURNAL'
p48365
aS'World J Gastroenterol 12:1657-70 (2006)'
p48366
aS'PMID:14642859'
p48367
ag48367
aS'AUTHORS'
p48368
aS'Wright EM, Martin MG, Turk E'
p48369
aS'TITLE'
p48370
aS'Intestinal absorption in health and disease--sugars.'
p48371
aS'JOURNAL'
p48372
aS'Best Pract Res Clin Gastroenterol 17:943-56 (2003)'
p48373
aS'PMID:18393659'
p48374
ag48374
aS'AUTHORS'
p48375
aS'Kellett GL, Brot-Laroche E, Mace OJ, Leturque A'
p48376
aS'TITLE'
p48377
aS'Sugar absorption in the intestine: the role of GLUT2.'
p48378
aS'JOURNAL'
p48379
aS'Annu Rev Nutr 28:35-54 (2008)'
p48380
aS'PMID:19001049'
p48381
ag48381
aS'AUTHORS'
p48382
aS'Mace OJ, Lister N, Morgan E, Shepherd E, Affleck J, Helliwell P, Bronk JR, Kellett GL, Meredith D, Boyd R, Pieri M, Bailey PD, Pettcrew R, Foley D'
p48383
aS'TITLE'
p48384
aS'An energy supply network of nutrient absorption coordinated by calcium and T1R taste receptors in rat small intestine.'
p48385
aS'JOURNAL'
p48386
aS'J Physiol 587:195-210 (2009)'
p48387
aS'PMID:16186415'
p48388
ag48388
aS'AUTHORS'
p48389
aS'Kellett GL, Brot-Laroche E'
p48390
aS'TITLE'
p48391
aS'Apical GLUT2: a major pathway of intestinal sugar absorption.'
p48392
aS'JOURNAL'
p48393
aS'Diabetes 54:3056-62 (2005)'
p48394
aS'PMID:20522896'
p48395
ag48395
aS'AUTHORS'
p48396
aS'Goodman BE'
p48397
aS'TITLE'
p48398
aS'Insights into digestion and absorption of major nutrients in humans.'
p48399
aS'JOURNAL'
p48400
aS'Adv Physiol Educ 34:44-53 (2010)'
p48401
aS'PMID:17222166'
p48402
ag48402
aS'AUTHORS'
p48403
aS'Wright EM, Hirayama BA, Loo DF'
p48404
aS'TITLE'
p48405
aS'Active sugar transport in health and disease.'
p48406
aS'JOURNAL'
p48407
aS'J Intern Med 261:32-43 (2007)'
p48408
aS'PMID:12512027'
p48409
ag48409
aS'AUTHORS'
p48410
aS'Santer R, Hillebrand G, Steinmann B, Schaub J'
p48411
aS'TITLE'
p48412
aS'Intestinal glucose transport: evidence for a membrane traffic-based pathway in humans.'
p48413
aS'JOURNAL'
p48414
aS'Gastroenterology 124:34-9 (2003)'
p48415
aS'PMID:11562503'
p48416
ag48416
aS'AUTHORS'
p48417
aS'Stumpel F, Burcelin R, Jungermann K, Thorens B'
p48418
aS'TITLE'
p48419
aS'Normal kinetics of intestinal glucose absorption in the absence of GLUT2: evidence for a transport pathway requiring glucose phosphorylation and transfer into the endoplasmic reticulum.'
p48420
aS'JOURNAL'
p48421
aS'Proc Natl Acad Sci U S A 98:11330-5 (2001)'
p48422
aS'PMID:15546855'
p48423
ag48423
aS'AUTHORS'
p48424
aS'Wright EM, Loo DD, Hirayama BA, Turk E'
p48425
aS'TITLE'
p48426
aS'Surprising versatility of Na+-glucose cotransporters: SLC5.'
p48427
aS'JOURNAL'
p48428
aS'Physiology (Bethesda) 19:370-6 (2004)'
p48429
aS'PMID:12750891'
p48430
ag48430
aS'AUTHORS'
p48431
aS'Uldry M, Thorens B'
p48432
aS'TITLE'
p48433
aS'The SLC2 family of facilitated hexose and polyol transporters.'
p48434
aS'JOURNAL'
p48435
aS'Pflugers Arch 447:480-9 (2004)'
p48436
aS'PMID:7555019'
p48437
ag48437
aS'AUTHORS'
p48438
aS'Van Beers EH, Buller HA, Grand RJ, Einerhand AW, Dekker J'
p48439
aS'TITLE'
p48440
aS'Intestinal brush border glycohydrolases: structure, function, and development.'
p48441
aS'JOURNAL'
p48442
aS'Crit Rev Biochem Mol Biol 30:197-262 (1995)'
p48443
aS'PMID:5089892'
p48444
ag48444
aS'AUTHORS'
p48445
aS'Marsh MN'
p48446
aS'TITLE'
p48447
aS'Digestive-absorptive functions of the enterocyte.'
p48448
aS'JOURNAL'
p48449
aS'Ann R Coll Surg Engl 48:356-68 (1971)'
p48450
aS'PMID:12583961'
p48451
ag48451
aS'AUTHORS'
p48452
aS'Guarner F, Malagelada JR'
p48453
aS'TITLE'
p48454
aS'Gut flora in health and disease.'
p48455
aS'JOURNAL'
p48456
aS'Lancet 361:512-9 (2003)'
p48457
aS'PMID:11427691'
p48458
ag48458
aS'AUTHORS'
p48459
aS'Topping DL, Clifton PM'
p48460
aS'TITLE'
p48461
aS'Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides.'
p48462
aS'JOURNAL'
p48463
aS'Physiol Rev 81:1031-64 (2001)'
p48464
asS'KO_PATHWAY'
p48465
(lp48466
S'ko04973'
p48467
asS'PATHWAY_MAP'
p48468
(lp48469
S'map04973'
p48470
asS'DISEASE'
p48471
(lp48472
S'H01261'
p48473
aS'Congenital glucose-galactose malabsorption (GGM)'
p48474
asS'DBLINKS'
p48475
(lp48476
S'GO: 0044245 0001951'
p48477
asS'ENTRY'
p48478
(lp48479
S'map04973'
p48480
aS'Pathway'
p48481
asS'CLASS'
p48482
(lp48483
S'Organismal Systems Digestive system'
p48484
asS'DESCRIPTION'
p48485
(lp48486
S'Dietary carbohydrate in humans and omnivorous animals is a major nutrient.'
p48487
assS'path:map04970'
p48488
(dp48489
S'NAME'
p48490
(lp48491
S'Salivary secretion'
p48492
asS'REFERENCE'
p48493
(lp48494
S'PMID:16799262'
p48495
ag48495
aS'AUTHORS'
p48496
aS'Ishikawa Y, Cho G, Yuan Z, Skowronski MT, Pan Y, Ishida H'
p48497
aS'TITLE'
p48498
aS'Water channels and zymogen granules in salivary glands.'
p48499
aS'JOURNAL'
p48500
aS'J Pharmacol Sci 100:495-512 (2006)'
p48501
aS'PMID:16712780'
p48502
ag48502
aS'AUTHORS'
p48503
aS'Ishikawa Y, Cho G, Yuan Z, Inoue N, Nakae Y'
p48504
aS'TITLE'
p48505
aS'Aquaporin-5 water channel in lipid rafts of rat parotid glands.'
p48506
aS'JOURNAL'
p48507
aS'Biochim Biophys Acta 1758:1053-60 (2006)'
p48508
aS'PMID:10682899'
p48509
ag48509
aS'AUTHORS'
p48510
aS'Ambudkar IS'
p48511
aS'TITLE'
p48512
aS'Regulation of calcium in salivary gland secretion.'
p48513
aS'JOURNAL'
p48514
aS'Crit Rev Oral Biol Med 11:4-25 (2000)'
p48515
aS'PMID:10928320'
p48516
ag48516
aS'AUTHORS'
p48517
aS'Ishikawa Y, Ishida H'
p48518
aS'TITLE'
p48519
aS'Aquaporin water channel in salivary glands.'
p48520
aS'JOURNAL'
p48521
aS'Jpn J Pharmacol 83:95-101 (2000)'
p48522
aS'PMID:8105741'
p48523
ag48523
aS'AUTHORS'
p48524
aS'Baum BJ'
p48525
aS'TITLE'
p48526
aS'Principles of saliva secretion.'
p48527
aS'JOURNAL'
p48528
aS'Ann N Y Acad Sci 694:17-23 (1993)'
p48529
aS'PMID:9720759'
p48530
ag48530
aS'AUTHORS'
p48531
aS'Fujita-Yoshigaki J'
p48532
aS'TITLE'
p48533
aS'Divergence and convergence in regulated exocytosis: the characteristics of cAMP-dependent enzyme secretion of parotid salivary acinar cells.'
p48534
aS'JOURNAL'
p48535
aS'Cell Signal 10:371-5 (1998)'
p48536
aS'PMID:18626068'
p48537
ag48537
aS'AUTHORS'
p48538
aS'Heitzmann D, Warth R'
p48539
aS'TITLE'
p48540
aS'Physiology and pathophysiology of potassium channels in gastrointestinal epithelia.'
p48541
aS'JOURNAL'
p48542
aS'Physiol Rev 88:1119-82 (2008)'
p48543
aS'PMID:17157080'
p48544
ag48544
aS'AUTHORS'
p48545
aS'Proctor GB, Carpenter GH'
p48546
aS'TITLE'
p48547
aS'Regulation of salivary gland function by autonomic nerves.'
p48548
aS'JOURNAL'
p48549
aS'Auton Neurosci 133:3-18 (2007)'
p48550
aS'PMID:11936453'
p48551
ag48551
aS'AUTHORS'
p48552
aS'Turner RJ, Sugiya H'
p48553
aS'TITLE'
p48554
aS'Understanding salivary fluid and protein secretion.'
p48555
aS'JOURNAL'
p48556
aS'Oral Dis 8:3-11 (2002)'
p48557
aS'PMID:15153696'
p48558
ag48558
aS'AUTHORS'
p48559
aS'Van Nieuw Amerongen A, Bolscher JG, Veerman EC'
p48560
aS'TITLE'
p48561
aS'Salivary proteins: protective and diagnostic value in cariology?'
p48562
aS'JOURNAL'
p48563
aS'Caries Res 38:247-53 (2004)'
p48564
aS'PMID:17347411'
p48565
ag48565
aS'AUTHORS'
p48566
aS'Nakamoto T, Srivastava A, Romanenko VG, Ovitt CE, Perez-Cornejo P, Arreola J, Begenisich T, Melvin JE'
p48567
aS'TITLE'
p48568
aS'Functional and molecular characterization of the fluid secretion mechanism in human parotid acinar cells.'
p48569
aS'JOURNAL'
p48570
aS'Am J Physiol Regul Integr Comp Physiol 292:R2380-90 (2007)'
p48571
aS'PMID:15709965'
p48572
ag48572
aS'AUTHORS'
p48573
aS'Melvin JE, Yule D, Shuttleworth T, Begenisich T'
p48574
aS'TITLE'
p48575
aS'Regulation of fluid and electrolyte secretion in salivary gland acinar cells.'
p48576
aS'JOURNAL'
p48577
aS'Annu Rev Physiol 67:445-69 (2005)'
p48578
aS'PMID:20224180'
p48579
ag48579
aS'AUTHORS'
p48580
aS'Catalan MA, Nakamoto T, Melvin JE'
p48581
aS'TITLE'
p48582
aS'The salivary gland fluid secretion mechanism.'
p48583
aS'JOURNAL'
p48584
aS'J Med Invest 56 Suppl:192-6 (2009)'
p48585
asS'KO_PATHWAY'
p48586
(lp48587
S'ko04970'
p48588
asS'PATHWAY_MAP'
p48589
(lp48590
S'map04970'
p48591
asS'DISEASE'
p48592
(lp48593
S'H00845'
p48594
aS'Familial amyloidosis'
p48595
asS'DBLINKS'
p48596
(lp48597
S'GO: 0046541'
p48598
asS'ENTRY'
p48599
(lp48600
S'map04970'
p48601
aS'Pathway'
p48602
asS'CLASS'
p48603
(lp48604
S'Organismal Systems Digestive system'
p48605
asS'DESCRIPTION'
p48606
(lp48607
S'Saliva has manifold functions in maintaining the integrity of the oral tissues, in protecting teeth from caries, in the tasting and ingestion of food, in speech and in the tolerance of tenures, for example. Salivary secretion occurs in response to stimulation by neurotransmitters released from autonomic nerve endings. There are two secretory pathways: protein exocytosis and fluid secretion. Sympathetic stimulation leads to the activation of adenylate cyclase and accumulation of intracellular cAMP. The elevation of cAMP causes the secretion of proteins such as amylase and mucin. In contrast, parasympathetic stimulation activates phospholipase C and causes the elevation of intracellular Ca2+, which leads to fluid secretion that is, water and ion transport. Ca2+ also induces amylase secretion, but the amount is smaller than that induced by cAMP.'
p48608
assS'path:map04971'
p48609
(dp48610
S'NAME'
p48611
(lp48612
S'Gastric acid secretion'
p48613
asS'REFERENCE'
p48614
(lp48615
S'PMID:18474247'
p48616
ag48616
aS'AUTHORS'
p48617
aS'Schubert ML, Peura DA'
p48618
aS'TITLE'
p48619
aS'Control of gastric acid secretion in health and disease.'
p48620
aS'JOURNAL'
p48621
aS'Gastroenterology 134:1842-60 (2008)'
p48622
aS'PMID:9307437'
p48623
ag48623
aS'AUTHORS'
p48624
aS'Urushidani T, Forte JG'
p48625
aS'TITLE'
p48626
aS'Signal transduction and activation of acid secretion in the parietal cell.'
p48627
aS'JOURNAL'
p48628
aS'J Membr Biol 159:99-111 (1997)'
p48629
aS'PMID:12500969'
p48630
ag48630
aS'AUTHORS'
p48631
aS'Yao X, Forte JG'
p48632
aS'TITLE'
p48633
aS'Cell biology of acid secretion by the parietal cell.'
p48634
aS'JOURNAL'
p48635
aS'Annu Rev Physiol 65:103-31 (2003)'
p48636
aS'PMID:17928547'
p48637
ag48637
aS'AUTHORS'
p48638
aS'Heitzmann D, Warth R'
p48639
aS'TITLE'
p48640
aS'No potassium, no acid: K+ channels and gastric acid secretion.'
p48641
aS'JOURNAL'
p48642
aS'Physiology (Bethesda) 22:335-41 (2007)'
p48643
aS'PMID:19889964'
p48644
ag48644
aS'AUTHORS'
p48645
aS'Kopic S, Murek M, Geibel JP'
p48646
aS'TITLE'
p48647
aS'Revisiting the parietal cell.'
p48648
aS'JOURNAL'
p48649
aS'Am J Physiol Cell Physiol 298:C1-C10 (2010)'
p48650
aS'PMID:15703676'
p48651
ag48651
aS'AUTHORS'
p48652
aS'Schubert ML'
p48653
aS'TITLE'
p48654
aS'Gastric secretion.'
p48655
aS'JOURNAL'
p48656
aS'Curr Opin Gastroenterol 20:519-25 (2004)'
p48657
aS'PMID:16391411'
p48658
ag48658
aS'AUTHORS'
p48659
aS'Konturek SJ, Konturek PC, Brzozowski T, Konturek JW, Pawlik WW'
p48660
aS'TITLE'
p48661
aS'From nerves and hormones to bacteria in the stomach Nobel prize for achievements in gastrology during last century.'
p48662
aS'JOURNAL'
p48663
aS'J Physiol Pharmacol 56:507-30 (2005)'
p48664
aS'PMID:20148676'
p48665
ag48665
aS'AUTHORS'
p48666
aS'Forte JG, Zhu L'
p48667
aS'TITLE'
p48668
aS'Apical recycling of the gastric parietal cell H,K-ATPase.'
p48669
aS'JOURNAL'
p48670
aS'Annu Rev Physiol 72:273-96 (2010)'
p48671
aS'PMID:18061403'
p48672
ag48672
aS'AUTHORS'
p48673
aS'Szaszak M, Christian F, Rosenthal W, Klussmann E'
p48674
aS'TITLE'
p48675
aS'Compartmentalized cAMP signalling in regulated exocytic processes in non-neuronal cells.'
p48676
aS'JOURNAL'
p48677
aS'Cell Signal 20:590-601 (2008)'
p48678
aS'PMID:18626068'
p48679
ag48679
aS'AUTHORS'
p48680
aS'Heitzmann D, Warth R'
p48681
aS'TITLE'
p48682
aS'Physiology and pathophysiology of potassium channels in gastrointestinal epithelia.'
p48683
aS'JOURNAL'
p48684
aS'Physiol Rev 88:1119-82 (2008)'
p48685
aS'PMID:15579540'
p48686
ag48686
aS'AUTHORS'
p48687
aS'Heitzmann D, Grahammer F, von Hahn T, Schmitt-Graff A, Romeo E, Nitschke R, Gerlach U, Lang HJ, Verrey F, Barhanin J, Warth R'
p48688
aS'TITLE'
p48689
aS'Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells.'
p48690
aS'JOURNAL'
p48691
aS'J Physiol 561:547-57 (2004)'
p48692
aS'PMID:20331540'
p48693
ag48693
aS'AUTHORS'
p48694
aS'Seidler U, Song P, Xiao F, Riederer B, Bachmann O, Chen M'
p48695
aS'TITLE'
p48696
aS'Recent advances in the molecular and functional characterization of acid/base and electrolyte transporters in the basolateral membranes of gastric and duodenal epithelial cells.'
p48697
aS'JOURNAL'
p48698
aS'Acta Physiol (Oxf) 201:3-20 (2011)'
p48699
asS'KO_PATHWAY'
p48700
(lp48701
S'ko04971'
p48702
asS'PATHWAY_MAP'
p48703
(lp48704
S'map04971'
p48705
asS'DISEASE'
p48706
(lp48707
S'H00933'
p48708
aS'Hereditary pancreatitis'
p48709
asS'DBLINKS'
p48710
(lp48711
S'GO: 0001696'
p48712
asS'ENTRY'
p48713
(lp48714
S'map04971'
p48715
aS'Pathway'
p48716
asS'CLASS'
p48717
(lp48718
S'Organismal Systems Digestive system'
p48719
asS'DESCRIPTION'
p48720
(lp48721
S'Gastric acid is a key factor in normal upper gastrointestinal functions, including protein digestion and calcium and iron absorption, as well as providing some protection against bacterial infections. The principal stimulants of acid secretion at the level of the parietal cell are histamine (paracrine), gastrin (hormonal), and acetycholine (ACh neurocrine). Stimulation of acid secretion typically involves an initial elevation of intracellular calcium and cAMP, followed by activation of protein kinase cascades, which trigger the translocation of the proton pump, H+,K+-ATPase, from cytoplasmic tubulovesicles to the apical plasma membrane and thereby H+ secretion into the stomach lumen.'
p48722
assS'path:map04978'
p48723
(dp48724
S'NAME'
p48725
(lp48726
S'Mineral absorption'
p48727
asS'REFERENCE'
p48728
(lp48729
S'PMID:18277073'
p48730
ag48730
aS'AUTHORS'
p48731
aS'Perez AV, Picotto G, Carpentieri AR, Rivoira MA, Peralta Lopez ME, Tolosa de Talamoni NG'
p48732
aS'TITLE'
p48733
aS'Minireview on regulation of intestinal calcium absorption. Emphasis on molecular'
p48734
aS'mechanisms of transcellular pathway.'
p48735
aS'JOURNAL'
p48736
aS'Digestion 77:22-34 (2008)'
p48737
aS'PMID:18598134'
p48738
ag48738
aS'AUTHORS'
p48739
aS'Khanal RC, Nemere I'
p48740
aS'TITLE'
p48741
aS'Regulation of intestinal calcium transport.'
p48742
aS'JOURNAL'
p48743
aS'Annu Rev Nutr 28:179-96 (2008)'
p48744
aS'PMID:15618484'
p48745
ag48745
aS'AUTHORS'
p48746
aS'Hoenderop JG, Nilius B, Bindels RJ'
p48747
aS'TITLE'
p48748
aS'Calcium absorption across epithelia.'
p48749
aS'JOURNAL'
p48750
aS'Physiol Rev 85:373-422 (2005)'
p48751
aS'PMID:12520535'
p48752
ag48752
aS'AUTHORS'
p48753
aS'Bouillon R, Van Cromphaut S, Carmeliet G'
p48754
aS'TITLE'
p48755
aS'Intestinal calcium absorption: Molecular vitamin D mediated mechanisms.'
p48756
aS'JOURNAL'
p48757
aS'J Cell Biochem 88:332-9 (2003)'
p48758
aS'PMID:17943492'
p48759
ag48759
aS'AUTHORS'
p48760
aS'Chua AC, Graham RM, Trinder D, Olynyk JK'
p48761
aS'TITLE'
p48762
aS'The regulation of cellular iron metabolism.'
p48763
aS'JOURNAL'
p48764
aS'Crit Rev Clin Lab Sci 44:413-59 (2007)'
p48765
aS'PMID:18636652'
p48766
ag48766
aS'AUTHORS'
p48767
aS'West AR, Oates PS'
p48768
aS'TITLE'
p48769
aS'Mechanisms of heme iron absorption: current questions and controversies.'
p48770
aS'JOURNAL'
p48771
aS'World J Gastroenterol 14:4101-10 (2008)'
p48772
aS'PMID:17194590'
p48773
ag48773
aS'AUTHORS'
p48774
aS'Dunn LL, Rahmanto YS, Richardson DR'
p48775
aS'TITLE'
p48776
aS'Iron uptake and metabolism in the new millennium.'
p48777
aS'JOURNAL'
p48778
aS'Trends Cell Biol 17:93-100 (2007)'
p48779
aS'PMID:16565477'
p48780
ag48780
aS'AUTHORS'
p48781
aS'Donovan A, Roy CN, Andrews NC'
p48782
aS'TITLE'
p48783
aS'The ins and outs of iron homeostasis.'
p48784
aS'JOURNAL'
p48785
aS'Physiology (Bethesda) 21:115-23 (2006)'
p48786
aS'PMID:18779306'
p48787
ag48787
aS'AUTHORS'
p48788
aS'Lonnerdal B'
p48789
aS'TITLE'
p48790
aS'Intestinal regulation of copper homeostasis: a developmental perspective.'
p48791
aS'JOURNAL'
p48792
aS'Am J Clin Nutr 88:846S-50S (2008)'
p48793
aS'PMID:18779302'
p48794
ag48794
aS'AUTHORS'
p48795
aS'Prohaska JR'
p48796
aS'TITLE'
p48797
aS'Role of copper transporters in copper homeostasis.'
p48798
aS'JOURNAL'
p48799
aS'Am J Clin Nutr 88:826S-9S (2008)'
p48800
aS'PMID:20120011'
p48801
ag48801
aS'AUTHORS'
p48802
aS'Wang X, Zhou B'
p48803
aS'TITLE'
p48804
aS'Dietary zinc absorption: A play of Zips and ZnTs in the gut.'
p48805
aS'JOURNAL'
p48806
aS'IUBMB Life 62:176-82 (2010)'
p48807
aS'PMID:19400752'
p48808
ag48808
aS'AUTHORS'
p48809
aS'Lichten LA, Cousins RJ'
p48810
aS'TITLE'
p48811
aS'Mammalian zinc transporters: nutritional and physiologic regulation.'
p48812
aS'JOURNAL'
p48813
aS'Annu Rev Nutr 29:153-76 (2009)'
p48814
aS'PMID:18301276'
p48815
ag48815
aS'AUTHORS'
p48816
aS'Quamme GA'
p48817
aS'TITLE'
p48818
aS'Recent developments in intestinal magnesium absorption.'
p48819
aS'JOURNAL'
p48820
aS'Curr Opin Gastroenterol 24:230-5 (2008)'
p48821
aS'PMID:19448074'
p48822
ag48822
aS'AUTHORS'
p48823
aS'Donowitz M, Mohan S, Zhu CX, Chen TE, Lin R, Cha B, Zachos NC, Murtazina R, Sarker R, Li X'
p48824
aS'TITLE'
p48825
aS'NHE3 regulatory complexes.'
p48826
aS'JOURNAL'
p48827
aS'J Exp Biol 212:1638-46 (2009)'
p48828
aS'PMID:21054167'
p48829
ag48829
aS'AUTHORS'
p48830
aS'Kato A, Romero MF'
p48831
aS'TITLE'
p48832
aS'Regulation of Electroneutral NaCl Absorption by the Small Intestine.'
p48833
aS'JOURNAL'
p48834
aS'Annu Rev Physiol 73:261-81 (2011)'
p48835
aS'PMID:19729436'
p48836
ag48836
aS'AUTHORS'
p48837
aS"Sabbagh Y, O'Brien SP, Song W, Boulanger JH, Stockmann A, Arbeeny C, Schiavi SC"
p48838
aS'TITLE'
p48839
aS'Intestinal npt2b plays a major role in phosphate absorption and homeostasis.'
p48840
aS'JOURNAL'
p48841
aS'J Am Soc Nephrol 20:2348-58 (2009)'
p48842
aS'PMID:16431934'
p48843
ag48843
aS'AUTHORS'
p48844
aS'Marks J, Srai SK, Biber J, Murer H, Unwin RJ, Debnam ES'
p48845
aS'TITLE'
p48846
aS'Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice.'
p48847
aS'JOURNAL'
p48848
aS'Exp Physiol 91:531-7 (2006)'
p48849
asS'KO_PATHWAY'
p48850
(lp48851
S'ko04978'
p48852
asS'PATHWAY_MAP'
p48853
(lp48854
S'map04978'
p48855
asS'DISEASE'
p48856
(lp48857
S'H00784'
p48858
aS'Localized autosomal recessive hypotrichosis'
p48859
ag48858
ag48859
aS'H00808'
p48860
aS'Idiopathic generalized epilepsies (IGEs)'
p48861
aS'H00833'
p48862
aS'Neurodegeneration with brain iron accumulation (NBIA)'
p48863
aS'H00843'
p48864
aS'Hartnup disorder'
p48865
aS'H00856'
p48866
aS'Distal hereditary motor neuropathies (dHMN)'
p48867
aS'H00905'
p48868
aS'Iminoglycinuria'
p48869
aS'H01143'
p48870
aS'Vitamin D-dependent rickets'
p48871
aS'H01145'
p48872
aS'Atransferrinemia'
p48873
aS'H01174'
p48874
aS'Congenital diarrhea'
p48875
aS'H01196'
p48876
aS'Hypochromic microcytic anemia'
p48877
aS'H01210'
p48878
aS'Hypomagnesemia'
p48879
aS'H01252'
p48880
aS'Hereditary folate malabsorption (HFM)'
p48881
aS'H01304'
p48882
aS'Hyperglycinuria'
p48883
asS'ENTRY'
p48884
(lp48885
S'map04978'
p48886
aS'Pathway'
p48887
asS'CLASS'
p48888
(lp48889
S'Organismal Systems Digestive system'
p48890
asS'DESCRIPTION'
p48891
(lp48892
S'Minerals are one of the five fundamental groups of nutrients needed to sustain life. Of the minerals, calcium plays innumerable roles in our bodies, serving as a main component of bone as well as an intracellular messenger in muscle contraction/relaxation, neural networks, the immune system, and endocrine/exocrine cells. Iron, copper, and other metals are required for redox reactions (as cofactors) and for oxygen transport and binding (in hemoglobin and myoglobin). Many enzymes require specific metal atoms to complete their catalytic functions. Animal tissues need moderate quantities of some elements (Ca, P, K, Na, Mg, S, and Cl) and trace amounts of others (Mn, Fe, I, Co, Cr, Cu, Zn, and Se). The minerals are absorbed by either passive or active transport systems through the intestinal mucosa, often using specialized transport proteins, such as ferritin for Fe3+ and vitamin D-induced protein for calcium.'
p48893
assS'path:map07215'
p48894
(dp48895
S'ENTRY'
p48896
(lp48897
S'map07215'
p48898
aS'Drug'
p48899
aS'Pathway'
p48900
asS'PATHWAY_MAP'
p48901
(lp48902
S'map07215'
p48903
asS'NAME'
p48904
(lp48905
S'alpha-Adrenergic receptor agonists/antagonists'
p48906
asS'COMPOUND'
p48907
(lp48908
S'D00076'
p48909
aS'Noradrenaline (JP16)'
p48910
ag48909
ag48910
aS'D00255'
p48911
aS'Carvedilol (JAN/USAN/INN)'
p48912
aS'D00281'
p48913
aS'Clonidine (JAN/USP/INN)'
p48914
aS'D00509'
p48915
aS'Phentolamine mesilate (JAN/INN)'
p48916
aS'D00511'
p48917
aS'Phenylephrine hydrochloride (JP16/USP)'
p48918
aS'D00514'
p48919
aS'Dexmedetomidine (USAN/INN)'
p48920
aS'D00604'
p48921
aS'Clonidine hydrochloride (JP16/USP)'
p48922
aS'D00605'
p48923
aS'Guanabenz acetate (JP16/USP)'
p48924
aS'D00606'
p48925
aS'Guanfacine hydrochloride (JAN/USP)'
p48926
aS'D00608'
p48927
aS'Doxazosin mesilate (JP16)'
p48928
aS'D00609'
p48929
aS'Prazosin hydrochloride (JP16/USP)'
p48930
aS'D00610'
p48931
aS'Terazosin hydrochloride hydrate (JAN)'
p48932
aS'D00679'
p48933
aS'Ergotamine tartrate (JP16/USP)'
p48934
aS'D00743'
p48935
aS'Naphazoline hydrochloride (JP16/USP)'
p48936
aS'D00997'
p48937
aS'Tolazoline hydrochloride (JAN/USP)'
p48938
aS'D01020'
p48939
aS'Methoxamine hydrochloride (JAN)'
p48940
aS'D01021'
p48941
aS'Naphazoline nitrate (JP16)'
p48942
aS'D01024'
p48943
aS'Tamsulosin hydrochloride (JP16/USAN)'
p48944
aS'D01163'
p48945
aS'Ergometrine maleate (JP16)'
p48946
aS'D01205'
p48947
aS'Dexmedetomidine hydrochloride (JAN/USAN)'
p48948
aS'D01333'
p48949
aS'Urapidil (JP16/INN)'
p48950
aS'D01469'
p48951
aS'Amosulalol hydrochloride (JP16)'
p48952
aS'D01674'
p48953
aS'Naftopidil (JP16/INN)'
p48954
aS'D01887'
p48955
aS'Bunazosin hydrochloride (JP16)'
p48956
aS'D03415'
p48957
aS'Carvedilol phosphate hydrate (JAN)'
p48958
aS'D04375'
p48959
aS'Guanabenz (USAN/INN)'
p48960
aS'D07451'
p48961
aS'Amosulalol (INN)'
p48962
aS'D07550'
p48963
aS'Bunazosin (INN)'
p48964
aS'D07874'
p48965
aS'Doxazosin (INN)'
p48966
aS'D07905'
p48967
aS'Ergometrine (INN)'
p48968
aS'D07906'
p48969
aS'Ergotamine (INN)'
p48970
aS'D08031'
p48971
aS'Guanfacine (INN)'
p48972
aS'D08201'
p48973
aS'Methoxamine (BAN)'
p48974
aS'D08362'
p48975
aS'Phentolamine (INN)'
p48976
aS'D08365'
p48977
aS'Phenylephrine (INN)'
p48978
aS'D08411'
p48979
aS'Prazosin (INN)'
p48980
aS'D08560'
p48981
aS'Tamsulosin (INN)'
p48982
aS'D08569'
p48983
aS'Terazosin (INN)'
p48984
aS'D08614'
p48985
aS'Tolazoline (INN)'
p48986
aS'D08662'
p48987
aS'Urapidil hydrochloride'
p48988
aS'D08966'
p48989
aS'Phenylephrine bitartrate (USP)'
p48990
assS'path:map00640'
p48991
(dp48992
S'NAME'
p48993
(lp48994
S'Propanoate metabolism'
p48995
asS'KO_PATHWAY'
p48996
(lp48997
S'ko00640'
p48998
asS'PATHWAY_MAP'
p48999
(lp49000
S'map00640'
p49001
asS'DISEASE'
p49002
(lp49003
S'H00174'
p49004
aS'Methylmalonic aciduria (MMA)'
p49005
ag49004
ag49005
aS'H00175'
p49006
aS'Propionic acidemia'
p49007
aS'H01283'
p49008
aS'Malonyl-CoA decarboxylase deficiency'
p49009
asS'MODULE'
p49010
(lp49011
S'M00013'
p49012
aS'Malonate semialdehyde pathway, propanoyl-CoA => Acetyl-CoA [PATH:map00640]'
p49013
asS'DBLINKS'
p49014
(lp49015
S'GO: 0019541'
p49016
asS'ENTRY'
p49017
(lp49018
S'map00640'
p49019
aS'Pathway'
p49020
asS'CLASS'
p49021
(lp49022
S'Metabolism Carbohydrate metabolism'
p49023
assS'path:map00642'
p49024
(dp49025
S'DBLINKS'
p49026
(lp49027
S'UMBBD: ethb2 ethb'
p49028
asS'NAME'
p49029
(lp49030
S'Ethylbenzene degradation'
p49031
asS'REFERENCE'
p49032
(lp49033
S'PMID:12420173'
p49034
ag49034
aS'AUTHORS'
p49035
aS'Rabus R, Kube M, Beck A, Widdel F, Reinhardt R.'
p49036
aS'TITLE'
p49037
aS'Genes involved in the anaerobic degradation of ethylbenzene in a denitrifying bacterium, strain EbN1.'
p49038
aS'JOURNAL'
p49039
aS'Arch Microbiol 178:506-16 (2002)'
p49040
aS'PMID:15551059'
p49041
ag49041
aS'AUTHORS'
p49042
aS'Rabus R, Kube M, Heider J, Beck A, Heitmann K, Widdel F, Reinhardt R.'
p49043
aS'TITLE'
p49044
aS'The genome sequence of an anaerobic aromatic-degrading denitrifying bacterium, strain EbN1.'
p49045
aS'JOURNAL'
p49046
aS'Arch Microbiol 183:27-36 (2005)'
p49047
asS'KO_PATHWAY'
p49048
(lp49049
S'ko00642'
p49050
asS'ENTRY'
p49051
(lp49052
S'map00642'
p49053
aS'Pathway'
p49054
asS'PATHWAY_MAP'
p49055
(lp49056
S'map00642'
p49057
asS'CLASS'
p49058
(lp49059
S'Metabolism Xenobiotics biodegradation and metabolism'
p49060
assS'path:map00643'
p49061
(dp49062
S'DBLINKS'
p49063
(lp49064
S'UMBBD: sty acr pao'
p49065
ag49065
aS'GO: 0042207'
p49066
asS'NAME'
p49067
(lp49068
S'Styrene degradation'
p49069
asS'REFERENCE'
p49070
(lp49071
S'PMID:11544206'
p49072
ag49072
aS'AUTHORS'
p49073
aS'Rodriguez-Saiz M, Barredo JL, Moreno MA, Fernandez-Canon JM, Penalva MA, Diez B.'
p49074
aS'TITLE'
p49075
aS'Reduced function of a phenylacetate-oxidizing cytochrome p450 caused strong genetic improvement in early phylogeny of penicillin-producing strains.'
p49076
aS'JOURNAL'
p49077
aS'J Bacteriol 183:5465-71 (2001)'
p49078
aS'PMID:17189487'
p49079
ag49079
aS'AUTHORS'
p49080
aS'Ferrer-Sevillano F, Fernandez-Canon JM.'
p49081
aS'TITLE'
p49082
aS'Novel phacB-encoded cytochrome P450 monooxygenase from Aspergillus nidulans with 3-hydroxyphenylacetate 6-hydroxylase and 3,4-dihydroxyphenylacetate 6-hydroxylase activities.'
p49083
aS'JOURNAL'
p49084
aS'Eukaryot Cell 6:514-20 (2007)'
p49085
asS'KO_PATHWAY'
p49086
(lp49087
S'ko00643'
p49088
asS'ENTRY'
p49089
(lp49090
S'map00643'
p49091
aS'Pathway'
p49092
asS'PATHWAY_MAP'
p49093
(lp49094
S'map00643'
p49095
asS'CLASS'
p49096
(lp49097
S'Metabolism Xenobiotics biodegradation and metabolism'
p49098
assS'path:map00130'
p49099
(dp49100
S'NAME'
p49101
(lp49102
S'Ubiquinone and other terpenoid-quinone biosynthesis'
p49103
asS'REFERENCE'
p49104
(lp49105
S'PMID:12908086'
p49106
ag49106
aS'AUTHORS'
p49107
aS'Ward MJ, Fu QS, Rhoads KR, Yeung CH, Spormann AM, Criddle CS.'
p49108
aS'TITLE'
p49109
aS'A derivative of the menaquinone precursor 1,4-dihydroxy-2-naphthoate is involved in the reductive transformation of carbon tetrachloride by aerobically grown Shewanella oneidensis MR-1.'
p49110
aS'JOURNAL'
p49111
aS'Appl Microbiol Biotechnol 63:571-7 (2004)'
p49112
aS'PMID:14499605'
p49113
ag49113
aS'AUTHORS'
p49114
aS'Monzingo AF, Gao J, Qiu J, Georgiou G, Robertus JD.'
p49115
aS'TITLE'
p49116
aS'The X-ray structure of Escherichia coli RraA (MenG), A protein inhibitor of RNA processing.'
p49117
aS'JOURNAL'
p49118
aS'J Mol Biol 332:1015-24 (2003)'
p49119
aS'PMID:11470786'
p49120
ag49120
aS'AUTHORS'
p49121
aS'Johnson TW, Zybailov B, Jones AD, Bittl R, Zech S, Stehlik D, Golbeck JH, Chitnis PR.'
p49122
aS'TITLE'
p49123
aS'Recruitment of a foreign quinone into the A1 site of photosystem I. In vivo replacement of plastoquinone-9 by media-supplemented naphthoquinones in phylloquinone biosynthetic pathway mutants of Synechocystis sp. PCC 6803.'
p49124
aS'JOURNAL'
p49125
aS'J Biol Chem 276:39512-21 (2001)'
p49126
aS'PMID:12615349'
p49127
ag49127
aS'AUTHORS'
p49128
aS'Wade Johnson T, Naithani S, Stewart C Jr, Zybailov B, Daniel Jones A, Golbeck JH, Chitnis PR.'
p49129
aS'TITLE'
p49130
aS'The menD and menE homologs code for 2-succinyl-6-hydroxyl-2,4-cyclohexadiene-1-carboxylate synthase and O-succinylbenzoic acid-CoA synthase in the phylloquinone biosynthetic pathway of Synechocystis sp. PCC 6803.'
p49131
aS'JOURNAL'
p49132
aS'Biochim Biophys Acta 1557:67-76 (2003)'
p49133
aS'PMID:12721307'
p49134
ag49134
aS'AUTHORS'
p49135
aS'Gin P, Hsu AY, Rothman SC, Jonassen T, Lee PT, Tzagoloff A, Clarke CF.'
p49136
aS'TITLE'
p49137
aS'The Saccharomyces cerevisiae COQ6 gene encodes a mitochondrial flavin-dependent monooxygenase required for coenzyme Q biosynthesis.'
p49138
aS'JOURNAL'
p49139
aS'J Biol Chem 278:25308-16 (2003)'
p49140
aS'PMID:18284213'
p49141
ag49141
aS'AUTHORS'
p49142
aS'Jiang M, Chen X, Guo ZF, Cao Y, Chen M, Guo Z.'
p49143
aS'TITLE'
p49144
aS'Identification and Characterization of (1R,6R)-2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate Synthase in the Menaquinone Biosynthesis of Escherichia coli.'
p49145
aS'JOURNAL'
p49146
aS'Biochemistry 47:3426-34 (2008)'
p49147
aS'PMID:17760421'
p49148
ag49148
aS'AUTHORS'
p49149
aS'Jiang M, Cao Y, Guo ZF, Chen M, Chen X, Guo Z.'
p49150
aS'TITLE'
p49151
aS'Menaquinone biosynthesis in Escherichia coli: identification of 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate as a novel intermediate and re-evaluation of MenD activity.'
p49152
aS'JOURNAL'
p49153
aS'Biochemistry 46:10979-89 (2007)'
p49154
aS'PMID:17956107'
p49155
ag49155
aS'AUTHORS'
p49156
aS'Jiang M, Chen M, Cao Y, Yang Y, Sze KH, Chen X, Guo Z.'
p49157
aS'TITLE'
p49158
aS'Determination of the stereochemistry of 2-succinyl-5-enolpyruvyl-6-hydroxy-3- cyclohexene-1-carboxylate, a key intermediate in menaquinone biosynthesis.'
p49159
aS'JOURNAL'
p49160
aS'Org Lett 9:4765-7 (2007)'
p49161
aS'PMID:18801996'
p49162
ag49162
aS'AUTHORS'
p49163
aS'Hiratsuka T, Furihata K, Ishikawa J, Yamashita H, Itoh N, Seto H, Dairi T'
p49164
aS'TITLE'
p49165
aS'An alternative menaquinone biosynthetic pathway operating in microorganisms.'
p49166
aS'JOURNAL'
p49167
aS'Science 321:1670-3 (2008)'
p49168
aS'PMID:12232327'
p49169
ag49169
aS'AUTHORS'
p49170
aS'Loscher R, Heide L'
p49171
aS'TITLE'
p49172
aS'Biosynthesis of p-Hydroxybenzoate from p-Coumarate and p-Coumaroyl-Coenzyme A in Cell-Free Extracts of Lithospermum erythrorhizon Cell Cultures.'
p49173
aS'JOURNAL'
p49174
aS'Plant Physiol 106:271-279 (1994)'
p49175
aS'PMID:11583838'
p49176
ag49176
aS'AUTHORS'
p49177
aS'Meganathan R'
p49178
aS'TITLE'
p49179
aS'Ubiquinone biosynthesis in microorganisms.'
p49180
aS'JOURNAL'
p49181
aS'FEMS Microbiol Lett 203:131-9 (2001)'
p49182
aS'PMID:14508009'
p49183
ag49183
aS'AUTHORS'
p49184
aS'Cheng Z, Sattler S, Maeda H, Sakuragi Y, Bryant DA, DellaPenna D'
p49185
aS'TITLE'
p49186
aS'Highly divergent methyltransferases catalyze a conserved reaction in tocopherol and plastoquinone synthesis in cyanobacteria and photosynthetic eukaryotes.'
p49187
aS'JOURNAL'
p49188
aS'Plant Cell 15:2343-56 (2003)'
p49189
aS'PMID:16989822'
p49190
ag49190
aS'AUTHORS'
p49191
aS'Sadre R, Gruber J, Frentzen M'
p49192
aS'TITLE'
p49193
aS'Characterization of homogentisate prenyltransferases involved in plastoquinone-9 and tocochromanol biosynthesis.'
p49194
aS'JOURNAL'
p49195
aS'FEBS Lett 580:5357-62 (2006)'
p49196
aS'PMID:12523993'
p49197
ag49197
aS'AUTHORS'
p49198
aS'Hofius D, Sonnewald U.'
p49199
aS'TITLE'
p49200
aS'Vitamin E biosynthesis: biochemistry meets cell biology.'
p49201
aS'JOURNAL'
p49202
aS'Trends Plant Sci 8:6-8 (2003)'
p49203
ag22
ag22
aS'AUTHORS'
p49204
aS'Kawamukai M'
p49205
aS'TITLE'
p49206
aS'Biosynthesis, bioproduction and novel roles of ubiquinone.'
p49207
aS'JOURNAL'
p49208
aS'J Bioscience Bioengineerinf'
p49209
aS'PMID:21239697'
p49210
ag49210
aS'AUTHORS'
p49211
aS'Tie JK, Jin DY, Straight DL, Stafford DW'
p49212
aS'TITLE'
p49213
aS'Functional study of the vitamin K cycle in mammalian cells.'
p49214
aS'JOURNAL'
p49215
aS'Blood 117:2967-74 (2011)'
p49216
aS'PMID:23113660'
p49217
ag49217
aS'AUTHORS'
p49218
aS'Zhou L, Wang JY, Wu J, Wang J, Poplawsky A, Lin S, Zhu B, Chang C, Zhou T, Zhang LH, He YW'
p49219
aS'TITLE'
p49220
aS'The diffusible factor synthase XanB2 is a bifunctional chorismatase that links the shikimate pathway to ubiquinone and xanthomonadins biosynthetic pathways.'
p49221
aS'JOURNAL'
p49222
aS'Mol Microbiol 87:80-93 (2013)'
p49223
asS'KO_PATHWAY'
p49224
(lp49225
S'ko00130'
p49226
asS'PATHWAY_MAP'
p49227
(lp49228
S'map00130'
p49229
asS'DISEASE'
p49230
(lp49231
S'H00999'
p49232
aS'Coenzyme Q10 deficiency'
p49233
asS'MODULE'
p49234
(lp49235
S'M00112'
p49236
aS'Tocopherol/tocotorienol biosynthesis [PATH:map00130]'
p49237
ag49236
ag49237
aS'M00116'
p49238
aS'Menaquinone biosynthesis, chorismate => menaquinone [PATH:map00130]'
p49239
aS'M00117'
p49240
aS'Ubiquinone biosynthesis, prokaryotes, chorismate => ubiquinone [PATH:map00130]'
p49241
aS'M00128'
p49242
aS'Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate => ubiquinone [PATH:map00130]'
p49243
asS'DBLINKS'
p49244
(lp49245
S'GO: 0006744 0009234 0042372'
p49246
asS'ENTRY'
p49247
(lp49248
S'map00130'
p49249
aS'Pathway'
p49250
asS'CLASS'
p49251
(lp49252
S'Metabolism Metabolism of cofactors and vitamins'
p49253
asS'DESCRIPTION'
p49254
(lp49255
S'Ubiquinone (UQ), also called coenzyme Q, and plastoquinone (PQ) are electron carriers in oxidative phosphorylation and photosynthesis, respectively. The quinoid nucleus of ubiquinone is derived from the shikimate pathway 4-hydroxybenzoate is directly formed from chorismate in bacteria, while it can be formed from either chorismate or tyrosine in yeast. The following biosynthesis of terpenoid moiety involves reactions of prenylation, decarboxylation, and three hydroxylations alternating with three methylations. The order of these reactions are somewhat different between bacteria and yeast. Phylloquinone (vitamin K1), menaquinone (vitamin K2), and tocopherol (vitamin E) are fat-soluble vitamins. Phylloquinone is a compound present in all photosynthetic plants serving as a cofactor for photosystem I-mediated electron transport. Menaquinone is an obligatory component of the electron-transfer pathway in bacteria.'
p49256
assS'path:map00521'
p49257
(dp49258
S'NAME'
p49259
(lp49260
S'Streptomycin biosynthesis'
p49261
asS'REFERENCE'
p49262
(lp49263
S'PMID:19362651'
p49264
ag49264
aS'AUTHORS'
p49265
aS'Wehmeier UF, Piepersberg W'
p49266
aS'TITLE'
p49267
aS'Enzymology of aminoglycoside biosynthesis-deduction from gene clusters.'
p49268
aS'JOURNAL'
p49269
aS'Methods Enzymol 459:459-91 (2009)'
p49270
aS'PMID:17390001'
p49271
ag49271
aS'AUTHORS'
p49272
aS'Flatt PM, Mahmud T'
p49273
aS'TITLE'
p49274
aS'Biosynthesis of aminocyclitol-aminoglycoside antibiotics and related compounds.'
p49275
aS'JOURNAL'
p49276
aS'Nat Prod Rep 24:358-92 (2007)'
p49277
aS'PMID:1698764'
p49278
ag49278
aS'AUTHORS'
p49279
aS'Walker JB'
p49280
aS'TITLE'
p49281
aS'Possible evolutionary relationships between streptomycin and bluensomycin biosynthetic pathways: detection of novel inositol kinase and O-carbamoyltransferase activities.'
p49282
aS'JOURNAL'
p49283
aS'J Bacteriol 172:5844-51 (1990)'
p49284
aS'PMID:2995326'
p49285
ag49285
aS'AUTHORS'
p49286
aS'Ohnuki T, Imanaka T, Aiba S'
p49287
aS'TITLE'
p49288
aS'Self-cloning in Streptomyces griseus of an str gene cluster for streptomycin biosynthesis and streptomycin resistance.'
p49289
aS'JOURNAL'
p49290
aS'J Bacteriol 164:85-94 (1985)'
p49291
aS'PMID:9238101'
p49292
ag49292
aS'AUTHORS'
p49293
aS'Ahlert J, Distler J, Mansouri K, Piepersberg W'
p49294
aS'TITLE'
p49295
aS'Identification of stsC, the gene encoding the L-glutamine:scyllo-inosose aminotransferase from streptomycin-producing Streptomycetes.'
p49296
aS'JOURNAL'
p49297
aS'Arch Microbiol 168:102-13 (1997)'
p49298
aS'PMID:1377151'
p49299
ag49299
aS'AUTHORS'
p49300
aS'Distler J, Mansouri K, Mayer G, Stockmann M, Piepersberg W'
p49301
aS'TITLE'
p49302
aS'Streptomycin biosynthesis and its regulation in Streptomycetes.'
p49303
aS'JOURNAL'
p49304
aS'Gene 115:105-11 (1992)'
p49305
aS'PMID:1654502'
p49306
ag49306
aS'AUTHORS'
p49307
aS'Mansouri K, Piepersberg W.'
p49308
aS'TITLE'
p49309
aS'Genetics of streptomycin production in Streptomyces griseus: nucleotide sequence of five genes, strFGHIK, including a phosphatase gene.'
p49310
aS'JOURNAL'
p49311
aS'Mol Gen Genet 228:459-69 (1991)'
p49312
aS'PMID:9922132'
p49313
ag49313
aS'AUTHORS'
p49314
aS'Fritsche E, Bergner A, Humm A, Piepersberg W, Huber R'
p49315
aS'TITLE'
p49316
aS'Crystal structure of L-arginine:inosamine-phosphate amidinotransferase StrB1 from Streptomyces griseus: an enzyme involved in streptomycin biosynthesis.'
p49317
aS'JOURNAL'
p49318
aS'Biochemistry 37:17664-72 (1998)'
p49319
asS'KO_PATHWAY'
p49320
(lp49321
S'ko00521'
p49322
asS'PATHWAY_MAP'
p49323
(lp49324
S'map00521'
p49325
asS'DBLINKS'
p49326
(lp49327
S'GO: 0019872'
p49328
asS'ENTRY'
p49329
(lp49330
S'map00521'
p49331
aS'Pathway'
p49332
asS'CLASS'
p49333
(lp49334
S'Metabolism Biosynthesis of other secondary metabolites'
p49335
asS'DESCRIPTION'
p49336
(lp49337
S'Streptomycin is an aminocyclitol-aminoglycoside antibiotic produced by Streptomyces griseus. Streptomycin consists of aminocyclitol (streptidine), 6-deoxyhexose (streptose), and N-methyl-L-glucosamine moieties, which are formed by independent biosynthetic pathways. All of the moieties are derived from D-glucose. The streptidine moiety is synthesized via myo-inositol, which is then oxidized at C-1 and transaminated to give scyllo-inosamine. After phosphorylation, the compound is transamidinated by arginine. The same procedure is repeated at the C-3 position. The streptose moiety is made from D-glucose via a dTDP-glucose pathway. The exact biosynthetic route for the N-methyl-L-glucosamine moiety is unknown, though the biosynthetic gene cluster have been proposed.'
p49338
assS'path:map00520'
p49339
(dp49340
S'NAME'
p49341
(lp49342
S'Amino sugar and nucleotide sugar metabolism'
p49343
asS'REFERENCE'
p49344
(lp49345
S'PMID:2793832'
p49346
ag49346
aS'AUTHORS'
p49347
aS'Wyk P, Reeves P'
p49348
aS'TITLE'
p49349
aS'Identification and sequence of the gene for abequose synthase, which confers antigenic specificity on group B salmonellae: homology with galactose epimerase.'
p49350
aS'JOURNAL'
p49351
aS'J Bacteriol 171:5687-93 (1989)'
p49352
aS'PMID:8071227'
p49353
ag49353
aS'AUTHORS'
p49354
aS'Thorson JS, Lo SF, Ploux O, He X, Liu HW'
p49355
aS'TITLE'
p49356
aS'Studies of the biosynthesis of 3,6-dideoxyhexoses: molecular cloning and characterization of the asc (ascarylose) region from Yersinia pseudotuberculosis serogroup VA.'
p49357
aS'JOURNAL'
p49358
aS'J Bacteriol 176:5483-93 (1994)'
p49359
aS'PMID:8444803'
p49360
ag49360
aS'AUTHORS'
p49361
aS'Kessler AC, Haase A, Reeves PR'
p49362
aS'TITLE'
p49363
aS'Molecular analysis of the 3,6-dideoxyhexose pathway genes of Yersinia pseudotuberculosis serogroup IIA.'
p49364
aS'JOURNAL'
p49365
aS'J Bacteriol 175:1412-22 (1993)'
p49366
aS'PMID:9811644'
p49367
ag49367
aS'AUTHORS'
p49368
aS'Danese PN, Oliver GR, Barr K, Bowman GD, Rick PD, Silhavy TJ'
p49369
aS'TITLE'
p49370
aS'Accumulation of the enterobacterial common antigen lipid II biosynthetic intermediate stimulates degP transcription in Escherichia coli.'
p49371
aS'JOURNAL'
p49372
aS'J Bacteriol 180:5875-84 (1998)'
p49373
aS'PMID:10931327'
p49374
ag49374
aS'AUTHORS'
p49375
aS'Skurnik M, Peippo A, Ervela E'
p49376
aS'TITLE'
p49377
aS'Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1b.'
p49378
aS'JOURNAL'
p49379
aS'Mol Microbiol 37:316-30 (2000)'
p49380
aS'PMID:10984043'
p49381
ag49381
aS'AUTHORS'
p49382
aS'Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV'
p49383
aS'TITLE'
p49384
aS'Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.'
p49385
aS'JOURNAL'
p49386
aS'Nature 406:959-64 (2000)'
p49387
aS'PMID:11447132'
p49388
ag49388
aS'AUTHORS'
p49389
aS'Ringenberg M, Lichtensteiger C, Vimr E'
p49390
aS'TITLE'
p49391
aS'Redirection of sialic acid metabolism in genetically engineered Escherichia coli.'
p49392
aS'JOURNAL'
p49393
aS'Glycobiology 11:533-9 (2001)'
p49394
aS'PMID:12562791'
p49395
ag49395
aS'AUTHORS'
p49396
aS'McCoy AJ, Sandlin RC, Maurelli AT'
p49397
aS'TITLE'
p49398
aS'In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance.'
p49399
aS'JOURNAL'
p49400
aS'J Bacteriol 185:1218-28 (2003)'
p49401
aS'PMID:14450717'
p49402
ag49402
aS'AUTHORS'
p49403
aS'JACOBSON B, DAVIDSON EA'
p49404
aS'TITLE'
p49405
aS'Biosynthesis of uronic acids by skin enzymes. I. Uridine diphosphate-D-glucuronic acid-5-epimerase.'
p49406
aS'JOURNAL'
p49407
aS'J Biol Chem 237:638-42 (1962)'
p49408
aS'PMID:15134748'
p49409
ag49409
aS'AUTHORS'
p49410
aS'Seifert GJ'
p49411
aS'TITLE'
p49412
aS'Nucleotide sugar interconversions and cell wall biosynthesis: how to bring the inside to the outside.'
p49413
aS'JOURNAL'
p49414
aS'Curr Opin Plant Biol 7:277-84 (2004)'
p49415
aS'PMID:15489439'
p49416
ag49416
aS'AUTHORS'
p49417
aS'Uehara T, Park JT'
p49418
aS'TITLE'
p49419
aS'The N-acetyl-D-glucosamine kinase of Escherichia coli and its role in murein recycling.'
p49420
aS'JOURNAL'
p49421
aS'J Bacteriol 186:7273-9 (2004)'
p49422
aS'PMID:15695810'
p49423
ag49423
aS'AUTHORS'
p49424
aS'Breazeale SD, Ribeiro AA, McClerren AL, Raetz CR.'
p49425
aS'TITLE'
p49426
aS'A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-Amino-4-deoxy-L-arabinose. Identification and function oF UDP-4-deoxy-4-formamido-L-arabinose.'
p49427
aS'JOURNAL'
p49428
aS'J Biol Chem 280:14154-67 (2005)'
p49429
aS'PMID:15809294'
p49430
ag49430
aS'AUTHORS'
p49431
aS'Williams GJ, Breazeale SD, Raetz CR, Naismith JH.'
p49432
aS'TITLE'
p49433
aS'Structure and function of both domains of ArnA, a dual function decarboxylase and a formyltransferase, involved in 4-amino-4-deoxy-L-arabinose biosynthesis.'
p49434
aS'JOURNAL'
p49435
aS'J Biol Chem 280:23000-8 (2005)'
p49436
aS'PMID:16237198'
p49437
ag49437
aS'AUTHORS'
p49438
aS'Maliekal P, Vertommen D, Delpierre G, Van Schaftingen E'
p49439
aS'TITLE'
p49440
aS'Identification of the sequence encoding N-acetylneuraminate-9-phosphate phosphatase.'
p49441
aS'JOURNAL'
p49442
aS'Glycobiology 16:165-72 (2006)'
p49443
aS'PMID:16277754'
p49444
ag49444
aS'AUTHORS'
p49445
aS'Campbell CT, Yarema KJ'
p49446
aS'TITLE'
p49447
aS'Large-scale approaches for glycobiology.'
p49448
aS'JOURNAL'
p49449
aS'Genome Biol 6:236 (2005)'
p49450
aS'PMID:16452451'
p49451
ag49451
aS'AUTHORS'
p49452
aS'Uehara T, Suefuji K, Jaeger T, Mayer C, Park JT'
p49453
aS'TITLE'
p49454
aS'MurQ Etherase is required by Escherichia coli in order to metabolize anhydro-N-acetylmuramic acid obtained either from the environment or from its own cell wall.'
p49455
aS'JOURNAL'
p49456
aS'J Bacteriol 188:1660-2 (2006)'
p49457
aS'PMID:16995900'
p49458
ag49458
aS'AUTHORS'
p49459
aS'Lanot A, Hodge D, Jackson RG, George GL, Elias L, Lim EK, Vaistij FE, Bowles DJ'
p49460
aS'TITLE'
p49461
aS'The glucosyltransferase UGT72E2 is responsible for monolignol 4-O-glucoside production in Arabidopsis thaliana.'
p49462
aS'JOURNAL'
p49463
aS'Plant J 48:286-95 (2006)'
p49464
aS'PMID:17085508'
p49465
ag49465
aS'AUTHORS'
p49466
aS'Muller R, Morant M, Jarmer H, Nilsson L, Nielsen TH'
p49467
aS'TITLE'
p49468
aS'Genome-wide analysis of the Arabidopsis leaf transcriptome reveals interaction of phosphate and sugar metabolism.'
p49469
aS'JOURNAL'
p49470
aS'Plant Physiol 143:156-71 (2007)'
p49471
aS'PMID:17190829'
p49472
ag49472
aS'AUTHORS'
p49473
aS'Oka T, Nemoto T, Jigami Y'
p49474
aS'TITLE'
p49475
aS'Functional analysis of Arabidopsis thaliana RHM2/MUM4, a multidomain protein involved in UDP-D-glucose to UDP-L-rhamnose conversion.'
p49476
aS'JOURNAL'
p49477
aS'J Biol Chem 282:5389-403 (2007)'
p49478
aS'PMID:17827295'
p49479
ag49479
aS'AUTHORS'
p49480
aS'Greenberg DE, Porcella SF, Zelazny AM, Virtaneva K, Sturdevant DE, Kupko JJ 3rd, Barbian KD, Babar A, Dorward DW, Holland SM.'
p49481
aS'TITLE'
p49482
aS'Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis.'
p49483
aS'JOURNAL'
p49484
aS'J Bacteriol 189:8727-36 (2007)'
p49485
aS'PMID:18199744'
p49486
ag49486
aS'AUTHORS'
p49487
aS'Kotake T, Hojo S, Tajima N, Matsuoka K, Koyama T, Tsumuraya Y'
p49488
aS'TITLE'
p49489
aS'A bifunctional enzyme with L-fucokinase and GDP-L-fucose pyrophosphorylase activities salvages free L-fucose in Arabidopsis.'
p49490
aS'JOURNAL'
p49491
aS'J Biol Chem 283:8125-35 (2008)'
p49492
aS'PMID:18304669'
p49493
ag49493
aS'AUTHORS'
p49494
aS'Vorholter FJ, Schneiker S, Goesmann A, Krause L, Bekel T, Kaiser O, Linke B, Patschkowski T, Ruckert C, Schmid J, Sidhu VK, Sieber V, Tauch A, Watt SA, Weisshaar B, Becker A, Niehaus K, Puhler A.'
p49495
aS'TITLE'
p49496
aS'The genome of Xanthomonas campestris pv. campestris B100 and its use for the reconstruction of metabolic pathways involved in xanthan biosynthesis.'
p49497
aS'JOURNAL'
p49498
aS'J Biotechnol 134:33-45 (2008)'
p49499
aS'PMID:11479276'
p49500
ag49500
aS'AUTHORS'
p49501
aS'Albermann C, Piepersberg W'
p49502
aS'TITLE'
p49503
aS'Expression and identification of the RfbE protein from Vibrio cholerae O1 and its use for the enzymatic synthesis of GDP-D-perosamine.'
p49504
aS'JOURNAL'
p49505
aS'Glycobiology 11:655-61 (2001)'
p49506
asS'KO_PATHWAY'
p49507
(lp49508
S'ko00520'
p49509
asS'PATHWAY_MAP'
p49510
(lp49511
S'map00520'
p49512
asS'DISEASE'
p49513
(lp49514
S'H00070'
p49515
aS'Galactosemia'
p49516
ag49515
ag49516
aS'H00147'
p49517
aS'Sialuria/ Sialic acid storage disease'
p49518
aS'H00235'
p49519
aS'Methemoglobinemia'
p49520
aS'H00594'
p49521
aS'Distal muscular dystrophies'
p49522
aS'H00596'
p49523
aS'Nonaka distal myopathy (NM)'
p49524
asS'MODULE'
p49525
(lp49526
S'M00267'
p49527
aS'PTS system, N-acetylglucosamine-specific II component [PATH:map00520]'
p49528
ag49527
ag49528
aS'M00282'
p49529
aS'PTS system, D-glucosamine-specific II component [PATH:map00520]'
p49530
aS'M00361'
p49531
aS'Nucleotide sugar biosynthesis, eukaryotes [PATH:map00520]'
p49532
aS'M00362'
p49533
aS'Nucleotide sugar biosynthesis, prokaryotes [PATH:map00520]'
p49534
aS'M00549'
p49535
aS'Nucleotide sugar biosynthesis, glucose => UDP-glucose [PATH:map00520]'
p49536
aS'M00554'
p49537
aS'Nucleotide sugar biosynthesis, galactose => UDP-galactose [PATH:map00520]'
p49538
asS'ENTRY'
p49539
(lp49540
S'map00520'
p49541
aS'Pathway'
p49542
asS'CLASS'
p49543
(lp49544
S'Metabolism Carbohydrate metabolism'
p49545
assS'path:map00523'
p49546
(dp49547
S'NAME'
p49548
(lp49549
S'Polyketide sugar unit biosynthesis'
p49550
asS'REFERENCE'
p49551
(lp49552
S'PMID:11336289'
p49553
ag49553
aS'AUTHORS'
p49554
aS'Rawlings BJ.'
p49555
aS'TITLE'
p49556
aS'Type I polyketide biosynthesis in bacteria (Part A--erythromycin biosynthesis).'
p49557
aS'JOURNAL'
p49558
aS'Nat Prod Rep 18:190-227 (2001)'
p49559
aS'PMID:11476481'
p49560
ag49560
aS'AUTHORS'
p49561
aS'Rawlings BJ.'
p49562
aS'TITLE'
p49563
aS'Type I polyketide biosynthesis in bacteria (part B).'
p49564
aS'JOURNAL'
p49565
aS'Nat Prod Rep 18:231-81 (2001)'
p49566
aS'PMID:11451669'
p49567
ag49567
aS'AUTHORS'
p49568
aS'Wohlert S, Lomovskaya N, Kulowski K, Fonstein L, Occi JL, Gewain KM, MacNeil DJ, Hutchinson CR'
p49569
aS'TITLE'
p49570
aS'Insights about the biosynthesis of the avermectin deoxysugar L-oleandrose through heterologous expression of Streptomyces avermitilis deoxysugar genes in Streptomyces lividans.'
p49571
aS'JOURNAL'
p49572
aS'Chem Biol 8:681-700 (2001)'
p49573
aS'PMID:10770761'
p49574
ag49574
aS'AUTHORS'
p49575
aS'Aguirrezabalaga I, Olano C, Allende N, Rodriguez L, Brana AF, Mendez C, Salas JA'
p49576
aS'TITLE'
p49577
aS'Identification and expression of genes involved in biosynthesis of L-oleandrose and its intermediate L-olivose in the oleandomycin producer Streptomyces antibioticus.'
p49578
aS'JOURNAL'
p49579
aS'Antimicrob Agents Chemother 44:1266-75 (2000)'
p49580
aS'PMID:10658660'
p49581
ag49581
aS'AUTHORS'
p49582
aS'Bate N, Butler AR, Smith IP, Cundliffe E'
p49583
aS'TITLE'
p49584
aS'The mycarose-biosynthetic genes of Streptomyces fradiae, producer of tylosin.'
p49585
aS'JOURNAL'
p49586
aS'Microbiology 146 ( Pt 1):139-46 (2000)'
p49587
aS'PMID:11553351'
p49588
ag49588
aS'AUTHORS'
p49589
aS'Amann S, Drager G, Rupprath C, Kirschning A, Elling L'
p49590
aS'TITLE'
p49591
aS'(Chemo)enzymatic synthesis of dTDP-activated 2,6-dideoxysugars as building blocks of polyketide antibiotics.'
p49592
aS'JOURNAL'
p49593
aS'Carbohydr Res 335:23-32 (2001)'
p49594
aS'PMID:17460661'
p49595
ag49595
aS'AUTHORS'
p49596
aS'Thibodeaux CJ, Melancon CE, Liu HW'
p49597
aS'TITLE'
p49598
aS'Unusual sugar biosynthesis and natural product glycodiversification.'
p49599
aS'JOURNAL'
p49600
aS'Nature 446:1008-16 (2007)'
p49601
aS'PMID:10972798'
p49602
ag49602
aS'AUTHORS'
p49603
aS'Volchegursky Y, Hu Z, Katz L, McDaniel R'
p49604
aS'TITLE'
p49605
aS'Biosynthesis of the anti-parasitic agent megalomicin: transformation of erythromycin to megalomicin in Saccharopolyspora erythraea.'
p49606
aS'JOURNAL'
p49607
aS'Mol Microbiol 37:752-62 (2000)'
p49608
aS'(PMID:15609849 (Article in Russian))'
p49609
ag49609
aS'AUTHORS'
p49610
aS'Mironov VA, Sergienko OV, Nastasiak IN, Danilenko VN.'
p49611
aS'TITLE'
p49612
aS'Biogenesis and regulation of biosynthesis of erythromycins in Saccharopolyspora.'
p49613
aS'JOURNAL'
p49614
aS'Applied Biochemistry and Microbiology 40(6): 531-541 (2004)'
p49615
asS'KO_PATHWAY'
p49616
(lp49617
S'ko00523'
p49618
asS'ENTRY'
p49619
(lp49620
S'map00523'
p49621
aS'Pathway'
p49622
asS'PATHWAY_MAP'
p49623
(lp49624
S'map00523'
p49625
asS'CLASS'
p49626
(lp49627
S'Metabolism Metabolism of terpenoids and polyketides'
p49628
assS'path:map00522'
p49629
(dp49630
S'NAME'
p49631
(lp49632
S'Biosynthesis of 12-, 14- and 16-membered macrolides'
p49633
asS'REFERENCE'
p49634
(lp49635
S'PMID:19514004'
p49636
ag49636
aS'AUTHORS'
p49637
aS'Hertweck C'
p49638
aS'TITLE'
p49639
aS'The biosynthetic logic of polyketide diversity.'
p49640
aS'JOURNAL'
p49641
aS'Angew Chem Int Ed Engl 48:4688-716 (2009)'
p49642
aS'PMID:11918808'
p49643
ag49643
aS'AUTHORS'
p49644
aS'Long PF, Wilkinson CJ, Bisang CP, Cortes J, Dunster N, Oliynyk M, McCormick E, McArthur H, Mendez C, Salas JA, Staunton J, Leadlay PF'
p49645
aS'TITLE'
p49646
aS'Engineering specificity of starter unit selection by the erythromycin-producing polyketide synthase.'
p49647
aS'JOURNAL'
p49648
aS'Mol Microbiol 43:1215-25 (2002)'
p49649
aS'PMID:10519556'
p49650
ag49650
aS'AUTHORS'
p49651
aS'Bisang C, Long PF, Cortes J, Westcott J, Crosby J, Matharu AL, Cox RJ, Simpson TJ, Staunton J, Leadlay PF'
p49652
aS'TITLE'
p49653
aS'A chain initiation factor common to both modular and aromatic polyketide synthases.'
p49654
aS'JOURNAL'
p49655
aS'Nature 401:502-5 (1999)'
p49656
aS'PMID:19362638'
p49657
ag49657
aS'AUTHORS'
p49658
aS'Katz L'
p49659
aS'TITLE'
p49660
aS'The DEBS paradigm for type I modular polyketide synthases and beyond.'
p49661
aS'JOURNAL'
p49662
aS'Methods Enzymol 459:113-42 (2009)'
p49663
aS'PMID:17719493'
p49664
ag49664
aS'AUTHORS'
p49665
aS'Kittendorf JD, Beck BJ, Buchholz TJ, Seufert W, Sherman DH'
p49666
aS'TITLE'
p49667
aS'Interrogating the molecular basis for multiple macrolactone ring formation by the pikromycin polyketide synthase.'
p49668
aS'JOURNAL'
p49669
aS'Chem Biol 14:944-54 (2007)'
p49670
aS'PMID:12031664'
p49671
ag49671
aS'AUTHORS'
p49672
aS'Beck BJ, Yoon YJ, Reynolds KA, Sherman DH'
p49673
aS'TITLE'
p49674
aS'The hidden steps of domain skipping: macrolactone ring size determination in the'
p49675
aS'pikromycin modular polyketide synthase.'
p49676
aS'JOURNAL'
p49677
aS'Chem Biol 9:575-83 (2002)'
p49678
aS'PMID:11223265'
p49679
ag49679
aS'AUTHORS'
p49680
aS'Chen S, Roberts JB, Xue Y, Sherman DH, Reynolds KA'
p49681
aS'TITLE'
p49682
aS'The Streptomyces venezuelae pikAV gene contains a transcription unit essential for expression of enzymes involved in glycosylation of narbonolide and 10-deoxymethynolide.'
p49683
aS'JOURNAL'
p49684
aS'Gene 263:255-64 (2001)'
p49685
aS'PMID:12368286'
p49686
ag49686
aS'AUTHORS'
p49687
aS'Kim BS, Cropp TA, Beck BJ, Sherman DH, Reynolds KA'
p49688
aS'TITLE'
p49689
aS'Biochemical evidence for an editing role of thioesterase II in the biosynthesis of the polyketide pikromycin.'
p49690
aS'JOURNAL'
p49691
aS'J Biol Chem 277:48028-34 (2002)'
p49692
aS'PMID:11851473'
p49693
ag49693
aS'AUTHORS'
p49694
aS'Ikeda H, Omura S'
p49695
aS'TITLE'
p49696
aS'Avermectin Biosynthesis.'
p49697
aS'JOURNAL'
p49698
aS'Chem Rev 97:2591-2610 (1997)'
p49699
aS'PMID:11780788'
p49700
ag49700
aS'AUTHORS'
p49701
aS'Ikeda H, Nonomiya T, Omura S'
p49702
aS'TITLE'
p49703
aS'Organization of biosynthetic gene cluster for avermectin in Streptomyces avermitilis: analysis of enzymatic domains in four polyketide synthases.'
p49704
aS'JOURNAL'
p49705
aS'J Ind Microbiol Biotechnol 27:170-6 (2001)'
p49706
aS'PMID:10972798'
p49707
ag49707
aS'AUTHORS'
p49708
aS'Volchegursky Y, Hu Z, Katz L, McDaniel R'
p49709
aS'TITLE'
p49710
aS'Biosynthesis of the anti-parasitic agent megalomicin: transformation of erythromycin to megalomicin in Saccharopolyspora erythraea.'
p49711
aS'JOURNAL'
p49712
aS'Mol Microbiol 37:752-62 (2000)'
p49713
aS'PMID:15870344'
p49714
ag49714
aS'AUTHORS'
p49715
aS'Peiru S, Menzella HG, Rodriguez E, Carney J, Gramajo H'
p49716
aS'TITLE'
p49717
aS'Production of the potent antibacterial polyketide erythromycin C in Escherichia coli.'
p49718
aS'JOURNAL'
p49719
aS'Appl Environ Microbiol 71:2539-47 (2005)'
p49720
aS'PMID:20418422'
p49721
ag49721
aS'AUTHORS'
p49722
aS'Useglio M, Peiru S, Rodriguez E, Labadie GR, Carney JR, Gramajo H'
p49723
aS'TITLE'
p49724
aS'TDP-L-megosamine biosynthesis pathway elucidation and megalomicin a production in Escherichia coli.'
p49725
aS'JOURNAL'
p49726
aS'Appl Environ Microbiol 76:3869-77 (2010)'
p49727
aS'PMID:11752428'
p49728
ag49728
aS'AUTHORS'
p49729
aS'Tsai SC, Miercke LJ, Krucinski J, Gokhale R, Chen JC, Foster PG, Cane DE, Khosla C, Stroud RM'
p49730
aS'TITLE'
p49731
aS'Crystal structure of the macrocycle-forming thioesterase domain of the erythromycin polyketide synthase: versatility from a unique substrate channel.'
p49732
aS'JOURNAL'
p49733
aS'Proc Natl Acad Sci U S A 98:14808-13 (2001)'
p49734
aS'PMID:19625248'
p49735
ag49735
aS'AUTHORS'
p49736
aS'Savino C, Montemiglio LC, Sciara G, Miele AE, Kendrew SG, Jemth P, Gianni S, Vallone B'
p49737
aS'TITLE'
p49738
aS'Investigating the structural plasticity of a cytochrome P450: three-dimensional structures of P450 EryK and binding to its physiological substrate.'
p49739
aS'JOURNAL'
p49740
aS'J Biol Chem 284:29170-9 (2009)'
p49741
aS'PMID:8300527'
p49742
ag49742
aS'AUTHORS'
p49743
aS'Hsieh YJ, Kolattukudy PE.'
p49744
aS'TITLE'
p49745
aS'Inhibition of erythromycin synthesis by disruption of malonyl-coenzyme A decarboxylase gene eryM in Saccharopolyspora erythraea.'
p49746
aS'JOURNAL'
p49747
aS'J Bacteriol 176:714-24 (1994)'
p49748
aS'PMID:8830278'
p49749
ag49749
aS'AUTHORS'
p49750
aS'Donadio S, Staver MJ, Katz L.'
p49751
aS'TITLE'
p49752
aS'Erythromycin production in Saccharopolyspora erythraea does not require a functional propionyl-CoA carboxylase.'
p49753
aS'JOURNAL'
p49754
aS'Mol Microbiol 19:977-84 (1996)'
p49755
aS'PMID:9353926'
p49756
ag49756
aS'AUTHORS'
p49757
aS'Summers RG, Donadio S, Staver MJ, Wendt-Pienkowski E, Hutchinson CR, Katz L.'
p49758
aS'TITLE'
p49759
aS'Sequencing and mutagenesis of genes from the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea that are involved in L-mycarose and D-desosamine production.'
p49760
aS'JOURNAL'
p49761
aS'Microbiology 143:3251-62 (1997)'
p49762
aS'PMID:11476481'
p49763
ag49763
aS'AUTHORS'
p49764
aS'Rawlings BJ.'
p49765
aS'TITLE'
p49766
aS'Type I polyketide biosynthesis in bacteria (part B).'
p49767
aS'JOURNAL'
p49768
aS'Nat Prod Rep 18:231-81 (2001)'
p49769
aS'PMID:11336289'
p49770
ag49770
aS'AUTHORS'
p49771
aS'Rawlings BJ.'
p49772
aS'TITLE'
p49773
aS'Type I polyketide biosynthesis in bacteria (Part A--erythromycin biosynthesis).'
p49774
aS'JOURNAL'
p49775
aS'Nat Prod Rep 18:190-227 (2001)'
p49776
aS'PMID:20695498'
p49777
ag49777
aS'AUTHORS'
p49778
aS'Borisova SA, Liu HW'
p49779
aS'TITLE'
p49780
aS'Characterization of glycosyltransferase DesVII and its auxiliary partner protein'
p49781
aS'DesVIII in the methymycin/picromycin biosynthetic pathway.'
p49782
aS'JOURNAL'
p49783
aS'Biochemistry 49:8071-84 (2010)'
p49784
aS'PMID:17049185'
p49785
ag49785
aS'AUTHORS'
p49786
aS'Hong JS, Park SJ, Parajuli N, Park SR, Koh HS, Jung WS, Choi CY, Yoon YJ'
p49787
aS'TITLE'
p49788
aS'Functional analysis of desVIII homologues involved in glycosylation of macrolide'
p49789
aS'antibiotics by interspecies complementation.'
p49790
aS'JOURNAL'
p49791
aS'Gene 386:123-30 (2007)'
p49792
aS'PMID:16514147'
p49793
ag49793
aS'AUTHORS'
p49794
aS'Rodriguez E, Peiru S, Carney JR, Gramajo H'
p49795
aS'TITLE'
p49796
aS'In vivo characterization of the dTDP-D-desosamine pathway of the megalomicin gene cluster from Micromonospora megalomicea.'
p49797
aS'JOURNAL'
p49798
aS'Microbiology 152:667-73 (2006)'
p49799
aS'PMID:22056329'
p49800
ag49800
aS'AUTHORS'
p49801
aS'Moncrieffe MC, Fernandez MJ, Spiteller D, Matsumura H, Gay NJ, Luisi BF, Leadlay PF'
p49802
aS'TITLE'
p49803
aS'Structure of the glycosyltransferase EryCIII in complex with its activating P450'
p49804
aS'homologue EryCII.'
p49805
aS'JOURNAL'
p49806
aS'J Mol Biol 415:92-101 (2012)'
p49807
aS'PMID:16218575'
p49808
ag49808
aS'AUTHORS'
p49809
aS'Yuan Y, Chung HS, Leimkuhler C, Walsh CT, Kahne D, Walker S'
p49810
aS'TITLE'
p49811
aS'In vitro reconstitution of EryCIII activity for the preparation of unnatural macrolides.'
p49812
aS'JOURNAL'
p49813
aS'J Am Chem Soc 127:14128-9 (2005)'
p49814
aS'PMID:16825192'
p49815
ag49815
aS'AUTHORS'
p49816
aS'Sherman DH, Li S, Yermalitskaya LV, Kim Y, Smith JA, Waterman MR, Podust LM'
p49817
aS'TITLE'
p49818
aS'The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae.'
p49819
aS'JOURNAL'
p49820
aS'J Biol Chem 281:26289-97 (2006)'
p49821
aS'PMID:19124459'
p49822
ag49822
aS'AUTHORS'
p49823
aS'Li S, Ouellet H, Sherman DH, Podust LM'
p49824
aS'TITLE'
p49825
aS'Analysis of transient and catalytic desosamine-binding pockets in cytochrome P-450 PikC from Streptomyces venezuelae.'
p49826
aS'JOURNAL'
p49827
aS'J Biol Chem 284:5723-30 (2009)'
p49828
asS'KO_PATHWAY'
p49829
(lp49830
S'ko00522'
p49831
asS'ENTRY'
p49832
(lp49833
S'map00522'
p49834
aS'Pathway'
p49835
asS'PATHWAY_MAP'
p49836
(lp49837
S'map00522'
p49838
asS'CLASS'
p49839
(lp49840
S'Metabolism Metabolism of terpenoids and polyketides'
p49841
assS'path:map00524'
p49842
(dp49843
S'NAME'
p49844
(lp49845
S'Butirosin and neomycin biosynthesis'
p49846
asS'REFERENCE'
p49847
(lp49848
S'PMID:19362652'
p49849
ag49849
aS'AUTHORS'
p49850
aS'Kudo F, Eguchi T'
p49851
aS'TITLE'
p49852
aS'Biosynthetic enzymes for the aminoglycosides butirosin and neomycin.'
p49853
aS'JOURNAL'
p49854
aS'Methods Enzymol 459:493-519 (2009)'
p49855
aS'PMID:19644520'
p49856
ag49856
aS'AUTHORS'
p49857
aS'Kudo F, Eguchi T'
p49858
aS'TITLE'
p49859
aS'Biosynthetic genes for aminoglycoside antibiotics.'
p49860
aS'JOURNAL'
p49861
aS'J Antibiot (Tokyo) 62:471-81 (2009)'
p49862
aS'PMID:17879343'
p49863
ag49863
aS'AUTHORS'
p49864
aS'Nango E, Kumasaka T, Hirayama T, Tanaka N, Eguchi T'
p49865
aS'TITLE'
p49866
aS'Structure of 2-deoxy-scyllo-inosose synthase, a key enzyme in the biosynthesis of 2-deoxystreptamine-containing aminoglycoside antibiotics, in complex with a mechanism-based inhibitor and NAD+.'
p49867
aS'JOURNAL'
p49868
aS'Proteins 70:517-27 (2008)'
p49869
aS'PMID:15839685'
p49870
ag49870
aS'AUTHORS'
p49871
aS'Yokoyama K, Kudo F, Kuwahara M, Inomata K, Tamegai H, Eguchi T, Kakinuma K'
p49872
aS'TITLE'
p49873
aS'Stereochemical recognition of doubly functional aminotransferase in 2-deoxystreptamine biosynthesis.'
p49874
aS'JOURNAL'
p49875
aS'J Am Chem Soc 127:5869-74 (2005)'
p49876
aS'PMID:12374384'
p49877
ag49877
aS'AUTHORS'
p49878
aS'Tamegai H, Nango E, Kuwahara M, Yamamoto H, Ota Y, Kuriki H, Eguchi T, Kakinuma K'
p49879
aS'TITLE'
p49880
aS'Identification of L-glutamine: 2-deoxy-scyllo-inosose aminotransferase required for the biosynthesis of butirosin in Bacillus circulans.'
p49881
aS'JOURNAL'
p49882
aS'J Antibiot (Tokyo) 55:707-14 (2002)'
p49883
aS'PMID:16506694'
p49884
ag49884
aS'AUTHORS'
p49885
aS'Kudo F, Yamamoto Y, Yokoyama K, Eguchi T, Kakinuma K'
p49886
aS'TITLE'
p49887
aS'Biosynthesis of 2-deoxystreptamine by three crucial enzymes in Streptomyces fradiae NBRC 12773.'
p49888
aS'JOURNAL'
p49889
aS'J Antibiot (Tokyo) 58:766-74 (2005)'
p49890
aS'PMID:18672902'
p49891
ag49891
aS'AUTHORS'
p49892
aS'Yokoyama K, Ohmori D, Kudo F, Eguchi T'
p49893
aS'TITLE'
p49894
aS'Mechanistic study on the reaction of a radical SAM dehydrogenase BtrN by electron paramagnetic resonance spectroscopy.'
p49895
aS'JOURNAL'
p49896
aS'Biochemistry 47:8950-60 (2008)'
p49897
aS'PMID:18001019'
p49898
ag49898
aS'AUTHORS'
p49899
aS'Yokoyama K, Numakura M, Kudo F, Ohmori D, Eguchi T'
p49900
aS'TITLE'
p49901
aS'Characterization and mechanistic study of a radical SAM dehydrogenase in the biosynthesis of butirosin.'
p49902
aS'JOURNAL'
p49903
aS'J Am Chem Soc 129:15147-55 (2007)'
p49904
aS'PMID:18311744'
p49905
ag49905
aS'AUTHORS'
p49906
aS'Yokoyama K, Yamamoto Y, Kudo F, Eguchi T'
p49907
aS'TITLE'
p49908
aS'Involvement of two distinct N-acetylglucosaminyltransferases and a dual-function'
p49909
aS'deacetylase in neomycin biosynthesis.'
p49910
aS'JOURNAL'
p49911
aS'Chembiochem 9:865-9 (2008)'
p49912
aS'PMID:18802637'
p49913
ag49913
aS'AUTHORS'
p49914
aS'Fan Q, Huang F, Leadlay PF, Spencer JB'
p49915
aS'TITLE'
p49916
aS'The neomycin biosynthetic gene cluster of Streptomyces fradiae NCIMB 8233: genetic and biochemical evidence for the roles of two glycosyltransferases and a deacetylase.'
p49917
aS'JOURNAL'
p49918
aS'Org Biomol Chem 6:3306-14 (2008)'
p49919
aS'PMID:17226887'
p49920
ag49920
aS'AUTHORS'
p49921
aS'Truman AW, Huang F, Llewellyn NM, Spencer JB'
p49922
aS'TITLE'
p49923
aS'Characterization of the enzyme BtrD from Bacillus circulans and revision of its functional assignment in the biosynthesis of butirosin.'
p49924
aS'JOURNAL'
p49925
aS'Angew Chem Int Ed Engl 46:1462-4 (2007)'
p49926
aS'PMID:17482823'
p49927
ag49927
aS'AUTHORS'
p49928
aS'Kudo F, Fujii T, Kinoshita S, Eguchi T'
p49929
aS'TITLE'
p49930
aS'Unique O-ribosylation in the biosynthesis of butirosin.'
p49931
aS'JOURNAL'
p49932
aS'Bioorg Med Chem 15:4360-8 (2007)'
p49933
aS'PMID:12870817'
p49934
ag49934
aS'AUTHORS'
p49935
aS'Yukita T, Nishida H, Eguchi T, Kakinuma K'
p49936
aS'TITLE'
p49937
aS'Biosynthesis of (2R)-4-amino-2-hydroxybutyric acid, unique and biologically significant substituent in butirosins.'
p49938
aS'JOURNAL'
p49939
aS'J Antibiot (Tokyo) 56:497-500 (2003)'
p49940
aS'PMID:15975512'
p49941
ag49941
aS'AUTHORS'
p49942
aS'Li Y, Llewellyn NM, Giri R, Huang F, Spencer JB'
p49943
aS'TITLE'
p49944
aS'Biosynthesis of the unique amino acid side chain of butirosin: possible protective-group chemistry in an acyl carrier protein-mediated pathway.'
p49945
aS'JOURNAL'
p49946
aS'Chem Biol 12:665-75 (2005)'
p49947
aS'PMID:17462573'
p49948
ag49948
aS'AUTHORS'
p49949
aS'Llewellyn NM, Li Y, Spencer JB'
p49950
aS'TITLE'
p49951
aS'Biosynthesis of butirosin: transfer and deprotection of the unique amino acid side chain.'
p49952
aS'JOURNAL'
p49953
aS'Chem Biol 14:379-86 (2007)'
p49954
aS'PMID:18685777'
p49955
ag49955
aS'AUTHORS'
p49956
aS'Llewellyn NM, Spencer JB'
p49957
aS'TITLE'
p49958
aS'Chemoenzymatic acylation of aminoglycoside antibiotics.'
p49959
aS'JOURNAL'
p49960
aS'Chem Commun (Camb) 3786-8 (2008)'
p49961
aS'PMID:19466609'
p49962
ag49962
aS'AUTHORS'
p49963
aS'Nepal KK, Oh TJ, Sohng JK'
p49964
aS'TITLE'
p49965
aS'Heterologous production of paromamine in Streptomyces lividans TK24 using kanamycin biosynthetic genes from Streptomyces kanamyceticus ATCC12853.'
p49966
aS'JOURNAL'
p49967
aS'Mol Cells 27:601-8 (2009)'
p49968
aS'PMID:21983602'
p49969
ag49969
aS'AUTHORS'
p49970
aS'Park JW, Park SR, Nepal KK, Han AR, Ban YH, Yoo YJ, Kim EJ, Kim EM, Kim D, Sohng JK, Yoon YJ'
p49971
aS'TITLE'
p49972
aS'Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation.'
p49973
aS'JOURNAL'
p49974
aS'Nat Chem Biol 7:843-52 (2011)'
p49975
asS'KO_PATHWAY'
p49976
(lp49977
S'ko00524'
p49978
asS'ENTRY'
p49979
(lp49980
S'map00524'
p49981
aS'Pathway'
p49982
asS'PATHWAY_MAP'
p49983
(lp49984
S'map00524'
p49985
asS'CLASS'
p49986
(lp49987
S'Metabolism Biosynthesis of other secondary metabolites'
p49988
assS'path:map00983'
p49989
(dp49990
S'NAME'
p49991
(lp49992
S'Drug metabolism - other enzymes'
p49993
asS'REFERENCE'
p49994
(lp49995
g22
ag22
aS'AUTHORS'
p49996
aS'Kato R, Kamatari T (eds).'
p49997
aS'TITLE'
p49998
aS'[Drug Metabolism] (In Japanese)'
p49999
aS'JOURNAL'
p50000
aS'Tokyo Kagaku Dojin (2000)'
p50001
aS'PMID:15788214'
p50002
ag50002
aS'AUTHORS'
p50003
aS'Al Hadithy AF, de Boer NK, Derijks LJ, Escher JC, Mulder CJ, Brouwers JR.'
p50004
aS'TITLE'
p50005
aS'Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.'
p50006
aS'JOURNAL'
p50007
aS'Dig Liver Dis 37:282-97 (2005)'
p50008
aS'PMID:16048561'
p50009
ag50009
aS'AUTHORS'
p50010
aS'Gearry RB, Barclay ML.'
p50011
aS'TITLE'
p50012
aS'Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.'
p50013
aS'JOURNAL'
p50014
aS'J Gastroenterol Hepatol 20:1149-57 (2005)'
p50015
aS'PMID:16880012'
p50016
ag50016
aS'AUTHORS'
p50017
aS'Gilissen LP, Derijks LJ, Verhoeven HM, Bierau J, Hooymans PM, Hommes DW, Engels LG.'
p50018
aS'TITLE'
p50019
aS"Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's disease."
p50020
aS'JOURNAL'
p50021
aS'Dig Liver Dis 39:182-6 (2007)'
p50022
aS'PMID:15514566'
p50023
ag50023
aS'AUTHORS'
p50024
aS'Fischel JL, Formento P, Ciccolini J, Etienne-Grimaldi MC, Milano G.'
p50025
aS'TITLE'
p50026
aS"Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes."
p50027
aS'JOURNAL'
p50028
aS'Anticancer Drugs 15:969-74 (2004)'
p50029
aS'PMID:10976516'
p50030
ag50030
aS'AUTHORS'
p50031
aS'Shimma N, Umeda I, Arasaki M, Murasaki C, Masubuchi K, Kohchi Y, Miwa M, Ura M, Sawada N, Tahara H, Kuruma I, Horii I, Ishitsuka H.'
p50032
aS'TITLE'
p50033
aS'The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine.'
p50034
aS'JOURNAL'
p50035
aS'Bioorg Med Chem 8:1697-706 (2000)'
p50036
aS'PMID:15173095'
p50037
ag50037
aS'AUTHORS'
p50038
aS'Chung YL, Troy H, Judson IR, Leek R, Leach MO, Stubbs M, Harris AL, Griffiths JR'
p50039
aS'TITLE'
p50040
aS'Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopy.'
p50041
aS'JOURNAL'
p50042
aS'Clin Cancer Res 10:3863-70 (2004)'
p50043
aS'PMID:11489791'
p50044
ag50044
aS'AUTHORS'
p50045
aS'Mathijssen RH, van Alphen RJ, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A'
p50046
aS'TITLE'
p50047
aS'Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).'
p50048
aS'JOURNAL'
p50049
aS'Clin Cancer Res 7:2182-94 (2001)'
p50050
aS'PMID:11379777'
p50051
ag50051
aS'AUTHORS'
p50052
aS'Kita T, Tanigawara Y, Chikazawa S, Hatanaka H, Sakaeda T, Komada F, Iwakawa S, Okumura K.'
p50053
aS'TITLE'
p50054
aS'N-Acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients.'
p50055
aS'JOURNAL'
p50056
aS'Biol Pharm Bull 24:544-9 (2001)'
p50057
asS'KO_PATHWAY'
p50058
(lp50059
S'ko00983'
p50060
asS'ENTRY'
p50061
(lp50062
S'map00983'
p50063
aS'Pathway'
p50064
asS'PATHWAY_MAP'
p50065
(lp50066
S'map00983'
p50067
asS'DISEASE'
p50068
(lp50069
S'H00193'
p50070
aS'Dihydropyrimidine dehydrogenase deficiency'
p50071
ag50070
ag50071
aS'H00199'
p50072
aS'Dihydropyrimidinase deficiency'
p50073
aS'H00200'
p50074
aS'Beta-ureidopropionase deficiency'
p50075
aS'H00964'
p50076
aS'Thiopurine S-methyltransferase deficiency (TPMT deficiency)'
p50077
asS'CLASS'
p50078
(lp50079
S'Metabolism Xenobiotics biodegradation and metabolism'
p50080
assS'path:map00450'
p50081
(dp50082
S'NAME'
p50083
(lp50084
S'Selenocompound metabolism'
p50085
asS'REFERENCE'
p50086
(lp50087
S'PMID:21190829'
p50088
ag50088
aS'AUTHORS'
p50089
aS'Hoefig CS, Renko K, Kohrle J, Birringer M, Schomburg L'
p50090
aS'TITLE'
p50091
aS'Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture.'
p50092
aS'JOURNAL'
p50093
aS'J Nutr Biochem (2010)'
p50094
aS'PMID:19051051'
p50095
ag50095
aS'AUTHORS'
p50096
aS'McKenzie MJ, Hunter DA, Pathirana R, Watson LM, Joyce NI, Matich AJ, Rowan DD, Brummell DA'
p50097
aS'TITLE'
p50098
aS'Accumulation of an organic anticancer selenium compound in a transgenic Solanaceous species shows wider applicability of the selenocysteine methyltransferase transgene from selenium hyperaccumulators.'
p50099
aS'JOURNAL'
p50100
aS'Transgenic Res 18:407-24 (2009)'
p50101
aS'PMID:20383543'
p50102
ag50102
aS'AUTHORS'
p50103
aS'Pinto JT, Lee JI, Sinha R, MacEwan ME, Cooper AJ'
p50104
aS'TITLE'
p50105
aS'Chemopreventive mechanisms of alpha-keto acid metabolites of naturally occurring'
p50106
aS'organoselenium compounds.'
p50107
aS'JOURNAL'
p50108
aS'Amino Acids 41:29-41 (2011)'
p50109
aS'PMID:17451884'
p50110
ag50110
aS'AUTHORS'
p50111
aS'Suzuki KT, Kurasaki K, Suzuki N'
p50112
aS'TITLE'
p50113
aS'Selenocysteine beta-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide.'
p50114
aS'JOURNAL'
p50115
aS'Biochim Biophys Acta 1770:1053-61 (2007)'
p50116
aS'PMID:11782468'
p50117
ag50117
aS'AUTHORS'
p50118
aS'Gromer S, Gross JH'
p50119
aS'TITLE'
p50120
aS'Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase. Implications for the antitumor effects of selenium.'
p50121
aS'JOURNAL'
p50122
aS'J Biol Chem 277:9701-6 (2002)'
p50123
asS'KO_PATHWAY'
p50124
(lp50125
S'ko00450'
p50126
asS'ENTRY'
p50127
(lp50128
S'map00450'
p50129
aS'Pathway'
p50130
asS'PATHWAY_MAP'
p50131
(lp50132
S'map00450'
p50133
asS'DISEASE'
p50134
(lp50135
S'H00183'
p50136
aS'Homocystinuria'
p50137
ag50136
ag50137
aS'H00184'
p50138
aS'Hypermethioninemia'
p50139
aS'H00761'
p50140
aS'SEMD, Pakistani type'
p50141
aS'H01285'
p50142
aS'Methylcobalamin deficiency type G (cblG)'
p50143
asS'CLASS'
p50144
(lp50145
S'Metabolism Metabolism of other amino acids'
p50146
assS'path:map04075'
p50147
(dp50148
S'DBLINKS'
p50149
(lp50150
S'GO: 0009734 0009736 0009738 0009742 0009867 0009873 0010476'
p50151
asS'NAME'
p50152
(lp50153
S'Plant hormone signal transduction'
p50154
asS'REFERENCE'
p50155
(lp50156
S'PMID:19686081'
p50157
ag50157
aS'AUTHORS'
p50158
aS'Chapman EJ, Estelle M'
p50159
aS'TITLE'
p50160
aS'Mechanism of auxin-regulated gene expression in plants.'
p50161
aS'JOURNAL'
p50162
aS'Annu Rev Genet 43:265-85 (2009)'
p50163
aS'PMID:16212609'
p50164
ag50164
aS'AUTHORS'
p50165
aS'Brenner WG, Romanov GA, Kollmer I, Burkle L, Schmulling T'
p50166
aS'TITLE'
p50167
aS'Immediate-early and delayed cytokinin response genes of Arabidopsis thaliana identified by genome-wide expression profiling reveal novel cytokinin-sensitive processes and suggest cytokinin action through transcriptional cascades.'
p50168
aS'JOURNAL'
p50169
aS'Plant J 44:314-33 (2005)'
p50170
aS'PMID:16227453'
p50171
ag50171
aS'AUTHORS'
p50172
aS'Mason MG, Mathews DE, Argyros DA, Maxwell BB, Kieber JJ, Alonso JM, Ecker JR, Schaller GE'
p50173
aS'TITLE'
p50174
aS'Multiple type-B response regulators mediate cytokinin signal transduction in Arabidopsis.'
p50175
aS'JOURNAL'
p50176
aS'Plant Cell 17:3007-18 (2005)'
p50177
aS'PMID:19470587'
p50178
ag50178
aS'AUTHORS'
p50179
aS'Harberd NP, Belfield E, Yasumura Y'
p50180
aS'TITLE'
p50181
aS'The angiosperm gibberellin-GID1-DELLA growth regulatory mechanism: how an "inhibitor of an inhibitor" enables flexible response to fluctuating environments.'
p50182
aS'JOURNAL'
p50183
aS'Plant Cell 21:1328-39 (2009)'
p50184
aS'PMID:17965273'
p50185
ag50185
aS'AUTHORS'
p50186
aS'Hirano K, Nakajima M, Asano K, Nishiyama T, Sakakibara H, Kojima M, Katoh E, Xiang H, Tanahashi T, Hasebe M, Banks JA, Ashikari M, Kitano H, Ueguchi-Tanaka M, Matsuoka M'
p50187
aS'TITLE'
p50188
aS'The GID1-mediated gibberellin perception mechanism is conserved in the Lycophyte'
p50189
aS'Selaginella moellendorffii but not in the Bryophyte Physcomitrella patens.'
p50190
aS'JOURNAL'
p50191
aS'Plant Cell 19:3058-79 (2007)'
p50192
aS'PMID:19805022'
p50193
ag50193
aS'AUTHORS'
p50194
aS'Umezawa T, Sugiyama N, Mizoguchi M, Hayashi S, Myouga F, Yamaguchi-Shinozaki K, Ishihama Y, Hirayama T, Shinozaki K'
p50195
aS'TITLE'
p50196
aS'Type 2C protein phosphatases directly regulate abscisic acid-activated protein kinases in Arabidopsis.'
p50197
aS'JOURNAL'
p50198
aS'Proc Natl Acad Sci U S A 106:17588-93 (2009)'
p50199
aS'PMID:15753119'
p50200
ag50200
aS'AUTHORS'
p50201
aS'Chen YF, Etheridge N, Schaller GE'
p50202
aS'TITLE'
p50203
aS'Ethylene signal transduction.'
p50204
aS'JOURNAL'
p50205
aS'Ann Bot 95:901-15 (2005)'
p50206
aS'PMID:12628921'
p50207
ag50207
aS'AUTHORS'
p50208
aS'Ouaked F, Rozhon W, Lecourieux D, Hirt H'
p50209
aS'TITLE'
p50210
aS'A MAPK pathway mediates ethylene signaling in plants.'
p50211
aS'JOURNAL'
p50212
aS'EMBO J 22:1282-8 (2003)'
p50213
aS'PMID:20192752'
p50214
ag50214
aS'AUTHORS'
p50215
aS'Kim TW, Wang ZY'
p50216
aS'TITLE'
p50217
aS'Brassinosteroid signal transduction from receptor kinases to transcription factors.'
p50218
aS'JOURNAL'
p50219
aS'Annu Rev Plant Biol 61:681-704 (2010)'
p50220
aS'PMID:19734888'
p50221
ag50221
aS'AUTHORS'
p50222
aS'Kim TW, Guan S, Sun Y, Deng Z, Tang W, Shang JX, Sun Y, Burlingame AL, Wang ZY'
p50223
aS'TITLE'
p50224
aS'Brassinosteroid signal transduction from cell-surface receptor kinases to nuclear transcription factors.'
p50225
aS'JOURNAL'
p50226
aS'Nat Cell Biol 11:1254-60 (2009)'
p50227
aS'PMID:20360743'
p50228
ag50228
aS'AUTHORS'
p50229
aS'Pauwels L, Barbero GF, Geerinck J, Tilleman S, Grunewald W, Perez AC, Chico JM, Bossche RV, Sewell J, Gil E, Garcia-Casado G, Witters E, Inze D, Long JA, De Jaeger G, Solano R, Goossens A'
p50230
aS'TITLE'
p50231
aS'NINJA connects the co-repressor TOPLESS to jasmonate signalling.'
p50232
aS'JOURNAL'
p50233
aS'Nature 464:788-91 (2010)'
p50234
aS'PMID:18583180'
p50235
ag50235
aS'AUTHORS'
p50236
aS'Katsir L, Chung HS, Koo AJ, Howe GA'
p50237
aS'TITLE'
p50238
aS'Jasmonate signaling: a conserved mechanism of hormone sensing.'
p50239
aS'JOURNAL'
p50240
aS'Curr Opin Plant Biol 11:428-35 (2008)'
p50241
aS'PMID:12897257'
p50242
ag50242
aS'AUTHORS'
p50243
aS'Johnson C, Boden E, Arias J'
p50244
aS'TITLE'
p50245
aS'Salicylic acid and NPR1 induce the recruitment of trans-activating TGA factors to a defense gene promoter in Arabidopsis.'
p50246
aS'JOURNAL'
p50247
aS'Plant Cell 15:1846-58 (2003)'
p50248
asS'KO_PATHWAY'
p50249
(lp50250
S'ko04075'
p50251
asS'ENTRY'
p50252
(lp50253
S'map04075'
p50254
aS'Pathway'
p50255
asS'PATHWAY_MAP'
p50256
(lp50257
S'map04075'
p50258
asS'CLASS'
p50259
(lp50260
S'Environmental Information Processing Signal transduction'
p50261
assS'path:map00980'
p50262
(dp50263
S'NAME'
p50264
(lp50265
S'Metabolism of xenobiotics by cytochrome P450'
p50266
asS'REFERENCE'
p50267
(lp50268
S'PMID:12487150'
p50269
ag50269
aS'AUTHORS'
p50270
aS'Buckpitt A, Boland B, Isbell M, Morin D, Shultz M, Baldwin R, Chan K, Karlsson A, Lin C, Taff A, West J, Fanucchi M, Van Winkle L, Plopper C.'
p50271
aS'TITLE'
p50272
aS'Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity.'
p50273
aS'JOURNAL'
p50274
aS'Drug Metab Rev 34:791-820 (2002)'
p50275
aS'PMID:10725110'
p50276
ag50276
aS'AUTHORS'
p50277
aS'Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ.'
p50278
aS'TITLE'
p50279
aS'Role of quinones in toxicology.'
p50280
aS'JOURNAL'
p50281
aS'Chem Res Toxicol 13:135-60 (2000)'
p50282
aS'PMID:10570027'
p50283
ag50283
aS'AUTHORS'
p50284
aS'Halladay JS, Sauer JM, Sipes IG.'
p50285
aS'TITLE'
p50286
aS'Metabolism and disposition of [(14)C]1-nitronaphthalene in male Sprague-Dawley rats.'
p50287
aS'JOURNAL'
p50288
aS'Drug Metab Dispos 27:1456-65 (1999)'
p50289
aS'PMID:10490505'
p50290
ag50290
aS'AUTHORS'
p50291
aS'Watt KC, Morin DM, Kurth MJ, Mercer RS, Plopper CG, Buckpitt AR.'
p50292
aS'TITLE'
p50293
aS'Glutathione conjugation of electrophilic metabolites of 1-nitronaphthalene in rat tracheobronchial airways and liver: identification by mass spectrometry and proton nuclear magnetic resonance spectroscopy.'
p50294
aS'JOURNAL'
p50295
aS'Chem Res Toxicol 12:831-9 (1999)'
p50296
aS'PMID:15319346'
p50297
ag50297
aS'AUTHORS'
p50298
aS'Simmonds AC, Reilly CA, Baldwin RM, Ghanayem BI, Lanza DL, Yost GS, Collins KS, Forkert PG.'
p50299
aS'TITLE'
p50300
aS'Bioactivation of 1,1-dichloroethylene to its epoxide by CYP2E1 and CYP2F enzymes.'
p50301
aS'JOURNAL'
p50302
aS'Drug Metab Dispos 32:1032-9 (2004)'
p50303
aS'PMID:15987776'
p50304
ag50304
aS'AUTHORS'
p50305
aS'Forkert PG, Baldwin RM, Millen B, Lash LH, Putt DA, Shultz MA, Collins KS.'
p50306
aS'TITLE'
p50307
aS'Pulmonary bioactivation of trichloroethylene to chloral hydrate: relative contributions of CYP2E1, CYP2F, and CYP2B1.'
p50308
aS'JOURNAL'
p50309
aS'Drug Metab Dispos 33:1429-37 (2005)'
p50310
aS'PMID:9107551'
p50311
ag50311
aS'AUTHORS'
p50312
aS'Wormhoudt LW, Commandeur JN, Ploemen JH, Abdoelgafoer RS, Makansi A, Van Bladeren PJ, Vermeulen NP.'
p50313
aS'TITLE'
p50314
aS'Urinary thiodiacetic acid. A selective biomarker for the cytochrome P450-catalyzed oxidation of 1,2-dibromoethane in the rat.'
p50315
aS'JOURNAL'
p50316
aS'Drug Metab Dispos 25:508-15 (1997)'
p50317
aS'PMID:4395686'
p50318
ag50318
aS'AUTHORS'
p50319
aS'Brodie BB, Reid WD, Cho AK, Sipes G, Krishna G, Gillette JR.'
p50320
aS'TITLE'
p50321
aS'Possible mechanism of liver necrosis caused by aromatic organic compounds.'
p50322
aS'JOURNAL'
p50323
aS'Proc Natl Acad Sci U S A 68:160-4 (1971)'
p50324
aS'PMID:15298956'
p50325
ag50325
aS'AUTHORS'
p50326
aS'Lodovici M, Luceri C, Guglielmi F, Bacci C, Akpan V, Fonnesu ML, Boddi V, Dolara P.'
p50327
aS'TITLE'
p50328
aS'Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.'
p50329
aS'JOURNAL'
p50330
aS'Cancer Epidemiol Biomarkers Prev 13:1342-8 (2004)'
p50331
ag22
ag22
aS'AUTHORS'
p50332
aS'Omura T, Ishimura Y, Fujii Y (eds).'
p50333
aS'TITLE'
p50334
aS'[Molecular Biology of P450] (In Japanese)'
p50335
aS'JOURNAL'
p50336
aS'Kodansya (2003)'
p50337
asS'KO_PATHWAY'
p50338
(lp50339
S'ko00980'
p50340
asS'ENTRY'
p50341
(lp50342
S'map00980'
p50343
aS'Pathway'
p50344
asS'PATHWAY_MAP'
p50345
(lp50346
S'map00980'
p50347
asS'DISEASE'
p50348
(lp50349
S'H01075'
p50350
aS'Peters anomaly'
p50351
ag50350
ag50351
aS'H01111'
p50352
aS'Cortisone reductase deficiency (CRD)'
p50353
aS'H01203'
p50354
aS'Primary congenital glaucoma (PCG)'
p50355
asS'CLASS'
p50356
(lp50357
S'Metabolism Xenobiotics biodegradation and metabolism'
p50358
assS'path:map03410'
p50359
(dp50360
S'NAME'
p50361
(lp50362
S'Base excision repair'
p50363
asS'REFERENCE'
p50364
(lp50365
S'PMID:17893748'
p50366
ag50366
aS'AUTHORS'
p50367
aS'Krwawicz J, Arczewska KD, Speina E, Maciejewska A, Grzesiuk E.'
p50368
aS'TITLE'
p50369
aS'Bacterial DNA repair genes and their eukaryotic homologues: 1. Mutations in genes involved in base excision repair (BER) and DNA-end processors and their implication in mutagenesis and human disease.'
p50370
aS'JOURNAL'
p50371
aS'Acta Biochim Pol 54:413-34 (2007)'
p50372
aS'PMID:17337257'
p50373
ag50373
aS'AUTHORS'
p50374
aS'Almeida KH, Sobol RW.'
p50375
aS'TITLE'
p50376
aS'A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification.'
p50377
aS'JOURNAL'
p50378
aS'DNA Repair (Amst) 6:695-711 (2007)'
p50379
aS'PMID:21665970'
p50380
ag50380
aS'AUTHORS'
p50381
aS'Moen MN, Knaevelsrud I, Haugland GT, Grosvik K, Birkeland NK, Klungland A, Bjelland S'
p50382
aS'TITLE'
p50383
aS'Uracil-DNA glycosylase of Thermoplasma acidophilum directs long-patch base excision repair, which is promoted by deoxynucleoside triphosphates and ATP/ADP,'
p50384
aS'into short-patch repair.'
p50385
aS'JOURNAL'
p50386
aS'J Bacteriol 193:4495-508 (2011)'
p50387
aS'PMID:11436317'
p50388
ag50388
aS'AUTHORS'
p50389
aS'Ikeda S, Seki S.'
p50390
aS'TITLE'
p50391
aS'[Base excision repair: DNA glycosylase and AP endonuclease] Japanese'
p50392
aS'JOURNAL'
p50393
aS'Tanpakushitsu Kakusan Koso 46:916-23 (2001)'
p50394
asS'KO_PATHWAY'
p50395
(lp50396
S'ko03410'
p50397
asS'PATHWAY_MAP'
p50398
(lp50399
S'map03410'
p50400
asS'DISEASE'
p50401
(lp50402
S'H01025'
p50403
aS'Familial adenomatous polyposis'
p50404
asS'MODULE'
p50405
(lp50406
S'M00262'
p50407
aS'DNA polymerase delta complex [PATH:map03410]'
p50408
ag50407
ag50408
aS'M00296'
p50409
aS'BER complex [PATH:map03410]'
p50410
asS'DBLINKS'
p50411
(lp50412
S'GO: 0006284 0006285 0006286 0006287 0006288'
p50413
asS'ENTRY'
p50414
(lp50415
S'map03410'
p50416
aS'Pathway'
p50417
asS'CLASS'
p50418
(lp50419
S'Genetic Information Processing Replication and repair'
p50420
asS'DESCRIPTION'
p50421
(lp50422
S'Base excision repair (BER) is the predominant DNA damage repair pathway for the processing of small base lesions, derived from oxidation and alkylation damages. BER is normally defined as DNA repair initiated by lesion-specific DNA glycosylases and completed by either of the two sub-pathways: short-patch BER where only one nucleotide is replaced and long-patch BER where 2-13 nucleotides are replaced. Each sub-pathway of BER relies on the formation of protein complexes that assemble at the site of the DNA lesion and facilitate repair in a coordinated fashion. This process of complex formation appears to provide an increase in specificity and efficiency to the BER pathway, thereby facilitating the maintenance of genome integrity by preventing the accumulation of highly toxic repair intermediates.'
p50423
assS'path:map04071'
p50424
(dp50425
S'NAME'
p50426
(lp50427
S'Sphingolipid signaling pathway'
p50428
asS'REFERENCE'
p50429
(lp50430
S'PMID:18216770'
p50431
ag50431
aS'AUTHORS'
p50432
aS'Hannun YA, Obeid LM'
p50433
aS'TITLE'
p50434
aS'Principles of bioactive lipid signalling: lessons from sphingolipids.'
p50435
aS'JOURNAL'
p50436
aS'Nat Rev Mol Cell Biol 9:139-50 (2008)'
p50437
aS'PMID:17161984'
p50438
ag50438
aS'AUTHORS'
p50439
aS'Taha TA, Mullen TD, Obeid LM'
p50440
aS'TITLE'
p50441
aS'A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death.'
p50442
aS'JOURNAL'
p50443
aS'Biochim Biophys Acta 1758:2027-36 (2006)'
p50444
aS'PMID:23919551'
p50445
ag50445
aS'AUTHORS'
p50446
aS'Liu J, Beckman BS, Foroozesh M'
p50447
aS'TITLE'
p50448
aS'A review of ceramide analogs as potential anticancer agents.'
p50449
aS'JOURNAL'
p50450
aS'Future Med Chem 5:1405-21 (2013)'
p50451
aS'PMID:18675379'
p50452
ag50452
aS'AUTHORS'
p50453
aS'Kono M, Allende ML, Proia RL'
p50454
aS'TITLE'
p50455
aS'Sphingosine-1-phosphate regulation of mammalian development.'
p50456
aS'JOURNAL'
p50457
aS'Biochim Biophys Acta 1781:435-41 (2008)'
p50458
aS'PMID:18403224'
p50459
ag50459
aS'AUTHORS'
p50460
aS'Olivera A'
p50461
aS'TITLE'
p50462
aS'Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model.'
p50463
aS'JOURNAL'
p50464
aS'Prostaglandins Other Lipid Mediat 86:1-11 (2008)'
p50465
aS'PMID:25309325'
p50466
ag50466
aS'AUTHORS'
p50467
aS'Brunkhorst R, Vutukuri R, Pfeilschifter W'
p50468
aS'TITLE'
p50469
aS'Fingolimod for the treatment of neurological diseases-state of play and future perspectives.'
p50470
aS'JOURNAL'
p50471
aS'Front Cell Neurosci 8:283 (2014)'
p50472
aS'PMID:15999095'
p50473
ag50473
aS'AUTHORS'
p50474
aS'Rosen H, Goetzl EJ'
p50475
aS'TITLE'
p50476
aS'Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.'
p50477
aS'JOURNAL'
p50478
aS'Nat Rev Immunol 5:560-70 (2005)'
p50479
aS'PMID:10880336'
p50480
ag50480
aS'AUTHORS'
p50481
aS'Pyne S, Pyne NJ'
p50482
aS'TITLE'
p50483
aS'Sphingosine 1-phosphate signalling in mammalian cells.'
p50484
aS'JOURNAL'
p50485
aS'Biochem J 349:385-402 (2000)'
p50486
aS'PMID:21705677'
p50487
ag50487
aS'AUTHORS'
p50488
aS'Egom EE, Mohamed TM, Mamas MA, Shi Y, Liu W, Chirico D, Stringer SE, Ke Y, Shaheen M, Wang T, Chacko S, Wang X, Solaro RJ, Fath-Ordoubadi F, Cartwright EJ, Lei M'
p50489
aS'TITLE'
p50490
aS'Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.'
p50491
aS'JOURNAL'
p50492
aS'Am J Physiol Heart Circ Physiol 301:H1487-95 (2011)'
p50493
aS'PMID:15451787'
p50494
ag50494
aS'AUTHORS'
p50495
aS'Jin ZQ, Goetzl EJ, Karliner JS'
p50496
aS'TITLE'
p50497
aS'Sphingosine kinase activation mediates ischemic preconditioning in murine heart.'
p50498
aS'JOURNAL'
p50499
aS'Circulation 110:1980-9 (2004)'
p50500
aS'PMID:17913601'
p50501
ag50501
aS'AUTHORS'
p50502
aS'Melendez AJ'
p50503
aS'TITLE'
p50504
aS'Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets.'
p50505
aS'JOURNAL'
p50506
aS'Biochim Biophys Acta 1784:66-75 (2008)'
p50507
aS'PMID:22654878'
p50508
ag50508
aS'AUTHORS'
p50509
aS'Halova I, Draberova L, Draber P'
p50510
aS'TITLE'
p50511
aS'Mast cell chemotaxis - chemoattractants and signaling pathways.'
p50512
aS'JOURNAL'
p50513
aS'Front Immunol 3:119 (2012)'
p50514
aS'PMID:17438574'
p50515
ag50515
aS'AUTHORS'
p50516
aS'Kraft S, Kinet JP'
p50517
aS'TITLE'
p50518
aS'New developments in FcepsilonRI regulation, function and inhibition.'
p50519
aS'JOURNAL'
p50520
aS'Nat Rev Immunol 7:365-78 (2007)'
p50521
aS'PMID:16470226'
p50522
ag50522
aS'AUTHORS'
p50523
aS'Gilfillan AM, Tkaczyk C.'
p50524
aS'TITLE'
p50525
aS'Integrated signalling pathways for mast-cell activation.'
p50526
aS'JOURNAL'
p50527
aS'Nat Rev Immunol 6:218-30 (2006)'
p50528
aS'PMID:11418646'
p50529
ag50529
aS'AUTHORS'
p50530
aS'Osawa Y, Banno Y, Nagaki M, Brenner DA, Naiki T, Nozawa Y, Nakashima S, Moriwaki H'
p50531
aS'TITLE'
p50532
aS'TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes.'
p50533
aS'JOURNAL'
p50534
aS'J Immunol 167:173-80 (2001)'
p50535
aS'PMID:20534702'
p50536
ag50536
aS'AUTHORS'
p50537
aS'Montfort A, Martin PG, Levade T, Benoist H, Segui B'
p50538
aS'TITLE'
p50539
aS'FAN (factor associated with neutral sphingomyelinase activation), a moonlighting'
p50540
aS'protein in TNF-R1 signaling.'
p50541
aS'JOURNAL'
p50542
aS'J Leukoc Biol 88:897-903 (2010)'
p50543
aS'PMID:11001563'
p50544
ag50544
aS'AUTHORS'
p50545
aS'Chatterjee S'
p50546
aS'TITLE'
p50547
aS'Neutral sphingomyelinase: past, present and future.'
p50548
aS'JOURNAL'
p50549
aS'Chem Phys Lipids 102:79-96 (1999)'
p50550
asS'KO_PATHWAY'
p50551
(lp50552
S'ko04071'
p50553
asS'ENTRY'
p50554
(lp50555
S'map04071'
p50556
aS'Pathway'
p50557
asS'PATHWAY_MAP'
p50558
(lp50559
S'map04071'
p50560
asS'CLASS'
p50561
(lp50562
S'Environmental Information Processing Signal transduction'
p50563
asS'DESCRIPTION'
p50564
(lp50565
S'Sphingomyelin (SM) and its metabolic products are now known to have second messenger functions in a variety of cellular signaling pathways. Particularly, the sphingolipid metabolites, ceramide (Cer) and sphingosine-1-phosphate (S1P), have emerged as a new class of potent bioactive molecules. Ceramide can be generated de novo or by hydrolysis of membrane sphingomyelin by sphingomyelinase (SMase). Ceramide is subsequently metabolized by ceramidase to generate sphingosine (Sph) which in turn produces S1P through phosphorylation by sphingosine kinases 1 and 2 (SphK1, 2). Both ceramide and S1P regulate cellular responses to stress, with generally opposing effects. S1P functions as a growth and survival factor, acting as a ligand for a family of G protein-coupled receptors, whereas ceramide activates intrinsic and extrinsic apoptotic pathways through receptor-independent mechanisms.'
p50566
assS'path:map04070'
p50567
(dp50568
S'NAME'
p50569
(lp50570
S'Phosphatidylinositol signaling system'
p50571
asS'KO_PATHWAY'
p50572
(lp50573
S'ko04070'
p50574
asS'ENTRY'
p50575
(lp50576
S'map04070'
p50577
aS'Pathway'
p50578
asS'PATHWAY_MAP'
p50579
(lp50580
S'map04070'
p50581
asS'DISEASE'
p50582
(lp50583
S'H00530'
p50584
aS'Joubert syndrome'
p50585
ag50584
ag50585
aS'H00692'
p50586
aS'Lowe syndrome'
p50587
aS'H00694'
p50588
aS'Dent disease'
p50589
aS'H00700'
p50590
aS'Centronuclear myopathy'
p50591
aS'H00865'
p50592
aS'Lethal congenital contractural syndrome (LCCS)'
p50593
aS'H00957'
p50594
aS'Fleck corneal dystrophy (FCD)'
p50595
aS'H01195'
p50596
aS'VACTERL/VATER association'
p50597
aS'H01307'
p50598
aS'Nonsyndromic congenital nail disorder (NDNC)'
p50599
asS'CLASS'
p50600
(lp50601
S'Environmental Information Processing Signal transduction'
p50602
assS'path:map00350'
p50603
(dp50604
S'NAME'
p50605
(lp50606
S'Tyrosine metabolism'
p50607
asS'REFERENCE'
p50608
(lp50609
S'PMID:8550403'
p50610
ag50610
aS'AUTHORS'
p50611
aS'Prieto MA, Diaz E, Garcia JL.'
p50612
aS'TITLE'
p50613
aS'Molecular characterization of the 4-hydroxyphenylacetate catabolic pathway of Escherichia coli W: engineering a mobile aromatic degradative cluster.'
p50614
aS'JOURNAL'
p50615
aS'J Bacteriol 178:111-20 (1996)'
p50616
aS'PMID:1194238'
p50617
ag50617
aS'AUTHORS'
p50618
aS'Sparnins VL, Dagley S.'
p50619
aS'TITLE'
p50620
aS'Alternative routes of aromatic catabolism in Pseudomonas acidovorans and Pseudomonas putida: gallic acid as a substrate and inhibitor of dioxygenases.'
p50621
aS'JOURNAL'
p50622
aS'J Bacteriol 124:1374-81 (1975)'
p50623
aS'PMID:18435614'
p50624
ag50624
aS'AUTHORS'
p50625
aS'Ito S, Wakamatsu K'
p50626
aS'TITLE'
p50627
aS'Chemistry of mixed melanogenesis--pivotal roles of dopaquinone.'
p50628
aS'JOURNAL'
p50629
aS'Photochem Photobiol 84:582-92 (2008)'
p50630
aS'PMID:11171088'
p50631
ag50631
aS'AUTHORS'
p50632
aS'Olivares C, Jimenez-Cervantes C, Lozano JA, Solano F, Garcia-Borron JC'
p50633
aS'TITLE'
p50634
aS'The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase.'
p50635
aS'JOURNAL'
p50636
aS'Biochem J 354:131-9 (2001)'
p50637
asS'KO_PATHWAY'
p50638
(lp50639
S'ko00350'
p50640
asS'PATHWAY_MAP'
p50641
(lp50642
S'map00350'
p50643
asS'DISEASE'
p50644
(lp50645
S'H00163'
p50646
aS'Alkaptonuria'
p50647
ag50646
ag50647
aS'H00165'
p50648
aS'Tyrosinemia'
p50649
aS'H00168'
p50650
aS'Oculocutaneous albinism (OCA)'
p50651
aS'H00251'
p50652
aS'Thyroid dyshormonogenesis'
p50653
aS'H00548'
p50654
aS'Brunner syndrome'
p50655
aS'H00831'
p50656
aS'Primary dystonia'
p50657
aS'H01005'
p50658
aS'Dopamine beta-hydroxylase deficiency'
p50659
aS'H01161'
p50660
aS'Aromatic L-amino acid decarboxylase (AADC) deficiency'
p50661
asS'MODULE'
p50662
(lp50663
S'M00042'
p50664
aS'Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline [PATH:map00350]'
p50665
ag50664
ag50665
aS'M00043'
p50666
aS'Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine [PATH:map00350]'
p50667
aS'M00044'
p50668
aS'Tyrosine degradation, tyrosine => homogentisate [PATH:map00350]'
p50669
aS'M00533'
p50670
aS'Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate [PATH:map00350]'
p50671
asS'DRUG'
p50672
(lp50673
S'D03787'
p50674
aS'Nepicastat hydrochloride (USAN)'
p50675
asS'DBLINKS'
p50676
(lp50677
S'GO: 0006570'
p50678
asS'ENTRY'
p50679
(lp50680
S'map00350'
p50681
aS'Pathway'
p50682
asS'CLASS'
p50683
(lp50684
S'Metabolism Amino acid metabolism'
p50685
assS'path:map00351'
p50686
(dp50687
S'DBLINKS'
p50688
(lp50689
S'UMBBD: ddt ddt2'
p50690
asS'NAME'
p50691
(lp50692
S'DDT degradation'
p50693
asS'REFERENCE'
p50694
(lp50695
S'PMID:9563945'
p50696
ag50696
aS'AUTHORS'
p50697
aS'Quensen JF 3rd, Mueller SA, Jain MK, Tiedje JM'
p50698
aS'TITLE'
p50699
aS'Reductive dechlorination of DDE to DDMU in marine sediment microcosms.'
p50700
aS'JOURNAL'
p50701
aS'Science 280:722-4 (1998)'
p50702
aS'PMID:19846197'
p50703
ag50703
aS'AUTHORS'
p50704
aS'Baczynski TP, Pleissner D, Grotenhuis T'
p50705
aS'TITLE'
p50706
aS'Anaerobic biodegradation of organochlorine pesticides in contaminated soil - significance of temperature and availability.'
p50707
aS'JOURNAL'
p50708
aS'Chemosphere 78:22-8 (2010)'
p50709
asS'KO_PATHWAY'
p50710
(lp50711
S'ko00351'
p50712
asS'ENTRY'
p50713
(lp50714
S'map00351'
p50715
aS'Pathway'
p50716
asS'PATHWAY_MAP'
p50717
(lp50718
S'map00351'
p50719
asS'CLASS'
p50720
(lp50721
S'Metabolism Xenobiotics biodegradation and metabolism'
p50722
assS'path:map04670'
p50723
(dp50724
S'NAME'
p50725
(lp50726
S'Leukocyte transendothelial migration'
p50727
asS'REFERENCE'
p50728
(lp50729
S'PMID:14976004'
p50730
ag50730
aS'AUTHORS'
p50731
aS'van Buul JD, Hordijk PL.'
p50732
aS'TITLE'
p50733
aS'Signaling in leukocyte transendothelial migration.'
p50734
aS'JOURNAL'
p50735
aS'Arterioscler Thromb Vasc Biol 24:824-33 (2004)'
p50736
aS'PMID:15604886'
p50737
ag50737
aS'AUTHORS'
p50738
aS'Wittchen ES, van Buul JD, Burridge K, Worthylake RA.'
p50739
aS'TITLE'
p50740
aS'Trading spaces: Rap, Rac, and Rho as architects of transendothelial migration.'
p50741
aS'JOURNAL'
p50742
aS'Curr Opin Hematol 12:14-21 (2005)'
p50743
aS'PMID:14977592'
p50744
ag50744
aS'AUTHORS'
p50745
aS'Barreiro O, Vicente-Manzanares M, Urzainqui A, Yanez-Mo M, Sanchez-Madrid F.'
p50746
aS'TITLE'
p50747
aS'Interactive protrusive structures during leukocyte adhesion and transendothelial migration.'
p50748
aS'JOURNAL'
p50749
aS'Front Biosci 9:1849-63 (2004)'
p50750
aS'PMID:15629883'
p50751
ag50751
aS'AUTHORS'
p50752
aS'Cook-Mills JM, Deem TL.'
p50753
aS'TITLE'
p50754
aS'Active participation of endothelial cells in inflammation.'
p50755
aS'JOURNAL'
p50756
aS'J Leukoc Biol 77:487-95 (2005)'
p50757
aS'PMID:15173832'
p50758
ag50758
aS'AUTHORS'
p50759
aS'Imhof BA, Aurrand-Lions M.'
p50760
aS'TITLE'
p50761
aS'Adhesion mechanisms regulating the migration of monocytes.'
p50762
aS'JOURNAL'
p50763
aS'Nat Rev Immunol 4:432-44 (2004)'
p50764
aS'PMID:15265790'
p50765
ag50765
aS'AUTHORS'
p50766
aS'Deem TL, Cook-Mills JM.'
p50767
aS'TITLE'
p50768
aS'Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species.'
p50769
aS'JOURNAL'
p50770
aS'Blood 104:2385-93 (2004)'
p50771
aS'PMID:10975856'
p50772
ag50772
aS'AUTHORS'
p50773
aS'Etienne-Manneville S, Manneville JB, Adamson P, Wilbourn B, Greenwood J, Couraud PO.'
p50774
aS'TITLE'
p50775
aS'ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines.'
p50776
aS'JOURNAL'
p50777
aS'J Immunol 165:3375-83 (2000)'
p50778
aS'PMID:12540948'
p50779
ag50779
aS'AUTHORS'
p50780
aS'Chavakis T, Preissner KT, Santoso S.'
p50781
aS'TITLE'
p50782
aS'Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle.'
p50783
aS'JOURNAL'
p50784
aS'Thromb Haemost 89:13-7 (2003)'
p50785
aS'PMID:15771581'
p50786
ag50786
aS'AUTHORS'
p50787
aS'Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL.'
p50788
aS'TITLE'
p50789
aS'Tec family kinases in T lymphocyte development and function.'
p50790
aS'JOURNAL'
p50791
aS'Annu Rev Immunol 23:549-600 (2005)'
p50792
asS'KO_PATHWAY'
p50793
(lp50794
S'ko04670'
p50795
asS'PATHWAY_MAP'
p50796
(lp50797
S'map04670'
p50798
asS'DISEASE'
p50799
(lp50800
S'H00099'
p50801
aS'Leukocyte adhesion deficiency (LAD)'
p50802
ag50801
ag50802
aS'H00742'
p50803
aS'Neonatal ichthyosis-sclerosing cholangitis (NISCH) syndrome'
p50804
aS'H00840'
p50805
aS'Band-like calcification with simplified gyration and polymicrogyria (BLC-PMG)'
p50806
aS'H00947'
p50807
aS'Pilomatricoma'
p50808
aS'H01018'
p50809
aS'Metachondromatosis'
p50810
aS'H01255'
p50811
aS'Juvenile-onset dystonia'
p50812
aS'H01387'
p50813
aS'Activated PI3K-delta syndrome (APDS)'
p50814
asS'DBLINKS'
p50815
(lp50816
S'GO: 0050900'
p50817
asS'ENTRY'
p50818
(lp50819
S'map04670'
p50820
aS'Pathway'
p50821
asS'CLASS'
p50822
(lp50823
S'Organismal Systems Immune system'
p50824
asS'DESCRIPTION'
p50825
(lp50826
S'Leukocyte migaration from the blood into tissues is vital for immune surveillance and inflammation. During this diapedesis of leukocytes, the leukocytes bind to endothelial cell adhesion molecules (CAM) and then migrate across the vascular endothelium. A leukocyte adherent to CAMs on the endothelial cells moves forward by leading-edge protrusion and retraction of its tail. In this process, alphaL /beta2 integrin activates through Vav1, RhoA, which subsequently activates the kinase p160ROCK. ROCK activation leads to MLC phosphorylation, resulting in retraction of the actin cytoskeleton. Moreover, Leukocytes activate endothelial cell signals that stimulate endothelial cell retraction during localized dissociation of the endothelial cell junctions. ICAM-1-mediated signals activate an endothelial cell calcium flux and PKC, which are required for ICAM-1 dependent leukocyte migration. VCAM-1 is involved in the opening of the "endothelial passage" through which leukocytes can extravasate. In this regard, VCAM-1 ligation induces NADPH oxidase activation and the production of reactive oxygen species (ROS) in a Rac-mediated manner, with subsequent activation of matrix metallopoteinases and loss of VE-cadherin-mediated adhesion.'
p50827
assS'path:map04672'
p50828
(dp50829
S'NAME'
p50830
(lp50831
S'Intestinal immune network for IgA production'
p50832
asS'REFERENCE'
p50833
(lp50834
S'PMID:12511876'
p50835
ag50835
aS'AUTHORS'
p50836
aS'Fagarasan S, Honjo T'
p50837
aS'TITLE'
p50838
aS'Intestinal IgA synthesis: regulation of front-line body defences.'
p50839
aS'JOURNAL'
p50840
aS'Nat Rev Immunol 3:63-72 (2003)'
p50841
aS'PMID:19079156'
p50842
ag50842
aS'AUTHORS'
p50843
aS'Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P'
p50844
aS'TITLE'
p50845
aS'The immune geography of IgA induction and function.'
p50846
aS'JOURNAL'
p50847
aS'Mucosal Immunol 1:11-22 (2008)'
p50848
aS'PMID:15971106'
p50849
ag50849
aS'AUTHORS'
p50850
aS'Kunisawa J, Kiyono H'
p50851
aS'TITLE'
p50852
aS'A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense.'
p50853
aS'JOURNAL'
p50854
aS'Cell Mol Life Sci 62:1308-21 (2005)'
p50855
aS'PMID:18549797'
p50856
ag50856
aS'AUTHORS'
p50857
aS'Cerutti A, Rescigno M'
p50858
aS'TITLE'
p50859
aS'The biology of intestinal immunoglobulin A responses.'
p50860
aS'JOURNAL'
p50861
aS'Immunity 28:740-50 (2008)'
p50862
aS'PMID:18243016'
p50863
ag50863
aS'AUTHORS'
p50864
aS'Tsuji M, Suzuki K, Kinoshita K, Fagarasan S'
p50865
aS'TITLE'
p50866
aS'Dynamic interactions between bacteria and immune cells leading to intestinal IgA'
p50867
aS'synthesis.'
p50868
aS'JOURNAL'
p50869
aS'Semin Immunol 20:59-66 (2008)'
p50870
aS'PMID:17182536'
p50871
ag50871
aS'AUTHORS'
p50872
aS'Corthesy B'
p50873
aS'TITLE'
p50874
aS'Roundtrip ticket for secretory IgA: role in mucosal homeostasis?'
p50875
aS'JOURNAL'
p50876
aS'J Immunol 178:27-32 (2007)'
p50877
aS'PMID:18838301'
p50878
ag50878
aS'AUTHORS'
p50879
aS'Suzuki K, Fagarasan S'
p50880
aS'TITLE'
p50881
aS'How host-bacterial interactions lead to IgA synthesis in the gut.'
p50882
aS'JOURNAL'
p50883
aS'Trends Immunol 29:523-31 (2008)'
p50884
aS'PMID:19079167'
p50885
ag50885
aS'AUTHORS'
p50886
aS'Mora JR, von Andrian UH'
p50887
aS'TITLE'
p50888
aS'Differentiation and homing of IgA-secreting cells.'
p50889
aS'JOURNAL'
p50890
aS'Mucosal Immunol 1:96-109 (2008)'
p50891
aS'PMID:17161619'
p50892
ag50892
aS'AUTHORS'
p50893
aS'Suzuki K, Ha SA, Tsuji M, Fagarasan S'
p50894
aS'TITLE'
p50895
aS'Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut.'
p50896
aS'JOURNAL'
p50897
aS'Semin Immunol 19:127-35 (2007)'
p50898
aS'PMID:18483500'
p50899
ag50899
aS'AUTHORS'
p50900
aS'Cerutti A'
p50901
aS'TITLE'
p50902
aS'The regulation of IgA class switching.'
p50903
aS'JOURNAL'
p50904
aS'Nat Rev Immunol 8:421-34 (2008)'
p50905
asS'KO_PATHWAY'
p50906
(lp50907
S'ko04672'
p50908
asS'PATHWAY_MAP'
p50909
(lp50910
S'map04672'
p50911
asS'DBLINKS'
p50912
(lp50913
S'GO: 0002387'
p50914
asS'ENTRY'
p50915
(lp50916
S'map04672'
p50917
aS'Pathway'
p50918
asS'CLASS'
p50919
(lp50920
S'Organismal Systems Immune system'
p50921
asS'DESCRIPTION'
p50922
(lp50923
S"The intestine is the largest lymphoid tissue in the body. One striking feature of intestinal immunity is its ability to generate great amounts of noninflammatory immunoglobulin A (IgA) antibodies that serve as the first line of defense against microorganisms. The basic map of IgA production includes induction of mucosal B cells in the Peyer's patches, circulation through the bloodstream and homing to intestinal mucosa of IgA-commited plasma cells, and local antibody production for export across the intestinal membranes. Multiple cytokines, including TGF-{beta}, IL-10, IL-4, IL-5, and IL-6, are required to promote IgA class switching and terminal differentiation process of the B cells. Secreted IgA promotes immune exclusion by entrapping dietary antigens and microorganisms in the mucus and functions for neutralization of toxins and pathogenic microbes."
p50924
assS'path:map01210'
p50925
(dp50926
S'NAME'
p50927
(lp50928
S'2-Oxocarboxylic acid metabolism'
p50929
asS'KO_PATHWAY'
p50930
(lp50931
S'ko01210'
p50932
asS'ENTRY'
p50933
(lp50934
S'map01210'
p50935
aS'Global'
p50936
aS'Pathway'
p50937
asS'PATHWAY_MAP'
p50938
(lp50939
S'map01210'
p50940
asS'CLASS'
p50941
(lp50942
S'Metabolism Overview'
p50943
asS'MODULE'
p50944
(lp50945
S'M00010'
p50946
aS'Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map01210]'
p50947
ag50946
ag50947
aS'M00019'
p50948
aS'Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map01210]'
p50949
aS'M00028'
p50950
aS'Ornithine biosynthesis, glutamate => ornithine [PATH:map01210]'
p50951
aS'M00031'
p50952
aS'Lysine biosynthesis, 2-aminoadipate => lysine [PATH:map01210]'
p50953
aS'M00033'
p50954
aS'Ectoine biosynthesis, aspartate => ectoine [PATH:map01210]'
p50955
aS'M00370'
p50956
aS'Glucosinolate biosynthesis, tryptophan => glucobrassicin [PATH:map01210]'
p50957
aS'M00432'
p50958
aS'Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map01210]'
p50959
aS'M00433'
p50960
aS'Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate [PATH:map01210]'
p50961
aS'M00535'
p50962
aS'Isoleucine biosynthesis, pyruvate => 2-oxobutanoate [PATH:map01210]'
p50963
aS'M00608'
p50964
aS'2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map01210]'
p50965
asS'DESCRIPTION'
p50966
(lp50967
S'2-Oxocarboxylic acids, also called 2-oxo acids and alpha-keto acids, are the most elementary set of metabolites that includes pyruvate (2-oxopropanoate), 2-oxobutanoate, oxaloacetate (2-oxosuccinate) and 2-oxoglutarate. This diagram illustrates the architecture of chain extension and modification reaction modules for 2-oxocarboxylic acids. The chain extension module RM001 is a tricarboxylic pathway where acetyl-CoA derived carbon is used to extend the chain length by one. The chain modification modules RM002 (including RM032) and RM033, together with a reductive amination step (RC00006 or RC00036), generate basic and branched-chain amino acids, respectively. The modification module RM030 is used in the biosynthesis of glucosinolates, a class of plant secondary metabolites, for conversion to oxime followed by addition of thio-glucose moiety. Furthermore, the chain extension from 2-oxoadipate to 2-oxosuberate is followed by coenzyme B biosynthesis in methonogenic archaea.'
p50968
assS'path:map01212'
p50969
(dp50970
S'NAME'
p50971
(lp50972
S'Fatty acid metabolism'
p50973
asS'KO_PATHWAY'
p50974
(lp50975
S'ko01212'
p50976
asS'ENTRY'
p50977
(lp50978
S'map01212'
p50979
aS'Global'
p50980
aS'Pathway'
p50981
asS'PATHWAY_MAP'
p50982
(lp50983
S'map01212'
p50984
asS'DISEASE'
p50985
(lp50986
S'H01352'
p50987
aS'Mitochondrial trifunctional protein (TFP) deficiency'
p50988
asS'MODULE'
p50989
(lp50990
S'M00082'
p50991
aS'Fatty acid biosynthesis, initiation [PATH:map01212]'
p50992
ag50991
ag50992
aS'M00083'
p50993
aS'Fatty acid biosynthesis, elongation [PATH:map01212]'
p50994
aS'M00085'
p50995
aS'Fatty acid biosynthesis, elongation, mitochondria [PATH:map01212]'
p50996
aS'M00086'
p50997
aS'beta-Oxidation, acyl-CoA synthesis [PATH:map01212]'
p50998
aS'M00087'
p50999
aS'beta-Oxidation [PATH:map01212]'
p51000
aS'M00415'
p51001
aS'Fatty acid biosynthesis, elongation, endoplasmic reticulum [PATH:map01212]'
p51002
asS'CLASS'
p51003
(lp51004
S'Metabolism Overview'
p51005
assS'path:map07023'
p51006
(dp51007
S'ENTRY'
p51008
(lp51009
S'map07023'
p51010
aS'Drug'
p51011
aS'Pathway'
p51012
asS'PATHWAY_MAP'
p51013
(lp51014
S'map07023'
p51015
asS'NAME'
p51016
(lp51017
S'Rifamycins'
p51018
asS'REFERENCE'
p51019
(lp51020
S'(Japanese)'
p51021
ag51021
aS'AUTHORS'
p51022
aS'Fukai S.'
p51023
aS'TITLE'
p51024
aS'[New Drugs Today (6th ed)] (In Japanese)'
p51025
aS'JOURNAL'
p51026
aS'Jiho (1995)'
p51027
ag22
ag22
aS'AUTHORS'
p51028
aS'David AW, Thomas LL, William OF.'
p51029
aS'TITLE'
p51030
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p51031
aS'JOURNAL'
p51032
aS'Lippincott Williams & Wilkins (2002)'
p51033
ag22
ag22
aS'AUTHORS'
p51034
aS'Hardman JG, Limbird LE, Gilman AG (eds).'
p51035
aS'TITLE'
p51036
aS"Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed)"
p51037
aS'JOURNAL'
p51038
aS'McGraw-Hill (2001)'
p51039
ag22
ag22
aS'AUTHORS'
p51040
aS'Walter S.'
p51041
aS'TITLE'
p51042
aS'Drug Discovery: A History'
p51043
aS'JOURNAL'
p51044
aS'Wiley (2005)'
p51045
aS'PMID:2039206'
p51046
ag51046
aS'AUTHORS'
p51047
aS'Saito H, Tomioka H, Sato K, Emori M, Yamane T, Yamashita K, Hosoe K, Hidaka T'
p51048
aS'TITLE'
p51049
aS'In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins.'
p51050
aS'JOURNAL'
p51051
aS'Antimicrob Agents Chemother 35:542-7 (1991)'
p51052
aS'PMID:9869560'
p51053
ag51053
aS'AUTHORS'
p51054
aS'Heifets L, Sanchez T, Vanderkolk J, Pham V'
p51055
aS'TITLE'
p51056
aS'Development of rifapentine susceptibility tests for Mycobacterium tuberculosis.'
p51057
aS'JOURNAL'
p51058
aS'Antimicrob Agents Chemother 43:25-8 (1999)'
p51059
aS'PMID:15700959'
p51060
ag51060
aS'AUTHORS'
p51061
aS'Floss HG, Yu TW.'
p51062
aS'TITLE'
p51063
aS'Rifamycin-mode of action, resistance, and biosynthesis.'
p51064
aS'JOURNAL'
p51065
aS'Chem Rev 105:621-32 (2005)'
p51066
asS'COMPOUND'
p51067
(lp51068
S'C14539'
p51069
aS'Krm 1657'
p51070
ag51069
ag51070
aS'C14540'
p51071
aS'Rifamycin S'
p51072
aS'D00211'
p51073
aS'Rifampicin (JP16/INN)'
p51074
aS'D00424'
p51075
aS'Rifabutin (JAN/USP/INN)'
p51076
aS'D00879'
p51077
aS'Rifapentine (USAN/INN)'
p51078
aS'D02549'
p51079
aS'Rifamycin (USAN/INN)'
p51080
aS'D02550'
p51081
aS'Rifalazil (USAN/INN)'
p51082
aS'D02553'
p51083
aS'Rifamide (USAN)'
p51084
aS'D02554'
p51085
aS'Rifaximin (JAN/USAN/INN)'
p51086
aS'D08479'
p51087
aS'Rifampicin sodium'
p51088
aS'D08480'
p51089
aS'Rifamycin sodium (USAN)'
p51090
assS'path:map00730'
p51091
(dp51092
S'NAME'
p51093
(lp51094
S'Thiamine metabolism'
p51095
asS'REFERENCE'
p51096
(lp51097
S'PMID:15614489'
p51098
ag51098
aS'AUTHORS'
p51099
aS'Kawasaki Y, Onozuka M, Mizote T, Nosaka K.'
p51100
aS'TITLE'
p51101
aS'Biosynthesis of hydroxymethylpyrimidine pyrophosphate in Saccharomyces cerevisiae.'
p51102
aS'JOURNAL'
p51103
aS'Curr Genet 47:156-62 (2005)'
p51104
aS'PMID:14567704'
p51105
ag51105
aS'AUTHORS'
p51106
aS'Park JH, Dorrestein PC, Zhai H, Kinsland C, McLafferty FW, Begley TP.'
p51107
aS'TITLE'
p51108
aS'Biosynthesis of the thiazole moiety of thiamin pyrophosphate (vitamin B1).'
p51109
aS'JOURNAL'
p51110
aS'Biochemistry 42:12430-8 (2003)'
p51111
aS'PMID:22616866'
p51112
ag51112
aS'AUTHORS'
p51113
aS'Begley TP, Ealick SE, McLafferty FW'
p51114
aS'TITLE'
p51115
aS'Thiamin biosynthesis: still yielding fascinating biological chemistry.'
p51116
aS'JOURNAL'
p51117
aS'Biochem Soc Trans 40:555-60 (2012)'
p51118
aS'PMID:12777485'
p51119
ag51119
aS'AUTHORS'
p51120
aS'Wightman R, Meacock PA'
p51121
aS'TITLE'
p51122
aS'The THI5 gene family of Saccharomyces cerevisiae: distribution of homologues among the hemiascomycetes and functional redundancy in the aerobic biosynthesis of thiamin from pyridoxine.'
p51123
aS'JOURNAL'
p51124
aS'Microbiology 149:1447-60 (2003)'
p51125
aS'PMID:22031445'
p51126
ag51126
aS'AUTHORS'
p51127
aS'Chatterjee A, Abeydeera ND, Bale S, Pai PJ, Dorrestein PC, Russell DH, Ealick SE, Begley TP'
p51128
aS'TITLE'
p51129
aS'Saccharomyces cerevisiae THI4p is a suicide thiamine thiazole synthase.'
p51130
aS'JOURNAL'
p51131
aS'Nature 478:542-6 (2011)'
p51132
aS'PMID:19348578'
p51133
ag51133
aS'AUTHORS'
p51134
aS'Jurgenson CT, Begley TP, Ealick SE'
p51135
aS'TITLE'
p51136
aS'The structural and biochemical foundations of thiamin biosynthesis.'
p51137
aS'JOURNAL'
p51138
aS'Annu Rev Biochem 78:569-603 (2009)'
p51139
asS'KO_PATHWAY'
p51140
(lp51141
S'ko00730'
p51142
asS'PATHWAY_MAP'
p51143
(lp51144
S'map00730'
p51145
asS'MODULE'
p51146
(lp51147
S'M00127'
p51148
aS'Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P [PATH:map00730]'
p51149
asS'DBLINKS'
p51150
(lp51151
S'GO: 0006772'
p51152
asS'ENTRY'
p51153
(lp51154
S'map00730'
p51155
aS'Pathway'
p51156
asS'CLASS'
p51157
(lp51158
S'Metabolism Metabolism of cofactors and vitamins'
p51159
assS'path:map01070'
p51160
(dp51161
S'ENTRY'
p51162
(lp51163
S'map01070'
p51164
aS'Pathway'
p51165
asS'PATHWAY_MAP'
p51166
(lp51167
S'map01070'
p51168
asS'NAME'
p51169
(lp51170
S'Biosynthesis of plant hormones'
p51171
asS'REFERENCE'
p51172
(lp51173
g22
ag22
aS'AUTHORS'
p51174
aS'Fukuda H, Matida Y, Kamiya Y, Kakimoto T.'
p51175
aS'TITLE'
p51176
aS'[Shinpan Syokubutuhorumon no Sigunarudentatu] (In Japanese)'
p51177
aS'JOURNAL'
p51178
aS'Syujyunsya:165-186 (2004)'
p51179
asS'KO_PATHWAY'
p51180
(lp51181
S'ko01070'
p51182
assS'path:map04550'
p51183
(dp51184
S'NAME'
p51185
(lp51186
S'Signaling pathways regulating pluripotency of stem cells'
p51187
asS'REFERENCE'
p51188
(lp51189
g22
ag22
aS'AUTHORS'
p51190
aS'Bhartiya D, Lenka N (ed).'
p51191
aS'TITLE'
p51192
aS'Pluripotent Stem Cells'
p51193
aS'JOURNAL'
p51194
aS'InTech (2013)'
p51195
aS'PMID:24147644'
p51196
ag51196
aS'AUTHORS'
p51197
aS'Hassani SN, Totonchi M, Gourabi H, Scholer HR, Baharvand H'
p51198
aS'TITLE'
p51199
aS'Signaling roadmap modulating naive and primed pluripotency.'
p51200
aS'JOURNAL'
p51201
aS'Stem Cells Dev 23:193-208 (2014)'
p51202
aS'PMID:18295576'
p51203
ag51203
aS'AUTHORS'
p51204
aS'Jaenisch R, Young R'
p51205
aS'TITLE'
p51206
aS'Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.'
p51207
aS'JOURNAL'
p51208
aS'Cell 132:567-82 (2008)'
p51209
aS'PMID:17647265'
p51210
ag51210
aS'AUTHORS'
p51211
aS'Zhang H, Wang ZZ'
p51212
aS'TITLE'
p51213
aS'Mechanisms that mediate stem cell self-renewal and differentiation.'
p51214
aS'JOURNAL'
p51215
aS'J Cell Biochem 103:709-18 (2008)'
p51216
aS'PMID:24910449'
p51217
ag51217
aS'AUTHORS'
p51218
aS'Itoh F, Watabe T, Miyazono K'
p51219
aS'TITLE'
p51220
aS'Roles of TGF-beta family signals in the fate determination of pluripotent stem cells.'
p51221
aS'JOURNAL'
p51222
aS'Semin Cell Dev Biol 32C:98-106 (2014)'
p51223
aS'PMID:23653415'
p51224
ag51224
aS'AUTHORS'
p51225
aS'Saunders A, Faiola F, Wang J'
p51226
aS'TITLE'
p51227
aS'Concise review: pursuing self-renewal and pluripotency with the stem cell factor'
p51228
aS'Nanog.'
p51229
aS'JOURNAL'
p51230
aS'Stem Cells 31:1227-36 (2013)'
p51231
aS'PMID:20705693'
p51232
ag51232
aS'AUTHORS'
p51233
aS'Kuijk EW, Chuva de Sousa Lopes SM, Geijsen N, Macklon N, Roelen BA'
p51234
aS'TITLE'
p51235
aS'The different shades of mammalian pluripotent stem cells.'
p51236
aS'JOURNAL'
p51237
aS'Hum Reprod Update 17:254-71 (2011)'
p51238
aS'PMID:18220859'
p51239
ag51239
aS'AUTHORS'
p51240
aS'Okita K, Yamanaka S'
p51241
aS'TITLE'
p51242
aS'Intracellular signaling pathways regulating pluripotency of embryonic stem cells.'
p51243
aS'JOURNAL'
p51244
aS'Curr Stem Cell Res Ther 1:103-11 (2006)'
p51245
aS'PMID:19571885'
p51246
ag51246
aS'AUTHORS'
p51247
aS'Niwa H, Ogawa K, Shimosato D, Adachi K'
p51248
aS'TITLE'
p51249
aS'A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES'
p51250
aS'cells.'
p51251
aS'JOURNAL'
p51252
aS'Nature 460:118-22 (2009)'
p51253
aS'PMID:23370346'
p51254
ag51254
aS'AUTHORS'
p51255
aS'Nakai-Futatsugi Y, Niwa H'
p51256
aS'TITLE'
p51257
aS'Transcription factor network in embryonic stem cells: heterogeneity under the stringency.'
p51258
aS'JOURNAL'
p51259
aS'Biol Pharm Bull 36:166-70 (2013)'
p51260
aS'PMID:22649650'
p51261
ag51261
aS'AUTHORS'
p51262
aS'Medvedev SP, Shevchenko AI, Zakian SM'
p51263
aS'TITLE'
p51264
aS'Molecular basis of Mammalian embryonic stem cell pluripotency and self-renewal.'
p51265
aS'JOURNAL'
p51266
aS'Acta Naturae 2:30-46 (2010)'
p51267
aS'PMID:19551525'
p51268
ag51268
aS'AUTHORS'
p51269
aS'Scheper W, Copray S'
p51270
aS'TITLE'
p51271
aS'The molecular mechanism of induced pluripotency: a two-stage switch.'
p51272
aS'JOURNAL'
p51273
aS'Stem Cell Rev 5:204-23 (2009)'
p51274
aS'PMID:16153702'
p51275
ag51275
aS'AUTHORS'
p51276
aS'Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA'
p51277
aS'TITLE'
p51278
aS'Core transcriptional regulatory circuitry in human embryonic stem cells.'
p51279
aS'JOURNAL'
p51280
aS'Cell 122:947-56 (2005)'
p51281
aS'PMID:24315442'
p51282
ag51282
aS'AUTHORS'
p51283
aS'Wang L, Miao YL, Zheng X, Lackford B, Zhou B, Han L, Yao C, Ward JM, Burkholder A, Lipchina I, Fargo DC, Hochedlinger K, Shi Y, Williams CJ, Hu G'
p51284
aS'TITLE'
p51285
aS'The THO complex regulates pluripotency gene mRNA export and controls embryonic stem cell self-renewal and somatic cell reprogramming.'
p51286
aS'JOURNAL'
p51287
aS'Cell Stem Cell 13:676-90 (2013)'
p51288
aS'PMID:24957798'
p51289
ag51289
aS'AUTHORS'
p51290
aS'Hasegawa Y, Tang D, Takahashi N, Hayashizaki Y, Forrest AR, Suzuki H'
p51291
aS'TITLE'
p51292
aS'CCL2 enhances pluripotency of human induced pluripotent stem cells by activating'
p51293
aS'hypoxia related genes.'
p51294
aS'JOURNAL'
p51295
aS'Sci Rep 4:5228 (2014)'
p51296
aS'PMID:23585347'
p51297
ag51297
aS'AUTHORS'
p51298
aS'Sui L, Bouwens L, Mfopou JK'
p51299
aS'TITLE'
p51300
aS'Signaling pathways during maintenance and definitive endoderm differentiation of'
p51301
aS'embryonic stem cells.'
p51302
aS'JOURNAL'
p51303
aS'Int J Dev Biol 57:1-12 (2013)'
p51304
aS'PMID:19427042'
p51305
ag51305
aS'AUTHORS'
p51306
aS'Do JT, Scholer HR'
p51307
aS'TITLE'
p51308
aS'Regulatory circuits underlying pluripotency and reprogramming.'
p51309
aS'JOURNAL'
p51310
aS'Trends Pharmacol Sci 30:296-302 (2009)'
p51311
aS'PMID:17211451'
p51312
ag51312
aS'AUTHORS'
p51313
aS'Pan G, Thomson JA'
p51314
aS'TITLE'
p51315
aS'Nanog and transcriptional networks in embryonic stem cell pluripotency.'
p51316
aS'JOURNAL'
p51317
aS'Cell Res 17:42-9 (2007)'
p51318
aS'PMID:16518401'
p51319
ag51319
aS'AUTHORS'
p51320
aS'Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH'
p51321
aS'TITLE'
p51322
aS'The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells.'
p51323
aS'JOURNAL'
p51324
aS'Nat Genet 38:431-40 (2006)'
p51325
aS'PMID:18414030'
p51326
ag51326
aS'AUTHORS'
p51327
aS'Loh YH, Ng JH, Ng HH'
p51328
aS'TITLE'
p51329
aS'Molecular framework underlying pluripotency.'
p51330
aS'JOURNAL'
p51331
aS'Cell Cycle 7:885-91 (2008)'
p51332
aS'PMID:22298652'
p51333
ag51333
aS'AUTHORS'
p51334
aS'Greenow K, Clarke AR'
p51335
aS'TITLE'
p51336
aS'Controlling the stem cell compartment and regeneration in vivo: the role of pluripotency pathways.'
p51337
aS'JOURNAL'
p51338
aS'Physiol Rev 92:75-99 (2012)'
p51339
asS'KO_PATHWAY'
p51340
(lp51341
S'ko04550'
p51342
asS'PATHWAY_MAP'
p51343
(lp51344
S'map04550'
p51345
asS'MODULE'
p51346
(lp51347
S'M00679'
p51348
aS'BMP signaling [PATH:map04550]'
p51349
ag51348
ag51349
aS'M00681'
p51350
aS'Activin signaling [PATH:map04550]'
p51351
asS'DBLINKS'
p51352
(lp51353
S'GO: 2000036'
p51354
asS'ENTRY'
p51355
(lp51356
S'map04550'
p51357
aS'Pathway'
p51358
asS'CLASS'
p51359
(lp51360
S'Cellular Processes Cellular commiunity'
p51361
asS'DESCRIPTION'
p51362
(lp51363
S"Pluripotent stem cells (PSCs) are basic cells with an indefinite self-renewal capacity and the potential to generate all the cell types of the three germinal layers. The types of PSCs known to date include embryonic stem (ES) and induced pluripotent stem (iPS) cells. ES cells are derived from the inner cell mass (ICM) of blastocyst-stage embryos. iPS cells are generated by reprogramming somatic cells back to pluripotent state with defined reprogramming factors, Oct4, Sox2, Klf4 and c-Myc (also known as Yamanaka factors). PSCs including ES cells and iPS cells are categorized into two groups by their morphology, gene expression profile and external signal dependence. Conventional mouse-type ES/iPS cells are called 'naive state' cells. They are mainly maintained under the control of LIF and BMP signaling. On the other hand, human-type ES/iPS cells, which are in need of Activin and FGF signaling, are termed 'primed state'. However, these signaling pathways converge towards the activation of a core transcriptional network"
p51364
assS'path:map05410'
p51365
(dp51366
S'NAME'
p51367
(lp51368
S'Hypertrophic cardiomyopathy (HCM)'
p51369
asS'REFERENCE'
p51370
(lp51371
S'PMID:12270949'
p51372
ag51372
aS'AUTHORS'
p51373
aS'Fatkin D, Graham RM'
p51374
aS'TITLE'
p51375
aS'Molecular mechanisms of inherited cardiomyopathies.'
p51376
aS'JOURNAL'
p51377
aS'Physiol Rev 82:945-80 (2002)'
p51378
aS'PMID:12844200'
p51379
ag51379
aS'AUTHORS'
p51380
aS'Moolman-Smook JC, Mayosi BM, Brink PA, Corfield VA'
p51381
aS'TITLE'
p51382
aS'Molecular genetics of cardiomyopathy: changing times, shifting paradigms.'
p51383
aS'JOURNAL'
p51384
aS'Cardiovasc J S Afr 14:145-55 (2003)'
p51385
aS'PMID:14711353'
p51386
ag51386
aS'AUTHORS'
p51387
aS'Taylor MR, Carniel E, Mestroni L'
p51388
aS'TITLE'
p51389
aS'Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.'
p51390
aS'JOURNAL'
p51391
aS'Expert Rev Mol Diagn 4:99-113 (2004)'
p51392
ag22
ag22
aS'AUTHORS'
p51393
aS'Tei C (ed).'
p51394
aS'TITLE'
p51395
aS'[Up to date of basic and clinical aspects of cardiomyopathies] (In Japanese)'
p51396
aS'JOURNAL'
p51397
aS'Ishiyakushupan (2009)'
p51398
aS'PMID:10615904'
p51399
ag51399
aS'AUTHORS'
p51400
aS'Marian AJ'
p51401
aS'TITLE'
p51402
aS'Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy.'
p51403
aS'JOURNAL'
p51404
aS'Lancet 355:58-60 (2000)'
p51405
aS'PMID:11371514'
p51406
ag51406
aS'AUTHORS'
p51407
aS'Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H'
p51408
aS'TITLE'
p51409
aS'Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.'
p51410
aS'JOURNAL'
p51411
aS'Hum Mol Genet 10:1215-20 (2001)'
p51412
aS'PMID:11716909'
p51413
ag51413
aS'AUTHORS'
p51414
aS'Franz WM, Muller OJ, Katus HA'
p51415
aS'TITLE'
p51416
aS'Cardiomyopathies: from genetics to the prospect of treatment.'
p51417
aS'JOURNAL'
p51418
aS'Lancet 358:1627-37 (2001)'
p51419
aS'PMID:18056765'
p51420
ag51420
aS'AUTHORS'
p51421
aS'Morimoto S'
p51422
aS'TITLE'
p51423
aS'Sarcomeric proteins and inherited cardiomyopathies.'
p51424
aS'JOURNAL'
p51425
aS'Cardiovasc Res 77:659-66 (2008)'
p51426
aS'PMID:19136482'
p51427
ag51427
aS'AUTHORS'
p51428
aS'Cambronero F, Marin F, Roldan V, Hernandez-Romero D, Valdes M, Lip GY'
p51429
aS'TITLE'
p51430
aS'Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.'
p51431
aS'JOURNAL'
p51432
aS'Eur Heart J 30:139-51 (2009)'
p51433
aS'PMID:11805847'
p51434
ag51434
aS'AUTHORS'
p51435
aS'Towbin JA, Bowles NE'
p51436
aS'TITLE'
p51437
aS'The failing heart.'
p51438
aS'JOURNAL'
p51439
aS'Nature 415:227-33 (2002)'
p51440
aS'PMID:11225594'
p51441
ag51441
aS'AUTHORS'
p51442
aS'Sorajja P, Elliott PM, McKenna WJ'
p51443
aS'TITLE'
p51444
aS'The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.'
p51445
aS'JOURNAL'
p51446
aS'Europace 2:4-14 (2000)'
p51447
aS'PMID:18572189'
p51448
ag51448
aS'AUTHORS'
p51449
aS'Landstrom AP, Parvatiyar MS, Pinto JR, Marquardt ML, Bos JM, Tester DJ, Ommen SR, Potter JD, Ackerman MJ'
p51450
aS'TITLE'
p51451
aS'Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.'
p51452
aS'JOURNAL'
p51453
aS'J Mol Cell Cardiol 45:281-8 (2008)'
p51454
asS'KO_PATHWAY'
p51455
(lp51456
S'ko05410'
p51457
asS'PATHWAY_MAP'
p51458
(lp51459
S'map05410'
p51460
asS'DISEASE'
p51461
(lp51462
S'H00292'
p51463
aS'Hypertrophic cardiomyopathy (HCM)'
p51464
ag51463
ag51464
aS'H00728'
p51465
aS'Brugada syndrome (BRS)'
p51466
aS'H01154'
p51467
aS'Wolff-Parkinson-White (WPW) syndrome'
p51468
asS'ENTRY'
p51469
(lp51470
S'map05410'
p51471
aS'Pathway'
p51472
asS'CLASS'
p51473
(lp51474
S'Human Diseases Cardiovascular diseases'
p51475
asS'DESCRIPTION'
p51476
(lp51477
S'Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder with an autosomal dominant pattern of inheritance that is characterized by hypertrophy of the left ventricles with histological features of myocyte hypertrophy, myfibrillar disarray, and interstitial fibrosis. HCM is one of the most common inherited cardiac disorders, with a prevalence in young adults of 1 in 500. Hundreds of mutations in the genes that encode protein constituents of the sarcomere have been identified in HCM. These mutations increase the Ca2+ sensitivity of cardiac myofilaments. Increased myofilament Ca2+ sensitivity is expected to increase the ATP utilization by actomyosin at submaximal Ca2+ concentrations, which might cause an imbalance in energy supply and demand in the heart under severe stress. The inefficient use of ATP suggests that an inability to maintain normal ATP levels could be the central abnormality. This theory might be supported by the discovery of the role of a mutant PRKAG2 gene in HCM, which in active form acts as a central sensing mechanism protecting cells from depletion of ATP supplies. The increase in the myfilament Ca2+ sensitivity well account for the diastolic dysfunction of model animals as well as human patients of HCM. It has been widely proposed that left ventricular hypertrophy is not a primary manifestation but develops as compensatory response to sarcomere dysfunction.'
p51478
assS'path:map05416'
p51479
(dp51480
S'NAME'
p51481
(lp51482
S'Viral myocarditis'
p51483
asS'REFERENCE'
p51484
(lp51485
S'PMID:18039131'
p51486
ag51486
aS'AUTHORS'
p51487
aS'Esfandiarei M, McManus BM'
p51488
aS'TITLE'
p51489
aS'Molecular biology and pathogenesis of viral myocarditis.'
p51490
aS'JOURNAL'
p51491
aS'Annu Rev Pathol 3:127-55 (2008)'
p51492
aS'PMID:12920582'
p51493
ag51493
aS'AUTHORS'
p51494
aS'Badorff C, Knowlton KU'
p51495
aS'TITLE'
p51496
aS'Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.'
p51497
aS'JOURNAL'
p51498
aS'Med Microbiol Immunol 193:121-6 (2004)'
p51499
aS'PMID:17200452'
p51500
ag51500
aS'AUTHORS'
p51501
aS'Maekawa Y, Ouzounian M, Opavsky MA, Liu PP'
p51502
aS'TITLE'
p51503
aS'Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.'
p51504
aS'JOURNAL'
p51505
aS'Circulation 115:5-8 (2007)'
p51506
aS'PMID:12439638'
p51507
ag51507
aS'AUTHORS'
p51508
aS'Pankuweit S, Portig I, Maisch B'
p51509
aS'TITLE'
p51510
aS'Pathophysiology of cardiac inflammation: molecular mechanisms.'
p51511
aS'JOURNAL'
p51512
aS'Herz 27:669-76 (2002)'
p51513
aS'PMID:16845885'
p51514
ag51514
aS'AUTHORS'
p51515
aS'Gao G, Luo H'
p51516
aS'TITLE'
p51517
aS'The ubiquitin-proteasome pathway in viral infections.'
p51518
aS'JOURNAL'
p51519
aS'Can J Physiol Pharmacol 84:5-14 (2006)'
p51520
aS'PMID:16413486'
p51521
ag51521
aS'AUTHORS'
p51522
aS'Coyne CB, Bergelson JM'
p51523
aS'TITLE'
p51524
aS'Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.'
p51525
aS'JOURNAL'
p51526
aS'Cell 124:119-31 (2006)'
p51527
aS'PMID:10904843'
p51528
ag51528
aS'AUTHORS'
p51529
aS'Badorff C, Lee GH, Knowlton KU'
p51530
aS'TITLE'
p51531
aS'Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.'
p51532
aS'JOURNAL'
p51533
aS'Herz 25:227-32 (2000)'
p51534
aS'PMID:18357777'
p51535
ag51535
aS'AUTHORS'
p51536
aS'Knowlton KU'
p51537
aS'TITLE'
p51538
aS'CVB infection and mechanisms of viral cardiomyopathy.'
p51539
aS'JOURNAL'
p51540
aS'Curr Top Microbiol Immunol 323:315-35 (2008)'
p51541
aS'PMID:18545064'
p51542
ag51542
aS'AUTHORS'
p51543
aS'Castellano G, Affuso F, Di Conza P, Fazio S'
p51544
aS'TITLE'
p51545
aS'Myocarditis and dilated cardiomyopathy: possible connections and treatments.'
p51546
aS'JOURNAL'
p51547
aS'J Cardiovasc Med (Hagerstown) 9:666-71 (2008)'
p51548
aS'PMID:19357408'
p51549
ag51549
aS'AUTHORS'
p51550
aS'Cooper LT Jr'
p51551
aS'TITLE'
p51552
aS'Myocarditis.'
p51553
aS'JOURNAL'
p51554
aS'N Engl J Med 360:1526-38 (2009)'
p51555
aS'PMID:10051305'
p51556
ag51556
aS'AUTHORS'
p51557
aS'Kawai C'
p51558
aS'TITLE'
p51559
aS'From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.'
p51560
aS'JOURNAL'
p51561
aS'Circulation 99:1091-100 (1999)'
p51562
aS'PMID:11524405'
p51563
ag51563
aS'AUTHORS'
p51564
aS'Liu PP, Mason JW'
p51565
aS'TITLE'
p51566
aS'Advances in the understanding of myocarditis.'
p51567
aS'JOURNAL'
p51568
aS'Circulation 104:1076-82 (2001)'
p51569
aS'PMID:14522402'
p51570
ag51570
aS'AUTHORS'
p51571
aS'Mason JW'
p51572
aS'TITLE'
p51573
aS'Myocarditis and dilated cardiomyopathy: an inflammatory link.'
p51574
aS'JOURNAL'
p51575
aS'Cardiovasc Res 60:5-10 (2003)'
p51576
aS'PMID:16817756'
p51577
ag51577
aS'AUTHORS'
p51578
aS'Tam PE'
p51579
aS'TITLE'
p51580
aS'Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.'
p51581
aS'JOURNAL'
p51582
aS'Viral Immunol 19:133-46 (2006)'
p51583
asS'KO_PATHWAY'
p51584
(lp51585
S'ko05416'
p51586
asS'PATHWAY_MAP'
p51587
(lp51588
S'map05416'
p51589
asS'DISEASE'
p51590
(lp51591
S'H00295'
p51592
aS'Viral myocarditis'
p51593
asS'ENTRY'
p51594
(lp51595
S'map05416'
p51596
aS'Pathway'
p51597
asS'CLASS'
p51598
(lp51599
S'Human Diseases Cardiovascular diseases'
p51600
asS'DESCRIPTION'
p51601
(lp51602
S'Myocarditis is a cardiac disease associated with inflammation and injury of the myocardium. It results from various etiologies, both noninfectious and infectious, but coxsackievirus B3 (CVB3) is still considered the dominant etiological agent. Myocarditis may be caused by direct cytopathic effects of virus, a pathologic immune response to persistent virus, or autoimmunity triggered by the viral infection. The virus enters the myocyte through internalization of the coxsackie-adenoviral receptor (CAR) and its coreceptor, decay-accelerating factor (DAF). Viral proteases cleave various proteins in the host cell. One example is viral protease 2A, which cleaves eukaryote initiation factor 4G (eIF4G) and the dystrophin protein, resulting in a complete shutdown of cap-dependent RNA translation and cytoskeletal destruction in infected cardiomyocytes, respectively. CVB3 also cleaves the member of the Bcl-2 family Bid, leading to apoptosis. CVB3 infection also induces the cleavage of cyclin D protein through a proteasome-dependent pathway, leading to the host cell-growth arrest. Viral infection and necrosis of myocytes may lead to the release of intracellular antigens, resulting in activation of self-reactive T cells. CVB infection is a significant cause of dilated cardiomyopathy (DCM) as well as myocarditis. Epidemiologically, myocarditis underlies a significant portion of patients with DCM.'
p51603
assS'path:map05414'
p51604
(dp51605
S'NAME'
p51606
(lp51607
S'Dilated cardiomyopathy'
p51608
asS'REFERENCE'
p51609
(lp51610
S'PMID:12270949'
p51611
ag51611
aS'AUTHORS'
p51612
aS'Fatkin D, Graham RM'
p51613
aS'TITLE'
p51614
aS'Molecular mechanisms of inherited cardiomyopathies.'
p51615
aS'JOURNAL'
p51616
aS'Physiol Rev 82:945-80 (2002)'
p51617
aS'PMID:18672201'
p51618
ag51618
aS'AUTHORS'
p51619
aS'Lappe JM, Pelfrey CM, Tang WH'
p51620
aS'TITLE'
p51621
aS'Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.'
p51622
aS'JOURNAL'
p51623
aS'J Card Fail 14:521-30 (2008)'
p51624
aS'PMID:19273156'
p51625
ag51625
aS'AUTHORS'
p51626
aS'Zhao P, Sharma AC, Ren J'
p51627
aS'TITLE'
p51628
aS'Pathogenesis and therapy of autoimmunity-induced dilated cardiomyopathy.'
p51629
aS'JOURNAL'
p51630
aS'Front Biosci 14:1708-15 (2009)'
p51631
aS'PMID:11716909'
p51632
ag51632
aS'AUTHORS'
p51633
aS'Franz WM, Muller OJ, Katus HA'
p51634
aS'TITLE'
p51635
aS'Cardiomyopathies: from genetics to the prospect of treatment.'
p51636
aS'JOURNAL'
p51637
aS'Lancet 358:1627-37 (2001)'
p51638
aS'PMID:11805847'
p51639
ag51639
aS'AUTHORS'
p51640
aS'Towbin JA, Bowles NE'
p51641
aS'TITLE'
p51642
aS'The failing heart.'
p51643
aS'JOURNAL'
p51644
aS'Nature 415:227-33 (2002)'
p51645
aS'PMID:19017683'
p51646
ag51646
aS'AUTHORS'
p51647
aS'Luk A, Ahn E, Soor GS, Butany J'
p51648
aS'TITLE'
p51649
aS'Dilated cardiomyopathy: a review.'
p51650
aS'JOURNAL'
p51651
aS'J Clin Pathol 62:219-25 (2009)'
p51652
aS'PMID:19246813'
p51653
ag51653
aS'AUTHORS'
p51654
aS'Yoshikawa T, Baba A, Nagatomo Y'
p51655
aS'TITLE'
p51656
aS'Autoimmune mechanisms underlying dilated cardiomyopathy.'
p51657
aS'JOURNAL'
p51658
aS'Circ J 73:602-7 (2009)'
p51659
aS'PMID:14522402'
p51660
ag51660
aS'AUTHORS'
p51661
aS'Mason JW'
p51662
aS'TITLE'
p51663
aS'Myocarditis and dilated cardiomyopathy: an inflammatory link.'
p51664
aS'JOURNAL'
p51665
aS'Cardiovasc Res 60:5-10 (2003)'
p51666
aS'PMID:15146239'
p51667
ag51667
aS'AUTHORS'
p51668
aS'Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ'
p51669
aS'TITLE'
p51670
aS'Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.'
p51671
aS'JOURNAL'
p51672
aS'J Clin Invest 113:1419-29 (2004)'
p51673
aS'PMID:11524405'
p51674
ag51674
aS'AUTHORS'
p51675
aS'Liu PP, Mason JW'
p51676
aS'TITLE'
p51677
aS'Advances in the understanding of myocarditis.'
p51678
aS'JOURNAL'
p51679
aS'Circulation 104:1076-82 (2001)'
p51680
aS'PMID:16817756'
p51681
ag51681
aS'AUTHORS'
p51682
aS'Tam PE'
p51683
aS'TITLE'
p51684
aS'Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.'
p51685
aS'JOURNAL'
p51686
aS'Viral Immunol 19:133-46 (2006)'
p51687
asS'KO_PATHWAY'
p51688
(lp51689
S'ko05414'
p51690
asS'PATHWAY_MAP'
p51691
(lp51692
S'map05414'
p51693
asS'DISEASE'
p51694
(lp51695
S'H00294'
p51696
aS'Dilated cardiomyopathy (DCM)'
p51697
ag51696
ag51697
aS'H00728'
p51698
aS'Brugada syndrome (BRS)'
p51699
asS'ENTRY'
p51700
(lp51701
S'map05414'
p51702
aS'Pathway'
p51703
asS'CLASS'
p51704
(lp51705
S'Human Diseases Cardiovascular diseases'
p51706
asS'DESCRIPTION'
p51707
(lp51708
S'Dilated cardiomyopathy (DCM) is a heart muscle disease characterised by dilation and impaired contraction of the left or both ventricles that results in progressive heart failure and sudden cardiac death from ventricular arrhythmia. Genetically inherited forms of DCM ("familial" DCM) have been identified in 25-35% of patients presenting with this disease, and the inherited gene defects are an important cause of "familial" DCM. The pathophysiology may be separated into two categories: defects in force generation and defects in force transmission. In cases where an underlying pathology cannot be identified, the patient is diagnosed with an "idiopathic" DCM. Current hypotheses regarding causes of "idiopathic" DCM focus on myocarditis induced by enterovirus and subsequent autoimmune myocardium impairments. Antibodies to the beta1-adrenergic receptor (beta1AR), which are detected in a substantial number of patients with "idiopathic" DCM,'
p51709
assS'path:map00910'
p51710
(dp51711
S'NAME'
p51712
(lp51713
S'Nitrogen metabolism'
p51714
asS'REFERENCE'
p51715
(lp51716
S'PMID:14702404'
p51717
ag51717
aS'AUTHORS'
p51718
aS'Scott JD, Ludwig RA'
p51719
aS'TITLE'
p51720
aS'Azorhizobium caulinodans electron-transferring flavoprotein N electrochemically couples pyruvate dehydrogenase complex activity to N2 fixation.'
p51721
aS'JOURNAL'
p51722
aS'Microbiology 150:117-26 (2004)'
p51723
aS'PMID:17408485'
p51724
ag51724
aS'AUTHORS'
p51725
aS'Kneip C, Lockhart P, Voss C, Maier UG'
p51726
aS'TITLE'
p51727
aS'Nitrogen fixation in eukaryotes--new models for symbiosis.'
p51728
aS'JOURNAL'
p51729
aS'BMC Evol Biol 7:55 (2007)'
p51730
aS'PMID:11004450'
p51731
ag51731
aS'AUTHORS'
p51732
aS'Whittaker M, Bergmann D, Arciero D, Hooper AB'
p51733
aS'TITLE'
p51734
aS'Electron transfer during the oxidation of ammonia by the chemolithotrophic bacterium Nitrosomonas europaea.'
p51735
aS'JOURNAL'
p51736
aS'Biochim Biophys Acta 1459:346-55 (2000)'
p51737
aS'PMID:15528644'
p51738
ag51738
aS'AUTHORS'
p51739
aS'Cabello P, Roldan MD, Moreno-Vivian C'
p51740
aS'TITLE'
p51741
aS'Nitrate reduction and the nitrogen cycle in archaea.'
p51742
aS'JOURNAL'
p51743
aS'Microbiology 150:3527-46 (2004)'
p51744
aS'PMID:11921398'
p51745
ag51745
aS'AUTHORS'
p51746
aS'Stolz JF, Basu P'
p51747
aS'TITLE'
p51748
aS'Evolution of nitrate reductase: molecular and structural variations on a common function.'
p51749
aS'JOURNAL'
p51750
aS'Chembiochem 3:198-206 (2002)'
p51751
aS'PMID:18021072'
p51752
ag51752
aS'AUTHORS'
p51753
aS'Morozkina EV, Zvyagilskaya RA'
p51754
aS'TITLE'
p51755
aS'Nitrate reductases: structure, functions, and effect of stress factors.'
p51756
aS'JOURNAL'
p51757
aS'Biochemistry (Mosc) 72:1151-60 (2007)'
p51758
aS'PMID:19247843'
p51759
ag51759
aS'AUTHORS'
p51760
aS'Jetten MS, Niftrik L, Strous M, Kartal B, Keltjens JT, Op den Camp HJ'
p51761
aS'TITLE'
p51762
aS'Biochemistry and molecular biology of anammox bacteria.'
p51763
aS'JOURNAL'
p51764
aS'Crit Rev Biochem Mol Biol 44:65-84 (2009)'
p51765
aS'PMID:22221911'
p51766
ag51766
aS'AUTHORS'
p51767
aS'Luesken FA, Wu ML, Op den Camp HJ, Keltjens JT, Stunnenberg H, Francoijs KJ, Strous M, Jetten MS'
p51768
aS'TITLE'
p51769
aS"Effect of oxygen on the anaerobic methanotroph 'Candidatus Methylomirabilis oxyfera': kinetic and transcriptional analysis."
p51770
aS'JOURNAL'
p51771
aS'Environ Microbiol 14:1024-34 (2012)'
p51772
asS'KO_PATHWAY'
p51773
(lp51774
S'ko00910'
p51775
asS'PATHWAY_MAP'
p51776
(lp51777
S'map00910'
p51778
asS'DISEASE'
p51779
(lp51780
S'H00923'
p51781
aS'Congenital systemic glutamine deficiency (CSGD)'
p51782
asS'MODULE'
p51783
(lp51784
S'M00175'
p51785
aS'Nitrogen fixation, nitrogen => ammonia [PATH:map00910]'
p51786
ag51785
ag51786
aS'M00528'
p51787
aS'Nitrification, ammonia => nitrite [PATH:map00910]'
p51788
aS'M00529'
p51789
aS'Denitrification, nitrate => nitrogen [PATH:map00910]'
p51790
aS'M00530'
p51791
aS'Dissimilatory nitrate reduction, nitrate => ammonia [PATH:map00910]'
p51792
aS'M00531'
p51793
aS'Assimilatory nitrate reduction, nitrate => ammonia [PATH:map00910]'
p51794
asS'DBLINKS'
p51795
(lp51796
S'GO: 0006807'
p51797
asS'ENTRY'
p51798
(lp51799
S'map00910'
p51800
aS'Pathway'
p51801
asS'CLASS'
p51802
(lp51803
S'Metabolism Energy metabolism'
p51804
asS'DESCRIPTION'
p51805
(lp51806
S'The biological process of the nitrogen cycle is a complex interplay among many microorganisms catalyzing different reactions, where nitrogen is found in various oxidation states ranging from +5 in nitrate to -3 in ammonia. The core nitrogen cycle involves four reduction pathways and two oxidation pathways. Nitrogen fixation [MD:M00175] is the process of reducing atmospheric molecular nitrogen to ammonia, a biologically useful reduced form incorporated into amino acids and other vital compounds. The ability of fixing atmospheric nitrogen by the nitrogenase enzyme complex is present in restricted prokaryotes (diazotrophs). The other reduction pathways are assimilatory nitrate reduction [MD:M00531] and dissimilatory nitrate reduction [MD:M00530] both for conversion to ammonia, and denitrification [MD:M00529]. Denitrification is a respiration in which nitrate or nitrite is reduced as a terminal electron acceptor under low oxygen or anoxic conditions, producing gaseous nitrogen compounds (N2, NO and N2O) to the atmosphere. The two oxidation pathways are nitrification [MD:M00528] and anaerobic ammonium oxidation (anammox). Nitrification is the oxidation of ammonia (NH3) with oxygen into nitrite followed by the oxidation of nitrite into nitrate. The first step is performed by ammonia-oxidizing microorganisms (e.g., Nitrosomonas and Nitrosococcus) and the second step by nitrite-oxidizing microorganisms (e.g., Nitrobacter). Anammox is a biochemical process of oxidizing ammonium (NH4+) into dinitrogen gas (N2) using nitrite as an electron acceptor. It occurs in the anammoxosome, a membrane bound compartment inside the cytoplasm, of anammox bacteria (e.g., Planctomycetes).'
p51807
assS'path:map07015'
p51808
(dp51809
S'ENTRY'
p51810
(lp51811
S'map07015'
p51812
aS'Drug'
p51813
aS'Pathway'
p51814
asS'PATHWAY_MAP'
p51815
(lp51816
S'map07015'
p51817
asS'NAME'
p51818
(lp51819
S'Local analgesics'
p51820
asS'REFERENCE'
p51821
(lp51822
S'(Japanese)'
p51823
ag51823
aS'AUTHORS'
p51824
aS'Sano T, Naito T, Kubo T (eds).'
p51825
aS'TITLE'
p51826
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p51827
aS'JOURNAL'
p51828
aS'Nankodo (2002)'
p51829
aS'PMID:11895133'
p51830
ag51830
aS'AUTHORS'
p51831
aS'Ruetsch YA, Boni T, Borgeat A.'
p51832
aS'TITLE'
p51833
aS'From cocaine to ropivacaine: the history of local anesthetic drugs.'
p51834
aS'JOURNAL'
p51835
aS'Curr Top Med Chem 1:175-82 (2001)'
p51836
asS'COMPOUND'
p51837
(lp51838
S'C14166'
p51839
aS'alpha-Eucaine'
p51840
ag51839
ag51840
aS'C14167'
p51841
aS'beta-Eucaine'
p51842
aS'C14168'
p51843
aS'3-(Dimethylamino)propyl benzoate'
p51844
aS'C14170'
p51845
aS'p-Aminosalicylic acid methyl ester'
p51846
aS'C14171'
p51847
aS'Orthoform'
p51848
aS'C14172'
p51849
aS'Hexylcaine'
p51850
aS'C14173'
p51851
aS'Piperocaine'
p51852
aS'D00110'
p51853
aS'Cocaine (USP)'
p51854
aS'D00551'
p51855
aS'Tetracaine (USP/INN)'
p51856
aS'D00552'
p51857
aS'Ethyl aminobenzoate (JP16)'
p51858
aS'D00740'
p51859
aS'Procaine hydrochloride (JP16/USP)'
p51860
aS'D00741'
p51861
aS'Tetracaine hydrochloride (JP16/USP)'
p51862
aS'D01768'
p51863
aS'Oxybuprocaine hydrochloride (JP16)'
p51864
aS'D02182'
p51865
aS'Cocaine hydrochloride (JP16/USP)'
p51866
aS'D02454'
p51867
aS'Hexylcaine hydrochloride'
p51868
aS'D02455'
p51869
aS'Piperocaine hydrochloride'
p51870
aS'D07454'
p51871
aS'Amylocaine (BAN)'
p51872
aS'D07572'
p51873
aS'Amylocaine hydrochloride'
p51874
aS'D08319'
p51875
aS'Oxybuprocaine (INN)'
p51876
aS'D08422'
p51877
aS'Procaine (INN)'
p51878
assS'path:map07017'
p51879
(dp51880
S'ENTRY'
p51881
(lp51882
S'map07017'
p51883
aS'Drug'
p51884
aS'Pathway'
p51885
asS'PATHWAY_MAP'
p51886
(lp51887
S'map07017'
p51888
asS'NAME'
p51889
(lp51890
S'Sulfonamide derivatives - diuretics'
p51891
asS'REFERENCE'
p51892
(lp51893
g22
ag22
aS'AUTHORS'
p51894
aS'Sano T, Naito T, Kubo T (eds).'
p51895
aS'TITLE'
p51896
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p51897
aS'JOURNAL'
p51898
aS'Nankodo (2002)'
p51899
ag22
ag22
aS'AUTHORS'
p51900
aS'Fukai S.'
p51901
aS'TITLE'
p51902
aS'[New Drugs Today (6th ed)] (In Japanese)'
p51903
aS'JOURNAL'
p51904
aS'Jiho (1995)'
p51905
ag22
ag22
aS'AUTHORS'
p51906
aS'David AW, Thomas LL, William OF.'
p51907
aS'TITLE'
p51908
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p51909
aS'JOURNAL'
p51910
aS'Lippincott Williams & Wilkins (2002)'
p51911
ag22
ag22
aS'AUTHORS'
p51912
aS'Walter S.'
p51913
aS'TITLE'
p51914
aS'Drug Discovery: A History'
p51915
aS'JOURNAL'
p51916
aS'Wiley (2005)'
p51917
ag22
ag22
aS'AUTHORS'
p51918
aS'Japan Pharmaceutical Association (ed).'
p51919
aS'TITLE'
p51920
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p51921
aS'JOURNAL'
p51922
aS'Yakuji Nippo (1999)'
p51923
ag22
ag22
aS'AUTHORS'
p51924
aS'Bertram GK (ed).'
p51925
aS'TITLE'
p51926
aS'Basic & Clinical Pharmacology (9th ed)'
p51927
aS'JOURNAL'
p51928
aS'Lange (2004)'
p51929
asS'COMPOUND'
p51930
(lp51931
S'D00218'
p51932
aS'Acetazolamide (JP16/USP/INN)'
p51933
ag51932
ag51933
aS'D00247'
p51934
aS'Bumetanide (JP16/USP/INN)'
p51935
aS'D00272'
p51936
aS'Chlortalidone (JAN/INN)'
p51937
aS'D00331'
p51938
aS'Furosemide (JP16/USP/INN)'
p51939
aS'D00340'
p51940
aS'Hydrochlorothiazide (JP16/USP/INN)'
p51941
aS'D00345'
p51942
aS'Indapamide (JP16/USP)'
p51943
aS'D00382'
p51944
aS'Torasemide (JAN/INN)'
p51945
aS'D00431'
p51946
aS'Metolazone (JAN/USP/INN)'
p51947
aS'D00461'
p51948
aS'Quinethazone (JAN/INN)'
p51949
aS'D00518'
p51950
aS'Diclofenamide (JP16/INN)'
p51951
aS'D00519'
p51952
aS'Chlorothiazide (JAN/USP/INN)'
p51953
aS'D00650'
p51954
aS'Bendroflumethiazide (JAN/USP/INN)'
p51955
aS'D00651'
p51956
aS'Benzthiazide (JAN/INN)'
p51957
aS'D00654'
p51958
aS'Hydroflumethiazide (JAN/USP/INN)'
p51959
aS'D00655'
p51960
aS'Methazolamide (JAN/USP/INN)'
p51961
aS'D00657'
p51962
aS'Polythiazide (JAN/USAN/INN)'
p51963
aS'D00658'
p51964
aS'Trichlormethiazide (JP16/USP/INN)'
p51965
aS'D01196'
p51966
aS'Acetazolamide sodium (JAN)'
p51967
aS'D01241'
p51968
aS'Penflutizide (JAN/INN)'
p51969
aS'D01246'
p51970
aS'Benzylhydrochlorothiazide (JAN)'
p51971
aS'D01323'
p51972
aS'Azosemide (JAN/USAN/INN)'
p51973
aS'D01605'
p51974
aS'Meticrane (JP16/INN)'
p51975
aS'D01634'
p51976
aS'Piretanide (JAN/USAN/INN)'
p51977
aS'D01822'
p51978
aS'Clofenamide (JAN/INN)'
p51979
aS'D01877'
p51980
aS'Mefruside (JP16/USAN/INN)'
p51981
aS'D01895'
p51982
aS'Tripamide (JAN/USAN/INN)'
p51983
aS'D02441'
p51984
aS'Ethoxzolamide'
p51985
aS'D02453'
p51986
aS'Flumethiazide (INN)'
p51987
aS'D03471'
p51988
aS'Chlorothiazide sodium (USP)'
p51989
aS'D06401'
p51990
aS'Indapamide hydrate'
p51991
aS'D07999'
p51992
aS'Sodium furosemide'
p51993
aS'D08001'
p51994
aS'Furosemide diolamine'
p51995
aS'D08543'
p51996
aS'Sulfanilamide (INN)'
p51997
aS'D08619'
p51998
aS'Torasemide sodium'
p51999
aS'D09322'
p52000
aS'Carzenide (INN)'
p52001
assS'path:map01100'
p52002
(dp52003
S'ENTRY'
p52004
(lp52005
S'map01100'
p52006
aS'Global'
p52007
aS'Pathway'
p52008
asS'PATHWAY_MAP'
p52009
(lp52010
S'map01100'
p52011
asS'NAME'
p52012
(lp52013
S'Metabolic pathways'
p52014
asS'DISEASE'
p52015
(lp52016
S'H00617'
p52017
aS'Desmosterolosis'
p52018
ag52017
ag52018
aS'H00689'
p52019
aS'Delayed sleep phase syndrome'
p52020
aS'H00734'
p52021
aS'Lamellar ichthyosis (LI) and Non-bullous congenital ichthyosiform erythroderma (NBCIE)'
p52022
aS'H00753'
p52023
aS'Urofacial syndrome'
p52024
aS'H00761'
p52025
aS'SEMD, Pakistani type'
p52026
aS'H00804'
p52027
aS'Multiple cutaneous and uterine leiomyomata'
p52028
aS'H00824'
p52029
aS'Calcification of joints and arteries'
p52030
aS'H00920'
p52031
aS'Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis'
p52032
aS'H00946'
p52033
aS'Arts syndrome'
p52034
aS'H01002'
p52035
aS'Generalized arterial calcification of infancy'
p52036
asS'KO_PATHWAY'
p52037
(lp52038
S'ko01100'
p52039
assS'path:map04060'
p52040
(dp52041
S'NAME'
p52042
(lp52043
S'Cytokine-cytokine receptor interaction'
p52044
asS'REFERENCE'
p52045
(lp52046
g22
ag22
aS'AUTHORS'
p52047
aS'Oppenheim JJ, Feldman M (ed).'
p52048
aS'TITLE'
p52049
aS'Cytokine Reference'
p52050
aS'JOURNAL'
p52051
aS'Academic Press (2001)'
p52052
ag22
ag22
aS'AUTHORS'
p52053
aS'Thomson AW, Lotze MT (ed).'
p52054
aS'TITLE'
p52055
aS'The Cytokine Handbook (Fourth edition)'
p52056
aS'JOURNAL'
p52057
aS'Academic Press (2003)'
p52058
aS'PMID:10714678'
p52059
ag52059
aS'AUTHORS'
p52060
aS'Zlotnik A, Yoshie O.'
p52061
aS'TITLE'
p52062
aS'Chemokines: a new classification system and their role in immunity.'
p52063
aS'JOURNAL'
p52064
aS'Immunity 12:121-7 (2000)'
p52065
aS'PMID:12072446'
p52066
ag52066
aS'AUTHORS'
p52067
aS'Ozaki K, Leonard WJ.'
p52068
aS'TITLE'
p52069
aS'Cytokine and cytokine receptor pleiotropy and redundancy.'
p52070
aS'JOURNAL'
p52071
aS'J Biol Chem 277:29355-8 (2002)'
p52072
aS'PMID:12039028'
p52073
ag52073
aS'AUTHORS'
p52074
aS'Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW.'
p52075
aS'TITLE'
p52076
aS'Signaling through the JAK/STAT pathway, recent advances and future challenges.'
p52077
aS'JOURNAL'
p52078
aS'Gene 285:1-24 (2002)'
p52079
aS'PMID:12651221'
p52080
ag52080
aS'AUTHORS'
p52081
aS'Li X, Eriksson U.'
p52082
aS'TITLE'
p52083
aS'Novel PDGF family members: PDGF-C and PDGF-D.'
p52084
aS'JOURNAL'
p52085
aS'Cytokine Growth Factor Rev 14:91-8 (2003)'
p52086
aS'PMID:11312110'
p52087
ag52087
aS'AUTHORS'
p52088
aS'Li X, Eriksson U.'
p52089
aS'TITLE'
p52090
aS'Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D.'
p52091
aS'JOURNAL'
p52092
aS'Int J Biochem Cell Biol 33:421-6 (2001)'
p52093
aS'PMID:11166270'
p52094
ag52094
aS'AUTHORS'
p52095
aS'Zachary I, Gliki G.'
p52096
aS'TITLE'
p52097
aS'Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.'
p52098
aS'JOURNAL'
p52099
aS'Cardiovasc Res 49:568-81 (2001)'
p52100
aS'PMID:11071910'
p52101
ag52101
aS'AUTHORS'
p52102
aS'Dey A, She H, Kim L, Boruch A, Guris DL, Carlberg K, Sebti SM, Woodley DT, Imamoto A, Li W.'
p52103
aS'TITLE'
p52104
aS'Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression.'
p52105
aS'JOURNAL'
p52106
aS'Mol Biol Cell 11:3835-48 (2000)'
p52107
aS'PMID:15032600'
p52108
ag52108
aS'AUTHORS'
p52109
aS'Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB.'
p52110
aS'TITLE'
p52111
aS'Interleukin-10 and related cytokines and receptors.'
p52112
aS'JOURNAL'
p52113
aS'Annu Rev Immunol 22:929-79 (2004)'
p52114
aS'PMID:11796220'
p52115
ag52115
aS'AUTHORS'
p52116
aS'Bodmer JL, Schneider P, Tschopp J.'
p52117
aS'TITLE'
p52118
aS'The molecular architecture of the TNF superfamily.'
p52119
aS'JOURNAL'
p52120
aS'Trends Biochem Sci 27:19-26 (2002)'
p52121
aS'PMID:9395284'
p52122
ag52122
aS'AUTHORS'
p52123
aS'Derynck R, Feng XH.'
p52124
aS'TITLE'
p52125
aS'TGF-beta receptor signaling.'
p52126
aS'JOURNAL'
p52127
aS'Biochim Biophys Acta 1333:F105-50 (1997)'
p52128
aS'PMID:7791754'
p52129
ag52129
aS'AUTHORS'
p52130
aS'Liu F, Ventura F, Doody J, Massague J.'
p52131
aS'TITLE'
p52132
aS'Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs.'
p52133
aS'JOURNAL'
p52134
aS'Mol Cell Biol 15:3479-86 (1995)'
p52135
aS'PMID:9759503'
p52136
ag52136
aS'AUTHORS'
p52137
aS'Massague J.'
p52138
aS'TITLE'
p52139
aS'TGF-beta signal transduction.'
p52140
aS'JOURNAL'
p52141
aS'Annu Rev Biochem 67:753-91 (1998)'
p52142
aS'PMID:11252892'
p52143
ag52143
aS'AUTHORS'
p52144
aS'Massague J.'
p52145
aS'TITLE'
p52146
aS'How cells read TGF-beta signals.'
p52147
aS'JOURNAL'
p52148
aS'Nat Rev Mol Cell Biol 1:169-78 (2000)'
p52149
aS'PMID:12651226'
p52150
ag52150
aS'AUTHORS'
p52151
aS'Moseley TA, Haudenschild DR, Rose L, Reddi AH.'
p52152
aS'TITLE'
p52153
aS'Interleukin-17 family and IL-17 receptors.'
p52154
aS'JOURNAL'
p52155
aS'Cytokine Growth Factor Rev 14:155-74 (2003)'
p52156
aS'PMID:12421671'
p52157
ag52157
aS'AUTHORS'
p52158
aS'Martin MU, Wesche H.'
p52159
aS'TITLE'
p52160
aS'Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.'
p52161
aS'JOURNAL'
p52162
aS'Biochim Biophys Acta 1592:265-80 (2002)'
p52163
aS'PMID:9862719'
p52164
ag52164
aS'AUTHORS'
p52165
aS'Lang D, Knop J, Wesche H, Raffetseder U, Kurrle R, Boraschi D, Martin MU.'
p52166
aS'TITLE'
p52167
aS'The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.'
p52168
aS'JOURNAL'
p52169
aS'J Immunol 161:6871-7 (1998)'
p52170
asS'KO_PATHWAY'
p52171
(lp52172
S'ko04060'
p52173
asS'PATHWAY_MAP'
p52174
(lp52175
S'map04060'
p52176
asS'DISEASE'
p52177
(lp52178
S'H00097'
p52179
aS'Chemokine receptor defect'
p52180
ag52179
ag52180
aS'H00227'
p52181
aS'Congenital amegakaryocytic thrombocytopenia (CAMT)'
p52182
aS'H00344'
p52183
aS'Leprosy'
p52184
aS'H00408'
p52185
aS'Type I diabetes mellitus'
p52186
aS'H00609'
p52187
aS'46,XY disorders of sex development (Other)'
p52188
aS'H00632'
p52189
aS'Heterotaxy'
p52190
aS'H00651'
p52191
aS'Ectodermal dysplasia'
p52192
aS'H00800'
p52193
aS'Loeys-Dietz syndrome (LDS)'
p52194
aS'H00801'
p52195
aS'Familial thoracic aortic aneurysm and dissection (TAAD)'
p52196
aS'H00821'
p52197
aS'Macular degeneration'
p52198
aS'H00912'
p52199
aS'Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)'
p52200
aS'H00935'
p52201
aS'Cold-induced sweating syndrome (CISS) and Crisponi syndrome (CRISPS)'
p52202
aS'H01023'
p52203
aS'Juvenile polyposis syndrome'
p52204
aS'H01024'
p52205
aS'Hereditary mixed polyposis syndrome'
p52206
aS'H01109'
p52207
aS'Chronic mucocutaneous candidiasis (CMC)'
p52208
aS'H01122'
p52209
aS'Pulmonary alveolar proteinosis (PAP)'
p52210
aS'H01217'
p52211
aS'Primary localized cutaneous amyloidosis (PLCA)'
p52212
aS'H01227'
p52213
aS'Inflammatory bowel disease'
p52214
asS'ENTRY'
p52215
(lp52216
S'map04060'
p52217
aS'Pathway'
p52218
asS'CLASS'
p52219
(lp52220
S'Environmental Information Processing Signaling molecules and interaction'
p52221
asS'DESCRIPTION'
p52222
(lp52223
S'Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, differentiation, cell death, angiogenesis, and development and repair processes aimed at the restoration of homeostasis. Cytokines are released by various cells in the body, usually in response to an activating stimulus, and they induce responses through binding to specific receptors on the cell surface of target cells. Cytokines can be grouped by structure into different families and their receptors can likewise be grouped.'
p52224
assS'path:map04750'
p52225
(dp52226
S'NAME'
p52227
(lp52228
S'Inflammatory mediator regulation of TRP channels'
p52229
asS'REFERENCE'
p52230
(lp52231
S'PMID:15820689'
p52232
ag52232
aS'AUTHORS'
p52233
aS'Wang H, Woolf CJ'
p52234
aS'TITLE'
p52235
aS'Pain TRPs.'
p52236
aS'JOURNAL'
p52237
aS'Neuron 46:9-12 (2005)'
p52238
aS'PMID:17321113'
p52239
ag52239
aS'AUTHORS'
p52240
aS'Levine JD, Alessandri-Haber N'
p52241
aS'TITLE'
p52242
aS'TRP channels: targets for the relief of pain.'
p52243
aS'JOURNAL'
p52244
aS'Biochim Biophys Acta 1772:989-1003 (2007)'
p52245
aS'PMID:18427980'
p52246
ag52246
aS'AUTHORS'
p52247
aS'Cheng JK, Ji RR'
p52248
aS'TITLE'
p52249
aS'Intracellular signaling in primary sensory neurons and persistent pain.'
p52250
aS'JOURNAL'
p52251
aS'Neurochem Res 33:1970-8 (2008)'
p52252
aS'PMID:24099085'
p52253
ag52253
aS'AUTHORS'
p52254
aS'Julius D'
p52255
aS'TITLE'
p52256
aS'TRP channels and pain.'
p52257
aS'JOURNAL'
p52258
aS'Annu Rev Cell Dev Biol 29:355-84 (2013)'
p52259
aS'PMID:12838328'
p52260
ag52260
aS'AUTHORS'
p52261
aS'Patapoutian A, Peier AM, Story GM, Viswanath V'
p52262
aS'TITLE'
p52263
aS'ThermoTRP channels and beyond: mechanisms of temperature sensation.'
p52264
aS'JOURNAL'
p52265
aS'Nat Rev Neurosci 4:529-39 (2003)'
p52266
aS'PMID:16776582'
p52267
ag52267
aS'AUTHORS'
p52268
aS'Dhaka A, Viswanath V, Patapoutian A'
p52269
aS'TITLE'
p52270
aS'Trp ion channels and temperature sensation.'
p52271
aS'JOURNAL'
p52272
aS'Annu Rev Neurosci 29:135-61 (2006)'
p52273
aS'PMID:18615141'
p52274
ag52274
aS'AUTHORS'
p52275
aS'Story GM'
p52276
aS'TITLE'
p52277
aS'The emerging role of TRP channels in mechanisms of temperature and pain sensation.'
p52278
aS'JOURNAL'
p52279
aS'Curr Neuropharmacol 4:183-96 (2006)'
p52280
aS'PMID:17548207'
p52281
ag52281
aS'AUTHORS'
p52282
aS'Velazquez KT, Mohammad H, Sweitzer SM'
p52283
aS'TITLE'
p52284
aS'Protein kinase C in pain: involvement of multiple isoforms.'
p52285
aS'JOURNAL'
p52286
aS'Pharmacol Res 55:578-89 (2007)'
p52287
aS'PMID:16319926'
p52288
ag52288
aS'AUTHORS'
p52289
aS'Zhang X, Huang J, McNaughton PA'
p52290
aS'TITLE'
p52291
aS'NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels.'
p52292
aS'JOURNAL'
p52293
aS'EMBO J 24:4211-23 (2005)'
p52294
aS'PMID:19074743'
p52295
ag52295
aS'AUTHORS'
p52296
aS'Bessac BF, Jordt SE'
p52297
aS'TITLE'
p52298
aS'Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control.'
p52299
aS'JOURNAL'
p52300
aS'Physiology (Bethesda) 23:360-70 (2008)'
p52301
aS'PMID:17684094'
p52302
ag52302
aS'AUTHORS'
p52303
aS'Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, Imamachi N, Andre E, Patacchini R, Cottrell GS, Gatti R, Basbaum AI, Bunnett NW, Julius D, Geppetti P'
p52304
aS'TITLE'
p52305
aS'4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.'
p52306
aS'JOURNAL'
p52307
aS'Proc Natl Acad Sci U S A 104:13519-24 (2007)'
p52308
aS'PMID:21841075'
p52309
ag52309
aS'AUTHORS'
p52310
aS'Latorre R, Brauchi S, Madrid R, Orio P'
p52311
aS'TITLE'
p52312
aS'A cool channel in cold transduction.'
p52313
aS'JOURNAL'
p52314
aS'Physiology (Bethesda) 26:273-85 (2011)'
p52315
aS'PMID:20932256'
p52316
ag52316
aS'AUTHORS'
p52317
aS'Babes A, Ciobanu AC, Neacsu C, Babes RM'
p52318
aS'TITLE'
p52319
aS'TRPM8, a sensor for mild cooling in mammalian sensory nerve endings.'
p52320
aS'JOURNAL'
p52321
aS'Curr Pharm Biotechnol 12:78-88 (2011)'
p52322
aS'PMID:23000387'
p52323
ag52323
aS'AUTHORS'
p52324
aS'Loyd DR, Henry MA, Hargreaves KM'
p52325
aS'TITLE'
p52326
aS'Serotonergic neuromodulation of peripheral nociceptors.'
p52327
aS'JOURNAL'
p52328
aS'Semin Cell Dev Biol 24:51-7 (2013)'
p52329
aS'PMID:17124270'
p52330
ag52330
aS'AUTHORS'
p52331
aS'Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, Altier C, Cenac N, Zamponi GW, Bautista-Cruz F, Lopez CB, Joseph EK, Levine JD, Liedtke W, Vanner S, Vergnolle N, Geppetti P, Bunnett NW'
p52332
aS'TITLE'
p52333
aS'Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice.'
p52334
aS'JOURNAL'
p52335
aS'J Physiol 578:715-33 (2007)'
p52336
aS'PMID:22470230'
p52337
ag52337
aS'AUTHORS'
p52338
aS'Mandadi S, Armati PJ, Roufogalis BD'
p52339
aS'TITLE'
p52340
aS'Protein kinase C modulation of thermo-sensitive transient receptor potential channels: Implications for pain signaling.'
p52341
aS'JOURNAL'
p52342
aS'J Nat Sci Biol Med 2:13-25 (2011)'
p52343
asS'KO_PATHWAY'
p52344
(lp52345
S'ko04750'
p52346
asS'PATHWAY_MAP'
p52347
(lp52348
S'map04750'
p52349
asS'DISEASE'
p52350
(lp52351
S'H01391'
p52352
aS'Familial episodic pain syndrome (FEPS)'
p52353
asS'DBLINKS'
p52354
(lp52355
S'GO: 0019233'
p52356
asS'ENTRY'
p52357
(lp52358
S'map04750'
p52359
aS'Pathway'
p52360
asS'CLASS'
p52361
(lp52362
S'Organismal Systems Sensory system'
p52363
asS'DESCRIPTION'
p52364
(lp52365
S'The TRP channels that exhibit a unique response to temperature have been given the name thermo-TRPs.'
p52366
assS'path:map04062'
p52367
(dp52368
S'NAME'
p52369
(lp52370
S'Chemokine signaling pathway'
p52371
asS'REFERENCE'
p52372
(lp52373
S'PMID:12495636'
p52374
ag52374
aS'AUTHORS'
p52375
aS'Wong MM, Fish EN'
p52376
aS'TITLE'
p52377
aS'Chemokines: attractive mediators of the immune response.'
p52378
aS'JOURNAL'
p52379
aS'Semin Immunol 15:5-14 (2003)'
p52380
aS'PMID:11872087'
p52381
ag52381
aS'AUTHORS'
p52382
aS'Curnock AP, Logan MK, Ward SG'
p52383
aS'TITLE'
p52384
aS'Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.'
p52385
aS'JOURNAL'
p52386
aS'Immunology 105:125-36 (2002)'
p52387
aS'PMID:12069927'
p52388
ag52388
aS'AUTHORS'
p52389
aS'Olson TS, Ley K'
p52390
aS'TITLE'
p52391
aS'Chemokines and chemokine receptors in leukocyte trafficking.'
p52392
aS'JOURNAL'
p52393
aS'Am J Physiol Regul Integr Comp Physiol 283:R7-28 (2002)'
p52394
aS'PMID:17169327'
p52395
ag52395
aS'AUTHORS'
p52396
aS'Busillo JM, Benovic JL'
p52397
aS'TITLE'
p52398
aS'Regulation of CXCR4 signaling.'
p52399
aS'JOURNAL'
p52400
aS'Biochim Biophys Acta 1768:952-63 (2007)'
p52401
aS'PMID:11244042'
p52402
ag52402
aS'AUTHORS'
p52403
aS'Mellado M, Rodriguez-Frade JM, Manes S, Martinez-A C'
p52404
aS'TITLE'
p52405
aS'Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation.'
p52406
aS'JOURNAL'
p52407
aS'Annu Rev Immunol 19:397-421 (2001)'
p52408
aS'PMID:8576262'
p52409
ag52409
aS'AUTHORS'
p52410
aS'Knall C, Young S, Nick JA, Buhl AM, Worthen GS, Johnson GL'
p52411
aS'TITLE'
p52412
aS'Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils.'
p52413
aS'JOURNAL'
p52414
aS'J Biol Chem 271:2832-8 (1996)'
p52415
aS'PMID:17537990'
p52416
ag52416
aS'AUTHORS'
p52417
aS'Patrussi L, Ulivieri C, Lucherini OM, Paccani SR, Gamberucci A, Lanfrancone L, Pelicci PG, Baldari CT'
p52418
aS'TITLE'
p52419
aS'p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells.'
p52420
aS'JOURNAL'
p52421
aS'Blood 110:1730-8 (2007)'
p52422
aS'PMID:18662984'
p52423
ag52423
aS'AUTHORS'
p52424
aS'Sai J, Raman D, Liu Y, Wikswo J, Richmond A'
p52425
aS'TITLE'
p52426
aS'Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis.'
p52427
aS'JOURNAL'
p52428
aS'J Biol Chem 283:26538-47 (2008)'
p52429
aS'PMID:10852130'
p52430
ag52430
aS'AUTHORS'
p52431
aS'Hauck CR, Klingbeil CK, Schlaepfer DD'
p52432
aS'TITLE'
p52433
aS'Focal adhesion kinase functions as a receptor-proximal signaling component required for directed cell migration.'
p52434
aS'JOURNAL'
p52435
aS'Immunol Res 21:293-303 (2000)'
p52436
aS'PMID:14625285'
p52437
ag52437
aS'AUTHORS'
p52438
aS'Chandrasekar B, Bysani S, Mummidi S'
p52439
aS'TITLE'
p52440
aS'CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation.'
p52441
aS'JOURNAL'
p52442
aS'J Biol Chem 279:3188-96 (2004)'
p52443
aS'PMID:17371236'
p52444
ag52444
aS'AUTHORS'
p52445
aS'Smith L, Webb A, Ward SG'
p52446
aS'TITLE'
p52447
aS'T-lymphocyte navigation and migration: beyond the PI3K paradigm.'
p52448
aS'JOURNAL'
p52449
aS'Biochem Soc Trans 35:193-8 (2007)'
p52450
aS'PMID:16144840'
p52451
ag52451
aS'AUTHORS'
p52452
aS'Huttenrauch F, Pollok-Kopp B, Oppermann M'
p52453
aS'TITLE'
p52454
aS'G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers.'
p52455
aS'JOURNAL'
p52456
aS'J Biol Chem 280:37503-15 (2005)'
p52457
aS'PMID:18711432'
p52458
ag52458
aS'AUTHORS'
p52459
aS'Thelen M, Stein JV'
p52460
aS'TITLE'
p52461
aS'How chemokines invite leukocytes to dance.'
p52462
aS'JOURNAL'
p52463
aS'Nat Immunol 9:953-9 (2008)'
p52464
aS'PMID:19159344'
p52465
ag52465
aS'AUTHORS'
p52466
aS'Ward SG, Marelli-Berg FM'
p52467
aS'TITLE'
p52468
aS'Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation.'
p52469
aS'JOURNAL'
p52470
aS'Biochem J 418:13-27 (2009)'
p52471
aS'PMID:15803148'
p52472
ag52472
aS'AUTHORS'
p52473
aS'Schwartzberg PL, Finkelstein LD, Readinger JA'
p52474
aS'TITLE'
p52475
aS'TEC-family kinases: regulators of T-helper-cell differentiation.'
p52476
aS'JOURNAL'
p52477
aS'Nat Rev Immunol 5:284-95 (2005)'
p52478
aS'PMID:15771581'
p52479
ag52479
aS'AUTHORS'
p52480
aS'Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL.'
p52481
aS'TITLE'
p52482
aS'Tec family kinases in T lymphocyte development and function.'
p52483
aS'JOURNAL'
p52484
aS'Annu Rev Immunol 23:549-600 (2005)'
p52485
aS'PMID:17496928'
p52486
ag52486
aS'AUTHORS'
p52487
aS'Ticchioni M, Essafi M, Jeandel PY, Davi F, Cassuto JP, Deckert M, Bernard A'
p52488
aS'TITLE'
p52489
aS'Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a.'
p52490
aS'JOURNAL'
p52491
aS'Oncogene 26:7081-91 (2007)'
p52492
aS'PMID:9765254'
p52493
ag52493
aS'AUTHORS'
p52494
aS'Korchak HM, Rossi MW, Kilpatrick LE'
p52495
aS'TITLE'
p52496
aS'Selective role for beta-protein kinase C in signaling for O-2 generation but not degranulation or adherence in differentiated HL60 cells.'
p52497
aS'JOURNAL'
p52498
aS'J Biol Chem 273:27292-9 (1998)'
p52499
aS'PMID:15046611'
p52500
ag52500
aS'AUTHORS'
p52501
aS'Johnson Z, Power CA, Weiss C, Rintelen F, Ji H, Ruckle T, Camps M, Wells TN, Schwarz MK, Proudfoot AE, Rommel C'
p52502
aS'TITLE'
p52503
aS'Chemokine inhibition--why, when, where, which and how?'
p52504
aS'JOURNAL'
p52505
aS'Biochem Soc Trans 32:366-77 (2004)'
p52506
aS'PMID:12051620'
p52507
ag52507
aS'AUTHORS'
p52508
aS'Zhelev DV, Alteraifi A'
p52509
aS'TITLE'
p52510
aS'Signaling in the motility responses of the human neutrophil.'
p52511
aS'JOURNAL'
p52512
aS'Ann Biomed Eng 30:356-70 (2002)'
p52513
aS'PMID:17675482'
p52514
ag52514
aS'AUTHORS'
p52515
aS'Bach TL, Chen QM, Kerr WT, Wang Y, Lian L, Choi JK, Wu D, Kazanietz MG, Koretzky GA, Zigmond S, Abrams CS'
p52516
aS'TITLE'
p52517
aS'Phospholipase cbeta is critical for T cell chemotaxis.'
p52518
aS'JOURNAL'
p52519
aS'J Immunol 179:2223-7 (2007)'
p52520
aS'PMID:14607270'
p52521
ag52521
aS'AUTHORS'
p52522
aS'Hornstein I, Alcover A, Katzav S'
p52523
aS'TITLE'
p52524
aS'Vav proteins, masters of the world of cytoskeleton organization.'
p52525
aS'JOURNAL'
p52526
aS'Cell Signal 16:1-11 (2004)'
p52527
asS'KO_PATHWAY'
p52528
(lp52529
S'ko04062'
p52530
asS'PATHWAY_MAP'
p52531
(lp52532
S'map04062'
p52533
asS'DISEASE'
p52534
(lp52535
S'H00539'
p52536
aS'PTEN hamartoma tumor syndrome (PHTS)'
p52537
ag52536
ag52537
aS'H00540'
p52538
aS'Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID)'
p52539
aS'H00645'
p52540
aS'Incontinentia pigmenti'
p52541
aS'H00821'
p52542
aS'Macular degeneration'
p52543
aS'H00882'
p52544
aS'Cocoon syndrome'
p52545
aS'H00931'
p52546
aS'Growth hormone insensitivity with immunodeficiency'
p52547
aS'H01109'
p52548
aS'Chronic mucocutaneous candidiasis (CMC)'
p52549
asS'DESCRIPTION Inflammatory immune response requires the recruitment of leukocytes to the site of inflammation upon foreign insult. Chemokines are small chemoattractant peptides that provide directional cues for the cell trafficking and thus are vital for protective host response. In addition, chemokines regulate plethora of biological processes of hematopoietic cells to lead cellular activation, differentiation and survival.'
p52550
(lp52551
S'The chemokine signal is transduced by chemokine receptors (G-protein coupled receptors) expressed on the immune cells. After receptor activation, the alpha- and beta-gamma-subunits of G protein dissociate to activate diverse downstream pathways resulting in cellular polarization and actin reorganization. Various members of small GTPases are involved in this process. Induction of nitric oxide and production of reactive oxygen species are as well regulated by chemokine signal via calcium mobilization and diacylglycerol production.'
p52552
asS'DBLINKS'
p52553
(lp52554
S'GO: 0070098'
p52555
asS'ENTRY'
p52556
(lp52557
S'map04062'
p52558
aS'Pathway'
p52559
asS'CLASS'
p52560
(lp52561
S'Organismal Systems Immune system'
p52562
asS'DESCRIPTION'
p52563
(lp52564
S'Inflammatory immune response requires the recruitment of leukocytes to the site of inflammation upon foreign insult. Chemokines are small chemoattractant peptides that provide directional cues for the cell trafficking and thus are vital for protective host response. In addition, chemokines regulate plethora of biological processes of hematopoietic cells to lead cellular activation, differentiation and survival.'
p52565
assS'path:map04390'
p52566
(dp52567
S'NAME'
p52568
(lp52569
S'Hippo signaling pathway'
p52570
asS'REFERENCE'
p52571
(lp52572
S'PMID:22750148'
p52573
ag52573
aS'AUTHORS'
p52574
aS'Schroeder MC, Halder G'
p52575
aS'TITLE'
p52576
aS'Regulation of the Hippo pathway by cell architecture and mechanical signals.'
p52577
aS'JOURNAL'
p52578
aS'Semin Cell Dev Biol 23:803-11 (2012)'
p52579
aS'PMID:21808241'
p52580
ag52580
aS'AUTHORS'
p52581
aS'Zhao B, Tumaneng K, Guan KL'
p52582
aS'TITLE'
p52583
aS'The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.'
p52584
aS'JOURNAL'
p52585
aS'Nat Cell Biol 13:877-83 (2011)'
p52586
aS'PMID:21874053'
p52587
ag52587
aS'AUTHORS'
p52588
aS'Mauviel A, Nallet-Staub F, Varelas X'
p52589
aS'TITLE'
p52590
aS'Integrating developmental signals: a Hippo in the (path)way.'
p52591
aS'JOURNAL'
p52592
aS'Oncogene 31:1743-56 (2012)'
p52593
aS'PMID:21084559'
p52594
ag52594
aS'AUTHORS'
p52595
aS'Zhao B, Li L, Guan KL'
p52596
aS'TITLE'
p52597
aS'Hippo signaling at a glance.'
p52598
aS'JOURNAL'
p52599
aS'J Cell Sci 123:4001-6 (2010)'
p52600
aS'PMID:20439427'
p52601
ag52601
aS'AUTHORS'
p52602
aS'Zhao B, Li L, Lei Q, Guan KL'
p52603
aS'TITLE'
p52604
aS'The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.'
p52605
aS'JOURNAL'
p52606
aS'Genes Dev 24:862-74 (2010)'
p52607
aS'PMID:23034192'
p52608
ag52608
aS'AUTHORS'
p52609
aS'Tremblay AM, Camargo FD'
p52610
aS'TITLE'
p52611
aS'Hippo signaling in mammalian stem cells.'
p52612
aS'JOURNAL'
p52613
aS'Semin Cell Dev Biol 23:818-26 (2012)'
p52614
aS'PMID:21138973'
p52615
ag52615
aS'AUTHORS'
p52616
aS'Halder G, Johnson RL'
p52617
aS'TITLE'
p52618
aS'Hippo signaling: growth control and beyond.'
p52619
aS'JOURNAL'
p52620
aS'Development 138:9-22 (2011)'
p52621
aS'PMID:22658639'
p52622
ag52622
aS'AUTHORS'
p52623
aS'Ramos A, Camargo FD'
p52624
aS'TITLE'
p52625
aS'The Hippo signaling pathway and stem cell biology.'
p52626
aS'JOURNAL'
p52627
aS'Trends Cell Biol 22:339-46 (2012)'
p52628
aS'PMID:20951342'
p52629
ag52629
aS'AUTHORS'
p52630
aS'Pan D'
p52631
aS'TITLE'
p52632
aS'The hippo signaling pathway in development and cancer.'
p52633
aS'JOURNAL'
p52634
aS'Dev Cell 19:491-505 (2010)'
p52635
aS'PMID:21324984'
p52636
ag52636
aS'AUTHORS'
p52637
aS'Bao Y, Hata Y, Ikeda M, Withanage K'
p52638
aS'TITLE'
p52639
aS'Mammalian Hippo pathway: from development to cancer and beyond.'
p52640
aS'JOURNAL'
p52641
aS'J Biochem 149:361-79 (2011)'
p52642
aS'PMID:18955139'
p52643
ag52643
aS'AUTHORS'
p52644
aS'Zhao B, Lei QY, Guan KL'
p52645
aS'TITLE'
p52646
aS'The Hippo-YAP pathway: new connections between regulation of organ size and cancer.'
p52647
aS'JOURNAL'
p52648
aS'Curr Opin Cell Biol 20:638-46 (2008)'
p52649
aS'PMID:20945341'
p52650
ag52650
aS'AUTHORS'
p52651
aS'Chan SW, Lim CJ, Chen L, Chong YF, Huang C, Song H, Hong W'
p52652
aS'TITLE'
p52653
aS'The Hippo pathway in biological control and cancer development.'
p52654
aS'JOURNAL'
p52655
aS'J Cell Physiol 226:928-39 (2011)'
p52656
aS'PMID:18328423'
p52657
ag52657
aS'AUTHORS'
p52658
aS'Zeng Q, Hong W'
p52659
aS'TITLE'
p52660
aS'The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals.'
p52661
aS'JOURNAL'
p52662
aS'Cancer Cell 13:188-92 (2008)'
p52663
aS'PMID:19846288'
p52664
ag52664
aS'AUTHORS'
p52665
aS'Badouel C, Garg A, McNeill H'
p52666
aS'TITLE'
p52667
aS'Herding Hippos: regulating growth in flies and man.'
p52668
aS'JOURNAL'
p52669
aS'Curr Opin Cell Biol 21:837-43 (2009)'
p52670
aS'PMID:17975546'
p52671
ag52671
aS'AUTHORS'
p52672
aS'Buttitta LA, Edgar BA'
p52673
aS'TITLE'
p52674
aS'How size is controlled: from Hippos to Yorkies.'
p52675
aS'JOURNAL'
p52676
aS'Nat Cell Biol 9:1225-7 (2007)'
p52677
aS'PMID:22683405'
p52678
ag52678
aS'AUTHORS'
p52679
aS'Liu AM, Wong KF, Jiang X, Qiao Y, Luk JM'
p52680
aS'TITLE'
p52681
aS'Regulators of mammalian Hippo pathway in cancer.'
p52682
aS'JOURNAL'
p52683
aS'Biochim Biophys Acta 1826:357-64 (2012)'
p52684
aS'PMID:22830020'
p52685
ag52685
aS'AUTHORS'
p52686
aS'Fausti F, Di Agostino S, Sacconi A, Strano S, Blandino G'
p52687
aS'TITLE'
p52688
aS'Hippo and rassf1a Pathways: A Growing Affair.'
p52689
aS'JOURNAL'
p52690
aS'Mol Biol Int 2012:307628 (2012)'
p52691
aS'PMID:22895435'
p52692
ag52692
aS'AUTHORS'
p52693
aS'Halder G, Dupont S, Piccolo S'
p52694
aS'TITLE'
p52695
aS'Transduction of mechanical and cytoskeletal cues by YAP and TAZ.'
p52696
aS'JOURNAL'
p52697
aS'Nat Rev Mol Cell Biol 13:591-600 (2012)'
p52698
aS'PMID:22153608'
p52699
ag52699
aS'AUTHORS'
p52700
aS'Varelas X, Wrana JL'
p52701
aS'TITLE'
p52702
aS'Coordinating developmental signaling: novel roles for the Hippo pathway.'
p52703
aS'JOURNAL'
p52704
aS'Trends Cell Biol 22:88-96 (2012)'
p52705
aS'PMID:21376238'
p52706
ag52706
aS'AUTHORS'
p52707
aS'Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR, Camargo FD'
p52708
aS'TITLE'
p52709
aS'Yap1 acts downstream of alpha-catenin to control epidermal proliferation.'
p52710
aS'JOURNAL'
p52711
aS'Cell 144:782-95 (2011)'
p52712
asS'KO_PATHWAY'
p52713
(lp52714
S'ko04390'
p52715
asS'PATHWAY_MAP'
p52716
(lp52717
S'map04390'
p52718
asS'DISEASE'
p52719
(lp52720
S'H00800'
p52721
aS'Loeys-Dietz syndrome (LDS)'
p52722
ag52721
ag52722
aS'H01385'
p52723
aS'Rienhoff syndrome'
p52724
asS'MODULE'
p52725
(lp52726
S'M00679'
p52727
aS'BMP signaling [PATH:map04390]'
p52728
ag52727
ag52728
aS'M00680'
p52729
aS'TGF-beta signaling [PATH:map04390]'
p52730
aS'M00683'
p52731
aS'Hippo signaling [PATH:map04390]'
p52732
asS'DBLINKS'
p52733
(lp52734
S'GO: 0035329'
p52735
asS'ENTRY'
p52736
(lp52737
S'map04390'
p52738
aS'Pathway'
p52739
asS'CLASS'
p52740
(lp52741
S'Environmental Information Processing Signal transduction'
p52742
asS'DESCRIPTION'
p52743
(lp52744
S'Hippo signaling is an evolutionarily conserved signaling pathway that controls organ size from flies to humans. In humans and mice, the pathway consists of the MST1 and MST2 kinases, their cofactor Salvador and LATS1 and LATS2. In response to high cell densities, activated LATS1/2 phosphorylates the transcriptional coactivators YAP and TAZ, promoting its cytoplasmic localization, leading to cell apoptosis and restricting organ size overgrowth. When the Hippo pathway is inactivated at low cell density, YAP/TAZ translocates into the nucleus to bind to the transcription enhancer factor (TEAD/TEF) family of transcriptional factors to promote cell growth and proliferation. YAP/TAZ also interacts with other transcriptional factors or signaling molecules, by which Hippo pathway-mediated processes are interconnected with those of other key signaling cascades, such as those mediated by TGF-beta and Wnt growth factors.'
p52745
assS'path:map04391'
p52746
(dp52747
S'NAME'
p52748
(lp52749
S'Hippo signaling pathway - fly'
p52750
asS'REFERENCE'
p52751
(lp52752
S'PMID:21138973'
p52753
ag52753
aS'AUTHORS'
p52754
aS'Halder G, Johnson RL'
p52755
aS'TITLE'
p52756
aS'Hippo signaling: growth control and beyond.'
p52757
aS'JOURNAL'
p52758
aS'Development 138:9-22 (2011)'
p52759
aS'PMID:20439427'
p52760
ag52760
aS'AUTHORS'
p52761
aS'Zhao B, Li L, Lei Q, Guan KL'
p52762
aS'TITLE'
p52763
aS'The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.'
p52764
aS'JOURNAL'
p52765
aS'Genes Dev 24:862-74 (2010)'
p52766
aS'PMID:20951342'
p52767
ag52767
aS'AUTHORS'
p52768
aS'Pan D'
p52769
aS'TITLE'
p52770
aS'The hippo signaling pathway in development and cancer.'
p52771
aS'JOURNAL'
p52772
aS'Dev Cell 19:491-505 (2010)'
p52773
aS'PMID:22750148'
p52774
ag52774
aS'AUTHORS'
p52775
aS'Schroeder MC, Halder G'
p52776
aS'TITLE'
p52777
aS'Regulation of the Hippo pathway by cell architecture and mechanical signals.'
p52778
aS'JOURNAL'
p52779
aS'Semin Cell Dev Biol 23:803-11 (2012)'
p52780
aS'PMID:21808241'
p52781
ag52781
aS'AUTHORS'
p52782
aS'Zhao B, Tumaneng K, Guan KL'
p52783
aS'TITLE'
p52784
aS'The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.'
p52785
aS'JOURNAL'
p52786
aS'Nat Cell Biol 13:877-83 (2011)'
p52787
aS'PMID:22035868'
p52788
ag52788
aS'AUTHORS'
p52789
aS'Yin M, Zhang L'
p52790
aS'TITLE'
p52791
aS'Hippo signaling: a hub of growth control, tumor suppression and pluripotency maintenance.'
p52792
aS'JOURNAL'
p52793
aS'J Genet Genomics 38:471-81 (2011)'
p52794
aS'PMID:20945341'
p52795
ag52795
aS'AUTHORS'
p52796
aS'Chan SW, Lim CJ, Chen L, Chong YF, Huang C, Song H, Hong W'
p52797
aS'TITLE'
p52798
aS'The Hippo pathway in biological control and cancer development.'
p52799
aS'JOURNAL'
p52800
aS'J Cell Physiol 226:928-39 (2011)'
p52801
aS'PMID:21415026'
p52802
ag52802
aS'AUTHORS'
p52803
aS'Hilman D, Gat U'
p52804
aS'TITLE'
p52805
aS'The evolutionary history of YAP and the hippo/YAP pathway.'
p52806
aS'JOURNAL'
p52807
aS'Mol Biol Evol 28:2403-17 (2011)'
p52808
aS'PMID:18955139'
p52809
ag52809
aS'AUTHORS'
p52810
aS'Zhao B, Lei QY, Guan KL'
p52811
aS'TITLE'
p52812
aS'The Hippo-YAP pathway: new connections between regulation of organ size and cancer.'
p52813
aS'JOURNAL'
p52814
aS'Curr Opin Cell Biol 20:638-46 (2008)'
p52815
aS'PMID:19846288'
p52816
ag52816
aS'AUTHORS'
p52817
aS'Badouel C, Garg A, McNeill H'
p52818
aS'TITLE'
p52819
aS'Herding Hippos: regulating growth in flies and man.'
p52820
aS'JOURNAL'
p52821
aS'Curr Opin Cell Biol 21:837-43 (2009)'
p52822
aS'PMID:19164949'
p52823
ag52823
aS'AUTHORS'
p52824
aS'Zhang L, Yue T, Jiang J'
p52825
aS'TITLE'
p52826
aS'Hippo signaling pathway and organ size control.'
p52827
aS'JOURNAL'
p52828
aS'Fly (Austin) 3:68-73 (2009)'
p52829
aS'PMID:17318211'
p52830
ag52830
aS'AUTHORS'
p52831
aS'Harvey K, Tapon N'
p52832
aS'TITLE'
p52833
aS'The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network.'
p52834
aS'JOURNAL'
p52835
aS'Nat Rev Cancer 7:182-91 (2007)'
p52836
aS'PMID:19517570'
p52837
ag52837
aS'AUTHORS'
p52838
aS'Kango-Singh M, Singh A'
p52839
aS'TITLE'
p52840
aS'Regulation of organ size: insights from the Drosophila Hippo signaling pathway.'
p52841
aS'JOURNAL'
p52842
aS'Dev Dyn 238:1627-37 (2009)'
p52843
aS'PMID:21145886'
p52844
ag52844
aS'AUTHORS'
p52845
aS'Sun G, Irvine KD'
p52846
aS'TITLE'
p52847
aS'Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors.'
p52848
aS'JOURNAL'
p52849
aS'Dev Biol 350:139-51 (2011)'
p52850
aS'PMID:22830020'
p52851
ag52851
aS'AUTHORS'
p52852
aS'Fausti F, Di Agostino S, Sacconi A, Strano S, Blandino G'
p52853
aS'TITLE'
p52854
aS'Hippo and rassf1a Pathways: A Growing Affair.'
p52855
aS'JOURNAL'
p52856
aS'Mol Biol Int 2012:307628 (2012)'
p52857
aS'PMID:20452772'
p52858
ag52858
aS'AUTHORS'
p52859
aS'Oh H, Irvine KD'
p52860
aS'TITLE'
p52861
aS'Yorkie: the final destination of Hippo signaling.'
p52862
aS'JOURNAL'
p52863
aS'Trends Cell Biol 20:410-7 (2010)'
p52864
aS'PMID:17975546'
p52865
ag52865
aS'AUTHORS'
p52866
aS'Buttitta LA, Edgar BA'
p52867
aS'TITLE'
p52868
aS'How size is controlled: from Hippos to Yorkies.'
p52869
aS'JOURNAL'
p52870
aS'Nat Cell Biol 9:1225-7 (2007)'
p52871
aS'PMID:21213102'
p52872
ag52872
aS'AUTHORS'
p52873
aS'Chen L, Loh PG, Song H'
p52874
aS'TITLE'
p52875
aS'Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway.'
p52876
aS'JOURNAL'
p52877
aS'Protein Cell 1:1073-83 (2010)'
p52878
aS'PMID:19733165'
p52879
ag52879
aS'AUTHORS'
p52880
aS'Oh H, Reddy BV, Irvine KD'
p52881
aS'TITLE'
p52882
aS'Phosphorylation-independent repression of Yorkie in Fat-Hippo signaling.'
p52883
aS'JOURNAL'
p52884
aS'Dev Biol 335:188-97 (2009)'
p52885
aS'PMID:18952051'
p52886
ag52886
aS'AUTHORS'
p52887
aS'Badouel C, McNeill H'
p52888
aS'TITLE'
p52889
aS'Apical junctions and growth control in Drosophila.'
p52890
aS'JOURNAL'
p52891
aS'Biochim Biophys Acta 1788:755-60 (2009)'
p52892
asS'KO_PATHWAY'
p52893
(lp52894
S'ko04391'
p52895
asS'PATHWAY_MAP'
p52896
(lp52897
S'map04391'
p52898
asS'MODULE'
p52899
(lp52900
S'M00683'
p52901
aS'Hippo signaling [PATH:map04391]'
p52902
asS'DBLINKS'
p52903
(lp52904
S'GO: 0035329'
p52905
asS'ENTRY'
p52906
(lp52907
S'map04391'
p52908
aS'Pathway'
p52909
asS'CLASS'
p52910
(lp52911
S'Environmental Information Processing Signal transduction'
p52912
asS'DESCRIPTION'
p52913
(lp52914
S'Hippo signaling is an evolutionarily conserved signaling pathway that controls organ size during development from flies to humans. The core of the drosophila pathway is a kinase cascade consisting of four proteins including Hippo, Salvador, Warts and Mats. Upon activation by stimuli such as high cell density in cell culture, the Hippo pathway kinase cascade phosphorylates and inhibits the transcriptional co-activator Yorkie, thereby promoting cell apoptosis and restricting organ size overgrowth. When the Hippo pathway is inactivated, Yorkie translocates into the nucleus to bind to transcriptional factors to promote cell growth and proliferation.'
p52915
assS'path:map04520'
p52916
(dp52917
S'NAME'
p52918
(lp52919
S'Adherens junction'
p52920
asS'REFERENCE'
p52921
(lp52922
S'PMID:15001769'
p52923
ag52923
aS'AUTHORS'
p52924
aS'Nelson WJ, Nusse R.'
p52925
aS'TITLE'
p52926
aS'Convergence of Wnt, beta-catenin, and cadherin pathways.'
p52927
aS'JOURNAL'
p52928
aS'Science 303:1483-7 (2004)'
p52929
aS'PMID:10204118'
p52930
ag52930
aS'AUTHORS'
p52931
aS'Potter E, Bergwitz C, Brabant G.'
p52932
aS'TITLE'
p52933
aS'The cadherin-catenin system: implications for growth and differentiation of endocrine tissues.'
p52934
aS'JOURNAL'
p52935
aS'Endocr Rev 20:207-39 (1999)'
p52936
aS'PMID:10959047'
p52937
ag52937
aS'AUTHORS'
p52938
aS'Beavon IR.'
p52939
aS'TITLE'
p52940
aS'The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation.'
p52941
aS'JOURNAL'
p52942
aS'Eur J Cancer 36:1607-20 (2000)'
p52943
aS'PMID:15489912'
p52944
ag52944
aS'AUTHORS'
p52945
aS'Reynolds AB, Roczniak-Ferguson A.'
p52946
aS'TITLE'
p52947
aS'Emerging roles for p120-catenin in cell adhesion and cancer.'
p52948
aS'JOURNAL'
p52949
aS'Oncogene 23:7947-56 (2004)'
p52950
aS'PMID:11171368'
p52951
ag52951
aS'AUTHORS'
p52952
aS'Angst BD, Marcozzi C, Magee AI.'
p52953
aS'TITLE'
p52954
aS'The cadherin superfamily: diversity in form and function.'
p52955
aS'JOURNAL'
p52956
aS'J Cell Sci 114:629-41 (2001)'
p52957
aS'PMID:11984870'
p52958
ag52958
aS'AUTHORS'
p52959
aS'Lilien J, Balsamo J, Arregui C, Xu G.'
p52960
aS'TITLE'
p52961
aS'Turn-off, drop-out: functional state switching of cadherins.'
p52962
aS'JOURNAL'
p52963
aS'Dev Dyn 224:18-29 (2002)'
p52964
aS'PMID:12640114'
p52965
ag52965
aS'AUTHORS'
p52966
aS'Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia de Herreros A, Dunach M.'
p52967
aS'TITLE'
p52968
aS'p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.'
p52969
aS'JOURNAL'
p52970
aS'Mol Cell Biol 23:2287-97 (2003)'
p52971
aS'PMID:14623871'
p52972
ag52972
aS'AUTHORS'
p52973
aS"Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A."
p52974
aS'TITLE'
p52975
aS'Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.'
p52976
aS'JOURNAL'
p52977
aS'J Cell Biol 163:847-57 (2003)'
p52978
aS'PMID:11703922'
p52979
ag52979
aS'AUTHORS'
p52980
aS'Ciruna B, Rossant J.'
p52981
aS'TITLE'
p52982
aS'FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak.'
p52983
aS'JOURNAL'
p52984
aS'Dev Cell 1:37-49 (2001)'
p52985
aS'PMID:12665527'
p52986
ag52986
aS'AUTHORS'
p52987
aS'Peinado H, Quintanilla M, Cano A.'
p52988
aS'TITLE'
p52989
aS'Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.'
p52990
aS'JOURNAL'
p52991
aS'J Biol Chem 278:21113-23 (2003)'
p52992
aS'PMID:10890911'
p52993
ag52993
aS'AUTHORS'
p52994
aS'Labbe E, Letamendia A, Attisano L.'
p52995
aS'TITLE'
p52996
aS'Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.'
p52997
aS'JOURNAL'
p52998
aS'Proc Natl Acad Sci U S A 97:8358-63 (2000)'
p52999
aS'PMID:15551862'
p53000
ag53000
aS'AUTHORS'
p53001
aS'Nakanishi H, Takai Y.'
p53002
aS'TITLE'
p53003
aS'Roles of nectins in cell adhesion, migration and polarization.'
p53004
aS'JOURNAL'
p53005
aS'Biol Chem 385:885-92 (2004)'
p53006
aS'PMID:15561584'
p53007
ag53007
aS'AUTHORS'
p53008
aS'Irie K, Shimizu K, Sakisaka T, Ikeda W, Takai Y.'
p53009
aS'TITLE'
p53010
aS'Roles and modes of action of nectins in cell-cell adhesion.'
p53011
aS'JOURNAL'
p53012
aS'Semin Cell Dev Biol 15:643-56 (2004)'
p53013
asS'KO_PATHWAY'
p53014
(lp53015
S'ko04520'
p53016
asS'PATHWAY_MAP'
p53017
(lp53018
S'map04520'
p53019
asS'DISEASE'
p53020
(lp53021
S'H00170'
p53022
aS'Piebaldism'
p53023
ag53022
ag53023
aS'H00626'
p53024
aS'Nephrotic syndrome and focal segmental glomerulosclerosis'
p53025
aS'H00647'
p53026
aS'Ectodermal dysplasia-syndactyly syndrome (EDSS)'
p53027
aS'H00719'
p53028
aS'Leprechaunism'
p53029
aS'H00759'
p53030
aS'Waardenburg syndrome (WS)'
p53031
aS'H00800'
p53032
aS'Loeys-Dietz syndrome (LDS)'
p53033
aS'H00801'
p53034
aS'Familial thoracic aortic aneurysm and dissection (TAAD)'
p53035
aS'H00942'
p53036
aS'Rabson-Mendenhall syndrome'
p53037
aS'H00947'
p53038
aS'Pilomatricoma'
p53039
aS'H01023'
p53040
aS'Juvenile polyposis syndrome'
p53041
aS'H01207'
p53042
aS'Trigonocephaly'
p53043
aS'H01228'
p53044
aS'Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN)'
p53045
aS'H01255'
p53046
aS'Juvenile-onset dystonia'
p53047
aS'H01274'
p53048
aS'Growth delay due to insulin-like growth factor I resistance'
p53049
asS'DBLINKS'
p53050
(lp53051
S'GO: 0005912'
p53052
asS'ENTRY'
p53053
(lp53054
S'map04520'
p53055
aS'Pathway'
p53056
asS'CLASS'
p53057
(lp53058
S'Cellular Processes Cellular commiunity'
p53059
asS'DESCRIPTION'
p53060
(lp53061
S'Cell-cell adherens junctions (AJs), the most common type of intercellular adhesions, are important for maintaining tissue architecture and cell polarity and can limit cell movement and proliferation. At AJs, E-cadherin serves as an essential cell adhesion molecules (CAMs). The cytoplasmic tail binds beta-catenin, which in turn binds alpha-catenin. Alpha-catenin is associated with F-actin bundles directly and indirectly. The integrity of the cadherin-catenin complex is negatively regulated by phosphorylation of beta-catenin by receptor tyrosine kinases (RTKs) and cytoplasmic tyrosine kinases (Fer, Fyn, Yes, and Src), which leads to dissociation of the cadherin-catenin complex. Integrity of this complex is positively regulated by beta -catenin phosphorylation by casein kinase II, and dephosphorylation by protein tyrosine phosphatases. Changes in the phosphorylation state of beta-catenin affect cell-cell adhesion, cell migration and the level of signaling beta-catenin. Wnt signaling acts as a positive regulator of beta-catenin by inhibiting beta-catenin degradation, which stabilizes beta-catenin, and causes its accumulation. Cadherin may acts as a negative regulator of signaling beta-catenin as it binds beta-catenin at the cell surface and thereby sequesters it from the nucleus. Nectins also function as CAMs at AJs, but are more highly concentrated at AJs than E-cadherin. Nectins transduce signals through Cdc42 and Rac, which reorganize the actin cytoskeleton, regulate the formation of AJs, and strengthen cell-cell adhesion.'
p53062
assS'path:map04150'
p53063
(dp53064
S'NAME'
p53065
(lp53066
S'mTOR signaling pathway'
p53067
asS'REFERENCE'
p53068
(lp53069
S'PMID:15624019'
p53070
ag53070
aS'AUTHORS'
p53071
aS'Inoki K, Corradetti MN, Guan KL.'
p53072
aS'TITLE'
p53073
aS'Dysregulation of the TSC-mTOR pathway in human disease.'
p53074
aS'JOURNAL'
p53075
aS'Nat Genet 37:19-24 (2005)'
p53076
aS'PMID:16404421'
p53077
ag53077
aS'AUTHORS'
p53078
aS'Petroulakis E, Mamane Y, Le Bacquer O, Shahbazian D, Sonenberg N.'
p53079
aS'TITLE'
p53080
aS'mTOR signaling: implications for cancer and anticancer therapy.'
p53081
aS'JOURNAL'
p53082
aS'Br J Cancer 94:195-9 (2006)'
p53083
aS'PMID:16226444'
p53084
ag53084
aS'AUTHORS'
p53085
aS'Sarbassov dos D, Ali SM, Sabatini DM.'
p53086
aS'TITLE'
p53087
aS'Growing roles for the mTOR pathway.'
p53088
aS'JOURNAL'
p53089
aS'Curr Opin Cell Biol 17:596-603 (2005)'
p53090
aS'PMID:16469695'
p53091
ag53091
aS'AUTHORS'
p53092
aS'Wullschleger S, Loewith R, Hall MN.'
p53093
aS'TITLE'
p53094
aS'TOR signaling in growth and metabolism.'
p53095
aS'JOURNAL'
p53096
aS'Cell 124:471-84 (2006)'
p53097
aS'PMID:16288290'
p53098
ag53098
aS'AUTHORS'
p53099
aS'Plas DR, Thompson CB.'
p53100
aS'TITLE'
p53101
aS'Akt-dependent transformation: there is more to growth than just surviving.'
p53102
aS'JOURNAL'
p53103
aS'Oncogene 24:7435-42 (2005)'
p53104
aS'PMID:16452501'
p53105
ag53105
aS'AUTHORS'
p53106
aS'Levine AJ, Feng Z, Mak TW, You H, Jin S'
p53107
aS'TITLE'
p53108
aS'Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways.'
p53109
aS'JOURNAL'
p53110
aS'Genes Dev 20:267-75 (2006)'
p53111
aS'PMID:15509864'
p53112
ag53112
aS'AUTHORS'
p53113
aS'Hardie DG.'
p53114
aS'TITLE'
p53115
aS'The AMP-activated protein kinase pathway--new players upstream and downstream.'
p53116
aS'JOURNAL'
p53117
aS'J Cell Sci 117:5479-87 (2004)'
p53118
aS'PMID:15780593'
p53119
ag53119
aS'AUTHORS'
p53120
aS'Hardie DG.'
p53121
aS'TITLE'
p53122
aS'New roles for the LKB1--&gtAMPK pathway.'
p53123
aS'JOURNAL'
p53124
aS'Curr Opin Cell Biol 17:167-73 (2005)'
p53125
aS'PMID:16288294'
p53126
ag53126
aS'AUTHORS'
p53127
aS'Astrinidis A, Henske EP.'
p53128
aS'TITLE'
p53129
aS'Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.'
p53130
aS'JOURNAL'
p53131
aS'Oncogene 24:7475-81 (2005)'
p53132
aS'PMID:15928081'
p53133
ag53133
aS'AUTHORS'
p53134
aS'Feng Z, Zhang H, Levine AJ, Jin S.'
p53135
aS'TITLE'
p53136
aS'The coordinate regulation of the p53 and mTOR pathways in cells.'
p53137
aS'JOURNAL'
p53138
aS'Proc Natl Acad Sci U S A 102:8204-9 (2005)'
p53139
aS'PMID:16288292'
p53140
ag53140
aS'AUTHORS'
p53141
aS'Altomare DA, Testa JR.'
p53142
aS'TITLE'
p53143
aS'Perturbations of the AKT signaling pathway in human cancer.'
p53144
aS'JOURNAL'
p53145
aS'Oncogene 24:7455-64 (2005)'
p53146
aS'PMID:16244323'
p53147
ag53147
aS'AUTHORS'
p53148
aS'Kwiatkowski DJ, Manning BD.'
p53149
aS'TITLE'
p53150
aS'Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.'
p53151
aS'JOURNAL'
p53152
aS'Hum Mol Genet 14 Spec No. 2:R251-8 (2005)'
p53153
aS'PMID:16002336'
p53154
ag53154
aS'AUTHORS'
p53155
aS'Guertin DA, Sabatini DM.'
p53156
aS'TITLE'
p53157
aS'An expanding role for mTOR in cancer.'
p53158
aS'JOURNAL'
p53159
aS'Trends Mol Med 11:353-61 (2005)'
p53160
aS'PMID:14684182'
p53161
ag53161
aS'AUTHORS'
p53162
aS'Tokunaga C, Yoshino K, Yonezawa K.'
p53163
aS'TITLE'
p53164
aS'mTOR integrates amino acid- and energy-sensing pathways.'
p53165
aS'JOURNAL'
p53166
aS'Biochem Biophys Res Commun 313:443-6 (2004)'
p53167
aS'PMID:16341064'
p53168
ag53168
aS'AUTHORS'
p53169
aS'Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB.'
p53170
aS'TITLE'
p53171
aS'Exploiting the PI3K/AKT pathway for cancer drug discovery.'
p53172
aS'JOURNAL'
p53173
aS'Nat Rev Drug Discov 4:988-1004 (2005)'
p53174
aS'PMID:15681023'
p53175
ag53175
aS'AUTHORS'
p53176
aS'Luo Z, Saha AK, Xiang X, Ruderman NB.'
p53177
aS'TITLE'
p53178
aS'AMPK, the metabolic syndrome and cancer.'
p53179
aS'JOURNAL'
p53180
aS'Trends Pharmacol Sci 26:69-76 (2005)'
p53181
aS'PMID:15659337'
p53182
ag53182
aS'AUTHORS'
p53183
aS'Tee AR, Blenis J.'
p53184
aS'TITLE'
p53185
aS'mTOR, translational control and human disease.'
p53186
aS'JOURNAL'
p53187
aS'Semin Cell Dev Biol 16:29-37 (2005)'
p53188
aS'PMID:15276465'
p53189
ag53189
aS'AUTHORS'
p53190
aS'Proud CG.'
p53191
aS'TITLE'
p53192
aS'Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.'
p53193
aS'JOURNAL'
p53194
aS'Cardiovasc Res 63:403-13 (2004)'
p53195
aS'PMID:15988001'
p53196
ag53196
aS'AUTHORS'
p53197
aS'Sofer A, Lei K, Johannessen CM, Ellisen LW.'
p53198
aS'TITLE'
p53199
aS'Regulation of mTOR and cell growth in response to energy stress by REDD1.'
p53200
aS'JOURNAL'
p53201
aS'Mol Cell Biol 25:5834-45 (2005)'
p53202
aS'PMID:16099218'
p53203
ag53203
aS'AUTHORS'
p53204
aS'Deretic V.'
p53205
aS'TITLE'
p53206
aS'Autophagy in innate and adaptive immunity.'
p53207
aS'JOURNAL'
p53208
aS'Trends Immunol 26:523-8 (2005)'
p53209
aS'PMID:15928708'
p53210
ag53210
aS'AUTHORS'
p53211
aS'Lum JJ, DeBerardinis RJ, Thompson CB.'
p53212
aS'TITLE'
p53213
aS'Autophagy in metazoans: cell survival in the land of plenty.'
p53214
aS'JOURNAL'
p53215
aS'Nat Rev Mol Cell Biol 6:439-48 (2005)'
p53216
aS'PMID:15261137'
p53217
ag53217
aS'AUTHORS'
p53218
aS'Brugarolas J, Kaelin WG Jr.'
p53219
aS'TITLE'
p53220
aS'Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes.'
p53221
aS'JOURNAL'
p53222
aS'Cancer Cell 6:7-10 (2004)'
p53223
aS'PMID:16109716'
p53224
ag53224
aS'AUTHORS'
p53225
aS'Hui L, Rodrik V, Pielak RM, Knirr S, Zheng Y, Foster DA.'
p53226
aS'TITLE'
p53227
aS'mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells.'
p53228
aS'JOURNAL'
p53229
aS'J Biol Chem 280:35829-35 (2005)'
p53230
aS'PMID:19100909'
p53231
ag53231
aS'AUTHORS'
p53232
aS'Hall MN'
p53233
aS'TITLE'
p53234
aS'mTOR-what does it do?'
p53235
aS'JOURNAL'
p53236
aS'Transplant Proc 40:S5-8 (2008)'
p53237
aS'PMID:18598780'
p53238
ag53238
aS'AUTHORS'
p53239
aS'Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschlager M'
p53240
aS'TITLE'
p53241
aS'The mTOR pathway and its role in human genetic diseases.'
p53242
aS'JOURNAL'
p53243
aS'Mutat Res 659:284-92 (2008)'
p53244
aS'PMID:18604198'
p53245
ag53245
aS'AUTHORS'
p53246
aS'Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL'
p53247
aS'TITLE'
p53248
aS'Regulation of TORC1 by Rag GTPases in nutrient response.'
p53249
aS'JOURNAL'
p53250
aS'Nat Cell Biol 10:935-45 (2008)'
p53251
aS'PMID:18497260'
p53252
ag53252
aS'AUTHORS'
p53253
aS'Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, Sabatini DM'
p53254
aS'TITLE'
p53255
aS'The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.'
p53256
aS'JOURNAL'
p53257
aS'Science 320:1496-501 (2008)'
p53258
aS'PMID:19963289'
p53259
ag53259
aS'AUTHORS'
p53260
aS'Hoeffer CA, Klann E'
p53261
aS'TITLE'
p53262
aS'mTOR signaling: at the crossroads of plasticity, memory and disease.'
p53263
aS'JOURNAL'
p53264
aS'Trends Neurosci 33:67-75 (2010)'
p53265
asS'KO_PATHWAY'
p53266
(lp53267
S'ko04150'
p53268
asS'ENTRY'
p53269
(lp53270
S'map04150'
p53271
aS'Pathway'
p53272
asS'PATHWAY_MAP'
p53273
(lp53274
S'map04150'
p53275
asS'DISEASE'
p53276
(lp53277
S'H00539'
p53278
aS'PTEN hamartoma tumor syndrome (PHTS)'
p53279
ag53278
ag53279
aS'H00666'
p53280
aS'Peutz-Jeghers syndrome'
p53281
aS'H00896'
p53282
aS'Lymphangioleiomyomatosis (LAM)'
p53283
aS'H00915'
p53284
aS'Tuberous sclerosis complex (TSC)'
p53285
aS'H01112'
p53286
aS'Polyhydramnios, megalencephaly, and symptomatic epilepsy'
p53287
aS'H01251'
p53288
aS'Focal cortical dysplasia of Taylor'
p53289
asS'CLASS'
p53290
(lp53291
S'Environmental Information Processing Signal transduction'
p53292
assS'path:map04151'
p53293
(dp53294
S'NAME'
p53295
(lp53296
S'PI3K-Akt signaling pathway'
p53297
asS'REFERENCE'
p53298
(lp53299
S'PMID:16847462'
p53300
ag53300
aS'AUTHORS'
p53301
aS'Engelman JA, Luo J, Cantley LC'
p53302
aS'TITLE'
p53303
aS'The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.'
p53304
aS'JOURNAL'
p53305
aS'Nat Rev Genet 7:606-19 (2006)'
p53306
aS'PMID:15784165'
p53307
ag53307
aS'AUTHORS'
p53308
aS'Song G, Ouyang G, Bao S'
p53309
aS'TITLE'
p53310
aS'The activation of Akt/PKB signaling pathway and cell survival.'
p53311
aS'JOURNAL'
p53312
aS'J Cell Mol Med 9:59-71 (2005)'
p53313
aS'PMID:21620960'
p53314
ag53314
aS'AUTHORS'
p53315
aS'Hers I, Vincent EE, Tavare JM'
p53316
aS'TITLE'
p53317
aS'Akt signalling in health and disease.'
p53318
aS'JOURNAL'
p53319
aS'Cell Signal 23:1515-27 (2011)'
p53320
aS'PMID:18842113'
p53321
ag53321
aS'AUTHORS'
p53322
aS'Duronio V'
p53323
aS'TITLE'
p53324
aS'The life of a cell: apoptosis regulation by the PI3K/PKB pathway.'
p53325
aS'JOURNAL'
p53326
aS'Biochem J 415:333-44 (2008)'
p53327
aS'PMID:16248975'
p53328
ag53328
aS'AUTHORS'
p53329
aS'Kim D, Chung J.'
p53330
aS'TITLE'
p53331
aS'Akt: versatile mediator of cell survival and beyond.'
p53332
aS'JOURNAL'
p53333
aS'J Biochem Mol Biol 35:106-15 (2002)'
p53334
aS'PMID:12660731'
p53335
ag53335
aS'AUTHORS'
p53336
aS'Koyasu S'
p53337
aS'TITLE'
p53338
aS'The role of PI3K in immune cells.'
p53339
aS'JOURNAL'
p53340
aS'Nat Immunol 4:313-9 (2003)'
p53341
aS'PMID:12669022'
p53342
ag53342
aS'AUTHORS'
p53343
aS'Okkenhaug K, Vanhaesebroeck B.'
p53344
aS'TITLE'
p53345
aS'PI3K in lymphocyte development, differentiation and activation.'
p53346
aS'JOURNAL'
p53347
aS'Nat Rev Immunol 3:317-30 (2003)'
p53348
aS'PMID:15209374'
p53349
ag53349
aS'AUTHORS'
p53350
aS'Richardson CJ, Schalm SS, Blenis J'
p53351
aS'TITLE'
p53352
aS'PI3-kinase and TOR: PIKTORing cell growth.'
p53353
aS'JOURNAL'
p53354
aS'Semin Cell Dev Biol 15:147-59 (2004)'
p53355
aS'PMID:21440011'
p53356
ag53356
aS'AUTHORS'
p53357
aS'Zhang X, Tang N, Hadden TJ, Rishi AK'
p53358
aS'TITLE'
p53359
aS'Akt, FoxO and regulation of apoptosis.'
p53360
aS'JOURNAL'
p53361
aS'Biochim Biophys Acta 1813:1978-86 (2011)'
p53362
aS'PMID:21779440'
p53363
ag53363
aS'AUTHORS'
p53364
aS'Georgescu MM'
p53365
aS'TITLE'
p53366
aS'PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.'
p53367
aS'JOURNAL'
p53368
aS'Genes Cancer 1:1170-7 (2010)'
p53369
aS'PMID:12531180'
p53370
ag53370
aS'AUTHORS'
p53371
aS'West KA, Castillo SS, Dennis PA'
p53372
aS'TITLE'
p53373
aS'Activation of the PI3K/Akt pathway and chemotherapeutic resistance.'
p53374
aS'JOURNAL'
p53375
aS'Drug Resist Updat 5:234-48 (2002)'
p53376
aS'PMID:9838078'
p53377
ag53377
aS'AUTHORS'
p53378
aS'Wymann MP, Pirola L'
p53379
aS'TITLE'
p53380
aS'Structure and function of phosphoinositide 3-kinases.'
p53381
aS'JOURNAL'
p53382
aS'Biochim Biophys Acta 1436:127-50 (1998)'
p53383
aS'PMID:12048182'
p53384
ag53384
aS'AUTHORS'
p53385
aS'Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M'
p53386
aS'TITLE'
p53387
aS'Regulation of Raf-Akt Cross-talk.'
p53388
aS'JOURNAL'
p53389
aS'J Biol Chem 277:31099-106 (2002)'
p53390
aS'PMID:16187290'
p53391
ag53391
aS'AUTHORS'
p53392
aS'Kikani CK, Dong LQ, Liu F'
p53393
aS'TITLE'
p53394
aS'"New"-clear functions of PDK1: beyond a master kinase in the cytosol?'
p53395
aS'JOURNAL'
p53396
aS'J Cell Biochem 96:1157-62 (2005)'
p53397
aS'PMID:11357143'
p53398
ag53398
aS'AUTHORS'
p53399
aS'Blume-Jensen P, Hunter T'
p53400
aS'TITLE'
p53401
aS'Oncogenic kinase signalling.'
p53402
aS'JOURNAL'
p53403
aS'Nature 411:355-65 (2001)'
p53404
aS'PMID:15505410'
p53405
ag53405
aS'AUTHORS'
p53406
aS'Osaki M, Oshimura M, Ito H'
p53407
aS'TITLE'
p53408
aS'PI3K-Akt pathway: its functions and alterations in human cancer.'
p53409
aS'JOURNAL'
p53410
aS'Apoptosis 9:667-76 (2004)'
p53411
aS'PMID:17360849'
p53412
ag53412
aS'AUTHORS'
p53413
aS'Noguchi M, Ropars V, Roumestand C, Suizu F'
p53414
aS'TITLE'
p53415
aS'Proto-oncogene TCL1: more than just a coactivator for Akt.'
p53416
aS'JOURNAL'
p53417
aS'FASEB J 21:2273-84 (2007)'
p53418
asS'KO_PATHWAY'
p53419
(lp53420
S'ko04151'
p53421
asS'PATHWAY_MAP'
p53422
(lp53423
S'map04151'
p53424
asS'DISEASE'
p53425
(lp53426
S'H01338'
p53427
aS'Myosclerosis'
p53428
ag53427
ag53428
aS'H01340'
p53429
aS'Bethlem myopathy'
p53430
aS'H01341'
p53431
aS'Collagen VI myopathy'
p53432
aS'H01370'
p53433
aS'SHORT syndrome'
p53434
aS'H01387'
p53435
aS'Activated PI3K-delta syndrome (APDS)'
p53436
aS'H01388'
p53437
aS'Hyperprolactinemia'
p53438
asS'MODULE'
p53439
(lp53440
S'M00676'
p53441
aS'PI3K-Akt signaling [PATH:map04151]'
p53442
asS'DBLINKS'
p53443
(lp53444
S'GO: 0043491'
p53445
asS'ENTRY'
p53446
(lp53447
S'map04151'
p53448
aS'Pathway'
p53449
asS'CLASS'
p53450
(lp53451
S'Environmental Information Processing Signal transduction'
p53452
asS'DESCRIPTION'
p53453
(lp53454
S"The phosphatidylinositol 3' -kinase(PI3K)-Akt signaling pathway is activated by many types of cellular stimuli or toxic insults and regulates fundamental cellular functions such as transcription, translation, proliferation, growth, and survival. The binding of growth factors to their receptor tyrosine kinase (RTK) or G protein-coupled receptors (GPCR) stimulates class Ia and Ib PI3K isoforms, respectively. PI3K catalyzes the production of phosphatidylinositol-3,4,5-triphosphate (PIP3) at the cell membrane. PIP3 in turn serves as a second messenger that helps to activate Akt. Once active, Akt can control key cellular processes by phosphorylating substrates involved in apoptosis, protein synthesis, metabolism, and cell cycle."
p53455
assS'path:map04152'
p53456
(dp53457
S'NAME'
p53458
(lp53459
S'AMPK signaling pathway'
p53460
asS'REFERENCE'
p53461
(lp53462
S'PMID:19584320'
p53463
ag53463
aS'AUTHORS'
p53464
aS'Steinberg GR, Kemp BE'
p53465
aS'TITLE'
p53466
aS'AMPK in Health and Disease.'
p53467
aS'JOURNAL'
p53468
aS'Physiol Rev 89:1025-78 (2009)'
p53469
aS'PMID:15509864'
p53470
ag53470
aS'AUTHORS'
p53471
aS'Hardie DG.'
p53472
aS'TITLE'
p53473
aS'The AMP-activated protein kinase pathway--new players upstream and downstream.'
p53474
aS'JOURNAL'
p53475
aS'J Cell Sci 117:5479-87 (2004)'
p53476
aS'PMID:23747347'
p53477
ag53477
aS'AUTHORS'
p53478
aS'Russo GL, Russo M, Ungaro P'
p53479
aS'TITLE'
p53480
aS'AMP-activated protein kinase: a target for old drugs against diabetes and cancer.'
p53481
aS'JOURNAL'
p53482
aS'Biochem Pharmacol 86:339-50 (2013)'
p53483
aS'PMID:19393004'
p53484
ag53484
aS'AUTHORS'
p53485
aS'Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S'
p53486
aS'TITLE'
p53487
aS'AMPK in the brain: its roles in energy balance and neuroprotection.'
p53488
aS'JOURNAL'
p53489
aS'J Neurochem 109 Suppl 1:17-23 (2009)'
p53490
aS'PMID:20010958'
p53491
ag53491
aS'AUTHORS'
p53492
aS'Li J, McCullough LD'
p53493
aS'TITLE'
p53494
aS'Effects of AMP-activated protein kinase in cerebral ischemia.'
p53495
aS'JOURNAL'
p53496
aS'J Cereb Blood Flow Metab 30:480-92 (2010)'
p53497
aS'PMID:22700795'
p53498
ag53498
aS'AUTHORS'
p53499
aS'Sanchez AM, Candau RB, Csibi A, Pagano AF, Raibon A, Bernardi H'
p53500
aS'TITLE'
p53501
aS'The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis.'
p53502
aS'JOURNAL'
p53503
aS'Am J Physiol Cell Physiol 303:C475-85 (2012)'
p53504
aS'PMID:16644802'
p53505
ag53505
aS'AUTHORS'
p53506
aS'Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F'
p53507
aS'TITLE'
p53508
aS'Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.'
p53509
aS'JOURNAL'
p53510
aS'J Physiol 574:41-53 (2006)'
p53511
aS'PMID:19629071'
p53512
ag53512
aS'AUTHORS'
p53513
aS'Shackelford DB, Shaw RJ'
p53514
aS'TITLE'
p53515
aS'The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.'
p53516
aS'JOURNAL'
p53517
aS'Nat Rev Cancer 9:563-75 (2009)'
p53518
aS'PMID:22885100'
p53519
ag53519
aS'AUTHORS'
p53520
aS'Chung JH, Manganiello V, Dyck JR'
p53521
aS'TITLE'
p53522
aS'Resveratrol as a calorie restriction mimetic: therapeutic implications.'
p53523
aS'JOURNAL'
p53524
aS'Trends Cell Biol 22:546-54 (2012)'
p53525
aS'PMID:20357764'
p53526
ag53526
aS'AUTHORS'
p53527
aS'Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T'
p53528
aS'TITLE'
p53529
aS'Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.'
p53530
aS'JOURNAL'
p53531
aS'Nature 464:1313-9 (2010)'
p53532
aS'PMID:17307971'
p53533
ag53533
aS'AUTHORS'
p53534
aS'Towler MC, Hardie DG'
p53535
aS'TITLE'
p53536
aS'AMP-activated protein kinase in metabolic control and insulin signaling.'
p53537
aS'JOURNAL'
p53538
aS'Circ Res 100:328-41 (2007)'
p53539
aS'PMID:23899560'
p53540
ag53540
aS'AUTHORS'
p53541
aS'Richter EA, Hargreaves M'
p53542
aS'TITLE'
p53543
aS'Exercise, GLUT4, and skeletal muscle glucose uptake.'
p53544
aS'JOURNAL'
p53545
aS'Physiol Rev 93:993-1017 (2013)'
p53546
aS'PMID:16054041'
p53547
ag53547
aS'AUTHORS'
p53548
aS'Kahn BB, Alquier T, Carling D, Hardie DG'
p53549
aS'TITLE'
p53550
aS'AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.'
p53551
aS'JOURNAL'
p53552
aS'Cell Metab 1:15-25 (2005)'
p53553
aS'PMID:23565491'
p53554
ag53554
aS'AUTHORS'
p53555
aS'Minokoshi Y, Toda C, Okamoto S'
p53556
aS'TITLE'
p53557
aS'Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle.'
p53558
aS'JOURNAL'
p53559
aS'Indian J Endocrinol Metab 16:S562-8 (2012)'
p53560
aS'PMID:16723978'
p53561
ag53561
aS'AUTHORS'
p53562
aS'Guggino WB, Stanton BA'
p53563
aS'TITLE'
p53564
aS'New insights into cystic fibrosis: molecular switches that regulate CFTR.'
p53565
aS'JOURNAL'
p53566
aS'Nat Rev Mol Cell Biol 7:426-36 (2006)'
p53567
aS'PMID:16479585'
p53568
ag53568
aS'AUTHORS'
p53569
aS'Cheng A, Saltiel AR'
p53570
aS'TITLE'
p53571
aS'More TORC for the gluconeogenic engine.'
p53572
aS'JOURNAL'
p53573
aS'Bioessays 28:231-4 (2006)'
p53574
aS'PMID:19197243'
p53575
ag53575
aS'AUTHORS'
p53576
aS'Herrero-Martin G, Hoyer-Hansen M, Garcia-Garcia C, Fumarola C, Farkas T, Lopez-Rivas A, Jaattela M'
p53577
aS'TITLE'
p53578
aS'TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells.'
p53579
aS'JOURNAL'
p53580
aS'EMBO J 28:677-85 (2009)'
p53581
aS'PMID:19724019'
p53582
ag53582
aS'AUTHORS'
p53583
aS'Morris DL, Rui L'
p53584
aS'TITLE'
p53585
aS'Recent advances in understanding leptin signaling and leptin resistance.'
p53586
aS'JOURNAL'
p53587
aS'Am J Physiol Endocrinol Metab 297:E1247-59 (2009)'
p53588
aS'PMID:18725075'
p53589
ag53589
aS'AUTHORS'
p53590
aS'Minokoshi Y, Shiuchi T, Lee S, Suzuki A, Okamoto S'
p53591
aS'TITLE'
p53592
aS'Role of hypothalamic AMP-kinase in food intake regulation.'
p53593
aS'JOURNAL'
p53594
aS'Nutrition 24:786-90 (2008)'
p53595
aS'PMID:23024365'
p53596
ag53596
aS'AUTHORS'
p53597
aS'Miyamoto L, Ebihara K, Kusakabe T, Aotani D, Yamamoto-Kataoka S, Sakai T, Aizawa-Abe M, Yamamoto Y, Fujikura J, Hayashi T, Hosoda K, Nakao K'
p53598
aS'TITLE'
p53599
aS"Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and alpha1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin."
p53600
aS'JOURNAL'
p53601
aS'J Biol Chem 287:40441-7 (2012)'
p53602
asS'KO_PATHWAY'
p53603
(lp53604
S'ko04152'
p53605
asS'PATHWAY_MAP'
p53606
(lp53607
S'map04152'
p53608
asS'DBLINKS'
p53609
(lp53610
S'GO: 2000479'
p53611
asS'ENTRY'
p53612
(lp53613
S'map04152'
p53614
aS'Pathway'
p53615
asS'CLASS'
p53616
(lp53617
S'Environmental Information Processing Signal transduction'
p53618
asS'DESCRIPTION'
p53619
(lp53620
S'AMP-activated protein kinase (AMPK) is a serine threonine kinase that is highly conserved through evolution. AMPK system acts as a sensor of cellular energy status. It is activated by increases in the cellular AMP:ATP ratio caused by metabolic stresses that either interfere with ATP production (eg, deprivation for glucose or oxygen) or that accelerate ATP consumption (eg, muscle contraction). Several upstream kinases, including liver kinase B1 (LKB1), calcium/calmodulin kinase kinase-beta (CaMKK beta), and TGF-beta-activated kinase-1 (TAK-1), can activate AMPK by phosphorylating a threonine residue on its catalytic alpha-subunit. Once activated, AMPK leads to a concomitant inhibition of energy-consuming biosynthetic pathways, such as protein, fatty acid and glycogen synthesis, and activation of ATP-producing catabolic pathways, such as fatty acid oxidation and glycolysis.'
p53621
assS'path:map00363'
p53622
(dp53623
S'DBLINKS'
p53624
(lp53625
S'UMBBD: tbp2 bpa hap bpf'
p53626
asS'NAME'
p53627
(lp53628
S'Bisphenol degradation'
p53629
asS'REFERENCE'
p53630
(lp53631
S'PMID:15635150'
p53632
ag53632
aS'AUTHORS'
p53633
aS'Kitamura S, Suzuki T, Sanoh S, Kohta R, Jinno N, Sugihara K, Yoshihara S, Fujimoto N, Watanabe H, Ohta S.'
p53634
aS'TITLE'
p53635
aS'Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds.'
p53636
aS'JOURNAL'
p53637
aS'Toxicol Sci 84:249-59 (2005)'
p53638
aS'PMID:9607780'
p53639
ag53639
aS'AUTHORS'
p53640
aS'Steinmetz R, Mitchner NA, Grant A, Allen DL, Bigsby RM, Ben-Jonathan N.'
p53641
aS'TITLE'
p53642
aS'The xenoestrogen bisphenol A induces growth, differentiation, and c-fos gene expression in the female reproductive tract.'
p53643
aS'JOURNAL'
p53644
aS'Endocrinology 139:2741-7 (1998)'
p53645
aS'PMID:11259533'
p53646
ag53646
aS'AUTHORS'
p53647
aS'Elsby R, Maggs JL, Ashby J, Park BK.'
p53648
aS'TITLE'
p53649
aS'Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans.'
p53650
aS'JOURNAL'
p53651
aS'J Pharmacol Exp Ther 297:103-13 (2001)'
p53652
aS'PMID:10831413'
p53653
ag53653
aS'AUTHORS'
p53654
aS'Ronen Z, Abeliovich A.'
p53655
aS'TITLE'
p53656
aS'Anaerobic-aerobic process for microbial degradation of tetrabromobisphenol A.'
p53657
aS'JOURNAL'
p53658
aS'Appl Environ Microbiol 66:2372-7 (2000)'
p53659
aS'PMID:14559264'
p53660
ag53660
aS'AUTHORS'
p53661
aS'Eriksson J, Rahm S, Green N, Bergman A, Jakobsson E.'
p53662
aS'TITLE'
p53663
aS'Photochemical transformations of tetrabromobisphenol A and related phenols in water.'
p53664
aS'JOURNAL'
p53665
aS'Chemosphere 54:117-26 (2004)'
p53666
aS'PMID:12242676'
p53667
ag53667
aS'AUTHORS'
p53668
aS'Ike M, Chen MY, Jin CS, Fujita M.'
p53669
aS'TITLE'
p53670
aS'Acute toxicity, mutagenicity, and estrogenicity of biodegradation products of bisphenol-A.'
p53671
aS'JOURNAL'
p53672
aS'Environ Toxicol 17:457-61 (2002)'
p53673
aS'PMID:8031091'
p53674
ag53674
aS'AUTHORS'
p53675
aS'Jones KH, Trudgill PW, Hopper DJ'
p53676
aS'TITLE'
p53677
aS'4-Ethylphenol metabolism by Aspergillus fumigatus.'
p53678
aS'JOURNAL'
p53679
aS'Appl Environ Microbiol 60:1978-83 (1994)'
p53680
aS'PMID:18024680'
p53681
ag53681
aS'AUTHORS'
p53682
aS'Inoue D, Hara S, Kashihara M, Murai Y, Danzl E, Sei K, Tsunoi S, Fujita M, Ike M'
p53683
aS'TITLE'
p53684
aS'Degradation of Bis(4-Hydroxyphenyl)methane (bisphenol F) by Sphingobium yanoikuyae strain FM-2 isolated from river water.'
p53685
aS'JOURNAL'
p53686
aS'Appl Environ Microbiol 74:352-8 (2008)'
p53687
asS'KO_PATHWAY'
p53688
(lp53689
S'ko00363'
p53690
asS'ENTRY'
p53691
(lp53692
S'map00363'
p53693
aS'Pathway'
p53694
asS'PATHWAY_MAP'
p53695
(lp53696
S'map00363'
p53697
asS'CLASS'
p53698
(lp53699
S'Metabolism Xenobiotics biodegradation and metabolism'
p53700
assS'path:map07046'
p53701
(dp53702
S'ENTRY'
p53703
(lp53704
S'map07046'
p53705
aS'Drug'
p53706
aS'Pathway'
p53707
asS'PATHWAY_MAP'
p53708
(lp53709
S'map07046'
p53710
asS'NAME'
p53711
(lp53712
S'Immunosuppressive agents'
p53713
asS'REFERENCE'
p53714
(lp53715
g22
ag22
aS'AUTHORS'
p53716
aS'Bertram GK (ed).'
p53717
aS'TITLE'
p53718
aS'Basic & Clinical Pharmacology (9th ed)'
p53719
aS'JOURNAL'
p53720
aS'Lange (2004)'
p53721
ag22
ag22
aS'AUTHORS'
p53722
aS'Walter S.'
p53723
aS'TITLE'
p53724
aS'Drug Discovery: A History'
p53725
aS'JOURNAL'
p53726
aS'Wiley (2005)'
p53727
ag22
ag22
aS'AUTHORS'
p53728
aS'David AW, Thomas LL, William OF.'
p53729
aS'TITLE'
p53730
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p53731
aS'JOURNAL'
p53732
aS'Lippincott Williams & Wilkins (2002)'
p53733
ag22
ag22
aS'AUTHORS'
p53734
aS'Fukai S.'
p53735
aS'TITLE'
p53736
aS'[New Drugs Today (6th ed)] (In Japanese)'
p53737
aS'JOURNAL'
p53738
aS'Jiho (1995)'
p53739
ag22
ag22
aS'AUTHORS'
p53740
aS'Katori S.'
p53741
aS'TITLE'
p53742
aS'[Standard Pharmacology (6th ed)] (In Japanese)'
p53743
aS'JOURNAL'
p53744
aS'Igaku shoin'
p53745
ag22
ag22
aS'AUTHORS'
p53746
aS'Wermuth CG (ed).'
p53747
aS'TITLE'
p53748
aS'[The Practice of Medicinal Chemistry vol.1 (2nd ed)] (In Japanese)'
p53749
aS'JOURNAL'
p53750
aS'Technomics (2006)'
p53751
aS'PMID:11896891'
p53752
ag53752
aS'AUTHORS'
p53753
aS'Tsuzuki K.'
p53754
aS'TITLE'
p53755
aS'Role of mizoribine in renal transplantation.'
p53756
aS'JOURNAL'
p53757
aS'Pediatr Int 44:224-31 (2002)'
p53758
aS'PMID:2195722'
p53759
ag53759
aS'AUTHORS'
p53760
aS"Crandall BG, Gilbert EM, Renlund DG, Menlove RL, Herrick CM, Holland CS, Hagan ME, Rasmussen LG, Karwande SV, O'Connell JB, et al."
p53761
aS'TITLE'
p53762
aS'A randomized trial of the immunosuppressive efficacy of vincristine in cardiac transplantation.'
p53763
aS'JOURNAL'
p53764
aS'Transplantation 50:34-8 (1990)'
p53765
aS'PMID:17287604'
p53766
ag53766
aS'AUTHORS'
p53767
aS'Nakanishi C, Kawagishi N, Sekiguchi S, Akamatsu Y, Sato K, Miyagi S, Takeda I, Hukushima K, Aiso T, Sato A, Fujimori K, Satomi S.'
p53768
aS'TITLE'
p53769
aS'Steroid-resistant late acute rejection after a living donor liver transplantation: case report and review of the literature.'
p53770
aS'JOURNAL'
p53771
aS'Tohoku J Exp Med 211:195-200 (2007)'
p53772
aS'PMID:9233698'
p53773
ag53773
aS'AUTHORS'
p53774
aS'Schuler W, Sedrani R, Cottens S, Haberlin B, Schulz M, Schuurman HJ, Zenke G, Zerwes HG, Schreier MH.'
p53775
aS'TITLE'
p53776
aS'SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.'
p53777
aS'JOURNAL'
p53778
aS'Transplantation 64:36-42 (1997)'
p53779
asS'COMPOUND'
p53780
(lp53781
S'D00107'
p53782
aS'Tacrolimus hydrate (JP16)'
p53783
ag53782
ag53783
aS'D00142'
p53784
aS'Methotrexate (JP16/USP/INN)'
p53785
aS'D00161'
p53786
aS'Mercaptopurine hydrate (JP16)'
p53787
aS'D00168'
p53788
aS'Cytarabine (JP16/USP/INN)'
p53789
aS'D00184'
p53790
aS'Ciclosporin (JP16)'
p53791
aS'D00214'
p53792
aS'Actinomycin D (JP16)'
p53793
aS'D00238'
p53794
aS'Azathioprine (JP16/USP/INN)'
p53795
aS'D00287'
p53796
aS'Cyclophosphamide hydrate (JP16)'
p53797
aS'D00292'
p53798
aS'Dexamethasone (JP16/USP/INN)'
p53799
aS'D00369'
p53800
aS'Melphalan (JP16/USP/INN)'
p53801
aS'D00472'
p53802
aS'Prednisolone (JP16/USP/INN)'
p53803
aS'D00473'
p53804
aS'Prednisone (USP)'
p53805
aS'D00749'
p53806
aS'Leflunomide (JAN/USAN/INN)'
p53807
aS'D00752'
p53808
aS'Mycophenolate mofetil (JAN/USAN)'
p53809
aS'D00753'
p53810
aS'Sirolimus (JAN/USAN/INN)'
p53811
aS'D00754'
p53812
aS'Thalidomide (JAN/USP/INN)'
p53813
aS'D01068'
p53814
aS'Vinblastine sulfate (JP16/USP)'
p53815
aS'D01392'
p53816
aS'Mizoribine (JP16/INN)'
p53817
aS'D01566'
p53818
aS'Gusperimus hydrochloride (JAN)'
p53819
aS'D02115'
p53820
aS'Methotrexate sodium'
p53821
aS'D02197'
p53822
aS'Vincristine sulfate (JP16/USP)'
p53823
aS'D02714'
p53824
aS'Everolimus (JAN/USAN/INN)'
p53825
aS'D03033'
p53826
aS'Azathioprine sodium (USP)'
p53827
aS'D03637'
p53828
aS'Cytarabine hydrochloride (USAN)'
p53829
aS'D04687'
p53830
aS'Lenalidomide (USAN/INN)'
p53831
aS'D04931'
p53832
aS'Mercaptopurine (INN)'
p53833
aS'D05094'
p53834
aS'Mycophenolate mofetil hydrochloride (USAN)'
p53835
aS'D05095'
p53836
aS'Mycophenolate sodium (USAN)'
p53837
aS'D05096'
p53838
aS'Mycophenolic acid (USAN/INN)'
p53839
aS'D06673'
p53840
aS'Meprednisone (USP/INN)'
p53841
aS'D07760'
p53842
aS'Cyclophosphamide (INN)'
p53843
aS'D08032'
p53844
aS'Gusperimus (INN)'
p53845
aS'D08173'
p53846
aS'Melphalan hydrochloride'
p53847
aS'D08556'
p53848
aS'Tacrolimus (INN)'
p53849
aS'D08675'
p53850
aS'Vinblastine (INN)'
p53851
aS'D08679'
p53852
aS'Vincristine (INN)'
p53853
assS'path:map02020'
p53854
(dp53855
S'NAME'
p53856
(lp53857
S'Two-component system'
p53858
asS'REFERENCE'
p53859
(lp53860
S'PMID:15522865'
p53861
ag53861
aS'AUTHORS'
p53862
aS'Yamamoto K, Hirao K, Oshima T, Aiba H, Utsumi R, Ishihama A.'
p53863
aS'TITLE'
p53864
aS'Functional characterization in vitro of all two-component signal transduction systems from Escherichia coli.'
p53865
aS'JOURNAL'
p53866
aS'J Biol Chem 280:1448-56 (2005)'
p53867
aS'PMID:16030210'
p53868
ag53868
aS'AUTHORS'
p53869
aS'Abdel-Fattah WR, Chen Y, Eldakak A, Hulett FM.'
p53870
aS'TITLE'
p53871
aS'Bacillus subtilis phosphorylated PhoP: direct activation of the E(sigma)A- and repression of the E(sigma)E-responsive phoB-PS+V promoters during pho response.'
p53872
aS'JOURNAL'
p53873
aS'J Bacteriol 187:5166-78 (2005)'
p53874
aS'PMID:15813739'
p53875
ag53875
aS'AUTHORS'
p53876
aS'Navarre WW, Halsey TA, Walthers D, Frye J, McClelland M, Potter JL, Kenney LJ, Gunn JS, Fang FC, Libby SJ.'
p53877
aS'TITLE'
p53878
aS'Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ.'
p53879
aS'JOURNAL'
p53880
aS'Mol Microbiol 56:492-508 (2005)'
p53881
aS'PMID:11973328'
p53882
ag53882
aS'AUTHORS'
p53883
aS'Cai SJ, Inouye M.'
p53884
aS'TITLE'
p53885
aS'EnvZ-OmpR interaction and osmoregulation in Escherichia coli.'
p53886
aS'JOURNAL'
p53887
aS'J Biol Chem 277:24155-61 (2002)'
p53888
aS'PMID:16077119'
p53889
ag53889
aS'AUTHORS'
p53890
aS'Batchelor E, Walthers D, Kenney LJ, Goulian M.'
p53891
aS'TITLE'
p53892
aS'The Escherichia coli CpxA-CpxR envelope stress response system regulates expression of the porins ompF and ompC.'
p53893
aS'JOURNAL'
p53894
aS'J Bacteriol 187:5723-31 (2005)'
p53895
aS'PMID:12107133'
p53896
ag53896
aS'AUTHORS'
p53897
aS'Nagakubo S, Nishino K, Hirata T, Yamaguchi A.'
p53898
aS'TITLE'
p53899
aS'The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC.'
p53900
aS'JOURNAL'
p53901
aS'J Bacteriol 184:4161-7 (2002)'
p53902
aS'PMID:15322361'
p53903
ag53903
aS'AUTHORS'
p53904
aS'Hagiwara D, Yamashino T, Mizuno T.'
p53905
aS'TITLE'
p53906
aS'A Genome-wide view of the Escherichia coli BasS-BasR two-component system implicated in iron-responses.'
p53907
aS'JOURNAL'
p53908
aS'Biosci Biotechnol Biochem 68:1758-67 (2004)'
p53909
aS'PMID:11004187'
p53910
ag53910
aS'AUTHORS'
p53911
aS"Munson GP, Lam DL, Outten FW, O'Halloran TV."
p53912
aS'TITLE'
p53913
aS'Identification of a copper-responsive two-component system on the chromosome of Escherichia coli K-12.'
p53914
aS'JOURNAL'
p53915
aS'J Bacteriol 182:5864-71 (2000)'
p53916
aS'PMID:11929534'
p53917
ag53917
aS'AUTHORS'
p53918
aS'Sperandio V, Torres AG, Kaper JB.'
p53919
aS'TITLE'
p53920
aS'Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli.'
p53921
aS'JOURNAL'
p53922
aS'Mol Microbiol 43:809-21 (2002)'
p53923
aS'PMID:14604015'
p53924
ag53924
aS'AUTHORS'
p53925
aS'Epstein W.'
p53926
aS'TITLE'
p53927
aS'The roles and regulation of potassium in bacteria.'
p53928
aS'JOURNAL'
p53929
aS'Prog Nucleic Acid Res Mol Biol 75:293-320 (2003)'
p53930
aS'PMID:10648521'
p53931
ag53931
aS'AUTHORS'
p53932
aS'Ansaldi M, Simon G, Lepelletier M, Mejean V.'
p53933
aS'TITLE'
p53934
aS'The TorR high-affinity binding site plays a key role in both torR autoregulation and torCAD operon expression in Escherichia coli.'
p53935
aS'JOURNAL'
p53936
aS'J Bacteriol 182:961-6 (2000)'
p53937
aS'PMID:15326287'
p53938
ag53938
aS'AUTHORS'
p53939
aS'Malpica R, Franco B, Rodriguez C, Kwon O, Georgellis D.'
p53940
aS'TITLE'
p53941
aS'Identification of a quinone-sensitive redox switch in the ArcB sensor kinase.'
p53942
aS'JOURNAL'
p53943
aS'Proc Natl Acad Sci U S A 101:13318-23 (2004)'
p53944
aS'PMID:2666399'
p53945
ag53945
aS'AUTHORS'
p53946
aS'Widenhorn KA, Somers JM, Kay WW.'
p53947
aS'TITLE'
p53948
aS'Genetic regulation of the tricarboxylate transport operon (tctI) of Salmonella typhimurium.'
p53949
aS'JOURNAL'
p53950
aS'J Bacteriol 171:4436-41 (1989)'
p53951
aS'PMID:11555295'
p53952
ag53952
aS'AUTHORS'
p53953
aS'Hyyrylainen HL, Bolhuis A, Darmon E, Muukkonen L, Koski P, Vitikainen M, Sarvas M, Pragai Z, Bron S, van Dijl JM, Kontinen VP.'
p53954
aS'TITLE'
p53955
aS'A novel two-component regulatory system in Bacillus subtilis for the survival of severe secretion stress.'
p53956
aS'JOURNAL'
p53957
aS'Mol Microbiol 41:1159-72 (2001)'
p53958
aS'PMID:10972837'
p53959
ag53959
aS'AUTHORS'
p53960
aS'Zhang X, Hulett FM.'
p53961
aS'TITLE'
p53962
aS'ResD signal transduction regulator of aerobic respiration in Bacillus subtilis: ctaA promoter regulation.'
p53963
aS'JOURNAL'
p53964
aS'Mol Microbiol 37:1208-19 (2000)'
p53965
aS'PMID:15937169'
p53966
ag53966
aS'AUTHORS'
p53967
aS'Senadheera MD, Guggenheim B, Spatafora GA, Huang YC, Choi J, Hung DC, Treglown JS, Goodman SD, Ellen RP, Cvitkovitch DG.'
p53968
aS'TITLE'
p53969
aS'A VicRK signal transduction system in Streptococcus mutans affects gtfBCD, gbpB, and ftf expression, biofilm formation, and genetic competence development.'
p53970
aS'JOURNAL'
p53971
aS'J Bacteriol 187:4064-76 (2005)'
p53972
aS'PMID:15601704'
p53973
ag53973
aS'AUTHORS'
p53974
aS'He H, Zahrt TC.'
p53975
aS'TITLE'
p53976
aS'Identification and characterization of a regulatory sequence recognized by Mycobacterium tuberculosis persistence regulator MprA.'
p53977
aS'JOURNAL'
p53978
aS'J Bacteriol 187:202-12 (2005)'
p53979
aS'PMID:17448786'
p53980
ag53980
aS'AUTHORS'
p53981
aS'Hutchings MI'
p53982
aS'TITLE'
p53983
aS'Unusual two-component signal transduction pathways in the actinobacteria.'
p53984
aS'JOURNAL'
p53985
aS'Adv Appl Microbiol 61:1-26 (2007)'
p53986
aS'PMID:19308662'
p53987
ag53987
aS'AUTHORS'
p53988
aS'Kramer R'
p53989
aS'TITLE'
p53990
aS'Osmosensing and osmosignaling in Corynebacterium glutamicum.'
p53991
aS'JOURNAL'
p53992
aS'Amino Acids 37:487-97 (2009)'
p53993
aS'PMID:7751278'
p53994
ag53994
aS'AUTHORS'
p53995
aS'Eraso JM, Kaplan S.'
p53996
aS'TITLE'
p53997
aS'Oxygen-insensitive synthesis of the photosynthetic membranes of Rhodobacter sphaeroides: a mutant histidine kinase.'
p53998
aS'JOURNAL'
p53999
aS'J Bacteriol 177:2695-706 (1995)'
p54000
aS'PMID:10089160'
p54001
ag54001
aS'AUTHORS'
p54002
aS'Haydel SE, Dunlap NE, Benjamin WH Jr.'
p54003
aS'TITLE'
p54004
aS'In vitro evidence of two-component system phosphorylation between the Mycobacterium tuberculosis TrcR/TrcS proteins.'
p54005
aS'JOURNAL'
p54006
aS'Microb Pathog 26:195-206 (1999)'
p54007
aS'PMID:11673427'
p54008
ag54008
aS'AUTHORS'
p54009
aS'Quisel JD, Burkholder WF, Grossman AD.'
p54010
aS'TITLE'
p54011
aS'In vivo effects of sporulation kinases on mutant Spo0A proteins in Bacillus subtilis.'
p54012
aS'JOURNAL'
p54013
aS'J Bacteriol 183:6573-8 (2001)'
p54014
aS'PMID:11889485'
p54015
ag54015
aS'AUTHORS'
p54016
aS'Kaspar S, Bott M.'
p54017
aS'TITLE'
p54018
aS'The sensor kinase CitA (DpiB) of Escherichia coli functions as a high-affinity citrate receptor.'
p54019
aS'JOURNAL'
p54020
aS'Arch Microbiol 177:313-21 (2002)'
p54021
aS'PMID:12167640'
p54022
ag54022
aS'AUTHORS'
p54023
aS'Janausch IG, Garcia-Moreno I, Unden G.'
p54024
aS'TITLE'
p54025
aS'Function of DcuS from Escherichia coli as a fumarate-stimulated histidine protein kinase in vitro.'
p54026
aS'JOURNAL'
p54027
aS'J Biol Chem 277:39809-14 (2002)'
p54028
aS'PMID:8550490'
p54029
ag54029
aS'AUTHORS'
p54030
aS'Brunskill EW, Bayles KW.'
p54031
aS'TITLE'
p54032
aS'Identification and molecular characterization of a putative regulatory locus that affects autolysis in Staphylococcus aureus.'
p54033
aS'JOURNAL'
p54034
aS'J Bacteriol 178:611-8 (1996)'
p54035
aS'PMID:10940023'
p54036
ag54036
aS'AUTHORS'
p54037
aS'Fujimoto DF, Brunskill EW, Bayles KW.'
p54038
aS'TITLE'
p54039
aS'Analysis of genetic elements controlling Staphylococcus aureus lrgAB expression: potential role of DNA topology in SarA regulation.'
p54040
aS'JOURNAL'
p54041
aS'J Bacteriol 182:4822-8 (2000)'
p54042
aS'PMID:11807079'
p54043
ag54043
aS'AUTHORS'
p54044
aS'Dufour P, Jarraud S, Vandenesch F, Greenland T, Novick RP, Bes M, Etienne J, Lina G.'
p54045
aS'TITLE'
p54046
aS'High genetic variability of the agr locus in Staphylococcus species.'
p54047
aS'JOURNAL'
p54048
aS'J Bacteriol 184:1180-6 (2002)'
p54049
aS'PMID:8501030'
p54050
ag54050
aS'AUTHORS'
p54051
aS'Rabin RS, Stewart V.'
p54052
aS'TITLE'
p54053
aS'Dual response regulators (NarL and NarP) interact with dual sensors (NarX and NarQ) to control nitrate- and nitrite-regulated gene expression in Escherichia coli K-12.'
p54054
aS'JOURNAL'
p54055
aS'J Bacteriol 175:3259-68 (1993)'
p54056
aS'PMID:9220011'
p54057
ag54057
aS'AUTHORS'
p54058
aS'Chiang RC, Cavicchioli R, Gunsalus RP.'
p54059
aS'TITLE'
p54060
aS"'Locked-on' and 'locked-off' signal transduction mutations in the periplasmic domain of the Escherichia coli NarQ and NarX sensors affect nitrate- and nitrite-dependent regulation by NarL and NarP."
p54061
aS'JOURNAL'
p54062
aS'Mol Microbiol 24:1049-60 (1997)'
p54063
aS'PMID:12107138'
p54064
ag54064
aS'AUTHORS'
p54065
aS'Verhamme DT, Postma PW, Crielaard W, Hellingwerf KJ.'
p54066
aS'TITLE'
p54067
aS'Cooperativity in signal transfer through the Uhp system of Escherichia coli.'
p54068
aS'JOURNAL'
p54069
aS'J Bacteriol 184:4205-10 (2002)'
p54070
aS'PMID:13129944'
p54071
ag54071
aS'AUTHORS'
p54072
aS'Hagiwara D, Sugiura M, Oshima T, Mori H, Aiba H, Yamashino T, Mizuno T.'
p54073
aS'TITLE'
p54074
aS'Genome-wide analyses revealing a signaling network of the RcsC-YojN-RcsB phosphorelay system in Escherichia coli.'
p54075
aS'JOURNAL'
p54076
aS'J Bacteriol 185:5735-46 (2003)'
p54077
aS'PMID:12951338'
p54078
ag54078
aS'AUTHORS'
p54079
aS'Hirakawa H, Nishino K, Yamada J, Hirata T, Yamaguchi A.'
p54080
aS'TITLE'
p54081
aS'Beta-lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli.'
p54082
aS'JOURNAL'
p54083
aS'J Antimicrob Chemother 52:576-82 (2003)'
p54084
aS'PMID:12193630'
p54085
ag54085
aS'AUTHORS'
p54086
aS'Suzuki K, Wang X, Weilbacher T, Pernestig AK, Melefors O, Georgellis D, Babitzke P, Romeo T.'
p54087
aS'TITLE'
p54088
aS'Regulatory circuitry of the CsrA/CsrB and BarA/UvrY systems of Escherichia coli.'
p54089
aS'JOURNAL'
p54090
aS'J Bacteriol 184:5130-40 (2002)'
p54091
aS'PMID:10923791'
p54092
ag54092
aS'AUTHORS'
p54093
aS'Kato A, Ohnishi H, Yamamoto K, Furuta E, Tanabe H, Utsumi R.'
p54094
aS'TITLE'
p54095
aS'Transcription of emrKY is regulated by the EvgA-EvgS two-component system in Escherichia coli K-12.'
p54096
aS'JOURNAL'
p54097
aS'Biosci Biotechnol Biochem 64:1203-9 (2000)'
p54098
aS'PMID:14679219'
p54099
ag54099
aS'AUTHORS'
p54100
aS'Ansaldi M, Dubnau D.'
p54101
aS'TITLE'
p54102
aS'Diversifying selection at the Bacillus quorum-sensing locus and determinants of modification specificity during synthesis of the ComX pheromone.'
p54103
aS'JOURNAL'
p54104
aS'J Bacteriol 186:15-21 (2004)'
p54105
aS'PMID:16035234'
p54106
ag54106
aS'AUTHORS'
p54107
aS'Gabdrakhmanova L, Vishniakov I, Sharipova M, Balaban N, Kostrov S, Leshchinskaya I.'
p54108
aS'TITLE'
p54109
aS'Salt stress induction of glutamyl endopeptidase biosynthesis in Bacillus intermedius.'
p54110
aS'JOURNAL'
p54111
aS'Microbiol Res 160:233-42 (2005)'
p54112
aS'PMID:11285232'
p54113
ag54113
aS'AUTHORS'
p54114
aS'Aguilar PS, Hernandez-Arriaga AM, Cybulski LE, Erazo AC, de Mendoza D.'
p54115
aS'TITLE'
p54116
aS'Molecular basis of thermosensing: a two-component signal transduction thermometer in Bacillus subtilis.'
p54117
aS'JOURNAL'
p54118
aS'EMBO J 20:1681-91 (2001)'
p54119
aS'PMID:12864861'
p54120
ag54120
aS'AUTHORS'
p54121
aS'Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K.'
p54122
aS'TITLE'
p54123
aS'Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus.'
p54124
aS'JOURNAL'
p54125
aS'Mol Microbiol 49:807-21 (2003)'
p54126
aS'PMID:15073296'
p54127
ag54127
aS'AUTHORS'
p54128
aS'Saini DK, Malhotra V, Dey D, Pant N, Das TK, Tyagi JS.'
p54129
aS'TITLE'
p54130
aS'DevR-DevS is a bona fide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR.'
p54131
aS'JOURNAL'
p54132
aS'Microbiology 150:865-75 (2004)'
p54133
aS'PMID:12426351'
p54134
ag54134
aS'AUTHORS'
p54135
aS'Fedtke I, Kamps A, Krismer B, Gotz F.'
p54136
aS'TITLE'
p54137
aS'The nitrate reductase and nitrite reductase operons and the narT gene of Staphylococcus carnosus are positively controlled by the novel two-component system NreBC.'
p54138
aS'JOURNAL'
p54139
aS'J Bacteriol 184:6624-34 (2002)'
p54140
aS'PMID:8416895'
p54141
ag54141
aS'AUTHORS'
p54142
aS'Shiau SP, Chen P, Reitzer LJ.'
p54143
aS'TITLE'
p54144
aS'Effects of insertions and deletions in glnG (ntrC) of Escherichia coli on nitrogen regulator I-dependent DNA binding and transcriptional activation.'
p54145
aS'JOURNAL'
p54146
aS'J Bacteriol 175:190-9 (1993)'
p54147
aS'PMID:11243806'
p54148
ag54148
aS'AUTHORS'
p54149
aS'Leonhartsberger S, Huber A, Lottspeich F, Bock A.'
p54150
aS'TITLE'
p54151
aS'The hydH/G Genes from Escherichia coli code for a zinc and lead responsive two-component regulatory system.'
p54152
aS'JOURNAL'
p54153
aS'J Mol Biol 307:93-105 (2001)'
p54154
aS'PMID:15200682'
p54155
ag54155
aS'AUTHORS'
p54156
aS'Lioliou EE, Kyriakidis DA.'
p54157
aS'TITLE'
p54158
aS'The role of bacterial antizyme: From an inhibitory protein to AtoC transcriptional regulator.'
p54159
aS'JOURNAL'
p54160
aS'Microb Cell Fact 3:8 (2004)'
p54161
aS'PMID:15773991'
p54162
ag54162
aS'AUTHORS'
p54163
aS'Yamamoto K, Ishihama A'
p54164
aS'TITLE'
p54165
aS'Transcriptional response of Escherichia coli to external copper.'
p54166
aS'JOURNAL'
p54167
aS'Mol Microbiol 56:215-27 (2005)'
p54168
aS'PMID:10585546'
p54169
ag54169
aS'AUTHORS'
p54170
aS'Ashby MK, Mullineaux CW'
p54171
aS'TITLE'
p54172
aS'Cyanobacterial ycf27 gene products regulate energy transfer from phycobilisomes to photosystems I and II.'
p54173
aS'JOURNAL'
p54174
aS'FEMS Microbiol Lett 181:253-60 (1999)'
p54175
aS'PMID:11849552'
p54176
ag54176
aS'AUTHORS'
p54177
aS'Lopez-Maury L, Garcia-Dominguez M, Florencio FJ, Reyes JC'
p54178
aS'TITLE'
p54179
aS'A two-component signal transduction system involved in nickel sensing in the cyanobacterium Synechocystis sp. PCC 6803.'
p54180
aS'JOURNAL'
p54181
aS'Mol Microbiol 43:247-56 (2002)'
p54182
aS'PMID:17526710'
p54183
ag54183
aS'AUTHORS'
p54184
aS'Glover RT, Kriakov J, Garforth SJ, Baughn AD, Jacobs WR Jr'
p54185
aS'TITLE'
p54186
aS'The two-component regulatory system senX3-regX3 regulates phosphate-dependent gene expression in Mycobacterium smegmatis.'
p54187
aS'JOURNAL'
p54188
aS'J Bacteriol 189:5495-503 (2007)'
p54189
aS'PMID:15175302'
p54190
ag54190
aS'AUTHORS'
p54191
aS'Hsiao HY, He Q, Van Waasbergen LG, Grossman AR'
p54192
aS'TITLE'
p54193
aS'Control of photosynthetic and high-light-responsive genes by the histidine kinase DspA: negative and positive regulation and interactions between signal transduction pathways.'
p54194
aS'JOURNAL'
p54195
aS'J Bacteriol 186:3882-8 (2004)'
p54196
aS'PMID:12626498'
p54197
ag54197
aS'AUTHORS'
p54198
aS'Mutsuda M, Michel KP, Zhang X, Montgomery BL, Golden SS'
p54199
aS'TITLE'
p54200
aS'Biochemical properties of CikA, an unusual phytochrome-like histidine protein kinase that resets the circadian clock in Synechococcus elongatus PCC 7942.'
p54201
aS'JOURNAL'
p54202
aS'J Biol Chem 278:19102-10 (2003)'
p54203
aS'PMID:9278513'
p54204
ag54204
aS'AUTHORS'
p54205
aS'Yeh KC, Wu SH, Murphy JT, Lagarias JC'
p54206
aS'TITLE'
p54207
aS'A cyanobacterial phytochrome two-component light sensory system.'
p54208
aS'JOURNAL'
p54209
aS'Science 277:1505-8 (1997)'
p54210
aS'PMID:7635815'
p54211
ag54211
aS'AUTHORS'
p54212
aS'Niu S, Jiang SQ, Hong J'
p54213
aS'TITLE'
p54214
aS'Salmonella typhimurium pgtB mutants conferring constitutive expression of phosphoglycerate transporter pgtP independent of pgtC.'
p54215
aS'JOURNAL'
p54216
aS'J Bacteriol 177:4297-302 (1995)'
p54217
aS'PMID:16882723'
p54218
ag54218
aS'AUTHORS'
p54219
aS'Takai N, Nakajima M, Oyama T, Kito R, Sugita C, Sugita M, Kondo T, Iwasaki H'
p54220
aS'TITLE'
p54221
aS'A KaiC-associating SasA-RpaA two-component regulatory system as a major circadian timing mediator in cyanobacteria.'
p54222
aS'JOURNAL'
p54223
aS'Proc Natl Acad Sci U S A 103:12109-14 (2006)'
p54224
aS'PMID:11803016'
p54225
ag54225
aS'AUTHORS'
p54226
aS'Janausch IG, Zientz E, Tran QH, Kroger A, Unden G'
p54227
aS'TITLE'
p54228
aS'C4-dicarboxylate carriers and sensors in bacteria.'
p54229
aS'JOURNAL'
p54230
aS'Biochim Biophys Acta 1553:39-56 (2002)'
p54231
aS'PMID:18725229'
p54232
ag54232
aS'AUTHORS'
p54233
aS'Zhou YF, Nan B, Nan J, Ma Q, Panjikar S, Liang YH, Wang Y, Su XD'
p54234
aS'TITLE'
p54235
aS'C4-dicarboxylates sensing mechanism revealed by the crystal structures of DctB sensor domain.'
p54236
aS'JOURNAL'
p54237
aS'J Mol Biol 383:49-61 (2008)'
p54238
aS'PMID:14523104 (Staphylococcus)'
p54239
ag54239
aS'AUTHORS'
p54240
aS'Novick RP, Jiang D'
p54241
aS'TITLE'
p54242
aS'The staphylococcal saeRS system coordinates environmental signals with agr quorum sensing.'
p54243
aS'JOURNAL'
p54244
aS'Microbiology 149:2709-17 (2003)'
p54245
aS'PMID:17981963 (Pseudomonas)'
p54246
ag54246
aS'AUTHORS'
p54247
aS'Leech AJ, Sprinkle A, Wood L, Wozniak DJ, Ohman DE'
p54248
aS'TITLE'
p54249
aS'The NtrC family regulator AlgB, which controls alginate biosynthesis in mucoid Pseudomonas aeruginosa, binds directly to the algD promoter.'
p54250
aS'JOURNAL'
p54251
aS'J Bacteriol 190:581-9 (2008)'
p54252
aS'PMID:18455986 (Caulobacter)'
p54253
ag54253
aS'AUTHORS'
p54254
aS'Paul R, Jaeger T, Abel S, Wiederkehr I, Folcher M, Biondi EG, Laub MT, Jenal U'
p54255
aS'TITLE'
p54256
aS'Allosteric regulation of histidine kinases by their cognate response regulator determines cell fate.'
p54257
aS'JOURNAL'
p54258
aS'Cell 133:452-61 (2008)'
p54259
aS'PMID:15101991 (Pseudomonas)'
p54260
ag54260
aS'AUTHORS'
p54261
aS'Whitchurch CB, Leech AJ, Young MD, Kennedy D, Sargent JL, Bertrand JJ, Semmler AB, Mellick AS, Martin PR, Alm RA, Hobbs M, Beatson SA, Huang B, Nguyen L, Commolli JC, Engel JN, Darzins A, Mattick JS.'
p54262
aS'TITLE'
p54263
aS'Characterization of a complex chemosensory signal transduction system which controls twitching motility in Pseudomonas aeruginosa.'
p54264
aS'JOURNAL'
p54265
aS'Mol Microbiol 52:873-93 (2004)'
p54266
aS'PMID:15170479 (Synechocystis)'
p54267
ag54267
aS'AUTHORS'
p54268
aS'Yoshihara S, Ikeuchi M.'
p54269
aS'TITLE'
p54270
aS'Phototactic motility in the unicellular cyanobacterium Synechocystis sp. PCC 6803.'
p54271
aS'JOURNAL'
p54272
aS'Photochem Photobiol Sci 3:512-8 (2004)'
p54273
aS'PMID:12039966 (Synechocystis)'
p54274
ag54274
aS'AUTHORS'
p54275
aS'Ogawa T, Bao DH, Katoh H, Shibata M, Pakrasi HB, Bhattacharyya-Pakrasi M'
p54276
aS'TITLE'
p54277
aS'A two-component signal transduction pathway regulates manganese homeostasis in Synechocystis 6803, a photosynthetic organism.'
p54278
aS'JOURNAL'
p54279
aS'J Biol Chem 277:28981-6 (2002)'
p54280
aS'PMID:12417709 (Synechocystis)'
p54281
ag54281
aS'AUTHORS'
p54282
aS'Yamaguchi K, Suzuki I, Yamamoto H, Lyukevich A, Bodrova I, Los DA, Piven I, Zinchenko V, Kanehisa M, Murata N'
p54283
aS'TITLE'
p54284
aS'A two-component Mn2+-sensing system negatively regulates expression of the mntCAB operon in Synechocystis.'
p54285
aS'JOURNAL'
p54286
aS'Plant Cell 14:2901-13 (2002)'
p54287
aS'PMID:15273097 (Bacillus)'
p54288
ag54288
aS'AUTHORS'
p54289
aS'Mascher T, Zimmer SL, Smith TA, Helmann JD'
p54290
aS'TITLE'
p54291
aS'Antibiotic-inducible promoter regulated by the cell envelope stress-sensing two-component system LiaRS of Bacillus subtilis.'
p54292
aS'JOURNAL'
p54293
aS'Antimicrob Agents Chemother 48:2888-96 (2004)'
p54294
aS'PMID:15856219 (Bacillus)'
p54295
ag54295
aS'AUTHORS'
p54296
aS'Hyyrylainen HL, Sarvas M, Kontinen VP'
p54297
aS'TITLE'
p54298
aS'Transcriptome analysis of the secretion stress response of Bacillus subtilis.'
p54299
aS'JOURNAL'
p54300
aS'Appl Microbiol Biotechnol 67:389-96 (2005)'
p54301
aS'PMID:15941986 (Bacillus)'
p54302
ag54302
aS'AUTHORS'
p54303
aS'Serizawa M, Sekiguchi J'
p54304
aS'TITLE'
p54305
aS'The Bacillus subtilis YdfHI two-component system regulates the transcription of ydfJ, a member of the RND superfamily.'
p54306
aS'JOURNAL'
p54307
aS'Microbiology 151:1769-78 (2005)'
p54308
aS'PMID:12890034 (Bacillus)'
p54309
ag54309
aS'AUTHORS'
p54310
aS'Ohki R, Giyanto, Tateno K, Masuyama W, Moriya S, Kobayashi K, Ogasawara N'
p54311
aS'TITLE'
p54312
aS'The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis.'
p54313
aS'JOURNAL'
p54314
aS'Mol Microbiol 49:1135-44 (2003)'
p54315
aS'PMID:17322186 (Bacillus)'
p54316
ag54316
aS'AUTHORS'
p54317
aS'Ogura M, Tsukahara K, Hayashi K, Tanaka T'
p54318
aS'TITLE'
p54319
aS'The Bacillus subtilis NatK-NatR two-component system regulates expression of the natAB operon encoding an ABC transporter for sodium ion extrusion.'
p54320
aS'JOURNAL'
p54321
aS'Microbiology 153:667-75 (2007)'
p54322
aS'PMID:10972810 (Bacillus)'
p54323
ag54323
aS'AUTHORS'
p54324
aS'Yamamoto H, Murata M, Sekiguchi J'
p54325
aS'TITLE'
p54326
aS'The CitST two-component system regulates the expression of the Mg-citrate transporter in Bacillus subtilis.'
p54327
aS'JOURNAL'
p54328
aS'Mol Microbiol 37:898-912 (2000)'
p54329
aS'PMID:15995196 (Bacillus)'
p54330
ag54330
aS'AUTHORS'
p54331
aS'Satomura T, Shimura D, Asai K, Sadaie Y, Hirooka K, Fujita Y'
p54332
aS'TITLE'
p54333
aS'Enhancement of glutamine utilization in Bacillus subtilis through the GlnK-GlnL two-component regulatory system.'
p54334
aS'JOURNAL'
p54335
aS'J Bacteriol 187:4813-21 (2005)'
p54336
aS'PMID:12949160 (Bacillus)'
p54337
ag54337
aS'AUTHORS'
p54338
aS'Doan T, Servant P, Tojo S, Yamaguchi H, Lerondel G, Yoshida K, Fujita Y, Aymerich S'
p54339
aS'TITLE'
p54340
aS'The Bacillus subtilis ywkA gene encodes a malic enzyme and its transcription is activated by the YufL/YufM two-component system in response to malate.'
p54341
aS'JOURNAL'
p54342
aS'Microbiology 149:2331-43 (2003)'
p54343
aS'PMID:12949159 (Bacillus)'
p54344
ag54344
aS'AUTHORS'
p54345
aS'Tanaka K, Kobayashi K, Ogasawara N'
p54346
aS'TITLE'
p54347
aS'The Bacillus subtilis YufLM two-component system regulates the expression of the malate transporters MaeN (YufR) and YflS, and is essential for utilization of malate in minimal medium.'
p54348
aS'JOURNAL'
p54349
aS'Microbiology 149:2317-29 (2003)'
p54350
aS'PMID:10708364 (Bacillus)'
p54351
ag54351
aS'AUTHORS'
p54352
aS'Asai K, Baik SH, Kasahara Y, Moriya S, Ogasawara N'
p54353
aS'TITLE'
p54354
aS'Regulation of the transport system for C4-dicarboxylic acids in Bacillus subtilis.'
p54355
aS'JOURNAL'
p54356
aS'Microbiology 146 ( Pt 2):263-71 (2000)'
p54357
aS'PMID:8455557 (Rhodobacter)'
p54358
ag54358
aS'AUTHORS'
p54359
aS'Hamblin MJ, Shaw JG, Kelly DJ'
p54360
aS'TITLE'
p54361
aS'Sequence analysis and interposon mutagenesis of a sensor-kinase (DctS) and response-regulator (DctR) controlling synthesis of the high-affinity C4-dicarboxylate transport system in Rhodobacter capsulatus.'
p54362
aS'JOURNAL'
p54363
aS'Mol Gen Genet 237:215-24 (1993)'
p54364
aS'PMID:9287004 (Rhodobacter)'
p54365
ag54365
aS'AUTHORS'
p54366
aS'Forward JA, Behrendt MC, Wyborn NR, Cross R, Kelly DJ'
p54367
aS'TITLE'
p54368
aS'TRAP transporters: a new family of periplasmic solute transport systems encoded by the dctPQM genes of Rhodobacter capsulatus and by homologs in diverse gram-negative bacteria.'
p54369
aS'JOURNAL'
p54370
aS'J Bacteriol 179:5482-93 (1997)'
p54371
aS'PMID:16820295'
p54372
ag54372
aS'AUTHORS'
p54373
aS'Martin B, Quentin Y, Fichant G, Claverys JP'
p54374
aS'TITLE'
p54375
aS'Independent evolution of competence regulatory cascades in streptococci?'
p54376
aS'JOURNAL'
p54377
aS'Trends Microbiol 14:339-45 (2006)'
p54378
aS'PMID:10231485'
p54379
ag54379
aS'AUTHORS'
p54380
aS'Hensel M, Hinsley AP, Nikolaus T, Sawers G, Berks BC'
p54381
aS'TITLE'
p54382
aS'The genetic basis of tetrathionate respiration in Salmonella typhimurium.'
p54383
aS'JOURNAL'
p54384
aS'Mol Microbiol 32:275-87 (1999)'
p54385
aS'PMID:18028314'
p54386
ag54386
aS'AUTHORS'
p54387
aS'Guvener ZT, Harwood CS'
p54388
aS'TITLE'
p54389
aS'Subcellular location characteristics of the Pseudomonas aeruginosa GGDEF protein, WspR, indicate that it produces cyclic-di-GMP in response to growth on surfaces.'
p54390
aS'JOURNAL'
p54391
aS'Mol Microbiol 66:1459-73 (2007)'
p54392
aS'PMID:17339222'
p54393
ag54393
aS'AUTHORS'
p54394
aS'Bantinaki E, Kassen R, Knight CG, Robinson Z, Spiers AJ, Rainey PB'
p54395
aS'TITLE'
p54396
aS'Adaptive divergence in experimental populations of Pseudomonas fluorescens. III.'
p54397
aS'Mutational origins of wrinkly spreader diversity.'
p54398
aS'JOURNAL'
p54399
aS'Genetics 176:441-53 (2007)'
p54400
aS'PMID:11069677'
p54401
ag54401
aS'AUTHORS'
p54402
aS'Jiang M, Shao W, Perego M, Hoch JA'
p54403
aS'TITLE'
p54404
aS'Multiple histidine kinases regulate entry into stationary phase and sporulation in Bacillus subtilis.'
p54405
aS'JOURNAL'
p54406
aS'Mol Microbiol 38:535-42 (2000)'
p54407
aS'PMID:19781638'
p54408
ag54408
aS'AUTHORS'
p54409
aS'Jenal U'
p54410
aS'TITLE'
p54411
aS'The role of proteolysis in the Caulobacter crescentus cell cycle and development.'
p54412
aS'JOURNAL'
p54413
aS'Res Microbiol 160:687-95 (2009)'
p54414
aS'PMID:19246239'
p54415
ag54415
aS'AUTHORS'
p54416
aS'Jenal U, Galperin MY'
p54417
aS'TITLE'
p54418
aS'Single domain response regulators: molecular switches with emerging roles in cell organization and dynamics.'
p54419
aS'JOURNAL'
p54420
aS'Curr Opin Microbiol 12:152-60 (2009)'
p54421
aS'PMID:16640581'
p54422
ag54422
aS'AUTHORS'
p54423
aS'Drepper T, Wiethaus J, Giaourakis D, Gross S, Schubert B, Vogt M, Wiencek Y, McEwan AG, Masepohl B'
p54424
aS'TITLE'
p54425
aS'Cross-talk towards the response regulator NtrC controlling nitrogen metabolism in Rhodobacter capsulatus.'
p54426
aS'JOURNAL'
p54427
aS'FEMS Microbiol Lett 258:250-6 (2006)'
p54428
aS'PMID:1661370'
p54429
ag54429
aS'AUTHORS'
p54430
aS'Pawlowski K, Klosse U, de Bruijn FJ'
p54431
aS'TITLE'
p54432
aS'Characterization of a novel Azorhizobium caulinodans ORS571 two-component regulatory system, NtrY/NtrX, involved in nitrogen fixation and metabolism.'
p54433
aS'JOURNAL'
p54434
aS'Mol Gen Genet 231:124-38 (1991)'
p54435
aS'PMID:18422428'
p54436
ag54436
aS'AUTHORS'
p54437
aS'Chatterjee S, Almeida RP, Lindow S'
p54438
aS'TITLE'
p54439
aS'Living in two worlds: the plant and insect lifestyles of Xylella fastidiosa.'
p54440
aS'JOURNAL'
p54441
aS'Annu Rev Phytopathol 46:243-71 (2008)'
p54442
aS'PMID:18506032'
p54443
ag54443
aS'AUTHORS'
p54444
aS'Dow M'
p54445
aS'TITLE'
p54446
aS'Diversification of the function of cell-to-cell signaling in regulation of virulence within plant pathogenic xanthomonads.'
p54447
aS'JOURNAL'
p54448
aS'Sci Signal 1:pe23 (2008)'
p54449
aS'PMID:17902112'
p54450
ag54450
aS'AUTHORS'
p54451
aS'Colnaghi Simionato AV, da Silva DS, Lambais MR, Carrilho E'
p54452
aS'TITLE'
p54453
aS'Characterization of a putative Xylella fastidiosa diffusible signal factor by HRGC-EI-MS.'
p54454
aS'JOURNAL'
p54455
aS'J Mass Spectrom 42:1375-81 (2007)'
p54456
aS'PMID:19203648'
p54457
ag54457
aS'AUTHORS'
p54458
aS'Miller LD, Russell MH, Alexandre G'
p54459
aS'TITLE'
p54460
aS'Diversity in bacterial chemotactic responses and niche adaptation.'
p54461
aS'JOURNAL'
p54462
aS'Adv Appl Microbiol 66:53-75 (2009)'
p54463
aS'PMID:8760916'
p54464
ag54464
aS'AUTHORS'
p54465
aS'Eder S, Shi L, Jensen K, Yamane K, Hulett FM'
p54466
aS'TITLE'
p54467
aS'A Bacillus subtilis secreted phosphodiesterase/alkaline phosphatase is the product of a Pho regulon gene, phoD.'
p54468
aS'JOURNAL'
p54469
aS'Microbiology 142 ( Pt 8):2041-7 (1996)'
p54470
asS'KO_PATHWAY'
p54471
(lp54472
S'ko02020'
p54473
asS'PATHWAY_MAP'
p54474
(lp54475
S'map02020'
p54476
asS'MODULE'
p54477
(lp54478
S'M00314'
p54479
aS'Bacitracin transport system [PATH:map02020]'
p54480
ag54479
ag54480
aS'M00315'
p54481
aS'Uncharacterized ABC transport system [PATH:map02020]'
p54482
aS'M00316'
p54483
aS'Manganese transport system [PATH:map02020]'
p54484
aS'M00434'
p54485
aS'PhoR-PhoB (phosphate starvation response) two-component regulatory system [PATH:map02020]'
p54486
aS'M00443'
p54487
aS'SenX3-RegX3 (phosphate starvation response) two-component regulatory system [PATH:map02020]'
p54488
aS'M00444'
p54489
aS'PhoQ-PhoP (magnesium transport) two-component regulatory system [PATH:map02020]'
p54490
aS'M00445'
p54491
aS'EnvZ-OmpR (osmotic stress response) two-component regulatory system [PATH:map02020]'
p54492
aS'M00446'
p54493
aS'RstB-RstA two-component regulatory system [PATH:map02020]'
p54494
aS'M00447'
p54495
aS'CpxA-CpxR (envelope stress response) two-component regulatory system [PATH:map02020]'
p54496
aS'M00448'
p54497
aS'CssS-CssR (secretion stress response) two-component regulatory system [PATH:map02020]'
p54498
aS'M00449'
p54499
aS'CreC-CreB (phosphate regulation) two-component regulatory system [PATH:map02020]'
p54500
aS'M00450'
p54501
aS'BaeS-BaeR (envelope stress response) two-component regulatory system [PATH:map02020]'
p54502
aS'M00451'
p54503
aS'BasS-BasR (antimicrobial peptide resistance) two-component regulatory system [PATH:map02020]'
p54504
aS'M00452'
p54505
aS'CusS-CusR (copper tolerance) two-component regulatory system [PATH:map02020]'
p54506
aS'M00453'
p54507
aS'QseC-QseB (quorum sensing) two-component regulatory system [PATH:map02020]'
p54508
aS'M00454'
p54509
aS'KdpD-KdpE (potassium transport) two-component regulatory system [PATH:map02020]'
p54510
aS'M00455'
p54511
aS'TorS-TorR (TMAO respiration) two-component regulatory system [PATH:map02020]'
p54512
aS'M00456'
p54513
aS'ArcB-ArcA (anoxic redox control) two-component regulatory system [PATH:map02020]'
p54514
aS'M00457'
p54515
aS'TctE-TctD (tricarboxylic acid transport) two-component regulatory system [PATH:map02020]'
p54516
aS'M00458'
p54517
aS'ResE-ResD (aerobic and anaerobic respiration) two-component regulatory system [PATH:map02020]'
p54518
aS'M00459'
p54519
aS'VicK-VicR (cell wall metabolism) two-component regulatory system [PATH:map02020]'
p54520
aS'M00460'
p54521
aS'MprB-MprA (maintenance of persistent infection) two-component regulatory system [PATH:map02020]'
p54522
aS'M00461'
p54523
aS'MtrB-MtrA (osmotic stress response) two-component regulatory system [PATH:map02020]'
p54524
aS'M00462'
p54525
aS'PrrB-PrrA (intracellular multiplication) two-component regulatory system [PATH:map02020]'
p54526
aS'M00463'
p54527
aS'TrcS-TrcR two-component regulatory system [PATH:map02020]'
p54528
aS'M00464'
p54529
aS'NrsS-NrsR (nickel tolerance) two-component regulatory system [PATH:map02020]'
p54530
aS'M00465'
p54531
aS'ManS-ManR (manganese homeostasis) two-component regulatory system [PATH:map02020]'
p54532
aS'M00466'
p54533
aS'NblS-NblR (photosynthesis) two-component regulatory system [PATH:map02020]'
p54534
aS'M00467'
p54535
aS'SasA-RpaAB (circadian timing mediating) two-component regulatory system [PATH:map02020]'
p54536
aS'M00468'
p54537
aS'SaeS-SaeR (staphylococcal virulence regulation) two-component regulatory system [PATH:map02020]'
p54538
aS'M00469'
p54539
aS'BceS-BceR (bacitracin transport) two-component regulatory system [PATH:map02020]'
p54540
aS'M00470'
p54541
aS'YxdK-YxdJ (antimicrobial peptide response) two-component regulatory system [PATH:map02020]'
p54542
aS'M00471'
p54543
aS'NarX-NarL (nitrate respiration) two-component regulatory system [PATH:map02020]'
p54544
aS'M00472'
p54545
aS'NarQ-NarP (nitrate respiration) two-component regulatory system [PATH:map02020]'
p54546
aS'M00473'
p54547
aS'UhpB-UhpA (hexose phosphates uptake) two-component regulatory system [PATH:map02020]'
p54548
aS'M00474'
p54549
aS'RcsC-RcsD-RcsB (capsule synthesis) two-component regulatory system [PATH:map02020]'
p54550
aS'M00475'
p54551
aS'BarA-UvrY (central carbon metabolism) two-component regulatory system [PATH:map02020]'
p54552
aS'M00476'
p54553
aS'ComP-ComA (competence) two-component regulatory system [PATH:map02020]'
p54554
aS'M00477'
p54555
aS'EvgS-EvgA (acid and drug tolerance) two-component regulatory system [PATH:map02020]'
p54556
aS'M00478'
p54557
aS'DegS-DegU (multicellular behavior control) two-component regulatory system [PATH:map02020]'
p54558
aS'M00479'
p54559
aS'DesK-DesR (membrane lipid fluidity regulation) two-component regulatory system [PATH:map02020]'
p54560
aS'M00480'
p54561
aS'VraS-VraR (cell-wall peptidoglycan synthesis) two-component regulatory system [PATH:map02020]'
p54562
aS'M00481'
p54563
aS'LiaS-LiaR (cell wall stress response) two-component regulatory system [PATH:map02020]'
p54564
aS'M00482'
p54565
aS'DevS-DevR (redox response) two-component regulatory system [PATH:map02020]'
p54566
aS'M00483'
p54567
aS'NreB-NreC (dissimilatory nitrate/nitrite reduction) two-component regulatory system [PATH:map02020]'
p54568
aS'M00484'
p54569
aS'YdfH-YdfI two-component regulatory system [PATH:map02020]'
p54570
aS'M00485'
p54571
aS'KinABCDE-Spo0FA (sporulation control) two-component regulatory system [PATH:map02020]'
p54572
aS'M00486'
p54573
aS'CitA-CitB (citrate fermentation) two-component regulatory system [PATH:map02020]'
p54574
aS'M00487'
p54575
aS'CitS-CitT (magnesium-citrate transport) two-component regulatory system [PATH:map02020]'
p54576
aS'M00488'
p54577
aS'DcuS-DcuR (C4-dicarboxylate metabolism) two-component regulatory system [PATH:map02020]'
p54578
aS'M00489'
p54579
aS'DctS-DctR (C4-dicarboxylate transport) two-component regulatory system [PATH:map02020]'
p54580
aS'M00490'
p54581
aS'MalK-MalR (malate transport) two-component regulatory system [PATH:map02020]'
p54582
aS'M00492'
p54583
aS'LytS-LytR two-component regulatory system [PATH:map02020]'
p54584
aS'M00493'
p54585
aS'AlgZ-AlgR (alginate production) two-component regulatory system [PATH:map02020]'
p54586
aS'M00494'
p54587
aS'NatK-NatR (sodium extrusion) two-component regulatory system [PATH:map02020]'
p54588
aS'M00495'
p54589
aS'AgrC-AgrA (exoprotein synthesis) two-component regulatory system [PATH:map02020]'
p54590
aS'M00496'
p54591
aS'ComD-ComE (competence) two-component regulatory system [PATH:map02020]'
p54592
aS'M00497'
p54593
aS'GlnL-GlnG (nitrogen regulation) two-component regulatory system [PATH:map02020]'
p54594
aS'M00498'
p54595
aS'NtrY-NtrX (nitrogen regulation) two-component regulatory system [PATH:map02020]'
p54596
aS'M00499'
p54597
aS'HydH-HydG (metal tolerance) two-component regulatory system [PATH:map02020]'
p54598
aS'M00500'
p54599
aS'AtoS-AtoC (cPHB biosynthesis) two-component regulatory system [PATH:map02020]'
p54600
aS'M00501'
p54601
aS'PilS-PilR (type 4 fimbriae synthesis) two-component regulatory system [PATH:map02020]'
p54602
aS'M00502'
p54603
aS'GlrK-GlrR (amino sugar metabolism) two-component regulatory system [PATH:map02020]'
p54604
aS'M00503'
p54605
aS'PgtB-PgtA (phosphoglycerate transport) two-component regulatory system [PATH:map02020]'
p54606
aS'M00504'
p54607
aS'DctB-DctD (C4-dicarboxylate transport) two-component regulatory system [PATH:map02020]'
p54608
aS'M00505'
p54609
aS'KinB-AlgB (alginate production) two-component regulatory system [PATH:map02020]'
p54610
aS'M00506'
p54611
aS'CheA-CheYBV (chemotaxis) two-component regulatory system [PATH:map02020]'
p54612
aS'M00507'
p54613
aS'ChpA-ChpB/PilGH (chemosensory) two-component regulatory system [PATH:map02020]'
p54614
aS'M00508'
p54615
aS'PixL-PixGH (positive phototaxis) two-component regulatory system [PATH:map02020]'
p54616
aS'M00509'
p54617
aS'WspE-WspRF (chemosensory) two-component regulatory system [PATH:map02020]'
p54618
aS'M00510'
p54619
aS'Cph1-Rcp1 (light response) two-component regulatory system [PATH:map02020]'
p54620
aS'M00511'
p54621
aS'PleC-PleD (cell fate control) two-component regulatory system [PATH:map02020]'
p54622
aS'M00512'
p54623
aS'CckA-CtrA/CpdR (cell cycle control) two-component regulatory system [PATH:map02020]'
p54624
aS'M00513'
p54625
aS'LuxQN/CqsS-LuxU-LuxO (quorum sensing) two-component regulatory system [PATH:map02020]'
p54626
aS'M00514'
p54627
aS'TtrS-TtrR (tetrathionate respiration) two-component regulatory system [PATH:map02020]'
p54628
aS'M00515'
p54629
aS'FlrB-FlrC (polar flagellar synthesis) two-component regulatory system [PATH:map02020]'
p54630
aS'M00516'
p54631
aS'SLN1-YPD1-SSK1/SKN7 (osmosensing) two-component regulatory system [PATH:map02020]'
p54632
aS'M00517'
p54633
aS'RpfC-RpfG (cell-to-cell signaling) two-component regulatory system [PATH:map02020]'
p54634
aS'M00518'
p54635
aS'GlnK-GlnL (glutamine utilization) two-component regulatory system [PATH:map02020]'
p54636
aS'M00519'
p54637
aS'YesM-YesN two-component regulatory system [PATH:map02020]'
p54638
aS'M00520'
p54639
aS'ChvG-ChvI (acidity sensing) two-component regulatory system [PATH:map02020]'
p54640
aS'M00521'
p54641
aS'CiaH-CiaR two-component regulatory system [PATH:map02020]'
p54642
aS'M00522'
p54643
aS'SalK-SalR two-component regulatory system [PATH:map02020]'
p54644
aS'M00523'
p54645
aS'RegB-RegA (redox response) two-component regulatory system [PATH:map02020]'
p54646
aS'M00524'
p54647
aS'FixL-FixJ (nitrogen fixation) two-component regulatory system [PATH:map02020]'
p54648
aS'M00645'
p54649
aS'Multidrug resistance, efflux pump SmeABC [PATH:map02020]'
p54650
aS'M00646'
p54651
aS'Multidrug resistance, efflux pump AcrAD-TolC [PATH:map02020]'
p54652
aS'M00648'
p54653
aS'Multidrug resistance, efflux pump MdtABC [PATH:map02020]'
p54654
aS'M00651'
p54655
aS'Vancomycin resistance, D-Ala-D-Lac type [PATH:map02020]'
p54656
aS'M00652'
p54657
aS'Vancomycin resistance, D-Ala-D-Ser type [PATH:map02020]'
p54658
aS'M00653'
p54659
aS'AauS-AauR (acidic amino acids utilization) two-component regulatory system [PATH:map02020]'
p54660
aS'M00654'
p54661
aS'ParS-ParR (polymyxin-adaptive resistance) two-component regulatory system [PATH:map02020]'
p54662
aS'M00656'
p54663
aS'VanS-VanR (VanB type vancomycin resistance) two-component regulatory system [PATH:map02020]'
p54664
aS'M00657'
p54665
aS'VanS-VanR (VanE type vancomycin resistance) two-component regulatory system [PATH:map02020]'
p54666
aS'M00658'
p54667
aS'VanS-VanR (actinomycete type vancomycin resistance) two-component regulatory system [PATH:map02020]'
p54668
aS'M00662'
p54669
aS'Hk1-Rrp1 (glycerol uptake and utilization) two-component regulatory system [PATH:map02020]'
p54670
aS'M00663'
p54671
aS'SsrA-SsrB two-component regulatory system [PATH:map02020]'
p54672
aS'M00716'
p54673
aS'ArlS-ArlR (virulence regulation) two-component regulatory system [PATH:map02020]'
p54674
aS'M00719'
p54675
aS'Ihk-Irr (virulence regulation) two-component regulatory system [PATH:map02020]'
p54676
asS'DBLINKS'
p54677
(lp54678
S'GO: 0000160'
p54679
asS'ENTRY'
p54680
(lp54681
S'map02020'
p54682
aS'Pathway'
p54683
asS'CLASS'
p54684
(lp54685
S'Environmental Information Processing Signal transduction'
p54686
asS'DESCRIPTION'
p54687
(lp54688
S'Two-component signal transduction systems enable bacteria to sense, respond, and adapt to changes in their environment or in their intracellular state. Each two-component system consists of a sensor protein-histidine kinase (HK) and a response regulator (RR). In the prototypical two-component pathway, the sensor HK phosphorylates its own conserved His residue in response to a signal(s) in the environment. Subsequently, the phosphoryl group of HK is transferred onto a specific Asp residue on the RR. The activated RR can then effect changes in cellular physiology, often by regulating gene expression. Two-component pathways thus often enable cells to sense and respond to stimuli by inducing changes in transcription.'
p54689
assS'path:map00361'
p54690
(dp54691
S'DBLINKS'
p54692
(lp54693
S'UMBBD: hch ghch dcz 2,4-d pcp 2,4,5-t tcb'
p54694
asS'NAME'
p54695
(lp54696
S'Chlorocyclohexane and chlorobenzene degradation'
p54697
asS'REFERENCE'
p54698
(lp54699
S'PMID:10600501'
p54700
ag54700
aS'AUTHORS'
p54701
aS'Xun L, Bohuslavek J, Cai M.'
p54702
aS'TITLE'
p54703
aS'Characterization of 2,6-dichloro-p-hydroquinone 1,2-dioxygenase (PcpA) of Sphingomonas chlorophenolica ATCC 39723.'
p54704
aS'JOURNAL'
p54705
aS'Biochem Biophys Res Commun 266:322-5 (1999)'
p54706
aS'PMID:1987135'
p54707
ag54707
aS'AUTHORS'
p54708
aS'van der Meer JR, van Neerven AR, de Vries EJ, de Vos WM, Zehnder AJ.'
p54709
aS'TITLE'
p54710
aS'Cloning and characterization of plasmid-encoded genes for the degradation of 1,2-dichloro-, 1,4-dichloro-, and 1,2,4-trichlorobenzene of Pseudomonas sp. strain P51.'
p54711
aS'JOURNAL'
p54712
aS'J Bacteriol 173:6-15 (1991)'
p54713
aS'PMID:10464214'
p54714
ag54714
aS'AUTHORS'
p54715
aS'Nagata Y, Futamura A, Miyauchi K, Takagi M.'
p54716
aS'TITLE'
p54717
aS'Two different types of dehalogenases, LinA and LinB, involved in gamma-hexachlorocyclohexane degradation in Sphingomonas paucimobilis UT26 are localized in the periplasmic space without molecular processing.'
p54718
aS'JOURNAL'
p54719
aS'J Bacteriol 181:5409-13 (1999)'
p54720
aS'PMID:11423959'
p54721
ag54721
aS'AUTHORS'
p54722
aS'Nagata Y, Miyauchi K, Takagi M.'
p54723
aS'TITLE'
p54724
aS'Complete analysis of genes and enzymes for gamma-hexachlorocyclohexane degradation in Sphingomonas paucimobilis UT26.'
p54725
aS'JOURNAL'
p54726
aS'J Ind Microbiol Biotechnol 23:380-390 (1999)'
p54727
aS'PMID:15060023'
p54728
ag54728
aS'AUTHORS'
p54729
aS'Dogra C, Raina V, Pal R, Suar M, Lal S, Gartemann KH, Holliger C, van der Meer JR, Lal R.'
p54730
aS'TITLE'
p54731
aS'Organization of lin genes and IS6100 among different strains of hexachlorocyclohexane-degrading Sphingomonas paucimobilis: evidence for horizontal gene transfer.'
p54732
aS'JOURNAL'
p54733
aS'J Bacteriol 186:2225-35 (2004)'
p54734
aS'PMID:12676719'
p54735
ag54735
aS'AUTHORS'
p54736
aS'Nagata Y, Prokop Z, Marvanova S, Sykorova J, Monincova M, Tsuda M, Damborsky J.'
p54737
aS'TITLE'
p54738
aS'Reconstruction of mycobacterial dehalogenase Rv2579 by cumulative mutagenesis of haloalkane dehalogenase LinB.'
p54739
aS'JOURNAL'
p54740
aS'Appl Environ Microbiol 69:2349-55 (2003)'
p54741
aS'PMID:15489427'
p54742
ag54742
aS'AUTHORS'
p54743
aS'Vedler E, Vahter M, Heinaru A.'
p54744
aS'TITLE'
p54745
aS'The completely sequenced plasmid pEST4011 contains a novel IncP1 backbone and a catabolic transposon harboring tfd genes for 2,4-dichlorophenoxyacetic acid degradation.'
p54746
aS'JOURNAL'
p54747
aS'J Bacteriol 186:7161-74 (2004)'
p54748
aS'PMID:9148781'
p54749
ag54749
aS'AUTHORS'
p54750
aS'Sommer C, Gorisch H.'
p54751
aS'TITLE'
p54752
aS'Enzymology of the degradation of (di)chlorobenzenes by Xanthobacter flavus 14p1.'
p54753
aS'JOURNAL'
p54754
aS'Arch Microbiol 167:384-91 (1997)'
p54755
aS'PMID:12070765'
p54756
ag54756
aS'AUTHORS'
p54757
aS'Laemmli CM, Schonenberger R, Suter M, Zehnder AJ, van der Meer JR.'
p54758
aS'TITLE'
p54759
aS'TfdD(II), one of the two chloromuconate cycloisomerases of Ralstonia eutropha JMP134 (pJP4), cannot efficiently convert 2-chloro- cis, cis-muconate to trans-dienelactone to allow growth on 3-chlorobenzoate.'
p54760
aS'JOURNAL'
p54761
aS'Arch Microbiol 178:13-25 (2002)'
p54762
aS'PMID:16977465'
p54763
ag54763
aS'AUTHORS'
p54764
aS'Wu J, Hong Q, Han P, He J, Li S.'
p54765
aS'TITLE'
p54766
aS'A gene linB2 responsible for the conversion of beta-HCH and 2,3,4,5,6-pentachlorocyclohexanol in Sphingomonas sp. BHC-A.'
p54767
aS'JOURNAL'
p54768
aS'Appl Microbiol Biotechnol 73:1097-105 (2007)'
p54769
aS'PMID:9758802'
p54770
ag54770
aS'AUTHORS'
p54771
aS'Potrawfke T, Timmis KN, Wittich RM'
p54772
aS'TITLE'
p54773
aS'Degradation of 1,2,3,4-tetrachlorobenzene by pseudomonas chlororaphis RW71'
p54774
aS'JOURNAL'
p54775
aS'Appl Environ Microbiol 64:3798-806 (1998)'
p54776
aS'PMID:11208799'
p54777
ag54777
aS'AUTHORS'
p54778
aS'Potrawfke T, Armengaud J, Wittich RM'
p54779
aS'TITLE'
p54780
aS'Chlorocatechols substituted at positions 4 and 5 are substrates of the broad-spectrum chlorocatechol 1,2-dioxygenase of Pseudomonas chlororaphis RW71.'
p54781
aS'JOURNAL'
p54782
aS'J Bacteriol 183:997-1011 (2001)'
p54783
asS'KO_PATHWAY'
p54784
(lp54785
S'ko00361'
p54786
asS'ENTRY'
p54787
(lp54788
S'map00361'
p54789
aS'Pathway'
p54790
asS'PATHWAY_MAP'
p54791
(lp54792
S'map00361'
p54793
asS'CLASS'
p54794
(lp54795
S'Metabolism Xenobiotics biodegradation and metabolism'
p54796
assS'path:map07218'
p54797
(dp54798
S'ENTRY'
p54799
(lp54800
S'map07218'
p54801
aS'Drug'
p54802
aS'Pathway'
p54803
asS'PATHWAY_MAP'
p54804
(lp54805
S'map07218'
p54806
asS'NAME'
p54807
(lp54808
S'HIV protease inhibitors'
p54809
asS'REFERENCE'
p54810
(lp54811
g22
ag22
aS'AUTHORS'
p54812
aS'Tanaka C, Kato R (eds).'
p54813
aS'TITLE'
p54814
aS'[New Pharmacology (4th ed)] (In Japanese)'
p54815
aS'JOURNAL'
p54816
aS'Nankodo (2002)'
p54817
aS'PMID:9646869'
p54818
ag54818
aS'AUTHORS'
p54819
aS'Wlodawer A, Vondrasek J.'
p54820
aS'TITLE'
p54821
aS'Inhibitors of HIV-1 protease: a major success of structure-assisted drug design.'
p54822
aS'JOURNAL'
p54823
aS'Annu Rev Biophys Biomol Struct 27:249-84 (1998)'
p54824
aS'PMID:12929379'
p54825
ag54825
aS'AUTHORS'
p54826
aS'Brik A, Wong CH.'
p54827
aS'TITLE'
p54828
aS'HIV-1 protease: mechanism and drug discovery.'
p54829
aS'JOURNAL'
p54830
aS'Org Biomol Chem 1:5-14 (2003)'
p54831
aS'PMID:15123854'
p54832
ag54832
aS'AUTHORS'
p54833
aS'Wynn GH, Zapor MJ, Smith BH, Wortmann G, Oesterheld JR, Armstrong SC, Cozza KL.'
p54834
aS'TITLE'
p54835
aS'Antiretrovirals, part 1: overview, history, and focus on protease inhibitors.'
p54836
aS'JOURNAL'
p54837
aS'Psychosomatics 45:262-70 (2004)'
p54838
aS'PMID:16308534'
p54839
ag54839
aS'AUTHORS'
p54840
aS'Sugiura W.'
p54841
aS'TITLE'
p54842
aS'[Progress in antiretroviral drugs]'
p54843
aS'JOURNAL'
p54844
aS'Uirusu 55:85-94 (2005)'
p54845
aS'PMID:1799953'
p54846
ag54846
aS'AUTHORS'
p54847
aS'Mimoto T, Imai J, Tanaka S, Hattori N, Kisanuki S, Akaji K, Kiso Y.'
p54848
aS'TITLE'
p54849
aS'KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.'
p54850
aS'JOURNAL'
p54851
aS'Chem Pharm Bull (Tokyo) 39:3088-90 (1991)'
p54852
asS'COMPOUND'
p54853
(lp54854
S'C07051'
p54855
aS'Indinavir'
p54856
ag54855
ag54856
aS'C15659'
p54857
aS'TMC 126'
p54858
aS'C15660'
p54859
aS'A 77003'
p54860
aS'C15661'
p54861
aS'A 80987'
p54862
aS'C15662'
p54863
aS'Dmp 323'
p54864
aS'D00427'
p54865
aS'Ritonavir (JAN/USAN/INN)'
p54866
aS'D00429'
p54867
aS'Saquinavir (JAN/USP/INN)'
p54868
aS'D00894'
p54869
aS'Amprenavir (JAN/USAN/INN)'
p54870
aS'D00897'
p54871
aS'Indinavir sulfate (USAN)'
p54872
aS'D00899'
p54873
aS'Nelfinavir mesilate (JAN)'
p54874
aS'D01160'
p54875
aS'Saquinavir mesilate (JAN)'
p54876
aS'D01276'
p54877
aS'Atazanavir sulfate (JAN/USAN)'
p54878
aS'D01425'
p54879
aS'Lopinavir (JAN/USAN/INN)'
p54880
aS'D02497'
p54881
aS'Fosamprenavir (INN)'
p54882
aS'D02861'
p54883
aS'Indinavir sulfate ethanolate (JAN)'
p54884
aS'D02867'
p54885
aS'Fosamprenavir calcium hydrate (JAN)'
p54886
aS'D03253'
p54887
aS'Brecanavir (USAN)'
p54888
aS'D03656'
p54889
aS'Darunavir (USAN/INN)'
p54890
aS'D03833'
p54891
aS'Indinavir (USAN)'
p54892
aS'D03835'
p54893
aS'Fosamprenavir calcium (USAN)'
p54894
aS'D03837'
p54895
aS'Fosamprenavir sodium (USAN)'
p54896
aS'D03839'
p54897
aS'Droxinavir hydrochloride (USAN)'
p54898
aS'D03843'
p54899
aS'Tipranavir disodium (USAN)'
p54900
aS'D05538'
p54901
aS'Mozenavir (INN)'
p54902
aS'D06478'
p54903
aS'Darunavir ethanolate (JAN)'
p54904
aS'D07471'
p54905
aS'Atazanavir (INN)'
p54906
aS'D08259'
p54907
aS'Nelfinavir (INN)'
p54908
aS'D08605'
p54909
aS'Tipranavir (INN)'
p54910
assS'path:map00360'
p54911
(dp54912
S'NAME'
p54913
(lp54914
S'Phenylalanine metabolism'
p54915
asS'REFERENCE'
p54916
(lp54917
g22
ag22
aS'AUTHORS'
p54918
aS'Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).'
p54919
aS'TITLE'
p54920
aS'[Cellular Functions and Metabolic Maps] (In Japanese)'
p54921
aS'JOURNAL'
p54922
aS'Tokyo Kagaku Dojin (1997)'
p54923
aS'PMID:10537203'
p54924
ag54924
aS'AUTHORS'
p54925
aS'Arai H, Yamamoto T, Ohishi T, Shimizu T, Nakata T, Kudo T.'
p54926
aS'TITLE'
p54927
aS'Genetic organization and characteristics of the 3-(3-hydroxyphenyl)propionic acid degradation pathway of Comamonas testosteroni TA441.'
p54928
aS'JOURNAL'
p54929
aS'Microbiology 145 ( Pt 10):2813-20 (1999)'
p54930
aS'PMID:9603882'
p54931
ag54931
aS'AUTHORS'
p54932
aS'Diaz E, Ferrandez A, Garcia JL.'
p54933
aS'TITLE'
p54934
aS'Characterization of the hca cluster encoding the dioxygenolytic pathway for initial catabolism of 3-phenylpropionic acid in Escherichia coli K-12.'
p54935
aS'JOURNAL'
p54936
aS'J Bacteriol 180:2915-23 (1998)'
p54937
aS'PMID:9098055'
p54938
ag54938
aS'AUTHORS'
p54939
aS'Ferrandez A, Garcia JL, Diaz E.'
p54940
aS'TITLE'
p54941
aS'Genetic characterization and expression in heterologous hosts of the 3-(3-hydroxyphenyl)propionate catabolic pathway of Escherichia coli K-12.'
p54942
aS'JOURNAL'
p54943
aS'J Bacteriol 179:2573-81 (1997)'
p54944
aS'PMID:19016485'
p54945
ag54945
aS'AUTHORS'
p54946
aS'Hwang JY, Park J, Seo JH, Cha M, Cho BK, Kim J, Kim BG'
p54947
aS'TITLE'
p54948
aS'Simultaneous synthesis of 2-phenylethanol and L-homophenylalanine using aromatic transaminase with yeast Ehrlich pathway.'
p54949
aS'JOURNAL'
p54950
aS'Biotechnol Bioeng 102:1323-9 (2009)'
p54951
aS'PMID:20660314'
p54952
ag54952
aS'AUTHORS'
p54953
aS'Teufel R, Mascaraque V, Ismail W, Voss M, Perera J, Eisenreich W, Haehnel W, Fuchs G'
p54954
aS'TITLE'
p54955
aS'Bacterial phenylalanine and phenylacetate catabolic pathway revealed.'
p54956
aS'JOURNAL'
p54957
aS'Proc Natl Acad Sci U S A 107:14390-5 (2010)'
p54958
asS'KO_PATHWAY'
p54959
(lp54960
S'ko00360'
p54961
asS'PATHWAY_MAP'
p54962
(lp54963
S'map00360'
p54964
asS'DISEASE'
p54965
(lp54966
S'H00165'
p54967
aS'Tyrosinemia'
p54968
asS'MODULE'
p54969
(lp54970
S'M00350'
p54971
aS'Capsaicin biosynthesis, L-Phenylalanine => Capsaicin [PATH:map00360]'
p54972
ag54971
ag54972
aS'M00545'
p54973
aS'Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA [PATH:map00360]'
p54974
asS'DBLINKS'
p54975
(lp54976
S'GO: 0006558'
p54977
asS'ENTRY'
p54978
(lp54979
S'map00360'
p54980
aS'Pathway'
p54981
asS'CLASS'
p54982
(lp54983
S'Metabolism Amino acid metabolism'
p54984
assS'path:map07212'
p54985
(dp54986
S'ENTRY'
p54987
(lp54988
S'map07212'
p54989
aS'Drug'
p54990
aS'Pathway'
p54991
asS'PATHWAY_MAP'
p54992
(lp54993
S'map07212'
p54994
asS'NAME'
p54995
(lp54996
S'Histamine H1 receptor antagonists'
p54997
asS'REFERENCE'
p54998
(lp54999
g22
ag22
aS'AUTHORS'
p55000
aS'Japan Pharmaceutical Association (ed).'
p55001
aS'TITLE'
p55002
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p55003
aS'JOURNAL'
p55004
aS'Yakuji Nippo (1999)'
p55005
ag22
ag22
aS'AUTHORS'
p55006
aS'Noguchi S, Hibino S (eds).'
p55007
aS'TITLE'
p55008
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p55009
aS'JOURNAL'
p55010
aS'Hirokawa (2002)'
p55011
ag22
ag22
aS'AUTHORS'
p55012
aS'Yamakawa K., Kanaoka Y., Iwasawa Y.'
p55013
aS'TITLE'
p55014
aS'[Medicinal Chemistry (5th ed)] (In Japanase)'
p55015
aS'JOURNAL'
p55016
aS'Kodansha Scientific'
p55017
ag22
ag22
aS'AUTHORS'
p55018
aS'Tanaka C., Kato R. (eds)'
p55019
aS'TITLE'
p55020
aS'[New pharmacology (revision 5th ed)] (In Japanese)'
p55021
aS'JOURNAL'
p55022
aS'Nankodo'
p55023
ag22
ag22
aS'AUTHORS'
p55024
aS'Watanabe T., Kamisaki Y.'
p55025
aS'TITLE'
p55026
aS'[Molecular Targeting Pharmacology 2nd Ed)] (In Japanase)'
p55027
aS'JOURNAL'
p55028
aS'Ishiyaku Publishers'
p55029
asS'COMPOUND'
p55030
(lp55031
S'C14410'
p55032
aS'Phenbenzamine hydrochloride'
p55033
ag55032
ag55033
aS'D00234'
p55034
aS'Astemizole (JAN/USP/INN)'
p55035
aS'D00270'
p55036
aS'Chlorpromazine (USP/INN)'
p55037
aS'D00300'
p55038
aS'Diphenhydramine (JP16/INN)'
p55039
aS'D00364'
p55040
aS'Loratadine (JAN/USAN/INN)'
p55041
aS'D00480'
p55042
aS'Promethazine hydrochloride (JP16/USP)'
p55043
aS'D00494'
p55044
aS'Promethazine (JAN/INN)'
p55045
aS'D00521'
p55046
aS'Terfenadine (JAN/USAN/INN)'
p55047
aS'D00659'
p55048
aS'Azelastine hydrochloride (JP16/USAN)'
p55049
aS'D00662'
p55050
aS'Azatadine maleate (USP)'
p55051
aS'D00663'
p55052
aS'Brompheniramine maleate (USAN)'
p55053
aS'D00664'
p55054
aS'Cetirizine hydrochloride (JP16/USAN)'
p55055
aS'D00665'
p55056
aS'Chlorpheniramine maleate (JP16/USP)'
p55057
aS'D00666'
p55058
aS'Clemastine fumarate (JP16/USP)'
p55059
aS'D00668'
p55060
aS'd-Chlorpheniramine maleate (JP16)'
p55061
aS'D00669'
p55062
aS'Diphenhydramine hydrochloride (JP16/USP)'
p55063
aS'D00671'
p55064
aS'Fexofenadine hydrochloride (JP16/USAN)'
p55065
aS'D00672'
p55066
aS'Hydroxyzine hydrochloride (JP16/USP)'
p55067
aS'D00789'
p55068
aS'Chlorpromazine hydrochloride (JP16/USP)'
p55069
aS'D01096'
p55070
aS'Hydroxyzine pamoate (JP16/USP)'
p55071
aS'D01143'
p55072
aS'Isothipendyl hydrochloride (JAN)'
p55073
aS'D01172'
p55074
aS'Diphenylpyraline hydrochloride (JAN)'
p55075
aS'D01174'
p55076
aS'Pheniramine maleate (JAN/USP)'
p55077
aS'D01192'
p55078
aS'Olopatadine hydrochloride (JP16/USAN)'
p55079
aS'D01242'
p55080
aS'Promethazine teoclate (JAN/INN)'
p55081
aS'D01317'
p55082
aS'Meclizine hydrochloride (JAN/USP)'
p55083
aS'D01324'
p55084
aS'Mequitazine (JP16/INN)'
p55085
aS'D01332'
p55086
aS'Ketotifen fumarate (JP16/USAN)'
p55087
aS'D01336'
p55088
aS'Carbinoxamine maleate (JAN/USP)'
p55089
aS'D01460'
p55090
aS'Homochlorcyclizine hydrochloride (JP16)'
p55091
aS'D01478'
p55092
aS'Ebastine (JP16/USAN/INN)'
p55093
aS'D01627'
p55094
aS'Diphenylpyraline teoclate (JAN)'
p55095
aS'D01654'
p55096
aS'Bepotastine besilate (JP16)'
p55097
aS'D01713'
p55098
aS'Epinastine hydrochloride (JAN)'
p55099
aS'D01717'
p55100
aS'Levocabastine hydrochloride (JAN/USAN)'
p55101
aS'D01773'
p55102
aS'Oxatomide (JAN/USAN/INN)'
p55103
aS'D01782'
p55104
aS'Triprolidine hydrochloride hydrate (JAN)'
p55105
aS'D01801'
p55106
aS'Thonzylamine hydrochloride (JAN/USAN)'
p55107
aS'D02089'
p55108
aS'Buclizine hydrochloride (USAN)'
p55109
aS'D02090'
p55110
aS'Cyclizine lactate (BAN)'
p55111
aS'D02091'
p55112
aS'Tripelennamine hydrochloride (USP)'
p55113
aS'D02148'
p55114
aS'Phenindamine tartrate (USAN)'
p55115
aS'D02234'
p55116
aS'Cyproheptadine hydrochloride (JP16/USP)'
p55117
aS'D02245'
p55118
aS'Alimemazine tartrate (JP16)'
p55119
aS'D02249'
p55120
aS'Emedastine difumarate (JP16/USP)'
p55121
aS'D02327'
p55122
aS'Doxylamine succinate (USP)'
p55123
aS'D02419'
p55124
aS'Diphenhydramine salicylate (JAN)'
p55125
aS'D02760'
p55126
aS'Acrivastine (USAN/INN)'
p55127
aS'D03166'
p55128
aS'Bromodiphenhydramine hydrochloride (USP)'
p55129
aS'D03274'
p55130
aS'Chlorpromazine hibenzate (JAN)'
p55131
aS'D03285'
p55132
aS'Diphenhydramine tannate (JP16)'
p55133
aS'D03290'
p55134
aS'Promethazine methylenedisalicylate (JAN)'
p55135
aS'D03360'
p55136
aS'Diphenhydramine laurylsulfate (JAN)'
p55137
aS'D03535'
p55138
aS'Clemastine (USAN)'
p55139
aS'D03621'
p55140
aS'Cyclizine (INN)'
p55141
aS'D03622'
p55142
aS'Cyclizine hydrochloride (USP)'
p55143
aS'D03854'
p55144
aS'Diphenhydramine citrate (USP)'
p55145
aS'D04034'
p55146
aS'Chlorpromazine phenolphthalinate (JAN)'
p55147
aS'D04979'
p55148
aS'Methdilazine (INN)'
p55149
aS'D04980'
p55150
aS'Methdilazine hydrochloride (USP)'
p55151
aS'D05660'
p55152
aS'Pyrilamine maleate (USP)'
p55153
aS'D06063'
p55154
aS'Temelastine (USAN/INN)'
p55155
aS'D06246'
p55156
aS'Tripelennamine citrate'
p55157
aS'D07125'
p55158
aS'Alimemazine (INN)'
p55159
aS'D07198'
p55160
aS'Chlorphenoxamine (INN)'
p55161
aS'D07398'
p55162
aS'Chlorphenamine (INN)'
p55163
aS'D07402'
p55164
aS'Levocetirizine (USAN/INN)'
p55165
aS'D07482'
p55166
aS'Azatadine (INN)'
p55167
aS'D07483'
p55168
aS'Azelastine (INN)'
p55169
aS'D07543'
p55170
aS'Brompheniramine (INN)'
p55171
aS'D07547'
p55172
aS'Buclizine (INN)'
p55173
aS'D07617'
p55174
aS'Carbinoxamine (INN)'
p55175
aS'D07662'
p55176
aS'Cetirizine (INN)'
p55177
aS'D07684'
p55178
aS'Chlorphenoxamine hydrochloride'
p55179
aS'D07765'
p55180
aS'Cyproheptadine (INN)'
p55181
aS'D07803'
p55182
aS'Dexchlorpheniramine (INN)'
p55183
aS'D07862'
p55184
aS'Diphenylpyraline (INN)'
p55185
aS'D07878'
p55186
aS'Doxylamine (INN)'
p55187
aS'D07890'
p55188
aS'Emedastine (INN)'
p55189
aS'D07900'
p55190
aS'Epinastine (INN)'
p55191
aS'D07958'
p55192
aS'Fexofenadine (INN)'
p55193
aS'D08041'
p55194
aS'Homochlorcyclizine (INN)'
p55195
aS'D08054'
p55196
aS'Hydroxyzine (INN)'
p55197
aS'D08091'
p55198
aS'Isothipendyl (INN)'
p55199
aS'D08105'
p55200
aS'Ketotifen (INN)'
p55201
aS'D08117'
p55202
aS'Levocabastine (INN)'
p55203
aS'D08118'
p55204
aS'Levocetirizine hydrochloride (JAN/USAN)'
p55205
aS'D08163'
p55206
aS'Meclozine (BAN)'
p55207
aS'D08183'
p55208
aS'Mepyramine (INN)'
p55209
aS'D08184'
p55210
aS'Mepyramine theophyllineacetate'
p55211
aS'D08293'
p55212
aS'Olopatadine (INN)'
p55213
aS'D08353'
p55214
aS'Phenindamine (INN)'
p55215
aS'D08355'
p55216
aS'Pheniramine (INN)'
p55217
aS'D08432'
p55218
aS'Promethazine maleate'
p55219
aS'D08587'
p55220
aS'Thonzylamine (INN)'
p55221
aS'D08645'
p55222
aS'Tripelennamine (INN)'
p55223
aS'D08648'
p55224
aS'Triprolidine (INN)'
p55225
aS'D08768'
p55226
aS'Promethazine hibenzate'
p55227
assS'path:map07213'
p55228
(dp55229
S'ENTRY'
p55230
(lp55231
S'map07213'
p55232
aS'Drug'
p55233
aS'Pathway'
p55234
asS'PATHWAY_MAP'
p55235
(lp55236
S'map07213'
p55237
asS'NAME'
p55238
(lp55239
S'Dopamine receptor agonists/antagonists'
p55240
asS'REFERENCE'
p55241
(lp55242
g22
ag22
aS'AUTHORS'
p55243
aS'Fukai S.'
p55244
aS'TITLE'
p55245
aS'[New Drugs Today (6th ed)] (In Japanese)'
p55246
aS'JOURNAL'
p55247
aS'Jiho (1995)'
p55248
ag22
ag22
aS'AUTHORS'
p55249
aS'Katori S.'
p55250
aS'TITLE'
p55251
aS'[Standard Pharmacology (6th ed)] (In Japanese)'
p55252
aS'JOURNAL'
p55253
aS'Igaku shoin'
p55254
asS'COMPOUND'
p55255
(lp55256
S'D00136'
p55257
aS'Haloperidol (JP16/USP/INN)'
p55258
ag55257
ag55258
aS'D00270'
p55259
aS'Chlorpromazine (USP/INN)'
p55260
aS'D00274'
p55261
aS'Cisapride (USAN/INN)'
p55262
aS'D00283'
p55263
aS'Clozapine (JAN/USP/INN)'
p55264
aS'D00308'
p55265
aS'Droperidol (JP16/USP/INN)'
p55266
aS'D00426'
p55267
aS'Risperidone (JP16/USAN/INN)'
p55268
aS'D00454'
p55269
aS'Olanzapine (JAN/USAN/INN)'
p55270
aS'D00458'
p55271
aS'Quetiapine fumarate (JP16/USAN)'
p55272
aS'D00477'
p55273
aS'Procainamide hydrochloride (JP16/USP)'
p55274
aS'D00480'
p55275
aS'Promethazine hydrochloride (JP16/USP)'
p55276
aS'D00494'
p55277
aS'Promethazine (JAN/INN)'
p55278
aS'D00559'
p55279
aS'Pramipexole hydrochloride hydrate (JAN)'
p55280
aS'D00633'
p55281
aS'Dopamine hydrochloride (JP16/USP)'
p55282
aS'D00726'
p55283
aS'Metoclopramide (JP16/INN)'
p55284
aS'D00780'
p55285
aS'Bromocriptine mesilate (JP16)'
p55286
aS'D00789'
p55287
aS'Chlorpromazine hydrochloride (JP16/USP)'
p55288
aS'D00815'
p55289
aS'Imipramine hydrochloride (JP16/USP)'
p55290
aS'D01051'
p55291
aS'Spiperone (JAN/USAN)'
p55292
aS'D01164'
p55293
aS'Aripiprazole (JAN/USAN/INN)'
p55294
aS'D01226'
p55295
aS'Sulpiride (JP16/USAN/INN)'
p55296
aS'D01242'
p55297
aS'Promethazine teoclate (JAN/INN)'
p55298
aS'D01462'
p55299
aS'Lisuride maleate (JAN)'
p55300
aS'D01468'
p55301
aS'Nemonapride (JAN/INN)'
p55302
aS'D01505'
p55303
aS'Talipexole hydrochloride (JAN)'
p55304
aS'D01548'
p55305
aS'Mosapramine hydrochloride (JAN)'
p55306
aS'D01742'
p55307
aS'Clebopride malate (JP16)'
p55308
aS'D01745'
p55309
aS'Domperidone (JP16/USAN/INN)'
p55310
aS'D01898'
p55311
aS'Haloperidol decanoate (JAN/USAN)'
p55312
aS'D02004'
p55313
aS'Apomorphine hydrochloride hydrate (JAN)'
p55314
aS'D02092'
p55315
aS'Cisapride (JAN)'
p55316
aS'D02208'
p55317
aS'Sultopride hydrochloride (JAN)'
p55318
aS'D02213'
p55319
aS'Metoclopramide hydrochloride (JAN)'
p55320
aS'D02371'
p55321
aS'Clocapramine hydrochloride hydrate (JP16)'
p55322
aS'D02372'
p55323
aS'Perospirone hydrochloride hydrate (JAN)'
p55324
aS'D03165'
p55325
aS'Bromocriptine (USAN/INN)'
p55326
aS'D03274'
p55327
aS'Chlorpromazine hibenzate (JAN)'
p55328
aS'D03290'
p55329
aS'Promethazine methylenedisalicylate (JAN)'
p55330
aS'D03534'
p55331
aS'Clebopride (USAN)'
p55332
aS'D04034'
p55333
aS'Chlorpromazine phenolphthalinate (JAN)'
p55334
aS'D05575'
p55335
aS'Pramipexole (USAN/INN)'
p55336
aS'D06623'
p55337
aS'Olanzapine pamoate (USAN)'
p55338
aS'D07312'
p55339
aS'Levosulpiride (INN)'
p55340
aS'D07460'
p55341
aS'Apomorphine (BAN)'
p55342
aS'D07718'
p55343
aS'Clocapramine (INN)'
p55344
aS'D07868'
p55345
aS'Domperidone maleate'
p55346
aS'D07870'
p55347
aS'Dopamine (INN)'
p55348
aS'D08035'
p55349
aS'Haloperidol lactate'
p55350
aS'D08132'
p55351
aS'Lisuride (INN)'
p55352
aS'D08235'
p55353
aS'Mosapramine (INN)'
p55354
aS'D08421'
p55355
aS'Procainamide (INN)'
p55356
aS'D08432'
p55357
aS'Promethazine maleate'
p55358
aS'D08456'
p55359
aS'Quetiapine (INN)'
p55360
aS'D08549'
p55361
aS'Sultopride (INN)'
p55362
aS'D08558'
p55363
aS'Talipexole (INN)'
p55364
aS'D08768'
p55365
aS'Promethazine hibenzate'
p55366
assS'path:map07211'
p55367
(dp55368
S'ENTRY'
p55369
(lp55370
S'map07211'
p55371
aS'Drug'
p55372
aS'Pathway'
p55373
asS'PATHWAY_MAP'
p55374
(lp55375
S'map07211'
p55376
asS'NAME'
p55377
(lp55378
S'Serotonin receptor agonists/antagonists'
p55379
asS'REFERENCE'
p55380
(lp55381
g22
ag22
aS'AUTHORS'
p55382
aS'Sano T, Naito T, Kubo T (eds).'
p55383
aS'TITLE'
p55384
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p55385
aS'JOURNAL'
p55386
aS'Nankodo (2002)'
p55387
ag22
ag22
aS'AUTHORS'
p55388
aS'Fukai S.'
p55389
aS'TITLE'
p55390
aS'[New Drugs Today (6th ed)] (In Japanese)'
p55391
aS'JOURNAL'
p55392
aS'Jiho (1995)'
p55393
ag22
ag22
aS'AUTHORS'
p55394
aS'Noguchi S, Hibino S (eds).'
p55395
aS'TITLE'
p55396
aS'[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)'
p55397
aS'JOURNAL'
p55398
aS'Hirokawa (2002)'
p55399
aS'(ISBN4-260-10535-3)'
p55400
ag55400
aS'AUTHORS'
p55401
aS'Katori S.'
p55402
aS'TITLE'
p55403
aS'[Standard Pharmacology (6th ed)] (In Japanese)'
p55404
aS'JOURNAL'
p55405
aS'Igaku shoin'
p55406
aS'PMID:11555327'
p55407
ag55407
aS'AUTHORS'
p55408
aS'Kii Y, Nakatsuji K, Nose I, Yabuuchi M, Mizuki Y, Ito T.'
p55409
aS'TITLE'
p55410
aS'Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats.'
p55411
aS'JOURNAL'
p55412
aS'Pharmacol Toxicol 89:96-103 (2001)'
p55413
asS'COMPOUND'
p55414
(lp55415
S'C00780'
p55416
aS'Serotonin'
p55417
ag55416
ag55417
aS'D00274'
p55418
aS'Cisapride (USAN/INN)'
p55419
aS'D00283'
p55420
aS'Clozapine (JAN/USP/INN)'
p55421
aS'D00415'
p55422
aS'Zolmitriptan (JAN/USAN/INN)'
p55423
aS'D00426'
p55424
aS'Risperidone (JP16/USAN/INN)'
p55425
aS'D00451'
p55426
aS'Sumatriptan (JAN/USP/INN)'
p55427
aS'D00454'
p55428
aS'Olanzapine (JAN/USAN/INN)'
p55429
aS'D00456'
p55430
aS'Ondansetron (JAN/USP/INN)'
p55431
aS'D00676'
p55432
aS'Sumatriptan succinate (JAN/USAN)'
p55433
aS'D00677'
p55434
aS'Granisetron hydrochloride (JAN/USAN)'
p55435
aS'D00678'
p55436
aS'Ondansetron hydrochloride hydrate (JAN/USP)'
p55437
aS'D00681'
p55438
aS'Methysergide maleate (USP)'
p55439
aS'D00702'
p55440
aS'Buspirone hydrochloride (USP)'
p55441
aS'D00726'
p55442
aS'Metoclopramide (JP16/INN)'
p55443
aS'D01462'
p55444
aS'Lisuride maleate (JAN)'
p55445
aS'D01613'
p55446
aS'Azasetron hydrochloride (JAN)'
p55447
aS'D01624'
p55448
aS'Sarpogrelate hydrochloride (JP16)'
p55449
aS'D01992'
p55450
aS'Tandospirone citrate (JAN/USAN)'
p55451
aS'D01994'
p55452
aS'Mosapride citrate hydrate (JP16)'
p55453
aS'D02016'
p55454
aS'Ramosetron hydrochloride (JAN)'
p55455
aS'D02041'
p55456
aS'Tropisetron hydrochloride (JAN)'
p55457
aS'D02092'
p55458
aS'Cisapride (JAN)'
p55459
aS'D02130'
p55460
aS'Tropisetron (INN)'
p55461
aS'D02213'
p55462
aS'Metoclopramide hydrochloride (JAN)'
p55463
aS'D02357'
p55464
aS'Methysergide (USAN/INN)'
p55465
aS'D02363'
p55466
aS'Ketanserin (USAN/INN)'
p55467
aS'D02372'
p55468
aS'Perospirone hydrochloride hydrate (JAN)'
p55469
aS'D04370'
p55470
aS'Granisetron (JAN/USAN/INN)'
p55471
aS'D05008'
p55472
aS'Metoclopramide hydrochloride (USAN)'
p55473
aS'D06353'
p55474
aS'Zacopride hydrochloride (USAN)'
p55475
aS'D06396'
p55476
aS'Renzapride (INN)'
p55477
aS'D06623'
p55478
aS'Olanzapine pamoate (USAN)'
p55479
aS'D07481'
p55480
aS'Azasetron (INN)'
p55481
aS'D07593'
p55482
aS'Buspirone (INN)'
p55483
aS'D08099'
p55484
aS'Ketanserin tartrate'
p55485
aS'D08132'
p55486
aS'Lisuride (INN)'
p55487
aS'D08236'
p55488
aS'Mosapride (INN)'
p55489
aS'D08466'
p55490
aS'Ramosetron (INN)'
p55491
aS'D08508'
p55492
aS'Sarpogrelate (INN)'
p55493
aS'D08561'
p55494
aS'Tandospirone (INN)'
p55495
assS'path:map07216'
p55496
(dp55497
S'ENTRY'
p55498
(lp55499
S'map07216'
p55500
aS'Drug'
p55501
aS'Pathway'
p55502
asS'PATHWAY_MAP'
p55503
(lp55504
S'map07216'
p55505
asS'NAME'
p55506
(lp55507
S'Catecholamine transferase inhibitors'
p55508
asS'REFERENCE'
p55509
(lp55510
g22
ag22
aS'AUTHORS'
p55511
aS'Sano T, Naito T, Kubo T (eds).'
p55512
aS'TITLE'
p55513
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p55514
aS'JOURNAL'
p55515
aS'Nankodo (2002)'
p55516
ag22
ag22
aS'AUTHORS'
p55517
aS'Fukai S.'
p55518
aS'TITLE'
p55519
aS'[New Drugs Today (6th ed)] (In Japanese)'
p55520
aS'JOURNAL'
p55521
aS'Jiho (1995)'
p55522
ag22
ag22
aS'AUTHORS'
p55523
aS'Tanaka C, Kato R (eds).'
p55524
aS'TITLE'
p55525
aS'[New Pharmacology (4th ed)] (In Japanese)'
p55526
aS'JOURNAL'
p55527
aS'Nankodo (2002)'
p55528
aS'PMID:1103160'
p55529
ag55529
aS'AUTHORS'
p55530
aS'Guldberg HC, Marsden CA.'
p55531
aS'TITLE'
p55532
aS'Catechol-O-methyl transferase: pharmacological aspects and physiological role.'
p55533
aS'JOURNAL'
p55534
aS'Pharmacol Rev 27:135-206 (1975)'
p55535
aS'PMID:10565698'
p55536
ag55536
aS'AUTHORS'
p55537
aS'Micek ST, Ernst ME.'
p55538
aS'TITLE'
p55539
aS"Tolcapone: a novel approach to Parkinson's disease."
p55540
aS'JOURNAL'
p55541
aS'Am J Health Syst Pharm 56:2195-205 (1999)'
p55542
aS'PMID:16604736'
p55543
ag55543
aS'AUTHORS'
p55544
aS'.'
p55545
aS'TITLE'
p55546
aS"Tolcapone: new drug. In Parkinson's disease: unacceptable risk of severe hepatitis."
p55547
aS'JOURNAL'
p55548
aS'Prescrire Int 15:54-7 (2006)'
p55549
aS'PMID:7835624'
p55550
ag55550
aS'AUTHORS'
p55551
aS'Kaakkola S, Gordin A, Mannisto PT.'
p55552
aS'TITLE'
p55553
aS'General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase.'
p55554
aS'JOURNAL'
p55555
aS'Gen Pharmacol 25:813-24 (1994)'
p55556
aS'PMID:8119326'
p55557
ag55557
aS'AUTHORS'
p55558
aS'Tornwall M, Mannisto PT.'
p55559
aS'TITLE'
p55560
aS'Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats.'
p55561
aS'JOURNAL'
p55562
aS'Eur J Pharmacol 250:77-84 (1993)'
p55563
aS'PMID:11159700'
p55564
ag55564
aS'AUTHORS'
p55565
aS'Youdim MB, Gross A, Finberg JP.'
p55566
aS'TITLE'
p55567
aS'Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.'
p55568
aS'JOURNAL'
p55569
aS'Br J Pharmacol 132:500-6 (2001)'
p55570
aS'PMID:16402116'
p55571
ag55571
aS'AUTHORS'
p55572
aS'Youdim MB, Bakhle YS.'
p55573
aS'TITLE'
p55574
aS"Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness."
p55575
aS'JOURNAL'
p55576
aS'Br J Pharmacol 147 Suppl 1:S287-96 (2006)'
p55577
aS'PMID:10581325'
p55578
ag55578
aS'AUTHORS'
p55579
aS'Mannisto PT, Kaakkola S.'
p55580
aS'TITLE'
p55581
aS'Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.'
p55582
aS'JOURNAL'
p55583
aS'Pharmacol Rev 51:593-628 (1999)'
p55584
asS'COMPOUND'
p55585
(lp55586
S'C01108'
p55587
aS'1,2,3-Trihydroxybenzene'
p55588
ag55587
ag55588
aS'C15474'
p55589
aS'Tropolone'
p55590
aS'C15475'
p55591
aS'U 0521'
p55592
aS'C15476'
p55593
aS'Norselegiline'
p55594
aS'C15477'
p55595
aS'CGP 28014'
p55596
aS'D00152'
p55597
aS'Phloroglucinol (JAN)'
p55598
aS'D00346'
p55599
aS'Isoniazid (JP16/USP/INN)'
p55600
aS'D00505'
p55601
aS'Phenelzine sulfate (USP)'
p55602
aS'D00781'
p55603
aS'Entacapone (JAN/USAN/INN)'
p55604
aS'D00785'
p55605
aS'Selegiline hydrochloride (JAN/USP)'
p55606
aS'D00786'
p55607
aS'Tolcapone (JAN/USAN/INN)'
p55608
aS'D00826'
p55609
aS'Tranylcypromine sulfate (USP XXI)'
p55610
aS'D01097'
p55611
aS'Lazabemide hydrochloride (JAN/USAN)'
p55612
aS'D01259'
p55613
aS'Flopropione (JP16/INN)'
p55614
aS'D01365'
p55615
aS'Trepibutone (JP16/INN)'
p55616
aS'D01888'
p55617
aS'Safrazine hydrochloride (JAN)'
p55618
aS'D02559'
p55619
aS'Toloxatone (INN)'
p55620
aS'D02560'
p55621
aS'Brofaromine (INN)'
p55622
aS'D02561'
p55623
aS'Moclobemide (USAN/INN)'
p55624
aS'D02562'
p55625
aS'Rasagiline mesylate (USAN)'
p55626
aS'D02563'
p55627
aS'Befloxatone (INN)'
p55628
aS'D02564'
p55629
aS'Pargyline hydrochloride (USAN)'
p55630
aS'D02579'
p55631
aS'Iproniazid (INN)'
p55632
aS'D02580'
p55633
aS'Isocarboxazid (INN)'
p55634
aS'D03239'
p55635
aS'Ladostigil tartrate (USAN)'
p55636
aS'D03241'
p55637
aS'Nitecapone (INN)'
p55638
aS'D03248'
p55639
aS'Clorgiline (INN)'
p55640
aS'D03731'
p55641
aS'Selegiline (USAN/INN)'
p55642
aS'D04681'
p55643
aS'Lazabemide (USAN/INN)'
p55644
aS'D08085'
p55645
aS'Iproniazid phosphate'
p55646
aS'D08349'
p55647
aS'Phenelzine (BAN)'
p55648
aS'D08453'
p55649
aS'Pargyline (INN)'
p55650
aS'D08469'
p55651
aS'Rasagiline (USAN/INN)'
p55652
aS'D08625'
p55653
aS'Tranylcypromine (INN)'
p55654
assS'path:map07217'
p55655
(dp55656
S'ENTRY'
p55657
(lp55658
S'map07217'
p55659
aS'Drug'
p55660
aS'Pathway'
p55661
asS'PATHWAY_MAP'
p55662
(lp55663
S'map07217'
p55664
asS'NAME'
p55665
(lp55666
S'Renin-angiotensin system inhibitors'
p55667
asS'REFERENCE'
p55668
(lp55669
g22
ag22
aS'AUTHORS'
p55670
aS'Sano T, Naito T, Kubo T (eds).'
p55671
aS'TITLE'
p55672
aS'[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)'
p55673
aS'JOURNAL'
p55674
aS'Nankodo (2002)'
p55675
ag22
ag22
aS'AUTHORS'
p55676
aS'Fukai S.'
p55677
aS'TITLE'
p55678
aS'[New Drugs Today (6th ed)] (In Japanese)'
p55679
aS'JOURNAL'
p55680
aS'Jiho (1995)'
p55681
ag22
ag22
aS'AUTHORS'
p55682
aS'Walter S.'
p55683
aS'TITLE'
p55684
aS'Drug Discovery: A History'
p55685
aS'JOURNAL'
p55686
aS'Wiley (2005)'
p55687
ag22
ag22
aS'AUTHORS'
p55688
aS'Japan Pharmaceutical Association (ed).'
p55689
aS'TITLE'
p55690
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p55691
aS'JOURNAL'
p55692
aS'Yakuji Nippo (1999)'
p55693
aS'PMID:14526382'
p55694
ag55694
aS'AUTHORS'
p55695
aS'Lewis RJ, Garcia ML.'
p55696
aS'TITLE'
p55697
aS'Therapeutic potential of venom peptides.'
p55698
aS'JOURNAL'
p55699
aS'Nat Rev Drug Discov 2:790-802 (2003)'
p55700
aS'PMID:10579749'
p55701
ag55701
aS'AUTHORS'
p55702
aS'Timmermans PB.'
p55703
aS'TITLE'
p55704
aS'Pharmacological properties of angiotensin II receptor antagonists.'
p55705
aS'JOURNAL'
p55706
aS'Can J Cardiol 15 Suppl F:26F-8F (1999)'
p55707
asS'COMPOUND'
p55708
(lp55709
S'C11711'
p55710
aS'Succinylproline'
p55711
ag55710
ag55711
aS'C11712'
p55712
aS'Teprotide'
p55713
aS'D00251'
p55714
aS'Captopril (JP16/USP/INN)'
p55715
aS'D00362'
p55716
aS'Lisinopril hydrate (JP16)'
p55717
aS'D00421'
p55718
aS'Ramipril (USP/INN)'
p55719
aS'D00459'
p55720
aS'Quinapril hydrochloride (JP16/USP)'
p55721
aS'D00620'
p55722
aS'Benazepril hydrochloride (JAN/USAN)'
p55723
aS'D00621'
p55724
aS'Enalapril maleate (JP16/USP)'
p55725
aS'D00622'
p55726
aS'Fosinopril sodium (USAN)'
p55727
aS'D01069'
p55728
aS'Cilazapril hydrate (JP16)'
p55729
aS'D01119'
p55730
aS'Temocapril hydrochloride (JP16/USAN)'
p55731
aS'D01549'
p55732
aS'Imidapril hydrochloride (JP16)'
p55733
aS'D01667'
p55734
aS'Delapril hydrochloride (JAN/USAN)'
p55735
aS'D01900'
p55736
aS'Alacepril (JP16/INN)'
p55737
aS'D03208'
p55738
aS'Aliskiren (USAN/INN)'
p55739
aS'D03440'
p55740
aS'Ceronapril (USAN/INN)'
p55741
aS'D03738'
p55742
aS'Enalkiren (USAN/INN)'
p55743
aS'D03752'
p55744
aS'Quinapril (USP/INN)'
p55745
aS'D03756'
p55746
aS'Indolapril hydrochloride (USAN)'
p55747
aS'D03769'
p55748
aS'Enalaprilat (USP)'
p55749
aS'D06076'
p55750
aS'Teprotide (USAN/INN)'
p55751
aS'D06412'
p55752
aS'Aliskiren fumarate (JAN/USAN)'
p55753
aS'D07499'
p55754
aS'Benazepril (INN)'
p55755
aS'D07699'
p55756
aS'Cilazapril (INN)'
p55757
aS'D07781'
p55758
aS'Delapril'
p55759
aS'(INN)'
p55760
aS'D07892'
p55761
aS'Enalapril (INN)'
p55762
aS'D07992'
p55763
aS'Fosinopril (INN)'
p55764
aS'D08068'
p55765
aS'Imidapril (INN)'
p55766
aS'D08131'
p55767
aS'Lisinopril (INN)'
p55768
aS'D08566'
p55769
aS'Temocapril (INN)'
p55770
aS'D09038'
p55771
aS'Remikiren (INN)'
p55772
assS'path:map07214'
p55773
(dp55774
S'ENTRY'
p55775
(lp55776
S'map07214'
p55777
aS'Drug'
p55778
aS'Pathway'
p55779
asS'PATHWAY_MAP'
p55780
(lp55781
S'map07214'
p55782
asS'NAME'
p55783
(lp55784
S'beta-Adrenergic receptor agonists/antagonists'
p55785
asS'COMPOUND'
p55786
(lp55787
S'C11772'
p55788
aS'DCI'
p55789
ag55788
ag55789
aS'D00095'
p55790
aS'Adrenaline (JP16)'
p55791
aS'D00235'
p55792
aS'Atenolol (JP16/USP/INN)'
p55793
aS'D00483'
p55794
aS'Propranolol hydrochloride (JP16/USP)'
p55795
aS'D00513'
p55796
aS'Pindolol (JP16/USP/INN)'
p55797
aS'D00600'
p55798
aS'Labetalol hydrochloride (JP16/USP)'
p55799
aS'D00601'
p55800
aS'Metoprolol tartrate (JP16/USP)'
p55801
aS'D00632'
p55802
aS'Dobutamine hydrochloride (JP16/USP)'
p55803
aS'D00634'
p55804
aS'Bisoprolol fumarate (JP16/USP)'
p55805
aS'D00635'
p55806
aS'Metoprolol succinate (USP)'
p55807
aS'D00644'
p55808
aS'Esmolol hydrochloride (JAN/USAN)'
p55809
aS'D00685'
p55810
aS'Orciprenaline sulfate (JP16)'
p55811
aS'D00996'
p55812
aS'Epinephrine hydrochloride (JAN)'
p55813
aS'D01182'
p55814
aS'Alprenolol hydrochloride (JP16/USAN)'
p55815
aS'D01369'
p55816
aS'Bevantolol hydrochloride (JAN/USAN)'
p55817
aS'D01390'
p55818
aS'dl-Isoprenaline hydrochloride (JAN)'
p55819
aS'D01469'
p55820
aS'Amosulalol hydrochloride (JP16)'
p55821
aS'D01830'
p55822
aS'Arotinolol hydrochloride (JP16)'
p55823
aS'D02066'
p55824
aS'Isoprenaline sulfate (JAN)'
p55825
aS'D02149'
p55826
aS'Epinephrine bitartrate (JAN/USP)'
p55827
aS'D02150'
p55828
aS'l-Isoprenaline hydrochloride (JP16)'
p55829
aS'D02342'
p55830
aS'Bisoprolol (JAN/USAN/INN)'
p55831
aS'D02358'
p55832
aS'Metoprolol (USAN/INN)'
p55833
aS'D02404'
p55834
aS'Procaterol hydrochloride (USAN)'
p55835
aS'D02614'
p55836
aS'Denopamine (JAN/INN)'
p55837
aS'D03879'
p55838
aS'Dobutamine (USP/INN)'
p55839
aS'D03880'
p55840
aS'Dobutamine lactobionate (USAN)'
p55841
aS'D03881'
p55842
aS'Dobutamine tartrate (USP)'
p55843
aS'D05011'
p55844
aS'Metoprolol fumarate (USP)'
p55845
aS'D05366'
p55846
aS'Procaterol hydrochloride hydrate (JP16)'
p55847
aS'D07156'
p55848
aS'Alprenolol (INN)'
p55849
aS'D07451'
p55850
aS'Amosulalol (INN)'
p55851
aS'D07465'
p55852
aS'Arotinolol (INN)'
p55853
aS'D07916'
p55854
aS'Esmolol (INN)'
p55855
aS'D08090'
p55856
aS'Isoprenaline (INN)'
p55857
aS'D08106'
p55858
aS'Labetalol (INN)'
p55859
aS'D08300'
p55860
aS'Orciprenaline (INN)'
p55861
aS'D08424'
p55862
aS'Procaterol (INN)'
p55863
aS'D08443'
p55864
aS'Propranolol (INN)'
p55865
assS'path:map07042'
p55866
(dp55867
S'ENTRY'
p55868
(lp55869
S'map07042'
p55870
aS'Drug'
p55871
aS'Pathway'
p55872
asS'PATHWAY_MAP'
p55873
(lp55874
S'map07042'
p55875
asS'NAME'
p55876
(lp55877
S'Antineoplastics - agents from natural products'
p55878
asS'REFERENCE'
p55879
(lp55880
g22
ag22
aS'AUTHORS'
p55881
aS'Skeel RT (ed).'
p55882
aS'TITLE'
p55883
aS'[Handbook of Cancer Chemotherapy (6th ed)] (In Japanese)'
p55884
aS'JOURNAL'
p55885
aS'Medical science international (2005)'
p55886
ag22
ag22
aS'AUTHORS'
p55887
aS'Fukai S.'
p55888
aS'TITLE'
p55889
aS'[New Drugs Today (6th ed)] (In Japanese)'
p55890
aS'JOURNAL'
p55891
aS'Jiho (1995)'
p55892
ag22
ag22
aS'AUTHORS'
p55893
aS'Japan Pharmaceutical Association (ed).'
p55894
aS'TITLE'
p55895
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p55896
aS'JOURNAL'
p55897
aS'Yakuji Nippo (1999)'
p55898
ag22
ag22
aS'AUTHORS'
p55899
aS'Tanaka C, Kato R (eds).'
p55900
aS'TITLE'
p55901
aS'[New Pharmacology (4th ed)] (In Japanese)'
p55902
aS'JOURNAL'
p55903
aS'Nankodo (2002)'
p55904
ag22
ag22
aS'AUTHORS'
p55905
aS'Walter S.'
p55906
aS'TITLE'
p55907
aS'Drug Discovery: A History'
p55908
aS'JOURNAL'
p55909
aS'Wiley (2005)'
p55910
ag22
ag22
aS'AUTHORS'
p55911
aS'David AW, Thomas LL, William OF.'
p55912
aS'TITLE'
p55913
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p55914
aS'JOURNAL'
p55915
aS'Lippincott Williams & Wilkins (2002)'
p55916
ag22
ag22
aS'AUTHORS'
p55917
aS'Bertram GK (ed).'
p55918
aS'TITLE'
p55919
aS'Basic & Clinical Pharmacology (9th ed)'
p55920
aS'JOURNAL'
p55921
aS'Lange (2004)'
p55922
asS'COMPOUND'
p55923
(lp55924
S'C01897'
p55925
aS'Camptothecin'
p55926
ag55925
ag55926
aS'D00125'
p55927
aS'Etoposide (JP16/USP/INN)'
p55928
aS'D00208'
p55929
aS'Mitomycin C (JP16)'
p55930
aS'D00214'
p55931
aS'Actinomycin D (JP16)'
p55932
aS'D00491'
p55933
aS'Paclitaxel (JAN/USP/INN)'
p55934
aS'D00753'
p55935
aS'Sirolimus (JAN/USAN/INN)'
p55936
aS'D01061'
p55937
aS'Irinotecan hydrochloride hydrate (JAN)'
p55938
aS'D01068'
p55939
aS'Vinblastine sulfate (JP16/USP)'
p55940
aS'D01264'
p55941
aS'Daunorubicin hydrochloride (JP16/USP)'
p55942
aS'D01275'
p55943
aS'Doxorubicin hydrochloride (JP16/USP)'
p55944
aS'D01747'
p55945
aS'Idarubicin hydrochloride (JP16/USP)'
p55946
aS'D01769'
p55947
aS'Vindesine sulfate (JAN/USAN)'
p55948
aS'D01885'
p55949
aS'Pirarubicin (JP16/INN)'
p55950
aS'D01911'
p55951
aS'Aclarubicin hydrochloride (JP16)'
p55952
aS'D01935'
p55953
aS'Vinorelbine ditartrate (JAN)'
p55954
aS'D02063'
p55955
aS'Peplomycin sulfate (JP16/USAN)'
p55956
aS'D02165'
p55957
aS'Docetaxel hydrate (JP16)'
p55958
aS'D02166'
p55959
aS'Mitoxantrone hydrochloride (JAN/USP)'
p55960
aS'D02168'
p55961
aS'Nogitecan hydrochloride (JAN)'
p55962
aS'D02177'
p55963
aS'Bleomycin sulfate (JP16/USP)'
p55964
aS'D02197'
p55965
aS'Vincristine sulfate (JP16/USP)'
p55966
aS'D02214'
p55967
aS'Epirubicin hydrochloride (JP16/USAN)'
p55968
aS'D02698'
p55969
aS'Teniposide (USAN/INN)'
p55970
aS'D02714'
p55971
aS'Everolimus (JAN/USAN/INN)'
p55972
aS'D02756'
p55973
aS'Aclarubicin (USAN/INN)'
p55974
aS'D03229'
p55975
aS'Bleomycin hydrochloride (JP16)'
p55976
aS'D03899'
p55977
aS'Doxorubicin (USAN/INN)'
p55978
aS'D04107'
p55979
aS'Etoposide phosphate (USAN)'
p55980
aS'D05333'
p55981
aS'Paclitaxel poliglumex (USAN/INN)'
p55982
aS'D05529'
p55983
aS'Podofilox (USAN)'
p55984
aS'D06068'
p55985
aS'Temsirolimus (JAN/USAN/INN)'
p55986
aS'D06304'
p55987
aS'Vindesine (USAN/INN)'
p55988
aS'D07100'
p55989
aS'Amrubicin hydrochloride (JAN/USAN)'
p55990
aS'D07535'
p55991
aS'Bleomycin (INN)'
p55992
aS'D07776'
p55993
aS'Daunorubicin (INN)'
p55994
aS'D07866'
p55995
aS'Docetaxel (JAN/INN)'
p55996
aS'D07901'
p55997
aS'Epirubicin (INN)'
p55998
aS'D08062'
p55999
aS'Idarubicin (INN)'
p56000
aS'D08086'
p56001
aS'Irinotecan (INN)'
p56002
aS'D08224'
p56003
aS'Mitoxantrone (INN)'
p56004
aS'D08336'
p56005
aS'Peplomycin (INN)'
p56006
aS'D08386'
p56007
aS'Pirarubicin hydrochloride'
p56008
aS'D08618'
p56009
aS'Topotecan (BAN)'
p56010
aS'D08675'
p56011
aS'Vinblastine (INN)'
p56012
aS'D08679'
p56013
aS'Vincristine (INN)'
p56014
aS'D08680'
p56015
aS'Vinorelbine (INN)'
p56016
aS'D08854'
p56017
aS'Amrubicin (USAN/INN)'
p56018
assS'path:map07041'
p56019
(dp56020
S'ENTRY'
p56021
(lp56022
S'map07041'
p56023
aS'Drug'
p56024
aS'Pathway'
p56025
asS'PATHWAY_MAP'
p56026
(lp56027
S'map07041'
p56028
asS'NAME'
p56029
(lp56030
S'Antineoplastics - antimetabolic agents'
p56031
asS'REFERENCE'
p56032
(lp56033
g22
ag22
aS'AUTHORS'
p56034
aS'Skeel RT (ed).'
p56035
aS'TITLE'
p56036
aS'[Handbook of Cancer Chemotherapy (6th ed)] (In Japanese)'
p56037
aS'JOURNAL'
p56038
aS'Medical science international (2005)'
p56039
ag22
ag22
aS'AUTHORS'
p56040
aS'Fukai S.'
p56041
aS'TITLE'
p56042
aS'[New Drugs Today (6th ed)] (In Japanese)'
p56043
aS'JOURNAL'
p56044
aS'Jiho (1995)'
p56045
ag22
ag22
aS'AUTHORS'
p56046
aS'Japan Pharmaceutical Association (ed).'
p56047
aS'TITLE'
p56048
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p56049
aS'JOURNAL'
p56050
aS'Yakuji Nippo (1999)'
p56051
ag22
ag22
aS'AUTHORS'
p56052
aS'Tanaka C, Kato R (eds).'
p56053
aS'TITLE'
p56054
aS'[New Pharmacology (4th ed)] (In Japanese)'
p56055
aS'JOURNAL'
p56056
aS'Nankodo (2002)'
p56057
ag22
ag22
aS'AUTHORS'
p56058
aS'Walter S.'
p56059
aS'TITLE'
p56060
aS'Drug Discovery: A History'
p56061
aS'JOURNAL'
p56062
aS'Wiley (2005)'
p56063
ag22
ag22
aS'AUTHORS'
p56064
aS'David AW, Thomas LL, William OF.'
p56065
aS'TITLE'
p56066
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p56067
aS'JOURNAL'
p56068
aS'Lippincott Williams & Wilkins (2002)'
p56069
ag22
ag22
aS'AUTHORS'
p56070
aS'Bertram GK (ed).'
p56071
aS'TITLE'
p56072
aS'Basic & Clinical Pharmacology (9th ed)'
p56073
aS'JOURNAL'
p56074
aS'Lange (2004)'
p56075
ag22
ag22
aS'AUTHORS'
p56076
aS'Kijjoa A, Sawangwong P.'
p56077
aS'TITLE'
p56078
aS'Drugs and cosmetics from the sea.'
p56079
aS'JOURNAL'
p56080
aS'Marine Drugs 2:73-82 (2004)'
p56081
aS'(Japanese)'
p56082
ag56082
aS'AUTHORS'
p56083
aS'Wermuth CG (ed).'
p56084
aS'TITLE'
p56085
aS'[The Practice of Medicinal Chemistry vol.1 (2nd ed)] (In Japanese)'
p56086
aS'JOURNAL'
p56087
aS'Technomics (2006)'
p56088
asS'COMPOUND'
p56089
(lp56090
S'D00142'
p56091
aS'Methotrexate (JP16/USP/INN)'
p56092
ag56091
ag56092
aS'D00155'
p56093
aS'Pentostatin (JAN/USAN/INN)'
p56094
aS'D00161'
p56095
aS'Mercaptopurine hydrate (JP16)'
p56096
aS'D00168'
p56097
aS'Cytarabine (JP16/USP/INN)'
p56098
aS'D00341'
p56099
aS'Hydroxycarbamide (JAN/INN)'
p56100
aS'D00406'
p56101
aS'Vidarabine (USP)'
p56102
aS'D00584'
p56103
aS'Fluorouracil (JP16/USP/INN)'
p56104
aS'D01064'
p56105
aS'Raltitrexed (JAN/USAN/INN)'
p56106
aS'D01155'
p56107
aS'Gemcitabine hydrochloride (JAN/USAN)'
p56108
aS'D01223'
p56109
aS'Capecitabine (JAN/USAN/INN)'
p56110
aS'D01244'
p56111
aS'Tegafur (JP16/USAN/INN)'
p56112
aS'D01309'
p56113
aS'Doxifluridine (JP16/INN)'
p56114
aS'D01370'
p56115
aS'Cladribine (JAN/USAN/INN)'
p56116
aS'D01651'
p56117
aS'Ancitabine hydrochloride (JAN)'
p56118
aS'D01678'
p56119
aS'Thioinosine (JAN)'
p56120
aS'D01907'
p56121
aS'Fludarabine phosphate (JAN/USP)'
p56122
aS'D02115'
p56123
aS'Methotrexate sodium'
p56124
aS'D02368'
p56125
aS'Gemcitabine (USAN/INN)'
p56126
aS'D02527'
p56127
aS'Aminopterin sodium (INN)'
p56128
aS'D03021'
p56129
aS'Azacitidine (JAN/USAN/INN)'
p56130
aS'D03637'
p56131
aS'Cytarabine hydrochloride (USAN)'
p56132
aS'D03828'
p56133
aS'Pemetrexed disodium (USAN)'
p56134
aS'D04197'
p56135
aS'Floxuridine (USP/INN)'
p56136
aS'D04931'
p56137
aS'Mercaptopurine (INN)'
p56138
aS'D06109'
p56139
aS'Thioguanine (USP)'
p56140
aS'D06238'
p56141
aS'Trimetrexate (USAN/INN)'
p56142
aS'D06239'
p56143
aS'Trimetrexate glucuronate (USAN)'
p56144
aS'D06298'
p56145
aS'Vidarabine (JAN)'
p56146
aS'D06300'
p56147
aS'Vidarabine sodium phosphate (USAN)'
p56148
aS'D06503'
p56149
aS'Pemetrexed sodium hydrate (JAN)'
p56150
aS'D07472'
p56151
aS'Pemetrexed (INN)'
p56152
aS'D07966'
p56153
aS'Fludarabine (INN)'
p56154
aS'D07974'
p56155
aS'Fluorouracil sodium salt'
p56156
assS'path:map07040'
p56157
(dp56158
S'ENTRY'
p56159
(lp56160
S'map07040'
p56161
aS'Drug'
p56162
aS'Pathway'
p56163
asS'PATHWAY_MAP'
p56164
(lp56165
S'map07040'
p56166
asS'NAME'
p56167
(lp56168
S'Antineoplastics - alkylating agents'
p56169
asS'REFERENCE'
p56170
(lp56171
S'(Japanese)'
p56172
ag56172
aS'AUTHORS'
p56173
aS'Skeel RT (ed).'
p56174
aS'TITLE'
p56175
aS'[Handbook of Cancer Chemotherapy (6th ed)] (In Japanese)'
p56176
aS'JOURNAL'
p56177
aS'Medical science international (2005)'
p56178
ag22
ag22
aS'AUTHORS'
p56179
aS'Fukai S.'
p56180
aS'TITLE'
p56181
aS'[New Drugs Today (6th ed)] (In Japanese)'
p56182
aS'JOURNAL'
p56183
aS'Jiho (1995)'
p56184
ag22
ag22
aS'AUTHORS'
p56185
aS'Japan Pharmaceutical Association (ed).'
p56186
aS'TITLE'
p56187
aS'[Face of Medecine: Structure Activity Relationship] (In Japanese)'
p56188
aS'JOURNAL'
p56189
aS'Yakuji Nippo (1999)'
p56190
ag22
ag22
aS'AUTHORS'
p56191
aS'Tanaka C, Kato R (eds).'
p56192
aS'TITLE'
p56193
aS'[New Pharmacology (4th ed)] (In Japanese)'
p56194
aS'JOURNAL'
p56195
aS'Nankodo (2002)'
p56196
ag22
ag22
aS'AUTHORS'
p56197
aS'Walter S.'
p56198
aS'TITLE'
p56199
aS'Drug Discovery: A History'
p56200
aS'JOURNAL'
p56201
aS'Wiley (2005)'
p56202
ag22
ag22
aS'AUTHORS'
p56203
aS'David AW, Thomas LL, William OF.'
p56204
aS'TITLE'
p56205
aS"Foye's Principles of Medicinal Chemistry (5th ed)"
p56206
aS'JOURNAL'
p56207
aS'Lippincott Williams & Wilkins (2002)'
p56208
ag22
ag22
aS'AUTHORS'
p56209
aS'Bertram GK (ed).'
p56210
aS'TITLE'
p56211
aS'Basic & Clinical Pharmacology (9th ed)'
p56212
aS'JOURNAL'
p56213
aS'Lange (2004)'
p56214
asS'COMPOUND'
p56215
(lp56216
S'C07642'
p56217
aS'Triethylenemelamine'
p56218
ag56217
ag56218
aS'C14595'
p56219
aS'Methylnitrosourea'
p56220
aS'C16250'
p56221
aS'MTIC'
p56222
aS'D00208'
p56223
aS'Mitomycin C (JP16)'
p56224
aS'D00248'
p56225
aS'Busulfan (JP16/USP/INN)'
p56226
aS'D00254'
p56227
aS'Carmustine (JAN/USAN/INN)'
p56228
aS'D00266'
p56229
aS'Chlorambucil (USP/INN)'
p56230
aS'D00275'
p56231
aS'Cisplatin (JP16/USP/INN)'
p56232
aS'D00287'
p56233
aS'Cyclophosphamide hydrate (JP16)'
p56234
aS'D00288'
p56235
aS'Dacarbazine (JAN/USP/INN)'
p56236
aS'D00343'
p56237
aS'Ifosfamide (JAN/USP/INN)'
p56238
aS'D00363'
p56239
aS'Lomustine (USAN/INN)'
p56240
aS'D00369'
p56241
aS'Melphalan (JP16/USP/INN)'
p56242
aS'D00583'
p56243
aS'Thiotepa (JAN/USP/INN)'
p56244
aS'D01059'
p56245
aS'Nimustine hydrochloride (JAN)'
p56246
aS'D01270'
p56247
aS'Carboquone (JAN/INN)'
p56248
aS'D01363'
p56249
aS'Carboplatin (JP16/USP/INN)'
p56250
aS'D01416'
p56251
aS'Nedaplatin (JAN/INN)'
p56252
aS'D01493'
p56253
aS'Nitrogen mustard N-oxide hydrochloride (JAN)'
p56254
aS'D01760'
p56255
aS'Ranimustine (JAN/INN)'
p56256
aS'D01790'
p56257
aS'Oxaliplatin (JAN/USAN/INN)'
p56258
aS'D02398'
p56259
aS'Estramustine phosphate sodium (USAN)'
p56260
aS'D04066'
p56261
aS'Estramustine (USAN/INN)'
p56262
aS'D04872'
p56263
aS'Mechlorethamine hydrochloride (USP)'
p56264
aS'D05822'
p56265
aS'Semustine (USAN/INN)'
p56266
aS'D05932'
p56267
aS'Streptozocin (JAN/USAN/INN)'
p56268
aS'D06067'
p56269
aS'Temozolomide (JAN/USAN/INN)'
p56270
aS'D06294'
p56271
aS'Miriplatin hydrate (JAN)'
p56272
aS'D06397'
p56273
aS'Estramustine phosphate sodium hydrate (JAN)'
p56274
aS'D07671'
p56275
aS'Chlormethine (INN)'
p56276
aS'D07760'
p56277
aS'Cyclophosphamide (INN)'
p56278
aS'D07772'
p56279
aS'Dacarbazine citrate'
p56280
aS'D08173'
p56281
aS'Melphalan hydrochloride'
p56282
aS'D08276'
p56283
aS'Nimustine (INN)'
p56284
assS'path:map05230'
p56285
(dp56286
S'NAME'
p56287
(lp56288
S'Central carbon metabolism in cancer'
p56289
asS'REFERENCE'
p56290
(lp56291
S'PMID:23279446'
p56292
ag56292
aS'AUTHORS'
p56293
aS'Soga T'
p56294
aS'TITLE'
p56295
aS'Cancer metabolism: key players in metabolic reprogramming.'
p56296
aS'JOURNAL'
p56297
aS'Cancer Sci 104:275-81 (2013)'
p56298
aS'PMID:19460998'
p56299
ag56299
aS'AUTHORS'
p56300
aS'Vander Heiden MG, Cantley LC, Thompson CB'
p56301
aS'TITLE'
p56302
aS'Understanding the Warburg effect: the metabolic requirements of cell proliferation.'
p56303
aS'JOURNAL'
p56304
aS'Science 324:1029-33 (2009)'
p56305
aS'PMID:23071355'
p56306
ag56306
aS'AUTHORS'
p56307
aS'Teicher BA, Linehan WM, Helman LJ'
p56308
aS'TITLE'
p56309
aS'Targeting cancer metabolism.'
p56310
aS'JOURNAL'
p56311
aS'Clin Cancer Res 18:5537-45 (2012)'
p56312
aS'PMID:21127244'
p56313
ag56313
aS'AUTHORS'
p56314
aS'Levine AJ, Puzio-Kuter AM'
p56315
aS'TITLE'
p56316
aS'The control of the metabolic switch in cancers by oncogenes and tumor suppressor'
p56317
aS'genes.'
p56318
aS'JOURNAL'
p56319
aS'Science 330:1340-4 (2010)'
p56320
aS'PMID:24079832'
p56321
ag56321
aS'AUTHORS'
p56322
aS'Amoedo ND, Valencia JP, Rodrigues MF, Galina A, Rumjanek FD'
p56323
aS'TITLE'
p56324
aS'How does the metabolism of tumour cells differ from that of normal cells.'
p56325
aS'JOURNAL'
p56326
aS'Biosci Rep 33 (2013)'
p56327
aS'PMID:21258394'
p56328
ag56328
aS'AUTHORS'
p56329
aS'Cairns RA, Harris IS, Mak TW'
p56330
aS'TITLE'
p56331
aS'Regulation of cancer cell metabolism.'
p56332
aS'JOURNAL'
p56333
aS'Nat Rev Cancer 11:85-95 (2011)'
p56334
aS'PMID:22237205'
p56335
ag56335
aS'AUTHORS'
p56336
aS'Munoz-Pinedo C, El Mjiyad N, Ricci JE'
p56337
aS'TITLE'
p56338
aS'Cancer metabolism: current perspectives and future directions.'
p56339
aS'JOURNAL'
p56340
aS'Cell Death Dis 3:e248 (2012)'
p56341
aS'PMID:22156302'
p56342
ag56342
aS'AUTHORS'
p56343
aS'Cairns RA, Harris I, McCracken S, Mak TW'
p56344
aS'TITLE'
p56345
aS'Cancer cell metabolism.'
p56346
aS'JOURNAL'
p56347
aS'Cold Spring Harb Symp Quant Biol 76:299-311 (2011)'
p56348
aS'PMID:18538731'
p56349
ag56349
aS'AUTHORS'
p56350
aS'Kroemer G, Pouyssegur J'
p56351
aS'TITLE'
p56352
aS"Tumor cell metabolism: cancer's Achilles' heel."
p56353
aS'JOURNAL'
p56354
aS'Cancer Cell 13:472-82 (2008)'
p56355
aS'PMID:18177721'
p56356
ag56356
aS'AUTHORS'
p56357
aS'DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB'
p56358
aS'TITLE'
p56359
aS'The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.'
p56360
aS'JOURNAL'
p56361
aS'Cell Metab 7:11-20 (2008)'
p56362
aS'PMID:21508971'
p56363
ag56363
aS'AUTHORS'
p56364
aS'Koppenol WH, Bounds PL, Dang CV'
p56365
aS'TITLE'
p56366
aS"Otto Warburg's contributions to current concepts of cancer metabolism."
p56367
aS'JOURNAL'
p56368
aS'Nat Rev Cancer 11:325-37 (2011)'
p56369
aS'PMID:21801601'
p56370
ag56370
aS'AUTHORS'
p56371
aS'Fogg VC, Lanning NJ, Mackeigan JP'
p56372
aS'TITLE'
p56373
aS'Mitochondria in cancer: at the crossroads of life and death.'
p56374
aS'JOURNAL'
p56375
aS'Chin J Cancer 30:526-39 (2011)'
p56376
aS'PMID:16982728'
p56377
ag56377
aS'AUTHORS'
p56378
aS'Kim JW, Dang CV'
p56379
aS'TITLE'
p56380
aS"Cancer's molecular sweet tooth and the Warburg effect."
p56381
aS'JOURNAL'
p56382
aS'Cancer Res 66:8927-30 (2006)'
p56383
aS'PMID:18766298'
p56384
ag56384
aS'AUTHORS'
p56385
aS'Yeung SJ, Pan J, Lee MH'
p56386
aS'TITLE'
p56387
aS'Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer.'
p56388
aS'JOURNAL'
p56389
aS'Cell Mol Life Sci 65:3981-99 (2008)'
p56390
aS'PMID:23897900'
p56391
ag56391
aS'AUTHORS'
p56392
aS'Li B, Simon MC'
p56393
aS'TITLE'
p56394
aS'Molecular Pathways: Targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer.'
p56395
aS'JOURNAL'
p56396
aS'Clin Cancer Res 19:5835-41 (2013)'
p56397
aS'PMID:22307140'
p56398
ag56398
aS'AUTHORS'
p56399
aS'Shen L, Sun X, Fu Z, Yang G, Li J, Yao L'
p56400
aS'TITLE'
p56401
aS'The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy.'
p56402
aS'JOURNAL'
p56403
aS'Clin Cancer Res 18:1561-7 (2012)'
p56404
aS'PMID:19270154'
p56405
ag56405
aS'AUTHORS'
p56406
aS'Jones RG, Thompson CB'
p56407
aS'TITLE'
p56408
aS'Tumor suppressors and cell metabolism: a recipe for cancer growth.'
p56409
aS'JOURNAL'
p56410
aS'Genes Dev 23:537-48 (2009)'
p56411
aS'PMID:21340684'
p56412
ag56412
aS'AUTHORS'
p56413
aS'Maddocks OD, Vousden KH'
p56414
aS'TITLE'
p56415
aS'Metabolic regulation by p53.'
p56416
aS'JOURNAL'
p56417
aS'J Mol Med (Berl) 89:237-45 (2011)'
p56418
aS'PMID:22750268'
p56419
ag56419
aS'AUTHORS'
p56420
aS'Chen JQ, Russo J'
p56421
aS'TITLE'
p56422
aS'Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.'
p56423
aS'JOURNAL'
p56424
aS'Biochim Biophys Acta 1826:370-84 (2012)'
p56425
aS'PMID:20520704'
p56426
ag56426
aS'AUTHORS'
p56427
aS'Kaelin WG Jr, Thompson CB'
p56428
aS'TITLE'
p56429
aS'Q&ampA: Cancer: clues from cell metabolism.'
p56430
aS'JOURNAL'
p56431
aS'Nature 465:562-4 (2010)'
p56432
aS'PMID:24113830'
p56433
ag56433
aS'AUTHORS'
p56434
aS'Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G'
p56435
aS'TITLE'
p56436
aS'Metabolic targets for cancer therapy.'
p56437
aS'JOURNAL'
p56438
aS'Nat Rev Drug Discov 12:829-46 (2013)'
p56439
aS'PMID:24738035'
p56440
ag56440
aS'AUTHORS'
p56441
aS'Phan LM, Yeung SC, Lee MH'
p56442
aS'TITLE'
p56443
aS'Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies.'
p56444
aS'JOURNAL'
p56445
aS'Cancer Biol Med 11:1-19 (2014)'
p56446
aS'PMID:22101401'
p56447
ag56447
aS'AUTHORS'
p56448
aS'Icard P, Poulain L, Lincet H'
p56449
aS'TITLE'
p56450
aS'Understanding the central role of citrate in the metabolism of cancer cells.'
p56451
aS'JOURNAL'
p56452
aS'Biochim Biophys Acta 1825:111-6 (2012)'
p56453
aS'PMID:22349059'
p56454
ag56454
aS'AUTHORS'
p56455
aS'Daye D, Wellen KE'
p56456
aS'TITLE'
p56457
aS'Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.'
p56458
aS'JOURNAL'
p56459
aS'Semin Cell Dev Biol 23:362-9 (2012)'
p56460
aS'PMID:23018234'
p56461
ag56461
aS'AUTHORS'
p56462
aS'Chiarugi A, Dolle C, Felici R, Ziegler M'
p56463
aS'TITLE'
p56464
aS'The NAD metabolome--a key determinant of cancer cell biology.'
p56465
aS'JOURNAL'
p56466
aS'Nat Rev Cancer 12:741-52 (2012)'
p56467
aS'PMID:24398961'
p56468
ag56468
aS'AUTHORS'
p56469
aS'Guarente L'
p56470
aS'TITLE'
p56471
aS'The many faces of sirtuins: Sirtuins and the Warburg effect.'
p56472
aS'JOURNAL'
p56473
aS'Nat Med 20:24-5 (2014)'
p56474
aS'PMID:15916903'
p56475
ag56475
aS'AUTHORS'
p56476
aS'Fuchs BC, Bode BP'
p56477
aS'TITLE'
p56478
aS'Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?'
p56479
aS'JOURNAL'
p56480
aS'Semin Cancer Biol 15:254-66 (2005)'
p56481
asS'KO_PATHWAY'
p56482
(lp56483
S'ko05230'
p56484
asS'ENTRY'
p56485
(lp56486
S'map05230'
p56487
aS'Pathway'
p56488
asS'PATHWAY_MAP'
p56489
(lp56490
S'map05230'
p56491
asS'CLASS'
p56492
(lp56493
S'Human Diseases Cancers'
p56494
asS'DESCRIPTION'
p56495
(lp56496
S"Malignant transformation of cells requires specific adaptations of cellular metabolism to support growth and survival. In the early twentieth century, Otto Warburg established that there are fundamental differences in the central metabolic pathways operating in malignant tissue. He showed that cancer cells consume a large amount of glucose, maintain high rate of glycolysis and convert a majority of glucose into lactic acid even under normal oxygen concentrations (Warburg's Effects). More recently, it has been recognized that the 'Warburg effect' encompasses a similarly increased utilization of glutamine. From the intermediate molecules provided by enhanced glycolysis and glutaminolysis, cancer cells synthesize most of the macromolecules required for the duplication of their biomass and genome. These cancer-specific alterations represent a major consequence of genetic mutations and the ensuing changes of signalling pathways in cancer cells. Three transcription factors, c-MYC, HIF-1 and p53, are key regulators and coordinate regulation of cancer metabolism in different ways, and many other oncogenes and tumor suppressor genes cluster along the signaling pathways that regulate c-MYC, HIF-1 and p53."
p56497
assS'path:map05231'
p56498
(dp56499
S'NAME'
p56500
(lp56501
S'Choline metabolism in cancer'
p56502
asS'REFERENCE'
p56503
(lp56504
S'PMID:22089420'
p56505
ag56505
aS'AUTHORS'
p56506
aS'Glunde K, Bhujwalla ZM, Ronen SM'
p56507
aS'TITLE'
p56508
aS'Choline metabolism in malignant transformation.'
p56509
aS'JOURNAL'
p56510
aS'Nat Rev Cancer 11:835-48 (2011)'
p56511
aS'PMID:19935796'
p56512
ag56512
aS'AUTHORS'
p56513
aS'Beloueche-Babari M, Chung YL, Al-Saffar NM, Falck-Miniotis M, Leach MO'
p56514
aS'TITLE'
p56515
aS'Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy.'
p56516
aS'JOURNAL'
p56517
aS'Br J Cancer 102:1-7 (2010)'
p56518
aS'PMID:22429397'
p56519
ag56519
aS'AUTHORS'
p56520
aS'Abalsamo L, Spadaro F, Bozzuto G, Paris L, Cecchetti S, Lugini L, Iorio E, Molinari A, Ramoni C, Podo F'
p56521
aS'TITLE'
p56522
aS'Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.'
p56523
aS'JOURNAL'
p56524
aS'Breast Cancer Res 14:R50 (2012)'
p56525
aS'PMID:19264150'
p56526
ag56526
aS'AUTHORS'
p56527
aS'Foster DA'
p56528
aS'TITLE'
p56529
aS'Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.'
p56530
aS'JOURNAL'
p56531
aS'Biochim Biophys Acta 1791:949-55 (2009)'
p56532
aS'PMID:16432178'
p56533
ag56533
aS'AUTHORS'
p56534
aS'Beloueche-Babari M, Jackson LE, Al-Saffar NM, Eccles SA, Raynaud FI, Workman P, Leach MO, Ronen SM'
p56535
aS'TITLE'
p56536
aS'Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells.'
p56537
aS'JOURNAL'
p56538
aS'Mol Cancer Ther 5:187-96 (2006)'
p56539
aS'PMID:23350810'
p56540
ag56540
aS'AUTHORS'
p56541
aS'Ridgway ND'
p56542
aS'TITLE'
p56543
aS'The role of phosphatidylcholine and choline metabolites to cell proliferation and survival.'
p56544
aS'JOURNAL'
p56545
aS'Crit Rev Biochem Mol Biol 48:20-38 (2013)'
p56546
aS'PMID:22921309'
p56547
ag56547
aS'AUTHORS'
p56548
aS'Awwad HM, Geisel J, Obeid R'
p56549
aS'TITLE'
p56550
aS'The role of choline in prostate cancer.'
p56551
aS'JOURNAL'
p56552
aS'Clin Biochem 45:1548-53 (2012)'
p56553
aS'PMID:16230400'
p56554
ag56554
aS'AUTHORS'
p56555
aS"Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D'Ascenzo S, Millimaggi D, Pavan A, Dolo V, Canevari S, Podo F"
p56556
aS'TITLE'
p56557
aS'Alterations of choline phospholipid metabolism in ovarian tumor progression.'
p56558
aS'JOURNAL'
p56559
aS'Cancer Res 65:9369-76 (2005)'
p56560
aS'PMID:14523987'
p56561
ag56561
aS'AUTHORS'
p56562
aS'Ackerstaff E, Glunde K, Bhujwalla ZM'
p56563
aS'TITLE'
p56564
aS'Choline phospholipid metabolism: a target in cancer cells?'
p56565
aS'JOURNAL'
p56566
aS'J Cell Biochem 90:525-33 (2003)'
p56567
aS'PMID:23076158'
p56568
ag56568
aS'AUTHORS'
p56569
aS'Park JB, Lee CS, Jang JH, Ghim J, Kim YJ, You S, Hwang D, Suh PG, Ryu SH'
p56570
aS'TITLE'
p56571
aS'Phospholipase signalling networks in cancer.'
p56572
aS'JOURNAL'
p56573
aS'Nat Rev Cancer 12:782-92 (2012)'
p56574
aS'PMID:19855431'
p56575
ag56575
aS'AUTHORS'
p56576
aS'Yalcin A, Clem B, Makoni S, Clem A, Nelson K, Thornburg J, Siow D, Lane AN, Brock SE, Goswami U, Eaton JW, Telang S, Chesney J'
p56577
aS'TITLE'
p56578
aS'Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.'
p56579
aS'JOURNAL'
p56580
aS'Oncogene 29:139-49 (2010)'
p56581
aS'PMID:21793073'
p56582
ag56582
aS'AUTHORS'
p56583
aS'Glunde K, Jiang L, Moestue SA, Gribbestad IS'
p56584
aS'TITLE'
p56585
aS'MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline'
p56586
aS'and glucose metabolism in cancer.'
p56587
aS'JOURNAL'
p56588
aS'NMR Biomed 24:673-90 (2011)'
p56589
aS'PMID:19136975'
p56590
ag56590
aS'AUTHORS'
p56591
aS'Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, Armstrong MD, Arteaga CL, Lindsley CW, Brown HA'
p56592
aS'TITLE'
p56593
aS'Design of isoform-selective phospholipase D inhibitors that modulate cancer cell'
p56594
aS'invasiveness.'
p56595
aS'JOURNAL'
p56596
aS'Nat Chem Biol 5:108-17 (2009)'
p56597
aS'PMID:14517341'
p56598
ag56598
aS'AUTHORS'
p56599
aS'Foster DA, Xu L'
p56600
aS'TITLE'
p56601
aS'Phospholipase D in cell proliferation and cancer.'
p56602
aS'JOURNAL'
p56603
aS'Mol Cancer Res 1:789-800 (2003)'
p56604
aS'PMID:20528734'
p56605
ag56605
aS'AUTHORS'
p56606
aS'Zhou H, Huang S'
p56607
aS'TITLE'
p56608
aS'mTOR signaling in cancer cell motility and tumor metastasis.'
p56609
aS'JOURNAL'
p56610
aS'Crit Rev Eukaryot Gene Expr 20:1-16 (2010)'
p56611
asS'KO_PATHWAY'
p56612
(lp56613
S'ko05231'
p56614
asS'ENTRY'
p56615
(lp56616
S'map05231'
p56617
aS'Pathway'
p56618
asS'PATHWAY_MAP'
p56619
(lp56620
S'map05231'
p56621
asS'CLASS'
p56622
(lp56623
S'Human Diseases Cancers'
p56624
asS'DESCRIPTION'
p56625
(lp56626
S'Abnormal choline metabolism is emerging as a metabolic hallmark that is associated with oncogenesis and tumour progression. Following transformation, oncogenic signalling via pathways such as the RAS and PI3K-AKT pathways, and transcription factors associated with oncogenesis such as hypoxia-inducible factor 1 (HIF1) mediate overexpression and activation of choline cycle enzymes, which causes increased levels of choline-containing precursors and breakdown products of membrane phospholipids. These products of choline phospholipid metabolism, such as phosphocholine (PCho), diacylglycerol (DAG) and phosphatidic acid, may function as second messengers that are essential for the mitogenic activity of growth factors, particularly in the activation of the ras-raf-1-MAPK cascade and protein kinase C pathway.'
p56627
assS'path:map04320'
p56628
(dp56629
S'ENTRY'
p56630
(lp56631
S'map04320'
p56632
aS'Pathway'
p56633
asS'PATHWAY_MAP'
p56634
(lp56635
S'map04320'
p56636
asS'CLASS'
p56637
(lp56638
S'Organismal Systems Development'
p56639
asS'NAME'
p56640
(lp56641
S'Dorso-ventral axis formation'
p56642
asS'KO_PATHWAY'
p56643
(lp56644
S'ko04320'
p56645
assS'path:map00073'
p56646
(dp56647
S'NAME'
p56648
(lp56649
S'Cutin, suberine and wax biosynthesis'
p56650
asS'REFERENCE'
p56651
(lp56652
S'PMID:18621978'
p56653
ag56653
aS'AUTHORS'
p56654
aS'Li F, Wu X, Lam P, Bird D, Zheng H, Samuels L, Jetter R, Kunst L'
p56655
aS'TITLE'
p56656
aS'Identification of the wax ester synthase/acyl-coenzyme A: diacylglycerol acyltransferase WSD1 required for stem wax ester biosynthesis in Arabidopsis.'
p56657
aS'JOURNAL'
p56658
aS'Plant Physiol 148:97-107 (2008)'
p56659
aS'PMID:16866954'
p56660
ag56660
aS'AUTHORS'
p56661
aS'Shepherd T, Wynne Griffiths D'
p56662
aS'TITLE'
p56663
aS'The effects of stress on plant cuticular waxes.'
p56664
aS'JOURNAL'
p56665
aS'New Phytol 171:469-99 (2006)'
p56666
aS'PMID:19649180'
p56667
ag56667
aS'AUTHORS'
p56668
aS'Raffaele S, Leger A, Roby D'
p56669
aS'TITLE'
p56670
aS'Very long chain fatty acid and lipid signaling in the response of plants to pathogens.'
p56671
aS'JOURNAL'
p56672
aS'Plant Signal Behav 4:94-9 (2009)'
p56673
aS'PMID:16404574'
p56674
ag56674
aS'AUTHORS'
p56675
aS'Kurdyukov S, Faust A, Trenkamp S, Bar S, Franke R, Efremova N, Tietjen K, Schreiber L, Saedler H, Yephremov A'
p56676
aS'TITLE'
p56677
aS'Genetic and biochemical evidence for involvement of HOTHEAD in the biosynthesis of long-chain alpha-,omega-dicarboxylic fatty acids and formation of extracellular matrix.'
p56678
aS'JOURNAL'
p56679
aS'Planta 224:315-29 (2006)'
p56680
aS'PMID:17323080'
p56681
ag56681
aS'AUTHORS'
p56682
aS'King A, Nam JW, Han J, Hilliard J, Jaworski JG'
p56683
aS'TITLE'
p56684
aS'Cuticular wax biosynthesis in petunia petals: cloning and characterization of an'
p56685
aS'alcohol-acyltransferase that synthesizes wax-esters.'
p56686
aS'JOURNAL'
p56687
aS'Planta 226:381-94 (2007)'
p56688
aS'PMID:18440267'
p56689
ag56689
aS'AUTHORS'
p56690
aS'Pollard M, Beisson F, Li Y, Ohlrogge JB'
p56691
aS'TITLE'
p56692
aS'Building lipid barriers: biosynthesis of cutin and suberin.'
p56693
aS'JOURNAL'
p56694
aS'Trends Plant Sci 13:236-46 (2008)'
p56695
aS'PMID:19344744'
p56696
ag56696
aS'AUTHORS'
p56697
aS'Li Y, Beisson F'
p56698
aS'TITLE'
p56699
aS'The biosynthesis of cutin and suberin as an alternative source of enzymes for the production of bio-based chemicals and materials.'
p56700
aS'JOURNAL'
p56701
aS'Biochimie 91:685-91 (2009)'
p56702
asS'KO_PATHWAY'
p56703
(lp56704
S'ko00073'
p56705
asS'PATHWAY_MAP'
p56706
(lp56707
S'map00073'
p56708
asS'DISEASE'
p56709
(lp56710
S'H00184'
p56711
aS'Hypermethioninemia'
p56712
asS'DBLINKS'
p56713
(lp56714
S'GO: 0010143 0010345 0010025'
p56715
asS'ENTRY'
p56716
(lp56717
S'map00073'
p56718
aS'Pathway'
p56719
asS'CLASS'
p56720
(lp56721
S'Metabolism Lipid metabolism'
p56722
assS'path:map00072'
p56723
(dp56724
S'NAME'
p56725
(lp56726
S'Synthesis and degradation of ketone bodies'
p56727
asS'KO_PATHWAY'
p56728
(lp56729
S'ko00072'
p56730
asS'ENTRY'
p56731
(lp56732
S'map00072'
p56733
aS'Pathway'
p56734
asS'PATHWAY_MAP'
p56735
(lp56736
S'map00072'
p56737
asS'DISEASE'
p56738
(lp56739
S'H01076'
p56740
aS'Alpha-methylacetoacetic aciduria'
p56741
ag56740
ag56741
aS'H01121'
p56742
aS'Succinyl CoA:3-oxoacid CoA transferase (SCOT) deficiency'
p56743
aS'H01123'
p56744
aS'HMG-CoA synthase (HMGCS) deficiency'
p56745
asS'MODULE'
p56746
(lp56747
S'M00088'
p56748
aS'Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone [PATH:map00072]'
p56749
asS'CLASS'
p56750
(lp56751
S'Metabolism Lipid metabolism'
p56752
assS'path:map00071'
p56753
(dp56754
S'NAME'
p56755
(lp56756
S'Fatty acid degradation'
p56757
asS'REFERENCE'
p56758
(lp56759
S'PMID:869535'
p56760
ag56760
aS'AUTHORS'
p56761
aS'Parekh VR, Traxler RW, Sobek JM'
p56762
aS'TITLE'
p56763
aS'N-Alkane oxidation enzymes of a pseudomonad.'
p56764
aS'JOURNAL'
p56765
aS'Appl Environ Microbiol 33:881-4 (1977)'
p56766
asS'KO_PATHWAY'
p56767
(lp56768
S'ko00071'
p56769
asS'PATHWAY_MAP'
p56770
(lp56771
S'map00071'
p56772
asS'DISEASE'
p56773
(lp56774
S'H00162'
p56775
aS'Sjogren-Larsson syndrome'
p56776
ag56775
ag56776
aS'H00178'
p56777
aS'Glutaric acidemia'
p56778
aS'H00407'
p56779
aS'Peroxisomal beta-oxidation enzyme deficiency'
p56780
aS'H00525'
p56781
aS'Disorders of fatty-acid oxidation'
p56782
aS'H01267'
p56783
aS'Familial hyperinsulinemic hypoglycemia (HHF)'
p56784
aS'H01352'
p56785
aS'Mitochondrial trifunctional protein (TFP) deficiency'
p56786
aS'H01364'
p56787
aS'3-Hydroxyacyl-CoA dehydrogenase deficiency'
p56788
aS'H01400'
p56789
aS'Secondary hyperammonemia'
p56790
asS'MODULE'
p56791
(lp56792
S'M00086'
p56793
aS'beta-Oxidation, acyl-CoA synthesis [PATH:map00071]'
p56794
ag56793
ag56794
aS'M00087'
p56795
aS'beta-Oxidation [PATH:map00071]'
p56796
asS'ENTRY'
p56797
(lp56798
S'map00071'
p56799
aS'Pathway'
p56800
asS'CLASS'
p56801
(lp56802
S'Metabolism Lipid metabolism'
p56803
assS'path:map05310'
p56804
(dp56805
S'NAME'
p56806
(lp56807
S'Asthma'
p56808
asS'REFERENCE'
p56809
(lp56810
S'PMID:11172168'
p56811
ag56811
aS'AUTHORS'
p56812
aS'Busse WW, Lemanske RF Jr.'
p56813
aS'TITLE'
p56814
aS'Asthma.'
p56815
aS'JOURNAL'
p56816
aS'N Engl J Med 344:350-62 (2001)'
p56817
aS'PMID:11477111'
p56818
ag56818
aS'AUTHORS'
p56819
aS'Renauld JC.'
p56820
aS'TITLE'
p56821
aS'New insights into the role of cytokines in asthma.'
p56822
aS'JOURNAL'
p56823
aS'J Clin Pathol 54:577-89 (2001)'
p56824
aS'PMID:10719286'
p56825
ag56825
aS'AUTHORS'
p56826
aS'Romagnani S.'
p56827
aS'TITLE'
p56828
aS'The role of lymphocytes in allergic disease.'
p56829
aS'JOURNAL'
p56830
aS'J Allergy Clin Immunol 105:399-408 (2000)'
p56831
aS'PMID:17976144'
p56832
ag56832
aS'AUTHORS'
p56833
aS'Averbeck M, Gebhardt C, Emmrich F, Treudler R, Simon JC.'
p56834
aS'TITLE'
p56835
aS'Immunologic principles of allergic disease.'
p56836
aS'JOURNAL'
p56837
aS'J Dtsch Dermatol Ges 5:1015-28 (2007)'
p56838
aS'PMID:11686879'
p56839
ag56839
aS'AUTHORS'
p56840
aS'Conroy DM, Williams TJ.'
p56841
aS'TITLE'
p56842
aS'Eotaxin and the attraction of eosinophils to the asthmatic lung.'
p56843
aS'JOURNAL'
p56844
aS'Respir Res 2:150-6 (2001)'
p56845
aS'PMID:17133123'
p56846
ag56846
aS'AUTHORS'
p56847
aS'Effros RM, Nagaraj H.'
p56848
aS'TITLE'
p56849
aS'Asthma: new developments concerning immune mechanisms, diagnosis and treatment.'
p56850
aS'JOURNAL'
p56851
aS'Curr Opin Pulm Med 13:37-43 (2007)'
p56852
aS'PMID:18274560'
p56853
ag56853
aS'AUTHORS'
p56854
aS'Barnes PJ.'
p56855
aS'TITLE'
p56856
aS'Immunology of asthma and chronic obstructive pulmonary disease.'
p56857
aS'JOURNAL'
p56858
aS'Nat Rev Immunol 8:183-92 (2008)'
p56859
aS'PMID:18274559'
p56860
ag56860
aS'AUTHORS'
p56861
aS'Holgate ST, Polosa R.'
p56862
aS'TITLE'
p56863
aS'Treatment strategies for allergy and asthma.'
p56864
aS'JOURNAL'
p56865
aS'Nat Rev Immunol 8:218-30 (2008)'
p56866
aS'PMID:12093011'
p56867
ag56867
aS'AUTHORS'
p56868
aS'Valenta R.'
p56869
aS'TITLE'
p56870
aS'The future of antigen-specific immunotherapy of allergy.'
p56871
aS'JOURNAL'
p56872
aS'Nat Rev Immunol 2:446-53 (2002)'
p56873
aS'PMID:17364144'
p56874
ag56874
aS'AUTHORS'
p56875
aS'Trivedi SG, Lloyd CM.'
p56876
aS'TITLE'
p56877
aS'Eosinophils in the pathogenesis of allergic airways disease.'
p56878
aS'JOURNAL'
p56879
aS'Cell Mol Life Sci 64:1269-89 (2007)'
p56880
aS'PMID:10811837'
p56881
ag56881
aS'AUTHORS'
p56882
aS'Heinecke JW.'
p56883
aS'TITLE'
p56884
aS'Eosinophil-dependent bromination in the pathogenesis of asthma.'
p56885
aS'JOURNAL'
p56886
aS'J Clin Invest 105:1331-2 (2000)'
p56887
asS'KO_PATHWAY'
p56888
(lp56889
S'ko05310'
p56890
asS'PATHWAY_MAP'
p56891
(lp56892
S'map05310'
p56893
asS'DISEASE'
p56894
(lp56895
S'H00079'
p56896
aS'Asthma'
p56897
ag56896
ag56897
aS'H01094'
p56898
aS'Eosinophil peroxidase deficiency'
p56899
asS'ENTRY'
p56900
(lp56901
S'map05310'
p56902
aS'Pathway'
p56903
asS'CLASS'
p56904
(lp56905
S'Human Diseases Immune diseases'
p56906
asS'DESCRIPTION'
p56907
(lp56908
S'Asthma is a complex syndrome with many clinical phenotypes in both adults and children. Its major characteristics include a variable degree of airflow obstruction, bronchial hyperresponsiveness, and airway inflammation. Inhaled allergens encounter antigen presenting cells (APC) that line the airway. Upon recognition of the antigen and activation by APC, naive T cells differentiate into TH2 cells. Activated TH2 stimulate the formation of IgE by B cells. IgE molecules bind to IgE receptors located on mast cells. The crosslinking of mast-cell-bound IgE by allergens leads to the release of biologically active mediators (histamine, leukotrienes) by means of degranulation and, so, to the immediate symptoms of allergy. Mast cells also release chemotactic factors that contribute to the recruitment of inflammatory cells, particularly eosinophils, whose proliferation and differentiation from bone marrow progenitors is promoted by IL-5. The activation of eosinophils leads to release of toxic granules and oxygen free radicals that lead to tissue damage and promote the development of chronic inflammation.'
p56909
ass.